<SEC-DOCUMENT>0000927653-23-000038.txt : 20230509
<SEC-HEADER>0000927653-23-000038.hdr.sgml : 20230509
<ACCEPTANCE-DATETIME>20230508174640
ACCESSION NUMBER:		0000927653-23-000038
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		141
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230509
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		23899183

	BUSINESS ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
		BUSINESS PHONE:		972-446-4800

	MAIL ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>mck-20230331.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:1eea9b32-7227-4c4c-b033-5c353ea41e5b,g:3de8d065-e076-4ee0-8f0c-2df01cc3ca1e,d:04335d018da94076b0acf21e81ac886b--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:mck="http://mckesson123.com/20230331" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mck-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl80L2ZyYWc6OTk5ZDg4MzYzZTUyNDA1ZTkzNjVjZGIzZTM2MmU0YzIvdGFibGU6OTE1OGUzNGE1NGI5NDBhY2EwOTFiOGVkNzQwYjM0NDcvdGFibGVyYW5nZTo5MTU4ZTM0YTU0Yjk0MGFjYTA5MWI4ZWQ3NDBiMzQ0N18zLTItMS0xLTIxODc0OA_7db1adf8-2aa9-4428-b564-47369d992357">0000927653</ix:nonNumeric><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl80L2ZyYWc6OTk5ZDg4MzYzZTUyNDA1ZTkzNjVjZGIzZTM2MmU0YzIvdGFibGU6OTE1OGUzNGE1NGI5NDBhY2EwOTFiOGVkNzQwYjM0NDcvdGFibGVyYW5nZTo5MTU4ZTM0YTU0Yjk0MGFjYTA5MWI4ZWQ3NDBiMzQ0N181LTItMS0xLTIxODc0OA_eb5d471d-be84-4676-aff0-33b29276d929">FY</ix:nonNumeric><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl80L2ZyYWc6OTk5ZDg4MzYzZTUyNDA1ZTkzNjVjZGIzZTM2MmU0YzIvdGFibGU6OTE1OGUzNGE1NGI5NDBhY2EwOTFiOGVkNzQwYjM0NDcvdGFibGVyYW5nZTo5MTU4ZTM0YTU0Yjk0MGFjYTA5MWI4ZWQ3NDBiMzQ0N182LTItMS0xLTIxODc0OA_7d855d96-cb8e-4386-bef6-f3a0747e0ae0">2023</ix:nonNumeric><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl80L2ZyYWc6OTk5ZDg4MzYzZTUyNDA1ZTkzNjVjZGIzZTM2MmU0YzIvdGFibGU6OTE1OGUzNGE1NGI5NDBhY2EwOTFiOGVkNzQwYjM0NDcvdGFibGVyYW5nZTo5MTU4ZTM0YTU0Yjk0MGFjYTA5MWI4ZWQ3NDBiMzQ0N183LTItMS0xLTIxODc0OA_ba0ca071-01f5-4a21-977b-b4a2787b1a04">false</ix:nonNumeric><ix:nonNumeric contextRef="i2a4af360e7154c9e8ccdf22798b63fbb_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzc5_434691cb-3c7b-46f0-b8e5-b9ad93bbc229">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="id5e672e286474d2e9f8e1f5fe1e234e0_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0MzI0_4fd24846-796a-4644-bf59-7de3fb2a6e2d">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i78c87aed7caa4ad198dca1602c85ed23_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0NDA0_da16eb7b-c863-47a8-b5b6-560d55f8d8c1">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i7385cd355dd4468ba773e9d23bf40348_D20220401-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE4NzYz_104a5783-416c-41d1-9774-e5859d78ef41">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i4a39186a14424d8bafc2b9cf028fffd8_D20220401-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzIxMDA_29caba71-3a79-4459-a81e-59ee51b81951">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2cb43d7d-4dbe-40be-891b-5b154c0f7e7e">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2e8bafc9-a699-4ad1-a382-140d4fabd947">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_481d8594-6d0e-48c4-a516-41181b6ee1a8">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_b132aa89-d101-44a4-8856-5a1aefc7a3ca">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_9a3e0520-2b32-4c2a-8b14-f87e23310cf5">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_fbb0bd27-adff-497f-b17f-ffe770574fee">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="i925b096ac7224e21909543318e72b500_I20230331" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM2MjQ_b3387c7e-31d8-45e1-b5f8-dc61fc04b015">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i04f759a37fee446ab4c24b7a4aa7fd2c_D20220401-20230331" name="mck:GuarantorObligationsPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzYyMA_f70be4f2-8308-4872-ada2-b3f0a675b674">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ibb01f985e84846568b14aa2b0bf489e5_D20220401-20230331" name="mck:GuarantorObligationsPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzY3OA_6036989f-413d-4a9a-9e98-c93fb0ca4aa4">P1Y</ix:nonNumeric><ix:nonFraction unitRef="state" contextRef="i057d846c99e24512ad9cb275e0ad3de8_I20200302" decimals="INF" name="mck:LossContingencyNumberOfStatesFiledOnBehalfOf" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNjU4L2ZyYWc6MTM4N2FlNGFkNmEwNDFjZjg4YTk3MTFlNDlmMDMwMmQvdGFibGU6NTg3OTcxYjNkZjc3NDI3ODllZDU1YjMzYTc4ZDJiYzgvdGFibGVyYW5nZTo1ODc5NzFiM2RmNzc0Mjc4OWVkNTViMzNhNzhkMmJjOF8wLTEtMS0xLTI2NDkzMw_e2c0a557-44e4-419c-adcd-c9a6adfec990">33</ix:nonFraction><ix:nonFraction unitRef="state" contextRef="i2f35dd91b0344cb6ba1c6fc2ce024afc_I20180425" decimals="INF" name="mck:LossContingencyNumberOfStatesFiledOnBehalfOf" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNjU4L2ZyYWc6MTM4N2FlNGFkNmEwNDFjZjg4YTk3MTFlNDlmMDMwMmQvdGFibGU6NTg3OTcxYjNkZjc3NDI3ODllZDU1YjMzYTc4ZDJiYzgvdGFibGVyYW5nZTo1ODc5NzFiM2RmNzc0Mjc4OWVkNTViMzNhNzhkMmJjOF8wLTEtMS0xLTI2NDkzMw_f561e2f4-a11d-4e05-8b0b-50ee3b97bd51">33</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mck-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a1cd3cc23a14e3c8567f6f5021d4d29_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4d9c8c16b9c41c79238cd17c37cf884_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.500NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35936bfe99754ea0b2d8151940f323d5_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.625NotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0407835b367a4e4ea273bf9f6036ebaa_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3.125NotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i399f6860da294568aba7949399d70dcc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i1da02b0e502e472ba1f749732b72467c_I20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2ff10e823cba4f38b2c4399434a229ba_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24ea2536cc79402c87a81416ae3171dd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bc582f275f5403289fded6bcb155630_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6a1485449e34a8ea1bffd8f744aa580_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a1422fa33ff4ef8be96240fe701c4a8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c7ce235f09242b1a7dd13dd1873da14_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b4ad18ecc1b43159d4657ee792f26c1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14f8bb56f1e4471588d3ee861bf56425_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia09f86adf45346869fdfd6e2c5e84729_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28949ffb8bb2424c94e02d81ae0b5d27_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56ca92db1bf347039646a68953e87fed_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37de8b6ee05745e3861fbe7542070721_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60a6fff3dabd4c79b50c2bf8f6f2c365_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbe6a88a06904b1cab91937548e19519_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ab59611846a49f2b03ee48497e3100f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16ef48415e2d41019530a2f69364659e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib06de7ab957b4a4d88a689f7f6a590e7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fda731c4c8243d8b5bf494fa64e80af_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4b8982f387147d193c2d960f77258b8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef2c063f0184f93894500720ce4015e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8551607689bb4731bc5de364f262218e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f30127a64d74d9e8d4865e42e4cbf4c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if49d7008347c45e9a5c3670667639536_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6de2dc307ac14073bdb93ae09a60b176_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c3e18a28c2e4303a930bfe449b415f1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd2b75e00f334c31915664ac94e7674e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73dc7887d5ec4c559ba7ed149b2a2e5c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47e91f2d45c04afe94f7d67b691dde7e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6e648d6891241edbef964d4d9ee910a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05b7ccb4f8144bea8f3d6c3af844c49d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i183ca81b5799440d9119d0fe988e65c3_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4def4e91aef84e1483b875342987eb63_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45aab0fb88544a5484bbea268be3db79_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i243683b0717241af93096502d0de6cfd_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i018191f728124dca8ee428ea5cf8cef8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ddf4f8a62464df1938e09cf326c73ea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i229bafbff863466083e1c27c4d7dfc34_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff055f45df5945548e9f06839bf74bac_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea824d5b394948b6bd119948e0fe3df9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i967edbc39aee4ecb80a07170518c493d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ace641432ca4f1aab983fa4bd125d85_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06314da3128a4c098170cd700e3e914e_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52d6cbef9c014a779d83f8e789f001b6_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i284da6d569754ff58e9c0e3c01fd1f5a_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8a72099ceda422ba14d79222a77f39e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ebb46144e314022b145d5a691b3751b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f0fe405ebb24cc3b0ba09f049f2c10b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389a9bd705fb43da948f7f435028f032_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf262331a9f54dcaa1ab7d2f24876767_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>mck:segment</xbrli:measure></xbrli:unit><xbrli:context id="i1dcb8f3258544de983570a2447cfa80a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7264b2fb579741cdab359e1aba22aede_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:TenLargestCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ic04e9e22dc634dfca9e2377700f0d82f_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:TenLargestCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i932aecaa6796433d9fa0f50f4ddd4f32_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfb139caacd149a5b3fdff785111e258_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3969df882b2a4177a8ac36cb92b0b6c7_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i515e802e55bc4ca1b11dd1a584ef8dde_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i223505a11e384113a49c9b97f61ec445_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc4a0c9d2b824683901b0907b93e42dd_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i655245d8cb514931a14931cc038eb490_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a4af360e7154c9e8ccdf22798b63fbb_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie30f2480525c49ada9cabfe8e2d20354_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5e672e286474d2e9f8e1f5fe1e234e0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aaff57b7c384456ab86bd2b5fccb87a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78c87aed7caa4ad198dca1602c85ed23_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia26faef7d39742839185203bac54e495_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic711bd1052674b80ad0f571918f35552_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:RealPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7385cd355dd4468ba773e9d23bf40348_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a7c37dc0f5d4bfb9f78bc365e926644_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie56d43006f754d499f7e19cd5720562c_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22171c2b91104f3f9aae6c7df97e030e_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i915d437ab7bb4f499b0ca40841b44528_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib344714960c14cd0aaa14d648eb58138_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63f0fcb2e0aa4013b42d29b5ade1e28b_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if322074120a140808e8c82b1bed2d7ec_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9641805d39b54755bb865f24f51f1b5d_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4dd209b573244c7881d99fe517c75d8_D20221101-20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59947628e39647249591b0cbaa3bf334_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if401780d59f34141aabbaf7ca4d032ab_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf8aef407b7f488e85c6b12526cca4c8_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:SCRIOncologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:SCRIOncologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-31</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9259fb307c6141ab8b52ca6d3a1907c8_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:SarahCannonResearchInstituteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:SCRIOncologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i625dd0b0aa6e4e8d97d061d0a70a7e97_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:McKessonUSOncologyResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:SCRIOncologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7746d7d6c7f74bd5a522363e31a8b366_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i260e787e79514142b7c391cce58ca8d4_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54bfea324a094e7f996dd8a56ee105f4_D20221031-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-31</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i522ab9fff9ee4ecb8c2fbd1f12f1d934_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b9815e733a0475592cd7fada3bced42_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc7a65af5b26474e8427ff7f8bd6ce64_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i382c204f13554d4e8ece4058bc5b69c6_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternallyDevelopedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib62a5923230c46c49e36098ccca7369e_I20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="i4c4a29b7f1134f299939b7067a5bbc68_I20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia42344bf1adb4cdeb5624c43ce11a349_D20220406-20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-06</xbrli:startDate><xbrli:endDate>2022-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie11de948c9444efb94e5917cae16710f_D20220406-20220406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-06</xbrli:startDate><xbrli:endDate>2022-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58454d4bece0446ab49687291c0c1cd5_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c359290f5374ebcb781e2a05480221e_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i85ba3e843a814a899aaf3a87e8422f9d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10dc0fc369ee4d088df51fef92fe40e1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4656299b20c436497390a7e79147f34_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7351ec7b72b6422a82ab0afffdd65c27_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd040622e9b1489ba2addf0494df3a62_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2646e19a2c8440d08bc15a4216ccadaf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if02745e482324982aa1ae5309d602ded_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2e3b761b77d4b7cbc297831b399408a_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c75333b88e542c4ba71e94b1d28056e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfc71eef9d254de48d739e651f3d7561_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a6fc260a6de4b629a6b4970e20fe6aa_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a4a0202812f4880a82a0487047cc47f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa888a5ec0d944f1a58684506e131405_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia88c62cc31154e05941895097f4eb653_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f3eb833b0314352811520832d05703c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica9a08587ca04030b0e7cc35fa7d526b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i663d657bf1e24bbcb2dbc5356bd8a9d7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0450b305293d4d12a476155c59674aac_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf0b80c33ebe40fbb027ad323e881fa7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i842e5c3e1d294131aa2e71ec30e3c3e1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i948e2e219f854ac082a3c472c583fe7d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie936d943185b4ffbb312cec2d0a11ea1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56dc2bee6bfd4893aaf3550953e9f904_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3977781f98d2482e9204ee3df23b62ef_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca2257eaa5a4089b39072f8a37a459e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i493ee32637374fef85bb13b3cde7de11_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbec207732c741a7b5cd533ccd6d7102_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab47b293b1e6457e9220acf589c14011_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d3e584c30524ea7abc9a6d31589fd8b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd5164d3ebc94282adf69fe3daa1dd18_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e022c6735f44aafbc94894561402456_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3947bd9bcc904e12bbce546550846178_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8be50c56aed545d6a05664ecf4cd0520_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9271e52fbc4b4051bc42f5edf6a60c46_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i196be4042ab946ffab53968cba582319_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if642126ed2f24282b10b29e0c453e35e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1ad9e5e8f13437e83ec2ed5b6ca20ee_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f6f943ac64c470b961d73cf2c5fbcf3_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic06aa85305f44c8fbb86fb2d2319293a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9556991f875d4713b5b62bb435eaf7d2_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9cc1088918d4bdf9fec9c448e29978f_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4e58f11e8ff4837b70351c42fecfe2a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83d13ad17dcb49b4899c2f0e3cc432d9_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife447a3b57f0484f98349ca82b7c8778_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15f030c588ac48cfbb2352300d303adb_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e22ae69db0e4c909043949b0bf363e3_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f18df5cf4f04ff894901fbf46e6dba6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2022StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa24a0cfb242478997ad1819397e47c8_I20130731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a10efc6895245d08afc780fe46cc0c0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a39186a14424d8bafc2b9cf028fffd8_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia330d79374df4f04b29816d2c53ad7e3_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19acbfe54421472fb6c6c57213d527bf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89b0a5df63447d995cd0a4593059729_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:PerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i194bfd7f58694118b6608f52ec99adf8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i022f37e081eb4c90b78d43940f46aff4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i289228fb848b4f3baeb89b15df8f45fa_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1369c60e05b34b468652499b286a05d6_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0c1b4f588c94865ab50e59ee67700cb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd1fd6d108f04354be5ba6979cfef798_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i280391a88a5f4cfc9ae3305390b982af_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d695f8e4fe74cf68dd4c19a1015fbad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5042c611135944438746cce257499d4f_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibee85f1796ce4da18771743ac93a0bf7_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79fd2475cde549da9b49f44a3b1d5fa7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf485190a9674be1a5f6e8cc04f2de3a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9363c5254cf4b7b9d31529bc982ca01_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d4a1d2617604c3abf9cdc6b550d8e12_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupAndAustrianBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeefc9d1d76042fbbba383f76527d7a5_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id73f9b34f34c41d6ad73b7db3ed24dfd_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2c162cb2b9c417883dd91ccec907c32_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf6fd4d81f1f416290d250974ba098e2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d415447fbd94360ba64460c62a0a537_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a85db8cbb4b46c1b80086fe84b2ad90_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3af290b74f9b45468794a2c3907f33d0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i925b096ac7224e21909543318e72b500_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied7b454e7843455ab8ab7494918c2873_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0d9f68e5c994bf59aeea678b50b65af_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i85eec0525fe24f99b37fe1b51e6c5a23_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3133b1be91fc45ce9e09a9108d5d72ff_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id814aee4543a4f3b8149ab5107886aa3_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i629eed48f7a6425b99da3d0911202452_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64073e3798b24140a877b78902322039_D20180919-20180919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-19</xbrli:startDate><xbrli:endDate>2018-09-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f2d9133245747b1a400a98a3daea68f_I20180919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42752d505455466fbf8fbf4f49c40afc_I20210412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dc0714e08b14ba2814d733ed7fd0102_I20210412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i702ec37556b84e119a5f3bb8522ed174_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbd55a5a04e24729999d4fa3eb8ae352_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if79bf94dc2504cb2a88b82abdd979b19_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf838c191f224e90921deb0c9dd4d8b0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c0a87d5a109411fae8be9b302d9a229_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60796f3f508f4327a4e738afb42dcf8b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bf2274fbdb7410f92df8d07c6a7f201_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45f0ee99639740adb0c22db01af096ac_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58348ef8cf7b4b6faf2cce35de2978c5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9e8557376044f0fa6608b862b7e25c2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c04e8513e99429391fedba4d6dad8af_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3119e2458b4d43bd8aac84c146e9a100_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2799afba52094088a0aec4099f2cd4f8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1ceabaf0dff4adc9d75414a157e0e6f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80ef17e0a1714077b0570474802db35d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i849ee3b7fa1d4cb8ba90315b84e6817c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76fe5a1e46444faa97974d14a8212357_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie36e6e5e651d4dac8a530797e7a70c18_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62db101872a24148a919c634afca4814_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i888e928ebad143cbb7a499ff02241d61_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ac9479cfdf4484f9e8701e0f82d2e4c_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19b668b117b34adcb089b01f3153c8f0_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i969dadb6a5014e4e97c0701a8fa71817_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i716b019882fd4fceb551ac9e5a422c18_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06c8b950234148b09f83c9527bf5b802_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief5e2ae4563940bf95c8d1d8e28f2353_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic03f6f90300b411c9d23b5538357dc9b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fb6e5f190e74ccdae10ef40017a5792_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia73bbbf5c3f94136997b8becbe0d75fb_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51a5d02d9bff429da29560b39c8f2ff3_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if336d47d141c481c95e420c0cf744a34_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i460359d3c86945e3bca1ddec5b04da33_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64e47ed80ef449548b1acb824907d26d_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i444f9a88357b4522a70b67e00782860a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7c8512e869e4882979001a21c27cc1a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice102114e53046c0990a7f9b97933076_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26dce1de93254045b3bf97178b2dd2bf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf6e4b73c21f44648aa84b01813ff828_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3aea8ed8bb64f248ee3ba0de12e5974_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibddbc2840c8d47d1a8b3d4d03ad88e0e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58d94f46b8eb44d5abcdcf4c68ffd4af_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfb74fdbaafc42b5bc38853f2956af25_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e7a74f1e4ec41a08eb7da7766828283_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i618590d34e9e40beaae759c50efa5248_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0496c19ac0ab424285907e4b8bdfd63c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanAssetsHeldForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i202cd9cf62f0431e8d01300563014a7d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1765debe58fa477bb60f4fa358d03763_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae09054075242708b4f1b92c5ad9435_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf954d0b17fa4afcbd832a5b25242889_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74f232fbbdd542a68a67aac5bb01a3ad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6020b3dcea424492aa70f65876ac2906_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i768c441bead74af990375d494dcd615f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46014a69e7bb46d7804f90bfac7336a1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6a8fb9420154ab99c47ee021794a752_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A525NotesDueFebruary152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15a119cca4d54ce1b9e9b15b07ecb555_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A525NotesDueFebruary152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia67ce7e8257446a8a749a51dd4e61f1e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6923623dff6a4c21af62ba66950bbca1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i836c135ad296412391b52c76ec2d65af_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i584398e2f2774124928de1b3733debf3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc18546dd5254ad9bc27e6a28551e869_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf67d81b73484a2ab862ae6562f12c8f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib792f01cad394fa9a6b5b6007690d92d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22b455fe9626429d82d1312274a08717_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6305f106d8224c67a7f1f4f9d248c6ee_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00eb8e4aa01348e88c908410c24dbed9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2db8c6c2c8154fc292aa5199f298a4cd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ded6a5da3964377b85a8496b7db3a17_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib30972cf50704e17b9605f2bd2f62293_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i215f3153999b49f994c67efb2f5ca414_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i844ae52bcc2545d293dac8695661ad1c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if363f9768e7c4dfda22b43256fce94cf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5694cf86b13649b19e91a4472f2dd301_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35cacf2366014f2ea0f9ac27e0b29d39_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieea3066b4198415db491f3e894ce0b14_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1b5510456d4c02b2ecb86d2a690ce1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i976e4c827b4549e1961c10a386b91abb_I20230213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A525NotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa0ffbdeacb64a09986b957e9f96a042_D20230213-20230213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A525NotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-13</xbrli:startDate><xbrli:endDate>2023-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i535b3f0e572b482a8d1a1dedf038fe50_I20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78a368c4b72d42cf8b1a224dc65b0f47_D20210812-20210812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a24f716c6be4a4696ca08b8cc9d7ad8_I20201203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11be422271b0497c8bb2cbf054b40bdd_D20201203-20201203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-03</xbrli:startDate><xbrli:endDate>2020-12-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i772fb832f6354412ad17d3bfd7fe6b1d_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icac00852e08b4922ad11b375efe1e1b0_D20230315-20230315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-15</xbrli:startDate><xbrli:endDate>2023-03-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia19e57b1a46b4e69ae2d79da972f650a_I20221215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3851e69ede76406a8a5a4117e99d5ec4_D20221215-20221215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-15</xbrli:startDate><xbrli:endDate>2022-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib44bfb223bc14e29aeac77c05bbc39d7_I20221215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i453005c054c0476fbb9853e512d6bd28_D20210717-20210717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-17</xbrli:startDate><xbrli:endDate>2021-07-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0e1375f02f24ba79ea97f55a3b99d89_I20210717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic756400c1f7e46c38b850bd10c43a377_D20201201-20201201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f46bdc3df244190a4f3caa01c5eccdd_I20201201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fd03415c82341b0bcd801b36c1a28fe_D20201130-20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-30</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f7ee8f00bf1412e813d7abd850dc07b_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4592baf7793041fa8e76756aac03670e_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib143d3ffb79a4cc4bd2ad4ebae133edc_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34d77590b6c24730802120c45ff43aa6_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia499a63a8849486aa054b9140660701a_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic327cefb81b34e5a82369680f27dfba6_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2959faada6aa43a892063ae50e28b434_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida05874ce18a4f4fb630c33eac2a3138_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c2fdc8cd1ed4cabbe44be3bfdd3a3f2_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie691f38e48be4843a3fd39459645f39b_D20210723-20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-23</xbrli:startDate><xbrli:endDate>2021-07-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bdacb5a0bcc4ad480dec225518c10c8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cc5f04c5c2d4d70aa2d95e18cd6bef4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0de40eac191846698bafb26987f8db02_I20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2939e16a3a648eeadc8fe5b14335874_D20221107-20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-07</xbrli:startDate><xbrli:endDate>2022-11-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id005fd4ac6fa46378f61401585bd1f21_I20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic980d09285fc4708a8a6eafe8b8a5655_I20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6df2825430ea48468dedc27f049659e5_D20221107-20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-07</xbrli:startDate><xbrli:endDate>2022-11-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63af9e33b0074a89b174bb79dc0563a6_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34acb3e619be4e479ffc9dd6d3c2637e_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieffd80ee181540709a1840aa1e6b331a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37179d6482964d95b578a69074ef0010_I20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ded1a9c1439414ab4b7d6ef1c80ea50_I20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A2022TermLoanCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ea2abb1609b4016be9ea5ea390f3ddb_D20221107-20221107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A2022TermLoanCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-07</xbrli:startDate><xbrli:endDate>2022-11-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8c8b37718a34ccf97efe28b40fa8b98_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86beb9ab012e4ab98ab444ffd6a60f1d_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fc646c92280442fa50dc0dd90fd3b8f_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mck:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie365f78409fa4f7c8fab2a443f6508cb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i764185698f6248c8a59dd7255743615b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia236aca49f824360a041b24156a09309_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9be4134ad35a4d88b4b59aff8d5eb2fc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bf2f9269b0245f082bf1b61c46287fc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf74b96be12f4a219ff712ac02236787_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d0480bcc6d3431ab87336fe586f8dd4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725249281f6448479928864a02cfeb84_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9285759f0f7e48fc96862d938f16f2c4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd224bce6d5d4f0ebf52968e5025d793_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29ce9dc1593049718fe7bb3e0475e10e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ac7e4d1dc5b4f05b72d3e857f067e82_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib91bd719aec14a16b34e473ef04b8e30_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaebb395b037444299908403308be0b79_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i513eafe450024d3a99fd378acb5c768e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c2b6a539b6d496b8795e813d345ea7c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba0180b4473b4cc5ada51da9d6909ece_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6af7427ba4784b7fab08180a13ff9b1c_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10bcba3ec49146f58e7e91f9b293ca33_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i722584ad23f0453f86285951f75a1700_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i205b3862163e4e678a0394523279c14a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51610f05cd18459b963569b57c8bbbe1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71bf1a36819e476c85f3a6d8663bdea3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45ba471960e744afa8691f9d48e62f13_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida7184b50fa64a8dbc5cde66e602da28_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i994dc07d79bd4a03a6631b10f5eceac2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie758338a330442f68f01dd372842ee71_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b161706e1cc4841adfb4249122e7e93_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9871350b1e94507bc4d2b7948cd34e2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i125e3486c8434dc7b093af7f724a9223_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77514bdd2d89462c9211465f0a766ec7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8973019f6d64483a30bda7006efbc09_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e169cd345664994a6d79eea226c19b3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6b05b2e1ce7435294b2dbf7fb0aae99_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8307fb561294672b090c1bb5d05d513_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3f1ee10031041a3af07110ab4849733_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72ad2547012c48f4936cd2741754a6d9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc7ed483c5154a59a6c8c3b34afc8b2c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a004834e91942e79a1a035a54eb8430_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24fb96b7e1ad440a909f91f9f5db78a3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0efc094e70304787b594a72d0060b612_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f2387351c284073a3585ae340c96f38_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic30de0ea7dbf4ca294f03806a898ccb9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i657e7112d45443199c58b406acf29838_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5327b1083ed94e798541f3da89104dc9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39dae6d084c84047aa582ca074a0d078_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia46e3fa973c947b48594cb4ab31a9c66_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13d1edaf8e3f4acab8850b098880754d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i227439bd64d1487db0754f92fbcd1a4f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i759d43483f4048ec80ee7227fa0f70f5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62410ab1336048ada10bb12a73da0a7c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28cf440d298c42adb27df58f03c66fea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4193615347d4fe29a971e9dd9b5227f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i918e287d03514df6b3bfe695542d3887_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia011b94ec27b40e8b51a633a0bcbd4a5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb1fcabf197142b5bd6d52bf694fa67b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43e7a92a6d5e4ada8cc90026e6b3229d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd1cb19b0477476cb20d2a0e4982c520_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac3be98a2bbc4274ace7d610d1288ff9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3f016b2ef3e440eb97d4400be55876f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41a1d6ce3a444d7e82696c5f8ff77d6d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81ad37783f6e4af8b246e63c8f3a99c0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica1476e409e7402b9a147a0ba6312dff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f69217e7cff424dbb573dfbe087faa5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie63109b7002f4f4f93a996b521f5b59e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i829df4d042954ba09a94b3ab60df2ee6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94b0345b6b1d434596b0988c93100635_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38c1211ca3bd47ccaa63f4d573ef3eb9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8613bd2d24b24d0c91d02304e304ef0e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i999721f0f4df4c2db0a933b5978923b6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18b9e6dc3e4246a78043d39c8c8a997d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1ce3ce209624caf96b787927d453e69_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i846de7923abc4c97892d8ae4ffa6a848_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i087f9375fa6f4e85b3f512df46958583_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03a25adf74c747e3af066921668300d8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2c7699ae1b14f20a774af95b9906d4e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1da20a00fd7c41bf882c2c4b0fca97bc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd8f41a67f1d4ac6bcd66decef5d2d36_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib77b1393ed7f4e1cb5cdf0a8cceb3947_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cb089efc1bd4c339e696998159d126a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i736fe7819f714241ad16df84489ece06_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i403dc252a03943a08391aee80b76db38_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e959507a65a46d4953fdcacc156df2a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2c0f39a48f745c181b6f5d69c3f1b19_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aff01889e07438fb29743fe2ba9c669_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22203a08a73a45f287b95b3462d5d578_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a7ce7882d7346b99cf64d531cb03268_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i548b65f153fe455fb735edc18c43071c_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib463cce9887841b580560f381cb2da5b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i320f8fd67c4948f0a308006480a2c5ad_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedac49b197d6406986b0d015faf7d0db_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6665b3b43b04da588b52399a7fe54b5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a7df9519bd34e78875fe27cd2ff763e_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7a9b9f544264510b97f94b12eb3d7b2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if513543f51ba4b0d91334260d63c6376_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:FirstPartOfPayContributionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i957a9c83570946a8bff0405f80b94b7f_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:SecondPartOfPayContributionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica96366b6bcf4de3a3a5a18786d44260_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb54d0a7ddd04860a8ac09f3e04418f4_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i942e6213795a47479851045f390d686e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i570d5007fbb6461f83baab05592c1bd4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6581ce23346b4adc8afb8d7c98565984_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61ed85ae587d438299585235a376442d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if95560d064ba4166a3331f01665e7c28_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f756df8d9cf4ff5bf43b455279a736b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i377c89ac0f94417ab6e32711608e6849_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7746cd80fb0e4dba825522f21e14c35c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icde86b5b9cf640a3857b79b2a12f38f7_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bf4620f35c94ffe8b0ced9de2482405_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5ed5bad9fbc48a79bf500f2ea6d7a22_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ff470a2b6a24f96a0586ed7a59b7b7b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="ifd33b3ebae6e4d2496772717c3f8c273_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i451f85a810074a318c6fdba6392654ed_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie46f20f9252c435eb905f97640abaa6c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie365683768f34533b940d20aee5be735_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d0ea17b2eb84516bc5d182b18413d90_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d2f247e11ef4383a78c76952ded2871_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i012704ce27234402832a8bc9c0017988_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ff7efcd13d54a859f0cdcd3c236d712_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58eb9e87b3f1463fbab075c07679076d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18e62823c6c34113847dd36bdd196aee_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc76b912e3064681bcafdf4fb127e946_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b463726a6524dd3ba88c8289035c4c4_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1212e8cf47b1431fba4fec0f85eaa49f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:InterestRateSwapEnteredIntoYTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b574ca5d25e4e77b9ac4175842add0c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e74926dad464e94bdc3f1c87eb5109a_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a201725780545cb9926c7c283f7d7d0_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie12bcf044f834b0ebb0a13192a63245b_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8dab7068d7b4998b54b905773776649_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94135546f3234d41991f401e92d4d4d6_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e3950dedac64c34a7acce736f0bc228_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42e31d06ed3643fbae42793a45735ac5_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69be7012e79640bfb23e05de78108936_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa333c469edc4e739ef41e09656c0dfe_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae39c5b703e44224ad9561aadf22dcaa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08578346a1c640a69d5c8c9dbc6cef2f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib89a2c4aa24f415ebad33a8ffc064667_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ab3273dc18846c0891c616e297f96e1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i570b23d2fb4f453cb4925aebe582d8f1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5af88ef9b934cc4a000f911d7bc1a8c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27091f652077438a88c26df46b3f0175_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96f88968ebe444dd9eb39629b0d33d5c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9919373fdaa44e9488d392bca8c37b57_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72369ee3bdc242a584b516b6b0220cd3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i193367ab1bd147669e6aa97c4b68b27c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ed31f2e5a9e4fa5b8dcaf9650e3ac4c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04f759a37fee446ab4c24b7a4aa7fd2c_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4296c0b84d346e4b89b55d58821c05d_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb01f985e84846568b14aa2b0bf489e5_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d14a00ce32c46e7b5068767e2553b8b_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c2dfca8ca434187bc4a0181f1cd5d18_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1be6be612b674d65a670c15307e93ab4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied8ab1ea89bb4a8492bbac67f1f3dd79_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b2d6726cb4b46f2902ab30560ff644c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="distributor"><xbrli:measure>mck:distributor</xbrli:measure></xbrli:unit><xbrli:unit id="state"><xbrli:measure>mck:state</xbrli:measure></xbrli:unit><xbrli:context id="if0f3c705d63d43aaae784ab3543e3e80_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestUSPharmaceuticalDistributorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mck:case</xbrli:measure></xbrli:unit><xbrli:context id="i7e87a690a6d84ef49943e4b9a57bf486_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfAlabamaAndSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if55961281a7144958d26ffefe3ca4b9b_I20220704"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="subdivision"><xbrli:measure>mck:subdivision</xbrli:measure></xbrli:unit><xbrli:context id="ia95d07e149ed453ca958daff0b5e82b2_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i129e51149a384d2ca3e97d96fc3cd639_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="jurisdiction"><xbrli:measure>mck:jurisdiction</xbrli:measure></xbrli:unit><xbrli:context id="ifc24b7896b6c4e3e9686133fcdf77aaf_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1db22ae3a3cb4da3b2e5eb909147033a_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4deb4bb0d31640d6839b768c83fb82d3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0140a17cab884d1492bcaa9df5a4d5a3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b22d4f28fe34a62b1126f5d988f8052_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i634cecdea7c5420991fa07409e24bae9_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i480f6acdd20745c3951ffb01a8a1f2fd_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndCherokeeNationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia186f3731bcd4bec9362d4010651c39a_D20230724-20230724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-24</xbrli:startDate><xbrli:endDate>2023-07-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plaintiff"><xbrli:measure>mck:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="i7ba50f0dfc7944c88deff9f8478101c4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3930fd7ff02f439e9ab59431524b3678_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88153d2f52214fe0a9768ef8344eaabd_D20190225-20190225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-25</xbrli:startDate><xbrli:endDate>2019-02-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88a1d24ff9dc4dde993d7cc58d70cee1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="complaint"><xbrli:measure>mck:complaint</xbrli:measure></xbrli:unit><xbrli:context id="i33396fbf2486428a890309fa325b4aaa_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="relator"><xbrli:measure>mck:relator</xbrli:measure></xbrli:unit><xbrli:context id="i76d4bda7231445d895623496e61e3afe_I20201023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InsuranceCoverageLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fe1c6d47bac41768956c525d9da297c_I20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InsuranceCoverageLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="policy"><xbrli:measure>mck:policy</xbrli:measure></xbrli:unit><xbrli:context id="if37f55f8d74d4f7e856241b5044f79a1_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa4d87725ecc4620b0b0c4339cac0d54_D20130517-20130517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-05-17</xbrli:startDate><xbrli:endDate>2013-05-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i590634e41f954ae590139d3aba0164cd_I20190813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="faxnumber"><xbrli:measure>mck:faxNumber</xbrli:measure></xbrli:unit><xbrli:unit id="fax"><xbrli:measure>mck:fax</xbrli:measure></xbrli:unit><xbrli:context id="icf72768e9e58489a9cfe3dcada7cea25_D20211008-20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-08</xbrli:startDate><xbrli:endDate>2021-10-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i604155abded247ec9c473e57fc99aa9b_D20220427-20220427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-27</xbrli:startDate><xbrli:endDate>2022-04-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6909fc49de54c13a5acf0f3f0cd933d_D20130416-20130416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelPiacentileVAmgenIncEtAlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-04-16</xbrli:startDate><xbrli:endDate>2013-04-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24b5bf7bd68d425d9982f2b10d0f20f4_I20130416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelPiacentileVAmgenIncEtAlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-04-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="defendant"><xbrli:measure>mck:defendant</xbrli:measure></xbrli:unit><xbrli:context id="i2f35dd91b0344cb6ba1c6fc2ce024afc_I20180425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="city"><xbrli:measure>mck:city</xbrli:measure></xbrli:unit><xbrli:context id="i057d846c99e24512ad9cb275e0ad3de8_I20200302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddc589cd657a4746a04bdd0a051ab071_I20181212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:EvanstonPolicePensionFundv.McKessonCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="officer"><xbrli:measure>mck:officer</xbrli:measure></xbrli:unit><xbrli:context id="i3b893491327d4a5081fd775de27171a8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:EvanstonPolicePensionFundv.McKessonCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23f831232dbf484481fae3a05bce6513_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia91da99152ad44428ddb96bcf738d999_I20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fa7ddfc765f423794371f1af3723e4f_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="softwareproduct"><xbrli:measure>mck:softwareProduct</xbrli:measure></xbrli:unit><xbrli:context id="icf0b205ff8cb4fe6bbf197d316b47f43_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20873e9ecf6d4345bd56d1540cbbe862_I20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1aa84dc10f44e2ea8914b72f7921ce2_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dea821e32924b6585e37a6e0736d3bc_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibee4b1dcd2594498a8e665ad78a26929_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b320ce88af7493b8137e9d513e29859_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7989fb6981db44d6a082cf3c02a024b6_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7403b5a9a1b84b5cb7c8a882d6a51fd2_D20230301-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc03527a8d334d539c474fe9c3791d14_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="site"><xbrli:measure>mck:site</xbrli:measure></xbrli:unit><xbrli:context id="i9db2aeb8a3924ed5bd9d03fb72c6cd8d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddb1a3b6365b4643bd368941bb1a62c9_D20160301-20160331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-01</xbrli:startDate><xbrli:endDate>2016-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i219f752cc9d64079a2574ee8f7108652_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia153892cce85447fb85d9233bdf56fff_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c415789acee4283a6ed5420c5137fc9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>mck:vote</xbrli:measure></xbrli:unit><xbrli:context id="i71dc2fb8cd8f4fab8df832f11c64c6e4_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf21b957ae1643249d6ecd39408dd77d_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9446f02c71545a69aa3169ca6418b21_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3376bdc454704e8a84932b1b7dd33e89_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMay2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9218dd12bc66496ba1bcdebfe2a9ca2b_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cde46cdcba64ab9acfd06498904f049_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseFebruary2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20292928a6df4630869820c5c913bbdb_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseFebruary2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45ac0ae0f55f4a1db80ab683ab3f7655_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMay2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96f090a3fbc74514b59f02f20a563b79_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseDecember2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32ef665f7e9f47f8a52f2b7ccd1c1642_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b31f8221c34827bfa4b4c4223aef53_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if81af84863b849ee84346934e78dd3d1_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseFebruary2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b81b5ce8e3946c486bacd3228a6502d_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i609db64ab4224f9ab5523d7c2bb0d613_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1c0f65c88014f1ca2d67069e57a5ee6_D20220501-20220531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i831c04a5da8247afbc87577d86b34cfe_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i606c3a6a2202458da025615d9b410a00_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i074564bccb7c4a93a2b47e7194a97423_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a12d8177d3a4bca8f20394c549b2ba4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia24155bbe2b64b13a5839bc953e73126_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia06fe5f5c08242e7988383eb561e7daf_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i541d58c4043e481c86a354b16272d39f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief34de8c02864055a306f0805902d830_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ab34673c6cd4865a1526b689d28d9e5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4de62b174ea943d98bbc5ea010c68a3b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idebabd22268d4aa5be5fdcb7615dcb80_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica7e852a88784746894a205a0250f9e2_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i996effba6e534e53953b29d2c0934e15_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide3cc36767984833bee114be85420104_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c2e1ec251cb4ae3beaeb30c7c423caf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie30cfb911148404bb4945fff687165b3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36eca1d194984dd68f29ddaa4c2a05f9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i124bd77619314a38a6b7cf276d1570cd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7f24a9d3204464d821c538c01648b18_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cf65ea6698449018a0c90a7c5bde4ab_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icebbfa315f6f4c3badea80ba552d9fb3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9073522e455946228d949f1757f5c414_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ab73b88a84e4a3399c2d709d8b90830_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa875c8421764c2c97f433701036010f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia639b6ffb08b44728499feae92d1c0c8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0d5849c66ff44049855a2ac70d7759e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceb7460499a94969a987f6e8ded5348e_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i710b6d1dd56e4af4adf0dcdc5a56ecad_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if772d42044f24743833c57e3767d2780_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a2892fe126a4d66a63dd15b65453356_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id978da015466413b89b3f2baa572ef6d_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8b0a03505314b06b91188743cad0dec_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29863184fd5348ff9a2a8abf0a0f8828_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0df62424e8a4e62973e47b8bfd93a08_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7a2b38fb7fa4ffd985ec84c91b96f08_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f27de4692d94ce8a48a3d7cc406987a_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7674cea30624b1d8ca527142731b3ad_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfa165efd60744789333c4342a1321b6_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib04ea519904c428dbf874fb64037adad_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05710b61fa6a461a86f2ce635e26e4b7_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49a0432e3a7549c3a03b803ce21875b6_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5247400d4124ca0b0a07ce0631d83e8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56f911c056b9484b92530a2457c3bafb_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3df0606471a49beaeceeaa20d347abb_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd7c7850d8804f519104e7d06502da80_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia92f8f2aaaa94d78b491c9cdf4615c44_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic465b0622cf24cb28f75710b46a76fb2_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2e8b60c81a24e6fb0f18c0151fbdea0_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f0021b2207044be8e84e8be9891a203_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i264e209968434d6cab289a945e761bb9_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ShareholderDerivativeActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4d3a7b2492845f594e7eb9cb4d9ba34_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27b479eb9b0a4205ac5ae85acf2eab9f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f12ecf10c5748808acbd2a3b98687df_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1892be5575524f3e9fca14e45be67594_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a645887208e4db486fb4c28bf9e9789_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3437a5a1fdb04c6e8b55de243f4372f2_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63e0cc8c15f34a96905c888bc0341914_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i900587631c7346db9cea5a03126cc912_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7384817abd64241a01371e5ab5d3497_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb89c7229e47468d9dc24fe8eae25115_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia81ff60f8db142b3b909cdcd9740380f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8940a83e694049a79488bf11a8ab865b_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cd212f902f34f7f840d70349edad45f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4edda4c7cace4760a6ee6c90e9c98795_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ed2dcfef9ef48c5bb328cf03b40b504_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bde156294a94d568921fd8650774394_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i759399c0e9f1473c9e22bd29f133ffe0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b8997759ac04bec85bf84dabe68cba0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a62067dd1e740e787533693c47c4cad_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a3854feff1f4556b7bc99ddcbb54572_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57b78c8af30b448bbccd7dfac95d2712_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e0851153ff84a2cb14ce3cf28fc235d_D20220401-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19cf323fe7a0413b901a209d2006acbe_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f46ce261be141779d217de93096c2dc_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i04335d018da94076b0acf21e81ac886b_1"></div><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl84NA_b24d6a7b-c12f-4f3d-ae56-190c06cdaa21">10-K</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"></td><td style="width:28.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:472.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6OTExODI0M2FmNjFiNGFlY2I3NzVlNmE0YzdhNjcyNmUvdGFibGVyYW5nZTo5MTE4MjQzYWY2MWI0YWVjYjc3NWU2YTRjN2E2NzI2ZV8wLTAtMS0xLTIxODc0OA_89915ee8-4470-4785-a39b-883e69ed4da0">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8xNjQ5MjY3NDUyODI4_08a4d4c4-9cbd-4e0e-8210-fdd540c59baa"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8xNjQ5MjY3NDUyODI4_467b6b2b-44b1-415d-a9f9-715b0489ecf4">March&#160;31</ix:nonNumeric>, 2023</ix:nonNumeric></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"></td><td style="width:28.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:472.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6ZDdlZDk4ZDI0OTZiNDlkYWFmOWJiMWRmZTdiYjllMTYvdGFibGVyYW5nZTpkN2VkOThkMjQ5NmI0OWRhYWY5YmIxZGZlN2JiOWUxNl8wLTAtMS0xLTIxODc0OA_63687bd2-bfd0-43a6-863e-859dceebc1fe">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yMDU_ed6526ef-9f37-4fb1-8dbe-5f557cc94f2d">1-13252</ix:nonNumeric></span></div><div style="text-align:center"><img src="mck-20230331_g1.jpg" alt="mckessonlogoa01.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:217px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yMTA_027685a4-cc7d-4a40-9e78-6c49b4c846dc">McKESSON CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.898%"><tr><td style="width:1.0%"></td><td style="width:50.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.178%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6ZDRkNDUyNjRlYWQ0NDQyN2I3YTM1OThjOGI1YWQwZmMvdGFibGVyYW5nZTpkNGQ0NTI2NGVhZDQ0NDI3YjdhMzU5OGM4YjVhZDBmY18wLTAtMS0xLTIxODc0OA_ff306fff-4c41-4c9e-b942-89f9fc83f101">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6ZDRkNDUyNjRlYWQ0NDQyN2I3YTM1OThjOGI1YWQwZmMvdGFibGVyYW5nZTpkNGQ0NTI2NGVhZDQ0NDI3YjdhMzU5OGM4YjVhZDBmY18wLTItMS0xLTIxODc0OA_1236edea-87bb-400c-afac-1a647fc008c5">94-3207296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yNzI_d2f28bb2-3038-4562-a394-4246827c4c52">6555 State Hwy 161</ix:nonNumeric>, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yNzc_5813e2ba-2e64-491f-8934-0c858e7c0ec4">Irving</ix:nonNumeric>, <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yODE_0f3ab321-e367-4afe-9658-356a47c00d7c">TX</ix:nonNumeric> <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yODQ_fd5f790c-dc04-4eeb-8e28-73eaad28a0ac">75039</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8zNTA_af4393e8-c7a4-4a2c-96e2-29bebc231a95">972</ix:nonNumeric>) <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8zNTQ_f13a6785-eb15-4ae3-af15-a02dd878eb4c">446-4800</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(Title of each class)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(Trading Symbol)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(Name of each exchange on which registered)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a1cd3cc23a14e3c8567f6f5021d4d29_D20220401-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8xLTAtMS0xLTIxODc0OA_d71195de-7911-4d8a-9fd2-6ea2019d3043">Common stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a1cd3cc23a14e3c8567f6f5021d4d29_D20220401-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8xLTEtMS0xLTIxODc0OA_2ac21fef-92b1-40d8-a594-7328bf0614fe">MCK</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a1cd3cc23a14e3c8567f6f5021d4d29_D20220401-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8xLTItMS0xLTIxODc0OA_5b903727-2a45-42d3-9c7e-21b1d8812e10">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib4d9c8c16b9c41c79238cd17c37cf884_D20220401-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8yLTAtMS0xLTIxODc0OA_1ff61c0e-4737-419c-b323-4c652c589dde">1.500% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib4d9c8c16b9c41c79238cd17c37cf884_D20220401-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8yLTEtMS0xLTIxODc0OA_5cdf12cd-e144-4d1d-a786-745c46c923bb">MCK25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib4d9c8c16b9c41c79238cd17c37cf884_D20220401-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8yLTItMS0xLTIxODc0OA_baa90745-51e1-4af2-b171-d1fbb00e4649">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i35936bfe99754ea0b2d8151940f323d5_D20220401-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8zLTAtMS0xLTIxODc0OA_73f51f98-f065-461f-868e-d612ec03d4ad">1.625% Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i35936bfe99754ea0b2d8151940f323d5_D20220401-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8zLTEtMS0xLTIxODc0OA_dcce9c94-1892-4585-ab0b-a0558684ae53">MCK26</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i35936bfe99754ea0b2d8151940f323d5_D20220401-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8zLTItMS0xLTIxODc0OA_d7f14c7b-0ee5-497c-9f13-4ac62336acce">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0407835b367a4e4ea273bf9f6036ebaa_D20220401-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF80LTAtMS0xLTIxODc0OA_3d2afcc3-7485-491c-9d89-3f62eb0331d4">3.125% Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0407835b367a4e4ea273bf9f6036ebaa_D20220401-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF80LTEtMS0xLTIxODc0OA_5bad6052-4727-4274-be18-3a9b7b3760b0">MCK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0407835b367a4e4ea273bf9f6036ebaa_D20220401-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF80LTItMS0xLTIxODc0OA_a6c4df23-92d7-4bbb-8905-1b1bf3e02b77">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities&#160;Act.&#160; <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl82NTk_21f7fd07-f78c-4f4c-9a4d-aedc48ce3846">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the&#160;Act.&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl84MDI_778d4acd-2195-457c-be16-82cd3236e60d">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8xMTU0_86e56c52-1709-42e9-ae4c-10a1750be65f">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8xNDc5_4623b291-a072-4fa8-83e3-95b9f69b9f0f">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.00pt"><tr><td style="width:1.0pt"></td><td style="width:199.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:195.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6MjJiYzQ5Y2Q0MDlkNDU0OTlkNWJjMmMwMWMwNjVhM2MvdGFibGVyYW5nZToyMmJjNDljZDQwOWQ0NTQ5OWQ1YmMyYzAxYzA2NWEzY18wLTAtMS0xLTIxODc0OA_a7536f05-77d0-4c98-83fa-48847c84ed8b">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6MjJiYzQ5Y2Q0MDlkNDU0OTlkNWJjMmMwMWMwNjVhM2MvdGFibGVyYW5nZToyMmJjNDljZDQwOWQ0NTQ5OWQ1YmMyYzAxYzA2NWEzY18xLTYtMS0xLTIxODc0OA_a64a382d-162a-4877-be95-127a82a71d6d">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6MjJiYzQ5Y2Q0MDlkNDU0OTlkNWJjMmMwMWMwNjVhM2MvdGFibGVyYW5nZToyMmJjNDljZDQwOWQ0NTQ5OWQ1YmMyYzAxYzA2NWEzY18yLTYtMS0xLTIxODc0OA_f3d998c1-b8d7-4830-aaaa-afbc11f20708">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8zMTAx_bdfb9197-f001-4208-9669-276b43c2bdaa">&#9746;</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yNTQ2_f8f2c45b-95a0-4a13-ba9d-909ca4b0d3c3">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, computed by reference to the closing price as of the last business day of the registrant&#8217;s most recently completed second fiscal quarter, September 30, 2022, was approximately $<ix:nonFraction unitRef="usd" contextRef="i399f6860da294568aba7949399d70dcc_I20220930" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yODMw_3f49b33b-a5ba-45bf-9333-6570f1e1aad8">48.2</ix:nonFraction> billion.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Number of shares of common stock outstanding on April 28, 2023: <ix:nonFraction unitRef="shares" contextRef="i1da02b0e502e472ba1f749732b72467c_I20230428" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yODk2_7a46cbac-8824-4d30-b804-3b73e668280d">135,602,262</ix:nonFraction></span></div><div style="margin-bottom:2pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8zMTAy_8a4b75fb-1a86-43c5-aa06-30e7457c3ee9" continuedAt="ied1b00b9221246328cd4ef58bb0f401b" escape="true">DOCUMENTS INCORPORATED BY REFERENCE</ix:nonNumeric></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ied1b00b9221246328cd4ef58bb0f401b">Portions of the registrant&#8217;s Proxy Statement for its calendar year 2023 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K.</ix:continuation></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.947%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.183%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_10">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">3</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">14</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_19">25</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_22">25</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_25">25</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_28">25</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_31">Information about our Executive Officers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_31">26</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_34">PART II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_37">Market for </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_37">Registrant's Common Equity, Related Stockholder Matters, and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_37">Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_37">27</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_40">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_40">29</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">30</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_91">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_91">58</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">59</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_184">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_184">134</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_187">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_187">134</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_190">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_190">134</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_193">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_193">134</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_196">PART III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_199">Directors, Executive Officers, and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_199">134</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_202">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_202">135</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_205">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_205">135</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_208">Certain Relationships and Related Transactions</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_208">,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_208"> and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_208">137</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_211">Principal Account</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_211">ant</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_211"> Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_211">137</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_214">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_217">Exhibits and Financial Statement Schedule</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_217">138</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_226">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_226">143</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_229">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_229">144</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_10"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i04335d018da94076b0acf21e81ac886b_13"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Business.</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO BUSINESS</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Section</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_4947802327005">General</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_4947802327005">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_4947802326990">Business Segments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_4947802326990">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2189">U.S. Pharmaceutical</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2189">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2207">Prescription Technology Solutions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2207">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2225">Medical-Surgical Solutions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2225">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2243">International</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2243">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_4947802326975">Restructuring, Business Combinations, Investments, and Divestitures </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_4947802326975">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_4947802327026">Competition</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_4947802327026">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2051">Patents, Trademarks, Copyrights, and Licenses</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2051">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2068">Human Capital</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2068">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2085">Government Regulation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2085">11</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2102">Other Information about the Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2102">13</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2119">Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2119">14</a></span></div></td></tr></table></div><div id="i04335d018da94076b0acf21e81ac886b_4947802327005"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Corporation (&#8220;McKesson,&#8221; the &#8220;Company,&#8221; or &#8220;we,&#8221; and other similar pronouns), which traces its business roots to 1833, is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references in this document to a particular year refers to the Company&#8217;s fiscal year. The Company was incorporated on July 7, 1994 in the State of Delaware.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), are available free of charge on the Company&#8217;s website (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.mckesson.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the &#8220;Investors &#8212; Financials &#8212; SEC Filings&#8221; caption) as soon as reasonably practicable after such material is electronically filed with, or furnished to, the Securities and Exchange Commission (&#8220;SEC&#8221; or the &#8220;Commission&#8221;). The content on any website referred to in this Annual Report on Form 10-K (&#8220;Annual Report&#8221;) is not incorporated by reference into this report, unless expressly noted otherwise. The SEC maintains a website that contains reports, proxy and information statements, and other information regarding issuers, including the Company, that file electronically with the SEC. The address of the website is </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_4947802326990"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates its business in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter (&#8220;OTC&#8221;) pharmaceutical drugs, and other healthcare-related products in the United States (&#8220;U.S.&#8221;). This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate sites) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. RxTS serves our biopharma and life sciences partners, delivering innovative solutions that help people get the medicine they need to live healthier lives. RxTS also offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution support designed to benefit stakeholders. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. We offer more than 285,000 national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers in the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada where we own, partner, or franchise with retail pharmacies, and support better, safer patient care by delivering vital medicines, supplies, and information technology solutions.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2189"></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Pharmaceutical Segment:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and OTC pharmaceutical drugs along with other healthcare-related products to customers. This business provides solutions and services to pharmacies, hospitals, oncology and other specialty practices, pharmaceutical manufacturers, biopharma partners, physicians, payers, and patients throughout the U.S. We also source generic pharmaceutical drugs through our ClarusONE Sourcing Services LLP joint venture with Walmart Inc. (&#8220;ClarusONE&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. Pharmaceutical segment operates and serves customers through a network of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> distribution centers in the U.S., including two strategic redistribution centers. We invest in technology and other systems at all of our distribution centers to enhance safety, reliability, and product availability. For example, we offer McKesson Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an internet-based ordering system that provides item look-up and real-time inventory availability as well as ordering, purchasing, third-party reconciliation, and account management functionality. We make extensive use of technology as an enabler to ensure customers have the right products at the right time in the right place.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To maximize distribution efficiency and effectiveness, we follow the Six Sigma methodology, which is an analytical approach that emphasizes setting high-quality objectives, collecting data, and analyzing results to a fine degree in order to improve processes, reduce costs, and enhance service accuracy and safety. We provide solutions to our customers including supply management technology, world-class marketing programs, managed care, repackaging products, and services to help them meet their business and quality goals. We continue to implement information systems to help achieve greater consistency and accuracy both internally and for our customers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have four primary customer pharmaceutical distribution channels: (i) retail national accounts, which include national and regional retail chains, food and drug combinations, mail order pharmacies, and mass merchandisers, (ii) community pharmacies and health (formerly described as independent, small, and medium chain retail pharmacies), (iii) institutional healthcare providers such as hospitals, health systems, integrated delivery networks, and long-term care providers, and (iv) oncology, biopharma, and other specialty partners.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail National Accounts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide business solutions that help our retail national account customers increase revenues and profitability. Solutions include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Central Fill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Prescription refill service that enables pharmacies to more quickly refill prescriptions remotely, more accurately, and at a lower cost, while reducing inventory levels and improving customer service.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strategic Redistribution Centers &#8211; Two facilities totaling over </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">740,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> square feet that offer access to inventory for single source warehouse purchasing, including pharmaceuticals and biologics. These distribution centers also provide the foundation for a two-tiered distribution network that supports best-in-class direct store delivery. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson SynerGx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Generic pharmaceutical purchasing program and inventory management that helps pharmacies maximize their cost savings with a broad selection of generic drugs, competitive pricing, and one-stop shopping.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inventory Management &#8211; An integrated solution comprised of forecasting software and automated replenishment technologies that reduce inventory-carrying costs.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ExpressRx Track&#8482; &#8211; Pharmacy automation solution featuring state-of-the-art robotics, upgraded imaging, and expanded vial capabilities, and industry-leading speed and accuracy in a small footprint. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Community Pharmacy and Health: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We strengthen the overall health of community pharmacies and elevate the role they play in people&#8217;s lives. We accomplish this by providing supply chain excellence, pharmacy and patient solutions, as well as supporting independent pharmacies through industry and legislative advocacy. Our pharmacy and patient solutions include: </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Mart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; A national network of approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> independently-owned pharmacies and one of the industry&#8217;s most comprehensive pharmacy franchise programs. Health Mart provides franchisees support for operational excellence, managed care contracting, marketing, a private label line of products, merchandising solutions, and clinical programs to enhance patient care.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Mart Atlas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Comprehensive managed care and reconciliation assistance services that help community pharmacies save time, access competitive reimbursement rates, and improve cash flow.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson Reimbursement Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;MRA&#8221;) &#8211; MRA is one of the industry&#8217;s most comprehensive reimbursement optimization packages, comprising financial services (automated claim resubmission), analytic services, and customer care.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson OneStop Generics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Generic pharmaceutical purchasing program that helps pharmacies maximize their cost savings with a broad selection of generic drugs, competitive pricing, and one-stop shopping.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pinpoint Community Solutions &#8211; McKesson&#8217;s perpetual inventory management system targeted to independent pharmacy owners with five or fewer stores. The solution provides customers the opportunity to improve cash flow and increase efficiency with inventory visibility to help maximize operational performance. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FrontEdge&#8482; &#8211; Strategic planning, merchandising, and price maintenance program that helps community pharmacies maximize store profitability.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson RxOwnership Program &#8211; A confidential, no-fee resource for pharmacists and pharmacy owners interested in buying, starting, or selling an independent pharmacy, regardless of their pharmacy affiliation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Institutional Healthcare Providers:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At McKesson, we are relentless in our pursuit of opportunities to achieve operational efficiency, reduce waste, and improve the financial performance of our customers so they can achieve more of their goals today and into the future. Solutions include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">RxO Advisory Services &#8211; A suite of supply chain management, pharmacy optimization, and 340B program advisory services driven by data and analytics.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson Plasma and Biologics &#8211; Specialty and plasma drug distributor that leads in market exclusive drug access; partner to health systems customers in navigating the complexities of limited distribution drug; and optimization of McKesson Distribution benefits. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Outpatient and Specialty Pharmacy &#8211; A portfolio of services and solutions customized to each customer&#8217;s business and clinical strategy.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Contracting and Contract/Purchasing Optimization &#8211; Solutions across generics, specialty, branded products, biosimilars, and 340B products, for inpatient and outpatient settings. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Supply Assurance &#8211; Solutions and strategies to enhance product availability and proactively manage inventory of critical items. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patient Assistance Solutions &#8211; Technologies and services that enable health systems and providers to better financially support their patients and community benefit programs.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment also offers solutions which enable its customers to drive greater efficiencies in their day to day operations, effectively managing their inventories and complying with complex government regulations. Solutions include McKesson Pharmacy Systems, MacroHelix, and Supply Logix, all of which provide innovative software technology and services that support retail pharmacies and hospitals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oncology, Biopharma, and Other Specialty Partners:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment provides a range of solutions to oncology and other specialty practices and offers community specialists (oncologists, rheumatologists, ophthalmologists, urologists, neurologists, and other specialists) an extensive set of customizable solutions and services designed to strengthen core practice operations, enhance value-based care delivery, and expand their service offering to patients. Community-based physicians in this business have broad flexibility and discretion to select the products and commitment levels that best meet their practice needs. Services in provider solutions include specialty drug distribution, group purchasing organizations (&#8220;GPO&#8221;) like Onmark</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, technology solutions, practice consulting services, and vaccine distribution, including our exclusive distributor relationship with the Centers for Disease Control and Prevention&#8217;s (&#8220;CDC&#8221;) Vaccines for Children program. Additionally, to support the U.S. efforts to fight the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;), this segment has been distributing certain COVID-19 vaccines since December 2020 at the direction of the U.S. government. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This business provides a variety of solutions, including practice operations, healthcare information technology, revenue cycle management and managed care contracting solutions, evidence-based guidelines, and quality measurements to support The U.S. Oncology Network (&#8220;USON&#8221;), one of the nation&#8217;s largest networks of physician-led, integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. In October 2022, McKesson completed a transaction with HCA Healthcare, Inc. (&#8220;HCA&#8221;) to form an oncology research business, combining McKesson&#8217;s U.S. Oncology Research (&#8220;USOR&#8221;) and HCA&#8217;s Sarah Cannon Research Institute (&#8220;SCRI&#8221;), which is one of the world&#8217;s leading oncology research organizations, to enhance clinical trial access and availability across the country.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This segment includes Ontada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, McKesson&#8217;s oncology technology and insights business providing software to support the clinical, financial, and operational needs of our oncology practice customers. Ontada also partners with oncology providers and biopharma partners to perform real-world evidence studies, retrospective research, and to provide clinical data insights, advisory solutions and education opportunities.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we discuss specialty products or services, we consider the following factors: diseases requiring complex treatment regimens such as cancer and rheumatoid arthritis; plasma and biologics products; ongoing clinical monitoring requirements, high-cost, special handling, storage, and delivery requirements and, in some cases, exclusive distribution arrangements. Our use of the term &#8220;specialty&#8221; may not be comparable to that used by other industry participants, including our competitors.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_2207"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prescription Technology Solutions Segment:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Prescription Technology Solutions segment works across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver medication access, affordability, and adherence solutions that support patients from first prescription fill to ongoing therapy, regardless of their insurance coverage. RxTS has connections with most electronic health record systems, over 50,000 pharmacies, approximately 900,000 providers, most pharmacy benefit managers and health plans, and has supported over 650 biopharma brands representing most therapeutic areas. Through its industry connections and ability to navigate the healthcare ecosystems, RxTS offers innovative solutions created to benefit healthcare stakeholders. Its comprehensive solution suites span across the entire patient journey, including medication access and affordability, prescription decision support, prescription price transparency, benefit insight and dispensing support services, as well as third-party logistics and wholesale distribution support, to help increase speed to therapy, reduce prescription abandonment, and support improved health outcomes for the patient. In the past year, RxTS helped patients save more than </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8 billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on brand and specialty medications, helped to prevent an estimated 9.9 million prescriptions from being abandoned due to affordability challenges, and helped patients access their medicine more than </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78 million ti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mes.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2225"></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical-Surgical Solutions Segment: </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical-Surgical Solutions segment delivers medical-supply distribution, logistics, biomedical maintenance, and other services to healthcare providers across the alternate-site spectrum. Our more than 275,000 customers include physician offices, surgery centers, post-acute care facilities, hospital reference labs, and home health agencies. We partner with manufacturers and channel partners to support our key target end-markets, including primary care, extended care, government, and other markets. We distribute medical-surgical supplies (such as gloves, needles, syringes, and wound care products), infusion pumps, laboratory equipment, and pharmaceuticals. Through a network of distribution centers in the U.S., we offer more than 285,000 products from national brand manufacturers and McKesson&#8217;s own brand of high-quality products. Through the right mix of products and services, we help improve efficiencies, profitability, and compliance. We also never lose focus on helping customers improve patient and business outcomes. We develop customized plans to address the product, operational, and clinical support needs of our customers, including inventory management, reducing administrative burdens, and training and educating clinical staff. We deliver for our customers, so they can deliver and care for their patients. Additionally, under contracts with the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) and Pfizer, Inc., McKesson&#8217;s Medical-Surgical business leverages its expertise to manage the assembly, storage, and distribution of supply kits needed to administer COVID-19 vaccines, as well as some of the sourcing of those supplies. The kits are produced and distributed at the direction of HHS to support the administration of all COVID-19 vaccines approved in the U.S. </span></div><div id="i04335d018da94076b0acf21e81ac886b_2243"></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Segment:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada where we own, partner, or franchise with retail pharmacies. Our operations in Canada also support better, safer patient care by delivering vital medicines, supplies, and information technology solutions to customers, and through several retail health and wellness brands, across Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we announced our intention to exit our businesses in Europe. On January 31, 2022, we completed the sale of our Austrian business to Quadrifolia Management GmbH. On April 6, 2022, we completed the sale of our retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited. On October 31, 2022, we completed the sale of certain of our businesses in the European Union (&#8220;E.U.&#8221;) located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, our German headquarters and wound-care business, part of a shared services center in Lithuania, and our ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group. In executing our strategy to exit Europe, we continue to evaluate suitable exit alternatives for our remaining retail and distribution businesses in Norway. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report for additional information on our European divestiture activities</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the European divestiture activities described above, we operated through two businesses in Europe: Pharmaceutical Distribution and Retail Pharmacy. Our European Pharmaceutical Distribution business delivered pharmaceutical and other healthcare-related products to pharmacies across Europe. This business functioned as a vital link, using technology-enabled management systems at our regional wholesale branches to connect manufacturers to retail pharmacies, supplying medicines and other products sold in pharmacies.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our European Retail Pharmacy business served patients and consumers in European countries directly through our own pharmacies and participant pharmacies operating under brand partnership arrangements. This business provided customers with traditional prescription pharmaceuticals, non-prescription products, and medical services, as well as e-commerce operating under the Lloyds pharmacy branding in Belgium, Ireland, and Italy up until the sale of the E.U. disposal group. In addition, we partnered with independent pharmacies under local banner programs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Canada is one of the largest pharmaceutical wholesale and retail distributors in Canada. The wholesale business delivers products to retail pharmacies, hospitals, long-term care centers, clinics and institutions in Canada through a national network of distribution centers and provides logistics and distribution services for manufacturers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beyond wholesale pharmaceutical logistics and distribution, McKesson Canada provides automation and technology solutions to its retail and hospital customers. Additionally, McKesson Canada provides comprehensive specialty health services to Canadians, including a national network of specialty pharmacies, personalized patient care and support programs, and INVIVA, Canada&#8217;s first and largest accredited network of private infusion clinics. McKesson Canada also owns and operates PDCI, Canada&#8217;s leading market access consultancy, supporting manufacturers as they introduce new products into the Canadian market.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Canada retail business includes approximately 2,700 banner pharmacies under the IDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Guardian</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, The Medicine Shoppe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Remedy&#8217;sRx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Proxim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Uniprix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> banners, and approximately 400 owned pharmacies under the Rexall</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand where we provide patients with greater choice and access, integrated pharmacy care and industry-leading service levels. McKesson Canada also owns and operates Well.ca</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a leading Canadian online health and wellness retailer.</span></div><div id="i04335d018da94076b0acf21e81ac886b_4947802326975"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring, Business Combinations, Investments, and Divestitures </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have undertaken additional strategic initiatives in recent years designed to increase operational efficiencies, focus on our core healthcare businesses, execute on our business strategy, and enhance our competitive position. These initiatives are detailed in Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; and Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div id="i04335d018da94076b0acf21e81ac886b_4947802327026"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in highly competitive environments in North America and Europe. In recent years, the healthcare industry has been subject to increasing consolidation. In the pharmaceutical distribution environment in which our U.S. Pharmaceutical and International segments operate, we face strong competition from international, national, regional, and local full-line, short-line, and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations. We consider our largest competitors in distribution, wholesaling, and logistics to be AmerisourceBergen Corporation and Cardinal Health, Inc. Our retail businesses, which primarily operate in our International segment, face competition from various global, national, regional, and local retailers, including chain and independent pharmacies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our RxTS business experiences substantial competition from many companies, including other biopharma services companies, software services firms, consulting firms, shared service vendors, and internet-based companies with technology applicable to the healthcare industry. Competition in this business varies in size from large to small companies, in geographical coverage, and in scope and breadth of products and services offered.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, home health care agencies, and other alternative sites with competition from a wide range of national and regional medical supply and equipment distributors throughout the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we compete with other service providers and healthcare manufacturers, as well as other potential customers of our businesses, which may from time to time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses. We believe that our scale and diversity of product and service offerings are our primary competitive advantages. In all areas, key competitive factors include price, quality of service, breadth of product lines, innovation and, in some cases, convenience to the customer. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_2051"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patents, Trademarks, Copyrights, and Licenses</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson and its subsidiaries hold patents, copyrights, trademarks, and trade secrets related to McKesson products and services. We pursue patent protection for our innovations and obtain copyright protection for our original works of authorship, when such protection is advantageous. Through these efforts, we have developed a portfolio of patents and copyrights in the U.S. and worldwide. In addition, we have registered or applied to register certain trademarks and service marks in the U.S. and in foreign countries.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that, in the aggregate, McKesson&#8217;s confidential information, patents, copyrights, trademarks, and intellectual property licenses are important to its operations and market position, but we do not consider any of our businesses to be dependent upon any one patent, copyright, trademark, or trade secret, or any family or families of the same. We cannot guarantee that our intellectual property portfolio will be sufficient to deter misappropriation, theft, or misuse of our technology, nor that we can successfully enjoin infringers. We periodically receive notices alleging that our products or services infringe on third-party patents and other intellectual property rights. These claims may result in McKesson entering settlement agreements, paying damages, discontinuing use or sale of accused products, or ceasing other activities. While the outcome of any litigation or dispute is inherently uncertain, we do not believe that the resolution of any of these infringement notices would have a material adverse impact on our results of operations. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold inbound licenses for certain intellectual property that is used internally, and in some cases, utilized in McKesson&#8217;s products or services. While in the future it may be necessary to seek or renew licenses relating to various aspects of our products and services, we believe, based upon past experience and industry practice, such licenses generally can be obtained on commercially reasonable terms. We believe our operations as well as our products and services are not materially dependent on any single license or other agreement with any third party.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2068"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our vision for a healthier world begins with our employees, who bring our mission to life every day. We deliver programs that focus on improving employee health and wellness, creating opportunities for growth and development, and providing an inclusive workplace where our employees can reach their full potential. At March 31, 2023, we had approximately 51,000 employees worldwide, including 6,000 part-time employees. We had approximately 35,000 employees in the U.S., 13,000 employees in Canada, and 3,000 employees in Europe. Our employees in Europe primarily relate to our remaining operations in Norway. Our headcount at March 31, 2023 decreased compared to the same prior year period due to the completed divestitures of the E.U. disposal group and U.K. disposal group during fiscal 2023. Approximately 26,000 former employees were associated with these divestitures. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report for additional information on our European divestiture activities. We also supplement our work force with contractors and/or consultants for certain business projects, processes, and/or operations as demand requires, including for programs such as the COVID-19 vaccine distribution and related ancillary supply kit programs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity, Equity, and Inclusion (&#8220;DEI&#8221;):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are committed to making the principles of DEI integral to everything we do because we believe building a healthier future is everyone&#8217;s business. We build successful teams by recruiting, developing, and retaining diverse talent and we recognize our culture of inclusion and belonging as an important element that drives long-term shareholder value. We offer various ongoing learning opportunities, such as our company-wide inclusion curriculum, to recognize, value, and leverage the diversity of our workforce, enhance the inclusiveness of our culture, and candidly discuss DEI topics. We also offer our employees the opportunity to join employee resource groups (&#8220;ERGs&#8221;), which are voluntary, employee-led, company-sponsored groups that focus on making a difference among our employees in North America. ERGs can help employees make authentic connections, showcase leadership skills, and create a positive impact. Our ERGs make our community even stronger by connecting people of all backgrounds and experiences and enabling them to feel that they are a part of something greater. Our 11 ERGs provide community and insights into the perspectives and experiences across different ethnicities, genders, generations, disability or military/veteran status, as well as members and allies of the LGBTQIA+ community. We hold regular town hall meetings where employees can ask questions of executives and make their voices heard.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023, women and people of color represented the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">McKesson<br/>Overall</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">McKesson</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leadership </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Metric </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">People of Color </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) (4)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The data for our metrics is derived from our voluntary self-identification process as of March 31, 2023 and therefore represents our best estimate at this time.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents our leadership at the vice president level and above.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents U.S. employees only because the data for Canada and Europe is not available.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">People of Color includes the following self-identification categories: American Indian or Alaska Native, Asian, Black or African American, Hispanic or Latino, Native Hawaiian or Other Pacific Islander, or Two or More Races.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Culture and Leadership:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> What sets McKesson apart as an exceptional place is our people. Our employees understand that together, unified by our global I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CARE and ILEAD principles, we fulfill our mission of improving care in every setting. Our I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CARE values (Integrity, Inclusion, Customer-First, Accountability, Respect, Excellence) are foundational to all that we do, and who we are as a company. ILEAD (Inspire, Leverage, Execute, Advance, Develop) is our common definition of and shared commitment to leadership. By embracing this commitment, we bring out the best in ourselves and position McKesson to continue to drive better health &#8211; for our company, our customers, and the patients they serve &#8211; for years to come. We promote leadership behaviors through culture initiatives that offer practical tips on how to debate, decide, and commit, be open and candid, and maintain an enterprise-first mindset when navigating conversations affecting operations within and across our business segments. These values and behaviors help make McKesson unique.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Employees: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support employee growth and development, we provide regular feedback and training, and work to create and maintain an inclusive environment where everyone can bring their authentic self to work and know they are appreciated, with their perspectives heard and considered. Through training, we encourage leaders to embrace diverse perspectives and lead inclusively. Employee development programs include training, coaching, and 360-degree assessments, which can support the careers of future leaders and their teams. We offer financial assistance programs for higher education opportunities that support employees&#8217; career growth at the company. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To provide compensation that is focused on attracting and retaining talent with the skills and experience necessary for a specific role, our compensation program is built on a set of quantifiable factors defined by our guiding principles of internal equity, market competitiveness, and pay for performance. We operate in several countries and our benefits vary accordingly. Our compensation philosophy is rooted in a commitment to our people by offering a fair and transparent program that regularly assesses the competitive job market based on geography and cost of labor. We use external resources to provide competitive benchmarking analyses against other companies and set pay ranges around the median of the competitive market.&#8239;&#8239;As part of our commitment to pay transparency, during fiscal 2023, we enhanced the insight and visibility of our employee compensation. The majority of our employees in North America can view the competitive base pay range for their roles as well as for new internal and external job postings. Also, the pay range for new external job postings is included on McKesson&#8217;s website (www.mckesson.com under the &#8220;Careers&#8221; caption). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer health and wellness benefits to advance the physical, mental, and social well-being of our people, savings programs to help prepare them for retirement, and flexible work arrangements, among other offerings, when possible. We seek employee feedback through annual and mid-year employee opinion surveys, which assesses our employees&#8217; levels of engagement, commitment, and overall satisfaction using industry benchmarks, and then design action plans to improve those metrics. We seek feedback on our people leaders through our annual manager quality survey, which is an opportunity for employees to help their managers grow professionally and build valuable leadership skills that create a positive, productive, and inclusive workplace at McKesson.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As broader U.S. labor markets continue to be challenging and evolving, we continue our dedication to recruiting and retaining qualified employees across the organization. In fiscal 2022, we made investments in our talent acquisition team by adding recruiters, systems, and process improvements to strengthen our ability to attract employees and reduce the lead time to fill open positions as well as updating and enhancing the benefits, rewards, and experiences we offer to our employees, making McKesson a great place to work. This is known as our &#8220;Employee Value Proposition&#8221; (&#8220;EVP&#8221;). Our EVP reflects what makes McKesson unique and which is demonstrated through the care we show to our employees and communities, the meaning we find in our work, and the sense of belonging we build across the organization. We continued to make investments in fiscal 2023 to retain our top talent, including providing long-term incentive awards for certain job markets and job classes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, we approved changes to our real estate strategy to increase efficiencies and support flexibility for our employees, as discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report. Our North American future of work approach is based on the following for certain employees: purposeful collaboration, flexibility, co-location, and leader-driven connections. We embraced a hybrid work model and certain of our employees have been coming together in person to collaborate with a purpose. While we remain committed to working flexibly, collaboration will continue to be a cornerstone of our philosophy. We believe that collaboration is critically important to staying connected and maintaining our culture. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health and Safety:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our security and safety departments employ systems designed to continually monitor our facilities and work environment to help identify and prevent or mitigate potential risks. This includes having procedures in place and investing in equipment for both physical and electronic security. We routinely assess facilities to closely monitor adherence to established security and safety standards. If we identify a vulnerability, it is documented, and the facility prepares an action plan. Our employees receive specialized training related to their role, work setting, and equipment used in their work environment. As our processes evolve, we update relevant safety training modules, which may include new employee training programs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, our priority has been, and continues to be, protecting the health and safety of our employees, customers, patients, and communities while also safeguarding the healthcare supply chain. We offer medical benefits covering COVID-19 related visits, testing (including over-the-counter tests), treatment and vaccines, telehealth options, and paid time off (&#8220;PTO&#8221;). We also have COVID-19 protocols in place, which have been designed, and updated as necessary, to be consistent with federal, state, and local laws and with customer requirements for our U.S. and Canada employees.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2085"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in many highly regulated industries and are subject to oversight by various federal, state, and local governmental entities in the U.S. and elsewhere. We incur significant expense and make large capital expenditures and investments to enable us to comply with regulations and guidance promulgated by governmental entities. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Risk Factors&#8221; in Item 1A of Part I below for information regarding material risks associated with our compliance with governmental regulations. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Controlled Substances:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are subject to the operating and security standards of the U.S. Drug Enforcement Administration (&#8220;DEA&#8221;), the U.S. Food and Drug Administration (&#8220;FDA&#8221;), HHS, the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), various state boards of pharmacy, state health departments, and comparable agencies in the U.S. and other countries. Certain of our businesses may be required to register for permits and/or licenses with government agencies, depending upon the type of operations and location of product development, manufacture, distribution, and sale. For example, we are required to hold valid DEA and state-level registrations and licenses, meet various security and operating standards, and comply with the Controlled Substances Act and its accompanying regulations governing the sale, marketing, packaging, holding, distribution, and disposal of controlled substances. We maintain extensive controlled substance monitoring and reporting programs at considerable expense in order to help us meet those standards. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Contracts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with government entities typically are subject to procurement laws that include socio-economic, employment practices, environmental protection, recordkeeping and accounting, and other requirements. These statutory and regulatory requirements complicate our business and increase our compliance burden. We are subject to audits, investigations, and oversight proceedings about our compliance with contractual and legal requirements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state, and local governmental entities in the U.S. and elsewhere continue to strengthen their position and scrutiny of practices that may indicate fraud, waste, and abuse affecting government healthcare programs such as Medicare and Medicaid. Our relationships with pharmaceutical and medical surgical product manufacturers, healthcare providers, and other companies and individuals, as well as our provision of products and services to government entities, subject our business to statutes, regulations, and government guidance that are intended to prevent fraud and abuse. Among other things, those laws: (1) prohibit persons from soliciting, offering, receiving, or paying any remuneration in order to induce the referral of an individual for, or to induce the ordering or purchasing of, items or services that are in any way paid for by Medicare, Medicaid, or other government-sponsored healthcare programs; (2) impose many restrictions upon referring physicians and providers of designated health services under Medicare and Medicaid programs; and (3) prohibit the knowing submission of a false or fraudulent claim for payment to, and knowing retention of an overpayment by, a federal healthcare program such as Medicare and Medicaid. Many of these laws are vague or indefinite and are often subject to varied and evolving interpretations by courts, regulators, and enforcing agencies and, as such, may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require us to make changes in our operations at added expense. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Patient Protection and Affordable Care Act (&#8220;ACA&#8221;) significantly expanded health insurance coverage to uninsured Americans and changed the way healthcare is financed by both governmental and private payers. The implementation of the Inflation Reduction Act of 2022 (&#8220;IR Act&#8221;) is anticipated to change benefit design and how Medicare pays for drugs, which are all intended to reduce the price of drugs. Three central features of the IR Act would authorize the government to negotiate drug prices for certain Parts B and D drugs over time, establish an inflation rebate program, and cap patient cost sharing under Medicare. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs. For example, provincial governments have taken steps to reduce consumer prices for generic pharmaceuticals and, in some provinces, change professional allowances paid to pharmacists by generic drug manufacturers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson continues to advocate for policies that would improve drug cost transparency under a patient's drug plan to better inform prescribing decisions, and also address access to care, affordability, and treatment regimen adherence, all designed to improve clinical outcomes and reduce the health spending burden.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, there have been increasing efforts by governments to regulate the pharmaceutical drug supply chain in order to prevent the introduction of counterfeit, stolen, contaminated, or otherwise harmful drugs into the pharmaceutical distribution system, otherwise known as pedigree tracking. For example, the U.S. Drug Quality and Security Act of 2013 (&#8220;DQSA&#8221;) requires us to participate in a federal prescription drug track and trace system that preempts state drug pedigree requirements, and the U.S. Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate effective technologies, such as track and trace or authentication technologies, to secure the pharmaceutical supply chain against counterfeit drugs. The Drug Supply Chain Security Act requires standardized, unit-level traceability of pharmaceutical products along the entire drug supply chain, with a goal of end-to-end unit-level traceability by November 27, 2023. Pedigree tracking laws such as these increase our compliance burden and our pharmaceutical distribution costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Security and Privacy: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to many privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction. Our efforts to comply with these laws complicates our operations and adds to our costs. For example, under the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) we must maintain administrative, physical, and technological safeguards to protect individually identifiable health information and ensure the confidentiality, integrity, and availability of electronic protected health information. We are subject to significant compliance obligations under privacy laws such as the General Data Protection Regulation (&#8220;GDPR&#8221;) in the European Union, the Personal Information Protection and Electronic Documents Act (&#8220;PIPEDA&#8221;) in Canada, and an expanding list of comprehensive state privacy laws in the United States. Some privacy laws prohibit the transfer of personal information to certain other jurisdictions or otherwise limit our use of data. Many of these laws also require us to provide access or other data rights (modification, deletion, portability, etc.) to consumers&#8217; and patients&#8217; individual personal data records within specified periods of time. Laws such as the federal Cyber Incident Reporting for Critical Infrastructure Act of 2022 may require us to provide notifications of significant data privacy breaches or cybersecurity incidents before our investigations are complete. We are subject to privacy and data protection compliance audits or investigations by various government agencies. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to many environmental and hazardous materials regulations, including those relating to radiation-emitting equipment operated at U.S. Oncology Network practices. Additionally, our operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes, and the cleanup of contaminated sites. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sold our chemical distribution operations in 1987 and retained responsibility for certain environmental obligations. Agreements with the U.S. Environmental Protection Agency and certain states may require environmental assessments and cleanups at several closed sites. These matters are described further in Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Climate Change Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governments in the U.S. and abroad are considering new or expanded laws to address climate change. Such laws may require reductions of greenhouse gas (&#8220;GHG&#8221;) emissions, mandates that companies implement processes to monitor and disclose climate-related matters, additional taxes or offset charges on specified energy sources, and other requirements. Compliance with climate-related laws may be further complicated by disparate regulatory approaches in various jurisdictions. New or expanded climate-related laws could impose costs on us, including capital expenditures to develop data gathering and reporting systems and additional GHG reduction measures. Until the timing and extent of climate-related laws are clarified, we cannot predict their potential effect on our capital expenditures, results of operations, or competitive position.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2102"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information about the Business</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During fiscal 2023, sales to our ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;) accounted for approximately 68% of our total consolidated revenues. Sales to our largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 27% of our total consolidated revenues in fiscal 2023. In fiscal 2023, we extended our pharmaceutical distribution partnership with CVS to June 2027. Our ten largest customers comprised approximately 42%, and CVS was approximately 21%, of our total trade accounts receivable at March 31, 2023. We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies, and other healthcare providers, as well as with government entities and agencies. The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. Substantially all of these revenues and accounts receivable are included in our U.S. Pharmaceutical segment. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Suppliers: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain pharmaceutical and other products from manufacturers, none of which accounted for more than our largest supplier at 12% of our total purchases in fiscal 2023. The loss of a supplier could adversely affect our business if alternate sources of supply are unavailable. We believe that our relationships with our suppliers are generally sound. The ten largest suppliers in fiscal 2023 accounted for approximately 70% of our total purchases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our distribution arrangements with manufacturers provide us consideration based on a percentage of our purchases. In addition, we have certain distribution arrangements with pharmaceutical manufacturers that include an inflation-based consideration component whereby we benefit when the manufacturers increase their prices as we sell our existing inventory at the new higher prices. For these manufacturers, a reduction in the frequency and magnitude of price increases, as well as restrictions in the amount of inventory available to us, could have an adverse impact on our gross profit margin.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and development expenses were $89&#160;million, $70&#160;million, and $74&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Information About Foreign and Domestic Operations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain financial information relating to foreign and domestic operations is discussed in Financial Note 20, &#8220;Segments of Business,&#8221; to the consolidated financial statements included in this Annual Report as well as in &#8220;Foreign Operations&#8221; in Item 7 of Part II of this Annual Report. See &#8220;Risk Factors&#8221; in Item 1A of Part I below for information regarding risks associated with our foreign operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_2119"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_13">Item 1 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report, including &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 7 of Part II of this report and the &#8220;Risk Factors&#8221; in Item 1A of Part I of this report, contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 (&#8220;Securities Act&#8221;) and section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by their use of terminology such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;approximately,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; &#8220;targets,&#8221; or the negative of these words or other comparable terminology. The discussion of financial trends, strategy, plans, assumptions, or intentions may also include forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, or implied. Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, the factors discussed in Item 1A of Part I of this report under &#8220;Risk Factors&#8221; and in our publicly available SEC filings and press releases. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date such statements were first made. Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to any forward-looking statements to reflect events or circumstances after the date the statements are made, or to reflect the occurrence of unanticipated events.</span></div><div id="i04335d018da94076b0acf21e81ac886b_16"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.&#160;&#160;&#160;&#160;Risk Factors. </span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO RISK FACTORS</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Section</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2271">Litigation and Regulatory Risks</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2271">14</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2298">Company and Operational Risks </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2298">16</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2325">Industry and Economic Risks</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2325">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2351">General Risks</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_2351">24</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below identifies certain representative risks that might cause our actual business results to materially differ from our estimates. It is not practical to identify or describe all risks and uncertainties that might materially impact our business operations, reputation, financial position, or results of operations. Our business could be materially affected by risks that we have not yet identified or that we currently consider to be immaterial. This is not a complete statement of all potential risks and uncertainties.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2271"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation and Regulatory Risks</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We experience costly and disruptive legal disputes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are routinely named as a defendant in litigation or regulatory proceedings and other legal disputes, which may include asserted class action litigation, such as those described in Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report. Regulatory proceedings involve allegations such as false claims, healthcare fraud and abuse, and antitrust violations. Civil litigation proceedings involve commercial, employment, environmental, intellectual property, tort, and other claims. Despite valid defenses that we assert, legal disputes are often costly, time-consuming, distracting to management, and disruptive to normal business operations. The uncertainty and expense associated with unresolved legal disputes might harm our business and reputation even if the matter ultimately is favorably resolved. The outcome of legal disputes is difficult to predict, and outcomes may occur that we believe are not justified by the evidence or existing law. Outcomes include monetary damages, penalties and fines, and injunctive or other relief that requires us to change our business operations and incur significant expense. Accordingly, legal disputes might have a materially adverse impact on our reputation, our business operations, and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">Item 1A Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might experience losses not covered by insurance or indemnification.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business exposes us to risks that are inherent in the distribution, manufacturing, dispensing, and administration of pharmaceuticals and medical-surgical supplies, the provision of ancillary services, the conduct of our payer businesses, and the provision of products that assist clinical decision-making and relate to patient medical histories and treatment plans. For example, pharmacy operations are exposed to risks such as improper filling of prescriptions, mislabeling of prescriptions, inadequacy of warnings, unintentional distribution of counterfeit drugs, and expiration of drugs. Although we seek to maintain adequate insurance coverage, such as property insurance for inventory and professional and general liability insurance, coverages on acceptable terms might be unavailable, or coverages might not cover our losses. We generally seek to limit our contractual exposure, but limitations of liability or indemnity provisions in our contracts may not be enforceable or adequately protect us from liability. Uninsured losses might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We experience costly legal disputes, government actions, and adverse publicity regarding our role in distributing controlled substances such as opioids.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a defendant in many litigation matters alleging claims related to the distribution of controlled substances (opioids), as described in Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements in this Annual Report. We are sometimes named as a defendant in similar, new cases. The plaintiffs in those cases include governmental entities (such as states, provinces, counties, and municipalities) as well as businesses, groups, and individuals. The cases allege violations of controlled substance laws and other laws, and they make common law claims such as negligence and public nuisance. Many of these cases raise novel theories of liability and can have unexpected outcomes that we believe are not justified by evidence or existing law. Legal proceedings such as these often involve significant expense, management time and distraction, and risk of loss that can be difficult to predict or quantify. It is not uncommon for claims to be resolved over many years. Outcomes include monetary damages, penalties and fines, and injunctive or other relief that requires us to change our business operations and incur significant expense. Although the Company has valid defenses and is vigorously defending itself, some proceedings have been and others may be resolved by negotiated outcome. For example, we are also subject to consent decrees issued by state courts that govern our distribution of controlled substances. Not all proceedings, however, are resolved by settlement. Our reputation has been and may continue to be impacted by publicity regarding opioids litigation and related allegations. An adverse outcome of any such legal proceedings might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might experience increased costs to distribute controlled substances such as opioids.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory, or industry measures related to the distribution of controlled substances such as prescription opioids could affect our business in ways that we may not be able to predict. For example, some states have passed legislation that could require us to pay taxes or assessments on the distribution of opioid medications in those states and other states have considered similar legislation. Liabilities for taxes or assessments or other costs of compliance under any such laws might have a materially adverse impact on our reputation, our business operations, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive, complex, and challenging healthcare, environmental, and other laws.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in &#8220;Government Regulation&#8221; in Item 1 of Part I above, our industry is highly regulated, and further regulation of our distribution businesses and technology products and services could impose increased costs, negatively impact our profit margins and the profit margins of our customers, delay the introduction or implementation of our new products, or otherwise negatively impact our business and expose the Company to litigation and regulatory investigations. We incur cleanup costs under environmental laws and may incur additional costs under environmental laws. Additionally, we are subject to various routine and ad hoc inspections by government agencies to determine compliance with various statutes and regulations. Any noncompliance by us with applicable laws or the failure to maintain, renew, or obtain necessary permits and licenses could lead to enforcement actions or litigation and might have a materially adverse impact on our business operations and our financial position or results of operations. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">Item 1A Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We are subject to extensive and frequently changing laws relating to healthcare fraud, waste, and abuse.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in &#8220;Government Regulation&#8221; in Item 1 of Part I above, federal, state, and local governmental entities in the U.S. and elsewhere continue to strengthen their position and scrutiny over practices that may indicate fraud, waste, and abuse affecting government healthcare programs such as Medicare and Medicaid. Those laws may be interpreted or applied in a manner that could require us to make changes in our operations at added expense. Failures to comply with those laws, including the federal Anti-Kickback Statute, expose us to federal or state government investigations or qui tam actions, and to liability for damages and civil and criminal penalties. Such failures might result in the loss of licenses or our ability to participate in Medicare, Medicaid, or other federal and state healthcare programs, or pursue government contracts. These sanctions might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might lose our ability to purchase, compound, store, or distribute pharmaceuticals and controlled substances.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in &#8220;Government Regulation&#8221; in Item 1 of Part I above, we are subject to the operating and security standards of the DEA, the FDA, various state boards of pharmacy, state health departments, the CMS, and other comparable agencies. Noncompliance with these requirements results in monetary penalties and/or licensing sanctions. Any inability to obtain, maintain, or renew permits, licenses, or other regulatory approvals needed for the operation of our businesses might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privacy and data protection laws increase our compliance burden.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in &#8220;Government Regulation&#8221; in Item 1 of Part I above, we are subject to a variety of privacy and data protection laws that change frequently and have requirements that vary from jurisdiction to jurisdiction. Failure to comply with these laws subjects us to potential regulatory enforcement activity, fines, private litigation including class actions, reputational impacts, and other costs. We also have contractual obligations that might be breached if we fail to comply with privacy and data security laws. Our efforts to comply with privacy and data security laws complicate our operations and add to our costs. A significant privacy breach or failure to comply with privacy and data security laws might have a materially adverse impact on our reputation, our business operations, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-bribery and anti-corruption laws increase our compliance burden.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws prohibiting improper payments and bribery, including the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, and similar regulations in other jurisdictions. Our failure to comply with these laws might subject us to civil and criminal penalties that might have a materially adverse impact on our reputation, our business operations, and our financial position or results of operations.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2298"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company and Operational Risks</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might record significant charges from impairment to goodwill, intangibles, and other long-lived assets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required under U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) to test our goodwill for impairment annually or more frequently if indicators for potential impairment exist. Indicators that are considered include significant changes in performance relative to expected operating results, significant changes in the use of the assets, significant negative industry or economic trends, or a significant decline in the Company&#8217;s stock price and/or market capitalization for a sustained period of time. In addition, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances, such as a divestiture, indicate the carrying value may not be recoverable. Factors that may be considered a change in circumstances indicating that the carrying value of our intangible and other long-lived assets may not be recoverable include slower growth rates, the loss of a significant customer, burdensome new laws, or divestiture of a business or asset for less than its carrying value. There are inherent uncertainties in management&#8217;s estimates, judgments, and assumptions used in assessing recoverability of goodwill, intangibles, and other long-lived assets. Any material changes in key assumptions, including failure to meet business plans, negative changes in government reimbursement rates, a deterioration in the U.S. and global financial markets, an increase in interest rates, an increase in inflation, or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances, may decrease the projected cash flows or increase the discount rates and could potentially result in an impairment charge. We may be required to record a significant charge to earnings in our consolidated financial statements during the period in which any impairment of our goodwill or intangible and other long-lived assets is determined, which might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">Item 1A Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We experience cybersecurity incidents that might significantly compromise our technology systems or might result in material data breaches.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, our external service providers, and other third parties with which we do business, use technology and systems to perform our business operations, such as the secure electronic transmission, processing, storage, and hosting of sensitive information, including protected health information and other types of personal information, confidential financial information, proprietary information, and other sensitive information relating to our customers, company, and workforce. Despite physical, technical, and administrative security measures, technology systems and operations of the Company and third parties with which we do business are subject to cyberattacks and cybersecurity incidents. Cybersecurity incidents include unauthorized occurrences on or conducted through our information systems, such as tampering, malware insertion, ransomware attacks, or other system integrity events. The risk of cyberattacks increases from time to time due to a variety of internal and external factors, including during political tensions, military conflicts, or civil unrest. A cybersecurity incident might involve a material data breach or other material impact to the confidentiality, integrity, availability, and operations of our technology systems or data, which might result in injury to patients or consumers, litigation or regulatory action, disruption of our business operations, loss of customers or revenue, and increased expense, any of which might have a materially adverse impact on our business, our reputation, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might experience significant problems with information systems or networks.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on sophisticated information systems and networks to perform our business operations, such as to obtain, rapidly process, analyze, and manage data that facilitate the purchase and distribution of thousands of inventory items from distribution centers. We provide remote services that involve hosting customer data and operating software on our own or third-party systems. Our customers rely on their ability to access and use these the systems and their data as needed. The networks and hosting systems are vulnerable to interruption or damage from sources beyond our control, such as power loss, telecommunications failures, fire, natural disasters, including as a result of climate change, software and hardware failures, and cybersecurity incidents. If those information systems or networks suffer errors, interruptions, or become unavailable, or if the timely delivery of medical care or other customer business requirements are impaired by data access, network, or systems problems, we might experience injury to patients or consumers, litigation or regulatory action, disruption of our business operations, loss of customers or revenue, and increased expense. Any such problems might have a materially adverse impact on our business, our reputation, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our technology products or services might not conform to specifications or perform as we intend.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell and provide services involving complex software and technology that may contain errors, especially when first introduced to market. Healthcare professionals delivering patient care tend to have heightened sensitivity to system and software errors. If our software and technology services are alleged to have contributed to faulty clinical decisions or injury to patients, we might be subject to claims or litigation by users of our software or services or their patients. Errors or failures might damage our reputation and negatively affect future sales. A failure of a system or software to conform to specifications might constitute a breach of warranty that could result in repair costs, contract termination, refunds of amounts previously paid, or claims for damages. Any of these types of errors or failures might have a materially adverse impact on our reputation, our business operations, and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmaceutical and medical products that we distribute might not conform to specifications or perform as intended.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We distribute pharmaceutical and medical products manufactured by third parties and by our private label generic pharmaceutical business, including medications that may be temperature sensitive and have limited shelf lives. Our systems are designed to maintain the safety and efficacy of the products throughout the distribution process. Issues affecting product efficacy or safety can arise from manufacturing, storing, distributing, dispensing or using products, and can result in safety alerts, recalls, regulatory action, civil lawsuits, fines or other sanctions, and reputational damage. Any of these types of issues or results might have a materially adverse impact on our reputation, our business operations, and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">Item 1A Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might not realize expected benefits from business process initiatives.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may implement restructuring, cost reduction, or other business process initiatives that might result in significant charges and expenses, failures to achieve our desired objectives, or unintended consequences such as distraction of our management and employees, business disruption, attrition beyond any planned reduction in workforce, inability to attract or retain key personnel and reduced employee productivity. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be unable to successfully complete or integrate acquisitions or other business combinations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth strategy includes consummating acquisitions or other business combinations that either expand or complement our business. To fund acquisitions, we may require financing that may not be available on acceptable terms. We may not receive regulatory approvals needed to complete proposed transactions, or such approvals may be subject to delays or conditions that reduce transaction benefits. Achieving the desired outcomes of business combinations involves significant risks including: diverting management&#8217;s attention from other business operations; challenges with assimilating the acquired businesses, such as integration of operations and systems; failure or delay in realizing operating synergies; difficulty retaining key acquired company personnel; unanticipated accounting or financial systems issues with the acquired business, which might affect our internal controls over financial reporting; unanticipated compliance issues in the acquired business; challenges retaining customers of the acquired business; unanticipated expenses or charges to earnings, including depreciation and amortization or potential impairment charges; and risks of known and unknown assumed liabilities in the acquired business. Any of these risks could adversely affect our ability to achieve the anticipated benefits of an acquisition and might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exclusive forum provisions in our Bylaws could limit our stockholders&#8217; ability to choose their preferred judicial forum for disputes with us or our directors, officers, or employees.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated bylaws provide that, unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for specified legal actions is the Court of Chancery of the State of Delaware or the United States District Court for the District of Delaware if the Court of Chancery does not have or declines to accept jurisdiction (collectively, &#8220;Delaware Courts&#8221;). Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action. These provisions of the bylaws are not a waiver of, and do not relieve anyone of duties to comply with, federal securities laws including those specifying the exclusive jurisdiction of federal courts under the Exchange Act and concurrent jurisdiction of federal and state courts under the Securities Act. To the extent that these provisions of the bylaws limit a current or former stockholder&#8217;s ability to select a judicial forum other than the Delaware Courts, they might discourage the specified legal actions, might cause current or former stockholders to incur additional litigation-related expenses, and might result in outcomes unfavorable to current or former stockholders. A court might determine that these provisions of the bylaws are inapplicable or unenforceable in any particular action, in which case we may incur additional litigation related expenses in such action, and the action may result in outcomes unfavorable to us, which could have a materially adverse impact on our reputation, our business operations, and our financial position or results of operations. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by delays or other difficulties with divestitures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we decide to sell assets or a business, we may encounter difficulty in finding buyers or exit strategies on acceptable terms or in a timely manner, which could delay the achievement of our strategic objectives. After the disposition, we might experience greater dissynergies than expected, and the impact of the divestiture on our revenue or profit might be larger than we expected. We might have difficulties with pre-closing conditions such as regulatory and governmental approvals, which could delay or prevent the divestiture. We might have financial exposure in a divested business, such as through minority equity ownership, financial or performance guarantees, indemnities, or other obligations, such that conditions outside of our control might negate the expected benefits of the disposition. Any of these risks could adversely affect our ability to achieve the anticipated benefits of a divestiture and might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">Item 1A Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might not realize the expected tax treatment from our split-off of Change Healthcare.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2020, the Company completed a separation of its interest in Change Healthcare LLC (&#8220;Change Healthcare JV&#8221;). The divestiture was effected through the split-off of PF2 SpinCo, Inc. (&#8220;SpinCo&#8221;), a wholly owned subsidiary of the Company that held all of the Company&#8217;s interest in the Change Healthcare JV, to certain of the Company&#8217;s stockholders through an exchange offer (the &#8220;Exchange Offer&#8221;), followed by a merger of SpinCo with and into Change Healthcare Inc. (&#8220;Change&#8221;), with Change surviving the merger (the &#8220;Merger&#8221; and, together with the Exchange Offer, the &#8220;Transactions&#8221;). The Company received an opinion from outside legal counsel to the effect that the Transactions qualified as generally tax-free transactions to the Company and its shareholders for U.S. federal income tax purposes. An opinion of legal counsel is not binding on the Internal Revenue Service (the &#8220;IRS&#8221;) or the courts, and the IRS or the courts may not agree with the intended tax-free treatment of the Transactions. In addition, the opinion could not be relied upon if certain assumptions, representations, and undertakings upon which the opinion was based are materially inaccurate or incomplete, or are violated in any material respect. If the intended tax-free treatment of the Transactions is not sustained, the Company and its stockholders who participated in the Transactions may be required to pay substantial U.S. federal income taxes. In connection with the Transactions, the Company, SpinCo, Change, and the Change Healthcare JV entered into the Tax Matters Agreement, which governs their respective rights, responsibilities, and obligations with respect to tax liabilities and benefits, tax attributes, tax contests, and other tax sharing regarding U.S. federal, state, and local, and non-U.S. taxes, other tax matters, and related tax returns. Under the Tax Matters Agreement, Change is required to indemnify the Company if the Transactions become taxable as a result of certain actions by Change or SpinCo, or as a result of certain changes in ownership of the stock of Change after the Merger. If Change does not honor its obligations to indemnify the Company, or if the Transactions fail to qualify for the intended tax-free treatment for reasons not related to a disqualifying action by Change or SpinCo, the resulting tax to the Company could have a significant adverse effect on our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by outsourcing or similar third-party relationships.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third parties to perform certain business and administrative functions for us. We might not adequately develop, implement, and monitor these outsourced service providers, and we might not realize expected cost savings or other benefits. Third-party services providers might fail to perform as anticipated, may experience cybersecurity incidents, or might cause us to incur operational difficulties, additional compliance requirements, or increased costs related to outsourced services. For example, our ability to use outsourcing resources in certain jurisdictions might be limited by legislative action or customer contracts, with the result that the work must be performed at greater expense or we may be subject to sanctions for non-compliance. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unsuccessful in achieving our strategic growth objectives.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business strategy as a diversified healthcare services company includes investing to build an integrated oncology service business and expand our biopharma services business. Our ability to grow those businesses will depend on our: hiring and retaining talented individuals with necessary knowledge and skills; acquiring, developing, and implementing new technologies and capabilities; forming and expanding business relationships; and successfully competing against providers of similar services. Some competitors have more experience than we do in enabling technologies such as data analytics. We may not achieve our desired return on our investments through our growth strategies. If we fail to achieve acceptable sales and profitability in our strategic growth areas, it might have a materially adverse impact on our business prospects and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be harmed by large customer purchase reductions, payment defaults, or contract non-renewal.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a significant portion of our revenue from, and have a significant portion of our accounts receivable with, a small number of customers. At March 31, 2023, sales to our largest customer represented approximately 27% of our total consolidated revenues and approximately 21% of our total trade receivables, and those of our ten largest customers combined accounted for approximately 68% of our consolidated revenues and approximately 42% of our trade receivables. Refer to &#8220;Other Information about the Business&#8221; in Item 1 of Part I above for additional details on our customers. A material default in payment, reduction in purchases, or the loss of business from a large customer might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">Item 1A Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our contracts with government entities involve future funding and compliance risks.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with government entities are subject to risks such as lack of funding and compliance with unique requirements. For example, government contract purchase obligations are typically subject to the availability of funding, which may be eliminated or reduced. In addition, the future volume of products or services purchased by a government customer is often uncertain. Our government contracts might not be renewed or might be terminated for convenience with little prior notice. Government contracts typically expose us to higher potential liability than do other types of contracts. In addition, government contracts typically are subject to procurement laws that include socio-economic, employment practices, environmental protection, recordkeeping and accounting, and other requirements. For example, our contracts with the U.S. government generally require us to comply with the Federal Acquisition Regulations, Procurement Integrity Act, Buy American Act, Trade Agreements Act, and other laws and regulations. We are subject to government audits, investigations, and oversight proceedings. Government agencies routinely review and audit government contractors to determine whether they are complying with contractual and legal requirements. If we fail to comply with these requirements, or we fail an audit, we may be subject to various sanctions such as monetary damages, criminal and civil penalties, termination of contracts, and suspension or debarment from government contract work. These requirements complicate our business and increase our compliance burden. The occurrence of any of these risks could harm our reputation and might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our participation in vaccination distribution programs may materially affect our operating results, reputation, and business.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our participation as a distributor in government-sponsored vaccination programs, such as the U.S. government&#8217;s COVID-19 distribution and related ancillary supply kit programs, exposes us to various uncertainties. For example, the changing distribution scope of COVID-19 vaccines, consumer demand, supply chain stability, and the cost of distribution subject our operating results to variability. Our participation in such programs also exposes us to various risks, including regulatory compliance, government oversight, dependence on government funding, contractual performance, litigation, security risks, and supply chain challenges. Any significant problems with our participation in such programs might have a materially adverse impact on our reputation and our business. Because of these risks and uncertainties, our operating results may be materially higher or lower than our projections.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We might be harmed by changes in our relationships or contracts with suppliers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We attempt to structure our pharmaceutical distribution agreements with manufacturers to ensure that we are appropriately and predictably compensated for the services we provide. Certain distribution agreements with manufacturers include pharmaceutical price inflation as a component of our consideration, and we cannot control the frequency or magnitude of pharmaceutical price changes. Laws limiting or reducing pharmaceutical prices may impact our distribution agreements. We might be unable to renew pharmaceutical distribution agreements with manufacturers in a timely and favorable manner. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might infringe intellectual property rights or our intellectual property protections might be inadequate.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our products and services do not infringe the proprietary rights of third parties, but third parties have asserted infringement claims against us and may do so in the future. If a court were to hold that we infringed other&#8217;s rights, we might be required to pay substantial damages, develop non-infringing products or services, obtain a license, stop selling or using the infringing products or services, or incur other sanctions. We rely on trade secret, patent, copyright, and trademark laws, nondisclosure obligations, and other contractual provisions and technical measures to protect our proprietary rights in our products and solutions. We might initiate costly and time-consuming litigation to protect our trade secrets, to enforce our patent, copyright, and trademark rights and to determine the scope and validity of the proprietary rights of others. Our intellectual property protection efforts might be inadequate to protect our rights. Our competitors might develop non-infringing products or services equivalent or superior to ours. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">Item 1A Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our use of third-party data is subject to limitations that could impede the growth of our data services business.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We attempt to structure our diligence processes to satisfy contractual and other operative data usage rights and limitations associated with customer, industry partners, and other third-party data flowing through our businesses. These rights and limitations can apply to confidential commercial data and personal data provided to us. Failure to satisfy these data usage rights and limitations can lead to legal claims such as contractual breaches or privacy law violations. If a court were to hold that our use of data is not consistent with our rights and limitations, we might be required to pay substantial damages; we may need to stop using, sharing, and/or selling certain products and services; or we could incur other financial, legal, and/or reputational consequences. In addition, in order to reach our data strategy growth objectives, we might be unable to obtain at an acceptable cost the data usage rights needed to advance such goals. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be unable to successfully recruit and retain qualified employees.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract, engage, develop, and retain qualified and experienced employees, including key executives and other talent, is essential for us to meet our objectives. We compete with many other businesses to attract and retain employees. Competition among potential employers results in increased salaries, benefits, or other employee-related costs, or in our failure to recruit and retain employees. We may experience sudden loss of key personnel due to a variety of causes, such as illness, and must adequately plan for succession of key management roles. Employees might not successfully transition into new roles. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2325"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry and Economic Risks</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by healthcare reform such as changes in pricing and reimbursement models.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our products and services are designed and intended to function within the structure of current healthcare financing and reimbursement systems. The healthcare industry and related government programs are changing. Some of these changes increase our risks and create uncertainties for our business. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, some changes in reimbursement methodologies (including government rates) for pharmaceuticals, medical treatments, and related services reduce profit margins for us and our customers and impose new legal requirements on healthcare providers. Those changes have included cuts in Medicare and Medicaid reimbursement levels, changes in the basis for payments, shifts from fee-for-service pricing towards value-based payments and risk-sharing models, and increases in the use of managed care.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the ACA significantly expanded health insurance coverage to uninsured Americans and changed the way healthcare is financed by both governmental and private payers. Enactment of the IR Act and its implementation over the next several years is anticipated to bring meaningful changes in how Medicare pays for drugs and various benefit design changes, which are all intended to reduce the price of drugs. Three central features of the IR Act would authorize the government to negotiate drug prices for certain Parts B and D drugs over time, establish an inflationary rebate program, and cap patient cost sharing under Medicare. The implementation of these and other features of the IR Act may result in significant changes to the pharmaceutical value chain as manufacturers, pharmacy benefit managers, managed care organizations, and other industry stakeholders look to implement new transactional flows and adapt their business models. Any such changes to arrangements involving our business as a result of this legislation, such as changes to our distribution agreements with manufacturers impacted by the IR Act, may materially affect our business. The extent of the effects of the IR Act remains uncertain due to a number of factors, including the potential for future regulations promulgated by the HHS to implement provisions of the IR Act. We continue to evaluate the impact of this law on our business.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Private challenges to government healthcare policy may also have significant impacts on our business. For example, over a dozen pharmaceutical manufacturers have unilaterally restricted sales under the 340B drug pricing program to contract pharmacies. The 340B drug pricing program requires manufacturers to offer discounts on certain drugs purchased by &#8220;covered entities,&#8221; which include safety-net providers. The Health Resources and Services Administration has taken the position that a covered entity may dispense such discounted drugs through multiple contract pharmacies. Starting in 2020, some manufacturers began to restrict such practices. Some manufacturers and the HHS continue to litigate these issues. The U.S. Court of Appeals for the Third Circuit has ruled that Section 340B does not require discounts for an unlimited number of contract pharmacies. Two other courts of appeal are addressing this issue but have not yet ruled.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">Item 1A Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provincial governments in Canada that provide partial funding for the purchase of pharmaceuticals and independently regulate the sale and reimbursement of drugs have sought to reduce the costs of publicly funded health programs. For example, provincial governments have taken steps to reduce consumer prices for generic pharmaceuticals and, in some provinces, change professional allowances paid to pharmacists by generic manufacturers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there is substantial uncertainty about the likelihood, timing, and results of these health reform efforts, their implementation might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by competition and industry consolidation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses face a highly competitive global environment with strong competition from international, national, regional, and local full-line, short-line, and specialty distributors, service merchandisers, self-warehousing chain drug stores, manufacturers engaged in direct distribution, third-party logistics companies, and large payer organizations. In addition, our businesses face competition from various other service providers and from pharmaceutical and other healthcare manufacturers as well as other potential customers, which may from time-to-time decide to develop, for their own internal needs, supply management capabilities that might otherwise be provided by our businesses. Due to consolidation, a few large suppliers control a significant share of the pharmaceuticals market. This concentration reduces our ability to negotiate favorable terms with suppliers and causes us to depend on a smaller number of suppliers. Many of our customers, including healthcare organizations, have consolidated or joined group purchasing organizations and have greater power to negotiate favorable prices. Consolidation by our customers, suppliers, and competitors might reduce the number of market participants and give the remaining enterprises greater bargaining power, which might lead to erosion in our profit margin. Consolidation might increase counter-party credit risk because credit purchases increase for fewer market participants. These competitive pressures and industry consolidation might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by changes or disruptions in product supply and have difficulties in sourcing or selling products due to a variety of causes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We might experience difficulties and delays in sourcing and selling products due to a variety of causes, such as: difficulties in complying with the legal requirements for export or import of pharmaceuticals or components; suppliers&#8217; failure to satisfy production demand; manufacturing or supply problems such as inadequate resources; and real or perceived quality issues. For example, the FDA banned certain manufacturers from selling raw materials and drug ingredients or finished goods in the U.S. due to quality issues. Difficulties in product manufacturing or access to raw materials or finished goods could result in supplier production shutdowns, product shortages, and other supply disruptions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our supply arrangements might be interrupted or adversely affected by a variety of causes over which we have no control, such as export controls or trade sanctions, labor disputes, unavailability of key manufacturing sites, inability to procure raw materials or finished goods, quality control concerns, ethical sourcing issues, supplier&#8217;s financial distress, natural disasters, including as a result of climate change, civil unrest or acts of war, the impact of epidemics or pandemics, and other general supply constraints. Our inventory might be requisitioned, diverted, or allocated by government order such as under emergency, disaster, and civil defense declarations. Changes in the healthcare industry&#8217;s or our suppliers&#8217; pricing, selling, inventory, distribution, or supply policies or practices could significantly reduce our revenues and net income. Any of these changes or disruptions might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">Item 1A Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted as a result of our distribution of generic pharmaceuticals. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our generic pharmaceuticals distribution business is subject to both availability and pricing risks. We might experience disruptions in our supply of higher margin pharmaceuticals, including generic pharmaceuticals. We have been impacted when, due to regulatory and supply chain challenges, our supplier partners are not able to deliver products that we have committed to purchase and source from them. Input cost increases and market shortages could result in ClarusONE, our joint venture with Walmart Inc., being unsuccessful in sourcing product to meet the needs of our customers, or negatively impacting our margin. Generic drug manufacturers offer a generic version of branded pharmaceuticals and routinely challenge the validity or enforceability of branded pharmaceutical patents in order to launch the drug pre- or post-loss of exclusivity. Patent holders have asserted infringement claims against us for distributing those generic versions they believed to have infringed a patent, and the generic drug manufactures may not fully indemnify us against such claims. These risks and outcomes, as well as changes in the availability, pricing volatility, regulatory, or significant changes in the nature, frequency, or magnitude of generic pharmaceutical launches, might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by changes in the economic environments in which we operate, including from inflation, an economic slowdown, or a recession.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflationary conditions result in increased costs and decreased levels of consumer commercial spending and, to the extent we are not able to offset such cost increases from our suppliers, increase the costs which we incur to purchase inventories and services. Inflationary pressure is increased by factors such as supply chain disruptions, including the reduced availability of key commodities, labor market tightness, and government policies that lower interest rates or do not raise them sufficiently to counteract inflation. Cost inflation during fiscal 2023 generally increased our transportation, operational, and other administrative costs associated with our normal business operations. An economic slowdown or a recession could reduce the prices our customers are able or willing to pay for our products and services and reduce the volume of their purchases. In addition to rising inflation, rising interest rates, the impact of recent banking failures or perceived failures and related contagion, political tensions, military conflicts, and civil unrest may contribute to recessionary pressure. Changes in the economic environments in which we operate might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes affecting capital and credit markets might impede access to credit, increase borrowing costs, and disrupt banking services for us and our customers and suppliers and might impair the financial soundness of our customers and suppliers.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volatility and disruption in global capital and credit markets, including the bankruptcy or restructuring of certain financial institutions, reduced lending activity by financial institutions, reduced creditworthiness of our customers or suppliers, or decreased liquidity and increased costs in the commercial paper market, might adversely affect the borrowing ability and cost of borrowing for us and our customers and suppliers. We generally sell our products and services under short-term unsecured credit arrangements. An adverse change in general or entity specific economic conditions or access to capital might cause our customers to reduce their purchases from us, or delay or fail paying amounts owed to us. Suppliers might increase their prices, reduce their output, or change their terms of sale due to limited availability of credit. Suppliers might be unable to make payments due to us for fees, returned products, or incentives. Interest rate increases or changes in capital market conditions, including as a result of macroeconomic events, might impede our or our customers&#8217; or suppliers&#8217; ability or cost to obtain credit. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by tax legislation or challenges to our tax positions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the tax laws in the U.S. at the federal, state, and local government levels and to the tax laws of other jurisdictions in which we operate or sell products or services. Tax laws might change in ways that adversely affect our tax positions, effective tax rate, and cash flow. The tax laws are extremely complex and subject to varying interpretations. We are subject to tax examinations in various jurisdictions that might assess additional tax liabilities against us. Our tax reporting positions are sometimes challenged by relevant tax authorities, we might incur significant expense in our efforts to defend those challenges, and we might be unsuccessful in those efforts. Developments in examinations and challenges might materially change our provision for taxes in the affected periods and might differ materially from our historical tax accruals. Any of these risks might have a materially adverse impact on our business operations, our cash flows, and our financial position or results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_16">Item 1A Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by fluctuations in foreign currency exchange rates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct our business in various currencies, including the U.S. dollar, Canadian dollar, Euro, and British pound sterling. Changes in foreign currency exchange rates could reduce our revenues, increase our costs, or otherwise adversely affect our financial results reported in U.S. dollars. For example, we are exposed to transactional currency exchange risk due to our import and export of products that are purchased or sold in currencies other than the U.S. dollar. We also have currency exchange risk due to intercompany loans denominated in various currencies. Currency exchange rates and their volatility are affected by factors outside of our control, such as political tensions, military conflicts, and civil unrest. We may from time to time enter into foreign currency contracts, foreign currency borrowings, or other techniques intended to hedge a portion of our foreign currency exchange rate risks. These hedging activities may not completely offset the adverse financial effects of unfavorable movements in foreign currency exchange rates during the time the hedges are in place. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2351"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risks</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We might be adversely impacted by events outside of our control, such as widespread public health issues, natural disasters, political events, and other catastrophic events.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We might be adversely affected by events outside of our control, including: widespread public health issues, such as epidemic or pandemic infectious diseases; natural disasters such as earthquakes, floods, or severe weather, including as a result of climate change; political events such as terrorism, political tensions, military conflicts, civil unrest, and trade wars; and by other catastrophic events. These events can disrupt operations for us, our suppliers, our vendors, and our customers. They might affect consumer confidence levels and spending or the availability of certain goods or commodities. For example, the war between Russia and Ukraine has resulted in global economic uncertainty and increased costs of various commodities. The COVID-19 pandemic impaired, and future pandemics might impair, product manufacturing, supply, and transport availability and cost in unpredictable ways that depend on highly uncertain future developments. In response to these types of events, we might suspend operations, implement extraordinary procedures, seek alternate sources for product supply, or suffer consequences that are unexpected and difficult to mitigate. Any of these risks might have a materially adverse impact on our business operations and our financial position or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by global climate change or by legal, regulatory, or market responses to such change.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The long-term effects of climate change are difficult to predict and may be widespread. The impacts may include physical risks (such as rising sea levels or frequency and severity of extreme weather conditions), social and human effects (such as population dislocations or harm to health and well-being), compliance costs and transition risks (such as regulatory or technology changes), costs for critical services (such as transportation costs), and other adverse effects. The effects could impair, for example, the availability and cost of certain products, commodities, transportation, and energy (including utilities), which in turn may impact our ability to procure goods or services, and transport those goods, required for the operation of our business at the quantities and levels we require. Proposed changes to federal acquisition regulations and securities reporting rules, for example, would impose increased costs to comply with reporting and disclosure requirements. We bear losses incurred as a result of, for example, physical damage to or destruction of our facilities (such as distribution or fulfillment centers), loss or spoilage of inventory due to unusual ambient temperatures, and business interruption due to weather events that may be attributable to climate change. These events and impacts could have a materially adversely impact on our business operations and our financial position or results of operation.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_19"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B.&#160;&#160;&#160;&#160;Unresolved Staff Comments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i04335d018da94076b0acf21e81ac886b_22"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Properties.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the nature of our principal businesses, our plant, warehousing, retail pharmacies, offices, and other facilities are operated in widely dispersed locations, primarily throughout North America. Retail pharmacies and most warehouses are typically owned or leased on a long-term basis. We consider our operating properties to be in satisfactory condition and adequate to meet our needs for the next several years without making capital expenditures materially higher than historical levels. Information as to material lease commitments is included in Financial Note 9, &#8220;Leases,&#8221; to the consolidated financial statements included in this Annual Report. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we announced our</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intention to exit our businesses in Europe. As of March 31, 2023, the majority of our properties in Europe were divested and our remaining business operations reside in Norway, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, we approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of our office space in North America. Where we ceased using office space, we exited the portion of the facility no longer used. We also retained and repurposed certain other office locations. This initiative was substantially completed in fiscal 2022. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report for further details</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </span></div><div id="i04335d018da94076b0acf21e81ac886b_25"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Legal Proceedings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain legal proceedings in which we are involved are discussed in Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report. Disclosure of an environmental proceeding with a governmental agency is generally included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.</span></div><div id="i04335d018da94076b0acf21e81ac886b_28"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Mine Safety Disclosures.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_31"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information about our Executive Officers</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding the executive officers of the Company, including their principal occupations during the past five years.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships between any of the executive officers or directors of the Company. The term of office of each executive officer expires at the first meeting of the Board of Directors (the &#8220;Board&#8221;) following the annual meeting of shareholders, or until their successors are elected and have qualified, or until death, resignation, or removal, whichever is sooner.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Age</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Position with Registrant and Business Experience</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian S. Tyler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and a director since April 2019; President and Chief Operating Officer from August 2018 to March 2019; Chairman of the Management Board of McKesson Europe AG from 2017 to 2018; President and Chief Operating Officer, McKesson Europe from 2016 to 2017; President of North America Distribution and Services from 2015 to 2016; and Executive Vice President, Corporate Strategy and Business Development from 2012 to 2015.&#160;Service with the Company - 26 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Britt J. Vitalone</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer since January 2018; Senior Vice President and Chief Financial Officer, U.S. Pharmaceutical from July 2014 to December 2017; Senior Vice President and Chief Financial Officer, U.S. Pharmaceutical and Specialty Health from October 2017 to December 2017; Senior Vice President of Corporate Finance and M&amp;A Finance from March 2012 to June 2014.&#160;Service with the Company - 17 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LeAnn B. Smith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Human Resources Officer since December 2022. Previously, Senior Vice President, Talent Management and Development from 2021 to 2022. Chief People Leader, Global Corporate Functions for Walmart Inc. from 2018 to 2021. Service with the Company - 2 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nancy Avila</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Information Officer and Chief Technology Officer since January 2020. Chief Information Officer, Johnson Controls from 2018 to July 2019. Corporate Officer and Vice President of Business and Technology Services, Abbott Laboratories from 1996 to 2018. Service with the Company - 3 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas L. Rodgers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Strategy and Business Development Officer since June 2020. Previously, Senior Vice President and Managing Director of McKesson Ventures from 2014 to 2020. Service with the Company - 9 years.</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lori A. Schechter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Legal Officer and General Counsel since June 2014. Associate General Counsel from January 2012 to June 2014. Litigation Partner, Morrison &amp; Foerster LLP from 1995 to December 2011. Service with the Company - 11&#160;years.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_34"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i04335d018da94076b0acf21e81ac886b_37"></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market Information: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal market on which our common stock is traded is the New York Stock Exchange (&#8220;NYSE&#8221;) under the trading symbol &#8220;MCK.&#8221;</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Holders: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023, there were 4,425 holders of record of our common stock.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In July 2022, our quarterly dividend was raised from $0.47 to $0.54 per common share for dividends declared on or after such date by the Board.&#160;We declared regular cash dividends of $2.09, $1.83, and $1.67 per share for the years ended March 31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will continue to pay quarterly cash dividends in the future. However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plans:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Information relating to this item is provided under Item 12 of Part III included in this Annual Report.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board has authorized the repurchase of McKesson&#8217;s common stock. Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, tax implications, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. During the last three fiscal years, our share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our share repurchases for the last three fiscal years:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2021 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2022 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - December 2022 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,693)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $8 million was accrued within &#8220;Other accrued liabilities&#8221; in our Consolidated Balance Sheet as of March 31, 2021, included in our Annual Report on Form 10-K for the year ended March 31, 2022, for share repurchases that were executed in late March 2021 and settled in early April 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In February 2022, we entered into an ASR program with a third-party financial institution to repurchase $1.5 billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.1 million shares at an average price per share of $295.16. We received 4.8 million shares as the initial share settlement in the fourth quarter of fiscal 2022 based on an initial share purchase price, and in May 2022, we received an additional 0.3 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $27 million was accrued within &#8220;Other accrued liabilities&#8221; in our Consolidated Balance Sheet as of March 31, 2023 for share repurchases that were executed in late March 2023 and settled in early April 2023.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our share repurchases during the fourth quarter of fiscal 2023:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2023 - January 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2023 - February 28, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2023 - March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In December 2022, we entered into an ASR program with a third-party financial institution to repurchase $972 million of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 2.6 million shares at an average price per share of $369.20. We received 2.2 million shares as the initial share settlement in the third quarter of fiscal 2023, and in February 2023, we received an additional 0.4 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In July 2022, the Board authorized the Company to repurchase up to an additional $4.0 billion of its common shares in a manner deemed in the best interest of the Company and its stockholders, considering other growth opportunities and prevailing business and market conditions. The authorization has no expiration date. </span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Price Performance Graph*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The following graph compares the cumulative total stockholder return on our common stock for the periods indicated with the Standard &amp; Poor&#8217;s (&#8220;S&amp;P&#8221;) 500 Index and the S&amp;P 500 Health Care Index. The S&amp;P 500 Health Care Index was selected as a comparator because it is generally available to investors and broadly used by other companies in the same industry.</span></div><div style="text-align:center"><img src="mck-20230331_g2.jpg" alt="3944" style="height:350px;margin-bottom:5pt;vertical-align:text-bottom;width:640px"/><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:28.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.05&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Index</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Health Care Index</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.89&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.73&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.44&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.55&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.83&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Assumes $100 invested in McKesson Common Stock and in each index on March 31, 2018 and that all dividends are reinvested.</span></div><div id="i04335d018da94076b0acf21e81ac886b_40"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Reserved.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_43"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Section</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_46">General</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_46">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_49">Overview of Our Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_49">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_52">Executive Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_52">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_55">Trends and Uncertainties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_55">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_58">Overview of Consolidated Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_58">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_61">Overview of Segment Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_61">43</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_67">Foreign Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_67">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_70">Business Combinations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_70">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_73">Fiscal 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_73">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_73"> Outlook</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_73">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_76">Critical Accounting</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_76"> Estimates</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_76">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_79">Financial Condition, Liquidity, and Capital Resources</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_79">51</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_85">Related Party Balances and Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_85">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_88">New Accounting Pronouncements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_88">57</a></span></div></td></tr></table></div><div id="i04335d018da94076b0acf21e81ac886b_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of financial condition and results of operations, referred to as the &#8220;Financial Review,&#8221; is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of McKesson Corporation together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;McKesson,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221; and other similar pronouns). This discussion and analysis should be read in conjunction with the consolidated financial statements and accompanying financial notes in Item 8 of Part II of this Annual Report on Form 10-K (&#8220;Annual Report&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean our fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Financial Review within this Annual Report generally discusses fiscal 2023 and fiscal 2022 results and year-over-year comparisons between fiscal 2023 and fiscal 2022. For a discussion of our year-over-year comparisons between fiscal 2022 and fiscal 2021, refer to Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of Part II of our Annual Report on Form 10-K for the year ended March 31, 2022, previously filed with the Securities and Exchange Commission on May&#160;9, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this Annual Report constitute forward-looking statements. See Item 1 - Business - Forward-Looking Statements in Part I of this Annual Report for additional factors relating to these statements and Item 1A - Risk Factors in Part I of this Annual Report for a list of certain risk factors applicable to our business, financial condition and liquidity, and results of operations.</span></div><div id="i04335d018da94076b0acf21e81ac886b_49"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Our Business:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report our financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects as well as the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of individual business activities. We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes our four reportable segments. Refer to Financial Note 20, &#8220;Segments of Business,&#8221; to the consolidated financial statements included in this Annual Report for further information regarding our reportable segments.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">U.S. Pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a reportable segment that combines automation and our ability to navigate the healthcare ecosystems to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to address patients&#8217; medication access, affordability, and adherence challenges. RxTS also offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that provides medical-surgical supply distribution, logistics, and other services to healthcare providers in the United States (&#8220;U.S.&#8221;), including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the U.S.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that includes our operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. During fiscal 2023, we completed transactions to sell certain of our businesses in the European Union (&#8220;E.U.&#8221;) and our retail and distribution businesses in the United Kingdom (&#8220;U.K.&#8221;), and during fiscal 2022, we completed the sale of our Austrian business. These divestitures are further described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;European Divestiture Activities&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section below. Our remaining operations in Europe provide distribution and services to wholesale, institutional, and retail customers in Norway where we own, partner, or franchise with retail pharmacies. Our operations in Canada deliver vital medicines, supplies and information technology solutions throughout Canada and includes Rexall Health pharmacies.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Acquisitions and Divestitures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rx Savings Solutions, LLC</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed the acquisition of 100% of the shares of Rx Savings Solutions, LLC (&#8220;RxSS&#8221;), a privately-owned company headquartered in Overland Park, Kansas, to further connect our biopharma and payer services to patients. RxSS is a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers. The purchase consideration included a payment of $600&#160;million in cash made upon closing and a maximum of $275&#160;million of contingent consideration based on RxSS&#8217; operational and financial performance through calendar year 2025. The payment made upon closing was funded from cash on hand, and we recorded a liability of $92&#160;million as of the acquisition date representing the estimated fair value of the contingent consideration. As of March 31, 2023, the current portion of $83&#160;million is included within &#8220;Other accrued liabilities&#8221; and the long-term portion of $9&#160;million is included within &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet. The financial results of RxSS are included in our RxTS segment as of the acquisition date. The transaction was accounted for as a business combination.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SCRI Oncology, LLC</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, we completed a transaction with HCA to form SCRI Oncology, LLC (&#8220;SCRI Oncology&#8221;), an oncology research business, combining our U.S. Oncology Research (&#8220;USOR&#8221;) and HCA&#8217;s Sarah Cannon Research Institute (&#8220;SCRI&#8221;) based in Nashville, Tennessee, to advance cancer care and increase access to oncology clinical research. Upon consummation of the transaction, we own a 51% controlling interest in the combined business, and the financial results are consolidated and reported within our U.S. Pharmaceutical segment as of the acquisition date. Transaction consideration included the transfer of full ownership interest in USOR to the combined business and $173&#160;million of cash paid to HCA, which was funded from cash on hand. The transaction was accounted for as a business combination.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, we completed the previously announced transaction to sell certain of our businesses in the E.U. located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with our German headquarters and wound-care business, part of a shared services center in Lithuania, and our ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group. As part of the transaction, we received cash proceeds of $892 million and divested net assets of $1.3 billion, including cash of $319 million, derecognized the carrying value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) of $382 million, and released $153 million of net accumulated other comprehensive loss. We recorded net gains of $66 million and net charges of $438 million for the years ended March 31, 2023 and 2022, respectively, in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations to remeasure the assets and liabilities of our E.U. disposal group to fair value less costs to sell. The fiscal 2022 charges also included impairments of certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole, and net losses of $151 million related to the accumulated other comprehensive loss balances associated with our E.U. disposal group, driven by declines in the Euro.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2022, we completed the previously announced sale of our retail and distribution businesses in the U.K. (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;110 million (or, approximately $144 million), including certain adjustments. As part of the transaction, we divested net assets of $615 million and released $731 million of accumulated other comprehensive loss. During the year ended March 31, 2022, we recorded charges totaling $1.2 billion within &#8220;Selling, distribution, general, and administrative expenses&#8221; in our Consolidated Statement of Operations to remeasure the U.K. disposal group to fair value less costs to sell. The remeasurement adjustment included a $734 million loss related to the accumulated other comprehensive loss balances associated with the U.K. disposal group, driven by declines in the British pound sterling.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2022, we completed the sale of our Austrian business to Quadrifolia Management GmbH in a management-led buyout for a purchase price of &#8364;244 million (or, approximately $276 million), including certain adjustments. During the year ended March 31, 2022, we recognized a loss of $32 million related to this divestiture which was recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in our Consolidated Statement of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, we had no assets or liabilities related to these completed European divestiture activities that met the classification of held for sale in the Consolidated Balance Sheet. Subsequent to the divestiture activities discussed above, the Company&#8217;s European operations primarily consist of its retail and distribution businesses in Norway. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report for more information regarding these acquisition and divestiture transactions.</span></div><div id="i04335d018da94076b0acf21e81ac886b_52"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Summary:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary provides highlights and key factors that impacted our business, operating results, financial condition, and liquidity for the year ended March 31, 2023:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For the year ended March 31, 2023 compared to the prior year, revenues increased by 5%, gross profit decreased by 6%, total operating expenses decreased by 28%, and other income, net increased by 92%. Refer to the &#8220;Overview of Consolidated Results&#8221; section below for an analysis of these changes;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.2pt">Diluted earnings per common share from continuing operations attributable to McKesson Corporation increased to $25.05 in fiscal 2023 from $7.26 in the prior year, primarily driven by lower remeasurement charges of the U.K. and E.U. disposal groups recorded in fiscal 2023 compared to the prior year, and a lower share count due to the cumulative effect of share repurchases;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In fiscal 2023, we extended our pharmaceutical distribution partnership with CVS to June 2027; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On November 1, 2022, we completed our acquisition of RxSS. The purchase consideration included a payment of $600&#160;million in cash made upon closing and a maximum of $275&#160;million of contingent consideration, as discussed in further detail in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Business Acquisitions and Divestitures&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On October 31, 2022, we completed a transaction with HCA to form SCRI Oncology. The transaction consideration included the transfer of full ownership interest in USOR to the combined business and $173&#160;million of cash paid to HCA as discussed in further detail in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Business Acquisitions and Divestitures&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On October 31, 2022, we completed the sale of our E.U. disposal group and received cash proceeds of $892 million, as discussed in further detail in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Business Acquisitions and Divestitures&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">In October 2022, we received </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$129 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to our share of an antitrust settlement. This amount was recorded as a gain within &#8220;Cost of sales&#8221; in the Consolidated Statement of Operations within our U.S. Pharmaceutical segment;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">In October 2022, we received </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$126 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due to early termination of a tax receivable agreement (&#8220;TRA&#8221;) with Change Healthcare Inc. (&#8220;Change&#8221;). This amount was recorded as a gain within &#8220;Other income, net&#8221; in the Consolidated Statement of Operations within Corporate;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">During the third quarter of fiscal 2023, we terminated our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$500 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> notional forward starting fixed interest rate swaps and recognized a gain on the termination of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$97 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within &#8220;Other income, net&#8221; in the Consolidated Statement of Operations within Corporate;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">In July 2022, we exited one of our investments in equity securities for proceeds of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$179 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and recognized a gain of $142 million within &#8220;Other income, net&#8221; in the Consolidated Statement of Operations within our U.S. Pharmaceutical segment;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">On March 15, 2023, we retired our $360&#160;million outstanding principal amount of 2.85% Notes due 2023 (the &#8220;2.85% Notes&#8221;) upon maturity. These notes were repaid using cash on hand;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On February 15, 2023, we completed a public offering of 5.25% Notes due 2026 (the &#8220;5.25% Notes&#8221;) in a principal amount of $500 million. Proceeds received from this note issuance, net of discounts and offering expenses, were $497 million;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">On December 15, 2022, we retired our $400&#160;million outstanding principal amount of 2.70% Notes due 2022 (the &#8220;2.70% Notes&#8221;) upon maturity. These notes were repaid using cash on hand;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On November 7, 2022, we entered into a syndicated $4.0 billion five-year senior unsecured credit facility (the &#8220;2022 Credit Facility&#8221;) which matures in November 2027 and replaced our previous syndicated senior unsecured credit facility which was scheduled to mature in September 2024;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Concurrent with our entry into the 2022 Credit Facility, on November 7, 2022, we entered into a $500&#160;million unsecured delayed draw term loan facility (the &#8220;2022 Term Loan Credit Facility&#8221;). We drew $500&#160;million of cash on the term loan in December 2022 which was used for general corporate purposes and was repaid in February 2023 using proceeds from the 5.25% Notes issuance described above;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We returned $3.9 billion of cash to shareholders through $3.6 billion of common stock repurchases under accelerated share repurchase (&#8220;ASR&#8221;) programs and open market transactions and through $292 million of dividend payments during fiscal 2023. The total remaining authorization outstanding for repurchase of the Company&#8217;s common stock at March 31, 2023 was $3.6 billion. In July 2022, we raised our quarterly dividend to $0.54 from $0.47 per common share; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">McKesson continued to play a leading role in the fight against the disease caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;). In fiscal 2021, we began distributing certain COVID-19 vaccines under the direction of the Centers for Disease Control and Prevention (&#8220;CDC&#8221;). Since then, and through the end of fiscal 2023, we distributed over 480 million COVID-19 vaccine doses to administration sites all across the U.S. and in support of the U.S. government&#8217;s international donation mission. Although contributions from sales of COVID-19 tests and our COVID-19 vaccine and related ancillary supply kit distribution programs were favorable to our results for the year ended March 31, 2023, they were less favorable compared to fiscal 2022 as the recovery from the pandemic continued. For a more in-depth discussion of how COVID-19 impacted our business, operations, financial results, and outlook, refer to the COVID-19 section of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Trends and Uncertainties"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_55"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trends and Uncertainties:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Legislative Developments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;). Among other provisions, the IR Act includes a 15% corporate minimum tax, a 1% excise tax on certain repurchases of an entity&#8217;s own common stock after December 31, 2022, and various drug pricing reforms. Based on our preliminary assessment, we do not currently expect the IR Act to have a material impact on our results of operations, our financial position, or cash flows in the foreseeable future. We will continue to evaluate the full impact of these legislative changes as they are implemented.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The Impact of Inflationary and Global Events</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and our results of operations, financial condition, and liquidity are impacted by broad economic conditions including rising interest rates, inflation, increased competition for talent, and disruption of the supply chain, as well as by political or civil unrest or military action. Cost inflation generally affects us by increasing transportation, operational, and other administrative costs associated with our business operations which we might not be able to fully pass along to our customers. Although it is difficult to predict the impact that these factors may have on our business in the future, they did not have a material impact on our results of operations, our financial condition, or liquidity for the year ended March 31, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">COVID-19 </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 has continued to evolve since it was declared a global pandemic by the World Health Organization on March 11, 2020. We continue to evaluate the nature and extent of the ongoing impacts of COVID-19, including the impacts from the continued pandemic recovery, on our business, operations, and financial results. The disclosures below include significant updates that occurred during fiscal 2023 and the financial impacts of COVID-19 in fiscal 2023 compared to fiscal 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Role in the Distribution of COVID-19 Vaccines and Ancillary Supply Kits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a diversified healthcare services leader, we have been well positioned to respond to the COVID-19 pandemic in the U.S. and Canada, and in Europe prior to the divestiture of the E.U. and U.K. disposal groups. We work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including personal protective equipment (&#8220;PPE&#8221;), and medicine reach our customers and their patients.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since December 2020, we have supported the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies used to administer vaccines through a contract with the Centers for Disease Control and Prevention (&#8220;CDC&#8221;) and, in July 2022, we renewed our relationship with the CDC under this agreement. The results of operations related to this program are reflected in our U.S. Pharmaceutical segment. We also continue to operate under a contract to manage the assembly, storage, and distribution of ancillary supply kits needed to administer COVID-19 vaccines as directed by the U.S. Department of Health and Human Services (&#8220;HHS&#8221;), the results of which are reflected in our Medical-Surgical Solutions segment. Our contracts with the CDC and HHS will continue into July 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Canada, and McKesson Europe prior to the divestiture of the E.U. and U.K. disposal groups, support governments and public health entities through distributing COVID-19 vaccines and administering them in pharmacies as well as distributing COVID-19 tests and certain PPE.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends in our Business</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We observed growth in prescription volumes within our U.S. Pharmaceutical segment and stability in patient visits in our primary care business within our Medical-Surgical Solutions segment during the year ended March 31, 2023, compared to the prior year as the recovery from COVID-19 continued. While the U.S. distribution of COVID-19 vaccines and related ancillary kits combined with higher sales for COVID-19 tests, corresponding to increased demand from the spike in positive COVID-19 cases as a result of the Delta and Omicron variants favorably impacted our results during the year ended March 31, 2022, the contributions from COVID-19 tests and our vaccine and related kitting distribution programs decreased year over year in fiscal 2023 primarily driven by lower demand as the pandemic recovery continued.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Supply Chain </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor and address the impacts on our supply chain which were initially related to the COVID-19 pandemic. Although the availability of various products is dependent on our suppliers, their locations, and the extent to which they continue to be impacted by the COVID-19 pandemic, we proactively work with manufacturers, industry partners, and government agencies to meet the needs of our customers. Overall, during fiscal 2023, we had an increase in supply chain costs primarily related to transportation and labor; however, this did not materially impact our results of operations for the year ended March 31, 2023. As potential shortages or disruptions of any products are identified, we address supply continuity, which includes securing additional products when available, sourcing back-up products when needed, and following allocation procedures to maintain and protect supply as much as possible. We utilize business continuity action planning to maintain and protect operations across all locations and facilities.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Results of Operations, Financial Condition, and Liquidity</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of COVID-19 vaccines in our U.S. Pharmaceutical segment decreased during fiscal 2023 when compared to the same prior year period. The contribution was less than 10% to segment operating profit for each of the years ended March 31, 2023 and 2022. The financial impacts from our COVID-19 response efforts in the International segment during fiscal 2023 and fiscal 2022 were not material to our consolidated or segment operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended March 31, 2023, COVID-19 tests and the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately $765 million and $216 million to segment revenues and segment operating profit, respectively. For the year ended March 31, 2022, the contribution was approximately $1.8 billion to segment revenues and, including total inventory charges as further described below, increased our segment operating profit by approximately $208 million.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These COVID-19 related items had a net unfavorable impact on consolidated income from continuing operations before income taxes for fiscal 2023 compared to the same prior year period, primarily driven by lower demand for COVID-19 tests as well as COVID-19 vaccines and related ancillary supply kits. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2022 we recorded inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment. We have taken measures to mitigate risks for market price volatility and changes to anticipated customer demand that may require additional write-downs in future periods of other PPE and related product categories.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2023 and fiscal 2022, we maintained appropriate labor and overall vendor supply levels and experienced no material impacts to our liquidity or net working capital due to the COVID-19 pandemic. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioid-Related Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a defendant in many legal proceedings asserting claims related to the distribution of controlled substances (opioids) in federal and state courts throughout the U.S., and in Puerto Rico and Canada. The plaintiffs in these actions have included state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and two other national pharmaceutical distributors (collectively &#8220;Distributors&#8221;) settled with 48 of 49 eligible states and their participating subdivisions, as well as the District of Columbia and all eligible territories (collectively, &#8220;Settling Governmental Entities&#8221;) effective on April 2, 2022 (the &#8220;Settlement&#8221;). Under the Settlement, the Distributors will pay the Settling Governmental Entities up to approximately $20.3 billion over 18 years, with up to approximately $7.8 billion to be paid by the Company for its 38.1% portion. Consent judgments have been entered in all participating states and territories, and approximately 2,300 cases have been dismissed pursuant to the Settlement. A minimum of 85% of the Settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and is payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Settlement provides that the Distributors do not admit liability or wrongdoing and do not waive any defenses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement only addresses the claims of attorneys general of U.S. states and territories and political subdivisions in participating states and territories. Governmental entities not participating in the Settlement may continue to pursue their claims. The state of Alabama chose not to participate in the Settlement, and West Virginia was not eligible to participate. We have reached separate agreements to settle the claims of these states and their participating subdivisions. The Distributors also settled the claims of federally recognized Native American Tribes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total estimated liability for opioid-related claims was $7.2 billion as of March 31, 2023, of which $548 million was included in &#8220;Other accrued liabilities&#8221; for the amount estimated to be paid prior to March 31, 2024, and the remaining liability was included in &#8220;Long-term litigation liabilities&#8221; in our Consolidated Balance Sheet. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as four cases brought in Canada (three by governmental or tribal entities and one by an individual). These claims, and those of private individuals or entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with ongoing opioid-related litigation matters, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. In light of the uncertainty, the amount of any ultimate loss may differ materially from the amount accrued.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the Settlement, we also continue to prepare for trial in pending matters. We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on our financial position, cash flows or liquidity, or results of operations. Refer to Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report for more information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Forward-Looking Information</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key assumptions and estimates about future performance and values, including those used in our impairment assessments, can be affected by a variety of factors, including the impacts of socio-political events on industry and economic trends, as well as on our business strategy and internal forecasts. Recent such events include the COVID-19 pandemic and the war between Russia and Ukraine, and the associated economic impacts, which have disrupted aspects of the global economy over the last several years. We have experienced and may experience difficulties in sourcing products and changes in costs and pricing due to the effects of various socio-political events on supply chains. We periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Material changes to key assumptions and estimates could decrease the projected cash flows or increase the discount rates that could potentially result in future impairment charges, or otherwise adversely impact our financial position, cash flows or liquidity, or results of operations. Refer to Item 1A - Risk Factors in Part I of this Annual Report for a discussion of risk factors that could cause our actual results to differ materially from our projections.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_58"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Consolidated Results:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.972%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,358&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,977)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total operating expenses as a percentage of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reported income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,722&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,560&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues increased for the year ended March 31, 2023 compared to the prior year largely due to market growth in our U.S. Pharmaceutical segment. Market growth includes growing drug utilization, price increases, and newly launched products, partially offset by price deflation associated with branded to generic drug conversion. This revenue growth was partially offset by lower revenues in our International segment driven by the completed divestitures of our U.K. and E.U. disposal groups and our Austrian business, and unfavorable effects of foreign currency exchange fluctuations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit decreased for the year ended March 31, 2023 compared to the prior year primarily in our International segment driven by the completed divestitures of our U.K. and E.U. disposal groups, our Austrian business, and unfavorable effects of foreign currency exchange fluctuations, partially offset by growth of specialty pharmaceuticals and increased contributions from our generics programs in our U.S. Pharmaceutical segment and an increase in gross profit in our Medical-Surgical Solutions segment from prior year inventory charges on certain PPE and other related products and favorability in our core primary care business. Gross profit in fiscal 2023 was also favorably impacted by increased volumes with new and existing customers in our RxTS segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit for the years ended March 31, 2023 and 2022 included net cash proceeds received of $129&#160;million and $46&#160;million, respectively, representing our share of antitrust legal settlements. Gross profit for the year ended March 31, 2023 also included last-in, first-out (&#8220;LIFO&#8221;) inventory charges of $1&#160;million and LIFO credits of $23&#160;million in 2022. The LIFO charges in fiscal 2023 compared to LIFO credits in fiscal 2022 are primarily due to higher brand inflation and lower generics deflation, offset by significantly higher off patent launch activity in fiscal 2023. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Critical Accounting Policies and Estimates&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section included in this Financial Review for further information regarding use of the LIFO method of accounting within our U.S. Pharmaceutical business.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Operating Expenses</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary and description of the components of our total operating expenses for the years ended March 31, 2023 and 2022 was as follows:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Selling, distribution, general, and administrative expenses (&#8220;SDG&amp;A&#8221;):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SDG&amp;A consists of personnel costs, transportation costs, depreciation and amortization, lease costs, professional fee expenses, administrative expenses, remeasurement charges to the lower of carrying value or fair value less costs to sell, and other general charges.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Claims and litigation charges, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These charges and credits include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates. Legal fees to defend claims, which are expensed as incurred, are included within SDG&amp;A.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Restructuring, impairment, and related charges, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Charges recorded under this component include those incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted, as well as long-lived asset impairments. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.972%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,092&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Percent of revenues</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2.88&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses and total operating expenses as a percentage of revenues decreased for the year ended March 31, 2023 compared to the prior year. Total operating expenses for the years ended March 31, 2023 and 2022 were affected by the following significant items:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2023</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A reflects lower operating expenses due to the completed divestitures of our U.K. and E.U. disposal groups in April 2022 and October 2022, respectively; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes net credits of $66 million associated with the divestiture of our E.U. disposal group in October 2022;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims and litigation charges, net was not material. Refer to the Opioid-Related Litigation and Claims section of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above for further discussion;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.2pt">Restructuring, impairment, and related charges, net primarily includes charges related to Corporate expenses, net, as well as our RxTS segment. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Restructuring Initiatives and Long-Lived Asset Impairments&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section below as well as Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report for more information; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses were favorably impacted by foreign currency exchange fluctuations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes charges totaling $1.2&#160;billion to remeasure our U.K. disposal group to fair value less costs to sell. The remeasurement adjustment includes a $734&#160;million loss related to the accumulated other comprehensive loss balances associated with the U.K. disposal group, driven by declines in the British pound sterling. Of the total charges recorded during the period, $1.1&#160;billion are included within our International segment and $42&#160;million are included within Corporate expenses, net;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes charges of $438 million to remeasure assets and liabilities of our E.U. disposal group held for sale to fair value less costs to sell and to impair certain internal-use software that will not be utilized in the future. The remeasurement adjustment includes a $151 million loss related to the accumulated other comprehensive loss balances associated with the E.U. disposal group, driven by declines in the Euro. Of the total charges recorded during the period, $383 million are included within our International segment and $55 million are included within Corporate expenses, net;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A reflects a cost reduction of $142 million related to the cessation of depreciation and amortization of long-lived assets and operating lease right-of-use assets classified as held for sale for our European divestiture disposal groups;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes opioid-related charges of $130 million, primarily litigation expenses;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SDG&amp;A includes a gain of $59 million related to the sale of our Canadian health benefit claims management and plan administrative services business;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims and litigation charges, net includes a charge of $274 million related to our estimated liability for opioid-related claims as previously discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.2pt">Restructuring, impairment, and related charges, net includes charges related to Corporate expenses, net, as well as our International segment. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Restructuring Initiatives and Long-Lived Asset Impairments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Operating Profit (Loss) and Corporate Expenses, Net&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sections below as well as Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report for more information; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses were unfavorably impacted by foreign currency exchange fluctuations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment on an annual basis and at an interim date if indicators of potential impairment exist. During the first quarter of fiscal 2023, we voluntarily changed our annual goodwill impairment testing date from October 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to April 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to align with the change in timing of our annual long-term planning process. This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual impairment testing performed in fiscal 2023 and fiscal 2022 did not indicate any impairment of goodwill. However, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within the International segment, where the risk of material goodwill impairment is higher than other reporting units. Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Critical Accounting Policies and Estimates&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Financial Review for further information. At March 31, 2023 and March 31, 2022, the balance of goodwill in our International segment primarily relates to our McKesson Canada reporting unit. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives and Long-Lived Asset Impairments </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, we approved a broad set of initiatives to drive operational efficiencies and increase cost optimization efforts, with the intent of simplifying our infrastructure and realizing long-term sustainable growth. These initiatives include headcount reductions and the exit or downsizing of certain facilities. We anticipate total charges of approximately $125&#160;million across our RxTS and U.S. Pharmaceutical segments as well as Corporate, consisting primarily of employee severance and other employee-related costs, facility and other exit-related costs, as well as long-lived asset impairments. We recorded charges of $60 million for the year ended March 31, 2023 related to this program, which reflects severance and other employee-related costs within our RxTS segment as well as asset impairments and accelerated depreciation, including certain asset impairments primarily within our U.S. Pharmaceutical segment and real estate charges within Corporate. This restructuring program is anticipated to be substantially complete by the end of fiscal 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, we approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of our office space in North America. Where we ceased using office space, we exited the portion of the facility no longer used. We also retained and repurposed certain other office locations. We recorded charges of $124 million for the year ended March 31, 2022 primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially completed in fiscal 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2022, we recognized charges totaling $36 million to impair certain long-lived assets within our International segment related to our operations in Denmark and our retail pharmacy businesses in Canada.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 3 , &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report for more information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net increased for the year ended March 31, 2023 compared to fiscal 2022 primarily due to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a gain of $142 million related to the exit of one of our investments in equity securities held within our U.S. Pharmaceutical segment;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a gain of $126 million due to the cash received for the early termination of the TRA entered into as part of the formation of the joint venture with Change, from which McKesson has now exited. This gain was recorded within Corporate expenses, net;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a gain of $97 million from the termination of certain forward starting fixed interest rate swaps within Corporate expenses, net; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase of $97 million in interest income driven by higher interest rates on certain of our cash balances compared to the prior year.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These gains were partially offset by net losses of $36 million recognized for the year ended March 31, 2023 compared to net gains of $98&#160;million recognized for the year ended March 31, 2022 from our equity investments held within Corporate. These amounts primarily reflect mark-to-market net gains and impairments on certain of our investments in U.S. growth stage companies in the healthcare industry and realized net gains on the exit of some of these investments as further described in Financial Note 15, &#8220;Fair Value Measurements,&#8221; to the consolidated financial statements included in this Annual Report. In future periods, fair value adjustments recognized in our operating results for these types of investments may be adversely impacted by market volatility. Other income, net for the year ended March 31, 2022 also includes a gain of $42&#160;million related to the sale of our 30% interest in our German pharmaceutical wholesale joint venture with Walgreens Boots Alliance (&#8220;WBA&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss on Debt Extinguishment</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss on debt extinguishment recorded for the year ended March 31, 2022 of $191&#160;million includes premiums of $182&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred of $9&#160;million, and was driven by our July 2021 tender offer to redeem a portion of our existing debt. Refer to Financial Note 11, &#8220;Debt and Financing Activities,&#8221; to the consolidated financial statements included in this Annual Report for more information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased in 2023 compared to the prior year primarily due to the unfavorable impacts of higher interest rates and changes in our derivative portfolio primarily as a result of our European divestiture activities. This was partially offset by a decrease in interest expense driven by lower existing debt due to our tender offer in late July 2021. Interest expense may fluctuate based on timing, amounts, and interest rates of term debt repaid and new term debt issued, as well as amounts incurred associated with financing fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded income tax expense of $905 million and $636 million for the years ended March 31, 2023 and 2022, respectively. Our reported income tax expense rates were 19.5% and 33.0% in 2023 and 2022, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in our reported income tax rates are primarily due to non-cash charges related to remeasuring the value of our E.U. and U.K. disposal groups held for sale to fair value less costs to sell in fiscal 2022, changes in our business mix of earnings between various taxing jurisdictions, and discrete tax benefits recognized during 2023 and 2022. Refer to Financial Note 6, &#8220;Income Taxes,&#8221; to the consolidated financial statements included in this Annual Report for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgments and estimates are required in determining the consolidated income tax provision and evaluating income tax uncertainties. Although our major taxing jurisdictions include the U.S. and Canada, we are subject to income taxes in numerous foreign jurisdictions. Our income tax expense, deferred tax assets and liabilities, and uncertain tax liabilities reflect management&#8217;s best assessment of estimated current and future taxes to be paid. We believe that we have made adequate provision for all income tax uncertainties. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss from Discontinued Operations, Net of Tax </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from discontinued operations, net of tax, was $3 million and $5 million for the years ended March 31, 2023 and 2022, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Noncontrolling Interests </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests primarily represents ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and the accrual of the annual recurring compensation amount of &#8364;0.83 per McKesson Europe share that McKesson was obligated to pay to the noncontrolling shareholders of McKesson Europe under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;) through its divestiture in October 2022. For fiscal 2023, noncontrolling interests also includes the proportionate results of SCRI Oncology from its acquisition date in October 2022. Noncontrolling interests with redemption features, such as put rights, that are not solely within our control are considered redeemable noncontrolling interests. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Selected Measures of Liquidity and Capital Resources&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this Financial Review and Financial Note 7, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the consolidated financial statements included in this Annual Report for additional information on changes to our redeemable and noncontrolling interests that occurred during the third quarter of fiscal 2023 and the first quarter of 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to McKesson Corporation </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to McKesson Corporation was $3.6 billion and $1.1 billion for the years ended March 31, 2023 and 2022, respectively. Diluted earnings per common share attributable to McKesson Corporation was $25.03 and $7.23 for the years ended March 31, 2023 and 2022, respectively. Our diluted earnings per share reflects the cumulative effects of share repurchases during each period.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted-Average Diluted Common Shares Outstanding </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per common share was calculated based on a weighted-average number of shares outstanding of 142.2 million and 154.1 million for the years ended March 31, 2023 and 2022, respectively. The weighted-average diluted common shares outstanding was impacted by the cumulative effect of share repurchases and exercise and settlement of share-based awards.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_61"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Segment Results: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Revenues:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.992%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.972%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,711&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,966&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the year ended March 31, 2023 increased $28.5 billion or 13% compared to the prior year. Within the segment, sales to pharmacies and institutional healthcare providers increased $27.0 billion and sales to specialty practices and other increased $1.5 billion. Overall, these increases were primarily due to market growth, including growth in specialty pharmaceuticals driven by higher volumes from retail national account customers, branded pharmaceutical price increases, and higher volumes from other existing customers. These increases were partially offset by branded to generic drug conversions and decreased distribution of COVID-19 vaccines.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the year ended March 31, 2023 increased $523 million or 14% compared to the prior year due to increased volume with new and existing customers primarily in our third-party logistics and wholesale distribution services as well as higher technology service revenues.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the year ended March 31, 2023 decreased $498 million or 4% compared to the prior year. Within the segment, sales to primary care customers decreased $307 million driven by lower sales of COVID-19 tests, partially offset by underlying core business growth including higher sales of flu test kits. Sales to extended care customers increased $7 million. Other sales declined $198 million driven by lower contribution from the kitting and distribution of ancillary supplies used to administer COVID-19 vaccines.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the year ended March 31, 2023 decreased $15.7 billion or 43% compared to the prior year which included $1.9 billion unfavorable effects of foreign currency exchange fluctuations. Within the segment, sales in Europe declined by $14.8 billion largely due to the completed divestitures of our U.K. and E.U. disposal groups, and Austrian business. This was partially offset by increased sales in Canada of $1.0 billion largely driven by higher pharmaceutical distribution volumes.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_64"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Segment Operating Profit (Loss) and Corporate Expenses, Net:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.972%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,025&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,630&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) margin</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.66)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for our reportable segments. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our U.S. Pharmaceutical segment includes the following:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">cash receipts for our share of antitrust legal settlements of $129 million and $46 million for the years ended March 31, 2023 and 2022, respectively;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $1&#160;million and credits of $23&#160;million for the years ended March 31, 2023 and 2022, respectively; related to the LIFO method of accounting for inventories; and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $142 million for the year ended March 31, 2023 related to the exit of one of our investments in equity securities.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our RxTS segment for the year ended March 31, 2023 includes restructuring charges of $43&#160;million primarily for severance and employee-related costs, as well as asset impairments and accelerated depreciation.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our Medical-Surgical Solutions segment for the year ended March 31, 2022 includes charges totaling $164&#160;million on certain PPE and other related products due to inventory impairments and excess inventory.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit (loss) for our International segment includes the following:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $1.1 billion for the year ended March 31, 2022 to remeasure our U.K. disposal group held for sale to fair value less costs to sell;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $240 million and $383 million for the years ended March 31, 2023 and 2022, respectively, to remeasure our E.U. disposal group held for sale to fair value less costs to sell and, in fiscal 2022, to impair certain internal-use software that will not be utilized in the future;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $59 million for the year ended March 31, 2022 related to the sale of our Canadian health benefit claims management and plan administrative services business; and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $42 million for the year ended March 31, 2022 related to the sale to WBA of our 30% interest in our German pharmaceutical wholesale joint venture.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net includes the following:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">credits of $306 million and charges of $55 million for the years ended March 31, 2023 and 2022, respectively, primarily related to the effect of accumulated other comprehensive loss components from our E.U. disposal group;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $126 million for the year ended March 31, 2023 related to the cash payment received for the early termination of our TRA with Change;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $97 million for the year ended March 31, 2023 related to the termination of certain forward starting fixed interest rate swaps;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">restructuring charges of $83 million and $100 million for the years ended March 31, 2023 and 2022, respectively, primarily due to costs for business transformation and optimization efforts related to the Company&#8217;s technology organization and the transition to a partial remote work model for certain employees.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">net losses of $36 million and net gains of $98 million for the years ended March 31, 2023 and 2022, respectively, associated with certain of our equity investments;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $42 million for the year ended March 31, 2022 primarily related to the effect of accumulated other comprehensive loss components from our U.K. disposal group;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $274 million for the year ended March 31, 2022 related to our estimated liability for opioid-related claims;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $130 million for the year ended March 31, 2022 of opioid-related costs, primarily litigation expenses; and</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for the year ended March 31, 2022 consists of a charge of $191 million on debt extinguishment related to our July 2021 tender offer to redeem a portion of our existing debt.</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for the year ended March 31, 2023 compared to the prior year primarily due to growth in specialty pharmaceuticals, increased contributions from our generics programs, a gain recognized from the exit of one of our investments in equity securities in July 2022, and higher cash proceeds received representing our share of antitrust legal settlements. This was partially offset by an increase in operating expenses to support higher volumes, and a decrease in the contribution from our COVID-19 vaccine distribution program.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for the year ended March 31, 2023 compared to the prior year primarily driven by increased volumes with new and existing customers due to growth in our access, affordability, and adherence solutions.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for the year ended March 31, 2023 compared to the prior year primarily due to favorability in our core primary care business, including favorable illness season testing and sourcing activities, and prior year inventory charges on certain PPE and other related products, partially offset by lower sales of COVID-19 tests and a lower contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment for the year ended March 31, 2023 compared to an operating loss for the prior year was primarily a result of higher remeasurement charges recorded in the prior year related to our divestitures of the U.K. and E.U. disposal groups and our Austrian business, as well as lower restructuring expenses for optimization programs in Canada. This was partially offset by a gain recognized in the prior year from the sale of our Canadian health benefit claims management and plan administrative services business.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net decreased for the year ended March 31, 2023 compared to the prior year primarily due to:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">year-over-year favorability from lower fair value remeasurement adjustments of our E.U. and U.K. disposal groups compared to fiscal 2022;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower charges related to our estimated liability for opioid-related claims;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a gain related to the cash payment received for the early termination of our TRA with Change; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a gain related to the termination of certain forward starting fixed interest rate swaps;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decrease in opioid-related costs, primarily litigation expenses;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior year restructuring charges for the transition to a partial remote work model for certain employees; and </span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a favorable impact to interest income from higher interest rates on certain of our cash balances compared to the prior year period.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These were partially offset by net losses from our equity investments compared to net gains in the prior year period.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_67"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOREIGN OPERATIONS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign operations represented approximately 7% and 14% of our consolidated revenues in fiscal 2023 and fiscal 2022, respectively. Foreign operations are subject to certain risks, including currency fluctuations. Refer to Item 1A - Risk Factors in Part I of this Annual Report for a risk factor related to fluctuations in foreign currency exchange rates. We monitor our operations and adopt strategies responsive to changes in the economic and political environment in each of the countries in which we operate. We conduct our business worldwide in local currencies, including the Canadian dollar and, more significantly prior to our European divestiture activities discussed above, Euro and British pound sterling. As a result, the comparability of our results reported in U.S. dollars can be affected by changes in foreign currency exchange rates.&#160;In discussing our operating results, we may use the term &#8220;foreign currency exchange fluctuations,&#8221; which refers to the effect of changes in foreign currency exchange rates used to convert the local currency results of our operations in foreign countries where the functional currency is not the U.S. dollar. We present this information to provide a framework for assessing how our business performed excluding the effect of foreign currency exchange rate fluctuations.&#160;In computing the foreign currency exchange fluctuations, we translate our current year results of our operations in foreign countries recorded in local currencies into U.S. dollars by applying their respective average foreign currency exchange rates of the corresponding prior year periods, and we subsequently compare those results to the previously reported results of the comparable prior year periods reported in U.S. dollars.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we announced our intention to exit our businesses in Europe. In fiscal 2023, we completed the previously announced sale of our E.U. and U.K. disposal groups and in fiscal 2022 we completed the previously announced sale of our Austrian business. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report for more information on these European divestitures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information regarding our foreign operations is also included in Financial Note 20, &#8220;Segments of Business,&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div id="i04335d018da94076b0acf21e81ac886b_70"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS COMBINATIONS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report for additional information.</span></div><div id="i04335d018da94076b0acf21e81ac886b_73"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FISCAL 2024 OUTLOOK</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the Company&#8217;s fiscal 2024 outlook is contained in the release of our fourth quarter fiscal 2023 financial results included as an exhibit to our Form 8-K furnished to the SEC on May&#160;8, 2023, which is not incorporated by reference into this Annual Report. That Form 8-K should be read in conjunction with the forward-looking statements in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Trends and Uncertainties"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this Financial Review, as well as the cautionary statements in Item 1 - Business - Forward-Looking Statements, and Item 1A - Risk Factors, in Part I of this Annual Report.</span></div><div id="i04335d018da94076b0acf21e81ac886b_76"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider an accounting estimate to be critical if the estimate requires us to make assumptions about matters based upon past experience and management&#8217;s judgment that were uncertain at the time the accounting estimate was made and if different estimates that we reasonably could have used in the current period, or changes in the accounting estimate that are reasonably likely to occur from period to period, could have a material impact on our financial condition or results from operations. Below are the estimates that we believe are critical to the understanding of our operating results and financial condition. Other accounting policies are described in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the consolidated financial statements included in this Annual Report. Because of the uncertainty inherent in such estimates, actual results may differ from these estimates.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowances for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our receivables primarily consist of short-term trade accounts receivable from customers that result from the sale of goods and services. We also provide customer financing arrangements to customers who purchase our products and services. Customer financing primarily relates to guarantees provided to our customers, or their creditors, regarding the repurchase of inventories. We also provide financing to certain customers related to the purchase of pharmacies, which serve as collateral for the loans. We estimate the receivables for which we do not expect full collection based on historical collection rates and specific knowledge regarding the current creditworthiness of our customers and record an allowance in our consolidated financial statements for these amounts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers historical credit losses, the current economic environment, customer credit ratings, collections on past due amounts, legal disputes, and bankruptcies, as well as reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to the Company&#8217;s ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately 68% of total consolidated revenues in fiscal 2023 and comprised approximately 42% of total trade accounts receivable at March 31, 2023. Sales to our largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 27% of our total consolidated revenues in fiscal 2023 and comprised approximately 21% of total trade accounts receivable at March 31, 2023. As a result, our sales and credit concentration is significant. We also have agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies and other healthcare providers, as well as with government entities and agencies. The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from these or any other large customers, or the loss of a large customer or GPO could have a material adverse impact on our financial position, results of operations, and liquidity.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserve methodologies are assessed annually based on historical losses and economic, business, and market trends. In addition, reserves are reviewed quarterly and updated if unusual circumstances or trends are present. We believe the reserves maintained and expenses recorded in fiscal 2023 are appropriate and consistent in the context of historical methodologies employed, as well as assessment of trends currently available.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, trade and notes receivables were $17.5 billion prior to allowances of $114 million. Our provision for bad debts was $45 million, $29 million, and $4 million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively. At March&#160;31, 2023 and 2022, the allowance as a percentage of trade and notes receivables was 0.7% and 0.6%, respectively. An increase or decrease of a hypothetical 0.1% in the fiscal 2023 allowance as a percentage of trade and notes receivables would result in an increase or decrease in the provision for bad debts of approximately $17 million. The selected 0.1% hypothetical change does not reflect what could be considered the best or worst-case scenarios. Additional information concerning our allowances for credit losses may be found in Schedule II included in this Annual Report.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Inventories consist of merchandise held for resale. We report inventories at the lower of cost or net realizable value, except for inventories determined using the LIFO method which are valued at the lower of LIFO cost or market. LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors relating to the purchase or distribution of inventory are considered product discounts and are accounted for as a reduction in the cost of inventory and are recognized when the inventory is sold. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether an inventory valuation allowance is required, we consider various factors including estimated quantities of slow-moving inventory by reviewing on-hand quantities, outstanding purchase obligations, and forecasted sales. Shifts in market trends and conditions, changes in customer preferences due to the introduction of generic drugs or new pharmaceutical products, or the loss of one or more significant customers are factors that could affect the value of our inventories. We write down inventories which are considered excess and obsolete as a result of these reviews. These factors could make our estimates of inventory valuation differ from actual results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and 2022, total inventories, net were $19.7 billion and $18.7 billion, respectively, in our Consolidated Balance Sheets. The LIFO method was used to value approximately 64% and 63% of our inventories at March 31, 2023 and 2022, respectively. If we had used the moving average method of inventory valuation, inventories would have been approximately $384&#160;million and $383&#160;million higher than the amounts reported at March 31, 2023 and 2022, respectively. These amounts are equivalent to our LIFO reserves. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. We recognized a LIFO charge of $1 million in fiscal 2023 and LIFO credits of $23 million and $38 million in fiscal 2022 and fiscal 2021, respectively, all within &#8220;Cost of Sales&#8221; in our Consolidated Statements of Operations. The LIFO charge in fiscal 2023 compared to LIFO credits in fiscal 2022 and fiscal 2021 are primarily due to higher brand inflation and lower generics deflation, offset by significantly higher off patent launch activity in fiscal 2023. Our LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, our LIFO inventory is valued at the lower of LIFO or market.&#160;As of March&#160;31, 2023 and 2022, inventories at LIFO did not exceed market. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, including contingent consideration, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that we obtain control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, we typically use a variation of the income approach, whereby a forecast of future cash flows attributable to the asset is discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#8217;s expected useful life. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report for additional information regarding our acquisitions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain business combinations involve the potential for future payments of consideration that is contingent upon the achievement of performance milestones or other agreed-upon events. The liability for the contingent consideration is measured at its fair value as of the acquisition date using unobservable inputs. These inputs include the estimated amount and timing of projected operational and financial information, the probability of achievement of performance milestones or other agreed-upon events, and the risk-adjusted discount rate used to calculate the present value of the probability-weighted projected financial information</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Contingent liabilities are remeasured to fair value at each reporting date until the liability is resolved with changes in fair value being recognized within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. Changes in any of the inputs may result in a significant adjustment to the fair value.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Long-Lived Assets:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of acquiring businesses, we have $9.9 billion and $9.5&#160;billion of goodwill at March 31, 2023 and 2022, respectively, and $2.3 billion and $2.1&#160;billion of intangible assets, net at March 31, 2023 and 2022, respectively. During the first quarter of fiscal 2023, we voluntarily changed our annual goodwill impairment testing date from October 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to April 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to align with a change in the timing of our annual long-term planning process. This change was not material to our consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform an impairment test on goodwill balances annually in the first fiscal quarter and more frequently if indicators for potential impairment exist. Indicators that are considered include significant declines in performance relative to expected operating results, significant changes in the use of the assets, significant negative industry or economic trends, or a significant decline in the Company&#8217;s stock price and/or market capitalization for a sustained period of time. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or a component, one level below our operating segments, for which discrete financial information is available and where segment management regularly reviews the operating results of that reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and an impairment charge is recorded equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To estimate the fair value of our reporting units, we generally use a combination of the market approach and the income approach. Under the market approach, we estimate fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, we use a discounted cash flow model in which cash flows anticipated over several periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. In addition, we compare the aggregate of the reporting units&#8217; fair values to our market capitalization as further corroboration of the reasonableness of our concluded fair values.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimates of fair value result from a complex series of judgments about future events and uncertainties and rely heavily on estimates and assumptions at a point in time. Judgments made in determining an estimate of fair value may materially impact our results of operations.&#160;The valuations are based on information available as of the impairment testing date and are based on expectations and assumptions that have been deemed reasonable by management. Any material changes in key assumptions, including failure to meet business plans, negative changes in government reimbursement rates, deterioration in the U.S. and global financial markets, an increase in interest rates, or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances may decrease the projected cash flows or increase the discount rates and could potentially result in an impairment charge. Under the market approach, significant estimates and assumptions also include the selection of appropriate guideline public companies and the determination of appropriate valuation multiples to apply to the reporting unit. Under the income approach, significant estimates and assumptions also include the determination of discount rates.&#160;The discount rates represent the weighted-average cost of capital measuring the reporting unit&#8217;s cost of debt and equity financing, which are weighted by the percentage of debt and percentage of equity in a company&#8217;s target capital structure. Included in the estimate of the weighted-average cost of capital is the assumption of an unsystematic risk premium to address incremental uncertainty related to the reporting units&#8217; future cash flow projections.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual impairment testing performed for fiscal 2023, fiscal 2022, and fiscal 2021 did not indicate any impairment of goodwill. The segment change in the second quarter of fiscal 2021 prompted changes in multiple reporting units across the Company and as a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation. We recorded a goodwill impairment charge of $69 million in fiscal 2021 as the estimated fair value of the Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. At March 31, 2023 and 2022, the balance of goodwill in the International segment primarily relates to our McKesson Canada reporting unit. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our McKesson Canada reporting unit in our International segment exceeded the carrying value of the reporting unit by approximately 30% in fiscal 2023. The goodwill balance of this reporting unit was $1.4 billion at March 31, 2023, or approximately 14% of the consolidated goodwill balance. A decline in estimated future cash flows in excess of approximately 22% for McKesson Canada or an increase in the discount rate in excess of approximately 2% could result in an indication of goodwill impairment for this reporting unit in future reporting periods under the income approach. Other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions may require us to further revise the projected cash flows, which could adversely affect the fair value of our other reporting units in future periods. Refer to Financial Note 10, &#8220;Goodwill and Intangible Assets, Net,&#8221; to the consolidated financial statements included in this Annual Report for additional information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, all of our intangible and other long-lived assets are amortized or depreciated based on the pattern of their economic consumption or a straight-line&#160;basis over their estimated useful lives, ranging from one to 25 years.&#160;We review intangible and other long-lived assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.&#160;Determination of recoverability of intangible and other long-lived assets is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from the use of the asset and its eventual disposition.&#160;Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its fair value.&#160;Assumptions and estimates about future values and the remaining useful lives of our purchased intangible assets are complex and subjective.&#160;They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy and our internal forecasts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing consideration of all the factors described previously could result in further impairment charges in the future, which could adversely affect our net income. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; to the consolidated financial statements included in this Annual Report for additional information on our long-lived asset impairments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets classified as held for sale are measured at the lower of their carrying amount or fair value less costs to sell and are not depreciated or amortized. Fair value is determined based on the total consideration expected to be received by the Company. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain restructuring reserves which require significant estimates related to the timing and amount of future employee severance and other exit-related costs to be incurred when the restructuring actions take place. We generally recognize employee severance costs when payments are probable and amounts are estimable. Costs related to contracts without future benefit or contract termination are recognized at the earlier of the contract termination or the cease-use dates. Other exit-related costs are recognized as incurred. In connection with these restructuring actions, we also assess the recoverability of long-lived assets used in the business, and as a result, we may recognize accelerated depreciation and amortization reflecting shortened useful lives of the underlying assets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax expense and deferred tax assets and liabilities reflect management&#8217;s best assessment of estimated current and future taxes to be paid. We are subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgments and estimates are required in determining the consolidated income tax provision and in evaluating income tax uncertainties, including those used to conclude on the tax-free nature of the separation of the Change Healthcare JV and the unrecognized tax position related to opioid-related litigation and claims, and may differ from the actual amounts of tax benefit recognized. We review our tax positions at the end of each quarter and adjust the balances as new information becomes available.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense. In evaluating our ability to recover our deferred tax assets, we consider all available positive and negative evidence including our past operating results, the existence of cumulative net operating losses in the most recent years, and our forecast of future taxable income. In estimating future taxable income, we develop assumptions including the amount of future federal, state, and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment about the forecasts of future taxable income and are consistent with the plans and estimates we use to manage the underlying businesses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future. Should tax laws change, our tax expense and cash flows could be materially impacted. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the calculation of our tax liabilities includes estimates for uncertainties in the application of complex new tax regulations across multiple global jurisdictions where we conduct our operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize liabilities for tax and related interest for issues in the U.S. and other tax jurisdictions based on our estimate of whether, and the extent to which, additional taxes and related interest will be due. If our current estimate of tax and interest liabilities is less than the ultimate settlement, an additional charge to income tax expense may result. If our current estimate of tax and interest liabilities is more than the ultimate settlement, a reduction to income tax expense may be recognized. Refer to Financial Note 6, &#8220;Income Taxes,&#8221; to the consolidated financial statements included in this Annual Report for additional information on income tax matters. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, including claims with customers and vendors, pending and potential legal actions for damages, investigations relating to laws and regulations and other matters arising out of the normal conduct of our business. When a loss is considered probable and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict, and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate a range of possible loss. When a material loss is reasonably possible or probable but a reasonable estimate cannot be made, disclosure of the proceeding is provided. Legal fees are recognized as incurred when the legal services are provided.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review all contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the potential loss or range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on future negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the preparation of the consolidated financial statements included in this Annual Report, we considered matters related to ongoing controlled substances claims to which we are a party. At March 31, 2023, our estimated accrued liability for the opioid-related claims of governmental entities was $7.2 billion. Because of the many uncertainties associated with the remaining opioid-related litigation matters, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible losses for all opioid-related litigation matters. We are not able to predict the outcome in these matters, and an adverse judgment or negotiated resolution in any of these matters could have a material adverse effect on our results of operations, financial position, and cash flows or liquidity. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Opioid-Related Litigation and Claims&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this Financial Review and Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report for additional information. </span></div><div id="i04335d018da94076b0acf21e81ac886b_79"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our available cash generated from operations and our short-term investment portfolio, together with our existing sources of liquidity through access to the debt market generally and from our credit facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements. We remain well-capitalized with access to liquidity from our $4.0 billion 2022 Credit Facility. At March 31, 2023, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net change in cash, cash equivalents, and restricted cash for the periods shown:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(542)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in cash, cash equivalents, and restricted cash classified within Assets held for sale </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,461)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,205&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The fiscal 2023 change reflects a reversal of cash, cash equivalents, and restricted cash previously classified within assets held for sale at March 31, 2022 as part of the U.K. disposal group and is offset by cash outflows primarily related to the settlement of liabilities which is reflected in operating activities. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the accompanying consolidated financial statements included in this Annual Report for further information.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities provided cash of $5.2 billion and $4.4 billion for the years ended March 31, 2023 and 2022, respectively. Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers, inventory receipts, and payments to vendors. Additionally, working capital is primarily a function of sales and purchase volumes, inventory requirements, and vendor payment terms.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities for the year ended March 31, 2023 were affected by net income of $3.7 billion adjusted for non-cash items, and an increase in drafts and accounts payable of $3.8 billion offset by increases in inventories and receivables of $1.3 billion and $1.1 billion, respectively, were primarily driven by higher revenues and timing. Our litigation liabilities decreased by $1.1 billion due to payments made during fiscal 2023 associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes. Other non-cash items within operating activities for the year ended March 31, 2023 includes stock-based compensation of $162 million.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities for the year ended March 31, 2022 were affected by net income adjusted for non-cash items, including the losses on our European businesses held for sale and our classifications of receivables, drafts and accounts payables, and inventories as held for sale. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report for further information. Excluding the aforementioned classifications, operating activities for the year ended March 31, 2022 were affected by increases in inventory of $1.2 billion and drafts and accounts payable of $2.8 billion due to timing of purchases, and an increase in receivables of $1.8 billion resulting from timing of collections and higher revenues. Other non-cash items within operating activities for the year ended March 31, 2022 includes an adjustment to net income of $191 million related to loss on debt extinguishment, non-cash inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment, and stock-based compensation of $161 million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $542 million and $89 million for the years ended March 31, 2023 and 2022, respectively. Investing activities for the year ended March 31, 2023 includes $867 million of net cash payments for acquisitions, including $600&#160;million for our acquisition of RxSS and $173&#160;million for our formation of SCRI Oncology with HCA. Investing activities for the year ended March 31, 2023 also includes $390 million and $168 million in capital expenditures for property, plant, and equipment and capitalized software, respectively, and reflects proceeds from sales of businesses and investments of $1.1 billion, including cash proceeds, net of cash divested, of $573 million from the completed divestiture of our E.U. disposal group, $202 million of net cash from the completed divestiture of our U.K. disposal group, and $179 million of cash from the exit of one of our investments in equity securities in July 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities for the year ended March 31, 2022 includes $388 million and $147 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in capital expenditures for property, plant, and equipment and capitalized software, respectively. Investing activities for the year ended March 31, 2022 also includes net cash proceeds of $578 million from sales of businesses and investments, primarily driven by our European divestiture activities described above, including the disposal of our Austria business, and the sale of certain of our equity investments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities was $4.4&#160;billion and $6.3&#160;billion for the years ended March 31, 2023 and 2022, respectively. Financing activities for the year ended March 31, 2023 includes $3.6&#160;billion of cash paid for share repurchases and $292 million of cash paid for dividends. Financing activities also includes cash receipts of $8.5 billion and payments of $8.5 billion for short-term borrowings of commercial paper in fiscal 2023. In November 2022, we entered into the 2022 Term Loan Credit Facility which provided an unsecured term loan facility of up to $500 million, which we drew upon in full in December 2022 and which we subsequently repaid in February 2023. The proceeds of this loan were used for general corporate purposes. In February 2023, we completed a public offering of the 5.25% Notes with net proceeds of $497 million, which were used to repay existing debt. In December 2022, we retired our $400&#160;million outstanding principal amount of the 2.70% Notes and on March 15, 2023, we retired our $360&#160;million outstanding principal amount of the 2.85% Notes, both upon maturity using cash on hand. Cash used for other financing activities generally includes shares surrendered for tax withholding and payments to noncontrolling interests.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities for the year ended March 31, 2022 includes cash receipts of $11.2 billion and payments of $11.2 billion from short-term borrowings of commercial paper. Financing activities for the year ended March 31, 2022 includes a cash tender offer of $1.1&#160;billion to redeem certain notes with a principal amount of $922 million and the redemption of our 0.63% Euro-denominated notes with a principal amount of &#8364;600 million (or, approximately $709 million) prior to the maturity date of August 17, 2021 using cash on hand. This resulted in total repayments of long-term debt during the year ended March 31, 2022 of $1.8 billion, including $184 million of cash paid for premiums and transaction fees. This was partially offset by the issuance of long-term debt in August 2021 pursuant to a public offering of 1.30% Notes due 2026 for net proceeds of $498 million, which was utilized for general corporate purposes. Financing activities for the year ended March 31, 2022 also includes $3.5 billion of cash paid for share repurchases and $277 million of cash paid for dividends. Additionally, financing activities for the year ended March 31, 2022 includes payments of $1.0&#160;billion to purchase shares of McKesson Europe through exercises of a put right option by noncontrolling shareholders. Cash used for other financing activities for the year ended March 31, 2022 includes payments to noncontrolling interests, and funds temporarily held on behalf of unaffiliated medical practice groups.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2564"></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has authorized the repurchase of McKesson&#8217;s common stock from time to time in open market transactions, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, tax implications, restrictions under our debt obligations, and other market and economic conditions. During the last two years, our share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the share repurchase activity over the last two fiscal years was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2021 ASR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2022 ASR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - December 2022 ASR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,693)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards.</span></div><div style="margin-bottom:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In February 2022, we entered into an ASR program with a third-party financial institution to repurchase $1.5 billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.1 million shares at an average price per share of $295.16. We received 4.8 million shares as the initial share settlement in the fourth quarter of fiscal 2022 based on an initial share purchase price, and in May 2022, we received an additional 0.3 million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $27 million was accrued within &#8220;Other accrued liabilities&#8221; in our Consolidated Balance Sheet as of March 31, 2023 for share repurchases that were executed in late March 2023 and settled in early April 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future operating cash flow, financial assets, and current access to capital and credit markets, including our existing credit facilities, will give us the ability to meet our financing needs for the foreseeable future. However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_82"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected Measures of Liquidity and Capital Resources</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,235)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Days sales outstanding for: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt to capital ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Based on year-end balances and sales or cost of sales for the last 90 days of the year.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This ratio describes the relationship and changes within our capital resources, and is computed as the sum of total debt divided by the sum of total debt and McKesson stockholders&#8217; deficit, which excludes noncontrolling interests and accumulated other comprehensive loss.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds, short-term deposits with financial institutions, and short-term commercial papers issued by non-financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Canadian dollars, Euro, and British pounds sterling. Deposits could exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents balance as of&#160;March 31, 2023 and 2022&#160;included approximately $1.3 billion and&#160;$1.5 billion&#160;of cash held by our subsidiaries outside of the U.S., respectively. Our primary intent is to utilize this cash for foreign operations for an indefinite period of time. Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.&#160;We may remit foreign earnings to the U.S. to the extent it is tax efficient to do so. We do not expect the tax impact from remitting these earnings to be material. Following enactment of the 2017 Tax Cuts and Jobs Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital primarily includes cash and cash equivalents, receivables, and inventories, net of drafts and accounts payable, short-term borrowings, current portion of long-term debt, and other accrued liabilities. Working capital also includes net assets and liabilities classified as held for sale which have decreased in fiscal 2023 as a result of the divestiture of our E.U. and U.K. disposal groups. Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands. Inventory purchase activity is a function of sales activity and other requirements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated working capital decreased at March 31, 2023 compared to the prior year primarily due to an increase in drafts and accounts payable, partially offset by an increase in cash and cash equivalents, inventory and receivables, driven by higher revenues and timing.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt to capital ratio increased for the year ended March 31, 2023 primarily due to share repurchases and net repayments of long-term debt, partially offset by net income attributable to McKesson for the year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, we raised our quarterly dividend from $0.47 to $0.54 per common share for dividends declared on or after such date by the Board. Dividends were $2.09 per share in fiscal 2023 and $1.83 per share in fiscal 2022. We anticipate that we will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors. In fiscal 2023 and fiscal 2022, we paid total cash dividends of $292 million and $277 million, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Continued)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our previously recognized redeemable noncontrolling interests primarily related to our consolidated subsidiary, McKesson Europe. Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published semi-annually by the German Bundesbank, less any compensation amount or guaranteed dividend already paid by McKesson. During fiscal 2022, we paid $1.0 billion to purchase 34.5&#160;million shares of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders, which reduced the balance of our redeemable noncontrolling interests.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, valued at $287 million, were transferred from redeemable noncontrolling interests to noncontrolling interests and as a result, we no longer have redeemable noncontrolling interests presented in our consolidated balance sheets at March 31, 2023 or 2022. Our noncontrolling interest in McKesson Europe was included in the sale of our E.U. disposal group in October 2022, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, prior to the sale of our E.U. disposal group in October 2022, we were obligated to pay an annual recurring compensation of &#8364;0.83 per McKesson Europe share (the &#8220;Compensation Amount&#8221;) to the noncontrolling shareholders of McKesson Europe under the Domination Agreement. The Compensation Amount was recognized ratably during the applicable annual period through the October 31, 2022 divestiture. The Domination Agreement did not expire, but it may be terminated at the end of any fiscal year by giving at least six months&#8217; advance notice. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 7, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying consolidated financial statements included in this Annual Report for additional information regarding redeemable noncontrolling interests.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2592"></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Cash Requirements: </span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table and information below presents our significant financial obligations and commitments as of</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2023:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Within 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Over 1 to 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Over 3 to 5</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After 5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">On balance sheet</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Off balance sheet</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,591&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,123&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,919&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,209&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents maturities of the Company&#8217;s long-term obligations, including finance lease obligations. Refer to Financial Note 11, &#8220;Debt and Financing Activities,&#8221; to the consolidated financial statements included in this Annual Report for more information. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents undiscounted minimum operating lease obligations under non-cancelable operating leases having an initial remaining term over one year and is not adjusted for imputed interest. Refer to Financial Note 9, &#8220;Leases,&#8221; to the consolidated financial statements included in this Annual Report for more information. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes estimated benefit payments for our unfunded benefit plans and minimum funding requirements for our pension plans as well as the contingent consideration liability related to our acquisition of RxSS in November 2022.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents interest that will become due on our fixed rate long-term debt obligations.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily relates to the expected purchase of goods and services, including inventory and capital commitments, from vendors in the normal course of business. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes agreements under which we have guaranteed the repurchase of our customers&#8217; inventory and our customers&#8217; debt in the event these customers are unable to meet their obligations to those financial institutions. Refer to Financial Note 16, &#8220;Financial Guarantees and Warranties,&#8221; to the consolidated financial statements included in this Annual Report for more information. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_43">MD&amp;A Index</a></span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> REVIEW (Concluded)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material cash requirements table above excludes the following obligations:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023, the Company had accrued liabilities of $7.2 billion related to the settlement of opioid-related litigation claims with U.S. governmental entities, including Native American tribes, as described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this Financial Review and Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in this Annual Report. The majority of this amount relates to a global settlement payable in annual installments through 2038 pursuant to the schedule set forth in the agreement. As of March 31, 2023, $548 million is estimated to be paid within the next twelve months.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023, the liability recorded for uncertain tax positions, excluding associated interest and penalties, was approximately $974 million. The ultimate amount and timing of any related future cash settlements cannot be predicted with reasonable certainty. Refer to Financial Note 6, &#8220;Income Taxes,&#8221; to the consolidated financial statements included in this Annual Report for additional information on income tax matters.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023, our banks and insurance companies have issued $206 million of standby letters of credit and surety bonds. These were issued on our behalf and are mostly related to our customer contracts and to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, pension obligations in Europe, and our workers&#8217; compensation and automotive liability programs.</span></div><div id="i04335d018da94076b0acf21e81ac886b_2615"></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Resources</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund our working capital requirements primarily with cash and cash equivalents as well as short-term borrowings from our commercial paper issuances. Funds necessary for future debt maturities and our other cash requirements, including any future payments that may be made related to our total estimated litigation liability of $7.2 billion as of March 31, 2023 payable under the terms of various settlement agreements for opioid-related claims, are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions. Long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, are open and accessible to us should we decide to access those markets. Detailed information regarding our debt and financing activities is included in Financial Note 11, &#8220;Debt and Financing Activities,&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div id="i04335d018da94076b0acf21e81ac886b_85"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RELATED PARTY BALANCES AND TRANSACTIONS </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding our related party balances and transactions is included in Financial Note 19, &#8220;Related Party Balances and Transactions,&#8221; to the consolidated financial statements included in this Annual Report. </span></div><div id="i04335d018da94076b0acf21e81ac886b_88"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEW ACCOUNTING PRONOUNCEMENTS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New accounting pronouncements that we have recently adopted, as well as those that have been recently issued but not yet adopted by us, are included in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_91"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate risk:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our long-term debt bears interest predominately at fixed rates, whereas our short-term borrowings are at variable interest rates. Our cash and cash equivalents balances earn interest at variable rates. At March 31, 2023 and 2022, we had $4.7 billion and $3.5 billion, respectively, in cash and cash equivalents. At March 31, 2023, we also had fixed-to-floating interest rate swaps with a total notional amount of $1.3 billion. The effect of a hypothetical 50 basis points increase in the underlying interest rate on our cash and cash equivalents, net of short-term borrowings and fixed-to-floating interest rate swaps, would not have resulted in a material impact to earnings in fiscal 2023 or fiscal 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency exchange rate risk: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct our business worldwide in U.S. dollars and the functional currencies of our foreign subsidiaries, including Canadian dollars, Euro, and British pounds sterling. Changes in foreign currency exchange rates could have a material adverse impact on our financial results that are reported in U.S. dollars. We are also exposed to foreign currency exchange rate risk related to our foreign currency-denominated notes and our foreign subsidiaries, including intercompany loans denominated in non-functional currencies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain foreign currency exchange rate risk programs that utilize cross-currency swaps which are intended to reduce the income statement effects from fluctuations in foreign currency exchange rates and have been designated as cash flow hedges or fair value hedges. These programs reduce but do not entirely eliminate foreign currency exchange rate risk. However, our risk management programs are designed such that changes in the value of the underlying exposure would be largely offset by the potential changes in the value of the risk management portfolios. Refer to Financial Note 14, &#8220;Hedging Activities,&#8221; to the consolidated financial statements included in this Annual Report for more information on our cross-currency swaps.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries are also exposed to balances denominated in currencies other than their functional currency. At March 31, 2023 and 2022, the effect of a hypothetical adverse 10% change in the foreign currency exchange rates on underlying balances not reported in the functional currencies of the Company and these subsidiaries would not have resulted in a material impact to our earnings in fiscal 2023 or fiscal 2022. Refer to Financial Note 1, &#8220;Significant Accounting Policies,&#8221; under the section &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for more information regarding our exposure to transactional gains and losses.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we announced our intention to exit our businesses in Europe. We completed the divestitures of our Austrian business in January 2022, the U.K. disposal group in April 2022, and the E.U. disposal group in October 2022. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; to the consolidated financial statements included in this Annual Report for more information on these divestitures. The completion of these divestitures has reduced our foreign currency exchange rate risk as it relates to the Euro and British pound sterling. The selected hypothetical change in interest rates and foreign currency exchange rates described above does not reflect what could be considered the best or worst case scenarios.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_94"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Supplementary Data.</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL INFORMATION</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:91.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_97">Management's Annual Report on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_97">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_100">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_100">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_103">Consolidated Statements of Operations for the years ended March 31, 2023, 2022, and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_103">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_106">Consolidated Statements of Comprehensive Income (Loss) for the years ended March 31, 2023, 2022, and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_106">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_109">Consolidated Balance Sheets as of March 31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_109">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_112">Consolidated Statements of Stockholders&#8217; Equity (Deficit) for the years ended March 31, 2023, 2022, and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_112">68</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_115">Consolidated Statements of Cash Flows for the years ended March 31, 2023, 2022, and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_115">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_118">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_118">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_121">Note 1 - Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_121">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_124">Note 2 - Business Acquisitions and Divestitures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_124">78</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_127">Note 3 - Restructuring, Impairment, and Related Charges, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_127">84</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_133">Note 4 - Share-Based Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_133">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_136">Note 5 - Other Income, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_136">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_139">Note 6 - Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_139">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_142">Note 7 - Redeemable Noncontrolling Interests and Noncontrolling Interests </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_142">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_145">Note 8 - Earnings (Loss) Per Common Share</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_145">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_148">Note 9 - Leases</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_148">98</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_151">Note 10 - Goodwill and Intangible Assets, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_151">100</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_154">Note 11 - Debt and Financing Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_154">103</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_157">Note 12 - Variable Interest Entities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_157">106</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_160">Note 13 - Pension Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_160">106</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_163">Note 14 - Hedging Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_163">113</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_166">Note 15 - Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_166">116</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_169">Note 16 - Financial Guarantees and Warranties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_169">119</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_172">Note 17 - Commitments and Contingent Liabilities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_172">119</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_175">Note 18 - Stockholders' Equity (Deficit)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_175">126</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_178">Note 19 - Related Party Balances and Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_178">129</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_181">Note 20 - Segments of Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_181">129</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_97"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S ANNUAL REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The management of McKesson Corporation is responsible for establishing and maintaining an adequate system of internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). With the participation of the Chief Executive Officer and the Chief Financial Officer, our management conducted an assessment of the effectiveness of our internal control over financial reporting based on the framework and criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, our management has concluded that our internal control over financial reporting was effective as of March 31, 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deloitte &amp; Touche LLP, an independent registered public accounting firm, audited the financial statements included in this Annual Report on Form 10-K and has also audited the effectiveness of the Company&#8217;s internal control over financial reporting as of March 31, 2023. This audit report appears on the following page of this Annual Report on Form 10-K. </span></div><div style="margin-bottom:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May&#160;8, 2023 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:263.25pt"><tr><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brian S. Tyler</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:263.25pt"><tr><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Britt J. Vitalone</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_100"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of McKesson Corporation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of McKesson Corporation and subsidiaries (the &#8220;Company&#8221;) as of March 31, 2023 and 2022, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity (deficit), and cash flows, for each of the three years in the period ended March 31, 2023, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the &#8220;financial statements&#8221;). We also have audited the Company&#8217;s internal control over financial reporting as of March 31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2023, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of March 31, 2023, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by COSO.</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinions</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our responsibility is to express an opinion on these financial statements and an opinion on the Company&#8217;s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioid litigation and related uncertain tax position - refer to Note 1, Note 6, and Note 17 to the financial statements</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in numerous cases asserting claims related to distribution of controlled substances, including opioids. Plaintiffs in these actions have included state attorneys general, county and municipal governments, tribal nations, as well as private plaintiffs such as hospitals, health and welfare funds, third-party payors, and individuals, as well as cases brought in Canada (&#8220;opioid litigation&#8221;). The Company recognizes a liability for loss contingencies, including opioid litigation, when it is probable that a liability has been incurred and the amount of loss or range of loss is reasonably estimable. The Company has recorded a $7.2 billion liability related to opioid litigation as of March 31, 2023. In connection with this liability, the Company recognized a related income tax benefit, and has an unrecognized tax benefit resulting from uncertainty in the amount that is more likely than not to be deductible for U.S. federal and state income tax purposes.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified opioid litigation as a critical audit matter because of the significant judgment in auditing management&#8217;s accounting and disclosure for these matters. Such judgment led to an increased extent of effort, including the need to involve specialists. Specifically, auditing management&#8217;s assessment of whether a loss in excess of the opioid litigation accrual is probable and reasonably estimable for unresolved cases is subjective and requires significant judgment given the novelty and complexity of the Company&#8217;s opioid litigation. There is also significant judgment associated with the Company&#8217;s disclosure of opioid litigation, including auditing management&#8217;s assertion that no range of loss can be estimated outside of the amount currently accrued. In addition, auditing management&#8217;s estimate of the amount of related income tax benefit deemed more-likely-than-not of being realized is challenging because the evaluation of the technical merits of such tax positions requires significant judgment and an increased extent of effort, including the need to involve our tax specialists.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to liabilities arising from opioid claims brought by Governmental Entities included the following, among others:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of the Company&#8217;s internal controls related to opioid litigation and the related uncertain tax position. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We inquired of the Company&#8217;s internal and external legal counsel and tax experts, as well as executives and other members of management, to understand the basis for the Company&#8217;s accounting conclusions, including any changes in facts potentially impacting the Company&#8217;s reserves for uncertain tax positions.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We inspected responses to inquiry letters sent to both internal and external counsel.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated management&#8217;s analysis of liabilities arising from opioid claims.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our tax specialists, we evaluated management&#8217;s analysis of the uncertain tax position associated with the Company&#8217;s opioid litigation.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We examined Board of Directors meeting minutes and compared to internal and external counsel&#8217;s written responses to our inquiry letters. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated any events relevant to opioid litigation occurring subsequent to March 31, 2023.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We obtained written representations from executives and internal counsel of the Company.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We examined terms related to settlements of opioid claims.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated the adequacy of the Company&#8217;s related disclosures for consistency with our testing and also searched for contradictory evidence by reading disclosures from peer companies, who are also party to opioid litigation.</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill - Refer to Note 1 and Note 10 to the financial statements</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s evaluation of goodwill for impairment involves comparing the carrying amount of each reporting unit to its fair value on the first day of the first fiscal quarter or whenever the Company believes a potential indicator of impairment requiring a more frequent assessment has occurred. The Company uses a combination of the income and market approaches to estimate reporting unit fair value. Under the market approach, fair value is estimated by comparing the business to similar businesses, or guideline companies whose equity securities are actively traded in public markets. Under the income approach, the Company uses a discounted cash flow (&#8220;DCF&#8221;) model where cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate discount rate that is commensurate with the risk inherent within the reporting unit. The rate used to discount to present value includes an unsystematic risk premium, which is intended to address uncertainty related to the reporting unit&#8217;s future cash flow projections. The goodwill balance was $9.9 billion as of March 31, 2023, of which $1.4 billion was allocated to the McKesson Canada reporting unit. The fair value of all reporting units exceeded their respective carrying amounts as of the measurement date and, therefore, no impairment was recognized.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the estimation of the fair value of the McKesson Canada reporting unit used to evaluate the recoverability of goodwill as a critical audit matter because of the challenges auditing significant judgments used in the selection of a discount rate, including the unsystematic risk premium. In particular, the fair value estimate is sensitive to the unsystematic risk premium assumption, which is affected by potential additional risk of changes in the Canadian business and regulatory environments. Auditing management&#8217;s selected discount rate required a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialists.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the Company&#8217;s selection of a discount rate, including determination of the unsystematic risk premium, for the McKesson Canada reporting unit, included the following, among others:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of internal controls related to management&#8217;s goodwill impairment evaluation, including those related to the selection of a discount rate and determination of an unsystematic risk premium.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated management&#8217;s ability to accurately forecast operating results for the McKesson Canada reporting unit by comparing actual results to management&#8217;s historical forecasts, in order to consider the reasonableness and adequacy of management&#8217;s selected unsystematic risk premium.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As part of our assessment of the unsystematic risk premium, we evaluated the reasonableness of strategic plans expected to be implemented during the forecast period by comparing the forecasts to:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Actual results of historical strategic plans</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Internal communications to management and the Board of Directors</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including the unsystematic risk premium, by developing a range of independent estimates, testing the mathematical accuracy of the calculation, and comparing to the discount rate selected by management.</span></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:263.25pt"><tr><td style="width:1.0pt"></td><td style="width:261.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDAvZnJhZzpkMzU1YTMxMzNjOTE0ZDE0YTViYTAzNmExMmFjNDVjZS90YWJsZTo2ZWM1MzVjZDliZTE0NGQ2YjcxMDQzYzcwNzdmMzAwMC90YWJsZXJhbmdlOjZlYzUzNWNkOWJlMTQ0ZDZiNzEwNDNjNzA3N2YzMDAwXzEtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246ZDNkNDkzZDZhMTllNGNkMGE0ZDJlNmRlMjJjODhmMWFfOQ_2ed2d760-f222-4372-8605-2b3d0ce0a36c">Deloitte &amp; Touche LLP</ix:nonNumeric></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDAvZnJhZzpkMzU1YTMxMzNjOTE0ZDE0YTViYTAzNmExMmFjNDVjZS90YWJsZTo2ZWM1MzVjZDliZTE0NGQ2YjcxMDQzYzcwNzdmMzAwMC90YWJsZXJhbmdlOjZlYzUzNWNkOWJlMTQ0ZDZiNzEwNDNjNzA3N2YzMDAwXzItMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246YTBhMjU3ZGMwMmUwNDE2MWJiN2FjOWM4N2YxODQ2MjlfNA_2975ed31-36f0-4690-b696-49c49dccdb4d">Dallas, Texas</ix:nonNumeric></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1968.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzItMS0xLTEtMjE4NzQ4_88ad45eb-6172-453c-b924-2fa60d56ce15">276,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzItMy0xLTEtMjE4NzQ4_51a066b3-9dd8-4f28-96c0-b8ed3d64b3c2">263,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzItNS0xLTEtMjE4NzQ4_67e8791f-023a-4994-a327-4d33b4c7bca8">238,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMtMS0xLTEtMjE4NzQ4_93d57cac-d6c1-46b9-a7bc-8a0e3292b4ff">264,353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMtMy0xLTEtMjE4NzQ4_bc26cedf-3004-4855-9831-ae0639399dc8">250,836</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMtNS0xLTEtMjE4NzQ4_867ccbb8-737d-4ac3-8651-67c56f9700d8">226,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzQtMS0xLTEtMjE4NzQ4_8cd15df2-ab89-4a01-8b19-0cfe08ad37de">12,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzQtMy0xLTEtMjE4NzQ4_e163edb3-edf5-4a0c-b197-f4c84887dff6">13,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzQtNS0xLTEtMjE4NzQ4_147a4c73-3ede-44a1-93e7-9ecd512e1ccf">12,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzUtMS0xLTEtMjE4NzQ4_74283a64-83de-4959-9a9c-d8e6c0e0e734">7,776</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzUtMy0xLTEtMjE4NzQ4_b18e4f18-4f00-4d64-9ec6-bc6034b34933">10,537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzUtNS0xLTEtMjE4NzQ4_fff63f52-08a2-441b-907d-d6174a8360b6">8,849</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzYtMS0xLTEtMjE4NzQ4_8a243802-134b-4c26-a45e-6106d26b5315">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzYtMy0xLTEtMjE4NzQ4_505a4b3f-88e4-4d54-ac7d-bfac338d7179">274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzYtNS0xLTEtMjE4NzQ4_7d55d540-c3d9-40e0-86c2-1f859b2b5141">7,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzctMS0xLTEtMjE4NzQ4_a26993b0-0be6-4d21-8f50-6b6481469a9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzctMy0xLTEtMjE4NzQ4_732730ee-b81b-42c7-bd43-f2dd57956208">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzctNS0xLTEtMjE4NzQ4_d64bebe3-2215-4ad9-8df7-11f508435f6c">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzgtMS0xLTEtMjE4NzQ4_9a1a7f9c-a530-488d-b156-8bef65c7c809">209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzgtMy0xLTEtMjE4NzQ4_3c23df35-0ea0-4fbc-a3db-4122cc9c1bb4">281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzgtNS0xLTEtMjE4NzQ4_5f8322bb-de00-462a-a18a-289b1dc9734e">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzktMS0xLTEtMjE4NzQ4_956bf118-f3e9-42c4-91f7-a5525b947a2f">7,977</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzktMy0xLTEtMjE4NzQ4_52dce289-4e9f-4e66-894c-219e6e80b047">11,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzktNS0xLTEtMjE4NzQ4_ffa03781-1537-44a9-8402-4f86d5dc0879">17,188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEwLTEtMS0xLTIxODc0OA_a7994695-1529-46bb-ba1e-5fb6c0d72c2f">4,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEwLTMtMS0xLTIxODc0OA_d46bd1d4-89e8-4646-8a30-6576fc818d1a">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEwLTUtMS0xLTIxODc0OA_5ca81391-3cda-4b38-80b2-ffb4387093f3">5,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzExLTEtMS0xLTIxODc0OA_2964803a-e0d0-4b6a-8aac-28cb8a14d980">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzExLTMtMS0xLTIxODc0OA_04b3f4ef-e537-4993-8078-8b354e039c55">259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzExLTUtMS0xLTIxODc0OA_4a623e7d-74ac-4b19-9667-4c6e08f96a5f">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEzLTEtMS0xLTIxODc0OA_94fbea38-f61e-49d3-aa8c-8c372cb72392">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEzLTMtMS0xLTIxODc0OA_b35c1d20-febf-4c6a-bbdf-6cba12a8aaa5">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEzLTUtMS0xLTIxODc0OA_baf7144f-de34-4606-83ea-28ff71600f5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE0LTEtMS0xLTIxODc0OA_275929f9-bb84-4749-b24f-89cef19e738a">248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE0LTMtMS0xLTIxODc0OA_34bda097-28a8-49d1-b7ab-b465aaa446d6">178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE0LTUtMS0xLTIxODc0OA_5e079b1d-6b7b-4b43-80fb-9c1813b534fb">217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE1LTEtMS0xLTIxODc0OA_1da40179-f804-42b7-8b6f-dbcfd008f53b">4,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE1LTMtMS0xLTIxODc0OA_27e0309c-1a33-44fb-afd4-7903655274ee">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE1LTUtMS0xLTIxODc0OA_cd391289-128c-4ccf-96ea-e1962ef25855">5,034</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE2LTEtMS0xLTIxODc0OA_2e90d1d8-a5b7-45cc-b0d5-c47856b716f3">905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE2LTMtMS0xLTIxODc0OA_35ce6d27-00b3-488a-862a-bee02489a05c">636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE2LTUtMS0xLTIxODc0OA_f36ed28c-0b7f-4f4d-9b9b-181d51d2b8fa">695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE3LTEtMS0xLTIxODc0OA_429ec7ce-04a7-4d48-bc10-accacd17c346">3,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE3LTMtMS0xLTIxODc0OA_34fe81a3-ef24-4151-a569-986bfeab7b46">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE3LTUtMS0xLTIxODc0OA_a9ac4a1c-055f-48f2-b452-4a0896353692">4,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE4LTEtMS0xLTIxODc0OA_7f3a0b73-9a8e-4fb7-a398-2c9588526095">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE4LTMtMS0xLTIxODc0OA_97173305-9bac-4d9b-ab7f-48137d0c7c16">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE4LTUtMS0xLTIxODc0OA_30ed9553-003b-4aac-8dd4-b554564c528e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE5LTEtMS0xLTIxODc0OA_9ed33e9e-5942-48df-9158-733b0d9758f1">3,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE5LTMtMS0xLTIxODc0OA_1a24b173-3137-478a-9985-4382a65aa4fd">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE5LTUtMS0xLTIxODc0OA_65529e24-3270-483b-b6b3-b431ba2e2600">4,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIwLTEtMS0xLTIxODc0OA_11cf3b64-3304-4f97-9742-212467431764">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIwLTMtMS0xLTIxODc0OA_b23a6f63-5964-4717-aa95-1e6923defafd">173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIwLTUtMS0xLTIxODc0OA_859f820f-b73a-4a4f-9fbc-c237b74d5e11">199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIxLTEtMS0xLTIxODc0OA_19ca6810-45e1-4b02-a7b7-7082e9a3b237">3,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIxLTMtMS0xLTIxODc0OA_df15a823-c6dd-425b-8732-d4b3a2940549">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIxLTUtMS0xLTIxODc0OA_f5b828ba-aed0-4af8-a423-4ff9679e7d3a">4,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI1LTEtMS0xLTIxODc0OA_f0fca01a-812f-4773-9fd0-1c8d98163cb4">25.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI1LTMtMS0xLTIxODc0OA_8489e818-f235-4dab-b8f5-43cb0b02356a">7.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI1LTUtMS0xLTIxODc0OA_5f9e78be-948e-4885-b9df-045102f4e900">28.26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI2LTEtMS0xLTIxODc0OA_503ddbe6-5856-4515-adbc-a77525bafc87">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI2LTMtMS0xLTIxODc0OA_e07aa815-0f46-455b-84f7-5ab8ff9e5f87">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI2LTUtMS0xLTIxODc0OA_a021036c-47c1-49ac-b8e1-b300c8f67656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI3LTEtMS0xLTIxODc0OA_a91c4e85-4eeb-461e-a2e6-ae798f4bc53c">25.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI3LTMtMS0xLTIxODc0OA_62e6866c-7bda-4285-b413-89f2ce76e5fa">7.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI3LTUtMS0xLTIxODc0OA_532c80de-f0a5-47ef-a2c2-c7423b9f4fb9">28.26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI5LTEtMS0xLTIxODc0OA_3f22a7d9-407b-4477-b013-ae4f36ccc42a">25.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI5LTMtMS0xLTIxODc0OA_dd5c5345-c1ed-4edb-846c-7cef9a643652">7.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI5LTUtMS0xLTIxODc0OA_ec49d15c-c9f7-438d-938f-b720e412ceae">28.26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMwLTEtMS0xLTIxODc0OA_7ec3a040-6f6d-4d13-b9e8-a3bffa6c0647">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMwLTMtMS0xLTIxODc0OA_e6c69636-47cb-4689-b041-b9a27fe64537">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMwLTUtMS0xLTIxODc0OA_a4798472-8d5a-442e-b07e-24c2383c47ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMxLTEtMS0xLTIxODc0OA_036130da-dcf1-4657-8a22-edc90daf9ea9">25.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMxLTMtMS0xLTIxODc0OA_17955968-617e-4ff7-99a2-569b9a0c94df">7.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMxLTUtMS0xLTIxODc0OA_9deaff92-127e-4fe6-98e7-172c3bf45de5">28.26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM0LTEtMS0xLTIxODc0OA_533850be-162e-48c8-a604-8f52154f7f3a">142.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM0LTMtMS0xLTIxODc0OA_27aa7b0d-e640-452b-a85e-d51ef4cb0b46">154.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM0LTUtMS0xLTIxODc0OA_6f73424d-fff4-443f-bf9d-b635c2379a68">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM1LTEtMS0xLTIxODc0OA_09368807-73fc-4118-96fa-684eb38b87fa">141.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM1LTMtMS0xLTIxODc0OA_78226c0e-1b2e-4fc1-aaf2-19749fbd8f99">152.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM1LTUtMS0xLTIxODc0OA_271d3647-613d-4a70-b9d6-fc398850407c">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzItMS0xLTEtMjE4NzQ4_bfeee902-5edd-48d6-b2a1-40819e9da6f7">3,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzItMy0xLTEtMjE4NzQ4_cf788c6c-9096-43e8-8ce3-c5a8d21d25bb">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzItNS0xLTEtMjE4NzQ4_415d239a-511d-438b-be5b-da6f1b45cf3c">4,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzUtMS0xLTEtMjE4NzQ4_4142ca3c-f91e-43f6-b92a-57414364ef4d">674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzUtMy0xLTEtMjE4NzQ4_6a5dd140-115c-475b-8a86-7f81023430be">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzUtNS0xLTEtMjE4NzQ4_c981900e-5a7e-4e4b-9112-7430e3417912">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on cash flow and other hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzYtMS0xLTEtMjE4NzQ4_3fdeb3c6-e556-4c54-b0aa-e792c58fc46f">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzYtMy0xLTEtMjE4NzQ4_b11e2b1d-b852-4d27-a592-798ab2bb25b3">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzYtNS0xLTEtMjE4NzQ4_3b040794-edcd-4255-8f4b-2017260948ae">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzctMS0xLTEtMjE4NzQ4_cc5d8c29-1953-46d7-b391-497a7e36deb4">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzctMy0xLTEtMjE4NzQ4_caad97f0-9f33-4ae9-9211-c9f8e6afd496">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzctNS0xLTEtMjE4NzQ4_da1d649f-6de3-40ab-b63a-d13c5d7032b1">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzgtMS0xLTEtMjE4NzQ4_7e98a942-1337-4919-95fd-2a3ba3690187">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzgtMy0xLTEtMjE4NzQ4_bd01910e-4646-4278-8f79-7b58d9c1a383">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzgtNS0xLTEtMjE4NzQ4_8ab6007e-d319-4d2f-b390-9508ee703812">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEwLTEtMS0xLTIxODc0OA_4fa9834d-de0e-4102-81b0-02afe41c7c28">4,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEwLTMtMS0xLTIxODc0OA_3a7629a2-dbf5-462e-ae2a-79e4f4fd24e2">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEwLTUtMS0xLTIxODc0OA_23f34e91-4cfa-43ff-afdc-b4457ca09b66">4,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzExLTEtMS0xLTIxODc0OA_d12b930e-632a-4f84-aab1-09c96ab7d7e1">206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzExLTMtMS0xLTIxODc0OA_654cde86-39fb-48f5-95c0-9f936003308a">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzExLTUtMS0xLTIxODc0OA_8503db74-3166-48a1-acf5-8a44a7f41686">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEyLTEtMS0xLTIxODc0OA_e3d7a598-efc6-493a-a352-e71b9d47dcca">4,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEyLTMtMS0xLTIxODc0OA_5ee6e9b8-540e-4cf3-b6ff-90b5f5ea3d78">1,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEyLTUtMS0xLTIxODc0OA_68da7ccb-ef48-4a50-9500-e08e9f142add">4,316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQtMS0xLTEtMjE4NzQ4_9a4cbc8a-9671-4bd1-b980-fbbb2c5afd9c">4,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQtMy0xLTEtMjE4NzQ4_a3ad3aaf-cf92-410a-8488-b65b58e248e5">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzUtMS0xLTEtMjE4NzQ4_0e88cbd8-3e2d-4a5c-81d7-8002c218ccd4">19,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzUtMy0xLTEtMjE4NzQ4_793f2684-b60f-4caf-a31e-077add2dbe6d">18,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzYtMS0xLTEtMjE4NzQ4_f758d0ef-a496-46f9-b141-49e83812d0b6">19,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzYtMy0xLTEtMjE4NzQ4_85258063-516a-4bbf-9a88-db8a5af01fc6">18,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzctMS0xLTEtMjE4NzQ4_ae6db0ba-37ad-4519-9737-665629459956">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzctMy0xLTEtMjE4NzQ4_f1312ce9-0416-4d8f-afe3-9fb44af8f991">4,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzgtMS0xLTEtMjE4NzQ4_3e32bb19-60e4-48d8-a8ea-4c781bed5511">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzgtMy0xLTEtMjE4NzQ4_f833d8be-4825-4899-b26f-481ef0101689">898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzktMS0xLTEtMjE4NzQ4_447f7b88-02a8-482f-82e6-c2df663f64e1">44,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzktMy0xLTEtMjE4NzQ4_8b4e6070-5b9b-475d-a02d-f9e391572042">46,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEwLTEtMS0xLTIxODc0OA_01755b96-1055-42e1-be9f-40a97529281b">2,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEwLTMtMS0xLTIxODc0OA_3bb157a6-64ab-4532-b87d-cd19d627c5fc">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzExLTEtMS0xLTIxODc0OA_479429e8-b537-46d4-9b56-c6ea84549275">1,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzExLTMtMS0xLTIxODc0OA_386c0a3e-eb58-48c0-9dac-ae7f15629f23">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEyLTEtMS0xLTIxODc0OA_0995da66-8d3e-4837-8073-d07d92d7d58f">9,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEyLTMtMS0xLTIxODc0OA_54dde658-d362-4f40-83f7-855d36ed4620">9,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEzLTEtMS0xLTIxODc0OA_fbab9d1e-c824-4ffc-993e-d23e62e6ac52">2,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEzLTMtMS0xLTIxODc0OA_56d3db69-fea6-4344-9582-4253c3e62176">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE0LTEtMS0xLTIxODc0OA_0282e379-0428-4018-89dc-c1a32b105b6a">1,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE0LTMtMS0xLTIxODc0OA_06a429e4-5a9f-4c0e-bb6d-93b9ccc2a6a7">1,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE1LTEtMS0xLTIxODc0OA_9c47650d-797e-49f6-88d8-8977bb9ac4c0">62,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE1LTMtMS0xLTIxODc0OA_f5e46338-377b-4da9-8552-5da5c9a11498">63,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND DEFICIT</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE4LTEtMS0xLTIxODc0OA_52c3393f-6484-4623-8170-644dfaf1b89c">42,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE4LTMtMS0xLTIxODc0OA_120a0b1e-220d-4a7d-9965-f5faefdb9915">38,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIwLTEtMS0xLTIxODc0OA_3d2b959d-2aa1-4cfa-9f5f-fd0212984b3f">968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIwLTMtMS0xLTIxODc0OA_59a5a071-d34c-4b7a-aa1d-8ed83ebee136">799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIxLTEtMS0xLTIxODc0OA_40497ea8-0ca2-4c2a-bdeb-4c08508f91ca">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIxLTMtMS0xLTIxODc0OA_2422f37b-7613-4576-a6b9-67bd2df88541">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIyLTEtMS0xLTIxODc0OA_00110dc1-d48d-400c-b05e-c9ba3a8a5f01">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIyLTMtMS0xLTIxODc0OA_df9e6645-2138-45b1-a304-1316015387c1">4,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIzLTEtMS0xLTIxODc0OA_b8cc4a99-aced-40a5-a937-f766007b247e">4,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIzLTMtMS0xLTIxODc0OA_c9cf0593-f053-4f3d-b4e4-a8cb77e8d5d9">4,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI0LTEtMS0xLTIxODc0OA_e997b700-5538-42b1-be99-4d6d8c97a3d3">47,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI0LTMtMS0xLTIxODc0OA_e68f9ff2-7130-4995-8d62-5938911d4d45">48,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI1LTEtMS0xLTIxODc0OA_2cfdf8ed-87ac-40e3-af71-a0bc53542f12">4,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI1LTMtMS0xLTIxODc0OA_3d74699e-46db-4273-a91e-aab49d38aab8">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI2LTEtMS0xLTIxODc0OA_685a7dff-3cbc-4e2f-b4e3-197bc95c0a5b">1,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI2LTMtMS0xLTIxODc0OA_d890faf2-22fb-4956-bac2-ec7465450def">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI3LTEtMS0xLTIxODc0OA_3bb443b2-5445-4163-83fe-7a74254fbd70">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI3LTMtMS0xLTIxODc0OA_0b2e5384-969d-44f7-80e7-fc8c081f3bb5">1,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI4LTEtMS0xLTIxODc0OA_560379b0-a46e-4f3f-b8d1-715bc172a237">6,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:LitigationReserveNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI4LTMtMS0xLTIxODc0OA_bc164b80-c6fb-41fa-b1fa-fd68f04e0590">7,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI5LTEtMS0xLTIxODc0OA_095d97b0-057a-4ac2-9c9f-207a7ec888be">1,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI5LTMtMS0xLTIxODc0OA_3e5db2eb-aa18-425a-bbb9-53c72e61af1e">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingent liabilities (Note 17)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMwLTEtMS0xLTIxODc0OA_246ba068-a88c-4f1f-816a-09a5e62068cc"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMwLTMtMS0xLTIxODc0OA_e61a75f0-6e41-4a4b-96e0-59fb173a84e4"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzIx_6a21a9b7-18b9-4ca6-aee3-ce09b40e17b5"><ix:nonFraction unitRef="usdPerShare" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzIx_ed755c36-6eee-4b74-968b-3ba545c479aa">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzM1_7e4fbc58-93af-45e1-8710-6a2c987f5b8e"><ix:nonFraction unitRef="shares" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzM1_be35ffb6-aafa-42e1-a9c0-9d04ee02f506">100</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzU3_1483ae8b-7788-42d3-abcc-026c04c234ca"><ix:nonFraction unitRef="shares" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzU3_aab1cc53-0aec-4dff-ae9e-6be0b4be9d3a"><ix:nonFraction unitRef="shares" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzU3_b8bccd9b-4f5a-4a48-94e0-6ed11e2bb71b"><ix:nonFraction unitRef="shares" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzU3_dce8669f-4860-4bd2-9ca5-b97c6d7b07d9">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTEtMS0xLTIxODc0OA_ee49b595-6464-4f2d-ab3a-12c696304f5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTMtMS0xLTIxODc0OA_cfb697bc-7540-489d-ac1b-876f0b8b6cd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzE4_7ca49d84-6322-41e8-9ed5-4ce6b0249b67"><ix:nonFraction unitRef="usdPerShare" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzE4_d6cd490e-9886-4023-a30b-5c558f18f017">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzMy_908a1048-8275-479e-8233-c3c15e9cd22a"><ix:nonFraction unitRef="shares" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzMy_9e2f847c-d198-45bb-93f3-3ac11ccdf9e6">800</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzU0_ff12431c-ce38-425c-9d38-ec20e778b2b6">277</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzYx_8f21e05a-2108-44b4-a035-20a94de78819">275</ix:nonFraction> shares issued at March 31, 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTEtMS0xLTIxODc0OA_0b678abe-487e-41d0-8da5-215b6a0897e2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTMtMS0xLTIxODc0OA_371bb4bc-bdd1-433e-ba33-ab82fc3e60ff">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM1LTEtMS0xLTIxODc0OA_a004af86-0c7d-4698-bfea-9c5854cfc69e">7,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM1LTMtMS0xLTIxODc0OA_ff1f435c-8180-4a28-a347-e24f50e5e2ee">7,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM2LTEtMS0xLTIxODc0OA_5b4fff3d-1800-436e-a909-9f461123db5b">12,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM2LTMtMS0xLTIxODc0OA_797dbf64-ca6c-41c1-9574-4371f8d31be3">9,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM3LTEtMS0xLTIxODc0OA_675b4744-8064-45dd-a490-072bd5589702">905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM3LTMtMS0xLTIxODc0OA_fe26442c-85c8-41a9-a18d-22cb91f8223f">1,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury shares, at cost, <ix:nonFraction unitRef="shares" contextRef="i3bc582f275f5403289fded6bcb155630_I20230331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM5LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjgxODIzZGNiZmY1ODQwY2ViYzEyNGI4Yjk3OTllODU0XzMw_a2f6a21f-3c55-47d5-9345-2d1828d74286">141</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia6a1485449e34a8ea1bffd8f744aa580_I20220331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM5LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjgxODIzZGNiZmY1ODQwY2ViYzEyNGI4Yjk3OTllODU0XzM3_cb4e13ed-3326-4f7a-9437-3933ffffc927">130</ix:nonFraction> shares at March 31, 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM5LTEtMS0xLTIxODc0OA_c6f20479-62d0-4aa4-85f0-855217a6c70a">20,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM5LTMtMS0xLTIxODc0OA_a9fce8ce-3670-4fad-a034-d4133654e862">17,045</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQwLTEtMS0xLTIxODc0OA_77d02d91-bb8e-4e57-921f-7803d9a1c47b">1,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQwLTMtMS0xLTIxODc0OA_cf2abfa0-4ed8-4cc0-be4d-444068da7a2f">2,272</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQxLTEtMS0xLTIxODc0OA_4b8ac458-9934-4c78-a19c-988b29904ac5">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQxLTMtMS0xLTIxODc0OA_d11cf834-ae48-46e9-995b-68179adccdfc">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deficit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQyLTEtMS0xLTIxODc0OA_ba14187f-d0e2-4ee2-90b5-79e64e4d3eec">1,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQyLTMtMS0xLTIxODc0OA_8fa93d90-2991-4839-8282-057532989bb8">1,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and deficit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQzLTEtMS0xLTIxODc0OA_73c76140-58c5-414e-a975-046c1cbbd4b6">62,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQzLTMtMS0xLTIxODc0OA_3aac8c1c-bd23-4c6d-ba2f-48de6f34accf">63,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.479%"><tr><td style="width:1.0%"></td><td style="width:35.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.182%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.323%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.182%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.172%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.193%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">McKesson Corporation Stockholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common <br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity (Deficit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a1422fa33ff4ef8be96240fe701c4a8_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMS0xLTEtMjE4NzQ4_40b661af-3de8-4926-a834-59862ab71a8a">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a1422fa33ff4ef8be96240fe701c4a8_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMy0xLTEtMjE4NzQ4_8181029f-425a-49e9-bb6d-7b9ced3a8d06">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c7ce235f09242b1a7dd13dd1873da14_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtNS0xLTEtMjE4NzQ4_70a9ac42-e679-44bf-8b63-0a4dfdba3d33">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b4ad18ecc1b43159d4657ee792f26c1_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtOS0xLTEtMjE4NzQ4_03efd11f-def0-4ded-81c7-09a4b76305de">13,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14f8bb56f1e4471588d3ee861bf56425_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMTEtMS0xLTIxODc0OA_470f33fa-4eee-400c-a80a-4521d411df45">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia09f86adf45346869fdfd6e2c5e84729_I20200331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMTMtMS0xLTIxODc0OA_708ea203-6db8-46ba-be09-7c7fb52c2d0e">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia09f86adf45346869fdfd6e2c5e84729_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMTUtMS0xLTIxODc0OA_9b2656b0-cd2f-4485-b95c-1143936e63a9">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28949ffb8bb2424c94e02d81ae0b5d27_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMTctMS0xLTIxODc0OA_e99ccf1e-426f-4b94-89ca-5dc89e5b844e">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ca92db1bf347039646a68953e87fed_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMTktMS0xLTIxODc0OA_b9251ba3-760f-48cf-ba68-5ae3c90241c0">5,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opening retained earnings adjustments: adoption of new accounting standards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37de8b6ee05745e3861fbe7542070721_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzQtOS0xLTEtMjE4NzQ4_6ca2e692-11e3-42ee-b4e8-971c03748d09">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60a6fff3dabd4c79b50c2bf8f6f2c365_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzQtMTktMS0xLTIxODc0OA_716d6ae5-e9d5-436a-83e8-b27aae35af7d">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, April 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idbe6a88a06904b1cab91937548e19519_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMS0xLTEtMjE4NzQ4_38315c6b-57aa-4fe6-9726-8e49be7aa48d">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbe6a88a06904b1cab91937548e19519_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMy0xLTEtMjE4NzQ4_744a929c-17e3-4477-a984-21b85bf34011">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab59611846a49f2b03ee48497e3100f_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtNS0xLTEtMjE4NzQ4_b1b6e92b-e1cd-4ea7-9bf7-1f85f4d3f071">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16ef48415e2d41019530a2f69364659e_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtOS0xLTEtMjE4NzQ4_c7308e61-3e94-46fb-bdf2-fe71de39a36e">13,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib06de7ab957b4a4d88a689f7f6a590e7_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMTEtMS0xLTIxODc0OA_fdac3293-518a-4a59-8edd-3001d992bb6e">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3fda731c4c8243d8b5bf494fa64e80af_I20200331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMTMtMS0xLTIxODc0OA_d586fb26-8b80-4741-9a9f-2f56dcde1f27">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fda731c4c8243d8b5bf494fa64e80af_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMTUtMS0xLTIxODc0OA_40902453-f597-4ac0-866e-89470e353c24">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4b8982f387147d193c2d960f77258b8_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMTctMS0xLTIxODc0OA_adefdf00-6e3e-4992-a493-9d72fcfdaebe">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icef2c063f0184f93894500720ce4015e_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMTktMS0xLTIxODc0OA_9ff9a0d8-fadd-4c74-86d8-c4f455082d1d">5,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8551607689bb4731bc5de364f262218e_D20200401-20210331" decimals="-6" name="mck:StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzYtMS0xLTEtMjE4NzQ4_9f17dc81-1617-4df3-b835-5c2a63b19812">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzYtNS0xLTEtMjE4NzQ4_b59c4d38-6575-43ea-931d-9714ee33fb70">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f30127a64d74d9e8d4865e42e4cbf4c_D20200401-20210331" decimals="-6" sign="-" name="mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzYtMTUtMS0xLTIxODc0OA_e3df3648-d2f9-4be9-87ba-be253bcda46b">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzYtMTktMS0xLTIxODc0OA_402d6c36-88c5-4bf3-bcb9-bb1a6a6f164d">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzctNS0xLTEtMjE4NzQ4_20b8cc47-1a6d-4234-8f03-76f140c1eb38">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzctMTktMS0xLTIxODc0OA_897c08ea-5698-47e5-8021-1c269915593c">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4f30127a64d74d9e8d4865e42e4cbf4c_D20200401-20210331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzgtMTMtMS0xLTI0MDc2Ng_297971bf-3b9d-46b7-8dc0-3d01943c6de6">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f30127a64d74d9e8d4865e42e4cbf4c_D20200401-20210331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzgtMTUtMS0xLTI0MDc2Ng_a5a59bc7-6cdf-4575-b6f0-663cb753af1d">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzgtMTktMS0xLTI0MDc2Ng_6a9a51d2-c1f8-472c-b0dc-4474d8087bf1">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if49d7008347c45e9a5c3670667639536_D20200401-20210331" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzktOS0xLTEtMjQwNzc1_23bb877d-42ce-43d7-afbc-ead223744a4d">4,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzktMTctMS0xLTI0MDc3NQ_9b447542-c10f-4d60-93c5-1b732758ee24">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzktMTktMS0xLTI0MDc3NQ_b7a14094-dd79-4f25-ab72-ae4a710a58d5">4,383</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6de2dc307ac14073bdb93ae09a60b176_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzEwLTExLTEtMS0yNDA3ODQ_15b36d3e-b201-4bdf-aee3-4a19e5ae30c1">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzEwLTE5LTEtMS0yNDA3ODQ_18b65ccc-36dc-42d6-a931-2a3448ba3f8f">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzExLTAtMS0xLTI0MDc5MS90ZXh0cmVnaW9uOjYyYjYwNzlmM2YwMTRmMmQ4NzE1MTgxMDM4YmQ2YjBiXzI5_4881de47-8beb-4b30-b3ea-eef5b2d5cdfe">1.67</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if49d7008347c45e9a5c3670667639536_D20200401-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzExLTktMS0xLTI0MDc5MQ_2fbe4747-f689-4f8e-9f51-387550df3fd5">270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzExLTE5LTEtMS0yNDA3OTE_adf574e1-db34-4859-ba2a-26b56e071cdc">270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzgtMTctMS0xLTIxODc0OA_ab0787dd-e5f6-459e-ad32-0e3cef81cbd2">177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzgtMTktMS0xLTIxODc0OA_73e8195a-865a-4177-ba96-d35d8a4b81be">177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzExLTUtMS0xLTIyOTg2OQ_cf225fb0-b4e1-41a9-9af2-76ee8849165f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzExLTE5LTEtMS0yMjk4Njk_8dd910d7-c6ee-45e1-b0ef-d4b27efbcb88">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzEzLTUtMS0xLTIxODc0OA_690a4731-739e-4fed-ae43-6f399eca8726">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49d7008347c45e9a5c3670667639536_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzEzLTktMS0xLTIxODc0OA_6e18e60f-b2bc-4874-9615-e207846e3bc8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzEzLTE5LTEtMS0yMTg3NDg_1d813921-1b05-46a6-9fa5-86e6c8a253b9">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c3e18a28c2e4303a930bfe449b415f1_I20210331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTEtMS0xLTIxODc0OA_e9d06063-8937-4bef-9e46-7d3509528278">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c3e18a28c2e4303a930bfe449b415f1_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTMtMS0xLTIxODc0OA_7d18c0f6-1dbf-4de0-9999-9063f69b3a5a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd2b75e00f334c31915664ac94e7674e_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTUtMS0xLTIxODc0OA_32f4e5c8-e689-4045-b2e1-9952ac1795e2">6,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73dc7887d5ec4c559ba7ed149b2a2e5c_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTktMS0xLTIxODc0OA_8ac1622d-b8d4-46b9-9e6f-b3143385489f">8,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47e91f2d45c04afe94f7d67b691dde7e_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTExLTEtMS0yMTg3NDg_b76d4059-ce3c-409d-85ff-20340c7d41dd">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib6e648d6891241edbef964d4d9ee910a_I20210331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTEzLTEtMS0yMTg3NDg_1fd74746-ce6e-4c6f-8fab-e777387749ec">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6e648d6891241edbef964d4d9ee910a_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTE1LTEtMS0yMTg3NDg_74e45f6e-8024-4b57-8f8f-4ebf37c31f62">13,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7ccb4f8144bea8f3d6c3af844c49d_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTE3LTEtMS0yMTg3NDg_8bec0339-29d3-476c-9cc6-3c59aff38461">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTE5LTEtMS0yMTg3NDg_4b34dc21-6f82-457d-b444-b826c4a535ba">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i183ca81b5799440d9119d0fe988e65c3_D20210401-20220331" decimals="-6" name="mck:StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE1LTEtMS0xLTIxODc0OA_9e718dbb-7349-4dcb-a4f3-6b8b15f9fce6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE1LTUtMS0xLTIxODc0OA_d7032f8c-d58f-4cb6-8256-cbb0643657b6">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4def4e91aef84e1483b875342987eb63_D20210401-20220331" decimals="-6" sign="-" name="mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE1LTE1LTEtMS0yMTg3NDg_4954f00a-7cc3-458f-a796-6525a4258a5b">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE1LTE5LTEtMS0yMTg3NDg_2f967fe9-feac-4633-be55-23cd56ef50fa">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE2LTUtMS0xLTIxODc0OA_cf68c940-bbe7-4798-b70d-3db1a8c978eb">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE2LTE5LTEtMS0yMTg3NDg_f1a5c28a-d1df-4329-b0ea-4f88b5c0847b">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTUtMS0xLTI0MDgwMg_38add395-8ed2-4bea-bce9-d1d86a7cc5b3">204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4def4e91aef84e1483b875342987eb63_D20210401-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTEzLTEtMS0yNDA4MDI_6708cf22-e59a-43c6-9ba2-779d560cba73">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4def4e91aef84e1483b875342987eb63_D20210401-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTE1LTEtMS0yNDA4MDI_c60620e2-6db0-45dc-af3a-65f9bae8f151">3,304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTE5LTEtMS0yNDA4MDI_cfd0f24d-5d7e-4acd-b907-42374b1f8ca6">3,508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45aab0fb88544a5484bbea268be3db79_D20210401-20220331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE5LTktMS0xLTI0MDgwNQ_5bd0b612-1ff4-4695-a06c-48fe5c612fc0">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE5LTE3LTEtMS0yNDA4MDU_134e6b9b-f063-4d22-a55d-f576fc4a17b5">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE5LTE5LTEtMS0yNDA4MDU_d1cc03c8-b547-4997-870e-686e970ac551">1,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i018191f728124dca8ee428ea5cf8cef8_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIwLTExLTEtMS0yNDA4MDg_5a8071c2-819e-47c8-b540-5e2bf00e6eff">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIwLTE3LTEtMS0yNDA4MDg_ddb7e835-8a45-4be4-adb9-c1d687e78154">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIwLTE5LTEtMS0yNDA4MDg_b0eca1e3-2343-48ac-90d9-668f234daa45">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIxLTAtMS0xLTI0MDgxMi90ZXh0cmVnaW9uOmM2MTBjZWZhMWE5MTRmM2Q5ZDc0OTZjMjNjMDlkYjRlXzI5_548196c8-c5e1-4fd1-ae10-c48d308b4901">1.83</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45aab0fb88544a5484bbea268be3db79_D20210401-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIxLTktMS0xLTI0MDgxMg_00bb0661-bab7-472a-9cd4-722dc9bcf8c9">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIxLTE5LTEtMS0yNDA4MTI_847c0a73-337a-47f5-9689-8a144b097af3">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE3LTE3LTEtMS0yMTg3NDg_79933832-6750-467d-a067-d2c82035cead">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE3LTE5LTEtMS0yMTg3NDg_2d9ff000-7459-4146-8b89-a449d5799bc6">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTUtMS0xLTI0MDgyNQ_768289ad-ae4f-43a4-8cd1-29ac124be9e8">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i018191f728124dca8ee428ea5cf8cef8_D20210401-20220331" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTExLTEtMS0yNDA4MjU_57e92414-cec3-4967-a505-c68c8b5e1d82">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTE5LTEtMS0yNDA4MjU_ae30dcef-57e2-4043-be64-5a9df114af0d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe AG redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTE3LTEtMS0yNDA4MzM_11da9b54-4cbd-4eac-9e90-029969c39f6a">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTE5LTEtMS0yNDA4MzM_de438ec7-fdc1-48e4-9b31-ea2d4c61f645">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTE3LTEtMS0yMTg3NDg_6e1088cf-d8de-42d9-a980-523ec1339e77">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTE5LTEtMS0yMTg3NDg_0fd4f48d-769e-4798-8035-33ae67867793">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTUtMS0xLTIxODc0OA_5fd2a01d-3db0-47d7-86b7-d25b5e2cade9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45aab0fb88544a5484bbea268be3db79_D20210401-20220331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTktMS0xLTIxODc0OA_58d867cd-7e57-4b11-a913-c2dd8c1aad7c">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTE3LTEtMS0yMTg3NDg_e0398f85-9bbe-41e1-9c0f-1d875dec257d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTE5LTEtMS0yMTg3NDg_fb4e0be9-c104-4ae2-9d3c-94745095998b">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ddf4f8a62464df1938e09cf326c73ea_I20220331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTEtMS0xLTIxODc0OA_ec1ff7e4-78a5-4b21-9df7-df55763aae3d">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ddf4f8a62464df1938e09cf326c73ea_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTMtMS0xLTIxODc0OA_d8064fdb-5086-4399-acae-ae1282c1e49a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i229bafbff863466083e1c27c4d7dfc34_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTUtMS0xLTIxODc0OA_6ddf95a0-9ed9-4ece-a7df-8457dfdeeb0b">7,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff055f45df5945548e9f06839bf74bac_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTktMS0xLTIxODc0OA_019b78b8-11a1-4456-86bb-db6dc338545f">9,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea824d5b394948b6bd119948e0fe3df9_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTExLTEtMS0yMTg3NDg_17937b89-d67e-4acd-96d6-0225ebc86b8a">1,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia6a1485449e34a8ea1bffd8f744aa580_I20220331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTEzLTEtMS0yMTg3NDg_518c914f-ca30-4d53-8ba8-979234e8d8f7">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6a1485449e34a8ea1bffd8f744aa580_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTE1LTEtMS0yMTg3NDg_65f067c1-7313-4930-817d-5d467f8556bd">17,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967edbc39aee4ecb80a07170518c493d_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTE3LTEtMS0yMTg3NDg_83a1e93f-48fb-42fb-a20b-c4be8162b579">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTE5LTEtMS0yMTg3NDg_e35aabac-e793-406a-b728-66da8f111f26">1,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans, net of forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ace641432ca4f1aab983fa4bd125d85_D20220401-20230331" decimals="-6" name="mck:StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI1LTEtMS0xLTIxODc0OA_acb400b0-3fe8-4192-98d5-34465056eedb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ace641432ca4f1aab983fa4bd125d85_D20220401-20230331" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI1LTMtMS0xLTIxODc0OA_394f8b60-0908-4664-a6c5-4dc505cedafd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI1LTUtMS0xLTIxODc0OA_d3f25020-325f-4e1c-863f-c25a8d7ec1a7">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06314da3128a4c098170cd700e3e914e_D20220401-20230331" decimals="-6" sign="-" name="mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI1LTE1LTEtMS0yMTg3NDg_be3a4c34-1536-497c-8ba2-9bf8bdc2a6fe">160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI1LTE5LTEtMS0yMTg3NDg_73987a1c-4d07-4d69-9137-e35013d47378">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI2LTUtMS0xLTIxODc0OA_70b60515-48f0-4de1-9448-fa952aace841">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI2LTE5LTEtMS0yMTg3NDg_00709498-013a-481f-9ceb-5f2bedf0f8fa">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMwLTUtMS0xLTI0MDg0MA_f7c12ade-5efe-4284-bd4c-94809f1644ce">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i06314da3128a4c098170cd700e3e914e_D20220401-20230331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMwLTEzLTEtMS0yNDA4NDA_073c7dd8-7b3a-4611-9063-16ff99e85588">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06314da3128a4c098170cd700e3e914e_D20220401-20230331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMwLTE1LTEtMS0yNDA4NDA_a91e1d79-09b3-4fa8-b64f-9c3371cd0359">3,792</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMwLTE5LTEtMS0yNDA4NDA_4a11e74b-fdf5-4a43-90e6-0dbfcee9ee1f">3,665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d6cbef9c014a779d83f8e789f001b6_D20220401-20230331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMxLTktMS0xLTI0MDg0Nw_83079c98-7eaa-4a8a-8742-5818e5297135">3,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMxLTE3LTEtMS0yNDA4NDc_d39c3ccf-6ae1-4679-91a9-09439dfc18f3">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMxLTE5LTEtMS0yNDA4NDc_13ca4161-491d-4521-b127-417a21231b1e">3,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i284da6d569754ff58e9c0e3c01fd1f5a_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMyLTExLTEtMS0yNDA4NTQ_5e27d2a8-1d6b-4a8c-ba80-4ac918ad9c7b">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMyLTE3LTEtMS0yNDA4NTQ_0b8e4746-b285-42a5-82e7-e2c0d66633c9">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMyLTE5LTEtMS0yNDA4NTQ_e6025318-a247-420d-9592-05eb6815ba53">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMzLTAtMS0xLTI0MDg2MS90ZXh0cmVnaW9uOjM4NjFhYzBlMTk2NDRkODk4ZDQzN2JhNGFiMWU0YzdiXzMw_7dc11172-0710-4406-b02c-a917c9bc80a2">2.09</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d6cbef9c014a779d83f8e789f001b6_D20220401-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMzLTktMS0xLTI0MDg2MQ_a060341e-2364-4cf6-9169-b1781161791d">296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMzLTE5LTEtMS0yNDA4NjE_2e2f9cd2-b522-4ac1-b492-2423cdc950fc">296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI3LTE3LTEtMS0yMTg3NDg_250688e8-425c-4eb1-90fc-a94140726c53">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI3LTE5LTEtMS0yMTg3NDg_c54e2a11-e656-4666-8ccb-0a8bfe165ba1">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMzLTE3LTEtMS0yMTg3NDg_8b297925-8e7c-4e93-bf90-06cd2bdfde4f">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:NoncontrollingInterestDecreaseFromReclassificationToLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMzLTE5LTEtMS0yMTg3NDg_c11165cb-1fdb-4536-bd96-257a75b6ca96">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Formation of SCRI Oncology, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331" decimals="-6" name="mck:FormationOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM4LTUtMS0xLTIyOTk2MA_d360ca65-551e-4684-b117-39f6f1df594d">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="mck:FormationOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM4LTE3LTEtMS0yMjk5NjA_29e3f87e-0887-41bb-972d-a33f63e97d1c">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:FormationOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM4LTE5LTEtMS0yMjk5NjA_bd9cd0d8-7235-4ff7-b764-8df5f45d0d8f">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derecognition of noncontrolling interests in McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="mck:DerecognitionOfNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM5LTE3LTEtMS0yMjk5NjA_0ed7b278-d37e-4bc6-8365-dbb3476a11af">382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:DerecognitionOfNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM5LTE5LTEtMS0yMjk5NjA_b71689de-86e9-48ee-84f8-cf0279639c30">382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM1LTUtMS0xLTIxODc0OA_22cb2e9c-9b9c-4e0b-bfea-cde59a9ccde9">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d6cbef9c014a779d83f8e789f001b6_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM1LTktMS0xLTIxODc0OA_710076a0-3f82-4031-a63f-9fb6edfac1ea">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM1LTE3LTEtMS0yMTg3NDg_b0300ac8-523a-41d9-80d5-666b5172dd09">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM1LTE5LTEtMS0yMTg3NDg_09f5a147-9c14-4089-9858-9082b7900c57">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id8a72099ceda422ba14d79222a77f39e_I20230331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTEtMS0xLTIxODc0OA_e4f1c849-ce03-4531-ab4a-2428379ea369">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a72099ceda422ba14d79222a77f39e_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTMtMS0xLTIxODc0OA_04ef7eb6-24e7-416b-b72e-adf5a0627e2a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebb46144e314022b145d5a691b3751b_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTUtMS0xLTIxODc0OA_e0402492-04c1-49a5-8986-f5cf707fc667">7,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f0fe405ebb24cc3b0ba09f049f2c10b_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTktMS0xLTIxODc0OA_28b51499-b08c-4b58-8bb9-53787aa74121">12,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i389a9bd705fb43da948f7f435028f032_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTExLTEtMS0yMTg3NDg_41892315-1c24-4e00-8fad-c479ae42a0e9">905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3bc582f275f5403289fded6bcb155630_I20230331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTEzLTEtMS0yMTg3NDg_df6753e9-6451-4df2-83ec-a17243287c09">141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bc582f275f5403289fded6bcb155630_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTE1LTEtMS0yMTg3NDg_07a8a1d7-2217-4c67-98c3-5d54a2b4d602">20,997</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf262331a9f54dcaa1ab7d2f24876767_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTE3LTEtMS0yMTg3NDg_b5510654-489c-489a-acb2-7383f7399f71">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTE5LTEtMS0yMTg3NDg_7e375f59-2266-4c06-8cc7-a1cf8a789fe6">1,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions) </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMtMS0xLTEtMjE4NzQ4_d88c252c-de3e-4c03-9b94-438a756251b5">3,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMtMy0xLTEtMjE4NzQ4_44a4a69c-1ebe-4fbc-9fb0-3c6fa4eb85ad">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMtNS0xLTEtMjE4NzQ4_a1ea6081-53dc-44fb-a3e1-956886b215bc">4,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUtMS0xLTEtMjE4NzQ4_e16ca416-aea7-4ea8-8077-6738f3825168">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUtMy0xLTEtMjE4NzQ4_f9d0cb99-38fd-4d40-8b13-8f9dd33859e1">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUtNS0xLTEtMjE4NzQ4_b235ab6d-2c5d-4541-9fab-52e188f33054">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzYtMS0xLTEtMjE4NzQ4_faf82b73-520b-4507-9762-9218f2bd37d4">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzYtMy0xLTEtMjE4NzQ4_fe1d4b6c-8897-4971-b303-9edc29cf569a">481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzYtNS0xLTEtMjE4NzQ4_f87e595f-f11b-4d6d-b5ad-1267ea493484">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and long-lived asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzctMS0xLTEtMjE4NzQ4_d743960d-be0a-4208-9228-57b26cd1aaad">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzctMy0xLTEtMjE4NzQ4_0ac1318d-d00e-4a5c-8664-1847c969a29d">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:OtherAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzctNS0xLTEtMjE4NzQ4_06277085-a77c-4b97-a0d8-76ff85e9672e">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzktMS0xLTEtMjE4NzQ4_7e692a44-2ed5-4a3e-a396-ec55b191db7b">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzktMy0xLTEtMjE4NzQ4_c71642cc-c773-4d54-acad-9ba0b790b62e">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzktNS0xLTEtMjE4NzQ4_684f3a60-ca47-4710-b615-5d41eaa2b2e6">908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges (credits) associated with last-in, first-out inventory method</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEwLTEtMS0xLTIxODc0OA_c24f16a8-9190-4ef5-a1a2-cd29ced175f2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEwLTMtMS0xLTIxODc0OA_bb47e749-6717-4750-b720-d73e3e96647d">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEwLTUtMS0xLTIxODc0OA_01a5e6e7-824c-4a71-8a4a-02df4ecaf491">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzExLTEtMS0xLTIxODc0OA_bf764cd2-2d4c-420b-9d62-a3d297fd1e5a">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzExLTMtMS0xLTIxODc0OA_65ba7a7d-811e-40d8-8d31-4bef02a44f66">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzExLTUtMS0xLTIxODc0OA_6a235ca7-8991-41c7-b191-d0d115145676">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain from sales of businesses and investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEyLTEtMS0xLTIxODc0OA_a40fde1a-8070-4c02-9603-a2a616dbb447">211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEyLTMtMS0xLTIxODc0OA_1a6d08e3-e497-4bbf-b61c-07242c697729">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEyLTUtMS0xLTIxODc0OA_4a84fd51-7489-444e-831f-14175b81b889">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">European businesses held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEzLTEtMS0xLTIxODc0OA_09c828c5-8fde-4bde-99f0-c735e559b9ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEzLTMtMS0xLTIxODc0OA_0980e3f5-005f-4e56-8c04-afe5a57b6353">1,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEzLTUtMS0xLTIxODc0OA_04555632-685a-4d89-b0d5-6dd08c2efd53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE0LTEtMS0xLTIxODc0OA_a245c69e-f43b-45c1-ac73-0ec774e66272">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE0LTMtMS0xLTIxODc0OA_241203d9-3ada-4822-aef5-a7e259e059e6">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE0LTUtMS0xLTIxODc0OA_6d174d93-fb49-4fe0-84d0-f7aa7baa32ea">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE2LTEtMS0xLTIxODc0OA_f7767a3b-e863-4e96-bc42-8174b9bfc7ed">1,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE2LTMtMS0xLTIxODc0OA_e8f433c1-553f-43d1-a36a-406767e198d5">1,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE2LTUtMS0xLTIxODc0OA_28c595ec-aae5-4ec6-8e06-9ced08ae6b9d">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE3LTEtMS0xLTIxODc0OA_d8f0d1fb-4332-4abb-a1ce-3e6f955d70fd">1,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE3LTMtMS0xLTIxODc0OA_eadfcb37-01ac-4241-876e-01a350b35111">1,169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE3LTUtMS0xLTIxODc0OA_013f6cb1-05fd-4de6-9077-e2834e001a5f">2,276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE4LTEtMS0xLTIxODc0OA_2c8794d5-44f0-43c9-a865-746e371767f0">3,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE4LTMtMS0xLTIxODc0OA_ed233475-3326-41ff-a359-10f5cd662919">2,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE4LTUtMS0xLTIxODc0OA_3d6088ca-6a19-4ed1-94c9-436c85471bd7">1,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE5LTEtMS0xLTIxODc0OA_1fbf2aa1-490a-48c2-a567-9fbd2823281f">338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE5LTMtMS0xLTIxODc0OA_f409f7be-5a58-4922-a70e-546b07ebf9b8">356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE5LTUtMS0xLTIxODc0OA_525d433c-16c7-481d-84a4-714b39986cfb">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIwLTEtMS0xLTIxODc0OA_1659978b-09ab-4811-8db9-b704ffd12b17">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIwLTMtMS0xLTIxODc0OA_ddaa2ccc-8086-44d3-9431-16bae62c936d">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIwLTUtMS0xLTIxODc0OA_10b69cdf-92b2-4aa2-8f40-6ee8c06adc6c">166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="mck:IncreaseDecreaseInLitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIxLTEtMS0xLTIxODc0OA_f2186e29-b1b6-4a89-b260-fd8f4e661661">1,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIxLTMtMS0xLTIxODc0OA_63160e85-63da-4cbf-a745-1624debcd197">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:IncreaseDecreaseInLitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIxLTUtMS0xLTIxODc0OA_075c3b6e-710f-4050-ab0a-29b2683ac25b">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIyLTEtMS0xLTIxODc0OA_a973c7ae-208a-4220-960f-87ba1a4ae8a5">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIyLTMtMS0xLTIxODc0OA_b664fb1d-afca-47ed-a33e-9db0343d1e26">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIyLTUtMS0xLTIxODc0OA_3b60e46e-4e84-4f2c-9ce1-8691e821f31b">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIzLTEtMS0xLTIxODc0OA_7ba85f74-b46e-4593-8f02-b41871396b78">5,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIzLTMtMS0xLTIxODc0OA_c717cb1f-4375-421a-8e02-debc3a8268dd">4,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIzLTUtMS0xLTIxODc0OA_3609a9d6-ac70-4def-9d46-c55f2dbc0654">4,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI2LTEtMS0xLTIxODc0OA_34f8241f-9f34-4694-9fef-0291097b7aee">390</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI2LTMtMS0xLTIxODc0OA_4d2e95f4-3081-40bc-9599-9bd2c1c71172">388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI2LTUtMS0xLTIxODc0OA_28d0a5c8-50b5-42f0-934d-d57fa94fb1d1">451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized software expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI3LTEtMS0xLTIxODc0OA_ed7ea2f1-afbc-459e-8ad2-32307f275111">168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI3LTMtMS0xLTIxODc0OA_ba09415c-901f-46d0-b09d-ff1fba4d31f9">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI3LTUtMS0xLTIxODc0OA_61710bda-869c-43f6-ab17-de425043a25f">190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI4LTEtMS0xLTIxODc0OA_6bae67cf-2009-4be4-8d69-b58c782fc2b0">867</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI4LTMtMS0xLTIxODc0OA_f6f0809b-fad3-482f-bdbc-625ec4c84b8a">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI4LTUtMS0xLTIxODc0OA_856a08f9-a8bf-42bd-8ae2-a72a7044ad09">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of businesses and investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI5LTEtMS0xLTIxODc0OA_12ad615d-83d5-4b75-996c-b5af18559c19">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI5LTMtMS0xLTIxODc0OA_a504a515-0e34-458d-82dd-bbb7b7f28be1">578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI5LTUtMS0xLTIxODc0OA_20b36861-fcd0-4fca-8618-d547761298ef">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMwLTEtMS0xLTIxODc0OA_484c19a0-a0a4-43bc-b8c9-d2ddcaccb9f4">194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMwLTMtMS0xLTIxODc0OA_b2f86877-0a3e-46f7-aab1-53c2d8e2c794">126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMwLTUtMS0xLTIxODc0OA_e3312af9-43dc-4989-9e6b-192598e6e70d">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMxLTEtMS0xLTIxODc0OA_4311a248-9dc1-481e-964b-19745c8a7124">542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMxLTMtMS0xLTIxODc0OA_63cdf8a4-63e5-445c-8c9e-e37a0b122903">89</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMxLTUtMS0xLTIxODc0OA_32ecc65d-963e-4e19-82b6-9d813a1205a4">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM0LTEtMS0xLTIxODc0OA_ae7eda42-166e-4187-ba54-8f164446dc58">8,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM0LTMtMS0xLTIxODc0OA_043fd378-b860-45e4-a05f-5870a596b895">11,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM0LTUtMS0xLTIxODc0OA_01a61ffd-1066-4cd2-af5d-bf420d058a0b">6,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM1LTEtMS0xLTIxODc0OA_8997378c-fc4e-4e46-a020-1cb224970a81">8,450</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM1LTMtMS0xLTIxODc0OA_a91d775b-613e-4dd0-9580-3d274ac8cdb6">11,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM1LTUtMS0xLTIxODc0OA_f5f59712-cdfb-40b5-bec0-f567bf8dfa31">6,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuances of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM2LTEtMS0xLTIxODc0OA_3fe8bb72-b5f6-4a12-b999-cd223fe49a4f">997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM2LTMtMS0xLTIxODc0OA_a59331d8-4a30-4c4c-a8f3-f17d26e7aa5d">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM2LTUtMS0xLTIxODc0OA_18df11f5-e242-4ee7-9c8c-3b24713f6c91">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM3LTEtMS0xLTIxODc0OA_a43a0bb6-727f-44ad-862f-7f4ba81bf6b2">1,274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM3LTMtMS0xLTIxODc0OA_e2f71874-8e37-484c-b7fa-d17a2780e5cd">1,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM3LTUtMS0xLTIxODc0OA_5cb59487-f092-4275-bb2d-41a51344b86e">1,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for debt extinguishments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM4LTEtMS0xLTIxODc0OA_1b136f0d-0e0e-4dde-84a6-1561fe894e8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM4LTMtMS0xLTIxODc0OA_ebcef6d9-e63c-4dbf-adf5-cd5916031e94">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM4LTUtMS0xLTIxODc0OA_1f3ea4cf-08ac-47a8-a60e-35d3b87f0f30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQwLTEtMS0xLTIxODc0OA_73550085-5f45-4892-b7bb-044daa2ff511">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQwLTMtMS0xLTIxODc0OA_db25c7a3-c31a-4913-a894-b4dd94b17243">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQwLTUtMS0xLTIxODc0OA_31eed7a5-9c29-4871-af8a-355112792fec">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQxLTEtMS0xLTIxODc0OA_220506b5-811c-4ad3-a7f9-6a02aa98a6f1">3,638</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQxLTMtMS0xLTIxODc0OA_442768a4-2df7-4898-a9e8-b6c1e1fecefa">3,516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQxLTUtMS0xLTIxODc0OA_62f07ce8-164d-4ba2-80c6-6b9c578e4072">742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQyLTEtMS0xLTIxODc0OA_afddb713-9096-40b1-93bc-39d6a90fe110">292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQyLTMtMS0xLTIxODc0OA_53c492e9-19cf-4822-8b96-79df79d0f462">277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQyLTUtMS0xLTIxODc0OA_14802659-eaed-4307-9a3a-10b6698e8556">276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQzLTEtMS0xLTIxODc0OA_0e1c6dbd-0a64-404e-bcc0-e78f750b1ebd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQzLTMtMS0xLTIxODc0OA_1af9ad66-2839-46c4-86e8-59787efb9210">1,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQzLTUtMS0xLTIxODc0OA_7dbb9538-55b2-4b82-90a2-f119a287a05b">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ0LTEtMS0xLTIxODc0OA_6fe3e27b-a671-42a9-ae64-1b219cef6ed7">324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ0LTMtMS0xLTIxODc0OA_323303fb-fcf4-422d-9cb9-0c5bdc70c88d">383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ0LTUtMS0xLTIxODc0OA_71454ddc-6c02-419e-b3df-0f8687a13502">178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ1LTEtMS0xLTIxODc0OA_efaec1dc-3863-4739-a663-068e409562bc">4,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ1LTMtMS0xLTIxODc0OA_b941a87a-9de0-43c7-931b-aa2ff10382b0">6,321</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ1LTUtMS0xLTIxODc0OA_bd76297a-0f3e-4eff-84a8-3e6b4cee8bad">1,693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ2LTEtMS0xLTIxODc0OA_38ec464e-144d-4ccd-b581-2b1b83f075c4">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ2LTMtMS0xLTIxODc0OA_d0d1c16e-16ef-4360-b32f-27d2aed68552">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ2LTUtMS0xLTIxODc0OA_6340a5ac-4d92-4434-9ae4-8af8270902b5">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash classified within Assets held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ3LTEtMS0xLTIxODc0OA_feb0daab-0162-4f45-8aa9-43a9ed6f96c3">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ3LTMtMS0xLTIxODc0OA_abb94914-6e08-4068-b625-7045cfc11a3e">540</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ3LTUtMS0xLTIxODc0OA_7bf40982-3e05-46a2-b700-dad0e6b5931e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ4LTEtMS0xLTIxODc0OA_dd1d9a8b-eefc-463b-9a0d-a0e87531ee9a">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ4LTMtMS0xLTIxODc0OA_08ad9438-7324-407a-934e-679533dafceb">2,461</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ4LTUtMS0xLTIxODc0OA_935e43e0-d704-4440-8c6d-3c5c57254455">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ5LTEtMS0xLTIxODc0OA_a48ea3e3-51b9-42b8-9952-d1e160cc5abb">3,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ5LTMtMS0xLTIxODc0OA_a5740763-2889-44a3-81f7-3717ff987d7d">6,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ca92db1bf347039646a68953e87fed_I20200331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ5LTUtMS0xLTIxODc0OA_d6c39dd4-2949-44d3-b0d1-310a1f7344a6">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUwLTEtMS0xLTIxODc0OA_78225560-b673-4a68-a969-9c0c68815486">4,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUwLTMtMS0xLTIxODc0OA_6ecbe39d-1263-4223-81e9-ff6c2974f4be">3,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUwLTUtMS0xLTIxODc0OA_e26262b7-2fce-40fa-bf96-b2c2f5aa2435">6,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Restricted cash at end of year included in Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUxLTEtMS0xLTIxODc0OA_8054d5dd-07a8-4aa2-be13-b48008a0340f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUxLTMtMS0xLTIxODc0OA_1566b8b9-e80b-40ad-8097-f4cbcb51a17e">403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUxLTUtMS0xLTIxODc0OA_afdf631f-2a86-4a56-a08f-fe1210b4268c">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUzLTEtMS0xLTIxODc0OA_d5008e4d-7e88-463e-9262-5c8849397b48">4,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUzLTMtMS0xLTIxODc0OA_3152903f-852c-4ab2-86c4-c1fdb021f44d">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUzLTUtMS0xLTIxODc0OA_26879216-61d2-4ea5-a1cd-53791d92da48">6,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SUPPLEMENTAL CASH FLOW INFORMATION</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU3LTEtMS0xLTIxODc0OA_1aa53046-f2fe-48e7-ac43-87aff0609300">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU3LTMtMS0xLTIxODc0OA_af97bdca-a8e3-47a9-88e7-de6c14eac0f0">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU3LTUtMS0xLTIxODc0OA_d19d4039-e9ea-4e4d-8b9f-e8dbc406e5cc">220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU4LTEtMS0xLTIxODc0OA_16cac791-f0ec-4f2e-ab0a-5e2bde0f1435">562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU4LTMtMS0xLTIxODc0OA_d1b5b165-5b0c-47b1-9d21-4d67bdeda5ec">359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU4LTUtMS0xLTIxODc0OA_1965e80d-a4ff-43e2-96ba-4d592afc0b9d">379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_118"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i04335d018da94076b0acf21e81ac886b_121"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDEy_df886772-4b56-4c64-9135-592e7b8e84be" continuedAt="i11fe5f58f06745718f605450684b7579" escape="true">Significant Accounting Policies </ix:nonNumeric></span></div><ix:continuation id="i11fe5f58f06745718f605450684b7579" continuedAt="i60a3d77fb65d4c5c854b4e9b09f34c54"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson partners with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzQ2MQ_2b2b6b16-36aa-4ce0-8614-9beac4f018e8">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Refer to Financial Note 20, &#8220;Segments of Business,&#8221; for additional information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDkw_c0df4c6a-3c42-4afd-a6f9-c3f2c2975368" continuedAt="i95de2d79d36447bfbc3408afe395bffd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i95de2d79d36447bfbc3408afe395bffd">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control, but instead has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDMy_4a9bfe77-02e1-4195-8b28-2bbc30645c26" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzM1_9f0bac32-10eb-470e-a0a0-5f28edb1aa12" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Certain prior period amounts have been reclassified to conform to the current year presentation.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDM1_f4058709-b745-477f-8472-42955cbae9ec" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;). Among other provisions, the IR Act includes a 15% corporate minimum tax, a 1% excise tax on certain repurchases of an entity&#8217;s own common stock after December 31, 2022, and various drug pricing reforms. Based on its preliminary assessment, the Company does not currently expect the IR Act to have a material impact on its results of operations, financial position, or cash flows in the foreseeable future. The Company will continue to evaluate the full impact of these legislative changes as they are implemented.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzAy_75b1dedb-9d95-4d5c-894b-7e5d14f0f8ac" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds, short-term deposits with financial institutions, and short-term commercial papers issued by non-financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#8217;s foreign subsidiaries, including Canadian dollars, Euro, and British pounds sterling. Deposits could exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i60a3d77fb65d4c5c854b4e9b09f34c54" continuedAt="i74dd3e8246c845a5837d4b469eed2bca"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzk4_e1de4980-bf6d-43ce-8c06-d71320121142" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#8220;Prepaid expenses and other&#8221; and &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. Restricted cash at</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2022 primarily consisted of $<ix:nonFraction unitRef="usd" contextRef="i1dcb8f3258544de983570a2447cfa80a_I20220331" decimals="-6" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzQzNjQ_39d19f6b-8626-4d32-85a2-f95def89ef15">395</ix:nonFraction>&#160;million held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities and all amounts were released during fiscal 2023, as discussed in more detail in Financial Note 17, &#8220;Commitments and Contingent Liabilities.&#8221; Additionally, restricted cash at March 31, 2022 included funds temporarily held on behalf of unaffiliated medical practice groups related to their business continuity borrowings as a result of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;). These amounts were designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds were recorded by the Company within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets at March 31, 2022. These funds were fully disbursed during fiscal 2023.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NTAw_67aff153-6ca4-4483-8c38-238f217c44d9" continuedAt="ib2aa656f7ef04af29e20f7655129dc01" escape="true">Equity Method Investments:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib2aa656f7ef04af29e20f7655129dc01"> Investments in business entities in which the Company does not have control, but instead has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that could have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.</ix:continuation> </span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDU5_61a0e884-802b-4407-b8ef-fb4e6bdae9d1" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables, Net and Allowances for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are presented net of an allowance for credit losses and primarily consist of trade accounts receivable from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings, collections on past due amounts, legal disputes, and bankruptcies, as well as reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzY1MTk_70ba7072-570b-40fc-9414-fc5b6fdedb03">111</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzY1MjY_fb5233dd-e938-40e9-a28b-59c9b9084e4e">89</ix:nonFraction> million were included in &#8220;Receivables, net&#8221; in the Consolidated Balance Sheets as of March 31, 2023 and 2022, respectively. Changes in the allowance for the year ended March 31, 2023 were primarily within the U.S Pharmaceutical and Medical-Surgical Solutions segments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDU2_a0fb7157-a4d6-4d7a-a980-9e16f18eb9fa" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s receivables as of March 31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:AccountsReceivableCustomerAccountsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzItMS0xLTEtMjE4NzQ4_e11be425-bd35-438e-9284-07d786577c57">17,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="mck:AccountsReceivableCustomerAccountsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzItMy0xLTEtMjE4NzQ4_f0856881-a7f1-425f-93da-8f6f2f51b87e">16,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:OtherReceivablesGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzMtMS0xLTEtMjE4NzQ4_729a029f-14b1-452b-84ab-76f832a863d5">2,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:OtherReceivablesGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzMtMy0xLTEtMjE4NzQ4_5bbc4dd0-983f-4b87-a7de-d64d0c10f4b2">2,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzQtMS0xLTEtMjE4NzQ4_a3b5a77c-6025-496a-b3f5-66b06de12484">19,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzQtMy0xLTEtMjE4NzQ4_98e09775-ff63-409e-994f-40912d294363">18,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzUtMS0xLTEtMjE4NzQ4_cf7272a1-0aca-481d-a014-61a733d21833">158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzUtMy0xLTEtMjE4NzQ4_d42e577a-f620-45b3-9108-76d9d62f9d78">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzYtMS0xLTEtMjE4NzQ4_67f318ab-b392-4410-a655-b796b784526c">19,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzYtMy0xLTEtMjE4NzQ4_595bf35b-ab76-4400-b0e8-2319fd5ec303">18,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i74dd3e8246c845a5837d4b469eed2bca" continuedAt="i539c8fb9814d420c8567d54916af2d41"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzA1_fdac7b9d-538f-4b7a-83ee-c85fb6998c4c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentrations of Credit Risk and Receivables: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During fiscal 2023, sales to the Company&#8217;s ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately <ix:nonFraction unitRef="number" contextRef="i7264b2fb579741cdab359e1aba22aede_D20220401-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzcxNjA_efbd257c-bac1-426a-91a2-01771b088e02">68</ix:nonFraction>% of its total consolidated revenues and approximately <ix:nonFraction unitRef="number" contextRef="ic04e9e22dc634dfca9e2377700f0d82f_D20220401-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzcyMTY_949022db-7b56-4f5c-af68-4ab66dfa7a58">42</ix:nonFraction>% of total trade accounts receivable at March 31, 2023. Sales to the Company&#8217;s largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately <ix:nonFraction unitRef="number" contextRef="i932aecaa6796433d9fa0f50f4ddd4f32_D20220401-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzczNjI_feda8f0c-4df3-44fb-ba5a-016a100bea8a">27</ix:nonFraction>% of its total consolidated revenues in fiscal 2023 and comprised approximately <ix:nonFraction unitRef="number" contextRef="ibfb139caacd149a5b3fdff785111e258_D20220401-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzc0MzQ_771260eb-ebef-4715-a4cb-b0c19dc220bf">21</ix:nonFraction>% of total trade accounts receivable at March 31, 2023. As a result, the Company&#8217;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies, and other healthcare providers, as well as with government entities and agencies. The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from GPOs or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#8217;s financial condition, results of operations, and liquidity. In addition, trade accounts receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy, changes in reimbursement policies, and other factors. This credit risk is mitigated by the size and diversity of the Company&#8217;s customer base as well as its geographic dispersion.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzA2_744717a0-6463-4d60-86e7-4bbf8d7d3966" continuedAt="i573b84a2b24045ee87564b339d392417" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#8220;LIFO&#8221;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and 2022, total inventories, net were $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk0Mjc_4b74cb02-fa1f-4f17-85b9-9b992f5b2179">19.7</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-8" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk0MzQ_e08fefb1-deda-4782-b3b4-af7442d14e85">18.7</ix:nonFraction> billion, respectively, in the Company&#8217;s Consolidated Balance Sheets. The LIFO method was used to value approximately <ix:nonFraction unitRef="number" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="2" name="us-gaap:PercentageOfLIFOInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk1NDY_577c3b96-fb77-4f27-b777-929065d4a99b">64</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="2" name="us-gaap:PercentageOfLIFOInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk1NTM_17cdd363-0509-4e2a-9560-60f10e38953f">63</ix:nonFraction>% of the Company&#8217;s inventories at March 31, 2023 and 2022, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:InventoryLIFOReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk3Mjk_746cdb13-c5d3-4f01-89e4-fee5231c5024">384</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:InventoryLIFOReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk3MzY_c4790ece-12de-49ff-8641-1eee72ba934b">383</ix:nonFraction>&#160;million higher than the amounts reported at March 31, 2023 and 2022, respectively. These amounts are equivalent to the Company&#8217;s LIFO reserves. The Company&#8217;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized a LIFO charge of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk5OTg_b9e903e0-3bb3-4cbc-9ad3-314ba14fb134">1</ix:nonFraction> million in fiscal 2023 and LIFO credits of $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEwMDAy_0dc03165-e3a6-4c66-b1a5-e3a648041d30">23</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEwMDEw_e87ede39-7295-4f6b-90e3-56af0ee5e731">38</ix:nonFraction> million in fiscal 2022 and fiscal 2021, respectively, all within &#8220;Cost of sales&#8221; in its Consolidated Statements of Operations. The LIFO charge in fiscal 2023 compared to LIFO credits in fiscal 2022 and fiscal 2021 are primarily due to higher brand inflation and lower generics deflation, offset by significantly higher off patent launch activity in fiscal 2023. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. </span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i573b84a2b24045ee87564b339d392417">The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March 31, 2023 and 2022, inventories at LIFO did not exceed market.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mjcx_dbf64ea9-52e5-4345-bd5e-b2ab79208c04" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and Handling Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company includes costs to pack and deliver inventory to its customers in &#8220;Selling, distribution, general, and administrative expenses&#8221; in its Consolidated Statements of Operations. Shipping and handling costs of $<ix:nonFraction unitRef="usd" contextRef="i3969df882b2a4177a8ac36cb92b0b6c7_D20220401-20230331" decimals="-8" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzExMTg1_993c2a42-872c-4ebf-8ff8-43c03b44e535">1.2</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i515e802e55bc4ca1b11dd1a584ef8dde_D20210401-20220331" decimals="-8" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzExMjE0_38c4caf7-a33b-4e58-b5fd-d7c7f35a9bfa">1.1</ix:nonFraction> billion, and $<ix:nonFraction unitRef="usd" contextRef="i223505a11e384113a49c9b97f61ec445_D20200401-20210331" decimals="-8" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE2NDkyNjc0ODE3MDA_fa85e1eb-443f-47d7-b85a-b8a2b56f8774">1.0</ix:nonFraction> billion were recognized in fiscal 2023, fiscal 2022 and fiscal 2021, respectively.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i539c8fb9814d420c8567d54916af2d41" continuedAt="if6977ac4a6334103ab9dfb96636ee460"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:HeldforSalePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mjg3_98629df8-7145-46a9-a2ba-25fae5a84c8c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Held for Sale: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed during each reporting period it remains classified as held for sale, and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for additional information.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzQ4_84f7f6fa-0e3b-4973-8767-fed23ba4b4be" continuedAt="if4a5b47bb8634b859c278ba1282e4c8f" escape="true">Property, Plant, and Equipment, Net: </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if4a5b47bb8634b859c278ba1282e4c8f">Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from <ix:nonNumeric contextRef="ibc4a0c9d2b824683901b0907b93e42dd_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzM2_0d414740-241f-4c76-8404-ef21c6eec225">15</ix:nonNumeric> to <ix:nonNumeric contextRef="i655245d8cb514931a14931cc038eb490_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzQy_e49e4979-7c43-4fc5-95aa-d7cb17b9d12d">30</ix:nonNumeric> years for building and improvements and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzc5_434691cb-3c7b-46f0-b8e5-b9ad93bbc229">three</span> to <ix:nonNumeric contextRef="ie30f2480525c49ada9cabfe8e2d20354_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzg1_e2ec2299-9262-4010-9bf6-46e046b1983a">15</ix:nonNumeric> years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives of the right-of-use (&#8220;ROU&#8221;) asset or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts.</ix:continuation> </span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzg3_00a787dc-c79d-4121-ac07-877450f07ddd" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s property, plant, and equipment, net as of March 31, 2023 and 2022:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzItMS0xLTEtMjE4NzQ4_40128617-58f6-46a9-84ab-c94ae8f0b83e">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzItMy0xLTEtMjE4NzQ4_685892e7-0d11-42d7-a978-240a8b536a4c">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzMtMS0xLTEtMjE4NzQ4_19b95c7c-973b-4e3d-8327-eac03cacc42d">1,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzMtMy0xLTEtMjE4NzQ4_daeebd07-a3e3-46f2-a0ce-bf35e5b282d3">1,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzQtMS0xLTEtMjE4NzQ4_54344579-9d5e-494e-be05-2a6e85214798">2,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzQtMy0xLTEtMjE4NzQ4_391f50fb-9b30-4b11-ba63-7d9b997eac5b">2,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzUtMS0xLTEtMjE4NzQ4_30ca322b-9a77-4421-a4c9-ef8f09bb4bad">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzUtMy0xLTEtMjE4NzQ4_46c88839-2dda-4115-aa00-44c2d865a8cc">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzYtMS0xLTEtMjE4NzQ4_73c4902b-7422-40b1-82a5-1e5ec4a3420a">4,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzYtMy0xLTEtMjE4NzQ4_09cef1c4-41a7-411b-a3ad-96bec7bb2f43">4,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzctMS0xLTEtMjE4NzQ4_ff242647-66a9-431e-ad85-229ec9d2777f">2,231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzctMy0xLTEtMjE4NzQ4_065fc4f9-9509-4338-b109-b9eca269d0c4">1,994</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzgtMS0xLTEtMjE4NzQ4_d654eced-ecf9-440f-8724-d920eadf73c1">2,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzgtMy0xLTEtMjE4NzQ4_3bc0163a-659d-4457-9b4d-1459e47aa1dc">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total depreciation expense for property, plant, and equipment, net and amortization of the ROU assets of finance leases was $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEzNjY4_d0a33df7-ddfc-4718-b807-80bbe6c3b625">272</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEzNjcy_59318fd8-6149-410a-8107-8c277aa93bd4">312</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEzNjgw_cbc27261-713e-4065-94e9-8d3e7ad19ee2">344</ix:nonFraction>&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDQ1_6c56efaf-2a00-42d1-bab0-d400bfd5c41a" continuedAt="i53d8b8951b0942579ec9cf364401a76d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company leases facilities and equipment primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components, such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0MzI0_4fd24846-796a-4644-bf59-7de3fb2a6e2d">one</span>&#160;to <ix:nonNumeric contextRef="i1aaff57b7c384456ab86bd2b5fccb87a_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEzNzQzODk1NDI4MTg2_d1c7ed3c-2703-4f3f-99fb-6b03398fb806">15</ix:nonNumeric> years, while remaining terms for equipment leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0NDA0_da16eb7b-c863-47a8-b5b6-560d55f8d8c1">one</span>&#160;to <ix:nonNumeric contextRef="ia26faef7d39742839185203bac54e495_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0NDEw_751319e9-e9d0-45d1-a7d3-1823b7d96541">five years</ix:nonNumeric>. Most real property leases contain renewal options (typically for <ix:nonNumeric contextRef="ic711bd1052674b80ad0f571918f35552_I20230331" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDA4_2ab78e94-6ecf-45eb-a66d-84a052db1570">five-year</ix:nonNumeric> increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="if6977ac4a6334103ab9dfb96636ee460" continuedAt="i272b104226ae4e32b232c8b6c69ec2d4"><ix:continuation id="i53d8b8951b0942579ec9cf364401a76d"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating ROU assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#8217;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#8217;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. Operating lease liabilities are recorded in &#8220;Current portion of operating lease liabilities&#8221; and &#8220;Long-term operating lease liabilities,&#8221; and the corresponding lease assets are recorded in &#8220;Operating lease right-of-use assets&#8221; in the Company&#8217;s Consolidated Balance Sheets. Finance lease assets are included in &#8220;Property, plant, and equipment, net&#8221; and finance lease liabilities are included in &#8220;Current portion of long-term debt&#8221; and &#8220;Long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a lessor, the Company primarily leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 9, &#8220;Leases,&#8221; for additional information on the Company&#8217;s leases.</span></div></ix:continuation><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDA5_6822d60b-1e9d-4184-b923-d725cb5061de" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment on an annual basis in the first fiscal quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#8220;DCF&#8221;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#8217; fair values to the Company&#8217;s market capitalization as further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline public companies for comparisons, and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzQ2_aec65f8e-3382-4063-af81-66ebd5daa9c2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently all of the Company&#8217;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE4NzYz_104a5783-416c-41d1-9774-e5859d78ef41">one</span> to <ix:nonNumeric contextRef="i5a7c37dc0f5d4bfb9f78bc365e926644_D20220401-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEzNzQzODk1NDI4MTg1_797e51db-af71-44a4-8e6f-8bf22c69de55">25</ix:nonNumeric> years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from the use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair value.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:InternalUseSoftwarePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzk2_85ad870c-45fa-4db4-83aa-79fd46e5a767" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitalized Software Held for Internal Use: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed <ix:nonNumeric contextRef="i5a7c37dc0f5d4bfb9f78bc365e926644_D20220401-20230331" name="mck:CapitalizedSoftwareHeldforInternalUseUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE5NTU2_5660e8f4-ec35-401a-a5ee-e3c10810f835">10</ix:nonNumeric> years. As of March 31, 2023 and 2022, capitalized software held for internal use was $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE5NjI0_8a91cacb-f936-4a59-b250-24993778a6ba">353</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE5NjMx_a2215203-ae9d-4bf7-86d9-cd51ddec913e">320</ix:nonFraction> million, respectively, net of accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzYwNDczMTQwMDEyNzM_f05628ce-cf32-4739-b0fd-acbad24675a2">1.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-8" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzU0OTc1NTkwMzYzNg_8f721276-7795-45fc-b74b-7fc8923eacb3">1.4</ix:nonFraction> billion, respectively, and is included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIwMjQ0_fb0532a0-7115-4157-a9a1-b7100f5aba18">101</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIwMjQ4_2f6ccc40-f61a-448e-aa1c-06505be636ba">116</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIwMjU2_5bd9e64e-860b-4a4a-a0f7-0bfaf91fa5ba">117</ix:nonFraction>&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i272b104226ae4e32b232c8b6c69ec2d4" continuedAt="i3d3045f9975249d8af2a6a6825e52cc2"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:InsuranceProgramsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzI1_8e54b1d2-86c0-42b7-8ffd-373318538a66" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Programs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#8220;Captives&#8221;) from which it obtains coverage for various exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company as discussed in more detail in Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; as well as those risks required to be insured by law or contract. It is the Company&#8217;s policy to retain a significant portion of certain losses, including those related to workers&#8217; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#8217;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#8217;s premium costs within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDA1_13c484bf-37a2-48a6-91d9-21b371ca045c" continuedAt="i43e1608e52ab4ac89d8e8483d3916b66" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#8217;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#8217; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#8217;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately <ix:nonFraction unitRef="number" contextRef="ie56d43006f754d499f7e19cd5720562c_D20220401-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIyNzE4_05114ae9-18ee-4665-b468-721ebdd30344">99</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i22171c2b91104f3f9aae6c7df97e030e_D20220401-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIyNzI1_30dac889-986f-498b-acd2-710130057f77">1</ix:nonFraction>% of total revenues, respectively, for the year ended March 31, 2023, and approximately <ix:nonFraction unitRef="number" contextRef="i915d437ab7bb4f499b0ca40841b44528_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM4NDgyOTA3ODc0ODY_62ca3aa8-a14f-4934-83f6-2c929f0fd4e6"><ix:nonFraction unitRef="number" contextRef="ib344714960c14cd0aaa14d648eb58138_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM4NDgyOTA3ODc0ODY_75cc1105-e67e-4f92-ad15-fcef0af31a48">98</ix:nonFraction></ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i63f0fcb2e0aa4013b42d29b5ade1e28b_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM4NDgyOTA3ODc0OTA_45183bbe-f4c3-45d2-8e17-e1b2bac322a0"><ix:nonFraction unitRef="number" contextRef="if322074120a140808e8c82b1bed2d7ec_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM4NDgyOTA3ODc0OTA_cec8f472-7550-4e29-9370-405ff1615b57">2</ix:nonFraction></ix:nonFraction>% of total revenues, respectively, for each of the years ended March 31, 2022 and 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-8" name="mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIzMzk3_5a68dc96-b2c5-455d-9031-bbf298d6b9eb">3.1</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-8" name="mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzcxNDY4MjU2MjUyMjE_2172f643-31b9-4d52-8fe4-3d463178ad0c">3.2</ix:nonFraction> billion, and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-8" name="mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzcxNDY4MjU2MjUyMjk_92a845d3-2112-4913-82f0-496d04cb7c5d">3.1</ix:nonFraction> billion for fiscal 2023, fiscal 2022, and fiscal 2021, respectively. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March 31, 2023 and 2022. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#8217;s services arrangements and are recognized as revenues over the periods when services are performed. </span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i43e1608e52ab4ac89d8e8483d3916b66">The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March 31, 2023 and 2022. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:SupplierIncentivesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDg0_67d5ce7a-62ee-40a7-b8dd-741c4153cf89" continuedAt="ib9384eea2c834c7ea7dc961349f8fe6b" escape="true">Supplier Incentives:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib9384eea2c834c7ea7dc961349f8fe6b"> Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:SupplierReservesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mjgx_7f73fb18-f557-4f0d-9ca0-4914d00ecee7" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Reserves: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims could be different than the Company&#8217;s estimate. The supplier reserves primarily pertain to the Company&#8217;s U.S. Pharmaceutical segment.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i3d3045f9975249d8af2a6a6825e52cc2" continuedAt="i8630d7395a544d51a2cf28c19b62c456"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDcw_984e3b79-5694-4a80-b29a-c54e47fbbf1e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon effective settlement.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:InterestExpensePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDcx_0dd98cb1-98df-417b-ad89-524dca82299d" continuedAt="if2f66ef7f9f14c13847ed7586b1b57cb" escape="true">Interest Expense</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if2f66ef7f9f14c13847ed7586b1b57cb">: Interest expense primarily includes interest for the Company&#8217;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mjg0_6a97ab20-4bea-483e-8e4c-c26b9c40145c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#8217; deficit accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; deficit section of the Consolidated Balance Sheets. Gains and losses from currency exchange transactions are recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations and were not material for the years ended March 31, 2023, 2022, or 2021. The Company releases cumulative translation adjustments from stockholders&#8217; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro-rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzY5_b14ac114-99a3-40fa-accf-589a41280571" continuedAt="i063e0d8c92774a66920f822daa528e75" escape="true">Derivative Financial Instruments:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i063e0d8c92774a66920f822daa528e75"> Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company has used foreign currency-denominated notes and uses cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; deficit section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Any cash flows received or paid as part of the termination of derivative financial instruments are classified within the Consolidated Statements of Cash Flows in accordance with the nature of the hedged item. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings. Refer to Financial Note 14, &#8220;Hedging Activities,&#8221; for additional information.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDU3_23f46fc9-25dd-4e45-83a0-3418259efd1b" continuedAt="ie082079a3de94084b5982d1743fc7681" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Income (Loss): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, as well as gains and losses that are recorded as an element of stockholders&#8217; deficit but are excluded from earnings. The Company&#8217;s other comprehensive income (loss) primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency, including gains and losses on net investment hedges, as well as unrealized gains and losses on cash flow hedges and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie082079a3de94084b5982d1743fc7681">unrealized gains and losses on retirement-related benefit plans.</ix:continuation> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i8630d7395a544d51a2cf28c19b62c456" continuedAt="i11d4f878ddd04abe9b98280e84e1f7fd"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mjkx_965c1e4e-0e6d-4b42-a549-a6a72e5ee83e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests and Redeemable Noncontrolling Interests: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income or loss that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes third-party equity interests in the Company&#8217;s consolidated entities, including: ClarusONE Sourcing Services LLP (&#8220;ClarusONE&#8221;), a joint venture established between McKesson and Walmart Inc. in fiscal 2017; Vantage Oncology Holdings, LLC (&#8220;Vantage&#8221;), a provider of integrated oncology and radiation services acquired in fiscal 2017; and SCRI Oncology, LLC (&#8220;SCRI Oncology&#8221;), an oncology research business formed in the third quarter of fiscal 2023 combining McKesson&#8217;s U.S. Oncology Research (&#8220;USOR&#8221;) and HCA Healthcare, Inc.&#8217;s (&#8220;HCA&#8221;) Sarah Cannon Research Institute (&#8220;SCRI&#8221;). Net income attributable to noncontrolling interests also included recurring compensation that the Company was obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. The Company&#8217;s noncontrolling interest in McKesson Europe was included in the divestiture of certain of the Company&#8217;s businesses in the European Union (&#8220;E.U.&#8221;) in October 2022. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#8217;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#8217; deficit in the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 7, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; for additional information on noncontrolling and redeemable noncontrolling interests, and Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for additional information on the acquisition and divestiture activity discussed above.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzEz_cb746396-9de3-4d3c-99de-62a8380a5568" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees. Refer to Financial Note 4, &#8220;Share-Based Compensation,&#8221; for additional information.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzg4_b42e195d-c9d7-46f9-9835-b573d90b86ca" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews all material contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; for additional information related to controlled substances claims to which the Company is a party.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MjY4_81cf0fcd-a814-4d15-9041-5b09c7cd4e25" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at fair value at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are expensed as incurred. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; for additional information.</span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i11d4f878ddd04abe9b98280e84e1f7fd"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDg1_937c2c66-2f10-4695-bd44-cf3bf1cf509e" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, including contingent consideration, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a variation of the income approach, whereby a forecast of future cash flows attributable to the asset is discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#8217;s expected useful life.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration liabilities are measured at their fair value as of the acquisition date using unobservable inputs. These inputs include the estimated amount and timing of projected operational and financial information, the probability of achievement of performance milestones or other agreed-upon events, and the risk-adjusted discount rate used to calculate the present value of the probability-weighted projected financial information. Contingent liabilities are remeasured to fair value at each reporting date until the liability is resolved. Changes in any of the inputs could result in a significant adjustment to the fair value.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:TreasuryStockPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzg5_584d15c5-5bd6-47c3-8c8e-72b4d5d3d212" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Treasury Stock:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> We record purchases of treasury stock at cost, which is reflected as a reduction to stockholders&#8217; equity in the Company&#8217;s Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock, including any excise tax recognized as a result of the IR Act, are included in the cost of the shares acquired. Treasury stock also includes shares withheld to satisfy the tax obligations of recipients of share-based compensation.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzk0_7c766e90-2620-458e-bc08-53d0660869fd" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adopted accounting standards during fiscal 2023 that had a material impact to the Company&#8217;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of such equity security, and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect that this guidance will have a material impact on its consolidated financial statements or related disclosures.</span></div></ix:nonNumeric></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_124"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjQvZnJhZzpjZTA2NzAzZGUwYjc0YmM2YjEzMjQ0NWRhNWJiMzZkNy90ZXh0cmVnaW9uOmNlMDY3MDNkZTBiNzRiYzZiMTMyNDQ1ZGE1YmIzNmQ3XzcyMzI_05a75fae-7f17-44a5-82f8-3cbdd6b677b3" continuedAt="ica7ebff12f4c4b3681adc161cbf93229" escape="true">Business Acquisitions and Divestitures </ix:nonNumeric></span></div><div id="i04335d018da94076b0acf21e81ac886b_2378"></div><ix:continuation id="ica7ebff12f4c4b3681adc161cbf93229" continuedAt="i77cc749359fa4740b92f092ddf2cebdf"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rx Savings Solutions, LLC</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, the Company completed its acquisition of <ix:nonFraction unitRef="number" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xMDc_0de768c9-8e4f-4253-900a-40e3f894d498">100</ix:nonFraction>% of the shares of Rx Savings Solutions, LLC (&#8220;RxSS&#8221;), a privately-owned company headquartered in Overland Park, Kansas, to further connect biopharma and payer services to patients. RxSS is a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers. The purchase consideration included a payment of $<ix:nonFraction unitRef="usd" contextRef="ia4dd209b573244c7881d99fe517c75d8_D20221101-20221101" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF80OTU_b6beb293-6b0a-444c-9f60-42517048ae18">600</ix:nonFraction>&#160;million in cash made upon closing and a maximum of $<ix:nonFraction unitRef="usd" contextRef="i59947628e39647249591b0cbaa3bf334_I20221101" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF81NDE_70393261-0407-493a-89d3-f74340fc6131">275</ix:nonFraction>&#160;million of contingent consideration based on RxSS&#8217; operational and financial performance through calendar year 2025. The payment made upon closing was funded from cash on hand. The financial results of RxSS are included in the Company&#8217;s RxTS segment as of the acquisition date. The transaction was accounted for as a business combination.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i77cc749359fa4740b92f092ddf2cebdf" continuedAt="i64cdd9d111b44caaaa22ca08c28b9942"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a liability for the contingent consideration at its fair value of $<ix:nonFraction unitRef="usd" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF85NjI_efa3a44a-845c-4358-99be-6052e144fcfe">92</ix:nonFraction>&#160;million as of the acquisition date. As of March 31, 2023, the current portion of $<ix:nonFraction unitRef="usd" contextRef="if401780d59f34141aabbaf7ca4d032ab_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF80OTQ3ODAyMzQ1MzQ5_f59d2c7d-a774-4149-8e2c-0524e141aed4">83</ix:nonFraction>&#160;million is included within &#8220;Other accrued liabilities&#8221; and the long-term portion of $<ix:nonFraction unitRef="usd" contextRef="if401780d59f34141aabbaf7ca4d032ab_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF80OTQ3ODAyMzQ1MzY1_239d8e73-3405-4032-a520-5fb44b2c14f4">9</ix:nonFraction>&#160;million is included within &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet. The fair value of the contingent consideration liability was estimated using a Monte Carlo simulation model, utilizing internal cash flow projections which are Level 3 inputs under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The contingent liability will be remeasured to fair value at each reporting date until the liability is resolved with changes in fair value being recognized within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Company&#8217;s Consolidated Statements of Operations. Recognition of the initial fair value of this contingent consideration is a non-cash investing activity.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation included acquired identifiable intangible assets of $<ix:nonFraction unitRef="usd" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xNzc4_3961ea80-7503-4737-97e3-077be9e9d41e">229</ix:nonFraction>&#160;million, primarily representing customer relationships and technology with a weighted average amortization period of <ix:nonNumeric contextRef="ia4dd209b573244c7881d99fe517c75d8_D20221101-20221101" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xMzc0Mzg5NTM2NjgwMA_41d044b0-872e-4d56-adcd-af89daf3fae4">12</ix:nonNumeric> years, and goodwill of $<ix:nonFraction unitRef="usd" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xOTE2_75afd898-ca40-419b-a990-a5531921d5b6">463</ix:nonFraction>&#160;million. Goodwill has been allocated to the Company&#8217;s RxTS segment, which reflects the expected future benefits from certain synergies and intangible assets that do not qualify for separate recognition. Goodwill attributable to the acquisition is deductible for tax purposes.</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xMzc0Mzg5NTM2NjgwMQ_e509485c-6f83-4689-ad51-c8303eccb016" continuedAt="i6e6f1ad5956d4025b2058ad5b91ba134" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary purchase price allocation for this acquisition:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized<br/>as of Acquisition Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4dd209b573244c7881d99fe517c75d8_D20221101-20221101" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8yLTEtMS0xLTIyMjcxNQ_b6beb293-6b0a-444c-9f60-42517048ae18">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8zLTEtMS0xLTIyMjcxNQ_efa3a44a-845c-4358-99be-6052e144fcfe">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4dd209b573244c7881d99fe517c75d8_D20221101-20221101" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF80LTEtMS0xLTIyMjcxNQ_8cf13244-94c0-4d0d-a4d0-3147e0bdb36a">692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets acquired and liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF83LTEtMS0xLTIyMjcxNQ_eaafc9e0-6df7-4d4f-a79e-f4c5f2aebf46">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF84LTEtMS0xLTIyMjcxNQ_3961ea80-7503-4737-97e3-077be9e9d41e">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF85LTEtMS0xLTIyMjcxNQ_6f0b5421-154a-4344-8ebc-6db23386093e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8xMC0xLTEtMS0yMjI3MTU_6a663247-2f20-4d8a-be98-e2c69c1db6b2">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable net assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8xMi0xLTEtMS0yMjI3MTU_7aadfc89-6da4-4b4e-bd6b-39e8c1fb65d4">229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8xMy0xLTEtMS0yMjI3MTU_75afd898-ca40-419b-a990-a5531921d5b6">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8xNC0xLTEtMS0yMjI3MTU_d33af551-02f5-42b2-85e0-e0eccae0d074">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SCRI Oncology, LLC</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, the Company completed a transaction with HCA to form SCRI Oncology, an oncology research business, combining McKesson&#8217;s USOR and HCA&#8217;s SCRI based in Nashville, Tennessee, to advance cancer care and increase access to oncology clinical research. Upon consummation of the transaction, McKesson owns a <ix:nonFraction unitRef="number" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8yNzA0_678f8a24-571a-4767-bcf3-e3e95c920e9a">51</ix:nonFraction>% controlling interest in the combined business, and the financial results are consolidated by the Company and reported within its U.S. Pharmaceutical segment as of the acquisition date. Transaction consideration included the transfer of full ownership interest in USOR to the combined business and $<ix:nonFraction unitRef="usd" contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zMDA1_4b961137-026c-49ee-904c-9f09183e2874">173</ix:nonFraction>&#160;million of cash paid to HCA, which was funded from cash on hand. The transaction was accounted for as a business combination.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i64cdd9d111b44caaaa22ca08c28b9942" continuedAt="ic579903adb7b4ffca861ce6c0705a35d"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation included acquired identifiable intangible assets of $<ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zMjA4_8c956e0e-7597-4131-92e0-f7ec019eb17a">177</ix:nonFraction>&#160;million, primarily representing customer relationships as well as trademarks and trade names with a weighted average amortization period of <ix:nonNumeric contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xMzc0Mzg5NTM2NjgwMg_04a00163-7bf7-4a81-853a-09be0d8bd16e">17</ix:nonNumeric> years, and goodwill of $<ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zMzY5_3b126107-3e1c-4b3b-93ed-3aa6b0b225f8">120</ix:nonFraction>&#160;million. Goodwill has been allocated to the Company&#8217;s U.S. Pharmaceutical segment, which reflects the expected future benefits from certain synergies and intangible assets that do not qualify for separate recognition. Goodwill attributable to the acquisition of $<ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zNjI2_6dc4904a-aae9-4bfe-8711-0cd4a7822e5d">49</ix:nonFraction>&#160;million is deductible for tax purposes. The Company recorded noncontrolling interest of $<ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zNzA5_340969bf-5c19-4a1f-b50c-aeb687f91b40">225</ix:nonFraction>&#160;million as a component of equity, which includes HCA&#8217;s proportionate interest in the identifiable net assets of SCRI at fair value of $<ix:nonFraction unitRef="usd" contextRef="i9259fb307c6141ab8b52ca6d3a1907c8_I20221031" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zODM4_59d3d014-f284-444f-9589-89311462c583">205</ix:nonFraction>&#160;million and its proportionate interest in the contributed net assets of USOR at carrying value of $<ix:nonFraction unitRef="usd" contextRef="i625dd0b0aa6e4e8d97d061d0a70a7e97_I20221031" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zOTMx_c0e5db4e-f315-455e-88bb-9bd61608490c">20</ix:nonFraction>&#160;million. The difference between the fair value of the Company&#8217;s acquired interest in SCRI net assets and the $<ix:nonFraction unitRef="usd" contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF80MDM1_4b961137-026c-49ee-904c-9f09183e2874">173</ix:nonFraction>&#160;million of cash paid to HCA was recognized as additional paid in capital, as well as the Company&#8217;s reduction in ownership interest in USOR net assets. </span></div><ix:continuation id="i6e6f1ad5956d4025b2058ad5b91ba134"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary purchase price allocation for this acquisition:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized<br/>as of Acquisition Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8yLTEtMS0xLTIyMjcxNQ_4b961137-026c-49ee-904c-9f09183e2874">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution of USOR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031" decimals="-6" name="mck:BusinessCombinationConsiderationTransferredOwnershipInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8zLTEtMS0xLTIyMjcxNQ_51cc7deb-590b-4863-9375-d9cedcd0ed46">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV80LTEtMS0xLTIyMjcxNQ_b2f26eb6-64de-4fd2-8f96-6b41598fa31c">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets acquired and liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV83LTEtMS0xLTIyMjcxNQ_a9d4f468-8edf-4585-bfbe-ed0ea01dc7cd">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV85LTEtMS0xLTIyMjcxNQ_2b7d9fdf-d716-4028-b32b-775dbce5171b">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xMC0xLTEtMS0yMjI3MTU_e94fb0ae-5a1a-4fbe-ad20-68f8477d3dbc">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xMS0xLTEtMS0yMjI3MTU_8c956e0e-7597-4131-92e0-f7ec019eb17a">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xMy0xLTEtMS0yMjI3MTU_ed20a7a0-00c4-4167-8ef4-d91024ca171d">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xNC0xLTEtMS0yMjI3MTU_75de5cc0-6c63-4672-bd3f-0eaab69952d9">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xNS0xLTEtMS0yMjI3MTU_6ff33e18-e996-4a23-a1cf-6ccd09790da3">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable net assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xNi0xLTEtMS0yMjI3MTU_6cfba9af-3a4d-4ee0-9e30-f4e108f5e3f3">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xNy0xLTEtMS0yMjI3MTU_340969bf-5c19-4a1f-b50c-aeb687f91b40">225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xOC0xLTEtMS0yMjI3MTU_6407e30a-eb69-4755-bed6-cd633fc4740d">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xOS0xLTEtMS0yMjI3MTU_3b126107-3e1c-4b3b-93ed-3aa6b0b225f8">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8yMC0xLTEtMS0yMjI3MTU_98c1ef5f-1097-427d-b6d2-421e9abe884e">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the acquired identifiable intangible assets from the acquisitions discussed above were determined by applying the income approach, using a discounted cash flow model in which cash flows anticipated over several periods are discounted to their present value using an appropriate rate that is commensurate with the risk inherent with the transaction. These inputs are considered Level 3 inputs under the fair value measurements and disclosure guidance. Due to the recent timing of these acquisitions, the amounts presented above are subject to change as the Company&#8217;s fair value assessments are finalized. Pro forma financial information has not been provided as these acquisitions did not have a material impact, individually, or in the aggregate, to the Company&#8217;s consolidated results of operations.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_2405"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ic579903adb7b4ffca861ce6c0705a35d" continuedAt="ie94cc4fe8ed140febf0921b6e1cb32c3"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe (&#8220;European Divestiture Activities&#8221;), as discussed in more detail below. Assets and liabilities of $<ix:nonFraction unitRef="usd" contextRef="i7746d7d6c7f74bd5a522363e31a8b366_I20220331" decimals="-8" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8zOTU_b9670dc6-bb76-41b6-bc28-5c53dbd38b65">4.5</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i7746d7d6c7f74bd5a522363e31a8b366_I20220331" decimals="-8" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF80MDI_67d34130-ef3c-4b5f-b850-a7e0cd88b873">4.7</ix:nonFraction>&#160;billion, respectively as of March 31, 2022, met the criteria for classification as held for sale in the Company&#8217;s Consolidated Balance Sheet, primarily consisting of disposal groups related to the Company&#8217;s European Divestiture Activities within the International segment. At March 31, 2023, the Company had no assets or liabilities related to these divestiture activities that met the classification of held for sale and the decrease in these amounts during fiscal 2023 was driven by the divestiture of the Company&#8217;s E.U. disposal group (as defined below) in October 2022 and U.K. disposal group (as defined below) in April 2022, each as discussed in more detail below. During the year ended March 31, 2022, the Company recorded charges totaling $<ix:nonFraction unitRef="usd" contextRef="i260e787e79514142b7c391cce58ca8d4_D20210401-20220331" decimals="-8" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF83MDU_9c43cbd4-f534-434a-9f87-32ab991bdc01">1.6</ix:nonFraction>&#160;billion primarily to remeasure the assets and liabilities of the disposal groups to fair value less costs to sell. These charges were largely driven by declines in the Euro and British pound sterling. Net gains and charges related to these divestiture activities during the years ended March 31, 2023 and 2021 were not material. The gains and charges for each year were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. The Company determined that the disposal groups did not meet the criteria for classification as discontinued operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, the Company completed its previously announced transaction to sell certain of its businesses in the E.U. located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group. As part of the transaction, the Company received cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i54bfea324a094e7f996dd8a56ee105f4_D20221031-20221031" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTM4_0a6f8390-4130-42e2-8eff-1baa9953e9b6">892</ix:nonFraction>&#160;million and divested net assets of $<ix:nonFraction unitRef="usd" contextRef="i522ab9fff9ee4ecb8c2fbd1f12f1d934_I20221031" decimals="-8" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTQz_3f524a0e-5769-4504-8152-5e273568af99">1.3</ix:nonFraction>&#160;billion, including cash of $<ix:nonFraction unitRef="usd" contextRef="i522ab9fff9ee4ecb8c2fbd1f12f1d934_I20221031" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTUw_6cc76c7d-3203-40fd-a3a3-61473b6dfb09">319</ix:nonFraction>&#160;million, derecognized the carrying value of its noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) of $<ix:nonFraction unitRef="usd" contextRef="i522ab9fff9ee4ecb8c2fbd1f12f1d934_I20221031" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTU0_e1edec51-e543-4329-866f-aa0a1ba098f2">382</ix:nonFraction>&#160;million, and released $<ix:nonFraction unitRef="usd" contextRef="i54bfea324a094e7f996dd8a56ee105f4_D20221031-20221031" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTY1_759278f0-480e-4c7e-89d0-0361c5d4bf95">153</ix:nonFraction>&#160;million of net accumulated other comprehensive loss.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended March 31, 2023 and 2022, the Company recorded net gains of $<ix:nonFraction unitRef="usd" contextRef="i9b9815e733a0475592cd7fada3bced42_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjM5ODE2_c28dd133-1ef5-4011-801d-e1e86feb1ff8">66</ix:nonFraction>&#160;million and net charges totaling $<ix:nonFraction unitRef="usd" contextRef="ifc7a65af5b26474e8427ff7f8bd6ce64_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8yMjgz_a9e26b09-ebf0-4d7a-9d0e-5ed844493030">438</ix:nonFraction>&#160;million, respectively, to remeasure the E.U. disposal group to fair value less costs to sell. The charges for the year ended March 31, 2022 also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole and net losses of $<ix:nonFraction unitRef="usd" contextRef="ifc7a65af5b26474e8427ff7f8bd6ce64_D20210401-20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8yNjA1_9a78e85a-5184-4963-aa43-711e78c66333">151</ix:nonFraction>&#160;million related to the accumulated other comprehensive loss balances associated with the E.U. disposal group, driven by declines in the Euro. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ie94cc4fe8ed140febf0921b6e1cb32c3" continuedAt="id86429df0ec64a04b5b182f15d734ece"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF83MjM1_aa6c8085-9bb5-465e-a33c-269f2ab4b3da" continuedAt="i82799d9195c8477a8ecdec161ad07117" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet at March 31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18zLTEtMS0xLTIyMjczNA_1a994681-aee6-42fd-b423-2c6a7ffe1715">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y180LTEtMS0xLTIyMjczNA_574529ea-efe5-4a5c-8f5c-0d4bd90cd85b">809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y181LTEtMS0xLTIyMjczNA_fddf1e4d-01fb-4837-98eb-0efdb9137144">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y182LTEtMS0xLTIyMjczNA_82f61da0-b415-4f50-b387-e8eee6b2bdd9">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y183LTEtMS0xLTIyMjczNA_311efa28-1860-4042-b6bc-6cd5aecfbc54">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y184LTEtMS0xLTIyMjczNA_2d27d4a6-5a33-4cb3-8776-d38893c35263">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y185LTEtMS0xLTIyMjczNA_d8c3ee53-3882-498e-ab2c-16b5665b1724">328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xMC0xLTEtMS0yMjI3MzQ_3b5bc39f-e8fe-4182-a86c-6a37d216b30d">302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xMS0xLTEtMS0yMjI3MzQ_45da52ac-153c-45ac-a5c1-d43a55e0287a">3,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xNS0xLTEtMS0yMjI3MzQ_5dfcdf16-1c32-483c-9fef-cbe68b35a614">1,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xNi0xLTEtMS0yMjI3MzQ_769ac0bd-bb1f-413d-9fef-d7ca31bcb544">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xNy0xLTEtMS0yMjI3MzQ_1afed3f1-5691-4e62-9226-44610d27d6ca">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xOC0xLTEtMS0yMjI3MzQ_d75bc6ed-07cd-4dff-8c05-d57f47a79cf6">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xOS0xLTEtMS0yMjI3MzQ_6fdcce88-a1d5-4ffd-8d86-88f04ac5576c">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18yMC0xLTEtMS0yMjI3MzQ_28f3fbd1-c855-40c2-9ed3-8f775a4c8345">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18yMS0xLTEtMS0yMjI3MzQ_2aec0820-45c2-406a-94ac-81d0d1091811">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18yMi0xLTEtMS0yMjI3MzQ_f47c06a3-9a95-431a-b447-46f73e6b5c1c">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18yMy0xLTEtMS0yMjI3MzQ_6725a2c7-58cf-49f1-b06f-5691732cf10a">2,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges in fiscal 2022 related to the impairment of individual assets, including a $<ix:nonFraction unitRef="usd" contextRef="i382c204f13554d4e8ece4058bc5b69c6_D20210401-20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8zNDIx_ea8f3847-c531-4904-aac3-cd27d90292e5">113</ix:nonFraction> million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2022, the Company completed the previously announced sale of its retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;<ix:nonFraction unitRef="gbp" contextRef="ib62a5923230c46c49e36098ccca7369e_I20220406" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8zODA3_b9450423-42a7-4441-830b-e5bd4064f00b">110</ix:nonFraction>&#160;million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="ib62a5923230c46c49e36098ccca7369e_I20220406" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8zODI5_29826d81-bd26-45e8-abd9-9bb86d0c9df7">144</ix:nonFraction> million), including certain adjustments. As part of the transaction, the Company divested net assets of $<ix:nonFraction unitRef="usd" contextRef="i4c4a29b7f1134f299939b7067a5bbc68_I20220406" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTc5_758a10b9-9d7c-44b9-a79a-644a2a117edb">615</ix:nonFraction>&#160;million and released $<ix:nonFraction unitRef="usd" contextRef="ia42344bf1adb4cdeb5624c43ce11a349_D20220406-20220406" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTg2_104ee135-a39b-438b-a95b-f2feea770217">731</ix:nonFraction>&#160;million of accumulated other comprehensive loss and the buyer assumed and repaid a note payable to the Company of $<ix:nonFraction unitRef="usd" contextRef="ie11de948c9444efb94e5917cae16710f_D20220406-20220406" decimals="-6" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTc1_497d6306-27cb-4f5a-8de0-de29614a438a">118</ix:nonFraction>&#160;million. During the year ended March 31, 2022, the Company recorded charges totaling $<ix:nonFraction unitRef="usd" contextRef="i58454d4bece0446ab49687291c0c1cd5_D20210401-20220331" decimals="-8" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8zOTI5_cd34ab3e-88ac-4ba1-bf34-c92068366294">1.2</ix:nonFraction> billion, primarily consisting of adjustments to remeasure the U.K. disposal group to fair value less costs to sell. The remeasurement adjustments included a $<ix:nonFraction unitRef="usd" contextRef="i58454d4bece0446ab49687291c0c1cd5_D20210401-20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF80MDgw_487ce79d-5c29-4329-8af5-19149a00bd7c">734</ix:nonFraction> million loss related to the accumulated other comprehensive loss balances associated with the U.K. disposal group, driven by declines in the British pound sterling. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations. The Company&#8217;s measurement of the fair value of the U.K. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="id86429df0ec64a04b5b182f15d734ece" continuedAt="ia46ae514e91a4809884dbeca2374bb43"><ix:continuation id="i82799d9195c8477a8ecdec161ad07117"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet at March 31, 2022 were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8zLTEtMS0xLTIyMjczNA_bc03964b-6b20-4aa4-ad8e-e384237b03b1">531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl80LTEtMS0xLTIyMjczNA_bccf5e43-a083-44c2-b386-a14492073743">931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl81LTEtMS0xLTIyMjczNA_725c8db8-b341-4537-9f81-24ba3e280d08">563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl82LTEtMS0xLTIyMjczNA_c9cb00f0-09dd-4630-8259-c8482a04b018">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl83LTEtMS0xLTIyMjczNA_8527fc19-eea8-4be8-b433-cfef9b6795a1">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl84LTEtMS0xLTIyMjczNA_5c9c04ea-484f-44eb-bc3d-3a16b95c3c55">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl85LTEtMS0xLTIyMjczNA_fcff1731-4582-4e61-a395-2f019098a743">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xMC0xLTEtMS0yMjI3MzQ_40a4c848-aafe-4d5b-8d08-670055d3cda8">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xMS0xLTEtMS0yMjI3MzQ_5eff57bf-f12f-4b81-965c-3d92610b04b5">1,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xMi0xLTEtMS0yMjI3MzQ_5515d16e-f119-44ca-8c9f-b5e55038b932">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xNi0xLTEtMS0yMjI3MzQ_b17ac424-f3d1-4a81-9d75-9a9ef4bed510">1,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xOC0xLTEtMS0yMjI3MzQ_f3a4da1a-6b55-43c8-981d-6d38a9a8a27a">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xOS0xLTEtMS0yMjI3MzQ_f3203f25-5c2b-49a6-a556-27edcb1bf21b">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8yMS0xLTEtMS0yMjI3MzQ_2ffc1fe6-cf6c-43bf-971a-876f0ffedebf">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8yMi0xLTEtMS0yMjI3MzQ_928abdd6-3265-4c04-8671-a492e4c4dc41">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8yMy0xLTEtMS0yMjI3MzQ_7dab4953-9439-4421-b8ff-a58ffb1bbae8">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8yNC0xLTEtMS0yMjI3MzQ_2d110ee8-1b17-4d7d-ba6b-7597ebeb12b3">2,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2022, the Company completed the sale of its Austrian business to Quadrifolia Management GmbH in a management-led buyout for a purchase price of &#8364;<ix:nonFraction unitRef="eur" contextRef="i4c359290f5374ebcb781e2a05480221e_I20220131" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81MTE0_ba4d2f00-2ccf-4c9b-aa78-30ef57dd87ea">244</ix:nonFraction>&#160;million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i4c359290f5374ebcb781e2a05480221e_I20220131" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81MTM2_27e0866c-197c-46ff-8cb3-637cb3085295">276</ix:nonFraction> million), including certain adjustments. The Company divested net assets of the Austrian business of $<ix:nonFraction unitRef="usd" contextRef="i85ba3e843a814a899aaf3a87e8422f9d_I20220331" decimals="-6" name="us-gaap:AssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81MjMy_8eb0a8f4-65e1-48a9-8fc8-3a4ed174c1fc">272</ix:nonFraction> million and the buyer assumed a note payable to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="i10dc0fc369ee4d088df51fef92fe40e1_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81MzQ5_29260afb-67ed-4f21-a1dd-fffc445cf39a">63</ix:nonFraction> million which was paid to McKesson in the fourth quarter of fiscal 2022. During the year ended March 31, 2022, the Company recognized a loss of $<ix:nonFraction unitRef="usd" contextRef="ie4656299b20c436497390a7e79147f34_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81NDY5_c7d3a9ed-aa7c-4394-b597-c4280e86b810">32</ix:nonFraction> million which was recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the divestiture activities discussed above, the Company&#8217;s European operations primarily consist of its retail and distribution businesses in Norway.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ia46ae514e91a4809884dbeca2374bb43" continuedAt="i0e4aa39b53ef4d51a3777f9c394baa1e"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">German Pharmaceutical Wholesale Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020, the Company completed a transaction with Walgreens Boots Alliance (&#8220;WBA&#8221;) whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson had a <ix:nonFraction unitRef="number" contextRef="i7351ec7b72b6422a82ab0afffdd65c27_I20201101" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81ODAx_a8a27c37-6652-4ff0-a17d-906c02cd40bc">30</ix:nonFraction>% noncontrolling interest. Transaction consideration for the contribution included a receivable amount of $<ix:nonFraction unitRef="usd" contextRef="ifd040622e9b1489ba2addf0494df3a62_I20201101" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81OTA4_373c3e97-a904-4bf2-86e7-8fc67b30ecaa">41</ix:nonFraction> million, primarily related to working capital and net debt adjustments from WBA, which was received in the first quarter of fiscal 2022, and the <ix:nonFraction unitRef="number" contextRef="i7351ec7b72b6422a82ab0afffdd65c27_I20201101" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF82MDQx_a8a27c37-6652-4ff0-a17d-906c02cd40bc">30</ix:nonFraction>% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was <ix:nonFraction unitRef="usd" contextRef="i2646e19a2c8440d08bc15a4216ccadaf_I20210331" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF82MzU4_77fde351-5b5a-44af-b871-41e82b301846">nil</ix:nonFraction> as of March 31, 2021. The Company accounted for its interest in the joint venture as an equity method investment within the International segment. The joint venture also assumed a note payable to the Company in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="if02745e482324982aa1ae5309d602ded_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF82NTg4_88bd520c-af8e-4326-941a-3ba93c4a087b">291</ix:nonFraction> million as of the transaction date, which was paid to the Company in fiscal 2021. In conjunction with the contribution, the Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="if2e3b761b77d4b7cbc297831b399408a_D20200401-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF82NzI3_45ffbf42-dfbd-406c-982d-2137a3ac6ac0">58</ix:nonFraction> million in the year ended March 31, 2021, which included adjustments to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations. The Company&#8217;s measurement of the fair value of the German pharmaceutical wholesale business disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA. Refer to Financial Note 5, &#8220;Other Income, Net,&#8221; for information regarding the divestiture of this investment.</span></div></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_2537"></div><ix:continuation id="i0e4aa39b53ef4d51a3777f9c394baa1e"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the periods presented, the Company also completed de minimis acquisitions and divestitures within its operating segments. Financial results for the Company&#8217;s business acquisitions have been included in its consolidated financial statements as of their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates.</span></div></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_127"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3NDU_e7369fcc-d723-4d99-9465-eebaffd1ebf7" continuedAt="i9d65dd7cd5e047939445cd188075407f" escape="true">Restructuring, Impairment, and Related Charges, Net </ix:nonNumeric></span></div><ix:continuation id="i9d65dd7cd5e047939445cd188075407f" continuedAt="i88a83daa77be4daba296a852240ef88c"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges, net, of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzkw_9a1a7f9c-a530-488d-b156-8bef65c7c809">209</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzk0_3c23df35-0ea0-4fbc-a3db-4122cc9c1bb4">281</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzEwMg_5f8322bb-de00-462a-a18a-289b1dc9734e">334</ix:nonFraction> million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively. These charges are included in &#8220;Restructuring, impairment, and related charges, net&#8221; in the Consolidated Statements of Operations. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, the Company approved a broad set of initiatives to drive operational efficiencies and increase cost optimization efforts, with the intent of simplifying its infrastructure and realizing long-term sustainable growth. These initiatives include headcount reductions and the exit or downsizing of certain facilities. The Company anticipates total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i9c75333b88e542c4ba71e94b1d28056e_I20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3OTYwOTMwNDgxNDY_f42f5f29-574c-47e9-8556-340526fe747b">125</ix:nonFraction>&#160;million across its RxTS and U.S. Pharmaceutical segments as well as Corporate, consisting primarily of employee severance and other employee-related costs, facility and other exit-related costs, as well as long-lived asset impairments. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="ibfc71eef9d254de48d739e651f3d7561_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgzOTUyNg_e0872bc8-377e-479e-8735-795329f92c33">60</ix:nonFraction> million for the year ended March 31, 2023 related to this program, which reflects severance and other employee-related costs within its RxTS segment as well as asset impairments and accelerated depreciation, including certain asset impairments primarily within its U.S. Pharmaceutical segment and real estate charges within Corporate. This restructuring program is anticipated to be substantially complete by the end of fiscal 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#8217;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i7a6fc260a6de4b629a6b4970e20fe6aa_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzYwNDczMTM5NjM3ODA_83553d8b-563f-479b-8fbe-7785f4706fe6">124</ix:nonFraction>&#160;million for the year ended March 31, 2022, primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in fiscal 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i88a83daa77be4daba296a852240ef88c" continuedAt="i5ffdecb7a98545f0a8533b286007212f"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2021, the Company committed to an initiative within the U.K., which was included in the Company&#8217;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative included reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Charges incurred for this initiative were <ix:nonFraction unitRef="usd" contextRef="i7a4a0202812f4880a82a0487047cc47f_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3OTYwOTMwNDQ4ODQ_c5656c7c-01e2-4b49-994a-3b4ef08e5dc9">no</ix:nonFraction>t material for the year ended March 31, 2022 and were $<ix:nonFraction unitRef="usd" contextRef="ifa888a5ec0d944f1a58684506e131405_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgyNTA5MQ_79197b9e-7194-41e0-8abc-0bc03b23d4af">57</ix:nonFraction> million for the year ended March 31, 2021, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. This initiative was substantially complete in fiscal 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company implemented centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also included reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="ia88c62cc31154e05941895097f4eb653_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgyNTcwNg_54bda34b-1d25-4a6c-b0ee-8b1fb3e82b63">62</ix:nonFraction> million for the year ended March 31, 2021, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. This initiative was substantially complete in fiscal 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. As a result, the Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i9f3eb833b0314352811520832d05703c_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgyNjI2Nw_81600214-2019-4a6b-b40f-0664e2865306">28</ix:nonFraction> million for the year ended March 31, 2021, consisting primarily of employee retention expenses, severance, long-lived asset impairments, and accelerated depreciation. The relocation was substantially complete in January 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2023 </span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3NTA_ce5e4e70-3b78-4db5-9d67-51189aac7d1e" continuedAt="i3b564f44d4874185b98d81d7b8271af7" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2023 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItMS0xLTEtMjE4NzQ4_67c3ca33-9ec8-4400-85a7-96b53ebdf100">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItMy0xLTEtMjE4NzQ4_894c3aca-ef63-4e4e-940e-be0cf2092f44">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItNS0xLTEtMjE4NzQ4_1d1f245a-f0f0-488f-a2b8-706b6f81bd5b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItNy0xLTEtMjE4NzQ4_fd267ce9-d40b-48f6-aa7a-082c41d8eec9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItOS0xLTEtMjE4NzQ4_3d78b770-3c56-47f4-818c-e391207f6aa0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItMTEtMS0xLTIxODc0OA_282f7db0-438e-46c0-a60a-e8e6a7a1a1ba">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtMS0xLTEtMjE4NzQ4_96e0c371-81ed-4ae4-ba7a-efb9bf12ae9e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtMy0xLTEtMjE4NzQ4_7776767a-61b2-4774-938a-98aec9754e96">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtNS0xLTEtMjE4NzQ4_778d52fa-d644-40c1-b6d4-5a9a7fa74db6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtNy0xLTEtMjE4NzQ4_f59f76d3-b0b3-4bf8-b7e9-e688c465d0c6">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtOS0xLTEtMjE4NzQ4_bbbc42cd-4319-4286-ac51-d7ff4a2912ae">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtMTEtMS0xLTIxODc0OA_26f4023b-6059-4947-b401-f369b01781ea">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtMS0xLTEtMjE4NzQ4_2988d6ad-f248-4863-bf57-d80597715b82">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtMy0xLTEtMjE4NzQ4_39a1446a-52d7-4572-a724-9de35a7ed7ab">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtNS0xLTEtMjE4NzQ4_a1e1f614-e6c0-4b8d-ac77-4b32bc524029">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtNy0xLTEtMjE4NzQ4_441a8bc9-0a59-4eb9-8d7e-85c9de7f46f1">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtOS0xLTEtMjE4NzQ4_ed3ae0ce-8967-4cf3-82a7-1780a1588c5e">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtMTEtMS0xLTIxODc0OA_1d8eacbb-dd95-43ba-9ca0-1f31b82677a7">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtMS0xLTEtMjE4NzQ4_9c83d7bf-864d-437e-ba1b-bb1719428e4e">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtMy0xLTEtMjE4NzQ4_038535f4-5c99-49c9-9385-8f3bfa78048d">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtNS0xLTEtMjE4NzQ4_ddb2fef9-b2b2-4aba-b0a3-50a3a0bb517c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtNy0xLTEtMjE4NzQ4_04663a3e-ccde-4470-a342-ba7c6432c841">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtOS0xLTEtMjE4NzQ4_e966d969-dbd6-4339-a320-cc8eb75618f9">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtMTEtMS0xLTIxODc0OA_b1d1a2dc-7470-4585-95b5-c3244f91d9b6">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to operational efficiencies and cost optimization efforts described above to support the Company&#8217;s technology solutions.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. Corporate includes costs for business transformation and optimization efforts related to the Company&#8217;s technology organization. The International segment includes costs related to the Company&#8217;s European divestitures. </span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i5ffdecb7a98545f0a8533b286007212f" continuedAt="i0fe4b3dde8ed4be7ace581054877bf48"><ix:continuation id="i3b564f44d4874185b98d81d7b8271af7"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2022</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2022 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItMS0xLTEtMjE4NzQ4_f9ed6fe0-6deb-4218-9b48-33223912793e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItMy0xLTEtMjE4NzQ4_9dbbc1cc-0207-4690-9933-f6f23d725c6f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItNS0xLTEtMjE4NzQ4_0777a5f1-60b3-41e6-93d5-87d0c478e68a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItNy0xLTEtMjE4NzQ4_81f528a3-bfca-4b27-a48f-62c8c7591254">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItOS0xLTEtMjE4NzQ4_0913ace5-b272-400b-a1a7-263ebfd30362">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItMTEtMS0xLTIxODc0OA_de639d83-68c4-44d7-8a53-fe6c0556c2df">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtMS0xLTEtMjE4NzQ4_ef42fb05-52b5-47b8-8508-9f41408bc7ce">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtMy0xLTEtMjE4NzQ4_3e2a8ed5-5111-4d51-9b47-9e3cd8c7d7ae">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtNS0xLTEtMjE4NzQ4_30fc74d4-7ecf-448b-ac77-1c37c37ab78b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtNy0xLTEtMjE4NzQ4_b717f76f-7161-43df-becd-bb6cc93156ff">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtOS0xLTEtMjE4NzQ4_5657485b-a129-4054-8af0-e39d0b09db62">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtMTEtMS0xLTIxODc0OA_a4ded195-075b-4779-a850-82ef78800c9b">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtMS0xLTEtMjE4NzQ4_dc51a33a-51ea-4087-86d6-42d1a96d2f8d">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtMy0xLTEtMjE4NzQ4_89db1188-fd79-44ac-a5d0-858cbcf05231">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtNS0xLTEtMjE4NzQ4_7851ee50-3db2-47d5-a15f-8d38915f93bd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtNy0xLTEtMjE4NzQ4_2cf883e4-735f-463b-b034-d86e04ec3c63">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtOS0xLTEtMjE4NzQ4_961bc2d0-8c62-4119-8f3b-e4a7bd3c2b3a">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtMTEtMS0xLTIxODc0OA_947280fe-4421-4505-b2d7-09cdece13659">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtMS0xLTEtMjE4NzQ4_48de05e8-0f08-4cbf-947a-1e0c75b97a7e">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtMy0xLTEtMjE4NzQ4_478b4967-e0d8-4f8b-bfa4-88ab0cfa7ce4">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtNS0xLTEtMjE4NzQ4_97b0cbed-d186-45b0-9ee4-1ba73cfce8ec">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtNy0xLTEtMjE4NzQ4_dde76f4c-2c69-408b-a24b-b51b68446607">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtOS0xLTEtMjE4NzQ4_199793ae-9c2b-40c4-8558-0d7756f1b8d6">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtMTEtMS0xLTIxODc0OA_617696ea-1773-43d0-bd3e-5866e472cc1c">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. For the Company&#8217;s International segment, costs primarily relate to optimization programs in Canada, exit-related actions for the Company&#8217;s European Divestiture Activities, and programs for operating model and cost optimization efforts in the U.K. as described above. For Corporate, primarily represents costs related to the transition to the partial remote work model described above and various other initiatives. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItMS0xLTEtMjM1MjUz_86032241-dc96-49b2-8b87-c15ce56ccabc">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItMy0xLTEtMjM1MjUz_e22ad945-1301-41e2-9b5e-1c06eec0a620">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItNS0xLTEtMjM1MjUz_a4103037-37d8-47b9-9a1a-3bcadd330e7a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItNy0xLTEtMjM1MjUz_2ae67b2a-0ca5-4d3d-8a94-01a03e1908a1">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItOS0xLTEtMjM1MjUz_d4f18335-1920-4627-b4b5-9e3465d0aa86">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItMTEtMS0xLTIzNTI1Mw_3e0ea8c6-3960-4e8f-b832-19b19c33b304">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtMS0xLTEtMjM1MjUz_d50a92f4-f877-48d6-8ba3-e800a69faebf">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtMy0xLTEtMjM1MjUz_29d7c08c-e141-40c7-ae82-d0a9317feee0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtNS0xLTEtMjM1MjUz_49ac6572-7f0c-4315-8949-dac0b06db87b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtNy0xLTEtMjM1MjUz_3dfa5a48-1721-4a2b-a45d-be015faa076f">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtOS0xLTEtMjM1MjUz_e9e7540e-19c1-4781-a01f-71121930c324">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtMTEtMS0xLTIzNTI1Mw_80439d6d-77a7-4974-91a1-5418e0517ac0">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtMS0xLTEtMjM1MjUz_dbac34c4-7f2f-4981-a76f-1268b9c10f6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtMy0xLTEtMjM1MjUz_bc859aea-66b9-44be-96c9-0a1e86dfc902">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtNS0xLTEtMjM1MjUz_6c73182b-9fc8-498c-aed8-d9034c8f3721">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtNy0xLTEtMjM1MjUz_99b9366c-1c69-467b-b00d-86bf42264681">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtOS0xLTEtMjM1MjUz_9df35b4a-4e68-4247-86dc-cf428b9f122e">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtMTEtMS0xLTIzNTI1Mw_1cdd8872-5a35-414c-82d2-6bb9accd1587">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtMS0xLTEtMjM1MjUz_78aafa78-2e98-40f8-99ee-ee8ec8760607">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtMy0xLTEtMjM1MjUz_a158d998-218c-45b8-9792-6d8d28a0b263">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtNS0xLTEtMjM1MjUz_4008fa5c-307a-4716-82d6-5d6b2699a54f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtNy0xLTEtMjM1MjUz_fee68f92-4eae-4e2b-988b-78dbec03ad94">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtOS0xLTEtMjM1MjUz_db22c55a-35ac-4db2-a813-55d9ec1bcc7a">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtMTEtMS0xLTIzNTI1Mw_d8f86498-6fa1-4714-8c4e-175c940cb587">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#8217;s headquarters described above in addition to various other initiatives.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i0fe4b3dde8ed4be7ace581054877bf48" continuedAt="ie5b060b3bba4406eb7dfd044ea4310f5"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3NDQ_49c00ec9-cf3f-4479-a790-0848bd725e59" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the years ended March 31, 2023 and 2022: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica9a08587ca04030b0e7cc35fa7d526b_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtMS0xLTEtMjE4NzQ4_a77059e1-f6d8-4ff9-bce0-5540a5c8bc95">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663d657bf1e24bbcb2dbc5356bd8a9d7_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtMy0xLTEtMjE4NzQ4_15f7ed5e-5a02-48de-88fd-3128998f7161">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0450b305293d4d12a476155c59674aac_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtNS0xLTEtMjE4NzQ4_732acdf6-728d-4a5d-a7fd-181872afadd4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf0b80c33ebe40fbb027ad323e881fa7_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtNy0xLTEtMjE4NzQ4_59b88ace-86d9-419a-b5bc-7060075b2f6c">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i842e5c3e1d294131aa2e71ec30e3c3e1_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtOS0xLTEtMjE4NzQ4_0b4dce1d-36fc-4531-910b-8701d88c7788">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtMTEtMS0xLTIxODc0OA_4a93fae4-1bc5-493e-a5dc-3515bec96942">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItMS0xLTEtMjE4NzQ4_f698b501-dd5b-4898-9cb0-723cdd933076">35</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItMy0xLTEtMjE4NzQ4_91340250-21c7-4b49-8968-e8dd64cf14a4">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItNS0xLTEtMjE4NzQ4_fd4eaa9d-7520-458b-87b3-04f7280d70a3">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItNy0xLTEtMjE4NzQ4_45a96a86-cba7-4ee1-9ee6-7c987078b031">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItOS0xLTEtMjE4NzQ4_c1a1385a-9d55-4b9b-8857-55db03ff1245">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItMTEtMS0xLTIxODc0OA_f509ac17-9c99-4d76-995c-dc6a9740e922">245</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtMS0xLTEtMjE4NzQ4_94f0aabc-6dad-4c4a-931b-f3dc38991180">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtMy0xLTEtMjE4NzQ4_db4edd8b-d3d0-465e-bb75-c97d4859d095">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtNS0xLTEtMjE4NzQ4_dd15853d-7c28-42ce-b9ed-32983de3e4fd">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtNy0xLTEtMjE4NzQ4_d53aa838-3cc0-4678-9579-5ddf9775ff89">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtOS0xLTEtMjE4NzQ4_82b547c4-7db5-4100-8c47-282ea83371f5">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtMTEtMS0xLTIxODc0OA_d3a4a288-8ff1-42d7-81bb-e26943957847">139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtMS0xLTEtMjE4NzQ4_e8053886-eea4-4ef5-be5f-cabcb9c195d7">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtMy0xLTEtMjE4NzQ4_4807facf-374a-4d24-8c69-b46893b9f8b5">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtNS0xLTEtMjE4NzQ4_bfa7f849-5da2-44d1-b61d-54ac2f6b68a4">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtNy0xLTEtMjE4NzQ4_5b160ba4-323e-409e-ab33-a5865efa7a67">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtOS0xLTEtMjE4NzQ4_9189a3a1-3c15-4e7e-9604-6c43f50ef3b7">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtMTEtMS0xLTIxODc0OA_a0726802-cab2-45e8-a70b-50e2b2ea12ec">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtMS0xLTEtMjE4NzQ4_e58e0310-e1cf-46c6-81d9-876a69fa799b">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtMy0xLTEtMjE4NzQ4_79c4799d-99c4-4cd2-be94-f0cb6fd3b3b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtNS0xLTEtMjE4NzQ4_a8119eab-e567-4ab4-bdcf-ae10c3b49601">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtNy0xLTEtMjE4NzQ4_63f6ed8a-c63a-4005-855f-a78cd775b63a">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtOS0xLTEtMjE4NzQ4_53297414-27b2-4d12-ab00-59bdac396ebc">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtMTEtMS0xLTIxODc0OA_f840d422-edeb-4517-b57d-2186fd305a37">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i948e2e219f854ac082a3c472c583fe7d_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtMS0xLTEtMjE4NzQ4_d140ba62-2a18-460b-9ae9-84033a63514f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie936d943185b4ffbb312cec2d0a11ea1_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtMy0xLTEtMjE4NzQ4_076c3a75-b4e7-4e61-9d93-e539c9450480">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56dc2bee6bfd4893aaf3550953e9f904_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtNS0xLTEtMjE4NzQ4_420fa12f-aa50-4a63-855e-6f826b87ee0c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3977781f98d2482e9204ee3df23b62ef_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtNy0xLTEtMjE4NzQ4_67734c1a-147d-46d5-a706-83622bea7755">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca2257eaa5a4089b39072f8a37a459e_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtOS0xLTEtMjE4NzQ4_6e539c38-a609-40ad-80cc-fc4b6c0439dc">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtMTEtMS0xLTIxODc0OA_7ddc78b9-f6c4-44b7-b6cf-e28b7073edd5">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctMS0xLTEtMjE4NzQ4_3016d79f-7e57-41a4-8ceb-5dfe40829cec">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctMy0xLTEtMjE4NzQ4_5171b3e5-6b7b-450d-a210-19b444193367">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctNS0xLTEtMjE4NzQ4_5705d0a9-7e0e-4926-8d40-fbff2b3c43f3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctNy0xLTEtMjE4NzQ4_09e23ddb-de68-426f-ba77-fddc866594ab">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctOS0xLTEtMjE4NzQ4_e0f8e16f-c660-4184-8db6-9116bbd3cf08">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctMTEtMS0xLTIxODc0OA_d69c1781-5496-4c9c-a21c-37435b3ee929">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtMS0xLTEtMjE4NzQ4_6ea1a4b8-970c-4f6f-bf22-c7a8f3f87d98">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtMy0xLTEtMjE4NzQ4_1dbe79e3-54a4-4820-a37e-d5616d837dde">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtNS0xLTEtMjE4NzQ4_d4b2309d-1c02-4619-bcdd-1f8ade3cc2f1">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtNy0xLTEtMjE4NzQ4_8e1bbaa1-cde1-4b3b-8ea2-599d6d56044e">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtOS0xLTEtMjE4NzQ4_a1885e86-9951-4eda-bc26-48b5449d4452">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtMTEtMS0xLTIxODc0OA_83f9525e-1bff-4b2d-a6c6-40890e0955c2">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktMS0xLTEtMjE4NzQ4_dda2d26a-7471-4759-8cd5-bfcccb594697">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktMy0xLTEtMjE4NzQ4_03fdf1ab-4576-4c77-9406-71643061585c">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktNS0xLTEtMjE4NzQ4_2b063fe0-bd13-4425-8627-092245789b6b">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktNy0xLTEtMjE4NzQ4_383766f1-2b45-41f2-97f6-bbdc5d0f3477">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktOS0xLTEtMjE4NzQ4_d2c49557-ac7a-4e39-8e64-8c5587e229e6">86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktMTEtMS0xLTIxODc0OA_260a21df-dba2-4103-b0d7-4339c64c6df0">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTEtMS0xLTIxODc0OA_45edb7ba-7835-472c-841d-263cf550bd77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTMtMS0xLTIxODc0OA_74d03256-fdbd-4774-ac12-0b2488225bc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTUtMS0xLTIxODc0OA_78a86cb4-8fa5-459f-89b0-5a63842f1447">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTctMS0xLTIxODc0OA_8be82976-30c1-40b3-8089-7159479a0764">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTktMS0xLTIxODc0OA_5c02d23b-f69c-4b61-91f2-7f90a713b13d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTExLTEtMS0yMTg3NDg_d12f50fc-ff22-4b1b-8aaf-304bfdb44535">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493ee32637374fef85bb13b3cde7de11_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTEtMS0xLTIxODc0OA_7b3c4d42-717d-4d97-84ce-51a5c27b658d">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbec207732c741a7b5cd533ccd6d7102_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTMtMS0xLTIxODc0OA_9967a56e-6934-45b5-b065-4143901ff38e">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab47b293b1e6457e9220acf589c14011_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTUtMS0xLTIxODc0OA_8d724b54-93e6-4327-8192-f771ee12c0d8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3e584c30524ea7abc9a6d31589fd8b_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTctMS0xLTIxODc0OA_8a2aba23-dc27-46ff-aadd-43788d300dfd">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd5164d3ebc94282adf69fe3daa1dd18_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTktMS0xLTIxODc0OA_80877ca4-9c92-4580-bfcb-6261a53e0e6a">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTExLTEtMS0yMTg3NDg_648f1911-8207-43ab-b0d5-a8d94edf70b4">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Other primarily includes cumulative translation adjustments and transfers to certain other liabilities. For the Company&#8217;s International segment, other also includes a reduction to the liability for the divestitures of the E.U. disposal group and the U.K. disposal group in fiscal 2023, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;As of March 31, 2022, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzYzNjg_7248e279-e9dc-4092-8bb8-272049f77a32">130</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i8e022c6735f44aafbc94894561402456_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzYzODE_94d5296b-cd51-42fe-abe5-cde0d7711769">58</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities,&#8221; $<ix:nonFraction unitRef="usd" contextRef="i3947bd9bcc904e12bbce546550846178_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgzMzA0Nw_06d85a9f-fc04-42c2-9313-95c81eadd397">36</ix:nonFraction> million was recorded in &#8220;Liabilities held for sale,&#8221; and $<ix:nonFraction unitRef="usd" contextRef="i8be50c56aed545d6a05664ecf4cd0520_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzY0MDk_663fed10-a54e-403b-a3ab-65a688503723">36</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets. </span></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;As of March 31, 2023, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzY1MjQ_435c1902-cd04-4915-9d3e-669135401445">92</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i9271e52fbc4b4051bc42f5edf6a60c46_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzY1Mzc_780bcb43-99e6-47b7-85a6-ce28eed21167">66</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities&#8221; and $<ix:nonFraction unitRef="usd" contextRef="i196be4042ab946ffab53968cba582319_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzY1OTE_15688f78-14ba-4384-9c2f-08842916409e">26</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2023</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3OTYwOTMwNTI4NzU_0150df67-d94f-4409-9c0b-78efb877d0b9">no</ix:nonFraction> material long-lived asset impairments recorded in fiscal 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2022</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2022, the Company recognized charges totaling $<ix:nonFraction unitRef="usd" contextRef="if642126ed2f24282b10b29e0c453e35e_D20210401-20220331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgzNDM4OA_48b68db6-a1e5-4a7c-a8e4-f6a66cb76a07">36</ix:nonFraction> million to impair certain long-lived assets within the International segment related to the Company&#8217;s previous operations in Denmark and its retail pharmacy businesses in Canada. The Company used an income approach and a market approach to estimate the fair value of the long-lived assets. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:continuation id="ie5b060b3bba4406eb7dfd044ea4310f5" continuedAt="i46f519a23f4b4e799045c007980e3bcb"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i46f519a23f4b4e799045c007980e3bcb">fiscal 2021, the Company recognized charges of $<ix:nonFraction unitRef="usd" contextRef="ie1ad9e5e8f13437e83ec2ed5b6ca20ee_D20200401-20210331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgzNDM5NQ_a197f91b-f9ba-41a8-ae06-26162e1c286c">115</ix:nonFraction> million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach and a market approach to estimate the fair value of the long-lived assets.</ix:continuation> </span></div><div id="i04335d018da94076b0acf21e81ac886b_133"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0OTc_ab82ab34-2888-454a-9858-23f9e67ed906" continuedAt="ic53735cb0a3848d2ad69e20ac58adf26" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic53735cb0a3848d2ad69e20ac58adf26" continuedAt="i0bcd5b4e021c437e8bcf8c93e352d025">The Company provides share-based compensation to its employees, officers, and non-employee directors, including restricted stock units (&#8220;RSUs&#8221;), performance-based stock units (&#8220;PSUs&#8221;), stock options, and an employee stock purchase plan (&#8220;ESPP&#8221;) (collectively, &#8220;share-based awards&#8221;). Most of the share-based awards are granted in the first quarter of each fiscal year.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i0bcd5b4e021c437e8bcf8c93e352d025" continuedAt="i248bb5e4d1514f0e9878aba63748a8b1"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest. The Company estimates the number of share-based awards that will ultimately vest primarily based on historical experience. The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur. The actual forfeitures in future reporting periods could be higher or lower than current estimates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact on Net Income</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0NzQ_1efca864-9cc7-425e-9e35-976c0c105a9d" continuedAt="i12cebaf2fcd948f7a7eda478dd79a82b" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of share-based compensation expense and related tax benefits were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6f943ac64c470b961d73cf2c5fbcf3_D20220401-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzItMS0xLTEtMjE4NzQ4_5b7bb67e-67e3-49af-b126-d8fe74c08067">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic06aa85305f44c8fbb86fb2d2319293a_D20210401-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzItMy0xLTEtMjE4NzQ4_6e281a31-0236-4618-9b29-3cd3560eb1d2">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9556991f875d4713b5b62bb435eaf7d2_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzItNS0xLTEtMjE4NzQ4_07d104d1-e44f-42b9-a4a5-0d16c470ae2f">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9cc1088918d4bdf9fec9c448e29978f_D20220401-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzMtMS0xLTEtMjE4NzQ4_4c79d9e2-e341-4266-bfc0-c01e85ac110e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4e58f11e8ff4837b70351c42fecfe2a_D20210401-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzMtMy0xLTEtMjE4NzQ4_24bf8934-ead6-48ec-b006-7747de3200b6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d13ad17dcb49b4899c2f0e3cc432d9_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzMtNS0xLTEtMjE4NzQ4_0be90235-8eec-4472-bc88-e643459589e0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife447a3b57f0484f98349ca82b7c8778_D20220401-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzQtMS0xLTEtMjE4NzQ4_6a8c27da-6029-407a-9437-7efd200d5fd9">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f030c588ac48cfbb2352300d303adb_D20210401-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzQtMy0xLTEtMjE4NzQ4_bef95f0a-3082-4743-ad39-33069398b289">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e22ae69db0e4c909043949b0bf363e3_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzQtNS0xLTEtMjE4NzQ4_6893696b-6ed2-470b-b60b-f675d21d4747">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzUtMS0xLTEtMjE4NzQ4_303c971f-fc70-4e91-b8a4-2fb40bca2bc3">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzUtMy0xLTEtMjE4NzQ4_c059d17b-fabc-48c2-ae48-01a242d2771b">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzUtNS0xLTEtMjE4NzQ4_94ce3ee9-8f35-4a28-b4bf-bd5361f2ec5a">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit for share-based compensation expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzYtMS0xLTEtMjE4NzQ4_af46fc4b-991f-4336-87cd-d2836d9063c2">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzYtMy0xLTEtMjE4NzQ4_f45a219c-398e-4fb6-a20f-238072fa17df">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzYtNS0xLTEtMjE4NzQ4_a42a910a-6a6c-4ad0-ad46-be9e4fe01270">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzctMS0xLTEtMjE4NzQ4_f4810e6f-f224-4a04-8f9e-23291dffba3d">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzctMy0xLTEtMjE4NzQ4_881f205e-85a2-49f9-b323-2f501ffa1734">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzctNS0xLTEtMjE4NzQ4_5b948a5d-6ccb-4783-a4ed-a5143f5d5322">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes compensation expense recognized for RSUs and PSUs.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i12cebaf2fcd948f7a7eda478dd79a82b" continuedAt="ia8de044f3c5a430b8451912ea31c99c2">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="ia8de044f3c5a430b8451912ea31c99c2">Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax benefit for fiscal 2023, fiscal 2022, and fiscal 2021 included discrete income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzE0Mzc_34c87311-3946-4e2f-b0bd-389c8b8a9457">58</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzE0NDE_b6b23b4d-2eb7-4b4f-a061-f220bd8754d0">10</ix:nonFraction> million, and discrete income tax expense of $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzE0NDk_b22ef7eb-6c67-416b-977e-2fb3d9b5cf5b">1</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company&#8217;s stockholders approved the McKesson Corporation 2022 Stock Plan (the &#8220;2022 Stock Plan&#8221;), to replace the McKesson Corporation 2013 Stock Plan (the &#8220;2013 Stock Plan&#8221;), which expired in 2023. The 2022 Stock Plan permits the grant of awards in the form of restricted stock, RSUs, PSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The shares previously reserved under the 2013 Stock Plan described below are no longer available for issuance pursuant to the 2022 Stock Plan. As of March 31, 2023, <ix:nonFraction unitRef="shares" contextRef="i1f18df5cf4f04ff894901fbf46e6dba6_I20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzYwNDczMTM5NjU3MjQ_1c28f78e-d1af-4452-9699-f1a04af000e5">4.9</ix:nonFraction> million shares remain available for future grant under the 2022 Stock Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2013, the Company&#8217;s stockholders approved the 2013 Stock Plan to replace the McKesson Corporation 2005 Stock Plan (the &#8220;2005 Stock Plan&#8221;), which expired in 2013. Under these stock plans, the Company issued restricted stock, RSUs, PSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The 2013 Stock Plan reserved <ix:nonFraction unitRef="shares" contextRef="iaa24a0cfb242478997ad1819397e47c8_I20130731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzE3OTM_f253721d-9bf5-4251-b1e1-b20d63fa8f87">30.0</ix:nonFraction> million shares plus unused reserved shares under the 2005 Stock Plan. As of March 31, 2023, <ix:nonFraction unitRef="shares" contextRef="i9a10efc6895245d08afc780fe46cc0c0_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzE4Njg_e2857738-4836-469d-a5c0-625c239f9f0b">no</ix:nonFraction> shares remain available for future grant under the 2013 Stock Plan.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Unit Awards</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs entitle the holder to receive a specified number of shares of the Company&#8217;s common stock which vest over a period of generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzIxMDA_29caba71-3a79-4459-a81e-59ee51b81951">three</span> to <ix:nonNumeric contextRef="ia330d79374df4f04b29816d2c53ad7e3_D20220401-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzIxMDY_c9ba5e24-bae9-4dfb-9ac5-96d39a94df1f">four years</ix:nonNumeric> as determined by the Compensation Committee at the time of grant. The fair value of the award is determined based on the price of the Company&#8217;s common stock on the grant date and the related compensation expense is recognized over the vesting period on a straight-line basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors receive an annual grant of RSUs, which vest immediately and are expensed upon grant. The director may elect to receive the underlying shares immediately or defer receipt of the shares if they meet director stock ownership guidelines. The shares will be automatically deferred for those directors who do not meet the director stock ownership guidelines. At March 31, 2023, approximately <ix:nonFraction unitRef="shares" contextRef="i19acbfe54421472fb6c6c57213d527bf_I20230331" decimals="-3" name="mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzI3ODM_ae2d8e31-4886-444c-9f94-2a9509f6c371">37,000</ix:nonFraction> RSUs for the Company&#8217;s directors were vested.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i248bb5e4d1514f0e9878aba63748a8b1" continuedAt="i6d7d993af4d64647ad0fe36e886e46f6"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs are conditional upon the attainment of market and performance objectives over a specified period. The number of vested PSUs is assessed at the end of a <ix:nonNumeric contextRef="ia89b0a5df63447d995cd0a4593059729_D20220401-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0NzE_c21a8fa6-93f8-48b4-afe7-925c9d35cd20">three-year</ix:nonNumeric> performance period upon attainment of meeting certain earnings per share targets, average return on invested capital, and for certain participants, total shareholder return relative to a peer group of companies and, for special PSUs granted in 2019, meeting certain cumulative operating profit metrics. The Company uses the Monte Carlo simulation model to measure the fair value of the total shareholder return portion of the PSUs. The earnings per share portion of the PSUs is measured at the grant date market price. PSUs have a requisite service period of generally <ix:nonNumeric contextRef="ia89b0a5df63447d995cd0a4593059729_D20220401-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzM1NjU_3afe3786-661b-45cd-b1a4-849b2870687f">three years</ix:nonNumeric>. Expense is attributed to the requisite service period on a straight-line basis based on the fair value of the PSUs, adjusted for the performance modifier at the end of each reporting period. For PSUs that are designated as equity awards, the fair value is measured at the grant date.</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0Njg_86faf531-9ef4-4fa1-b435-85dfb95dc695" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the Monte Carlo valuations were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzItMS0xLTEtMjE4NzQ4_86912f36-98bf-4bbd-8805-7d69c5e3160d">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzItMy0xLTEtMjE4NzQ4_85a8ac89-b8c9-4648-8b01-d1020e8d69b9">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzItNS0xLTEtMjE4NzQ4_a991ee7d-39f5-4fa4-9c21-f60814286c3e">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzMtMS0xLTEtMjE4NzQ4_b37aa0d2-c22c-453f-a43b-edc90fff88c4">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzMtMy0xLTEtMjE4NzQ4_beb42e00-ad32-4d90-a33f-675d3d869980">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzMtNS0xLTEtMjE4NzQ4_382e8d26-5318-4a3d-981b-466f73c02f6d">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzQtMS0xLTEtMjE4NzQ4_e91bf8d5-9a1e-4228-aa4c-361a0713b41a">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzQtMy0xLTEtMjE4NzQ4_bcb56217-d004-46c1-af1e-e869a9f1775a">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzQtNS0xLTEtMjE4NzQ4_dd7f6600-8f46-4d52-b0ed-8ac8369d2998">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></div></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzUtMS0xLTEtMjE4NzQ4_97353a81-3a69-495e-9b63-12b023bbf65c">3</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzUtMy0xLTEtMjE4NzQ4_4e143a71-c466-4226-af98-2dc4923b90c3">3</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzUtNS0xLTEtMjE4NzQ4_42024dd3-30d1-44bc-a525-da589096cdb8">3</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY1MjE_ef97c2f9-6237-4f99-b75e-954d617cea00" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity for restricted stock unit awards (RSUs and PSUs) during fiscal 2023:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i194bfd7f58694118b6608f52ec99adf8_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzEtMS0xLTEtMjE4NzQ4_bf95756c-fc57-4f6d-8cc4-28d939ccdbb7">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i194bfd7f58694118b6608f52ec99adf8_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzEtMy0xLTEtMjE4NzQ4_4f8ddf5e-381d-4496-83f3-f4b4ed005667">160.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzItMS0xLTEtMjE4NzQ4_b8398e91-7c8c-4705-bbce-6b9ab614469f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzItMy0xLTEtMjE4NzQ4_f23c0703-e61e-448a-a357-873d5358382b">332.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" decimals="-6" name="mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzMtMS0xLTEtMjE4NzQ4_3547b215-6c5c-4840-b101-c27a0c3d9a11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" decimals="2" name="mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzMtMy0xLTEtMjE4NzQ4_9d7bfe65-64fb-4daf-8813-4cdf7bcdae42">201.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzQtMS0xLTEtMjE4NzQ4_6a8df46a-7a7d-48af-8c25-7a862a6ecabd">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzQtMy0xLTEtMjE4NzQ4_bb7e55cc-07a2-4de8-ab1b-4fb5f91060b2">149.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i022f37e081eb4c90b78d43940f46aff4_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzUtMS0xLTEtMjE4NzQ4_34d5e4d7-12e7-454e-89a7-b778bf3ac870">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i022f37e081eb4c90b78d43940f46aff4_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzUtMy0xLTEtMjE4NzQ4_ab0d07f3-7eda-4b7e-beb7-30caf1083b4a">238.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts less than a million are shown as zero in the table above.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:DataRelatedtoRSUActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0NTg_1caf09bb-8923-49c7-8f50-890fd61f651b" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to restricted stock unit award activity: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzItMS0xLTEtMjE4NzQ4_f68c4deb-903e-4bb5-be73-0b37b5eb53c8">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzItMy0xLTEtMjE4NzQ4_1abe0346-a992-425b-acfc-62e364ed9823">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzItNS0xLTEtMjE4NzQ4_0c719c19-b1f6-4832-bfa1-102cf3f0ca19">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022f37e081eb4c90b78d43940f46aff4_I20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzMtMS0xLTEtMjE4NzQ4_4c81908d-bbe0-4dba-a2d9-ab79cd50fc18">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i194bfd7f58694118b6608f52ec99adf8_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzMtMy0xLTEtMjE4NzQ4_5b6c9b86-697c-4b9b-b398-e57e46ac1340">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i289228fb848b4f3baeb89b15df8f45fa_I20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzMtNS0xLTEtMjE4NzQ4_02b5f7d2-98ad-4e14-bc2c-907d80801b5d">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzQtMS0xLTEtMjE4NzQ4_0a829fc9-5647-4790-b91d-17db3d37e30b">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzQtMy0xLTEtMjE4NzQ4_421c93cd-17f5-4b36-8c59-2c4e3b1ccea7">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzQtNS0xLTEtMjE4NzQ4_938d9b08-8024-4abc-b4f2-b919c2f41082">2</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted with an exercise price at no less than the fair market value and those options granted under the stock plans generally have a contractual term of <ix:nonNumeric contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzQzMTM_f1decab9-5486-488b-a921-32beb6f9a07e">seven years</ix:nonNumeric> and follow a <ix:nonNumeric contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY1MDI_5ef01145-ea5e-45a2-85f2-a42a481894ad">four-year</ix:nonNumeric> vesting schedule. The Company did <ix:nonFraction unitRef="shares" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY1MTc_3594b682-559b-4e28-b9af-1ade5fd4180f"><ix:nonFraction unitRef="shares" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY1MTc_91d8c1ed-63cd-4676-913e-3e11871d840a"><ix:nonFraction unitRef="shares" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY1MTc_f7f56b6a-68a8-4b9e-b087-d451384a54a7">not</ix:nonFraction></ix:nonFraction></ix:nonFraction> grant any stock options during the years ended March 31, 2023, 2022, and 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for stock options is recognized on a straight-line basis over the requisite service period and is based on the grant-date fair value for the portion of the awards that is ultimately expected to vest. The Company uses the Black-Scholes options-pricing model to estimate the fair value of its stock options. Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i6d7d993af4d64647ad0fe36e886e46f6"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0OTA_d717990b-24f0-4ff6-83eb-6f2968f633cd" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock options outstanding at March 31, 2023:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.560%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range of Exercise<br/>Prices</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Outstanding<br/>at Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Exercisable at<br/>Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtMC0xLTEtMjE4NzQ4_d3e543d4-1f3e-4fe4-a364-d69c15729122">123.98</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtMi0xLTEtMjE4NzQ4_31115c9e-fc06-4d57-9f3f-6c635a07b847">182.78</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtNC0xLTEtMjE4NzQ4_b3d67635-5c70-4c2c-987c-970953eca110">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtNi0xLTEtMjE4NzQ4_56bbaed1-09cb-4264-9afb-e2320b75f18f">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtOC0xLTEtMjE4NzQ4_bfc93310-80c7-438a-a1e1-d8c4951b42d4">154.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtMTAtMS0xLTIxODc0OA_08ed511c-5a44-4df2-a2fa-1bc08b0b72cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtMTItMS0xLTIxODc0OA_e53ea7f3-f02c-44a4-a95c-f041397058bc">154.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0OTE_8aa457d8-b06e-4e6c-b2ab-dce9a72505e7" continuedAt="i191d17a097bf471d85de036339c196a6" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during fiscal 2023:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzEtMS0xLTEtMjE4NzQ4_2ccf8483-163e-438c-84bc-125fdff91f0e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzEtMy0xLTEtMjE4NzQ4_df754bb4-ebd7-4139-849f-754b6459a97c">175.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzEtNS0xLTEtMjE4NzQ4_4a424a95-0d4f-4465-b5fe-e75b77706ea7">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzEtNy0xLTEtMjE4NzQ4_b5b0ed60-2947-4ece-bc92-fffd920572e6">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzItMS0xLTEtMjE4NzQ4_1ed2f10b-1f40-462a-82c6-e046e1efca35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzItMy0xLTEtMjE4NzQ4_4974cfc2-edfd-4975-b9ee-2f0d0e36653c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzMtMS0xLTEtMjE4NzQ4_38948a97-40e9-40f1-a825-bffa517ac899">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzMtMy0xLTEtMjE4NzQ4_11751373-e7e3-4da2-a48a-ef9626f41969">125.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzQtMS0xLTEtMjE4NzQ4_cc86b615-ebd8-4f1d-975d-f88527df18b8">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzQtMy0xLTEtMjE4NzQ4_0fa85cb1-7d3b-46a2-a066-4018c9f31dcf">191.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzUtMS0xLTEtMjE4NzQ4_8258d09a-9958-46e2-9b0f-968b0001582c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzUtMy0xLTEtMjE4NzQ4_a72fdac3-c79b-42ef-9e31-0f58b8fb1880">154.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzUtNS0xLTEtMjE4NzQ4_6d2e1d89-cd90-4bf9-829a-285d4b5d42f2">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzUtNy0xLTEtMjE4NzQ4_55696bd0-bb53-4ab4-aa6c-6df4b7163416">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzYtMS0xLTEtMjE4NzQ4_f49936d0-3d00-4f3f-b598-91a74f31b5cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzYtMy0xLTEtMjE4NzQ4_ba3a4d46-d502-46a8-ba5c-0c5d892c56e7">154.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzYtNS0xLTEtMjE4NzQ4_18e0da3c-7dcb-45b1-a262-c13b9f78c464">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzYtNy0xLTEtMjE4NzQ4_b1c20a1f-ab97-48b7-9903-37844334bccc">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable, March 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzctMS0xLTEtMjE4NzQ4_16f17f00-1ef1-4319-8d92-fe52f52294dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzctMy0xLTEtMjE4NzQ4_92b66ea3-b62c-4334-ba6f-bc0d52eb765d">154.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzctNS0xLTEtMjE4NzQ4_2deb4017-426d-4938-ba9f-500a86c21aa3">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzctNy0xLTEtMjE4NzQ4_a041a5e5-f500-4528-afb8-78c2775c43f1">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of options expected to vest takes into account an estimate of expected forfeitures.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i191d17a097bf471d85de036339c196a6" continuedAt="iddab83fa5b6a4e10b5a994c1482debf5">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="iddab83fa5b6a4e10b5a994c1482debf5">The intrinsic value is calculated as the difference between the period-end market price of the Company&#8217;s common stock and the exercise price of &#8220;in-the-money&#8221; options.</ix:continuation> </span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0ODU_c219d9a2-26df-4020-a07b-4eae934f571f" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to stock option activity:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzItMS0xLTEtMjE4NzQ4_c1a10991-79bb-4f57-a598-233aedacbcf1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzItMy0xLTEtMjE4NzQ4_7ea0d15f-4a72-4c98-a43e-fc6a4be63f0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzItNS0xLTEtMjE4NzQ4_bbbe1067-87c2-49ae-b18e-aa8e32d9242d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value on exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzMtMS0xLTEtMjE4NzQ4_c7fb8cb7-4c47-42a1-b6a2-e635eeaf1ef2">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzMtMy0xLTEtMjE4NzQ4_21e48707-cbbf-4809-8c49-4f5b40b1a65c">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzMtNS0xLTEtMjE4NzQ4_87b49db7-10ca-4d73-a57e-7bd5f6dfa9aa">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received upon exercise</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzQtMS0xLTEtMjE4NzQ4_66e1bbc7-6d4e-47f1-9b3d-9873c8013b86">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzQtMy0xLTEtMjE4NzQ4_ecc08565-31a3-428e-a0be-6f2469539aeb">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzQtNS0xLTEtMjE4NzQ4_b70ea88d-8583-46ef-9b42-580355411c06">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized related to exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzUtMS0xLTEtMjE4NzQ4_28ecf438-1e50-4d3b-b3e0-7935f594262d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzUtMy0xLTEtMjE4NzQ4_344a7c1b-cc2b-4437-92fe-e2050f6c20f9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzUtNS0xLTEtMjE4NzQ4_97911f25-e660-44f2-b004-f87323b84613">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of stock options vested</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzYtMS0xLTEtMjE4NzQ4_b2369ca7-3dc2-42eb-b67a-0020fecdbf0d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzYtMy0xLTEtMjE4NzQ4_ecba71aa-be75-429e-bd47-902fbc738bd4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzYtNS0xLTEtMjE4NzQ4_b8802b92-c225-4512-b43b-165dbbc85189">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c1b4f588c94865ab50e59ee67700cb_I20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzctMS0xLTEtMjE4NzQ4_3c62140a-8b51-4b6f-997c-e8a58987bfcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd1fd6d108f04354be5ba6979cfef798_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzctMy0xLTEtMjE4NzQ4_a15d2866-2b67-4985-b55e-b4903ff90ef3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280391a88a5f4cfc9ae3305390b982af_I20210331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzctNS0xLTEtMjE4NzQ4_d7aa53a3-c32e-4ce3-8533-f4691d6bcdda">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which stock option compensation cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzgtMS0xLTEtMjE4NzQ4_8c02117a-3d1e-45e4-aed1-31359eb879fe">0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzgtMy0xLTEtMjE4NzQ4_6839e499-8ae9-475c-be6b-3c48cef31a3a">0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzgtNS0xLTEtMjE4NzQ4_414ac21d-dff1-45f0-ba38-f87e9787d422">2</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an ESPP under which <ix:nonFraction unitRef="shares" contextRef="i9d695f8e4fe74cf68dd4c19a1015fbad_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzU0NzU_ef55acc4-fd48-466e-8b5a-b5f6dfd0b7f9">23.1</ix:nonFraction> million shares have been authorized for issuance. The ESPP allows eligible employees to purchase shares of the Company&#8217;s common stock through payroll deductions. The deductions occur over <ix:nonNumeric contextRef="ife447a3b57f0484f98349ca82b7c8778_D20220401-20230331" name="mck:EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0NjA_912ba7b7-8332-4580-aa1f-a1b2752fbcb8">three-month</ix:nonNumeric> purchase periods and the shares are then purchased at <ix:nonFraction unitRef="number" contextRef="ife447a3b57f0484f98349ca82b7c8778_D20220401-20230331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzU3MjE_0aed9bc4-8a18-43cd-b6c8-9d7a91e9f00f">85</ix:nonFraction>% of the market price at the end of each purchase period. Employees are allowed to terminate their participation in the ESPP at any time during the purchase period prior to the purchase of the shares. The <ix:nonFraction unitRef="number" contextRef="ife447a3b57f0484f98349ca82b7c8778_D20220401-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzU5Mjc_3ac04325-da5d-4358-aa3f-dd3d55a08e86">15</ix:nonFraction>% discount provided to employees on these shares is included in compensation expense. The shares related to funds outstanding at the end of a quarter are included in the calculation of diluted weighted-average shares outstanding. These amounts have not been significant for all the years presented. The Company recognizes costs for employer matching contributions as ESPP expense over the relevant purchase period. Shares issued under the ESPP were not material in fiscal 2023, fiscal 2022, and fiscal 2021. At March 31, 2023, <ix:nonFraction unitRef="shares" contextRef="i9d695f8e4fe74cf68dd4c19a1015fbad_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0MTY_27ea7e0e-79b3-4e5c-af4e-9d4fde9cfd27">3.6</ix:nonFraction> million shares remain available for issuance.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_136"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzExNDA_e654b142-8c33-4f3a-8824-425129a32241" continuedAt="i82fa7a2bec244c9b82738dc26c89c0b9" escape="true">Other Income, Net</ix:nonNumeric></span></div><ix:continuation id="i82fa7a2bec244c9b82738dc26c89c0b9" continuedAt="id618b72e963a48489a448300f5075182"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzExNDE_ea1a4f93-a35a-4db2-9bde-cd4f4ad6bc8c" continuedAt="i7d830ae15217488e8ca0b7fabcf21acd" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of the following:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzItMS0xLTEtMjE4NzQ4_8b1d1cc0-e32b-47b3-b345-c6b79d6e58a8">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzItMy0xLTEtMjE4NzQ4_c70a979d-02be-4101-a9f0-f901a019db44">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzItNS0xLTEtMjE4NzQ4_4d33c569-36b7-48dc-9417-24c2e1e612e5">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzMtMS0xLTEtMjE4NzQ4_3d565f6a-1393-4024-9b25-266c758c4024">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzMtMy0xLTEtMjE4NzQ4_360c3ee6-a6ee-45d8-ac3e-72742635c964">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzMtNS0xLTEtMjE4NzQ4_dd1e4eff-0244-452c-adf6-c59fd625e090">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains on investments in equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:EquitySecuritiesFVNIGainLossExcludingImpairmentLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzQtMS0xLTEtMjE4NzQ4_0835701b-8f15-40d7-ac2e-9dcd60caf125">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:EquitySecuritiesFVNIGainLossExcludingImpairmentLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzQtMy0xLTEtMjE4NzQ4_fa700308-aff8-4ae9-a386-3b13611a614d">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:EquitySecuritiesFVNIGainLossExcludingImpairmentLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzQtNS0xLTEtMjE4NzQ4_56dee12c-bb7d-44e0-b0b2-07be9edf601d">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzYtMS0xLTEtMjE4NzQ4_168dbfdc-6d7c-419a-8bde-7cecd3c61476">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzYtMy0xLTEtMjE4NzQ4_2443df1d-b7d6-4cf4-ae8c-a44be8023a98">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzYtNS0xLTEtMjE4NzQ4_7ddc2f81-85e2-406a-a4f1-1943fe38c299">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzctMS0xLTEtMjE4NzQ4_b090377c-3709-4a55-bbc8-e78014d25c64">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzctMy0xLTEtMjE4NzQ4_4a605399-3a6b-4123-81b6-6652080a07da">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzctNS0xLTEtMjE4NzQ4_fee7f93c-a6c1-4b15-acea-d135cb003343">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The increase in interest income for fiscal 2023 compared to fiscal 2022 and fiscal 2021 is primarily due to higher interest rates on certain cash balances.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily recorded within the Company&#8217;s International segment for fiscal 2022 and fiscal 2021. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents net realized and unrealized gains as well as impairment charges on the Company&#8217;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on the disposal of certain of these investments, including a gain of $<ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzU0OTc1NTgxNzI2Nw_b6e0d868-e1ef-40c1-959f-74f2734ad126">142</ix:nonFraction> million for the year ended March 31, 2023 related to the exit of one of the Company&#8217;s investments in equity securities in July 2022 for proceeds of $<ix:nonFraction unitRef="usd" contextRef="i5042c611135944438746cce257499d4f_D20220701-20220731" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzU0OTc1NTgxNzM5MA_107ba45d-634f-4c9d-a932-449a7d528b96">179</ix:nonFraction> million. Refer to Financial Note 15, &#8220;Fair Value Measurements&#8221; for more information on these types of investments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other, net for year ended March 31, 2023 includes the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $<ix:nonFraction unitRef="usd" contextRef="ibee85f1796ce4da18771743ac93a0bf7_D20220401-20230331" decimals="-6" name="us-gaap:GainLossOnContractTermination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzU0OTc1NTgxNTgwOQ_62ff2e1a-4b34-47a8-9244-867614d53ddf">126</ix:nonFraction> million related to a cash payment received for the early termination of a tax receivable agreement (&#8220;TRA&#8221;) exercised by Change Healthcare Inc. (&#8220;Change&#8221;) in October 2022. The Company was a party to a TRA entered into as part of the formation of the joint venture with Change, from which McKesson has since exited. The TRA generally required Change to pay the Company <ix:nonFraction unitRef="number" contextRef="i79fd2475cde549da9b49f44a3b1d5fa7_I20230331" decimals="2" name="mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4Xzg3OTYwOTMwMjU3NzY_9029da24-b907-4323-908c-069837954752">85</ix:nonFraction>% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the amortization allocated to Change by the joint venture. In October 2022, Change exercised its right pursuant to the TRA to terminate the agreement; and </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:GainLossOnDerivativeTermination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzU0OTc1NTgxNjkwMA_fe9c6f0a-a441-4aef-bf86-36e70f4f5a5d">97</ix:nonFraction> million recognized from the termination of certain forward starting fixed interest rate swaps, as discussed in more detail in Financial Note 14, &#8220;Hedging Activities.&#8221;</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other, net for the year ended March 31, 2022 includes a gain of $<ix:nonFraction unitRef="usd" contextRef="idf485190a9674be1a5f6e8cc04f2de3a_D20210401-20220331" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4Xzg2Ng_1736194b-eff7-46d0-86b2-a09f3207edc4">42</ix:nonFraction>&#160;million as part of the completed sale of the Company&#8217;s previously held <ix:nonFraction unitRef="number" contextRef="ie9363c5254cf4b7b9d31529bc982ca01_I20220331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzkzOA_ede4c4d2-2ec5-4208-80d3-f00de9419367">30</ix:nonFraction>% interest in its German pharmaceutical wholesale joint venture to WBA. </span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="id618b72e963a48489a448300f5075182"><ix:continuation id="i7d830ae15217488e8ca0b7fabcf21acd">Other, net for all periods presented also includes income recognized from finance charges to customers primarily for late fees.</ix:continuation></ix:continuation> </span></div><div id="i04335d018da94076b0acf21e81ac886b_139"></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MTg_faf85a8c-7824-4a00-bbc6-1e3c2d0aba41" continuedAt="i5a4e613cdd9b4aa1a2df5e33e1847920" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center"><ix:continuation id="i5a4e613cdd9b4aa1a2df5e33e1847920" continuedAt="i2891a718cca14d96a77e8d4472a329d3"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MjM_76c5df74-1bf6-4de9-afa8-fb4b31f22d33" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzMtMS0xLTEtMjE4NzQ4_6b0d25c6-dd3b-4beb-8f12-954487de8b98">3,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzMtMy0xLTEtMjE4NzQ4_b159efef-1530-4036-810a-5b742c1876d0">1,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzMtNS0xLTEtMjE4NzQ4_d79d0320-fd48-4977-a376-ee63a3b28d75">6,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzQtMS0xLTEtMjE4NzQ4_e1f07082-7274-49af-bea9-4f54e81773cd">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzQtMy0xLTEtMjE4NzQ4_eef34eb2-46d5-45d0-8aa7-ce0309b6a798">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzQtNS0xLTEtMjE4NzQ4_78bc64f6-a33b-4f70-9e64-29eb07bb3d5f">985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzUtMS0xLTEtMjE4NzQ4_86259e68-210c-4f97-8bcd-8480f093c441">4,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzUtMy0xLTEtMjE4NzQ4_56b85967-8105-4e53-9e91-846d690df6da">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzUtNS0xLTEtMjE4NzQ4_202c1742-a142-4f6e-ab17-c53b5f4db6f1">5,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i2891a718cca14d96a77e8d4472a329d3" continuedAt="ic47901fcc14041de971a799f23be216b"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MDA_f9338723-d32a-4b91-bea8-1b139ade9ee0" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) related to continuing operations consists of the following: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except percentages)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzMtMS0xLTEtMjE4NzQ4_fa0539fd-ec0f-44d4-b849-5547f3a3f8bd">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzMtMy0xLTEtMjE4NzQ4_27932efa-7a1c-48b5-b527-596830e7fc67">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzMtNS0xLTEtMjE4NzQ4_862b5a35-9102-4bbc-a1fd-7d28fc0c8cfa">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzQtMS0xLTEtMjE4NzQ4_1bc1d0c0-c9b6-4202-8be2-ee90ad5acad9">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzQtMy0xLTEtMjE4NzQ4_de8533f8-ce48-4fcb-bf73-ef7f42af3615">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzQtNS0xLTEtMjE4NzQ4_f1060d4e-545f-4c5e-a686-e7009eafd650">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzUtMS0xLTEtMjE4NzQ4_96c1d762-6a0e-4062-9532-679a12c15e43">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzUtMy0xLTEtMjE4NzQ4_19eaa021-4578-48a1-8f96-ef082c35e543">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzUtNS0xLTEtMjE4NzQ4_3b5e09bb-f3c0-45b5-b0c2-6c0ec83ac4ed">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzYtMS0xLTEtMjE4NzQ4_7eecb405-54ce-4964-b789-918e83b4ad98">925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzYtMy0xLTEtMjE4NzQ4_dd024b1c-e8b4-43d7-8a45-6123aea21190">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzYtNS0xLTEtMjE4NzQ4_9d91b22b-4dc2-4d33-9eb3-1defc9ac86e6">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzktMS0xLTEtMjE4NzQ4_c3d6d819-974f-47cf-a245-d7939bea22b7">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzktMy0xLTEtMjE4NzQ4_95c826fe-fd73-4360-a946-26a64beeeb70">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzktNS0xLTEtMjE4NzQ4_db721849-612d-47dd-ad11-4825dac10b4a">562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEwLTEtMS0xLTIxODc0OA_c5bef177-a729-45ed-ab19-b370279f0326">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEwLTMtMS0xLTIxODc0OA_bdc01e64-cfc8-40d7-a992-791061f61696">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEwLTUtMS0xLTIxODc0OA_53886e95-72bf-4ec5-ac3a-bed8db28fe6e">204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzExLTEtMS0xLTIxODc0OA_e6d863e1-ab01-4f50-bb64-256de52a3cfb">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzExLTMtMS0xLTIxODc0OA_ab0e1bd1-486d-4516-9c04-80edd46488c7">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzExLTUtMS0xLTIxODc0OA_a859d794-dc99-4d14-bf6c-17158556abdf">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEyLTEtMS0xLTIxODc0OA_700cb5ac-d46d-4f4c-a07d-b4d8345d491e">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEyLTMtMS0xLTIxODc0OA_cea64ac9-a5e6-48ba-be09-490173ac7aa2">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEyLTUtMS0xLTIxODc0OA_54718d47-8db3-429f-9dca-fd4ac227df60">908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEzLTEtMS0xLTIxODc0OA_ed57b9e1-a4ce-4be7-afde-f3ebfbe98aae">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEzLTMtMS0xLTIxODc0OA_06040098-0d12-4f62-a255-fada4b355529">636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEzLTUtMS0xLTIxODc0OA_08d15625-1468-470c-9d48-03457bdf5b65">695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzE0LTEtMS0xLTIzOTU2Ng_d965e5b5-44c2-4b9e-b7a3-e546ecd382b0">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzE0LTMtMS0xLTIzOTU3Nw_5720e447-8cb0-414b-9a28-0dcc456a1543">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzE0LTUtMS0xLTIzOTU4OA_f19f9b37-2922-41d1-9784-bd0eee039d47">13.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the Company&#8217;s reported income tax rates are primarily due to non-cash charges related to remeasuring the value of the E.U. disposal group and U.K. disposal group held for sale to fair value less costs to sell in fiscal 2022, the impact of opioid-related claims, including charges of $<ix:nonFraction unitRef="usd" contextRef="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331" decimals="-8" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzcxNDY4MjU1ODgxNzU_1c07c8a7-f068-4909-91d0-299ecfd7b07b">8.1</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331" decimals="-8" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzcxNDY4MjU1ODgxODA_e7f6302a-2481-4a99-85c4-2fd000ddaacb">6.8</ix:nonFraction> billion after-tax) in fiscal 2021, changes in the mix of earnings between various taxing jurisdictions, and other discrete items recognized in each fiscal year.</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MDE_e116a96c-1728-44fc-90cc-da81dff67f81" continuedAt="i9089284c95de4c9986481db1aca2c883" escape="true"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of <ix:nonFraction unitRef="number" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2NQ_2dcdd17e-c9c8-43cb-a8c6-97fc7c3dd35d"><ix:nonFraction unitRef="number" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2NQ_43f79519-69c8-4770-8331-09886fa4a43f"><ix:nonFraction unitRef="number" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2NQ_54985641-269e-4daa-a236-5e325ea70465">21.0</ix:nonFraction></ix:nonFraction></ix:nonFraction>% to income before income taxes was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzItMS0xLTEtMjE4NzQ4_527002ff-7f92-4902-842d-6898ba2fd583">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzItMy0xLTEtMjE4NzQ4_4f24f8ed-b611-415a-9609-5eb0b6bef747">405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzItNS0xLTEtMjE4NzQ4_d5378366-06ad-435f-abfa-d588e686260a">1,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzMtMS0xLTEtMjE4NzQ4_9c127168-850d-479e-8275-596f4b001702">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzMtMy0xLTEtMjE4NzQ4_987670fd-b9d6-4541-856b-f62b85c8ea42">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzMtNS0xLTEtMjE4NzQ4_0498f273-8696-42ed-a05f-4f40ac96b081">206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzQtMS0xLTEtMjE4NzQ4_12f7e0a7-7a99-4da5-bce3-c22800471b95">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzQtMy0xLTEtMjE4NzQ4_2e045e74-9bbb-4397-9b3c-2ffbbd5f65e0">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzQtNS0xLTEtMjE4NzQ4_79e28580-f740-4f7e-bf47-d45aa5d4536a">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzUtMS0xLTEtMjE4NzQ4_92d1f507-ca88-48a9-b351-075b4cc700d7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzUtMy0xLTEtMjE4NzQ4_b6499a35-4d2a-47b8-bca9-fd5c74e886fe">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzUtNS0xLTEtMjE4NzQ4_a0b93ed6-a1cb-4a30-891b-5a9b2165cac5">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzctMS0xLTEtMjE4NzQ4_23c419db-b9ea-4869-b455-155131f09f34">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzctMy0xLTEtMjE4NzQ4_020b3d3f-66b5-4fdb-a2df-0ec83601000e">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzctNS0xLTEtMjE4NzQ4_c6a9b98a-7fa3-4cfe-b832-8a6cdd9f7897">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax benefit on intellectual property transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzgtMS0xLTEtMjE4NzQ4_b44ccf36-4805-49d3-87f5-5c6628527e9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzgtMy0xLTEtMjE4NzQ4_0fe24583-736f-4b9c-8551-5439732ee1fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzgtNS0xLTEtMjE4NzQ4_a28ce4d8-07fd-46cf-8068-13251b2262d3">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E.U. disposal transaction loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEwLTEtMS0xLTIxODc0OA_259a2efe-1b07-4c8b-a853-43cd750f083a">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEwLTMtMS0xLTIxODc0OA_dacb2261-3daf-41e3-9c36-887627deb91d">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEwLTUtMS0xLTIxODc0OA_565732cc-baf9-4c7b-81d6-0b3d4c6e6dc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEyLTEtMS0xLTIxODc0OA_de50e0c2-9891-4d63-aa43-1a6adb6c39af">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEyLTMtMS0xLTIxODc0OA_5b6d95bd-f2f0-4796-8034-7593d8c777fb">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEyLTUtMS0xLTIxODc0OA_86eb9788-de65-4a79-8ced-3590cb4581b9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEzLTEtMS0xLTIxODc0OA_f154a53a-c43a-4941-b28b-2064d9b03cc7">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEzLTMtMS0xLTIxODc0OA_7a2344cf-17d7-4915-bc70-2ef9b6be78db">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEzLTUtMS0xLTIxODc0OA_64534376-b0de-441c-a0d6-626fab5a12f7">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzE0LTEtMS0xLTIxODc0OA_12aef5e9-7495-4649-8902-81f4e6618415">905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzE0LTMtMS0xLTIxODc0OA_8a485c42-605b-4043-9b87-bb57270e3dbf">636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzE0LTUtMS0xLTIxODc0OA_2877e035-03ad-490a-a325-197bb6e3e69b">695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i9089284c95de4c9986481db1aca2c883" continuedAt="id7b40c198b0e453c93893caf14aa0f30">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="id7b40c198b0e453c93893caf14aa0f30">The Company&#8217;s effective tax rates were impacted by other favorable U.S. federal permanent differences, including research and development credits of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzEwNzQ_2e1e9d80-545d-475d-92f0-8ec92fbf20c9"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzEwNzQ_4442f6ce-ff19-4b74-be08-6a160253f9c4">4</ix:nonFraction></ix:nonFraction> million in each of fiscal 2023 and fiscal 2022, and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzEwODY_868c1d2d-ea19-4ac3-b17a-c4ab6202aa98">5</ix:nonFraction> million in fiscal 2021.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2023, the Company recognized discrete tax benefits primarily consisting of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="mck:EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYwNDczMTM5NzE2MTQ_8b6966c3-7003-480d-a3d8-6e114ee87572">115</ix:nonFraction> million related to statute of limitation expirations and tax settlements in various taxing jurisdictions and $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYwNDczMTM5NzE2MzA_e3d3f9d7-d2ff-4e15-bc9f-b265d55ccd18">58</ix:nonFraction> million related to the tax impact of share-based compensation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2022, the Company recorded non-deductible, non-cash pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="ifc7a65af5b26474e8427ff7f8bd6ce64_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzEyMDA_a9e26b09-ebf0-4d7a-9d0e-5ed844493030">438</ix:nonFraction> million primarily to remeasure the E.U. disposal group to fair value less costs to sell, and $<ix:nonFraction unitRef="usd" contextRef="i7d4a1d2617604c3abf9cdc6b550d8e12_D20210401-20220331" decimals="-8" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzEyODg_79acfd5c-0c19-4cac-b959-496f101f123c">1.2</ix:nonFraction> billion to remeasure the U.K. disposal group to fair value less costs to sell, as described in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ic47901fcc14041de971a799f23be216b" continuedAt="i5dd66f956dd141e6836520eb6566eec6"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rate for fiscal 2022 and fiscal 2021 was impacted by the charge for opioid-related claims of $<ix:nonFraction unitRef="usd" contextRef="ibeefc9d1d76042fbbba383f76527d7a5_D20210401-20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzU0OTc1NTgzMTkxMQ_7adb4d7c-a8d2-4ed6-8684-c7d8758dc39f">274</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="id73f9b34f34c41d6ad73b7db3ed24dfd_D20210401-20220331" decimals="-6" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzU0OTc1NTgzMTkxNg_bab1e474-60ec-4213-bafe-00700876943f">237</ix:nonFraction> million after-tax) and $<ix:nonFraction unitRef="usd" contextRef="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331" decimals="-8" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzU0OTc1NTgzMTkzNQ_1c07c8a7-f068-4909-91d0-299ecfd7b07b">8.1</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331" decimals="-8" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzU0OTc1NTgzMTk0MA_e7f6302a-2481-4a99-85c4-2fd000ddaacb">6.8</ix:nonFraction> billion after-tax), respectively, as described in Financial Note 17, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rate for fiscal 2021 was unfavorably impacted by a non-deductible, non-cash pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="ie2c162cb2b9c417883dd91ccec907c32_D20200401-20210331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzE0OTE_b654fa5a-964d-4382-8ca7-76c8768d9653">58</ix:nonFraction> million, primarily to remeasure the carrying value of assets and liabilities held for sale related to the formation of a German pharmaceutical wholesale joint venture, which the Company exited in fiscal 2022. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; and Financial Note 5, &#8220;Other Income, Net,&#8221; for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gains were eliminated upon consolidation. The acquiring entities of the intellectual property were entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; discrete tax benefits of $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="mck:IncomeTaxExpenseBenefitDiscreteItems" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzU0OTc1NTgzMTExNw_69356793-4fc2-47d0-b528-5565206b0765">105</ix:nonFraction> million were recognized for fiscal 2021, with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#8217;s excess tax basis.</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MTI_3ab5056d-c951-4325-88a7-0b87731bb7d6" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax balances consisted of the following:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable allowances</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzMtMS0xLTEtMjE4NzQ4_f46d154e-cfd8-42f4-89ab-af19e0100dc3">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzMtMy0xLTEtMjE4NzQ4_4a49bdf9-881d-4f4e-a223-8f2fe71cefd8">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:DeferredTaxAssetLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzQtMS0xLTEtMjE4NzQ4_c154f190-1e28-40b0-9533-7da222557949">699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="mck:DeferredTaxAssetLitigationAndClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzQtMy0xLTEtMjE4NzQ4_a4bbb230-5595-4996-ad64-067b61415bb2">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefit related accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzUtMS0xLTEtMjE4NzQ4_5d3578c7-d43c-4de4-98b5-a954c1893cc8">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzUtMy0xLTEtMjE4NzQ4_ded1af54-c5be-42cb-8288-042f38d7b8b9">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzYtMS0xLTEtMjE4NzQ4_7a04175a-67f6-4973-a4e3-3586e67ea75f">760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzYtMy0xLTEtMjE4NzQ4_5c4f41f5-803e-4008-a096-dfd83858032c">739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:DeferredTaxAssetLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzctMS0xLTEtMjE4NzQ4_51ec98e9-f1fe-44e3-a518-c4db65e6a24e">427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="mck:DeferredTaxAssetLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzctMy0xLTEtMjE4NzQ4_5f8142c4-dabc-404f-b79b-e3ac677e9b47">422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzgtMS0xLTEtMjE4NzQ4_fddf3868-4e3d-4617-b25d-18eca8a379b8">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzgtMy0xLTEtMjE4NzQ4_f1a06df9-37c9-474d-8f6a-20e569c7a7db">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzktMS0xLTEtMjE4NzQ4_28be4e55-f217-4066-9119-74120e1105a8">2,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzktMy0xLTEtMjE4NzQ4_5a2ef36b-97ac-4cfc-8678-8815c7991c05">2,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzEwLTEtMS0xLTIxODc0OA_14380c0e-8d87-4b39-8bad-c1fd3ed75436">696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzEwLTMtMS0xLTIxODc0OA_128204a3-50d1-4276-85df-828edfcc9c8d">726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzExLTEtMS0xLTIxODc0OA_11b14126-c059-4ed4-bf2a-65f0d7914a11">1,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzExLTMtMS0xLTIxODc0OA_ca30b610-d0b9-43af-b18c-eccf681d69f5">1,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory valuation and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzEzLTEtMS0xLTIxODc0OA_1c224bb4-b3bb-4477-b24a-7394186ef523">2,079</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzEzLTMtMS0xLTIxODc0OA_cc9d4842-dc8a-447f-bdf8-8309fd51a1d9">1,993</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets and systems development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE0LTEtMS0xLTIxODc0OA_83fbcbc9-c51c-49ea-9b0d-25611849db6e">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE0LTMtMS0xLTIxODc0OA_74d91ee7-f6f1-4903-87a1-05366490d3f1">184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE1LTEtMS0xLTIxODc0OA_c9437577-a979-4c8e-a53a-feede0ec9382">267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE1LTMtMS0xLTIxODc0OA_1f0bcb44-020e-4cbd-b527-a28269312ffa">233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:DeferredTaxLiabilitiesLeaseRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE2LTEtMS0xLTIxODc0OA_294e7212-e6ea-40ac-b1c7-362e686307c3">412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="mck:DeferredTaxLiabilitiesLeaseRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE2LTMtMS0xLTIxODc0OA_8e491c05-0a8a-4e2c-90fc-139596b0f4fc">401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE3LTEtMS0xLTIxODc0OA_c7226bab-7003-4cb5-934d-fa6db0462699">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE3LTMtMS0xLTIxODc0OA_52e43a59-b28a-43e9-a7dd-7f294cf2c95a">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE4LTEtMS0xLTIxODc0OA_0c9094b0-b546-41f4-b255-c1ebaf9beb6b">2,809</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE4LTMtMS0xLTIxODc0OA_9c4b7f13-dc81-407b-829e-45cc07bff7ff">2,828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE5LTEtMS0xLTIxODc0OA_6ab69a97-0abf-4b8d-9331-7e54a3a5fbab">1,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE5LTMtMS0xLTIxODc0OA_0604ba6a-a41f-4c73-a477-6a9826f92632">1,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIxLTEtMS0xLTIxODc0OA_8902e9cb-139b-4255-b822-56dc1b5b7291">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIxLTMtMS0xLTIxODc0OA_d4ef5749-0acd-4127-bd58-8e42803335d4">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIyLTEtMS0xLTIxODc0OA_3f178217-4ff0-4556-9c7c-77650bfd8b7a">1,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIyLTMtMS0xLTIxODc0OA_337e8208-ae79-432a-bb1b-7a8ce3582e89">1,418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIzLTEtMS0xLTIxODc0OA_3df564a5-9265-4d18-82fd-d7f4385c0abd">1,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIzLTMtMS0xLTIxODc0OA_ce516a60-8344-42fd-a1db-c35bc583e3b6">1,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i5dd66f956dd141e6836520eb6566eec6" continuedAt="i26c66488978443cdaf1faec045ad6e29"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the available positive and negative evidence to determine whether deferred tax assets are more likely than not to be realized.&#160;As a result of this assessment, valuation allowances have been recorded on certain deferred tax assets in various tax jurisdictions.&#160;The valuation allowances were approximately $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzM3NzI_14380c0e-8d87-4b39-8bad-c1fd3ed75436">696</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzM3Nzk_128204a3-50d1-4276-85df-828edfcc9c8d">726</ix:nonFraction> million in fiscal 2023 and fiscal 2022, respectively, and primarily relate to net operating and capital losses incurred in certain tax jurisdictions for which no tax benefit was recognized. The decrease in the valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzM5ODk_fa25ed50-80ee-46a8-b5c0-40cf2b9e9fce">30</ix:nonFraction> million in the current fiscal year relates primarily to the remeasurement of foreign loss carryforwards and their related valuation allowance for foreign exchange fluctuations, partially offset by the net operating losses incurred and deferred tax movements in certain tax jurisdictions for which no tax benefit was recognized. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has federal, state, and foreign net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ibf6fd4d81f1f416290d250974ba098e2_I20230331" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQzODU_092a0cd9-361e-43bc-9c47-cc9da7f44b77">49</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i3d415447fbd94360ba64460c62a0a537_I20230331" decimals="-8" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQzODk_38e55c17-f94f-4826-84f4-a70d244f4eb4">3.4</ix:nonFraction> billion, and $<ix:nonFraction unitRef="usd" contextRef="i3a85db8cbb4b46c1b80086fe84b2ad90_I20230331" decimals="-8" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQzOTc_3614f840-b373-42f5-bbcc-8865934370a7">2.0</ix:nonFraction> billion at March 31, 2023, respectively. Federal and state net operating losses will expire at various dates from 2024 through 2043. Substantially all its foreign net operating losses have indefinite lives. In addition, the Company has foreign capital loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i3af290b74f9b45468794a2c3907f33d0_I20230331" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQ2NTA_7c329120-a5b6-44d1-8c43-626dadb228e8">701</ix:nonFraction> million with indefinite lives. </span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MDg_68ba88e7-ca4a-4cab-912c-bf8ae93200ef" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits for the last three fiscal years:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzItMS0xLTEtMjE4NzQ4_be343d98-0bf4-418d-a02d-33ae48d1b660">1,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzItMy0xLTEtMjE4NzQ4_464f3e12-36ae-4a23-91ea-72357d602f6d">1,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ca92db1bf347039646a68953e87fed_I20200331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzItNS0xLTEtMjE4NzQ4_2afc828d-f87d-4dc9-832a-7237f355edab">958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzMtMS0xLTEtMjE4NzQ4_34412307-c339-4489-8e0b-cebbb5a20651">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzMtMy0xLTEtMjE4NzQ4_7490362e-7c95-404d-b139-48085d3bd04c">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzMtNS0xLTEtMjE4NzQ4_07760c3a-4095-4a71-9bb2-635378bc562e">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzQtMS0xLTEtMjE4NzQ4_f641a64e-2748-44fc-ba1c-da9c01bc8f3a">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzQtMy0xLTEtMjE4NzQ4_0f9c3557-774a-42d2-afbf-33e2393aaee7">131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzQtNS0xLTEtMjE4NzQ4_475877da-9298-46b9-9460-edfe98781fc2">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzUtMS0xLTEtMjE4NzQ4_4973b827-caa7-4adb-92e2-998a5d4af2ef">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzUtMy0xLTEtMjE4NzQ4_0aaaf7cb-dc6b-4b42-a544-1bd303804267">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzUtNS0xLTEtMjE4NzQ4_008482a7-5f15-41d0-85e5-d62c9abd23b0">755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzYtMS0xLTEtMjE4NzQ4_19fc333a-adf6-48ee-b2ac-08a2fc4d12b9">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzYtMy0xLTEtMjE4NzQ4_0d1c0216-6b64-490a-a4cd-0b56520abf65">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzYtNS0xLTEtMjE4NzQ4_34a4d57c-bf0a-435b-857a-013a7543772d">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on the lapse of the applicable statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzctMS0xLTEtMjE4NzQ4_7c0dd5f1-0625-4624-ae3c-8058f220d06f">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzctMy0xLTEtMjE4NzQ4_c8b61c5e-3ef6-4dd2-9403-b2f6e9c5dda7">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzctNS0xLTEtMjE4NzQ4_22997d88-4ea6-4b8b-8f9f-ef0806c1d2e2">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzgtMS0xLTEtMjE4NzQ4_ae952341-3681-4a53-bbe1-c44a145791f3">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzgtMy0xLTEtMjE4NzQ4_1f4d882d-baf7-4af8-8336-be9a52771a40">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzgtNS0xLTEtMjE4NzQ4_46cc73f3-2119-4347-a2d7-80f33d58cde2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzktMS0xLTEtMjE4NzQ4_8f8cf1b4-ff54-430a-bd4f-a844e7c9437a">1,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzktMy0xLTEtMjE4NzQ4_38bdf6e0-559b-4862-be05-bbc8de7adac2">1,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzktNS0xLTEtMjE4NzQ4_9f9ec11f-9e8b-46a1-954b-9c75e84f39c4">1,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company had $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQ4MzI_46383c3a-9ec0-4cc0-9202-31c3bcf95dff">1.4</ix:nonFraction> billion of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQ4NzQ_c2561315-ff03-4c96-a085-a99074b7692b">1.3</ix:nonFraction> billion would reduce income tax expense and the effective tax rate, if recognized. The decreases in unrecognized tax benefits in each fiscal year are primarily attributable to statute of limitation expirations in various taxing jurisdictions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the next twelve months, the Company does not expect any material reduction in its unrecognized tax benefits. However, this may change as the Company continues to have ongoing discussions with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 17, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, the Internal Revenue Service (&#8220;IRS&#8221;) communicated proposed adjustments to taxable income reported in the Company&#8217;s fiscal 2018 and fiscal 2019 U.S. Federal Corporate Income Tax returns. The adjustments would increase federal income tax liability in the range of $<ix:nonFraction unitRef="usd" contextRef="i925b096ac7224e21909543318e72b500_I20230331" decimals="-6" name="mck:IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYwNDczMTM5ODMzMjE_a531c79c-0b34-4f32-9d38-d14276d093ce">600</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="ied7b454e7843455ab8ab7494918c2873_I20230331" decimals="-6" name="mck:IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYwNDczMTM5ODMzMjg_aff10fa6-4327-4420-8efa-ec05f208a675">700</ix:nonFraction>&#160;million. The Company disagrees with the proposed adjustments and intends to pursue resolution through the administrative process with the IRS Independent Office of Appeals and, if necessary, through judicial remedies. The Company expects it could take several years to reach a final resolution on these matters. Although the final resolution of these matters is uncertain, the Company believes in the merits of its tax positions and believes that it has adequately reserved for any adjustments to the provision of income taxes that may ultimately result. However, if the IRS prevails in these matters, the assessed tax and interest, if any, could have a material adverse effect on the Company&#8217;s financial position, results of operations, and cash flows in the period of resolution.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports interest and penalties on income taxes as income tax expense. It recognized income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYzMTk_4c327115-6c48-4c3e-acdb-c4eb3d129a9a">31</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYzMjM_60252a06-58cd-440f-bec8-b9ae99bb4771">8</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYzMzE_8fd23c07-c245-492d-8c09-3470f1001c53">9</ix:nonFraction> million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively, representing interest and penalties, in its Consolidated Statements of Operations. As of March 31, 2023 and 2022, the Company accrued cumulatively $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzY0Nzg_fd944c49-6257-419a-8273-ada89dd01fcd">138</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzY0ODU_74ecc0b7-b5b5-423c-ba80-af73987b0133">108</ix:nonFraction>&#160;million, respectively, in interest and penalties on unrecognized tax benefits in its Consolidated Balance Sheets.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i26c66488978443cdaf1faec045ad6e29"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal 2015 through the current fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign operations of approximately $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzcwNzM_226b9d32-3bf0-4c96-b5be-2814a3e34574">4.8</ix:nonFraction> billion were considered indefinitely reinvested at March 31, 2023. Following the enactment of the 2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. However, the repatriation of cash held outside the U.S. could be subject to applicable foreign withholding taxes and state income taxes.&#160;The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so. It does not expect the tax impact from remitting these earnings to be material.</span></div></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_142"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQ3NDY_f8fd2272-554c-4a20-971f-d2ad2a02ed7e" continuedAt="i9945612e156a4e1c8b6d1d2bc8bc9e4c" escape="true">Redeemable Noncontrolling Interests and Noncontrolling Interests</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9945612e156a4e1c8b6d1d2bc8bc9e4c" continuedAt="i077dbeeb38fa4469b8545c25d60f6c3b"> </ix:continuation></span></div><ix:continuation id="i077dbeeb38fa4469b8545c25d60f6c3b" continuedAt="ib2c40d9bc5674d9aa259f12419c73a9f"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s previously recognized redeemable noncontrolling interests primarily related to its former consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="ia0d9f68e5c994bf59aeea678b50b65af_I20141231" decimals="2" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzM4OA_94271ac1-eef6-4e2e-a18c-5e9af814abbe">0.83</ix:nonFraction> per share. The Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $<ix:nonFraction unitRef="usd" contextRef="i85eec0525fe24f99b37fe1b51e6c5a23_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzE2NDkyNjc0NDY0MTc_2ef3578e-9625-4f40-b35c-1ef396d4fce9">8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3133b1be91fc45ce9e09a9108d5d72ff_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzU2Mg_467e21af-5582-4af5-9ba2-240e348bf127">43</ix:nonFraction> million for the years ended March 31, 2022 and 2021, respectively. All amounts were recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Consolidated Statements of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="id814aee4543a4f3b8149ab5107886aa3_I20141231" decimals="2" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzkyMw_4f042bbe-b62f-4ecd-9b87-82adb1363035">22.99</ix:nonFraction> per share, increased annually for interest in the amount of <ix:nonFraction unitRef="number" contextRef="i629eed48f7a6425b99da3d0911202452_I20141231" decimals="INF" name="mck:PutRightValueInterestRateSpread" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1Xzk4Ng_d07fba94-7030-4cba-8b15-f337d838755d">five</ix:nonFraction> percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Domination Agreement&#8217;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#8220;Appraisal Proceedings&#8221;) with the Stuttgart Regional Court to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified in the Domination Agreement. On September 19, 2018, that court ruled that the Put Amount shall be increased by &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i64073e3798b24140a877b78902322039_D20180919-20180919" decimals="2" name="mck:NoncontrollingInterestsPutRightExercisePriceIncrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzE3MjE_178538c9-67a1-450a-a1ac-182c87d32c36">0.51</ix:nonFraction> resulting in an adjusted Put Amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i1f2d9133245747b1a400a98a3daea68f_I20180919" decimals="2" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzE3NjM_6df47f5f-7e82-4c69-b4e6-b659e2067639">23.50</ix:nonFraction>. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount remained at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i42752d505455466fbf8fbf4f49c40afc_I20210412" decimals="2" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzIxMjE_7a588282-e5e9-4243-baae-6b82afdacd20">22.99</ix:nonFraction>, thereby rejecting the lower court&#8217;s increase, and the recurring compensation remained at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i9dc0714e08b14ba2814d733ed7fd0102_I20210412" decimals="2" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzIyMTQ_125d2378-03b1-4b67-a8c6-4c68036de74f">0.83</ix:nonFraction> per share.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercises of the Put Right reduced the balance of redeemable noncontrolling interests. The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income or loss, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022 and fiscal 2021, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i85eec0525fe24f99b37fe1b51e6c5a23_D20210401-20220331" decimals="-8" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI1ODI_c4413d65-37be-4457-9502-9d7bcb1bb503">1.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i3133b1be91fc45ce9e09a9108d5d72ff_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI1ODk_c7e699d2-294e-43ca-b3b5-838dbfa51e2e">49</ix:nonFraction> million, respectively, to purchase <ix:nonFraction unitRef="shares" contextRef="i85eec0525fe24f99b37fe1b51e6c5a23_D20210401-20220331" decimals="-5" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI2MTk_3002bbe7-2875-427a-8960-5965f8007800">34.5</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="i3133b1be91fc45ce9e09a9108d5d72ff_D20200401-20210331" decimals="-5" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI2MjY_9a8b0f43-1191-49b8-9992-45a2b6a8e78b">1.8</ix:nonFraction>&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the redeemable noncontrolling interests by $<ix:nonFraction unitRef="usd" contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzE2NDkyNjc0NDY0NjE_6ff86b03-d0b5-44f3-b909-cbf28d8f0c4d">983</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI4MTc_ba24af5d-463a-40ad-823e-7dbf6f587341">49</ix:nonFraction>&#160;million, respectively, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $<ix:nonFraction unitRef="usd" contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI5Mzc_8e065323-9008-4162-ad90-5b1e418b3f88">178</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI5NDQ_a37434a5-89d7-4ce6-a530-03807de4e94d">3</ix:nonFraction> million, respectively, as an increase to McKesson stockholders&#8217; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331" decimals="-6" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzE2NDkyNjc0NDY0NzA_57382aa4-92e5-4c86-bb39-86418eafc691">287</ix:nonFraction> million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; in the Consolidated Balance Sheet.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ib2c40d9bc5674d9aa259f12419c73a9f"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE, Vantage, and SCRI Oncology. As discussed above, after June 15, 2021, noncontrolling interests also represented minority shareholder equity interests in McKesson Europe and at March 31, 2022, the Company owned approximately <ix:nonFraction unitRef="number" contextRef="i702ec37556b84e119a5f3bb8522ed174_I20220331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzU0OTc1NTgyMDg1MQ_eb0828d3-3e0c-45c2-9bf7-68465ac8d2bd">95</ix:nonFraction>% of McKesson Europe&#8217;s outstanding common shares. The Company&#8217;s noncontrolling interest in McKesson Europe was included in the divestiture of the E.U. disposal group in October 2022, as discussed in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests in the Company&#8217;s Consolidated Balance Sheets were $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQxOTY_4b8ac458-9934-4c78-a19c-988b29904ac5">367</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQyMDM_d11cf834-ae48-46e9-995b-68179adccdfc">480</ix:nonFraction> million at March 31, 2023 and 2022, respectively. For the years ended March 31, 2023, 2022, and 2021, the Company allocated a total of $<ix:nonFraction unitRef="usd" contextRef="idbd55a5a04e24729999d4fa3eb8ae352_D20220401-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQ1MzA_90248959-15e8-4ff7-9e35-f1e4863f566b">162</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="if79bf94dc2504cb2a88b82abdd979b19_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQ1MzQ_7a9b0941-baa2-46f5-b3a8-32ea53e688e8">165</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="icf838c191f224e90921deb0c9dd4d8b0_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQ1NDI_f31831f2-039d-4db4-adca-45d8edcca1ed">156</ix:nonFraction> million of net income to noncontrolling interests, respectively.</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQ3NDU_9adae30f-a965-464b-a202-421ff2fecba9" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March 31, 2023, 2022, and 2021 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28949ffb8bb2424c94e02d81ae0b5d27_I20200331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEtMi0xLTEtMjE4NzQ4_0148e247-109e-4962-9fc0-0213d827d15a">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c0a87d5a109411fae8be9b302d9a229_I20200331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEtNC0xLTEtMjE4NzQ4_1ba084e7-5cc8-4c02-bb98-17257fb3c82f">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzItMi0xLTEtMjE4NzQ4_9169b96a-c2ad-4f26-9ef8-70a95cbbf9db">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzItNC0xLTEtMjE4NzQ4_210541cc-5572-4286-afce-612d0a513570">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzMtMi0xLTEtMjQzMDU4_b256cb28-75d1-4b5f-874e-d5bb7e6f2273">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzMtNC0xLTEtMjQzMDU4_2fc82789-43f2-4a9f-9263-e6ec49488596">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzMtMi0xLTEtMjQzMDM2_2bbaa97e-286e-4824-85db-90ed7dd3b949">177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzMtNC0xLTEtMjQzMDM2_5725cf7d-cb41-46f3-acee-42652f9a9358">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzQtMi0xLTEtMjQzMDQ2_530bcbc7-99b8-4976-979f-99305ad21392">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzQtNC0xLTEtMjQzMDQ2_bc69704a-d921-4948-9104-6c97749dabb9">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzYtMi0xLTEtMjIzOTIz_b6bc48c5-9fb9-4eb9-b738-777a6ec2a85a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzYtNC0xLTEtMjIzOTMx_fe55a433-8888-43ad-96c9-992b4c7aa863">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzYtMi0xLTEtMjE4NzQ4_8b03d5cb-bd9e-4060-acf6-92e4f6ebd692">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzYtNC0xLTEtMjE4NzQ4_5a1c852b-37de-47b4-8ca0-01675729d9de">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7ccb4f8144bea8f3d6c3af844c49d_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzctMi0xLTEtMjE4NzQ4_18f5fb41-fa1c-48e9-951c-f6ad22534ee0">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60796f3f508f4327a4e738afb42dcf8b_I20210331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzctNC0xLTEtMjE4NzQ4_2923d1f0-83ef-45cd-91e3-15deb9d4f319">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzgtMi0xLTEtMjE4NzQ4_eb1fbe94-dc6a-414f-9629-85a287f6b0aa">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzgtNC0xLTEtMjE4NzQ4_2d80a004-f326-43f0-8ca6-c07d3944a438">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzktMi0xLTEtMjE4NzQ4_a40feb1d-a44e-4cb8-8d45-2fdd154b75de">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzktNC0xLTEtMjE4NzQ4_9d9827d5-0461-4414-aeb9-c920f205d499">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzExLTItMS0xLTI0MzA3MA_0e095fd2-5935-4c97-bedf-5ac1306aa8c6">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzExLTQtMS0xLTI0MzA3MA_3baf23ab-bff6-4f16-a1ee-55f367eb6600">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEwLTItMS0xLTIxODc0OA_510b81aa-b6d4-4599-ae78-30ae254e5f5e">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEwLTQtMS0xLTIxODc0OA_efa681e6-835f-45e3-896c-ee8b47750ba5">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEyLTItMS0xLTIxODc0OA_7d11c343-c36d-4c14-9cf7-dd3b849c8024">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEyLTQtMS0xLTIxODc0OA_6ff86b03-d0b5-44f3-b909-cbf28d8f0c4d">983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE0LTItMS0xLTI0MjgzOQ_82962702-166b-4f2a-9f78-34a79c6d6172">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331" decimals="-6" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE0LTQtMS0xLTI0Mjg0Mg_57382aa4-92e5-4c86-bb39-86418eafc691">287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEzLTItMS0xLTIxODc0OA_3aff9a70-8206-4762-b0fe-bc609bc02840">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEzLTQtMS0xLTIxODc0OA_947aa2b3-8c61-4bcb-8727-e3b6f6c85d82">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i967edbc39aee4ecb80a07170518c493d_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE0LTItMS0xLTIxODc0OA_91396ce9-42e5-48fa-9be8-f38c4ac044e5">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf2274fbdb7410f92df8d07c6a7f201_I20220331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE0LTQtMS0xLTIxODc0OA_c4c3804c-6ecd-4966-8dce-f8d75904e0ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE1LTItMS0xLTIxODc0OA_de18768f-fd7e-4efd-8e50-8b2993c89700">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE1LTQtMS0xLTIxODc0OA_6524eb31-b5ce-4b15-8029-bc37f966ac16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE2LTItMS0xLTIxODc0OA_473d3db5-1e12-46e7-9938-d06e73dc5ffb">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE2LTQtMS0xLTIxODc0OA_afb4fa37-da3a-4072-b5b3-983cefd553dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE5LTItMS0xLTI0MzA3NQ_ef20441d-d6d6-489e-939d-7a9c3ac4d01a">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE5LTQtMS0xLTI0MzA3NQ_2637678c-a406-4ccf-82ab-387a7b58bb7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE3LTItMS0xLTIxODc0OA_59bef57a-ef5a-4e41-97e2-a8064dc636f5">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE3LTQtMS0xLTIxODc0OA_19800b2b-9119-494a-a6f0-013a6735252c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Formation of SCRI Oncology</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="mck:FormationOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE4LTItMS0xLTIxODc0OA_ceaa4f74-0a2f-4806-9dc1-e96c3de24254">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331" decimals="-6" name="mck:FormationOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE4LTQtMS0xLTIxODc0OA_6e330c5d-9ced-45fd-888b-fcabfe05de22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derecognition of noncontrolling interests in McKesson Europe</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" name="mck:DerecognitionOfNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIyLTItMS0xLTI0MzYzNA_2e8a98ad-35b7-4008-bf4b-f4a1993d8747">382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331" decimals="-6" name="mck:DerecognitionOfNoncontrollingInterests" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIyLTQtMS0xLTI0MzYzOA_2ee31d7e-9040-4490-9325-17a08c220742">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIxLTItMS0xLTIxODc0OA_1992b068-39e1-4cda-8350-73cf47524037">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIxLTQtMS0xLTIxODc0OA_39c6b3c1-6a69-46d6-806e-186c208df7c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></div></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf262331a9f54dcaa1ab7d2f24876767_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIyLTItMS0xLTIxODc0OA_7ab34ffe-6f2f-49db-9a2c-3e2d9c8e73d3">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f0ee99639740adb0c22db01af096ac_I20230331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIyLTQtMS0xLTIxODc0OA_d39e9229-d7f8-477d-97e6-597e15dc2cb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_145"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90ZXh0cmVnaW9uOjI4NzdjYjI1NTYzNjRlY2FiYTA2Nzc1N2NlMDA5ODk2XzEyNjI_98e6cef4-ce7e-4c30-b249-2711885c67e6" continuedAt="i8727ed22923c4326a85e3fa452ae5226" escape="true">Earnings (Loss) Per Common Share</ix:nonNumeric></span></div><ix:continuation id="i8727ed22923c4326a85e3fa452ae5226" continuedAt="i32822a3ae98948b1ba3b4474c96e9bee"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted loss per common share for the year ended March 31, 2021 was calculated by excluding all dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Less than <ix:nonFraction unitRef="shares" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90ZXh0cmVnaW9uOjI4NzdjYjI1NTYzNjRlY2FiYTA2Nzc1N2NlMDA5ODk2Xzg3OTYwOTMwMjM2Njc_2f6f60ce-b918-4886-a339-d767253f5179"><ix:nonFraction unitRef="shares" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90ZXh0cmVnaW9uOjI4NzdjYjI1NTYzNjRlY2FiYTA2Nzc1N2NlMDA5ODk2Xzg3OTYwOTMwMjM2Njc_b81bbeb4-810c-47e2-9e4f-ddeec604f053">1</ix:nonFraction></ix:nonFraction>&#160;million of potentially dilutive securities for fiscal 2023 and fiscal 2022 were excluded from the computation of diluted earnings (loss) per common share as they were anti-dilutive.</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90ZXh0cmVnaW9uOjI4NzdjYjI1NTYzNjRlY2FiYTA2Nzc1N2NlMDA5ODk2XzEyNTI_9d05a324-b288-45a3-acb5-3ca25431736d" continuedAt="i49369c5bcdf34ee9b0af5c4cf1546e73" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share were as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzItMS0xLTEtMjE4NzQ4_77827422-81b3-43b7-8f57-68ca9128ea54">3,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzItMy0xLTEtMjE4NzQ4_b76e4c3f-0b78-482c-a428-a67d1ec059d2">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzItNS0xLTEtMjE4NzQ4_0b6785f6-f895-40ee-9f70-a5ad87010a57">4,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzMtMS0xLTEtMjE4NzQ4_125d6867-c7bb-49eb-a1a3-370037d0d389">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzMtMy0xLTEtMjE4NzQ4_6fddf77f-7142-4171-bfb6-0aa54453eb2b">173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzMtNS0xLTEtMjE4NzQ4_03216d8f-2668-4e3d-904b-0b8233224654">199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzQtMS0xLTEtMjE4NzQ4_1540e0f1-012e-40d3-9800-2a33fbb21cf5">3,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzQtMy0xLTEtMjE4NzQ4_677a09c5-2d5d-48e8-ae46-4bd522dd624a">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzQtNS0xLTEtMjE4NzQ4_3cf876f8-2b96-46d2-b517-575f830acb5d">4,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzUtMS0xLTEtMjE4NzQ4_bf6e8281-791f-48b6-92da-3bbfeecff5d9">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzUtMy0xLTEtMjE4NzQ4_2a6f8af8-6a4f-4b36-ab0a-b9f5183256fc">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzUtNS0xLTEtMjE4NzQ4_5703f260-7d58-4984-82a0-99b3f1ce1903">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzYtMS0xLTEtMjE4NzQ4_dabfd3ed-9f3f-4a68-8f63-293f28b55741">3,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzYtMy0xLTEtMjE4NzQ4_c04d4ff7-f4bf-43c7-ac9d-fe6c550e06f2">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzYtNS0xLTEtMjE4NzQ4_3ea5a8de-dd83-4ad6-b6f0-e172454c8c72">4,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzktMS0xLTEtMjE4NzQ4_63987e7e-c5a2-4f4b-a4af-8c940f776771">141.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzktMy0xLTEtMjE4NzQ4_346cfb52-4e12-4801-80a3-d63b13be8f7a">152.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzktNS0xLTEtMjE4NzQ4_dab16532-d183-4129-968f-232acc0c7989">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzExLTEtMS0xLTIxODc0OA_fc5b0d2e-aa75-4d2f-a543-e7ba301b92d2">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzExLTMtMS0xLTIxODc0OA_6c53e621-313f-4fb2-b36b-cfd3fa9ec6b0">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzExLTUtMS0xLTIxODc0OA_46a49c21-7c3e-46df-a1da-3abc1806e71b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f6f943ac64c470b961d73cf2c5fbcf3_D20220401-20230331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEyLTEtMS0xLTIxODc0OA_e0466eb3-5c7c-4d36-b07d-a683756dbf4b">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic06aa85305f44c8fbb86fb2d2319293a_D20210401-20220331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEyLTMtMS0xLTIxODc0OA_af4b09e2-958b-465d-a353-adf56679b409">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9556991f875d4713b5b62bb435eaf7d2_D20200401-20210331" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEyLTUtMS0xLTIxODc0OA_b2c3a809-badf-4e92-a03d-ccd3951d580d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEzLTEtMS0xLTIxODc0OA_bfcd4b07-ffc3-4422-ada5-4fae475a0281">142.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEzLTMtMS0xLTIxODc0OA_54025fc7-b541-4741-bf9d-f75d468b261a">154.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEzLTUtMS0xLTIxODc0OA_ba2a0d45-238f-49e6-8642-c65cdaa829a4">160.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE3LTEtMS0xLTIxODc0OA_f1ed569b-4874-4e3f-b940-86d5d8dec1c9">25.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE3LTMtMS0xLTIxODc0OA_c421eb54-8a09-4220-902c-21f1fedbf7ac">7.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE3LTUtMS0xLTIxODc0OA_0342bc02-10b4-4eeb-a410-3073a6edeaef">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE4LTEtMS0xLTIxODc0OA_dc922598-b165-4f22-b0ed-b6cd609ff0ed">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE4LTMtMS0xLTIxODc0OA_420f25bf-dbf4-40a0-9b1b-20c08ccfbe9a">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE4LTUtMS0xLTIxODc0OA_5e9b3a26-0cb1-4311-b816-de34bccd174e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE5LTEtMS0xLTIxODc0OA_bd53816f-9e27-4cd9-847a-36ee9464f721">25.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE5LTMtMS0xLTIxODc0OA_91cac982-269f-444a-8af3-3ca10397e0cb">7.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE5LTUtMS0xLTIxODc0OA_d4363379-8562-4757-85e6-a1c09d2a815e">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIxLTEtMS0xLTIxODc0OA_8ec39aef-fb9d-446c-af89-b5723d47cee9">25.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIxLTMtMS0xLTIxODc0OA_e35aed27-656c-4e40-a1e8-afcf5ed43773">7.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIxLTUtMS0xLTIxODc0OA_6779aee3-1575-47ad-b080-a7237553ee0a">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIyLTEtMS0xLTIxODc0OA_034f36e8-a968-4143-8766-d299bb1dfde9">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIyLTMtMS0xLTIxODc0OA_715f2c38-d396-4876-b3b9-c6a8a1b06422">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIyLTUtMS0xLTIxODc0OA_27e53612-a19a-4b05-98b0-024a2838b851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIzLTEtMS0xLTIxODc0OA_6d497f9e-7796-4496-978a-43861e9aab22">25.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIzLTMtMS0xLTIxODc0OA_ac2153d3-530a-481a-9809-180ccb991b3e">7.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIzLTUtMS0xLTIxODc0OA_a587512c-2dfe-4d6e-9f5a-c1cc4eba518f">28.26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i32822a3ae98948b1ba3b4474c96e9bee" continuedAt="i4b323b7eea2041cabe2f2027ccebfd91"><ix:continuation id="i49369c5bcdf34ee9b0af5c4cf1546e73" continuedAt="i847b6e1d8c854f0bbd2b9daa6e0c2e1c">(2)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"><ix:continuation id="i4b323b7eea2041cabe2f2027ccebfd91"><ix:continuation id="i847b6e1d8c854f0bbd2b9daa6e0c2e1c">Certain computations may reflect rounding adjustments.</ix:continuation></ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_148"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5OTg_720ee3ae-bc02-4f44-8462-ddcbff3bc399" continuedAt="i0830a80c982e4ebab2bb0c0fb02201b0" escape="true"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:LessorDirectFinancingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5OTk_541cee0b-724d-4531-973f-d8efff948390" continuedAt="ie0997b404c8e4f9d81da22cc7904cbe2" escape="true"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:LessorSalesTypeLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5OTk_97f21d53-016b-489a-b9da-d3f33e0f66ab" continuedAt="i40edd28993f947b597e6e7c1dfa47817" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i0830a80c982e4ebab2bb0c0fb02201b0" continuedAt="i389cec4ffa50437d8a7344c293acbb35"><ix:continuation id="ie0997b404c8e4f9d81da22cc7904cbe2" continuedAt="iafe8b59140794bc09b8365e947faba85"><ix:continuation id="i40edd28993f947b597e6e7c1dfa47817" continuedAt="i03272c021ec34f4799fadc21d42f9bcf"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5ODc_a95e1e01-dc37-40ff-97c4-c0c9ce415a4d" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzQtMS0xLTEtMjE4NzQ4_4f3a6730-5e46-40a1-b983-e0e76d41221b">1,635</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzQtMy0xLTEtMjE4NzQ4_16b6c587-ad9a-4d0d-99cc-af8ae1328e0a">1,548</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzYtMS0xLTEtMjE4NzQ4_99f6e103-ecaa-4cef-89d4-a295d7fea2a6">299</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzYtMy0xLTEtMjE4NzQ4_7f868f31-7581-4479-834e-24155d9596a8">297</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzctMS0xLTEtMjE4NzQ4_aba8b46f-8953-4752-9861-f9089d4cc9c8">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzctMy0xLTEtMjE4NzQ4_5fd6e441-adba-4cbb-a24b-33e01305da57">1,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzgtMS0xLTEtMjE4NzQ4_e677a168-03ef-490b-b383-bd6eebe4a79e">1,701</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzgtMy0xLTEtMjE4NzQ4_8a1ae4d5-41b8-4e7b-838e-7b6135ebf470">1,663</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2cb43d7d-4dbe-40be-891b-5b154c0f7e7e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2e8bafc9-a699-4ad1-a382-140d4fabd947">Property, plant, and equipment, net</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTEtMS0xLTIxODc0OA_54df4485-9b1c-48bc-8dd0-9635f7543637">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTMtMS0xLTIxODc0OA_419d4bcb-abe5-4764-a88a-64ea7ae16846">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_481d8594-6d0e-48c4-a516-41181b6ee1a8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_b132aa89-d101-44a4-8856-5a1aefc7a3ca">Current portion of long-term debt</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTEtMS0xLTIxODc0OA_e17218b0-b189-4b7e-a067-e3eb0f5d5cad">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTMtMS0xLTIxODc0OA_1d61c22c-0f88-40e0-aa3b-c28ac0d3e22e">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_9a3e0520-2b32-4c2a-8b14-f87e23310cf5"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_fbb0bd27-adff-497f-b17f-ffe770574fee">Long-term debt</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTEtMS0xLTIxODc0OA_88ff613e-4419-4974-b7c2-7b3e13a16667">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTMtMS0xLTIxODc0OA_c1545082-b685-497f-8338-b77305a33674">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE1LTEtMS0xLTIxODc0OA_43e3353c-3d75-41a5-b32d-62ab680e6103">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE1LTMtMS0xLTIxODc0OA_351dc062-64cf-4d9a-b4d0-c7918b359a0c">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE4LTEtMS0xLTIxODc0OA_271ed771-f1e8-4b90-a606-42e37994ae1f">6.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE4LTMtMS0xLTIxODc0OA_cf7b5bdb-813e-400f-924e-41628cccc2d7">6.9</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE5LTEtMS0xLTIxODc0OA_31acdf98-a313-446a-9655-b05df63210db">7.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE5LTMtMS0xLTIxODc0OA_addeb603-69cf-4ece-a2ea-b4f9b55113c3">8.8</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzIyLTEtMS0xLTIxODc0OA_b4188887-cf1a-42e3-a229-1d7454b4d2ea">3.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzIyLTMtMS0xLTIxODc0OA_bbcf2e02-c56f-44a3-acad-8a3f7cf38e99">2.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzIzLTEtMS0xLTIxODc0OA_410dd78e-1a94-4dcd-b4a3-6f8b4189aa50">2.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzIzLTMtMS0xLTIxODc0OA_adf3e18d-bb5b-4e29-a872-d6e8560a86b2">2.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; in fiscal 2022, the Company rationalized its office space, including certain property leases in North America, and in fiscal 2023, management approved further changes to its real estate footprint as part of a broader set of initiatives. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. These initiatives did not have a material financial impact to the Company&#8217;s operating lease ROU assets and liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes operating lease right-of-use assets of approximately $<ix:nonFraction unitRef="usd" contextRef="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzg3OTYwOTMwMzI3ODI_99e83c3f-dc2b-4a35-a40a-0b9ca54a6338">494</ix:nonFraction>&#160;million, as well as current and long-term operating lease liabilities of approximately $<ix:nonFraction unitRef="usd" contextRef="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzU0OTc1NTgyNjU5NQ_abb8a2a5-bfe7-4ea8-a8ea-fd4bfd830ba4">83</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzU0OTc1NTgyNjYwMw_8a7c1c27-b151-4d0c-86dd-e5ec8e328983">442</ix:nonFraction>&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included under the caption &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of the assets ceased upon classification as held for sale.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div></ix:nonNumeric></ix:continuation></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i389cec4ffa50437d8a7344c293acbb35" continuedAt="if2a506262e0042eb8493e6edceb72f66"><ix:continuation id="iafe8b59140794bc09b8365e947faba85" continuedAt="i3ca2eae1f7424227afed50aed365a2d4"><ix:continuation id="i03272c021ec34f4799fadc21d42f9bcf" continuedAt="i13e49f4697854666a976df897a04db1a"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5OTQ_5f50fac5-7bd8-4001-b18d-691f865d79c0" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzItMS0xLTEtMjE4NzQ4_b718dce5-72bf-47cc-89e2-849f28d82926">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzItMy0xLTEtMjE4NzQ4_1a9539d4-8910-4d44-82a4-0358f39af872">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzItNS0xLTEtMjE4NzQ4_d6b17196-4720-4d88-bebf-7c8bb24c3ecc">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzMtMS0xLTEtMjE4NzQ4_1884faa0-64dd-4858-8e4d-77f78e1aeb10">384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzMtMy0xLTEtMjE4NzQ4_e9e4134c-53e3-4565-8ef9-de5ad9e5966a">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzMtNS0xLTEtMjE4NzQ4_a5296440-6822-499a-807c-4fc09dd91f52">465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzYtMS0xLTEtMjE4NzQ4_50d6f60b-48a6-4401-9ccf-49caa2b31535">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzYtMy0xLTEtMjE4NzQ4_54cb7baf-e373-469d-a0f9-dfc6654867bd">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzYtNS0xLTEtMjE4NzQ4_ea221d4d-aa53-4c8d-ad20-9cee512b07e7">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzctMS0xLTEtMjE4NzQ4_a990274f-0a9c-400b-87fc-6a69f9e932a7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzctMy0xLTEtMjE4NzQ4_e7789e1e-fff3-4ab1-be47-bce936eb73f0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzctNS0xLTEtMjE4NzQ4_12d8221d-b360-4788-b657-324bd80c235b">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzgtMS0xLTEtMjE4NzQ4_1da509b4-03bd-4bbc-9b05-134d417ad981">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzgtMy0xLTEtMjE4NzQ4_f5f30a1c-11bc-4bb0-b8bd-2e15c385ca40">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzgtNS0xLTEtMjE4NzQ4_521e9a8c-7792-4346-b218-3bafc1b9c2ab">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEwLTEtMS0xLTIxODc0OA_9f322afc-8fe8-4d60-b3ba-bf79cc8aab7f">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEwLTMtMS0xLTIxODc0OA_fc9fadfe-5119-4a55-8361-ec7876fd39b2">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEwLTUtMS0xLTIxODc0OA_955a5e59-967b-4f30-8436-9fe382a934c2">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzExLTEtMS0xLTIxODc0OA_b12da451-9af9-4954-a39a-2ded14188af8">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzExLTMtMS0xLTIxODc0OA_f7123f56-a840-4778-bc3e-f3c4ac2b0767">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzExLTUtMS0xLTIxODc0OA_370cc3ed-8e2e-4fd0-b99c-935f0fb35147">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEyLTEtMS0xLTIxODc0OA_a562412c-27e3-4700-abdf-f758ef2d30f3">529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEyLTMtMS0xLTIxODc0OA_18316c87-1fe3-42ca-b3d4-44b251c5899d">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEyLTUtMS0xLTIxODc0OA_7563b959-70c5-4183-90c0-dc7d60c1a248">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzMtMS0xLTEtMjE4NzQ4_871b6b02-d2ec-407c-a2c6-4d920de97736">338</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzMtMy0xLTEtMjE4NzQ4_1c3cde57-417b-48ed-acec-f52efba85d33">356</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzMtNS0xLTEtMjE4NzQ4_ce1fd9aa-4781-44ab-83ce-f989119c4377">362</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzQtMS0xLTEtMjE4NzQ4_0aeb7f3e-fb5c-4341-9a92-766b26058d57">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzQtMy0xLTEtMjE4NzQ4_50ad5af3-4c65-4480-8a57-179e8f24295f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzQtNS0xLTEtMjE4NzQ4_ff7d4935-d9f0-44e7-9cef-82636941b324">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzUtMS0xLTEtMjE4NzQ4_920dc048-af3e-40cf-adc3-c753e91047ac">29</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzUtMy0xLTEtMjE4NzQ4_aa7bcb53-5baa-4f7c-aed3-fc7c9cdbe9cd">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzUtNS0xLTEtMjE4NzQ4_a11ad591-114b-4e38-8d56-77df552aa12a">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzctMS0xLTEtMjE4NzQ4_8f0ea54e-bab3-4cf1-b4e5-175d4eb994a8">462</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzctMy0xLTEtMjE4NzQ4_e6c13464-d191-491d-bec6-11b7334b0630">286</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzctNS0xLTEtMjE4NzQ4_c04da261-0db1-48f7-bba3-e997fd79bbf1">321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzgtMS0xLTEtMjE4NzQ4_ca29d5e7-0842-484b-afe9-1ca60f797487">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzgtMy0xLTEtMjE4NzQ4_820e3d34-3933-42b6-a625-dc5337656e5d">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzgtNS0xLTEtMjE4NzQ4_d8254e06-31ec-4f39-9437-03e4c7360f8a">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5ODk_d319d4ae-525f-4a0d-9b16-f496f91b9182" escape="true"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzQwMDE_0a9acc00-e22f-41a3-bf71-5d57d9a33251" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2023 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzItMS0xLTEtMjE4NzQ4_9d40caf3-6086-483a-8236-5c9cb6fc6083">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzItMy0xLTEtMjE4NzQ4_8cdb8cc1-9f32-4d21-9e5a-ea76c91f0996">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzItNS0xLTEtMjE4NzQ4_6549121e-d026-4183-95f1-ed60fa9993e5">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzMtMS0xLTEtMjE4NzQ4_be61be3d-a820-4ff7-aeb0-aee76bda732f">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzMtMy0xLTEtMjE4NzQ4_e6e49ae9-9689-4484-b072-28d14130fcf1">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzMtNS0xLTEtMjE4NzQ4_dab78d6e-fcb8-4f73-a2ee-13a54abd07da">352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzQtMS0xLTEtMjE4NzQ4_d588c1a8-6a07-4d8b-a195-e54f4e940aee">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzQtMy0xLTEtMjE4NzQ4_e1c693bb-1521-4ff4-87a1-04cde190c526">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzQtNS0xLTEtMjE4NzQ4_90932fd5-e784-4ab1-be71-228ff34be467">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzUtMS0xLTEtMjE4NzQ4_26edd7cc-d4fd-441a-8931-e611d89fe091">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzUtMy0xLTEtMjE4NzQ4_85172460-b75f-4185-9326-8f1dfc60b568">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzUtNS0xLTEtMjE4NzQ4_5fc7e314-3d9d-4e9e-ab77-2638a6deb57b">258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzYtMS0xLTEtMjE4NzQ4_e756fdab-bbc8-44d8-993c-e1156ff76b77">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzYtMy0xLTEtMjE4NzQ4_c5f4c321-dce0-40ed-b0d9-42349c5b1a0e">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzYtNS0xLTEtMjE4NzQ4_cc3167f1-95fb-421b-97b1-345aa072e5a6">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzctMS0xLTEtMjE4NzQ4_67fa5b16-bf98-4434-bedb-2721d8d689b1">547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzctMy0xLTEtMjE4NzQ4_796ea07f-b2a8-4aa6-b7a4-9ce3af22db3a">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:LeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzctNS0xLTEtMjE4NzQ4_44a3983f-e89c-46f0-81e7-ec9777017e44">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzgtMS0xLTEtMjE4NzQ4_6cd5fdf9-f435-4832-83bb-1624dc14685f">1,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzgtMy0xLTEtMjE4NzQ4_afdccfb8-9c11-4b6c-b564-0c9e50077ac0">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:LeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzgtNS0xLTEtMjE4NzQ4_8fe19c1c-552b-46cf-953d-90c09a085899">2,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzktMS0xLTEtMjE4NzQ4_6f14bedf-7bd4-4614-992d-91cfb3d140ce">193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzktMy0xLTEtMjE4NzQ4_2bf6011c-9ca2-48fa-a0c6-aac5c71ecb0c">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:LeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzktNS0xLTEtMjE4NzQ4_fea9f32a-4022-4d1e-a75d-ad3e8c7c4033">217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzEwLTEtMS0xLTIxODc0OA_79b3f467-681f-4f7d-bcec-a2b0009c4f03">1,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzEwLTMtMS0xLTIxODc0OA_dd124c76-b5eb-4854-83c2-24e27d0a97f4">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:LeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzEwLTUtMS0xLTIxODc0OA_f3f692f1-5def-4219-939d-500470b32755">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by future minimum sublease income&#160;of $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:LessorLeasePaymentstobeReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzMyOTY_23f061f2-9a7f-420f-8dc0-56b158f7868c">191</ix:nonFraction> million which is due under noncancellable subleases.</span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="if2a506262e0042eb8493e6edceb72f66"><ix:continuation id="i3ca2eae1f7424227afed50aed365a2d4"><ix:continuation id="i13e49f4697854666a976df897a04db1a"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM0ODg_edc1db31-96ff-4fa9-843c-9cdcaf6712cf">98</ix:nonFraction> million that are not reflected in the table above. These operating leases will commence in calendar year 2023 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM2MjQ_b3387c7e-31d8-45e1-b5f8-dc61fc04b015">two</span> to <ix:nonNumeric contextRef="ied7b454e7843455ab8ab7494918c2873_I20230331" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzg3OTYwOTMwMjkzNTU_de1a1485-d885-4d8c-b595-fbabe8230a45">ten years</ix:nonNumeric>.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2023 and 2022, the total lease receivable was $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzU0OTc1NTgyNTUyMw_3fe26ac6-cee0-4aa0-9736-fc679c0d05cc">342</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM4MTY_67faf532-0b3d-4724-a21a-73c6b3403615">298</ix:nonFraction> million, respectively, with a weighted-average remaining lease term of approximately <ix:nonNumeric contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" name="mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzg3OTYwOTMwMzUzMjI_cbad47da-6d94-4f17-bc83-f335e0b401c2"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzg3OTYwOTMwMzUzMjI_ea5f975e-bc9e-424a-8b94-a3dab43420ea">seven years</ix:nonNumeric></ix:nonNumeric>. Interest income from these leases was not material for the years ended March 31, 2023, 2022, and 2021.</span></div></ix:continuation></ix:continuation></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_151"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTEvZnJhZzpmZGI5ZDBhODY1MzI0YmI3ODZhZTk2NzQxMWNhOGMxMy90ZXh0cmVnaW9uOmZkYjlkMGE4NjUzMjRiYjc4NmFlOTY3NDExY2E4YzEzXzQ0NTk_8a1af392-6517-44f0-8695-fc863b69e851" continuedAt="i161355f8881a49af88df6828e1638272" escape="true">Goodwill and Intangible Assets, Net </ix:nonNumeric></span></div><div id="i04335d018da94076b0acf21e81ac886b_2431"></div><ix:continuation id="i161355f8881a49af88df6828e1638272" continuedAt="i61c7b0d095dc4ead8053b2d0de5cba38"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGV4dHJlZ2lvbjoxNTJlNmMxZWMxYjc0NTU2ODBhOTI4NGZmYjc3MTgxYl80NDU3_e80e7ad2-891b-44ce-bc8a-d794024d6531" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.941%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58348ef8cf7b4b6faf2cce35de2978c5_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xLTEtMS0xLTIyMjc1Mg_07508008-9f08-40af-b4ad-3eed4a0eac52">3,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e8557376044f0fa6608b862b7e25c2_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xLTMtMS0xLTIyMjc1Mg_30d60406-b657-4816-9632-d72bbb2ee6bd">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c04e8513e99429391fedba4d6dad8af_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xLTUtMS0xLTIyMjc1Mg_9f028525-30d4-4fd1-9aec-f25614ad3db6">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3119e2458b4d43bd8aac84c146e9a100_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xLTctMS0xLTIyMjc1Mg_9e90f0a8-02aa-46a6-9ce0-6fb95712cbde">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xLTktMS0xLTIyMjc1Mg_57f46b7e-c475-4d51-9358-ab8e9f776644">9,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2799afba52094088a0aec4099f2cd4f8_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8yLTEtMS0xLTIyMjc1Mg_7740139d-d1bd-405f-badd-bbb1b68cd181">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ceabaf0dff4adc9d75414a157e0e6f_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8yLTMtMS0xLTIyMjc1Mg_5ea4a37d-bea7-4bd9-973a-2f01e6109a71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ef17e0a1714077b0570474802db35d_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8yLTUtMS0xLTIyMjc1Mg_49bf6dd1-9106-498b-9b43-3c638fb579ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if642126ed2f24282b10b29e0c453e35e_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8yLTctMS0xLTIyMjc1Mg_05f8679f-683c-481f-b8c9-eea21e686272">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8yLTktMS0xLTIyMjc1Mg_ae9d6e61-f811-4c34-bc6c-9a0a9153b570">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2799afba52094088a0aec4099f2cd4f8_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl82LTEtMS0xLTIyMjc1Mg_5ddcda40-f3f7-4091-9e1f-cb9a013c1fb1">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1ceabaf0dff4adc9d75414a157e0e6f_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl82LTMtMS0xLTIyMjc1Mg_b4d34f63-ea0e-4468-86f4-69bccb2fa9ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ef17e0a1714077b0570474802db35d_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl82LTUtMS0xLTIyMjc1Mg_9a04192c-3087-44b0-9739-f264ecf254a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if642126ed2f24282b10b29e0c453e35e_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl82LTctMS0xLTIyMjc1Mg_2a053b3c-c12b-4381-9910-290e107e3783">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl82LTktMS0xLTIyMjc1Mg_dadca23c-92dc-4a2c-9b14-d0120cbfc869">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i849ee3b7fa1d4cb8ba90315b84e6817c_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl83LTEtMS0xLTIyMjc1Mg_3f7d3855-a9e7-4b8f-baa9-fd3387b19e96">3,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76fe5a1e46444faa97974d14a8212357_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl83LTMtMS0xLTIyMjc1Mg_2ac6146b-a9c4-4023-baf3-e0e4a7961ef6">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36e6e5e651d4dac8a530797e7a70c18_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl83LTUtMS0xLTIyMjc1Mg_70a3e9a0-34c1-4e43-80a6-470d33e87025">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62db101872a24148a919c634afca4814_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl83LTctMS0xLTIyMjc1Mg_350d75bb-0030-4ac1-9743-8fb8cde8103b">1,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl83LTktMS0xLTIyMjc1Mg_3b70e6a8-fdc9-4889-be7a-09c9d0498982">9,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888e928ebad143cbb7a499ff02241d61_D20220401-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl84LTEtMS0xLTIyMjc1Mg_5e9d9ca3-56d8-4926-b10b-1cf881e939c3">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac9479cfdf4484f9e8701e0f82d2e4c_D20220401-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl84LTMtMS0xLTIyMjc1Mg_5066b789-b6fb-4c72-8251-ce28b36cd063">463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b668b117b34adcb089b01f3153c8f0_D20220401-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl84LTUtMS0xLTIyMjc1Mg_304875a8-e9d3-4db3-bc26-48c499a6d6dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969dadb6a5014e4e97c0701a8fa71817_D20220401-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl84LTctMS0xLTIyMjc1Mg_5e6fc8ba-37ec-46a5-a4b5-906351c7b21a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl84LTktMS0xLTIyMjc1Mg_bb9dfd85-f683-469a-a102-f20f2ba37027">628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i888e928ebad143cbb7a499ff02241d61_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMi0xLTEtMS0yMjI3NTI_db346ec8-8bac-4f2d-acf5-be651615f6c7">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac9479cfdf4484f9e8701e0f82d2e4c_D20220401-20230331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMi0zLTEtMS0yMjI3NTI_8537a69c-dfd8-4a37-9c7f-79146d34ea41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b668b117b34adcb089b01f3153c8f0_D20220401-20230331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMi01LTEtMS0yMjI3NTI_576406ff-841d-4ad5-a590-09ced5f7a8a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i969dadb6a5014e4e97c0701a8fa71817_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMi03LTEtMS0yMjI3NTI_d0f940e2-d157-4fe4-b838-4f093770f755">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMi05LTEtMS0yMjI3NTI_297b14fc-d7f2-4449-a7f5-d4a924583de5">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i888e928ebad143cbb7a499ff02241d61_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy0xLTEtMS0yMzU5NjQ_a6e066bc-367b-4dab-946d-3b52d43c1139">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ac9479cfdf4484f9e8701e0f82d2e4c_D20220401-20230331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy0zLTEtMS0yMzU5NjQ_703ec1f8-61c7-4f2a-b377-2c8229ac699a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b668b117b34adcb089b01f3153c8f0_D20220401-20230331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy01LTEtMS0yMzU5NjQ_5812a7a4-6afd-4766-a447-e030b45cefb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969dadb6a5014e4e97c0701a8fa71817_D20220401-20230331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy03LTEtMS0yMzU5NjQ_e8c48b23-4d13-4e85-966f-81db67565e50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy05LTEtMS0yMzU5NjQ_e5bce742-c120-46d7-95b9-92fa0ec4845d">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i716b019882fd4fceb551ac9e5a422c18_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy0xLTEtMS0yMjI3NTI_174283f7-7b1d-4dd6-bd11-55a214d39253">4,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c8b950234148b09f83c9527bf5b802_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy0zLTEtMS0yMjI3NTI_833cc8d9-73de-42ef-8caf-36429b8fde7b">2,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5e2ae4563940bf95c8d1d8e28f2353_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy01LTEtMS0yMjI3NTI_49e4e831-6916-4d00-a45c-0d1e8577411f">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03f6f90300b411c9d23b5538357dc9b_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy03LTEtMS0yMjI3NTI_ad7096da-39a3-47e0-b545-8013ccb56ada">1,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy05LTEtMS0yMjI3NTI_0af6740d-dde3-48e5-b145-9d36bafca24b">9,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment Charges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis and at an interim date, if indicators of potential impairment exist. Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit. During the first quarter of fiscal 2023, the Company voluntarily changed its annual goodwill impairment testing date from October 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to April 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to align with a change in the timing of the Company&#8217;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from April 1, 2022, as a retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#8217;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i61c7b0d095dc4ead8053b2d0de5cba38" continuedAt="ie6e11a6498dc4ef5a078cb367318d20a"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the reporting units is determined using a combination of an income approach based on a DCF model and a market approach based on appropriate valuation multiples observed for the reporting unit&#8217;s guideline public companies. Fair value estimates result from a complex series of judgments about future events and uncertainties and relies heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date. Any material changes in key assumptions, including failure to improve operations of certain retail pharmacy stores, additional government reimbursement reductions, deterioration in the financial markets, an increase in interest rates, or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances, may affect such estimates. The discount rates are the weighted-average cost of capital measuring the reporting unit&#8217;s cost of debt and equity financing weighted by the percentage of debt and percentage of equity in a company&#8217;s target capital. The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit&#8217;s future cash flow projections. Fair value assessments of the reporting unit are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual impairment testing performed for fiscal 2023, fiscal 2022, and fiscal 2021 did not indicate any impairment of goodwill. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of fiscal 2021, the Company implemented a new segment reporting structure which resulted in the Company&#8217;s current <ix:nonFraction unitRef="segment" contextRef="i2fb6e5f190e74ccdae10ef40017a5792_D20200701-20200930" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGV4dHJlZ2lvbjoxNTJlNmMxZWMxYjc0NTU2ODBhOTI4NGZmYjc3MTgxYl8yMjUw_d9f5c56a-d4b8-4edc-b2e3-b21af8ea205f">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="ie1ad9e5e8f13437e83ec2ed5b6ca20ee_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGV4dHJlZ2lvbjoxNTJlNmMxZWMxYjc0NTU2ODBhOTI4NGZmYjc3MTgxYl81NDk3NTU4Mjk2ODQ_7c3d0f23-270a-4902-a345-0121e267e886">69</ix:nonFraction> million in fiscal 2021 as the estimated fair value of the former Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This charge was recorded in &#8220;Goodwill impairment charges&#8221; in the Consolidated Statements of Operations. At March 31, 2023 and 2022, the balance of goodwill in the International segment primarily relates to the Company&#8217;s McKesson Canada reporting unit. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 15, &#8220;Fair Value Measurements,&#8221; for more information on this nonrecurring fair value measurement. As of March 31, 2023 and 2022, accumulated goodwill impairment losses in the Company&#8217;s International segment were approximately $<ix:nonFraction unitRef="usd" contextRef="ia73bbbf5c3f94136997b8becbe0d75fb_D20210401-20220331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGV4dHJlZ2lvbjoxNTJlNmMxZWMxYjc0NTU2ODBhOTI4NGZmYjc3MTgxYl81NDk3NTU4MzA3MzE_0ec5a8c6-5f5b-4c1f-ba5a-722a3b305e7d">700</ix:nonFraction> million. Most of the goodwill impairment for these reporting units was generally not deductible for income tax purposes.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_2458"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ie6e11a6498dc4ef5a078cb367318d20a"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN184NTE_3cec2f28-f047-4eab-b68f-4dc49ec18668" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:22.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i51a5d02d9bff429da29560b39c8f2ff3_D20220401-20230331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTEtMS0xLTIyMjc3Mg_0a01ab5a-0677-4c0f-ae00-4d347cc42453">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if336d47d141c481c95e420c0cf744a34_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTMtMS0xLTIyMjc3Mg_187c5d24-c830-416c-bd6e-86b04eee6c0c">2,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if336d47d141c481c95e420c0cf744a34_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTUtMS0xLTIyMjc3Mg_c60af8c1-9e22-4039-b5c4-3df2c0e9008d">1,765</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if336d47d141c481c95e420c0cf744a34_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTctMS0xLTIyMjc3Mg_c474e9fc-340f-4f28-9987-e519c86783d4">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460359d3c86945e3bca1ddec5b04da33_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTktMS0xLTIyMjc3Mg_f0072eff-7a38-48b9-a07a-e9417c618dc6">2,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i460359d3c86945e3bca1ddec5b04da33_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTExLTEtMS0yMjI3NzI_619867b8-75f3-45c6-a8d9-c1a5b94542cd">1,691</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460359d3c86945e3bca1ddec5b04da33_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTEzLTEtMS0yMjI3NzI_7afe6f8f-5fa3-4156-a25c-1ac4989aba4f">1,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64e47ed80ef449548b1acb824907d26d_D20220401-20230331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTEtMS0xLTIyMjc3Mg_917a081c-78ea-4093-bf35-da248d82d77e">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444f9a88357b4522a70b67e00782860a_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTMtMS0xLTIyMjc3Mg_5c612d3f-745f-498d-bf2e-db21a0b923b4">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i444f9a88357b4522a70b67e00782860a_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTUtMS0xLTIyMjc3Mg_6f4c5bec-14bd-43b2-b2f4-3bfdcefa8c40">623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444f9a88357b4522a70b67e00782860a_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTctMS0xLTIyMjc3Mg_0d0480cc-c4ea-4423-b1c9-fe96120f0fe1">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7c8512e869e4882979001a21c27cc1a_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTktMS0xLTIyMjc3Mg_c30ab9eb-6f5c-46a3-8a16-45bf95230d8d">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7c8512e869e4882979001a21c27cc1a_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTExLTEtMS0yMjI3NzI_fb5d2f66-a148-4d01-9bcb-cacc86a926e5">573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7c8512e869e4882979001a21c27cc1a_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTEzLTEtMS0yMjI3NzI_4669f314-63c3-4bb4-b9a7-9a510eeea5e9">512</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ice102114e53046c0990a7f9b97933076_D20220401-20230331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTEtMS0xLTIyMjc3Mg_9d99cc7a-b93e-4117-9213-4cb4fbbd075b">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26dce1de93254045b3bf97178b2dd2bf_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTMtMS0xLTIyMjc3Mg_534d2f87-dd42-47f0-b1fb-51f397a1153f">833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26dce1de93254045b3bf97178b2dd2bf_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTUtMS0xLTIyMjc3Mg_efcd8799-5cad-400a-bb54-3d46d8a799cf">430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26dce1de93254045b3bf97178b2dd2bf_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTctMS0xLTIyMjc3Mg_c5c1d06a-9f2a-43b4-a6c5-ffb942b5330f">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf6e4b73c21f44648aa84b01813ff828_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTktMS0xLTIyMjc3Mg_a63f2a5c-4cbf-4664-87c9-359c0d7ca099">819</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf6e4b73c21f44648aa84b01813ff828_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTExLTEtMS0yMjI3NzI_d00a7400-00bb-4d48-b99b-c128381a45c7">386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf6e4b73c21f44648aa84b01813ff828_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTEzLTEtMS0yMjI3NzI_f9e68d41-8bae-4013-9688-e8a2bc83b59e">433</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib3aea8ed8bb64f248ee3ba0de12e5974_D20220401-20230331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTEtMS0xLTIyMjc3Mg_74e7139d-759e-417c-8b21-9c1d2e364377">11</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddbc2840c8d47d1a8b3d4d03ad88e0e_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTMtMS0xLTIyMjc3Mg_e4ac0eb9-27dd-44dc-80f6-c973ccb9b12a">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibddbc2840c8d47d1a8b3d4d03ad88e0e_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTUtMS0xLTIyMjc3Mg_d1e97158-4afb-4972-9962-0d08327275b7">129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibddbc2840c8d47d1a8b3d4d03ad88e0e_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTctMS0xLTIyMjc3Mg_ff77cbe9-ce7f-4508-90c5-6af865d6a578">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d94f46b8eb44d5abcdcf4c68ffd4af_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTktMS0xLTIyMjc3Mg_ba6ebeef-537e-476c-bfd3-33e35264038f">128</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58d94f46b8eb44d5abcdcf4c68ffd4af_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTExLTEtMS0yMjI3NzI_3cc9f907-a5d3-475a-8a69-98d04cd3c24c">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d94f46b8eb44d5abcdcf4c68ffd4af_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTEzLTEtMS0yMjI3NzI_91010dba-071d-4c07-8d23-1264a186bf23">12</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icfb74fdbaafc42b5bc38853f2956af25_D20220401-20230331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTEtMS0xLTIyMjc3Mg_a0e743da-cfc6-4011-8e16-1fb8da9f2561">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7a74f1e4ec41a08eb7da7766828283_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTMtMS0xLTIyMjc3Mg_a91d6fbb-441b-4e53-98cd-c1fbfa1adbb7">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e7a74f1e4ec41a08eb7da7766828283_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTUtMS0xLTIyMjc3Mg_d00adb8b-79ae-48a3-94af-8370322f182b">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7a74f1e4ec41a08eb7da7766828283_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTctMS0xLTIyMjc3Mg_eca8a34a-6cf9-410c-a5b1-60404307a216">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i618590d34e9e40beaae759c50efa5248_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTktMS0xLTIyMjc3Mg_0649edba-2e11-4178-8c9f-bc4711f6b6a3">187</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i618590d34e9e40beaae759c50efa5248_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTExLTEtMS0yMjI3NzI_1987af2d-f411-48b4-adaa-addf131c742f">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i618590d34e9e40beaae759c50efa5248_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTEzLTEtMS0yMjI3NzI_6daaeddb-72e3-4c16-95ad-f7e06565c94d">16</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTMtMS0xLTIyMjc3Mg_5c82a768-1bd7-44ff-b8a3-991ff4fa2cd0">5,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTUtMS0xLTIyMjc3Mg_2f03446c-b48b-42b5-8b53-9174d9375492">3,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTctMS0xLTIyMjc3Mg_a1ab24ff-fa3c-4371-a9f3-488c97df1477">2,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTktMS0xLTIyMjc3Mg_ca5fdd4d-1558-40f0-9992-8c30fdb698e7">4,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTExLTEtMS0yMjI3NzI_eb21b0e0-d123-4c1f-90f1-7b703b847442">2,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTEzLTEtMS0yMjI3NzI_1fa4dd3f-a270-4931-809d-f7487b1f31a1">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes net intangible assets of approximately $<ix:nonFraction unitRef="usd" contextRef="i0496c19ac0ab424285907e4b8bdfd63c_I20230331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN181NDk3NTU4MTQ4Nzc_e7205849-7b5e-42ad-9ac2-7892ef0e5024">384</ix:nonFraction> million related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; This amount was included under the caption &#8220;Assets held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of fiscal 2022.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intangible assets were subject to amortization as of March 31, 2023 and 2022. Amortization expense of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN181NDg_a3de599e-36a3-4267-b42c-b9a705cbf1d4">236</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN181NTM_d9129445-7bc8-472a-ac21-10f8b02b6436">332</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN181NjE_5bd640db-3916-413d-83f2-135b08787189">422</ix:nonFraction> million for fiscal 2023, fiscal 2022, and fiscal 2021, respectively. Estimated annual amortization expense of intangible assets was as follows: $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN182NzM_14311356-2196-4bff-a5b8-11319e80e6fd">246</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN182Nzc_d972efa1-1e02-4075-826f-bc224c23248b">240</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN182ODE_b42261d8-dc7f-4a6c-99a7-ff9310b03dfa">208</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN182ODU_ee840b88-7bb3-413d-97f4-2b39ab7c5822">201</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN182OTM_5de7c8d5-4cee-45b7-ae03-dfe20e90b3f0">197</ix:nonFraction> million for fiscal 2024 through fiscal 2028, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN183MTk_8816d24c-4ee8-49de-8642-3d892dc5f1fd">1.2</ix:nonFraction> billion thereafter. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for a description of the goodwill and intangible assets recognized as part of the RxSS acquisition and formation of SCRI Oncology.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; for more information on intangible asset impairment charges recorded in fiscal 2022 and fiscal 2021.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_154"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzc0NDc_688c5df9-1c9d-4481-8032-30b7955485b5" continuedAt="ia841b59fa3d747d6850820bf41ea54d5" escape="true">Debt and Financing Activities</ix:nonNumeric></span></div><ix:continuation id="ia841b59fa3d747d6850820bf41ea54d5" continuedAt="ifdecd924d80149229f000501e129c550"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzc0NTY_3e3f516f-31cb-463c-80ec-87b59e7a78fd" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i202cd9cf62f0431e8d01300563014a7d_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzMtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246NjRkYWMyMTgzODdlNDllOWFmNGI4Y2IwOGIyNzBlNWRfNA_87a8a339-6867-4e16-8c74-4bb266157df9">2.70</ix:nonFraction>% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i202cd9cf62f0431e8d01300563014a7d_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzMtMS0xLTEtMjE4NzQ4_ffb44435-3808-42e5-9b00-1b0a1943ace5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1765debe58fa477bb60f4fa358d03763_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzMtMy0xLTEtMjE4NzQ4_c0612b22-52e4-4773-affb-f1cfbcbe8e18">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibae09054075242708b4f1b92c5ad9435_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzQtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246MTRiMThjM2NjYTQyNGVlYzhjODc1MzJhN2FjMjNmNDlfNA_d0aba5cf-8ef7-4fa6-a50a-44c515905e3f">2.85</ix:nonFraction>% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae09054075242708b4f1b92c5ad9435_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzQtMS0xLTEtMjE4NzQ4_d215abd5-27d3-4a4a-88f4-a094682da017">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf954d0b17fa4afcbd832a5b25242889_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzQtMy0xLTEtMjE4NzQ4_31b38b8b-bf26-4480-9cad-b2a32d56b6ac">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74f232fbbdd542a68a67aac5bb01a3ad_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzUtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246ZmQxMTZiZTEyNjUwNDZiMThkZGU4NDUzODRjMDRlYTJfNA_f38706f3-09e9-4202-b9b3-e453e6333578">3.80</ix:nonFraction>% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f232fbbdd542a68a67aac5bb01a3ad_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzUtMS0xLTEtMjE4NzQ4_119055cc-2a2b-481a-836e-30b8397a273b">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6020b3dcea424492aa70f65876ac2906_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzUtMy0xLTEtMjE4NzQ4_d68f1287-502f-48a2-b67c-b5342e922ad4">918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i768c441bead74af990375d494dcd615f_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzYtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246MDcyMjM3ZDEwMWVjNGEyOTkwMjg3ODNiMmQ4NTJhMzVfNA_7f43654f-633a-4a22-a459-3a765e2016bf">0.90</ix:nonFraction>% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i768c441bead74af990375d494dcd615f_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzYtMS0xLTEtMjE4NzQ4_7df7dd87-74a5-491c-8caf-f99d44d326e6">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46014a69e7bb46d7804f90bfac7336a1_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzYtMy0xLTEtMjE4NzQ4_0c0b0988-1a99-4c10-9d8f-66acb8cc637a">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id6a8fb9420154ab99c47ee021794a752_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMC0xLTEtMjQzNjY3L3RleHRyZWdpb246YmNhNGVmYmIyZGQ0NGE0MjgxOWYwNDhjYjI3MTM0NDFfMTY0OTI2NzQ0MTcwNg_0ea110ba-fe70-4c8c-b578-79ef134715e9">5.25</ix:nonFraction>% Notes due February 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6a8fb9420154ab99c47ee021794a752_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMS0xLTEtMjIzNzcx_2db25fda-2a1a-4e66-9fa4-65dc351b9110">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15a119cca4d54ce1b9e9b15b07ecb555_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMy0xLTEtMjIzNzcx_f48964c4-9edf-4fcb-8e58-8226362882f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia67ce7e8257446a8a749a51dd4e61f1e_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246Njk2NGM3MTAxMTdkNDVlZjg2NjA2ZDE2YjRlMDViOGFfNA_e152d987-7e17-4507-8228-d0aae529bf42">1.30</ix:nonFraction>% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia67ce7e8257446a8a749a51dd4e61f1e_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMS0xLTEtMjE4NzQ4_57325a0f-925e-4cb5-8aa8-f2335429529d">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6923623dff6a4c21af62ba66950bbca1_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMy0xLTEtMjE4NzQ4_1e673a98-d055-4903-a04e-ad359b4759c1">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i836c135ad296412391b52c76ec2d65af_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzgtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246NmI0M2QyZDI3MWU5NDg0OWE4Y2YzMzQzNTg3OTFmOGRfNA_f8a1ba5a-2894-421c-8e23-5bf427ba2059">7.65</ix:nonFraction>% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i836c135ad296412391b52c76ec2d65af_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzgtMS0xLTEtMjE4NzQ4_d83b4664-d4ab-4e85-8556-42c6550ca33f">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584398e2f2774124928de1b3733debf3_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzgtMy0xLTEtMjE4NzQ4_09f46535-eb08-487f-b148-815a833336f5">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc18546dd5254ad9bc27e6a28551e869_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzktMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246OGE1NTdlMDc2N2Q2NGFlMDgxZjgxYjcwNDI5NTVlNTBfNA_3656891e-7672-47bd-afe9-81d2fd6bd150">3.95</ix:nonFraction>% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc18546dd5254ad9bc27e6a28551e869_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzktMS0xLTEtMjE4NzQ4_ce5e6ba5-1e3d-4e87-80c0-e641f31b874b">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf67d81b73484a2ab862ae6562f12c8f_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzktMy0xLTEtMjE4NzQ4_7185ff50-abd8-487a-ba95-963e87f71349">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib792f01cad394fa9a6b5b6007690d92d_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEwLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjMzNzhmNDQzYTM3MzQ2ZTI4YTQ2MjFiN2NmMjdlYTM5XzQ_286bcc2e-5d7a-4375-9ab6-615c2e61d1aa">4.75</ix:nonFraction>% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib792f01cad394fa9a6b5b6007690d92d_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEwLTEtMS0xLTIxODc0OA_ecc0f169-3486-4997-abc6-8cd549b21a25">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22b455fe9626429d82d1312274a08717_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEwLTMtMS0xLTIxODc0OA_0c299901-8532-4be2-86f9-aaf8e10c3055">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6305f106d8224c67a7f1f4f9d248c6ee_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzExLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjBmYzllYWQyZjgxZDQ4MDlhZDk0YzNlMWU3ODE0NzRiXzQ_e260fee0-aa34-4d84-845a-184c20e85182">6.00</ix:nonFraction>% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6305f106d8224c67a7f1f4f9d248c6ee_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzExLTEtMS0xLTIxODc0OA_1a7118a5-6dd4-4581-b626-a0c14e98da13">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00eb8e4aa01348e88c908410c24dbed9_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzExLTMtMS0xLTIxODc0OA_5af8653e-a02a-401d-b78c-f713574f3a75">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2db8c6c2c8154fc292aa5199f298a4cd_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEyLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOmY3MzYwNDhmYWE1ODQ2YzJiYjY3NWFkN2E5ODZkZDgzXzQ_53ed88af-528f-4b5d-9fe9-280769a9594c">4.88</ix:nonFraction>% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2db8c6c2c8154fc292aa5199f298a4cd_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEyLTEtMS0xLTIxODc0OA_77b48336-6618-4343-87bd-76c3cdb87784">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ded6a5da3964377b85a8496b7db3a17_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEyLTMtMS0xLTIxODc0OA_8c5c1402-9d0d-464c-a323-8fc0b62c3281">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib30972cf50704e17b9605f2bd2f62293_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE1LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc5NjExZGFjOTA1ODQzNzA5MTU5MzQ1MzFjYzA1ZjU2XzQ_726da56e-ed0c-46df-a9cf-071e8614b069">1.50</ix:nonFraction>% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib30972cf50704e17b9605f2bd2f62293_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE1LTEtMS0xLTIxODc0OA_708ec2c2-1ce3-41a8-ba6b-396f0f4f59ba">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i215f3153999b49f994c67efb2f5ca414_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE1LTMtMS0xLTIxODc0OA_d8985fdf-afb8-4443-b32e-d6a46d3e8cc9">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i844ae52bcc2545d293dac8695661ad1c_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE2LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjQ3MjNkNmU4ODc4OTQ2MGY5Y2VlYmZkZDNkNzc0OWRkXzQ_92858a7e-42dc-410d-9880-c6aa7bb0462d">1.63</ix:nonFraction>% Euro Notes due October 30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i844ae52bcc2545d293dac8695661ad1c_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE2LTEtMS0xLTIxODc0OA_fe1f6d50-09fb-44a8-b920-2a911cd31535">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if363f9768e7c4dfda22b43256fce94cf_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE2LTMtMS0xLTIxODc0OA_2402f814-8645-498e-baca-fe1ac1239d05">554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5694cf86b13649b19e91a4472f2dd301_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE3LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOmJmNTdiYmMyOTFkMTRjZjY5YTQ3NTJkMDdjOThjY2E0XzQ_df7bbe9f-2691-4a25-a393-9cbf0df162d5">3.13</ix:nonFraction>% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5694cf86b13649b19e91a4472f2dd301_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE3LTEtMS0xLTIxODc0OA_a70dea57-3af4-49b3-be65-f6ba50c3ecc4">555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35cacf2366014f2ea0f9ac27e0b29d39_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE3LTMtMS0xLTIxODc0OA_9861a5a7-6f88-44a2-9f03-d680c58a41d1">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea3066b4198415db491f3e894ce0b14_I20230331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE5LTEtMS0xLTIxODc0OA_ad8b8bba-65a1-40a9-a03a-89e40bba1f76">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1b5510456d4c02b2ecb86d2a690ce1_I20220331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE5LTMtMS0xLTIxODc0OA_91caf450-34f5-4c2e-bafe-7acf693cc62b">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIwLTEtMS0xLTIxODc0OA_ad4ca98a-c92f-4f51-8593-2e0d35facf60">5,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIwLTMtMS0xLTIxODc0OA_38fb3b98-2e27-453c-8f57-3469673a476c">5,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIxLTEtMS0xLTIxODc0OA_0444af75-2ebb-468d-9187-c570729cca93">968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIxLTMtMS0xLTIxODc0OA_9eec57b0-b645-45b6-9573-8da75e8d3023">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIyLTEtMS0xLTIxODc0OA_fc796c24-8e2f-4234-ac5e-8a11fbb7240d">4,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIyLTMtMS0xLTIxODc0OA_638644a0-af45-40f0-8948-62b41cf12d1e">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these U.S. dollar notes is payable semi-annually.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term debt of approximately $<ix:nonFraction unitRef="usd" contextRef="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg2ODc_1e333c8a-912d-4484-b7fd-3ec4d85b6385">4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg2OTk_d048256b-a148-4030-afe7-80be15034ec9">11</ix:nonFraction>&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. At March 31, 2023 and 2022, $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzY2MQ_fe7f691b-ddab-45bb-b2fd-ef2edb573937">5.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-8" name="us-gaap:DebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzY2OA_7d5a5315-16ec-4ed3-89da-ed67dfc07974">5.9</ix:nonFraction> billion, respectively, of total debt was outstanding, of which $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzcyNg_2e384163-e6ab-4ae5-b491-574b57b0e805">968</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczMw_8b95d84e-b703-4f07-a083-f351802b07ff">799</ix:nonFraction> million, respectively, was included in &#8220;Current portion of long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2023, the Company completed a public offering of <ix:nonFraction unitRef="number" contextRef="i976e4c827b4549e1961c10a386b91abb_I20230213" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE1NzE_22ba0850-77af-4977-a871-cd2d82c73b8e">5.25</ix:nonFraction>% Notes due 2026 (the &#8220;February 2026 Notes&#8221;) in a principal amount of $<ix:nonFraction unitRef="usd" contextRef="i976e4c827b4549e1961c10a386b91abb_I20230213" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE1ODY_4472bd89-59a9-4f43-9444-e9519e384cae">500</ix:nonFraction> million. Interest on the February 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on August 15, 2023. Proceeds received from this note issuance, net of discounts and offering expenses, were $<ix:nonFraction unitRef="usd" contextRef="ifa0ffbdeacb64a09986b957e9f96a042_D20230213-20230213" decimals="-6" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE2MDg_05e0e940-fae7-407c-80ec-7189f59154b1">497</ix:nonFraction> million. The Company utilized the net proceeds from this note issuance to repay existing debt. On or after February 15, 2024, the Company may redeem the February 2026 Notes at its option, in whole or in part, at any time and from time to time, for cash at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="ifa0ffbdeacb64a09986b957e9f96a042_D20230213-20230213" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNjMwMjg_72b340c2-043b-4394-8a91-84337fcc0201">100</ix:nonFraction>% of the principal amount of the notes being redeemed plus accrued and unpaid interest thereon to, but not including, the redemption date.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ifdecd924d80149229f000501e129c550" continuedAt="i2d1ad9fd9f634276bf197144895953b4"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021, the Company completed a public offering of <ix:nonFraction unitRef="number" contextRef="i535b3f0e572b482a8d1a1dedf038fe50_I20210812" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg4Mg_f7754e82-628e-4263-bacf-701e40c1d475">1.30</ix:nonFraction>% Notes due August 15, 2026 (the &#8220;August 2026 Notes&#8221;) in a principal amount of $<ix:nonFraction unitRef="usd" contextRef="i535b3f0e572b482a8d1a1dedf038fe50_I20210812" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzk1NQ_9cc269c8-21ea-4133-85ab-1c60866d0fdc">500</ix:nonFraction>&#160;million. Interest on the August 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on February 15, 2022. Proceeds received from this note issuance, net of discounts and offering expenses, were $<ix:nonFraction unitRef="usd" contextRef="i78a368c4b72d42cf8b1a224dc65b0f47_D20210812-20210812" decimals="-6" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzExNzk_059732c9-d6d3-445e-baaf-ea2c49a12dc0">495</ix:nonFraction>&#160;million. The Company utilized the net proceeds from this note issuance for general corporate purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2020, the Company completed a public offering of <ix:nonFraction unitRef="number" contextRef="i2a24f716c6be4a4696ca08b8cc9d7ad8_I20201203" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3MTI_8ce25eef-d27a-43ec-b90f-0d6547c3fde7">0.90</ix:nonFraction>% Notes due December 3, 2025 (the &#8220;2025 Notes&#8221;) in a principal amount of $<ix:nonFraction unitRef="usd" contextRef="i2a24f716c6be4a4696ca08b8cc9d7ad8_I20201203" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3MTk_9e88ac22-26bb-4d3b-8459-b46815c70e43">500</ix:nonFraction>&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $<ix:nonFraction unitRef="usd" contextRef="i11be422271b0497c8bb2cbf054b40bdd_D20201203-20201203" decimals="-6" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3MzM_4b6fdb44-45c0-4010-9e09-946ead7e9490">496</ix:nonFraction>&#160;million. The Company utilized the net proceeds from this note issuance for general corporate purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each note, which constitutes a &#8220;Series,&#8221; is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#8217;s existing, and from time-to-time, future unsecured and unsubordinated indebtedness outstanding. Each Series is governed by materially similar indentures and officers&#8217; certificates as those of other Series issued by the Company. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, an offer must be made to purchase that Series from the holders at a price equal to <ix:nonFraction unitRef="number" contextRef="i772fb832f6354412ad17d3bfd7fe6b1d_D20220401-20230331" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg0ODg3Ng_4f0d09f1-c40f-4c86-b0a6-16a0fbd24e10">101</ix:nonFraction>% of the then outstanding principal amount of that Series, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#8217; certificate for each Series, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without the lenders&#8217; consent. The indentures also contain customary events of default provisions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 15, 2023, the Company retired its $<ix:nonFraction unitRef="usd" contextRef="icac00852e08b4922ad11b375efe1e1b0_D20230315-20230315" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0Nzg3NTk_f84fea45-b3b1-4173-bb41-c414ad5b8a45">360</ix:nonFraction>&#160;million outstanding principal amount of <ix:nonFraction unitRef="number" contextRef="ia19e57b1a46b4e69ae2d79da972f650a_I20221215" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0Nzg3Njc_0a2e71b4-c67f-466a-8ca3-2d84daf8f193">2.85</ix:nonFraction>% Notes due 2023 upon maturity. On December 15, 2022, the Company retired its $<ix:nonFraction unitRef="usd" contextRef="i3851e69ede76406a8a5a4117e99d5ec4_D20221215-20221215" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg0OTY2MQ_672db05e-e009-4960-880c-e8c834e49d40">400</ix:nonFraction>&#160;million outstanding principal amount of <ix:nonFraction unitRef="number" contextRef="ib44bfb223bc14e29aeac77c05bbc39d7_I20221215" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg0OTY5Nw_34333bec-4541-4b43-b1c7-cea02d6ddc5d">2.70</ix:nonFraction>% Notes due 2022 upon maturity. On July 17, 2021, the Company redeemed its &#8364;<ix:nonFraction unitRef="eur" contextRef="i453005c054c0476fbb9853e512d6bd28_D20210717-20210717" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzMxODM_0e7fdb33-53f7-49df-abdd-f46e520fc28a">600</ix:nonFraction> million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i453005c054c0476fbb9853e512d6bd28_D20210717-20210717" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzMyMDU_04260e15-5937-480c-8077-b4767f4df6c1">709</ix:nonFraction> million) outstanding principal amount of Euro-denominated <ix:nonFraction unitRef="number" contextRef="ie0e1375f02f24ba79ea97f55a3b99d89_I20210717" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg1NjI0Nw_2e740a34-6780-481f-b873-bccd68f43680">0.63</ix:nonFraction>% Notes due 2021, prior to maturity at par value. On December 1, 2020, the Company redeemed its $<ix:nonFraction unitRef="usd" contextRef="ic756400c1f7e46c38b850bd10c43a377_D20201201-20201201" decimals="INF" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM0MDk_505838de-2a55-4df5-926a-63424998e685">323</ix:nonFraction>&#160;million outstanding principal amount of <ix:nonFraction unitRef="number" contextRef="i3f46bdc3df244190a4f3caa01c5eccdd_I20201201" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg1NjMzMg_2e503813-09ec-45c5-8b6e-8a033099797b">4.75</ix:nonFraction>% Notes due 2021 prior to maturity. On November 30, 2020, the Company retired its $<ix:nonFraction unitRef="usd" contextRef="i7fd03415c82341b0bcd801b36c1a28fe_D20201130-20201130" decimals="INF" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM1MjY_96e13712-d68b-4892-944a-403f22861435">700</ix:nonFraction>&#160;million outstanding principal amount of <ix:nonFraction unitRef="number" contextRef="i1f7ee8f00bf1412e813d7abd850dc07b_I20201130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg1NjM3Nw_d70f3584-af2a-4341-95a4-1f5d7584c3e8">3.65</ix:nonFraction>% Notes due 2020 upon maturity. All of these notes were repaid or redeemed using cash on hand.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tender Offer</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) <ix:nonFraction unitRef="number" contextRef="i4592baf7793041fa8e76756aac03670e_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM4ODQ_ee0e5fbc-a826-43a0-82fa-771281832584">2.85</ix:nonFraction>% Notes due 2023, (ii) <ix:nonFraction unitRef="number" contextRef="ib143d3ffb79a4cc4bd2ad4ebae133edc_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM5MDg_66304062-ea79-4bcb-acd7-69b0e03bc244">3.80</ix:nonFraction>% Notes due 2024, (iii) <ix:nonFraction unitRef="number" contextRef="i34d77590b6c24730802120c45ff43aa6_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM5MzM_a8f202b6-6dc4-4d52-bc76-9c9a14e16a9a">7.65</ix:nonFraction>% Debentures due 2027, (iv) <ix:nonFraction unitRef="number" contextRef="ia499a63a8849486aa054b9140660701a_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM5NjI_f4fc1367-d1ee-4157-bfe1-5dd561ba2faa">3.95</ix:nonFraction>% Notes due 2028, (v) <ix:nonFraction unitRef="number" contextRef="ic327cefb81b34e5a82369680f27dfba6_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM5ODU_e0872f41-c6ba-4eca-acf2-0184967c91ce">4.75</ix:nonFraction>% Notes due 2029, (vi) <ix:nonFraction unitRef="number" contextRef="i2959faada6aa43a892063ae50e28b434_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQwMDk_8fbbf4a8-f4bb-4665-b363-374fccfb1eaa">6.00</ix:nonFraction>% Notes due 2041, and (vii) <ix:nonFraction unitRef="number" contextRef="ida05874ce18a4f4fb630c33eac2a3138_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQwMzg_99ad85b4-2521-4f4b-a522-d36a356872e7">4.88</ix:nonFraction>% Notes due 2044 (collectively referred to herein as the &#8220;Tender Offer Notes&#8221;). In connection with the tender offer, the Company paid an aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="i9c2fdc8cd1ed4cabbe44be3bfdd3a3f2_I20210723" decimals="-8" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQyMDM_ff5de359-b4c0-477c-996e-f9c48a5e6133">1.1</ix:nonFraction> billion to redeem $<ix:nonFraction unitRef="usd" contextRef="i9c2fdc8cd1ed4cabbe44be3bfdd3a3f2_I20210723" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQyMTY_dbfb663b-f9d9-430f-9a88-6e6af61f7c28">922</ix:nonFraction> million principal amount of the Tender Offer Notes at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="ie691f38e48be4843a3fd39459645f39b_D20210723-20210723" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQyODA_92ccc99f-019a-4fad-afa5-b89e8911be7a">100</ix:nonFraction>% of the principal amount and premiums of $<ix:nonFraction unitRef="usd" contextRef="ie691f38e48be4843a3fd39459645f39b_D20210723-20210723" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQzMjM_5fecef03-06a9-435e-b4ff-11803bb3684a">182</ix:nonFraction> million, plus accrued and unpaid interest of $<ix:nonFraction unitRef="usd" contextRef="ie691f38e48be4843a3fd39459645f39b_D20210723-20210723" decimals="-6" name="us-gaap:InterestPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQzNjM_dcef01e4-2c3c-488c-a6ad-d5311aeed6c4">14</ix:nonFraction> million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $<ix:nonFraction unitRef="usd" contextRef="i5bdacb5a0bcc4ad480dec225518c10c8_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ1NDU_e0802ddb-feda-4b0c-8523-232fd2945f95">191</ix:nonFraction> million for the year ended March 31, 2022, which included premiums of $<ix:nonFraction unitRef="usd" contextRef="i7cc5f04c5c2d4d70aa2d95e18cd6bef4_I20220331" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ1OTc_1f4ae9d0-22e7-4fd9-8031-ee8a78454589">182</ix:nonFraction>&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $<ix:nonFraction unitRef="usd" contextRef="i5bdacb5a0bcc4ad480dec225518c10c8_D20210401-20220331" decimals="-6" name="mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ2OTk_a1658042-ba9d-43de-b0b1-d931e760fa84">9</ix:nonFraction> million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments of long-term debt are $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ3NzI_947aea02-94f8-4dcf-8fac-202746e0c84c">968</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ3ODI_af083832-4675-4eb8-b7ef-7db63b79613a">39</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ3OTI_2467e8f0-d28c-4261-88d5-6a079348b91b">1.7</ix:nonFraction>&#160;billion, $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ4MDI_db27afc4-9eea-4c13-8888-29e183713676">1.2</ix:nonFraction>&#160;billion, and $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ4MTI_b1d958ee-ed59-45f9-9fa6-235d252c1a00">376</ix:nonFraction> million for fiscal 2024 through fiscal 2028, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ4MjY_5098e4c6-cbcf-4a0e-ada4-febbfca3f044">1.3</ix:nonFraction>&#160;billion thereafter.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i2d1ad9fd9f634276bf197144895953b4"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 7, 2022, the Company entered into a Credit Agreement (the &#8220;2022 Credit Facility&#8221;), that provides a syndicated $<ix:nonFraction unitRef="usd" contextRef="i0de40eac191846698bafb26987f8db02_I20221107" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE2ODI_414c33dd-ca9d-467a-ab3b-f4e6eb5933c2">4.0</ix:nonFraction> billion <ix:nonNumeric contextRef="id2939e16a3a648eeadc8fe5b14335874_D20221107-20221107" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTI1Mzc_9f6c9f21-90bd-4571-8cf5-034dadb0f765">five-year</ix:nonNumeric> senior unsecured credit facility with a $<ix:nonFraction unitRef="usd" contextRef="id005fd4ac6fa46378f61401585bd1f21_I20221107" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE2OTE_617ee65d-19ad-420a-91e4-831c9d0f5498">3.6</ix:nonFraction> billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. The 2022 Credit Facility replaced the Company&#8217;s previous syndicated $<ix:nonFraction unitRef="usd" contextRef="ic980d09285fc4708a8a6eafe8b8a5655_I20221107" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE2OTY_f8c152bd-0b87-4bdf-a4d0-5eec337fcd98">4.0</ix:nonFraction> billion <ix:nonNumeric contextRef="i6df2825430ea48468dedc27f049659e5_D20221107-20221107" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTI1Mzg_d138d68c-f14b-4c1e-827d-5a0ed3755ff7">five-year</ix:nonNumeric> senior unsecured credit facility, dated as of September 25, 2019, as amended (the &#8220;2020 Credit Facility&#8221;), which was scheduled to mature in September 2024. The 2020 Credit Facility was terminated in connection with the execution of the 2022 Credit Facility. There were <ix:nonFraction unitRef="usd" contextRef="i63af9e33b0074a89b174bb79dc0563a6_D20200401-20210331" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NTU5MzE_17266d10-7451-4812-a8ce-c00eebb5e6ef"><ix:nonFraction unitRef="usd" contextRef="i34acb3e619be4e479ffc9dd6d3c2637e_D20220401-20230331" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NTU5MzE_2ff15a40-9543-4990-bc66-04c655d76c7c"><ix:nonFraction unitRef="usd" contextRef="ieffd80ee181540709a1840aa1e6b331a_D20210401-20220331" decimals="INF" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NTU5MzE_b60c044b-d7d0-4df0-a33c-f350d5215336">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> borrowings under the 2020 Credit Facility during the years ended March 31, 2023, 2022, and 2021, and <ix:nonFraction unitRef="usd" contextRef="i37179d6482964d95b578a69074ef0010_I20221107" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NTYwMDk_0e3dbf90-b407-4697-9692-5a9ccdabc600">no</ix:nonFraction> amounts outstanding at the time of its termination. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2022 Credit Facility bear interest based upon the Term Secured Overnight Financing Rate (&#8220;SOFR&#8221;) for credit extensions denominated in U.S. dollars, the Sterling Overnight Index Average Reference Rate for credit extensions denominated in British pound sterling, the Euro Interbank Offered Rate for credit extensions denominated in Euros, the Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates, as applicable, plus agreed upon margins. The 2022 Credit Facility contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the 2022 Credit Facility. If the Company does not comply with these covenants, its ability to use the 2022 Credit Facility may be suspended and repayment of any outstanding balances under the 2022 Credit Facility may be required. At March 31, 2023, the Company was in compliance with all covenants under the 2022 Credit Facility. The 2022 Credit Facility also permits the Company to establish key performance indicators with respect to certain sustainability targets of the Company in consultation with certain sustainability coordinators. The Company may enter into an amendment to the 2022 Credit Facility to provide for certain adjustments to the otherwise applicable facility fee and margins based on the Company&#8217;s performance against any established key performance indicators. The 2022 Credit Facility is scheduled to mature in November 2027. The remaining terms and conditions of the 2022 Credit Facility are substantially similar to those previously in place under the 2020 Credit Facility. The Company can use funds obtained under the 2022 Credit Facility for general corporate purposes. There were no borrowings under the 2022 Credit Facility during the year ended March 31, 2023 and no amounts outstanding at March 31, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Term Loan Credit Facility </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 7, 2022, the Company entered into a Credit Agreement (the &#8220;2022 Term Loan Credit Facility&#8221;) pursuant to which the Company had an unsecured delayed draw term loan facility up to $<ix:nonFraction unitRef="usd" contextRef="i3ded1a9c1439414ab4b7d6ef1c80ea50_I20221107" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE4Nzc_1a3648e4-8558-41d7-a213-d6e76d3a4739">500</ix:nonFraction>&#160;million which was available for borrowing for <ix:nonNumeric contextRef="i7ea2abb1609b4016be9ea5ea390f3ddb_D20221107-20221107" name="mck:DebtInstrumentDaysAvailableForBorrowing" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTI1Mzk_74026532-0335-4b70-894c-4d8356771c77">90</ix:nonNumeric> days after the closing date in up to three separate borrowings. During the third quarter of fiscal 2023, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="ib8c8b37718a34ccf97efe28b40fa8b98_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3NzQ_fd1592dd-ed30-4d60-a1af-2bd525a06b8a">500</ix:nonFraction>&#160;million under the 2022 Term Loan Credit Facility at an interest rate of <ix:nonNumeric contextRef="i86beb9ab012e4ab98ab444ffd6a60f1d_D20221001-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3NDY_564fe6af-f14a-434b-8680-eaecc75d6716">three-month</ix:nonNumeric> Term SOFR plus <ix:nonFraction unitRef="number" contextRef="i2fc646c92280442fa50dc0dd90fd3b8f_D20221001-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE5MTI_8748c174-e22f-44f3-8692-0ccf2d7563f6">110</ix:nonFraction> basis points, which was payable quarterly and had an original maturity date of November 7, 2025. The funds obtained were used for general corporate purposes. In February 2023, the Company repaid all borrowings outstanding under the 2022 Term Loan Credit Facility, at which point this facility was terminated in its entirety.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Facilities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintained bilateral credit facilities primarily denominated in Euros with a committed amount of $<ix:nonFraction unitRef="usd" contextRef="ie365f78409fa4f7c8fab2a443f6508cb_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3NDg_ad45825f-2be3-4d73-9a0c-1e58895690bd">7</ix:nonFraction>&#160;million and an uncommitted amount of $<ix:nonFraction unitRef="usd" contextRef="ie365f78409fa4f7c8fab2a443f6508cb_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3NjA_66d9be05-870e-4449-931c-55f51f2e2c4b">111</ix:nonFraction>&#160;million as of March 31, 2022, which were transferred as part of the divestiture of the E.U. disposal group in October 2022. Borrowings and repayments were not material during the years ended March 31, 2023, 2022, and 2021, and amounts outstanding under these credit lines were not material at March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $<ix:nonFraction unitRef="usd" contextRef="i764185698f6248c8a59dd7255743615b_I20230331" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzcxOTc_5e6c3707-0fb9-4d6d-88ff-e52aec6b150a">4.0</ix:nonFraction>&#160;billion in outstanding commercial paper notes. During the years ended March 31, 2023, 2022, and 2021, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzcyODM_c8b179bf-0b05-4b5a-99ee-24dc9c3cdd83">8.5</ix:nonFraction>&#160;billion, $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzcyODc_fb9969f5-a7b2-44fd-a4e7-8d9731ba7bcb">11.2</ix:nonFraction>&#160;billion, and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzcyOTU_872136a0-a0d7-4884-92f1-5bf053900f7e">6.3</ix:nonFraction>&#160;billion, respectively, and repaid $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-8" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczMjQ_40117c93-cbb3-4771-a849-42e84e4ad9bf">8.5</ix:nonFraction>&#160;billion, $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-8" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczMjg_b8d49c8c-fe9d-484b-beab-a107bab3aa80">11.2</ix:nonFraction>&#160;billion, and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-8" name="us-gaap:RepaymentsOfCommercialPaper" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczMzY_5b8f5b0b-29b2-49ef-a231-a2bac73aa6c5">6.3</ix:nonFraction>&#160;billion, respectively, under the program. At March 31, 2023 and 2022, there were <ix:nonFraction unitRef="usd" contextRef="ia236aca49f824360a041b24156a09309_I20220331" decimals="-8" name="us-gaap:LongTermDebt" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczOTg_c114cdad-c1ca-4947-b717-252a10fd3020"><ix:nonFraction unitRef="usd" contextRef="i764185698f6248c8a59dd7255743615b_I20230331" decimals="-8" name="us-gaap:LongTermDebt" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczOTg_dd85673e-9bb8-4081-a64c-2ad8fce5e517">no</ix:nonFraction></ix:nonFraction> commercial paper notes outstanding.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_157"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzMwNDA_52fb3039-9dc3-4efe-acbc-7ef619cf0be6" continuedAt="i3d8a46731b7a4e7dac5e8286529d5643" escape="true">Variable Interest Entities </ix:nonNumeric></span></div><ix:continuation id="i3d8a46731b7a4e7dac5e8286529d5643"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs if it has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates a VIE when it has the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE and, as a result, is considered the primary beneficiary of the VIE. It consolidates certain single-lessee leasing entities where it, as the lessee, has the majority risk of the leased assets due to its minimum lease payment obligations to these leasing entities. As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity. Consolidated VIEs do not have a material impact on the Company&#8217;s Consolidated Statements of Operations or Consolidated Statements of Cash Flows. Total assets and liabilities included in its Consolidated Balance Sheets for these VIEs were $<ix:nonFraction unitRef="usd" contextRef="i9be4134ad35a4d88b4b59aff8d5eb2fc_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzE1MDI_e6d3807a-e407-44bf-9ff4-626ad158e62e">621</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9be4134ad35a4d88b4b59aff8d5eb2fc_I20230331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzE1MDk_3654e044-2acb-4fd2-9cb5-452a544eaa56">53</ix:nonFraction> million, respectively, at March 31, 2023, and $<ix:nonFraction unitRef="usd" contextRef="i7bf2f9269b0245f082bf1b61c46287fc_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzE1Mzg_dc25cf54-ad62-4d48-8f77-abe3492db024">660</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7bf2f9269b0245f082bf1b61c46287fc_I20220331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzE1NDU_b7db5c44-3bc8-4184-89af-4bdf7949725e">65</ix:nonFraction>&#160;million, respectively, at March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Unconsolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved with VIEs which it does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Its relationships include equity method investments and lending, leasing, contractual, or other relationships with the VIEs. The Company&#8217;s most significant VIE relationships are with oncology and other specialty practices. Under these practice arrangements, the Company generally owns or leases all of the real estate and equipment used by the practices and manages the practices&#8217; administrative functions. Prior to the divestment of the Austrian business in the fourth quarter of fiscal 2022, the Company had relationships with certain pharmacies in Europe with whom it provided financing, had equity ownership, and/or had a supply agreement whereby it supplied the vast majority of the pharmacies&#8217; purchases. The Company&#8217;s maximum exposure to loss (regardless of probability) as a result of all unconsolidated VIEs was $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-8" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzI2NzE_760a3d96-ecef-44fe-a675-220c780542c9"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzI2NzE_ad483107-9e90-49e9-b8e1-2fc60d8a2747">1.4</ix:nonFraction></ix:nonFraction> billion at March 31, 2023 and 2022, which primarily represents the value of intangible assets related to service agreements, equity investments, and lease and loan receivables. This amount excludes the customer loan guarantees discussed in Financial Note 16, &#8220;Financial Guarantees and Warranties.&#8221; The Company believes there is no material loss exposure on these assets or from these relationships.</span></div></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_160"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzYy_46ecffca-c733-4098-b4ad-55fd8eb44254" continuedAt="id0fc8c0542374412990e616428afb71d" escape="true">Pension Benefits</ix:nonNumeric></span></div><ix:continuation id="id0fc8c0542374412990e616428afb71d" continuedAt="ieee22bba8f3641b8b75dbdbaea770961"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a number of qualified and nonqualified defined benefit pension plans and defined contribution plans for eligible employees.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-U.S. Defined Benefit Pension Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company&#8217;s non-U.S. defined benefit pension plans cover eligible employees located predominantly in Norway and Canada. Benefits for these plans are based primarily on each employee&#8217;s final salary, with annual adjustments for inflation. The obligations in Norway are largely related to the state-regulated pension plan which is managed by the Norwegian Public Service Pension Fund (&#8220;SPK&#8221;). According to the terms of the SPK, the plan assets of state regulated plans in Norway must correspond very closely to the pension obligation calculated using the principles codified in Norwegian law.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; pension liabilities of $<ix:nonFraction unitRef="usd" contextRef="icf74b96be12f4a219ff712ac02236787_I20220331" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1Mjg_c3d482d2-4ac9-4a8d-849c-f2a4f1d8b33e">85</ix:nonFraction>&#160;million, as part of the E.U. disposal group, and pension assets of $<ix:nonFraction unitRef="usd" contextRef="i0d0480bcc6d3431ab87336fe586f8dd4_I20220331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1Njc_0e145f5b-8aa0-4a7b-a134-9607a745a082">49</ix:nonFraction>&#160;million, as part of the U.K. disposal group, were included under the captions &#8220;Liabilities held for sale&#8221; and &#8220;Assets held for sale,&#8221; respectively, in the Consolidated Balance Sheet as of March 31, 2022. During the third quarter of fiscal 2023, the Company divested pension liabilities totaling $<ix:nonFraction unitRef="usd" contextRef="i725249281f6448479928864a02cfeb84_D20221001-20221231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1NDE_834618a8-c075-49d8-ba4f-0363e5e05e28">75</ix:nonFraction>&#160;million and released $<ix:nonFraction unitRef="usd" contextRef="i725249281f6448479928864a02cfeb84_D20221001-20221231" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1NTQ_c56e9556-5c67-4dbe-b370-701275f577ef">13</ix:nonFraction>&#160;million of gains from accumulated other comprehensive loss related to the divestiture of the E.U. disposal group. During the first quarter of fiscal 2023, the Company divested pension assets of $<ix:nonFraction unitRef="usd" contextRef="i9285759f0f7e48fc96862d938f16f2c4_I20220630" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1OTM_997577ef-f78e-40e2-bfab-900aea2344e3">49</ix:nonFraction>&#160;million and released $<ix:nonFraction unitRef="usd" contextRef="ibd224bce6d5d4f0ebf52968e5025d793_D20220401-20220630" decimals="-6" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1ODA_24b7b452-1cd2-4a82-a2f0-820b250c7481">30</ix:nonFraction>&#160;million of accumulated other comprehensive loss related to the divestiture of the U.K. disposal group.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ieee22bba8f3641b8b75dbdbaea770961" continuedAt="i4e33cfbc083147c1953fb5dfe632ec44"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2022, the Company divested $<ix:nonFraction unitRef="usd" contextRef="i29ce9dc1593049718fe7bb3e0475e10e_I20220331" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzI2Njc_33d2f98c-9873-4d39-b884-8df93d67ef68">43</ix:nonFraction>&#160;million of pension liabilities and released $<ix:nonFraction unitRef="usd" contextRef="i10dc0fc369ee4d088df51fef92fe40e1_D20220101-20220331" decimals="-6" sign="-" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzI3MzU_71c9351c-14f8-480d-8c5f-74ea0103bea6">11</ix:nonFraction>&#160;million of accumulated other comprehensive loss related to the sale of its Austrian business. During the third quarter of fiscal 2021, the Company divested $<ix:nonFraction unitRef="usd" contextRef="i2ac7e4d1dc5b4f05b72d3e857f067e82_I20201231" decimals="-6" name="mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzI4ODM_d6dc8b67-57f5-4d4e-b461-8e2fb315c68f">187</ix:nonFraction>&#160;million of pension liabilities and released $<ix:nonFraction unitRef="usd" contextRef="ib91bd719aec14a16b34e473ef04b8e30_D20201001-20201231" decimals="-6" sign="-" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzI5NTE_a490d58b-f165-4cc6-859c-421e8d529bbb">33</ix:nonFraction>&#160;million of accumulated other comprehensive loss related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit plan assets and obligations are measured as of the Company&#8217;s fiscal year-end. <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzI4_6153170f-fd2d-4481-8182-91e1e2e5d51b" continuedAt="id419b00b7cdc4550af0d0c4bb7f3885d" escape="true">The net periodic expense for the Company&#8217;s pension plans were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:12pt"><ix:continuation id="id419b00b7cdc4550af0d0c4bb7f3885d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost - benefits earned during the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzMtNy0xLTEtMjE4NzQ4_5d72a6b0-5cc4-4da5-8a1f-05f45f5fbfe2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzMtOS0xLTEtMjE4NzQ4_a4186391-0f41-4bb6-a0b4-da1bade14abd">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzMtMTEtMS0xLTIxODc0OA_0aa5f719-9a1a-4d2b-b3ee-b6f1f856d153">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzQtNy0xLTEtMjE4NzQ4_7373a51b-20ea-46bf-ae5e-00d5c7da097c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzQtOS0xLTEtMjE4NzQ4_5bb79775-b330-45a7-97c6-0a3f0e72689a">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzQtMTEtMS0xLTIxODc0OA_7433ed80-2310-4de5-a2ac-43eb7051c2e4">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzUtNy0xLTEtMjE4NzQ4_ae2fb120-9223-4b5a-8070-252c41aad7d0">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzUtOS0xLTEtMjE4NzQ4_5687d56a-e67e-4aa9-8d22-25f158c1cdf5">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzUtMTEtMS0xLTIxODc0OA_263e51ce-7453-44b4-8029-8ad7e6f615ed">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized actuarial loss and prior service costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzYtNy0xLTEtMjE4NzQ4_1bd90461-cb5c-4b97-b7e7-a7a1bab3f7d8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzYtOS0xLTEtMjE4NzQ4_7c83dc50-b4b1-4611-ada6-deb52a7021a5">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" name="mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzYtMTEtMS0xLTIxODc0OA_c8be42e6-fc3a-4b16-a9fb-a429316e2334">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzctNy0xLTEtMjE4NzQ4_712649c0-cab6-4bb0-b48a-8ed8e1608d85">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzctOS0xLTEtMjE4NzQ4_c9287b6e-fdca-45c8-be94-ae4ac65f1e5b">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzctMTEtMS0xLTIxODc0OA_946ca1a7-45d4-4ac2-9f4e-126910a5fb1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzktNy0xLTEtMjE4NzQ4_c5a3e808-20e1-43af-87fb-fb5ebf106ef4">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzktOS0xLTEtMjE4NzQ4_06e16a55-d89e-472a-8789-44020a2fd015">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzktMTEtMS0xLTIxODc0OA_7ff6dc92-8d4d-4382-862c-6ec3c7d13535">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding <ix:nonFraction unitRef="number" contextRef="iaebb395b037444299908403308be0b79_I20230331" decimals="2" name="mck:DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzM0ODU_122f0e58-cff2-4493-be1f-b112192d2a14">10</ix:nonFraction>% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service period of active employees.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i4e33cfbc083147c1953fb5dfe632ec44" continuedAt="i714a9cfe6ab2492483e5594012c3e00b"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzU5_8409d61e-22c7-4485-8b08-0aa95f2f8d45" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the changes in benefit obligations and plan assets for the Company&#8217;s pension plans was as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.495%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzQtNS0xLTEtMjE4NzQ4_190d8aea-9b13-4ced-809c-ee626ce75d53">701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2b6a539b6d496b8795e813d345ea7c_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzQtNy0xLTEtMjE4NzQ4_d07d90bf-6e00-4680-85d5-ca76589503f8">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzUtNS0xLTEtMjE4NzQ4_7a53d485-9b97-4981-97db-c9f639fcd4d3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzUtNy0xLTEtMjE4NzQ4_c3ccbf57-f134-4209-a285-e6e932def0d5">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzYtNS0xLTEtMjE4NzQ4_818af69d-a74c-45ad-a918-2548e08e8561">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzYtNy0xLTEtMjE4NzQ4_40892cd8-6e7a-4a7b-9c45-3768079adb08">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzctNS0xLTEtMjE4NzQ4_0cd38f01-8214-4968-8320-2fb5f9dfa98e">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzctNy0xLTEtMjE4NzQ4_f6395a65-667e-4e90-9e01-f748c5dcb38b">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzgtNS0xLTEtMjE4NzQ4_1b135ad1-8034-4792-97fd-8b6636058351">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzgtNy0xLTEtMjE4NzQ4_bade7adc-99c7-44bb-8523-de75c514600b">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzktNS0xLTEtMjE4NzQ4_bf7e78fd-c680-4e69-8ca4-55e0df780921">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzktNy0xLTEtMjE4NzQ4_73677dd9-51c2-4db8-9616-95d5ba1105bd">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationsExpensesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzEwLTUtMS0xLTIxODc0OA_e33a159a-78e5-438a-aed3-77d7ee9e1197">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationsExpensesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzEwLTctMS0xLTIxODc0OA_53c51194-b0a2-42d1-9fbd-ffe125924e98">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzExLTUtMS0xLTIxODc0OA_611131e9-1027-4aac-a1b1-df3f31de6e99">408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzExLTctMS0xLTIxODc0OA_d65c5c94-ba66-4dbc-b4b6-c2f2aa9f2a30">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzEzLTUtMS0xLTIxODc0OA_cb21a14f-e475-41c0-b61b-8ec3e8481e5c">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzEzLTctMS0xLTIxODc0OA_10b1f0ee-984a-4e32-accf-0714e9312b4f">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE0LTUtMS0xLTIxODc0OA_cad0b3df-82aa-4360-b3d3-49fd99811962">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE0LTctMS0xLTIxODc0OA_dcb31106-fff5-4a91-a9fb-8908451c0d57">701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE3LTUtMS0xLTIxODc0OA_7c663faf-6a67-49e3-8c9d-6a1b61750d4b">681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2b6a539b6d496b8795e813d345ea7c_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE3LTctMS0xLTIxODc0OA_1232240e-b18c-409a-85f3-3512abac1000">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE4LTUtMS0xLTIxODc0OA_a0672e53-75d7-454d-8299-ee30c953b7f9">51</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE4LTctMS0xLTIxODc0OA_eb5ede18-fc0f-480b-8187-c7c577dcf621">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer and participant contributions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE5LTUtMS0xLTIxODc0OA_940bf2fc-98d8-47c3-b506-3861f74c38e0">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE5LTctMS0xLTIxODc0OA_076b3b8d-97c9-4533-947e-90e59945a5b1">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIwLTUtMS0xLTIxODc0OA_6b7368de-90eb-4da1-b02c-8413055963f5">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIwLTctMS0xLTIxODc0OA_367d18a6-5bcb-400b-a537-ceb2043dc161">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="mck:DefinedBenefitPlanPlanAssetsExpensesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIyLTUtMS0xLTIxODc0OA_50d20d90-b6f5-4ffc-91c7-d703e81c40e3">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanPlanAssetsExpensesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIyLTctMS0xLTIxODc0OA_1deb64c6-f032-43dc-9fe4-bc072920cc1c">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIzLTQtMS0xLTI2MTU0NQ_09f71681-49a3-458c-9b8f-9a93a09e55a7">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIzLTYtMS0xLTI2MTQ4Mg_835d8f25-2b33-4c37-96d0-e5de16f85c1e">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIzLTUtMS0xLTIxODc0OA_a19cb55b-6047-4905-b259-5a10ac3dd68c">393</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIzLTctMS0xLTIxODc0OA_956092bf-9bd8-43d0-836c-53e635b7d399">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI0LTUtMS0xLTIxODc0OA_9082fba1-f79e-4c33-a3f5-0c865a25ccf6">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI0LTctMS0xLTIxODc0OA_a5efc28b-5339-4df4-bc18-093ba38ea2b1">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI1LTUtMS0xLTIxODc0OA_b65dc237-afec-4ae1-a937-8aeab0e92f21">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI1LTctMS0xLTIxODc0OA_5abd09ba-d500-4c50-a192-e11b81deea50">681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of period</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI3LTUtMS0xLTIxODc0OA_50068207-185c-4bf3-9b9f-2aaf8755e52c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI3LTctMS0xLTIxODc0OA_1ef26022-038a-40b4-bc52-84497631f419">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on the balance sheet</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMwLTUtMS0xLTIxODc0OA_f30181f9-4d8d-4537-aac1-6ccdb182b632">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMwLTctMS0xLTIxODc0OA_165cce2a-83de-4655-b183-70b0dd0999f0">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMxLTUtMS0xLTIxODc0OA_5a6e6460-e43c-406e-bc63-227d024c4d0f">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMxLTctMS0xLTIxODc0OA_cbe1b553-68e4-4a4e-8f59-ce4c03335a6d">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMyLTUtMS0xLTIxODc0OA_54a3bf9d-d922-4521-aee7-e1e3db89584b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMyLTctMS0xLTIxODc0OA_7668c0ad-383f-4534-beeb-9a957a01d7df">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMzLTUtMS0xLTIxODc0OA_33daea70-3288-4421-aca9-358079e80f74">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMzLTctMS0xLTIxODc0OA_aed05859-c996-4957-b2c6-747209a76a48">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzM0LTUtMS0xLTIxODc0OA_b54aa2f1-c6b4-456a-874e-2f124dad8dfa">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzM0LTctMS0xLTIxODc0OA_dbb81dfe-1114-4212-9662-7d7ae7e0d590">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The benefit obligation is the projected benefit obligation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Relates to the completed divestitures of the E.U. disposal group and U.K. disposal group in fiscal 2023 and the completed divestiture of the Company&#8217;s Austrian business in fiscal 2022 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Current assets at March 31, 2022 include $<ix:nonFraction unitRef="usd" contextRef="iba0180b4473b4cc5ada51da9d6909ece_I20220331" decimals="-6" name="mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQxMjA_67e667cc-5df3-4c4b-bb97-d445d964dbe6">49</ix:nonFraction>&#160;million reclassified from long-term assets to assets held for sale as part of the Company&#8217;s U.K. disposal group, which was divested in fiscal 2023. Current liabilities at March 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="iba0180b4473b4cc5ada51da9d6909ece_I20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQyNjI_7fae7d2d-6616-44c3-ad97-b731f0b02835">85</ix:nonFraction>&#160;million reclassified from long-term liabilities to liabilities held for sale as part of the Company&#8217;s E.U. disposal group, which was divested in fiscal 2023. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures&#8221; for additional information.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial gain of $<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ0NTg_0cd38f01-8214-4968-8320-2fb5f9dfa98e">65</ix:nonFraction> million in fiscal 2023 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates ($<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ1MTQ_65893957-2f80-4d9c-8de4-e9f52793e6eb">69</ix:nonFraction>&#160;million gain):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> The weighted average discount rate for Non-U.S. plans increased to <ix:nonFraction unitRef="number" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ1OTE_c0d55ec2-2651-43cd-856a-77327821a0b3">4.54</ix:nonFraction>% as of March 31, 2023 from <ix:nonFraction unitRef="number" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ2MDg_8f70c292-9dd9-4182-8f84-35eec2383de8">2.67</ix:nonFraction>% as of March 31, 2022. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i714a9cfe6ab2492483e5594012c3e00b" continuedAt="ic0203d215a5c451ab9649563fea33ec2"><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes ($<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" sign="-" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ2NTg_57faaab3-1194-4ceb-ad73-18e3246f92c1">4</ix:nonFraction>&#160;million loss):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial gain of $<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ5NDM_f6395a65-667e-4e90-9e01-f748c5dcb38b">55</ix:nonFraction> million in fiscal 2022 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">($<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzcxNDY4MjU2MDQxNzA_b5d011f5-6913-44f4-9e49-507963c22405">69</ix:nonFraction>&#160;million gain):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> The weighted average discount rate for Non-U.S plans increased to <ix:nonFraction unitRef="number" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzUwNzY_e4d9ff37-555b-4183-aaef-b4ba309c8eec">2.67</ix:nonFraction>% as of March 31, 2022 from <ix:nonFraction unitRef="number" contextRef="i6c2b6a539b6d496b8795e813d345ea7c_I20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzUwOTM_395becc6-bf4b-40c4-9c26-04e8068f5b2f">1.89</ix:nonFraction>% as of March 31, 2021.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes ($<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" sign="-" name="mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzUxNDI_218dfafc-9d69-4a24-a70c-2bf508fb7848">14</ix:nonFraction>&#160;million loss):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the European divestitures in fiscal 2022.</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzA5_9b0c3d7e-db40-41db-92bf-a5f5cac64c0a" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#8217;s pension plans, including accumulated benefit obligation in excess of plan assets:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.495%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzMtNS0xLTEtMjE4NzQ4_1324cea0-47f5-417d-b083-79f39705691f">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzMtNy0xLTEtMjE4NzQ4_8e81fb23-48c2-4633-a279-b5edc9c4a589">701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzQtNS0xLTEtMjE4NzQ4_9bd6c590-6588-4cf7-b32c-33e287f0f77a">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzQtNy0xLTEtMjE4NzQ4_7c121d26-3276-4393-ad56-ddeb5d28eaf1">689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzUtNS0xLTEtMjE4NzQ4_896eaf5f-c827-4ccc-a37b-7c481b2b946f">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzUtNy0xLTEtMjE4NzQ4_571a5c7b-9f35-497b-bf81-602d086e3e77">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzM1_34083610-abee-4164-a399-450a94114ce6" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in accumulated other comprehensive loss consist of: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.495%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzMtNS0xLTEtMjE4NzQ4_21e1439d-397d-4ce3-83a2-eb3b44909cfd">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzMtNy0xLTEtMjE4NzQ4_8d0119af-a37b-4814-b2a5-4ab6bc957225">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzQtNS0xLTEtMjE4NzQ4_d645b675-6ed7-41ce-9f8b-edab5ed2c986">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzQtNy0xLTEtMjE4NzQ4_b95cc9ca-a6cb-4d15-a8a5-b8ae38f2f3e9">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzUtNS0xLTEtMjE4NzQ4_38d13c41-1f82-4da3-bca1-3878b47fa5d7">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzUtNy0xLTEtMjE4NzQ4_d4e1dc10-df49-4ac9-ba59-b98d86ca823c">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2Nzc0_288417c5-1ad4-4fcf-af9a-edd031cd9ac8" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other changes in accumulated other comprehensive loss were as follows: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:55.058%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzMtNy0xLTEtMjE4NzQ4_7831899f-6730-4bdd-a537-b56e12012609">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzMtOS0xLTEtMjE4NzQ4_cbe49db5-2069-4aaa-a1f6-9bb3c8f8e22f">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzMtMTEtMS0xLTIxODc0OA_84b46a53-1cf2-4720-9085-247be3d6f9ac">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzQtNy0xLTEtMjE4NzQ4_023c3e1f-2f2a-4347-9d86-086b912e179b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzQtOS0xLTEtMjE4NzQ4_7a9f8aeb-1e4c-4bd4-a061-f761ca0f74e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzQtMTEtMS0xLTIxODc0OA_10af6ad9-122e-4ebd-960e-eede4ae0f218">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzYtNy0xLTEtMjE4NzQ4_0d042e49-614f-4fb1-8239-9214b8c723d6">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzYtOS0xLTEtMjE4NzQ4_b35e39f1-5503-4165-aeeb-b6ef31d2ca36">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzYtMTEtMS0xLTIxODc0OA_d744487d-7ade-40e8-ae15-536366d49cbb">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzctNy0xLTEtMjE4NzQ4_72844934-d87d-4bf0-851c-3649a91b0bc9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzctOS0xLTEtMjE4NzQ4_14d75292-3517-4c1d-ba99-dfbabf82a96d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzctMTEtMS0xLTIxODc0OA_dcbcc820-9416-4620-ad77-27ff23361eff">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzgtNy0xLTEtMjE4NzQ4_eb2a8104-33f3-4627-830f-fdd50af29e18">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzgtOS0xLTEtMjE4NzQ4_b5ef3232-59e4-44fb-9a7f-4648e7c9540b">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" sign="-" name="mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzgtMTEtMS0xLTIxODc0OA_f909f583-a2b9-4c0b-ba5c-d15831fb1fe5">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive income </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzktNy0xLTEtMjE4NzQ4_dfe95f21-40dc-49e2-8adb-f1b4982076e7">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzktOS0xLTEtMjE4NzQ4_43d1ff57-937b-415b-bcd8-a3d956cef096">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzktMTEtMS0xLTIxODc0OA_11488063-9647-42f4-9c3c-2e98348e6f49">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2023, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i6af7427ba4784b7fab08180a13ff9b1c_D20220401-20230331" decimals="-6" sign="-" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTY0Mjg_a11fdeb8-d08d-4f98-8383-be6e8d4a5b5d">17</ix:nonFraction>&#160;million in actuarial losses for pension plans to stockholders&#8217; deficit as a result of the sale of its E.U. disposal group and U.K. disposal group. In fiscal 2022, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="ie4656299b20c436497390a7e79147f34_D20210401-20220331" decimals="-6" sign="-" name="mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzU4MTc_64967f61-8c9f-4e14-90b3-d107910d4a30">11</ix:nonFraction>&#160;million in actuarial losses for pension plans to stockholders&#8217; deficit as a result of the sale of its Austrian business. In fiscal 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i10bcba3ec49146f58e7e91f9b293ca33_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzU5NjQ_2efe816b-b907-469f-bf7c-a4696ef37e4c">33</ix:nonFraction>&#160;million in actuarial losses for pension plans to stockholders&#8217; equity as a result of the contribution of its German pharmaceutical wholesale business to a joint venture. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for more information on the Company&#8217;s European divestiture activities. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected benefit obligations related to the Company&#8217;s unfunded plans were $<ix:nonFraction unitRef="usd" contextRef="i722584ad23f0453f86285951f75a1700_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY3NDU_c7a72152-f83f-4e71-b45e-b7ab2fdea8b1">18</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i205b3862163e4e678a0394523279c14a_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY3NTI_4c84db06-0338-465b-bb70-282d736a1f1e">101</ix:nonFraction> million at March 31, 2023 and 2022, respectively. Funding obligations for its plans vary based on the laws of each jurisdiction.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ic0203d215a5c451ab9649563fea33ec2" continuedAt="i15815f445fff4f1e921ce136615b6ffb"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments for the Company&#8217;s pension plans were as follows: $<ix:nonFraction unitRef="usd" contextRef="iaebb395b037444299908403308be0b79_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY5NTQ_d04f3fb4-d76f-4e3e-84c9-de3ab19e4e61">8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iaebb395b037444299908403308be0b79_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY5NTg_50105e44-abf6-49d7-aa81-faaad199e775">9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iaebb395b037444299908403308be0b79_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY5NjI_cbc01c3a-40b8-46d5-8ceb-3fb76c997ab6">9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iaebb395b037444299908403308be0b79_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY5NjY_577c3a5d-08a2-4e4e-94ca-874c66692f6d">9</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iaebb395b037444299908403308be0b79_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY5NzQ_ed5fcfeb-5aab-4d74-a409-e1fd6b2274fb">9</ix:nonFraction> million for fiscal 2024 to fiscal 2028, respectively, and $<ix:nonFraction unitRef="usd" contextRef="iaebb395b037444299908403308be0b79_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzcwMDk_24128585-4256-4ec9-914e-081a0058dcf8">50</ix:nonFraction> million for fiscal 2029 through fiscal 2033. Expected benefit payments are based on the same assumptions used to measure the benefit obligations and include estimated future employee service. Expected contributions to be made for the Company&#8217;s pension plans are $<ix:nonFraction unitRef="usd" contextRef="iaebb395b037444299908403308be0b79_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzcyNDg_ee56c216-2893-4720-8467-7f777466dccd">3</ix:nonFraction> million for fiscal 2024.</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2Nzg2_06031851-b9a0-44c8-95a4-0d12f23ca105" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:55.140%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.528%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.532%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic pension expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzQtNy0xLTEtMjE4NzQ4_e5b7d63e-5134-45a7-bfe0-463f81a2e9ab">2.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzQtOS0xLTEtMjE4NzQ4_fd42174f-a2bb-40c7-9313-00e6c4164265">1.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzQtMTEtMS0xLTIxODc0OA_bbddac2b-776f-4152-a34a-f45571cc3c98">1.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzUtNy0xLTEtMjE4NzQ4_aa2bff21-7b01-45e7-ab21-91edf8b1a675">3.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzUtOS0xLTEtMjE4NzQ4_b45d7cc4-cb8a-4d58-83bb-ed36fa5ed61b">3.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzUtMTEtMS0xLTIxODc0OA_4dfa621a-6288-4666-b9d6-b13f80ecc731">3.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzYtNy0xLTEtMjE4NzQ4_5050ddf9-3cf6-4610-828c-52edafaaea41">1.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzYtOS0xLTEtMjE4NzQ4_491d4d6c-c948-4b48-b746-be2e7abff6fc">2.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzYtMTEtMS0xLTIxODc0OA_8f3984fa-7255-4bda-ac31-4275d23f3a1a">2.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzgtNy0xLTEtMjE4NzQ4_efb43441-3273-4bec-a641-1b388712739b">4.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzgtOS0xLTEtMjE4NzQ4_b57ba9b2-fe55-40aa-a587-22294281da54">2.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c2b6a539b6d496b8795e813d345ea7c_I20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzgtMTEtMS0xLTIxODc0OA_b0a31a0b-2086-457e-bb93-eb4d96aea0f3">1.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzktNy0xLTEtMjE4NzQ4_2ae680c9-0a11-44aa-911a-028aba334896">3.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzktOS0xLTEtMjE4NzQ4_327af806-6eea-457e-9307-cd6dfab80a9b">3.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c2b6a539b6d496b8795e813d345ea7c_I20210331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzktMTEtMS0xLTIxODc0OA_8e074e71-2c56-43ad-9086-84ebb7dfbf2b">3.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s defined benefit pension plan liabilities are valued using a discount rate based on a yield curve developed from a portfolio of high quality corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans. The Company&#8217;s defined benefit pension plan liabilities are valued using a weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzgxNTc_376ec830-76b2-4adb-9319-2a380ca71a74">4.54</ix:nonFraction>%, which represents an increase of <ix:nonFraction unitRef="number" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="4" name="mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzgxOTM_c89066a1-d3b2-407c-8bc6-7052bb3f7f80">187</ix:nonFraction> basis points from its fiscal 2022 weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzgyNTU_3ccad312-1060-41e2-8124-91863a00f2ae">2.67</ix:nonFraction>%.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Assets </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Strategy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For plan assets, the investment strategies are subject to local regulations and the asset/liability profiles of the plans in each individual country. Plan assets are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans. Plan assets are primarily invested in high-quality corporate and government bond funds and equity securities. Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops the expected long-term rate of return assumption based on the projected performance of the asset classes in which plan assets are invested. The target asset allocation was determined based on the liability and risk tolerance characteristics of the plans and at times may be adjusted to achieve overall investment objectives.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i15815f445fff4f1e921ce136615b6ffb" continuedAt="i9e9947f207f94ab8be1cfbb89d066134"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on unadjusted quoted prices in active markets for identical assets. Level&#160;2 refers to fair values estimated using significant other observable inputs and Level 3 includes fair values estimated using significant unobservable inputs. <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzQy_a36b94f8-5a6b-49be-9c36-f741d82360bf" continuedAt="i5b3479d2cfec4b37865b32f8f4372210" escape="true">The following tables represent the Company&#8217;s plan assets as of March&#160;31, 2023 and 2022, using the fair value hierarchy by asset class:</ix:nonNumeric></span></div><ix:continuation id="i5b3479d2cfec4b37865b32f8f4372210"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51610f05cd18459b963569b57c8bbbe1_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtMS0xLTEtMjE4NzQ4_12c1756d-8b7e-4f05-88d1-988300ef0f60">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71bf1a36819e476c85f3a6d8663bdea3_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtMy0xLTEtMjE4NzQ4_1129e770-4405-44f1-aa7c-2021afe6e873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ba471960e744afa8691f9d48e62f13_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtNS0xLTEtMjE4NzQ4_3afc80e7-ef84-4c8d-b140-e4a06d3eac64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida7184b50fa64a8dbc5cde66e602da28_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtNy0xLTEtMjE4NzQ4_0d42e1ed-bd77-44be-9831-137d18b1e54b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i994dc07d79bd4a03a6631b10f5eceac2_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtOS0xLTEtMjE4NzQ4_284dce55-a2d4-47c4-8a79-e063a0b8075b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie758338a330442f68f01dd372842ee71_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtMTEtMS0xLTIxODc0OA_732ebae3-ff01-4387-aea8-455723b5bc13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b161706e1cc4841adfb4249122e7e93_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtMTMtMS0xLTIxODc0OA_55b8515c-9a16-408d-8f4b-10a137eb91f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9871350b1e94507bc4d2b7948cd34e2_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtMTUtMS0xLTIxODc0OA_85b3c8a5-4012-4317-a8ca-5000e0c6dd6b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125e3486c8434dc7b093af7f724a9223_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtMS0xLTEtMjE4NzQ4_df6dd9dd-51c7-4c63-ac8c-809564711c10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77514bdd2d89462c9211465f0a766ec7_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtMy0xLTEtMjE4NzQ4_e916d783-791e-4df7-bb1f-bee40710902a">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8973019f6d64483a30bda7006efbc09_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtNS0xLTEtMjE4NzQ4_60cd9cb0-15ce-4b80-bf31-0e4ad7c72e66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e169cd345664994a6d79eea226c19b3_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtNy0xLTEtMjE4NzQ4_a065e872-ddc3-4403-84e9-657a93f92234">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b05b2e1ce7435294b2dbf7fb0aae99_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtOS0xLTEtMjE4NzQ4_1f3abf07-568d-4733-ab87-a46db647271d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8307fb561294672b090c1bb5d05d513_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtMTEtMS0xLTIxODc0OA_6e59cf05-14ff-453f-a7a2-06748bb4ee99">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f1ee10031041a3af07110ab4849733_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtMTMtMS0xLTIxODc0OA_e79c491a-e73f-4a0c-8c49-ac3e2beea70b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ad2547012c48f4936cd2741754a6d9_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtMTUtMS0xLTIxODc0OA_c564da9b-1de4-4ac6-9620-865f62385a7c">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7ed483c5154a59a6c8c3b34afc8b2c_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtMS0xLTEtMjE4NzQ4_f3a6c43d-6dd0-45c8-bc04-99c3d9430f79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a004834e91942e79a1a035a54eb8430_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtMy0xLTEtMjE4NzQ4_962e11e7-c7a7-4dc7-a9da-50ea7f9bd2cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24fb96b7e1ad440a909f91f9f5db78a3_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtNS0xLTEtMjE4NzQ4_864b7b58-2a21-4e28-aff2-f98288823218">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0efc094e70304787b594a72d0060b612_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtNy0xLTEtMjE4NzQ4_475099d8-212f-4fca-9a6d-e50d13e4d2ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f2387351c284073a3585ae340c96f38_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtOS0xLTEtMjE4NzQ4_9f8a4ee6-b477-468f-8676-0a62895dbe4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic30de0ea7dbf4ca294f03806a898ccb9_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtMTEtMS0xLTIxODc0OA_9d24fadf-f8e7-4081-af18-8a6ffeb41b8d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i657e7112d45443199c58b406acf29838_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtMTMtMS0xLTIxODc0OA_468f97db-3239-447c-895e-b89cca88c0e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5327b1083ed94e798541f3da89104dc9_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtMTUtMS0xLTIxODc0OA_a6a41b12-9315-44cd-b46e-16fb2e843e33">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39dae6d084c84047aa582ca074a0d078_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktMS0xLTEtMjE4NzQ4_1238975a-8a58-40be-91cb-f4471ce00399">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia46e3fa973c947b48594cb4ab31a9c66_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktMy0xLTEtMjE4NzQ4_7d1f610b-2452-4648-8a85-aa0a126e4e15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13d1edaf8e3f4acab8850b098880754d_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktNS0xLTEtMjE4NzQ4_acebd463-31a4-4186-8b71-5d75e342507c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i227439bd64d1487db0754f92fbcd1a4f_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktNy0xLTEtMjE4NzQ4_8ebaf7b8-c0e3-49ad-be81-021709c4f360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d43483f4048ec80ee7227fa0f70f5_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktOS0xLTEtMjE4NzQ4_7ff3bcbc-8083-4f34-9eb4-526d5e6280b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62410ab1336048ada10bb12a73da0a7c_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktMTEtMS0xLTIxODc0OA_209c4018-5513-4bc4-a84a-70d611be7188">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28cf440d298c42adb27df58f03c66fea_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktMTMtMS0xLTIxODc0OA_8176a1d5-2a01-45a6-9ecf-1c64f773c216">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4193615347d4fe29a971e9dd9b5227f_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktMTUtMS0xLTIxODc0OA_1a2c1d5e-dc38-4359-84e1-5abc388f001a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i918e287d03514df6b3bfe695542d3887_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTEtMS0xLTIxODc0OA_588e25c3-09f5-4fe6-ab93-caf2d7f64bfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia011b94ec27b40e8b51a633a0bcbd4a5_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTMtMS0xLTIxODc0OA_9b33fad5-1780-40af-8c1b-1247e921cf57">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb1fcabf197142b5bd6d52bf694fa67b_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTUtMS0xLTIxODc0OA_23133e48-c747-45a4-bd82-5286f6756b46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43e7a92a6d5e4ada8cc90026e6b3229d_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTctMS0xLTIxODc0OA_fea1e548-f394-49d5-ad63-48df8b6067ef">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd1cb19b0477476cb20d2a0e4982c520_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTktMS0xLTIxODc0OA_11c16751-e2af-4f1e-92d3-40e6a0f019da">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac3be98a2bbc4274ace7d610d1288ff9_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTExLTEtMS0yMTg3NDg_3e9e4bf3-f0cf-4d1c-8ee1-4540c89b874b">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3f016b2ef3e440eb97d4400be55876f_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTEzLTEtMS0yMTg3NDg_d6686150-bcf8-4954-9240-6c4487afd444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a1d6ce3a444d7e82696c5f8ff77d6d_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTE1LTEtMS0yMTg3NDg_0c796fd4-afd6-46a8-a02e-6300eb6cb802">361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ad37783f6e4af8b246e63c8f3a99c0_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTEtMS0xLTIxODc0OA_ac9c1a69-b038-4ee2-9cc1-4b156ac5f5df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica1476e409e7402b9a147a0ba6312dff_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTMtMS0xLTIxODc0OA_aacd07a1-4268-4edd-92d4-1671ef13525a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f69217e7cff424dbb573dfbe087faa5_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTUtMS0xLTIxODc0OA_b73501b4-e944-489a-8ce6-b9f88cf523a0">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63109b7002f4f4f93a996b521f5b59e_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTctMS0xLTIxODc0OA_4b4608aa-d7ce-4f19-813b-742e962e23c0">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i829df4d042954ba09a94b3ab60df2ee6_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTktMS0xLTIxODc0OA_6b62b234-610c-4f4b-acc9-9e90410e566f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94b0345b6b1d434596b0988c93100635_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTExLTEtMS0yMTg3NDg_f7f35706-f5d4-4385-b608-cbf8a2ef071f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38c1211ca3bd47ccaa63f4d573ef3eb9_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTEzLTEtMS0yMTg3NDg_ffcf88b8-2f36-4948-8205-dc558e67c1bd">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8613bd2d24b24d0c91d02304e304ef0e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTE1LTEtMS0yMTg3NDg_dd1cfa3d-5f94-4ef7-aa01-3e4c1f324cb8">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999721f0f4df4c2db0a933b5978923b6_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTEtMS0xLTIxODc0OA_022941cb-ac86-4323-ade1-dde0f894cc9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18b9e6dc3e4246a78043d39c8c8a997d_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTMtMS0xLTIxODc0OA_1586bd56-77d9-45d6-bbae-eef207686acc">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ce3ce209624caf96b787927d453e69_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTUtMS0xLTIxODc0OA_359efc59-cc7d-4bb1-9f5d-d90d850449e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i846de7923abc4c97892d8ae4ffa6a848_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTctMS0xLTIxODc0OA_523687d0-77b5-491c-901c-b1fd351a04de">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i087f9375fa6f4e85b3f512df46958583_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTktMS0xLTIxODc0OA_83892178-fa7d-4e3b-8cd6-c32df66c2ad2">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a25adf74c747e3af066921668300d8_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTExLTEtMS0yMTg3NDg_50530fda-9faa-4a43-8a09-810698c6d62e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2c7699ae1b14f20a774af95b9906d4e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTEzLTEtMS0yMTg3NDg_d4cb1f35-1024-40cf-a331-709e3187a33a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da20a00fd7c41bf882c2c4b0fca97bc_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTE1LTEtMS0yMTg3NDg_cf605dc9-5b94-49ba-85df-3e14f714ea62">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8f41a67f1d4ac6bcd66decef5d2d36_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTEtMS0xLTIxODc0OA_4909eeb9-7b62-4760-9291-3b1668d2b253">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77b1393ed7f4e1cb5cdf0a8cceb3947_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTMtMS0xLTIxODc0OA_57abc6d5-8081-4149-8dc7-edf4c09f77fa">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb089efc1bd4c339e696998159d126a_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTUtMS0xLTIxODc0OA_4b47ac39-cf9c-4e4b-a573-ff6785e8c2af">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i736fe7819f714241ad16df84489ece06_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTctMS0xLTIxODc0OA_1ca626fa-1e0d-4d1a-976d-a02159e31659">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i403dc252a03943a08391aee80b76db38_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTktMS0xLTIxODc0OA_3581a896-a281-4dba-b5f7-fd6730f73ae1">382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e959507a65a46d4953fdcacc156df2a_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTExLTEtMS0yMTg3NDg_0340ce8c-74d5-4d0e-8885-e764a69861ab">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2c0f39a48f745c181b6f5d69c3f1b19_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTEzLTEtMS0yMTg3NDg_9ce82ebc-3559-4332-b9f1-ec587a083d4e">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aff01889e07438fb29743fe2ba9c669_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTE1LTEtMS0yMTg3NDg_0b2993e8-ca67-4fe6-a7ef-e7db2eefe6fd">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held at NAV practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22203a08a73a45f287b95b3462d5d578_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzIyLTctMS0xLTIxODc0OA_c507449f-10d2-45e3-94d1-0776bf2eba1c">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a7ce7882d7346b99cf64d531cb03268_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzIyLTE1LTEtMS0yMTg3NDg_8172c30d-8a7a-4151-96a2-2319dce38edb">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzIzLTctMS0xLTIxODc0OA_c9acce3b-c973-4c11-8095-ab7598a3159d">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzIzLTE1LTEtMS0yMTg3NDg_b3838930-6978-463a-972e-ad6eb41f986b">681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents - Cash and cash equivalents include short-term investment funds that maintain daily liquidity and aim to have constant unit values of $<ix:nonFraction unitRef="usdPerShare" contextRef="i548b65f153fe455fb735edc18c43071c_D20220401-20230331" decimals="2" name="mck:UnitValueOfCashAndCashEquivalents" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzEwMjc0_0eb605d0-3d11-4edf-8c60-767d61a59cf1">1.00</ix:nonFraction>. The funds invest in short-term fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and high credit quality. Directly held cash and cash equivalents are classified as Level 1 investments. Cash and cash equivalents include money market funds and other commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity commingled funds - Some equity investments are held in commingled funds, which have daily net asset values derived from quoted prices for the underlying securities in active markets; these are classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities - Government securities consist of bonds and debentures issued by central governments or federal agencies; corporate bonds consist of bonds and debentures issued by corporations. Inputs to the valuation methodology include quoted prices for similar assets in active markets, and inputs that are observable for the asset, either directly or indirectly, for substantially the full term of the asset. Multiple prices and price types are obtained from pricing vendors whenever possible, enabling cross-provider price validations. Fixed income securities are generally classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income commingled funds - Some fixed income investments are held in exchange traded or commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1, 2, or 3 investments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annuity contracts - The value of the annuity contracts is reported by the Trustee and is based on a valuation of the remaining contracted cash flow of the contract. Inputs in the valuation include discounted future cash flows; these are classified as Level 3 investments. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i9e9947f207f94ab8be1cfbb89d066134" continuedAt="i7a3fa18231bb4abfbba06178f538ed3c"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real estate funds - The value of the real estate funds is reported by the fund manager and is based on a valuation of the underlying properties. Inputs used in the valuation include items such as cost, discounted future cash flows, independent appraisals, and market based comparable data. The real estate funds are classified as Level 1, 2, or 3 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other - At March 31, 2023 and 2022, this includes $<ix:nonFraction unitRef="usd" contextRef="ib463cce9887841b580560f381cb2da5b_I20230331" decimals="-6" name="mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzEyNTEy_85e8b271-8e21-4b48-8d56-8bfe4d23c125">30</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i320f8fd67c4948f0a308006480a2c5ad_I20220331" decimals="-6" name="mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzEyNTE5_327427b7-0957-4c6a-86c2-76384eda3779">35</ix:nonFraction> million, respectively, of plan asset value relating to the SPK. In principle, the SPK is organized as a pay-as-you-go system guaranteed by the Norwegian government as it holds no Company-owned assets to back the pension liabilities. The Company pays a pension premium used to fund the plan, which is paid directly to the Norwegian government who establishes an account for each participating employer to keep track of the financial status of the plan, including managing the contributions and the payments. Further, the investment return credited to this account is determined annually by the SPK based on the performance of long-term government bonds.</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzI2_0493a587-e8dc-41e5-be05-b760c5f0880c" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the Level 3 plan assets measured on a recurring basis for the years ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.298%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedac49b197d6406986b0d015faf7d0db_I20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzEtMS0xLTEtMjM5NzQ3_7fe585c9-86b1-4db7-a982-aae46ad5b860">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzItMS0xLTEtMjM5NzQ3_83f14599-ef40-4d72-b428-75ee4abc8a6d">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzMtMS0xLTEtMjM5NzQ3_fe47a707-88af-4592-8f05-dd22e4e0318e">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6665b3b43b04da588b52399a7fe54b5_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzEtMS0xLTEtMjE4NzQ4_f7094046-6506-484c-8344-37ac11404628">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a7df9519bd34e78875fe27cd2ff763e_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzItMS0xLTEtMjE4NzQ4_cf90d92c-da77-4535-89ef-a4f24383b2f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a7df9519bd34e78875fe27cd2ff763e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzMtMS0xLTEtMjE4NzQ4_583f6be2-6a4a-46e3-b829-1cbdeccd5087">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a9b9f544264510b97f94b12eb3d7b2_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzUtMS0xLTEtMjE4NzQ4_2538ddcb-437e-4b72-80ae-ecac72ffe53f">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover union-represented employees in the U.S. In 2017, it also contributed to the Pensjonsordningen for Apoteketaten (&#8220;POA&#8221;), a mandatory multiemployer pension scheme for its pharmacy employees in Norway, managed by the association of Norwegian Pharmacies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks of participating in these multiemployer plans are different from single-employer pension plans in the following aspects: (i)&#160;assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers; (ii)&#160;if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers; and (iii)&#160;if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability. Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company&#8217;s withdrawal liability and contributions may increase.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contributions and amounts accrued for U.S. multiemployer pension plans were not material for the years ended March 31, 2023, 2022, and 2021. Contributions to the POA for non-U.S. plans exceeding <ix:nonFraction unitRef="number" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="INF" name="mck:DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE0ODA3_34ec3a72-0c07-41d8-926a-7735116aaf14">5</ix:nonFraction>% of total plan contributions were&#160;$<ix:nonFraction unitRef="usd" contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE0ODQz_17ec697d-5586-4b7e-b587-3e8ab57d4aac">19</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE0ODQ3_64cd40ce-7cdd-4e11-ab4a-39de61135c0e">20</ix:nonFraction> million, and&#160;$<ix:nonFraction unitRef="usd" contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE0ODU1_dce7b4bb-be24-4700-9a90-7b74b96f91cb">22</ix:nonFraction> million for the years ended March 31, 2023, 2022, and 2021, respectively. Based on actuarial calculations, the Company estimates the funded status for its non-U.S. Plans to be approximately <ix:nonFraction unitRef="number" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="2" name="mck:MultiemployerPlanFundedStatusPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1MDA3_1f1191c4-c5e0-43a3-89a8-bca2c8eb8c78">85</ix:nonFraction>% as of March 31, 2023. <ix:nonFraction unitRef="usd" contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331" decimals="INF" name="us-gaap:MultiemployerPlansWithdrawalObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1MDIw_1012ff5f-83a1-4baa-904a-f4803f265cb5">No</ix:nonFraction> amounts were accrued for liability associated with the POA as the Company has no intention to withdraw from the plan.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Defined Contribution Plans </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a contributory retirement savings plan (&#8220;RSP&#8221;) for U.S. eligible employees. Eligible employees may contribute to the RSP up to <ix:nonFraction unitRef="number" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1MzEy_2ed07781-6afa-4e71-b4e9-fcd515f85be1">75</ix:nonFraction>% of their eligible compensation on a pre-tax or post-tax basis not to exceed IRS limits. The Company makes matching contributions in an amount equal to <ix:nonFraction unitRef="number" contextRef="if513543f51ba4b0d91334260d63c6376_D20220401-20230331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1NDY2_d10d3b52-3d58-48ad-a78a-43ae01d6cee4">100</ix:nonFraction>% of the employee&#8217;s first <ix:nonFraction unitRef="number" contextRef="if513543f51ba4b0d91334260d63c6376_D20220401-20230331" decimals="INF" name="mck:EmployeeContributions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1NDkz_e9911970-f154-4ab7-b263-567d0bab4515">3</ix:nonFraction>% of pay contributed and <ix:nonFraction unitRef="number" contextRef="i957a9c83570946a8bff0405f80b94b7f_D20220401-20230331" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1NTE5_711e6faf-2f78-42d2-92c1-8197620ffed9">50</ix:nonFraction>% for the next <ix:nonFraction unitRef="number" contextRef="i957a9c83570946a8bff0405f80b94b7f_D20220401-20230331" decimals="INF" name="mck:EmployeeContributions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1NTM1_815126b0-0f74-4f11-9dfc-cb216141a3da">2</ix:nonFraction>% of pay contributed. The Company also may make an additional annual matching contribution for each plan year to enable participants to receive a full match based on their annual contribution. The Company also contributed to non-U.S. plans that are available in certain countries. Contribution expenses for the RSP and non-U.S. plans were $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1ODc1_50af9dd3-cba5-47a2-9a63-5839ed1285bc">125</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1OTA0_8d66fb07-f776-425e-a43b-178f3c418d80">116</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzU0OTc1NTg0NzgzOA_70bf8f05-f945-4bb5-b8ba-c9208583ad73">102</ix:nonFraction> million for the years ended March 31, 2023, 2022, and 2021, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i7a3fa18231bb4abfbba06178f538ed3c"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Postretirement Benefits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a number of postretirement benefit plans, primarily consisting of healthcare and life insurance (&#8220;welfare&#8221;) benefits, for certain eligible U.S. employees. Eligible employees consist of those who retired before March 31, 1999 and those who retired after March 31, 1999, but were an active employee as of that date, after meeting other age-related criteria. It also provides postretirement benefits for certain U.S. executives. Defined benefit plan obligations are measured as of the Company&#8217;s fiscal year-end. The net periodic (credit) expense for the Company&#8217;s postretirement welfare benefits was <ix:nonFraction unitRef="usd" contextRef="ica96366b6bcf4de3a3a5a18786d44260_D20220401-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NTg5_81546fc3-876f-40b0-88e9-4747b826c99e"><ix:nonFraction unitRef="usd" contextRef="idb54d0a7ddd04860a8ac09f3e04418f4_D20200401-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NTg5_d505276a-b98b-44af-ae47-6ad9f39cea02"><ix:nonFraction unitRef="usd" contextRef="i942e6213795a47479851045f390d686e_D20210401-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NTg5_e11f9926-0e52-4cd2-917c-d0feb6c3eeba">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t material for the years ended March 31, 2023, 2022, and 2021. The benefit obligation at March 31, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="i570d5007fbb6461f83baab05592c1bd4_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2Njc4_86d29928-ee10-493b-a521-199ac79d60cc">45</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6581ce23346b4adc8afb8d7c98565984_I20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2Njg1_64e950e4-52eb-491b-943e-a81e8e3d0011">56</ix:nonFraction> million, respectively.</span></div></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_163"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzExNTk2_87ab95d2-3109-4052-95bc-9067b0f525e6" continuedAt="i66e8b52392ba4221a42de1b73e226a2d" escape="true">Hedging Activities </ix:nonNumeric></span></div><ix:continuation id="i66e8b52392ba4221a42de1b73e226a2d" continuedAt="i27c889e8c43744db9d96a0a93ee75308"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives as described below. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. The Company uses different counterparties for its derivative contracts to minimize the exposure to credit risk but does not anticipate non-performance by these parties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Canadian dollars, Euro, and British pounds sterling. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the Company had &#8364;<ix:nonFraction unitRef="eur" contextRef="i61ed85ae587d438299585235a376442d_I20220331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzYwNDczMTM5NzAyNzc_02505b1c-e216-406f-9b94-f985fe6cb014">1.1</ix:nonFraction> billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges were utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that were designated as net investment hedges and met effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates were recorded as foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency-denominated notes designated as net investment hedges were ineffective, changes in carrying value attributable to the change in spot rates were recorded in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the E.U. disposal group in October 2022, the Company reclassified $<ix:nonFraction unitRef="usd" contextRef="if95560d064ba4166a3331f01665e7c28_D20220401-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzYwNDczMTM5NzE1MzM_669726e1-7a64-4995-b80a-8efeecaf7b56">112</ix:nonFraction> million of gains from accumulated other comprehensive loss to</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2023. This amount related to the &#8364;<ix:nonFraction unitRef="eur" contextRef="i7f756df8d9cf4ff5bf43b455279a736b_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNjc_45233a0e-01fd-44c5-90cf-15175c4ad037"><ix:nonFraction unitRef="eur" contextRef="i61ed85ae587d438299585235a376442d_I20220331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNjc_9e4e397d-37c9-4350-803c-31faca784be2">1.1</ix:nonFraction></ix:nonFraction>&#160;billion of Euro-denominated notes described above, along with certain other Euro-denominated notes which were previously accounted for as net investment hedges and matured in prior periods, and was included in the fiscal 2023 and fiscal 2022 calculations of charges to remeasure the assets and liabilities of the disposal group to fair value less costs to sell.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the U.K. disposal group in April 2022, the Company reclassified $<ix:nonFraction unitRef="usd" contextRef="i377c89ac0f94417ab6e32711608e6849_D20220401-20230331" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzYwNDczMTM5NzE1NTk_dd559eb3-c412-4e57-8091-6f2774c2b840">26</ix:nonFraction> million of gains from accumulated other comprehensive loss to &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2023. This amount related to the Company&#8217;s &#163;<ix:nonFraction unitRef="gbp" contextRef="i7746cd80fb0e4dba825522f21e14c35c_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzYwNDczMTM5Njk5MTI_eddf9df1-894a-440a-87f7-5c841399e17a">450</ix:nonFraction> million of British pound sterling-denominated notes, which were previously accounted for as net investment hedges until de-designated in fiscal 2020, and was included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities of the disposal group to fair value less costs to sell.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i27c889e8c43744db9d96a0a93ee75308" continuedAt="i1bf042bb2a32413b8cd5ad698b41b9d8"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNDk_3b2d918d-590f-412c-bc1c-ee0b693cf451" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde86b5b9cf640a3857b79b2a12f38f7_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpmZmY4OGQxYTYxZmU0NmNhYjFmZWNiYjY2MzFhNDQ2Ni90YWJsZXJhbmdlOmZmZjg4ZDFhNjFmZTQ2Y2FiMWZlY2JiNjYzMWE0NDY2XzMtMS0xLTEtMjM3NzM4_cf1e6c3c-1915-4823-8bde-a60e02404f35">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf4620f35c94ffe8b0ced9de2482405_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpmZmY4OGQxYTYxZmU0NmNhYjFmZWNiYjY2MzFhNDQ2Ni90YWJsZXJhbmdlOmZmZjg4ZDFhNjFmZTQ2Y2FiMWZlY2JiNjYzMWE0NDY2XzMtMy0xLTEtMjM3NzM4_aa4ae77f-4e68-4240-9ae4-0fbc0dacbac8">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5ed5bad9fbc48a79bf500f2ea6d7a22_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpmZmY4OGQxYTYxZmU0NmNhYjFmZWNiYjY2MzFhNDQ2Ni90YWJsZXJhbmdlOmZmZjg4ZDFhNjFmZTQ2Y2FiMWZlY2JiNjYzMWE0NDY2XzMtNS0xLTEtMjM3NzM4_be2847bf-f99d-4a76-b57c-1cdda8936431">118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the years ended March 31, 2023, 2022 and 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the year ended March 31, 2023, includes amounts reclassified to earnings of $<ix:nonFraction unitRef="usd" contextRef="icde86b5b9cf640a3857b79b2a12f38f7_D20220401-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzYwNDczMTM5NzE4NTg_9dc4afd3-f70c-4974-b104-80892e04cabd">112</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments </span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNTA_bc6477a5-3c4a-4c66-a81d-002aa3010907" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023 and 2022, the notional amounts of the Company&#8217;s outstanding derivatives were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-24 to Mar-25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="i5ff470a2b6a24f96a0586ed7a59b7b7b_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzMtNS0xLTEtMjM4MDk3_5def9f4b-205b-47a3-8690-55f1d0451a0b">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="ifd33b3ebae6e4d2496772717c3f8c273_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzMtNy0xLTEtMjM4MDk3_42067552-e74f-4f1c-b72d-369ee139dc0e">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as fair value hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-28</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="i451f85a810074a318c6fdba6392654ed_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzYtNS0xLTEtMjM4MDk3_84db09c7-8fe7-4070-a590-cfa435da539d">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="gbp" contextRef="ie46f20f9252c435eb905f97640abaa6c_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzYtNy0xLTEtMjM4MDk3_b4008b9a-84c8-4efd-99d1-a1edfdb36fdb">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aug-25 to Jul-26</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="ie365683768f34533b940d20aee5be735_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzctNS0xLTEtMjM4MDk3_bc40573c-7d72-4b50-b372-232f1c442add">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="eur" contextRef="i9d0ea17b2eb84516bc5d182b18413d90_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzctNy0xLTEtMjM4MDk3_71dd676f-f4c6-4f7d-a70a-072af0c036b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feb-26 to Sep-29</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2f247e11ef4383a78c76952ded2871_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzgtNS0xLTEtMjM4MDk3_9939640c-2d19-40df-a141-0eb295f3b1b9">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i012704ce27234402832a8bc9c0017988_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzgtNy0xLTEtMjM4MDk3_530ff181-1b70-464f-b10d-6c1461af62c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan-24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="i8ff7efcd13d54a859f0cdcd3c236d712_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzExLTUtMS0xLTIzODA5Nw_a5eda248-83a1-4ff1-a0e8-bc1c03c2222b">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cad" contextRef="i58eb9e87b3f1463fbab075c07679076d_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzExLTctMS0xLTIzODA5Nw_89630ebf-8dab-4e4c-8c33-8c3abbf2ffcc">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jun-33</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18e62823c6c34113847dd36bdd196aee_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzEyLTUtMS0xLTIzODA5Nw_cf5cf608-389e-428e-87b6-4a7dc933e382">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc76b912e3064681bcafdf4fb127e946_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzEyLTctMS0xLTIzODA5Nw_7221dec5-9e0e-4864-aee8-f4e08a0b870c">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The maturity date reflected is for outstanding derivatives as of March 31, 2023.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the years ended March 31, 2023, 2022, and 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In fiscal 2023, represents cross-currency fixed-to-fixed interest rate swaps to mitigate the foreign currency exchange fluctuations on its foreign currency-denominated notes. In fiscal 2022, represents fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread.  </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in accumulated other comprehensive loss and offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i1bf042bb2a32413b8cd5ad698b41b9d8" continuedAt="i229183f208164ebf8d3ba8bf31742d67"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge the changes in the fair value of its foreign currency notes resulting from changes in benchmark interest rates and foreign currency exchange rates. In February 2023, &#163;<ix:nonFraction unitRef="gbp" contextRef="i6b463726a6524dd3ba88c8289035c4c4_I20230228" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNzQyNTU_fa0e7922-c9ec-48f6-8575-642748ed7ffd">450</ix:nonFraction>&#160;million of cross-currency swaps matured and the Company executed new cross-currency swaps with similar terms to continue to mitigate interest rate and foreign exchange rate risks. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2023, the Company entered into cross-currency fixed-to-fixed interest rate swaps with a total notional amount of &#8364;<ix:nonFraction unitRef="eur" contextRef="ie365683768f34533b940d20aee5be735_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzcxNDY4MjU2MTEzOTg_df9b5d33-6547-4881-8568-60d9fc57d341">1.1</ix:nonFraction> billion to hedge the changes in the fair value of its underlying Euro-denominated notes resulting from changes in benchmark interest rates and foreign currency exchange rates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2023, the Company also entered into floating interest rate swaps to convert $<ix:nonFraction unitRef="usd" contextRef="i1212e8cf47b1431fba4fec0f85eaa49f_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzcxNDY4MjU2MTE0Nzc_0d143ec0-af53-4903-b916-ffd96596e27e">1.3</ix:nonFraction>&#160;billion of its fixed rate debt to floating interest rate in order to hedge the changes in fair value caused by fluctuations in the benchmark interest rate. The changes in the fair value of these derivatives are recorded in &#8220;Interest expense&#8221; in the Consolidated Statements of Operations. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the fair value of these derivatives and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from the changes in the Company&#8217;s fair value hedges recorded in earnings were largely offset by the losses recorded in earnings on the hedged item. For components excluded from the assessment of hedge effectiveness, the initial value of the excluded component is recognized in accumulated other comprehensive income (loss) and then released into earnings over the life of the hedging instrument. The difference between the change in the fair value of the excluded component and the amount amortized into earnings during the period is recorded in other comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies to reduce the income statement effects arising from fluctuations in foreign currency rates and also enters into forward contracts to hedge the variability of future benchmark interest rates on planned bond issuances. The effective portion of changes in the fair value&#160;of these hedges is recorded in accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. Gains or losses reclassified from accumulated other comprehensive loss and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations were not material for the years ended March 31, 2023, 2022, and 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2023, the Company terminated its $<ix:nonFraction unitRef="usd" contextRef="i18e62823c6c34113847dd36bdd196aee_I20230331" decimals="-6" name="mck:DerivativeNotionalAmountTerminated" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzcxNDY4MjU2MDQ1ODg_60ff5614-706c-40f7-9df0-787dca5c02d5">500</ix:nonFraction>&#160;million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">notional forward starting fixed interest rate swaps and recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:GainLossOnDerivativeTermination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzcxNDY4MjU2MDQ2NTI_84ff939f-432e-4922-a9a0-a8beb2833e65">97</ix:nonFraction> million within &#8220;Other income, net&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2023, the Company also entered into forward starting fixed interest rate swaps designated as cash flow hedges, with a combined notional amount of $<ix:nonFraction unitRef="usd" contextRef="i5b574ca5d25e4e77b9ac4175842add0c_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNzQyNjk_b9979882-bdbb-42b5-a3d5-4982df69582b">450</ix:nonFraction>&#160;million, to hedge the variability of future benchmark interest rates on a planned bond issuance. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings. Prior to the divestitures of the E.U. disposal group and U.K. disposal group, the Company had entered into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. Changes in the fair values for contracts not designated as hedges were recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. Changes in the fair values were not material for the years ended March 31, 2022 and 2021, and the Company did not have any outstanding derivative instruments not designated as hedges during fiscal 2023. Gains or losses from these contracts were largely offset by changes in the value of the underlying intercompany obligations.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i229183f208164ebf8d3ba8bf31742d67"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information on Derivative Instruments</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNTE_2c2baeb0-38fc-4112-8cd3-513c3fd9ed44" escape="true"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNTE_2d56452b-d800-4e79-b964-84354d587588" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains (losses) from derivatives included in other comprehensive income (loss) in the Consolidated Statements of Comprehensive Income (Loss) were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e74926dad464e94bdc3f1c87eb5109a_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzMtMS0xLTEtMjM4NDk5_b0c56d2a-9eec-4855-839b-c768c08f4318">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a201725780545cb9926c7c283f7d7d0_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzMtMy0xLTEtMjM4NDk5_42de335e-1174-4eca-9abd-35ef23acefcc">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie12bcf044f834b0ebb0a13192a63245b_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzMtNS0xLTEtMjM4NDk5_d66afda2-c97b-4312-861f-02d059ad2c9b">119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow and other hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8dab7068d7b4998b54b905773776649_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzYtMS0xLTEtMjM4NDk5_f3255c35-4fae-4158-a5f7-37d9664a506c">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94135546f3234d41991f401e92d4d4d6_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzYtMy0xLTEtMjM4NDk5_e14eebed-3385-4c93-a73c-c3620cc2813c">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e3950dedac64c34a7acce736f0bc228_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzYtNS0xLTEtMjM4NDk5_438bf000-0351-40fa-ae01-e7aa5065dbda">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42e31d06ed3643fbae42793a45735ac5_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzctMS0xLTEtMjM4NDk5_ca2e54f7-c376-49f0-9c23-ba9ecbfc66be">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69be7012e79640bfb23e05de78108936_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzctMy0xLTEtMjM4NDk5_1ba0f53f-d252-453d-bdbd-25117976a02c">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa333c469edc4e739ef41e09656c0dfe_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzctNS0xLTEtMjM4NDk5_9d0ab03c-3cac-4feb-8bb6-fbbfc8db0688">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes other comprehensive income related to the excluded component of certain fair value hedges.</span></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzExNTk3_5ddee9a5-9200-4271-a813-659de97c7506" escape="true"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.263%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated for hedge accounting:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae39c5b703e44224ad9561aadf22dcaa_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtMi0xLTEtMjE4NzQ4_6ab8368e-667f-453a-bc1f-68643f69f81a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae39c5b703e44224ad9561aadf22dcaa_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtNC0xLTEtMjE4NzQ4_780a58c9-9edf-43b4-802b-b4a2147e6cf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae39c5b703e44224ad9561aadf22dcaa_I20230331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtNi0xLTEtMjE4NzQ4_7e7e9b19-ddca-44f9-9e25-61e8fd97b412">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08578346a1c640a69d5c8c9dbc6cef2f_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtOC0xLTEtMjE4NzQ4_8d2e2c4d-a19c-4b54-866e-3639e629b2f1">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08578346a1c640a69d5c8c9dbc6cef2f_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtMTAtMS0xLTIxODc0OA_64ffe065-fc9d-455c-a339-ab0fd0421116">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08578346a1c640a69d5c8c9dbc6cef2f_I20220331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtMTItMS0xLTIxODc0OA_e58b905b-1320-4c49-ac9a-4647eba5ca0a">1,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89a2c4aa24f415ebad33a8ffc064667_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtMi0xLTEtMjE4NzQ4_96189d3a-d138-4dcd-9be0-9e117bbb3093">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89a2c4aa24f415ebad33a8ffc064667_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtNC0xLTEtMjE4NzQ4_af12577b-e2db-4b9a-8f5f-352d13d9dc05">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89a2c4aa24f415ebad33a8ffc064667_I20230331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtNi0xLTEtMjE4NzQ4_0451f7cb-aebc-40e0-b056-23ec301e9cce">2,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab3273dc18846c0891c616e297f96e1_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtOC0xLTEtMjE4NzQ4_68726062-de17-404a-8ec8-fa8bbb099529">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab3273dc18846c0891c616e297f96e1_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtMTAtMS0xLTIxODc0OA_8c1c7ea0-394f-4a85-8553-c97d2b43415a">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab3273dc18846c0891c616e297f96e1_I20220331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtMTItMS0xLTIxODc0OA_d39ac54c-79a3-4f39-b226-54094054266e">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i570b23d2fb4f453cb4925aebe582d8f1_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctMi0xLTEtMjE4NzQ4_463526e1-401e-47cf-af00-c1ab03866c7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i570b23d2fb4f453cb4925aebe582d8f1_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctNC0xLTEtMjE4NzQ4_2cecbc9c-a3be-4ec0-a1ed-0c36a23b0f89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i570b23d2fb4f453cb4925aebe582d8f1_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctNi0xLTEtMjE4NzQ4_ecab0a8a-4f46-4674-8cc1-763ea3d56eb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5af88ef9b934cc4a000f911d7bc1a8c_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctOC0xLTEtMjE4NzQ4_f6c1c215-0236-4bcd-9a2d-e12ef2f47ac9">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5af88ef9b934cc4a000f911d7bc1a8c_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctMTAtMS0xLTIxODc0OA_d44ad424-9cb2-48a3-b82a-a01562d3b864">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5af88ef9b934cc4a000f911d7bc1a8c_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctMTItMS0xLTIxODc0OA_58117bbd-d42d-43d1-8c4d-1a49fc3d1264">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27091f652077438a88c26df46b3f0175_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtMi0xLTEtMjE4NzQ4_10a35188-9697-480b-be62-f6666a583004">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27091f652077438a88c26df46b3f0175_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtNC0xLTEtMjE4NzQ4_4188014a-5134-4484-9db8-e40913ad31fe">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27091f652077438a88c26df46b3f0175_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtNi0xLTEtMjE4NzQ4_bfa52b6e-b7e7-46cc-a3c0-22a17f7e628e">1,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96f88968ebe444dd9eb39629b0d33d5c_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtOC0xLTEtMjE4NzQ4_0e5cbaf4-fd85-459d-9147-8073d84524d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96f88968ebe444dd9eb39629b0d33d5c_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtMTAtMS0xLTIxODc0OA_f87d0d60-acaa-485f-8a69-4ada697901a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96f88968ebe444dd9eb39629b0d33d5c_I20220331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtMTItMS0xLTIxODc0OA_fafa2ec5-80ce-4b8f-a26e-da2f6e58a8df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9919373fdaa44e9488d392bca8c37b57_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzktMi0xLTEtMjE4NzQ4_d7cfb8f3-1ff6-4b18-9c42-c6a0d112a6c3">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9919373fdaa44e9488d392bca8c37b57_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzktNC0xLTEtMjE4NzQ4_21dbcbed-4d94-4aed-b897-6e7aaf487b2b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72369ee3bdc242a584b516b6b0220cd3_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzktOC0xLTEtMjE4NzQ4_46b39a23-f50e-41a0-8139-b4eb860c1c59">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72369ee3bdc242a584b516b6b0220cd3_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzktMTAtMS0xLTIxODc0OA_4a0920fe-be75-4a5a-aa57-bbba73e2c563">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 15, &#8220;Fair Value Measurements,&#8221; for more information on these recurring fair value measurements.</span></div></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_166"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1Xzc3MDk_2812925c-6292-47f3-8aac-f5180e19a619" continuedAt="i5da6e91d88dd4177b2a3a829af1a6b79" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i5da6e91d88dd4177b2a3a829af1a6b79" continuedAt="i458bc58b64a746db96fb58666f316107"><div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i458bc58b64a746db96fb58666f316107" continuedAt="i502637d5e8a4437b9420b3b8c67a0954"><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at March 31, 2023 and 2022 included investments in money market funds of $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-8" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1Xzc2Nw_9cd0795f-55f4-4c62-ac70-5f90608cb382">1.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1Xzc3NA_1469e6bf-0ae7-4f60-8be3-90089b535c2b">981</ix:nonFraction> million, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. The fair values for the Company&#8217;s marketable securities were not material at March 31, 2022, and were liquidated during fiscal 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 14, &#8220;Hedging Activities,&#8221; for fair values and other information on the Company&#8217;s derivatives.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzIxNDM_49c6539d-01c5-4c69-88ff-4503b1914561">237</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzIxNTA_7ff81cea-c8a7-4b2a-bf63-6e04d48e0e29">346</ix:nonFraction>&#160;million at March 31, 2023 and 2022, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. During fiscal 2023, the Company recognized impairment charges and realized gains on the exit of certain investments. During fiscal 2022, certain of the Company&#8217;s investments in equity securities without readily determinable fair values were remeasured to fair value based on transactions which resulted in changes in the observable price of those securities. During fiscal 2021, certain of the Company&#8217;s investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. The Company exited most of its investments in publicly traded shares in the fourth quarter of fiscal 2021. The Company recognized net losses of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzI5Mjg_b0c64079-cbba-4b3a-bbd9-e2097347a55b">36</ix:nonFraction> million, including impairments of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzU0OTc1NTgyNjUzMw_79d309dd-32c7-4da1-b68d-3e196ca628ea">59</ix:nonFraction>&#160;million, for the year ended March 31, 2023, and recognized net gains of $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzI5MzU_17f06690-f741-484c-b344-f762f561b345">98</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzU0OTc1NTgyMjUzMQ_c7532c18-be6d-4bef-a725-304a1128602d">133</ix:nonFraction> million for the years ended March 31, 2022 and 2021, respectively. These amounts were recorded in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges, including long-lived assets associated with the Company&#8217;s restructuring initiatives as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; or as a result of charges to remeasure assets classified as held for sale to fair value less costs to sell.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023, the contingent consideration liability related to the Company&#8217;s acquisition of RxSS in November 2022 was measured at fair value on a nonrecurring basis. At March 31, 2022, the assets and liabilities associated with the E.U. disposal group and U.K. disposal group classified as held for sale were measured at the lower of carrying value or fair value less costs to sell. The E.U. disposal group was divested in October 2022 and the U.K. disposal group was divested in April 2022. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures" for more information on these transactions. Additionally, at March 31, 2022, assets measured at fair value on a nonrecurring basis included certain long-lived assets within the International segment related to the Company&#8217;s previous operations in Denmark and its retail pharmacy businesses in Canada, as discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs related to changes in observable price are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Inputs related to impairments of investments are generally considered Level 3 fair value measurements due to their inherently unobservable nature based on significant assumptions by management and use of company-specific information.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i502637d5e8a4437b9420b3b8c67a0954"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other material assets or liabilities measured at fair value on a nonrecurring basis at March 31, 2023 and 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023 and 2022, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short-term maturity of these financial instruments.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1Xzc3MTA_62c95a99-7e4e-4eab-8d3d-4c0ffd089f68" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193367ab1bd147669e6aa97c4b68b27c_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90YWJsZTo4Y2UyZDNhYjU0Mzc0Y2IxYWVhNGRkNjZhODlkMjJiZS90YWJsZXJhbmdlOjhjZTJkM2FiNTQzNzRjYjFhZWE0ZGQ2NmE4OWQyMmJlXzItMS0xLTEtMjE4NzQ4_db2b3ee8-e1fc-4126-ae44-e216fe88562d">5,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193367ab1bd147669e6aa97c4b68b27c_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90YWJsZTo4Y2UyZDNhYjU0Mzc0Y2IxYWVhNGRkNjZhODlkMjJiZS90YWJsZXJhbmdlOjhjZTJkM2FiNTQzNzRjYjFhZWE0ZGQ2NmE4OWQyMmJlXzItMy0xLTEtMjE4NzQ4_04014798-e194-4213-89af-f4b85fb0ddc4">5,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed31f2e5a9e4fa5b8dcaf9650e3ac4c_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90YWJsZTo4Y2UyZDNhYjU0Mzc0Y2IxYWVhNGRkNjZhODlkMjJiZS90YWJsZXJhbmdlOjhjZTJkM2FiNTQzNzRjYjFhZWE0ZGQ2NmE4OWQyMmJlXzItNS0xLTEtMjE4NzQ4_04b6e4ce-236b-4f0c-a3c5-de22d641d3ea">5,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed31f2e5a9e4fa5b8dcaf9650e3ac4c_I20220331" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90YWJsZTo4Y2UyZDNhYjU0Mzc0Y2IxYWVhNGRkNjZhODlkMjJiZS90YWJsZXJhbmdlOjhjZTJkM2FiNTQzNzRjYjFhZWE0ZGQ2NmE4OWQyMmJlXzItNy0xLTEtMjE4NzQ4_aeec0bcd-e5fd-4d4b-a64d-736847f82c1a">5,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 10, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information regarding goodwill impairment charges recorded for certain reporting units during fiscal 2021. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net&#8221; under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Asset Impairments&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_169"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:FinancialGuaranteesAndWarrantiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzM0Mzg_b3186142-7a51-4687-a7a6-a868cbfa1a79" continuedAt="i8cf1aa3e8b424c1b9a1c580db4ec8589" escape="true">Financial Guarantees and Warranties</ix:nonNumeric></span></div><ix:continuation id="i8cf1aa3e8b424c1b9a1c580db4ec8589"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Guarantees</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with certain of its customers&#8217; financial institutions, primarily in its International segment, under which it has guaranteed the repurchase of its customers&#8217; inventory or its customers&#8217; debt in the event these customers are unable to meet their obligations to those financial institutions. For the Company&#8217;s inventory repurchase agreements, among other requirements, inventories must be in a resalable condition and any repurchase would be at a discount. The inventory repurchase agreements mostly relate to certain Canadian customers and generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzYyMA_f70be4f2-8308-4872-ada2-b3f0a675b674">one</span> to <ix:nonNumeric contextRef="ia4296c0b84d346e4b89b55d58821c05d_D20220401-20230331" name="mck:GuarantorObligationsPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzYyNg_8ae3d152-07df-4e7b-a266-9ed2fc58669c">two years</ix:nonNumeric>. Customers&#8217; debt guarantees generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzY3OA_6036989f-413d-4a9a-9e98-c93fb0ca4aa4">one</span> to <ix:nonNumeric contextRef="i9d14a00ce32c46e7b5068767e2553b8b_D20220401-20230331" name="mck:GuarantorObligationsPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzg3OTYwOTMwMjU4OTU_15b3436c-fa15-4ee3-a14b-0df6cbc7d3db">five years</ix:nonNumeric> and are primarily provided to facilitate financing for certain customers. The majority of the Company&#8217;s customers&#8217; debt guarantees are secured by certain assets of the customer. At March 31, 2023, the maximum amounts of inventory repurchase guarantees and customers&#8217; debt guarantees were $<ix:nonFraction unitRef="usd" contextRef="i7c2dfca8ca434187bc4a0181f1cd5d18_I20230331" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzk2Mw_2acf2ab8-86d2-4eb5-920d-b4d10fce1413">343</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1be6be612b674d65a670c15307e93ab4_I20230331" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzk3MA_e21fda29-d9f7-468e-ac43-719d41aa1501">17</ix:nonFraction> million, respectively, of which the Company has not accrued any material amounts. The expirations of these financial guarantees were as follows: $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearOne" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExMDk_9896434a-f86d-4aa8-b25a-82db10e1d9e5">18</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExMTM_ba038e5c-e088-4371-aba6-ef4ac7baff6a">108</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExMTc_1b2ff040-699b-40ac-b2cf-3782c73b9a1d">195</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExMjE_b8b50b32-b151-47a2-9145-36a24f22d4de">10</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExMjk_44a41915-05e3-4eb7-89b8-8b0615740a8e">8</ix:nonFraction> million&#160;from fiscal 2024 through fiscal 2028, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:GuaranteeObligationsExposureExpiringinYearFiveThereafter" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExNzA_bfe9825f-3e6f-41bd-a6f2-ca2dbf143349">21</ix:nonFraction> million thereafter.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023, the Company&#8217;s banks and insurance companies have issued $<ix:nonFraction unitRef="usd" contextRef="ied8ab1ea89bb4a8492bbac67f1f3dd79_I20230331" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzEyNDg_6b951148-33c1-430d-942a-ffedb361372a">206</ix:nonFraction> million of standby letters of credit and surety bonds, which were issued on the Company&#8217;s behalf primarily related to its customer contracts and in order to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, pension obligations in Europe, and its workers&#8217; compensation and automotive liability programs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s software license agreements generally include certain provisions for indemnifying customers against liabilities if its software products infringe a third party&#8217;s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnification agreements and has not accrued any liabilities related to such obligations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with certain transactions, primarily divestitures, the Company may provide routine indemnification agreements (such as retention of previously existing environmental, tax, and employee liabilities) whose terms vary in duration and often are not explicitly defined. Where appropriate, obligations for such indemnifications are recorded as liabilities. Because the amounts of these indemnification obligations often are not explicitly stated, the overall maximum amount of these commitments cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of divestiture, the Company has historically not made material payments as a result of these indemnification provisions.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services. For example, the Company provides warranties that the pharmaceutical and medical-surgical products it distributes are in compliance with the U.S. Food, Drug, and Cosmetic Act and other applicable laws and regulations. It has received the same warranties from its suppliers, which customarily are the manufacturers of the products. In addition, the Company has indemnity obligations to its customers for these products, which have also been provided from its suppliers, either through express agreement or by operation of law. Accrued warranty costs were not material to the Consolidated Balance Sheets as of March 31, 2023 and 2022.</span></div></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_172"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzM4MTc0_08d40ea5-8f53-4123-ae48-096f076c80ee" continuedAt="i82831735850841c091d8952d498868c5" escape="true">Commitments and Contingent Liabilities</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:continuation id="i82831735850841c091d8952d498868c5" continuedAt="id8749fdc08e745cd8a1fdfd94235fb44"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="id8749fdc08e745cd8a1fdfd94235fb44" continuedAt="iaa7800cc31644807b40a2d7341a3022d"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacies. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They have sought monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes. Because of the many uncertainties associated with opioid-related litigation matters, the Company is not able to conclude that a liability is probable or to reasonably estimate a range of ultimate possible loss for opioid-related litigation matters other than those for which an accrual is described below. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State and Local Government Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of these cases were brought by state and local government entities in the U.S. The Company and <ix:nonFraction unitRef="distributor" contextRef="i3b2d6726cb4b46f2902ab30560ff644c_I20230331" decimals="INF" name="mck:LossContingencyNumberOfOtherDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NTk3MTkxOQ_551b388d-eb9f-4967-88dc-a85079f86bc2">two</ix:nonFraction> other national pharmaceutical distributors (collectively &#8220;Distributors&#8221;) entered into a settlement agreement (the &#8220;Settlement&#8221;) with <ix:nonFraction unitRef="state" contextRef="i3b2d6726cb4b46f2902ab30560ff644c_I20230331" decimals="INF" name="mck:LossContingencyNumberofStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzQwMDY_2b3e6d70-7745-4dfa-95ab-07566b420330">48</ix:nonFraction> states and their participating subdivisions, as well as the District of Columbia and all eligible territories (the &#8220;Settling Governmental Entities&#8221;). The Company has paid the Settling Governmental Entities approximately $<ix:nonFraction unitRef="usd" contextRef="if0f3c705d63d43aaae784ab3543e3e80_D20220401-20230331" decimals="-8" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzQ3NjM_e2dc1565-3ad0-44c9-8cf2-67a02952053e">1.0</ix:nonFraction>&#160;billion as of March 31, 2023, and, under the Settlement, will pay the Settling Governmental Entities additional amounts up to approximately $<ix:nonFraction unitRef="usd" contextRef="if0f3c705d63d43aaae784ab3543e3e80_D20220401-20230331" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzQ4MDA_1a5e2454-e61e-44b1-a3b7-0f0491ba7a75">6.8</ix:nonFraction>&#160;billion through 2038. A minimum of <ix:nonFraction unitRef="number" contextRef="i3b2d6726cb4b46f2902ab30560ff644c_I20230331" decimals="2" name="mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzQ4ODQ_90375260-4928-43b5-94ef-9e03b78a136a">85</ix:nonFraction>% of the Settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and is payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Distributors do not admit liability or wrongdoing and do not waive any defenses pursuant to the Settlement. Consent judgments have been entered in all participating states and territories, and approximately <ix:nonFraction unitRef="case" contextRef="i3b2d6726cb4b46f2902ab30560ff644c_I20230331" decimals="INF" name="mck:LossContingencyNumberOfCasesDismissed" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE1ODE_372c67b3-722f-48bb-865e-56cbda7a358f">2,300</ix:nonFraction> cases have been dismissed pursuant to the Settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alabama and West Virginia did not participate in the Settlement. Under a separate agreement with Alabama and its subdivisions, the Company has paid approximately $<ix:nonFraction unitRef="usd" contextRef="i7e87a690a6d84ef49943e4b9a57bf486_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyNDI_97d18bc9-606f-4047-8681-f703c6d81e7f">42</ix:nonFraction>&#160;million as of March 31, 2023, and will pay additional amounts totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i7e87a690a6d84ef49943e4b9a57bf486_D20220401-20230331" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzYzMzY_e3caf258-0f2d-4ead-9863-509921ddf1ca">132</ix:nonFraction>&#160;million through 2031. The Company previously settled with the state of West Virginia in 2018, and West Virginia and its subdivisions were not eligible to participate in the Settlement. After a trial, the claims of <ix:nonFraction unitRef="subdivision" contextRef="if55961281a7144958d26ffefe3ca4b9b_I20220704" decimals="INF" name="mck:LossContingencyClaimsSettledNumberOfSubdivisions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyNjg_15c6dea6-d3ae-4bf9-85b4-990bd3d5641b">two</ix:nonFraction> West Virginia subdivisions, Cabell County and the City of Huntington, were decided in the Company&#8217;s favor on July 4, 2022. That decision is under appeal. The claims of certain other West Virginia subdivisions were settled pursuant to an agreement requiring the Company to pay approximately $<ix:nonFraction unitRef="usd" contextRef="ia95d07e149ed453ca958daff0b5e82b2_D20220401-20230331" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE2MzY_1e82148e-0749-42d3-b14f-3d533720a09e">152</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="ia95d07e149ed453ca958daff0b5e82b2_D20220401-20230331" name="mck:LossContingencySettlementInstallmentPaymentsTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyNTQ_556165f8-011f-42fe-8d45-c6c0ed08ca34">11</ix:nonNumeric> years. The Company has paid the settling subdivisions $<ix:nonFraction unitRef="usd" contextRef="i129e51149a384d2ca3e97d96fc3cd639_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyNTY_866fe4b2-0365-4070-ad88-ef9f91ab34b8">38</ix:nonFraction>&#160;million as of March 31, 2023, and will pay additional amounts totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i129e51149a384d2ca3e97d96fc3cd639_D20220401-20230331" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyMjg_a117bb18-c70e-46be-9446-2903489d7002">114</ix:nonFraction>&#160;million through 2033. All participating litigating subdivisions have dismissed their claims against the Company, but the agreement does not include school districts or the claims of Cabell County and the City of Huntington. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="iaa7800cc31644807b40a2d7341a3022d" continuedAt="i418dc6957c11405eabbef9a9752c1ae2"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some subdivisions did not participate in the Settlement, including certain municipal governments, government hospitals, school districts, and government-affiliated third-party payors. The Company contends these claims are foreclosed by the Settlement or otherwise subject to strong defenses, while the non-participating subdivisions assert that they are not bound by the Settlement for a variety of reasons. The Company intends to defend itself vigorously in these matters. The City of Baltimore, Maryland, is <ix:nonFraction unitRef="jurisdiction" contextRef="i3b2d6726cb4b46f2902ab30560ff644c_I20230331" decimals="INF" name="mck:LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzOTM_49f0b0fa-6e0b-469b-8633-33887012bd96">one</ix:nonFraction> jurisdiction that did not participate in the settlement. Trial of the City of Baltimore&#8217;s claims is currently scheduled to begin September 26, 2024. The Company&#8217;s loss contingency accruals for these subdivisions are reflected in the estimated liability for opioid-related claims consistent with what would be allocated under the framework of the Settlement.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Native American Tribe Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the claims of Native American tribes, the Company has reached agreements that achieve a broad resolution of opioid-related claims brought by federally recognized Native American tribes. Under the agreements, the Company will pay approximately $<ix:nonFraction unitRef="usd" contextRef="ifc24b7896b6c4e3e9686133fcdf77aaf_D20220401-20230331" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg2Mzk_0621ba9c-337f-40e1-908b-93d8637b1dbe">196</ix:nonFraction>&#160;million over <ix:nonNumeric contextRef="ifc24b7896b6c4e3e9686133fcdf77aaf_D20220401-20230331" name="mck:LossContingencySettlementInstallmentPaymentsTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg2NDc_fa829046-069d-4a0b-a8cf-f3ae21cdb52f">6.5</ix:nonNumeric> years to resolve the claims of participating Native American tribes. The Company has paid the settling Native American tribes $<ix:nonFraction unitRef="usd" contextRef="ifc24b7896b6c4e3e9686133fcdf77aaf_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyNzA_b0e58e91-0cc5-4dfc-a4b3-ca41e8fe2713">56</ix:nonFraction>&#160;million as of March 31, 2023, and will pay additional amounts totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i1db22ae3a3cb4da3b2e5eb909147033a_D20220401-20230331" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzcxNDY4MjU2NDM2MjY_94508926-e6fd-4db1-979d-d58f0b480330">140</ix:nonFraction>&#160;million through 2027. Under these agreements, a minimum of <ix:nonFraction unitRef="number" contextRef="i4deb4bb0d31640d6839b768c83fb82d3_I20230331" decimals="2" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE3MTE_73a4d7bb-f50e-4be0-af2f-9cb97cd8a629">85</ix:nonFraction>% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic.</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzM4MTc1_57516c88-b5f8-4750-8c27-0138ac03a576" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for the opioid-related claims of U.S. governmental entities, including Native American tribes, was as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0140a17cab884d1492bcaa9df5a4d5a3_I20230331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzEtMS0xLTEtMjE4NzQ4_e98018fd-9471-4230-aae1-ef0cd739962e">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b22d4f28fe34a62b1126f5d988f8052_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzEtMy0xLTEtMjE4NzQ4_c3cea26f-2b04-4fd6-8f6a-a8209daf1456">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0140a17cab884d1492bcaa9df5a4d5a3_I20230331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzItMS0xLTEtMjE4NzQ4_50ecebbf-63fc-495c-bfb6-c38bc1ff12f8">6,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b22d4f28fe34a62b1126f5d988f8052_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzItMy0xLTEtMjE4NzQ4_8b2294ed-95ec-4655-89ae-26fad2756c9a">7,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0140a17cab884d1492bcaa9df5a4d5a3_I20230331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzQtMS0xLTEtMjE4NzQ4_1aa07118-d382-413d-addb-0fd0eefb37a4">7,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b22d4f28fe34a62b1126f5d988f8052_I20220331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzQtMy0xLTEtMjE4NzQ4_8bd580bd-d7c7-4716-b44a-45aba7a2e764">8,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These amounts, recorded in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2023 and fiscal 2022, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i634cecdea7c5420991fa07409e24bae9_D20220401-20230331" decimals="-8" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjAxMTIyOA_76bf43a4-0a25-4b40-abce-a4ddbf9c9fa9">1.1</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i480f6acdd20745c3951ffb01a8a1f2fd_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjAxMTI2OQ_ee72655a-e13c-428a-a155-4af403d5802f">74</ix:nonFraction>&#160;million, respectively, associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes. In conjunction with the payments made in fiscal 2023, all funds have been released from escrow.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Governmental Plaintiff Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Though the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals. These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One such case was brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court seeking to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CE19-00472. On March 1, 2023, the jury in that case returned a verdict in favor of the defendants, including the Company. That verdict is now the subject of post-trial motions, including a plaintiffs&#8217; motion for a new trial.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In another, several hospitals brought suit in the Circuit Court of Conecuh County, Alabama; trial on the claims of <ix:nonFraction unitRef="plaintiff" contextRef="ia186f3731bcd4bec9362d4010651c39a_D20230724-20230724" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjIxOTE_2a15d4ea-147f-42d8-bc3d-8cfb024e67d9">eight</ix:nonFraction> of these hospitals is currently scheduled for July 24, 2023. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fort Payne Hospital Corporation et al. v. McKesson Corp., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CV-2021-900016. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i418dc6957c11405eabbef9a9752c1ae2" continuedAt="iefbfc75f1d0d4aaf807341a991937353"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Plaintiff Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition to the opioid-related claims brought in the U.S., the Company and its Canadian affiliate are also defendants in <ix:nonFraction unitRef="case" contextRef="i7ba50f0dfc7944c88deff9f8478101c4_I20230331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzEyMDg2_70f9a429-df5d-425c-90ad-6ed2c7e10c3b">four</ix:nonFraction> cases pending in Canada. These cases involve the claims of the provincial governments, a group representing indigenous people, as well as <ix:nonFraction unitRef="case" contextRef="i3930fd7ff02f439e9ab59431524b3678_I20230331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzEyMTU2_4cb92e7a-5b79-4b92-acb9-3faca7f7239d">one</ix:nonFraction> case brought by an individual. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Qui Tam Litigation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2018, the Company was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint pending in the United States District Court for the District of Massachusetts alleging that the Company violated the federal False Claims Act and various state false claims acts due to the alleged failure of the Company and other defendants to report providers who were engaged in diversion of controlled substances. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Manchester v. Purdue Pharma, L.P., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 1-16-cv-10947. On August 22, 2018, the United States filed a motion to dismiss. The relator died, and on February 25, 2019 the court entered an order staying the matter until a proper party can be substituted, and providing that if no party is substituted within <ix:nonNumeric contextRef="i88153d2f52214fe0a9768ef8344eaabd_D20190225-20190225" name="mck:LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE0MDUz_3c689113-c34f-49b1-b6f9-b717a6f9514a">90</ix:nonNumeric> days of February 25, 2019, the case would be dismissed. In April 2019, the widow of the relator filed a motion to substitute their daughter as the relator; the United States and defendants opposed this substitution request. The motion remains pending and the case remains stayed.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company was served with <ix:nonFraction unitRef="complaint" contextRef="i88a1d24ff9dc4dde993d7cc58d70cee1_I20191231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE0Mzc3_b98023a6-101f-4132-8816-2f2cfbb543f8">two</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by the same <ix:nonFraction unitRef="relator" contextRef="i33396fbf2486428a890309fa325b4aaa_D20191201-20191231" decimals="INF" name="mck:LossContingencyNumberofRelators" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE0NDE3_64123a88-304d-47e0-b996-fdead9c6585a">two</ix:nonFraction> relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-2233, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State of California ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit, which affirmed the dismissal on March 10, 2022. On June 28, 2021, the court in the state action dismissed the complaint with prejudice, and the relators appealed the dismissal to the California Court of Appeal, which affirmed the dismissal on February 24, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Coverage Litigation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="case" contextRef="i76d4bda7231445d895623496e61e3afe_I20201023" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE1MzU5_d2895edf-d253-4bcc-9292-b6c2ad0217cf">Two</ix:nonFraction> cases pending in the Northern District of California were filed against McKesson by its liability umbrella insurers about policies they issued to the Company for the period 1999-2017, AIU Insurance Company and National Union Fire Insurance Company of Pittsburgh, Pa. (together "AIG") and ACE Property and Casualty Insurance Company ("ACE"). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AIU Insurance Company et al. v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-07469 (N.D. Cal.) was initiated by AIG in the Northern District of California on October 23, 2020. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ace Property and Casualty Insurance Company v. McKesson Corporation et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-09356 (N.D. Cal.) was brought by ACE in California state court on November 2, 2020, and was removed by McKesson to federal court, transferred to the Northern District of California, and designated as related to the AIU action. AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits filed in federal and state courts related to opioids. In both actions, McKesson has asserted claims under the AIG and ACE policies seeking declarations and damages for past and future defense and indemnity costs. On April 5, 2022, the court issued an order granting partial summary judgment to the insurers that the Company&#8217;s defense costs in certain opioid-related litigation were not covered by <ix:nonFraction unitRef="policy" contextRef="i8fe1c6d47bac41768956c525d9da297c_I20220405" decimals="INF" name="mck:LossContingencyInsufficientCoverageNumberOfInsurancePolicies" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjIyMDE_c39fbd5a-b0b4-487d-bf11-5a19f2c37715">two</ix:nonFraction> of the insurance policies, which the Company has appealed to the U.S. Court of Appeals for the Ninth Circuit.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="iefbfc75f1d0d4aaf807341a991937353" continuedAt="i67aea6295e884a8d85998510d7e35374"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$<ix:nonFraction unitRef="usd" contextRef="if37f55f8d74d4f7e856241b5044f79a1_D20130517-20130517" decimals="INF" name="mck:LossContingencyDamagesSoughtPerViolationValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE3MjU4_eea136d9-148f-4410-9ebb-3f858aac1023">500</ix:nonFraction>&#160;to&#160;$<ix:nonFraction unitRef="usd" contextRef="ifa4d87725ecc4620b0b0c4339cac0d54_D20130517-20130517" decimals="INF" name="mck:LossContingencyDamagesSoughtPerViolationValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE3MjY0_b404470c-c812-4478-b433-45645dacc6c2">1,500</ix:nonFraction>&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, <ix:nonFraction unitRef="faxnumber" contextRef="i590634e41f954ae590139d3aba0164cd_I20190813" decimals="INF" name="mck:LossContingencyClassActionNumberofFaxesRemainingintheClass" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE3NzY3_03a642dd-4386-459b-ba3d-7389e715320c">9,490</ix:nonFraction> fax numbers remain in the class, representing <ix:nonFraction unitRef="fax" contextRef="i590634e41f954ae590139d3aba0164cd_I20190813" decimals="INF" name="mck:LossContingencyClassActionNumberofFaxesReceived" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE3ODE2_44fb3b72-fa23-4e4f-8c25-4f9b16568a10">48,769</ix:nonFraction> faxes received. On October 8, 2021, the court de-certified the class citing the plaintiffs lacked class-wide proof identifying the manner of receipt, thus leaving <ix:nonFraction unitRef="plaintiff" contextRef="icf72768e9e58489a9cfe3dcada7cea25_D20211008-20211008" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNzQwODE_37dabf64-116b-4f05-8f9f-bf02af2dc36b">two</ix:nonFraction> named Plaintiffs remaining in the case. On April 27, 2022, the Court found that the named Plaintiffs had failed to meet their burden to show Defendants willfully or knowingly violated the TCPA and therefore were not entitled to treble damages. The Court found McKesson liable for statutory damages in the amount of $<ix:nonFraction unitRef="usd" contextRef="i604155abded247ec9c473e57fc99aa9b_D20220427-20220427" decimals="INF" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE4MzAx_fd65507a-32be-4481-b873-8d1ef94ac972">6,500</ix:nonFraction>. The Company appealed the finding of liability and the plaintiffs cross-appealed the denial of class certification and the ruling denying treble damages.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2013, the Company&#8217;s subsidiary, U.S. Oncology, Inc. (&#8220;USON&#8221;), was served with a third amended qui tam complaint filed in the United States District Court for the Eastern District of New York by <ix:nonFraction unitRef="relator" contextRef="ic6909fc49de54c13a5acf0f3f0cd933d_D20130416-20130416" decimals="INF" name="mck:LossContingencyNumberOfRelators" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE4NTEy_8b38c511-a7b9-4c4b-bd78-13be0e3cf15e">two</ix:nonFraction> relators, purportedly on behalf of the United States, <ix:nonFraction unitRef="state" contextRef="i24b5bf7bd68d425d9982f2b10d0f20f4_I20130416" decimals="INF" name="mck:LossContingencyNumberOfStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE4NTY5_82a05f52-b2ce-4446-b80e-199631674b8f">21</ix:nonFraction> states and the District of Columbia, against USON and <ix:nonFraction unitRef="defendant" contextRef="ic6909fc49de54c13a5acf0f3f0cd933d_D20130416-20130416" decimals="INF" name="mck:LossContingencyNumberOfAdditionalDefendants" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE4NjI2_aad8f446-e1ac-48b6-b302-544e87bce1cf">five</ix:nonFraction> other defendants, alleging that USON solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Piacentile v. Amgen Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al., CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On November 16, 2018, the relators filed a fourth amended complaint; that complaint was dismissed with prejudice on December 1, 2021. On March 28, 2023, the Court of Appeals for the Second Circuit affirmed dismissal.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2014, U.S. Oncology Specialty, LP (&#8220;USOS&#8221;) was served with a fifth amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Eastern District of New York by a relator alleging that USOS, among others, solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the federal False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hanks v. Amgen, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CV-08-03096 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 17, 2018, the court granted USOS&#8217;s motion to dismiss. Following the relator&#8217;s appeal, the United States Court of Appeals for the Second Circuit vacated the district court&#8217;s order and remanded the suit to the district court, directing it to consider the question of whether the suit should be dismissed for lack of jurisdiction. The district court granted the relator leave to amend the complaint for a seventh time. The relator filed the seventh amended complaint on November 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or about April 25, 2018, a second amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint filed in the U.S. District Court for the Eastern District of New York was served on McKesson Corporation, McKesson Specialty Care Distribution Corporation, McKesson Specialty Distribution LLC, McKesson Specialty Care Distribution Joint Venture, L.P., Oncology Therapeutics Network Corporation, Oncology Therapeutics Network Joint Venture, L.P., US Oncology, Inc., and US Oncology Specialty, L.P. by Omni Healthcare, Inc. as relator, purportedly on behalf of the United States and <ix:nonFraction unitRef="city" contextRef="i2f35dd91b0344cb6ba1c6fc2ce024afc_I20180425" decimals="INF" name="mck:LossContingencyNumberOfCitiesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNzQwNzg_f9449915-8c3c-4ea7-a1b6-faa31951b576">33</ix:nonFraction> cities and states alleging that from 2001 through 2010 the defendants repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America ex rel. Omni Healthcare, Inc. v. McKesson Corp., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 1:12-cv-06440 (E.D.N.Y.). The United States and the other governmental plaintiffs declined to intervene in the suit. In February 2019, the court dismissed all of the defendants except McKesson Corporation and Oncology Therapeutics Network Corp. On February 2, 2022, the court entered a scheduling order under which non-government fact discovery was set to close on June 15, 2022. On June 14, 2022, relator moved for additional discovery and an extension of the discovery schedule. On October 13, 2022, the Court granted relator permission to take certain additional discovery, directed relator to move for leave to amend its complaint, and otherwise denied relator's motion without prejudice. On November 14, 2022, relator served its motion for leave to amend its complaint, which remains pending.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i67aea6295e884a8d85998510d7e35374" continuedAt="ia104b427767541b2bf1e35fa4e361af9"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or about March 2, 2020, another </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint filed in the U.S. District Court for the Eastern District of New York was served on US Oncology, Inc. by the same relator purportedly on behalf of the United States and <ix:nonFraction unitRef="city" contextRef="i057d846c99e24512ad9cb275e0ad3de8_I20200302" decimals="INF" name="mck:LossContingencyNumberOfCitiesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNzQwOTA_e9d73c7d-dd7f-4ad0-b412-6d02576e4f0e">33</ix:nonFraction> cities and states alleging the same misconduct and seeking the same relief. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Civil Action No. 1:19-cv-05125. The United States and the other governmental plaintiffs declined to intervene in the suit. On July 21, 2022, the Court granted defendant&#8217;s motion to dismiss without prejudice. Relator subsequently filed an amended complaint. On October 21, 2022, defendant moved to dismiss the amended complaint and that motion remains pending.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, a group of independent pharmacies and a hospital filed a purported class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliable Pharmacy, et al. v. Actavis Holdco US, et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. On May 25, 2022, the district court granted distributor defendants&#8217; motion to dismiss the complaint, but granted the plaintiffs leave to amend the complaint. Plaintiffs filed an amended complaint on July 1, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, the Company received a purported class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and <ix:nonFraction unitRef="officer" contextRef="iddc589cd657a4746a04bdd0a051ab071_I20181212" decimals="INF" name="mck:LossContingencyNumberofFormerOfficers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI0Nzg2_ae5eff53-ce00-4b3c-843f-3cf585110ca5">two</ix:nonFraction>&#160;of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evanston Police Pension Fund v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. In October 2022, the parties reached an agreement in principle to settle this class action lawsuit for an amount covered in full by the Company&#8217;s insurance policy. The settlement is subject to, among other things, final approval by the court. This settlement does not include any admission of liability, and defendants expressly deny wrongdoing. The Company&#8217;s estimated probable loss, entirely offset by probable loss recovery from the Company&#8217;s insurers, was $<ix:nonFraction unitRef="usd" contextRef="i3b893491327d4a5081fd775de27171a8_I20220930" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0MTI_267486ff-5ee8-4175-9b17-819dcca06fe4"><ix:nonFraction unitRef="usd" contextRef="i3b893491327d4a5081fd775de27171a8_I20220930" decimals="-6" name="us-gaap:EstimatedInsuranceRecoveries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0MTI_38570e68-4477-42f2-9eba-5f518bc84243">141</ix:nonFraction></ix:nonFraction>&#160;million, both of which were recognized in the Condensed Consolidated Balance Sheet as of September 30, 2022 within &#8220;Other accrued liabilities&#8221; and &#8220;Prepaid expenses and other.&#8221; In February 2023, the insurance carriers funded the settlement, and the probable loss and loss recovery of $<ix:nonFraction unitRef="usd" contextRef="i3b893491327d4a5081fd775de27171a8_I20220930" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0MjY_0aa41d2e-fcb0-4bf9-88b9-23bbe2435539"><ix:nonFraction unitRef="usd" contextRef="i3b893491327d4a5081fd775de27171a8_I20220930" decimals="-6" name="us-gaap:EstimatedInsuranceRecoveries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0MjY_5d5319ce-5600-4998-96ab-61af7c53ea63">141</ix:nonFraction></ix:nonFraction>&#160;million have been reversed in the Consolidated Balance Sheet as of March 31, 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2015, The Great Atlantic &amp; Pacific Tea Company (&#8220;A&amp;P&#8221;), a former customer of the Company, filed for reorganization in bankruptcy under Chapter 11 of the United States Bankruptcy Code in the Bankruptcy Court for the Southern District of New York. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re The Great Atlantic &amp; Pacific Tea Company, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;Case No. 15-23007. A suit filed in 2017 against the Company in this bankruptcy case seeks to recover alleged preferential transfers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Official Committee of Unsecured Creditors on behalf of the bankruptcy estate of The Great Atlantic &amp; Pacific Tea Company, Inc., et al. v. McKesson Corporation d/b/a McKesson Drug Co.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Adv. Proc. No. 17-08264.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company was served with a first amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., <ix:nonFraction unitRef="state" contextRef="i23f831232dbf484481fae3a05bce6513_I20200731" decimals="INF" name="mck:LossContingencyNumberOfStatesFiledOnBehalfOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI4MDM2_30388ce5-f2f5-40ac-b9c9-5cd14eb374b3">27</ix:nonFraction> states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hart v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. On May 5, 2022, the district court granted the Company&#8217;s motion to dismiss the complaint, but granted the plaintiff leave to amend the complaint. The relator filed the second amended complaint on June 7, 2022, which was dismissed again on March 28, 2023, but the district court granted the plaintiff leave to amend. On April 7, 2023, Plaintiff advised the court he would not amend and asked the court to enter the final judgment dismissing the complaint. Once the court issues the final judgment, that decision will be appealable to the Second Circuit Court of Appeals.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ia104b427767541b2bf1e35fa4e361af9" continuedAt="i745937a4e3e14e828ba1bd5317531ce9"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">III.&#160;Government Subpoenas and Investigations </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough, and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. The following are examples of the type of subpoenas or requests the Company receives from time to time.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017 and August 2018, respectively, the Company was served with&#160;<ix:nonFraction unitRef="case" contextRef="ia91da99152ad44428ddb96bcf738d999_I20170531" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI5NzE3_3e1c4f45-d2e3-4728-985b-bcd834802b4b"><ix:nonFraction unitRef="case" contextRef="i9fa7ddfc765f423794371f1af3723e4f_I20180831" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI5NzE3_855cca28-be6c-4f83-b91f-3c69614767ab">two</ix:nonFraction></ix:nonFraction>&#160;separate Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York relating to the certification the Company obtained for <ix:nonFraction unitRef="softwareproduct" contextRef="i9fa7ddfc765f423794371f1af3723e4f_I20180831" decimals="INF" name="mck:NumberofSoftwareProducts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI5ODc5_0aa091a2-1cdb-42f4-b285-f4f13bd4cb4c"><ix:nonFraction unitRef="softwareproduct" contextRef="ia91da99152ad44428ddb96bcf738d999_I20170531" decimals="INF" name="mck:NumberofSoftwareProducts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI5ODc5_6b48a21f-fd16-4a8b-ae0b-47248239452f">two</ix:nonFraction></ix:nonFraction> software products under the U.S. Department of Health and Human Services&#8217; Electronic Health Record Incentive Program. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the United States Attorney&#8217;s Office for the District of Massachusetts served a Civil Investigative Demand on the Company seeking documents related to certain discounts and rebates paid to physician practice customers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2021, the Norwegian Competition Authority carried out an inspection of Norsk Medisinaldepot AS regarding its and its competitors alleged sharing of competitively sensitive information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the United States Department of Justice served a Civil Investigative Demand on the Company seeking documents related to distribution arrangements for ophthalmology products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IV. State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the State of New York Opioid Stewardship Act (&#8220;OSA&#8221;) imposed an aggregate $<ix:nonFraction unitRef="usd" contextRef="icf0b205ff8cb4fe6bbf197d316b47f43_I20170331" decimals="INF" name="mck:OpioidStewardshipActNewYorkAnnualSurcharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzMxODk1_0955e2ec-37eb-4a02-8eb8-e74feefca9a1"><ix:nonFraction unitRef="usd" contextRef="i20873e9ecf6d4345bd56d1540cbbe862_I20180331" decimals="INF" name="mck:OpioidStewardshipActNewYorkAnnualSurcharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzMxODk1_c49705ba-4d0e-4369-9299-b1b62ff779b2">100</ix:nonFraction></ix:nonFraction>&#160;million annual surcharge for 2017 and 2018 on all manufacturers and distributors licensed to sell or distribute opioids in New York. Pending resolution of a challenge to the OSA filed by the Healthcare Distribution Alliance (&#8220;HDA&#8221;), the Company accrued its estimated OSA surcharges as a $<ix:nonFraction unitRef="usd" contextRef="id1aa84dc10f44e2ea8914b72f7921ce2_D20200401-20210331" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzMyNzAx_58667d5e-6558-46ab-998e-051e24f5a8e1">50</ix:nonFraction>&#160;million provision in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet as of March 31, 2021. In December 2021, after the HDA challenge was dismissed, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i7dea821e32924b6585e37a6e0736d3bc_D20211201-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE3MTY_9921cce0-0d94-49c9-99a9-44bc9879f198">26</ix:nonFraction>&#160;million for the 2017 OSA surcharge assessment. On May 18, 2022, the Company filed a lawsuit in New York state court challenging the constitutionality of the OSA. In November 2022, the Company received a 2018 OSA surcharge assessment of approximately $<ix:nonFraction unitRef="usd" contextRef="ibee4b1dcd2594498a8e665ad78a26929_I20221130" decimals="-6" name="mck:OpioidStewardshipActNewYorkAnnualSurcharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE3Mjk_88059a1a-2aff-4d19-9acb-22a9988bc938">42</ix:nonFraction>&#160;million, and therefore the Company accrued an additional $<ix:nonFraction unitRef="usd" contextRef="i9b320ce88af7493b8137e9d513e29859_D20220401-20230331" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE3NDI_c653cbb2-2573-42f0-8844-d946d1919988">18</ix:nonFraction>&#160;million provision in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2023. On December 14, 2022, the state court ruled that the OSA is constitutional. In December 2022, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i7989fb6981db44d6a082cf3c02a024b6_D20221201-20221231" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE3NTU_b385038f-4eea-4104-a5e5-07c1bb0dbe9c">11</ix:nonFraction>&#160;million as the first installment of the 2018 OSA surcharge assessment, and in March 2023, the Company paid another $<ix:nonFraction unitRef="usd" contextRef="i7403b5a9a1b84b5cb7c8a882d6a51fd2_D20230301-20230331" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0NDA_d1d3aa8b-6498-49a8-ae4a-e100f973a63d">11</ix:nonFraction>&#160;million as the second installment. The Company&#8217;s OSA challenge is pending before the New York Supreme Court Appellate Division. The Company reserves its rights and intends to vigorously challenge the OSA and the OSA surcharge assessments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">V.&#160;Environmental Matters</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primarily as a result of the operation of the Company&#8217;s former chemical businesses, which were fully divested by 1987, the Company is involved in various matters pursuant to environmental laws and regulations. The Company has received claims and demands from governmental agencies relating to investigative and remedial actions purportedly required to address environmental conditions alleged to exist at <ix:nonFraction unitRef="site" contextRef="idc03527a8d334d539c474fe9c3791d14_D20220401-20230331" decimals="INF" name="mck:EnvironmentalLossContingencyAgreedRemediationNumberOfSites" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzODQ_5008dc56-1c73-4cc0-afbb-9c1404341ac2">four</ix:nonFraction> sites where it, or entities acquired by it, formerly conducted operations and the Company, by administrative order or otherwise, has agreed to take certain actions at those sites, including soil and groundwater remediation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on a determination by the Company&#8217;s environmental staff, in consultation with outside environmental specialists and counsel, the current estimate of the Company&#8217;s probable loss associated with the remediation costs for these <ix:nonFraction unitRef="site" contextRef="idc03527a8d334d539c474fe9c3791d14_D20220401-20230331" decimals="INF" name="mck:EnvironmentalLossContingencyAgreedRemediationNumberOfSites" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzNjA_ae1037ac-380a-463d-8ad0-3506308bb0d0">four</ix:nonFraction> sites is $<ix:nonFraction unitRef="usd" contextRef="i9db2aeb8a3924ed5bd9d03fb72c6cd8d_I20230331" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzNDg_cf11d824-bdc3-42f8-b56c-90b2973c668f">24</ix:nonFraction>&#160;million, net of amounts anticipated from third parties. The $<ix:nonFraction unitRef="usd" contextRef="i9db2aeb8a3924ed5bd9d03fb72c6cd8d_I20230331" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzMDM_af947080-c551-439f-9113-663c0af94684">24</ix:nonFraction>&#160;million is expected to be paid out between April 2023 and March 2053. The Company has accrued $<ix:nonFraction unitRef="usd" contextRef="i9db2aeb8a3924ed5bd9d03fb72c6cd8d_I20230331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzMTY_e88e8d64-4ad4-4783-89de-4b175ca023e7">24</ix:nonFraction>&#160;million for the estimated probable loss for these environmental matters in its <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="mck:EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjIyMTA_a8c4c602-98b3-499d-a7a2-ee7af8805ca7">Consolidated Balance Sheet</ix:nonNumeric> as of March 31, 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i745937a4e3e14e828ba1bd5317531ce9"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been designated as a Potentially Responsible Party (&#8220;PRP&#8221;) under the Superfund law for environmental assessment and cleanup costs as the result of its alleged disposal of hazardous substances at <ix:nonFraction unitRef="site" contextRef="iddb1a3b6365b4643bd368941bb1a62c9_D20160301-20160331" decimals="INF" name="mck:HazardousSubstanceSites" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzM1MjAw_3676f36b-064e-4cd3-a033-4d1af6e7638f">14</ix:nonFraction> sites. With respect to these sites, numerous other PRPs have similarly been designated and while the current state of the law potentially imposes joint and several liabilities upon PRPs, as a practical matter, costs of these sites are typically shared with other PRPs. For <ix:nonFraction unitRef="site" contextRef="iddb1a3b6365b4643bd368941bb1a62c9_D20160301-20160331" decimals="INF" name="mck:HazardousSubstanceSitesRecipientOfDirectives" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0MDI_e5913c0e-1a1f-4c47-af88-fa82e8b09ddb">one</ix:nonFraction> such site, the Company was one of multiple recipients of a New Jersey Department of Environmental Protection directive and a separate U.S. Environmental Protection Agency (&#8220;EPA&#8221;) directive concerning natural resources damages to the Passaic River associated with the Company&#8217;s Newark, New Jersey facility.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2016, the EPA selected a preferred remedy for this Lower Passaic River site with an estimated cost of approximately $<ix:nonFraction unitRef="usd" contextRef="iddb1a3b6365b4643bd368941bb1a62c9_D20160301-20160331" decimals="-8" name="mck:EstimatedEnvironmentalAssessmentAndCleanupCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzM1NjE2_03196b19-5d6c-4c4d-8246-6bc9f3880343">1.4</ix:nonFraction> billion. In December 2022, the Company entered into a Consent Decree with the EPA that is currently pending approval by the U.S. District Court for the District of New Jersey and requires the Company to pay $<ix:nonFraction unitRef="usd" contextRef="i219f752cc9d64079a2574ee8f7108652_I20221231" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjAxMzE3Ng_87baa105-f501-4f7a-92cf-c47994d318c3">3</ix:nonFraction>&#160;million, which had already been accrued for in the Consolidated Balance Sheets based on past estimated probable loss. Accordingly, the Company&#8217;s estimated probable loss at the remaining <ix:nonFraction unitRef="site" contextRef="ia153892cce85447fb85d9233bdf56fff_D20220401-20230331" decimals="INF" name="mck:HazardousSubstanceSitesRecipientOfDirectives" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzNDQ_04ac47cb-e991-4de0-ade0-31fd511f0398">13</ix:nonFraction> sites is approximately $<ix:nonFraction unitRef="usd" contextRef="i2c415789acee4283a6ed5420c5137fc9_I20230331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzMzA_fcfc62a1-b79d-47ca-9910-c37505c9574d">23</ix:nonFraction>&#160;million, which has been accrued for in the Consolidated Balance Sheets as of March 31, 2023. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">VI. Value Added Tax Assessments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in various countries outside the U.S. which collect value added taxes (&#8220;VAT&#8221;). The determination of the manner in which a VAT applies to the Company&#8217;s foreign operations is subject to varying interpretations arising from the complex nature of the tax laws. The Company has received assessments for VAT which are in various stages of appeal. The Company disagrees with these assessments and believes that it has a strong legal argument to defend its tax positions. Certain VAT assessments relate to years covered by an indemnification agreement. Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters. However, based on currently available information, the Company believes the ultimate outcome of these matters will not have a material adverse effect on its financial position, cash flows or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">VII.&#160;Antitrust Settlements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous lawsuits have been filed against certain brand pharmaceutical manufacturers alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. These lawsuits are typically brought as class actions. The Company has not been named a plaintiff in any of these class action lawsuits, but has been a member of the class of those who purchased directly from the pharmaceutical manufacturers. Some of these class action lawsuits have settled in the past with the Company receiving proceeds, including $<ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjA0MzA5NA_7145bd41-57ff-425d-8568-cafad874ee2f">129</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjA0MzEwMA_afdb7aba-91ed-40a7-9b0a-b1c9cfc0f00f">46</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjA0MzEwOQ_2b79bcfd-6673-4f47-a445-81e89d6de041">181</ix:nonFraction>&#160;million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively, which were included in &#8220;Cost of sales&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">VIII. Other Matters </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various other litigation, governmental proceedings, and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings, or claims, the Company believes, based on current knowledge and the advice of counsel, that such litigation, proceedings, and claims will not have a material impact on the Company&#8217;s financial position or results of operations.</span></div></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_175"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzUyMzg_d4489b7a-6bf8-439a-b59a-7136810fa0e2" continuedAt="i22bd91619e224644b3dc2441b022c02a" escape="true">Stockholders' Equity (Deficit) </ix:nonNumeric></span></div><ix:continuation id="i22bd91619e224644b3dc2441b022c02a" continuedAt="iee39b0ccbb04445690d051455f3a8392"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted <ix:nonFraction unitRef="vote" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="INF" name="mck:CommonStockVotingRightsNumberofVotesPerCommonShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0Xzc5_23b03a88-24b4-4984-b2c8-98d99e50a043">one</ix:nonFraction> vote on proposals presented to stockholders and is entitled to participate equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Company&#8217;s quarterly dividend was raised from $<ix:nonFraction unitRef="usdPerShare" contextRef="i71dc2fb8cd8f4fab8df832f11c64c6e4_D20220401-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzI1Mw_17a4f875-4550-404b-bb43-342352f491e8">0.47</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="idf21b957ae1643249d6ecd39408dd77d_D20220701-20220731" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzI1OQ_5f2b94de-11c8-4d2a-9511-3dd9e25dbf4a">0.54</ix:nonFraction> per common share for dividends declared on or after such date by the Board. The Company declared regular cash dividends of $<ix:nonFraction unitRef="usdPerShare" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzM1Mw_7dc11172-0710-4406-b02c-a917c9bc80a2">2.09</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzM3Mw_548196c8-c5e1-4fd1-ae10-c48d308b4901">1.83</ix:nonFraction>, and $<ix:nonFraction unitRef="usdPerShare" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzM5Nw_4881de47-8beb-4b30-b3ea-eef5b2d5cdfe">1.67</ix:nonFraction> per share for the years ended March 31, 2023, 2022, and 2021, respectively. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company&#8217;s future earnings, financial condition, capital requirements, and other factors.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_2484"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="iee39b0ccbb04445690d051455f3a8392" continuedAt="i9d60d66b85aa426097039ef21ce13a71"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has authorized the repurchase of McKesson&#8217;s common stock. Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, tax implications, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. During the last three fiscal years, the Company&#8217;s share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:AcceleratedShareRepurchasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV80NTM0_1dda83c3-581d-429a-80c2-279754ea85ed" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding share repurchase activity over the last three fiscal years were as follows:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.449%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ca92db1bf347039646a68953e87fed_I20200331" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18yLTYtMS0xLTIyMjc4Nw_e5f0d458-7206-4169-8667-611ae468e54e">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18zLTYtMS0xLTIyMjc4Nw_b0be8a57-5d5d-4d8a-98db-7ce099c220f2">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9446f02c71545a69aa3169ca6418b21_D20200401-20210331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY180LTItMS0xLTIyMjc4Nw_84a8596c-3ef8-481e-aba1-55bb56dbee80">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9446f02c71545a69aa3169ca6418b21_D20200401-20210331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY180LTQtMS0xLTIyMjc4Nw_5ba22329-320c-4eac-8257-e8883b27365b">160.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9446f02c71545a69aa3169ca6418b21_D20200401-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY180LTYtMS0xLTIyMjc4Nw_184598aa-e272-4066-a195-49ca4df74f58">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY181LTYtMS0xLTIyMjc4Nw_32741208-cd27-40e9-a954-f6f6e642586b">2,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2021 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3376bdc454704e8a84932b1b7dd33e89_D20210401-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY182LTItMS0xLTIzNDMxNw_5e7c7ce9-13bc-4313-b85e-99d7b333e80d">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3376bdc454704e8a84932b1b7dd33e89_D20210401-20220331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY182LTQtMS0xLTIzNDMyMQ_ad77a244-92b9-46a8-b3c9-2d71a31bc157">193.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3376bdc454704e8a84932b1b7dd33e89_D20210401-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY182LTYtMS0xLTIyMjc4Nw_6c6cbd3b-12ef-4afa-8082-c887753be7e8">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9218dd12bc66496ba1bcdebfe2a9ca2b_D20210401-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY183LTItMS0xLTIyMjc4Nw_8005cd3e-b048-4984-92f4-a433dd567202">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9218dd12bc66496ba1bcdebfe2a9ca2b_D20210401-20220331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY183LTQtMS0xLTIyMjc4Nw_044ad54b-4968-4a9b-baed-63ae3def96ff">217.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9218dd12bc66496ba1bcdebfe2a9ca2b_D20210401-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY183LTYtMS0xLTIyMjc4Nw_1cfc7f96-c535-446f-8dc3-99d47080c9ab">1,007</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY184LTYtMS0xLTIyNDUyOA_c2b79a7c-66f9-4ff5-b9ba-abd6a74cc2bc">4,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9cde46cdcba64ab9acfd06498904f049_D20210401-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTItMS0xLTIyNDUxNA_8fd6debb-2c7d-4a9e-84df-a73f1e186da0">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9cde46cdcba64ab9acfd06498904f049_D20210401-20220331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTQtMS0xLTIyNDUxNA_35790583-cb55-42c7-948f-d21fb4c62d6a">265.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cde46cdcba64ab9acfd06498904f049_D20210401-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTYtMS0xLTIyNDUyOA_de9c2216-967d-497d-a24c-965eec1dc21e">1,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY184LTYtMS0xLTIyMjc4Nw_178dfb1a-457a-4956-accb-e4c40624f8da">3,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i20292928a6df4630869820c5c913bbdb_D20220401-20230331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMS0yLTEtMS0yMzYyMDY_9e01b99c-bab5-412d-9048-a1498a307ccb">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i20292928a6df4630869820c5c913bbdb_D20220401-20230331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMS00LTEtMS0yMzYyMDY_4e6de2e8-ab9e-488a-a54c-94ba230b55ea">295.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20292928a6df4630869820c5c913bbdb_D20220401-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMS02LTEtMS0yMzYyMDY_2f7e75c7-b396-480d-a2d6-389026a1a34b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2022 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45ac0ae0f55f4a1db80ab683ab3f7655_D20220401-20230331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTItMS0xLTIyMjc4Nw_281ae973-5bed-4a70-bac8-277511c5ccac">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i45ac0ae0f55f4a1db80ab683ab3f7655_D20220401-20230331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTQtMS0xLTIyMjc4Nw_d3e50e5d-d125-474e-975f-a2c8f02568bc">321.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45ac0ae0f55f4a1db80ab683ab3f7655_D20220401-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTYtMS0xLTIyMjc4Nw_10b80101-772b-441a-9762-45ebad8e5854">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMS02LTEtMS0yMjI3ODc_0c5f7965-692c-4068-85e3-42cd492a4dd1">4,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - December 2022 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96f090a3fbc74514b59f02f20a563b79_D20220401-20230331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMi0yLTEtMS0yMjI3ODc_d50d40cf-cb21-48c0-a084-06874624e23f">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i96f090a3fbc74514b59f02f20a563b79_D20220401-20230331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMi00LTEtMS0yMjI3ODc_19ff9bdf-efbe-4796-94bb-3b196f3bc6db">369.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96f090a3fbc74514b59f02f20a563b79_D20220401-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMi02LTEtMS0yMjI3ODc_a154f659-969a-4428-9a1a-389071855bf7">972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32ef665f7e9f47f8a52f2b7ccd1c1642_D20220401-20230331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xNi0yLTEtMS0yMzYyMTA_2f735ec1-58a3-459a-81d5-e67198b1a160">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32ef665f7e9f47f8a52f2b7ccd1c1642_D20220401-20230331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xNi00LTEtMS0yMzYyMTA_ffff8665-c582-4b68-9ed5-44482717f16d">363.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32ef665f7e9f47f8a52f2b7ccd1c1642_D20220401-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xNi02LTEtMS0yMzYyMTA_7a230aa0-8298-4f7e-9a56-b0383b54e234">1,693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMy02LTEtMS0yMjI3ODc_9fc9735d-f3db-40fc-a614-6d4feb4bc149">3,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $<ix:nonFraction unitRef="usd" contextRef="i62b31f8221c34827bfa4b4c4223aef53_I20210331" decimals="-6" name="mck:AccruedShareRepurchases" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV8xMjU5_6cea931d-3516-415a-9141-df2e8bb8a06b">8</ix:nonFraction>&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet as of March 31, 2021, included in the Company&#8217;s Annual Report on Form 10-K for the year ended March 31, 2022,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for share repurchases that were executed in late March 2021 and settled in early April 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $<ix:nonFraction unitRef="usd" contextRef="if81af84863b849ee84346934e78dd3d1_D20220201-20220228" decimals="-8" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV84Nzk2MDkzMDMxMzg3_f6ffe804-2907-45db-bc3a-46bf9ba5ba0c">1.5</ix:nonFraction>&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was <ix:nonFraction unitRef="shares" contextRef="i4b81b5ce8e3946c486bacd3228a6502d_D20220201-20220228" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV84Nzk2MDkzMDMxMTU0_942134b8-9f6e-4ab5-967d-8deecc3dc023">5.1</ix:nonFraction>&#160;million shares at an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4b81b5ce8e3946c486bacd3228a6502d_D20220201-20220228" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV84Nzk2MDkzMDMxMTgw_1a90c2d6-9d6a-43aa-9504-78bc84071ee7">295.16</ix:nonFraction>. The Company received <ix:nonFraction unitRef="shares" contextRef="i609db64ab4224f9ab5523d7c2bb0d613_D20220101-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV84Nzk2MDkzMDMxMTY3_74d8600d-53a0-4020-bee7-551043af4efe">4.8</ix:nonFraction>&#160;million shares as the initial share settlement in the fourth quarter of fiscal 2022 based on an initial share purchase price, and in May 2022, it received an additional <ix:nonFraction unitRef="shares" contextRef="id1c0f65c88014f1ca2d67069e57a5ee6_D20220501-20220531" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV84Nzk2MDkzMDMxMTg5_88ed9204-aab1-409c-83de-6eba12d55a3b">0.3</ix:nonFraction>&#160;million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $<ix:nonFraction unitRef="usd" contextRef="i831c04a5da8247afbc87577d86b34cfe_D20220401-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV8xNjQ5MjY3NDUwMzk5_1df5136d-e077-4993-a1f5-810ab3261b79">27</ix:nonFraction> million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet as of March 31, 2023 for share repurchases that were executed in late March 2023 and settled in early April 2023.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_2511"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i9d60d66b85aa426097039ef21ce13a71" continuedAt="ibf86d426086d4e8aae88872a83e8b69c"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl8xODAz_0ab6f428-18cf-47de-b15f-4114da445dae" continuedAt="if227e010fd794cc38d36e384b27b108f" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s accumulated other comprehensive loss by component were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.419%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow and Other Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i606c3a6a2202458da025615d9b410a00_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yLTEtMS0xLTIyMjgwNg_0a2fad01-4ff5-47f7-860f-be697bf0cf5b">1,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i074564bccb7c4a93a2b47e7194a97423_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yLTMtMS0xLTIyMjgwNg_b9578c81-68b4-4ddf-9294-d4b9f38ba49c">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a12d8177d3a4bca8f20394c549b2ba4_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yLTUtMS0xLTIyMjgwNg_6f1e9ed3-c9e4-4dfe-b242-3220ca076aff">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia24155bbe2b64b13a5839bc953e73126_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yLTctMS0xLTIyMjgwNg_56ca6ca1-5d07-499a-9198-53549a88d92a">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia06fe5f5c08242e7988383eb561e7daf_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yLTktMS0xLTIyMjgwNg_2551b108-718f-40b7-8118-5363f7f99eaa">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18zLTEtMS0xLTIyMjgwNg_ed91af41-8f46-4086-870e-54d7579e1327">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18zLTMtMS0xLTIyMjgwNg_61964087-2056-467f-83ee-d7865a535521">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18zLTUtMS0xLTIyMjgwNg_ca06b039-58cf-4694-829c-fb3834a9aa93">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18zLTctMS0xLTIyMjgwNg_7b7c8afa-1885-4895-a8b0-222445d20213">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18zLTktMS0xLTIyMjgwNg_7a40d41f-aff9-4088-ba5e-590ffc70ec85">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM180LTEtMS0xLTIyMjgwNg_1c5443cb-622c-4fde-bdfe-4844ba4b8165">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM180LTMtMS0xLTIyMjgwNg_1b99a2b3-554d-44e7-ab91-ee6c7411e0c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM180LTUtMS0xLTIyMjgwNg_f34153d7-2333-4b86-9fa9-b8b8fc38cbd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM180LTctMS0xLTIyMjgwNg_5711a0a0-35d3-4ae8-b93e-0970afd378f1">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM180LTktMS0xLTIyMjgwNg_b1ac0d5f-9709-4866-b0c5-039a04995c93">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM181LTEtMS0xLTIyMjgwNg_d5bbb26b-f868-4899-8323-c456261ec237">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM181LTMtMS0xLTIyMjgwNg_90d04605-2cc7-400b-a746-eb52728350e9">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM181LTUtMS0xLTIyMjgwNg_15538e0b-b939-42d3-8832-c3136bc9e14f">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM181LTctMS0xLTIyMjgwNg_76d409dd-8e59-4765-998c-9eb768bd2c39">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM181LTktMS0xLTIyMjgwNg_955a6097-e525-4067-8911-e824c1420d33">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM182LTEtMS0xLTIyMjgwNg_adb42812-dc5d-43bc-87f8-6effd6ca5b2f">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM182LTMtMS0xLTIyMjgwNg_98209968-e688-43c1-9646-63a3408e6eb5">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM182LTUtMS0xLTIyMjgwNg_01a56520-dd3e-42cb-aba1-ce9497bf34f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM182LTctMS0xLTIyMjgwNg_2fc67287-b06b-4ace-9245-e516402abc8f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM182LTktMS0xLTIyMjgwNg_2fc43944-5351-4908-8640-cad1f8ca57d4">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM183LTEtMS0xLTIyMjgwNg_4e6b04d0-7386-4e17-810b-f9ebc9ef5638">419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM183LTMtMS0xLTIyMjgwNg_69cc76f5-973a-49e7-ac7e-516a3e21115d">174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM183LTUtMS0xLTIyMjgwNg_1f2b0c25-61d2-4ec6-94b9-90c26dd54a5a">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM183LTctMS0xLTIyMjgwNg_fff319dc-335a-4f96-a8f3-6723ad151451">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM183LTktMS0xLTIyMjgwNg_aeb5a083-7809-4ff2-9320-146dbc21ef92">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i541d58c4043e481c86a354b16272d39f_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM184LTEtMS0xLTIyMjgwNg_9d888582-20f9-45e4-bade-8b60aa5eb46d">1,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief34de8c02864055a306f0805902d830_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM184LTMtMS0xLTIyMjgwNg_b62936f8-2767-4565-a34b-e57a67666f61">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ab34673c6cd4865a1526b689d28d9e5_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM184LTUtMS0xLTIyMjgwNg_6f9005b6-2d44-479d-b767-cbb2b97293b0">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de62b174ea943d98bbc5ea010c68a3b_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM184LTctMS0xLTIyMjgwNg_9391e79b-9ef1-4687-9f00-d9b7a6d972ce">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idebabd22268d4aa5be5fdcb7615dcb80_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM184LTktMS0xLTIyMjgwNg_492afa5a-4a0f-4fa0-b01e-da9e96d0634b">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica7e852a88784746894a205a0250f9e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM185LTEtMS0xLTIyMjgwNg_c6a920ff-64b1-45aa-b163-f10401b384b7">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM185LTMtMS0xLTIyMjgwNg_d7927d33-da48-418d-bfed-1a84473af835">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM185LTUtMS0xLTIyMjgwNg_346de2cc-9853-425f-a00d-08ea05c3feba">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM185LTctMS0xLTIyMjgwNg_ad36dbde-febb-41a9-97a0-192d97a70e8e">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM185LTktMS0xLTIyMjgwNg_962e5348-f103-43de-aa10-f4848a41df4a">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica7e852a88784746894a205a0250f9e2_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMC0xLTEtMS0yMjI4MDY_9d72ce7b-62cc-4c57-baac-263cd88c1be3">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMC0zLTEtMS0yMjI4MDY_fe830a62-27f8-4390-b253-8adcecab1805">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMC01LTEtMS0yMjI4MDY_f52d221a-659a-47c2-9326-2095732e6796">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMC03LTEtMS0yMjI4MDY_6b9e4bfc-14a6-467f-b9c4-3a0a061b7c6a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMC05LTEtMS0yMjI4MDY_901a73f7-26df-43ac-9459-152015d27f7e">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica7e852a88784746894a205a0250f9e2_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMS0xLTEtMS0yMjI4MDY_ad6fb346-7e2a-4e5c-a741-fe9cd7cdd9bf">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMS0zLTEtMS0yMjI4MDY_30efa56e-f651-4401-a63b-ad6c24acc600">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMS01LTEtMS0yMjI4MDY_5b5fde1f-7de7-4690-bfd1-42f65cc0de6b">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMS03LTEtMS0yMjI4MDY_b47af9e0-931c-40c6-92da-12c2f96fcc01">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMS05LTEtMS0yMjI4MDY_0e3a1963-3e73-4131-ad89-8612d208f6b0">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica7e852a88784746894a205a0250f9e2_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMi0xLTEtMS0yMjI4MDY_ed71dc2c-c1bf-4bbb-a8e3-d7bfc9423f00">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMi0zLTEtMS0yMjI4MDY_6574715d-3e11-40dd-9aab-c62a66cc2619">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMi01LTEtMS0yMjI4MDY_9616e35e-3169-4751-bdef-791473d10308">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMi03LTEtMS0yMjI4MDY_d38b1d05-4f42-4dd1-828c-732a2190ecb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMi05LTEtMS0yMjI4MDY_27daae3d-eb9e-4e3d-b0d1-5b79c369b2c2">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica7e852a88784746894a205a0250f9e2_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMy0xLTEtMS0yMjI4MDY_e7b214b8-1541-4ffa-b45e-9a29c3028816">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMy0zLTEtMS0yMjI4MDY_114cbd2e-bb88-4c94-87b0-3d29d800ec45">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMy01LTEtMS0yMjI4MDY_4628de81-89d7-48d3-82cf-f21406398841">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMy03LTEtMS0yMjI4MDY_0a9e5cb8-060d-44e4-ab0b-b0ac5b5a9006">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMy05LTEtMS0yMjI4MDY_90bb14c4-bdf1-42f8-b298-d99d3ce6e8d5">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling<br/>shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC0xLTEtMS0yNDEzMzQ_f4611816-8a63-42a4-b71a-ead01bde4235">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC0zLTEtMS0yNDEzMzg_3b861f5c-7e7a-450f-bb44-8fa761ad9374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC01LTEtMS0yNDEzNDI_a40a5fa7-42d5-4402-ab07-663b670134cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC03LTEtMS0yNDM3OTM_83f93b12-dab6-4081-86af-f76f4fa58bda">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC05LTEtMS0yNDEzNDg_90b79d48-dde5-4418-92b4-37a55012bd66">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c2e1ec251cb4ae3beaeb30c7c423caf_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC0xLTEtMS0yMjI4MDY_cb2bb5b9-8f78-4c1f-9a1a-227a96ba6a48">1,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie30cfb911148404bb4945fff687165b3_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC0zLTEtMS0yMjI4MDY_a46b319e-f4b0-40c0-aafc-7540dbe75eac">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36eca1d194984dd68f29ddaa4c2a05f9_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC01LTEtMS0yMjI4MDY_35ce15c5-01bb-4ab2-842e-4c4e476b3130">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i124bd77619314a38a6b7cf276d1570cd_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC03LTEtMS0yMjI4MDY_59433e03-f107-4bde-af50-c574062caef6">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7f24a9d3204464d821c538c01648b18_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC05LTEtMS0yMjI4MDY_26249fe6-e0fb-4bb2-9658-96d925ba310f">1,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNS0xLTEtMS0yMjI4MDY_d8a95817-a533-4ed4-8484-53b6088cbdb2">329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNS0zLTEtMS0yMjI4MDY_a8d69f06-6266-4749-aa7c-8a5899d3aa05">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNS01LTEtMS0yMjI4MDY_fdca13f2-7fd8-4794-a4aa-03dbfd765f4c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNS03LTEtMS0yMjI4MDY_13886464-f273-4d92-8dd0-1427fbc41a37">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNS05LTEtMS0yMjI4MDY_ce5ea564-00c5-4e1e-88ed-335593d07a9a">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNi0xLTEtMS0yMjI4MDY_ffaa655b-400d-4370-a938-e2cc28433c65">1,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNi0zLTEtMS0yMjI4MDY_19f2f5af-ca14-4bef-a586-1b1afaedd561">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNi01LTEtMS0yMjI4MDY_433567f0-ddb0-4a6f-b2d7-334fb98b3fe3">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNi03LTEtMS0yMjI4MDY_21a2e4e5-2771-4c98-a786-d47253c0f100">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNi05LTEtMS0yMjI4MDY_3c67fb25-2a5c-4455-be8a-f1dc3c7d7133">852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNy0xLTEtMS0yMjI4MDY_92ed015a-ae63-4508-bab7-4a10ea1ac609">698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNy0zLTEtMS0yMjI4MDY_b8e0d5cb-38bc-4b43-9753-62baab8b55e2">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNy01LTEtMS0yMjI4MDY_63dac46a-607a-4ebf-a5c3-cb334b02d488">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNy03LTEtMS0yMjI4MDY_8cd5a771-7249-4639-9206-dc2164cb75f7">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNy05LTEtMS0yMjI4MDY_b5b3c29e-602e-401b-8db4-70b8c566d41a">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOC0xLTEtMS0yMjI4MDY_65835a57-05e0-4572-a780-453fdd93f1a1">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOC0zLTEtMS0yMjI4MDY_b3f6ee1a-91cd-409d-8bbf-7fda04a70627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOC01LTEtMS0yMjI4MDY_27ad8ecd-20ab-484e-9a10-5b4c52fc66c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOC03LTEtMS0yMjI4MDY_c4af22a2-972c-44fb-a827-1b055f6f8e40">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOC05LTEtMS0yMjI4MDY_592df65d-1ea3-4016-baa9-b318e2805887">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOS0xLTEtMS0yMjI4MDY_f35aba77-6749-4fdd-b825-daa1ec42f890">657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOS0zLTEtMS0yMjI4MDY_4961c8af-9213-4ee9-a4fa-618d448e6d64">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOS01LTEtMS0yMjI4MDY_faddcce3-dcbb-4ef7-81f6-319d41cdb9fc">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOS03LTEtMS0yMjI4MDY_9aaebe12-24d0-42f2-a35a-14f0e0adc9f1">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOS05LTEtMS0yMjI4MDY_b7295c3f-2da1-47ae-a761-d607383fee68">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cf65ea6698449018a0c90a7c5bde4ab_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yMS0xLTEtMS0yMjI4MDY_2009105b-5b7d-4c09-9de2-217ea68944a2">847</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icebbfa315f6f4c3badea80ba552d9fb3_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yMS0zLTEtMS0yMjI4MDY_fc1fac6f-7c91-4dfb-a79a-df64af0add2a">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9073522e455946228d949f1757f5c414_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yMS01LTEtMS0yMjI4MDY_7037f4c6-a947-47d3-8ae0-cfc425da36ef">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ab73b88a84e4a3399c2d709d8b90830_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yMS03LTEtMS0yMjI4MDY_dfd60132-c9f2-4689-8454-365d7d43d027">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa875c8421764c2c97f433701036010f_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yMS05LTEtMS0yMjI4MDY_9607aa6c-b2d4-4536-a5e5-db38e0b28294">905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts before reclassifications recorded in fiscal 2023, fiscal 2022, and fiscal 2021 include gains (losses) of $<ix:nonFraction unitRef="usd" contextRef="icde86b5b9cf640a3857b79b2a12f38f7_D20220401-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl80NDE_cf1e6c3c-1915-4823-8bde-a60e02404f35">7</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i5bf4620f35c94ffe8b0ced9de2482405_D20210401-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl80NDU_aa4ae77f-4e68-4240-9ae4-0fbc0dacbac8">73</ix:nonFraction>&#160;million, and $(<ix:nonFraction unitRef="usd" contextRef="ib5ed5bad9fbc48a79bf500f2ea6d7a22_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl80NTM_ba3e2618-94e2-4b81-8301-1e78fe714682">118</ix:nonFraction>)&#160;million, respectively, related to net investment hedges from Euro-denominated notes and gains (losses) of $<ix:nonFraction unitRef="usd" contextRef="i4e74926dad464e94bdc3f1c87eb5109a_D20220401-20230331" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl81NTQ_a6a8fe12-4665-4b62-8078-57f8392d5799">28</ix:nonFraction>&#160;million, $(<ix:nonFraction unitRef="usd" contextRef="i9a201725780545cb9926c7c283f7d7d0_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl81NTg_ffc0a7d3-8e94-4b0b-b4fb-f19c4897ffe7">4</ix:nonFraction>)&#160;million, and $(<ix:nonFraction unitRef="usd" contextRef="ie12bcf044f834b0ebb0a13192a63245b_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl81NjY_704a2d12-eadc-4c9c-a1d1-bc13a00ebae3">119</ix:nonFraction>)&#160;million, respectively, related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit (expense) of $(<ix:nonFraction unitRef="usd" contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl80OTQ3ODAyMzI5OTI0_377f1882-84d9-48ed-a08b-5755fdc39d25">33</ix:nonFraction>)&#160;million, $(<ix:nonFraction unitRef="usd" contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl83MDU_976f091d-1206-437f-8445-27d6c1a36123">23</ix:nonFraction>)&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl83MTM_5e8f89a6-ef40-4484-a776-11c67fb8b9ff">62</ix:nonFraction>&#160;million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="ibf86d426086d4e8aae88872a83e8b69c"><ix:continuation id="if227e010fd794cc38d36e384b27b108f"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures&#8221; and Financial Note 5, &#8220;Other Income, Net.&#8221; These amounts were included in the fiscal 2021 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the Company&#8217;s Austrian business, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the divestitures of the E.U. disposal group in October 2022, including the impact of amounts previously attributed to the noncontrolling interest in McKesson Europe, and the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included in the fiscal 2023 and fiscal 2022 calculations of charges to remeasure the assets and liabilities of the disposal groups to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. Amounts reclassified to earnings and other includes a net income tax impact of $<ix:nonFraction unitRef="usd" contextRef="ia639b6ffb08b44728499feae92d1c0c8_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl84Nzk2MDkzMDI3MTY4_e19a9fdb-86e5-4904-9639-cc29e34c2e82">6</ix:nonFraction>&#160;million.</span></div></ix:continuation></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_178"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzgvZnJhZzo4NGNkOGFhMzc4YjU0N2E5YjFlMWEyZmI1YzMzMjJjMS90ZXh0cmVnaW9uOjg0Y2Q4YWEzNzhiNTQ3YTliMWUxYTJmYjVjMzMyMmMxXzE0MDY_3db760a4-55ff-4996-a336-54fc185d6b97" continuedAt="i0a1ecd238f2240a4a244e3f3028d1199" escape="true">Related Party Balances and Transactions</ix:nonNumeric></span></div><ix:continuation id="i0a1ecd238f2240a4a244e3f3028d1199"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Europe had investments in pharmacies located across Europe that were accounted for under the equity method. McKesson Europe maintained distribution arrangements with these pharmacies for the sale of related goods and services under which revenues of $<ix:nonFraction unitRef="usd" contextRef="ia0d5849c66ff44049855a2ac70d7759e_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzgvZnJhZzo4NGNkOGFhMzc4YjU0N2E5YjFlMWEyZmI1YzMzMjJjMS90ZXh0cmVnaW9uOjg0Y2Q4YWEzNzhiNTQ3YTliMWUxYTJmYjVjMzMyMmMxXzI3Mw_2ff77713-f99e-477c-89a2-7b84670c8cee">137</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iceb7460499a94969a987f6e8ded5348e_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzgvZnJhZzo4NGNkOGFhMzc4YjU0N2E5YjFlMWEyZmI1YzMzMjJjMS90ZXh0cmVnaW9uOjg0Y2Q4YWEzNzhiNTQ3YTliMWUxYTJmYjVjMzMyMmMxXzI4MQ_b2fa46eb-c182-47d7-b1d5-7712b164546e">178</ix:nonFraction> million are included in the Consolidated Statements of Operations for the years ended March 31, 2022 and 2021, respectively, and receivables related to these transactions included in the Consolidated Balance Sheet were not material as of March 31, 2022. Predominately all of these pharmacies were divested from the Company in the fourth quarter of fiscal 2022 as part of the completed divestiture of the Company&#8217;s Austrian business, and in fiscal 2023 as part of the completed divestitures of the E.U. disposal group and U.K. disposal group. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for additional information on the Company&#8217;s European divestiture activities.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended March 31, 2022 and 2021, the Company&#8217;s pharmaceutical sales to one of its equity method investees in the U.S. Pharmaceutical segment totaled $<ix:nonFraction unitRef="usd" contextRef="i710b6d1dd56e4af4adf0dcdc5a56ecad_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzgvZnJhZzo4NGNkOGFhMzc4YjU0N2E5YjFlMWEyZmI1YzMzMjJjMS90ZXh0cmVnaW9uOjg0Y2Q4YWEzNzhiNTQ3YTliMWUxYTJmYjVjMzMyMmMxXzk4NA_27a5901c-0902-4af8-888b-1e100e0c5038">100</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if772d42044f24743833c57e3767d2780_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzgvZnJhZzo4NGNkOGFhMzc4YjU0N2E5YjFlMWEyZmI1YzMzMjJjMS90ZXh0cmVnaW9uOjg0Y2Q4YWEzNzhiNTQ3YTliMWUxYTJmYjVjMzMyMmMxXzk5Mg_2c5f423d-56ba-4d40-aded-70c62117f1ab">111</ix:nonFraction> million, respectively. During fiscal 2022, the Company&#8217;s investment in this investee was no longer accounted for using the equity method and is not considered a related party as of March 31, 2022.</span></div></ix:continuation><div id="i04335d018da94076b0acf21e81ac886b_181"></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzkzNDQ_3bf396a1-d26e-45f9-b0f7-f1d71b108636" continuedAt="ibc2601093013481e8fb905f4860fb120" escape="true">Segments of Business </ix:nonNumeric></span></div><ix:continuation id="ibc2601093013481e8fb905f4860fb120" continuedAt="i5cd0800fa9234f48ab991b7ac4510e04"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzkx_5d0ec1b4-0a40-4457-afb2-75749bb147b5">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. RxTS serves our biopharma and life sciences partners, delivering innovative solutions that help people get the medicine they need to live healthier lives. RxTS also offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i5cd0800fa9234f48ab991b7ac4510e04" continuedAt="i414cf95d185d449e956ac1a0494bcb1a"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company completed the divestitures of its Austrian business in January 2022, the U.K. disposal group in April 2022, and the E.U. disposal group in October 2022. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for more information. The Company&#8217;s remaining operations in Europe provide distribution and services to wholesale, institutional, and retail customers in Norway where it owns, partners, or franchises with retail pharmacies. The Company&#8217;s Canadian operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="i414cf95d185d449e956ac1a0494bcb1a" continuedAt="idf78b20eb808476898158f7ad6fdef0c"><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzkzMDg_be3cd915-841d-4ec2-ba47-6c4363365e54" continuedAt="ida1307ad35614389a3aa226f37386638" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the consolidated totals was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i888e928ebad143cbb7a499ff02241d61_D20220401-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMtMS0xLTEtMjE4NzQ4_509b9f64-d427-4d20-b40c-4725931f42d1">240,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2799afba52094088a0aec4099f2cd4f8_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMtMy0xLTEtMjE4NzQ4_541e769a-a9b7-47ca-8751-a0389a08930b">212,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2892fe126a4d66a63dd15b65453356_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMtNS0xLTEtMjE4NzQ4_07d84bd1-f938-49c6-b379-d58fa0195dad">189,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id978da015466413b89b3f2baa572ef6d_D20220401-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzQtMS0xLTEtMjE4NzQ4_8a227fec-53ea-466e-b646-36007439b35b">4,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b0a03505314b06b91188743cad0dec_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzQtMy0xLTEtMjE4NzQ4_ca4d8187-fa68-45c1-8464-a90fb1833d88">3,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29863184fd5348ff9a2a8abf0a0f8828_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzQtNS0xLTEtMjE4NzQ4_31f453eb-175f-4e31-8a5d-4e01cb8531f6">2,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b668b117b34adcb089b01f3153c8f0_D20220401-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzUtMS0xLTEtMjE4NzQ4_9a8d554f-68f2-4f4b-b721-232c08e52445">11,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ef17e0a1714077b0570474802db35d_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzUtMy0xLTEtMjE4NzQ4_aa2a94c2-d2f6-48c8-b53a-28723a9a5aaf">11,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0df62424e8a4e62973e47b8bfd93a08_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzUtNS0xLTEtMjE4NzQ4_e0d0a50f-2dbe-4a6d-b150-a6c93ee8636b">10,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969dadb6a5014e4e97c0701a8fa71817_D20220401-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzYtMS0xLTEtMjE4NzQ4_2554925f-5630-43f2-8f0a-b42a4e11cc96">20,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if642126ed2f24282b10b29e0c453e35e_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzYtMy0xLTEtMjE4NzQ4_b9c55873-2b1b-4ba7-bd6e-1618d336a5ad">36,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c162cb2b9c417883dd91ccec907c32_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzYtNS0xLTEtMjE4NzQ4_35419cf1-d5fa-4f53-9e02-52b29c75378b">35,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzctMS0xLTEtMjE4NzQ4_ee4d6b1d-4d48-4f7b-a94e-84812717d022">276,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzctMy0xLTEtMjE4NzQ4_f847d0c2-1c0b-42f4-9e31-90508570f0ea">263,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzctNS0xLTEtMjE4NzQ4_d5443662-2689-4949-83b3-7883e24da051">238,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEwLTEtMS0xLTIxODc0OA_2db929aa-2759-48ef-a5a5-2f4bd9bdd5be">3,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEwLTMtMS0xLTIxODc0OA_73ed13ed-adaa-4a07-a432-999818e1d3b4">2,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEwLTUtMS0xLTIxODc0OA_f5cf5106-8bd1-4bc0-a051-ccd7a9eab65b">2,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzExLTEtMS0xLTIxODc0OA_ac69cb54-2927-4660-a8f7-d8c7da36c079">566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzExLTMtMS0xLTIxODc0OA_a5221928-8953-470b-ac1b-6a6b42b6a813">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzExLTUtMS0xLTIxODc0OA_3bf7ff69-9381-4c42-bcea-784efa68acd2">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEyLTEtMS0xLTIxODc0OA_b9b6a2a3-617f-43e2-a263-035fc651fb2d">1,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEyLTMtMS0xLTIxODc0OA_24f52fbd-e270-4443-b0d2-c897e619750c">959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEyLTUtMS0xLTIxODc0OA_a94bf807-3c97-42a4-ad9f-0ea017581926">707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEzLTEtMS0xLTIxODc0OA_03c6609d-2ade-49e1-b898-7c0ac9d6e792">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="-6" sign="-" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEzLTMtMS0xLTIxODc0OA_b04806b1-b8ce-4807-8c53-f21cb9bb45d2">968</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331" decimals="-6" sign="-" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEzLTUtMS0xLTIxODc0OA_90c6ef01-e9c9-4084-a70a-52e609e9317d">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE1LTEtMS0xLTIxODc0OA_74a85ad4-f878-4f2b-bdeb-076c2dd4201a">5,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE1LTMtMS0xLTIxODc0OA_29f264e7-9264-4924-b15b-d560a45be18a">3,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:GrossProfitNetofExpensesIncludingOtherIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE1LTUtMS0xLTIxODc0OA_896ddc14-ab7a-4070-8453-e18fe07153fc">3,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE2LTEtMS0xLTIxODc0OA_c5180f17-dcc4-4d8c-a59a-9db8c2752927">147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE2LTMtMS0xLTIxODc0OA_465417ca-5f2b-4b41-9240-17a575d84538">1,073</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE2LTUtMS0xLTIxODc0OA_06c15acf-ca79-4ad2-a7a1-d952f3631bc7">8,645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE3LTEtMS0xLTIxODc0OA_b2bff6d3-1620-40e6-bb4e-6424c87a241a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE3LTMtMS0xLTIxODc0OA_1cd2006a-5431-46e2-ac30-cfb6035fab07">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE3LTUtMS0xLTIxODc0OA_6f6d4d90-2934-4f19-b85b-b021eb1c45a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE4LTEtMS0xLTIxODc0OA_c3b991a2-6aaa-4627-9195-e1c12831b181">248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE4LTMtMS0xLTIxODc0OA_2ba7679c-89d6-4d42-a226-f1a890afc285">178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE4LTUtMS0xLTIxODc0OA_d8cea6c4-55c9-4016-8bed-5c1a638c4942">217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE5LTEtMS0xLTIxODc0OA_cd548eda-bdd6-4f81-8556-3010923fd4ab">4,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE5LTMtMS0xLTIxODc0OA_206fab7b-bb16-449b-8ff4-b8e35ff0df25">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE5LTUtMS0xLTIxODc0OA_448d66ff-04fe-477d-95e2-60fdbe11585f">5,034</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIyLTEtMS0xLTIxODc0OA_7e97abbd-4130-400f-8252-bd3bb3dc0f9c">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIyLTMtMS0xLTIxODc0OA_8ed8d24e-4266-44e1-8085-a585d73a5c9d">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIyLTUtMS0xLTIxODc0OA_025012f8-71cb-452b-bb56-8d01104d4694">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIzLTEtMS0xLTIxODc0OA_b5c79d93-e70d-4aab-b8d8-a9325deafe07">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIzLTMtMS0xLTIxODc0OA_99441495-de27-45e6-b2b1-c7d254e04218">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIzLTUtMS0xLTIxODc0OA_d550b389-84c4-442c-b8a2-eb688af7abd7">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI0LTEtMS0xLTIxODc0OA_2440526d-13cb-4545-a70e-a73702be570a">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI0LTMtMS0xLTIxODc0OA_11530316-ceb9-48ff-804f-e68e190e1dd9">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI0LTUtMS0xLTIxODc0OA_838e35d9-27a0-45a1-9c6c-5bc554534da2">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI1LTEtMS0xLTIxODc0OA_b75e432d-98c2-47fd-90ab-cd5efd0ed364">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI1LTMtMS0xLTIxODc0OA_221563c6-95e8-4618-b63c-50fb67de3b07">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI1LTUtMS0xLTIxODc0OA_cbd7f133-5f2a-4e38-87dc-b06ee3a57c36">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI2LTEtMS0xLTIxODc0OA_5e9b1f14-408d-4675-bbaa-fdded1352b12">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI2LTMtMS0xLTIxODc0OA_e13a299f-f66d-4e9f-a37c-55bb701db8c1">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI2LTUtMS0xLTIxODc0OA_e09e0844-ef88-4267-8f44-7f69b57c56b8">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI3LTEtMS0xLTIxODc0OA_889546c4-4dbc-44e1-a5df-b5cc6f541f54">608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI3LTMtMS0xLTIxODc0OA_59b47c62-b4ed-4b50-bec4-32cf0e0c557d">760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI3LTUtMS0xLTIxODc0OA_1e0d3318-51cd-4aa8-8f60-6541da589ae3">887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment expenditures for long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMwLTEtMS0xLTIxODc0OA_2b5281bb-7138-457c-9eee-42dd21362ffe">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMwLTMtMS0xLTIxODc0OA_41890426-a2c9-47bd-a594-79c79cb70420">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMwLTUtMS0xLTIxODc0OA_e9e612dd-6a95-4a40-ac73-b5e36556f576">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMxLTEtMS0xLTIxODc0OA_86aefca4-a44a-4a85-a1e6-ef8e2d1de6d1">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMxLTMtMS0xLTIxODc0OA_9cf4d93a-ca8e-4007-b597-d1f2f99361ee">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMxLTUtMS0xLTIxODc0OA_96e4d2b6-d19e-4949-9387-9c9a3d434419">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMyLTEtMS0xLTIxODc0OA_ea06ba8f-b2f1-4ed8-ab65-5d2df40ea2d0">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMyLTMtMS0xLTIxODc0OA_603b7bed-e77e-48a1-92cb-f06ca9117688">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMyLTUtMS0xLTIxODc0OA_0a83232f-8347-4c95-abbb-d184d915fcfd">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMzLTEtMS0xLTIxODc0OA_bce8585d-c666-4ed3-8ce6-b0eeeeb8a121">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMzLTMtMS0xLTIxODc0OA_d0da8309-c64f-49c7-8440-53a208285b67">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMzLTUtMS0xLTIxODc0OA_1102c9a7-6691-4cee-992c-7aaef903e809">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM0LTEtMS0xLTIxODc0OA_58afe414-5dad-44f3-a414-7f9c48b2a2a2">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM0LTMtMS0xLTIxODc0OA_efac513b-08cc-48d3-9ce8-f31edfec1589">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM0LTUtMS0xLTIxODc0OA_15e088f8-b2ed-4159-9248-97d46e64b27a">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenditures for long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM1LTEtMS0xLTIxODc0OA_3ecc9f46-bae6-4a16-9e71-6e95e396dbe2">558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM1LTMtMS0xLTIxODc0OA_091440d1-cc96-49a9-9bfe-2e1fb4a2e711">535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM1LTUtMS0xLTIxODc0OA_9b9200e9-dc11-4f97-bf08-a9819b065d7d">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than <ix:nonFraction unitRef="number" contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5MDI_471a868c-0f0b-4a55-a68f-0523c01c3174"><ix:nonFraction unitRef="number" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5MDI_6053b534-fcee-4453-abef-418722f65cee"><ix:nonFraction unitRef="number" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5MDI_96e5b227-faeb-46a3-932d-3e250e6cc68a">1</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5Njg_20b77280-a9e7-4e11-8dc6-e527ca96eb15"><ix:nonFraction unitRef="number" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5Njg_3aa9d296-4323-4d9f-ab03-50a1da8025f9"><ix:nonFraction unitRef="number" contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5Njg_49cfc1f5-1e41-4bbb-96c1-f4b94fe689e9">40</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the RxTS segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwMTk_9438e27a-1f3f-4688-bc0a-c728c3fd2493"><ix:nonFraction unitRef="number" contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwMTk_a2cce488-db73-4ed6-ae51-0968bc8f988d"><ix:nonFraction unitRef="number" contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwMTk_eca48fff-9099-4a6f-8a65-2a0b32c1da10">2</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than <ix:nonFraction unitRef="number" contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwOTY_a23e1029-2520-4191-9c2e-cb38923db6bc"><ix:nonFraction unitRef="number" contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwOTY_bda2fe69-d1de-4b2f-9c8d-7b5450ad8d40"><ix:nonFraction unitRef="number" contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwOTY_c785f27b-cac5-4978-a458-3ac987a0a39e">8</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit includes the following: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">cash receipts for the Company&#8217;s share of antitrust legal settlements were $<ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjM5NzI_7145bd41-57ff-425d-8568-cafad874ee2f">129</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjQwNDY_afdb7aba-91ed-40a7-9b0a-b1c9cfc0f00f">46</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjQwOTk_2b79bcfd-6673-4f47-a445-81e89d6de041">181</ix:nonFraction> million for the years ended March 31, 2023, 2022, 2021, respectively;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a charge of $<ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjU5ODg_a6315e91-a5a1-4d13-b613-011da5dac7bc">1</ix:nonFraction> million for the year ended March 31, 2023 and credits of $<ix:nonFraction unitRef="usd" contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331" decimals="-6" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjYwMDQ_cd5976b7-ba9e-47a6-99b6-f6f57521e950">23</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331" decimals="-6" name="us-gaap:InventoryLIFOReservePeriodCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjYwODM_0839877c-2e7d-403f-8c78-51422b48deab">38</ix:nonFraction> million for the years ended March 31, 2022 and 2021, respectively, related to the LIFO method of accounting for inventories;</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Continued)</span></div></div><ix:continuation id="idf78b20eb808476898158f7ad6fdef0c" continuedAt="id0517d19872a4a04bb4a65839415b34e"><ix:continuation id="ida1307ad35614389a3aa226f37386638" continuedAt="ic0fc906430ea44388bd40a9d1e64d722"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $<ix:nonFraction unitRef="usd" contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjYzMDE_b6e0d868-e1ef-40c1-959f-74f2734ad126">142</ix:nonFraction> million for the year ended March 31, 2023 related to the exit of one of the Company&#8217;s investments in equity securities in July 2022 for proceeds of $<ix:nonFraction unitRef="usd" contextRef="i5042c611135944438746cce257499d4f_D20220701-20220731" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjYzNTU_107ba45d-634f-4c9d-a932-449a7d528b96">179</ix:nonFraction> million, which is reflected within &#8220;Other income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in the Company&#8217;s Consolidated Statement of Operations; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $<ix:nonFraction unitRef="usd" contextRef="ic7a2b38fb7fa4ffd985ec84c91b96f08_D20220401-20230331" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzg3OTYwOTMwNDU3NTQ_59f8688f-c863-4b4d-a36c-ab70fc54a54c">18</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i6f27de4692d94ce8a48a3d7cc406987a_D20200401-20210331" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk5NjE_1e04d104-96cc-4f66-9812-26c119ee8b86">50</ix:nonFraction> million for fiscal 2023 and fiscal 2021, respectively, recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in Financial Note 17, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s RxTS segment&#8217;s operating profit for fiscal 2023 includes restructuring charges of $<ix:nonFraction unitRef="usd" contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzYwMDk_038535f4-5c99-49c9-9385-8f3bfa78048d">43</ix:nonFraction>&#160;million primarily for severance and employee-related costs, as well as asset impairments and accelerated depreciation. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net&#8221; for further information. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for fiscal 2022 and fiscal 2021 includes inventory charges of $<ix:nonFraction unitRef="usd" contextRef="i80ef17e0a1714077b0570474802db35d_D20210401-20220331" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzUzNDM_80e22ef8-6cf4-409a-8875-436988e885ef">164</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic0df62424e8a4e62973e47b8bfd93a08_D20200401-20210331" decimals="-6" name="us-gaap:InventoryWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzg3OTYwOTMwNDgxMjA_ef6f491b-663f-4391-94df-cb87c947d60a">136</ix:nonFraction>&#160;million, respectively, on certain personal protective equipment and other related products.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating profit (loss) includes the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $<ix:nonFraction unitRef="usd" contextRef="ia7674cea30624b1d8ca527142731b3ad_D20220401-20230331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjU2NzE_8fa42341-eae7-43fc-8721-46a862826598">240</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idfa165efd60744789333c4342a1321b6_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjU2NzU_13cc5028-33f7-4357-9f85-01e946e26e14">383</ix:nonFraction> million for the years ended March 31, 2023 and 2022, respectively, to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell and, in fiscal 2022, to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a charge of $<ix:nonFraction unitRef="usd" contextRef="ib04ea519904c428dbf874fb64037adad_D20210401-20220331" decimals="-8" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjU3MDU_f22d4b8e-42f5-4f98-9122-dd4ca1a7e7bb">1.1</ix:nonFraction> billion for the year ended March 31, 2022 to remeasure the assets and liabilities of the U.K. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $<ix:nonFraction unitRef="usd" contextRef="i05710b61fa6a461a86f2ce635e26e4b7_D20210401-20220331" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5Nzc4MTA_0df30f87-f15c-4a98-8571-9c228daaf855">59</ix:nonFraction> million for the year ended March 31, 2022 related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $<ix:nonFraction unitRef="usd" contextRef="i49a0432e3a7549c3a03b803ce21875b6_D20210401-20220331" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5Nzc5MzM_6ebf7b0a-d5dc-475b-bf05-13c8a7010477">42</ix:nonFraction> million for the year ended March 31, 2022 related to the sale of the Company&#8217;s previously held </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="id5247400d4124ca0b0a07ce0631d83e8_I20220331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYxNjA_f3367985-d20f-4c3e-8ec1-e26eddd25db5">30</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> interest in its German pharmaceutical wholesale joint venture to WBA. See Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; and Financial Note 5, &#8220;Other Income, Net,&#8221; for further details;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a goodwill impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzgwMTA_c6c6856e-ae92-4e53-ac97-f60d6777a603">69</ix:nonFraction> million for the year ended March 31, 2021 related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 10, &#8220;Goodwill and Intangible Assets, Net;&#8221; and</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a long-lived asset impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331" decimals="-6" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzgwODY_45a2d6ee-1657-4046-8cee-83a19152bd64">115</ix:nonFraction> million for the year ended March 31, 2021 primarily related to the retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net, includes the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $<ix:nonFraction unitRef="usd" contextRef="ibee85f1796ce4da18771743ac93a0bf7_D20220401-20230331" decimals="-6" name="us-gaap:GainLossOnContractTermination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzU0OTc1NTgyNTI2MA_62ff2e1a-4b34-47a8-9244-867614d53ddf">126</ix:nonFraction> million for the year ended March 31, 2023 related to a cash payment received for the early termination of a TRA exercised by Change in October 2022 and was recorded within &#8220;Other income, net&#8221; in the Consolidated Statement of Operations, as discussed in more detail in Financial Note 5, &#8220;Other Income, Net;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $<ix:nonFraction unitRef="usd" contextRef="i56f911c056b9484b92530a2457c3bafb_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjkzNDQ_a1f37bb7-efe5-4b22-867d-9a00094de2f5">306</ix:nonFraction> million in fiscal 2023 and a charge of $<ix:nonFraction unitRef="usd" contextRef="ic3df0606471a49beaeceeaa20d347abb_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjkzNDg_720cf83a-aeb7-44de-b9f7-2b47f2801ab0">55</ix:nonFraction> million in fiscal 2022 primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="mck:GainLossOnDerivativeTermination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjkzNjM_fe9c6f0a-a441-4aef-bf86-36e70f4f5a5d">97</ix:nonFraction> million for the year ended March 31, 2023 from the termination of certain forward starting fixed interest rate swaps, as discussed in more detail in Financial Note 14, &#8220;Hedging Activities;&#8221;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a charge of $<ix:nonFraction unitRef="usd" contextRef="ibd7c7850d8804f519104e7d06502da80_D20210401-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk0MzY_26a36eb0-dd40-4533-ae21-51245da61f96">42</ix:nonFraction> million in fiscal 2022 primarily related to the effect of accumulated other comprehensive loss components from the U.K. disposal group, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a credit of $<ix:nonFraction unitRef="usd" contextRef="ia92f8f2aaaa94d78b491c9cdf4615c44_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk0NjM_e5179c50-f054-49eb-b741-abe424ec0506">8</ix:nonFraction> million, and charges of $<ix:nonFraction unitRef="usd" contextRef="id73f9b34f34c41d6ad73b7db3ed24dfd_D20210401-20220331" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk0Njc_952a9cca-8afb-40fe-be5c-fc89db8ca426">274</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331" decimals="-8" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk0NzA_c8600d0f-ec4e-4bb4-b543-d129b2bfb084">8.1</ix:nonFraction> billion for the years ended March 31, 2023, 2022, and 2021, respectively, related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 17, &#8220;Commitments and Contingent Liabilities;" </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $<ix:nonFraction unitRef="usd" contextRef="ic465b0622cf24cb28f75710b46a76fb2_D20220401-20230331" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzU4ODI_1689860d-a8be-4b38-9181-e3d26a115c69">36</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="id2e8b60c81a24e6fb0f18c0151fbdea0_D20210401-20220331" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzU4Mjk_990b4d0b-3416-4b34-8ce0-538b663b88b8">130</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i1f0021b2207044be8e84e8be9891a203_D20200401-20210331" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzU4NjM_f3efc08f-d4a1-4770-8253-2329f2461c79">153</ix:nonFraction>&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively, of opioid-related costs, primarily litigation expenses; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $<ix:nonFraction unitRef="usd" contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5Nzg0Nzk_e966d969-dbd6-4339-a320-cc8eb75618f9">83</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk2Mzg_199793ae-9c2b-40c4-8558-0d7756f1b8d6">100</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5Nzg0OTA_db22c55a-35ac-4db2-a813-55d9ec1bcc7a">105</ix:nonFraction> million for the years ended March 31, 2023, 2022, and 2021, respectively, for restructuring initiatives as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a net loss of $<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzcyOTg_405af7ac-6be9-4c6d-8b95-afd38146bbce">36</ix:nonFraction> million, and net gains of $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzczMjA_5fda44b1-0216-486e-9be7-272d3c44b01e">98</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzczMjg_1b258187-c3fd-4193-853a-f07df93304bb">133</ix:nonFraction> million for the years ended March 31, 2023, 2022, and 2021, respectively, associated with certain of the Company&#8217;s equity investments, as discussed in more detail in Financial Note 15, &#8220;Fair Value Measurements;&#8221; and</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a net gain of $<ix:nonFraction unitRef="usd" contextRef="i264e209968434d6cab289a945e761bb9_D20200401-20210331" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk2ODQ_21730d9a-2c6e-42b0-8a08-935152d34dae">131</ix:nonFraction> million in fiscal 2021 recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for fiscal 2022 consists of a charge of $<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjkxMjA_f9ec6911-7a98-486a-a493-4e3b43d73848">191</ix:nonFraction> million related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 11, &#8220;Debt and Financing Activities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_94">Item 8 Index</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (Concluded)</span></div></div><ix:continuation id="id0517d19872a4a04bb4a65839415b34e"><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="ic0fc906430ea44388bd40a9d1e64d722"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span></ix:continuation></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzkzMTI_9e637055-b4b6-498a-a0d7-4143bd7fdb60" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment assets and long-lived assets by geographic areas were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493ee32637374fef85bb13b3cde7de11_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzMtMS0xLTEtMjE4NzQ4_de885df0-ef04-4c3a-bec8-ed09f6d75b6c">41,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i948e2e219f854ac082a3c472c583fe7d_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzMtMy0xLTEtMjE4NzQ4_617a26ed-afd0-4945-823c-a1a651977bbc">38,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbec207732c741a7b5cd533ccd6d7102_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzQtMS0xLTEtMjE4NzQ4_512a0c8b-a799-44c4-bffc-f0d442040f3e">4,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie936d943185b4ffbb312cec2d0a11ea1_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzQtMy0xLTEtMjE4NzQ4_9d6c8bf9-f079-4461-ae86-27f2e4c412d7">3,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab47b293b1e6457e9220acf589c14011_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzUtMS0xLTEtMjE4NzQ4_52c89e2a-8cc2-4f96-a7d6-bc8bfc601f20">5,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56dc2bee6bfd4893aaf3550953e9f904_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzUtMy0xLTEtMjE4NzQ4_5366435b-0099-48a6-9fb4-9e26e4a0fc4d">5,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3e584c30524ea7abc9a6d31589fd8b_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzYtMS0xLTEtMjE4NzQ4_b66a2b79-2b30-4a93-9d91-62158e269bbf">6,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3977781f98d2482e9204ee3df23b62ef_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzYtMy0xLTEtMjE4NzQ4_fc74d1ca-e713-44ce-8bb7-cdfefd89bc20">13,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd5164d3ebc94282adf69fe3daa1dd18_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzgtMS0xLTEtMjE4NzQ4_9b3fbf63-0a9c-4547-8998-464d6c018ce5">4,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca2257eaa5a4089b39072f8a37a459e_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzgtMy0xLTEtMjE4NzQ4_fd0831a1-1746-4d84-9e96-51f6a54936a5">1,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzktMS0xLTEtMjE4NzQ4_b06608ba-1606-44b9-b7f2-3ccfc39971eb">62,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzktMy0xLTEtMjE4NzQ4_3b69114c-3304-4f0e-a8d7-1a6fda57c4ee">63,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4d3a7b2492845f594e7eb9cb4d9ba34_I20230331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzEyLTEtMS0xLTIxODc0OA_3ce087ff-2a8e-4c31-8e24-40cd874f73c3">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b479eb9b0a4205ac5ae85acf2eab9f_I20220331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzEyLTMtMS0xLTIxODc0OA_9633eee7-af5a-4dbe-9279-fd1678da0839">2,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f12ecf10c5748808acbd2a3b98687df_I20230331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzEzLTEtMS0xLTIxODc0OA_7ff15151-ba5e-4f27-b050-823d8bd32c59">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1892be5575524f3e9fca14e45be67594_I20220331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzEzLTMtMS0xLTIxODc0OA_03217ac3-3284-4e48-8cba-b6ea5d9f34aa">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzE0LTEtMS0xLTIxODc0OA_2a6d58ba-4a6c-4fa8-b4f2-8c31f6a73e9e">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzE0LTMtMS0xLTIxODc0OA_d7fad197-70d1-46d0-94ed-02742e1aabf7">2,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The decrease in assets within the International segment is due to the completed divestitures of the U.K. disposal group in April 2022 and the E.U. disposal group in October 2022. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for more information.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software and fiscal 2022 excludes amounts classified as assets held for sale.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_184"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.&#160;&#160;&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i04335d018da94076b0acf21e81ac886b_187"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Controls and Procedures.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and our Chief Financial Officer, with the participation of other members of the Company&#8217;s management, have evaluated the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as such term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this report and have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internal Control over Financial Reporting</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s report on the Company&#8217;s internal control over financial reporting (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) and the related report of our independent registered public accounting firm are included in this Annual Report, under the headings, &#8220;Management&#8217;s Annual Report on Internal Control Over Financial Reporting&#8221; and &#8220;Report of Independent Registered Public Accounting Firm,&#8221; and are incorporated herein by reference.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Controls</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during our fourth quarter of fiscal 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="i04335d018da94076b0acf21e81ac886b_190"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i04335d018da94076b0acf21e81ac886b_193"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i04335d018da94076b0acf21e81ac886b_196"></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i04335d018da94076b0acf21e81ac886b_199"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors, Executive Officers, and Corporate Governance.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about our directors is incorporated by reference from the discussion under the heading &#8220;Election of Directors&#8221; under Item 1 of our Proxy Statement for the calendar year 2023 Annual Meeting of Shareholders, which will be filed with the SEC within 120 days of the Company&#8217;s fiscal year end covered by this Annual Report (the &#8220;Proxy Statement&#8221;). Information about our executive officers is incorporated by reference from the discussion in Part I of this Annual Report under the heading &#8220;Information about our Executive Officers.&#8221; Information about our Audit Committee, including the members of the committee and our Audit Committee Financial Experts, is incorporated by reference from the discussion in Item 1 of the Proxy Statement under the heading &#8220;The Board, Committees and Meetings,&#8221; and in Item 2 of the Proxy Statement under the heading &#8220;Audit Committee Report.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about the Code of Conduct applicable to all employees, officers, and directors can be found on our website, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.mckesson.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under the caption &#8220;Investors &#8212; Governance.&#8221; The Company&#8217;s Corporate Governance Guidelines and Charters for the Audit, Compensation and Talent, Compliance, Finance, as well as the Governance and Sustainability Committees can also be found on our website under the same caption.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to post on its website required information regarding any amendment to, or waiver from, the Code of Conduct that applies to our Chief Executive Officer, Chief Financial Officer, Controller, and persons performing similar functions within four business days after any such amendment or waiver. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_202"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Compensation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about executive compensation is incorporated by reference from the discussion under the heading &#8220;Executive Compensation&#8221; in the Proxy Statement.</span></div><div id="i04335d018da94076b0acf21e81ac886b_205"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about security ownership of certain beneficial owners and management is incorporated by reference from the discussion under the heading &#8220;Principal Shareholders&#8221; in the Proxy Statement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information as of March 31, 2023 with respect to the plans under which the Company&#8217;s common stock is authorized for issuance:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:38.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Plan Category<br/>(In millions, except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of securities<br/>to be issued upon<br/>exercise of<br/>outstanding options,<br/>warrants, and rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">exercise price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">outstanding options,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">warrants, and rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first column)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">security holders</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">security holders</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The weighted-average exercise price set forth in this column is calculated excluding outstanding restricted stock unit awards, since recipients are not required to pay an exercise price to receive the shares subject to these awards.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:7.52pt">Represents option and restricted stock unit awards outstanding under the following plans: (i) 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan; (ii) the 2005 Stock Plan; (iii) the 2013 Stock Plan; and (iv) the 2022 Stock Plan. This amount also includes 2.9&#160;million shares reserved for the potential of maximum payouts of outstanding performance stock units previously granted under the 2013 Stock Plan.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents 3.7&#160;million shares available for purchase under the 2000 Employee Stock Purchase Plan and 4.9&#160;million shares available for grant under the 2022 Stock Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are descriptions of equity plans that have been approved by the Company&#8217;s stockholders. The plans are administered by the Compensation and Talent Committee of the Board of Directors, except for the portion of the 2022 Stock Plan, 2013 Stock Plan, and 2005 Stock Plan related to non-employee directors, which is administered by the Board of Directors or its Governance and Sustainability Committee.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Stock Plan: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2022 Stock Plan was adopted by the Board of Directors on April 27, 2022 and approved by the Company&#8217;s stockholders on July 22, 2022. The 2022 Stock Plan permits the grant of awards in the form of stock options, stock appreciation rights, restricted stock (&#8220;RS&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance awards (including performance stock units (&#8220;PSUs&#8221;)), and other share-based awards. The Company has reserved approximately 5.0 million shares for issuance under the 2022 Stock Plan. Shares of common stock not issued or delivered as a result of the net exercise of a stock option, including in respect of the payment of applicable taxes, or shares repurchased on the open market with proceeds from the exercise of options shall not be returned to the reserve of shares available for issuance under the 2022 Stock Plan. Shares withheld to satisfy tax obligations relating to the vesting of a full-share award shall be returned to the reserve of shares available for issuance under the 2022 Stock Plan.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013 Stock Plan:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The 2013 Stock Plan was adopted by the Board of Directors on May 22, 2013 and approved by the Company&#8217;s stockholders on July 31, 2013. The 2013 Stock Plan permitted the grant of awards in the form of stock options, stock appreciation rights, RS, RSUs, performance-based restricted stock units (&#8220;PeRSUs&#8221;), performance shares, and other share-based awards. The number of shares reserved for issuance under the 2013 Stock Plan was equal to the sum of (i) 30.0 million shares, (ii) the number of shares reserved but unissued under the 2005 Stock Plan as of the effective date of the 2013 Stock Plan, and (iii) the number of shares that became available for reuse under the 2005 Stock Plan following the effective date of the 2013 Stock Plan. Pursuant to the 2013 Stock Plan, for any one share of common stock issued in connection with an RS, RSU, performance share, or other full-share award, three and one-half shares were deducted from the shares available for future grants. Shares of common stock not issued or delivered as a result of the net exercise of a stock option, including in respect of the payment of applicable taxes, or shares repurchased on the open market with proceeds from the exercise of options were not returned to the reserve of shares available for issuance under the 2013 Stock Plan. Shares withheld to satisfy tax obligations relating to the vesting of a full-share award were returned to the reserve of shares available for issuance under the 2013 Stock Plan. Under the terms of the 2022 Stock Plan and 2013 Stock Plan, the exercise price of stock options is no less than fair market value on the grant date, and options generally have a contractual term of seven years. Options generally become exercisable in four equal annual installments beginning one year after the grant date. The vesting of RS or RSUs is determined by the Compensation and Talent Committee at the time of grant. Awards of RS and RSUs generally vest over three years. The Company&#8217;s executive officers and other members of senior management are annually granted PSUs, which have a three-year performance period and are payable in shares without an additional vesting period. The shares previously reserved under the 2013 Stock Plan are no longer available for issuance in connection with the adoption of the 2022 Stock Plan. </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors may be granted an award on the date of each annual meeting of stockholders for up to 5,000 RSUs, as determined by the Board of Directors. Such non-employee director award is fully vested on the date of the grant.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2005 Stock Plan:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The 2005 Stock Plan was adopted by the Board of Directors on May 25, 2005 and approved by the Company&#8217;s stockholders on July 27, 2005. The 2005 Stock Plan permits the granting of up to 42.5 million shares in the form of stock options, RS, RSUs, PeRSUs, performance shares, and other share-based awards. Pursuant to the 2005 Stock Plan, for any one share of common stock issued in connection with an RS, RSU, performance share, or other full-share award, two shares shall be deducted from the shares available for future grants. Shares of common stock not issued or delivered as a result of the net exercise of a stock option, shares withheld to satisfy tax obligations relating to the vesting of a full-share award or shares repurchased on the open market with proceeds from the exercise of options shall not be returned to the reserve of shares available for issuance under the 2005 Stock Plan. Stock options were granted at no less than fair market value and options granted under the 2005 Stock Plan generally have a contractual term of seven years.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the effectiveness of the 2013 Stock Plan, no further shares were made subject to award under the 2005 Stock Plan. Shares reserved but unissued under the 2005 Stock Plan as of the effective date of the 2013 Stock Plan, and shares that became available for reuse under the 2005 Stock Plan following the effectiveness of the 2013 Stock Plan, were available for awards under the 2013 Stock Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan was approved by the Company&#8217;s stockholders on July 30, 1997; however, stockholder approval of the 2005 Stock Plan on July 27, 2005 had the effect of terminating the 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan such that no new awards would be granted under the 1997 Non-Employee Directors&#8217; Equity Compensation and Deferral Plan.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2000 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP is intended to qualify as an &#8220;employee stock purchase plan&#8221; within the meaning of Section 423 of the Internal Revenue Code. In March 2002, the Board amended the ESPP to allow for participation in the plan by employees of certain of the Company&#8217;s international and other subsidiaries. Currently, 23.1&#160;million shares have been approved by stockholders for issuance under the ESPP. The ESPP is implemented through a continuous series of three-month purchase periods (&#8220;Purchase Periods&#8221;) during which contributions can be made toward the purchase of common stock under the plan. Each eligible employee may elect to authorize regular payroll deductions during the next succeeding Purchase Period, the amount of which may not exceed 15% of a participant&#8217;s compensation. At the end of each Purchase Period, the funds withheld by each participant will be used to purchase shares of the Company&#8217;s common stock. The purchase price of each share of the Company&#8217;s common stock is 85% of the fair market value of each share on the last day of the applicable Purchase Period. In general, the maximum number of shares of common stock that may be purchased by a participant for each calendar year is determined by dividing $25,000 by the fair market value of one share of common stock on the offering date.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There currently are no equity awards outstanding that were granted under equity plans that were not submitted for approval by the Company&#8217;s stockholders.</span></div><div id="i04335d018da94076b0acf21e81ac886b_208"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to certain transactions with directors and management is incorporated by reference from the Proxy Statement under the heading &#8220;Related Party Transactions Policy and Transactions with Related Persons.&#8221; Information regarding Director independence is incorporated by reference from the Proxy Statement under the heading &#8220;Director Independence.&#8221; Additional information regarding certain related party balances and transactions is included in the &#8220;Financial Review" section of this Annual Report and Financial Note 19, &#8220;Related Party Balances and Transactions&#8221; to the consolidated financial statements included in this Annual Report.</span></div><div id="i04335d018da94076b0acf21e81ac886b_211"></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principal Accountant Fees and Services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding principal accountant fees and services is set forth under the heading &#8220;Ratification of Appointment of Deloitte &amp; Touche LLP as the Company&#8217;s Independent Registered Public Accounting Firm for Fiscal Year 2024&#8221; in the Proxy Statement is incorporated herein by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_214"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i04335d018da94076b0acf21e81ac886b_217"></div><div style="-sec-extract:summary;margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibits and Financial Statement Schedule.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.988%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(1)   Consolidated Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_100">Report of Deloitte &amp; Touche LLP, Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (PCAOB ID: <ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMTcvZnJhZzo0ZjE5OTBiZmE2ODQ0N2FiODhhNzVkZTZjMjFkMjMyYS90YWJsZTo5NGNhZTU2NDdmNTI0NDg1YjE2ZTk4MDc2Zjk5OTUwZC90YWJsZXJhbmdlOjk0Y2FlNTY0N2Y1MjQ0ODViMTZlOTgwNzZmOTk5NTBkXzMtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246MTY5ZTNiMzgyZjcxNDc1YmI4Mzc5YWIyM2ZlZGJmMDFfOTQ_bcc81310-2281-4c3d-be02-9a8e182abf9b">34</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_100">61</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_103">Consolidated Statements of Operations for the years ended March 31, 2023, 2022, and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_103">65</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_106">Consolidated Statements of Comprehensive Income (Loss) for the years ended March 31, 2023, 2022, and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_106">66</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_109">Consolidated Balance Sheets as of March&#160;31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_109">67</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_112">Consolidated Statements of Stockholders&#8217; Equity (Deficit) for the years ended March&#160;31, 2023, 2022, and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_112">68</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_115">Consolidated Statements of Cash Flows for the years ended March&#160;31, 2023, 2022, and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_115">69</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_118">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_118">70</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(2)   Financial Statement Schedule</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_220">Schedule II-Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_220">139</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other schedules not included have been omitted because of the absence of conditions under which they are required or because the required information, where material, is shown in the financial statements, financial notes, or supplementary financial information.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_223">(a)(3)   Exhibits submitted with this Annual Report on Form 10-K as filed with the SEC and those incorporated by reference to other filings are listed on the Exhibit Index</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_223">140</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_220"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II</span></div><ix:nonNumeric contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90ZXh0cmVnaW9uOmE4OTJkNjFjYjJlMDQxOTFhZDUyYWQ0MDg0YzBmMjIzXzEyOA_3b665675-9b65-4b94-9576-e047482b46d3" escape="true"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Other Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions From Allowance Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at End of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a645887208e4db486fb4c28bf9e9789_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzMtMS0xLTEtMjE4NzQ4_77a1e0bd-cd7b-4014-ab4f-5847a16784f9">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3437a5a1fdb04c6e8b55de243f4372f2_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzMtMy0xLTEtMjE4NzQ4_911e20b4-9e96-40ca-b00c-606c83a9136e">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3437a5a1fdb04c6e8b55de243f4372f2_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzMtNS0xLTEtMjE4NzQ4_75f102ff-d4f7-4769-aaf6-60efd49e1f79">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3437a5a1fdb04c6e8b55de243f4372f2_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzMtNy0xLTEtMjE4NzQ4_47cbdc21-7c68-4140-91e5-1f2b4665fc17">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e0cc8c15f34a96905c888bc0341914_I20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzMtOS0xLTEtMjE4NzQ4_fae76b55-b4a3-431e-8f3b-a57cf580f1d7">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900587631c7346db9cea5a03126cc912_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzQtMS0xLTEtMjE4NzQ4_56e06cc4-d5e6-4206-8b1c-2e851cac47ba">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7384817abd64241a01371e5ab5d3497_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzQtMy0xLTEtMjE4NzQ4_a8c7c9f4-2124-4197-aaf1-a48fe4012853">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7384817abd64241a01371e5ab5d3497_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzQtNS0xLTEtMjE4NzQ4_fcbfad29-1ac6-4f6c-8159-75b06e2c3be3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7384817abd64241a01371e5ab5d3497_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzQtNy0xLTEtMjE4NzQ4_c0e7d7aa-3086-4e12-ab71-819166c935ac">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb89c7229e47468d9dc24fe8eae25115_I20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzQtOS0xLTEtMjE4NzQ4_50381511-f56f-4925-ae48-6235928fd1c8">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzUtMS0xLTEtMjE4NzQ4_809f9c8f-fbb7-4867-a6cf-f671caee3317">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzUtMy0xLTEtMjE4NzQ4_33bebc42-a59a-4db7-889e-e64b010477cb">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzUtNS0xLTEtMjE4NzQ4_1b300556-510e-44ad-9547-6560a781ab25">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzUtNy0xLTEtMjE4NzQ4_0e7a2fed-9504-417c-ad67-db2f6e91e364">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzUtOS0xLTEtMjE4NzQ4_dfd3e3ac-d26f-49a4-b7c6-a5e33f6aac20">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81ff60f8db142b3b909cdcd9740380f_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzgtMS0xLTEtMjE4NzQ4_283b1e48-dbf6-41c0-840e-220e882a7d35">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8940a83e694049a79488bf11a8ab865b_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzgtMy0xLTEtMjE4NzQ4_0f2b0037-847b-4235-a209-b2708e439f6f">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8940a83e694049a79488bf11a8ab865b_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzgtNS0xLTEtMjE4NzQ4_575cdca3-4c03-4eaf-8222-3757b41b96dc">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8940a83e694049a79488bf11a8ab865b_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzgtNy0xLTEtMjE4NzQ4_ae6aba33-106d-4e48-aa38-40cc5cda5806">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a645887208e4db486fb4c28bf9e9789_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzgtOS0xLTEtMjE4NzQ4_7e286698-ee68-4c48-837f-e3b3a9a7c35f">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd212f902f34f7f840d70349edad45f_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzktMS0xLTEtMjE4NzQ4_10a4c33c-ea1d-42f0-ae81-e42351aead84">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edda4c7cace4760a6ee6c90e9c98795_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzktMy0xLTEtMjE4NzQ4_233faff4-1902-46b5-bbbe-4f3e648d3dbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edda4c7cace4760a6ee6c90e9c98795_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzktNS0xLTEtMjE4NzQ4_ec5802cf-fa2d-4778-86eb-92d66477f7e5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4edda4c7cace4760a6ee6c90e9c98795_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzktNy0xLTEtMjE4NzQ4_236d2c47-777b-4b5d-8d1f-d8b9c2f0d8e1">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900587631c7346db9cea5a03126cc912_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzktOS0xLTEtMjE4NzQ4_1382b11c-0de8-4c7d-a99b-45df55916e42">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEwLTEtMS0xLTIxODc0OA_a151c76e-822c-4d7c-82d7-aa0546d6a5c7">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEwLTMtMS0xLTIxODc0OA_0bf745c9-4096-4e18-9fe8-11dfd948fae3">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEwLTUtMS0xLTIxODc0OA_93a7dd31-bb0b-483f-9d9d-e805ca4b0afb">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEwLTctMS0xLTIxODc0OA_c717db85-ef20-4159-bc06-a2ce124ba00e">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEwLTktMS0xLTIxODc0OA_2d7cef6e-225d-46de-b6a9-34b3fe6bf143">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed2dcfef9ef48c5bb328cf03b40b504_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEzLTEtMS0xLTIxODc0OA_d2aac13a-32cf-4a3b-99ba-287380855c5d">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bde156294a94d568921fd8650774394_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEzLTMtMS0xLTIxODc0OA_1fa31185-59cf-4ebe-a29d-76a301b623ce">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bde156294a94d568921fd8650774394_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEzLTUtMS0xLTIxODc0OA_a276c6ad-e856-4a67-8782-a63af52cce0f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bde156294a94d568921fd8650774394_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEzLTctMS0xLTIxODc0OA_883ebbc7-005c-40fe-a8d4-e59ed4e90020">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81ff60f8db142b3b909cdcd9740380f_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEzLTktMS0xLTIxODc0OA_34cbd522-5ac8-4bf6-be54-86f31ce40fe2">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759399c0e9f1473c9e22bd29f133ffe0_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE0LTEtMS0xLTIxODc0OA_cd2e4a69-d588-4958-9e2f-532f90e5a57c">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8997759ac04bec85bf84dabe68cba0_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE0LTMtMS0xLTIxODc0OA_f078ad61-dab9-4450-83e1-e068d2fbc16d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8997759ac04bec85bf84dabe68cba0_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE0LTUtMS0xLTIxODc0OA_519487a5-83ae-4c33-a018-cec546439975">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8997759ac04bec85bf84dabe68cba0_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE0LTctMS0xLTIxODc0OA_a40f6732-9c40-476b-9859-3d39c8954d6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd212f902f34f7f840d70349edad45f_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE0LTktMS0xLTIxODc0OA_3bef2193-aede-4b95-9756-9caea4e09bdf">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56ca92db1bf347039646a68953e87fed_I20200331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE1LTEtMS0xLTIxODc0OA_1ac5ee5e-1414-407a-b8ff-ef3fe89e11ad">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE1LTMtMS0xLTIxODc0OA_f8c0a7e8-9ae7-4a66-b453-c44dd5ed120b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE1LTUtMS0xLTIxODc0OA_369c8b15-acd6-4bff-a5a9-e4b9bbf41053">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE1LTctMS0xLTIxODc0OA_11af3c48-ea30-4124-a571-ed23088a38ca">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE1LTktMS0xLTIxODc0OA_020cd77a-1bd6-4602-b9fd-5be0aecaeebd">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:2.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written-off</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a62067dd1e740e787533693c47c4cad_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzItMy0xLTEtMjE4NzQ4_a7638cc5-b55d-4108-bf13-8e2922a77a8b">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a3854feff1f4556b7bc99ddcbb54572_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzItNS0xLTEtMjE4NzQ4_857650d2-707b-41be-9b33-3b6541279217">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57b78c8af30b448bbccd7dfac95d2712_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzItNy0xLTEtMjE4NzQ4_82115d3d-ea16-432d-a46c-832279f144ff">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credited to other accounts and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e0851153ff84a2cb14ce3cf28fc235d_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzMtMy0xLTEtMjE4NzQ4_6c26f486-f703-4a68-9c77-2f388ea2974b">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19cf323fe7a0413b901a209d2006acbe_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzMtNS0xLTEtMjE4NzQ4_350d3698-9beb-4a18-87d0-a330a84aad25">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f46ce261be141779d217de93096c2dc_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzMtNy0xLTEtMjE4NzQ4_74879245-1a4d-4cf7-8a47-709d3480098e">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzQtMy0xLTEtMjE4NzQ4_490ba6bf-c8ff-4aff-824a-7bc8a0e3f74e">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzQtNS0xLTEtMjE4NzQ4_2e549488-89f8-41e3-b038-6ad72a8ec984">108</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzQtNy0xLTEtMjE4NzQ4_6e483ef9-154c-4f7a-a1c4-ce2a673ce17c">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts shown as deductions from current and non-current receivables (current allowances were $<ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtMS0xLTEtMjE4NzQ4L3RleHRyZWdpb246YjcwNGNlOGY2OGIxNGI3NDg1ZTdlMmZhY2U3NmMwODhfOTg_810fb33e-72a1-4f33-85fe-eca896f97d6e">158</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtMS0xLTEtMjE4NzQ4L3RleHRyZWdpb246YjcwNGNlOGY2OGIxNGI3NDg1ZTdlMmZhY2U3NmMwODhfMTAy_0ea0be9d-4192-46b1-afa7-64c015b4461a">144</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtMS0xLTEtMjE4NzQ4L3RleHRyZWdpb246YjcwNGNlOGY2OGIxNGI3NDg1ZTdlMmZhY2U3NmMwODhfMTEw_cb812a57-2829-4297-9ea6-db6b8d28b475">250</ix:nonFraction> million at March 31, 2023, 2022, and 2021, respectively)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtMy0xLTEtMjE4NzQ4_c9542ab0-a760-403d-8940-ce2238c22270">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtNS0xLTEtMjE4NzQ4_99aa69d4-09f5-4f82-9a79-09f83a59ec5e">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtNy0xLTEtMjE4NzQ4_2947d390-c9e3-40fd-8a1b-b7404732c79a">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primarily represents reclassifications to other balance sheet accounts.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_223"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements included as exhibits to this report are included to provide information regarding their terms and not intended to provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements may contain representations and warranties by each of the parties to the applicable agreement that were made solely for the benefit of the other parties to the applicable agreement. Those representations and warranties:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits identified under &#8220;Incorporated by Reference&#8221; in the table below are on file with the Commission and are incorporated by reference as exhibits hereto.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012311071695/f59658exv3w1.htm">Amended and Restated Certificate of Incorporation of the Company, as filed with the Delaware Secretary of State on July 27, 2011.</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2011</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765323000023/mckessoncorpby-laws2023.htm">Amended and Restated By-Laws of the Company, as amended</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765323000023/mckessoncorpby-laws2023.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765323000023/mckessoncorpby-laws2023.htm">April 26</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765323000023/mckessoncorpby-laws2023.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765323000023/mckessoncorpby-laws2023.htm">3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 28, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/0000929624-97-000781.txt">Indenture, dated as of March 11, 1997, by and between the Company, as issuer, and The First National Bank of Chicago, as trustee.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 19, 1997</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/0000929624-97-000853.txt">Officers&#8217; Certificate, dated as of March 11, 1997, and related Form of 2027 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-30899</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 8, 1997</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095013407004753/f27940exv4w1.htm">Indenture, dated as of March 5, 2007, by and between the Company, as issuer, and The Bank of New York Trust Company, N.A., as trustee.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 5, 2007</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012311019414/f58489exv4w2.htm">First Supplemental Indenture, dated as of February&#160;28, 2011, to the Indenture, dated as of March 5, 2007, among the Company, as issuer, the Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), and Wells Fargo Bank, National Association, as trustee, and related Form of 2021 Note and Form of 2041 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2011</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312512490067/d447856dex41.htm">Indenture, dated as of December 4, 2012, by and between the Company, as issuer, and Wells Fargo Bank, National Association, as trustee.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 4, 2012</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312514090428/d690531dex42.htm">Officers&#8217; Certificate, dated as of March 10, 2014, and related Form of 2024 Note, and Form of 2044 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 10, 2014</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312517047290/d347385dex41.htm">Officer&#8217;s Certificate, dated as of February 17, 2017, and related Form of 2021 Euro Note, Form of 2025 Euro Note, and Form of 2029 Sterling Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 17, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518040775/d730912dex41.htm">Officer&#8217;s Certificate, dated as of February 12, 2018, and related Form of 2026 Euro Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 13, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518051049/d507348dex41.htm">Officer&#8217;s Certificate, dated as of February 16, 2018, and related Form of 2028 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 21, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518339803/d634589dex41.htm">Officer&#8217;s Certificate, dated as of November&#160;30, 2018, and Form of 2029 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 30, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000927653/000119312520309508/d17547dex41.htm">Officer&#8217;s Certificate, dated as of December&#160;3, 2020, and related Form of 2025 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 3, 2020</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000119312521244658/d142323dex41.htm">Officer&#8217;s Certificate, dated as of August 12, 2021, and related Form of 2026 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 12, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000119312523040194/d419477dex41.htm">Indenture, dated as of February 15, 2023, by and between the Company, as issuer, and U.S. Bank Trust Company, National Association, as trustee.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000119312523040194/d419477dex42.htm">Officer&#8217;s Certificate, dated as of February 15, 2023, and related Form of 2026 Note.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit415x3312023.htm">Description of the Company&#8217;s Securities.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095014903001297/f90251exv10w6.txt">McKesson Corporation Supplemental Profit Sharing Investment Plan, as amended and restated on January 29, 2003.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 6, 2003</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765319000021/mckexhibit10209302019.htm">McKesson Corporation Supplemental Retirement Savings Plan, as amended and restated effective July 30, 2019.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095014908000067/f39986exv10w7.htm">McKesson Corporation Deferred Compensation Administration Plan II, as amended and restated as of October 28, 2004, and Amendment No. 1 thereto effective July 25, 2007.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 7, 2008</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765319000021/mckexhibit10109302019.htm">McKesson Corporation Deferred Compensation Administration Plan III, as amended and restated effective July 30, 2019.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 30, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012310004952/f54717exv10w1.htm">McKesson Corporation Executive Survivor Benefits Plan, as amended and restated as of January 20, 2010. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 25, 2010</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765322000051/mck_ex106xseverancepolicyf.htm">McKesson Corporation Severance Policy for Executive Employees, as amended and restated April 26, 2022.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765320000033/mckexhibit1083312020.htm">McKesson Corporation Change in Control Policy for Selected Executive Employees, as amended and restated effective January 28, 2020.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 22, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765322000051/mck_exx108xmanagementincen.htm">McKesson Corporation Management Incentive Plan, as amended and restated April 26, 2022.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765322000051/mck_ex109xmanagementincent.htm">Form of Statement of Terms and Conditions Applicable to Awards Pursuant to the McKesson Corporation Management Incentive Plan, effective April 26, 2022.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012310070537/f56102exv10w4.htm">McKesson Corporation 2005 Stock Plan, as amended and restated on July 28, 2010.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 30, 2010</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312512316890/d371102dex102.htm">Forms of (i) Statement of Terms and Conditions, (ii) Stock Option Grant Notice and (iii), Restricted Stock Unit Agreement, each as applicable to Awards under the McKesson Corporation 2005 Stock Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 26, 2012</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000156178713000015/mck_8kxannualxmeetingxex10-1.htm">McKesson Corporation 2013 Stock Plan, effective July 31, 2013.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2, 2013</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765322000051/mck_ex1013x3312022xstockpl.htm">Forms of Statement of Terms and Conditions and Grant Notices Applicable to Awards Pursuant to the McKesson Corporation 2013 Stock Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000119312522203635/d321230dex101.htm">McKesson Corporation 2022 Stock Plan, effective July 22, 2022.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-266356</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 27, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765322000077/mck_ex102xstockplantermsan.htm">Forms of Statement of Terms and Conditions and Grant Notices Applicable to Awards Pursuant to the McKesson Corporation 2022 Stock Plan.</a></span></div><div><span><br/></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000095012310043581/f54765exv10w27.htm">Form of Director and Officer Indemnification Agreement.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 4, 2010</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927653/000119312520072880/d846210dex101.htm">Tax Matters Agreement, by and between McKesson Corporation, PF2 SpinCo, Inc., Change Healthcare Inc., Change Healthcare LLC and Change Healthcare Holdings, LLC dated as of March 9, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 13, 2020</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1140859/000110465922055245/tm2212023d1_ex10-1.htm">Distributor Settlement Agreement related to opioids claims, entered into on February 25, 2022, among the Settling States, the Settling Distributors, and the Participating Subdivisions (as defined therein).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-6671</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 3, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/927653/000092765322000100/revolvingcreditagreement.htm">Credit Agreement, dated as of November 7, 2022, among the Company, as borrower, the lenders party thereto, the letter of credit issuers party thereto, Bank of America, N.A., as administrative agent, and the other parties thereto </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-13252</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 7, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit21x3312023.htm">List of Significant Subsidiaries of the Registrant.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit23x3312023.htm">Consent of Independent Registered Public Accounting Firm, Deloitte &amp; Touche LLP.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit311x3312023.htm">Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, and adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit312x3312023.htm">Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934 as amended, and adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#8224;&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit32x3312023.htm">Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the McKesson Corporation Annual Report on Form 10-K for the fiscal year ended March 31, 2023, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Consolidated Statements of Operations, (ii) Consolidated Statements of Comprehensive Income (Loss), (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Stockholders' Equity (Deficit), (v) Consolidated Statements of Cash Flows, and (vi) related Financial Notes.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101).</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Management contract or compensation plan or arrangement in which directors and/or executive officers are eligible to participate.</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#8224;&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant agrees to furnish to the Commission upon request a copy of each instrument defining the rights of security holders with respect to issues of long-term debt of the registrant, the authorized principal amount of which does not exceed 10% of the total assets of the registrant.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_226"></div><hr style="page-break-after:always"/><div style="min-height:76.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16.&#160;&#160;&#160;&#160;Form 10-K Summary.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><div id="i04335d018da94076b0acf21e81ac886b_229"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i04335d018da94076b0acf21e81ac886b_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKESSON CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.924%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brian S. Tyler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donald R. Knauss</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Donald R. Knauss, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Britt J. Vitalone</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bradley E. Lerman</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bradley E. Lerman, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Napoleon B. Rutledge Jr.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Linda P. Mantia</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Napoleon B. Rutledge Jr.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Controller</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Linda P. Mantia, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Richard H. Carmona</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Maria Martinez</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Richard H. Carmona, M.D., Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maria Martinez, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dominic J. Caruso</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Susan R. Salka</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dominic J. Caruso, Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Susan R. Salka, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ W. Roy Dunbar</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kathleen Wilson-Thompson</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">W. Roy Dunbar, Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Kathleen Wilson-Thompson, Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James H. Hinton</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">James H. Hinton, Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.15
<SEQUENCE>2
<FILENAME>mck_exhibit415x3312023.htm
<DESCRIPTION>EX-4.15
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i56a49a97beb1408c93a8dc2837c4e3a3_1"></div><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">DESCRIPTION OF THE COMPANY&#8217;S SECURITIES REGISTERED    <br>PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following are brief descriptions of (a) the common stock, $0.01 par value per share (the &#8220;Common Stock&#8221;), (b) the 1.500% Notes due 2025 (the &#8220;2025 Notes&#8221;), (c) the 1.625% Notes due 2026 (the &#8220;2026 Notes&#8221;), and (d) the 3.125% Notes due 2029 (the &#8220;2029 Notes&#8221; and, collectively with the 2025 Notes and the 2026 Notes, the &#8220;Notes&#8221;), of McKesson Corporation (the &#8220;Company&#8221; or &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;), which are the only securities of the Company registered pursuant to Section 12 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;).   </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description of Common Stock</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following descriptions of the Common Stock and of certain provisions of Delaware law do not purport to be complete and are subject to and qualified in their entirety by reference to our amended and restated certificate of incorporation, our amended and restated&#160;by-laws,&#160;and the Delaware General Corporation Law (&#8220;DGCL&#8221;). Copies of our amended and restated certificate of incorporation and our amended and restated&#160;by-laws&#160;have been filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) and are incorporated by reference herein. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of the date hereof, our authorized capital stock consists of 900,000,000 shares, of which 800,000,000 shares are Common Stock and 100,000,000 shares are preferred stock, par value $0.01 per share. We may amend from time to time our amended and restated certificate of incorporation to increase the number of authorized shares of Common Stock and&#47;or preferred stock. Any such amendment would require the approval of the holders of a majority of our shares entitled to vote.  All of our outstanding shares of Common Stock are fully paid and&#160;non-assessable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Dividend Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Subject to the dividend rights of the holders of any outstanding preferred stock, the holders of shares of Common Stock are entitled to receive ratably dividends out of assets legally available therefor at such times and in such amounts as our board of directors may from time to time determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Rights Upon Liquidation.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Upon liquidation, dissolution or winding up of our affairs, the holders of Common Stock are entitled to share ratably in our assets that are legally available for distribution, after payment of all debts, other liabilities, and any liquidation preferences of outstanding preferred stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Conversion, Redemption and Preemptive Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Holders of our Common Stock have no conversion, redemption, preemptive, or similar rights.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Voting Rights.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;Each outstanding share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders. Our amended and restated certificate of incorporation does not provide for cumulative voting in the election of directors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Anti-Takeover Effects of Provisions of Our Amended and Restated Certificate of Incorporation and Our Amended and Restated&#160;By-Laws</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation and our amended and restated&#160;by-laws&#160;contain certain provisions that may be deemed to have an anti-takeover effect and may delay, deter, or prevent a tender offer or takeover attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the market price for the shares held by stockholders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation also provides that any action required or permitted to be taken by the holders of Common Stock may be effected only at an annual or special meeting of such holders, and that stockholders may act in lieu of such meetings only by unanimous written consent. Our amended and restated&#160;by-laws&#160;provide that special meetings of holders of Common Stock may be called only by our Chair, Chief Executive Officer, or a majority of our board of directors for any purpose at any time. Holders of Common Stock owning at least 15% of the outstanding shares of Common Stock for at least one year are permitted to submit a special meeting request in accordance with the procedures described in our amended and restated&#160;by-laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated&#160;by-laws&#160;establish an advance notice procedure for the nomination, other than by or at the direction of our board of directors, of candidates for election as directors, as well as for other stockholder proposals to be considered at annual meetings of stockholders. In general, notice of intent to nominate a director or raise business at such meetings must be received by us not less than 90 nor more than 120 days prior to the date of the annual meeting and must contain certain specified information concerning the person to be nominated or the matters to be brought before the meeting and concerning the stockholder submitting the proposal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to our amended and restated certificate of incorporation and the DGCL, our amended and restated certificate of incorporation may be amended by a vote of a majority of our board of directors and by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon. Our amended and restated certificate of incorporation and our amended and restated&#160;by-laws&#160;provide that our amended and restated&#160;by-laws&#160;may be amended by a vote of a majority of our board of directors. In addition, our amended and restated&#160;by-laws&#160;provide that our amended and restated&#160;by-laws&#160;may be amended by the affirmative vote of a majority of the shares of the corporation entitled to vote thereon.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exclusive Forum Provision of our Amended and Restated By-Laws</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated by-laws provide that, unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for specified legal actions is the Court of Chancery of the State of Delaware or the United States District Court for the District of Delaware if the Court of Chancery does not have or declines to accept jurisdiction (collectively, &#8220;Delaware Courts&#8221;). Current and former stockholders are deemed to have consented to the personal jurisdiction of the Delaware Courts in connection with any action to enforce that exclusive forum provision and to service of process in any such action.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section&#160;203 of Delaware General Corporation Law</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We are subject to the &#8220;business combination&#8221; statute of the DGCL. In general, such statute prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with any &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an &#8220;interested stockholder,&#8221; unless&#58;&#160;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-31.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;such transaction is approved by our board of directors prior to the date the interested stockholder obtains such status,</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-31.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;upon consummation of such transaction, the &#8220;interested stockholder&#8221; beneficially owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding those shares owned by (a)&#160;persons who are directors and also officers and (b)&#160;employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer, or</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-31.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;the &#8220;business combination&#8221; is approved by our board of directors and authorized at an annual or special meeting of stockholders by the affirmative vote of at least&#160;66-2&#47;3%&#160;of the outstanding voting stock which is not owned by the &#8220;interested stockholder.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A &#8220;business combination&#8221; includes mergers, asset sales, and other transactions resulting in financial benefit to the &#8220;interested stockholder.&#8221; An &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns (or within three years, did own) beneficially 15% or more of a corporation&#8217;s voting stock. The statute could prohibit or delay mergers or other takeover or change in control attempts with respect to us and, accordingly, may discourage attempts to acquire us.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Certain Effects of Authorized but Unissued Stock</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our authorized but unissued shares of Common Stock and preferred stock may be issued without additional stockholder approval and may be utilized for a variety of corporate purposes, including future offerings to raise additional capital or to facilitate corporate acquisitions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The issuance of preferred stock could have the effect of delaying or preventing a change in control of us. The issuance of preferred stock could decrease the amount available for distribution to holders of our Common Stock or could adversely affect the rights and powers, including voting rights, of such holders. In certain circumstances, such issuance could have the effect of decreasing the market price of our Common Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">One of the effects of the existence of unissued and unreserved Common Stock or preferred stock may be to enable our board of directors to issue shares to persons friendly to current management, which could render more difficult or discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of management. Such additional shares also could be used to dilute the stock ownership of persons seeking to obtain control of us.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Limitation of Liability of Directors</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation contains a provision that limits the liability of our directors for monetary damages for breach of fiduciary duty as a director to the fullest extent permitted by the Delaware General Corporation Law. Such limitation does not, however, affect the liability of a director (1)&#160;for any breach of the director&#8217;s duty of loyalty to us or our stockholders, (2)&#160;for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, (3)&#160;in respect of certain unlawful dividend payments or stock redemptions or purchases, and (4)&#160;for any transaction from which the director derives an improper personal benefit. The effect of this provision is to eliminate our rights and the rights of our stockholders (through stockholders&#8217; derivative suits) to recover monetary damages against a director for breach of the fiduciary duty of care as a director (including breaches resulting from negligent or grossly negligent behavior) except in the situations described in clauses (1)&#160;through (4) above. This provision does not limit or eliminate our rights or the rights of our stockholders to seek&#160;non-monetary&#160;relief such as an injunction or rescission in the event of a breach of a director&#8217;s duty of care. In addition, our directors and officers have indemnification protection.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Transfer Agent and Registrar</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EQ Shareowner Services acts as transfer agent and registrar of our Common Stock.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Listing</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our Common Stock is listed on the New York Stock Exchange under the symbol &#8220;MCK&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">Description of Notes</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:144%">General</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 17, 2017, we issued &#163;450,000,000 aggregate principal amount of 3.125% Notes due 2029 and &#8364;600,000,000 aggregate principal amount of 1.500% Notes due 2025, and on February 12, 2018, we issued &#8364;500,000,000 aggregate principal amount of 1.625% Notes due 2026.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">   </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each series of the Notes was issued pursuant to the Indenture, dated as of December&#160;4, 2012 (the &#8220;Indenture&#8221;) between the Company and Wells Fargo Bank, National Association, as trustee (the &#8220;Trustee&#8221;), in each case, as supplemented by an Officer&#8217;s Certificate setting forth certain terms of the applicable series of the Notes (the &#8220;Officer&#8217;s Certificates&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each series of the Notes is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#8217;s existing and future unsecured and unsubordinated indebtedness from time to time outstanding. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following descriptions of the Indenture, the Officer&#8217;s Certificates and the Notes do not purport to be complete and are subject to and qualified in their entirety by reference to the Indenture, the Officer&#8217;s Certificates and the Notes, which have been filed with the SEC and are incorporated by reference herein. Unless otherwise specified, all capitalized and undefined terms in this &#8220;Description of Notes&#8221; have the meanings specified in the Indenture.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">General Terms of the Indenture</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may issue, from time to time, debt securities, in one or more series, that will consist of either our senior debt (&#8220;Senior Debt Securities&#8221;), our senior subordinated debt (&#8220;Senior Subordinated Debt Securities&#8221;), our subordinated debt (&#8220;Subordinated Debt Securities&#8221;) or our junior subordinated debt (&#8220;Junior Subordinated Debt Securities&#8221; and, together with the Senior Subordinated Debt Securities and the Subordinated Debt Securities, the &#8220;Subordinated Securities&#8221;). The Indenture does not limit the amount of debt securities that we may issue. It provides that we may issue debt securities up to the principal amount that we may authorize and may be in any currency or currency unit designated by us. Except for the limitations on consolidation, merger and sale of all or substantially all of our assets contained in the Indenture, the terms of the Indenture do not contain any covenants or other provisions designed to afford holders of any debt securities protection with respect to our operations, financial condition or transactions involving us.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Consolidation, Merger or Sale. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We cannot consolidate or merge with or into, or transfer or lease all or substantially all of our assets to, any person unless (a)&#160;we will be the continuing corporation or (b)&#160;the successor corporation or person formed by such consolidation or into which we are merged or to which our assets substantially as an entirety are transferred or leased is a corporation, limited liability company or limited partnership organized or existing under the laws of the United States, any state of the United States or the District of Columbia and, if such entity is not a corporation, a&#160;co-obligor&#160;of the debt securities is a corporation organized or existing under any such laws, and such successor corporation or person, including such&#160;co-obligor,&#160;if any, expressly assumes our obligations on the debt securities and under the Indenture. In addition, we cannot effect such a transaction unless immediately after giving effect to such transaction, no default or Event of Default under the Indenture shall have occurred and be continuing. Subject to certain exceptions, when the person to whom our assets are transferred or leased has assumed our obligations under the debt securities and the Indenture, we shall be discharged from all our obligations under the debt securities and the Indenture, except in limited circumstances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This covenant would not apply to any recapitalization transaction, a change of control of the Company or a highly leveraged transaction, unless the transaction or change of control were structured to include a merger or consolidation or transfer or lease of all or substantially all of our assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Events of Default. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless otherwise indicated, the term &#8220;Event of Default,&#8221; when used in the Indenture with respect to the debt securities of any series, means any of the following&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">failure to pay interest for 30 days after the date payment on any debt security of such series is due and payable&#59; provided that an extension of an interest payment period by the Company in accordance with the terms of the debt securities shall not constitute a failure to pay interest&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">failure to pay principal or premium, if any, on any debt security of such series when due, either at maturity, upon any redemption, by declaration or otherwise&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">failure to perform any other covenant in the Indenture or the debt securities of such series (&#8220;other covenants&#8221;) for 90 days after notice that performance was required&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">events in bankruptcy, insolvency or reorganization of the Company&#59; or</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any other Event of Default provided in the applicable resolution of our board of directors or the officers&#8217; certificate or supplemental Indenture under which we issue such series of debt securities.</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">An Event of Default for a particular series of debt securities does not necessarily constitute an Event of Default for any other series of debt securities issued under the Indenture. If an Event of Default relating to the payment of interest, principal or any sinking fund installment involving any series of debt securities has occurred and is continuing, the Trustee or the holders of not less than 25% in aggregate principal amount of the debt securities of each affected series may declare the entire principal of all the debt securities of that series to be due and payable immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If an Event of Default relating to the performance of other covenants occurs and is continuing for a period of 90 days after notice of such, or if any other Event of Default occurs and is continuing involving all of the series of Senior Debt Securities, then the Trustee or the holders of not less than 25% in aggregate principal amount of all of the series of Senior Debt Securities may declare the entire principal amount of all of the series of Senior Debt Securities due and payable immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Similarly, if an Event of Default relating to the performance of other covenants occurs and is continuing for a period of 90 days after notice of such, or if any other Event of Default occurs and is continuing involving all of the series of Subordinated Securities, then the Trustee or the holders of not less than 25% in aggregate principal amount of all of the series of Subordinated Securities may declare the entire principal amount of all of the series of Subordinated Securities due and payable immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If, however, the Event of Default relating to the performance of other covenants or any other Event of Default that has occurred and is continuing is for less than all of the series of Senior Debt Securities or Subordinated Securities, as the case may be, then the Trustee or the holders of not less than 25% in aggregate principal amount of each affected series of the Senior Debt Securities or the Subordinated Securities, as the case may be, may declare the entire principal amount of all debt securities of such affected series due and payable immediately. The holders of not less than a majority in aggregate principal amount of the debt securities of a series may, after satisfying conditions, rescind and annul any of the above-described declarations and consequences involving the series.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If an Event of Default relating to events in bankruptcy, insolvency or reorganization of the Company occurs and is continuing, then the principal amount of all of the debt securities outstanding, and any accrued interest, will automatically become due and payable immediately, without any declaration or other act by the Trustee or any holder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture imposes limitations on suits brought by holders of debt securities against us. Except as provided below, no holder of debt securities of any series may institute any action against us under the Indenture unless&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the holder has previously given to the Trustee written notice of default and continuance of that default&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the holders of at least 25% in principal amount of the outstanding debt securities of the affected series have requested that the Trustee institute the action&#59;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the requesting holders have offered the Trustee security or indemnity reasonably satisfactory to it for expenses and liabilities that may be incurred by bringing the action&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Trustee has not instituted the action within 60 days of the request&#59; and</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Trustee has not received inconsistent direction by the holders of a majority in principal amount of the outstanding debt securities of the affected series.</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, each holder of debt securities of any series has the right, which is absolute and unconditional, to receive payment of the principal of, and premium and interest, if any, on, such debt securities when due and to institute suit for the enforcement of any such payment, and such rights may not be impaired without the consent of that holder of debt securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We will be required to file annually with the Trustee a certificate, signed by an officer of the Company, stating whether or not the officer knows of any default by us in the performance, observance or fulfillment of any condition or covenant of the Indenture.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Modification of the Indenture.  </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture provides that we and the Trustee may enter into supplemental indentures without the consent of the holders of debt securities to&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">secure any debt securities&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">evidence the assumption by a successor corporation of our obligations&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">add covenants for the protection of the holders of debt securities&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">cure any ambiguity or correct any inconsistency in the Indenture&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">establish the forms or terms of debt securities of any series&#59; and</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">evidence and provide for the acceptance of appointment by a successor Trustee.</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture also provides that we and the Trustee may, with the consent of the holders of not less than a majority in aggregate principal amount of debt securities of all series of Senior Debt Securities or Subordinated Securities, as the case may be, then outstanding and affected thereby (voting as one class), add any provisions to, or change in any manner, eliminate or modify in any way the provisions of, the Indenture or modify in any manner the rights of the holders of the debt securities. We and the Trustee may not, however, without the consent of the holder of each outstanding debt security affected thereby&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">extend the final maturity of any debt security&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the principal amount or premium, if any&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the rate or extend the time of payment of interest&#59;</font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce any amount payable on redemption&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">change the currency in which the principal (other than as may be provided otherwise with respect to a series), premium, if any, or interest is payable&#59;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the amount of the principal of any debt security issued with an original issue discount that is payable upon acceleration or provable in bankruptcy&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">modify any of the subordination provisions or the definition of senior indebtedness applicable to any Subordinated Securities in a manner adverse to the holders of those securities&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">alter provisions of the Indenture relating to the debt securities not denominated in U.S. dollars&#59;</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">impair the right to institute suit for the enforcement of any payment on any debt security when due&#59; or</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reduce the percentage of holders of debt securities of any series whose consent is required for any modification of the Indenture.</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Certain Covenants</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Officer&#8217;s Certificate contains the following covenants.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Definitions. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Attributable Debt&#8221; shall mean in connection with a sale and lease-back transaction the lesser of (a)&#160;the fair value of the assets subject to such transaction, as determined by our Board of Directors, or (b)&#160;the present value of the remaining obligations of the lessee for net rental payments during the term of any lease discounted at the rate of interest set forth or implicit in the terms of such lease or, if not practicable to determine such rate, the weighted average interest rate per annum borne by the debt securities of each series outstanding pursuant to the Indenture and subject to limitations on sale and lease-back transaction covenants, compounded semi-annually in either case as determined by our principal accounting or financial officer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Consolidated Subsidiary&#8221; shall mean any Subsidiary (as defined in the Indenture), substantially all the property of which is located, and substantially all the operations of which are conducted, in the United States of America whose financial statements are consolidated with our financial statements in accordance with accounting principles generally accepted in the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Exempted Debt&#8221; shall mean the sum of the following as of the date of determination&#58; (1)&#160;Indebtedness of ours and our Consolidated Subsidiaries incurred after the date of issuance of the notes and secured by liens not permitted by the limitation on liens provisions, and (2)&#160;Attributable Debt of ours and our Consolidated Subsidiaries in respect of every sale and lease-back transaction entered into after the date of the issuance of the notes, other than leases permitted by the limitation on sale and lease-back provisions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Indebtedness&#8221; shall mean all items classified as indebtedness on our most recently available consolidated balance sheet, in accordance with accounting principles generally accepted in the United States of America.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Qualified Receivables Transaction&#8221; shall mean any transaction or series of transactions entered into by us or any of our Subsidiaries pursuant to which we or any of our Subsidiaries sells, conveys or otherwise transfers to (1)&#160;a Receivables Subsidiary (in the case of a transfer by us or any of our Subsidiaries) or (2)&#160;any other person (in the case of a transfer by a Receivables Subsidiary), or grants a security interest in, any accounts receivable (whether now existing or arising in the future) or inventory of us or any of our Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other obligations in respect of such accounts receivable or inventory, proceeds of such accounts receivable and other assets which are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable or inventory.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The term &#8220;Receivables Subsidiary&#8221; shall mean a Subsidiary of ours which engages in no activities other than in connection with the financing of accounts receivable or inventory (a)&#160;no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (1)&#160;is guaranteed by us or any Subsidiary of ours (excluding guarantees of obligations (other than the principal of, and interest on, Indebtedness) pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction), (2) is recourse or obligates us or any Subsidiary of ours in any way other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction or (3)&#160;subjects any property or asset of ours or any Subsidiary of ours (other than accounts receivable or inventory and related assets as provided in the definition of &#8220;Qualified Receivables Transaction&#8221;), directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to representations, warranties, covenants and indemnities entered into in the ordinary course of business in connection with a Qualified Receivables Transaction, (b)&#160;with which neither we nor any Subsidiary of ours has any material contract, agreement, arrangement or understanding other than on terms customary for securitization of receivables or inventory and (c)&#160;with which neither we nor any Subsidiary of ours has any obligations to maintain or preserve such Subsidiary&#8217;s financial condition or cause such Subsidiary to achieve certain levels of operating results.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Limitation on Liens</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. We covenant that, so long as any of the Notes remain outstanding, we will not, and will not permit any Consolidated Subsidiary, to create or assume any Indebtedness for money borrowed which is secured by a mortgage, pledge, security interest or lien (&#8220;liens&#8221;) of or upon any assets, whether now owned or hereafter acquired, of ours or any such Consolidated Subsidiary without equally and ratably securing the notes by a lien ranking equally to and ratably with (or, at our option, senior to) such secured Indebtedness, except that the foregoing restriction shall not apply to&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on assets of any corporation existing at the time such corporation becomes a Consolidated Subsidiary&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on assets existing at the time of acquisition thereof, or to secure the payment of the purchase price of such assets, or to secure indebtedness incurred or guaranteed by us or a Consolidated Subsidiary for the purpose of financing the purchase price of such assets or improvements or construction thereon, which indebtedness is incurred or guaranteed prior to, at the time of or within 360 days after such acquisition, or in the case of real property, completion of such improvement or construction or commencement of full operation of such property, whichever is later&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens securing indebtedness owed by any Consolidated Subsidiary to us or another wholly owned Subsidiary&#59;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on any assets of a corporation existing at the time such corporation is merged into or consolidated with us or a Subsidiary or at the time of a purchase, lease or other acquisition of the assets of the corporation or firm as an entirety or substantially as an entirety by us or a Subsidiary&#59;</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on any assets of ours or a Consolidated Subsidiary in favor of the United States of America or any state thereof, or in favor of any other country, or political subdivision thereof, to secure certain payments pursuant to any contract or statute or to secure any indebtedness incurred or guaranteed for the purpose of financing all or any part of the purchase price, or, in the case of real property, the cost of construction, of the assets subject to such liens, including, but not limited to, liens incurred in connection with pollution control, industrial revenue or similar financing&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any extension, renewal or replacement, or successive extensions, renewals or replacements, in whole or in part, of any lien referred to in the foregoing&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">certain statutory liens or other similar liens arising in the ordinary course of our or a Consolidated Subsidiary&#8217;s business, or certain liens arising out of government contracts&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">certain pledges, deposits or liens made or arising under the worker&#8217;s compensation or similar legislation or in certain other circumstances&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">certain liens in connection with legal proceedings, including certain liens arising out of judgments or awards&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens for certain taxes or assessments, landlord&#8217;s liens and liens and charges incidental to the conduct of the business or the ownership of our assets or those of a Consolidated Subsidiary, which were not incurred in connection with the borrowing of money and which do not, in our opinion, materially impair the use of such assets in the operation of our business or that of such Consolidated Subsidiary or the value of such assets for the purposes thereof&#59;</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens relating to accounts receivable of ours or any of our Subsidiaries which have been sold, assigned or otherwise transferred to another Person in a transaction classified as a sale of accounts receivable in accordance with accounting principles generally accepted in the United States of America, to the extent the sale by us or the applicable Subsidiary is deemed to give rise to a lien in favor of the purchaser thereof in such accounts receivable or the proceeds thereof&#59; or</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liens on any assets of ours or any of our Subsidiaries (including Receivables Subsidiaries) incurred in connection with a Qualified Receivables Transaction.</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the above, we or any of our Consolidated Subsidiaries may, without securing the notes, create or assume any Indebtedness which is secured by a lien which would otherwise be subject to the foregoing restrictions&#59; provided that after giving effect thereto the Exempted Debt then outstanding at such time does not exceed 10% of our total assets on a consolidated basis.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Limitation on Sale and Lease-Back Transactions.  </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sale and lease-back transactions, except such transactions involving leases for less than three years, by us or any Consolidated Subsidiary of any assets are prohibited unless (a)&#160;we or such Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt in respect of such transaction without equally and ratably securing the notes, or (b)&#160;the proceeds of the sale of the assets to be leased are at least equal to their fair market value (as determined by our Board of Directors) and the proceeds are applied to the purchase or acquisition, or, in the case of real property, the construction, of assets or to the retirement of Indebtedness. The foregoing limitation will not apply, if at the time we or any Consolidated Subsidiary enters into such sale and lease-back transaction, and after giving effect thereto, Exempted Debt does not exceed 10% of our total assets on a consolidated basis.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2025 Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2025 Notes bear interest at the rate of 1.500%&#160;per year.  Interest on the 2025 Notes is payable on November&#160;17 of each year.   The 2025 Notes will mature on November&#160;17, 2025.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may redeem the 2025 Notes prior to&#160;August&#160;17, 2025, the date that is three months before their maturity date, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer&#8217;s Certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On or after&#160;August&#160;17, 2025, we may redeem the 2025 Notes in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we may redeem the 2025 Notes for cash in whole, but not in part, at any time prior to maturity at a price equal to 100% of, plus accrued and unpaid interest, if certain tax events occur, as specified in the applicable Officer&#8217;s Certificate. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of the occurrence of both (1)&#160;a change of control of the Company and (2)&#160;a downgrade of a the 2025 Notes below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, unless the Company has previously exercised its optional redemption right with respect to the 2025 Notes in whole, the Company will be required to offer to repurchase the 2025 Notes from the holders at a price in cash equal to 101% of the then outstanding principal amount of 2025 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2026 Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2026 Notes bear interest at the rate of 1.625%&#160;per year. Interest on the 2026 Notes is payable on October&#160;30 of each year.  The 2025 Notes will mature on October 30, 2026.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may redeem the 2026 Notes for cash in whole, at any time, or in part, from time to time, prior to maturity, at a redemption price that includes accrued and unpaid interest and a make-whole premium.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we may redeem the 2026 Notes for cash in whole, but not in part, at any time prior to maturity at a price equal to 100% of, plus accrued and unpaid interest, if certain tax events occur, as specified in the applicable Officer&#8217;s Certificate. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of the occurrence of both (1)&#160;a change of control of the Company and (2)&#160;a downgrade of the 2026 Notes below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, unless the Company has previously exercised its optional redemption right with respect to the 2026 Notes in whole, the Company will be required to offer to repurchase the 2026 Notes from the holders at a price in cash equal to 101% of the then outstanding principal amount of 2026 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2029 Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The 2029 Notes bear interest at the rate of 3.125%&#160;per year.  Interest on the 2029 Notes is payable on February&#160;17 of each year.  The 2029 Notes will mature on February&#160;17, 2029.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We may redeem the 2029 Notes prior to&#160;November&#160;17, 2028, the date that is three months before their maturity date in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price that includes accrued and unpaid interest and a make-whole premium, as specified in the Indenture and the applicable Officer&#8217;s Certificate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On or after&#160;November&#160;17, 2028, we may redeem the 2029 Notes in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, we may redeem the 2029 Notes for cash in whole, but not in part, at any time prior to maturity at a price equal to 100% of, plus accrued and unpaid interest, if certain tax events occur, as specified in the applicable Officer&#8217;s Certificate. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event of the occurrence of both (1)&#160;a change of control of the Company and (2)&#160;a downgrade of a the 2029 Notes below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, unless the Company has previously exercised its optional redemption right with respect to the 2029 Notes in whole, the Company will be required to offer to repurchase the 2029 Notes from the holders at a price in cash equal to 101% of the then outstanding principal amount of 2029 Notes, plus accrued and unpaid interest to, but not including, the date of repurchase.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Concerning the Trustee</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Wells Fargo Bank, National Association is the Trustee under the Indenture with respect to the Notes. We may maintain deposit accounts or conduct other banking transactions with the Trustee in the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Governing Law</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Indenture and Notes are governed by, and construed in accordance with, the laws of the State of New York, including, without limitation, Sections&#160;5-1401&#160;and&#160;5-1402&#160;of the New York General Obligations Law and New York Civil Practice Law and Rules 327(b).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.15</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Listing</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our 2025 Notes are listed on the New York Stock Exchange under the symbol &#8220;MCK25.&#8221;  Our 2026 Notes are listed on the New York Stock Exchange under the symbol &#8220;MCK26.&#8221;  Our 2029 Notes are listed on the New York Stock Exchange under the symbol &#8220;MCK29.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:156%">13</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>3
<FILENAME>mck_exhibit21x3312023.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ica0908c00d40454bb442aca0ef3b838e_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 21</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">SUBSIDIARIES OF THE REGISTRANT</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:19pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">There is no parent of the Company. The following is a listing of the significant subsidiaries of the Company.</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:80.305%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.495%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JURISDICTION</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OF</font></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ORGANIZATION</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada Distribution Holdings Limited Partnership</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Global Procurement &#38; Sourcing Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson International Bermuda IP2A Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson International Bermuda IP3A Limited</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson International Holdings Unlimited Company</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Medical-Surgical Holdings Inc.</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Medical-Surgical Inc.</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Medical-Surgical Top Holdings Inc.</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Plasma and Biologics LLC</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Specialty Care Distribution LLC</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson UK Finance I Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson UK Finance II Limited</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson US Finance Corporation</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Oncology Holdings, Inc.</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Oncology, Inc.</font></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr></table></div><div style="margin-top:3pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>4
<FILENAME>mck_exhibit23x3312023.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7e1c6baca51a4ceaa2eb8eaa29a459d2_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 23</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in McKesson Corporation Registration Statement Nos. 333-84806, 333-163642, 333-190847, 333-213488, 333-249817, 333-266357 and 333-266356 on Form S-8, and Registration Statement No. 333-236808 on Form S-3, of our reports dated May&#160;8, 2023, relating to the consolidated financial statements and consolidated financial statement schedule of McKesson Corporation and subsidiaries, and the effectiveness of McKesson Corporation&#8217;s internal control over financial reporting, appearing in this Annual Report on Form 10-K of McKesson Corporation for the year ended March 31, 2023.</font></div><div style="margin-bottom:19pt;text-align:justify"><font><br></font></div><div style="margin-top:5pt;padding-left:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.233%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Deloitte &#38; Touche LLP</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dallas, Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td></tr></table></div><div style="margin-top:3pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>mck_exhibit311x3312023.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifcd55cdc19564d7982ab462003e927f5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian S. Tyler, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  May&#160;8, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>mck_exhibit312x3312023.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3e01d99ea8c141bd9e268b7013affbd8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Britt J. Vitalone, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  May&#160;8, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>7
<FILENAME>mck_exhibit32x3312023.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i45687f9b9a344b6d9ed5439f59e860a3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the annual report of McKesson Corporation (the &#8220;Company&#8221;) on Form 10-K for the year ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, in the capacities and on the dates indicated below, each hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:24pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><font><br></font></div><div style="margin-top:29pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Brian S. Tyler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Report pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to McKesson Corporation and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>mck-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1eea9b32-7227-4c4c-b033-5c353ea41e5b,g:3de8d065-e076-4ee0-8f0c-2df01cc3ca1e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mck="http://mckesson123.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mckesson123.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://mckesson123.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://mckesson123.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000005 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParentheticals" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParentheticals">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPolicies">
        <link:definition>0000010 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestitures" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures">
        <link:definition>0000011 - Disclosure - Business Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNet" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet">
        <link:definition>0000012 - Disclosure - Restructuring, Impairment, and Related Charges, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://mckesson123.com/role/ShareBasedCompensation">
        <link:definition>0000013 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNet" roleURI="http://mckesson123.com/role/OtherIncomeNet">
        <link:definition>0000014 - Disclosure - Other Income, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://mckesson123.com/role/IncomeTaxes">
        <link:definition>0000015 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterests" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests">
        <link:definition>0000016 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShare" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare">
        <link:definition>0000017 - Disclosure - Earnings (Loss) Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://mckesson123.com/role/Leases">
        <link:definition>0000018 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>0000019 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivities" roleURI="http://mckesson123.com/role/DebtandFinancingActivities">
        <link:definition>0000020 - Disclosure - Debt and Financing Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntities" roleURI="http://mckesson123.com/role/VariableInterestEntities">
        <link:definition>0000021 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefits" roleURI="http://mckesson123.com/role/PensionBenefits">
        <link:definition>0000022 - Disclosure - Pension Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivities" roleURI="http://mckesson123.com/role/HedgingActivities">
        <link:definition>0000023 - Disclosure - Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://mckesson123.com/role/FairValueMeasurements">
        <link:definition>0000024 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialGuaranteesandWarranties" roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarranties">
        <link:definition>0000025 - Disclosure - Financial Guarantees and Warranties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilities" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities">
        <link:definition>0000026 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficit" roleURI="http://mckesson123.com/role/StockholdersEquityDeficit">
        <link:definition>0000027 - Disclosure - Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyBalancesandTransactions" roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactions">
        <link:definition>0000028 - Disclosure - Related Party Balances and Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusiness" roleURI="http://mckesson123.com/role/SegmentsofBusiness">
        <link:definition>0000029 - Disclosure - Segments of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS">
        <link:definition>0000030 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>0000031 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesTables">
        <link:definition>0000032 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresTables" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables">
        <link:definition>0000033 - Disclosure - Business Acquisitions and Divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNetTables" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables">
        <link:definition>0000034 - Disclosure - Restructuring, Impairment, and Related Charges, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://mckesson123.com/role/ShareBasedCompensationTables">
        <link:definition>0000035 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNetTables" roleURI="http://mckesson123.com/role/OtherIncomeNetTables">
        <link:definition>0000036 - Disclosure - Other Income, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://mckesson123.com/role/IncomeTaxesTables">
        <link:definition>0000037 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables">
        <link:definition>0000038 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareTables" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables">
        <link:definition>0000039 - Disclosure - Earnings (Loss) Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://mckesson123.com/role/LeasesTables">
        <link:definition>0000040 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>0000041 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesTables" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables">
        <link:definition>0000042 - Disclosure - Debt and Financing Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsTables" roleURI="http://mckesson123.com/role/PensionBenefitsTables">
        <link:definition>0000043 - Disclosure - Pension Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesTables" roleURI="http://mckesson123.com/role/HedgingActivitiesTables">
        <link:definition>0000044 - Disclosure - Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://mckesson123.com/role/FairValueMeasurementsTables">
        <link:definition>0000045 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesTables" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables">
        <link:definition>0000046 - Disclosure - Commitments and Contingent Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitTables" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables">
        <link:definition>0000047 - Disclosure - Stockholders' Equity (Deficit) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessTables" roleURI="http://mckesson123.com/role/SegmentsofBusinessTables">
        <link:definition>0000048 - Disclosure - Segments of Business (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesDetails">
        <link:definition>0000049 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesReceivablesNetDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails">
        <link:definition>0000050 - Disclosure - Significant Accounting Policies - Receivables, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails">
        <link:definition>0000051 - Disclosure - Significant Accounting Policies - Property, Plant and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresAcquisitionsDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails">
        <link:definition>0000052 - Disclosure - Business Acquisitions and Divestitures - Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails">
        <link:definition>0000053 - Disclosure - Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Rx Savings Solutions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails">
        <link:definition>0000054 - Disclosure - Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Oncology Research) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresDivestituresandOtherDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails">
        <link:definition>0000055 - Disclosure - Business Acquisitions and Divestitures - Divestitures and Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails" roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails">
        <link:definition>0000056 - Disclosure - Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (E.U. and U.K. Disposal Groups) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNetNarrativeDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails">
        <link:definition>0000057 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails">
        <link:definition>0000058 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Details for Charges Recorded (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails">
        <link:definition>0000059 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Activity Related to Restructuring Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails">
        <link:definition>0000060 - Disclosure - Share-Based Compensation - Components of Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>0000061 - Disclosure - Share-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails">
        <link:definition>0000062 - Disclosure - Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails">
        <link:definition>0000063 - Disclosure - Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails">
        <link:definition>0000064 - Disclosure - Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSummaryofStockOptionsOutstandingDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails">
        <link:definition>0000065 - Disclosure - Share-Based Compensation - Summary of Stock Options Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofStockOptionActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails">
        <link:definition>0000066 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails">
        <link:definition>0000067 - Disclosure - Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomeNetScheduleofOtherIncomeNetDetails" roleURI="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails">
        <link:definition>0000068 - Disclosure - Other Income, Net - Schedule of Other Income, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails">
        <link:definition>0000069 - Disclosure - Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails">
        <link:definition>0000070 - Disclosure - Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000071 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" roleURI="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails">
        <link:definition>0000072 - Disclosure - Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsOfDeferredTaxBalancesDetails" roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails">
        <link:definition>0000073 - Disclosure - Income Taxes - Components Of Deferred Tax Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" roleURI="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails">
        <link:definition>0000074 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
        <link:definition>0000075 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails">
        <link:definition>0000076 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareNarrativeDetails" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareNarrativeDetails">
        <link:definition>0000077 - Disclosure - Earnings (Loss) Per Common Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails">
        <link:definition>0000078 - Disclosure - Earnings (Loss) Per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>0000079 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesComponentsofLeaseCostsDetails" roleURI="http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails">
        <link:definition>0000080 - Disclosure - Leases - Components of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://mckesson123.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>0000081 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>0000082 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>0000082 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_2" roleURI="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2">
        <link:definition>0000082 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://mckesson123.com/role/LeasesNarrativeDetails">
        <link:definition>0000083 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>0000084 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails">
        <link:definition>0000085 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
        <link:definition>0000086 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails">
        <link:definition>0000087 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
        <link:definition>0000088 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails">
        <link:definition>0000089 - Disclosure - Debt and Financing Activities - Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesTenderOfferandOtherInformationDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails">
        <link:definition>0000090 - Disclosure - Debt and Financing Activities - Tender Offer and Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
        <link:definition>0000091 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails">
        <link:definition>0000092 - Disclosure - Debt and Financing Activities - Other Facilities and Commercial Paper (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesDetails" roleURI="http://mckesson123.com/role/VariableInterestEntitiesDetails">
        <link:definition>0000093 - Disclosure - Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsNarrativeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails">
        <link:definition>0000094 - Disclosure - Pension Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails">
        <link:definition>0000095 - Disclosure - Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails">
        <link:definition>0000096 - Disclosure - Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails">
        <link:definition>0000097 - Disclosure - Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails">
        <link:definition>0000098 - Disclosure - Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>0000099 - Disclosure - Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails">
        <link:definition>0000100 - Disclosure - Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" roleURI="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails">
        <link:definition>0000101 - Disclosure - Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails" roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails">
        <link:definition>0000102 - Disclosure - Pension Benefits - Schedule of Investments Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesNarrativeDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails">
        <link:definition>0000103 - Disclosure - Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails">
        <link:definition>0000104 - Disclosure - Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails">
        <link:definition>0000105 - Disclosure - Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails">
        <link:definition>0000106 - Disclosure - Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails">
        <link:definition>0000107 - Disclosure - Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>0000108 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails">
        <link:definition>0000109 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialGuaranteesandWarrantiesDetails" roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails">
        <link:definition>0000110 - Disclosure - Financial Guarantees and Warranties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails">
        <link:definition>0000111 - Disclosure - Commitments and Contingent Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
        <link:definition>0000112 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitNarrativeDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails">
        <link:definition>0000113 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitScheduleofShareRepurchasesDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails">
        <link:definition>0000114 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails">
        <link:definition>0000115 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyBalancesandTransactionsDetails" roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails">
        <link:definition>0000116 - Disclosure - Related Party Balances and Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessNarrativeDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails">
        <link:definition>0000117 - Disclosure - Segments of Business - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessScheduleofSegmentInformationDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails">
        <link:definition>0000118 - Disclosure - Segments of Business - Schedule of Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails">
        <link:definition>0000119 - Disclosure - Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails">
        <link:definition>0000120 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mck_NationalPrescriptionOpiateLitigationMember" abstract="true" name="NationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_USPharmaceuticalSegmentMember" abstract="true" name="USPharmaceuticalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" abstract="false" name="ValuationAllowancesAndReservesDeductionsWrittenOffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_HazardousSubstanceSitesRecipientOfDirectives" abstract="false" name="HazardousSubstanceSitesRecipientOfDirectives" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:positiveIntegerItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember" abstract="true" name="SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" abstract="false" name="LossContingencyClassActionNumberofFaxesRemainingintheClass" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseMember" abstract="true" name="AcceleratedShareRepurchaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A2022TermLoanCreditFacilityMember" abstract="true" name="A2022TermLoanCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A475NotesDueMarch12021Member" abstract="true" name="A475NotesDueMarch12021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" abstract="false" name="EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_DefinedContributionPlanMatchingAxis" abstract="true" name="DefinedContributionPlanMatchingAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="mck_A2022StockPlanMember" abstract="true" name="A2022StockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UKBusinessesDisposalGroupMember" abstract="true" name="UKBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" abstract="false" name="DeferredTaxLiabilitiesLeaseRightofuseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LeaseLiabilitiesPaymentsDueAbstract" abstract="true" name="LeaseLiabilitiesPaymentsDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_A395NotesDueFebruary162028Member" abstract="true" name="A395NotesDueFebruary162028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RealPropertyMember" abstract="true" name="RealPropertyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DerivativeNotionalAmountTerminated" abstract="false" name="DerivativeNotionalAmountTerminated" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_IncreaseDecreaseInLitigationReserve" abstract="false" name="IncreaseDecreaseInLitigationReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" abstract="false" name="PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" abstract="false" name="ReclassificationOfTemporaryEquityToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearTwo" abstract="false" name="LeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A3.125NotesDue2029Member" abstract="true" name="A3.125NotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueAfterYearFive" abstract="false" name="LeaseLiabilityPaymentsDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ServicesBusinessMember" abstract="true" name="ServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EPSBasicAndDilutedAbstract" abstract="true" name="EPSBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseMay2022Member" abstract="true" name="AcceleratedShareRepurchaseMay2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MultiemployerPlanFundedStatusPercentage" abstract="false" name="MultiemployerPlanFundedStatusPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_A163EuroNotesDueOctober302026Member" abstract="true" name="A163EuroNotesDueOctober302026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" abstract="false" name="DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" abstract="false" name="PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A1.625NotesDue2026Member" abstract="true" name="A1.625NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PutRightValueInterestRateSpread" abstract="false" name="PutRightValueInterestRateSpread" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePriceIncrease" abstract="false" name="NoncontrollingInterestsPutRightExercisePriceIncrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_LeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencySettlementInstallmentPaymentsTerm" abstract="false" name="LossContingencySettlementInstallmentPaymentsTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_LossContingencyNumberOfAdditionalDefendants" abstract="false" name="LossContingencyNumberOfAdditionalDefendants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" abstract="false" name="CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_InterestRateSwapEnteredIntoYTDMember" abstract="true" name="InterestRateSwapEnteredIntoYTDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GermanWholesaleBusinessMember" abstract="true" name="GermanWholesaleBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearFour" abstract="false" name="GuaranteeObligationsExposureExpiringinYearFour" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseFebruary2022Member" abstract="true" name="AcceleratedShareRepurchaseFebruary2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GuaranteeObligationsCustomersDebtMember" abstract="true" name="GuaranteeObligationsCustomersDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RestructuringImpairmentandOtherRelatedCharges" abstract="false" name="RestructuringImpairmentandOtherRelatedCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_HazardousSubstanceSites" abstract="false" name="HazardousSubstanceSites" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:positiveIntegerItemType"/>
  <xs:element id="mck_RevenueDerivedFromServicesPercentage" abstract="false" name="RevenueDerivedFromServicesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_InsuranceProgramsPolicyTextBlock" abstract="false" name="InsuranceProgramsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_CherokeeNationMember" abstract="true" name="CherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DefinedContributionPlanMatchingDomain" abstract="true" name="DefinedContributionPlanMatchingDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" abstract="true" name="UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" abstract="false" name="TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_DefinedBenefitPlanOtherFundsMember" abstract="true" name="DefinedBenefitPlanOtherFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" abstract="false" name="StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" abstract="false" name="LossContingencyNumberOfCitiesFiledOnBehalfOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" abstract="false" name="UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" abstract="false" name="AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DistributionandRetailBusinessMember" abstract="true" name="DistributionandRetailBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyClaimsSettledNumberOfSubdivisions" abstract="false" name="LossContingencyClaimsSettledNumberOfSubdivisions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_TenderOfferNotesMember" abstract="true" name="TenderOfferNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearThree" abstract="false" name="LeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GainLossOnDerivativeTermination" abstract="false" name="GainLossOnDerivativeTermination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CommonStockVotingRightsNumberofVotesPerCommonShare" abstract="false" name="CommonStockVotingRightsNumberofVotesPerCommonShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_A1.500NotesDue2025Member" abstract="true" name="A1.500NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OpenMarketTransactionsMember" abstract="true" name="OpenMarketTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_TaxReceivableAgreementTRAMember" abstract="true" name="TaxReceivableAgreementTRAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" abstract="true" name="TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SecondPartOfPayContributionMember" abstract="false" name="SecondPartOfPayContributionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LeaseandOtherObligationsMember" abstract="true" name="LeaseandOtherObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" abstract="true" name="UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RetailPharmacyReportingUnitMember" abstract="true" name="RetailPharmacyReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SupplierIncentivesPolicyPolicyTextBlock" abstract="false" name="SupplierIncentivesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_HeldforSalePolicyTextBlock" abstract="false" name="HeldforSalePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember" abstract="true" name="ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" abstract="false" name="DefinedBenefitPlanBenefitObligationsExpensesPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDue" abstract="false" name="LeaseLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" abstract="false" name="DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_A313SterlingNotesDueFebruary172029Member" abstract="true" name="A313SterlingNotesDueFebruary172029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_InsuranceCoverageLitigationMember" abstract="true" name="InsuranceCoverageLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GrossProfitNetofExpensesIncludingOtherIncome" abstract="false" name="GrossProfitNetofExpensesIncludingOtherIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NewYorkOpioidTaxSurchargeMember" abstract="true" name="NewYorkOpioidTaxSurchargeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A525NotesDueFebruary152026Member" abstract="true" name="A525NotesDueFebruary152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" abstract="false" name="DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember" abstract="true" name="StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AureliusElephantLimitedMember" abstract="true" name="AureliusElephantLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures" abstract="false" name="StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_TreasuryStockPolicyTextBlock" abstract="false" name="TreasuryStockPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_AccruedShareRepurchases" abstract="false" name="AccruedShareRepurchases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanAnnuityContractsMember" abstract="true" name="DefinedBenefitPlanAnnuityContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LessorLeasePaymentstobeReceived" abstract="false" name="LessorLeasePaymentstobeReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" abstract="true" name="EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A130NotesDueAugust152026Member" abstract="true" name="A130NotesDueAugust152026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SarahCannonResearchInstituteMember" abstract="true" name="SarahCannonResearchInstituteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" abstract="false" name="ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseDecember2022Member" abstract="true" name="AcceleratedShareRepurchaseDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A090NotesDueDecember32025Member" abstract="true" name="A090NotesDueDecember32025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberOfStatesFiledOnBehalfOf" abstract="false" name="LossContingencyNumberOfStatesFiledOnBehalfOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DebtInstrumentDaysAvailableForBorrowing" abstract="false" name="DebtInstrumentDaysAvailableForBorrowing" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" abstract="false" name="DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" abstract="true" name="EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" abstract="false" name="LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_InternallyDevelopedSoftwareMember" abstract="true" name="InternallyDevelopedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AustrianBusinessOperationsMember" abstract="true" name="AustrianBusinessOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearTwo" abstract="false" name="GuaranteeObligationsExposureExpiringinYearTwo" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" abstract="false" name="EffectiveIncomeTaxRateReconciliationLitigationAndClaims" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_BusinessCombinationConsiderationTransferredOwnershipInterest" abstract="false" name="BusinessCombinationConsiderationTransferredOwnershipInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" abstract="false" name="DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GermanPharmaceuticalWholesaleJointVentureMember" abstract="true" name="GermanPharmaceuticalWholesaleJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" abstract="false" name="WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_A765DebenturesDueMarch12027Member" abstract="true" name="A765DebenturesDueMarch12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CurrentAssetLiabilityMember" abstract="true" name="CurrentAssetLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NotesDueNovember302020Member" abstract="true" name="NotesDueNovember302020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DataRelatedtoRSUActivityTableTextBlock" abstract="false" name="DataRelatedtoRSUActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_PrepaidExpensesAndOtherMember" abstract="true" name="PrepaidExpensesAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OpioidStewardshipActNewYorkAnnualSurcharge" abstract="false" name="OpioidStewardshipActNewYorkAnnualSurcharge" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites" abstract="false" name="EnvironmentalLossContingencyAgreedRemediationNumberOfSites" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_EUBusinessesDisposalGroupMember" abstract="true" name="EUBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" abstract="false" name="EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" abstract="false" name="AssetsForPlanBenefitsDefinedBenefitPlanCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" abstract="true" name="StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ShareholderDerivativeActionMember" abstract="true" name="ShareholderDerivativeActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" abstract="true" name="RestrictedStockUnitsandPerformancebasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearFour" abstract="false" name="LeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NumberofSoftwareProducts" abstract="false" name="NumberofSoftwareProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" abstract="true" name="UKBusinessesDisposalGroupAndAustrianBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_McKessonUSOncologyResearchMember" abstract="true" name="McKessonUSOncologyResearchMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_FormationOfBusiness" abstract="false" name="FormationOfBusiness" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" abstract="false" name="NoncontrollingInterestDecreaseForExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" abstract="false" name="OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EuropeanBusinessesDisposalGroupMember" abstract="true" name="EuropeanBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" abstract="true" name="UnitedStatesExRelPiacentileVAmgenIncEtAlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" abstract="true" name="SettlingGovernmentalEntitiesAndCherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfWestVirginiaAndSubdivisionsMember" abstract="true" name="StateOfWestVirginiaAndSubdivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MckessonEuropeSubsidiaryMember" abstract="true" name="MckessonEuropeSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LargestCustomerMember" abstract="true" name="LargestCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_IndividualClaimantMember" abstract="true" name="IndividualClaimantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OtherAllowancesMember" abstract="false" name="OtherAllowancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_UnitValueOfCashAndCashEquivalents" abstract="false" name="UnitValueOfCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" abstract="false" name="RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_RestructuringPlanRemoteWorkTransitioningMember" abstract="true" name="RestructuringPlanRemoteWorkTransitioningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" abstract="false" name="LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember" abstract="true" name="SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ReclassificationofTemporaryEquitytoLiability" abstract="false" name="ReclassificationofTemporaryEquitytoLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseMay2021Member" abstract="true" name="AcceleratedShareRepurchaseMay2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EmployeeContributions" abstract="false" name="EmployeeContributions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" abstract="false" name="LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OtherNonCurrentAssetsAndLiabilitiesMember" abstract="true" name="OtherNonCurrentAssetsAndLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_FixedInterestRateSwapMember" abstract="true" name="FixedInterestRateSwapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies" abstract="false" name="LossContingencyInsufficientCoverageNumberOfInsurancePolicies" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_PrescriptionTechnologySolutionsSegmentMember" abstract="true" name="PrescriptionTechnologySolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" abstract="false" name="EstimatedEnvironmentalAssessmentAndCleanupCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" abstract="false" name="AssetImpairmentChargesIncludingAcceleratedDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_FinancialGuaranteesAndWarrantiesAbstract" abstract="true" name="FinancialGuaranteesAndWarrantiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_WalgreensBootsAllianceJointVentureMember" abstract="true" name="WalgreensBootsAllianceJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SecuredOvernightFinancingRateSOFRMember" abstract="true" name="SecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A2013StockPlanMember" abstract="true" name="A2013StockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_LossContingencyNumberofFormerOfficers" abstract="false" name="LossContingencyNumberofFormerOfficers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePrice" abstract="false" name="NoncontrollingInterestsPutRightExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_StateOfAlabamaAndSubdivisionsMember" abstract="true" name="StateOfAlabamaAndSubdivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement" abstract="false" name="LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TenLargestCustomersMember" abstract="true" name="TenLargestCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" abstract="false" name="DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_MedicalSurgicalSolutionsSegmentMember" abstract="true" name="MedicalSurgicalSolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" abstract="true" name="UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueYearFive" abstract="false" name="LeaseLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberofStates" abstract="false" name="LossContingencyNumberofStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment" abstract="false" name="IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A475NotesDueMay302029Member" abstract="true" name="A475NotesDueMay302029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EuropeanAssetsHeldForSaleMember" abstract="true" name="EuropeanAssetsHeldForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EuroDenominatedNotesMember" abstract="true" name="EuroDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A285NotesDueMarch152023Member" abstract="true" name="A285NotesDueMarch152023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ThreeLargestUSPharmaceuticalDistributorsMember" abstract="true" name="ThreeLargestUSPharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" abstract="false" name="RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberOfOtherDefendants" abstract="false" name="LossContingencyNumberOfOtherDefendants" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" abstract="false" name="LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_DeferredTaxAssetLeaseObligations" abstract="false" name="DeferredTaxAssetLeaseObligations" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" abstract="true" name="StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_InternationalSegmentMember" abstract="true" name="InternationalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LeaseLiabilityPaymentsDueNextTwelveMonths" abstract="false" name="LeaseLiabilityPaymentsDueNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DerecognitionOfNoncontrollingInterests" abstract="false" name="DerecognitionOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_BritishPoundSterlingDenominatedNotesMember" abstract="true" name="BritishPoundSterlingDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A525NotesDue2026Member" abstract="true" name="A525NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DeferredTaxAssetLitigationAndClaims" abstract="false" name="DeferredTaxAssetLitigationAndClaims" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses" abstract="false" name="EquitySecuritiesFVNIGainLossExcludingImpairmentLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AccountsReceivableCustomerAccountsGross" abstract="false" name="AccountsReceivableCustomerAccountsGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A380NotesDueMarch152024Member" abstract="true" name="A380NotesDueMarch152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A150EuroNotesDueNovember172025Member" abstract="true" name="A150EuroNotesDueNovember172025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" abstract="true" name="CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" abstract="false" name="LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" abstract="false" name="DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_VantageandClarusOneSourcingServicesLLCMember" abstract="true" name="VantageandClarusOneSourcingServicesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearFive" abstract="false" name="GuaranteeObligationsExposureExpiringinYearFive" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" abstract="false" name="AnnualRecurringCompensationPerSharetoNoncontrollingInterests" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_A270NotesDueDecember152022Member" abstract="true" name="A270NotesDueDecember152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_U.S.PharmaceuticalandSpecialtySolutionsMember" abstract="true" name="U.S.PharmaceuticalandSpecialtySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SCRIOncologyLLCMember" abstract="true" name="SCRIOncologyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_MachineryEquipmentAndOtherMember" abstract="true" name="MachineryEquipmentAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" abstract="false" name="GuaranteeObligationsExposureExpiringinYearFiveThereafter" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyNumberOfCasesDismissed" abstract="false" name="LossContingencyNumberOfCasesDismissed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_ThreeNationalPharmaceuticalDistributorsMember" abstract="true" name="ThreeNationalPharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A063EuroNotesDueAugust172021Member" abstract="true" name="A063EuroNotesDueAugust172021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" abstract="false" name="NoncontrollingInterestDecreaseFromReclassificationToLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A600NotesDueMarch12041Member" abstract="true" name="A600NotesDueMarch12041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NorwegianPublicServicePensionFundSPKMember" abstract="true" name="NorwegianPublicServicePensionFundSPKMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PerformancebasedStockUnitsMember" abstract="true" name="PerformancebasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A488NotesDueMarch152044Member" abstract="true" name="A488NotesDueMarch152044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_FirstPartOfPayContributionMember" abstract="false" name="FirstPartOfPayContributionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RxSavingsSolutionsLLCMember" abstract="true" name="RxSavingsSolutionsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" abstract="true" name="UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" abstract="false" name="NoncontrollingInterestIncreaseDecreaseDuetoOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" abstract="false" name="DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_PrescriptionTechnologySolutionsMember" abstract="true" name="PrescriptionTechnologySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" abstract="true" name="CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mck_LossContingencyClassActionNumberofFaxesReceived" abstract="false" name="LossContingencyClassActionNumberofFaxesReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_LossContingencyDamagesSoughtPerViolationValue" abstract="false" name="LossContingencyDamagesSoughtPerViolationValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_FinancialGuaranteesAndWarrantiesTextBlock" abstract="false" name="FinancialGuaranteesAndWarrantiesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_RxTsSegmentMember" abstract="true" name="RxTsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberOfRelators" abstract="false" name="LossContingencyNumberOfRelators" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" abstract="true" name="AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearThree" abstract="false" name="GuaranteeObligationsExposureExpiringinYearThree" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" abstract="false" name="DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_SupplierReservesPolicyTextBlock" abstract="false" name="SupplierReservesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_EvanstonPolicePensionFundv.McKessonCorporationMember" abstract="true" name="EvanstonPolicePensionFundv.McKessonCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" abstract="true" name="DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" abstract="false" name="EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_LossContingencyNumberofRelators" abstract="false" name="LossContingencyNumberofRelators" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" abstract="true" name="ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mck_GuaranteeObligationsExposureExpiringinYearOne" abstract="false" name="GuaranteeObligationsExposureExpiringinYearOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NativeAmericanTribesOtherThanCherokeeNationMember" abstract="true" name="NativeAmericanTribesOtherThanCherokeeNationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CorporateOperatingExpenseandOtherIncomeNet" abstract="false" name="CorporateOperatingExpenseandOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" abstract="false" name="SECSchedule1209ValuationAllowancesandReservesCurrentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_IncomeTaxExpenseBenefitDiscreteItems" abstract="false" name="IncomeTaxExpenseBenefitDiscreteItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DefinedBenefitPlanPlanAssetsExpensesPaid" abstract="false" name="DefinedBenefitPlanPlanAssetsExpensesPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_EnvironmentalLitigationMember" abstract="true" name="EnvironmentalLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_GuarantorObligationsPeriod" abstract="false" name="GuarantorObligationsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" abstract="false" name="CapitalizedSoftwareHeldforInternalUseUsefulLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" abstract="true" name="GuaranteeObligationsInventoryRepurchaseGuaranteesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>mck-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1eea9b32-7227-4c4c-b033-5c353ea41e5b,g:3de8d065-e076-4ee0-8f0c-2df01cc3ca1e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_6c380df4-c110-4846-a5ae-195f4f93a507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9273a6d6-512c-43ce-b126-f768639f0aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_6c380df4-c110-4846-a5ae-195f4f93a507" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9273a6d6-512c-43ce-b126-f768639f0aa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_349e1a29-83a0-4f02-b37c-c8b692f211ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_6c380df4-c110-4846-a5ae-195f4f93a507" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_349e1a29-83a0-4f02-b37c-c8b692f211ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_425e053b-79da-4842-8c9d-fa89d5ae1225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_11bab215-78fd-43fd-800d-01ec8229bbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_425e053b-79da-4842-8c9d-fa89d5ae1225" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_11bab215-78fd-43fd-800d-01ec8229bbe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_fda5f67f-87e7-42cb-a1b8-339591687929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_425e053b-79da-4842-8c9d-fa89d5ae1225" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_fda5f67f-87e7-42cb-a1b8-339591687929" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e798e9e9-22c6-45f6-a130-35f440aef27d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_7be717f9-8320-4ce9-b98c-c9664f2fcf78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_e798e9e9-22c6-45f6-a130-35f440aef27d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_7be717f9-8320-4ce9-b98c-c9664f2fcf78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_436421c1-423c-43b6-8ccd-cbeb0334e1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_e798e9e9-22c6-45f6-a130-35f440aef27d" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_436421c1-423c-43b6-8ccd-cbeb0334e1e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9c727ddb-ddcf-41fe-bb29-aadfa3e3628d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_7a3abf20-3306-4ad4-a8f5-6f2b3e06cc15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_9c727ddb-ddcf-41fe-bb29-aadfa3e3628d" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_7a3abf20-3306-4ad4-a8f5-6f2b3e06cc15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e424aaa9-0b4c-4216-a0ac-da42080273f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_9c727ddb-ddcf-41fe-bb29-aadfa3e3628d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e424aaa9-0b4c-4216-a0ac-da42080273f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_424020b5-f812-4315-a713-bb4293f825db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_15cac815-5324-4d3b-9eb0-b47d4e395a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_424020b5-f812-4315-a713-bb4293f825db" xlink:to="loc_us-gaap_ProfitLoss_15cac815-5324-4d3b-9eb0-b47d4e395a6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5428c8f7-1d1f-4772-90b2-bedb03d235a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_424020b5-f812-4315-a713-bb4293f825db" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5428c8f7-1d1f-4772-90b2-bedb03d235a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_aef8fddf-3306-4b04-8a6b-94f2ee2de5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d7c0c0b2-99ea-430c-a48b-f21b674f2671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_aef8fddf-3306-4b04-8a6b-94f2ee2de5e5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d7c0c0b2-99ea-430c-a48b-f21b674f2671" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_912903f0-64ba-4dd1-accb-545336e302c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_aef8fddf-3306-4b04-8a6b-94f2ee2de5e5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_912903f0-64ba-4dd1-accb-545336e302c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_329b3c12-65de-44c0-8b46-2691867650ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_71b7611b-d523-4700-80c4-8d425068974f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_329b3c12-65de-44c0-8b46-2691867650ae" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_71b7611b-d523-4700-80c4-8d425068974f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_435a2740-9784-4757-9609-d16be56c5933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_329b3c12-65de-44c0-8b46-2691867650ae" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_435a2740-9784-4757-9609-d16be56c5933" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_cbed95af-12b6-4be1-abc5-291647e46e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_329b3c12-65de-44c0-8b46-2691867650ae" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_cbed95af-12b6-4be1-abc5-291647e46e80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_9e6d6ec0-e4a1-47df-8c13-4a8697925bc0" xlink:href="mck-20230331.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_329b3c12-65de-44c0-8b46-2691867650ae" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_9e6d6ec0-e4a1-47df-8c13-4a8697925bc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_05ffa477-95da-40c5-a263-da5ad12be9af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_1ef4a3e2-0ccd-4414-9dce-bb08239a81a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_05ffa477-95da-40c5-a263-da5ad12be9af" xlink:to="loc_us-gaap_GrossProfit_1ef4a3e2-0ccd-4414-9dce-bb08239a81a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_64daa1c3-9a44-42ac-a7ff-d6619e72dd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_05ffa477-95da-40c5-a263-da5ad12be9af" xlink:to="loc_us-gaap_OperatingExpenses_64daa1c3-9a44-42ac-a7ff-d6619e72dd9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6641ce16-e618-4f8b-b6f3-26cfeac0dea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f8bba2b8-b1ff-45c1-af40-3de43e5fb682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6641ce16-e618-4f8b-b6f3-26cfeac0dea4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f8bba2b8-b1ff-45c1-af40-3de43e5fb682" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f71a19aa-f6ae-49fd-95eb-25a60245f9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6641ce16-e618-4f8b-b6f3-26cfeac0dea4" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f71a19aa-f6ae-49fd-95eb-25a60245f9cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_29bcf458-1b0a-4c69-a687-69ea28d2a92b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6641ce16-e618-4f8b-b6f3-26cfeac0dea4" xlink:to="loc_us-gaap_OperatingIncomeLoss_29bcf458-1b0a-4c69-a687-69ea28d2a92b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8ee7feab-7f25-402c-8b7a-52d40a150c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6641ce16-e618-4f8b-b6f3-26cfeac0dea4" xlink:to="loc_us-gaap_InterestExpense_8ee7feab-7f25-402c-8b7a-52d40a150c42" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d3f10e1-6f66-4085-abc4-45eba769fc36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bd779e43-deca-4cef-87e5-4b6513e6f154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d3f10e1-6f66-4085-abc4-45eba769fc36" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bd779e43-deca-4cef-87e5-4b6513e6f154" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5eaa9b37-c58b-473d-a0f5-e5833916c7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d3f10e1-6f66-4085-abc4-45eba769fc36" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5eaa9b37-c58b-473d-a0f5-e5833916c7d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b0b632ed-21ca-481c-9d2b-d62b9f22c6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6d3f10e1-6f66-4085-abc4-45eba769fc36" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_b0b632ed-21ca-481c-9d2b-d62b9f22c6c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_08da0984-16b4-4d20-a481-01e477e0030f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_539c4945-b72b-455c-855e-b53a4ff286a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_08da0984-16b4-4d20-a481-01e477e0030f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_539c4945-b72b-455c-855e-b53a4ff286a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_96aa4647-5f13-411e-9a87-9554c7d970e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_08da0984-16b4-4d20-a481-01e477e0030f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_96aa4647-5f13-411e-9a87-9554c7d970e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b6e20a1a-6ba4-4366-bc70-a901f66c30dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3f175c0a-6c3a-4004-938b-9a3dbc147ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b6e20a1a-6ba4-4366-bc70-a901f66c30dd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3f175c0a-6c3a-4004-938b-9a3dbc147ba1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_38fe822c-e01a-4d67-b8ad-5c0b9cad5b67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b6e20a1a-6ba4-4366-bc70-a901f66c30dd" xlink:to="loc_us-gaap_ProfitLoss_38fe822c-e01a-4d67-b8ad-5c0b9cad5b67" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3993a165-c392-42ec-9780-3146828f4104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8a25392b-f45b-4a0e-949c-06e0c56396c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3993a165-c392-42ec-9780-3146828f4104" xlink:to="loc_us-gaap_CommonStockValue_8a25392b-f45b-4a0e-949c-06e0c56396c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6711b0d2-6955-44cf-a27d-b84d8c06deec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3993a165-c392-42ec-9780-3146828f4104" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6711b0d2-6955-44cf-a27d-b84d8c06deec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4a845af3-9c41-45ce-b117-c07710c916bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3993a165-c392-42ec-9780-3146828f4104" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4a845af3-9c41-45ce-b117-c07710c916bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_916ef647-0c62-46cd-bd74-1ca0fbd299d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3993a165-c392-42ec-9780-3146828f4104" xlink:to="loc_us-gaap_AdditionalPaidInCapital_916ef647-0c62-46cd-bd74-1ca0fbd299d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_1952e5eb-4209-47a8-b65e-244ed5c8ad35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3993a165-c392-42ec-9780-3146828f4104" xlink:to="loc_us-gaap_TreasuryStockCommonValue_1952e5eb-4209-47a8-b65e-244ed5c8ad35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_d579a83b-df4f-4892-90a1-8bae10c0b1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3993a165-c392-42ec-9780-3146828f4104" xlink:to="loc_us-gaap_PreferredStockValue_d579a83b-df4f-4892-90a1-8bae10c0b1f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8f162d78-5800-48f3-b185-37eea6e7d25e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e9832598-5455-468f-b1e9-00de10b1b1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f162d78-5800-48f3-b185-37eea6e7d25e" xlink:to="loc_us-gaap_AssetsCurrent_e9832598-5455-468f-b1e9-00de10b1b1ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_41dea58e-f8ac-4da1-8665-73afa9f96f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f162d78-5800-48f3-b185-37eea6e7d25e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_41dea58e-f8ac-4da1-8665-73afa9f96f8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1c8959d9-fde7-4891-9e29-bd710a29e4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f162d78-5800-48f3-b185-37eea6e7d25e" xlink:to="loc_us-gaap_Goodwill_1c8959d9-fde7-4891-9e29-bd710a29e4f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_39daaa33-8031-40f8-a924-06f34f0dd5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f162d78-5800-48f3-b185-37eea6e7d25e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_39daaa33-8031-40f8-a924-06f34f0dd5b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_45355f40-0658-4e9c-9eb7-7f7eb25f6b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f162d78-5800-48f3-b185-37eea6e7d25e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_45355f40-0658-4e9c-9eb7-7f7eb25f6b50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_78755806-7ebf-4c16-9073-9dd6c26d317e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f162d78-5800-48f3-b185-37eea6e7d25e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_78755806-7ebf-4c16-9073-9dd6c26d317e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ef365f85-6349-4898-8170-c849fa0e34f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ff335f96-932a-4c9c-aefa-17207eb8a4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef365f85-6349-4898-8170-c849fa0e34f4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ff335f96-932a-4c9c-aefa-17207eb8a4ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_99173298-f2ba-4272-82a4-2675c8c4c406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef365f85-6349-4898-8170-c849fa0e34f4" xlink:to="loc_us-gaap_ReceivablesNetCurrent_99173298-f2ba-4272-82a4-2675c8c4c406" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_25875f51-4cbf-4aa4-bfa7-4854cbcde3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef365f85-6349-4898-8170-c849fa0e34f4" xlink:to="loc_us-gaap_InventoryNet_25875f51-4cbf-4aa4-bfa7-4854cbcde3a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6b535fc5-a522-4782-b99e-e037ec65ac34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef365f85-6349-4898-8170-c849fa0e34f4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6b535fc5-a522-4782-b99e-e037ec65ac34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_93df92dc-c3f6-49b3-8ff2-367d1ba1b887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ef365f85-6349-4898-8170-c849fa0e34f4" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_93df92dc-c3f6-49b3-8ff2-367d1ba1b887" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fb16f3d4-a9e0-403b-b8cb-8a1b47e01bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3101b3c7-0066-4876-8062-6fba6a433950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fb16f3d4-a9e0-403b-b8cb-8a1b47e01bd9" xlink:to="loc_us-gaap_StockholdersEquity_3101b3c7-0066-4876-8062-6fba6a433950" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_7d5dc3a8-a269-42e0-af79-3c67d069c8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fb16f3d4-a9e0-403b-b8cb-8a1b47e01bd9" xlink:to="loc_us-gaap_MinorityInterest_7d5dc3a8-a269-42e0-af79-3c67d069c8bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_149ca316-a5ca-45d3-a329-023e46e2f2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_da4ae45b-f3fc-4f3d-858b-d06ccbd22d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_149ca316-a5ca-45d3-a329-023e46e2f2cc" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_da4ae45b-f3fc-4f3d-858b-d06ccbd22d55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_e333b299-b4ec-4661-a473-48de4556ebb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_149ca316-a5ca-45d3-a329-023e46e2f2cc" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_e333b299-b4ec-4661-a473-48de4556ebb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d9e42179-0c95-4dfb-99bf-b9d1448c1f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_149ca316-a5ca-45d3-a329-023e46e2f2cc" xlink:to="loc_us-gaap_AccountsPayableCurrent_d9e42179-0c95-4dfb-99bf-b9d1448c1f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c9f2a929-d1cf-473b-9321-359a0df2b084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_149ca316-a5ca-45d3-a329-023e46e2f2cc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c9f2a929-d1cf-473b-9321-359a0df2b084" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1d32f828-46ad-40a6-93fb-1aa0bdad9a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_149ca316-a5ca-45d3-a329-023e46e2f2cc" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_1d32f828-46ad-40a6-93fb-1aa0bdad9a74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e7ff0a7-ffd3-41d0-9cde-32646e11e1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8cede7e1-fc6a-4f3e-815d-4fae84810044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e7ff0a7-ffd3-41d0-9cde-32646e11e1ae" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8cede7e1-fc6a-4f3e-815d-4fae84810044" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_99beb18b-3f2a-4e14-a312-cd17c3d9a362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e7ff0a7-ffd3-41d0-9cde-32646e11e1ae" xlink:to="loc_us-gaap_LiabilitiesCurrent_99beb18b-3f2a-4e14-a312-cd17c3d9a362" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3da766db-d785-4efe-a109-d17b857e32a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e7ff0a7-ffd3-41d0-9cde-32646e11e1ae" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3da766db-d785-4efe-a109-d17b857e32a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0d782aa6-4d19-4466-aeef-9ae339c8328c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e7ff0a7-ffd3-41d0-9cde-32646e11e1ae" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0d782aa6-4d19-4466-aeef-9ae339c8328c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_788390be-b6a1-4b89-909a-4ed0996a0a04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e7ff0a7-ffd3-41d0-9cde-32646e11e1ae" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_788390be-b6a1-4b89-909a-4ed0996a0a04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c755d842-fc1b-4359-b1f7-2dd4d2a381bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e7ff0a7-ffd3-41d0-9cde-32646e11e1ae" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c755d842-fc1b-4359-b1f7-2dd4d2a381bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_eaf22a01-8cc8-4e10-adb7-69c630966abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e7ff0a7-ffd3-41d0-9cde-32646e11e1ae" xlink:to="loc_us-gaap_CommitmentsAndContingencies_eaf22a01-8cc8-4e10-adb7-69c630966abf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ee09f2e4-bf8e-4981-87a5-c48de9f8e93b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e7ff0a7-ffd3-41d0-9cde-32646e11e1ae" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ee09f2e4-bf8e-4981-87a5-c48de9f8e93b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9dc7e576-a5ac-43e6-9697-e90e839bc4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_52a7aa76-116f-4556-a9e5-c7a381b3e9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9dc7e576-a5ac-43e6-9697-e90e839bc4bc" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_52a7aa76-116f-4556-a9e5-c7a381b3e9ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_ad6314b6-ce5a-42ce-8463-eb852a24e978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9dc7e576-a5ac-43e6-9697-e90e839bc4bc" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_ad6314b6-ce5a-42ce-8463-eb852a24e978" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_beb52bc2-dab0-4eb6-90c9-1489bc2df5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9dc7e576-a5ac-43e6-9697-e90e839bc4bc" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_beb52bc2-dab0-4eb6-90c9-1489bc2df5ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4501fbc0-2ff1-4f0e-9987-0eec9b8a2493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9dc7e576-a5ac-43e6-9697-e90e839bc4bc" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4501fbc0-2ff1-4f0e-9987-0eec9b8a2493" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_104580d2-96ce-4796-82d0-95651d48ffd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9dc7e576-a5ac-43e6-9697-e90e839bc4bc" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_104580d2-96ce-4796-82d0-95651d48ffd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e3d44a07-6694-4b81-8b4a-cbc558e0808a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_818e7e5a-f7ea-4c63-97bf-9588b6941dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e3d44a07-6694-4b81-8b4a-cbc558e0808a" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_818e7e5a-f7ea-4c63-97bf-9588b6941dc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_de3c1373-f072-45ff-b060-b18bfbb3a44f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e3d44a07-6694-4b81-8b4a-cbc558e0808a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_de3c1373-f072-45ff-b060-b18bfbb3a44f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a0b736fa-2bbf-4230-847b-1438cc548fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e3d44a07-6694-4b81-8b4a-cbc558e0808a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a0b736fa-2bbf-4230-847b-1438cc548fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95b3b6af-adef-4a07-b43a-f217a2e00f26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e3d44a07-6694-4b81-8b4a-cbc558e0808a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95b3b6af-adef-4a07-b43a-f217a2e00f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_eca15f6d-a57d-4fac-8361-da780d5012fd" xlink:href="mck-20230331.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e3d44a07-6694-4b81-8b4a-cbc558e0808a" xlink:to="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_eca15f6d-a57d-4fac-8361-da780d5012fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3840d2e7-33be-47e9-8c85-8e33a008b1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5ca7aaeb-ac9e-47a3-8953-a41d24c40885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3840d2e7-33be-47e9-8c85-8e33a008b1b1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5ca7aaeb-ac9e-47a3-8953-a41d24c40885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_b4f6967d-f4d4-4184-bfcd-ead42b44bc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3840d2e7-33be-47e9-8c85-8e33a008b1b1" xlink:to="loc_us-gaap_RestrictedCashCurrent_b4f6967d-f4d4-4184-bfcd-ead42b44bc9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_61ca31a3-d99d-4f73-b7b8-4300a4272d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_61ca31a3-d99d-4f73-b7b8-4300a4272d40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_4347ace3-c8b5-4e75-a825-c94d264116e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_4347ace3-c8b5-4e75-a825-c94d264116e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_b4a67a45-fc25-4fca-9f0f-b153d0cc5a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_b4a67a45-fc25-4fca-9f0f-b153d0cc5a25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_220602fc-07c4-44e8-897e-c6da6251b4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_220602fc-07c4-44e8-897e-c6da6251b4c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_ec6db8c0-47d9-4b01-ba2d-2ac880812b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_ec6db8c0-47d9-4b01-ba2d-2ac880812b7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5c97d2a0-3ecf-4357-8a3e-3a091fc287ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5c97d2a0-3ecf-4357-8a3e-3a091fc287ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9a13ae38-e89f-4910-b590-ab2f788960e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9a13ae38-e89f-4910-b590-ab2f788960e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1b03d43d-5cf6-4c83-a6d0-940a49a559a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1b03d43d-5cf6-4c83-a6d0-940a49a559a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_437e8cf1-a18b-4f1f-8d2b-96f1f8e39384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_Depreciation_437e8cf1-a18b-4f1f-8d2b-96f1f8e39384" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_26283d74-b0e1-4bf8-bdf4-fa066648950d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_26283d74-b0e1-4bf8-bdf4-fa066648950d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_59294b8b-b5de-4328-af67-495f95ececde" xlink:href="mck-20230331.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_59294b8b-b5de-4328-af67-495f95ececde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_e973917c-28f1-4b71-adee-84cc27bf0b32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_e973917c-28f1-4b71-adee-84cc27bf0b32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_43a8a616-6cca-4cd3-bbac-36d2be887624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_AdjustmentForAmortization_43a8a616-6cca-4cd3-bbac-36d2be887624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e053c453-abed-46f8-9a44-cc56c3b51784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_ProfitLoss_e053c453-abed-46f8-9a44-cc56c3b51784" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_89461f56-b91d-4cfd-80f6-a8c7bf1446b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_OperatingLeaseExpense_89461f56-b91d-4cfd-80f6-a8c7bf1446b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_9a1c42e9-92bb-498f-8f4f-f0f4f09cf102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_9a1c42e9-92bb-498f-8f4f-f0f4f09cf102" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_7e0891d0-d1d3-400f-9719-97c07c63f3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e3962662-47d6-492f-8c7c-3612b37c7111" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_7e0891d0-d1d3-400f-9719-97c07c63f3b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2dfd29d-b642-4282-a8bf-a1ed1fd30dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_0b90d132-6715-4887-94d0-a39284022eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2dfd29d-b642-4282-a8bf-a1ed1fd30dcf" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_0b90d132-6715-4887-94d0-a39284022eec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c36694c6-0d3a-4b07-b806-a039a5713778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2dfd29d-b642-4282-a8bf-a1ed1fd30dcf" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c36694c6-0d3a-4b07-b806-a039a5713778" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_dbe039e5-b8e4-4aba-935c-69b5c51900be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2dfd29d-b642-4282-a8bf-a1ed1fd30dcf" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_dbe039e5-b8e4-4aba-935c-69b5c51900be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_e773e855-758e-4e07-baf6-d8509c494f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2dfd29d-b642-4282-a8bf-a1ed1fd30dcf" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_e773e855-758e-4e07-baf6-d8509c494f4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_0d53a4fd-0857-4473-b68e-5f2820b12644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2dfd29d-b642-4282-a8bf-a1ed1fd30dcf" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_0d53a4fd-0857-4473-b68e-5f2820b12644" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_08349db6-ed8f-4ae1-a702-e661805dcd19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2dfd29d-b642-4282-a8bf-a1ed1fd30dcf" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_08349db6-ed8f-4ae1-a702-e661805dcd19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_de396a75-cbac-4d30-a083-f028ed6e21e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2dfd29d-b642-4282-a8bf-a1ed1fd30dcf" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_de396a75-cbac-4d30-a083-f028ed6e21e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_b4df55ec-a9d5-405d-aaa1-169cb7e300f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2dfd29d-b642-4282-a8bf-a1ed1fd30dcf" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_b4df55ec-a9d5-405d-aaa1-169cb7e300f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_494a8591-6536-43b5-89ff-41ab20126dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2dfd29d-b642-4282-a8bf-a1ed1fd30dcf" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_494a8591-6536-43b5-89ff-41ab20126dc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_18bc7057-885d-4a3f-a178-ea36baa9c42d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b2dfd29d-b642-4282-a8bf-a1ed1fd30dcf" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_18bc7057-885d-4a3f-a178-ea36baa9c42d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SignificantAccountingPoliciesReceivablesNetDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_3b5edd90-1069-4e1c-8232-502467759c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccountsReceivableCustomerAccountsGross_5e5a83c1-c78e-43b6-a2f2-d2c532e2ac9e" xlink:href="mck-20230331.xsd#mck_AccountsReceivableCustomerAccountsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_3b5edd90-1069-4e1c-8232-502467759c26" xlink:to="loc_mck_AccountsReceivableCustomerAccountsGross_5e5a83c1-c78e-43b6-a2f2-d2c532e2ac9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_1955e953-bcb5-42ca-9725-79e35d325c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent_3b5edd90-1069-4e1c-8232-502467759c26" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_1955e953-bcb5-42ca-9725-79e35d325c58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_f6cc6bfd-5aaf-4c22-887a-15f01e6ff8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_e4d548cf-b1c3-41b0-8520-527164f9fc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_f6cc6bfd-5aaf-4c22-887a-15f01e6ff8a7" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_e4d548cf-b1c3-41b0-8520-527164f9fc60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_03efabdf-72e3-4730-8ffa-170720b8e78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_f6cc6bfd-5aaf-4c22-887a-15f01e6ff8a7" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_03efabdf-72e3-4730-8ffa-170720b8e78c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_edd4af0f-a043-4614-8bab-70e04036e3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_24ffdf15-0c6b-4706-9823-8961f9a9d6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_edd4af0f-a043-4614-8bab-70e04036e3b8" xlink:to="loc_us-gaap_ConstructionInProgressGross_24ffdf15-0c6b-4706-9823-8961f9a9d6f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_eb3482df-134a-4574-9bb5-92d40e8ec358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_edd4af0f-a043-4614-8bab-70e04036e3b8" xlink:to="loc_us-gaap_Land_eb3482df-134a-4574-9bb5-92d40e8ec358" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOther_bef04c27-3744-4fbb-b2cc-1f9f52abba40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_edd4af0f-a043-4614-8bab-70e04036e3b8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOther_bef04c27-3744-4fbb-b2cc-1f9f52abba40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_5ffaed0c-0eac-4c2d-b6d1-7dd2dc9ff97a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_edd4af0f-a043-4614-8bab-70e04036e3b8" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_5ffaed0c-0eac-4c2d-b6d1-7dd2dc9ff97a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_68e85e8c-f04a-486e-b3e8-afd0f9df53c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1caeb2f2-196a-4fe0-84b0-364c740b8c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_68e85e8c-f04a-486e-b3e8-afd0f9df53c5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1caeb2f2-196a-4fe0-84b0-364c740b8c7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_86dfeaf2-d999-4360-993d-17aa2be8f7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_68e85e8c-f04a-486e-b3e8-afd0f9df53c5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_86dfeaf2-d999-4360-993d-17aa2be8f7f3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresAcquisitionsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_75a04502-3071-4b44-8288-0308c31d2e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_895c4163-3513-46ba-a8ba-861d5fcc4557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_75a04502-3071-4b44-8288-0308c31d2e0c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_895c4163-3513-46ba-a8ba-861d5fcc4557" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_88ba67ff-19e1-405f-ad0f-819db5c4b051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_75a04502-3071-4b44-8288-0308c31d2e0c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_88ba67ff-19e1-405f-ad0f-819db5c4b051" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_9631307a-34d7-4bc9-aede-70726b8aee6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_275f088b-f79a-453b-9c54-6ae3fcd3b897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_9631307a-34d7-4bc9-aede-70726b8aee6b" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_275f088b-f79a-453b-9c54-6ae3fcd3b897" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital_c60de687-15b3-42ca-93eb-01b1a65db47b" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_9631307a-34d7-4bc9-aede-70726b8aee6b" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital_c60de687-15b3-42ca-93eb-01b1a65db47b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5815360c-535f-4f53-acac-6a731e2b65cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_9631307a-34d7-4bc9-aede-70726b8aee6b" xlink:to="loc_us-gaap_Goodwill_5815360c-535f-4f53-acac-6a731e2b65cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_14f11357-457e-40fd-9563-91c6b81baafa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_9631307a-34d7-4bc9-aede-70726b8aee6b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_14f11357-457e-40fd-9563-91c6b81baafa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_294b01fc-2db7-4ac9-9114-2de230546ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_432ac0d8-380d-4932-bbaf-afa43f8383e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_294b01fc-2db7-4ac9-9114-2de230546ee6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_432ac0d8-380d-4932-bbaf-afa43f8383e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b500ba32-9e28-4e9e-b57b-f035e0b23b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_294b01fc-2db7-4ac9-9114-2de230546ee6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b500ba32-9e28-4e9e-b57b-f035e0b23b6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_89be0cc4-924d-499f-80b7-24e6c333c6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_294b01fc-2db7-4ac9-9114-2de230546ee6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_89be0cc4-924d-499f-80b7-24e6c333c6b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_168d1e06-300c-47f5-933c-beeba3b8ffdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_294b01fc-2db7-4ac9-9114-2de230546ee6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_168d1e06-300c-47f5-933c-beeba3b8ffdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_c2cc49eb-71d9-4a48-88ea-44e1be0bbbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_294b01fc-2db7-4ac9-9114-2de230546ee6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_c2cc49eb-71d9-4a48-88ea-44e1be0bbbd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_9fb3b4ba-d2d8-424d-bc1c-4a1aeb6e5574" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_294b01fc-2db7-4ac9-9114-2de230546ee6" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_9fb3b4ba-d2d8-424d-bc1c-4a1aeb6e5574" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities_00c15037-9ca4-4bf1-a3e4-1ca1275279dc" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_294b01fc-2db7-4ac9-9114-2de230546ee6" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities_00c15037-9ca4-4bf1-a3e4-1ca1275279dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5f3b7f03-dcfe-40f5-b7dd-045179e5dbf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_294b01fc-2db7-4ac9-9114-2de230546ee6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_5f3b7f03-dcfe-40f5-b7dd-045179e5dbf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_9d7e2261-c2dc-4b25-be23-a7b281d4eeed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_294b01fc-2db7-4ac9-9114-2de230546ee6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_9d7e2261-c2dc-4b25-be23-a7b281d4eeed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8d8cb089-e8f0-4878-82c8-2502d27ccc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4c4fa199-3b54-458c-9640-626d4367e7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8d8cb089-e8f0-4878-82c8-2502d27ccc7b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_4c4fa199-3b54-458c-9640-626d4367e7b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_01104b72-ec82-4adc-92f7-2f990db7603e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8d8cb089-e8f0-4878-82c8-2502d27ccc7b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_01104b72-ec82-4adc-92f7-2f990db7603e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_dd689718-0620-4000-9a3b-c0bd99b9ca7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8d8cb089-e8f0-4878-82c8-2502d27ccc7b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_dd689718-0620-4000-9a3b-c0bd99b9ca7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3409ed9a-fe49-4eaf-848f-d98ee3b872f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8d8cb089-e8f0-4878-82c8-2502d27ccc7b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_3409ed9a-fe49-4eaf-848f-d98ee3b872f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_a179e0b9-f3f8-4150-bc70-6136120b1f98" xlink:href="mck-20230331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8d8cb089-e8f0-4878-82c8-2502d27ccc7b" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_a179e0b9-f3f8-4150-bc70-6136120b1f98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_d18bf759-da77-476d-a56e-1782b1ab6164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8d8cb089-e8f0-4878-82c8-2502d27ccc7b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_d18bf759-da77-476d-a56e-1782b1ab6164" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_66a19b83-413c-4a03-921e-0601e0f43d0a" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8d8cb089-e8f0-4878-82c8-2502d27ccc7b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_66a19b83-413c-4a03-921e-0601e0f43d0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_8c1b9372-f076-4678-998c-72461e073f06" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8d8cb089-e8f0-4878-82c8-2502d27ccc7b" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_8c1b9372-f076-4678-998c-72461e073f06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_85cd4123-d57a-43dd-ab2e-75125962e56c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_8d8cb089-e8f0-4878-82c8-2502d27ccc7b" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_85cd4123-d57a-43dd-ab2e-75125962e56c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa0b4c4a-579b-4e5e-9ba7-0c4ef8967f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_98ef56fc-f71d-4147-b250-935ac89622a1" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa0b4c4a-579b-4e5e-9ba7-0c4ef8967f03" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_98ef56fc-f71d-4147-b250-935ac89622a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_dca5f46d-b635-4416-b642-96bea93d798c" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa0b4c4a-579b-4e5e-9ba7-0c4ef8967f03" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_dca5f46d-b635-4416-b642-96bea93d798c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_44495747-cd1b-4c71-897e-a815e7de4bf2" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa0b4c4a-579b-4e5e-9ba7-0c4ef8967f03" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_44495747-cd1b-4c71-897e-a815e7de4bf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_20660002-a916-42a4-8364-23ae29ca7bf1" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa0b4c4a-579b-4e5e-9ba7-0c4ef8967f03" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_20660002-a916-42a4-8364-23ae29ca7bf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_ef2661b0-6b3c-4498-a42d-3a5dede88906" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa0b4c4a-579b-4e5e-9ba7-0c4ef8967f03" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_ef2661b0-6b3c-4498-a42d-3a5dede88906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_02bc49c7-104d-4ac2-976a-2ccbd53245bf" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa0b4c4a-579b-4e5e-9ba7-0c4ef8967f03" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_02bc49c7-104d-4ac2-976a-2ccbd53245bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_d4c16a5b-eaac-4369-9298-250fcc93383e" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa0b4c4a-579b-4e5e-9ba7-0c4ef8967f03" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_d4c16a5b-eaac-4369-9298-250fcc93383e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_7d95ca0a-65cd-4756-a70f-4f5cb71732cd" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_fa0b4c4a-579b-4e5e-9ba7-0c4ef8967f03" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_7d95ca0a-65cd-4756-a70f-4f5cb71732cd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_45f7fecd-e062-44f5-af4c-fddbb43205ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_bdf99fc7-1fb6-42b3-9846-cc2758e58c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_45f7fecd-e062-44f5-af4c-fddbb43205ed" xlink:to="loc_us-gaap_SeveranceCosts1_bdf99fc7-1fb6-42b3-9846-cc2758e58c96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_12481c59-dead-4a1b-99c1-8fd8116c2fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_45f7fecd-e062-44f5-af4c-fddbb43205ed" xlink:to="loc_us-gaap_BusinessExitCosts1_12481c59-dead-4a1b-99c1-8fd8116c2fc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_9293fdb6-ba5a-4474-88d4-60328b6333df" xlink:href="mck-20230331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_45f7fecd-e062-44f5-af4c-fddbb43205ed" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_9293fdb6-ba5a-4474-88d4-60328b6333df" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_11b5c8c9-9653-4053-9ea3-e5faf601498b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c4bedbb0-1a25-4ab1-9913-83800c8581e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_11b5c8c9-9653-4053-9ea3-e5faf601498b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c4bedbb0-1a25-4ab1-9913-83800c8581e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d3b4d12f-5ff5-4c89-87e7-933154290b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_11b5c8c9-9653-4053-9ea3-e5faf601498b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d3b4d12f-5ff5-4c89-87e7-933154290b5b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#OtherIncomeNetScheduleofOtherIncomeNetDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_844da785-c97d-4f2e-8283-64982cccbd32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_163a8708-4cb2-4db8-9c8e-1042028f76fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_844da785-c97d-4f2e-8283-64982cccbd32" xlink:to="loc_us-gaap_InvestmentIncomeInterest_163a8708-4cb2-4db8-9c8e-1042028f76fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cb745ae4-c2d9-4661-8fc7-19f4ab7e7cee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_844da785-c97d-4f2e-8283-64982cccbd32" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cb745ae4-c2d9-4661-8fc7-19f4ab7e7cee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses_487d45c0-83f3-47d5-b8ff-17d0c36ad973" xlink:href="mck-20230331.xsd#mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_844da785-c97d-4f2e-8283-64982cccbd32" xlink:to="loc_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses_487d45c0-83f3-47d5-b8ff-17d0c36ad973" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f5768c07-5a62-4568-a63c-9300ba8d6e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_844da785-c97d-4f2e-8283-64982cccbd32" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f5768c07-5a62-4568-a63c-9300ba8d6e83" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ca73607e-2607-42fd-bbee-ea1fe2f08421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_8e29dce8-b391-4587-b4c1-ba6931e9228b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ca73607e-2607-42fd-bbee-ea1fe2f08421" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_8e29dce8-b391-4587-b4c1-ba6931e9228b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f7bc951f-6aee-4ae7-859f-3d79d1ec40f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ca73607e-2607-42fd-bbee-ea1fe2f08421" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f7bc951f-6aee-4ae7-859f-3d79d1ec40f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3e959f0-b0f7-4b3b-952f-7bae04d279dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_593bfba9-0c58-47f4-b5fe-3218e5a65a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3e959f0-b0f7-4b3b-952f-7bae04d279dd" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_593bfba9-0c58-47f4-b5fe-3218e5a65a5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2a6da4b8-78d5-4ad3-8e20-405df6f83895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3e959f0-b0f7-4b3b-952f-7bae04d279dd" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2a6da4b8-78d5-4ad3-8e20-405df6f83895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_316d533c-e090-49c7-b036-478e8558a5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3e959f0-b0f7-4b3b-952f-7bae04d279dd" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_316d533c-e090-49c7-b036-478e8558a5d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e7fd4cd8-ce4b-4c00-9532-0d539a7d95d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_20f232f7-1c3d-4c9b-8368-1b4a9e0261a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e7fd4cd8-ce4b-4c00-9532-0d539a7d95d2" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_20f232f7-1c3d-4c9b-8368-1b4a9e0261a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3e8985fc-7789-4f92-92af-662930af941a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e7fd4cd8-ce4b-4c00-9532-0d539a7d95d2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3e8985fc-7789-4f92-92af-662930af941a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0455e2ce-999c-4058-be4d-a16c05c3801d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b8943cac-a3dd-48a0-ba3c-a1ef47e084dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0455e2ce-999c-4058-be4d-a16c05c3801d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b8943cac-a3dd-48a0-ba3c-a1ef47e084dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_71eef5e5-7462-41c2-a490-2cddbde97f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0455e2ce-999c-4058-be4d-a16c05c3801d" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_71eef5e5-7462-41c2-a490-2cddbde97f32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_fa131e74-841c-4797-a0c5-2959b1432908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0455e2ce-999c-4058-be4d-a16c05c3801d" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_fa131e74-841c-4797-a0c5-2959b1432908" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1d7aa8b0-af46-4a3c-9754-9f2ac8cc59b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_66118062-f022-405d-8470-b730159d56ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d7aa8b0-af46-4a3c-9754-9f2ac8cc59b3" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_66118062-f022-405d-8470-b730159d56ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_a8e09f8f-a2fa-4966-9e25-ba44879249cc" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d7aa8b0-af46-4a3c-9754-9f2ac8cc59b3" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_a8e09f8f-a2fa-4966-9e25-ba44879249cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_ae829c7d-f0d3-4cfd-955a-f87378a9a14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d7aa8b0-af46-4a3c-9754-9f2ac8cc59b3" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_ae829c7d-f0d3-4cfd-955a-f87378a9a14a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_7f1d2034-8554-4ff9-afdd-c66458a05974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d7aa8b0-af46-4a3c-9754-9f2ac8cc59b3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_7f1d2034-8554-4ff9-afdd-c66458a05974" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_9dfd197d-bff1-4d51-ac37-be71cef82889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d7aa8b0-af46-4a3c-9754-9f2ac8cc59b3" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_9dfd197d-bff1-4d51-ac37-be71cef82889" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_b486dbf0-b7bf-41d4-9a6f-7288a8adc384" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d7aa8b0-af46-4a3c-9754-9f2ac8cc59b3" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_b486dbf0-b7bf-41d4-9a6f-7288a8adc384" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2ec15d4f-a833-4fbd-acf4-a31feaf4e403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d7aa8b0-af46-4a3c-9754-9f2ac8cc59b3" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2ec15d4f-a833-4fbd-acf4-a31feaf4e403" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_9205e44f-2c03-4e76-b2a8-cc847b9fcb5f" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d7aa8b0-af46-4a3c-9754-9f2ac8cc59b3" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_9205e44f-2c03-4e76-b2a8-cc847b9fcb5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_2ae5bd06-974c-4e28-bf01-b2844347117c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1d7aa8b0-af46-4a3c-9754-9f2ac8cc59b3" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_2ae5bd06-974c-4e28-bf01-b2844347117c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesComponentsOfDeferredTaxBalancesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_86797dde-1bec-4571-ad8e-369e98dbc8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_e2270733-cd00-4fd2-89b4-05f0d866fc4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_86797dde-1bec-4571-ad8e-369e98dbc8f2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_e2270733-cd00-4fd2-89b4-05f0d866fc4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1a73fc75-4734-444a-8486-92d1403d991e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_86797dde-1bec-4571-ad8e-369e98dbc8f2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1a73fc75-4734-444a-8486-92d1403d991e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_7177df03-3175-4790-aab4-cfc6094910c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_86797dde-1bec-4571-ad8e-369e98dbc8f2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_7177df03-3175-4790-aab4-cfc6094910c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_f1f8e81b-1b0d-4f3a-91e5-412d7d1b1c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_86797dde-1bec-4571-ad8e-369e98dbc8f2" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_f1f8e81b-1b0d-4f3a-91e5-412d7d1b1c65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_df7ca67a-4ecf-490a-9b91-d4fd212fdd56" xlink:href="mck-20230331.xsd#mck_DeferredTaxLiabilitiesLeaseRightofuseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_86797dde-1bec-4571-ad8e-369e98dbc8f2" xlink:to="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_df7ca67a-4ecf-490a-9b91-d4fd212fdd56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_924f1156-e248-4218-af36-e6bc805448e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_76d09309-3226-4bc2-b9fe-e63a7e2a1271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_924f1156-e248-4218-af36-e6bc805448e1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_76d09309-3226-4bc2-b9fe-e63a7e2a1271" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLitigationAndClaims_fc4b6e10-954d-4fbe-af92-0e17d1391bc5" xlink:href="mck-20230331.xsd#mck_DeferredTaxAssetLitigationAndClaims"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_924f1156-e248-4218-af36-e6bc805448e1" xlink:to="loc_mck_DeferredTaxAssetLitigationAndClaims_fc4b6e10-954d-4fbe-af92-0e17d1391bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_07d40351-82f5-4e9e-b733-92e3bc3f3acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_924f1156-e248-4218-af36-e6bc805448e1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_07d40351-82f5-4e9e-b733-92e3bc3f3acf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5ae13a48-6f20-44cd-9256-b7a9717779a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_924f1156-e248-4218-af36-e6bc805448e1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5ae13a48-6f20-44cd-9256-b7a9717779a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLeaseObligations_665a5955-2da7-430c-85c9-c7d94f0ec534" xlink:href="mck-20230331.xsd#mck_DeferredTaxAssetLeaseObligations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_924f1156-e248-4218-af36-e6bc805448e1" xlink:to="loc_mck_DeferredTaxAssetLeaseObligations_665a5955-2da7-430c-85c9-c7d94f0ec534" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_7968dddd-f840-42a7-ae3a-63c43db726ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_924f1156-e248-4218-af36-e6bc805448e1" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_7968dddd-f840-42a7-ae3a-63c43db726ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e12ef20f-c57e-45f0-a601-d8634edc42bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_fabb98e0-075e-4b76-a097-369ce4ddc831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e12ef20f-c57e-45f0-a601-d8634edc42bc" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_fabb98e0-075e-4b76-a097-369ce4ddc831" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c75137f9-0f31-4fa5-aa85-2fd9a4c0cc72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e12ef20f-c57e-45f0-a601-d8634edc42bc" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c75137f9-0f31-4fa5-aa85-2fd9a4c0cc72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_82446f6d-1e72-48a8-99e8-d22fd0c70e20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5afe330d-a4c9-4f60-84ac-8232402fdd05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_82446f6d-1e72-48a8-99e8-d22fd0c70e20" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5afe330d-a4c9-4f60-84ac-8232402fdd05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_eacd5129-ef63-4545-adab-2d29762eb81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_82446f6d-1e72-48a8-99e8-d22fd0c70e20" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_eacd5129-ef63-4545-adab-2d29762eb81f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_299dce96-65c0-4e2c-98f6-ad3cdb6aaef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e7828eca-f0c3-4cf9-abf8-b3ff73e84252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_299dce96-65c0-4e2c-98f6-ad3cdb6aaef1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e7828eca-f0c3-4cf9-abf8-b3ff73e84252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_173cd144-bfcb-4fad-9b35-83c811c67d55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_299dce96-65c0-4e2c-98f6-ad3cdb6aaef1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_173cd144-bfcb-4fad-9b35-83c811c67d55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a7196e0-8d84-4ddc-8fc6-3cc6236519ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_24736760-7a9b-45b3-8a22-ead19ba6fea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a7196e0-8d84-4ddc-8fc6-3cc6236519ef" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_24736760-7a9b-45b3-8a22-ead19ba6fea0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8f798868-2f6d-47ac-81f0-f8ee5f0b6110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a7196e0-8d84-4ddc-8fc6-3cc6236519ef" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8f798868-2f6d-47ac-81f0-f8ee5f0b6110" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6febfba1-df5f-4007-a8cc-52536e546b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_478f41e9-d484-482e-bbb2-15744c5bc73a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6febfba1-df5f-4007-a8cc-52536e546b5c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_478f41e9-d484-482e-bbb2-15744c5bc73a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e9541b8a-5c9b-4381-aee1-c07f35e14e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6febfba1-df5f-4007-a8cc-52536e546b5c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e9541b8a-5c9b-4381-aee1-c07f35e14e54" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_40176e7c-6251-441e-b80d-7e15ab9d5ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_74453818-beeb-40e7-bfa8-503b1b8b4238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_40176e7c-6251-441e-b80d-7e15ab9d5ac3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_74453818-beeb-40e7-bfa8-503b1b8b4238" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f5630b04-0331-47d7-bdbe-585e300dbafc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_40176e7c-6251-441e-b80d-7e15ab9d5ac3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_f5630b04-0331-47d7-bdbe-585e300dbafc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_907d4067-1484-47a7-9512-53b1e1ea0070" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8711c001-4f06-42da-918e-22571a205298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_907d4067-1484-47a7-9512-53b1e1ea0070" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8711c001-4f06-42da-918e-22571a205298" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_57784fa8-82b0-4859-b26f-d284ac416b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_907d4067-1484-47a7-9512-53b1e1ea0070" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_57784fa8-82b0-4859-b26f-d284ac416b35" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesComponentsofLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost_9e6abc28-f24e-4b06-8abf-628417c39b8f" xlink:href="mck-20230331.xsd#mck_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b3b7a4d5-b970-4d5a-8297-ea2f55dc894e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_FinanceLeaseCost_9e6abc28-f24e-4b06-8abf-628417c39b8f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b3b7a4d5-b970-4d5a-8297-ea2f55dc894e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_79ba1d0f-0426-412e-865e-1b5973eda2df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_FinanceLeaseCost_9e6abc28-f24e-4b06-8abf-628417c39b8f" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_79ba1d0f-0426-412e-865e-1b5973eda2df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_ba69335c-115e-49d7-ac77-f6beffbea422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_df973ab5-26bf-4514-a313-ef796003e714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ba69335c-115e-49d7-ac77-f6beffbea422" xlink:to="loc_us-gaap_ShortTermLeaseCost_df973ab5-26bf-4514-a313-ef796003e714" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_1e17e028-676a-4fec-bfc4-2a040e6d9367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ba69335c-115e-49d7-ac77-f6beffbea422" xlink:to="loc_us-gaap_OperatingLeaseCost_1e17e028-676a-4fec-bfc4-2a040e6d9367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost_674c9051-221f-4e42-9828-73e188034718" xlink:href="mck-20230331.xsd#mck_FinanceLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ba69335c-115e-49d7-ac77-f6beffbea422" xlink:to="loc_mck_FinanceLeaseCost_674c9051-221f-4e42-9828-73e188034718" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_9f6ab5b4-7ef4-438e-9826-d6f9e3ab7d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ba69335c-115e-49d7-ac77-f6beffbea422" xlink:to="loc_us-gaap_VariableLeaseCost_9f6ab5b4-7ef4-438e-9826-d6f9e3ab7d63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_941c4945-55c6-4c5a-9b88-696353cef5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ba69335c-115e-49d7-ac77-f6beffbea422" xlink:to="loc_us-gaap_SubleaseIncome_941c4945-55c6-4c5a-9b88-696353cef5fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount_77784288-5c9a-47dd-aa2a-610733fcebad" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_462f5fdf-c16f-4083-ad00-01ba7a452594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityUndiscountedExcessAmount_77784288-5c9a-47dd-aa2a-610733fcebad" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_462f5fdf-c16f-4083-ad00-01ba7a452594" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_81a9657c-138a-495c-9c47-154c768a0a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityUndiscountedExcessAmount_77784288-5c9a-47dd-aa2a-610733fcebad" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_81a9657c-138a-495c-9c47-154c768a0a16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_450a5e2f-4215-47da-8d4c-7e0c67679377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d28ec41d-8876-4cf0-b64a-ba5590bae4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_450a5e2f-4215-47da-8d4c-7e0c67679377" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d28ec41d-8876-4cf0-b64a-ba5590bae4cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_95198b8e-c4d8-461e-9862-e877970bc82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_450a5e2f-4215-47da-8d4c-7e0c67679377" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_95198b8e-c4d8-461e-9862-e877970bc82a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_945283ab-ad22-4d3a-93f1-b5a7d919ad88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_450a5e2f-4215-47da-8d4c-7e0c67679377" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_945283ab-ad22-4d3a-93f1-b5a7d919ad88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4f8b9a2b-94f8-4b9e-91b8-0e8bc0cb441d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_450a5e2f-4215-47da-8d4c-7e0c67679377" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4f8b9a2b-94f8-4b9e-91b8-0e8bc0cb441d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b5b808c6-f31f-4e17-967b-9fcba5ec88f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_450a5e2f-4215-47da-8d4c-7e0c67679377" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b5b808c6-f31f-4e17-967b-9fcba5ec88f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_529ad635-b220-45be-aa7b-56524f2cf61f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_450a5e2f-4215-47da-8d4c-7e0c67679377" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_529ad635-b220-45be-aa7b-56524f2cf61f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_bd539c72-204a-4e01-b2e7-960d4222dba8" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_867f549d-621a-4ebe-aa06-bb623648d6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_bd539c72-204a-4e01-b2e7-960d4222dba8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_867f549d-621a-4ebe-aa06-bb623648d6d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3385c733-b62e-4a1f-8c70-cd14a1258f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_bd539c72-204a-4e01-b2e7-960d4222dba8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3385c733-b62e-4a1f-8c70-cd14a1258f8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_0d30f168-d2d6-4243-bba6-ba0da44382fc" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_88fc26f6-323b-4aec-a1c1-2203914b205c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_0d30f168-d2d6-4243-bba6-ba0da44382fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_88fc26f6-323b-4aec-a1c1-2203914b205c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_b79bd19f-b92e-4179-a6eb-c05f36f0aa3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_0d30f168-d2d6-4243-bba6-ba0da44382fc" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_b79bd19f-b92e-4179-a6eb-c05f36f0aa3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo_c6951b57-63d4-42ff-aedf-d896f397a183" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_499f53c3-afc5-4390-91eb-e108d0ca4fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearTwo_c6951b57-63d4-42ff-aedf-d896f397a183" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_499f53c3-afc5-4390-91eb-e108d0ca4fe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_53a15b8e-822a-4e2f-a880-e5a3a0cc62f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearTwo_c6951b57-63d4-42ff-aedf-d896f397a183" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_53a15b8e-822a-4e2f-a880-e5a3a0cc62f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d7cf3ee-6067-4e90-b60b-10c6cd095d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_5942f48d-528b-4399-b4d9-6c1e12d371f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d7cf3ee-6067-4e90-b60b-10c6cd095d97" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_5942f48d-528b-4399-b4d9-6c1e12d371f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_dabc4615-5a14-4186-86df-db3dd9dc5138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d7cf3ee-6067-4e90-b60b-10c6cd095d97" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_dabc4615-5a14-4186-86df-db3dd9dc5138" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_6fbe0a5b-3343-4b9e-8f11-732be29d61f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d7cf3ee-6067-4e90-b60b-10c6cd095d97" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_6fbe0a5b-3343-4b9e-8f11-732be29d61f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4a3d9dd3-db00-45c1-89e2-ca69e2e4a4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d7cf3ee-6067-4e90-b60b-10c6cd095d97" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4a3d9dd3-db00-45c1-89e2-ca69e2e4a4cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6d062aca-51fe-455b-8177-92b16723a8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d7cf3ee-6067-4e90-b60b-10c6cd095d97" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_6d062aca-51fe-455b-8177-92b16723a8a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_4d635932-1b42-4cf6-be34-f2f004b02e03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6d7cf3ee-6067-4e90-b60b-10c6cd095d97" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_4d635932-1b42-4cf6-be34-f2f004b02e03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour_62a301b0-1760-4af4-ab85-15edc43796cd" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9621a340-482c-4af4-b42a-702854eb33f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFour_62a301b0-1760-4af4-ab85-15edc43796cd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9621a340-482c-4af4-b42a-702854eb33f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_dd36fb7d-11a4-4539-aa14-66520117f9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFour_62a301b0-1760-4af4-ab85-15edc43796cd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_dd36fb7d-11a4-4539-aa14-66520117f9e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_ba7aee42-21b8-4278-9014-4839a09f17e7" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9ecc2f47-5a0f-4417-9456-05c5682f44a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_ba7aee42-21b8-4278-9014-4839a09f17e7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9ecc2f47-5a0f-4417-9456-05c5682f44a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_09752235-e1aa-44c0-b1e5-c4ee1e7e6a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_ba7aee42-21b8-4278-9014-4839a09f17e7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_09752235-e1aa-44c0-b1e5-c4ee1e7e6a3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive_48456d0d-711b-4168-a8a5-b5f0e190cee9" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e219ed12-983b-42ee-9cc5-a6b3513dec7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFive_48456d0d-711b-4168-a8a5-b5f0e190cee9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e219ed12-983b-42ee-9cc5-a6b3513dec7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1bc0e088-4a33-4c65-9533-f64037850fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFive_48456d0d-711b-4168-a8a5-b5f0e190cee9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_1bc0e088-4a33-4c65-9533-f64037850fb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability_e8e90cc8-c760-4ef7-95eb-e18479a61cc7" xlink:href="mck-20230331.xsd#mck_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_305fc07d-a256-40b5-8ec3-c48633ae76fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiability_e8e90cc8-c760-4ef7-95eb-e18479a61cc7" xlink:to="loc_us-gaap_OperatingLeaseLiability_305fc07d-a256-40b5-8ec3-c48633ae76fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_1e306851-2ca2-42ca-bef5-ba68baabf70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiability_e8e90cc8-c760-4ef7-95eb-e18479a61cc7" xlink:to="loc_us-gaap_FinanceLeaseLiability_1e306851-2ca2-42ca-bef5-ba68baabf70c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree_3595b2b3-8e3a-4049-9841-d30d109d1e7b" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3c645e19-88a6-46a3-b920-2e795e649526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearThree_3595b2b3-8e3a-4049-9841-d30d109d1e7b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3c645e19-88a6-46a3-b920-2e795e649526" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_11b5bf61-5ea2-45b3-a835-85c3910271cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearThree_3595b2b3-8e3a-4049-9841-d30d109d1e7b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_11b5bf61-5ea2-45b3-a835-85c3910271cb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_afd21ec4-b771-4302-ace7-58575669758f" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_61e111b3-ced9-409e-8a3f-4ed567bb3b6d" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_afd21ec4-b771-4302-ace7-58575669758f" xlink:to="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_61e111b3-ced9-409e-8a3f-4ed567bb3b6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo_82ebe0c8-b321-4df8-b043-861e9c7df94f" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_afd21ec4-b771-4302-ace7-58575669758f" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearTwo_82ebe0c8-b321-4df8-b043-861e9c7df94f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree_0351a871-f433-40b8-99f4-20f8f3fbaf24" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_afd21ec4-b771-4302-ace7-58575669758f" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearThree_0351a871-f433-40b8-99f4-20f8f3fbaf24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour_a3f58f47-a41f-4014-8a69-cab8dbb7ff83" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_afd21ec4-b771-4302-ace7-58575669758f" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFour_a3f58f47-a41f-4014-8a69-cab8dbb7ff83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive_e9b3d7ed-c467-4520-9447-26c9585a9c64" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_afd21ec4-b771-4302-ace7-58575669758f" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFive_e9b3d7ed-c467-4520-9447-26c9585a9c64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_df57e03d-1e11-4382-bf4c-1d4fa17992e2" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_afd21ec4-b771-4302-ace7-58575669758f" xlink:to="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_df57e03d-1e11-4382-bf4c-1d4fa17992e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_7ad62f96-37a6-4ce0-80f6-8343bf5f8b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c4754276-cf77-43ae-862c-3bd6ad69c3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_7ad62f96-37a6-4ce0-80f6-8343bf5f8b45" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c4754276-cf77-43ae-862c-3bd6ad69c3ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_26d517af-0602-463b-b29a-f3fdd8437d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_7ad62f96-37a6-4ce0-80f6-8343bf5f8b45" xlink:to="loc_us-gaap_FinanceLeaseLiability_26d517af-0602-463b-b29a-f3fdd8437d94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_55be44b0-5820-49af-bdd6-374c25ba472e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b90c9684-876e-43aa-955f-ea4f1fbf1120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_55be44b0-5820-49af-bdd6-374c25ba472e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b90c9684-876e-43aa-955f-ea4f1fbf1120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8e74c8eb-5bd8-4f37-8a0c-0d898776bc00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_55be44b0-5820-49af-bdd6-374c25ba472e" xlink:to="loc_us-gaap_OperatingLeaseLiability_8e74c8eb-5bd8-4f37-8a0c-0d898776bc00" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_2"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_9cfcf701-6fa6-4d83-8dbf-627ba6547a97" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount_246335ee-4c2c-475c-af88-ca7d5368ae0e" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_9cfcf701-6fa6-4d83-8dbf-627ba6547a97" xlink:to="loc_mck_LeaseLiabilityUndiscountedExcessAmount_246335ee-4c2c-475c-af88-ca7d5368ae0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability_4a5cf312-4fad-425f-a843-75c4d24d0c2c" xlink:href="mck-20230331.xsd#mck_LeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mck_LeaseLiabilityPaymentsDue_9cfcf701-6fa6-4d83-8dbf-627ba6547a97" xlink:to="loc_mck_LeaseLiability_4a5cf312-4fad-425f-a843-75c4d24d0c2c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c50450fe-3caf-4d09-9f42-592ceb737781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_badb18cb-1822-4201-b77e-3d77f4a56678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c50450fe-3caf-4d09-9f42-592ceb737781" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_badb18cb-1822-4201-b77e-3d77f4a56678" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_504dec70-02f0-4a96-94ad-29994d2af0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c50450fe-3caf-4d09-9f42-592ceb737781" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_504dec70-02f0-4a96-94ad-29994d2af0f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6580ef38-145e-4f62-9cef-4ab680704e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_868aa843-2af3-43ca-8ec0-c8592ca8358a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6580ef38-145e-4f62-9cef-4ab680704e28" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_868aa843-2af3-43ca-8ec0-c8592ca8358a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_e81df6e5-b5a4-41b1-a210-e2ae0da7c576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_6580ef38-145e-4f62-9cef-4ab680704e28" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_e81df6e5-b5a4-41b1-a210-e2ae0da7c576" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f0f59336-5cc3-4556-9ba1-d4feab622190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_282b04fa-71a8-484f-b056-15504282fb95" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f0f59336-5cc3-4556-9ba1-d4feab622190" xlink:to="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_282b04fa-71a8-484f-b056-15504282fb95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_dcbbc303-a188-4aa6-841c-cf1dec0eafd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f0f59336-5cc3-4556-9ba1-d4feab622190" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_dcbbc303-a188-4aa6-841c-cf1dec0eafd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_12f27b81-7a22-4dab-877b-fb28e54b9244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f0f59336-5cc3-4556-9ba1-d4feab622190" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_12f27b81-7a22-4dab-877b-fb28e54b9244" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_88128395-aa76-4102-90e7-eff3c4d5f4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f0f59336-5cc3-4556-9ba1-d4feab622190" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_88128395-aa76-4102-90e7-eff3c4d5f4eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_177f83b0-85cf-4698-a8e8-39b625b73bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f0f59336-5cc3-4556-9ba1-d4feab622190" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_177f83b0-85cf-4698-a8e8-39b625b73bdb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_c84ad8d0-7add-4d29-b192-22c6a743cdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_244fea9c-bd7d-4298-ba48-31e350cd4604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_c84ad8d0-7add-4d29-b192-22c6a743cdf0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_244fea9c-bd7d-4298-ba48-31e350cd4604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_1869b2c5-3db7-4ee1-a659-c71b8a278e93" xlink:href="mck-20230331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_c84ad8d0-7add-4d29-b192-22c6a743cdf0" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_1869b2c5-3db7-4ee1-a659-c71b8a278e93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_08c2bfde-b4a6-4c51-ac07-d7ce8140c363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_c84ad8d0-7add-4d29-b192-22c6a743cdf0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_08c2bfde-b4a6-4c51-ac07-d7ce8140c363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_a92209b6-c8ce-495b-b15d-0923d3cdd6ae" xlink:href="mck-20230331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_c84ad8d0-7add-4d29-b192-22c6a743cdf0" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_a92209b6-c8ce-495b-b15d-0923d3cdd6ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_c1297c84-360c-4a42-9153-d7c6d78a438a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_67bb56e9-294a-413a-bc61-e006020ac2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_c1297c84-360c-4a42-9153-d7c6d78a438a" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_67bb56e9-294a-413a-bc61-e006020ac2e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bcc1054e-afbe-4102-8a0d-1096d7a62d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_c1297c84-360c-4a42-9153-d7c6d78a438a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bcc1054e-afbe-4102-8a0d-1096d7a62d75" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_f5a5da24-e688-4f89-9b6a-c5004ed97f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_c329be4c-0216-4dfd-af84-4f6219990aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_f5a5da24-e688-4f89-9b6a-c5004ed97f08" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_c329be4c-0216-4dfd-af84-4f6219990aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_bf616b36-f110-4aed-ac76-6c0ac54a5946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_f5a5da24-e688-4f89-9b6a-c5004ed97f08" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_bf616b36-f110-4aed-ac76-6c0ac54a5946" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e0aa7b57-a58d-4105-acb3-0563807f1650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_242b9919-fa7d-4214-8741-53755ad5be5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e0aa7b57-a58d-4105-acb3-0563807f1650" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_242b9919-fa7d-4214-8741-53755ad5be5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_f0ac0b39-0e34-4901-ba3d-48e470db4cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e0aa7b57-a58d-4105-acb3-0563807f1650" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_f0ac0b39-0e34-4901-ba3d-48e470db4cde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_0150baed-4f82-4be6-8621-faf47b155cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e0aa7b57-a58d-4105-acb3-0563807f1650" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_0150baed-4f82-4be6-8621-faf47b155cb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_51ed70aa-ef2c-45c4-8340-a1986e94af10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e0aa7b57-a58d-4105-acb3-0563807f1650" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_51ed70aa-ef2c-45c4-8340-a1986e94af10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_ff149bca-2ada-4c00-a05a-86b748daa227" xlink:href="mck-20230331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_e0aa7b57-a58d-4105-acb3-0563807f1650" xlink:to="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_ff149bca-2ada-4c00-a05a-86b748daa227" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d3761f8c-273f-4e13-b477-666406295529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_99752302-ca83-4b90-8306-3f4addb0c2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d3761f8c-273f-4e13-b477-666406295529" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_99752302-ca83-4b90-8306-3f4addb0c2e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_df61b4f1-07fb-46ee-9893-23d8ee8a1e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_d3761f8c-273f-4e13-b477-666406295529" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_df61b4f1-07fb-46ee-9893-23d8ee8a1e55" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15ce3446-05f0-45ec-adf9-bf9faf8801b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c26a8e6f-45ad-4aa6-ac74-029ac11c2fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15ce3446-05f0-45ec-adf9-bf9faf8801b2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c26a8e6f-45ad-4aa6-ac74-029ac11c2fc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c54cd4d6-4e58-4fa6-b653-cfc2ef2ca89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15ce3446-05f0-45ec-adf9-bf9faf8801b2" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c54cd4d6-4e58-4fa6-b653-cfc2ef2ca89f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_533d8e56-900c-4d17-a7ed-d4a5fbbc7507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a6e874ec-ecd9-45c0-8c34-db586238a233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_533d8e56-900c-4d17-a7ed-d4a5fbbc7507" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a6e874ec-ecd9-45c0-8c34-db586238a233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_61fb932a-1070-4159-aab8-ffd7008c8aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_533d8e56-900c-4d17-a7ed-d4a5fbbc7507" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_61fb932a-1070-4159-aab8-ffd7008c8aaa" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>mck-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1eea9b32-7227-4c4c-b033-5c353ea41e5b,g:3de8d065-e076-4ee0-8f0c-2df01cc3ca1e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20230331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended" id="i409d57aeda04462da21de3ca3cc41c5c_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4035fa61-e677-4b67-b3b4-09ab5ed56801" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentType_4035fa61-e677-4b67-b3b4-09ab5ed56801" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_2ffb8436-f2ee-4bb6-baaa-d6f33f3e362f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentAnnualReport_2ffb8436-f2ee-4bb6-baaa-d6f33f3e362f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f3033b66-f638-4110-bc1c-d98144246969" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentPeriodEndDate_f3033b66-f638-4110-bc1c-d98144246969" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4a75515b-9072-4e09-99e7-27e4be29ae32" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_CurrentFiscalYearEndDate_4a75515b-9072-4e09-99e7-27e4be29ae32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_48f0b1a8-0009-4eb5-97bc-58cb1d6a9a5a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentTransitionReport_48f0b1a8-0009-4eb5-97bc-58cb1d6a9a5a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_580f4bc7-8482-43c0-a536-6040d6497add" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityFileNumber_580f4bc7-8482-43c0-a536-6040d6497add" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2256ff9f-95cf-4e98-9fd0-57489fbc896d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityRegistrantName_2256ff9f-95cf-4e98-9fd0-57489fbc896d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7771a1fe-ecfd-4ca1-baf0-1b2033de5327" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7771a1fe-ecfd-4ca1-baf0-1b2033de5327" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_cad67c1d-3a2b-4ede-8044-4fd5e6062554" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityTaxIdentificationNumber_cad67c1d-3a2b-4ede-8044-4fd5e6062554" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bc6e73f6-3715-49ab-ab71-acb558f43db6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityAddressAddressLine1_bc6e73f6-3715-49ab-ab71-acb558f43db6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e5f4fb25-48cc-4029-b8f5-77dc74fbfdc8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityAddressCityOrTown_e5f4fb25-48cc-4029-b8f5-77dc74fbfdc8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a71cfd1f-5f2b-4310-817d-af66ebfea3b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityAddressStateOrProvince_a71cfd1f-5f2b-4310-817d-af66ebfea3b1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a369e87c-1da5-46b1-ba51-c229e6495350" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityAddressPostalZipCode_a369e87c-1da5-46b1-ba51-c229e6495350" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a5b1f3d5-6097-4ad4-b0f3-3f8684b443b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_CityAreaCode_a5b1f3d5-6097-4ad4-b0f3-3f8684b443b2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_19778895-555b-45a0-9d69-ece01a465c28" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_LocalPhoneNumber_19778895-555b-45a0-9d69-ece01a465c28" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b6e20d5a-de07-4976-883a-5669ea57df94" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_Security12bTitle_b6e20d5a-de07-4976-883a-5669ea57df94" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4aa4d831-8bf6-478c-a737-83eda5837f2b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_TradingSymbol_4aa4d831-8bf6-478c-a737-83eda5837f2b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_153660a9-f511-4fe7-8a32-806165353608" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_SecurityExchangeName_153660a9-f511-4fe7-8a32-806165353608" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_3530ecfd-7e8a-407f-9528-35d289a12924" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_3530ecfd-7e8a-407f-9528-35d289a12924" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_c93a9cf9-c113-434f-aea5-1757ebe1620f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityVoluntaryFilers_c93a9cf9-c113-434f-aea5-1757ebe1620f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6c4772cc-278d-4729-9032-66c7747f254c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityCurrentReportingStatus_6c4772cc-278d-4729-9032-66c7747f254c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9be70cec-bfe1-4dea-ada7-54481d1ef18b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityInteractiveDataCurrent_9be70cec-bfe1-4dea-ada7-54481d1ef18b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_3e2e5d48-751f-4aac-95a6-ea59ae08a0e6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityFilerCategory_3e2e5d48-751f-4aac-95a6-ea59ae08a0e6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f5db3b4c-78c7-445c-ad10-7ed56760a74f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntitySmallBusiness_f5db3b4c-78c7-445c-ad10-7ed56760a74f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_2b65063a-535b-43b9-8d39-f97232dca689" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityEmergingGrowthCompany_2b65063a-535b-43b9-8d39-f97232dca689" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_718f042e-6a14-4cf9-b77d-5126eeb64ac0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_IcfrAuditorAttestationFlag_718f042e-6a14-4cf9-b77d-5126eeb64ac0" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_0ac3c77c-06eb-41db-b165-34d8e50fd32f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityShellCompany_0ac3c77c-06eb-41db-b165-34d8e50fd32f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_75b0b9b0-6bda-4f15-a7e9-ec7a74ba0336" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityPublicFloat_75b0b9b0-6bda-4f15-a7e9-ec7a74ba0336" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2df08074-0b91-43e3-b1a7-018676dcfe11" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2df08074-0b91-43e3-b1a7-018676dcfe11" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_2f1ef158-1ba1-4af4-bf90-de07fce86fd0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_2f1ef158-1ba1-4af4-bf90-de07fce86fd0" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_55e7b67d-be31-40d5-a981-6368ec3316e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityCentralIndexKey_55e7b67d-be31-40d5-a981-6368ec3316e2" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_185c1b22-1286-4701-b109-600977874c7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_185c1b22-1286-4701-b109-600977874c7a" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_68d307d4-6c03-4995-8047-976bcbabafa2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentFiscalYearFocus_68d307d4-6c03-4995-8047-976bcbabafa2" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_998b8780-da79-4f29-be4f-5e7906f47a68" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_AmendmentFlag_998b8780-da79-4f29-be4f-5e7906f47a68" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_bd0bb557-e128-4624-a6b1-f3a22a83be46" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntitiesTable_bd0bb557-e128-4624-a6b1-f3a22a83be46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0a5f6628-9718-4086-9e41-176883b440a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_bd0bb557-e128-4624-a6b1-f3a22a83be46" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0a5f6628-9718-4086-9e41-176883b440a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0a5f6628-9718-4086-9e41-176883b440a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0a5f6628-9718-4086-9e41-176883b440a1" xlink:to="loc_us-gaap_ClassOfStockDomain_0a5f6628-9718-4086-9e41-176883b440a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0a5f6628-9718-4086-9e41-176883b440a1" xlink:to="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7d893635-43d5-4732-b267-e16ee1207e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:to="loc_us-gaap_CommonStockMember_7d893635-43d5-4732-b267-e16ee1207e02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.500NotesDue2025Member_9a951edc-1ad8-4279-88ad-56366cfccc9d" xlink:href="mck-20230331.xsd#mck_A1.500NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:to="loc_mck_A1.500NotesDue2025Member_9a951edc-1ad8-4279-88ad-56366cfccc9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.625NotesDue2026Member_190d0389-d164-4909-b3b1-5128d3e38fd6" xlink:href="mck-20230331.xsd#mck_A1.625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:to="loc_mck_A1.625NotesDue2026Member_190d0389-d164-4909-b3b1-5128d3e38fd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3.125NotesDue2029Member_a682ae3a-ceed-4f7a-b805-c73966762ee4" xlink:href="mck-20230331.xsd#mck_A3.125NotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:to="loc_mck_A3.125NotesDue2029Member_a682ae3a-ceed-4f7a-b805-c73966762ee4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i14db094772224381b2686ba9164f072c_CONSOLIDATEDBALANCESHEETSParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5716aec5-c3f1-4391-9b6a-1a8c817fcc2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5716aec5-c3f1-4391-9b6a-1a8c817fcc2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_c6eba1fc-734a-424c-9682-1c0a2e667fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_c6eba1fc-734a-424c-9682-1c0a2e667fa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_2c28b02e-11b2-4b89-ad21-c21fdf436c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_PreferredStockSharesIssued_2c28b02e-11b2-4b89-ad21-c21fdf436c77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_87f6fc06-1587-4f1b-a3ca-d587ba6cd503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_87f6fc06-1587-4f1b-a3ca-d587ba6cd503" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a417599a-764e-49ef-8549-2111cc71fd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a417599a-764e-49ef-8549-2111cc71fd15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5f8a7423-7ace-4616-b50a-837efd0f6a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5f8a7423-7ace-4616-b50a-837efd0f6a95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4e4ee3cb-1d3f-464a-8ce0-c5088253548d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_CommonStockSharesIssued_4e4ee3cb-1d3f-464a-8ce0-c5088253548d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_8bb97fe7-cb51-40ff-bc5e-46a640386071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_TreasuryStockCommonShares_8bb97fe7-cb51-40ff-bc5e-46a640386071" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4d05a3c3-4917-4320-81ba-1dcf1fe9d649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_StatementTable_4d05a3c3-4917-4320-81ba-1dcf1fe9d649" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e5411619-4414-4b6a-98bf-e1900085443e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4d05a3c3-4917-4320-81ba-1dcf1fe9d649" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e5411619-4414-4b6a-98bf-e1900085443e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e5411619-4414-4b6a-98bf-e1900085443e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e5411619-4414-4b6a-98bf-e1900085443e" xlink:to="loc_us-gaap_EquityComponentDomain_e5411619-4414-4b6a-98bf-e1900085443e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_015c4c3f-c161-43e2-a53e-c496d53b19bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e5411619-4414-4b6a-98bf-e1900085443e" xlink:to="loc_us-gaap_EquityComponentDomain_015c4c3f-c161-43e2-a53e-c496d53b19bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_99b5ec42-0d48-46f0-8e60-4f00295e3e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_015c4c3f-c161-43e2-a53e-c496d53b19bb" xlink:to="loc_us-gaap_TreasuryStockCommonMember_99b5ec42-0d48-46f0-8e60-4f00295e3e18" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="i08bb125b280b4da1a7e251c55e9de728_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d064fd75-da1d-4215-a93a-829bf508f58e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d064fd75-da1d-4215-a93a-829bf508f58e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5a8c7184-5f86-466e-b101-85abb3a33afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_SharesOutstanding_5a8c7184-5f86-466e-b101-85abb3a33afc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_f7acf3f9-b472-48a2-9eeb-e97484773fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_TreasuryStockCommonShares_f7acf3f9-b472-48a2-9eeb-e97484773fb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc241ff7-38b1-492f-8c8a-0ad8a5634a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc241ff7-38b1-492f-8c8a-0ad8a5634a8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures_2c0fcbee-2419-4e8a-a341-1a82efb433d5" xlink:href="mck-20230331.xsd#mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures_2c0fcbee-2419-4e8a-a341-1a82efb433d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures_bf3f8d49-9864-4774-b669-f16d6897d63f" xlink:href="mck-20230331.xsd#mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures_bf3f8d49-9864-4774-b669-f16d6897d63f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2eb05c17-11e6-444e-bc92-9794304e0b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2eb05c17-11e6-444e-bc92-9794304e0b25" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_c0100a1e-416f-4abf-b4a1-c18fd2575d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_c0100a1e-416f-4abf-b4a1-c18fd2575d66" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_fd5b8e06-66fe-45b3-87f8-982680b8e168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_fd5b8e06-66fe-45b3-87f8-982680b8e168" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_fc1f6423-27b5-4725-a62d-e3135cc65d72" xlink:href="mck-20230331.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_fc1f6423-27b5-4725-a62d-e3135cc65d72" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4b7b49d8-6c28-45f6-b48e-e662005eb1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4b7b49d8-6c28-45f6-b48e-e662005eb1cd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_45df1eea-5185-48f0-a674-217e99242371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_DividendsCommonStockCash_45df1eea-5185-48f0-a674-217e99242371" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_5d879589-5013-4117-89d2-9834045b7702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_5d879589-5013-4117-89d2-9834045b7702" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_c87d5c0e-200a-4148-92ea-e2b0dd2bcd2f" xlink:href="mck-20230331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_c87d5c0e-200a-4148-92ea-e2b0dd2bcd2f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_a303a3e1-764f-493e-a26d-f9e8e247c741" xlink:href="mck-20230331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_a303a3e1-764f-493e-a26d-f9e8e247c741" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_ed0714e3-9ab9-4ab1-9c00-88c4ffa054ac" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_ed0714e3-9ab9-4ab1-9c00-88c4ffa054ac" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FormationOfBusiness_83ae2f9a-3ee3-491c-9d28-c2136acfe545" xlink:href="mck-20230331.xsd#mck_FormationOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_FormationOfBusiness_83ae2f9a-3ee3-491c-9d28-c2136acfe545" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DerecognitionOfNoncontrollingInterests_75601163-1685-4f4f-9569-7bbb51ae46f6" xlink:href="mck-20230331.xsd#mck_DerecognitionOfNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_DerecognitionOfNoncontrollingInterests_75601163-1685-4f4f-9569-7bbb51ae46f6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_88d995bd-c68d-4dc1-8fad-24b55eb709eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_StockholdersEquityOther_88d995bd-c68d-4dc1-8fad-24b55eb709eb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_c68206f9-5aa5-49b6-82ef-fe30dacf1ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_d97172fc-46cc-47a4-8cc0-c54299c20656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_253697da-7be8-4d7b-bfcc-4c1d87efdfb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5ee1dec8-05f2-4203-a2dc-1405db21abb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d064fd75-da1d-4215-a93a-829bf508f58e" xlink:to="loc_us-gaap_StatementTable_5ee1dec8-05f2-4203-a2dc-1405db21abb1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5bc0383f-6ddd-4fa2-9fc8-04e3a69fa15d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5ee1dec8-05f2-4203-a2dc-1405db21abb1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5bc0383f-6ddd-4fa2-9fc8-04e3a69fa15d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5bc0383f-6ddd-4fa2-9fc8-04e3a69fa15d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5bc0383f-6ddd-4fa2-9fc8-04e3a69fa15d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5bc0383f-6ddd-4fa2-9fc8-04e3a69fa15d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_05e2b321-1531-4035-8ebd-99a12078932b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5bc0383f-6ddd-4fa2-9fc8-04e3a69fa15d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_05e2b321-1531-4035-8ebd-99a12078932b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e672ddfb-7005-4ac0-b9f1-e1fa645f212a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_05e2b321-1531-4035-8ebd-99a12078932b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e672ddfb-7005-4ac0-b9f1-e1fa645f212a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_7179d315-5064-4a1e-9b19-ac46a4f3dc9c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_05e2b321-1531-4035-8ebd-99a12078932b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_7179d315-5064-4a1e-9b19-ac46a4f3dc9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9cecddcc-6d3c-4343-bc22-a8cb85037545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5ee1dec8-05f2-4203-a2dc-1405db21abb1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9cecddcc-6d3c-4343-bc22-a8cb85037545" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9cecddcc-6d3c-4343-bc22-a8cb85037545_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cecddcc-6d3c-4343-bc22-a8cb85037545" xlink:to="loc_us-gaap_EquityComponentDomain_9cecddcc-6d3c-4343-bc22-a8cb85037545_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cecddcc-6d3c-4343-bc22-a8cb85037545" xlink:to="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_87ba05b8-c367-4dd7-a778-a22d893db28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_CommonStockMember_87ba05b8-c367-4dd7-a778-a22d893db28f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c4259a2f-9208-488f-b398-2ace246e471d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c4259a2f-9208-488f-b398-2ace246e471d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3c36a4ee-6a44-4cd5-92a1-8ab655d52346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_RetainedEarningsMember_3c36a4ee-6a44-4cd5-92a1-8ab655d52346" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d8a7ca25-e03c-4a7b-801a-222faa305d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d8a7ca25-e03c-4a7b-801a-222faa305d3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_fed664e0-7368-4685-9b41-5a27f5eb9ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_TreasuryStockCommonMember_fed664e0-7368-4685-9b41-5a27f5eb9ac5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_fd6c69d6-e7f4-4b9e-8ee3-b796bd44274e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_NoncontrollingInterestMember_fd6c69d6-e7f4-4b9e-8ee3-b796bd44274e" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended" id="iaf89be752e9e4302a0c1b7637559772e_SignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_76ba45f9-47a0-45b5-965c-8ea30f6b8b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_NumberOfReportableSegments_76ba45f9-47a0-45b5-965c-8ea30f6b8b47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_88148526-782a-4950-98bf-f703fdae4506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_RestrictedCash_88148526-782a-4950-98bf-f703fdae4506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3129e5c1-67df-4d3e-b4df-7ab20479e6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3129e5c1-67df-4d3e-b4df-7ab20479e6c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c1b63840-bf66-4686-9543-7cf49814f90d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c1b63840-bf66-4686-9543-7cf49814f90d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_bc5ee66f-4632-404c-91b7-0270e67f9f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_InventoryNet_bc5ee66f-4632-404c-91b7-0270e67f9f69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_e4868357-2488-4244-8216-6d422b4339b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_PercentageOfLIFOInventory_e4868357-2488-4244-8216-6d422b4339b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_cf18b464-76bd-4235-8d3b-5aca4a0bb0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_InventoryLIFOReserve_cf18b464-76bd-4235-8d3b-5aca4a0bb0b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_6755ef0a-4b8e-48a9-9fa6-6cb85f017424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_6755ef0a-4b8e-48a9-9fa6-6cb85f017424" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cf0637e6-dbc3-495f-9f72-1a9f2090e168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cf0637e6-dbc3-495f-9f72-1a9f2090e168" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_83658a6f-3071-42f1-bbdd-8c272c5508da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_83658a6f-3071-42f1-bbdd-8c272c5508da" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0a71b962-bf0f-4b90-812f-067a01864201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0a71b962-bf0f-4b90-812f-067a01864201" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e6507280-6383-4587-a7e5-7fa18566bead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e6507280-6383-4587-a7e5-7fa18566bead" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_3f005459-e841-4a06-817e-883ac4805156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_3f005459-e841-4a06-817e-883ac4805156" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7220275a-ff48-48d9-99ce-3a71707a0a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7220275a-ff48-48d9-99ce-3a71707a0a5b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_688eed81-009d-45f3-b44c-309adfa61173" xlink:href="mck-20230331.xsd#mck_CapitalizedSoftwareHeldforInternalUseUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_688eed81-009d-45f3-b44c-309adfa61173" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_32cdf71d-c1fa-49fa-9f45-e6cd2657b972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_32cdf71d-c1fa-49fa-9f45-e6cd2657b972" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_a3b5ef35-aab9-48fa-ac4a-6516baa77f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_a3b5ef35-aab9-48fa-ac4a-6516baa77f8c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_89f8d165-c1a9-49ea-9f4f-ecf0d000420e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_89f8d165-c1a9-49ea-9f4f-ecf0d000420e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_b0ed8955-90e3-41f2-b98d-cdb3f8a55775" xlink:href="mck-20230331.xsd#mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_b0ed8955-90e3-41f2-b98d-cdb3f8a55775" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e15be108-0fd8-4ce8-a355-7b7d5afefd83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e15be108-0fd8-4ce8-a355-7b7d5afefd83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e15be108-0fd8-4ce8-a355-7b7d5afefd83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e15be108-0fd8-4ce8-a355-7b7d5afefd83" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e15be108-0fd8-4ce8-a355-7b7d5afefd83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5e6d3e5b-c3b9-41e3-b0f0-628a7c5914d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e15be108-0fd8-4ce8-a355-7b7d5afefd83" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5e6d3e5b-c3b9-41e3-b0f0-628a7c5914d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_d821024e-d9cf-4473-bc5d-c8a772b0e221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5e6d3e5b-c3b9-41e3-b0f0-628a7c5914d8" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_d821024e-d9cf-4473-bc5d-c8a772b0e221" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_de140be7-01a0-4574-911d-2a858e0a38ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5e6d3e5b-c3b9-41e3-b0f0-628a7c5914d8" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_de140be7-01a0-4574-911d-2a858e0a38ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d21a1735-c65f-4c1e-befb-33cc1d4e53ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d21a1735-c65f-4c1e-befb-33cc1d4e53ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d21a1735-c65f-4c1e-befb-33cc1d4e53ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d21a1735-c65f-4c1e-befb-33cc1d4e53ac" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d21a1735-c65f-4c1e-befb-33cc1d4e53ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ca98d759-d8a6-4c88-83ad-ff8451153846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d21a1735-c65f-4c1e-befb-33cc1d4e53ac" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ca98d759-d8a6-4c88-83ad-ff8451153846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_3187d042-4f0f-47ac-9ede-2795b8695de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ca98d759-d8a6-4c88-83ad-ff8451153846" xlink:to="loc_us-gaap_SalesRevenueNetMember_3187d042-4f0f-47ac-9ede-2795b8695de4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_febf1f6f-7322-437b-abb8-b811f70df59e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ca98d759-d8a6-4c88-83ad-ff8451153846" xlink:to="loc_us-gaap_AccountsReceivableMember_febf1f6f-7322-437b-abb8-b811f70df59e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_899c16b4-65d0-45d2-9cd2-6b9ac50903c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_srt_MajorCustomersAxis_899c16b4-65d0-45d2-9cd2-6b9ac50903c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_899c16b4-65d0-45d2-9cd2-6b9ac50903c1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_899c16b4-65d0-45d2-9cd2-6b9ac50903c1" xlink:to="loc_srt_NameOfMajorCustomerDomain_899c16b4-65d0-45d2-9cd2-6b9ac50903c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f5b6d6b5-6d12-417b-a897-131b6acbd1e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_899c16b4-65d0-45d2-9cd2-6b9ac50903c1" xlink:to="loc_srt_NameOfMajorCustomerDomain_f5b6d6b5-6d12-417b-a897-131b6acbd1e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenLargestCustomersMember_06fece1f-5909-4690-b6c8-9a5daa0e8162" xlink:href="mck-20230331.xsd#mck_TenLargestCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f5b6d6b5-6d12-417b-a897-131b6acbd1e5" xlink:to="loc_mck_TenLargestCustomersMember_06fece1f-5909-4690-b6c8-9a5daa0e8162" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LargestCustomerMember_abb7db18-e88b-4d6d-9ab8-d25bf0e0a14c" xlink:href="mck-20230331.xsd#mck_LargestCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f5b6d6b5-6d12-417b-a897-131b6acbd1e5" xlink:to="loc_mck_LargestCustomerMember_abb7db18-e88b-4d6d-9ab8-d25bf0e0a14c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_884e77d2-15c6-48f5-8b47-574b4d24eb83" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_srt_ProductOrServiceAxis_884e77d2-15c6-48f5-8b47-574b4d24eb83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_884e77d2-15c6-48f5-8b47-574b4d24eb83_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_884e77d2-15c6-48f5-8b47-574b4d24eb83" xlink:to="loc_srt_ProductsAndServicesDomain_884e77d2-15c6-48f5-8b47-574b4d24eb83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f7b73ce5-7fb1-437f-af92-4f470a4babca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_884e77d2-15c6-48f5-8b47-574b4d24eb83" xlink:to="loc_srt_ProductsAndServicesDomain_f7b73ce5-7fb1-437f-af92-4f470a4babca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_dbf8b836-8e42-4a2e-897d-daec70152116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f7b73ce5-7fb1-437f-af92-4f470a4babca" xlink:to="loc_us-gaap_ShippingAndHandlingMember_dbf8b836-8e42-4a2e-897d-daec70152116" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributionandRetailBusinessMember_efc99956-08f9-4b3b-a261-7172744c5816" xlink:href="mck-20230331.xsd#mck_DistributionandRetailBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f7b73ce5-7fb1-437f-af92-4f470a4babca" xlink:to="loc_mck_DistributionandRetailBusinessMember_efc99956-08f9-4b3b-a261-7172744c5816" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ServicesBusinessMember_28d9d2d8-e9ec-4dab-a086-7d8b299c58d1" xlink:href="mck-20230331.xsd#mck_ServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f7b73ce5-7fb1-437f-af92-4f470a4babca" xlink:to="loc_mck_ServicesBusinessMember_28d9d2d8-e9ec-4dab-a086-7d8b299c58d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a6578cc1-0696-45c4-8625-128a80018259" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_srt_RangeAxis_a6578cc1-0696-45c4-8625-128a80018259" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a6578cc1-0696-45c4-8625-128a80018259_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a6578cc1-0696-45c4-8625-128a80018259" xlink:to="loc_srt_RangeMember_a6578cc1-0696-45c4-8625-128a80018259_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19f08c2d-9029-4845-8b3f-ab76ff8793ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a6578cc1-0696-45c4-8625-128a80018259" xlink:to="loc_srt_RangeMember_19f08c2d-9029-4845-8b3f-ab76ff8793ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_908a0a74-a0d2-491a-b904-9b4e84e83fb9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_19f08c2d-9029-4845-8b3f-ab76ff8793ee" xlink:to="loc_srt_MinimumMember_908a0a74-a0d2-491a-b904-9b4e84e83fb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5644a311-20c8-4b85-942a-16198310243f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_19f08c2d-9029-4845-8b3f-ab76ff8793ee" xlink:to="loc_srt_MaximumMember_5644a311-20c8-4b85-942a-16198310243f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_661fa294-eaf9-4b97-a6de-bc007ed36e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_661fa294-eaf9-4b97-a6de-bc007ed36e63" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_661fa294-eaf9-4b97-a6de-bc007ed36e63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_661fa294-eaf9-4b97-a6de-bc007ed36e63" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_661fa294-eaf9-4b97-a6de-bc007ed36e63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_661fa294-eaf9-4b97-a6de-bc007ed36e63" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_8bf2dfef-23cd-4a15-bf47-39822362425b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_8bf2dfef-23cd-4a15-bf47-39822362425b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MachineryEquipmentAndOtherMember_feb776ca-c65c-47d9-a1e7-6c414741224b" xlink:href="mck-20230331.xsd#mck_MachineryEquipmentAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:to="loc_mck_MachineryEquipmentAndOtherMember_feb776ca-c65c-47d9-a1e7-6c414741224b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_bff59bb8-a7d9-4876-8fdf-c5d61f21ae52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:to="loc_us-gaap_BuildingMember_bff59bb8-a7d9-4876-8fdf-c5d61f21ae52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_03a64207-9e4a-445c-8110-64defd2805a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:to="loc_us-gaap_EquipmentMember_03a64207-9e4a-445c-8110-64defd2805a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RealPropertyMember_679b275e-9a76-4684-b037-6c9b9e81e69b" xlink:href="mck-20230331.xsd#mck_RealPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:to="loc_mck_RealPropertyMember_679b275e-9a76-4684-b037-6c9b9e81e69b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_982fffe7-d990-41d7-8276-e9a6466f5ad9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_srt_LitigationCaseAxis_982fffe7-d990-41d7-8276-e9a6466f5ad9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_982fffe7-d990-41d7-8276-e9a6466f5ad9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_982fffe7-d990-41d7-8276-e9a6466f5ad9" xlink:to="loc_srt_LitigationCaseTypeDomain_982fffe7-d990-41d7-8276-e9a6466f5ad9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_918df5f1-e4d0-4c2a-93c2-6525a6672137" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_982fffe7-d990-41d7-8276-e9a6466f5ad9" xlink:to="loc_srt_LitigationCaseTypeDomain_918df5f1-e4d0-4c2a-93c2-6525a6672137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_12d7b36e-4639-4d9e-98ae-de538e60d342" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_918df5f1-e4d0-4c2a-93c2-6525a6672137" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_12d7b36e-4639-4d9e-98ae-de538e60d342" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails" xlink:type="extended" id="iab1198320dc54b8dbaf654c3af9f9224_BusinessAcquisitionsandDivestituresAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b841de8e-7af3-4087-8a9a-d9e7b3fc47ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b841de8e-7af3-4087-8a9a-d9e7b3fc47ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6dde0b48-1813-4b5d-811a-922ba0bb45ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6dde0b48-1813-4b5d-811a-922ba0bb45ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6a1736ff-975e-419b-aa50-05ac2b6503e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6a1736ff-975e-419b-aa50-05ac2b6503e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_f96c0921-820e-4ea8-9148-0608a94b8c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_f96c0921-820e-4ea8-9148-0608a94b8c76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_50386833-f29b-4a29-9cd7-65fded9c9e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_50386833-f29b-4a29-9cd7-65fded9c9e7f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_31cf7e95-3dbc-4139-be13-f0fb956500a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_31cf7e95-3dbc-4139-be13-f0fb956500a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_272b4038-f9fd-4de5-b82d-066821df2b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_272b4038-f9fd-4de5-b82d-066821df2b75" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d6e0ff25-d5a3-442b-abfc-3ccff0a1eb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_Goodwill_d6e0ff25-d5a3-442b-abfc-3ccff0a1eb9f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_0f455585-71a6-46ad-85de-7bcb4de6fe40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_0f455585-71a6-46ad-85de-7bcb4de6fe40" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_e51e93e9-7efe-42d7-9b5e-3160dc024fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_e51e93e9-7efe-42d7-9b5e-3160dc024fe6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3da74409-8b9b-4dae-9718-609538fbf160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3da74409-8b9b-4dae-9718-609538fbf160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3da74409-8b9b-4dae-9718-609538fbf160_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3da74409-8b9b-4dae-9718-609538fbf160" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3da74409-8b9b-4dae-9718-609538fbf160_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6532226-bd57-4d36-878d-47b71acb5cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3da74409-8b9b-4dae-9718-609538fbf160" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6532226-bd57-4d36-878d-47b71acb5cff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxSavingsSolutionsLLCMember_815ace06-4c6f-4526-9c22-a4f829af86dc" xlink:href="mck-20230331.xsd#mck_RxSavingsSolutionsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6532226-bd57-4d36-878d-47b71acb5cff" xlink:to="loc_mck_RxSavingsSolutionsLLCMember_815ace06-4c6f-4526-9c22-a4f829af86dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SCRIOncologyLLCMember_9f6c24ea-2d9c-4b1e-81b0-070a945a01a4" xlink:href="mck-20230331.xsd#mck_SCRIOncologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6532226-bd57-4d36-878d-47b71acb5cff" xlink:to="loc_mck_SCRIOncologyLLCMember_9f6c24ea-2d9c-4b1e-81b0-070a945a01a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a7f33f3d-a92e-479e-8249-995b9e286c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a7f33f3d-a92e-479e-8249-995b9e286c65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a7f33f3d-a92e-479e-8249-995b9e286c65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7f33f3d-a92e-479e-8249-995b9e286c65" xlink:to="loc_us-gaap_SegmentDomain_a7f33f3d-a92e-479e-8249-995b9e286c65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_79bf93d0-2f48-4f42-b2a6-1d137d94142b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7f33f3d-a92e-479e-8249-995b9e286c65" xlink:to="loc_us-gaap_SegmentDomain_79bf93d0-2f48-4f42-b2a6-1d137d94142b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxTsSegmentMember_04437abf-1066-454f-a2be-23b507578673" xlink:href="mck-20230331.xsd#mck_RxTsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_79bf93d0-2f48-4f42-b2a6-1d137d94142b" xlink:to="loc_mck_RxTsSegmentMember_04437abf-1066-454f-a2be-23b507578673" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_98836257-c662-4871-a08e-a6157f2e920a" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_79bf93d0-2f48-4f42-b2a6-1d137d94142b" xlink:to="loc_mck_USPharmaceuticalSegmentMember_98836257-c662-4871-a08e-a6157f2e920a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5a24b614-533d-4fa5-bb56-90c4710808bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:to="loc_srt_OwnershipAxis_5a24b614-533d-4fa5-bb56-90c4710808bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5a24b614-533d-4fa5-bb56-90c4710808bb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_5a24b614-533d-4fa5-bb56-90c4710808bb" xlink:to="loc_srt_OwnershipDomain_5a24b614-533d-4fa5-bb56-90c4710808bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ec2d3251-3dcc-4a3d-a775-d3f6e0eadb81" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_5a24b614-533d-4fa5-bb56-90c4710808bb" xlink:to="loc_srt_OwnershipDomain_ec2d3251-3dcc-4a3d-a775-d3f6e0eadb81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SarahCannonResearchInstituteMember_cf82c7e0-6051-4a16-b45a-5c9d7440680c" xlink:href="mck-20230331.xsd#mck_SarahCannonResearchInstituteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_ec2d3251-3dcc-4a3d-a775-d3f6e0eadb81" xlink:to="loc_mck_SarahCannonResearchInstituteMember_cf82c7e0-6051-4a16-b45a-5c9d7440680c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_McKessonUSOncologyResearchMember_877cb09f-4445-4192-b066-3d5bfeab1acb" xlink:href="mck-20230331.xsd#mck_McKessonUSOncologyResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_ec2d3251-3dcc-4a3d-a775-d3f6e0eadb81" xlink:to="loc_mck_McKessonUSOncologyResearchMember_877cb09f-4445-4192-b066-3d5bfeab1acb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5fda7fad-84b5-4d8c-8535-34307a779fce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:to="loc_srt_RangeAxis_5fda7fad-84b5-4d8c-8535-34307a779fce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5fda7fad-84b5-4d8c-8535-34307a779fce_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5fda7fad-84b5-4d8c-8535-34307a779fce" xlink:to="loc_srt_RangeMember_5fda7fad-84b5-4d8c-8535-34307a779fce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db68f474-3841-48eb-afd1-12587790bf25" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5fda7fad-84b5-4d8c-8535-34307a779fce" xlink:to="loc_srt_RangeMember_db68f474-3841-48eb-afd1-12587790bf25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_74febf1c-a1a5-4ec1-b652-faa9fbb73ca8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db68f474-3841-48eb-afd1-12587790bf25" xlink:to="loc_srt_MaximumMember_74febf1c-a1a5-4ec1-b652-faa9fbb73ca8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails" xlink:type="extended" id="id0124454120c478bb47258ec431bc9a5_BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1e5759ab-3221-4191-8023-21770ab7dcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b0b852b3-2fad-46b4-a752-651c49c50480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1e5759ab-3221-4191-8023-21770ab7dcfd" xlink:to="loc_us-gaap_BusinessCombinationsAbstract_b0b852b3-2fad-46b4-a752-651c49c50480" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a680f1fc-85a8-4a99-9da1-cf8196bc9553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b0b852b3-2fad-46b4-a752-651c49c50480" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a680f1fc-85a8-4a99-9da1-cf8196bc9553" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a2a7ed0c-1338-45a3-a247-d69192f29cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b0b852b3-2fad-46b4-a752-651c49c50480" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a2a7ed0c-1338-45a3-a247-d69192f29cc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c22fe971-e0cd-4d51-8a3d-4270a717ff81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b0b852b3-2fad-46b4-a752-651c49c50480" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c22fe971-e0cd-4d51-8a3d-4270a717ff81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1e5759ab-3221-4191-8023-21770ab7dcfd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_6461ea96-cec6-4356-a4fd-75b6514bffc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_6461ea96-cec6-4356-a4fd-75b6514bffc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fbf3d3c6-f870-4aa6-ab1b-7089b27841be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fbf3d3c6-f870-4aa6-ab1b-7089b27841be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d1fd7c0e-21e6-46e6-b50d-d920a4e43182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d1fd7c0e-21e6-46e6-b50d-d920a4e43182" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_15cd38b0-f602-484e-8738-33feceac8f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_15cd38b0-f602-484e-8738-33feceac8f83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6bcdf4b0-16a3-47c3-be8c-19c5a3000ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6bcdf4b0-16a3-47c3-be8c-19c5a3000ad3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dbe669d6-40f7-485d-a70b-4e11846e9669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_Goodwill_dbe669d6-40f7-485d-a70b-4e11846e9669" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_ec4f7705-b0aa-4039-9991-cadf197c1ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_ec4f7705-b0aa-4039-9991-cadf197c1ad5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5761386f-0cf3-480c-8062-54cfcd5fbb84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1e5759ab-3221-4191-8023-21770ab7dcfd" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5761386f-0cf3-480c-8062-54cfcd5fbb84" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4bd7f8b5-fd6d-459d-aebd-0158f64990a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5761386f-0cf3-480c-8062-54cfcd5fbb84" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4bd7f8b5-fd6d-459d-aebd-0158f64990a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bd7f8b5-fd6d-459d-aebd-0158f64990a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4bd7f8b5-fd6d-459d-aebd-0158f64990a6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4bd7f8b5-fd6d-459d-aebd-0158f64990a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b60ebcd-3fb8-40f5-9ccb-5585bab1974d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4bd7f8b5-fd6d-459d-aebd-0158f64990a6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b60ebcd-3fb8-40f5-9ccb-5585bab1974d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxSavingsSolutionsLLCMember_161c4b10-743d-4778-b091-93b859e6b5a0" xlink:href="mck-20230331.xsd#mck_RxSavingsSolutionsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b60ebcd-3fb8-40f5-9ccb-5585bab1974d" xlink:to="loc_mck_RxSavingsSolutionsLLCMember_161c4b10-743d-4778-b091-93b859e6b5a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_db484178-4c84-4011-b314-db9ef6fbefe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5761386f-0cf3-480c-8062-54cfcd5fbb84" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_db484178-4c84-4011-b314-db9ef6fbefe6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_db484178-4c84-4011-b314-db9ef6fbefe6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_db484178-4c84-4011-b314-db9ef6fbefe6" xlink:to="loc_us-gaap_SegmentDomain_db484178-4c84-4011-b314-db9ef6fbefe6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b1879294-e158-4371-b203-e7873cb5985c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_db484178-4c84-4011-b314-db9ef6fbefe6" xlink:to="loc_us-gaap_SegmentDomain_b1879294-e158-4371-b203-e7873cb5985c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxTsSegmentMember_3c37738c-f22d-4736-b474-9083c8d04587" xlink:href="mck-20230331.xsd#mck_RxTsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b1879294-e158-4371-b203-e7873cb5985c" xlink:to="loc_mck_RxTsSegmentMember_3c37738c-f22d-4736-b474-9083c8d04587" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails" xlink:type="extended" id="iddfce404528d408490b4ccdabba2aa12_BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_908aa01c-eba8-46c3-859b-f92546603d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_bb3eb254-943e-4ca1-a0e3-6f375f61b31e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_908aa01c-eba8-46c3-859b-f92546603d8b" xlink:to="loc_us-gaap_BusinessCombinationsAbstract_bb3eb254-943e-4ca1-a0e3-6f375f61b31e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ca827260-4fc4-4466-8640-4ed21f996b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_bb3eb254-943e-4ca1-a0e3-6f375f61b31e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ca827260-4fc4-4466-8640-4ed21f996b57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationConsiderationTransferredOwnershipInterest_1498a218-cc6a-413d-af78-b177e29bd7bd" xlink:href="mck-20230331.xsd#mck_BusinessCombinationConsiderationTransferredOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_bb3eb254-943e-4ca1-a0e3-6f375f61b31e" xlink:to="loc_mck_BusinessCombinationConsiderationTransferredOwnershipInterest_1498a218-cc6a-413d-af78-b177e29bd7bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4af8e2f0-59d1-425e-a22e-833cb5ca1b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_bb3eb254-943e-4ca1-a0e3-6f375f61b31e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4af8e2f0-59d1-425e-a22e-833cb5ca1b21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_908aa01c-eba8-46c3-859b-f92546603d8b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a1ab282c-6446-4c75-a9ab-34f9645d5d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a1ab282c-6446-4c75-a9ab-34f9645d5d01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_6b5ce6fb-b0ac-44bb-8d9e-0f01cf533e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_6b5ce6fb-b0ac-44bb-8d9e-0f01cf533e52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_6c20c7d4-9a8c-4ac4-82a8-abddea4744dc" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_6c20c7d4-9a8c-4ac4-82a8-abddea4744dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e8827df9-5394-4820-a9a4-7bda9e3b90f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e8827df9-5394-4820-a9a4-7bda9e3b90f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3df65082-556a-466c-bf36-f80f4440da0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3df65082-556a-466c-bf36-f80f4440da0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities_6e2b9675-82e4-4549-8249-59b62909d278" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities_6e2b9675-82e4-4549-8249-59b62909d278" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5ae8c779-440e-46d4-a0fb-f6762296d0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5ae8c779-440e-46d4-a0fb-f6762296d0d9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a8ddc339-d1f0-46c1-b0f5-88df94cd2eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a8ddc339-d1f0-46c1-b0f5-88df94cd2eee" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_4466f54d-7a67-41c6-a3bd-60f47f5b880b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_4466f54d-7a67-41c6-a3bd-60f47f5b880b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital_2381fbe8-dd51-447d-b1df-c32560c7ed64" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital_2381fbe8-dd51-447d-b1df-c32560c7ed64" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_08ff1e4e-1692-4ff6-af0f-9b016dee23a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_Goodwill_08ff1e4e-1692-4ff6-af0f-9b016dee23a5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_90bc61f0-64ec-4221-8849-5049df082564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_90bc61f0-64ec-4221-8849-5049df082564" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_0c79e6a2-10c6-4968-9604-4ff58868bd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_908aa01c-eba8-46c3-859b-f92546603d8b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_0c79e6a2-10c6-4968-9604-4ff58868bd24" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0e9c6f48-62cd-411f-b73a-dad425c0eaad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_0c79e6a2-10c6-4968-9604-4ff58868bd24" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0e9c6f48-62cd-411f-b73a-dad425c0eaad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0e9c6f48-62cd-411f-b73a-dad425c0eaad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0e9c6f48-62cd-411f-b73a-dad425c0eaad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0e9c6f48-62cd-411f-b73a-dad425c0eaad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_238ef117-530e-49b1-9c49-c6f579e7d45d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0e9c6f48-62cd-411f-b73a-dad425c0eaad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_238ef117-530e-49b1-9c49-c6f579e7d45d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SCRIOncologyLLCMember_c6b266e1-70c1-4987-8f57-efc5611086ca" xlink:href="mck-20230331.xsd#mck_SCRIOncologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_238ef117-530e-49b1-9c49-c6f579e7d45d" xlink:to="loc_mck_SCRIOncologyLLCMember_c6b266e1-70c1-4987-8f57-efc5611086ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d32de903-2ab5-4566-badf-f902eb37fd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_0c79e6a2-10c6-4968-9604-4ff58868bd24" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d32de903-2ab5-4566-badf-f902eb37fd15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d32de903-2ab5-4566-badf-f902eb37fd15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d32de903-2ab5-4566-badf-f902eb37fd15" xlink:to="loc_us-gaap_SegmentDomain_d32de903-2ab5-4566-badf-f902eb37fd15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3fb31068-bead-4278-b91f-17e7972c552a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d32de903-2ab5-4566-badf-f902eb37fd15" xlink:to="loc_us-gaap_SegmentDomain_3fb31068-bead-4278-b91f-17e7972c552a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_20b6f727-2cdd-47d8-bbe9-7aaf903cd453" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3fb31068-bead-4278-b91f-17e7972c552a" xlink:to="loc_mck_USPharmaceuticalSegmentMember_20b6f727-2cdd-47d8-bbe9-7aaf903cd453" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails" xlink:type="extended" id="ia66af15bd53742ab8876bd4029f5a85a_BusinessAcquisitionsandDivestituresDivestituresandOtherDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_866e4fda-e8c7-4923-879b-2470fe9f1c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_866e4fda-e8c7-4923-879b-2470fe9f1c03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_caf2e0fa-bf57-44cd-bf28-dd0ad6614399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_caf2e0fa-bf57-44cd-bf28-dd0ad6614399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_72183b72-db27-446c-8b2f-ae5709ec84d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_72183b72-db27-446c-8b2f-ae5709ec84d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7942c516-cd6e-45d7-8e4f-4265ca6169e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7942c516-cd6e-45d7-8e4f-4265ca6169e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_6f7d8b72-3d64-46c6-a816-48a0493778fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_6f7d8b72-3d64-46c6-a816-48a0493778fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_1cfe5f52-e282-404e-b4d5-4f91eb5a1c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_1cfe5f52-e282-404e-b4d5-4f91eb5a1c5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest_b220e193-0fee-4711-9207-e2220d7086f1" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest_b220e193-0fee-4711-9207-e2220d7086f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_b539ceb8-ee30-4c40-9ef0-86952f860110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_b539ceb8-ee30-4c40-9ef0-86952f860110" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_d74fa97f-645f-4ad3-95e1-ae62454f03bb" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_d74fa97f-645f-4ad3-95e1-ae62454f03bb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_f637219e-930d-4633-92a2-2ed87266bceb" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_f637219e-930d-4633-92a2-2ed87266bceb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_0963b204-ccfc-4817-aed9-51ecf8d448e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_0963b204-ccfc-4817-aed9-51ecf8d448e4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c2f10cda-f3f5-4833-85c4-c3e7be3fc369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c2f10cda-f3f5-4833-85c4-c3e7be3fc369" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_c6a1927a-c3bd-44a8-9c4e-0dbf0a748b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_AssetsNet_c6a1927a-c3bd-44a8-9c4e-0dbf0a748b99" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0885e630-0054-413a-95bd-4d9d29fd6f92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0885e630-0054-413a-95bd-4d9d29fd6f92" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_c9bec91b-1185-4db4-9a6e-3d486e2f756a" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_c9bec91b-1185-4db4-9a6e-3d486e2f756a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_343feeac-5bec-4a23-a81d-a9cda98cc476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_EquityMethodInvestments_343feeac-5bec-4a23-a81d-a9cda98cc476" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ae0d953-77f6-4dba-b4c0-12ad042ae82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ae0d953-77f6-4dba-b4c0-12ad042ae82e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1ae0d953-77f6-4dba-b4c0-12ad042ae82e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ae0d953-77f6-4dba-b4c0-12ad042ae82e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1ae0d953-77f6-4dba-b4c0-12ad042ae82e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ae0d953-77f6-4dba-b4c0-12ad042ae82e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_c2219ee3-1700-48ad-99ec-57eb80b6d86e" xlink:href="mck-20230331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_c2219ee3-1700-48ad-99ec-57eb80b6d86e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_558e5759-f0c8-4c6a-b58f-be4c22e8bc70" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_558e5759-f0c8-4c6a-b58f-be4c22e8bc70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_4480b7c2-209b-4d7b-b004-04de7c69b73c" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_4480b7c2-209b-4d7b-b004-04de7c69b73c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_1da4f393-248d-4f84-a7db-0a96ce0b07ee" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_InternationalSegmentMember_1da4f393-248d-4f84-a7db-0a96ce0b07ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember_d62d1705-4177-4f94-8e57-5adf96116b02" xlink:href="mck-20230331.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_AustrianBusinessOperationsMember_d62d1705-4177-4f94-8e57-5adf96116b02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_04448bbf-2268-4bee-adaf-c092313f645c" xlink:href="mck-20230331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_GermanWholesaleBusinessMember_04448bbf-2268-4bee-adaf-c092313f645c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4d123a2c-8dc0-4d0c-980c-00e74396d3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4d123a2c-8dc0-4d0c-980c-00e74396d3a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4d123a2c-8dc0-4d0c-980c-00e74396d3a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4d123a2c-8dc0-4d0c-980c-00e74396d3a3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4d123a2c-8dc0-4d0c-980c-00e74396d3a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7a1ebaf5-5fab-48e4-b530-99a1a2d2c0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4d123a2c-8dc0-4d0c-980c-00e74396d3a3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7a1ebaf5-5fab-48e4-b530-99a1a2d2c0d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f23d07f5-08e9-4084-98bd-02c89b7f01c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7a1ebaf5-5fab-48e4-b530-99a1a2d2c0d1" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f23d07f5-08e9-4084-98bd-02c89b7f01c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_053e90c9-a94b-408b-a96d-cec60e96d187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7a1ebaf5-5fab-48e4-b530-99a1a2d2c0d1" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_053e90c9-a94b-408b-a96d-cec60e96d187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1752628a-ecab-41dc-8ad7-b1b3a0f11899" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_dei_LegalEntityAxis_1752628a-ecab-41dc-8ad7-b1b3a0f11899" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1752628a-ecab-41dc-8ad7-b1b3a0f11899_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1752628a-ecab-41dc-8ad7-b1b3a0f11899" xlink:to="loc_dei_EntityDomain_1752628a-ecab-41dc-8ad7-b1b3a0f11899_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_38bd4ea6-64d5-405f-915c-249a4f5f6ed9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1752628a-ecab-41dc-8ad7-b1b3a0f11899" xlink:to="loc_dei_EntityDomain_38bd4ea6-64d5-405f-915c-249a4f5f6ed9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AureliusElephantLimitedMember_570e0fc4-1258-4388-bbe1-506dac434a70" xlink:href="mck-20230331.xsd#mck_AureliusElephantLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_38bd4ea6-64d5-405f-915c-249a4f5f6ed9" xlink:to="loc_mck_AureliusElephantLimitedMember_570e0fc4-1258-4388-bbe1-506dac434a70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9d9b2eb0-5b9f-47bc-bfa3-28c857d1eb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9d9b2eb0-5b9f-47bc-bfa3-28c857d1eb78" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d9b2eb0-5b9f-47bc-bfa3-28c857d1eb78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9d9b2eb0-5b9f-47bc-bfa3-28c857d1eb78" xlink:to="loc_us-gaap_SegmentDomain_9d9b2eb0-5b9f-47bc-bfa3-28c857d1eb78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9969b4dc-43d0-4b36-a7ce-0b9c6596d030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9d9b2eb0-5b9f-47bc-bfa3-28c857d1eb78" xlink:to="loc_us-gaap_SegmentDomain_9969b4dc-43d0-4b36-a7ce-0b9c6596d030" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_e2e8753f-393b-4c39-a782-d5bdf78a1e5f" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9969b4dc-43d0-4b36-a7ce-0b9c6596d030" xlink:to="loc_mck_InternationalSegmentMember_e2e8753f-393b-4c39-a782-d5bdf78a1e5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_22bca7c5-b058-4941-8555-dab01a13f4d1" xlink:href="mck-20230331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9969b4dc-43d0-4b36-a7ce-0b9c6596d030" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_22bca7c5-b058-4941-8555-dab01a13f4d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a717a5da-c511-4890-bcc6-4c448c6c527a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a717a5da-c511-4890-bcc6-4c448c6c527a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a717a5da-c511-4890-bcc6-4c448c6c527a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a717a5da-c511-4890-bcc6-4c448c6c527a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a717a5da-c511-4890-bcc6-4c448c6c527a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7b136fd7-e8f4-4e8e-8079-8725684d0f43" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a717a5da-c511-4890-bcc6-4c448c6c527a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7b136fd7-e8f4-4e8e-8079-8725684d0f43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_96a90704-b188-4feb-95b3-e428948d9f90" xlink:href="mck-20230331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7b136fd7-e8f4-4e8e-8079-8725684d0f43" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_96a90704-b188-4feb-95b3-e428948d9f90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_3a19f3c1-8df6-431b-a4b4-dfaf5bff22ce" xlink:href="mck-20230331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7b136fd7-e8f4-4e8e-8079-8725684d0f43" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_3a19f3c1-8df6-431b-a4b4-dfaf5bff22ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6c8edf3a-020a-4ac7-b71f-23c47bb402c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_srt_ConsolidationItemsAxis_6c8edf3a-020a-4ac7-b71f-23c47bb402c4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6c8edf3a-020a-4ac7-b71f-23c47bb402c4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_6c8edf3a-020a-4ac7-b71f-23c47bb402c4" xlink:to="loc_srt_ConsolidationItemsDomain_6c8edf3a-020a-4ac7-b71f-23c47bb402c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9cb214ff-bbb1-4096-b8dd-fc3589853663" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_6c8edf3a-020a-4ac7-b71f-23c47bb402c4" xlink:to="loc_srt_ConsolidationItemsDomain_9cb214ff-bbb1-4096-b8dd-fc3589853663" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_bf324f01-fc13-41cd-b990-f9a760615977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9cb214ff-bbb1-4096-b8dd-fc3589853663" xlink:to="loc_us-gaap_OperatingSegmentsMember_bf324f01-fc13-41cd-b990-f9a760615977" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails" xlink:type="extended" id="if940b2d1f42c4c00b414aff437687235_BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_00822ae7-1b1c-4ef2-bd64-a9318202b76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_00822ae7-1b1c-4ef2-bd64-a9318202b76c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_4927c1c1-eb89-4d41-9c6b-f12923ce5d84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_4927c1c1-eb89-4d41-9c6b-f12923ce5d84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_2d4c7e38-ea51-4047-bed5-f96fc2652def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_2d4c7e38-ea51-4047-bed5-f96fc2652def" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_bcf31966-52b0-42be-87d3-10f24f4f3a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_bcf31966-52b0-42be-87d3-10f24f4f3a09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_f1376e76-158e-416d-af08-5e8a8e7300c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_f1376e76-158e-416d-af08-5e8a8e7300c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_c2cb8713-fe8c-4f64-ad39-63aa52e16fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_c2cb8713-fe8c-4f64-ad39-63aa52e16fa9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_21199e59-3ec1-4eab-a29b-7d72aeb763cc" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_21199e59-3ec1-4eab-a29b-7d72aeb763cc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_77057dd8-84a6-4aae-82f6-43b8eb8b16f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_77057dd8-84a6-4aae-82f6-43b8eb8b16f5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_9038231e-53e1-4c95-a65f-b69f405a5f80" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_9038231e-53e1-4c95-a65f-b69f405a5f80" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_9411c970-9ea2-4270-a6a6-42a792ac1306" xlink:href="mck-20230331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_9411c970-9ea2-4270-a6a6-42a792ac1306" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_49277781-83f8-4dff-a62c-f71a5a7eb448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_49277781-83f8-4dff-a62c-f71a5a7eb448" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_00822ae7-1b1c-4ef2-bd64-a9318202b76c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_e5b87372-3895-4496-8e46-ee66f6c3b00d" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_e5b87372-3895-4496-8e46-ee66f6c3b00d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_52f73d8e-be07-44ea-b6da-b7e42710a43d" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_52f73d8e-be07-44ea-b6da-b7e42710a43d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_cdd817e9-5d3a-41a3-834a-e48abeda7344" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_cdd817e9-5d3a-41a3-834a-e48abeda7344" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_17b56d89-d9fc-44e1-aaa1-c5079ff89d0c" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_17b56d89-d9fc-44e1-aaa1-c5079ff89d0c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_f0bd8bc6-5a9f-4649-8e2d-b9fee348daba" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_f0bd8bc6-5a9f-4649-8e2d-b9fee348daba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_f08b94d0-5ed9-4cb1-8cb0-b4a685d4af49" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_f08b94d0-5ed9-4cb1-8cb0-b4a685d4af49" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_911a7116-6aa3-4374-9654-30314904555e" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_911a7116-6aa3-4374-9654-30314904555e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_0908ec68-c07f-4e86-b49e-90c30b0a1d70" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_0908ec68-c07f-4e86-b49e-90c30b0a1d70" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_3865ddd9-64a9-4865-ac70-7c0241c21b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_3865ddd9-64a9-4865-ac70-7c0241c21b6e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_171ec500-a845-48c9-a459-022dc2deb93d" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_00822ae7-1b1c-4ef2-bd64-a9318202b76c" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_171ec500-a845-48c9-a459-022dc2deb93d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6a67f306-6bf2-4a49-976f-de8671424667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_00822ae7-1b1c-4ef2-bd64-a9318202b76c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6a67f306-6bf2-4a49-976f-de8671424667" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0570364b-6592-44f5-aed7-d56c0b470900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6a67f306-6bf2-4a49-976f-de8671424667" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0570364b-6592-44f5-aed7-d56c0b470900" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0570364b-6592-44f5-aed7-d56c0b470900_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0570364b-6592-44f5-aed7-d56c0b470900" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0570364b-6592-44f5-aed7-d56c0b470900_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5726ac85-56b9-44b9-9733-1a6fef3a57fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0570364b-6592-44f5-aed7-d56c0b470900" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5726ac85-56b9-44b9-9733-1a6fef3a57fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_37b7fa56-c973-4260-be88-cece83fc2032" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5726ac85-56b9-44b9-9733-1a6fef3a57fe" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_37b7fa56-c973-4260-be88-cece83fc2032" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_6d0f432e-51fd-42d5-894e-d841ff8f9efc" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5726ac85-56b9-44b9-9733-1a6fef3a57fe" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_6d0f432e-51fd-42d5-894e-d841ff8f9efc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember_bad45dbf-1352-4871-9cf5-d8231dc47988" xlink:href="mck-20230331.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5726ac85-56b9-44b9-9733-1a6fef3a57fe" xlink:to="loc_mck_InternallyDevelopedSoftwareMember_bad45dbf-1352-4871-9cf5-d8231dc47988" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b851ad6e-948c-41db-b062-8758b41e09f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6a67f306-6bf2-4a49-976f-de8671424667" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b851ad6e-948c-41db-b062-8758b41e09f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b851ad6e-948c-41db-b062-8758b41e09f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b851ad6e-948c-41db-b062-8758b41e09f3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b851ad6e-948c-41db-b062-8758b41e09f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d4aeb144-1716-40a6-94f7-e582598b148c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b851ad6e-948c-41db-b062-8758b41e09f3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d4aeb144-1716-40a6-94f7-e582598b148c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_326d9eae-4c16-4650-946b-6d0544ac4625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d4aeb144-1716-40a6-94f7-e582598b148c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_326d9eae-4c16-4650-946b-6d0544ac4625" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RestructuringImpairmentandRelatedChargesNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails" xlink:type="extended" id="i6e44aa3123f2469082c22d03bfd528d8_RestructuringImpairmentandRelatedChargesNetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_8b192483-9129-4302-923f-c0269aa536c0" xlink:href="mck-20230331.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_8b192483-9129-4302-923f-c0269aa536c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9416522d-bb8f-4ad2-b928-e7ab1e1f844a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9416522d-bb8f-4ad2-b928-e7ab1e1f844a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_28de2de7-4575-4f3e-9d69-2d3d3a81f250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:to="loc_us-gaap_RestructuringCharges_28de2de7-4575-4f3e-9d69-2d3d3a81f250" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_c6258f85-81de-49d9-a1f1-2fcde8f00d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:to="loc_us-gaap_AssetImpairmentCharges_c6258f85-81de-49d9-a1f1-2fcde8f00d6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_023a05c3-3470-4aad-9a78-7032dba4b7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:to="loc_us-gaap_RestructuringPlanAxis_023a05c3-3470-4aad-9a78-7032dba4b7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_023a05c3-3470-4aad-9a78-7032dba4b7ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_023a05c3-3470-4aad-9a78-7032dba4b7ef" xlink:to="loc_us-gaap_RestructuringPlanDomain_023a05c3-3470-4aad-9a78-7032dba4b7ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_023a05c3-3470-4aad-9a78-7032dba4b7ef" xlink:to="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember_c39e4fcd-7c4f-4672-986e-b8139572b95a" xlink:href="mck-20230331.xsd#mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:to="loc_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember_c39e4fcd-7c4f-4672-986e-b8139572b95a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_d2efee88-56b4-429d-8399-98198fea4e9a" xlink:href="mck-20230331.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_d2efee88-56b4-429d-8399-98198fea4e9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_0cf6dde2-937a-4be8-b5d1-b26ded877007" xlink:href="mck-20230331.xsd#mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:to="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_0cf6dde2-937a-4be8-b5d1-b26ded877007" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_bac1ae23-df6f-4bcd-b151-cc2d4c62a4f2" xlink:href="mck-20230331.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:to="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_bac1ae23-df6f-4bcd-b151-cc2d4c62a4f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5613d5e9-f6bf-4070-9f90-39e39d5838f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:to="loc_srt_StatementGeographicalAxis_5613d5e9-f6bf-4070-9f90-39e39d5838f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5613d5e9-f6bf-4070-9f90-39e39d5838f8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_5613d5e9-f6bf-4070-9f90-39e39d5838f8" xlink:to="loc_srt_SegmentGeographicalDomain_5613d5e9-f6bf-4070-9f90-39e39d5838f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_17cd3730-6ad5-4288-9d7e-8f90e36d38bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_5613d5e9-f6bf-4070-9f90-39e39d5838f8" xlink:to="loc_srt_SegmentGeographicalDomain_17cd3730-6ad5-4288-9d7e-8f90e36d38bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_9c246d78-578f-4c6d-a03b-c898e3491a63" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_17cd3730-6ad5-4288-9d7e-8f90e36d38bd" xlink:to="loc_country_GB_9c246d78-578f-4c6d-a03b-c898e3491a63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_17cd7c0e-578c-45f6-9d9c-c6e432698af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_17cd7c0e-578c-45f6-9d9c-c6e432698af6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_17cd7c0e-578c-45f6-9d9c-c6e432698af6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_17cd7c0e-578c-45f6-9d9c-c6e432698af6" xlink:to="loc_us-gaap_SegmentDomain_17cd7c0e-578c-45f6-9d9c-c6e432698af6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cece0b82-b046-4085-bf60-bf683df519cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_17cd7c0e-578c-45f6-9d9c-c6e432698af6" xlink:to="loc_us-gaap_SegmentDomain_cece0b82-b046-4085-bf60-bf683df519cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_4790b66c-5c20-4b8c-a753-b7aa6dbe086b" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cece0b82-b046-4085-bf60-bf683df519cc" xlink:to="loc_mck_InternationalSegmentMember_4790b66c-5c20-4b8c-a753-b7aa6dbe086b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_bcfdc081-19a9-4a79-aebf-48b089e7ad82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_bcfdc081-19a9-4a79-aebf-48b089e7ad82" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_bcfdc081-19a9-4a79-aebf-48b089e7ad82_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_bcfdc081-19a9-4a79-aebf-48b089e7ad82" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_bcfdc081-19a9-4a79-aebf-48b089e7ad82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6c6a8d28-5339-4869-b149-705cc820d1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_bcfdc081-19a9-4a79-aebf-48b089e7ad82" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6c6a8d28-5339-4869-b149-705cc820d1a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_26e259b2-7432-4c71-9c5a-8be4a84b6dd9" xlink:href="mck-20230331.xsd#mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6c6a8d28-5339-4869-b149-705cc820d1a7" xlink:to="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_26e259b2-7432-4c71-9c5a-8be4a84b6dd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_a364107b-1aea-4a60-855e-846c043fc0e8" xlink:href="mck-20230331.xsd#mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6c6a8d28-5339-4869-b149-705cc820d1a7" xlink:to="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_a364107b-1aea-4a60-855e-846c043fc0e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_940bf0b2-0d85-497b-9aef-5ec0aebfe339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:to="loc_us-gaap_ReportingUnitAxis_940bf0b2-0d85-497b-9aef-5ec0aebfe339" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_940bf0b2-0d85-497b-9aef-5ec0aebfe339_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_940bf0b2-0d85-497b-9aef-5ec0aebfe339" xlink:to="loc_us-gaap_ReportingUnitDomain_940bf0b2-0d85-497b-9aef-5ec0aebfe339_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_993ee814-3d5a-48da-aeb8-26e8743fa8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_940bf0b2-0d85-497b-9aef-5ec0aebfe339" xlink:to="loc_us-gaap_ReportingUnitDomain_993ee814-3d5a-48da-aeb8-26e8743fa8d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_f40734b9-6691-4a03-a23b-92c94354de86" xlink:href="mck-20230331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_993ee814-3d5a-48da-aeb8-26e8743fa8d6" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_f40734b9-6691-4a03-a23b-92c94354de86" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails" xlink:type="extended" id="ie274d9ab1e134ba584456e3b7b09f5b3_RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_df5045d8-3c16-4811-882a-895aa2819fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:to="loc_us-gaap_SeveranceCosts1_df5045d8-3c16-4811-882a-895aa2819fe0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_d8daedab-5d04-4f91-be39-dc6d17f1929e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:to="loc_us-gaap_BusinessExitCosts1_d8daedab-5d04-4f91-be39-dc6d17f1929e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_2b984efb-f20f-4f3c-9211-ae170a1036df" xlink:href="mck-20230331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_2b984efb-f20f-4f3c-9211-ae170a1036df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_d7b741f5-caeb-4e85-9b7f-d2b2894b86dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:to="loc_us-gaap_RestructuringCharges_d7b741f5-caeb-4e85-9b7f-d2b2894b86dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9bbcca9e-8c62-4cb3-93e7-03857ccd989e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9bbcca9e-8c62-4cb3-93e7-03857ccd989e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_120610ab-2747-4895-9266-7f79f9db0922" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9bbcca9e-8c62-4cb3-93e7-03857ccd989e" xlink:to="loc_srt_ConsolidationItemsAxis_120610ab-2747-4895-9266-7f79f9db0922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_120610ab-2747-4895-9266-7f79f9db0922_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_120610ab-2747-4895-9266-7f79f9db0922" xlink:to="loc_srt_ConsolidationItemsDomain_120610ab-2747-4895-9266-7f79f9db0922_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5ee27fd3-df88-4023-a2a3-ac193b7296ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_120610ab-2747-4895-9266-7f79f9db0922" xlink:to="loc_srt_ConsolidationItemsDomain_5ee27fd3-df88-4023-a2a3-ac193b7296ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f7f76ebc-aac5-451d-87e9-9b071d2f1b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_5ee27fd3-df88-4023-a2a3-ac193b7296ed" xlink:to="loc_us-gaap_OperatingSegmentsMember_f7f76ebc-aac5-451d-87e9-9b071d2f1b73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_1df5fc11-4ad1-465e-b1c4-d21956681b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_5ee27fd3-df88-4023-a2a3-ac193b7296ed" xlink:to="loc_us-gaap_CorporateNonSegmentMember_1df5fc11-4ad1-465e-b1c4-d21956681b21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_44db6021-4662-4b05-bd4e-55998bf186fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9bbcca9e-8c62-4cb3-93e7-03857ccd989e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_44db6021-4662-4b05-bd4e-55998bf186fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_44db6021-4662-4b05-bd4e-55998bf186fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_44db6021-4662-4b05-bd4e-55998bf186fa" xlink:to="loc_us-gaap_SegmentDomain_44db6021-4662-4b05-bd4e-55998bf186fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_44db6021-4662-4b05-bd4e-55998bf186fa" xlink:to="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_970d444e-2ac3-4826-a1e2-606d4a482642" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:to="loc_mck_USPharmaceuticalSegmentMember_970d444e-2ac3-4826-a1e2-606d4a482642" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_06a28485-b687-4426-8d8b-743713603653" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_06a28485-b687-4426-8d8b-743713603653" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_735aa27f-da37-488f-b937-2b6bc0ecdaba" xlink:href="mck-20230331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_735aa27f-da37-488f-b937-2b6bc0ecdaba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_32b50e50-6e07-4981-b2ce-885ee9ad1135" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:to="loc_mck_InternationalSegmentMember_32b50e50-6e07-4981-b2ce-885ee9ad1135" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="extended" id="i938c1287fb824035894a7095538d4db4_RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_735cf97c-11ef-4f7e-b290-69067a2ca13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_735cf97c-11ef-4f7e-b290-69067a2ca13b" xlink:to="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_913509a5-6f25-4af0-9d20-f6d57d443dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:to="loc_us-gaap_RestructuringReserve_913509a5-6f25-4af0-9d20-f6d57d443dbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_846dade0-03bf-48ba-8463-9688dbd52eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:to="loc_us-gaap_RestructuringCharges_846dade0-03bf-48ba-8463-9688dbd52eec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_4c1cc3af-652f-42b3-9ca3-287f8149aa75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_4c1cc3af-652f-42b3-9ca3-287f8149aa75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_b77f1860-f5c3-4f2b-bcf6-dc25ad3b184c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:to="loc_us-gaap_PaymentsForRestructuring_b77f1860-f5c3-4f2b-bcf6-dc25ad3b184c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_b370e1ef-f322-4ba2-9f50-f8021bcc4118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_b370e1ef-f322-4ba2-9f50-f8021bcc4118" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c98a5fb9-2479-42b6-938c-582e8266e437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_316902db-0d83-4e4d-947b-1f0fe5306822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_735cf97c-11ef-4f7e-b290-69067a2ca13b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_316902db-0d83-4e4d-947b-1f0fe5306822" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_455ad681-ce15-4626-b012-7381f2f13ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_316902db-0d83-4e4d-947b-1f0fe5306822" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_455ad681-ce15-4626-b012-7381f2f13ee3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_455ad681-ce15-4626-b012-7381f2f13ee3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_455ad681-ce15-4626-b012-7381f2f13ee3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_455ad681-ce15-4626-b012-7381f2f13ee3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_455ad681-ce15-4626-b012-7381f2f13ee3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_53cac341-9a10-4c34-8889-8ce1801c01bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_53cac341-9a10-4c34-8889-8ce1801c01bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d79169f5-3aec-49ba-a009-c43580ed69a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d79169f5-3aec-49ba-a009-c43580ed69a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_fc94a519-50ec-41e2-977a-8c4ca826957c" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_fc94a519-50ec-41e2-977a-8c4ca826957c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_47439937-80c3-476a-9109-f766f234f7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_47439937-80c3-476a-9109-f766f234f7cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_03e195bd-d603-4a4e-bde5-390fc9a9eecd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_316902db-0d83-4e4d-947b-1f0fe5306822" xlink:to="loc_srt_ConsolidationItemsAxis_03e195bd-d603-4a4e-bde5-390fc9a9eecd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_03e195bd-d603-4a4e-bde5-390fc9a9eecd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_03e195bd-d603-4a4e-bde5-390fc9a9eecd" xlink:to="loc_srt_ConsolidationItemsDomain_03e195bd-d603-4a4e-bde5-390fc9a9eecd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_11deaf2f-65dc-4dcf-837a-cee2df6361b1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_03e195bd-d603-4a4e-bde5-390fc9a9eecd" xlink:to="loc_srt_ConsolidationItemsDomain_11deaf2f-65dc-4dcf-837a-cee2df6361b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5b9d0f40-f756-4fff-b4bd-f4d94dc7281d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_11deaf2f-65dc-4dcf-837a-cee2df6361b1" xlink:to="loc_us-gaap_OperatingSegmentsMember_5b9d0f40-f756-4fff-b4bd-f4d94dc7281d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_833d1101-f87b-4750-9a80-6080b230ccc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_11deaf2f-65dc-4dcf-837a-cee2df6361b1" xlink:to="loc_us-gaap_CorporateNonSegmentMember_833d1101-f87b-4750-9a80-6080b230ccc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a40feedc-101b-49b3-ae98-2d536073fb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_316902db-0d83-4e4d-947b-1f0fe5306822" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a40feedc-101b-49b3-ae98-2d536073fb8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a40feedc-101b-49b3-ae98-2d536073fb8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a40feedc-101b-49b3-ae98-2d536073fb8a" xlink:to="loc_us-gaap_SegmentDomain_a40feedc-101b-49b3-ae98-2d536073fb8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a40feedc-101b-49b3-ae98-2d536073fb8a" xlink:to="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_cec004c5-ca2d-4588-a0d4-ed0f8d41b615" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:to="loc_mck_USPharmaceuticalSegmentMember_cec004c5-ca2d-4588-a0d4-ed0f8d41b615" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_6e06cdf7-3542-41b6-81cb-5529efc525aa" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_6e06cdf7-3542-41b6-81cb-5529efc525aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_c4e5699e-6a9c-492d-83a3-7256f181d01a" xlink:href="mck-20230331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_c4e5699e-6a9c-492d-83a3-7256f181d01a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_86d861ef-e60a-40b4-8ce3-0ff8ce0eb3b9" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:to="loc_mck_InternationalSegmentMember_86d861ef-e60a-40b4-8ce3-0ff8ce0eb3b9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="extended" id="ifbc8ebcca12b4ea38786151064684c65_ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_798807a6-2c79-4849-ab9a-c1d1a1f270ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_798807a6-2c79-4849-ab9a-c1d1a1f270ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_43696792-9fcb-4295-96ee-49688357871b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_43696792-9fcb-4295-96ee-49688357871b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_c9ffbacc-f62f-4aa3-94a0-f11d7278dc19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_c9ffbacc-f62f-4aa3-94a0-f11d7278dc19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_81157b10-d26f-4e58-abef-1c97e050ca0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_81157b10-d26f-4e58-abef-1c97e050ca0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0222964e-55f9-4b1f-a899-b6b8d16c443a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0222964e-55f9-4b1f-a899-b6b8d16c443a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e13dc520-103b-49b8-8e89-8b1aaf210c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0222964e-55f9-4b1f-a899-b6b8d16c443a" xlink:to="loc_us-gaap_AwardTypeAxis_e13dc520-103b-49b8-8e89-8b1aaf210c6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e13dc520-103b-49b8-8e89-8b1aaf210c6f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e13dc520-103b-49b8-8e89-8b1aaf210c6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e13dc520-103b-49b8-8e89-8b1aaf210c6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ea2fd96-20f1-428a-ad27-ab918bf0cb24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e13dc520-103b-49b8-8e89-8b1aaf210c6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ea2fd96-20f1-428a-ad27-ab918bf0cb24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6b0fa5a6-06b4-474f-bc61-e991d3132081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ea2fd96-20f1-428a-ad27-ab918bf0cb24" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6b0fa5a6-06b4-474f-bc61-e991d3132081" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_37a1f30a-98a6-4185-a9d0-d0eb0d2188ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ea2fd96-20f1-428a-ad27-ab918bf0cb24" xlink:to="loc_us-gaap_StockOptionMember_37a1f30a-98a6-4185-a9d0-d0eb0d2188ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_9d99cfb3-283b-4c59-b2f8-d55e44a4dcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ea2fd96-20f1-428a-ad27-ab918bf0cb24" xlink:to="loc_us-gaap_EmployeeStockMember_9d99cfb3-283b-4c59-b2f8-d55e44a4dcb7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" id="iaa1c75455a444a94ad404d877a164077_ShareBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7d0f17d5-18ec-4f14-b426-7f115f83e5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7d0f17d5-18ec-4f14-b426-7f115f83e5c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_86128ff8-9477-48b1-870c-b81af64f40d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_86128ff8-9477-48b1-870c-b81af64f40d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e2fd2e5e-33a9-4af6-9a27-0da11daf230e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e2fd2e5e-33a9-4af6-9a27-0da11daf230e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_6a8e73ab-71a4-4957-9656-74e5122476aa" xlink:href="mck-20230331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_6a8e73ab-71a4-4957-9656-74e5122476aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_abff5d99-83d6-4cbe-8918-e64142aca4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_abff5d99-83d6-4cbe-8918-e64142aca4ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_19ba857a-4da1-43c7-8cbc-eb68a6d61b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_19ba857a-4da1-43c7-8cbc-eb68a6d61b95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00f3982d-700c-4c64-b7bb-73cad5f96ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00f3982d-700c-4c64-b7bb-73cad5f96ac5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_6d4c1d80-a064-4329-8c29-bc7aeb75c55c" xlink:href="mck-20230331.xsd#mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_6d4c1d80-a064-4329-8c29-bc7aeb75c55c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b7db8684-eabf-45f0-ab40-120af9ee2d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b7db8684-eabf-45f0-ab40-120af9ee2d72" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_f2ef890e-98ae-458b-be2a-2eacca12f086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_f2ef890e-98ae-458b-be2a-2eacca12f086" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d7ed3530-5e3f-413f-a300-96feb2bbcfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:to="loc_us-gaap_PlanNameAxis_d7ed3530-5e3f-413f-a300-96feb2bbcfdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d7ed3530-5e3f-413f-a300-96feb2bbcfdd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d7ed3530-5e3f-413f-a300-96feb2bbcfdd" xlink:to="loc_us-gaap_PlanNameDomain_d7ed3530-5e3f-413f-a300-96feb2bbcfdd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_17972fee-993c-42ab-bcff-73881a6c114f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d7ed3530-5e3f-413f-a300-96feb2bbcfdd" xlink:to="loc_us-gaap_PlanNameDomain_17972fee-993c-42ab-bcff-73881a6c114f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2022StockPlanMember_3b35120b-406d-47b7-8dd3-e54f53d3843d" xlink:href="mck-20230331.xsd#mck_A2022StockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_17972fee-993c-42ab-bcff-73881a6c114f" xlink:to="loc_mck_A2022StockPlanMember_3b35120b-406d-47b7-8dd3-e54f53d3843d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2013StockPlanMember_06be3d9c-99f5-45f5-953c-c2795df7e49e" xlink:href="mck-20230331.xsd#mck_A2013StockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_17972fee-993c-42ab-bcff-73881a6c114f" xlink:to="loc_mck_A2013StockPlanMember_06be3d9c-99f5-45f5-953c-c2795df7e49e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3218fba7-8f00-4c28-a164-acfcc3d6b82c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:to="loc_us-gaap_AwardTypeAxis_3218fba7-8f00-4c28-a164-acfcc3d6b82c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3218fba7-8f00-4c28-a164-acfcc3d6b82c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3218fba7-8f00-4c28-a164-acfcc3d6b82c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3218fba7-8f00-4c28-a164-acfcc3d6b82c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3218fba7-8f00-4c28-a164-acfcc3d6b82c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fa81809b-827b-4fb2-ae22-afb54d1f7bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fa81809b-827b-4fb2-ae22-afb54d1f7bfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PerformancebasedStockUnitsMember_ee91bbd7-c0b9-4e85-b577-be1417016755" xlink:href="mck-20230331.xsd#mck_PerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:to="loc_mck_PerformancebasedStockUnitsMember_ee91bbd7-c0b9-4e85-b577-be1417016755" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ddd314bd-5ee3-4052-92b3-015f61031654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ddd314bd-5ee3-4052-92b3-015f61031654" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d12337ee-6e94-4bfc-843c-2d4cb8f40973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:to="loc_us-gaap_EmployeeStockMember_d12337ee-6e94-4bfc-843c-2d4cb8f40973" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f8c34e49-b61a-4376-babd-2c140665cc10" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:to="loc_srt_RangeAxis_f8c34e49-b61a-4376-babd-2c140665cc10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f8c34e49-b61a-4376-babd-2c140665cc10_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f8c34e49-b61a-4376-babd-2c140665cc10" xlink:to="loc_srt_RangeMember_f8c34e49-b61a-4376-babd-2c140665cc10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e2f780b9-5f04-498a-870e-0319b16f04fa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f8c34e49-b61a-4376-babd-2c140665cc10" xlink:to="loc_srt_RangeMember_e2f780b9-5f04-498a-870e-0319b16f04fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_27d725b3-c9a6-4b72-a191-602ffa099e9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e2f780b9-5f04-498a-870e-0319b16f04fa" xlink:to="loc_srt_MinimumMember_27d725b3-c9a6-4b72-a191-602ffa099e9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5cea6cfd-40ab-4c50-9a5f-d67860332cf6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e2f780b9-5f04-498a-870e-0319b16f04fa" xlink:to="loc_srt_MaximumMember_5cea6cfd-40ab-4c50-9a5f-d67860332cf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_d3585319-e634-4fe3-8eab-1de08ee362f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:to="loc_srt_TitleOfIndividualAxis_d3585319-e634-4fe3-8eab-1de08ee362f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d3585319-e634-4fe3-8eab-1de08ee362f6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_d3585319-e634-4fe3-8eab-1de08ee362f6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d3585319-e634-4fe3-8eab-1de08ee362f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e04497d0-f2e7-4727-a3bc-e15d3c0840ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_d3585319-e634-4fe3-8eab-1de08ee362f6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e04497d0-f2e7-4727-a3bc-e15d3c0840ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_60bb2d75-1aae-4b5e-88cd-539bd34eb783" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e04497d0-f2e7-4727-a3bc-e15d3c0840ee" xlink:to="loc_srt_DirectorMember_60bb2d75-1aae-4b5e-88cd-539bd34eb783" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="extended" id="i9dfc239a0f534eca95b31e1ae7428e59_ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0ae2a002-5127-4bc9-938d-373dff2df4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0ae2a002-5127-4bc9-938d-373dff2df4d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f41909e1-547c-4b3c-af49-9ec77145f7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f41909e1-547c-4b3c-af49-9ec77145f7dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fd2d7d1-4437-44c7-94a6-271775543ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fd2d7d1-4437-44c7-94a6-271775543ca8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f42a4d35-0858-420b-a792-0a2afb323a00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f42a4d35-0858-420b-a792-0a2afb323a00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7656d9df-fc65-46a7-89a4-cf2b65d47e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7656d9df-fc65-46a7-89a4-cf2b65d47e73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_64afce61-8bde-4d0c-ad0a-362f1857f939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7656d9df-fc65-46a7-89a4-cf2b65d47e73" xlink:to="loc_us-gaap_AwardTypeAxis_64afce61-8bde-4d0c-ad0a-362f1857f939" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_64afce61-8bde-4d0c-ad0a-362f1857f939_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_64afce61-8bde-4d0c-ad0a-362f1857f939" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_64afce61-8bde-4d0c-ad0a-362f1857f939_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a6d246cb-c17c-4209-9696-3d7ba384ea6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_64afce61-8bde-4d0c-ad0a-362f1857f939" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a6d246cb-c17c-4209-9696-3d7ba384ea6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_064f52ca-f459-48e9-b22d-a7e0e54177e6" xlink:href="mck-20230331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a6d246cb-c17c-4209-9696-3d7ba384ea6b" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_064f52ca-f459-48e9-b22d-a7e0e54177e6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="extended" id="i1ea3a804e53e4b60aa4a2b7c9eba6730_ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4396d691-60fc-4b89-95b7-518298d615ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4396d691-60fc-4b89-95b7-518298d615ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7c798371-10b0-43e4-9f22-8a8bc5f83766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7c798371-10b0-43e4-9f22-8a8bc5f83766" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_342fbbd1-e004-4d1b-8c82-3e43aaff41f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_342fbbd1-e004-4d1b-8c82-3e43aaff41f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_92607fa6-b577-4b23-b2a0-7fa10fa6e803" xlink:href="mck-20230331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_92607fa6-b577-4b23-b2a0-7fa10fa6e803" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5f57eaac-2c85-4f73-98c1-981d6f10aa31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5f57eaac-2c85-4f73-98c1-981d6f10aa31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4d2f3903-2a91-4617-99d2-c843aec4c80a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4396d691-60fc-4b89-95b7-518298d615ee" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8bdc3c9e-ad1d-4279-b237-7a30fd6dc005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8bdc3c9e-ad1d-4279-b237-7a30fd6dc005" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a7e789b9-d6d2-4da7-9ddc-9fd7dd54aef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a7e789b9-d6d2-4da7-9ddc-9fd7dd54aef1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_17feceff-e437-4ec1-a484-26f0c6df6392" xlink:href="mck-20230331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_17feceff-e437-4ec1-a484-26f0c6df6392" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e5e81d68-1cd6-4dfd-9adc-a31f1389f8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e5e81d68-1cd6-4dfd-9adc-a31f1389f8f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ae64feb4-0079-4c11-8d14-629b1da47bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eceb53b1-3674-4296-a16c-06936570cbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4396d691-60fc-4b89-95b7-518298d615ee" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eceb53b1-3674-4296-a16c-06936570cbb3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7fe94f0e-0e56-43f4-8382-bb8d1f6247cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eceb53b1-3674-4296-a16c-06936570cbb3" xlink:to="loc_us-gaap_AwardTypeAxis_7fe94f0e-0e56-43f4-8382-bb8d1f6247cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7fe94f0e-0e56-43f4-8382-bb8d1f6247cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7fe94f0e-0e56-43f4-8382-bb8d1f6247cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7fe94f0e-0e56-43f4-8382-bb8d1f6247cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7331e782-8f0a-4a03-9608-4e5be235e178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7fe94f0e-0e56-43f4-8382-bb8d1f6247cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7331e782-8f0a-4a03-9608-4e5be235e178" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_02e50a76-4fd4-4739-b6c2-79294a4be641" xlink:href="mck-20230331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7331e782-8f0a-4a03-9608-4e5be235e178" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_02e50a76-4fd4-4739-b6c2-79294a4be641" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="extended" id="i6031aea2c75e4f039bbac318fd58874c_ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f511e23b-330b-4a0b-99a4-f5fd61934e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a000b518-1e73-4997-b5f0-e63de9cbbf83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f511e23b-330b-4a0b-99a4-f5fd61934e2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a000b518-1e73-4997-b5f0-e63de9cbbf83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f646bf06-d711-4a49-91f9-529bc942529b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f511e23b-330b-4a0b-99a4-f5fd61934e2d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f646bf06-d711-4a49-91f9-529bc942529b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d0bcb600-d145-4169-b38a-ee25e2ca1240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f511e23b-330b-4a0b-99a4-f5fd61934e2d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d0bcb600-d145-4169-b38a-ee25e2ca1240" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebffcdf3-8106-4c6b-a685-12b534fa794b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f511e23b-330b-4a0b-99a4-f5fd61934e2d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebffcdf3-8106-4c6b-a685-12b534fa794b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_512d8d61-2f59-41eb-85cf-d01630cfe576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebffcdf3-8106-4c6b-a685-12b534fa794b" xlink:to="loc_us-gaap_AwardTypeAxis_512d8d61-2f59-41eb-85cf-d01630cfe576" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_512d8d61-2f59-41eb-85cf-d01630cfe576_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_512d8d61-2f59-41eb-85cf-d01630cfe576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_512d8d61-2f59-41eb-85cf-d01630cfe576_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4af17af-ad00-43d8-91c8-c249fc5b2487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_512d8d61-2f59-41eb-85cf-d01630cfe576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4af17af-ad00-43d8-91c8-c249fc5b2487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_dbcb2eb7-5921-4437-936b-d4c82c42b3d4" xlink:href="mck-20230331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4af17af-ad00-43d8-91c8-c249fc5b2487" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_dbcb2eb7-5921-4437-936b-d4c82c42b3d4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="extended" id="i646281df700f4a37a6331762fa1f0bde_ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9088e311-9f30-43bc-861f-c3e81d65e800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9088e311-9f30-43bc-861f-c3e81d65e800" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_788be0cb-674f-469a-bc15-d9290377242e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_788be0cb-674f-469a-bc15-d9290377242e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e08f45e5-a964-4322-ab5f-ed476ceeee4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e08f45e5-a964-4322-ab5f-ed476ceeee4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_c6184dc1-0107-4efc-87eb-3667edb2d0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_c6184dc1-0107-4efc-87eb-3667edb2d0a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_ca8f48f0-131e-4a45-b888-11fba81098bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_ca8f48f0-131e-4a45-b888-11fba81098bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c62c9926-4539-4e93-9614-81a70ee2ea07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c62c9926-4539-4e93-9614-81a70ee2ea07" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2cc6616e-3869-41ce-8f39-c7ca506710e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2cc6616e-3869-41ce-8f39-c7ca506710e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fc46602-d7a4-4543-b249-eb8ccb338c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fc46602-d7a4-4543-b249-eb8ccb338c3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_aa0aacb7-dc9a-4b39-bdc4-85f6168875a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fc46602-d7a4-4543-b249-eb8ccb338c3c" xlink:to="loc_us-gaap_AwardTypeAxis_aa0aacb7-dc9a-4b39-bdc4-85f6168875a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa0aacb7-dc9a-4b39-bdc4-85f6168875a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_aa0aacb7-dc9a-4b39-bdc4-85f6168875a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa0aacb7-dc9a-4b39-bdc4-85f6168875a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22e18a4e-32c1-4090-b22f-3df6d824a8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_aa0aacb7-dc9a-4b39-bdc4-85f6168875a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22e18a4e-32c1-4090-b22f-3df6d824a8a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f06c97bc-28ca-4ba2-9b4b-2b989c5dc226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22e18a4e-32c1-4090-b22f-3df6d824a8a0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f06c97bc-28ca-4ba2-9b4b-2b989c5dc226" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#OtherIncomeNetScheduleofOtherIncomeNetDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="extended" id="i0eec92b86591410f9b77ccce37a32a1b_OtherIncomeNetScheduleofOtherIncomeNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0a9c20e5-bf78-436e-94fd-d712d05765e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0a9c20e5-bf78-436e-94fd-d712d05765e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_75c4f654-7c7e-4f0a-a851-ce15b58af32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_75c4f654-7c7e-4f0a-a851-ce15b58af32b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses_b091b1e5-341e-4e08-ae48-0a1ddb260ebc" xlink:href="mck-20230331.xsd#mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:to="loc_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses_b091b1e5-341e-4e08-ae48-0a1ddb260ebc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1339c964-4fc5-4d11-a321-f5b4ce198ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1339c964-4fc5-4d11-a321-f5b4ce198ed5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_67481f6b-f565-48fc-b4dc-2b47be0d0f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_67481f6b-f565-48fc-b4dc-2b47be0d0f11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5b0b2013-ad99-4389-b2f6-705d7c0593ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5b0b2013-ad99-4389-b2f6-705d7c0593ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_1ea99464-006d-4dc0-9035-3c421f695fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_1ea99464-006d-4dc0-9035-3c421f695fee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_ac06d3ec-4d87-4b95-a99f-7fb169e11146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_us-gaap_GainLossOnContractTermination_ac06d3ec-4d87-4b95-a99f-7fb169e11146" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_6f5c109c-1e86-4bea-88af-8932aa486f2e" xlink:href="mck-20230331.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_6f5c109c-1e86-4bea-88af-8932aa486f2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnDerivativeTermination_a703d1d8-7dd7-4b40-b689-b6efb64b7071" xlink:href="mck-20230331.xsd#mck_GainLossOnDerivativeTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_mck_GainLossOnDerivativeTermination_a703d1d8-7dd7-4b40-b689-b6efb64b7071" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_336b6d45-0d88-4d2d-92af-2ecd441ef80f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_336b6d45-0d88-4d2d-92af-2ecd441ef80f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8a07048d-a11e-45e2-b267-96ae994d96d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8a07048d-a11e-45e2-b267-96ae994d96d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8a07048d-a11e-45e2-b267-96ae994d96d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8a07048d-a11e-45e2-b267-96ae994d96d7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8a07048d-a11e-45e2-b267-96ae994d96d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5561aff1-6cc8-44ab-a7cb-a75d91f2139c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8a07048d-a11e-45e2-b267-96ae994d96d7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5561aff1-6cc8-44ab-a7cb-a75d91f2139c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_e7158c61-2f36-4ffe-b9f6-dd1e3b7bddba" xlink:href="mck-20230331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5561aff1-6cc8-44ab-a7cb-a75d91f2139c" xlink:to="loc_mck_GermanWholesaleBusinessMember_e7158c61-2f36-4ffe-b9f6-dd1e3b7bddba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_80645b0f-c7ab-449d-8955-5b654358d77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_80645b0f-c7ab-449d-8955-5b654358d77a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_80645b0f-c7ab-449d-8955-5b654358d77a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_80645b0f-c7ab-449d-8955-5b654358d77a" xlink:to="loc_us-gaap_RelatedPartyDomain_80645b0f-c7ab-449d-8955-5b654358d77a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_efc4f275-835a-4d07-b547-39e12799745f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_80645b0f-c7ab-449d-8955-5b654358d77a" xlink:to="loc_us-gaap_RelatedPartyDomain_efc4f275-835a-4d07-b547-39e12799745f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_183fc3c5-5066-4ed6-a329-8c3731142453" xlink:href="mck-20230331.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_efc4f275-835a-4d07-b547-39e12799745f" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_183fc3c5-5066-4ed6-a329-8c3731142453" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d81e1347-1163-43cf-8293-c15e981cc811" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:to="loc_srt_OwnershipAxis_d81e1347-1163-43cf-8293-c15e981cc811" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_d81e1347-1163-43cf-8293-c15e981cc811_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_d81e1347-1163-43cf-8293-c15e981cc811" xlink:to="loc_srt_OwnershipDomain_d81e1347-1163-43cf-8293-c15e981cc811_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_20c164cf-1ba7-417f-90ac-f2e7e74dc50f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_d81e1347-1163-43cf-8293-c15e981cc811" xlink:to="loc_srt_OwnershipDomain_20c164cf-1ba7-417f-90ac-f2e7e74dc50f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_3deb3520-fa2a-4eaf-b696-c8e2e2d14baa" xlink:href="mck-20230331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_20c164cf-1ba7-417f-90ac-f2e7e74dc50f" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_3deb3520-fa2a-4eaf-b696-c8e2e2d14baa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b53a107f-492c-4045-b5b3-eddaf7af6c29" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:to="loc_srt_ConsolidationItemsAxis_b53a107f-492c-4045-b5b3-eddaf7af6c29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b53a107f-492c-4045-b5b3-eddaf7af6c29_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b53a107f-492c-4045-b5b3-eddaf7af6c29" xlink:to="loc_srt_ConsolidationItemsDomain_b53a107f-492c-4045-b5b3-eddaf7af6c29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a0ab65b3-7e07-46b0-ba4f-a1c5e454a575" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b53a107f-492c-4045-b5b3-eddaf7af6c29" xlink:to="loc_srt_ConsolidationItemsDomain_a0ab65b3-7e07-46b0-ba4f-a1c5e454a575" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_be2138ee-00c5-44e6-ae66-063b70f5348d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a0ab65b3-7e07-46b0-ba4f-a1c5e454a575" xlink:to="loc_us-gaap_OperatingSegmentsMember_be2138ee-00c5-44e6-ae66-063b70f5348d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4cbbe365-f154-40bc-9507-7525c00d69da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4cbbe365-f154-40bc-9507-7525c00d69da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4cbbe365-f154-40bc-9507-7525c00d69da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4cbbe365-f154-40bc-9507-7525c00d69da" xlink:to="loc_us-gaap_SegmentDomain_4cbbe365-f154-40bc-9507-7525c00d69da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2c333d6a-d5e3-4fd4-992e-9bce88aeb5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4cbbe365-f154-40bc-9507-7525c00d69da" xlink:to="loc_us-gaap_SegmentDomain_2c333d6a-d5e3-4fd4-992e-9bce88aeb5e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_270579b6-8fd7-40d8-9915-0014280919a1" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2c333d6a-d5e3-4fd4-992e-9bce88aeb5e0" xlink:to="loc_mck_USPharmaceuticalSegmentMember_270579b6-8fd7-40d8-9915-0014280919a1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i241465f6544444a9803a73f4d011c043_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_eeb549b6-2671-4f26-a9be-6ea3853380a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_eeb549b6-2671-4f26-a9be-6ea3853380a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_de15c2ba-b003-4cd7-8a61-877334ae9ac3" xlink:href="mck-20230331.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_de15c2ba-b003-4cd7-8a61-877334ae9ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount_1ebda689-169c-4c82-8c31-8544f80e23fe" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount_1ebda689-169c-4c82-8c31-8544f80e23fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ed3a3247-1001-4327-b2f7-d6db6f0ea5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ed3a3247-1001-4327-b2f7-d6db6f0ea5e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_13311f7f-18f2-4050-855b-deef8d93c46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_13311f7f-18f2-4050-855b-deef8d93c46b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_bd12d0d6-6755-40fc-b12a-e594cdffa5ec" xlink:href="mck-20230331.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_bd12d0d6-6755-40fc-b12a-e594cdffa5ec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_db9ed4fb-9bbd-4fe9-875e-8ebfa251ff3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_db9ed4fb-9bbd-4fe9-875e-8ebfa251ff3c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1234dccd-3eb2-4679-a9b3-d86fde383ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1234dccd-3eb2-4679-a9b3-d86fde383ef3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_c5d81d1a-5e41-46cc-963f-90bd92c8b8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_OperatingLossCarryforwards_c5d81d1a-5e41-46cc-963f-90bd92c8b8d6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_743806bc-bf43-469b-8b39-6ca3de413cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_743806bc-bf43-469b-8b39-6ca3de413cae" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_40df03d4-3d15-4dab-9195-64abd6347f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_40df03d4-3d15-4dab-9195-64abd6347f2d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment_b7374629-ab7d-4256-8921-cc82c752f10a" xlink:href="mck-20230331.xsd#mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment_b7374629-ab7d-4256-8921-cc82c752f10a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_98505e72-0780-43fa-b3ba-63238068dd22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_98505e72-0780-43fa-b3ba-63238068dd22" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_a63b9806-3f55-4aaf-b986-bd2a94f7f08c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_a63b9806-3f55-4aaf-b986-bd2a94f7f08c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_05b03fbe-2c1d-4925-808f-1de93d79cfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_05b03fbe-2c1d-4925-808f-1de93d79cfe2" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_6958da89-6035-4e75-b8c0-4ab74da5a32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_6958da89-6035-4e75-b8c0-4ab74da5a32d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_6958da89-6035-4e75-b8c0-4ab74da5a32d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_6958da89-6035-4e75-b8c0-4ab74da5a32d" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_6958da89-6035-4e75-b8c0-4ab74da5a32d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_e7e740ae-cb20-443d-9e2c-fb6b33eefb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_6958da89-6035-4e75-b8c0-4ab74da5a32d" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_e7e740ae-cb20-443d-9e2c-fb6b33eefb72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_6057ee84-84da-4a10-adac-bfa50e8d0a36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_e7e740ae-cb20-443d-9e2c-fb6b33eefb72" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_6057ee84-84da-4a10-adac-bfa50e8d0a36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d375e882-6eba-4fbc-ac6b-92e6007fec49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d375e882-6eba-4fbc-ac6b-92e6007fec49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d375e882-6eba-4fbc-ac6b-92e6007fec49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d375e882-6eba-4fbc-ac6b-92e6007fec49" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d375e882-6eba-4fbc-ac6b-92e6007fec49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_8586724e-5dbc-4aa8-9e2c-fa5011828190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d375e882-6eba-4fbc-ac6b-92e6007fec49" xlink:to="loc_us-gaap_LossContingencyNatureDomain_8586724e-5dbc-4aa8-9e2c-fa5011828190" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_4db33021-4b1e-44ee-ab43-2fb76d1f161b" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8586724e-5dbc-4aa8-9e2c-fa5011828190" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_4db33021-4b1e-44ee-ab43-2fb76d1f161b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cc9a985b-7a78-4200-9e97-559ae7b89e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cc9a985b-7a78-4200-9e97-559ae7b89e6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cc9a985b-7a78-4200-9e97-559ae7b89e6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cc9a985b-7a78-4200-9e97-559ae7b89e6a" xlink:to="loc_us-gaap_SegmentDomain_cc9a985b-7a78-4200-9e97-559ae7b89e6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d2dab8e1-da2b-4656-8bb8-4b8bd8856682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cc9a985b-7a78-4200-9e97-559ae7b89e6a" xlink:to="loc_us-gaap_SegmentDomain_d2dab8e1-da2b-4656-8bb8-4b8bd8856682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_6736e5f6-15be-4a4a-bc96-21603855be52" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d2dab8e1-da2b-4656-8bb8-4b8bd8856682" xlink:to="loc_mck_InternationalSegmentMember_6736e5f6-15be-4a4a-bc96-21603855be52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_d5123484-05ba-4835-a523-bb3bd769b3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_d5123484-05ba-4835-a523-bb3bd769b3c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d5123484-05ba-4835-a523-bb3bd769b3c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_d5123484-05ba-4835-a523-bb3bd769b3c0" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d5123484-05ba-4835-a523-bb3bd769b3c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_4bf6d0a0-979c-4134-beee-d8fccd8323dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_d5123484-05ba-4835-a523-bb3bd769b3c0" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_4bf6d0a0-979c-4134-beee-d8fccd8323dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_1abb979f-37aa-4177-b9fb-3471f90824c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4bf6d0a0-979c-4134-beee-d8fccd8323dc" xlink:to="loc_us-gaap_DomesticCountryMember_1abb979f-37aa-4177-b9fb-3471f90824c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_198e5737-20d4-49fc-93cc-6bb2178b87aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4bf6d0a0-979c-4134-beee-d8fccd8323dc" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_198e5737-20d4-49fc-93cc-6bb2178b87aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_8b7d7074-ddf0-456d-bf52-e640731fe2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4bf6d0a0-979c-4134-beee-d8fccd8323dc" xlink:to="loc_us-gaap_ForeignCountryMember_8b7d7074-ddf0-456d-bf52-e640731fe2ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_255e7e80-ca59-444e-b8cc-0d3a8a5747fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_255e7e80-ca59-444e-b8cc-0d3a8a5747fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_255e7e80-ca59-444e-b8cc-0d3a8a5747fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_255e7e80-ca59-444e-b8cc-0d3a8a5747fd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_255e7e80-ca59-444e-b8cc-0d3a8a5747fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ae1ccd38-53be-4daf-ba55-d130788a1505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_255e7e80-ca59-444e-b8cc-0d3a8a5747fd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ae1ccd38-53be-4daf-ba55-d130788a1505" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_567a5c5e-13ff-4b61-918f-22437fa47526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ae1ccd38-53be-4daf-ba55-d130788a1505" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_567a5c5e-13ff-4b61-918f-22437fa47526" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fac86b6b-548d-4a44-aceb-2e13a7becb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fac86b6b-548d-4a44-aceb-2e13a7becb5b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fac86b6b-548d-4a44-aceb-2e13a7becb5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fac86b6b-548d-4a44-aceb-2e13a7becb5b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fac86b6b-548d-4a44-aceb-2e13a7becb5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f3250c30-930b-4033-a406-8c4f7a619f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fac86b6b-548d-4a44-aceb-2e13a7becb5b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f3250c30-930b-4033-a406-8c4f7a619f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_191e7e61-3284-4b36-a5b4-c53cf824dd3f" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f3250c30-930b-4033-a406-8c4f7a619f69" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_191e7e61-3284-4b36-a5b4-c53cf824dd3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_46f943f5-3d45-4d7e-8d80-cb8ec7a1e12e" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupAndAustrianBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f3250c30-930b-4033-a406-8c4f7a619f69" xlink:to="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_46f943f5-3d45-4d7e-8d80-cb8ec7a1e12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_aee9060e-5852-479e-8beb-64a2f849fdfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_LitigationStatusAxis_aee9060e-5852-479e-8beb-64a2f849fdfa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_aee9060e-5852-479e-8beb-64a2f849fdfa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_aee9060e-5852-479e-8beb-64a2f849fdfa" xlink:to="loc_us-gaap_LitigationStatusDomain_aee9060e-5852-479e-8beb-64a2f849fdfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_eddab60b-25a2-42f2-b0a4-043f2ea5eb50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_aee9060e-5852-479e-8beb-64a2f849fdfa" xlink:to="loc_us-gaap_LitigationStatusDomain_eddab60b-25a2-42f2-b0a4-043f2ea5eb50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_1cffacd8-ed37-4813-84ff-15b65e6da8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_eddab60b-25a2-42f2-b0a4-043f2ea5eb50" xlink:to="loc_us-gaap_PendingLitigationMember_1cffacd8-ed37-4813-84ff-15b65e6da8e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e9a91119-8bc1-4545-af8c-937e923cdaa0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_srt_RangeAxis_e9a91119-8bc1-4545-af8c-937e923cdaa0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e9a91119-8bc1-4545-af8c-937e923cdaa0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e9a91119-8bc1-4545-af8c-937e923cdaa0" xlink:to="loc_srt_RangeMember_e9a91119-8bc1-4545-af8c-937e923cdaa0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16b830e8-b3a2-402b-893f-6ec1c07bf48a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e9a91119-8bc1-4545-af8c-937e923cdaa0" xlink:to="loc_srt_RangeMember_16b830e8-b3a2-402b-893f-6ec1c07bf48a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_53abbe7e-83da-4f81-a25e-83ee3cb81128" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16b830e8-b3a2-402b-893f-6ec1c07bf48a" xlink:to="loc_srt_MinimumMember_53abbe7e-83da-4f81-a25e-83ee3cb81128" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fc7f5f6e-5bc9-44e9-bb56-a129f3ab385c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16b830e8-b3a2-402b-893f-6ec1c07bf48a" xlink:to="loc_srt_MaximumMember_fc7f5f6e-5bc9-44e9-bb56-a129f3ab385c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesComponentsOfDeferredTaxBalancesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="extended" id="if4159c4e68c04c50b77f7e4291e0f340_IncomeTaxesComponentsOfDeferredTaxBalancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:to="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_39f078bf-6364-4706-9b4c-b0b37fffa42a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_39f078bf-6364-4706-9b4c-b0b37fffa42a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLitigationAndClaims_6a39afad-387b-428f-8441-3fdefa24bd04" xlink:href="mck-20230331.xsd#mck_DeferredTaxAssetLitigationAndClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_mck_DeferredTaxAssetLitigationAndClaims_6a39afad-387b-428f-8441-3fdefa24bd04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_b65a4b5b-a812-4dec-b57b-bab41f34a604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_b65a4b5b-a812-4dec-b57b-bab41f34a604" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ae41be77-7c4a-4abd-9f17-e6abb124759c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ae41be77-7c4a-4abd-9f17-e6abb124759c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLeaseObligations_13771f70-6226-4955-99c3-70742b5a6149" xlink:href="mck-20230331.xsd#mck_DeferredTaxAssetLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_mck_DeferredTaxAssetLeaseObligations_13771f70-6226-4955-99c3-70742b5a6149" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_af12fa1f-bc14-42a2-80ae-0f46bfeea6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_af12fa1f-bc14-42a2-80ae-0f46bfeea6f0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_694b7bc0-8d53-408c-bfaa-75be31a1b25f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_694b7bc0-8d53-408c-bfaa-75be31a1b25f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9d77acca-af55-4bd0-a2f2-592998f29260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9d77acca-af55-4bd0-a2f2-592998f29260" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_18079f16-a0ed-4db5-9df2-2c2d7b700bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_18079f16-a0ed-4db5-9df2-2c2d7b700bb8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:to="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_9df589fa-a78a-4681-bb4b-4c60912689d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_9df589fa-a78a-4681-bb4b-4c60912689d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_899b83b9-e046-4994-af17-7de205bd3bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_899b83b9-e046-4994-af17-7de205bd3bfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_639298d9-b9b9-4242-97cf-040b9235b818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_639298d9-b9b9-4242-97cf-040b9235b818" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_794a2a6d-cf52-4a48-b493-856057841d63" xlink:href="mck-20230331.xsd#mck_DeferredTaxLiabilitiesLeaseRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_794a2a6d-cf52-4a48-b493-856057841d63" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_3b9405dd-68e3-4819-b2b9-0c5524044f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_3b9405dd-68e3-4819-b2b9-0c5524044f3f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e9ab76c5-57c1-45d5-ad0a-1152e3f7b509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e9ab76c5-57c1-45d5-ad0a-1152e3f7b509" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_d038e780-ba61-4a71-a518-294abc50cae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:to="loc_us-gaap_DeferredTaxLiabilities_d038e780-ba61-4a71-a518-294abc50cae4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e78f2e9-bb40-43d4-b818-2d463266eba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e78f2e9-bb40-43d4-b818-2d463266eba0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fae46e14-1be6-4e5b-bdfb-bd661bc01528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fae46e14-1be6-4e5b-bdfb-bd661bc01528" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_19f35ba1-c960-4e77-bb1b-fca5513b9882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_19f35ba1-c960-4e77-bb1b-fca5513b9882" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_f3e34359-d49a-49f1-82ed-b45c9a2785af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_19f35ba1-c960-4e77-bb1b-fca5513b9882" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_f3e34359-d49a-49f1-82ed-b45c9a2785af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f3e34359-d49a-49f1-82ed-b45c9a2785af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f3e34359-d49a-49f1-82ed-b45c9a2785af" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f3e34359-d49a-49f1-82ed-b45c9a2785af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3c8141ed-ab6e-441b-b044-affbfa638043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f3e34359-d49a-49f1-82ed-b45c9a2785af" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3c8141ed-ab6e-441b-b044-affbfa638043" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_544ad687-ea4a-42cf-8a14-a06524bff1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3c8141ed-ab6e-441b-b044-affbfa638043" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_544ad687-ea4a-42cf-8a14-a06524bff1f4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended" id="ibc27214fa49244729d5f9f6c95e52317_RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_00039828-3bf7-40eb-8bc7-a1c75b83ae9d" xlink:href="mck-20230331.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_00039828-3bf7-40eb-8bc7-a1c75b83ae9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_46dbd9f6-1d13-4f24-a65a-65d1bd610a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_46dbd9f6-1d13-4f24-a65a-65d1bd610a30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_0fd27902-6cec-4682-ba6f-cc22ea8d7365" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_0fd27902-6cec-4682-ba6f-cc22ea8d7365" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_e84589b0-5bb2-4114-9dd1-d5f52ce4543a" xlink:href="mck-20230331.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_PutRightValueInterestRateSpread_e84589b0-5bb2-4114-9dd1-d5f52ce4543a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_0b3fb824-b90a-4763-8216-a02c1d7790e7" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_0b3fb824-b90a-4763-8216-a02c1d7790e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_ff6746ef-5061-4aae-8e8b-fd14f58bc22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_ff6746ef-5061-4aae-8e8b-fd14f58bc22e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_5d04d57f-7146-45a2-bd9f-f0af2d2917b7" xlink:href="mck-20230331.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_5d04d57f-7146-45a2-bd9f-f0af2d2917b7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_a33ddaa5-c468-4e8f-9516-20ce67ac9f2c" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_a33ddaa5-c468-4e8f-9516-20ce67ac9f2c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_6fc8d6d8-edf6-40f5-84a3-11754d4b44dd" xlink:href="mck-20230331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_6fc8d6d8-edf6-40f5-84a3-11754d4b44dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_55b74e34-46dd-4f21-bfa9-18a3fb983772" xlink:href="mck-20230331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_55b74e34-46dd-4f21-bfa9-18a3fb983772" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_373fd5c1-97cd-4cdf-9bcb-bccdd74ee746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_373fd5c1-97cd-4cdf-9bcb-bccdd74ee746" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_4b75c299-d5ab-4b91-a9bb-98391fd7a2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_us-gaap_MinorityInterest_4b75c299-d5ab-4b91-a9bb-98391fd7a2d9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d807650f-a21c-4e37-aeaa-5af6c63fe292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d807650f-a21c-4e37-aeaa-5af6c63fe292" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_79f8da15-ee21-4196-b7ad-9b8a19d9a518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_us-gaap_MinorityInterestTable_79f8da15-ee21-4196-b7ad-9b8a19d9a518" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_90a318d4-b27b-4cd8-9490-475e29f03bd2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_79f8da15-ee21-4196-b7ad-9b8a19d9a518" xlink:to="loc_dei_LegalEntityAxis_90a318d4-b27b-4cd8-9490-475e29f03bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_90a318d4-b27b-4cd8-9490-475e29f03bd2_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_90a318d4-b27b-4cd8-9490-475e29f03bd2" xlink:to="loc_dei_EntityDomain_90a318d4-b27b-4cd8-9490-475e29f03bd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5dae8dcc-b8c4-441f-8167-3e343bade2a0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_90a318d4-b27b-4cd8-9490-475e29f03bd2" xlink:to="loc_dei_EntityDomain_5dae8dcc-b8c4-441f-8167-3e343bade2a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_e7959347-a28c-4699-87a0-8802ef7fa086" xlink:href="mck-20230331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5dae8dcc-b8c4-441f-8167-3e343bade2a0" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_e7959347-a28c-4699-87a0-8802ef7fa086" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_8a9fc9b2-47cf-4b63-96a9-682c059f69f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_79f8da15-ee21-4196-b7ad-9b8a19d9a518" xlink:to="loc_srt_OwnershipAxis_8a9fc9b2-47cf-4b63-96a9-682c059f69f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_8a9fc9b2-47cf-4b63-96a9-682c059f69f7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_8a9fc9b2-47cf-4b63-96a9-682c059f69f7" xlink:to="loc_srt_OwnershipDomain_8a9fc9b2-47cf-4b63-96a9-682c059f69f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_cb40f38d-ce02-4c62-96ad-4d4dd51e2254" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_8a9fc9b2-47cf-4b63-96a9-682c059f69f7" xlink:to="loc_srt_OwnershipDomain_cb40f38d-ce02-4c62-96ad-4d4dd51e2254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_b883b12c-f0e0-48c3-8169-c77d52cbfc80" xlink:href="mck-20230331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_cb40f38d-ce02-4c62-96ad-4d4dd51e2254" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_b883b12c-f0e0-48c3-8169-c77d52cbfc80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_98355d90-b9d9-4bf0-accc-74de599d5534" xlink:href="mck-20230331.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_cb40f38d-ce02-4c62-96ad-4d4dd51e2254" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_98355d90-b9d9-4bf0-accc-74de599d5534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_df892de1-be7e-4098-ab58-394e90186717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_79f8da15-ee21-4196-b7ad-9b8a19d9a518" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_df892de1-be7e-4098-ab58-394e90186717" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_df892de1-be7e-4098-ab58-394e90186717_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_df892de1-be7e-4098-ab58-394e90186717" xlink:to="loc_us-gaap_EquityComponentDomain_df892de1-be7e-4098-ab58-394e90186717_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0fc30b50-d0dd-4183-aa47-db8b5b2fd583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_df892de1-be7e-4098-ab58-394e90186717" xlink:to="loc_us-gaap_EquityComponentDomain_0fc30b50-d0dd-4183-aa47-db8b5b2fd583" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_ec997bfc-c36f-4782-9a0f-c77b57eb662a" xlink:href="mck-20230331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0fc30b50-d0dd-4183-aa47-db8b5b2fd583" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_ec997bfc-c36f-4782-9a0f-c77b57eb662a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c124ecc0-699d-469a-8b39-e9b3cddb3a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0fc30b50-d0dd-4183-aa47-db8b5b2fd583" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c124ecc0-699d-469a-8b39-e9b3cddb3a4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_4d936971-15c9-4628-8b38-be8892f06347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0fc30b50-d0dd-4183-aa47-db8b5b2fd583" xlink:to="loc_us-gaap_NoncontrollingInterestMember_4d936971-15c9-4628-8b38-be8892f06347" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="extended" id="i95309d67794643568f5afb139be2c22e_RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_5d772b89-38ef-47b5-9609-3cc2f28ec5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_5d772b89-38ef-47b5-9609-3cc2f28ec5ed" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_772e82b4-283a-47f8-9315-f212548b1117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_MinorityInterest_772e82b4-283a-47f8-9315-f212548b1117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_7a1441fe-b7d9-4428-9380-80b1732f3b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_7a1441fe-b7d9-4428-9380-80b1732f3b07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_efe698aa-3927-4fee-a620-c112a90cf071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_efe698aa-3927-4fee-a620-c112a90cf071" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_06d44fc2-f3bc-40b7-a9d1-408e5bacb389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_06d44fc2-f3bc-40b7-a9d1-408e5bacb389" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_45dd8fbf-0e48-4634-aefa-a997fff5b052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_45dd8fbf-0e48-4634-aefa-a997fff5b052" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_94d8ae7d-0554-438b-accd-b2d3fcf5307e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_94d8ae7d-0554-438b-accd-b2d3fcf5307e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_b050cf6b-ab78-4bd9-b2af-914296d732e2" xlink:href="mck-20230331.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_b050cf6b-ab78-4bd9-b2af-914296d732e2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_6a4a15ac-a8d0-4340-8664-2033602cac6d" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_6a4a15ac-a8d0-4340-8664-2033602cac6d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_0b784432-3c8b-4747-852c-763735ef3dfc" xlink:href="mck-20230331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_0b784432-3c8b-4747-852c-763735ef3dfc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FormationOfBusiness_45f51bdd-1177-4f6f-97bc-fa7808c348ff" xlink:href="mck-20230331.xsd#mck_FormationOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_FormationOfBusiness_45f51bdd-1177-4f6f-97bc-fa7808c348ff" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DerecognitionOfNoncontrollingInterests_03f56595-6b89-466e-adab-422dda20e87d" xlink:href="mck-20230331.xsd#mck_DerecognitionOfNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_DerecognitionOfNoncontrollingInterests_03f56595-6b89-466e-adab-422dda20e87d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_5f457c48-977d-4bba-a001-d1c56e426e03" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_5f457c48-977d-4bba-a001-d1c56e426e03" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_efe860c2-80df-4302-be80-962277b65e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_983195cd-9f20-4790-8bed-b2ec2bf7accd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_2ba1d655-86e7-40e7-b26e-b4bdc0321805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_5d772b89-38ef-47b5-9609-3cc2f28ec5ed" xlink:to="loc_us-gaap_MinorityInterestTable_2ba1d655-86e7-40e7-b26e-b4bdc0321805" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_74a101fe-dfdd-45b8-a2f7-e2ce0f2ff4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_2ba1d655-86e7-40e7-b26e-b4bdc0321805" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_74a101fe-dfdd-45b8-a2f7-e2ce0f2ff4d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_74a101fe-dfdd-45b8-a2f7-e2ce0f2ff4d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74a101fe-dfdd-45b8-a2f7-e2ce0f2ff4d2" xlink:to="loc_us-gaap_EquityComponentDomain_74a101fe-dfdd-45b8-a2f7-e2ce0f2ff4d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_290ae2cf-8998-4c8b-8b6c-338fcdc49ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74a101fe-dfdd-45b8-a2f7-e2ce0f2ff4d2" xlink:to="loc_us-gaap_EquityComponentDomain_290ae2cf-8998-4c8b-8b6c-338fcdc49ed1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_4e46e8f5-c0db-496e-9c0b-79165acb6993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_290ae2cf-8998-4c8b-8b6c-338fcdc49ed1" xlink:to="loc_us-gaap_NoncontrollingInterestMember_4e46e8f5-c0db-496e-9c0b-79165acb6993" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_f6c9cea1-f099-43df-ab7c-b1220f487953" xlink:href="mck-20230331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_290ae2cf-8998-4c8b-8b6c-338fcdc49ed1" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_f6c9cea1-f099-43df-ab7c-b1220f487953" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended" id="i5baa62c80def44c0bfca27eb569c1f69_EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2517d1fa-5b72-4d0f-a899-2c3a540db226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2517d1fa-5b72-4d0f-a899-2c3a540db226" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f37c6fa6-b5b4-4bd0-8d4c-3d965b925a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f37c6fa6-b5b4-4bd0-8d4c-3d965b925a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_dd42e761-74c9-4918-a2c6-384e92b72093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_dd42e761-74c9-4918-a2c6-384e92b72093" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3d8a3f38-571a-4c44-914f-8ef7b1e71eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3d8a3f38-571a-4c44-914f-8ef7b1e71eef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0bc06f21-3094-4c1d-b911-2697b61eb309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_NetIncomeLoss_0bc06f21-3094-4c1d-b911-2697b61eb309" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6af3b398-8781-4ae0-b5ec-53e208fd1422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6af3b398-8781-4ae0-b5ec-53e208fd1422" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bcb4f145-d3d9-465e-a7a2-74ef23d046ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6af3b398-8781-4ae0-b5ec-53e208fd1422" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bcb4f145-d3d9-465e-a7a2-74ef23d046ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b9c90a86-dddc-4a10-87d6-68a748b23a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b9c90a86-dddc-4a10-87d6-68a748b23a9b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9f5024ae-02dc-47ac-8c5f-1f3dbb99fad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9f5024ae-02dc-47ac-8c5f-1f3dbb99fad5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EPSBasicAndDilutedAbstract_9e0ec922-470a-4ff1-96f8-265c68727f2e" xlink:href="mck-20230331.xsd#mck_EPSBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_mck_EPSBasicAndDilutedAbstract_9e0ec922-470a-4ff1-96f8-265c68727f2e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_dbef0acd-6408-4dad-9056-5cb2c718343a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_9e0ec922-470a-4ff1-96f8-265c68727f2e" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_dbef0acd-6408-4dad-9056-5cb2c718343a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_873af286-09d9-4857-a2ac-c1711e35eb84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_dbef0acd-6408-4dad-9056-5cb2c718343a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_873af286-09d9-4857-a2ac-c1711e35eb84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_515b6320-41f1-4978-a586-5e5796642153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_dbef0acd-6408-4dad-9056-5cb2c718343a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_515b6320-41f1-4978-a586-5e5796642153" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8faf02f8-3525-42e1-9157-35e671160d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_dbef0acd-6408-4dad-9056-5cb2c718343a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8faf02f8-3525-42e1-9157-35e671160d66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_0ee66093-1a4d-469c-836c-552d8f1e2ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_9e0ec922-470a-4ff1-96f8-265c68727f2e" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_0ee66093-1a4d-469c-836c-552d8f1e2ba6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_32ca1807-9653-4591-bef6-84715547ca30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0ee66093-1a4d-469c-836c-552d8f1e2ba6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_32ca1807-9653-4591-bef6-84715547ca30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_ba266a7a-bdb1-41ed-865d-8672fe1bc9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0ee66093-1a4d-469c-836c-552d8f1e2ba6" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_ba266a7a-bdb1-41ed-865d-8672fe1bc9b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d7a8ed82-092f-430c-809d-e3c1f9e09a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0ee66093-1a4d-469c-836c-552d8f1e2ba6" xlink:to="loc_us-gaap_EarningsPerShareBasic_d7a8ed82-092f-430c-809d-e3c1f9e09a40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf669a06-3fc8-4121-a6e8-88ad61605931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf669a06-3fc8-4121-a6e8-88ad61605931" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_53b0d331-a710-48c5-8681-0ccd41c884d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf669a06-3fc8-4121-a6e8-88ad61605931" xlink:to="loc_us-gaap_AwardTypeAxis_53b0d331-a710-48c5-8681-0ccd41c884d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53b0d331-a710-48c5-8681-0ccd41c884d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_53b0d331-a710-48c5-8681-0ccd41c884d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53b0d331-a710-48c5-8681-0ccd41c884d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01a3604b-a18e-4b21-bbe9-f436f2a6edb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_53b0d331-a710-48c5-8681-0ccd41c884d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01a3604b-a18e-4b21-bbe9-f436f2a6edb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4161447c-ccc8-4965-aec9-c5b1c8712e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01a3604b-a18e-4b21-bbe9-f436f2a6edb4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4161447c-ccc8-4965-aec9-c5b1c8712e2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_cd550c85-c8c7-42c2-808b-15130b49e557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01a3604b-a18e-4b21-bbe9-f436f2a6edb4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_cd550c85-c8c7-42c2-808b-15130b49e557" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i2c743468a8364166913acece671ad210_LeasesSupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e970d251-8ac0-4512-9d50-e01209637db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e970d251-8ac0-4512-9d50-e01209637db3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0f5dac67-9dad-4304-8844-b8e79ce29317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0f5dac67-9dad-4304-8844-b8e79ce29317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e63d23b1-8d44-4d83-89cb-1478cc73f3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e63d23b1-8d44-4d83-89cb-1478cc73f3a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_4f4ae5da-cea4-404d-a856-72ad3feebab0" xlink:href="mck-20230331.xsd#mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_4f4ae5da-cea4-404d-a856-72ad3feebab0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fa1e2d64-1f47-41fc-982c-f5195082c984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_82f831ae-3bc2-4ad4-9a97-395d935b3ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1d407eba-c672-443c-bf97-222f972dd280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b3ae8739-07f7-4f79-82cd-8efa7e5c6f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_4f4ae5da-cea4-404d-a856-72ad3feebab0" xlink:to="loc_us-gaap_OperatingLeaseLiability_b3ae8739-07f7-4f79-82cd-8efa7e5c6f44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:href="mck-20230331.xsd#mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_7f51f146-3ad5-458e-8429-4a0e9fc7986a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_7f51f146-3ad5-458e-8429-4a0e9fc7986a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f53ff49e-32cc-4144-8204-1526548348fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f53ff49e-32cc-4144-8204-1526548348fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_34ac1227-54ba-4a5c-a323-802231caf700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_34ac1227-54ba-4a5c-a323-802231caf700" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_fb4b6a95-7c24-4bbd-ada8-306972cb2420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_fb4b6a95-7c24-4bbd-ada8-306972cb2420" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5fd3b9fd-2b5e-4162-abb2-3a4ea6e9b424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5fd3b9fd-2b5e-4162-abb2-3a4ea6e9b424" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_3d0c2e1d-d43d-4659-8dd6-9e68e35f73ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_3d0c2e1d-d43d-4659-8dd6-9e68e35f73ad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_fdd24ff8-62c7-4d6c-9bae-9f61b9e64c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseLiability_fdd24ff8-62c7-4d6c-9bae-9f61b9e64c56" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WeightedAverageRemainingLeaseTermAbstract_074e50a9-82a0-4dcc-8106-14de6054ccac" xlink:href="mck-20230331.xsd#mck_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_mck_WeightedAverageRemainingLeaseTermAbstract_074e50a9-82a0-4dcc-8106-14de6054ccac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e72d75fa-b257-4495-9156-1c7b8f920693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_WeightedAverageRemainingLeaseTermAbstract_074e50a9-82a0-4dcc-8106-14de6054ccac" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e72d75fa-b257-4495-9156-1c7b8f920693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_34ffa244-b90f-480a-b3a8-45f215a32905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_WeightedAverageRemainingLeaseTermAbstract_074e50a9-82a0-4dcc-8106-14de6054ccac" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_34ffa244-b90f-480a-b3a8-45f215a32905" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeasesWeightedAverageDiscountRateAbstract_d7fecf54-06fa-4ffa-bcfc-1fe5f75e708e" xlink:href="mck-20230331.xsd#mck_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_mck_LeasesWeightedAverageDiscountRateAbstract_d7fecf54-06fa-4ffa-bcfc-1fe5f75e708e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fb7d827f-7498-4f98-99aa-15bb2a4c0e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_LeasesWeightedAverageDiscountRateAbstract_d7fecf54-06fa-4ffa-bcfc-1fe5f75e708e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fb7d827f-7498-4f98-99aa-15bb2a4c0e95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_0c3d1422-73fe-4774-9716-4550d201c96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_LeasesWeightedAverageDiscountRateAbstract_d7fecf54-06fa-4ffa-bcfc-1fe5f75e708e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_0c3d1422-73fe-4774-9716-4550d201c96e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_8bf288b9-60f0-4f72-bd4c-6e6542a95d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_8bf288b9-60f0-4f72-bd4c-6e6542a95d6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ae8792e6-1c93-4c22-a2d6-8dd7aef564b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_8bf288b9-60f0-4f72-bd4c-6e6542a95d6f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ae8792e6-1c93-4c22-a2d6-8dd7aef564b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ae8792e6-1c93-4c22-a2d6-8dd7aef564b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ae8792e6-1c93-4c22-a2d6-8dd7aef564b2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ae8792e6-1c93-4c22-a2d6-8dd7aef564b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_732358aa-46ac-48bd-ae50-1cfce1f251dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ae8792e6-1c93-4c22-a2d6-8dd7aef564b2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_732358aa-46ac-48bd-ae50-1cfce1f251dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4dbee5bd-1315-445d-aeb1-73d8152b4db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_732358aa-46ac-48bd-ae50-1cfce1f251dd" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4dbee5bd-1315-445d-aeb1-73d8152b4db3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e9e40009-57cd-47c9-8571-b8c2493c60d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_8bf288b9-60f0-4f72-bd4c-6e6542a95d6f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e9e40009-57cd-47c9-8571-b8c2493c60d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e9e40009-57cd-47c9-8571-b8c2493c60d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e9e40009-57cd-47c9-8571-b8c2493c60d0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e9e40009-57cd-47c9-8571-b8c2493c60d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_284622e2-8df2-4458-89b7-cdb3b274984b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e9e40009-57cd-47c9-8571-b8c2493c60d0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_284622e2-8df2-4458-89b7-cdb3b274984b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_5ed5cf9f-f80a-4515-a229-720d74c5e2e1" xlink:href="mck-20230331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_284622e2-8df2-4458-89b7-cdb3b274984b" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_5ed5cf9f-f80a-4515-a229-720d74c5e2e1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="extended" id="ie1d8457cd5d040b9a6404d1a0ad3616a_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_51c64d13-796b-4db7-8fef-ccacba54b1b9" xlink:href="mck-20230331.xsd#mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:to="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_51c64d13-796b-4db7-8fef-ccacba54b1b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_59cc2458-e35d-4fb6-a4c3-0baf8a490254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_59cc2458-e35d-4fb6-a4c3-0baf8a490254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_c4859bba-96a0-49ee-b80a-b41e86316349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_c4859bba-96a0-49ee-b80a-b41e86316349" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_361cf8fe-9d74-492c-bcb6-5a95366f76ec" xlink:href="mck-20230331.xsd#mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:to="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_361cf8fe-9d74-492c-bcb6-5a95366f76ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_84777c9b-a079-4e36-8852-6fcb874dea20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_84777c9b-a079-4e36-8852-6fcb874dea20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f129597b-cb85-4feb-ac9a-0d1c7d30a4c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_84777c9b-a079-4e36-8852-6fcb874dea20" xlink:to="loc_srt_RangeAxis_f129597b-cb85-4feb-ac9a-0d1c7d30a4c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f129597b-cb85-4feb-ac9a-0d1c7d30a4c2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f129597b-cb85-4feb-ac9a-0d1c7d30a4c2" xlink:to="loc_srt_RangeMember_f129597b-cb85-4feb-ac9a-0d1c7d30a4c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_18d91785-83bc-413c-9550-ca4cca3956a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f129597b-cb85-4feb-ac9a-0d1c7d30a4c2" xlink:to="loc_srt_RangeMember_18d91785-83bc-413c-9550-ca4cca3956a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d541ca3e-664f-4708-9f87-47ebb0cd69d9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_18d91785-83bc-413c-9550-ca4cca3956a2" xlink:to="loc_srt_MinimumMember_d541ca3e-664f-4708-9f87-47ebb0cd69d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ce40625a-bf38-4fc9-bba9-d248fa3e783b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_18d91785-83bc-413c-9550-ca4cca3956a2" xlink:to="loc_srt_MaximumMember_ce40625a-bf38-4fc9-bba9-d248fa3e783b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended" id="ie0e9988b506444e1a0b96312343e9994_GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_4114639a-e381-481d-b9c2-e13077c773b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_4114639a-e381-481d-b9c2-e13077c773b4" xlink:to="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4eb4c339-cd0a-4e37-b7d2-2948bbbbb6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:to="loc_us-gaap_Goodwill_4eb4c339-cd0a-4e37-b7d2-2948bbbbb6b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_388978bb-5a9f-4277-a4d2-0a2b021da068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_388978bb-5a9f-4277-a4d2-0a2b021da068" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0e083dd0-2864-4bbb-a411-240f7a423888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0e083dd0-2864-4bbb-a411-240f7a423888" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_497e0426-37aa-41c9-8c90-b446d6d3bad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_497e0426-37aa-41c9-8c90-b446d6d3bad3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c75fe8a6-bb99-4556-aa1f-ef6673c92d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_46a9f8d7-2c2a-4181-9836-7431848ac403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_4114639a-e381-481d-b9c2-e13077c773b4" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_46a9f8d7-2c2a-4181-9836-7431848ac403" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a791d4ef-37c4-422b-8a96-b8cb45555cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_46a9f8d7-2c2a-4181-9836-7431848ac403" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a791d4ef-37c4-422b-8a96-b8cb45555cd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a791d4ef-37c4-422b-8a96-b8cb45555cd3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a791d4ef-37c4-422b-8a96-b8cb45555cd3" xlink:to="loc_us-gaap_SegmentDomain_a791d4ef-37c4-422b-8a96-b8cb45555cd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a791d4ef-37c4-422b-8a96-b8cb45555cd3" xlink:to="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_781c8279-1e20-4d37-a55a-507c4a482e7a" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:to="loc_mck_USPharmaceuticalSegmentMember_781c8279-1e20-4d37-a55a-507c4a482e7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_c5bc274a-1035-48b9-b215-875bc452d822" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_c5bc274a-1035-48b9-b215-875bc452d822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_e3f5743c-0a7a-4bc8-a674-e04b62ed27e9" xlink:href="mck-20230331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_e3f5743c-0a7a-4bc8-a674-e04b62ed27e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_f97f1c59-6737-4aff-8b71-2973c1d117dd" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:to="loc_mck_InternationalSegmentMember_f97f1c59-6737-4aff-8b71-2973c1d117dd" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="extended" id="id9a6fdb5f9a849c2b396d17eaeea2be3_GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_8deae261-c43e-4368-9370-40feaaa70f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_d4d5c965-1def-4a49-a554-f014bd2c9117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8deae261-c43e-4368-9370-40feaaa70f1b" xlink:to="loc_us-gaap_NumberOfReportableSegments_d4d5c965-1def-4a49-a554-f014bd2c9117" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f8450270-bf77-47f7-818c-0e82e2295f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_8deae261-c43e-4368-9370-40feaaa70f1b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f8450270-bf77-47f7-818c-0e82e2295f5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7238abab-a05b-4a98-9731-16252f11a6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_8deae261-c43e-4368-9370-40feaaa70f1b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7238abab-a05b-4a98-9731-16252f11a6c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_c8308110-36b6-4109-9dd2-90a0b35bd9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7238abab-a05b-4a98-9731-16252f11a6c3" xlink:to="loc_us-gaap_ReportingUnitAxis_c8308110-36b6-4109-9dd2-90a0b35bd9a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_c8308110-36b6-4109-9dd2-90a0b35bd9a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_c8308110-36b6-4109-9dd2-90a0b35bd9a2" xlink:to="loc_us-gaap_ReportingUnitDomain_c8308110-36b6-4109-9dd2-90a0b35bd9a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_6917a62b-d4da-4a4f-8669-ad3ea9452ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_c8308110-36b6-4109-9dd2-90a0b35bd9a2" xlink:to="loc_us-gaap_ReportingUnitDomain_6917a62b-d4da-4a4f-8669-ad3ea9452ae6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_ede4b1e6-2e4c-43f0-9ee9-2507deaaec63" xlink:href="mck-20230331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_6917a62b-d4da-4a4f-8669-ad3ea9452ae6" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_ede4b1e6-2e4c-43f0-9ee9-2507deaaec63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_41854dae-7e0d-47c7-b2d2-0e73d2383acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7238abab-a05b-4a98-9731-16252f11a6c3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_41854dae-7e0d-47c7-b2d2-0e73d2383acb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_41854dae-7e0d-47c7-b2d2-0e73d2383acb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_41854dae-7e0d-47c7-b2d2-0e73d2383acb" xlink:to="loc_us-gaap_SegmentDomain_41854dae-7e0d-47c7-b2d2-0e73d2383acb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_34962155-775e-437a-9e58-4e34a1d2a881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_41854dae-7e0d-47c7-b2d2-0e73d2383acb" xlink:to="loc_us-gaap_SegmentDomain_34962155-775e-437a-9e58-4e34a1d2a881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_7f57970a-b6dd-469e-b9ab-f40a15fbc126" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_34962155-775e-437a-9e58-4e34a1d2a881" xlink:to="loc_mck_InternationalSegmentMember_7f57970a-b6dd-469e-b9ab-f40a15fbc126" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended" id="id0eef9c6fd2c4bacbd2db87d9bfc0a2c_GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_bbbf215a-4746-44ae-aab1-81ec4730e5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_bbbf215a-4746-44ae-aab1-81ec4730e5e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4ca620b4-5abf-4148-a4df-e2bd34df87d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4ca620b4-5abf-4148-a4df-e2bd34df87d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fa98449e-aec1-4ac2-a8b0-b05f52f103cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fa98449e-aec1-4ac2-a8b0-b05f52f103cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_00277201-3259-4747-a841-906f442c675b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_00277201-3259-4747-a841-906f442c675b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_a9040da6-8cdd-40fe-9327-b091180304b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_a9040da6-8cdd-40fe-9327-b091180304b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6ea6c96-51fd-4471-89b5-bc0668e8ca02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6ea6c96-51fd-4471-89b5-bc0668e8ca02" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_264ce5a4-7f4c-4e95-9c8c-56c7da7b4027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6ea6c96-51fd-4471-89b5-bc0668e8ca02" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_264ce5a4-7f4c-4e95-9c8c-56c7da7b4027" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_264ce5a4-7f4c-4e95-9c8c-56c7da7b4027_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_264ce5a4-7f4c-4e95-9c8c-56c7da7b4027" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_264ce5a4-7f4c-4e95-9c8c-56c7da7b4027_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c133dedd-3953-4b42-adc1-e87912d4e77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_264ce5a4-7f4c-4e95-9c8c-56c7da7b4027" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c133dedd-3953-4b42-adc1-e87912d4e77c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_606c77c7-cf6b-4fb2-8d13-57988cf5f8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c133dedd-3953-4b42-adc1-e87912d4e77c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_606c77c7-cf6b-4fb2-8d13-57988cf5f8da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1bb92ebb-ac5d-4076-a6f3-10f2bf9cc49a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6ea6c96-51fd-4471-89b5-bc0668e8ca02" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1bb92ebb-ac5d-4076-a6f3-10f2bf9cc49a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1bb92ebb-ac5d-4076-a6f3-10f2bf9cc49a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1bb92ebb-ac5d-4076-a6f3-10f2bf9cc49a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1bb92ebb-ac5d-4076-a6f3-10f2bf9cc49a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b2925b7-b670-4e73-9b78-9ec7342e967a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1bb92ebb-ac5d-4076-a6f3-10f2bf9cc49a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b2925b7-b670-4e73-9b78-9ec7342e967a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanAssetsHeldForSaleMember_86c6a6a8-4429-48f3-a666-d005ce765830" xlink:href="mck-20230331.xsd#mck_EuropeanAssetsHeldForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b2925b7-b670-4e73-9b78-9ec7342e967a" xlink:to="loc_mck_EuropeanAssetsHeldForSaleMember_86c6a6a8-4429-48f3-a666-d005ce765830" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cb4ebac5-d297-4db3-8cc5-633925c2f117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6ea6c96-51fd-4471-89b5-bc0668e8ca02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cb4ebac5-d297-4db3-8cc5-633925c2f117" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4ebac5-d297-4db3-8cc5-633925c2f117_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cb4ebac5-d297-4db3-8cc5-633925c2f117" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4ebac5-d297-4db3-8cc5-633925c2f117_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cb4ebac5-d297-4db3-8cc5-633925c2f117" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_020abbba-9e00-4ddf-b1e0-feafb017994d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:to="loc_us-gaap_CustomerRelationshipsMember_020abbba-9e00-4ddf-b1e0-feafb017994d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_8c01aa5d-7bd4-4810-b41b-f1a98fcb1f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:to="loc_us-gaap_ServiceAgreementsMember_8c01aa5d-7bd4-4810-b41b-f1a98fcb1f0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_c4db0aee-af40-4d5e-bd54-7449b0db89e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_c4db0aee-af40-4d5e-bd54-7449b0db89e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cc87d62b-e6e0-4f96-9ca2-fcbe2791e392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cc87d62b-e6e0-4f96-9ca2-fcbe2791e392" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_9db7c429-df8f-4cf3-a457-834944ebbaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_9db7c429-df8f-4cf3-a457-834944ebbaa6" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended" id="i13715ce7e7ea4de0b668df785569ac06_DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4491fae7-c4d7-46fd-9524-28f170626232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4491fae7-c4d7-46fd-9524-28f170626232" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_52f43290-fdea-4c07-a1fa-68bc0a555f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_us-gaap_LongTermDebt_52f43290-fdea-4c07-a1fa-68bc0a555f88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2467bc9b-76b3-4231-9a54-1e77151a7cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2467bc9b-76b3-4231-9a54-1e77151a7cce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_af7f8899-a701-4b93-a5c3-3c779f697f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_af7f8899-a701-4b93-a5c3-3c779f697f3f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_fbf522bd-cd5e-488e-bf58-1cd6d721c11a" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_fbf522bd-cd5e-488e-bf58-1cd6d721c11a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_42ba34eb-a66f-4dbc-9c55-8f46886d4a34" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_42ba34eb-a66f-4dbc-9c55-8f46886d4a34" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_87fd35a0-6996-4775-9fde-98f872fc6ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_87fd35a0-6996-4775-9fde-98f872fc6ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_87fd35a0-6996-4775-9fde-98f872fc6ba9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_87fd35a0-6996-4775-9fde-98f872fc6ba9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_87fd35a0-6996-4775-9fde-98f872fc6ba9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_db84f911-0766-4cbe-b85c-7be364cb977e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_87fd35a0-6996-4775-9fde-98f872fc6ba9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_db84f911-0766-4cbe-b85c-7be364cb977e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b8e0b851-85f6-4050-bfca-b089d43d7403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_db84f911-0766-4cbe-b85c-7be364cb977e" xlink:to="loc_us-gaap_LoansPayableMember_b8e0b851-85f6-4050-bfca-b089d43d7403" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseandOtherObligationsMember_0aa4a9ec-8296-4b44-ae8f-3b5b4934f574" xlink:href="mck-20230331.xsd#mck_LeaseandOtherObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_db84f911-0766-4cbe-b85c-7be364cb977e" xlink:to="loc_mck_LeaseandOtherObligationsMember_0aa4a9ec-8296-4b44-ae8f-3b5b4934f574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4f327149-4999-44ec-8fe3-f76e419d1ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4f327149-4999-44ec-8fe3-f76e419d1ea8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4f327149-4999-44ec-8fe3-f76e419d1ea8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4f327149-4999-44ec-8fe3-f76e419d1ea8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4f327149-4999-44ec-8fe3-f76e419d1ea8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5bf4a71c-95e9-4c53-8828-22937890a32a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4f327149-4999-44ec-8fe3-f76e419d1ea8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5bf4a71c-95e9-4c53-8828-22937890a32a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_0c596556-ba90-4c55-9a85-9984c217fd89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_5bf4a71c-95e9-4c53-8828-22937890a32a" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_0c596556-ba90-4c55-9a85-9984c217fd89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6c41efa3-9b17-49c2-86cc-0ca6bafe5f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6c41efa3-9b17-49c2-86cc-0ca6bafe5f3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6c41efa3-9b17-49c2-86cc-0ca6bafe5f3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6c41efa3-9b17-49c2-86cc-0ca6bafe5f3a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6c41efa3-9b17-49c2-86cc-0ca6bafe5f3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bed72a9-d9c6-4ec6-b643-208f146162fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6c41efa3-9b17-49c2-86cc-0ca6bafe5f3a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bed72a9-d9c6-4ec6-b643-208f146162fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_a1cb72c4-2216-41a5-8e39-77ac523638c7" xlink:href="mck-20230331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bed72a9-d9c6-4ec6-b643-208f146162fc" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_a1cb72c4-2216-41a5-8e39-77ac523638c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_81b4cac4-a140-458f-84e2-68bbeacb574b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:to="loc_us-gaap_DebtInstrumentAxis_81b4cac4-a140-458f-84e2-68bbeacb574b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_81b4cac4-a140-458f-84e2-68bbeacb574b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_81b4cac4-a140-458f-84e2-68bbeacb574b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_81b4cac4-a140-458f-84e2-68bbeacb574b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_81b4cac4-a140-458f-84e2-68bbeacb574b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_24065b59-07c3-4712-a312-d68c86eda246" xlink:href="mck-20230331.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A270NotesDueDecember152022Member_24065b59-07c3-4712-a312-d68c86eda246" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_d2710dde-adac-4dbd-bd62-6c7a17751f44" xlink:href="mck-20230331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A285NotesDueMarch152023Member_d2710dde-adac-4dbd-bd62-6c7a17751f44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_aa75fc99-62fb-46df-9ee0-d3becbc64a22" xlink:href="mck-20230331.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A380NotesDueMarch152024Member_aa75fc99-62fb-46df-9ee0-d3becbc64a22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_c076de99-617f-42c4-92fb-ed92a2975674" xlink:href="mck-20230331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A090NotesDueDecember32025Member_c076de99-617f-42c4-92fb-ed92a2975674" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A525NotesDueFebruary152026Member_22fe1771-5528-4616-a4f9-948197efa5ff" xlink:href="mck-20230331.xsd#mck_A525NotesDueFebruary152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A525NotesDueFebruary152026Member_22fe1771-5528-4616-a4f9-948197efa5ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_62f88e24-c8aa-41b4-8190-ca54f66a39ed" xlink:href="mck-20230331.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A130NotesDueAugust152026Member_62f88e24-c8aa-41b4-8190-ca54f66a39ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_5e9f40b2-0ba9-4926-a2f9-b61b274131ed" xlink:href="mck-20230331.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_5e9f40b2-0ba9-4926-a2f9-b61b274131ed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_67e672df-7313-4601-9ee4-c4191a3e8b10" xlink:href="mck-20230331.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A395NotesDueFebruary162028Member_67e672df-7313-4601-9ee4-c4191a3e8b10" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_17f11119-48c9-4375-a4aa-f8b68f562a5a" xlink:href="mck-20230331.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A475NotesDueMay302029Member_17f11119-48c9-4375-a4aa-f8b68f562a5a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_bc9122da-be2f-45e8-ad17-b377df5feaad" xlink:href="mck-20230331.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A600NotesDueMarch12041Member_bc9122da-be2f-45e8-ad17-b377df5feaad" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_bf6d5820-255c-4964-86d8-7eabb5d40bdc" xlink:href="mck-20230331.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A488NotesDueMarch152044Member_bf6d5820-255c-4964-86d8-7eabb5d40bdc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_cc6ca79e-49f7-4363-b7bf-ecbff2a19993" xlink:href="mck-20230331.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_cc6ca79e-49f7-4363-b7bf-ecbff2a19993" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_2186dfdc-8cbb-4735-bd00-09862f92b5e1" xlink:href="mck-20230331.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_2186dfdc-8cbb-4735-bd00-09862f92b5e1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_9f287b29-449c-4caf-851c-3ccad88ecd02" xlink:href="mck-20230331.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_9f287b29-449c-4caf-851c-3ccad88ecd02" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="extended" id="i49bf09c31af34dc09a92eedf324d434d_DebtandFinancingActivitiesLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_3834fce7-ad17-4a31-9ed8-9030eed82fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_3834fce7-ad17-4a31-9ed8-9030eed82fef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f87b872b-ad41-4242-aeec-7fc5c0cf2444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f87b872b-ad41-4242-aeec-7fc5c0cf2444" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_027b568d-2ce9-4ac4-880c-89bf8c9e22dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_027b568d-2ce9-4ac4-880c-89bf8c9e22dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cb765caa-8b00-4ab0-a0cf-129a1e289a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cb765caa-8b00-4ab0-a0cf-129a1e289a48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_69f168ca-199d-4b0c-aea9-f62b1bba70ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_69f168ca-199d-4b0c-aea9-f62b1bba70ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_ac766b03-affc-49d4-8ee5-0319205a5833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_ac766b03-affc-49d4-8ee5-0319205a5833" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_1faa8a8a-3373-4fc7-9a8e-3826e856fbcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_1faa8a8a-3373-4fc7-9a8e-3826e856fbcd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_040d2baa-7ca9-4f6b-8bee-0798ddd354ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_DebtInstrumentTable_040d2baa-7ca9-4f6b-8bee-0798ddd354ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_49da40b4-5e05-42c3-83cf-0f57fed60e66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_040d2baa-7ca9-4f6b-8bee-0798ddd354ac" xlink:to="loc_us-gaap_DebtInstrumentAxis_49da40b4-5e05-42c3-83cf-0f57fed60e66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_49da40b4-5e05-42c3-83cf-0f57fed60e66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_49da40b4-5e05-42c3-83cf-0f57fed60e66" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_49da40b4-5e05-42c3-83cf-0f57fed60e66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_49da40b4-5e05-42c3-83cf-0f57fed60e66" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A525NotesDue2026Member_36079c11-5bda-45fd-bd6b-beecef7078be" xlink:href="mck-20230331.xsd#mck_A525NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A525NotesDue2026Member_36079c11-5bda-45fd-bd6b-beecef7078be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_06e7383d-2fe0-4976-bdab-736d321a3ba9" xlink:href="mck-20230331.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A130NotesDueAugust152026Member_06e7383d-2fe0-4976-bdab-736d321a3ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_d8309b56-5aaf-43c7-a1db-ee9800f2f263" xlink:href="mck-20230331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A285NotesDueMarch152023Member_d8309b56-5aaf-43c7-a1db-ee9800f2f263" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_0414fcc9-bcac-4653-8877-97ea5198d13f" xlink:href="mck-20230331.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A270NotesDueDecember152022Member_0414fcc9-bcac-4653-8877-97ea5198d13f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_505db7cb-f914-47d9-9f48-4f5c810d2a74" xlink:href="mck-20230331.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_505db7cb-f914-47d9-9f48-4f5c810d2a74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_e9fcac53-421c-4514-9f1e-83f807aef060" xlink:href="mck-20230331.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A475NotesDueMarch12021Member_e9fcac53-421c-4514-9f1e-83f807aef060" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueNovember302020Member_7515cc59-0b07-49f5-b0c3-4f8476190d0b" xlink:href="mck-20230331.xsd#mck_NotesDueNovember302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_NotesDueNovember302020Member_7515cc59-0b07-49f5-b0c3-4f8476190d0b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A525NotesDueFebruary152026Member_55feb7d2-3e1e-467d-8e51-c18e663e9b77" xlink:href="mck-20230331.xsd#mck_A525NotesDueFebruary152026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A525NotesDueFebruary152026Member_55feb7d2-3e1e-467d-8e51-c18e663e9b77" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_c75bc5e0-b957-4ed0-bb96-640a5c2c3c59" xlink:href="mck-20230331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A090NotesDueDecember32025Member_c75bc5e0-b957-4ed0-bb96-640a5c2c3c59" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ddff147a-6715-458e-99c5-98d78a6970cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_040d2baa-7ca9-4f6b-8bee-0798ddd354ac" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ddff147a-6715-458e-99c5-98d78a6970cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ddff147a-6715-458e-99c5-98d78a6970cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ddff147a-6715-458e-99c5-98d78a6970cc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ddff147a-6715-458e-99c5-98d78a6970cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_382652c4-f1e1-43cc-80b1-a4a04390197d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ddff147a-6715-458e-99c5-98d78a6970cc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_382652c4-f1e1-43cc-80b1-a4a04390197d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_5a576340-fdb3-4b4e-8574-dc879275a78b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_382652c4-f1e1-43cc-80b1-a4a04390197d" xlink:to="loc_us-gaap_LoansPayableMember_5a576340-fdb3-4b4e-8574-dc879275a78b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails" xlink:type="extended" id="i60295fd02e6749309060a9e7aa248964_DebtandFinancingActivitiesTenderOfferandOtherInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_086356f0-2796-4a46-aef0-e009190403e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_086356f0-2796-4a46-aef0-e009190403e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_50bff019-343b-494d-9904-4b4234186e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_50bff019-343b-494d-9904-4b4234186e99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_be4baa42-14b5-4629-b884-c0e2a263105f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_be4baa42-14b5-4629-b884-c0e2a263105f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_bf2bc2ce-1193-4a73-ba96-8ff5236c16f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_bf2bc2ce-1193-4a73-ba96-8ff5236c16f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_20a2f078-f401-48c0-a2cc-2926ea5ada94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_20a2f078-f401-48c0-a2cc-2926ea5ada94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_24119d65-4c60-4ca8-913d-2be80e85486f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_InterestPaid_24119d65-4c60-4ca8-913d-2be80e85486f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f5847432-fe57-465e-a34c-063868259e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f5847432-fe57-465e-a34c-063868259e0e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_906ccfa0-3dfe-4338-9361-ae38184554f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_906ccfa0-3dfe-4338-9361-ae38184554f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_10af6d36-a1ed-49c4-8ab2-6ddf9f6b99bb" xlink:href="mck-20230331.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_10af6d36-a1ed-49c4-8ab2-6ddf9f6b99bb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_04d4962e-3be8-4068-b242-9127c8026048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_04d4962e-3be8-4068-b242-9127c8026048" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ef8ad88a-d71e-496a-b11a-53bc6c9edad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ef8ad88a-d71e-496a-b11a-53bc6c9edad5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c5e8e462-4735-426c-af36-9d0c6e502533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c5e8e462-4735-426c-af36-9d0c6e502533" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7705f0a8-a03a-4541-9023-dfedb5483705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7705f0a8-a03a-4541-9023-dfedb5483705" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_019fc6a9-d162-4aa7-8f0b-018a2030edf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_019fc6a9-d162-4aa7-8f0b-018a2030edf6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_665dafc6-d10c-4567-a647-621b31eab0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_665dafc6-d10c-4567-a647-621b31eab0b9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_70d1f41c-ae1e-40ad-ac02-17c83c632dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_DebtInstrumentTable_70d1f41c-ae1e-40ad-ac02-17c83c632dbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a2e4ecd9-e47f-4247-adf4-80b3908327eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_70d1f41c-ae1e-40ad-ac02-17c83c632dbb" xlink:to="loc_us-gaap_DebtInstrumentAxis_a2e4ecd9-e47f-4247-adf4-80b3908327eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a2e4ecd9-e47f-4247-adf4-80b3908327eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a2e4ecd9-e47f-4247-adf4-80b3908327eb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a2e4ecd9-e47f-4247-adf4-80b3908327eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a2e4ecd9-e47f-4247-adf4-80b3908327eb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_c7a23fb8-1399-4b10-b3d3-d9fbcd9a0578" xlink:href="mck-20230331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A285NotesDueMarch152023Member_c7a23fb8-1399-4b10-b3d3-d9fbcd9a0578" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_df2eac87-8a59-4ae1-a9b4-319498cfea1e" xlink:href="mck-20230331.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A380NotesDueMarch152024Member_df2eac87-8a59-4ae1-a9b4-319498cfea1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_2e760aee-5fcd-4c70-9c5d-21027f995a86" xlink:href="mck-20230331.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_2e760aee-5fcd-4c70-9c5d-21027f995a86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_b3856e28-916a-4487-9dc3-d31e07c89806" xlink:href="mck-20230331.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A395NotesDueFebruary162028Member_b3856e28-916a-4487-9dc3-d31e07c89806" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_ab94d528-7ccc-4173-8f48-3d07516e21a5" xlink:href="mck-20230331.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A475NotesDueMay302029Member_ab94d528-7ccc-4173-8f48-3d07516e21a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_44402ea9-4070-43f5-a6c6-8369e3fd6eed" xlink:href="mck-20230331.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A600NotesDueMarch12041Member_44402ea9-4070-43f5-a6c6-8369e3fd6eed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_247ee048-5c74-4ba4-8d79-c1219ae8db8c" xlink:href="mck-20230331.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A488NotesDueMarch152044Member_247ee048-5c74-4ba4-8d79-c1219ae8db8c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_2bc0ab61-8c3e-47b2-aa91-a3ce3ede978e" xlink:href="mck-20230331.xsd#mck_TenderOfferNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_TenderOfferNotesMember_2bc0ab61-8c3e-47b2-aa91-a3ce3ede978e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_27d3c654-e4d1-41a5-944a-aad70303c94e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_70d1f41c-ae1e-40ad-ac02-17c83c632dbb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_27d3c654-e4d1-41a5-944a-aad70303c94e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_27d3c654-e4d1-41a5-944a-aad70303c94e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_27d3c654-e4d1-41a5-944a-aad70303c94e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_27d3c654-e4d1-41a5-944a-aad70303c94e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_65536a46-f506-42ae-920a-46fa0e562554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_27d3c654-e4d1-41a5-944a-aad70303c94e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_65536a46-f506-42ae-920a-46fa0e562554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_63acdb6b-6220-45bc-8752-5fc8ec885d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_65536a46-f506-42ae-920a-46fa0e562554" xlink:to="loc_us-gaap_LoansPayableMember_63acdb6b-6220-45bc-8752-5fc8ec885d42" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended" id="ica4d80c47bf942429a56b938223c4f6e_DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ac58720e-1ddd-4ce8-a765-c2f3e1cc95be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ac58720e-1ddd-4ce8-a765-c2f3e1cc95be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c5b34a02-01f2-40a7-aa9d-c224fe0cc54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_DebtInstrumentTerm_c5b34a02-01f2-40a7-aa9d-c224fe0cc54b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_39013df5-40dc-4e72-aeef-b1d002a445bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_39013df5-40dc-4e72-aeef-b1d002a445bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ed1cf3a3-ed93-4a45-a212-f5ceb8fdde69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_LineOfCredit_ed1cf3a3-ed93-4a45-a212-f5ceb8fdde69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DebtInstrumentDaysAvailableForBorrowing_c35186d5-3ce4-4e80-a995-d72644087b00" xlink:href="mck-20230331.xsd#mck_DebtInstrumentDaysAvailableForBorrowing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_mck_DebtInstrumentDaysAvailableForBorrowing_c35186d5-3ce4-4e80-a995-d72644087b00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_00b2bd64-8a1e-4883-9cf6-1e912f3aaf4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_LongTermDebt_00b2bd64-8a1e-4883-9cf6-1e912f3aaf4a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_542bb109-f4fd-4567-8953-e369ba01e483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_542bb109-f4fd-4567-8953-e369ba01e483" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_04ac2c0a-1a79-4ae5-a058-abb303438cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:to="loc_us-gaap_DebtInstrumentAxis_04ac2c0a-1a79-4ae5-a058-abb303438cbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_04ac2c0a-1a79-4ae5-a058-abb303438cbb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_04ac2c0a-1a79-4ae5-a058-abb303438cbb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_04ac2c0a-1a79-4ae5-a058-abb303438cbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_04ac2c0a-1a79-4ae5-a058-abb303438cbb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember_e599c8e5-1cb9-4ac3-b6ae-43bc040b4285" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:to="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember_e599c8e5-1cb9-4ac3-b6ae-43bc040b4285" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember_b6bc4174-bff0-4eac-b4c4-76d958d5276c" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:to="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember_b6bc4174-bff0-4eac-b4c4-76d958d5276c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_5e7023e0-f1cd-4667-9d7c-170fa7849019" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_5e7023e0-f1cd-4667-9d7c-170fa7849019" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_c6e8a388-4716-4b7f-a57f-33a4523126ec" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_c6e8a388-4716-4b7f-a57f-33a4523126ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2022TermLoanCreditFacilityMember_cbd62ac3-749e-4664-98f9-ba286a2f488f" xlink:href="mck-20230331.xsd#mck_A2022TermLoanCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:to="loc_mck_A2022TermLoanCreditFacilityMember_cbd62ac3-749e-4664-98f9-ba286a2f488f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6dc64c8d-e92b-425f-95de-f2004242e4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6dc64c8d-e92b-425f-95de-f2004242e4c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6dc64c8d-e92b-425f-95de-f2004242e4c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6dc64c8d-e92b-425f-95de-f2004242e4c7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6dc64c8d-e92b-425f-95de-f2004242e4c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b13a4479-8eb1-40de-bcd7-75c25f93bb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6dc64c8d-e92b-425f-95de-f2004242e4c7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b13a4479-8eb1-40de-bcd7-75c25f93bb74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_8073bc05-f788-47aa-ab62-cac84242304d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b13a4479-8eb1-40de-bcd7-75c25f93bb74" xlink:to="loc_us-gaap_UnsecuredDebtMember_8073bc05-f788-47aa-ab62-cac84242304d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_09953032-5588-4e2f-a82e-63013230b384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b13a4479-8eb1-40de-bcd7-75c25f93bb74" xlink:to="loc_us-gaap_LineOfCreditMember_09953032-5588-4e2f-a82e-63013230b384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TermLoanMember_c8a42f63-3707-4704-a0c8-1b40cad5b964" xlink:href="mck-20230331.xsd#mck_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b13a4479-8eb1-40de-bcd7-75c25f93bb74" xlink:to="loc_mck_TermLoanMember_c8a42f63-3707-4704-a0c8-1b40cad5b964" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a0e6ed00-aaa5-48c1-ade3-d42bfb06c270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:to="loc_us-gaap_CreditFacilityAxis_a0e6ed00-aaa5-48c1-ade3-d42bfb06c270" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a0e6ed00-aaa5-48c1-ade3-d42bfb06c270_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a0e6ed00-aaa5-48c1-ade3-d42bfb06c270" xlink:to="loc_us-gaap_CreditFacilityDomain_a0e6ed00-aaa5-48c1-ade3-d42bfb06c270_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_61b84fb2-b0c4-491a-9374-6bad3e9ef6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a0e6ed00-aaa5-48c1-ade3-d42bfb06c270" xlink:to="loc_us-gaap_CreditFacilityDomain_61b84fb2-b0c4-491a-9374-6bad3e9ef6fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e7a1be3c-a345-4514-97f0-99743d81eb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_61b84fb2-b0c4-491a-9374-6bad3e9ef6fb" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e7a1be3c-a345-4514-97f0-99743d81eb5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_596817ed-6855-4d04-9757-c14eadefea79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:to="loc_us-gaap_VariableRateAxis_596817ed-6855-4d04-9757-c14eadefea79" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_596817ed-6855-4d04-9757-c14eadefea79_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_596817ed-6855-4d04-9757-c14eadefea79" xlink:to="loc_us-gaap_VariableRateDomain_596817ed-6855-4d04-9757-c14eadefea79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_104d3df8-c673-4b72-8e86-4203e24fc54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_596817ed-6855-4d04-9757-c14eadefea79" xlink:to="loc_us-gaap_VariableRateDomain_104d3df8-c673-4b72-8e86-4203e24fc54b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecuredOvernightFinancingRateSOFRMember_dadbd9a3-f00d-4881-b793-394215d63016" xlink:href="mck-20230331.xsd#mck_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_104d3df8-c673-4b72-8e86-4203e24fc54b" xlink:to="loc_mck_SecuredOvernightFinancingRateSOFRMember_dadbd9a3-f00d-4881-b793-394215d63016" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails" xlink:type="extended" id="iad2147d43882418992aee0a4fc4d6dde_DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_427f0e12-70cb-42c9-8b83-7d64deb90dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_427f0e12-70cb-42c9-8b83-7d64deb90dd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_a6cb60f2-7fd3-47f3-81fc-c9df0c84ef7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_a6cb60f2-7fd3-47f3-81fc-c9df0c84ef7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5973b444-f822-4918-8863-0d4d345f97f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5973b444-f822-4918-8863-0d4d345f97f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_ddf75321-f092-4cfb-9f76-a3e04c88e390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_ddf75321-f092-4cfb-9f76-a3e04c88e390" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_31c64c99-60dd-4e7c-9db3-f9aec0f1d807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_31c64c99-60dd-4e7c-9db3-f9aec0f1d807" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_aceff82e-01ce-4f85-ae86-be841d99c718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_LongTermDebt_aceff82e-01ce-4f85-ae86-be841d99c718" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8319d0bf-5ede-44c7-8e2d-03ebeb2cbf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_DebtInstrumentTable_8319d0bf-5ede-44c7-8e2d-03ebeb2cbf1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0e5c2daf-0ab3-4b52-a1eb-485b8a1d97bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8319d0bf-5ede-44c7-8e2d-03ebeb2cbf1a" xlink:to="loc_us-gaap_CreditFacilityAxis_0e5c2daf-0ab3-4b52-a1eb-485b8a1d97bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0e5c2daf-0ab3-4b52-a1eb-485b8a1d97bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_0e5c2daf-0ab3-4b52-a1eb-485b8a1d97bd" xlink:to="loc_us-gaap_CreditFacilityDomain_0e5c2daf-0ab3-4b52-a1eb-485b8a1d97bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_51cc8df5-9845-463c-8a2a-423c28dc9f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_0e5c2daf-0ab3-4b52-a1eb-485b8a1d97bd" xlink:to="loc_us-gaap_CreditFacilityDomain_51cc8df5-9845-463c-8a2a-423c28dc9f52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_accc5fee-4890-465b-b07e-e52476d406c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_51cc8df5-9845-463c-8a2a-423c28dc9f52" xlink:to="loc_us-gaap_CommercialPaperMember_accc5fee-4890-465b-b07e-e52476d406c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3937645b-962f-451a-a60b-3fb1f4128b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_51cc8df5-9845-463c-8a2a-423c28dc9f52" xlink:to="loc_us-gaap_LineOfCreditMember_3937645b-962f-451a-a60b-3fb1f4128b54" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#VariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="extended" id="i11752247a6a241a59ecac928aa8580d4_VariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_c9d2b5f1-0aad-4e28-beb7-5d313a1b37e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6641a147-d091-4fe6-bfb7-a54ac9fea195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_c9d2b5f1-0aad-4e28-beb7-5d313a1b37e8" xlink:to="loc_us-gaap_Assets_6641a147-d091-4fe6-bfb7-a54ac9fea195" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4b783a01-17f4-4985-9dec-922127861d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_c9d2b5f1-0aad-4e28-beb7-5d313a1b37e8" xlink:to="loc_us-gaap_Liabilities_4b783a01-17f4-4985-9dec-922127861d3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_5dc1e68c-b5b7-469f-9b00-79cf72d44807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_c9d2b5f1-0aad-4e28-beb7-5d313a1b37e8" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_5dc1e68c-b5b7-469f-9b00-79cf72d44807" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_470ec5bc-531f-4b17-9abc-a93ee6adb617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_c9d2b5f1-0aad-4e28-beb7-5d313a1b37e8" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_470ec5bc-531f-4b17-9abc-a93ee6adb617" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_eb01ae06-fa6c-4873-8a74-e85834a8d1c0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_470ec5bc-531f-4b17-9abc-a93ee6adb617" xlink:to="loc_srt_ConsolidatedEntitiesAxis_eb01ae06-fa6c-4873-8a74-e85834a8d1c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_eb01ae06-fa6c-4873-8a74-e85834a8d1c0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_eb01ae06-fa6c-4873-8a74-e85834a8d1c0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_eb01ae06-fa6c-4873-8a74-e85834a8d1c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_abaf97cf-41dc-47cb-a7ca-58a4029d8be1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_eb01ae06-fa6c-4873-8a74-e85834a8d1c0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_abaf97cf-41dc-47cb-a7ca-58a4029d8be1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_db91fe45-d480-4f25-a00c-7b67383a810d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_abaf97cf-41dc-47cb-a7ca-58a4029d8be1" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_db91fe45-d480-4f25-a00c-7b67383a810d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended" id="icea9d345762f41debbf3339a04d48dd8_PensionBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_67b3f133-ff4a-4525-882f-7aac21c9b879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_67b3f133-ff4a-4525-882f-7aac21c9b879" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_813b33e6-f825-4269-8ce0-89d3d968eeef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_813b33e6-f825-4269-8ce0-89d3d968eeef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized_873f6742-6b83-4451-868a-62c9dcc71924" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized_873f6742-6b83-4451-868a-62c9dcc71924" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_b90a9a65-1be4-47b7-b754-7352a3d6ab5d" xlink:href="mck-20230331.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_b90a9a65-1be4-47b7-b754-7352a3d6ab5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_fedba7e2-86ef-4d26-b36e-12895e99d6b8" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_fedba7e2-86ef-4d26-b36e-12895e99d6b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_ef5e9412-0865-46cd-a8f8-c647de694e04" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_ef5e9412-0865-46cd-a8f8-c647de694e04" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_71e09cc6-0fd8-419e-9ff8-b25e7b8000c2" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_71e09cc6-0fd8-419e-9ff8-b25e7b8000c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_5831aaf2-deaa-4648-9852-d379ed5a16ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_5831aaf2-deaa-4648-9852-d379ed5a16ec" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_249ef5fc-09a2-4d88-a6e7-29ee30cb88d0" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_249ef5fc-09a2-4d88-a6e7-29ee30cb88d0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8753bcc1-0c81-44e6-915f-9f960e69e4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8753bcc1-0c81-44e6-915f-9f960e69e4a0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_5aca2acb-bc76-41af-b9fa-ed85effbc56d" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_5aca2acb-bc76-41af-b9fa-ed85effbc56d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d15d5a7b-f7c8-4fd9-a6a9-7b0439a5c53f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d15d5a7b-f7c8-4fd9-a6a9-7b0439a5c53f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0fd18b7b-2b4f-4136-b121-161b71851ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0fd18b7b-2b4f-4136-b121-161b71851ea2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_08447a4f-2796-4ab0-9207-3bd4a72e51d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_08447a4f-2796-4ab0-9207-3bd4a72e51d6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_e3e1b9d8-ca0e-47ad-bbcb-ce9eed568fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_e3e1b9d8-ca0e-47ad-bbcb-ce9eed568fe8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_16341f5e-0845-41e3-a900-7529fbc2f85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_16341f5e-0845-41e3-a900-7529fbc2f85b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_69f85d94-b58c-473c-a8e6-90b44768edce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_69f85d94-b58c-473c-a8e6-90b44768edce" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_7d3f9a93-fa24-4cc0-b73d-31a7a8895689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_7d3f9a93-fa24-4cc0-b73d-31a7a8895689" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d89b612e-d2fa-4d0e-8463-0b56af65ae4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d89b612e-d2fa-4d0e-8463-0b56af65ae4c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_cda22edf-4e99-46d4-8350-c7c8b66fee9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_cda22edf-4e99-46d4-8350-c7c8b66fee9f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_cef31bb9-0fac-4344-85bc-2cf9db870025" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_cef31bb9-0fac-4344-85bc-2cf9db870025" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitValueOfCashAndCashEquivalents_bcf040eb-ae2d-41c8-b10c-5e88db6b0cf0" xlink:href="mck-20230331.xsd#mck_UnitValueOfCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_UnitValueOfCashAndCashEquivalents_bcf040eb-ae2d-41c8-b10c-5e88db6b0cf0" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_aab3969f-19fc-4fd6-8ea8-be61afad8ff4" xlink:href="mck-20230331.xsd#mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_aab3969f-19fc-4fd6-8ea8-be61afad8ff4" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_92ecd726-68a8-4638-ae6c-b0fc4927104f" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_92ecd726-68a8-4638-ae6c-b0fc4927104f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_77b90202-9c3a-4251-9545-a94b822e4f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_77b90202-9c3a-4251-9545-a94b822e4f9f" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MultiemployerPlanFundedStatusPercentage_817b0dd8-83f0-4cb4-82f4-954f8b39f4a9" xlink:href="mck-20230331.xsd#mck_MultiemployerPlanFundedStatusPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_MultiemployerPlanFundedStatusPercentage_817b0dd8-83f0-4cb4-82f4-954f8b39f4a9" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation_1d1d5658-3832-4063-91e7-f88d4b2f3c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_MultiemployerPlansWithdrawalObligation_1d1d5658-3832-4063-91e7-f88d4b2f3c6d" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_b6906cd4-8547-4dda-b33d-8db061a0ad9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_b6906cd4-8547-4dda-b33d-8db061a0ad9f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_7cbe7a8c-5f02-4b99-bdae-45d030423443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_7cbe7a8c-5f02-4b99-bdae-45d030423443" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeContributions_8eb3a7ed-ec5c-4767-b817-3ec889d394fd" xlink:href="mck-20230331.xsd#mck_EmployeeContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_EmployeeContributions_8eb3a7ed-ec5c-4767-b817-3ec889d394fd" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_3a797772-7838-4673-9ee2-0b5632986e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_3a797772-7838-4673-9ee2-0b5632986e68" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3eda58a7-64c9-453a-91d0-730515ec627d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3eda58a7-64c9-453a-91d0-730515ec627d" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_83f9bcf5-d8ef-41d7-a4f8-042e3e22c833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_83f9bcf5-d8ef-41d7-a4f8-042e3e22c833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_83f9bcf5-d8ef-41d7-a4f8-042e3e22c833_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_83f9bcf5-d8ef-41d7-a4f8-042e3e22c833" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_83f9bcf5-d8ef-41d7-a4f8-042e3e22c833_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_3247501a-d1c4-4a7b-91f8-dfeb7908eebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_83f9bcf5-d8ef-41d7-a4f8-042e3e22c833" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_3247501a-d1c4-4a7b-91f8-dfeb7908eebd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_00c83a3c-2521-4bf3-8377-a3de0406dab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_3247501a-d1c4-4a7b-91f8-dfeb7908eebd" xlink:to="loc_us-gaap_DomesticPlanMember_00c83a3c-2521-4bf3-8377-a3de0406dab8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5a43e022-8c67-47fa-bb02-0fcc5fa0bb59" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DomesticPlanMember_00c83a3c-2521-4bf3-8377-a3de0406dab8" xlink:to="loc_country_US_5a43e022-8c67-47fa-bb02-0fcc5fa0bb59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_71142570-0135-4a00-8d1a-141c9d059c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_3247501a-d1c4-4a7b-91f8-dfeb7908eebd" xlink:to="loc_us-gaap_ForeignPlanMember_71142570-0135-4a00-8d1a-141c9d059c31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_59b315b0-5fbf-4b2f-b43d-cba3bf4b28f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_59b315b0-5fbf-4b2f-b43d-cba3bf4b28f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_59b315b0-5fbf-4b2f-b43d-cba3bf4b28f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_59b315b0-5fbf-4b2f-b43d-cba3bf4b28f0" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_59b315b0-5fbf-4b2f-b43d-cba3bf4b28f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3990fc81-8c1a-4bca-930b-2cc0d85c68ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_59b315b0-5fbf-4b2f-b43d-cba3bf4b28f0" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3990fc81-8c1a-4bca-930b-2cc0d85c68ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_45713756-1056-4d70-b93e-915c6300bca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3990fc81-8c1a-4bca-930b-2cc0d85c68ea" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_45713756-1056-4d70-b93e-915c6300bca0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_0cf87071-d71d-439c-94b0-850ab14fe8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3990fc81-8c1a-4bca-930b-2cc0d85c68ea" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_0cf87071-d71d-439c-94b0-850ab14fe8c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis_2f470e0d-4e5e-414c-8a80-fa9265054043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_RetirementPlanFundingStatusAxis_2f470e0d-4e5e-414c-8a80-fa9265054043" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_2f470e0d-4e5e-414c-8a80-fa9265054043_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_2f470e0d-4e5e-414c-8a80-fa9265054043" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_2f470e0d-4e5e-414c-8a80-fa9265054043_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_87d0eb9b-7d8f-455d-abe6-ec71ce92b586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_2f470e0d-4e5e-414c-8a80-fa9265054043" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_87d0eb9b-7d8f-455d-abe6-ec71ce92b586" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember_c956b7e9-32fa-4d71-a68b-6c8500361da4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnfundedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain_87d0eb9b-7d8f-455d-abe6-ec71ce92b586" xlink:to="loc_us-gaap_UnfundedPlanMember_c956b7e9-32fa-4d71-a68b-6c8500361da4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b94b0540-d7ec-4415-942e-10051bafeb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b94b0540-d7ec-4415-942e-10051bafeb6e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b94b0540-d7ec-4415-942e-10051bafeb6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b94b0540-d7ec-4415-942e-10051bafeb6e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b94b0540-d7ec-4415-942e-10051bafeb6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ba9bb718-73e5-4d7d-b3c4-86f3ed80beae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b94b0540-d7ec-4415-942e-10051bafeb6e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ba9bb718-73e5-4d7d-b3c4-86f3ed80beae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2db43f86-5eb9-443b-84c8-86c613a5ac7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ba9bb718-73e5-4d7d-b3c4-86f3ed80beae" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2db43f86-5eb9-443b-84c8-86c613a5ac7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6a2fdc41-6b00-4668-8f90-648d6bbe122a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ba9bb718-73e5-4d7d-b3c4-86f3ed80beae" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6a2fdc41-6b00-4668-8f90-648d6bbe122a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_f4cd4670-f896-42de-a5c4-598d17dcbddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_RetirementPlanNameAxis_f4cd4670-f896-42de-a5c4-598d17dcbddd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_f4cd4670-f896-42de-a5c4-598d17dcbddd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_f4cd4670-f896-42de-a5c4-598d17dcbddd" xlink:to="loc_us-gaap_RetirementPlanNameDomain_f4cd4670-f896-42de-a5c4-598d17dcbddd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_31c4c804-9ae6-42cc-8d7c-ba55000f54ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_f4cd4670-f896-42de-a5c4-598d17dcbddd" xlink:to="loc_us-gaap_RetirementPlanNameDomain_31c4c804-9ae6-42cc-8d7c-ba55000f54ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NorwegianPublicServicePensionFundSPKMember_009478f2-c73e-4ba9-ab5d-72df94b9a3de" xlink:href="mck-20230331.xsd#mck_NorwegianPublicServicePensionFundSPKMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_31c4c804-9ae6-42cc-8d7c-ba55000f54ba" xlink:to="loc_mck_NorwegianPublicServicePensionFundSPKMember_009478f2-c73e-4ba9-ab5d-72df94b9a3de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingAxis_18384e00-f043-4ed0-8835-104d86153cab" xlink:href="mck-20230331.xsd#mck_DefinedContributionPlanMatchingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_mck_DefinedContributionPlanMatchingAxis_18384e00-f043-4ed0-8835-104d86153cab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain_18384e00-f043-4ed0-8835-104d86153cab_default" xlink:href="mck-20230331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis_18384e00-f043-4ed0-8835-104d86153cab" xlink:to="loc_mck_DefinedContributionPlanMatchingDomain_18384e00-f043-4ed0-8835-104d86153cab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain_e9ecf2b4-c34d-4e8c-abda-f398abab3376" xlink:href="mck-20230331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis_18384e00-f043-4ed0-8835-104d86153cab" xlink:to="loc_mck_DefinedContributionPlanMatchingDomain_e9ecf2b4-c34d-4e8c-abda-f398abab3376" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FirstPartOfPayContributionMember_1d02312f-2c89-455e-8cca-7a03683f5272" xlink:href="mck-20230331.xsd#mck_FirstPartOfPayContributionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_e9ecf2b4-c34d-4e8c-abda-f398abab3376" xlink:to="loc_mck_FirstPartOfPayContributionMember_1d02312f-2c89-455e-8cca-7a03683f5272" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecondPartOfPayContributionMember_ed5b34e5-0dc4-49d6-ac8c-9fc31b92614e" xlink:href="mck-20230331.xsd#mck_SecondPartOfPayContributionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_e9ecf2b4-c34d-4e8c-abda-f398abab3376" xlink:to="loc_mck_SecondPartOfPayContributionMember_ed5b34e5-0dc4-49d6-ac8c-9fc31b92614e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_30ec73cb-f51d-44ca-85e4-d6ce23113977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_30ec73cb-f51d-44ca-85e4-d6ce23113977" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_30ec73cb-f51d-44ca-85e4-d6ce23113977_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_30ec73cb-f51d-44ca-85e4-d6ce23113977" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_30ec73cb-f51d-44ca-85e4-d6ce23113977_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_30ec73cb-f51d-44ca-85e4-d6ce23113977" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_4740cf36-4191-4a1d-95b3-b969266501e5" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_4740cf36-4191-4a1d-95b3-b969266501e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_5b73ce59-4568-465d-b921-096afda031e7" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_5b73ce59-4568-465d-b921-096afda031e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember_0b85eb82-b1b8-4cc6-9e60-1256004f4671" xlink:href="mck-20230331.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:to="loc_mck_AustrianBusinessOperationsMember_0b85eb82-b1b8-4cc6-9e60-1256004f4671" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_9aa43867-7cdd-4554-9aba-ed24118ccb1f" xlink:href="mck-20230331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:to="loc_mck_GermanWholesaleBusinessMember_9aa43867-7cdd-4554-9aba-ed24118ccb1f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="extended" id="i044d962d947e42e58cf53ab3e9e790dc_PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_73f40cf6-f7ae-45bf-a9bc-1fc143480b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_73f40cf6-f7ae-45bf-a9bc-1fc143480b99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_d4679e7c-6a8e-44b3-82ec-8ece59433f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_d4679e7c-6a8e-44b3-82ec-8ece59433f88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2a7fbab1-d0e1-4d8b-939d-2a398bfef4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2a7fbab1-d0e1-4d8b-939d-2a398bfef4d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_fc6d8450-6e41-44cb-a724-b2c165a941c7" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_fc6d8450-6e41-44cb-a724-b2c165a941c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_712f385e-e8cb-4105-b51c-b3db34a71af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_712f385e-e8cb-4105-b51c-b3db34a71af8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ed11d10a-0471-48ba-b4ed-ae3a63be6e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ed11d10a-0471-48ba-b4ed-ae3a63be6e88" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6b610e5d-e42d-4f49-92ca-a1cbfc3068c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6b610e5d-e42d-4f49-92ca-a1cbfc3068c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9e32db50-966f-48e3-b28c-33bd71a21a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6b610e5d-e42d-4f49-92ca-a1cbfc3068c9" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9e32db50-966f-48e3-b28c-33bd71a21a16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9e32db50-966f-48e3-b28c-33bd71a21a16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9e32db50-966f-48e3-b28c-33bd71a21a16" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9e32db50-966f-48e3-b28c-33bd71a21a16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a58f8a0a-303a-43df-881f-1beec72f35fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9e32db50-966f-48e3-b28c-33bd71a21a16" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a58f8a0a-303a-43df-881f-1beec72f35fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a3c02e39-dc13-4c1c-99d4-229c2068a984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a58f8a0a-303a-43df-881f-1beec72f35fe" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a3c02e39-dc13-4c1c-99d4-229c2068a984" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fc0cb02-dbbc-42e8-a4c5-b196397a7938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6b610e5d-e42d-4f49-92ca-a1cbfc3068c9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fc0cb02-dbbc-42e8-a4c5-b196397a7938" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_6fc0cb02-dbbc-42e8-a4c5-b196397a7938_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fc0cb02-dbbc-42e8-a4c5-b196397a7938" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_6fc0cb02-dbbc-42e8-a4c5-b196397a7938_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4f905ede-9f8a-4e4a-90ea-042558a95df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fc0cb02-dbbc-42e8-a4c5-b196397a7938" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4f905ede-9f8a-4e4a-90ea-042558a95df2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_c5e7f586-4697-4caa-b742-4fec14307318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4f905ede-9f8a-4e4a-90ea-042558a95df2" xlink:to="loc_us-gaap_ForeignPlanMember_c5e7f586-4697-4caa-b742-4fec14307318" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="extended" id="iab9d7d977bf545c88d62bd2c7a7a5780_PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_1c9d0e58-3192-4cd5-aaa9-c8965c06890f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_1c9d0e58-3192-4cd5-aaa9-c8965c06890f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_7231bd23-4348-4b52-97a0-a9cb3e106e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_7231bd23-4348-4b52-97a0-a9cb3e106e45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_48a76b45-9912-45e7-bed2-9a2b7ef798cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_48a76b45-9912-45e7-bed2-9a2b7ef798cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7eb5cf75-7d13-4e06-bd16-06ca75947f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7eb5cf75-7d13-4e06-bd16-06ca75947f9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_a3013cc2-6d92-4588-8b8c-f8e2b36a2854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_a3013cc2-6d92-4588-8b8c-f8e2b36a2854" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_c5d1d4b5-f25e-441e-b289-5c537090d698" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_c5d1d4b5-f25e-441e-b289-5c537090d698" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_84faa455-f9d7-402c-af21-2eba85cfdce8" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationsExpensesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_84faa455-f9d7-402c-af21-2eba85cfdce8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_fed08399-af2c-42c6-a50e-4da17411ce00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_fed08399-af2c-42c6-a50e-4da17411ce00" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_0414c898-97c7-4e16-8b08-21cfe4196644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_0414c898-97c7-4e16-8b08-21cfe4196644" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_85b1d488-c0c4-4370-8a37-256fd48d858c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1ad7ecf4-cc09-4e30-bab2-732a2c75e3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1ad7ecf4-cc09-4e30-bab2-732a2c75e3da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_cee436fd-fd47-4971-9fe9-7b8d08e0dbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_cee436fd-fd47-4971-9fe9-7b8d08e0dbc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_abfa3bbf-8e9c-40d9-950c-854c8ab4d4b8" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_abfa3bbf-8e9c-40d9-950c-854c8ab4d4b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_414bdf08-8dbf-48a3-9af9-51dafa513dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_414bdf08-8dbf-48a3-9af9-51dafa513dbb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_0afc857b-19fa-496f-90e4-7a37fe601d00" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanPlanAssetsExpensesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_0afc857b-19fa-496f-90e4-7a37fe601d00" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_b7aa9e3a-c6cf-4114-b8c1-bf20dbd1ac66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_b7aa9e3a-c6cf-4114-b8c1-bf20dbd1ac66" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_e8763a77-044d-4cc1-a539-e565a99aa251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_e8763a77-044d-4cc1-a539-e565a99aa251" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_3bb4e202-0a81-4f3c-a4ca-126dea573838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_3bb4e202-0a81-4f3c-a4ca-126dea573838" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7e6f4fd6-d302-4bda-9db6-b731227939b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_137224d2-ba08-4360-a7e9-168e465a9771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_137224d2-ba08-4360-a7e9-168e465a9771" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_42ac3172-2059-4d5d-92c8-8998e0a726b1" xlink:href="mck-20230331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_42ac3172-2059-4d5d-92c8-8998e0a726b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_c3578ed8-1278-4b95-a7a0-19d9ea63c341" xlink:href="mck-20230331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_c3578ed8-1278-4b95-a7a0-19d9ea63c341" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_39f04f80-46f4-42a9-ae66-f26af9242bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_39f04f80-46f4-42a9-ae66-f26af9242bb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6bf5d05f-13c0-4984-af9f-f98a7a6102b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6bf5d05f-13c0-4984-af9f-f98a7a6102b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_ed18d4b4-2166-4f62-8e1a-bc4e43c9b4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_ed18d4b4-2166-4f62-8e1a-bc4e43c9b4e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d3bd1d70-8d77-4a0c-ad1a-2d62b8bee3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d3bd1d70-8d77-4a0c-ad1a-2d62b8bee3d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c62dab85-475f-40f6-a304-7fa6a6149551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d3bd1d70-8d77-4a0c-ad1a-2d62b8bee3d6" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c62dab85-475f-40f6-a304-7fa6a6149551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c62dab85-475f-40f6-a304-7fa6a6149551_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c62dab85-475f-40f6-a304-7fa6a6149551" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c62dab85-475f-40f6-a304-7fa6a6149551_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_60e27c46-ed9d-4151-a7be-5a343e1a2c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c62dab85-475f-40f6-a304-7fa6a6149551" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_60e27c46-ed9d-4151-a7be-5a343e1a2c5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_6e3b767f-e945-4833-8536-9c3c502987a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_60e27c46-ed9d-4151-a7be-5a343e1a2c5a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_6e3b767f-e945-4833-8536-9c3c502987a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_94a527fe-38bc-4170-9db8-5d623e7dfba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d3bd1d70-8d77-4a0c-ad1a-2d62b8bee3d6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_94a527fe-38bc-4170-9db8-5d623e7dfba3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_94a527fe-38bc-4170-9db8-5d623e7dfba3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_94a527fe-38bc-4170-9db8-5d623e7dfba3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_94a527fe-38bc-4170-9db8-5d623e7dfba3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aa2974a5-bdd8-414f-a85d-06938d8b9db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_94a527fe-38bc-4170-9db8-5d623e7dfba3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aa2974a5-bdd8-414f-a85d-06938d8b9db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_ef67bfa9-39db-466c-b10d-3043d08a5ca0" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aa2974a5-bdd8-414f-a85d-06938d8b9db3" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_ef67bfa9-39db-466c-b10d-3043d08a5ca0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_d88f40dc-5ca0-4d6c-a951-6c8f7af22ecf" xlink:href="mck-20230331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aa2974a5-bdd8-414f-a85d-06938d8b9db3" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_d88f40dc-5ca0-4d6c-a951-6c8f7af22ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_087d9ec9-8338-4719-8509-dd3cfe225a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d3bd1d70-8d77-4a0c-ad1a-2d62b8bee3d6" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_087d9ec9-8338-4719-8509-dd3cfe225a6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_087d9ec9-8338-4719-8509-dd3cfe225a6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_087d9ec9-8338-4719-8509-dd3cfe225a6c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_087d9ec9-8338-4719-8509-dd3cfe225a6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3acdfbb-0e8a-423d-8455-3f528a6f0746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_087d9ec9-8338-4719-8509-dd3cfe225a6c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3acdfbb-0e8a-423d-8455-3f528a6f0746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_3c0eb4c1-e37e-4ca0-80b5-acb361651345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3acdfbb-0e8a-423d-8455-3f528a6f0746" xlink:to="loc_us-gaap_ForeignPlanMember_3c0eb4c1-e37e-4ca0-80b5-acb361651345" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="extended" id="ib1e3add5d2bf418fa44dfeb7aced3b66_PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6420402f-d95d-40ae-b23c-cc1347e43801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ef0b61db-b9e7-4145-82ac-d0f2a5f0adc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6420402f-d95d-40ae-b23c-cc1347e43801" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ef0b61db-b9e7-4145-82ac-d0f2a5f0adc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_c9da59c1-3d1a-4156-8d7d-c1ad2fb0cef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6420402f-d95d-40ae-b23c-cc1347e43801" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_c9da59c1-3d1a-4156-8d7d-c1ad2fb0cef1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c8098287-ccd6-4c3b-a589-173a69a640c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6420402f-d95d-40ae-b23c-cc1347e43801" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c8098287-ccd6-4c3b-a589-173a69a640c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_15cfbf95-bd44-427c-b11c-618d6cb2c415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6420402f-d95d-40ae-b23c-cc1347e43801" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_15cfbf95-bd44-427c-b11c-618d6cb2c415" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_ca08e435-75bd-4eb4-b921-185be00f585b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_15cfbf95-bd44-427c-b11c-618d6cb2c415" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_ca08e435-75bd-4eb4-b921-185be00f585b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca08e435-75bd-4eb4-b921-185be00f585b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ca08e435-75bd-4eb4-b921-185be00f585b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_ca08e435-75bd-4eb4-b921-185be00f585b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8fb1d67a-4e3a-4bae-9143-7af5c00ef5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ca08e435-75bd-4eb4-b921-185be00f585b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8fb1d67a-4e3a-4bae-9143-7af5c00ef5c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_384308b4-ee7f-4916-9b98-f2bd90423e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8fb1d67a-4e3a-4bae-9143-7af5c00ef5c3" xlink:to="loc_us-gaap_ForeignPlanMember_384308b4-ee7f-4916-9b98-f2bd90423e10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_65210910-8f8c-4d74-824f-49d276234d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_15cfbf95-bd44-427c-b11c-618d6cb2c415" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_65210910-8f8c-4d74-824f-49d276234d0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_65210910-8f8c-4d74-824f-49d276234d0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_65210910-8f8c-4d74-824f-49d276234d0a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_65210910-8f8c-4d74-824f-49d276234d0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cec284b0-1dfa-4f45-a002-ebabed3b8ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_65210910-8f8c-4d74-824f-49d276234d0a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cec284b0-1dfa-4f45-a002-ebabed3b8ef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f3808a0f-a9e4-4662-9dc7-33b8a7d282ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cec284b0-1dfa-4f45-a002-ebabed3b8ef0" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f3808a0f-a9e4-4662-9dc7-33b8a7d282ac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="i5bc52c788aeb49caa4ca088b77b3eb6d_PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_14be3be9-71fe-4f46-9f7f-85f650b3cf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4da5a4f6-321c-4ebb-96b7-2b0600cc9d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_14be3be9-71fe-4f46-9f7f-85f650b3cf4b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4da5a4f6-321c-4ebb-96b7-2b0600cc9d06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_a4375cc8-4a4a-4020-9ce1-485eae4d26b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_14be3be9-71fe-4f46-9f7f-85f650b3cf4b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_a4375cc8-4a4a-4020-9ce1-485eae4d26b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_f5595a66-7c6a-4870-b03a-de440fde2299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_14be3be9-71fe-4f46-9f7f-85f650b3cf4b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_f5595a66-7c6a-4870-b03a-de440fde2299" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_27cb10b2-de1d-4d17-b6e8-08c6fd6130b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_14be3be9-71fe-4f46-9f7f-85f650b3cf4b" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_27cb10b2-de1d-4d17-b6e8-08c6fd6130b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_0813b917-0a64-4e37-898d-ab94e8e9440b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_27cb10b2-de1d-4d17-b6e8-08c6fd6130b3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_0813b917-0a64-4e37-898d-ab94e8e9440b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_0813b917-0a64-4e37-898d-ab94e8e9440b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0813b917-0a64-4e37-898d-ab94e8e9440b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_0813b917-0a64-4e37-898d-ab94e8e9440b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3cab80d-c00b-468c-b91a-f5ec81a2d537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0813b917-0a64-4e37-898d-ab94e8e9440b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3cab80d-c00b-468c-b91a-f5ec81a2d537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_b5a254ed-7afc-4a2e-876b-6b4aacc05262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3cab80d-c00b-468c-b91a-f5ec81a2d537" xlink:to="loc_us-gaap_ForeignPlanMember_b5a254ed-7afc-4a2e-876b-6b4aacc05262" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_fb6bbb44-f944-4683-9ba7-4fd37c6c3a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_27cb10b2-de1d-4d17-b6e8-08c6fd6130b3" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_fb6bbb44-f944-4683-9ba7-4fd37c6c3a6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_fb6bbb44-f944-4683-9ba7-4fd37c6c3a6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_fb6bbb44-f944-4683-9ba7-4fd37c6c3a6b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_fb6bbb44-f944-4683-9ba7-4fd37c6c3a6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5f4bea7c-c8d7-404b-8c83-cb53ccf4b9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_fb6bbb44-f944-4683-9ba7-4fd37c6c3a6b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5f4bea7c-c8d7-404b-8c83-cb53ccf4b9b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_98a80870-b642-487e-bfbd-684e56398f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_5f4bea7c-c8d7-404b-8c83-cb53ccf4b9b0" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_98a80870-b642-487e-bfbd-684e56398f66" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="i634b6504b9f9453c9c3009924960ee86_PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_096341c5-5c6a-4b88-8ccf-6012332b2d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_096341c5-5c6a-4b88-8ccf-6012332b2d92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_48432e15-31e6-4961-b773-d5e503a9f4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_48432e15-31e6-4961-b773-d5e503a9f4ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_9d79fda7-a523-4334-b507-c9f1617b14cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_9d79fda7-a523-4334-b507-c9f1617b14cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f8d6001f-466b-4963-b936-7c3c12ed4d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_9d79fda7-a523-4334-b507-c9f1617b14cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f8d6001f-466b-4963-b936-7c3c12ed4d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_3668a52a-6de0-449b-b4ab-40804041ef5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_9d79fda7-a523-4334-b507-c9f1617b14cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_3668a52a-6de0-449b-b4ab-40804041ef5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_27a3682c-b373-4bee-adfc-5f93f8e8879f" xlink:href="mck-20230331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:to="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_27a3682c-b373-4bee-adfc-5f93f8e8879f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_61df9b3e-4e6a-4296-a584-7fbd557b6b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_61df9b3e-4e6a-4296-a584-7fbd557b6b01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a14e3c8d-0a39-4eff-a32c-1ef1ad27ffaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a14e3c8d-0a39-4eff-a32c-1ef1ad27ffaa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c35c9bbd-8e95-410c-a78a-159c2ec75591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a14e3c8d-0a39-4eff-a32c-1ef1ad27ffaa" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c35c9bbd-8e95-410c-a78a-159c2ec75591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c35c9bbd-8e95-410c-a78a-159c2ec75591_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c35c9bbd-8e95-410c-a78a-159c2ec75591" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c35c9bbd-8e95-410c-a78a-159c2ec75591_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c92550d4-c08e-479a-9f3f-19bf983cdb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c35c9bbd-8e95-410c-a78a-159c2ec75591" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c92550d4-c08e-479a-9f3f-19bf983cdb1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_196ffaa5-4184-4d44-8e3d-0f60e26726ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c92550d4-c08e-479a-9f3f-19bf983cdb1e" xlink:to="loc_us-gaap_ForeignPlanMember_196ffaa5-4184-4d44-8e3d-0f60e26726ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9063a7c1-d071-4b1b-b472-354c5c2763a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a14e3c8d-0a39-4eff-a32c-1ef1ad27ffaa" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9063a7c1-d071-4b1b-b472-354c5c2763a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9063a7c1-d071-4b1b-b472-354c5c2763a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9063a7c1-d071-4b1b-b472-354c5c2763a7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9063a7c1-d071-4b1b-b472-354c5c2763a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d6bb72e7-5455-4e06-bd98-05d2f726c411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9063a7c1-d071-4b1b-b472-354c5c2763a7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d6bb72e7-5455-4e06-bd98-05d2f726c411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f520d1e4-5711-4528-a370-9928cd1b7edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d6bb72e7-5455-4e06-bd98-05d2f726c411" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f520d1e4-5711-4528-a370-9928cd1b7edf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="extended" id="i1e26eb9a4b79474c83c6591c14895510_PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b3b60fcc-73b1-40fc-9f97-effc9834570a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_583172ad-fd71-4b0d-aa4d-f4a75b431619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b3b60fcc-73b1-40fc-9f97-effc9834570a" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_583172ad-fd71-4b0d-aa4d-f4a75b431619" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_81bff4c4-805e-4a2a-8834-d2aa572df42a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_583172ad-fd71-4b0d-aa4d-f4a75b431619" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_81bff4c4-805e-4a2a-8834-d2aa572df42a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_84e404c5-3995-40c0-aa97-fb3f6e412492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_583172ad-fd71-4b0d-aa4d-f4a75b431619" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_84e404c5-3995-40c0-aa97-fb3f6e412492" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_249a5f30-204d-4895-8a95-dbeaf87f87ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_583172ad-fd71-4b0d-aa4d-f4a75b431619" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_249a5f30-204d-4895-8a95-dbeaf87f87ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_b2233ecf-9961-4230-8a9c-b3e72a999e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b3b60fcc-73b1-40fc-9f97-effc9834570a" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_b2233ecf-9961-4230-8a9c-b3e72a999e8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_f9469ab3-437b-4857-9224-cf7091b553de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_b2233ecf-9961-4230-8a9c-b3e72a999e8e" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_f9469ab3-437b-4857-9224-cf7091b553de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_dadc18ad-2200-49ca-a308-51406952d6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_b2233ecf-9961-4230-8a9c-b3e72a999e8e" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_dadc18ad-2200-49ca-a308-51406952d6d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_76fe2f9c-149a-4a04-b51b-1763f57c7755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b3b60fcc-73b1-40fc-9f97-effc9834570a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_76fe2f9c-149a-4a04-b51b-1763f57c7755" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_feaad9f6-6d54-4ca5-a934-763ae3d937c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_76fe2f9c-149a-4a04-b51b-1763f57c7755" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_feaad9f6-6d54-4ca5-a934-763ae3d937c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_feaad9f6-6d54-4ca5-a934-763ae3d937c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_feaad9f6-6d54-4ca5-a934-763ae3d937c0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_feaad9f6-6d54-4ca5-a934-763ae3d937c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_efabf8f9-0a9b-4ce3-b432-bdcfcf72e809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_feaad9f6-6d54-4ca5-a934-763ae3d937c0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_efabf8f9-0a9b-4ce3-b432-bdcfcf72e809" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_534b767a-092f-42c6-803d-b0d54d516f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_efabf8f9-0a9b-4ce3-b432-bdcfcf72e809" xlink:to="loc_us-gaap_ForeignPlanMember_534b767a-092f-42c6-803d-b0d54d516f06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_234ff75d-908f-4cb9-99d5-6558c105e075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_76fe2f9c-149a-4a04-b51b-1763f57c7755" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_234ff75d-908f-4cb9-99d5-6558c105e075" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_234ff75d-908f-4cb9-99d5-6558c105e075_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_234ff75d-908f-4cb9-99d5-6558c105e075" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_234ff75d-908f-4cb9-99d5-6558c105e075_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c04b0ea5-1e7e-4fab-b5f2-cafabe1baf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_234ff75d-908f-4cb9-99d5-6558c105e075" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c04b0ea5-1e7e-4fab-b5f2-cafabe1baf6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_43219deb-20eb-4b4b-8d52-a3fd019fcc25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_c04b0ea5-1e7e-4fab-b5f2-cafabe1baf6a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_43219deb-20eb-4b4b-8d52-a3fd019fcc25" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="extended" id="i1599ce1d63d24170bf4937855e3ebcbb_PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e81f7c12-f9fd-44f0-ad27-cc104192dc20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f41dffa8-efa2-4d0e-879a-f18fe95d871d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e81f7c12-f9fd-44f0-ad27-cc104192dc20" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f41dffa8-efa2-4d0e-879a-f18fe95d871d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e81f7c12-f9fd-44f0-ad27-cc104192dc20" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5ae87b59-6ff6-4bbf-a7e4-9693f3895f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5ae87b59-6ff6-4bbf-a7e4-9693f3895f13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5ae87b59-6ff6-4bbf-a7e4-9693f3895f13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5ae87b59-6ff6-4bbf-a7e4-9693f3895f13" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5ae87b59-6ff6-4bbf-a7e4-9693f3895f13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f4288907-d539-48b3-b806-dd3c412f1a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5ae87b59-6ff6-4bbf-a7e4-9693f3895f13" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f4288907-d539-48b3-b806-dd3c412f1a63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_3378c89f-cb22-4d54-9526-0762bb18b983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f4288907-d539-48b3-b806-dd3c412f1a63" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_3378c89f-cb22-4d54-9526-0762bb18b983" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_4f5794b2-053f-46da-a4fb-06dec42710aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_4f5794b2-053f-46da-a4fb-06dec42710aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4f5794b2-053f-46da-a4fb-06dec42710aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_4f5794b2-053f-46da-a4fb-06dec42710aa" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4f5794b2-053f-46da-a4fb-06dec42710aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8954b0b7-d7ef-428d-8415-d57d05b24448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_4f5794b2-053f-46da-a4fb-06dec42710aa" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8954b0b7-d7ef-428d-8415-d57d05b24448" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_729aac63-c184-4ea8-8268-aa14d2384289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8954b0b7-d7ef-428d-8415-d57d05b24448" xlink:to="loc_us-gaap_ForeignPlanMember_729aac63-c184-4ea8-8268-aa14d2384289" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7d5b6c4e-234a-40cd-8823-e94f64c40073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7d5b6c4e-234a-40cd-8823-e94f64c40073" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_7d5b6c4e-234a-40cd-8823-e94f64c40073_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7d5b6c4e-234a-40cd-8823-e94f64c40073" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_7d5b6c4e-234a-40cd-8823-e94f64c40073_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7d5b6c4e-234a-40cd-8823-e94f64c40073" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_33042ca0-a209-492c-a9e9-138fcac2a94f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_33042ca0-a209-492c-a9e9-138fcac2a94f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_3cd58dc0-a11c-49d8-ab70-9e488c099e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_us-gaap_MutualFundMember_3cd58dc0-a11c-49d8-ab70-9e488c099e44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_08312ee5-564f-48bb-b494-82f3297a6619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_08312ee5-564f-48bb-b494-82f3297a6619" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_63eec949-46c7-4f60-8a03-8276e8c2d0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_63eec949-46c7-4f60-8a03-8276e8c2d0b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_3d7b3780-0de8-4eed-9039-824a1ffff598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_us-gaap_FixedIncomeFundsMember_3d7b3780-0de8-4eed-9039-824a1ffff598" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAnnuityContractsMember_757998df-f368-40f3-b734-497a31dd2dfe" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanAnnuityContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_mck_DefinedBenefitPlanAnnuityContractsMember_757998df-f368-40f3-b734-497a31dd2dfe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanOtherFundsMember_99e641bb-93e2-4b94-ab91-dc710b7a8c3e" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanOtherFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_mck_DefinedBenefitPlanOtherFundsMember_99e641bb-93e2-4b94-ab91-dc710b7a8c3e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51a18a5d-ebdd-487a-b06e-5470701f484e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51a18a5d-ebdd-487a-b06e-5470701f484e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51a18a5d-ebdd-487a-b06e-5470701f484e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51a18a5d-ebdd-487a-b06e-5470701f484e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_51a18a5d-ebdd-487a-b06e-5470701f484e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e4e5b46-0495-4e0c-a056-41c923cfbb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51a18a5d-ebdd-487a-b06e-5470701f484e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e4e5b46-0495-4e0c-a056-41c923cfbb54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b2424b27-6b1e-42f7-9fe1-0b00f46af78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e4e5b46-0495-4e0c-a056-41c923cfbb54" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b2424b27-6b1e-42f7-9fe1-0b00f46af78a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_39e490cb-0fa6-45be-950e-43300f2952d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e4e5b46-0495-4e0c-a056-41c923cfbb54" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_39e490cb-0fa6-45be-950e-43300f2952d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_051588f8-cdc5-40e6-962e-7332214894f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e4e5b46-0495-4e0c-a056-41c923cfbb54" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_051588f8-cdc5-40e6-962e-7332214894f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_b31fc851-0081-4f77-a333-6a487ca5fe95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_b31fc851-0081-4f77-a333-6a487ca5fe95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b31fc851-0081-4f77-a333-6a487ca5fe95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_b31fc851-0081-4f77-a333-6a487ca5fe95" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_b31fc851-0081-4f77-a333-6a487ca5fe95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b77bd817-513c-4f86-bec6-18af224148e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_b31fc851-0081-4f77-a333-6a487ca5fe95" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b77bd817-513c-4f86-bec6-18af224148e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_24ec8c01-5667-4852-8fbd-9a19689aa725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b77bd817-513c-4f86-bec6-18af224148e0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_24ec8c01-5667-4852-8fbd-9a19689aa725" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_73e9d6fa-914f-46ba-9ffe-815ad1d934cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b77bd817-513c-4f86-bec6-18af224148e0" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_73e9d6fa-914f-46ba-9ffe-815ad1d934cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_6a1ffe5c-84bd-4703-8710-2c56256a2cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b77bd817-513c-4f86-bec6-18af224148e0" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_6a1ffe5c-84bd-4703-8710-2c56256a2cc0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails" xlink:type="extended" id="i6ce2658cb1a441eda9d25811aec1d312_PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6e8cd0a2-b545-40cb-84c9-3099691c81f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_98cc7b83-3ed4-4555-9c3e-61b51326222e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6e8cd0a2-b545-40cb-84c9-3099691c81f3" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_98cc7b83-3ed4-4555-9c3e-61b51326222e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e7440c72-24a2-42e9-aed6-012c89f764e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_98cc7b83-3ed4-4555-9c3e-61b51326222e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e7440c72-24a2-42e9-aed6-012c89f764e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_2b408edf-9b43-4cb4-b66d-3bf679153103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_98cc7b83-3ed4-4555-9c3e-61b51326222e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_2b408edf-9b43-4cb4-b66d-3bf679153103" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_04705fb8-62a7-4f93-9f23-ad7a1e0b9ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_98cc7b83-3ed4-4555-9c3e-61b51326222e" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_04705fb8-62a7-4f93-9f23-ad7a1e0b9ca7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_fa423b61-adad-4dcf-afb5-0d90084334f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_be4cc260-d5c3-4a86-b839-57fa89b9fe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6e8cd0a2-b545-40cb-84c9-3099691c81f3" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_be4cc260-d5c3-4a86-b839-57fa89b9fe8a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4c6457c-00ac-4f20-9d60-864f91f808d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_be4cc260-d5c3-4a86-b839-57fa89b9fe8a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4c6457c-00ac-4f20-9d60-864f91f808d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e4c6457c-00ac-4f20-9d60-864f91f808d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4c6457c-00ac-4f20-9d60-864f91f808d6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e4c6457c-00ac-4f20-9d60-864f91f808d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6dbc4cae-59e8-48aa-86e5-c6f370c4cfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4c6457c-00ac-4f20-9d60-864f91f808d6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6dbc4cae-59e8-48aa-86e5-c6f370c4cfe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8e86ce2d-5869-491b-a72d-f62f18ab8a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6dbc4cae-59e8-48aa-86e5-c6f370c4cfe6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8e86ce2d-5869-491b-a72d-f62f18ab8a6c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended" id="i23966d4534914348b24e3dd1213b73e7_HedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9bf8f633-b5ed-4f0c-85d8-ba61a2ba7c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9bf8f633-b5ed-4f0c-85d8-ba61a2ba7c8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_b35c3870-b7bc-4110-820f-bb767b826b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_b35c3870-b7bc-4110-820f-bb767b826b4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_81c3b81c-814d-4b6d-8dac-94503b7cc538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_81c3b81c-814d-4b6d-8dac-94503b7cc538" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f7472f0e-7fad-4ebe-866b-04f0196f7833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_us-gaap_LongTermDebt_f7472f0e-7fad-4ebe-866b-04f0196f7833" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DerivativeNotionalAmountTerminated_43a67cc3-6c81-4f16-9b9e-afb766c8956b" xlink:href="mck-20230331.xsd#mck_DerivativeNotionalAmountTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_mck_DerivativeNotionalAmountTerminated_43a67cc3-6c81-4f16-9b9e-afb766c8956b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnDerivativeTermination_1da01921-4061-432b-a0d2-5577757dc8e2" xlink:href="mck-20230331.xsd#mck_GainLossOnDerivativeTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_mck_GainLossOnDerivativeTermination_1da01921-4061-432b-a0d2-5577757dc8e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_054c0089-e835-429f-81fb-c680c638aaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_DebtInstrumentAxis_054c0089-e835-429f-81fb-c680c638aaf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_054c0089-e835-429f-81fb-c680c638aaf6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_054c0089-e835-429f-81fb-c680c638aaf6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_054c0089-e835-429f-81fb-c680c638aaf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c9608b0f-138d-4336-8dca-c71be3db018d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_054c0089-e835-429f-81fb-c680c638aaf6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c9608b0f-138d-4336-8dca-c71be3db018d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_f68f5744-592b-4fc8-948c-d8969b5bf31d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9608b0f-138d-4336-8dca-c71be3db018d" xlink:to="loc_us-gaap_CurrencySwapMember_f68f5744-592b-4fc8-948c-d8969b5bf31d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_cf914ccb-6f78-45be-bd89-3c092383ca2b" xlink:href="mck-20230331.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9608b0f-138d-4336-8dca-c71be3db018d" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_cf914ccb-6f78-45be-bd89-3c092383ca2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_836f6b5c-f9d3-4fc6-a0fa-645101af2533" xlink:href="mck-20230331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9608b0f-138d-4336-8dca-c71be3db018d" xlink:to="loc_mck_EuroDenominatedNotesMember_836f6b5c-f9d3-4fc6-a0fa-645101af2533" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f071dd62-f5e9-44bb-8f91-7c18071d7ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f071dd62-f5e9-44bb-8f91-7c18071d7ab9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f071dd62-f5e9-44bb-8f91-7c18071d7ab9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f071dd62-f5e9-44bb-8f91-7c18071d7ab9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f071dd62-f5e9-44bb-8f91-7c18071d7ab9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c990940e-8335-4981-a033-68a038e853e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f071dd62-f5e9-44bb-8f91-7c18071d7ab9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c990940e-8335-4981-a033-68a038e853e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_2d978a46-59f9-4630-83a9-6aa33bb74942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c990940e-8335-4981-a033-68a038e853e0" xlink:to="loc_us-gaap_LoansPayableMember_2d978a46-59f9-4630-83a9-6aa33bb74942" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61c50ea6-c8cc-496b-84b2-5378c8a4a2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61c50ea6-c8cc-496b-84b2-5378c8a4a2f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_61c50ea6-c8cc-496b-84b2-5378c8a4a2f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61c50ea6-c8cc-496b-84b2-5378c8a4a2f0" xlink:to="loc_us-gaap_HedgingRelationshipDomain_61c50ea6-c8cc-496b-84b2-5378c8a4a2f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3021baaa-924a-4ef7-8209-778366c5f2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61c50ea6-c8cc-496b-84b2-5378c8a4a2f0" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3021baaa-924a-4ef7-8209-778366c5f2f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_43816b00-3dfb-49ca-8fea-bbf518dc8061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3021baaa-924a-4ef7-8209-778366c5f2f3" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_43816b00-3dfb-49ca-8fea-bbf518dc8061" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_0ec6b4f2-8b12-4199-ba15-42f975d4ac26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3021baaa-924a-4ef7-8209-778366c5f2f3" xlink:to="loc_us-gaap_FairValueHedgingMember_0ec6b4f2-8b12-4199-ba15-42f975d4ac26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7e17079b-c7ae-463d-b159-865d6f52870a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3021baaa-924a-4ef7-8209-778366c5f2f3" xlink:to="loc_us-gaap_CashFlowHedgingMember_7e17079b-c7ae-463d-b159-865d6f52870a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f56de469-9b72-4fe6-8231-7afb8ffe87a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f56de469-9b72-4fe6-8231-7afb8ffe87a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f56de469-9b72-4fe6-8231-7afb8ffe87a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f56de469-9b72-4fe6-8231-7afb8ffe87a8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f56de469-9b72-4fe6-8231-7afb8ffe87a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f56de469-9b72-4fe6-8231-7afb8ffe87a8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_5e86f787-409f-4e29-a09f-d232d2cff013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:to="loc_us-gaap_CurrencySwapMember_5e86f787-409f-4e29-a09f-d232d2cff013" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2069a9f1-5542-4c6c-bf5f-eb845beccb79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:to="loc_us-gaap_InterestRateSwapMember_2069a9f1-5542-4c6c-bf5f-eb845beccb79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InterestRateSwapEnteredIntoYTDMember_030dbead-8d02-4321-91f0-69f3919d7781" xlink:href="mck-20230331.xsd#mck_InterestRateSwapEnteredIntoYTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:to="loc_mck_InterestRateSwapEnteredIntoYTDMember_030dbead-8d02-4321-91f0-69f3919d7781" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_167089f5-2080-49ab-9241-2889a9a71ebb" xlink:href="mck-20230331.xsd#mck_FixedInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:to="loc_mck_FixedInterestRateSwapMember_167089f5-2080-49ab-9241-2889a9a71ebb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b8a60e20-59e1-41c5-9af9-83466a161e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_HedgingDesignationAxis_b8a60e20-59e1-41c5-9af9-83466a161e19" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b8a60e20-59e1-41c5-9af9-83466a161e19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b8a60e20-59e1-41c5-9af9-83466a161e19" xlink:to="loc_us-gaap_HedgingDesignationDomain_b8a60e20-59e1-41c5-9af9-83466a161e19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3802031a-197c-4a77-8254-e9dfc5fa7447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b8a60e20-59e1-41c5-9af9-83466a161e19" xlink:to="loc_us-gaap_HedgingDesignationDomain_3802031a-197c-4a77-8254-e9dfc5fa7447" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_79c05604-d772-495c-9b1e-236d373ad4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_3802031a-197c-4a77-8254-e9dfc5fa7447" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_79c05604-d772-495c-9b1e-236d373ad4a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_460b9022-8e63-42c0-aaab-12d24203664c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_460b9022-8e63-42c0-aaab-12d24203664c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_460b9022-8e63-42c0-aaab-12d24203664c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_460b9022-8e63-42c0-aaab-12d24203664c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_460b9022-8e63-42c0-aaab-12d24203664c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6061bed5-4a0d-47b6-a9f7-4db00fa5d89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_460b9022-8e63-42c0-aaab-12d24203664c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6061bed5-4a0d-47b6-a9f7-4db00fa5d89a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8ee5790b-52b0-4d01-b60d-51be69b4858b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6061bed5-4a0d-47b6-a9f7-4db00fa5d89a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8ee5790b-52b0-4d01-b60d-51be69b4858b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6afa8a2e-28d9-4304-b28a-7ab715c74510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6afa8a2e-28d9-4304-b28a-7ab715c74510" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6afa8a2e-28d9-4304-b28a-7ab715c74510_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6afa8a2e-28d9-4304-b28a-7ab715c74510" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6afa8a2e-28d9-4304-b28a-7ab715c74510_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b341554c-56b8-4145-bac0-034b972532d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6afa8a2e-28d9-4304-b28a-7ab715c74510" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b341554c-56b8-4145-bac0-034b972532d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_2f977980-74e9-4d1f-b277-6f0728ebc759" xlink:href="mck-20230331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b341554c-56b8-4145-bac0-034b972532d2" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_2f977980-74e9-4d1f-b277-6f0728ebc759" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_57c27a98-879c-4168-b4a4-ab6581d0cd7b" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b341554c-56b8-4145-bac0-034b972532d2" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_57c27a98-879c-4168-b4a4-ab6581d0cd7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_a10e36be-1296-4ffe-9933-4b7eb371d8a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_srt_CurrencyAxis_a10e36be-1296-4ffe-9933-4b7eb371d8a5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_a10e36be-1296-4ffe-9933-4b7eb371d8a5_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_a10e36be-1296-4ffe-9933-4b7eb371d8a5" xlink:to="loc_currency_AllCurrenciesDomain_a10e36be-1296-4ffe-9933-4b7eb371d8a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_8e45b4c6-bba7-4259-aabf-a01fb1000725" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_a10e36be-1296-4ffe-9933-4b7eb371d8a5" xlink:to="loc_currency_AllCurrenciesDomain_8e45b4c6-bba7-4259-aabf-a01fb1000725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_d2027a1c-6cfa-482c-b546-af5054d98a02" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_8e45b4c6-bba7-4259-aabf-a01fb1000725" xlink:to="loc_currency_EUR_d2027a1c-6cfa-482c-b546-af5054d98a02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_bb1fc3e4-2a27-41a4-920e-e4c52193fa69" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_8e45b4c6-bba7-4259-aabf-a01fb1000725" xlink:to="loc_currency_USD_bb1fc3e4-2a27-41a4-920e-e4c52193fa69" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="extended" id="i1a05a339e6764119b6dcdfa3d734cf0f_HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_d53a83b5-c746-496a-a65a-bdb437bfcbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_3d1d5283-cd49-4fd2-b9ae-f223ea5f3003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d53a83b5-c746-496a-a65a-bdb437bfcbfd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_3d1d5283-cd49-4fd2-b9ae-f223ea5f3003" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7f4fb4f0-3458-4878-bb37-1f1bf9e7ce41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d53a83b5-c746-496a-a65a-bdb437bfcbfd" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7f4fb4f0-3458-4878-bb37-1f1bf9e7ce41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b3d59ae4-d337-43ff-9e1b-356050d70c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d53a83b5-c746-496a-a65a-bdb437bfcbfd" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b3d59ae4-d337-43ff-9e1b-356050d70c78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b68627fe-114e-418c-ad51-979a023db636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b3d59ae4-d337-43ff-9e1b-356050d70c78" xlink:to="loc_us-gaap_HedgingDesignationAxis_b68627fe-114e-418c-ad51-979a023db636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b68627fe-114e-418c-ad51-979a023db636_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b68627fe-114e-418c-ad51-979a023db636" xlink:to="loc_us-gaap_HedgingDesignationDomain_b68627fe-114e-418c-ad51-979a023db636_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ea84b490-f1c4-424d-99ad-e55f4aca86d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b68627fe-114e-418c-ad51-979a023db636" xlink:to="loc_us-gaap_HedgingDesignationDomain_ea84b490-f1c4-424d-99ad-e55f4aca86d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4fcf5dc9-ff13-43ca-9dda-53c9d893475f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ea84b490-f1c4-424d-99ad-e55f4aca86d2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4fcf5dc9-ff13-43ca-9dda-53c9d893475f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a174c3d1-fbfe-4d51-927e-105d09ccbec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b3d59ae4-d337-43ff-9e1b-356050d70c78" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a174c3d1-fbfe-4d51-927e-105d09ccbec6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a174c3d1-fbfe-4d51-927e-105d09ccbec6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a174c3d1-fbfe-4d51-927e-105d09ccbec6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a174c3d1-fbfe-4d51-927e-105d09ccbec6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0a15b0a3-afae-4ad3-a3b7-3b7dece9e1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a174c3d1-fbfe-4d51-927e-105d09ccbec6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0a15b0a3-afae-4ad3-a3b7-3b7dece9e1b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_9c7b940c-c9ed-4be7-83d5-3af6ac81e695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0a15b0a3-afae-4ad3-a3b7-3b7dece9e1b7" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_9c7b940c-c9ed-4be7-83d5-3af6ac81e695" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_faf79e45-3977-4da9-a9f6-1abc51b60953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b3d59ae4-d337-43ff-9e1b-356050d70c78" xlink:to="loc_us-gaap_DebtInstrumentAxis_faf79e45-3977-4da9-a9f6-1abc51b60953" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_faf79e45-3977-4da9-a9f6-1abc51b60953_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_faf79e45-3977-4da9-a9f6-1abc51b60953" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_faf79e45-3977-4da9-a9f6-1abc51b60953_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1fe87d57-be33-4144-aaf7-4187f77d8600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_faf79e45-3977-4da9-a9f6-1abc51b60953" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1fe87d57-be33-4144-aaf7-4187f77d8600" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_acd4aa40-bc9c-4448-8a1e-787a46fd0582" xlink:href="mck-20230331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1fe87d57-be33-4144-aaf7-4187f77d8600" xlink:to="loc_mck_EuroDenominatedNotesMember_acd4aa40-bc9c-4448-8a1e-787a46fd0582" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="extended" id="ic06d85ceb9e44f22989f698d7cb7078e_HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_ec8daeb0-1e84-4eab-8917-66e6e491288c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6053055f-9994-4f5b-9ab4-a7cfd3f209ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ec8daeb0-1e84-4eab-8917-66e6e491288c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6053055f-9994-4f5b-9ab4-a7cfd3f209ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ec8daeb0-1e84-4eab-8917-66e6e491288c" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8de4c0d2-6616-4da0-987a-d87a83e1bed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:to="loc_us-gaap_HedgingDesignationAxis_8de4c0d2-6616-4da0-987a-d87a83e1bed1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8de4c0d2-6616-4da0-987a-d87a83e1bed1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_8de4c0d2-6616-4da0-987a-d87a83e1bed1" xlink:to="loc_us-gaap_HedgingDesignationDomain_8de4c0d2-6616-4da0-987a-d87a83e1bed1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ee94152f-0e92-478a-99be-2031c46d9414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_8de4c0d2-6616-4da0-987a-d87a83e1bed1" xlink:to="loc_us-gaap_HedgingDesignationDomain_ee94152f-0e92-478a-99be-2031c46d9414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c64a24f4-9821-491a-80d3-d2cc54264e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ee94152f-0e92-478a-99be-2031c46d9414" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c64a24f4-9821-491a-80d3-d2cc54264e84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fbbb6182-1ad8-4330-9615-40657fd0c20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fbbb6182-1ad8-4330-9615-40657fd0c20b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fbbb6182-1ad8-4330-9615-40657fd0c20b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fbbb6182-1ad8-4330-9615-40657fd0c20b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fbbb6182-1ad8-4330-9615-40657fd0c20b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9cc4bc2b-d43b-4bfd-8cbf-c5d6755f267a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fbbb6182-1ad8-4330-9615-40657fd0c20b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9cc4bc2b-d43b-4bfd-8cbf-c5d6755f267a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_311caa36-4e0e-4188-8dfc-bd131a04b793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9cc4bc2b-d43b-4bfd-8cbf-c5d6755f267a" xlink:to="loc_us-gaap_CurrencySwapMember_311caa36-4e0e-4188-8dfc-bd131a04b793" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_671bdc2d-cd65-464d-b51f-8582909e0e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9cc4bc2b-d43b-4bfd-8cbf-c5d6755f267a" xlink:to="loc_us-gaap_InterestRateSwapMember_671bdc2d-cd65-464d-b51f-8582909e0e0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_864743dd-c953-4302-8693-e8dbfc12aff8" xlink:href="mck-20230331.xsd#mck_FixedInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9cc4bc2b-d43b-4bfd-8cbf-c5d6755f267a" xlink:to="loc_mck_FixedInterestRateSwapMember_864743dd-c953-4302-8693-e8dbfc12aff8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1f1d4329-7499-4ed4-8b3a-6e79bd0385ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1f1d4329-7499-4ed4-8b3a-6e79bd0385ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1f1d4329-7499-4ed4-8b3a-6e79bd0385ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1f1d4329-7499-4ed4-8b3a-6e79bd0385ac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1f1d4329-7499-4ed4-8b3a-6e79bd0385ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_206d66a4-adf1-4f42-9720-a44a2a6554ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1f1d4329-7499-4ed4-8b3a-6e79bd0385ac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_206d66a4-adf1-4f42-9720-a44a2a6554ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_1e61607d-2421-4c78-a9ae-0322442ff325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_206d66a4-adf1-4f42-9720-a44a2a6554ad" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_1e61607d-2421-4c78-a9ae-0322442ff325" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_9b0ea4cd-d611-4605-8154-b376a3a7463c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_206d66a4-adf1-4f42-9720-a44a2a6554ad" xlink:to="loc_us-gaap_FairValueHedgingMember_9b0ea4cd-d611-4605-8154-b376a3a7463c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_d99a0446-1b04-4825-beb0-4d8c24365345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_206d66a4-adf1-4f42-9720-a44a2a6554ad" xlink:to="loc_us-gaap_CashFlowHedgingMember_d99a0446-1b04-4825-beb0-4d8c24365345" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8f56d302-ebd2-426c-ada1-542dc3846dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:to="loc_us-gaap_DebtInstrumentAxis_8f56d302-ebd2-426c-ada1-542dc3846dfe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8f56d302-ebd2-426c-ada1-542dc3846dfe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f56d302-ebd2-426c-ada1-542dc3846dfe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8f56d302-ebd2-426c-ada1-542dc3846dfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f6b88a95-1939-4557-bbc9-0e199e0f24f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f56d302-ebd2-426c-ada1-542dc3846dfe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f6b88a95-1939-4557-bbc9-0e199e0f24f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_07a1c6ea-993a-432e-b8e1-ce10ddc0f169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6b88a95-1939-4557-bbc9-0e199e0f24f6" xlink:to="loc_us-gaap_CurrencySwapMember_07a1c6ea-993a-432e-b8e1-ce10ddc0f169" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_cbdb638a-7d62-4121-838a-34bc28d6fbe4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:to="loc_srt_CurrencyAxis_cbdb638a-7d62-4121-838a-34bc28d6fbe4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_cbdb638a-7d62-4121-838a-34bc28d6fbe4_default" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_cbdb638a-7d62-4121-838a-34bc28d6fbe4" xlink:to="loc_currency_AllCurrenciesDomain_cbdb638a-7d62-4121-838a-34bc28d6fbe4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_cbdb638a-7d62-4121-838a-34bc28d6fbe4" xlink:to="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_37597e98-ad53-4432-8e10-22b8902f36aa" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:to="loc_currency_CAD_37597e98-ad53-4432-8e10-22b8902f36aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_792877aa-3ea5-481a-8019-3352bfc3dc29" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:to="loc_currency_GBP_792877aa-3ea5-481a-8019-3352bfc3dc29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_a2307bbc-e6a3-498c-b460-e5d42e23e421" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:to="loc_currency_EUR_a2307bbc-e6a3-498c-b460-e5d42e23e421" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_41b73c90-c408-47a7-897d-1d5c5cf45690" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:to="loc_currency_USD_41b73c90-c408-47a7-897d-1d5c5cf45690" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="extended" id="i1e6abbf27c99444bb06180818f3d256c_HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_4c2e0b01-7711-48e6-8436-4c9df124ee25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_2acb29d9-125d-42e6-8982-97752b9df2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4c2e0b01-7711-48e6-8436-4c9df124ee25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_2acb29d9-125d-42e6-8982-97752b9df2e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_774b6115-6737-4a8b-a295-e55c8d2471bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4c2e0b01-7711-48e6-8436-4c9df124ee25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_774b6115-6737-4a8b-a295-e55c8d2471bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f33efa8-cb76-48de-bfc9-0707d3bca08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4c2e0b01-7711-48e6-8436-4c9df124ee25" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f33efa8-cb76-48de-bfc9-0707d3bca08a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c187067b-6c19-44f8-bb11-b3d6bcb5c83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f33efa8-cb76-48de-bfc9-0707d3bca08a" xlink:to="loc_us-gaap_HedgingDesignationAxis_c187067b-6c19-44f8-bb11-b3d6bcb5c83a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c187067b-6c19-44f8-bb11-b3d6bcb5c83a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_c187067b-6c19-44f8-bb11-b3d6bcb5c83a" xlink:to="loc_us-gaap_HedgingDesignationDomain_c187067b-6c19-44f8-bb11-b3d6bcb5c83a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_704225c8-7a74-4f6a-8a92-fb03b694a863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_c187067b-6c19-44f8-bb11-b3d6bcb5c83a" xlink:to="loc_us-gaap_HedgingDesignationDomain_704225c8-7a74-4f6a-8a92-fb03b694a863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_97153d59-8d89-46b5-ac13-6784a3d6fb65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_704225c8-7a74-4f6a-8a92-fb03b694a863" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_97153d59-8d89-46b5-ac13-6784a3d6fb65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5c12ed1f-5a85-454f-bbc3-451a36946d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f33efa8-cb76-48de-bfc9-0707d3bca08a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5c12ed1f-5a85-454f-bbc3-451a36946d1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5c12ed1f-5a85-454f-bbc3-451a36946d1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5c12ed1f-5a85-454f-bbc3-451a36946d1d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5c12ed1f-5a85-454f-bbc3-451a36946d1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_08acb4b0-9cab-4676-a9cd-4637a3de8b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5c12ed1f-5a85-454f-bbc3-451a36946d1d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_08acb4b0-9cab-4676-a9cd-4637a3de8b2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b66e1c4d-c34c-4f26-a07b-ff8a0edf21dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_08acb4b0-9cab-4676-a9cd-4637a3de8b2b" xlink:to="loc_us-gaap_CurrencySwapMember_b66e1c4d-c34c-4f26-a07b-ff8a0edf21dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_f42d8437-9bd0-4d7f-b5c3-12945a363487" xlink:href="mck-20230331.xsd#mck_FixedInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_08acb4b0-9cab-4676-a9cd-4637a3de8b2b" xlink:to="loc_mck_FixedInterestRateSwapMember_f42d8437-9bd0-4d7f-b5c3-12945a363487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_52ca8d30-f54b-436f-8d3c-bd9327279322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f33efa8-cb76-48de-bfc9-0707d3bca08a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_52ca8d30-f54b-436f-8d3c-bd9327279322" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_52ca8d30-f54b-436f-8d3c-bd9327279322_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_52ca8d30-f54b-436f-8d3c-bd9327279322" xlink:to="loc_us-gaap_HedgingRelationshipDomain_52ca8d30-f54b-436f-8d3c-bd9327279322_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5cc74f49-53f2-4a4a-9af8-627f97280549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_52ca8d30-f54b-436f-8d3c-bd9327279322" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5cc74f49-53f2-4a4a-9af8-627f97280549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_45d03fde-d26d-4682-b3bd-4a06c0e898a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5cc74f49-53f2-4a4a-9af8-627f97280549" xlink:to="loc_us-gaap_CurrencySwapMember_45d03fde-d26d-4682-b3bd-4a06c0e898a8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="extended" id="i5acf2a30aa1c4f788a167483427b2ab3_HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_25a5eaf8-b13e-49af-8483-aafb4f80789b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_25a5eaf8-b13e-49af-8483-aafb4f80789b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9707c312-a468-4c3f-a0a3-146b70d73fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9707c312-a468-4c3f-a0a3-146b70d73fac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_d198ccae-c10a-4f59-9ab4-06b7469180ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_d198ccae-c10a-4f59-9ab4-06b7469180ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_151f9dbd-fe3d-4024-9cf1-2cbe4ca07d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_151f9dbd-fe3d-4024-9cf1-2cbe4ca07d2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71ae8800-51dc-479b-87a5-e01e5b225c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71ae8800-51dc-479b-87a5-e01e5b225c3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_78a5c8b8-4a12-4ba2-aec0-76a3fcbb1a31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71ae8800-51dc-479b-87a5-e01e5b225c3b" xlink:to="loc_us-gaap_HedgingDesignationAxis_78a5c8b8-4a12-4ba2-aec0-76a3fcbb1a31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_78a5c8b8-4a12-4ba2-aec0-76a3fcbb1a31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_78a5c8b8-4a12-4ba2-aec0-76a3fcbb1a31" xlink:to="loc_us-gaap_HedgingDesignationDomain_78a5c8b8-4a12-4ba2-aec0-76a3fcbb1a31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_774cbe50-d62c-48ae-90f3-de9a24b2bbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_78a5c8b8-4a12-4ba2-aec0-76a3fcbb1a31" xlink:to="loc_us-gaap_HedgingDesignationDomain_774cbe50-d62c-48ae-90f3-de9a24b2bbda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d1cf6969-bdcd-4273-a9e5-58b92c8a61de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_774cbe50-d62c-48ae-90f3-de9a24b2bbda" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d1cf6969-bdcd-4273-a9e5-58b92c8a61de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fac76ce7-5d35-412a-88c4-c60c25be47d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71ae8800-51dc-479b-87a5-e01e5b225c3b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fac76ce7-5d35-412a-88c4-c60c25be47d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fac76ce7-5d35-412a-88c4-c60c25be47d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fac76ce7-5d35-412a-88c4-c60c25be47d0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fac76ce7-5d35-412a-88c4-c60c25be47d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f49ce20f-539f-4a92-ae5a-d770c50255de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fac76ce7-5d35-412a-88c4-c60c25be47d0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f49ce20f-539f-4a92-ae5a-d770c50255de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_db40718f-b259-408e-82c7-1991e0324f5a" xlink:href="mck-20230331.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f49ce20f-539f-4a92-ae5a-d770c50255de" xlink:to="loc_mck_CurrentAssetLiabilityMember_db40718f-b259-408e-82c7-1991e0324f5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember_572fb012-1ba0-413a-b9c6-6e69983ca93f" xlink:href="mck-20230331.xsd#mck_OtherNonCurrentAssetsAndLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f49ce20f-539f-4a92-ae5a-d770c50255de" xlink:to="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember_572fb012-1ba0-413a-b9c6-6e69983ca93f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesAndOtherMember_687aef0f-f43b-4695-a9b0-a1b4180afa78" xlink:href="mck-20230331.xsd#mck_PrepaidExpensesAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f49ce20f-539f-4a92-ae5a-d770c50255de" xlink:to="loc_mck_PrepaidExpensesAndOtherMember_687aef0f-f43b-4695-a9b0-a1b4180afa78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2a165662-3a73-40e1-82e4-9d927daf358b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71ae8800-51dc-479b-87a5-e01e5b225c3b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2a165662-3a73-40e1-82e4-9d927daf358b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2a165662-3a73-40e1-82e4-9d927daf358b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2a165662-3a73-40e1-82e4-9d927daf358b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2a165662-3a73-40e1-82e4-9d927daf358b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5ed218a4-a654-471d-be66-cf9b4987ea09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2a165662-3a73-40e1-82e4-9d927daf358b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5ed218a4-a654-471d-be66-cf9b4987ea09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_ecf58977-e7e3-4e76-b9ad-d00bc5edc637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5ed218a4-a654-471d-be66-cf9b4987ea09" xlink:to="loc_us-gaap_CurrencySwapMember_ecf58977-e7e3-4e76-b9ad-d00bc5edc637" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ae86e203-f2a2-4f23-b481-57763e96d801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5ed218a4-a654-471d-be66-cf9b4987ea09" xlink:to="loc_us-gaap_InterestRateSwapMember_ae86e203-f2a2-4f23-b481-57763e96d801" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended" id="ib4a4683aa2d3459393b986894e2fc7f4_FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a340ec8-58a1-4ed2-a58e-cf322e799965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_774a853a-6c07-4cc8-92ed-8b3227d1c2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a340ec8-58a1-4ed2-a58e-cf322e799965" xlink:to="loc_us-gaap_LongTermDebt_774a853a-6c07-4cc8-92ed-8b3227d1c2b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_472e7b4f-1e5a-4888-b0ae-6a4d421bb2be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a340ec8-58a1-4ed2-a58e-cf322e799965" xlink:to="loc_us-gaap_DebtInstrumentFairValue_472e7b4f-1e5a-4888-b0ae-6a4d421bb2be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_be46631e-60b4-49eb-b541-16b4d457f8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a340ec8-58a1-4ed2-a58e-cf322e799965" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_be46631e-60b4-49eb-b541-16b4d457f8e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fba9b023-3ed6-48c6-8576-439c8f7c6bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_be46631e-60b4-49eb-b541-16b4d457f8e6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fba9b023-3ed6-48c6-8576-439c8f7c6bd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fba9b023-3ed6-48c6-8576-439c8f7c6bd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fba9b023-3ed6-48c6-8576-439c8f7c6bd6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fba9b023-3ed6-48c6-8576-439c8f7c6bd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be463c49-b157-437a-97aa-96aad6349217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fba9b023-3ed6-48c6-8576-439c8f7c6bd6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be463c49-b157-437a-97aa-96aad6349217" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_00826310-6840-49a2-9953-6bdb1bd83f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be463c49-b157-437a-97aa-96aad6349217" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_00826310-6840-49a2-9953-6bdb1bd83f5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2fe0684c-baa6-4b2b-b4e2-b8939f2fc352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_be46631e-60b4-49eb-b541-16b4d457f8e6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2fe0684c-baa6-4b2b-b4e2-b8939f2fc352" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2fe0684c-baa6-4b2b-b4e2-b8939f2fc352_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2fe0684c-baa6-4b2b-b4e2-b8939f2fc352" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2fe0684c-baa6-4b2b-b4e2-b8939f2fc352_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b17b84d6-677a-467a-a6e3-3dc495c7d2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2fe0684c-baa6-4b2b-b4e2-b8939f2fc352" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b17b84d6-677a-467a-a6e3-3dc495c7d2c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_757a44f0-4d6f-4deb-9af2-1f4b0d64bb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b17b84d6-677a-467a-a6e3-3dc495c7d2c4" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_757a44f0-4d6f-4deb-9af2-1f4b0d64bb93" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#FinancialGuaranteesandWarrantiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="extended" id="i03363c6f8e444da395ec07988cbbe385_FinancialGuaranteesandWarrantiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuarantorObligationsPeriod_31802413-aedb-43c9-803c-b8ffad101e63" xlink:href="mck-20230331.xsd#mck_GuarantorObligationsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuarantorObligationsPeriod_31802413-aedb-43c9-803c-b8ffad101e63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_48ea9654-3928-414f-9c71-4d89607b69b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_48ea9654-3928-414f-9c71-4d89607b69b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_d32065ec-a317-44eb-a982-ddc4bd4db372" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_d32065ec-a317-44eb-a982-ddc4bd4db372" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_ef0ed1ef-b29f-4e8d-b080-057b8f1b51b8" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_ef0ed1ef-b29f-4e8d-b080-057b8f1b51b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_27ba8f66-ca9e-444d-8b58-f8ca9c5b490e" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_27ba8f66-ca9e-444d-8b58-f8ca9c5b490e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_68a80b92-83e2-4465-a6f8-d32decc00615" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_68a80b92-83e2-4465-a6f8-d32decc00615" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_aeb2a6de-db0e-4d3f-b01e-9591a12068d3" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_aeb2a6de-db0e-4d3f-b01e-9591a12068d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_a42f2a98-457a-4cb6-a9d7-46ab54232759" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_a42f2a98-457a-4cb6-a9d7-46ab54232759" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_fa2ecca6-2189-4cef-940a-4f69c2c5ab62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_fa2ecca6-2189-4cef-940a-4f69c2c5ab62" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_e6a02a35-6448-48eb-a82c-f865fbfc34af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_e6a02a35-6448-48eb-a82c-f865fbfc34af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6c31c0a2-e01a-4581-a393-6eae2b6215ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_e6a02a35-6448-48eb-a82c-f865fbfc34af" xlink:to="loc_srt_RangeAxis_6c31c0a2-e01a-4581-a393-6eae2b6215ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6c31c0a2-e01a-4581-a393-6eae2b6215ce_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6c31c0a2-e01a-4581-a393-6eae2b6215ce" xlink:to="loc_srt_RangeMember_6c31c0a2-e01a-4581-a393-6eae2b6215ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_30250fca-d65e-4457-922c-3f1d3541c006" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6c31c0a2-e01a-4581-a393-6eae2b6215ce" xlink:to="loc_srt_RangeMember_30250fca-d65e-4457-922c-3f1d3541c006" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1b6f5c42-31db-4bab-9b09-bcaac8d4562e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_30250fca-d65e-4457-922c-3f1d3541c006" xlink:to="loc_srt_MinimumMember_1b6f5c42-31db-4bab-9b09-bcaac8d4562e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_67d0c62a-5ad8-45e3-a957-036bea37e117" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_30250fca-d65e-4457-922c-3f1d3541c006" xlink:to="loc_srt_MaximumMember_67d0c62a-5ad8-45e3-a957-036bea37e117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_23eb383c-135e-44a9-ace2-bee539f12b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_e6a02a35-6448-48eb-a82c-f865fbfc34af" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_23eb383c-135e-44a9-ace2-bee539f12b9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_23eb383c-135e-44a9-ace2-bee539f12b9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_23eb383c-135e-44a9-ace2-bee539f12b9a" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_23eb383c-135e-44a9-ace2-bee539f12b9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_5f447178-4b34-40a8-9ce6-32d96552890f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_23eb383c-135e-44a9-ace2-bee539f12b9a" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_5f447178-4b34-40a8-9ce6-32d96552890f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_d4a50e0c-b6d9-4039-a3eb-d85cc3b2fa5f" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5f447178-4b34-40a8-9ce6-32d96552890f" xlink:to="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_d4a50e0c-b6d9-4039-a3eb-d85cc3b2fa5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsCustomersDebtMember_bae9a65c-2b8b-4caa-bf00-9b91dd5ef001" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsCustomersDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5f447178-4b34-40a8-9ce6-32d96552890f" xlink:to="loc_mck_GuaranteeObligationsCustomersDebtMember_bae9a65c-2b8b-4caa-bf00-9b91dd5ef001" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_ff924d2d-46ad-41ef-a0f4-02ea231cffdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5f447178-4b34-40a8-9ce6-32d96552890f" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_ff924d2d-46ad-41ef-a0f4-02ea231cffdc" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#CommitmentsandContingentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="extended" id="ib6e777db7cc0458390a8c595f2c07123_CommitmentsandContingentLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_c0d4b82c-4652-4cc6-a2ac-ae6de074e3b0" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_c0d4b82c-4652-4cc6-a2ac-ae6de074e3b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_aeaebf70-43df-4715-8436-8262ef43aae5" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberofStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberofStates_aeaebf70-43df-4715-8436-8262ef43aae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_1d5145a6-2ebf-48e1-8bb2-4e6235a67036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_1d5145a6-2ebf-48e1-8bb2-4e6235a67036" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0551acbf-6e80-4bf3-aeb1-6cac2fcf8370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0551acbf-6e80-4bf3-aeb1-6cac2fcf8370" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_08804423-f976-4118-8079-97cddfaf4ea9" xlink:href="mck-20230331.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_08804423-f976-4118-8079-97cddfaf4ea9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCasesDismissed_8c63c993-7c6f-4836-bb34-70564f7c6888" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfCasesDismissed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfCasesDismissed_8c63c993-7c6f-4836-bb34-70564f7c6888" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClaimsSettledNumberOfSubdivisions_d5637696-a90c-4383-986b-c8f0fac653f1" xlink:href="mck-20230331.xsd#mck_LossContingencyClaimsSettledNumberOfSubdivisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyClaimsSettledNumberOfSubdivisions_d5637696-a90c-4383-986b-c8f0fac653f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_d6c1cdfe-e320-4185-8537-84f2e4b5abee" xlink:href="mck-20230331.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_d6c1cdfe-e320-4185-8537-84f2e4b5abee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement_2c5a9ad7-9fbb-4f45-bfc5-a49fdd0cfa66" xlink:href="mck-20230331.xsd#mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement_2c5a9ad7-9fbb-4f45-bfc5-a49fdd0cfa66" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_ccaa472f-6add-49bd-bcbf-a34f4942fa3b" xlink:href="mck-20230331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_ccaa472f-6add-49bd-bcbf-a34f4942fa3b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_0675ef58-659e-435f-bba9-4dde18160e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_0675ef58-659e-435f-bba9-4dde18160e71" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d5f800b8-875d-4d5f-87a0-dcff74ff8396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d5f800b8-875d-4d5f-87a0-dcff74ff8396" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_c037a138-9659-4229-9b32-a4eec67401f0" xlink:href="mck-20230331.xsd#mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_c037a138-9659-4229-9b32-a4eec67401f0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies_cdad91a3-d401-47fa-8c49-38cfbf24602f" xlink:href="mck-20230331.xsd#mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies_cdad91a3-d401-47fa-8c49-38cfbf24602f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelators_3bf36500-5e42-433b-a85a-bab964f5a947" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberofRelators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberofRelators_3bf36500-5e42-433b-a85a-bab964f5a947" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_1f5475d7-53b8-422c-a2f7-8a428a2b72a0" xlink:href="mck-20230331.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_1f5475d7-53b8-422c-a2f7-8a428a2b72a0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_3ef0187e-8b5f-4412-852e-68824549f09e" xlink:href="mck-20230331.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_3ef0187e-8b5f-4412-852e-68824549f09e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_dd455f75-6c56-4d46-8aa8-fd3270c31b56" xlink:href="mck-20230331.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_dd455f75-6c56-4d46-8aa8-fd3270c31b56" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_d4ee4903-a437-4024-a4a7-34e345146a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_d4ee4903-a437-4024-a4a7-34e345146a23" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfRelators_bbb620cc-ab01-4639-ba57-be5e2a6239b4" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfRelators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfRelators_bbb620cc-ab01-4639-ba57-be5e2a6239b4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_6e0b84d4-71c8-467f-bde1-3d0f637f524c" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfCitiesFiledOnBehalfOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_6e0b84d4-71c8-467f-bde1-3d0f637f524c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_b5b928cb-0d62-45af-939a-bbaad79f1f8d" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfStatesFiledOnBehalfOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_b5b928cb-0d62-45af-939a-bbaad79f1f8d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfAdditionalDefendants_d6c9cd87-8c6e-4527-bcdd-85e6b430afe1" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfAdditionalDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfAdditionalDefendants_d6c9cd87-8c6e-4527-bcdd-85e6b430afe1" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofFormerOfficers_3c3d7e66-3576-4965-839d-d8336d259d54" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberofFormerOfficers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberofFormerOfficers_3c3d7e66-3576-4965-839d-d8336d259d54" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimatedInsuranceRecoveries_52ad820e-784b-4ce8-910c-9866e5f4d826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimatedInsuranceRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_EstimatedInsuranceRecoveries_52ad820e-784b-4ce8-910c-9866e5f4d826" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSoftwareProducts_a19260dc-aba1-4596-8c4e-6a2ff5e6ebcc" xlink:href="mck-20230331.xsd#mck_NumberofSoftwareProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_NumberofSoftwareProducts_a19260dc-aba1-4596-8c4e-6a2ff5e6ebcc" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_b85d13b4-5ac2-4a97-bfb1-c991c294bbc1" xlink:href="mck-20230331.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_b85d13b4-5ac2-4a97-bfb1-c991c294bbc1" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_39376d3f-9129-47a3-b37a-b25f2558fbba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_39376d3f-9129-47a3-b37a-b25f2558fbba" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_4ada03fc-72c2-4970-8ab0-70c89e272780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_4ada03fc-72c2-4970-8ab0-70c89e272780" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites_9b9ea897-3758-4d5c-adc6-00eec7b117f5" xlink:href="mck-20230331.xsd#mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites_9b9ea897-3758-4d5c-adc6-00eec7b117f5" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_6fd6b2a9-f481-4ee9-81ac-e71d39cf2a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_6fd6b2a9-f481-4ee9-81ac-e71d39cf2a70" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_4c718dc5-3cee-4581-9dd7-32fc1f9c890d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_4c718dc5-3cee-4581-9dd7-32fc1f9c890d" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSites_fedd820c-b636-4a6b-811e-6950c0b8fa18" xlink:href="mck-20230331.xsd#mck_HazardousSubstanceSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_HazardousSubstanceSites_fedd820c-b636-4a6b-811e-6950c0b8fa18" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSitesRecipientOfDirectives_c67e2d08-b028-45ea-9a15-4edd2ba67796" xlink:href="mck-20230331.xsd#mck_HazardousSubstanceSitesRecipientOfDirectives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_HazardousSubstanceSitesRecipientOfDirectives_c67e2d08-b028-45ea-9a15-4edd2ba67796" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_381c3656-2e9e-42b6-879b-e71e561da7ba" xlink:href="mck-20230331.xsd#mck_EstimatedEnvironmentalAssessmentAndCleanupCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_381c3656-2e9e-42b6-879b-e71e561da7ba" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_cd50d9c6-1bf7-400b-b707-1a5218316899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_cd50d9c6-1bf7-400b-b707-1a5218316899" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_317dcea8-1bfd-44af-8efe-0bc0d6148c60" xlink:href="mck-20230331.xsd#mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_317dcea8-1bfd-44af-8efe-0bc0d6148c60" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7a3ad31d-d225-4f51-89b2-1d0ea44e26ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_LitigationCaseAxis_7a3ad31d-d225-4f51-89b2-1d0ea44e26ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7a3ad31d-d225-4f51-89b2-1d0ea44e26ca_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_7a3ad31d-d225-4f51-89b2-1d0ea44e26ca" xlink:to="loc_srt_LitigationCaseTypeDomain_7a3ad31d-d225-4f51-89b2-1d0ea44e26ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_7a3ad31d-d225-4f51-89b2-1d0ea44e26ca" xlink:to="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_501c7c74-ba10-4b48-8f5d-a583ffadafc7" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_501c7c74-ba10-4b48-8f5d-a583ffadafc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_90069f74-7574-4692-9349-8f85c3d5e2ea" xlink:href="mck-20230331.xsd#mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_90069f74-7574-4692-9349-8f85c3d5e2ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_4bf64df2-e654-4749-b0ba-05b87ce5b6e9" xlink:href="mck-20230331.xsd#mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_4bf64df2-e654-4749-b0ba-05b87ce5b6e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceCoverageLitigationMember_1bce6c57-4b1e-4b9b-bfa6-d6e2dc0d06ee" xlink:href="mck-20230331.xsd#mck_InsuranceCoverageLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_InsuranceCoverageLitigationMember_1bce6c57-4b1e-4b9b-bfa6-d6e2dc0d06ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_e1ca692a-708a-46fd-b869-96cde23e850d" xlink:href="mck-20230331.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_e1ca692a-708a-46fd-b869-96cde23e850d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_2d3060c3-9f1b-4c34-a4fb-fe6341a6ac3a" xlink:href="mck-20230331.xsd#mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_2d3060c3-9f1b-4c34-a4fb-fe6341a6ac3a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_1878bb2b-87a1-4bd4-b79d-f8992d0fac42" xlink:href="mck-20230331.xsd#mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_1878bb2b-87a1-4bd4-b79d-f8992d0fac42" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_05442a56-3dda-4d92-9570-c7a57a90a91e" xlink:href="mck-20230331.xsd#mck_EvanstonPolicePensionFundv.McKessonCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_05442a56-3dda-4d92-9570-c7a57a90a91e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_be713a61-43ed-44ff-879b-d8be6b01d6db" xlink:href="mck-20230331.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_be713a61-43ed-44ff-879b-d8be6b01d6db" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_0f397f15-9b51-453e-bcc9-3943e301a9a2" xlink:href="mck-20230331.xsd#mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_0f397f15-9b51-453e-bcc9-3943e301a9a2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember_bba31fed-fa1b-4617-8bcc-b0ba28fd8bb9" xlink:href="mck-20230331.xsd#mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember_bba31fed-fa1b-4617-8bcc-b0ba28fd8bb9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_acd42dd1-39c2-475c-871a-61e10ddc7985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_us-gaap_LitigationStatusAxis_acd42dd1-39c2-475c-871a-61e10ddc7985" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_acd42dd1-39c2-475c-871a-61e10ddc7985_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_acd42dd1-39c2-475c-871a-61e10ddc7985" xlink:to="loc_us-gaap_LitigationStatusDomain_acd42dd1-39c2-475c-871a-61e10ddc7985_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_4c198626-1ad7-427d-a10a-a41b8f5b506b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_acd42dd1-39c2-475c-871a-61e10ddc7985" xlink:to="loc_us-gaap_LitigationStatusDomain_4c198626-1ad7-427d-a10a-a41b8f5b506b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_7d8bffa6-3b84-4db0-878e-ff5b8a1e032f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_4c198626-1ad7-427d-a10a-a41b8f5b506b" xlink:to="loc_us-gaap_SettledLitigationMember_7d8bffa6-3b84-4db0-878e-ff5b8a1e032f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e74d15a4-154a-4272-b5fc-fa9c7230ec56" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_StatementGeographicalAxis_e74d15a4-154a-4272-b5fc-fa9c7230ec56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e74d15a4-154a-4272-b5fc-fa9c7230ec56_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e74d15a4-154a-4272-b5fc-fa9c7230ec56" xlink:to="loc_srt_SegmentGeographicalDomain_e74d15a4-154a-4272-b5fc-fa9c7230ec56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5eb5217b-abb2-450d-b430-3ba3a49e2706" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e74d15a4-154a-4272-b5fc-fa9c7230ec56" xlink:to="loc_srt_SegmentGeographicalDomain_5eb5217b-abb2-450d-b430-3ba3a49e2706" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_b7b5b5f0-4b81-4814-8916-78c9b2af0689" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5eb5217b-abb2-450d-b430-3ba3a49e2706" xlink:to="loc_country_CA_b7b5b5f0-4b81-4814-8916-78c9b2af0689" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_093a9b64-a3b4-43be-8430-d6bbd5da5363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_093a9b64-a3b4-43be-8430-d6bbd5da5363" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_093a9b64-a3b4-43be-8430-d6bbd5da5363_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_093a9b64-a3b4-43be-8430-d6bbd5da5363" xlink:to="loc_us-gaap_LossContingencyNatureDomain_093a9b64-a3b4-43be-8430-d6bbd5da5363_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_8dea9dc7-e262-406c-b4d2-4a67e2933677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_093a9b64-a3b4-43be-8430-d6bbd5da5363" xlink:to="loc_us-gaap_LossContingencyNatureDomain_8dea9dc7-e262-406c-b4d2-4a67e2933677" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_3cb932b7-e818-4bcd-bc20-b8f93332b552" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8dea9dc7-e262-406c-b4d2-4a67e2933677" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_3cb932b7-e818-4bcd-bc20-b8f93332b552" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_3e6bf945-c206-49f5-8e16-2e265f0b96e7" xlink:href="mck-20230331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8dea9dc7-e262-406c-b4d2-4a67e2933677" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_3e6bf945-c206-49f5-8e16-2e265f0b96e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLitigationMember_1fc539b3-2fea-4ab0-a9d3-f9bd8157835b" xlink:href="mck-20230331.xsd#mck_EnvironmentalLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8dea9dc7-e262-406c-b4d2-4a67e2933677" xlink:to="loc_mck_EnvironmentalLitigationMember_1fc539b3-2fea-4ab0-a9d3-f9bd8157835b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_14a3d2c5-5362-411b-9884-17e73018ad9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_dei_LegalEntityAxis_14a3d2c5-5362-411b-9884-17e73018ad9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_14a3d2c5-5362-411b-9884-17e73018ad9a_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_14a3d2c5-5362-411b-9884-17e73018ad9a" xlink:to="loc_dei_EntityDomain_14a3d2c5-5362-411b-9884-17e73018ad9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a0c7de9b-9829-42d4-92be-5455618ecb0f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_14a3d2c5-5362-411b-9884-17e73018ad9a" xlink:to="loc_dei_EntityDomain_a0c7de9b-9829-42d4-92be-5455618ecb0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestUSPharmaceuticalDistributorsMember_57c53a66-cc93-4f64-9d5e-9dd6024f6947" xlink:href="mck-20230331.xsd#mck_ThreeLargestUSPharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a0c7de9b-9829-42d4-92be-5455618ecb0f" xlink:to="loc_mck_ThreeLargestUSPharmaceuticalDistributorsMember_57c53a66-cc93-4f64-9d5e-9dd6024f6947" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_8e8b5a37-b045-4709-8220-4ad87bef61b0" xlink:href="mck-20230331.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a0c7de9b-9829-42d4-92be-5455618ecb0f" xlink:to="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_8e8b5a37-b045-4709-8220-4ad87bef61b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7374fa08-7827-4201-9b4d-caee2a8decec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_RangeAxis_7374fa08-7827-4201-9b4d-caee2a8decec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7374fa08-7827-4201-9b4d-caee2a8decec_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7374fa08-7827-4201-9b4d-caee2a8decec" xlink:to="loc_srt_RangeMember_7374fa08-7827-4201-9b4d-caee2a8decec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_76a1c9d0-d88f-40db-b6d0-2743a402529c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7374fa08-7827-4201-9b4d-caee2a8decec" xlink:to="loc_srt_RangeMember_76a1c9d0-d88f-40db-b6d0-2743a402529c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d0bcf802-d43d-4bc1-bc29-e0e44c51aaa4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_76a1c9d0-d88f-40db-b6d0-2743a402529c" xlink:to="loc_srt_MinimumMember_d0bcf802-d43d-4bc1-bc29-e0e44c51aaa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7a18aa4a-f835-417c-85dc-f9d3fcd6ac99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_76a1c9d0-d88f-40db-b6d0-2743a402529c" xlink:to="loc_srt_MaximumMember_7a18aa4a-f835-417c-85dc-f9d3fcd6ac99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_37827789-b480-4e80-b847-18d7f33d36af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_CounterpartyNameAxis_37827789-b480-4e80-b847-18d7f33d36af" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_37827789-b480-4e80-b847-18d7f33d36af_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_37827789-b480-4e80-b847-18d7f33d36af" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_37827789-b480-4e80-b847-18d7f33d36af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_37827789-b480-4e80-b847-18d7f33d36af" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaAndSubdivisionsMember_f7a0bca8-5a3a-4b92-8593-8a389554fa0d" xlink:href="mck-20230331.xsd#mck_StateOfAlabamaAndSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_StateOfAlabamaAndSubdivisionsMember_f7a0bca8-5a3a-4b92-8593-8a389554fa0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember_e485e55e-c1ab-4722-9d1f-55546dea1f08" xlink:href="mck-20230331.xsd#mck_CherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_CherokeeNationMember_e485e55e-c1ab-4722-9d1f-55546dea1f08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_68a0d3b6-0b96-4f97-ae7f-d0a230bfc77f" xlink:href="mck-20230331.xsd#mck_IndividualClaimantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_IndividualClaimantMember_68a0d3b6-0b96-4f97-ae7f-d0a230bfc77f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_3c1d1740-56dd-4080-90a7-d0ca2c9dc687" xlink:href="mck-20230331.xsd#mck_StateOfWestVirginiaAndSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_3c1d1740-56dd-4080-90a7-d0ca2c9dc687" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_b31ff106-eaa9-4798-a8ac-426a3e2c2b87" xlink:href="mck-20230331.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_b31ff106-eaa9-4798-a8ac-426a3e2c2b87" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_9f1b0f28-5543-4829-8a6f-dc34bc70d44b" xlink:href="mck-20230331.xsd#mck_SettlingGovernmentalEntitiesAndCherokeeNationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_9f1b0f28-5543-4829-8a6f-dc34bc70d44b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_08bfe0f9-86f5-4860-8a97-0f14c0c3e9be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_08bfe0f9-86f5-4860-8a97-0f14c0c3e9be" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_08bfe0f9-86f5-4860-8a97-0f14c0c3e9be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_08bfe0f9-86f5-4860-8a97-0f14c0c3e9be" xlink:to="loc_us-gaap_SegmentDomain_08bfe0f9-86f5-4860-8a97-0f14c0c3e9be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_be307432-42a6-4d2f-9b18-6393d6936b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_08bfe0f9-86f5-4860-8a97-0f14c0c3e9be" xlink:to="loc_us-gaap_SegmentDomain_be307432-42a6-4d2f-9b18-6393d6936b4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_66ac5cdf-1723-4690-9bea-8d94b20585f3" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_be307432-42a6-4d2f-9b18-6393d6936b4d" xlink:to="loc_mck_USPharmaceuticalSegmentMember_66ac5cdf-1723-4690-9bea-8d94b20585f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0e59cd2b-515d-47cb-8baf-83bbed500b90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_ConsolidationItemsAxis_0e59cd2b-515d-47cb-8baf-83bbed500b90" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0e59cd2b-515d-47cb-8baf-83bbed500b90_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_0e59cd2b-515d-47cb-8baf-83bbed500b90" xlink:to="loc_srt_ConsolidationItemsDomain_0e59cd2b-515d-47cb-8baf-83bbed500b90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_61428bff-cdc4-4da9-9ae4-dfb8ff375402" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_0e59cd2b-515d-47cb-8baf-83bbed500b90" xlink:to="loc_srt_ConsolidationItemsDomain_61428bff-cdc4-4da9-9ae4-dfb8ff375402" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_8453ae3c-182d-48e0-a81c-0819d94b4375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_61428bff-cdc4-4da9-9ae4-dfb8ff375402" xlink:to="loc_us-gaap_OperatingSegmentsMember_8453ae3c-182d-48e0-a81c-0819d94b4375" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_347cb80b-988c-485e-abbe-77389ccf1c6b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_StatementScenarioAxis_347cb80b-988c-485e-abbe-77389ccf1c6b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_347cb80b-988c-485e-abbe-77389ccf1c6b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_347cb80b-988c-485e-abbe-77389ccf1c6b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_347cb80b-988c-485e-abbe-77389ccf1c6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a24fb5a3-c189-4698-88b6-9f7dbf6fd294" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_347cb80b-988c-485e-abbe-77389ccf1c6b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a24fb5a3-c189-4698-88b6-9f7dbf6fd294" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_e4399533-46ea-442e-9f29-33b56ba746c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a24fb5a3-c189-4698-88b6-9f7dbf6fd294" xlink:to="loc_srt_ScenarioForecastMember_e4399533-46ea-442e-9f29-33b56ba746c3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended" id="i8ec06cf7c8f748f28256bc74c69138ba_CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_5e55248c-ea6f-45ad-b471-a8f59a1d69bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_17d0f0df-136e-4ae9-a143-48253e2097c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e55248c-ea6f-45ad-b471-a8f59a1d69bb" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_17d0f0df-136e-4ae9-a143-48253e2097c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_ff04a8b0-59f2-4c29-bff1-731e17c132af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e55248c-ea6f-45ad-b471-a8f59a1d69bb" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_ff04a8b0-59f2-4c29-bff1-731e17c132af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_ded498fb-8eff-4904-97c3-3a2faeb21078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e55248c-ea6f-45ad-b471-a8f59a1d69bb" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_ded498fb-8eff-4904-97c3-3a2faeb21078" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_21d2ec2e-4b6d-4b86-bbe0-df29e5d10749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e55248c-ea6f-45ad-b471-a8f59a1d69bb" xlink:to="loc_us-gaap_LossContingenciesTable_21d2ec2e-4b6d-4b86-bbe0-df29e5d10749" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b9a770b0-e7ac-42d0-adc2-e8fd83c2387b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_21d2ec2e-4b6d-4b86-bbe0-df29e5d10749" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b9a770b0-e7ac-42d0-adc2-e8fd83c2387b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b9a770b0-e7ac-42d0-adc2-e8fd83c2387b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b9a770b0-e7ac-42d0-adc2-e8fd83c2387b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b9a770b0-e7ac-42d0-adc2-e8fd83c2387b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0243f0dc-1cd3-479c-8e6c-c34729a9d53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b9a770b0-e7ac-42d0-adc2-e8fd83c2387b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0243f0dc-1cd3-479c-8e6c-c34729a9d53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_0dc8b88e-5386-4a4a-9dae-abf6d6f980d7" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0243f0dc-1cd3-479c-8e6c-c34729a9d53c" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_0dc8b88e-5386-4a4a-9dae-abf6d6f980d7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#StockholdersEquityDeficitScheduleofShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails" xlink:type="extended" id="i2432f3e4fa9a48c0a3b484a4e7216951_StockholdersEquityDeficitScheduleofShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9756032a-391b-4753-ad07-43c295116c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9756032a-391b-4753-ad07-43c295116c67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_45e4d31c-80ae-49f3-a1dd-d998778ae609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_45e4d31c-80ae-49f3-a1dd-d998778ae609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_b9aa3e41-436c-49da-84de-c4ccf0896851" xlink:href="mck-20230331.xsd#mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:to="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_b9aa3e41-436c-49da-84de-c4ccf0896851" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_25a86c86-76cf-467b-b6be-76210c2a3f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_b9aa3e41-436c-49da-84de-c4ccf0896851" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_25a86c86-76cf-467b-b6be-76210c2a3f6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_45191d2e-4c6f-457b-9463-51c7585e685e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_b9aa3e41-436c-49da-84de-c4ccf0896851" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_45191d2e-4c6f-457b-9463-51c7585e685e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4f8e96b7-9a80-4206-9579-ee3c2e09cb81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_b9aa3e41-436c-49da-84de-c4ccf0896851" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4f8e96b7-9a80-4206-9579-ee3c2e09cb81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_da898cf4-0d18-43c1-a6fa-caacfdd313f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccruedShareRepurchases_66d9cb0c-dd3d-4368-a7db-9094b65a66f4" xlink:href="mck-20230331.xsd#mck_AccruedShareRepurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:to="loc_mck_AccruedShareRepurchases_66d9cb0c-dd3d-4368-a7db-9094b65a66f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_b6298e0b-5c83-4b70-836f-42e35d62f7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_b6298e0b-5c83-4b70-836f-42e35d62f7de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_36483b6c-dd09-4148-9fc5-6494c4164e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_36483b6c-dd09-4148-9fc5-6494c4164e3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_d83ebfae-94a2-4d43-9ccf-75f635cf1609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_36483b6c-dd09-4148-9fc5-6494c4164e3a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_d83ebfae-94a2-4d43-9ccf-75f635cf1609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_d83ebfae-94a2-4d43-9ccf-75f635cf1609_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d83ebfae-94a2-4d43-9ccf-75f635cf1609" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_d83ebfae-94a2-4d43-9ccf-75f635cf1609_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d83ebfae-94a2-4d43-9ccf-75f635cf1609" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketTransactionsMember_c53b36dc-e132-42fd-abe3-94072b08feb7" xlink:href="mck-20230331.xsd#mck_OpenMarketTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_OpenMarketTransactionsMember_c53b36dc-e132-42fd-abe3-94072b08feb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2021Member_4694d618-28b5-4446-8785-6cf3e9fcde60" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseMay2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_AcceleratedShareRepurchaseMay2021Member_4694d618-28b5-4446-8785-6cf3e9fcde60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseFebruary2022Member_0f4e3707-b944-4f4f-922b-116a4587eaea" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseFebruary2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_AcceleratedShareRepurchaseFebruary2022Member_0f4e3707-b944-4f4f-922b-116a4587eaea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2022Member_3555594a-1bb8-41b2-85d6-ef4dab4826cd" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseMay2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_AcceleratedShareRepurchaseMay2022Member_3555594a-1bb8-41b2-85d6-ef4dab4826cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseDecember2022Member_937261a0-9d33-480e-b79e-4bdf04e64cb5" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_AcceleratedShareRepurchaseDecember2022Member_937261a0-9d33-480e-b79e-4bdf04e64cb5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_c688c9e6-3963-48f3-acfd-8e1871ea7e73" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_c688c9e6-3963-48f3-acfd-8e1871ea7e73" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_37b0236c-0299-4b3c-9ffb-d16c077e2b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_36483b6c-dd09-4148-9fc5-6494c4164e3a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_37b0236c-0299-4b3c-9ffb-d16c077e2b00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_37b0236c-0299-4b3c-9ffb-d16c077e2b00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_37b0236c-0299-4b3c-9ffb-d16c077e2b00" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_37b0236c-0299-4b3c-9ffb-d16c077e2b00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_333495b0-6008-427e-b013-6da10826be2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_37b0236c-0299-4b3c-9ffb-d16c077e2b00" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_333495b0-6008-427e-b013-6da10826be2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_a460020a-0b3d-470b-ad98-2e811dc5a76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_333495b0-6008-427e-b013-6da10826be2b" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_a460020a-0b3d-470b-ad98-2e811dc5a76f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended" id="i0a3184847d0e42e7ac9c0f670b1b00e5_StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20c91c9e-467c-4984-ae88-05ddfa6f700d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20c91c9e-467c-4984-ae88-05ddfa6f700d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b262f3ad-e286-4a81-9205-1ae2dedb1dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b262f3ad-e286-4a81-9205-1ae2dedb1dfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ed9f4af9-e1bb-4f5b-a7f9-cac43ea5b7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ed9f4af9-e1bb-4f5b-a7f9-cac43ea5b7b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2958439a-0480-49c0-a131-5a9d430cf7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2958439a-0480-49c0-a131-5a9d430cf7a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2a8d1c30-ea93-4499-975e-f5c2b5f688a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2a8d1c30-ea93-4499-975e-f5c2b5f688a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_250bfcdf-72d2-48e1-befa-9650f3dd83a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_250bfcdf-72d2-48e1-befa-9650f3dd83a4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_b61413a0-3e4e-48f5-a2f5-40135ad068e3" xlink:href="mck-20230331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_b61413a0-3e4e-48f5-a2f5-40135ad068e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a49abbce-29d3-4c87-b1e3-c53d995fe076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_f91d2e01-08f8-4688-860f-aadfd47430eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_f91d2e01-08f8-4688-860f-aadfd47430eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_3b420f43-05f6-49d8-957e-d94bb0efb632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_3b420f43-05f6-49d8-957e-d94bb0efb632" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_1adfea84-02c9-407a-ac4d-4f3ea38f77ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_1adfea84-02c9-407a-ac4d-4f3ea38f77ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_39ba1dbc-741a-41c2-b829-6ffbea8ca810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_39ba1dbc-741a-41c2-b829-6ffbea8ca810" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_70f91ab7-8b7e-4253-a747-cc2c12b7ba00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_70f91ab7-8b7e-4253-a747-cc2c12b7ba00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_70f91ab7-8b7e-4253-a747-cc2c12b7ba00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_70f91ab7-8b7e-4253-a747-cc2c12b7ba00" xlink:to="loc_us-gaap_EquityComponentDomain_70f91ab7-8b7e-4253-a747-cc2c12b7ba00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e5201caa-9469-4e64-9e03-7c2327db170f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_70f91ab7-8b7e-4253-a747-cc2c12b7ba00" xlink:to="loc_us-gaap_EquityComponentDomain_e5201caa-9469-4e64-9e03-7c2327db170f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e5201caa-9469-4e64-9e03-7c2327db170f" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b8f0005b-7a58-4e1d-a331-b8c3c8bd94b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b8f0005b-7a58-4e1d-a331-b8c3c8bd94b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_91891783-dfda-4d54-b401-af7155b72504" xlink:href="mck-20230331.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:to="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_91891783-dfda-4d54-b401-af7155b72504" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_84257210-ec32-42b3-8283-12401b7f6afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_84257210-ec32-42b3-8283-12401b7f6afe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_31309e3c-15ce-41d0-9d72-a89b2bb7269a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_31309e3c-15ce-41d0-9d72-a89b2bb7269a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_780e1fb6-0ee2-434e-b50b-e8c3a9c71985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_780e1fb6-0ee2-434e-b50b-e8c3a9c71985" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_780e1fb6-0ee2-434e-b50b-e8c3a9c71985_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_780e1fb6-0ee2-434e-b50b-e8c3a9c71985" xlink:to="loc_us-gaap_HedgingRelationshipDomain_780e1fb6-0ee2-434e-b50b-e8c3a9c71985_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_133e0507-c7b9-4e79-bb9d-c022f6d26132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_780e1fb6-0ee2-434e-b50b-e8c3a9c71985" xlink:to="loc_us-gaap_HedgingRelationshipDomain_133e0507-c7b9-4e79-bb9d-c022f6d26132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_cb56f076-25e7-4ae0-9f78-a8d671390d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_133e0507-c7b9-4e79-bb9d-c022f6d26132" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_cb56f076-25e7-4ae0-9f78-a8d671390d94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_41f4c6b6-301a-495e-9e1b-380cfc7d89bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_133e0507-c7b9-4e79-bb9d-c022f6d26132" xlink:to="loc_us-gaap_CurrencySwapMember_41f4c6b6-301a-495e-9e1b-380cfc7d89bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8bc6eb68-93f7-41b9-905c-6bf0889fad64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:to="loc_us-gaap_HedgingDesignationAxis_8bc6eb68-93f7-41b9-905c-6bf0889fad64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8bc6eb68-93f7-41b9-905c-6bf0889fad64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_8bc6eb68-93f7-41b9-905c-6bf0889fad64" xlink:to="loc_us-gaap_HedgingDesignationDomain_8bc6eb68-93f7-41b9-905c-6bf0889fad64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b43562bc-2aed-425b-a3bb-4bbb114d0c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_8bc6eb68-93f7-41b9-905c-6bf0889fad64" xlink:to="loc_us-gaap_HedgingDesignationDomain_b43562bc-2aed-425b-a3bb-4bbb114d0c51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c78c040b-3694-41ac-a55e-a7d37cc2b414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_b43562bc-2aed-425b-a3bb-4bbb114d0c51" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c78c040b-3694-41ac-a55e-a7d37cc2b414" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5dbde897-1212-4ea8-9049-c352ebe89290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:to="loc_us-gaap_DebtInstrumentAxis_5dbde897-1212-4ea8-9049-c352ebe89290" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5dbde897-1212-4ea8-9049-c352ebe89290_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5dbde897-1212-4ea8-9049-c352ebe89290" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5dbde897-1212-4ea8-9049-c352ebe89290_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a5f9897b-24bc-4b1d-a2d8-c30a980b000b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5dbde897-1212-4ea8-9049-c352ebe89290" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a5f9897b-24bc-4b1d-a2d8-c30a980b000b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_f0552909-8dc0-48b9-a5de-458e25fec77b" xlink:href="mck-20230331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a5f9897b-24bc-4b1d-a2d8-c30a980b000b" xlink:to="loc_mck_EuroDenominatedNotesMember_f0552909-8dc0-48b9-a5de-458e25fec77b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RelatedPartyBalancesandTransactionsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="extended" id="i82df7d4482cf47299a39e9e3ff047bc8_RelatedPartyBalancesandTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_98db8d31-e421-4df3-8766-4a743d15a5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_b421a67c-2469-44b3-9209-56eac60bfab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_98db8d31-e421-4df3-8766-4a743d15a5f0" xlink:to="loc_us-gaap_RevenueFromRelatedParties_b421a67c-2469-44b3-9209-56eac60bfab2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c2b0a20c-7d41-4a0c-82e5-5b34d18ce09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_98db8d31-e421-4df3-8766-4a743d15a5f0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c2b0a20c-7d41-4a0c-82e5-5b34d18ce09b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9212970f-30a2-4005-824d-77102da4909a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c2b0a20c-7d41-4a0c-82e5-5b34d18ce09b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9212970f-30a2-4005-824d-77102da4909a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9212970f-30a2-4005-824d-77102da4909a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9212970f-30a2-4005-824d-77102da4909a" xlink:to="loc_us-gaap_RelatedPartyDomain_9212970f-30a2-4005-824d-77102da4909a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_81299959-5bd9-4e5a-8c4c-0dbc430ec4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9212970f-30a2-4005-824d-77102da4909a" xlink:to="loc_us-gaap_RelatedPartyDomain_81299959-5bd9-4e5a-8c4c-0dbc430ec4bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember_7e9243b1-93a3-4359-8457-77863e763bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_81299959-5bd9-4e5a-8c4c-0dbc430ec4bc" xlink:to="loc_us-gaap_InvesteeMember_7e9243b1-93a3-4359-8457-77863e763bb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_16cd94fc-21cf-4812-96cd-d43f904c8355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c2b0a20c-7d41-4a0c-82e5-5b34d18ce09b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_16cd94fc-21cf-4812-96cd-d43f904c8355" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_16cd94fc-21cf-4812-96cd-d43f904c8355_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_16cd94fc-21cf-4812-96cd-d43f904c8355" xlink:to="loc_us-gaap_SegmentDomain_16cd94fc-21cf-4812-96cd-d43f904c8355_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_77f6cabe-1fa3-4f9e-bc54-30254ad69146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_16cd94fc-21cf-4812-96cd-d43f904c8355" xlink:to="loc_us-gaap_SegmentDomain_77f6cabe-1fa3-4f9e-bc54-30254ad69146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_7d56b9f9-ddca-46db-b2a7-da7e2ba64e42" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_77f6cabe-1fa3-4f9e-bc54-30254ad69146" xlink:to="loc_mck_InternationalSegmentMember_7d56b9f9-ddca-46db-b2a7-da7e2ba64e42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_32d6931a-fb59-42c5-b3c9-8b88634789db" xlink:href="mck-20230331.xsd#mck_U.S.PharmaceuticalandSpecialtySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_77f6cabe-1fa3-4f9e-bc54-30254ad69146" xlink:to="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_32d6931a-fb59-42c5-b3c9-8b88634789db" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SegmentsofBusinessScheduleofSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="extended" id="i21de9d46ec0e46c4894eb224aeb022e2_SegmentsofBusinessScheduleofSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_98a6001b-d698-4d22-9b7a-de374648b60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_RevenuesAbstract_98a6001b-d698-4d22-9b7a-de374648b60e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_59f48e03-8a82-42de-808f-01d32434bc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_98a6001b-d698-4d22-9b7a-de374648b60e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_59f48e03-8a82-42de-808f-01d32434bc6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_b5ef3525-5022-43b4-979c-cb1dc1558d4d" xlink:href="mck-20230331.xsd#mck_GrossProfitNetofExpensesIncludingOtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:to="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_b5ef3525-5022-43b4-979c-cb1dc1558d4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_d8039514-aca9-46c2-9b92-8475e0813ac0" xlink:href="mck-20230331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_d8039514-aca9-46c2-9b92-8475e0813ac0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_24bc035a-e63f-487f-8d39-fb31f3e93a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_24bc035a-e63f-487f-8d39-fb31f3e93a77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_72f8f25b-9f61-4c1c-9abf-967a50d3ac0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:to="loc_us-gaap_InterestExpense_72f8f25b-9f61-4c1c-9abf-967a50d3ac0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4bb97ee7-00b7-4a65-855c-6a29a7b423f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4bb97ee7-00b7-4a65-855c-6a29a7b423f1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract_19a962e2-886f-448c-ae9d-da6a5551b686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_DepreciationAndAmortizationAbstract_19a962e2-886f-448c-ae9d-da6a5551b686" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_588d0b7a-e821-4b8c-975f-91d6ad0fcf9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract_19a962e2-886f-448c-ae9d-da6a5551b686" xlink:to="loc_us-gaap_DepreciationAndAmortization_588d0b7a-e821-4b8c-975f-91d6ad0fcf9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_f1058ecd-4ee8-460e-a06a-e57e1bdd1ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_f1058ecd-4ee8-460e-a06a-e57e1bdd1ea2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_2950a1fd-6630-44ae-872c-fc64e4df614b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_f1058ecd-4ee8-460e-a06a-e57e1bdd1ea2" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_2950a1fd-6630-44ae-872c-fc64e4df614b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_ae855daf-9ade-4406-b057-027e97283f78" xlink:href="mck-20230331.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_ae855daf-9ade-4406-b057-027e97283f78" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_cc792c09-7e30-49f1-84cb-84015a94fec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_cc792c09-7e30-49f1-84cb-84015a94fec5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_95166d19-3aa4-44d5-a63a-221f6ad68c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_95166d19-3aa4-44d5-a63a-221f6ad68c5a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_acfdb1e6-1970-46dd-85b5-eb6ebde1fcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_acfdb1e6-1970-46dd-85b5-eb6ebde1fcb9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_72b43b6d-fbc0-4f38-b136-0cf119449fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_72b43b6d-fbc0-4f38-b136-0cf119449fbb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_646c08d5-fdda-44ac-b037-eea515ec7fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_646c08d5-fdda-44ac-b037-eea515ec7fee" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_9d904958-2faa-4104-9751-4c4b23a3f615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_InventoryWriteDown_9d904958-2faa-4104-9751-4c4b23a3f615" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_cd82f084-b252-469f-a13c-f19e7f886590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_cd82f084-b252-469f-a13c-f19e7f886590" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_86de9996-c60e-46d1-be7a-425b75b7343e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_86de9996-c60e-46d1-be7a-425b75b7343e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_2626542a-d8b1-43ec-85d7-05f89ed2010e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_2626542a-d8b1-43ec-85d7-05f89ed2010e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_331276e4-0251-4f0c-b21b-ec2dce2232d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_331276e4-0251-4f0c-b21b-ec2dce2232d3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b0f8763f-fdb7-4e41-8e5e-48113ddc53a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_AssetImpairmentCharges_b0f8763f-fdb7-4e41-8e5e-48113ddc53a6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_0eee04da-f35e-4565-8358-2dadd80196e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_GainLossOnContractTermination_0eee04da-f35e-4565-8358-2dadd80196e7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnDerivativeTermination_bec69ee7-2c6f-47b7-96ce-d9a1a4108597" xlink:href="mck-20230331.xsd#mck_GainLossOnDerivativeTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_mck_GainLossOnDerivativeTermination_bec69ee7-2c6f-47b7-96ce-d9a1a4108597" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_ae4987ac-6a5a-4cf9-8c2a-dc6d9375037a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_ae4987ac-6a5a-4cf9-8c2a-dc6d9375037a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_58c0a557-47b5-43c9-8906-d23f93cdcbae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_LitigationSettlementExpense_58c0a557-47b5-43c9-8906-d23f93cdcbae" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_97c04b50-3252-4147-99f8-065a66e2eb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_RestructuringCharges_97c04b50-3252-4147-99f8-065a66e2eb34" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_6436b13d-c3d8-4d5f-a71c-f989d866ee82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_6436b13d-c3d8-4d5f-a71c-f989d866ee82" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d5e1ea90-cd4b-409d-8007-3e1e6485ec02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d5e1ea90-cd4b-409d-8007-3e1e6485ec02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d5e1ea90-cd4b-409d-8007-3e1e6485ec02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5e1ea90-cd4b-409d-8007-3e1e6485ec02" xlink:to="loc_us-gaap_SegmentDomain_d5e1ea90-cd4b-409d-8007-3e1e6485ec02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5e1ea90-cd4b-409d-8007-3e1e6485ec02" xlink:to="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_a147b04d-b84c-4bcc-89c4-43cbcd6449f8" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:to="loc_mck_USPharmaceuticalSegmentMember_a147b04d-b84c-4bcc-89c4-43cbcd6449f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e1b09591-e044-4595-a9ab-612ac609f8d8" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e1b09591-e044-4595-a9ab-612ac609f8d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_22b6275b-1e54-476c-8fc3-c9b5902e4cab" xlink:href="mck-20230331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_22b6275b-1e54-476c-8fc3-c9b5902e4cab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_68202d81-f19d-431b-b26d-109215fff85c" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:to="loc_mck_InternationalSegmentMember_68202d81-f19d-431b-b26d-109215fff85c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_167b0a9a-bba9-4daa-8a6a-ad489848e366" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_srt_ConsolidationItemsAxis_167b0a9a-bba9-4daa-8a6a-ad489848e366" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_167b0a9a-bba9-4daa-8a6a-ad489848e366_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_167b0a9a-bba9-4daa-8a6a-ad489848e366" xlink:to="loc_srt_ConsolidationItemsDomain_167b0a9a-bba9-4daa-8a6a-ad489848e366_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a1f2dc79-7bde-4d3a-b236-86239ea9d725" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_167b0a9a-bba9-4daa-8a6a-ad489848e366" xlink:to="loc_srt_ConsolidationItemsDomain_a1f2dc79-7bde-4d3a-b236-86239ea9d725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2be3d4e0-6ff4-4052-92f1-f49b7bf245ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a1f2dc79-7bde-4d3a-b236-86239ea9d725" xlink:to="loc_us-gaap_OperatingSegmentsMember_2be3d4e0-6ff4-4052-92f1-f49b7bf245ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_112186df-9d23-4030-83c1-640b93ed2bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a1f2dc79-7bde-4d3a-b236-86239ea9d725" xlink:to="loc_us-gaap_CorporateNonSegmentMember_112186df-9d23-4030-83c1-640b93ed2bd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_aa730f43-ec6e-401f-81ba-23ca3908b621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_aa730f43-ec6e-401f-81ba-23ca3908b621" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_aa730f43-ec6e-401f-81ba-23ca3908b621_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_aa730f43-ec6e-401f-81ba-23ca3908b621" xlink:to="loc_us-gaap_LossContingencyNatureDomain_aa730f43-ec6e-401f-81ba-23ca3908b621_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ead87b7a-094a-4ca3-b9d2-276ac9411349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_aa730f43-ec6e-401f-81ba-23ca3908b621" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ead87b7a-094a-4ca3-b9d2-276ac9411349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_cb1aa594-23ab-4b88-9649-bb272e873938" xlink:href="mck-20230331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ead87b7a-094a-4ca3-b9d2-276ac9411349" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_cb1aa594-23ab-4b88-9649-bb272e873938" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_07e9de4c-f148-418c-b885-6fb7ad55edb4" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ead87b7a-094a-4ca3-b9d2-276ac9411349" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_07e9de4c-f148-418c-b885-6fb7ad55edb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_bcc931c4-5c1e-485c-ae4d-26a151833077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_bcc931c4-5c1e-485c-ae4d-26a151833077" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bcc931c4-5c1e-485c-ae4d-26a151833077_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_bcc931c4-5c1e-485c-ae4d-26a151833077" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bcc931c4-5c1e-485c-ae4d-26a151833077_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e754dc32-fc8b-461d-9caa-d217d9dbc50e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_bcc931c4-5c1e-485c-ae4d-26a151833077" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e754dc32-fc8b-461d-9caa-d217d9dbc50e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_508d7c62-3994-44f6-9350-24dd714d561f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e754dc32-fc8b-461d-9caa-d217d9dbc50e" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_508d7c62-3994-44f6-9350-24dd714d561f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_5420d8ab-3f38-4773-8e7a-f90438efb0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e754dc32-fc8b-461d-9caa-d217d9dbc50e" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_5420d8ab-3f38-4773-8e7a-f90438efb0bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_de5a3901-2655-4b6e-9846-2fa8133cfbad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_de5a3901-2655-4b6e-9846-2fa8133cfbad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_de5a3901-2655-4b6e-9846-2fa8133cfbad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_de5a3901-2655-4b6e-9846-2fa8133cfbad" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_de5a3901-2655-4b6e-9846-2fa8133cfbad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_de5a3901-2655-4b6e-9846-2fa8133cfbad" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_c3dab798-ced6-4ea5-b7ee-43bea967b807" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_c3dab798-ced6-4ea5-b7ee-43bea967b807" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_f1d5aa5d-1d74-41b4-aadd-dcaac5ce9049" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_f1d5aa5d-1d74-41b4-aadd-dcaac5ce9049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_dd7f11f2-f3ba-4c83-aef5-4136ae54e80d" xlink:href="mck-20230331.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:to="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_dd7f11f2-f3ba-4c83-aef5-4136ae54e80d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_1d3bc7bb-100c-4a0d-a29b-b0d626a15a22" xlink:href="mck-20230331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:to="loc_mck_GermanWholesaleBusinessMember_1d3bc7bb-100c-4a0d-a29b-b0d626a15a22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_94be5ecb-50cd-48d9-936b-ebd005834374" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_srt_OwnershipAxis_94be5ecb-50cd-48d9-936b-ebd005834374" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_94be5ecb-50cd-48d9-936b-ebd005834374_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_94be5ecb-50cd-48d9-936b-ebd005834374" xlink:to="loc_srt_OwnershipDomain_94be5ecb-50cd-48d9-936b-ebd005834374_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_1c54d44a-3968-4682-9378-c422a6c2d606" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_94be5ecb-50cd-48d9-936b-ebd005834374" xlink:to="loc_srt_OwnershipDomain_1c54d44a-3968-4682-9378-c422a6c2d606" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_06923fc8-1174-49de-916f-721a66c99b89" xlink:href="mck-20230331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_1c54d44a-3968-4682-9378-c422a6c2d606" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_06923fc8-1174-49de-916f-721a66c99b89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_8365fffe-c490-47bb-bb45-837df83c4655" xlink:href="mck-20230331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_1c54d44a-3968-4682-9378-c422a6c2d606" xlink:to="loc_mck_GermanWholesaleBusinessMember_8365fffe-c490-47bb-bb45-837df83c4655" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5eac1955-b946-47ff-ab8e-0d62b24219e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5eac1955-b946-47ff-ab8e-0d62b24219e0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5eac1955-b946-47ff-ab8e-0d62b24219e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5eac1955-b946-47ff-ab8e-0d62b24219e0" xlink:to="loc_us-gaap_RelatedPartyDomain_5eac1955-b946-47ff-ab8e-0d62b24219e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ea61065e-6a55-450a-b830-4194fbcd8ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5eac1955-b946-47ff-ab8e-0d62b24219e0" xlink:to="loc_us-gaap_RelatedPartyDomain_ea61065e-6a55-450a-b830-4194fbcd8ab4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_d2b7a603-98e3-49c8-adef-ab6ca108f60c" xlink:href="mck-20230331.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_ea61065e-6a55-450a-b830-4194fbcd8ab4" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_d2b7a603-98e3-49c8-adef-ab6ca108f60c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_66b34c61-899b-4596-afdc-e46618e88d6c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_srt_LitigationCaseAxis_66b34c61-899b-4596-afdc-e46618e88d6c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_66b34c61-899b-4596-afdc-e46618e88d6c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_66b34c61-899b-4596-afdc-e46618e88d6c" xlink:to="loc_srt_LitigationCaseTypeDomain_66b34c61-899b-4596-afdc-e46618e88d6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_24b8a693-cf13-44fb-9f28-6a522aea82fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_66b34c61-899b-4596-afdc-e46618e88d6c" xlink:to="loc_srt_LitigationCaseTypeDomain_24b8a693-cf13-44fb-9f28-6a522aea82fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember_8f9a6716-87cb-4082-8f5a-a292e11905a5" xlink:href="mck-20230331.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_24b8a693-cf13-44fb-9f28-6a522aea82fc" xlink:to="loc_mck_ShareholderDerivativeActionMember_8f9a6716-87cb-4082-8f5a-a292e11905a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_63b6834f-c22f-47b3-8907-0add63b3bf58" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_24b8a693-cf13-44fb-9f28-6a522aea82fc" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_63b6834f-c22f-47b3-8907-0add63b3bf58" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails" xlink:type="extended" id="if19fb1816f7b4f02986317efd0ed7af1_SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e32f4f74-27e9-411c-a1b4-96e2001ed439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0e6fcb75-a02e-42ae-8e79-e6639308c4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e32f4f74-27e9-411c-a1b4-96e2001ed439" xlink:to="loc_us-gaap_AssetsAbstract_0e6fcb75-a02e-42ae-8e79-e6639308c4eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_27595d0d-1c85-4b22-8fd9-c25729b3c836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_0e6fcb75-a02e-42ae-8e79-e6639308c4eb" xlink:to="loc_us-gaap_Assets_27595d0d-1c85-4b22-8fd9-c25729b3c836" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5e5b13f8-f18f-4b24-abff-f15de9bee755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e32f4f74-27e9-411c-a1b4-96e2001ed439" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5e5b13f8-f18f-4b24-abff-f15de9bee755" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_fca4b710-e01a-42fa-8620-f317262f3d6b" xlink:href="mck-20230331.xsd#mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5e5b13f8-f18f-4b24-abff-f15de9bee755" xlink:to="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_fca4b710-e01a-42fa-8620-f317262f3d6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2fa321ee-f44e-4f6c-8c8e-c0096a54de2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e32f4f74-27e9-411c-a1b4-96e2001ed439" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2fa321ee-f44e-4f6c-8c8e-c0096a54de2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b7c3a125-f447-4f98-a498-8a405aea31e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2fa321ee-f44e-4f6c-8c8e-c0096a54de2f" xlink:to="loc_srt_ConsolidationItemsAxis_b7c3a125-f447-4f98-a498-8a405aea31e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b7c3a125-f447-4f98-a498-8a405aea31e3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b7c3a125-f447-4f98-a498-8a405aea31e3" xlink:to="loc_srt_ConsolidationItemsDomain_b7c3a125-f447-4f98-a498-8a405aea31e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_22b5070c-b3d2-4b5a-8eb1-7c82a6364303" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b7c3a125-f447-4f98-a498-8a405aea31e3" xlink:to="loc_srt_ConsolidationItemsDomain_22b5070c-b3d2-4b5a-8eb1-7c82a6364303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b0d1033f-7824-4ae1-815a-20f62e98aa1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_22b5070c-b3d2-4b5a-8eb1-7c82a6364303" xlink:to="loc_us-gaap_OperatingSegmentsMember_b0d1033f-7824-4ae1-815a-20f62e98aa1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_78248cc2-4bf6-4828-91d1-8c98cf7f5d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_22b5070c-b3d2-4b5a-8eb1-7c82a6364303" xlink:to="loc_us-gaap_CorporateNonSegmentMember_78248cc2-4bf6-4828-91d1-8c98cf7f5d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_68dfbcb6-8ce2-468c-adac-c1916111fb56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2fa321ee-f44e-4f6c-8c8e-c0096a54de2f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_68dfbcb6-8ce2-468c-adac-c1916111fb56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_68dfbcb6-8ce2-468c-adac-c1916111fb56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_68dfbcb6-8ce2-468c-adac-c1916111fb56" xlink:to="loc_us-gaap_SegmentDomain_68dfbcb6-8ce2-468c-adac-c1916111fb56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_68dfbcb6-8ce2-468c-adac-c1916111fb56" xlink:to="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_583f40d2-a2f7-4d7c-8b5d-a529119164e4" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:to="loc_mck_USPharmaceuticalSegmentMember_583f40d2-a2f7-4d7c-8b5d-a529119164e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_fcc0c1d1-74a2-46f8-8d3d-3d5eea1ae8ed" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_fcc0c1d1-74a2-46f8-8d3d-3d5eea1ae8ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_44819e10-5e7c-4e10-a471-27aebdf615c8" xlink:href="mck-20230331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_44819e10-5e7c-4e10-a471-27aebdf615c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_9ba5e453-ee10-4ab9-8b5f-f71459ec8eb4" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:to="loc_mck_InternationalSegmentMember_9ba5e453-ee10-4ab9-8b5f-f71459ec8eb4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c29bc1da-c406-4053-831c-e8c4e767f1a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2fa321ee-f44e-4f6c-8c8e-c0096a54de2f" xlink:to="loc_srt_StatementGeographicalAxis_c29bc1da-c406-4053-831c-e8c4e767f1a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c29bc1da-c406-4053-831c-e8c4e767f1a4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c29bc1da-c406-4053-831c-e8c4e767f1a4" xlink:to="loc_srt_SegmentGeographicalDomain_c29bc1da-c406-4053-831c-e8c4e767f1a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8c549829-5bd5-4087-822d-f5b941bcd454" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c29bc1da-c406-4053-831c-e8c4e767f1a4" xlink:to="loc_srt_SegmentGeographicalDomain_8c549829-5bd5-4087-822d-f5b941bcd454" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1bf170ed-93e7-4ea4-8230-67461d705da0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8c549829-5bd5-4087-822d-f5b941bcd454" xlink:to="loc_country_US_1bf170ed-93e7-4ea4-8230-67461d705da0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_b0c0a96e-1842-42da-99af-a2c3378abac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8c549829-5bd5-4087-822d-f5b941bcd454" xlink:to="loc_us-gaap_NonUsMember_b0c0a96e-1842-42da-99af-a2c3378abac3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended" id="ifc05aa60cce645df914e5f03dbc2be53_SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_630d1ace-224c-4057-94ae-264d3e932329" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_630d1ace-224c-4057-94ae-264d3e932329" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_14f9bbb8-9739-4301-b54b-23eb05b249bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_14f9bbb8-9739-4301-b54b-23eb05b249bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_5ae0bd7f-b0d9-4e7d-96dd-234b3e20aa56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_5ae0bd7f-b0d9-4e7d-96dd-234b3e20aa56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_42de0552-8bb9-4f1a-b0fd-ffa7fd8d9d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_42de0552-8bb9-4f1a-b0fd-ffa7fd8d9d22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d9a13203-a269-4053-8dca-ffa342ac8372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d9a13203-a269-4053-8dca-ffa342ac8372" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_37e291bb-fc3d-4985-85aa-a5d72672a343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_92906b46-22cf-42d0-a98c-c3351f24422c" xlink:href="mck-20230331.xsd#mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_630d1ace-224c-4057-94ae-264d3e932329" xlink:to="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_92906b46-22cf-42d0-a98c-c3351f24422c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_dfee6288-fdd8-4caf-ab16-397392486727" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_630d1ace-224c-4057-94ae-264d3e932329" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_dfee6288-fdd8-4caf-ab16-397392486727" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_61a416b6-5ec7-4ea2-9056-847409310309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_dfee6288-fdd8-4caf-ab16-397392486727" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_61a416b6-5ec7-4ea2-9056-847409310309" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_61a416b6-5ec7-4ea2-9056-847409310309_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_61a416b6-5ec7-4ea2-9056-847409310309" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_61a416b6-5ec7-4ea2-9056-847409310309_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_61a416b6-5ec7-4ea2-9056-847409310309" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_ef0e22cb-33ee-49ce-9776-adb73090b89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_ef0e22cb-33ee-49ce-9776-adb73090b89f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAllowancesMember_badff502-f998-4657-8917-0e5cc0c40cae" xlink:href="mck-20230331.xsd#mck_OtherAllowancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:to="loc_mck_OtherAllowancesMember_badff502-f998-4657-8917-0e5cc0c40cae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_0ded01fe-e716-4e35-b36e-48c4b0169c73" xlink:href="mck-20230331.xsd#mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_0ded01fe-e716-4e35-b36e-48c4b0169c73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_0b705591-3a30-4790-83cf-d4f782811718" xlink:href="mck-20230331.xsd#mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_0b705591-3a30-4790-83cf-d4f782811718" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>mck-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1eea9b32-7227-4c4c-b033-5c353ea41e5b,g:3de8d065-e076-4ee0-8f0c-2df01cc3ca1e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_93e03104-51cc-435b-af9b-32c4fd4d695a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures_b4da2e28-f40f-4dfc-933e-bac0b074e0e2_terseLabel_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans, net of forfeitures (in shares)</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures_label_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Plans Net of Forfeitures</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures_documentation_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Plans Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures" xlink:href="mck-20230331.xsd#mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures" xlink:to="lab_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NorwegianPublicServicePensionFundSPKMember_ea8004cd-2e0e-45be-8d17-2aa5b47e69c5_terseLabel_en-US" xlink:label="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwegian Public Service Pension Fund (SPK)</link:label>
    <link:label id="lab_mck_NorwegianPublicServicePensionFundSPKMember_label_en-US" xlink:label="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwegian Public Service Pension Fund (SPK) [Member]</link:label>
    <link:label id="lab_mck_NorwegianPublicServicePensionFundSPKMember_documentation_en-US" xlink:label="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwegian Public Service Pension Fund (SPK) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NorwegianPublicServicePensionFundSPKMember" xlink:href="mck-20230331.xsd#mck_NorwegianPublicServicePensionFundSPKMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NorwegianPublicServicePensionFundSPKMember" xlink:to="lab_mck_NorwegianPublicServicePensionFundSPKMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_d522a927-9dcc-4044-8a56-55d9632064a4_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_67f54028-8a04-44e9-b15f-23dd51fdf4f1_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_d2950120-c7ff-4cf3-8f2b-10804fdbdccf_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of complaints served</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_cc900333-9e3a-436b-95b4-adcbc225c2a8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_GBP_0f33c0dd-fa9c-45f4-93dd-c4f74a0337cf_terseLabel_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GBP</link:label>
    <link:label id="lab_currency_GBP_label_en-US" xlink:label="lab_currency_GBP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom, Pounds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_GBP" xlink:to="lab_currency_GBP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_7f49e304-df2c-4064-9d54-52fe4f787d15_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TreasuryStockPolicyTextBlock_aedc6e23-91e7-4741-95bc-82e56b78a083_terseLabel_en-US" xlink:label="lab_mck_TreasuryStockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_mck_TreasuryStockPolicyTextBlock_label_en-US" xlink:label="lab_mck_TreasuryStockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Policy Text Block]</link:label>
    <link:label id="lab_mck_TreasuryStockPolicyTextBlock_documentation_en-US" xlink:label="lab_mck_TreasuryStockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TreasuryStockPolicyTextBlock" xlink:href="mck-20230331.xsd#mck_TreasuryStockPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TreasuryStockPolicyTextBlock" xlink:to="lab_mck_TreasuryStockPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_3b24f385-8457-4771-86b0-8fdf0f2ac145_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_0cbb7422-d278-4e0e-b51e-5a93e95ee74d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_fe3e14ee-dd76-4c3b-8a18-eed73c1165b6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_cdbbfba3-6b06-405c-bbf4-019b30ca829a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_e71b4872-aa85-4fba-b202-1510effaed22_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit and other-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_27bfbeed-628d-4da8-8337-aaf78a5aae32_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_33a7853c-b465-4552-a730-26bb4f692242_terseLabel_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual, period increase (decrease), net of tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_label_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_documentation_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:href="mck-20230331.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:to="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_c1d9dcda-b02a-4b2c-8042-419534263f39_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseDecember2022Member_eab1bba3-42ec-482e-9917-ea2d20f94e72_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, December 2022</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseDecember2022Member_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, December 2022 [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseDecember2022Member_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, December 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseDecember2022Member" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseDecember2022Member" xlink:to="lab_mck_AcceleratedShareRepurchaseDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_1a06f43c-0273-4747-8b7c-a54c7796f468_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_e6f2b5a0-2975-43a7-a82d-883b04c4fbc2_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_f3a70548-636e-4d8c-b3c1-a4f62cc3fe78_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_3596bb15-9316-4350-9970-02290cc88f0c_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_e584a6a9-15eb-4ef9-aac6-6fcb039d8dfc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_d6d9f65f-e4b1-4244-97d3-d0d971afecee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in benefit obligations and plan assets for pension plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_f1cb9e08-f117-4330-a708-5423b7100c29_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FixedInterestRateSwapMember_ad01ef2d-b87c-49d5-b292-3f9150f34104_terseLabel_en-US" xlink:label="lab_mck_FixedInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed interest rate swaps</link:label>
    <link:label id="lab_mck_FixedInterestRateSwapMember_label_en-US" xlink:label="lab_mck_FixedInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Interest Rate Swap [Member]</link:label>
    <link:label id="lab_mck_FixedInterestRateSwapMember_documentation_en-US" xlink:label="lab_mck_FixedInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Interest Rate Swap</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember" xlink:href="mck-20230331.xsd#mck_FixedInterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FixedInterestRateSwapMember" xlink:to="lab_mck_FixedInterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_8b1f2626-c49b-433f-95d8-5d8521abe138_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, Net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_2c90aa4b-7c96-414b-b4da-3cd16ab62dde_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_d8b06d3f-5ac3-47ad-8f44-bf1d117b5bfb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_aef7d21f-ef37-49ce-96a2-42e2d30de607_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_92df1d87-68db-47f2-bdd8-77c733ee1647_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_7d584820-923c-487b-9fc1-9fcd3de58024_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transactions:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repurchase of) Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepurchaseOfEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:to="lab_us-gaap_ProceedsFromRepurchaseOfEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4ffb574b-7718-4af2-94b7-e77323e7f234_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_d9ddba06-1dda-4be6-8fe6-0e118d42665f_terseLabel_en-US" xlink:label="lab_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="mck-20230331.xsd#mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_8c4ef479-0977-4001-84ab-cd351f6922eb_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5176deb0-bfe5-4856-b5d1-b6000e2542d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MultiemployerPlanFundedStatusPercentage_0c9723fc-9822-44d9-8954-40968c10adeb_terseLabel_en-US" xlink:label="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status (as a percent)</link:label>
    <link:label id="lab_mck_MultiemployerPlanFundedStatusPercentage_label_en-US" xlink:label="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Funded Status, Percentage</link:label>
    <link:label id="lab_mck_MultiemployerPlanFundedStatusPercentage_documentation_en-US" xlink:label="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Funded Status, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MultiemployerPlanFundedStatusPercentage" xlink:href="mck-20230331.xsd#mck_MultiemployerPlanFundedStatusPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MultiemployerPlanFundedStatusPercentage" xlink:to="lab_mck_MultiemployerPlanFundedStatusPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_f0426c83-0edb-4908-a1f8-7542cbebb2f1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on debt instruments (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9d74f422-dad0-4d2e-8bac-afbc9070c2b0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_87962308-58e2-4a60-9fc4-aa13e62557e8_negatedTerseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses paid</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Expenses Paid</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Expenses Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanPlanAssetsExpensesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:to="lab_mck_DefinedBenefitPlanPlanAssetsExpensesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_56d4c7a3-8b56-4177-963e-7f6c9f3fed72_terseLabel_en-US" xlink:label="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</link:label>
    <link:label id="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_label_en-US" xlink:label="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]</link:label>
    <link:label id="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_documentation_en-US" xlink:label="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:href="mck-20230331.xsd#mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:to="lab_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_c515e7bb-fdab-406c-bc9c-7b2725685686_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other income, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income, by Component [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_79343eb8-56cb-49ed-963a-234a8ddcbe01_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4b273653-dd45-4ef0-9fba-ea37ec4f667c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_bb7607a4-f4fc-464f-99b8-24a8c4e43ed4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_92c522e8-4c36-49d4-96e2-fea81d18021a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_ff50ff11-7f3e-4a33-9ba7-73e46a35314e_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divested cash</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_835fdffc-221b-4b95-bb1f-b1c59c4a611a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_dd736ee4-0134-48ab-aed3-0493ad6cfc5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b09b529e-3981-487e-968d-74c908be202d_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities excluded from diluted earnings per share (less than)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_190a4a93-379e-4a35-a992-d7417361cd90_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_a454b499-9bdd-40c1-aacf-acb441090f19_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesGrossCurrent_9e0e2129-5983-42fc-8aaf-b927271643dd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesGrossCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Gross, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesGrossCurrent" xlink:to="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2b1dd494-d64e-4202-8fef-c791fe7a7e9a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_07dcda50-7e59-42c1-83bf-5157f848f38f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of options outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_8a45a420-ba14-464f-a88c-5c6528797814_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_81f86f8c-b97d-41db-a5ca-eca6f4b9ff6d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_a275402d-3c5c-4e6d-a035-6580c4b80ce8_terseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid-related litigation and claims</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Litigation and Claims</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Litigation and Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_da648e52-d982-4af7-96d2-d5993ddd4c8f_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_a0ec1d73-bb6b-47d2-a041-5f1ad2757bbd_terseLabel_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes due March 15, 2024</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_label_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024 [Member]</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_documentation_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member" xlink:href="mck-20230331.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A380NotesDueMarch152024Member" xlink:to="lab_mck_A380NotesDueMarch152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_77c8ff6a-88b2-4107-850e-660e3a0a657a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options Outstanding at Year End (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1880d736-8b41-45e7-9f20-40291188a423_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_fc24cfd9-0031-4f8d-bd79-373eb02a714a_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_f4653aec-b007-449c-8da9-3cd9f95c4ca0_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_396e632b-dce0-459f-b4c1-24489f32e8fb_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_fa5145bb-76c8-425d-98fc-fc91bc28fa03_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_73cacb56-5b5e-4116-95d5-51361a90bcf3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_39acc18d-3c52-4439-86de-88e969b8dd1d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_4458e500-2f68-46dd-8989-a4e97b433f1d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_fafb1b56-1dca-4f58-be37-ad6a4702724e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitValueOfCashAndCashEquivalents_3dac7d7c-6762-454f-9ae6-f9435e9070ca_terseLabel_en-US" xlink:label="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unit value of cash and cash equivalents (in dollars per share)</link:label>
    <link:label id="lab_mck_UnitValueOfCashAndCashEquivalents_label_en-US" xlink:label="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unit Value Of Cash And Cash Equivalents</link:label>
    <link:label id="lab_mck_UnitValueOfCashAndCashEquivalents_documentation_en-US" xlink:label="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unit value of cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitValueOfCashAndCashEquivalents" xlink:href="mck-20230331.xsd#mck_UnitValueOfCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitValueOfCashAndCashEquivalents" xlink:to="lab_mck_UnitValueOfCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_f0836026-8665-4258-a036-9278366142cc_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_1faf8351-9486-4f6e-be4d-efa2db7a6b36_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_fc150ac9-d664-4cd7-a153-88c8e3775ead_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1a141369-bcea-4cb9-94b1-e97a1a6ae72c_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at beginning of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6ed183b1-a86d-4881-bb91-968e1b317165_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at end of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_b9c946c8-d822-42ba-afb5-b6955ed28e89_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2743070d-98cf-4b4e-9c37-397255b7037d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearThree_b2047ae1-29b0-4577-9b4d-a7244716ee23_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2026</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearThree_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Three</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearThree_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_7998a60f-6fb2-48bc-bea4-360826844a12_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_3601103d-ffed-44f8-a56c-8882ee0d7d92_terseLabel_en-US" xlink:label="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which payroll is deducted to purchase shares</link:label>
    <link:label id="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_label_en-US" xlink:label="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share Based Compensation Period To Purchase Shares Through Payroll Deductions</link:label>
    <link:label id="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_documentation_en-US" xlink:label="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee service share based compensation period to purchase shares through payroll deductions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:href="mck-20230331.xsd#mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:to="lab_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_e33021aa-d232-4858-a291-099e5ae80583_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_29a1100f-0953-4d79-9886-463c23f527cd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMay302029Member_2247ca45-780d-4dec-8a73-23e0bf77cb3b_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due May 30, 2029</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_label_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member" xlink:href="mck-20230331.xsd#mck_A475NotesDueMay302029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMay302029Member" xlink:to="lab_mck_A475NotesDueMay302029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_290e84ea-af05-40c5-9544-5dc3b98637e7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_31815955-4a37-487b-85bd-079e01e33248_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_38800542-bca4-4b0f-802b-2b0a85cb31d0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e3f64bdc-dfe2-462c-b999-be3de29516e9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_73a8aea6-506a-4fb7-8f17-6c33b0b7cc6b_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_5e9a609b-4d87-4369-bddf-d1d1bdd0214c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_74f42006-7065-470c-a1c8-de50d28c3054_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_c501c83c-5822-428f-8ca4-53d90060e7f5_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2028</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_9b2f2355-1991-4dab-ba66-fc93b9752f36_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions based on settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_47629868-4778-46fb-a102-7ed391e4c57c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_fd98a098-047c-4cbe-8ecb-44646853b4d3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_71c0ba95-5b22-4770-b28b-ff293d56dc68_terseLabel_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:to="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_cd93f13e-e54d-43ee-9f7c-ee818e7477bf_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss in charge for remeasurement to fair value</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Loss in Charge for Remeasurement to Fair Value</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d4da72c2-d50e-4efe-844f-451b12fd38b8_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a092deb2-5722-487b-85c5-e475806f2606_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual, period increase (decrease)</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_a7d4b51e-0e03-443f-84d0-6025413832c4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds from divestiture</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_d06820b4-c3a8-49bc-b240-76e73a2caa80_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_71dece3a-fc07-4258-aad9-f34b48a83ade_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_0b8597f3-9d45-4031-97ce-32189a90c3de_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_3faf540a-6730-4ec5-b85c-f5b388f22558_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanOtherFundsMember_5b9cbb69-f403-431b-b9df-1682a796509b_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate funds and Other</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanOtherFundsMember_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Funds [Member]</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanOtherFundsMember_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanOtherFundsMember" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanOtherFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanOtherFundsMember" xlink:to="lab_mck_DefinedBenefitPlanOtherFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_d6f44aa5-3ce0-495e-90fc-f4fb77f4089e_terseLabel_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember" xlink:href="mck-20230331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuropeanBusinessesDisposalGroupMember" xlink:to="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_f399b23c-7acc-4bfa-a010-8c5e2e77ab1f_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE consolidated liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ae6f3008-9028-42d3-a588-9ed89606a413_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2a7884d6-2ecb-43e0-9ba2-2e3cd5a74c53_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_e760bf70-8a38-43f0-ac9a-33c1d62846c5_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f30536b0-4a12-4a64-9d34-25acf79ed8c7_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_df417aca-fd01-4325-a38b-10647bfcc98b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_46c0752d-0ba4-4827-a9f9-bb87dac6e369_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_424a1c29-92b6-4f9c-a653-8c1e84b92ca0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_9e36bff1-9d9d-4710-ae1b-70838f6efc69_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_b4127174-d8e9-4a46-8a81-1e8e16824c89_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a0967bbe-1dc5-4b27-a06e-f3608f559baf_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c24582f0-9fc6-4699-829b-f61b228a225c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_10401052-f6b0-4974-b764-76d0b12bde79_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_26c39f6b-d3df-4270-a221-ab185482020d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_eedc62d2-72da-4073-9d47-1f060977a310_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e2743bd6-2125-4e21-93c3-32dfd00dc98d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_db735146-cd2c-4f26-9a02-8d998626856a_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and employee-related costs, net</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_77665cd9-6128-4884-9717-a23980dda81e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e54ce9ac-6b30-40d2-881c-32d2a4bb612c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_7e689436-df58-4c10-8fad-4d978a4340ba_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_5d81a8bc-8ec5-4c56-9fc6-7869d7c2f5c9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Cash Flow and Other Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_bcab4407-231e-4b7f-bcf7-61469e241a8a_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_fff23c6b-4399-4606-a756-3cd0e2544b34_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss), demographic and assumption changes</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_503b94ac-7728-4801-add5-4c11191cf80f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_HazardousSubstanceSites_168922e9-aa9d-4af3-bcad-55499572c799_terseLabel_en-US" xlink:label="lab_mck_HazardousSubstanceSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hazardous substance sites</link:label>
    <link:label id="lab_mck_HazardousSubstanceSites_label_en-US" xlink:label="lab_mck_HazardousSubstanceSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hazardous substance sites</link:label>
    <link:label id="lab_mck_HazardousSubstanceSites_documentation_en-US" xlink:label="lab_mck_HazardousSubstanceSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites that hazardous substances were allegedly disposed at.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSites" xlink:href="mck-20230331.xsd#mck_HazardousSubstanceSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_HazardousSubstanceSites" xlink:to="lab_mck_HazardousSubstanceSites" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfCasesDismissed_20ed4fa3-7d3f-4b49-ab5e-5f18d367c8a6_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of cases dismissed</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfCasesDismissed_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases Dismissed</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfCasesDismissed_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfCasesDismissed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases Dismissed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCasesDismissed" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfCasesDismissed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfCasesDismissed" xlink:to="lab_mck_LossContingencyNumberOfCasesDismissed" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_a4198a17-d67a-4d45-aa13-1221e4f0d8a8_terseLabel_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes due August 15, 2026</link:label>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_label_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes Due August 15, 2026 [Member]</link:label>
    <link:label id="lab_mck_A130NotesDueAugust152026Member_documentation_en-US" xlink:label="lab_mck_A130NotesDueAugust152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes Due August 15, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member" xlink:href="mck-20230331.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A130NotesDueAugust152026Member" xlink:to="lab_mck_A130NotesDueAugust152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_efc4eb7e-341e-427a-b31c-1581b0f23b09_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_bf04ce0e-1762-40ee-a8c9-6d962a946fd7_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility)</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_b50811dd-d323-4508-9538-5a12123be22d_negatedLabel_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net discrete tax benefit</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_label_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:label id="lab_mck_IncomeTaxExpenseBenefitDiscreteItems_documentation_en-US" xlink:label="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Discrete Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:href="mck-20230331.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:to="lab_mck_IncomeTaxExpenseBenefitDiscreteItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5ac28e96-1e01-4f90-9f94-39341a4a913d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_081207b5-d7f9-4b31-9c15-879da6b1052b_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable net assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EnvironmentalLitigationMember_7bc0b00a-de08-4769-b27b-c39dc30df33c_terseLabel_en-US" xlink:label="lab_mck_EnvironmentalLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Litigation</link:label>
    <link:label id="lab_mck_EnvironmentalLitigationMember_label_en-US" xlink:label="lab_mck_EnvironmentalLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Litigation [Member]</link:label>
    <link:label id="lab_mck_EnvironmentalLitigationMember_documentation_en-US" xlink:label="lab_mck_EnvironmentalLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLitigationMember" xlink:href="mck-20230331.xsd#mck_EnvironmentalLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EnvironmentalLitigationMember" xlink:to="lab_mck_EnvironmentalLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_4cc11673-6559-42b2-9d0c-2439ea33242d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_b02d2767-a0ac-4e61-a10f-ed6ea47361c8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts of plan exceeding total plan contribution</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_a121a58a-38da-48cc-85ee-70380cda2f69_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit), before any tax effect, related to accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_bdcc02cd-801a-41c6-a864-bcb3d011b97a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_0a782843-7455-47ea-b335-48be3808972b_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_38098cb8-5b8e-4a45-b743-3b8cd243ab76_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_f1e54911-f0ef-4041-940b-ba2a9fdb7b33_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_4d524c89-aef4-40bd-8adc-e058fc99d553_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_b2afdb01-5a9c-4439-a57e-76932b3ae3da_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_c45031ee-eae6-4a7f-8f93-5e08c1f0b1f3_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_af27ccc3-4058-4311-8431-f523fe3d9186_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a6c6fa8f-2157-45e7-a08c-4e9d3f393041_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_4886a8d8-46ba-4e04-a464-24488fd071d6_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_c9dbad8e-5cd9-4a29-b236-4ebd8da2ed49_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_a7c88854-e7f0-42fa-b234-4a905711cdea_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_ad6f32b2-e435-4fc9-92e2-9cafad80426f_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost on projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_889b3074-a2ec-4266-a269-2d065541d33f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_04aad6a6-0852-4a4b-840e-72029f1d5a5b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_c43dda90-d246-4b86-8f80-f08cb467ad96_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_0bb8c3ab-acbc-467b-8d18-1210c8092b12_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable assets acquired and liabilities assumed:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_6ce49238-cabc-4df7-8cd5-21b6ab30dd56_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_64964ff2-6a01-46cf-bb42-e57b29bbcb52_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_660c1a38-df12-493e-98f2-87a6b18cb9ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of income tax expense (benefit) related to continuing operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_f02a5f6e-586a-4c48-8671-3ac5aeaaca22_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_95a2360d-3c30-44a0-98af-1ba1584f1bc5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ad392878-cff6-45f7-931f-31911257970a_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period in years over which stock option compensation cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_2b230840-9a9c-4c61-8af3-680072bd9ca2_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_6dd2b00c-7d30-47ce-8554-b9e94e1ea659_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ec65ea9f-ce9f-412e-aefe-bf8f98b31319_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_66dee93c-fef5-49b5-873d-77fcf80d1ea5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_40b79edc-3f96-4375-96c6-858bf0b284f0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_710af189-6a22-4684-a894-59f69a060c11_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payment to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_2fd8232a-9e6f-4c58-80b5-6318636bce7b_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_42ba3300-0ada-4a69-a64b-2af7c8e3bb35_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_09c4e617-5b78-4bfd-8a29-33cad1f08a2d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_96ef667d-f0a0-44dc-8a63-63d7a93c0195_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_22fab057-4c19-4747-8a0d-fb006643a2bd_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_0c7309a8-d90f-41a9-8d60-e558d02fd101_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_7c82c529-f167-4700-9eab-bfcb8d09b56d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, repurchased face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c65f6ffd-39ba-4ca4-b9dc-1abf16e98ae9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TenderOfferNotesMember_94ed4685-c91c-48d5-bf3d-f8989bbd3982_terseLabel_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes</link:label>
    <link:label id="lab_mck_TenderOfferNotesMember_label_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes [Member]</link:label>
    <link:label id="lab_mck_TenderOfferNotesMember_documentation_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember" xlink:href="mck-20230331.xsd#mck_TenderOfferNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TenderOfferNotesMember" xlink:to="lab_mck_TenderOfferNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_e0e98589-56c2-42e1-bd7c-0a16be0e4a05_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices upper limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_dafeeb1d-a47b-40bc-b59b-2e6b90c441f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5d1f07b0-95c7-4efc-b0a3-9b4a60f9b53a_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_942f16ec-0b6e-4804-9b92-c6be800c5b49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_bfe9481a-351b-425e-8d39-8366460aa9df_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to purchase shares of McKesson Europe</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_f16b937a-36df-4bf8-9ab1-2cb7bce7e909_terseLabel_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes due December 3, 2025</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_label_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025 [Member]</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_documentation_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member" xlink:href="mck-20230331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A090NotesDueDecember32025Member" xlink:to="lab_mck_A090NotesDueDecember32025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_4278e154-e9af-409e-af1f-e02216388c86_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_af99e986-6478-44d9-ae60-ab1228d2a9e6_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity commingled funds</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f3539a2e-b3f0-4f50-9a1e-7b1f7712f606_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f2da141-8f64-419f-9de1-fd885e433d32_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bb321099-cbc0-4cb1-b1f6-3ce834a26cfe_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_85f50192-62d6-4021-befb-7c4131fb64e8_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_d723c2dc-16ce-4e4e-9ea6-87d0084c621e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_ba07d0df-fccf-47df-a53e-30a1a2a93f78_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_aa348fb8-ecf8-47e3-895d-1af217ec078c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_45b90878-5a86-4400-ba6d-57d33869f1cc_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d964b7f2-f020-4dd1-9767-685862d708c1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_7e5f3278-af5e-4924-8017-9b535452f938_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down charges</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_280a958d-8387-4a60-abed-b5083a81c528_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_4adb6e47-d5d4-4e42-a94f-7ba1508e2ff2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on net investment hedges, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsCustomersDebtMember_491ade9d-1e9c-4398-9154-042084aa85a8_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Customers Debt</link:label>
    <link:label id="lab_mck_GuaranteeObligationsCustomersDebtMember_label_en-US" xlink:label="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Customers Debt [Member]</link:label>
    <link:label id="lab_mck_GuaranteeObligationsCustomersDebtMember_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Customers Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsCustomersDebtMember" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsCustomersDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsCustomersDebtMember" xlink:to="lab_mck_GuaranteeObligationsCustomersDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_88f3ed6c-f14c-4ffb-b5ea-296b1ed7ff93_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82350abc-1372-4fc5-a7ff-7f85093a5d4c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9c080df5-f5e5-4394-a030-ec7335359077_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_029da3ca-ffeb-4672-be3e-805424ebb6ae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e9a59038-3f8c-4738-8a90-f85cac5b5569_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_325c6c48-4c8c-40b1-99cb-39b4bdf8d30b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_cbf7a998-6eeb-41de-b4f9-e358b58df7c2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Price Paid Per Share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1725a217-2c32-4838-9f7d-035fa144aa37_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_c6b14a37-332e-4859-b260-e14560f9d3f5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Life (Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_416ca8f5-46af-49c9-b56e-47a7697fb773_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearThree_e8adde39-a116-48e3-878b-ebd88b875043_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2026</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearThree" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_334b9bc8-ee33-43ca-b159-086ec6394783_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_cf5731e5-1b37-43af-9703-218612974733_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_3b42f79c-6a32-4ee2-81db-5ed38b971e1e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c2997d53-61a9-43c1-b0db-92747b719388_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0f117725-b6ad-44f8-b57d-8b1e02746d9b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) rates (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_766a695c-bc4e-45b9-95bf-d1d0c1a10974_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount borrowed under facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_19bb8009-28f3-4a74-9044-a4116f539281_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_c6700641-d794-4da4-8ace-ec00c5b29b78_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected contributions in next fiscal year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_2fb29c46-3ca0-43f9-af80-cd73b4241044_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_0fcf3955-9ca8-48c7-b79b-dc1fe4dd8656_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_478041a5-df27-48f1-bbd5-2e51053ebd8a_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseMember" xlink:to="lab_mck_AcceleratedShareRepurchaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_4870b515-21a6-487c-9ada-27aa581b08a4_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e5555a41-53ba-41dc-92fe-f55c27eee514_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_631a4579-7aa4-4014-ac05-51891be48d54_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_7a7fc0f1-ee2d-4c1a-9d91-aa177dd1fcc5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total consolidated revenues (percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_8d9ec981-6acb-429c-ad69-10766840d098_terseLabel_en-US" xlink:label="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange rate fluctuations</link:label>
    <link:label id="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_label_en-US" xlink:label="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation</link:label>
    <link:label id="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:href="mck-20230331.xsd#mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:to="lab_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_82e34e30-e747-4321-820c-206bdabb08e7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_054a7ea6-3a63-4a22-9b33-605e98134ab0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from related parties</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_cea56c1f-46ab-40ad-b963-596eead3457d_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sales of businesses and investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_c01aecef-fdb9-416d-9795-ae2b956150a3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_bf1a821a-618f-46c3-b28d-7c00220a8e65_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d1971bd5-541e-4fe0-8e39-1c5c06ef006d_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SupplierReservesPolicyTextBlock_4118b693-de1c-4680-b196-a4cb5a85cb79_terseLabel_en-US" xlink:label="lab_mck_SupplierReservesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Reserves</link:label>
    <link:label id="lab_mck_SupplierReservesPolicyTextBlock_label_en-US" xlink:label="lab_mck_SupplierReservesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Reserves [Policy Text Block]</link:label>
    <link:label id="lab_mck_SupplierReservesPolicyTextBlock_documentation_en-US" xlink:label="lab_mck_SupplierReservesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for reserves against amounts due from suppliers relating to various price and rebate incentives, including deductions or billings taken against payments otherwise due to them. [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierReservesPolicyTextBlock" xlink:href="mck-20230331.xsd#mck_SupplierReservesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SupplierReservesPolicyTextBlock" xlink:to="lab_mck_SupplierReservesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_dadbc601-d5b8-41c9-9c7e-46cc2af67777_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Requisite service period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_4e046302-6cf0-4138-8a47-be9de8019111_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7d733465-7199-4c64-ac86-b79a9620813f_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, current period, before tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3fed5d3b-a2cb-4c0a-b614-ae87d252892a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_89e827f9-ef73-4fa2-b9bc-82a4eb80c4e2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3222745c-e542-4ec8-aba6-d487f48cab95_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_88d3a622-a46e-4173-a711-23c779759c50_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_51b8eff7-2737-4f2d-971a-e6e937a64449_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_7f5f2925-8838-4092-9743-b9eda6ed0ca7_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SCRIOncologyLLCMember_c4671afb-c477-4625-81da-402af78eca97_terseLabel_en-US" xlink:label="lab_mck_SCRIOncologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCRI Oncology, LLC</link:label>
    <link:label id="lab_mck_SCRIOncologyLLCMember_label_en-US" xlink:label="lab_mck_SCRIOncologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCRI Oncology, LLC [Member]</link:label>
    <link:label id="lab_mck_SCRIOncologyLLCMember_documentation_en-US" xlink:label="lab_mck_SCRIOncologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCRI Oncology, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SCRIOncologyLLCMember" xlink:href="mck-20230331.xsd#mck_SCRIOncologyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SCRIOncologyLLCMember" xlink:to="lab_mck_SCRIOncologyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_4d856b0a-f6ef-48f9-a46f-0a57e2b10a87_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_17a916ed-fc03-4988-9af8-20e4cb1e8ca6_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_665986bd-a64d-494f-b382-8ae8ea232dc3_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_c2028d17-49fc-44d6-86a8-71d4d00c9955_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_493f0f1d-8ef7-41cb-9152-08ed5a7b5121_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2028</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_a7a6ce74-0494-40c5-a816-5955d10e6017_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_4d812480-5786-40fb-ad75-aeef947e42b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount_6366afa2-d878-4efb-877e-cb1167ae9bf4_negatedTerseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax benefits related to statute of limitation expirations and tax settlements</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Lapse Of Applicable Statute Of Limitations And Tax Settlement, Amount</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Lapse Of Applicable Statute Of Limitations And Tax Settlement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fb8bef01-06ac-4efa-a54d-1caf566e138f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_34dec1f4-1124-4490-8778-4612a26f3812_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_91f3e73d-64a3-4931-9c6c-6ddff11ef2bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_16bbf26e-c274-482f-a88f-f0a3707a0bc1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_57dbd185-68b9-4f42-b512-d8b082a5c247_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt, thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_9aba0434-d719-4973-8d6a-58046daa4ff1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_c7d5e501-8d8c-4929-b7aa-0be0840048bf_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_mck_LeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_923fa774-e9fc-4705-8ce3-58146779a8f6_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_9ee145a0-d0e6-4666-919d-cc31e67910eb_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_e259331e-7cb2-4668-8cbe-a851c95b82f0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal option increments for leases (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_46685588-9505-458f-add5-097dfba729ab_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_715f5518-4ac1-4986-85cf-aa0645ea8d03_totalLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_7605d1e7-c5c5-4e29-8fdc-6e3079fddc60_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PerformancebasedStockUnitsMember_f851553f-ba33-48f3-a580-75101c17aeab_terseLabel_en-US" xlink:label="lab_mck_PerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSUs</link:label>
    <link:label id="lab_mck_PerformancebasedStockUnitsMember_label_en-US" xlink:label="lab_mck_PerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-based Stock Units [Member]</link:label>
    <link:label id="lab_mck_PerformancebasedStockUnitsMember_documentation_en-US" xlink:label="lab_mck_PerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-based Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PerformancebasedStockUnitsMember" xlink:href="mck-20230331.xsd#mck_PerformancebasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PerformancebasedStockUnitsMember" xlink:to="lab_mck_PerformancebasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_1b9b9cd0-4bab-4eee-bde7-f1b1b4d335d3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SecondPartOfPayContributionMember_95beec74-0a46-47cf-8e71-b3bf15fe96c2_terseLabel_en-US" xlink:label="lab_mck_SecondPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Part Of Pay Contribution</link:label>
    <link:label id="lab_mck_SecondPartOfPayContributionMember_label_en-US" xlink:label="lab_mck_SecondPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Part Of Pay Contribution [Member]</link:label>
    <link:label id="lab_mck_SecondPartOfPayContributionMember_documentation_en-US" xlink:label="lab_mck_SecondPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Part Of Pay Contribution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecondPartOfPayContributionMember" xlink:href="mck-20230331.xsd#mck_SecondPartOfPayContributionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SecondPartOfPayContributionMember" xlink:to="lab_mck_SecondPartOfPayContributionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_791bdfa5-371c-42f5-a283-2e3842a06df0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of market price deduction for share purchases</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_fd6f9a6a-d478-45bf-ad09-d84a1f85d8f2_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_e7471649-cf35-4000-b0a2-413f73fae093_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_0769ba1b-a337-4b8b-a3ec-94028ad72507_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_62b0063e-f457-4070-ae18-30d787b36125_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_706a1ebf-4a12-4c85-b951-03baba1c4a1c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_23ee031f-8163-4eed-81af-f8ef30937509_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_2687e8e2-6b71-453c-840b-b44287b78301_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Balances and Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_50f134df-2707-495b-a7d6-41a755c1772d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_6834bce6-9077-47e7-b6a4-19cfc9f61767_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_6e72a731-ba0e-4e55-8170-dbab12dd2b99_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. Plans</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RxSavingsSolutionsLLCMember_d3259fbf-13ee-4974-95fb-ac54cc10cf6d_terseLabel_en-US" xlink:label="lab_mck_RxSavingsSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rx Savings Solutions, LLC</link:label>
    <link:label id="lab_mck_RxSavingsSolutionsLLCMember_label_en-US" xlink:label="lab_mck_RxSavingsSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rx Savings Solutions, LLC [Member]</link:label>
    <link:label id="lab_mck_RxSavingsSolutionsLLCMember_documentation_en-US" xlink:label="lab_mck_RxSavingsSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rx Savings Solutions, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxSavingsSolutionsLLCMember" xlink:href="mck-20230331.xsd#mck_RxSavingsSolutionsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RxSavingsSolutionsLLCMember" xlink:to="lab_mck_RxSavingsSolutionsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_8451b023-1c8f-4fb9-bcd8-566c6bc2fe3b_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_b5b7537d-103d-4e10-a2a3-62b6db003f97_terseLabel_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes due March 1, 2041</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_label_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041 [Member]</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_documentation_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member" xlink:href="mck-20230331.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A600NotesDueMarch12041Member" xlink:to="lab_mck_A600NotesDueMarch12041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6e3d96ff-b3aa-4973-9a97-792650ca6e0d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_88cecc3a-25fe-4523-9054-f5ac55397abd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_ee6a62ce-505d-47bc-8614-cfc76faf80b9_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_b02c2199-489d-4760-ac21-19daadb3120b_terseLabel_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action</link:label>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_label_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action [Member]</link:label>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_documentation_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember" xlink:href="mck-20230331.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ShareholderDerivativeActionMember" xlink:to="lab_mck_ShareholderDerivativeActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_abd210c8-b150-4635-a33c-6598e61c08da_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration agreed upon for sale of business</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_fa9eb567-def7-4f4e-9a71-27f00c0be2bd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOther_7e28300d-cc17-4862-9c46-f20195913bc2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment, and other</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOther_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Other, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentOther" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9aeb21d4-3194-49cc-a748-bdb4b9f6b085_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_b4138043-f381-4111-aa2e-81765f8dbe3e_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total plan contribution - exceeding (percent)</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:to="lab_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CAD_49399b54-ec68-49a3-b6c7-6f8863d5fca3_terseLabel_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAD</link:label>
    <link:label id="lab_currency_CAD_label_en-US" xlink:label="lab_currency_CAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CAD" xlink:to="lab_currency_CAD" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1.625NotesDue2026Member_47b97185-b45c-4e57-a280-d52f34bbdc91_terseLabel_en-US" xlink:label="lab_mck_A1.625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes due 2026</link:label>
    <link:label id="lab_mck_A1.625NotesDue2026Member_label_en-US" xlink:label="lab_mck_A1.625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_mck_A1.625NotesDue2026Member_documentation_en-US" xlink:label="lab_mck_A1.625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.625NotesDue2026Member" xlink:href="mck-20230331.xsd#mck_A1.625NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1.625NotesDue2026Member" xlink:to="lab_mck_A1.625NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_f727147c-055c-45fc-a5aa-e76314e302f4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AustrianBusinessOperationsMember_6db816aa-bf51-4450-8832-d6f8cfe15f7f_terseLabel_en-US" xlink:label="lab_mck_AustrianBusinessOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austrian Business Operations</link:label>
    <link:label id="lab_mck_AustrianBusinessOperationsMember_label_en-US" xlink:label="lab_mck_AustrianBusinessOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austrian Business Operations [Member]</link:label>
    <link:label id="lab_mck_AustrianBusinessOperationsMember_documentation_en-US" xlink:label="lab_mck_AustrianBusinessOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Austrian Business Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember" xlink:href="mck-20230331.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AustrianBusinessOperationsMember" xlink:to="lab_mck_AustrianBusinessOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_b4e6fdbf-0138-4c5a-9dba-cd209d81d86a_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_863f56d1-a749-49d1-a0e6-2c628cd0d66e_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_38e83e72-b245-4605-9681-bfbfe404ab60_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, current period, before tax, attributable to parent</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofFormerOfficers_2616f44d-69c5-47ba-ba40-307a39772980_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofFormerOfficers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of former officers</link:label>
    <link:label id="lab_mck_LossContingencyNumberofFormerOfficers_label_en-US" xlink:label="lab_mck_LossContingencyNumberofFormerOfficers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Former Officers</link:label>
    <link:label id="lab_mck_LossContingencyNumberofFormerOfficers_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofFormerOfficers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Former Officers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofFormerOfficers" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberofFormerOfficers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofFormerOfficers" xlink:to="lab_mck_LossContingencyNumberofFormerOfficers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_e4ffc30e-6e55-48c2-8858-11420a04701d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expenditures for long-lived assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A2022TermLoanCreditFacilityMember_7113a9bd-33be-4d91-8a48-4f1ff15c5cdf_terseLabel_en-US" xlink:label="lab_mck_A2022TermLoanCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Term Loan Credit Facility</link:label>
    <link:label id="lab_mck_A2022TermLoanCreditFacilityMember_label_en-US" xlink:label="lab_mck_A2022TermLoanCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Term Loan Credit Facility [Member]</link:label>
    <link:label id="lab_mck_A2022TermLoanCreditFacilityMember_documentation_en-US" xlink:label="lab_mck_A2022TermLoanCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Term Loan Credit Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2022TermLoanCreditFacilityMember" xlink:href="mck-20230331.xsd#mck_A2022TermLoanCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A2022TermLoanCreditFacilityMember" xlink:to="lab_mck_A2022TermLoanCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_099f6184-736f-4263-9cf7-0ebc9c45ecec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_43b13cb1-0839-4717-8210-6a35ab31e9bc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock_940ab3f4-95d9-47db-a2d8-291613dced7d_terseLabel_en-US" xlink:label="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental balance sheet information</link:label>
    <link:label id="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="mck-20230331.xsd#mck_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_mck_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_64a07b35-0111-47e7-a6a2-46b1f0e0b2f6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearOne_a5a9658b-d475-4530-9325-427806d416d9_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2024</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearOne_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year One</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearOne_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_9e85ad80-c1a0-4e89-8072-36f965767db3_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_4aae4ab9-a76a-49da-a71a-3343898cab81_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_label_en-US" xlink:label="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_documentation_en-US" xlink:label="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:href="mck-20230331.xsd#mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:to="lab_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_355cc54e-1fab-42ab-b714-01f425429685_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_a79cd692-8c07-49df-879a-dd8cbea83d12_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_4378e272-5d0f-410b-ae09-eecbd4a5cf32_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_3db51f1a-4601-4560-876e-542e65f05f35_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cities filed on behalf of</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cities Filed On Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfCitiesFiledOnBehalfOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:to="lab_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_c0f97fe9-64f2-4b27-a595-ea5c33310f1f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:to="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_66524627-d837-4ea3-9827-f7fcc51e837b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6fa93b1c-379f-4ca2-9499-5f4f7fbb160b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_ec3b2b8c-db28-430e-90e6-e672bc126879_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_4e3568e8-7c04-4c78-8627-0025b3f38119_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses_952fc3af-150a-411f-ab89-07efe6854d08_terseLabel_en-US" xlink:label="lab_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains on investments in equity securities</link:label>
    <link:label id="lab_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses_label_en-US" xlink:label="lab_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss), Excluding Impairment Losses</link:label>
    <link:label id="lab_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses_documentation_en-US" xlink:label="lab_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss), Excluding Impairment Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses" xlink:href="mck-20230331.xsd#mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses" xlink:to="lab_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RxTsSegmentMember_39c8df14-6637-45d6-b6d2-f5f0cf4e4f23_terseLabel_en-US" xlink:label="lab_mck_RxTsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RxTs Segment</link:label>
    <link:label id="lab_mck_RxTsSegmentMember_label_en-US" xlink:label="lab_mck_RxTsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RxTs Segment [Member]</link:label>
    <link:label id="lab_mck_RxTsSegmentMember_documentation_en-US" xlink:label="lab_mck_RxTsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RxTs Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxTsSegmentMember" xlink:href="mck-20230331.xsd#mck_RxTsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RxTsSegmentMember" xlink:to="lab_mck_RxTsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_a7d61c29-73cf-49f1-bf1f-19a31b9c7523_terseLabel_en-US" xlink:label="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assumptions used to estimate fair value of PSUs</link:label>
    <link:label id="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:href="mck-20230331.xsd#mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5de9d573-d03a-4201-814a-72ad9cdffd15_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_af0c5ea2-dbe5-4f84-b129-9fb037998f9f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_652c9e84-bdf3-4119-af9b-3e57af71a068_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_29c5bfc2-4d46-4db0-bd49-8e66dddd5895_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_ea0dec08-0d70-4c6c-a3bb-324af2de562e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_a5641c07-ee6f-480a-9033-be2e4c8d9b7d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_dd7cdda9-d8b6-4a95-b16e-c0eaf61b3808_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17505ca8-c2ee-4d87-822e-255005780d59_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized_aa8a231d-4c28-4cf6-a7e2-e86401992716_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, including discontinued operations, pension plan obligation derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Obligation Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Obligation Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_6440a91b-88b1-440a-b082-3b18bce110f1_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_385bb031-a34f-48ba-95e3-40c5d8618237_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_d9116b3c-c4a7-48c5-931f-17e68c411edf_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_3e4211f8-6fba-4eae-add5-06f3f060c48a_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right (in euro per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f23cd97f-b850-4f64-82b1-6a3d8a2d09ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_e39db2c6-e99c-44ec-8143-32903b38eed4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_2198f89e-11d1-4786-affd-cc0694b93500_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest_92812818-b454-496c-9b3b-0c80015ff317_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divested carrying value of noncontrolling interest held by minority shareholders</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Carrying Value Of Noncontrolling Interest</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Carrying Value Of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_814af15a-3779-42f5-a030-f14d23a5985f_terseLabel_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Software Held for Internal Use</link:label>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_label_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalUseSoftwarePolicy" xlink:to="lab_us-gaap_InternalUseSoftwarePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_99a7b1e2-daff-4b82-b894-b55fa0ed3467_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_f804d24a-f647-49f0-aa12-e12551f45a64_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_3de0c5b5-f624-4f8f-bb3d-8a8b0037478d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_5162c040-1b5e-40e7-b999-60f75c537b6e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value, 800 shares authorized, 277 and 275 shares issued at March 31, 2023 and 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_a53c4ae4-b5fa-451a-8ee5-70f281902380_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_ac0ff90f-d2ee-4fa8-bb5e-08029fdb6c4e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_19488770-0dad-4c5b-b70c-8fad31e4e57b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_72d08c02-6334-4b4b-9428-8ac0ef27c6e4_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:href="mck-20230331.xsd#mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpensePolicyTextBlock_2864e6c7-22f6-4bcb-8131-27e7ce44ea09_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpensePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestExpensePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpensePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpensePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpensePolicyTextBlock" xlink:to="lab_us-gaap_InterestExpensePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_cf68784a-c90b-46c3-af82-d6742050b0f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_1530f86b-a737-49d7-a85b-450794151fb5_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to Other Accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_477e84aa-fea3-4afd-bb28-87b0d8cad019_terseLabel_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_label_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:href="mck-20230331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:to="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_b9251bf5-7e27-4620-900b-736606817bfa_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_53a4f02c-1380-42c6-b3f2-c380219eea69_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_716ef4eb-eabb-4903-858f-8c2ac2bef9ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_c322de4e-c9ae-4edb-a8d4-c65aea4dd3a7_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931</link:label>
    <link:label id="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_label_en-US" xlink:label="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_documentation_en-US" xlink:label="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:href="mck-20230331.xsd#mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:to="lab_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfAlabamaAndSubdivisionsMember_70455bc9-cd84-4345-bf67-f7e652dae1ba_terseLabel_en-US" xlink:label="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Alabama and Subdivisions</link:label>
    <link:label id="lab_mck_StateOfAlabamaAndSubdivisionsMember_label_en-US" xlink:label="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Alabama and Subdivisions [Member]</link:label>
    <link:label id="lab_mck_StateOfAlabamaAndSubdivisionsMember_documentation_en-US" xlink:label="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of Alabama and Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaAndSubdivisionsMember" xlink:href="mck-20230331.xsd#mck_StateOfAlabamaAndSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfAlabamaAndSubdivisionsMember" xlink:to="lab_mck_StateOfAlabamaAndSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_a7b57433-02b5-487c-a886-292f79028104_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_6410deea-a049-43ae-9347-59593aaf02c1_terseLabel_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens Boots Alliance Joint Venture</link:label>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_label_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens Boots Alliance Joint Venture [Member]</link:label>
    <link:label id="lab_mck_WalgreensBootsAllianceJointVentureMember_documentation_en-US" xlink:label="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Walgreens Boots Alliance Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember" xlink:href="mck-20230331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_WalgreensBootsAllianceJointVentureMember" xlink:to="lab_mck_WalgreensBootsAllianceJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_37a45ab9-cc3f-4711-9e3a-e73125acdb68_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d56e5d48-f270-4a59-a6b3-7b818e653235_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_7536c4b6-3548-4fc4-9f5a-ed6b59172645_terseLabel_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_label_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:label id="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_documentation_en-US" xlink:label="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:href="mck-20230331.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:to="lab_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_a9847fca-5730-452d-a451-aa296aefa062_terseLabel_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures due March 1, 2027</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_label_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027 [Member]</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_documentation_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member" xlink:href="mck-20230331.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A765DebenturesDueMarch12027Member" xlink:to="lab_mck_A765DebenturesDueMarch12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e11be613-b6dd-499c-8791-820776cce764_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_419b8927-342e-4fbd-a005-ae543bd5f6b6_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_36098a8d-0f2b-4228-bfa5-2c1d6c6f3218_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:to="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_75bd742d-de4d-47c2-902e-ec5872a69dd9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SupplierIncentivesPolicyPolicyTextBlock_98b43f0f-4ef8-40e3-aa7f-5b4a41e79597_terseLabel_en-US" xlink:label="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Incentives</link:label>
    <link:label id="lab_mck_SupplierIncentivesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Incentives, Policy [Policy Text Block]</link:label>
    <link:label id="lab_mck_SupplierIncentivesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Incentives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:href="mck-20230331.xsd#mck_SupplierIncentivesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:to="lab_mck_SupplierIncentivesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_8c9c7bfb-8f97-4f97-aa96-0bd30766dd46_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_c405bff4-8c4a-4ef2-bbde-7f2f0601d0d5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received upon exercise</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_5695be9b-4222-48a9-8bcb-b48a50ebb925_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DeferredTaxAssetLitigationAndClaims_9d144fe1-9d12-4daf-a30e-1875f9dc725a_terseLabel_en-US" xlink:label="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid-related litigation and claims</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLitigationAndClaims_label_en-US" xlink:label="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Litigation and Claims</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLitigationAndClaims_documentation_en-US" xlink:label="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Litigation and Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLitigationAndClaims" xlink:href="mck-20230331.xsd#mck_DeferredTaxAssetLitigationAndClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DeferredTaxAssetLitigationAndClaims" xlink:to="lab_mck_DeferredTaxAssetLitigationAndClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_e0b5e4e7-fcc3-4fae-b12b-8799e0f531b0_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross purchase price</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_bcea9de3-fea9-496d-8062-69f0737ee29e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5859efb8-1f97-4ea4-84a9-904307396647_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company match employee contributions (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_058ef1f9-065d-48fb-ada0-ea9b119ef925_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b17b6484-89b9-4820-abb3-5820387d0258_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9d745717-9978-4972-81f7-852908fc1906_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_703f9258-e078-42cc-9d99-7de16b14687d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_b816c7e2-1d53-49ed-ba52-ba2faaff3d1b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_b0119ab0-d9f1-4e72-9688-cafd2108556c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_1f9a4dce-f185-435b-96fb-870f48480ad2_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_947f9104-dc75-428b-889d-3ff0da2a9790_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_dcb813f8-ba05-4630-bb92-8f2aa508a69c_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of faxes received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesReceived_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:href="mck-20230331.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_46c5074d-d6a9-4d05-bebe-0874dd0079b7_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_82b45f6d-21f8-47cc-8f13-8baddc2222b3_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_f2e7763c-e03e-4fd7-a3c8-6d50683b1465_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_c64e8df5-1da5-438e-93f2-ee50546a456d_terseLabel_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opiate Litigation</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_3a433367-72d9-49c1-8769-79b4ff684201_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_71e177fa-9ea6-4b9f-a02f-807cc3819529_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other changes in plan assets and benefit obligations recognized in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ac800327-2259-48df-bfe1-40c2eb941685_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_41259336-a959-47c2-b833-44922e51f3ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7fcda0cb-77a1-42a2-9188-b75187dc5a8f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MultiemployerPlansWithdrawalObligation_0360cc06-5deb-45c1-a1be-56a6f8dca12f_terseLabel_en-US" xlink:label="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts accrued for liability</link:label>
    <link:label id="lab_us-gaap_MultiemployerPlansWithdrawalObligation_label_en-US" xlink:label="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plans, Withdrawal Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:to="lab_us-gaap_MultiemployerPlansWithdrawalObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9c4b29a6-11a5-4496-bb8d-c23d8adc4c69_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a7e87a8b-6ded-48b1-8bf8-f6bea3e83a4c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_30e5984d-5fbd-4d90-936b-189c7e4a5faf_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense for property, plant, and equipment, and amortization of finance leases</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_2e2a3bce-5097-42d7-be1c-50d23e680a31_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of market price for share purchase</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LessorLeasePaymentstobeReceived_da4756a5-b192-4231-854c-25ea005268b7_terseLabel_en-US" xlink:label="lab_mck_LessorLeasePaymentstobeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum sublease income</link:label>
    <link:label id="lab_mck_LessorLeasePaymentstobeReceived_label_en-US" xlink:label="lab_mck_LessorLeasePaymentstobeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Payments to be Received</link:label>
    <link:label id="lab_mck_LessorLeasePaymentstobeReceived_documentation_en-US" xlink:label="lab_mck_LessorLeasePaymentstobeReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorLeasePaymentstobeReceived" xlink:href="mck-20230331.xsd#mck_LessorLeasePaymentstobeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LessorLeasePaymentstobeReceived" xlink:to="lab_mck_LessorLeasePaymentstobeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvesteeMember_f40fce3c-eccd-4361-8af7-01dd5be83a08_terseLabel_en-US" xlink:label="lab_us-gaap_InvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investee</link:label>
    <link:label id="lab_us-gaap_InvesteeMember_label_en-US" xlink:label="lab_us-gaap_InvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvesteeMember" xlink:to="lab_us-gaap_InvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2e220d41-b7e2-4cd5-9636-ff2260790d3b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, after 2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_188f9d02-4590-4f4c-9142-7e1b5324f0a3_terseLabel_en-US" xlink:label="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical and Specialty Solutions</link:label>
    <link:label id="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_label_en-US" xlink:label="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical and Specialty Solutions [Member]</link:label>
    <link:label id="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_documentation_en-US" xlink:label="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical and Specialty Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:href="mck-20230331.xsd#mck_U.S.PharmaceuticalandSpecialtySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:to="lab_mck_U.S.PharmaceuticalandSpecialtySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseandOtherObligationsMember_bd614e10-59da-4e24-8598-b40b3d5cf39f_terseLabel_en-US" xlink:label="lab_mck_LeaseandOtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and other obligations</link:label>
    <link:label id="lab_mck_LeaseandOtherObligationsMember_label_en-US" xlink:label="lab_mck_LeaseandOtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and Other Obligations [Member]</link:label>
    <link:label id="lab_mck_LeaseandOtherObligationsMember_documentation_en-US" xlink:label="lab_mck_LeaseandOtherObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and Other Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseandOtherObligationsMember" xlink:href="mck-20230331.xsd#mck_LeaseandOtherObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseandOtherObligationsMember" xlink:to="lab_mck_LeaseandOtherObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_1ea74b76-1239-4647-92d8-99e36a1546cf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_9dbba7c1-4282-41fe-bb12-c83b494ed445_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_05b07930-a07c-4dbc-8048-c4ee001efd25_negatedTerseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of assets of businesses held for sale to fair value less costs to sell</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:href="mck-20230331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_5c64c402-8f27-4c0e-9f59-3460b373a310_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Accrual Liability</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Contingencies by Contingency [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:to="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_33dbd3e5-9d57-4e64-96ae-040242755c04_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired identifiable intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_af801cfd-2338-4fd7-9fcd-c2e206e976cf_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_75b02874-67e8-48ef-bb29-567acff8a37f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_1299ffed-9acd-4068-b38f-c21dd74f2545_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_cd9f4bfe-0030-418e-96fe-fd1ed7fe4fb8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_5f402b99-fa40-479b-9a88-063b0f84b103_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_af01dae8-5008-4406-8ed7-adf729a7bcb5_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retired and redeemed outstanding principal amount</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_82a9e299-5d86-4fe6-a3d3-46d944dc07a0_terseLabel_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_label_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_documentation_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:href="mck-20230331.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:to="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5142babc-f513-46fb-a127-ed14a5a20410_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_944f1101-3c35-4d9c-bb01-cf49048c6a54_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_9787f04b-1ba7-4752-a11e-220eebba33a1_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ffda2489-2f8d-466e-b435-8a13e4c0a5eb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0ce06eb9-11e0-4568-b44c-f1db666ed24f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected stock price volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_79f87a6c-42a9-4894-bd50-9e687264d46f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, Net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_8b3b79dd-64af-4ee5-97fe-546bf0f2088a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase for Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_193cc54f-c983-4b27-81be-d940a991b534_terseLabel_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes due October 30, 2026</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_label_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026 [Member]</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_documentation_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member" xlink:href="mck-20230331.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A163EuroNotesDueOctober302026Member" xlink:to="lab_mck_A163EuroNotesDueOctober302026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_646be38f-5dd9-4281-8662-ae74f72575a0_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, including discontinued operations, pension plan assets derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_89ea0e04-11d9-4e50-9593-1f0ed7369d64_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_a98f3c37-efe1-419c-8ea6-225f0ab4c863_terseLabel_en-US" xlink:label="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs and PSUs</link:label>
    <link:label id="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_label_en-US" xlink:label="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance-based Stock Units [Member]</link:label>
    <link:label id="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_documentation_en-US" xlink:label="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance-based Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:href="mck-20230331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:to="lab_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InterestRateSwapEnteredIntoYTDMember_21ab4464-5cd3-4111-8ac5-0d68c7774b1c_terseLabel_en-US" xlink:label="lab_mck_InterestRateSwapEnteredIntoYTDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Entered Into YTD</link:label>
    <link:label id="lab_mck_InterestRateSwapEnteredIntoYTDMember_label_en-US" xlink:label="lab_mck_InterestRateSwapEnteredIntoYTDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Entered Into YTD [Member]</link:label>
    <link:label id="lab_mck_InterestRateSwapEnteredIntoYTDMember_documentation_en-US" xlink:label="lab_mck_InterestRateSwapEnteredIntoYTDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Entered Into YTD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InterestRateSwapEnteredIntoYTDMember" xlink:href="mck-20230331.xsd#mck_InterestRateSwapEnteredIntoYTDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InterestRateSwapEnteredIntoYTDMember" xlink:to="lab_mck_InterestRateSwapEnteredIntoYTDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_16aad65a-b8d3-42a7-8443-330831eea72e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_44fda8d4-f83a-4efd-bebd-6edb06903884_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGuaranteeObligationsTable_dd653860-7f10-4cf5-9341-088db2cf3e0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Guarantor Obligations [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGuaranteeObligationsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Guarantor Obligations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:to="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4637fc9-b262-4387-a446-cf3b4a6bdbdb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_97f1dd5a-3c82-4f91-ab2c-d289378c912c_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_9ea186f8-3719-45ee-a289-4ccb71e97150_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_11d25761-9b3d-4ec7-a025-4217e9e168ec_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests and Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_b89475d8-33f1-4d1d-ae4d-1f963b36976d_terseLabel_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes due March 15, 2044</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_label_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044 [Member]</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_documentation_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member" xlink:href="mck-20230331.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A488NotesDueMarch152044Member" xlink:to="lab_mck_A488NotesDueMarch152044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_c16e80c7-8119-4b2d-bbe7-92ec73be8ac7_verboseLabel_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested RSUs (in shares)</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_label_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_documentation_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:href="mck-20230331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:to="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_30ac1a0c-eeb3-4881-ad36-ccdcdf6379d9_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_6f668a0c-3abc-4ba8-aa64-3b04e09f1efb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_82279756-e0bc-4df9-bce9-5a34c8a28155_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_9da58264-f640-4f9c-b69c-f7fa88f194de_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_1953f3e1-664f-4c3a-82e2-8588b15f2395_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_153504ec-e293-4eef-bd02-1d06b470b32a_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain (loss) on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_f749e4cc-c0fd-4ee0-9276-918640006182_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gains (losses) on investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_585e22d7-06a6-4d58-b6ab-390e99bd22bf_verboseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated for Hedge Accounting</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_ca4dd088-da2d-4adf-b297-49e9a9c662e8_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated for hedge accounting:</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_a23d9bbe-769c-4854-8761-53a72748cfd7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_6b880141-efc4-472f-b2dd-3672912ca214_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5c06e904-933e-461e-b4a3-ef6a76c05dfd_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_2bbf1e89-d46a-4a14-9c56-e18ad7a428a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net periodic expense for pension plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_c52ac2ad-302c-4a66-be9b-a6abac1f1d2d_terseLabel_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought per violation</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_label_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:label id="lab_mck_LossContingencyDamagesSoughtPerViolationValue_documentation_en-US" xlink:label="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought Per Violation, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:href="mck-20230331.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:to="lab_mck_LossContingencyDamagesSoughtPerViolationValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_bef247c1-d4a6-4d42-8c4f-e75aed1a9762_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_301b1c19-958c-4743-af43-5d29f4d822f6_terseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_label_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:href="mck-20230331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:to="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_7a7b017f-4302-4e2b-8f3d-38c65b8b2ca3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_272180e3-e9d7-4c53-b62f-979cc3533fa3_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_7b1dc1a2-4196-4e89-964a-3cb5cbdb91e4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_a622aa98-3661-4830-8240-97950faae1cd_terseLabel_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes due November 17, 2025</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_label_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025 [Member]</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_documentation_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member" xlink:href="mck-20230331.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A150EuroNotesDueNovember172025Member" xlink:to="lab_mck_A150EuroNotesDueNovember172025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_55cad824-8848-4a11-934b-a6d618301160_terseLabel_en-US" xlink:label="lab_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="mck-20230331.xsd#mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_8a5b965f-b4a5-4d2e-9dd5-169035630893_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_a5d20e39-fc86-4eb7-a17b-8a5c3b9e80c9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0b9824cf-fb5d-4114-8c88-8fbf278a69d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit for share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_db269a9a-2ab3-4511-b145-5890ec0c594d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_5d746855-54b9-4e10-b468-e3acefe930ca_negatedTerseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment/settlement</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment and Settlement</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment and Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9440be06-2af5-4d2c-a122-b98ffbb5aff6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_90c09d5f-4e4e-47a8-a810-661b9b6b9a71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_faea5f5a-fd94-4243-ae5b-b713fea0678c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest (percent)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_6fd8e7ce-7295-4ca9-acbc-9c0dee6798b1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_f68426a7-7189-4d52-82c0-de44e8ecce98_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of weighted-average assumptions used to estimate net periodic pension expense and actuarial present value of benefit obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpenMarketTransactionsMember_d9c8d321-7216-4929-ac1c-58983ce50638_terseLabel_en-US" xlink:label="lab_mck_OpenMarketTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Transactions</link:label>
    <link:label id="lab_mck_OpenMarketTransactionsMember_label_en-US" xlink:label="lab_mck_OpenMarketTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Transactions [Member]</link:label>
    <link:label id="lab_mck_OpenMarketTransactionsMember_documentation_en-US" xlink:label="lab_mck_OpenMarketTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Transactions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketTransactionsMember" xlink:href="mck-20230331.xsd#mck_OpenMarketTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpenMarketTransactionsMember" xlink:to="lab_mck_OpenMarketTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_98d8475f-80a1-45a7-a9cd-de11bc1a3f66_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_beb1ba9f-00bb-4f80-8846-3e403bf13282_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments of Business</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InsuranceCoverageLitigationMember_f31255ab-81dc-4397-ba2b-cca73509c64b_terseLabel_en-US" xlink:label="lab_mck_InsuranceCoverageLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Coverage Litigation</link:label>
    <link:label id="lab_mck_InsuranceCoverageLitigationMember_label_en-US" xlink:label="lab_mck_InsuranceCoverageLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Coverage Litigation [Member]</link:label>
    <link:label id="lab_mck_InsuranceCoverageLitigationMember_documentation_en-US" xlink:label="lab_mck_InsuranceCoverageLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Coverage Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceCoverageLitigationMember" xlink:href="mck-20230331.xsd#mck_InsuranceCoverageLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InsuranceCoverageLitigationMember" xlink:to="lab_mck_InsuranceCoverageLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_a19f4eae-51e1-47c9-9e08-3f555cad0bfa_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss resulting from discount rate changes</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Discount Rate</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_65321d7b-0598-42ff-a0f9-00592a99dbc0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation and other assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_c47b52a8-831d-4d76-b8a4-d817503087d3_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense (benefit), share-based payment arrangement</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_6d686744-6500-4127-b302-d67739125c9d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_113b89d8-9d19-4e2c-bce9-04b05dae57fc_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_28781aa5-6dd7-4034-b018-f5f8934be2b9_terseLabel_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business</link:label>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_label_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business [Member]</link:label>
    <link:label id="lab_mck_GermanWholesaleBusinessMember_documentation_en-US" xlink:label="lab_mck_GermanWholesaleBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember" xlink:href="mck-20230331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanWholesaleBusinessMember" xlink:to="lab_mck_GermanWholesaleBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cd781967-de72-4436-83f9-5fbf9a82fcb1_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND DEFICIT</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_97861dd3-e15e-4ee3-9076-dd345af67a35_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_ea77b46e-4a9a-4486-a9b7-022bcc37a4a8_terseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. disposal transaction loss</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1dccb5c3-155c-4efe-8ee2-e99b3c8eec8e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_2faf9430-c75b-461c-8e9b-8a510cf0a00b_terseLabel_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="mck-20230331.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6f876f62-aaf3-412f-b924-033bcea9278b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate amount expected to be paid</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_3559cb62-ba9f-42f8-9cf2-e9e8fb3ac8a3_terseLabel_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</link:label>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c04427fc-8283-4f1a-b180-b648021c02c2_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8038c745-5dd0-4e25-a185-81fa04ef3828_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_278d6897-6bc6-474b-bf00-6bc3e1181bd1_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_b5390f88-67a6-4508-8dc3-8ee784ade30f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_7738641a-bbc0-4e04-b94d-af165dadb355_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_6bbba604-3b01-41fb-b81f-1ea91bb6a689_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_c0796498-4e8d-49c1-9aba-8ddebd384a95_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_8a816f90-ca18-4ac7-ad1c-6fc81ed868d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_b4b7e1ce-9cca-44cd-80bc-b4b989a22459_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment_45e579ab-5429-46c7-b1c0-e095dda732f1_terseLabel_en-US" xlink:label="lab_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax liability increase due to proposed adjustment to taxable income</link:label>
    <link:label id="lab_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment_label_en-US" xlink:label="lab_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Estimate Of Possible Liability Adjustment</link:label>
    <link:label id="lab_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment_documentation_en-US" xlink:label="lab_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Estimate Of Possible Liability Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment" xlink:href="mck-20230331.xsd#mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment" xlink:to="lab_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8b9f5c92-6284-4044-a552-180bb333030f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_604b89ed-14a7-41e0-8f28-c27e1f78c4fb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_a2e67c6b-3a0a-42c1-8440-0944b2dde0e9_terseLabel_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeNationalPharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three National Pharmaceutical Distributors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:href="mck-20230331.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeNationalPharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DistributionandRetailBusinessMember_fd3c96b7-d7d0-4b5c-a7fe-306c439067b6_terseLabel_en-US" xlink:label="lab_mck_DistributionandRetailBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and Retail Business</link:label>
    <link:label id="lab_mck_DistributionandRetailBusinessMember_label_en-US" xlink:label="lab_mck_DistributionandRetailBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and Retail Business [Member]</link:label>
    <link:label id="lab_mck_DistributionandRetailBusinessMember_documentation_en-US" xlink:label="lab_mck_DistributionandRetailBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and Retail Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributionandRetailBusinessMember" xlink:href="mck-20230331.xsd#mck_DistributionandRetailBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DistributionandRetailBusinessMember" xlink:to="lab_mck_DistributionandRetailBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_a881ff55-9600-4cbe-9b0f-39b35b742cef_terseLabel_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other/Other accrued liabilities</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_label_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_documentation_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember" xlink:href="mck-20230331.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CurrentAssetLiabilityMember" xlink:to="lab_mck_CurrentAssetLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_cac4bf30-1518-4994-9c86-19c3899bacf0_totalLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_4efd6e90-7de6-44e0-83d6-3ccc4aac2104_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MachineryEquipmentAndOtherMember_bc99ea1c-3667-4a26-8ef7-7e46b113a08a_terseLabel_en-US" xlink:label="lab_mck_MachineryEquipmentAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, equipment, and other</link:label>
    <link:label id="lab_mck_MachineryEquipmentAndOtherMember_label_en-US" xlink:label="lab_mck_MachineryEquipmentAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, Equipment, and Other [Member]</link:label>
    <link:label id="lab_mck_MachineryEquipmentAndOtherMember_documentation_en-US" xlink:label="lab_mck_MachineryEquipmentAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery, Equipment, and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MachineryEquipmentAndOtherMember" xlink:href="mck-20230331.xsd#mck_MachineryEquipmentAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MachineryEquipmentAndOtherMember" xlink:to="lab_mck_MachineryEquipmentAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_3c31c442-17d2-4f73-b662-cf133297f73c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest in Joint Venture (percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b4694b87-a659-4907-92bf-85b3ec3591ce_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SecuredOvernightFinancingRateSOFRMember_7b64d38f-2596-476a-9cef-d3a9fbb790f8_terseLabel_en-US" xlink:label="lab_mck_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_mck_SecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_mck_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_mck_SecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_mck_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecuredOvernightFinancingRateSOFRMember" xlink:href="mck-20230331.xsd#mck_SecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SecuredOvernightFinancingRateSOFRMember" xlink:to="lab_mck_SecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusAxis_c525fa3d-a179-4b83-9172-7d6a3467d412_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Funding Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funding Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis" xlink:to="lab_us-gaap_RetirementPlanFundingStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_e069dd40-4c48-42de-91c6-7d38cfac8420_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts of derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_08de4244-240a-439c-938b-56e0c7e1a9bc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_c927adf5-2afb-4cba-8d58-8caacaf0660f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of year included in Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_68934dc1-b7ae-4122-91ed-0694493f8968_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_a5b405ec-f8ca-4d08-829b-3b7e0dcf4d1f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_cfa66f6e-fdce-450d-9fcc-f5cf24aa4127_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_d99e5a07-ea96-4154-914d-6e5d0f648797_terseLabel_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Asset Impairments and Accelerated Depreciation</link:label>
    <link:label id="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_label_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]</link:label>
    <link:label id="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_documentation_en-US" xlink:label="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:href="mck-20230331.xsd#mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:to="lab_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_e3ec1819-40e0-415e-83c6-4a83fc248233_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_fa504bf4-4891-46cd-a815-6a00c1a0e411_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_a7bbf4fd-4c0c-4386-809c-c8e70f8839cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_08489297-a77d-4d05-a71d-28390ef772e4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_0378156c-f5ad-425e-afd7-3e86b6a38d8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options Exercisable at Year End (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_e2065811-9be2-4136-95bb-c277ce3c55dd_negatedTerseLabel_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_label_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_documentation_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:href="mck-20230331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:to="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures_ee061027-2fcb-44e4-801d-63821a4c16eb_terseLabel_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans, net of forfeitures</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures_label_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Plans Net of Forfeitures</link:label>
    <link:label id="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures_documentation_en-US" xlink:label="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Plans Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" xlink:href="mck-20230331.xsd#mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" xlink:to="lab_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofRelators_99b94939-ee46-4877-8181-6059b4c36a54_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofRelators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of relators alleging violations</link:label>
    <link:label id="lab_mck_LossContingencyNumberofRelators_label_en-US" xlink:label="lab_mck_LossContingencyNumberofRelators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Relators</link:label>
    <link:label id="lab_mck_LossContingencyNumberofRelators_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofRelators" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number of Relators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelators" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberofRelators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofRelators" xlink:to="lab_mck_LossContingencyNumberofRelators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6607e918-1599-4763-a16f-68615116d57c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_5b8c85ae-c81c-480b-9ba2-565c70fa5fc3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_3001fa2a-1a19-407a-af13-9bf692a00717_terseLabel_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in dollars per share)</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_label_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1</link:label>
    <link:label id="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_documentation_en-US" xlink:label="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:href="mck-20230331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:to="lab_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_fc5a0600-22a4-4b8e-aad3-70075e8e0f5d_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_96752f1c-e1fa-43cf-b881-e24ecfcb6872_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of share-based compensation expense and related tax benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_240bacf6-20da-499d-b08a-01bb31f546f9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact and other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_9d3cfd63-e486-4620-be15-9e781346dcc3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase consideration:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f1e86b8b-4ae2-4280-ab15-4b17616457f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFour_875fe7c2-3ee7-4802-8ac4-dbc25279567c_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2027</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFour_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Four</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFour_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_0a44d162-b0df-4d76-97e4-7fab9db5ec6c_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_33eff235-9ad8-416b-ad3d-18ab09d0d64e_netLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_f08b69c9-bbe9-4a4c-ae82-cd3e5234a33d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge recorded related to Company's share of the litigation settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_cb4622dc-f5f1-4f4f-b3e8-bff76b208cee_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration receivable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_360bf68a-d5fa-4c64-a483-6662d3e81b1a_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of McKesson Europe AG redeemable noncontrolling interests</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_6dab2994-a70a-42da-a7a7-a7040d421d20_verboseLabel_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of McKesson Europe AG redeemable noncontrolling interests</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_label_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:href="mck-20230331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:to="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_7b0e3bf0-be72-4444-a87a-6f660ab118cb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of facility</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_248cd196-766a-4034-9154-ac1cb8eb4cad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of deferred tax balances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTextBlock_ed597484-5a4a-47f2-a3d8-a0066987f04f_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of shares repurchased over last three years</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTextBlock_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_19107ee8-02bd-4aae-b083-6a13d4f3db25_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_1bd71f12-1216-4eb0-a200-0b1afbc0ff13_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e46a926b-0434-4e1e-ad3f-11625968a6c7_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_98aacb0f-fb8e-4c0e-9f0d-03e1fd7e44e5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8cb676a1-706f-4c98-892d-b162ac9e81f1_verboseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_ef75e9b3-822b-49ab-9be1-2dbdc5d8a45e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_6567d160-337f-4f7c-bd02-da357349f063_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_0f07c0a3-b5cc-4c39-be1e-2c1465ef3518_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5bc7ad48-f0ea-4ccd-9048-017594be3dea_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c32e2bf9-77df-4fe4-95c9-b518712b16f4_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_405511d4-4f3f-482a-ae47-387e42c7bed4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_f46f192b-c43b-4286-8fd9-eb5552e77175_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of faxes remaining in class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_label_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:label id="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_documentation_en-US" xlink:label="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action, Number of Faxes Remaining in the Class</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:href="mck-20230331.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:to="lab_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies_81cded71-bb21-4c04-afc0-a080fb17bc60_terseLabel_en-US" xlink:label="lab_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Insurance Policies</link:label>
    <link:label id="lab_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies_label_en-US" xlink:label="lab_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Insufficient Coverage, Number Of Insurance Policies</link:label>
    <link:label id="lab_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies_documentation_en-US" xlink:label="lab_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Insufficient Coverage, Number Of Insurance Policies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies" xlink:href="mck-20230331.xsd#mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies" xlink:to="lab_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_ca13a2da-6deb-4861-8871-98251f4369a0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from collection of notes receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_dd839b10-64ef-494d-b979-38eb6b8581a4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_1677b695-049f-42c3-a6a7-2662852c63a6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, expected tax deductible amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_231faa18-cb93-4f42-aca1-d16f9354f269_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_1d320a98-5bf7-4764-bf08-f2f6c5257140_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_37792151-eb5c-4e3e-b8b0-d70ac326fa78_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divested net assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_99ccb387-737e-4c32-b63a-ee74a727e5a3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_19686dd9-5de9-418c-b4e7-06815b0a0da5_netLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AureliusElephantLimitedMember_c9c9adf1-63e4-4f51-8cff-161a618822cb_terseLabel_en-US" xlink:label="lab_mck_AureliusElephantLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurelius Elephant Limited</link:label>
    <link:label id="lab_mck_AureliusElephantLimitedMember_label_en-US" xlink:label="lab_mck_AureliusElephantLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurelius Elephant Limited [Member]</link:label>
    <link:label id="lab_mck_AureliusElephantLimitedMember_documentation_en-US" xlink:label="lab_mck_AureliusElephantLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurelius Elephant Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AureliusElephantLimitedMember" xlink:href="mck-20230331.xsd#mck_AureliusElephantLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AureliusElephantLimitedMember" xlink:to="lab_mck_AureliusElephantLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1c5cca37-9231-4159-9f54-76f447c8e975_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_67b0e0bd-d7c5-49fa-928f-287c60ed21d0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_c6b66f15-6720-4571-b5a2-13d9981e16ee_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_29bb6dc8-b3e2-4f19-84e0-aab6c8c5201c_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_11c1f7f0-4494-4eea-a4ca-0c2194f16a26_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of receivables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_993cec0f-ea99-45ad-b260-3f4ec54d3c39_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A525NotesDueFebruary152026Member_fcdf5107-9a8f-4f08-9204-4d4861d8d5d1_terseLabel_en-US" xlink:label="lab_mck_A525NotesDueFebruary152026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.25% Notes due February 15, 2026</link:label>
    <link:label id="lab_mck_A525NotesDueFebruary152026Member_label_en-US" xlink:label="lab_mck_A525NotesDueFebruary152026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.25% Notes Due February 15, 2026 [Member]</link:label>
    <link:label id="lab_mck_A525NotesDueFebruary152026Member_documentation_en-US" xlink:label="lab_mck_A525NotesDueFebruary152026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.25% Notes Due February 15, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A525NotesDueFebruary152026Member" xlink:href="mck-20230331.xsd#mck_A525NotesDueFebruary152026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A525NotesDueFebruary152026Member" xlink:to="lab_mck_A525NotesDueFebruary152026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_138de4f9-c02b-411b-a4a9-840544b9736a_terseLabel_en-US" xlink:label="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales returns from customers</link:label>
    <link:label id="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_label_en-US" xlink:label="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns</link:label>
    <link:label id="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_documentation_en-US" xlink:label="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:href="mck-20230331.xsd#mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:to="lab_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_ca28415f-690b-4b04-a2e7-7fa7fde69c18_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_54c851de-0387-448e-884e-2bcc798354e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of restricted stock unit award activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccountsReceivableCustomerAccountsGross_c53dd2dc-eb56-4f2d-87f0-4a4e5cdd52ac_terseLabel_en-US" xlink:label="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer accounts</link:label>
    <link:label id="lab_mck_AccountsReceivableCustomerAccountsGross_label_en-US" xlink:label="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Customer Accounts, Gross</link:label>
    <link:label id="lab_mck_AccountsReceivableCustomerAccountsGross_documentation_en-US" xlink:label="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Customer Accounts, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccountsReceivableCustomerAccountsGross" xlink:href="mck-20230331.xsd#mck_AccountsReceivableCustomerAccountsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccountsReceivableCustomerAccountsGross" xlink:to="lab_mck_AccountsReceivableCustomerAccountsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_cfaf02a0-77c9-433d-a94a-4c9d4edda912_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would Impact income tax expense and the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e6a4e530-7669-4bb6-b9b4-b81a6bf4a50f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_3d16c894-37a3-43df-abbf-b23d3991748b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices lower limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_02188a25-7d4b-46fa-bf97-7e60e64a9f25_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternationalSegmentMember_8c1340b4-50b2-42f5-b421-745f55cdb0e9_verboseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_7643baa7-dc06-4bd1-b701-dd590e8b1d39_terseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_label_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_documentation_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternationalSegmentMember" xlink:to="lab_mck_InternationalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_da915e1c-cb3b-499a-a991-3e7473884243_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2080394f-0a28-457f-ba01-df487872e6ae_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_f6c5df77-4e27-466e-a44a-78e28affb70f_terseLabel_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge</link:label>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_label_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge [Member]</link:label>
    <link:label id="lab_mck_NewYorkOpioidTaxSurchargeMember_documentation_en-US" xlink:label="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Opioid Tax Surcharge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember" xlink:href="mck-20230331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NewYorkOpioidTaxSurchargeMember" xlink:to="lab_mck_NewYorkOpioidTaxSurchargeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_ef4923da-8997-4954-b545-d0b7527d5c92_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as net investment hedges:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_a7ace76b-1512-4b14-8e7c-dbf74e707bc8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_298cd1d9-6b89-444b-bbc3-a1214308a651_verboseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_0075016c-8282-4e8b-87a0-aea924b814b2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_70efc920-560e-4283-8ed3-a0c44077e899_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al.</link:label>
    <link:label id="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_label_en-US" xlink:label="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al. [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_documentation_en-US" xlink:label="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Piacentile v. Amgen Inc., et al.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:href="mck-20230331.xsd#mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:to="lab_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_16bc8f96-3e8b-4391-84e8-3da86dcc9582_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_cac96f9e-e297-432a-8c60-73cb6afe1a22_terseLabel_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_label_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_documentation_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_USPharmaceuticalSegmentMember" xlink:to="lab_mck_USPharmaceuticalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_43cffe9f-c706-4cf1-81eb-0d5c0b812e52_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_68dce444-3a65-421e-b8b2-bc7fee02efdd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_490e6a5c-b123-44fb-b75e-c8e9b7da4145_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_0d0eceb9-eea8-4644-8e9b-bb111d4ad72f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_f8c03d77-731c-4ae9-826f-4c19c3bf2a84_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_59e61740-e299-4e5b-ac73-16f3ee01b8bb_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5538d1f7-60d7-4d24-ade0-1cfcb3e79e7f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_74339fd6-470f-40d6-8b52-056ebc581345_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_c9d75263-fc30-4874-96f6-c531ff8b40d1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3d6bad5f-7c8d-46e4-9670-146a00df76e9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0b5e62ed-35f9-4f90-a897-b3a625dc4448_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_c510ad8f-e157-400f-9c73-76fad536afae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and benefit related accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TermLoanMember_765baf0d-2869-4584-80a8-2cc5371dd18c_terseLabel_en-US" xlink:label="lab_mck_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_mck_TermLoanMember_label_en-US" xlink:label="lab_mck_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_mck_TermLoanMember_documentation_en-US" xlink:label="lab_mck_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TermLoanMember" xlink:href="mck-20230331.xsd#mck_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TermLoanMember" xlink:to="lab_mck_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_c55f877d-fd7d-4f21-b3db-503ca6f22e0b_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_3d7dc309-fe2d-45f8-b3dd-f8c4a3ea2890_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, maximum exposure</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_82dc33e5-81f9-4874-b83f-62aa528b8478_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_b638085b-8b1a-4ac3-b627-9c9b840157f9_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement payments</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_10a8c8f3-a9ad-45de-9a54-a0e4c9a68fda_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment/settlement gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a320f460-4191-430a-9e36-3b925ea882f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation between effective tax rate on income from continuing operations and statutory tax rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5ee1fa2f-a55a-44e1-9346-a6f95d6a4976_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_182862b2-0f37-428c-bc08-0252625c3576_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_8f6ed4dd-f559-4aff-a571-2c11314335ca_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_4c32855a-a30b-4858-8f8d-06b5d109976f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of details for charges recorded</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_134e6dc1-f353-40bf-8faf-b76b86356717_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_11b05256-15eb-4fca-aea3-0e65ce1f0423_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_053988f6-f7a6-4be2-abc7-963b9f151731_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Level 3 [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_248defe4-cf4c-4d6b-8dd9-e700b8b38ec3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ceba1a3-9fd1-424a-9d51-03927a39c2ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_169af722-9e68-4bb5-8efb-7be6359e6cc5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_beeb0a3a-d94a-427e-87d6-b0a7b87e786c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk and Receivables</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_9ce15a97-3b2a-43e3-bd8c-dd2739c5c767_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_c895573f-02ad-4d7e-b050-5e5cf8fab1d0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, net</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive_d5a5016c-9ca7-4da3-bbf9-00cdb12a04db_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due After Year Five</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_mck_LeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7bd96821-03cb-4ce3-b952-4b20b376a7ca_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_7e3fd7de-af2d-47a6-9326-6c8be160de14_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_a4bafbcb-f908-43ba-817a-917b9a787bc4_netLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_cf0a0364-22a2-4d26-82c8-f952f7e4b35a_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_8d2c1540-7bae-4b84-8080-0d8e537142b8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DataRelatedtoRSUActivityTableTextBlock_31f5a291-228c-4e28-bf0f-a836f53ea1e3_terseLabel_en-US" xlink:label="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of data related to restricted stock unit award activity</link:label>
    <link:label id="lab_mck_DataRelatedtoRSUActivityTableTextBlock_label_en-US" xlink:label="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Related to RSU Activity [Table Text Block]</link:label>
    <link:label id="lab_mck_DataRelatedtoRSUActivityTableTextBlock_documentation_en-US" xlink:label="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Related to RSU Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:href="mck-20230331.xsd#mck_DataRelatedtoRSUActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:to="lab_mck_DataRelatedtoRSUActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_fc96efdd-06f0-4dab-9da5-bfa77c1af136_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling Costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_47ec0439-2356-4b27-82f2-c50ba3e4d301_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_37b569fb-9de8-4a38-a9ff-3b6d8c7bf49d_negatedTerseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact and other</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:href="mck-20230331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_790b2159-f39c-40bd-ac01-2ee66d13d332_terseLabel_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes due March 15, 2023</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_label_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023 [Member]</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_documentation_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member" xlink:href="mck-20230331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A285NotesDueMarch152023Member" xlink:to="lab_mck_A285NotesDueMarch152023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3761f2f6-1e34-4de8-9835-ec766a86587f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_de7f4374-cfae-439c-9674-b463d4226ac8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_4bb5b833-aba9-407e-a031-da29c4a207a9_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_label_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:href="mck-20230331.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:to="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_fe01a160-e0ff-4eec-bd2b-fb21a064ebe9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_c627f544-426d-4e23-a164-f47a92f6ff73_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ad23415a-c29c-4911-9bcd-6d34ea01966a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value per stock option (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_eaee13db-7243-462b-b6ae-07db5f6de473_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_e181068f-1295-46e8-83e7-678212eaa788_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_caa0db46-ad7b-4c4e-bb34-92a4f1eeeb53_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_e45232d8-37c7-420d-89f5-b1349195fd3a_terseLabel_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual increase in interest (percent)</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_label_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_documentation_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread" xlink:href="mck-20230331.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PutRightValueInterestRateSpread" xlink:to="lab_mck_PutRightValueInterestRateSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_60b87b74-76a0-4f1a-9610-1dca00ec3630_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_McKessonUSOncologyResearchMember_de83e290-49fd-4af3-b922-0a1d398ff437_terseLabel_en-US" xlink:label="lab_mck_McKessonUSOncologyResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USOR</link:label>
    <link:label id="lab_mck_McKessonUSOncologyResearchMember_label_en-US" xlink:label="lab_mck_McKessonUSOncologyResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson U.S. Oncology Research [Member]</link:label>
    <link:label id="lab_mck_McKessonUSOncologyResearchMember_documentation_en-US" xlink:label="lab_mck_McKessonUSOncologyResearchMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson U.S. Oncology Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_McKessonUSOncologyResearchMember" xlink:href="mck-20230331.xsd#mck_McKessonUSOncologyResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_McKessonUSOncologyResearchMember" xlink:to="lab_mck_McKessonUSOncologyResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationAbstract_757fe280-232e-4da2-8e17-ba09c443a517_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationAbstract_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract" xlink:to="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_83371e8b-406f-41e0-ae7c-1d12efd9e501_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_2b7c41f8-fb48-44ce-9636-4c1c90042808_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_fcac0f1d-3746-4f8b-ac58-37ef0ceceef2_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at beginning of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_65805210-5608-4d2d-a6ad-249c20f2fa7d_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at end of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_02c0f21d-76ee-41ce-b8f0-3168b6ff2650_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_19f28d81-560b-490d-bb09-ef6cdea31ff9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of basic and diluted earnings per common share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7afb7839-b611-4749-83c5-2cad3de8dd89_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuroDenominatedNotesMember_00c51bbc-b3ec-4044-b429-7aba7c67c0d1_terseLabel_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_label_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember" xlink:href="mck-20230331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuroDenominatedNotesMember" xlink:to="lab_mck_EuroDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_6b68b971-9f9a-445f-86a4-bce86dc40ebc_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right increase (euros per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price, Increase</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price, Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_5caa687e-ddec-448f-8a63-eb5b21f722aa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_a45117be-a5c9-418e-9df8-70c46eed338a_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InsuranceProgramsPolicyTextBlock_451918a1-226f-4e3c-a5c6-5df1911d2e8a_terseLabel_en-US" xlink:label="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Programs</link:label>
    <link:label id="lab_mck_InsuranceProgramsPolicyTextBlock_label_en-US" xlink:label="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Programs [Policy Text Block]</link:label>
    <link:label id="lab_mck_InsuranceProgramsPolicyTextBlock_documentation_en-US" xlink:label="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of our insurance programs, we seek to obtain coverage for catastrophic exposures as well as those risks required to be insured by law or contract. [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceProgramsPolicyTextBlock" xlink:href="mck-20230331.xsd#mck_InsuranceProgramsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InsuranceProgramsPolicyTextBlock" xlink:to="lab_mck_InsuranceProgramsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_da956801-86b1-4439-9949-5be4596022d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount reclassified to earnings and other</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_74c88f2b-21bc-4c09-a20f-0927c72f80c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_02e0224e-7f67-4d42-809a-25df7ca86f74_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of increase in compensation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_da067475-7ee5-40af-8059-bbb27f6acfb4_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_d7a79684-b3ab-42d8-b537-dbb27677a1c0_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_7a0b1765-b7b1-417c-9a74-3a7b5e6026bd_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_fc787c46-d557-4d2d-a260-fd5bca869446_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_0dee2b80-b25f-4df0-84c1-acaceb3e10fd_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_34510293-2984-4812-b0eb-a7c93a830892_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</link:label>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_label_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_documentation_en-US" xlink:label="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:href="mck-20230331.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:to="lab_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_debea557-b057-4e79-a251-541f0bd1d14b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_aa283d49-c6e9-472f-8c48-164a066737b6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_c7b21245-5626-4700-9db6-6f6723da13b5_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_be90397d-49e0-4347-a52e-3cfb386b3793_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_51b48895-70fc-4591-9aca-c61337fde57b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b36ae7bd-70c5-4a41-b966-6f8632e8ede3_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility borrowing capacity (up to)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_56e3e08c-a0f5-41fd-97f9-433b04a3be16_terseLabel_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;)</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_label_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementTRAMember_documentation_en-US" xlink:label="lab_mck_TaxReceivableAgreementTRAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement (&#8220;TRA&#8221;) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember" xlink:href="mck-20230331.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxReceivableAgreementTRAMember" xlink:to="lab_mck_TaxReceivableAgreementTRAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_2c9f5a10-8bf6-406f-b0ef-5fbac29a4ca7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_358e505b-8761-4336-8f5d-80fa002f2750_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6699d6ac-8edf-48c5-8a5e-2436304239fa_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_179eafd6-1aab-4c77-942a-052dc367e408_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets and systems development costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_6b6b3d80-b966-4d60-a9dd-20b2b57b69a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions From Allowance Accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_a80ae57b-72a5-43b1-bc71-ca6e80172ed5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, statutory damages</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_fc386487-f369-4d95-8f96-f43b4a6db8ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_8f0a37b3-3ac0-4dba-a0c6-4b28dd4406c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_c01ed13e-1b01-4d13-86cf-ae32c79bdd00_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Inventory Repurchase Guarantees</link:label>
    <link:label id="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_label_en-US" xlink:label="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Inventory Repurchase Guarantees [Member]</link:label>
    <link:label id="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GuaranteeObligationsInventoryRepurchaseGuaranteesMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:to="lab_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_0675465b-21a2-4fc7-a1d8-223bb6c62809_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in basis points</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:to="lab_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_d887bc41-0754-420c-b190-9cc71b84028e_terseLabel_en-US" xlink:label="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period within which party can be substituted</link:label>
    <link:label id="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_label_en-US" xlink:label="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Party Substitution Period to Prevent Case Dismissal</link:label>
    <link:label id="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_documentation_en-US" xlink:label="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Party Substitution Period to Prevent Case Dismissal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:href="mck-20230331.xsd#mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:to="lab_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedContributionPlanMatchingAxis_d8e00cee-3e74-466b-beb1-21021c9d3f06_terseLabel_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Axis]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingAxis_label_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Axis]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingAxis_documentation_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingAxis" xlink:href="mck-20230331.xsd#mck_DefinedContributionPlanMatchingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis" xlink:to="lab_mck_DefinedContributionPlanMatchingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrepaidExpensesAndOtherMember_19d06bd1-9351-4660-ba36-f4388d061fd2_terseLabel_en-US" xlink:label="lab_mck_PrepaidExpensesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_mck_PrepaidExpensesAndOtherMember_label_en-US" xlink:label="lab_mck_PrepaidExpensesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other [Member]</link:label>
    <link:label id="lab_mck_PrepaidExpensesAndOtherMember_documentation_en-US" xlink:label="lab_mck_PrepaidExpensesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesAndOtherMember" xlink:href="mck-20230331.xsd#mck_PrepaidExpensesAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrepaidExpensesAndOtherMember" xlink:to="lab_mck_PrepaidExpensesAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b70af31b-3d3a-4a80-aa7b-543be82861cf_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_9eaa110f-adec-455e-947d-9e37c37478ef_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4260e48c-41e1-4d4d-ad26-70f4d7610755_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_f36be973-f869-439d-86fb-032b5d46644d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions based on the lapse of the applicable statutes of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_47d3247d-c3bf-45c1-b3c2-fcfb6822a3fc_terseLabel_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:href="mck-20230331.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:to="lab_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_78d3ad86-5fb8-4cb9-9b14-06343cc7f549_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_7aa3af60-38ee-4d92-ad22-81b17c412c8b_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_03535543-ab52-446c-9a84-e0270bd1e46a_terseLabel_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (shares)</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_label_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_documentation_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:href="mck-20230331.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:to="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_71eee580-e8af-4013-8b0e-dc5b391b4316_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_2ac1d7cf-7dbc-4944-9e6b-43db0d52ff74_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_b897007d-478f-476c-8318-db644c254754_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_21db9d7e-a5a0-491f-be63-3649e4d07bb5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_114a3b5f-776d-4eb4-9f4e-b55460a85f70_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_1b80a077-0775-44ff-8d9b-e1122c4cc003_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_71525392-609e-484a-ab5f-eb39da2f4a56_terseLabel_en-US" xlink:label="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York</link:label>
    <link:label id="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_label_en-US" xlink:label="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York [Member]</link:label>
    <link:label id="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_documentation_en-US" xlink:label="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:href="mck-20230331.xsd#mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:to="lab_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_a660b87b-7cb1-4e7d-a817-faf33ec1b902_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of increase in compensation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_bc149d04-8023-428e-9919-b0f3b268320e_terseLabel_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_label_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:to="lab_mck_PrescriptionTechnologySolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AuditorInformationAbstract_label_en-US" xlink:label="lab_mck_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_mck_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_mck_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AuditorInformationAbstract" xlink:href="mck-20230331.xsd#mck_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AuditorInformationAbstract" xlink:to="lab_mck_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_f9901f3c-86ed-494e-a439-e36c27b35a3d_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_115195ed-b2ec-46b2-add4-c95ffb22a3d6_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_1cf7f0ee-a6ea-453b-a7e6-0bce060f4948_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_ed495cc5-b239-419e-aef2-e5ad3978ac58_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_e4a702da-8246-4c17-8d39-85163fc08903_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_d7f310ba-0ef4-428a-891b-d5b45997fae5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncancelable lease terms</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_27a05f9e-43cb-44f6-8891-b52b32606ab4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_d60e322e-4650-4468-bc11-1cea11d83045_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_8d0b636f-a407-4fea-8f81-6e43bc55ee9b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares, at cost, 141 and 130 shares at March 31, 2023 and 2022, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_a2d9b8af-2c05-49ab-90a4-f96c6c4ada46_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_fe62eed3-88dc-4543-b818-7811c1a697a2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges (credits) associated with last-in, first-out inventory method</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve, Period Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_7f9dc738-236b-454c-9c91-d3e70956f48c_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense, net of tax</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_c31f183a-9e03-4d78-8715-25a2c5da3e91_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_69b3ed69-f06f-4139-856f-bd63c177f926_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_4e59e927-01d8-450b-930d-99e3a48746b5_terseLabel_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per share of common stock permitted on proposals presented to stockholders (vote)</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_label_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_documentation_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:href="mck-20230331.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:to="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_d2f2cb33-c977-4b76-af5b-8f688b83030e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_71f8a98c-6b33-4820-b019-522c9b0b122d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_5742da32-c033-44ca-ab2c-61072ba56f90_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_09113454-709b-45cf-8a4c-4440f317e0df_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireSoftware" xlink:to="lab_us-gaap_PaymentsToAcquireSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_7dd25046-7954-4e7a-a371-db95fe7d90ab_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_34e3fbee-d98d-4100-a126-469dfa43b9c0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_1df409bf-053d-4f99-8b0b-be58b25e0b0f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_53f745e8-c4dd-4730-9997-e718bc6b3339_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_9005a713-036b-4e34-b8f3-24c58cdda5f1_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_2f565642-a643-4c7d-98d5-48121fb3957c_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1ead99bf-8375-448a-b921-116f8f505074_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_cc3419b9-8aa1-4218-b7d8-49147fc3da35_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember_cda0d641-a067-45d1-94b7-57ed1a1d1a3e_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2022 Credit Facility)</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2022 Credit Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2022 Credit Facility)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuarantorObligationsPeriod_9ef97d38-7910-4920-b0ae-6e39288ca8bf_terseLabel_en-US" xlink:label="lab_mck_GuarantorObligationsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt guarantee period</link:label>
    <link:label id="lab_mck_GuarantorObligationsPeriod_label_en-US" xlink:label="lab_mck_GuarantorObligationsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Period</link:label>
    <link:label id="lab_mck_GuarantorObligationsPeriod_documentation_en-US" xlink:label="lab_mck_GuarantorObligationsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuarantorObligationsPeriod" xlink:href="mck-20230331.xsd#mck_GuarantorObligationsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuarantorObligationsPeriod" xlink:to="lab_mck_GuarantorObligationsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_46c8a2da-3467-4944-bbaa-0461eb15ded9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash proceeds from settlements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLegalSettlements" xlink:to="lab_us-gaap_ProceedsFromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_ba2f69ef-c890-4c6b-ac13-e7fb04745982_terseLabel_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual recurring compensation (in euro per share)</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_label_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_documentation_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:href="mck-20230331.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:to="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IndividualClaimantMember_70d2efa9-0216-47b9-ad83-2911734b7694_terseLabel_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_label_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant [Member]</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_documentation_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember" xlink:href="mck-20230331.xsd#mck_IndividualClaimantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IndividualClaimantMember" xlink:to="lab_mck_IndividualClaimantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_bc891b07-72f5-4eff-8ce4-73d85eeab8ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits and settlements</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_938b2aa1-fc9f-48fd-812d-dd63a6ef48d6_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_ecc6c496-f057-4e7e-8aee-1482b28fb5a3_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement, award amount to be used by state and local government</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_label_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:href="mck-20230331.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:to="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_17a1ba1b-08ed-40c4-ab0a-4a783cfeb100_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of eligible compensation (up to percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_ce36055c-a0fe-45a3-b03e-b91173b39a55_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs, anticipated total charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ac26698c-5318-492d-8c63-ddddefd75acf_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_20489d81-a8df-4526-ac38-d4dea2ccadcb_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_88d5e228-dd27-41ff-8bfd-047c54f60f25_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_ae499392-c79a-4263-9073-208ba9f71397_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as cash flow and other hedges:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_910bce56-4c12-476c-82cc-f81ebedf3a69_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_ef873cde-f72f-4f91-acb1-4f27d60a4191_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6097bd72-d1dc-419f-8dcb-f06aaebd11e5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, percentage of controlling interest in combined business</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_2e06c7fb-12c3-42d8-957b-2e4bd933300d_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_bca9356a-fd04-45d5-9e62-e9097c5ea231_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unconsolidated VIE maximum exposure to loss</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_23639890-042b-4390-8856-246e33dcb231_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_45de2c9f-2373-40a2-adff-62c011d0ccc5_terseLabel_en-US" xlink:label="lab_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_label_en-US" xlink:label="lab_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_documentation_en-US" xlink:label="lab_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:href="mck-20230331.xsd#mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:to="lab_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_dd57f162-1bc8-4558-a1fc-0ce2ff3e72a2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_ed3b7ac8-5332-4aa0-b927-4df73b62c61a_terseLabel_en-US" xlink:label="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current allowances</link:label>
    <link:label id="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_label_en-US" xlink:label="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount</link:label>
    <link:label id="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_documentation_en-US" xlink:label="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:href="mck-20230331.xsd#mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:to="lab_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_763c2029-0cdd-46db-96da-fdd068a9746e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_654b050e-4003-4a61-9e56-8d677fbe81d4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_0f46baa5-9da0-408a-aff6-e4198274ced3_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of period included in Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_03a3299c-1623-4946-a382-79ca30f87245_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDue_24b9e9c4-fe0b-4f72-a18a-4d8e4ec464bc_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDue" xlink:to="lab_mck_LeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_d5456f18-e1c5-4def-bdad-c9895fc5b23b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_ca4748e5-251a-4a05-bb47-86d0532b6da1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_1c70242f-ed1f-4372-95ed-be64cceef6e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_5ded32ce-e595-41ed-9b68-bbd2fc641d83_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Financing Activities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_de199bb2-639d-4363-a3dc-eff687497b65_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_9a9979a2-d62d-4be6-9d4a-d5f1a907fe64_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeLargestUSPharmaceuticalDistributorsMember_6eaa010f-0357-45cb-9953-3bcf5ad7c61b_terseLabel_en-US" xlink:label="lab_mck_ThreeLargestUSPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeLargestUSPharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeLargestUSPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeLargestUSPharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeLargestUSPharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestUSPharmaceuticalDistributorsMember" xlink:href="mck-20230331.xsd#mck_ThreeLargestUSPharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeLargestUSPharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeLargestUSPharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_dee139d4-b652-4a2b-b560-2aadeaf3ebd6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions based on tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_5a9f4c65-2214-4acb-b33f-cbd55d6accef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of pension plan assets using fair value hierarchy by asset class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_f4075b87-38af-43dc-aca4-ea4cad8e8bef_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0d0a30b5-e5c3-4cce-8bb6-138f14f15577_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5a2c53ea-2be8-4f61-bcca-afafc1c80765_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_53fb3f56-8c58-4e71-a1ee-19dca9042c63_terseLabel_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of unamortized debt issuance costs and transaction fees</link:label>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_label_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Cost and Transaction Costs</link:label>
    <link:label id="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_documentation_en-US" xlink:label="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Cost and Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:href="mck-20230331.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:to="lab_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_14204417-17dc-4d83-8b5c-7574f9459078_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_d836e4a4-64dc-4e25-a44d-186c12200bf7_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_bfb4bd4d-60cd-4fd3-aee7-3833c75e7a1e_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Net</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f73a4fb6-adae-4996-9bdb-b6f332f10697_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_15423cd0-18c9-4f5f-a7bf-cb8983d21c1e_negatedTerseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses paid</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligations, Expenses Paid</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligations, Expenses Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationsExpensesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:to="lab_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A3.125NotesDue2029Member_941b99ff-0cc2-4563-8454-d0f5f13c006f_terseLabel_en-US" xlink:label="lab_mck_A3.125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes due 2029</link:label>
    <link:label id="lab_mck_A3.125NotesDue2029Member_label_en-US" xlink:label="lab_mck_A3.125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:label id="lab_mck_A3.125NotesDue2029Member_documentation_en-US" xlink:label="lab_mck_A3.125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3.125NotesDue2029Member" xlink:href="mck-20230331.xsd#mck_A3.125NotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A3.125NotesDue2029Member" xlink:to="lab_mck_A3.125NotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b510bc0d-902c-44fa-ab77-865e2c25f4dd_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service credit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d5c67cf3-24b3-46fa-b86f-cb8b9fa0aa8b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_27cccd94-d57e-4894-967f-fd9e0d2127f8_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_f25898b5-aeff-4bab-9ad7-5809330745d2_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE consolidated assets</link:label>
    <link:label id="lab_us-gaap_Assets_d6d12e3c-22e6-41b5-b798-d3115409cd6a_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_80bbe5a6-a978-41bf-acb8-7da84ed446f6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_145bc144-5bf2-4672-a913-6be572889dc3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_5653adb6-572c-4c59-836e-0c04eaa02e13_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premiums</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_f0ebe625-ab4e-4e38-8818-5f3966946019_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities of growth stage companies</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_d3c2abe8-fdbe-48c7-bdcb-d7caf6581f5d_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper repaid</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_774d615e-6272-41ac-bf07-1ba50dd44176_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3f71731a-3e11-452f-9c26-2d674fc71041_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f3496f7c-80ff-436c-a7ce-9acc9a3c9488_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6be77a35-db71-450e-9f92-ef9797c6ca08_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_99565672-6988-428a-b7ce-4ee8a5d75d4b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract" xlink:to="lab_us-gaap_OperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_2cbff418-e880-4dc7-a509-f747ea2f7079_terseLabel_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_label_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions [Member]</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_documentation_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrescriptionTechnologySolutionsMember" xlink:to="lab_mck_PrescriptionTechnologySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d393b38f-4a9a-4701-afac-059ca234d4f2_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase authorization increase</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_7c0bccd1-2f74-42c5-8f0e-7b896fd07502_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_174a7710-0c1e-4783-a6c9-0544adec8a59_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96411ec6-deef-4b65-8e96-f53f5ae64a48_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_c61c3974-1afc-4045-9346-7175ed0d8fd3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_1146efa1-335f-4de3-845e-4d407f511f7e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_263659c8-c7e9-43e2-bcb2-8617c4f0dbad_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_005c7f3a-f5af-48cf-9d13-258a4a67fba9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_63e5de86-893a-46f3-b9b6-b0bc52beb14b_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_0005fc0d-7d3c-4495-a934-6dfe8f9a3199_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and unpaid interest</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_79dd8403-72d8-4e72-aa0a-b81e2f35750a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_c20b3c7f-811e-492b-9123-a14c4ccc3343_verboseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_label_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:to="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_de63de28-14cf-4de9-9476-378185951e9a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9bf06a47-6e94-4255-ba89-85b3fd0d530f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6038b062-16cb-4f62-8b8f-21804ff251cc_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_be1adc07-0b34-47b5-a292-2e32827049cf_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of stock options vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a6a02e12-f7a1-4697-a72c-e87f5c7ff20b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement_5857c09f-9566-45ea-84dd-cd1605570a3a_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of jurisdictions that did not participate in settlement</link:label>
    <link:label id="lab_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement_label_en-US" xlink:label="lab_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number Of Jurisdictions Not Participating In Settlement</link:label>
    <link:label id="lab_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement_documentation_en-US" xlink:label="lab_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number Of Jurisdictions Not Participating In Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement" xlink:href="mck-20230331.xsd#mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement" xlink:to="lab_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_7840e475-3991-4fda-aae1-3456d1ee2cbc_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_0f89203e-b4e1-4db9-accb-c6d346085d9d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_07e1ea8d-2928-4364-94cf-b4e060c83b4a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_5abb8764-3af9-4d2c-899e-74c8e6e62b57_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net and Allowances for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_23620b9c-8231-45ce-8050-c5e865d5d3bf_terseLabel_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Europe</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_label_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_documentation_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember" xlink:href="mck-20230331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MckessonEuropeSubsidiaryMember" xlink:to="lab_mck_MckessonEuropeSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_470d7644-5ae8-4073-b069-3cdb28d16ab1_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_a409a1d0-fc54-46f0-9ac0-fe88a8cb99c7_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedges</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_5299b45d-9174-4b3d-977c-c909ff5bcc18_terseLabel_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_label_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:href="mck-20230331.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:to="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_HazardousSubstanceSitesRecipientOfDirectives_eb811bae-0dbd-4392-8ff9-2f7cce6af787_terseLabel_en-US" xlink:label="lab_mck_HazardousSubstanceSitesRecipientOfDirectives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hazardous substance sites, number</link:label>
    <link:label id="lab_mck_HazardousSubstanceSitesRecipientOfDirectives_label_en-US" xlink:label="lab_mck_HazardousSubstanceSitesRecipientOfDirectives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hazardous Substance Sites, Recipient Of Directives</link:label>
    <link:label id="lab_mck_HazardousSubstanceSitesRecipientOfDirectives_documentation_en-US" xlink:label="lab_mck_HazardousSubstanceSitesRecipientOfDirectives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites that hazardous substances were allegedly disposed at.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSitesRecipientOfDirectives" xlink:href="mck-20230331.xsd#mck_HazardousSubstanceSitesRecipientOfDirectives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_HazardousSubstanceSitesRecipientOfDirectives" xlink:to="lab_mck_HazardousSubstanceSitesRecipientOfDirectives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_729582ae-7a36-49bd-8b61-d330b7973aa4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_30e6031c-692f-4132-96c8-c6c72002818a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_c0e8ee52-ce55-48b8-8004-a9a9b3eaee3b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_4b5fa50d-1fe0-44c4-9f60-cc84ecde9c1c_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_d54f943a-2aac-423b-bc35-4f18818d6dd4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Alignment Plan</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DebtInstrumentDaysAvailableForBorrowing_0c0c5e28-a23e-4208-ba12-4ecba6748fba_terseLabel_en-US" xlink:label="lab_mck_DebtInstrumentDaysAvailableForBorrowing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, days available for borrowing</link:label>
    <link:label id="lab_mck_DebtInstrumentDaysAvailableForBorrowing_label_en-US" xlink:label="lab_mck_DebtInstrumentDaysAvailableForBorrowing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Days Available For Borrowing</link:label>
    <link:label id="lab_mck_DebtInstrumentDaysAvailableForBorrowing_documentation_en-US" xlink:label="lab_mck_DebtInstrumentDaysAvailableForBorrowing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Days Available For Borrowing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DebtInstrumentDaysAvailableForBorrowing" xlink:href="mck-20230331.xsd#mck_DebtInstrumentDaysAvailableForBorrowing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DebtInstrumentDaysAvailableForBorrowing" xlink:to="lab_mck_DebtInstrumentDaysAvailableForBorrowing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_2fa9ce8c-c90a-4b83-927d-e88ae6e1222f_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8f3a39ad-2c34-43aa-a054-5f3372264905_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_7b77c16e-2050-4b3c-952e-6f533d70f177_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_e74ad04f-db42-4e32-b22e-515d7dcb956a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact and other</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_31b15ad2-ee27-40f1-ab08-eeacc8aaf217_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2029 through 2033</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_9ffdae12-05f8-40c1-ba65-d2d96ed1556c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_cfbade0b-3a1a-494f-a0a9-ca47cdece1ea_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_6bf1df9a-24e5-4046-8e58-b8928c16c75d_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_24ed3067-5d67-42d0-ba1e-376900cfa703_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_4fb79ade-473b-4bab-a2a5-5868b968fdcc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_90655331-465f-41c0-adab-c02a78c8d709_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember_8407cb86-f2c2-4714-8605-fd15613f4c36_terseLabel_en-US" xlink:label="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets/liabilities</link:label>
    <link:label id="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember_label_en-US" xlink:label="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets and Liabilities [Member]</link:label>
    <link:label id="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember_documentation_en-US" xlink:label="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets and Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:href="mck-20230331.xsd#mck_OtherNonCurrentAssetsAndLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:to="lab_mck_OtherNonCurrentAssetsAndLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesAbstract_d32bb922-ac56-40bb-93ec-40a9686dda2e_terseLabel_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Abstract]</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesAbstract_label_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Abstract]</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesAbstract_documentation_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:href="mck-20230331.xsd#mck_FinancialGuaranteesAndWarrantiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:to="lab_mck_FinancialGuaranteesAndWarrantiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_1b205b35-ed52-4822-abcb-236ca43de995_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties on unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseFebruary2022Member_63cd1f75-9a18-4291-ac87-c265c4bc1a65_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, February 2022</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseFebruary2022Member_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, February 2022 [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseFebruary2022Member_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, February 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseFebruary2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:to="lab_mck_AcceleratedShareRepurchaseFebruary2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_25370a2d-d63c-49bc-b199-9f6dfd316380_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_4141d97e-7291-473a-ad7d-99f93bd545c6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_048b6ba6-d19a-48d5-9d1c-db1eff755873_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_eeb31aef-4163-41b5-82e7-69f8e5b6d1de_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans, Defined Benefit</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanAnnuityContractsMember_ede5753a-45dc-4256-b7a0-633073abebc3_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annuity contracts</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAnnuityContractsMember_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Annuity Contracts [Member]</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAnnuityContractsMember_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Annuity Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanAnnuityContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:to="lab_mck_DefinedBenefitPlanAnnuityContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_c019ec8f-f123-4aa5-9cd6-6a7cc0350190_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal, state and foreign net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFour_29231dd5-700e-435e-bc19-7026cc44b1b2_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2027</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFour" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_6cf65369-6cff-4c89-8cf2-50f090954c50_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_b90ff7f0-83a1-42a1-b1f3-fe9a1bbf33e3_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, treasury common stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_ab299149-ac10-40c6-b537-3a6b5031ff1d_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, treasury common stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_ac7e331a-3635-4901-b36c-df9e0a91111c_verboseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss adjustment</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_0213ef5c-c869-4019-b8af-500b51ea7f93_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification to income statement, tax expense</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities_8c909f28-0f29-483a-a30a-daf83fcf834d_negatedTerseLabel_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities_label_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Operating Lease Liabilities</link:label>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities" xlink:to="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_4a734930-cbc4-41ac-bfce-37a513f0f748_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment expenditures for long-lived assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_8270d4ae-ac63-4443-9f3e-5e198b8142fa_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_4ec2d6ab-ffc8-4115-bfee-f0e247d5a315_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_0491549b-dbb2-42ed-9ea4-a2f1e4484eaf_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_12ccc881-c496-4049-afb1-b1278f46b235_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_9086faa3-7720-4dd7-82f9-4e9d8c69236f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfWestVirginiaAndSubdivisionsMember_3ba208ca-85d6-432c-a4cd-f02164d9052c_terseLabel_en-US" xlink:label="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of West Virginia and Subdivisions</link:label>
    <link:label id="lab_mck_StateOfWestVirginiaAndSubdivisionsMember_label_en-US" xlink:label="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of West Virginia and Subdivisions [Member]</link:label>
    <link:label id="lab_mck_StateOfWestVirginiaAndSubdivisionsMember_documentation_en-US" xlink:label="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of West Virginia and Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:href="mck-20230331.xsd#mck_StateOfWestVirginiaAndSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:to="lab_mck_StateOfWestVirginiaAndSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_287a5c15-89a2-4634-99bd-5a287942074b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_2a56a344-13e0-418b-85ae-338caed587cc_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock unit awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_a106ebd6-b015-4101-8a40-750effee701a_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_95cd27d8-1b59-47ba-90f0-720fa555589c_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_0a62d482-475c-4cbb-856a-a77ff445e339_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unexpected actuarial losses (as a percent) (exceeding)</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actuarial Losses, Percentage Exceeding Greater Of Projected Benefit Obligation Or Market Value of Assets</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:to="lab_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_a7d1191a-df15-4f99-86aa-b99ee835646f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_5efb1ffe-b2d8-4937-a4d5-cbd580a8fc6a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_87845e11-da93-4def-bd6b-887ff1e8b956_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar notional amount, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a089f81c-2329-4886-baf6-36afd74a7ebf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on cash flow and other hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_5af2f53e-3b0a-4447-ba2a-8517083401d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_8c6fdc28-2a40-46c2-96f7-72f9341666be_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring after 2028</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five Thereafter</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_1c914a95-e6ee-4342-8528-a6fa0f48af38_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_c01d7e73-668b-472e-a96e-43afe31395d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt extinguishments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_a258585d-2838-4a86-b90b-f018c3fb6614_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for debt extinguishments</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_234cdefa-ba37-4df9-a20c-1bb59f2debf8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_c4faff1a-72f2-4cb1-be01-15c1db277a58_terseLabel_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIFO inventory (percentage)</link:label>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_label_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of LIFO Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PercentageOfLIFOInventory" xlink:to="lab_us-gaap_PercentageOfLIFOInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_1ab35a93-2812-479e-969b-fcdf16ba7c30_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_c7e46d5a-fb9a-4682-94d3-30ce7855233e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in the carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_ad61d416-b3b9-4ca4-a50c-834b5362f197_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest, net</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_13c1389f-1fe4-4524-9c9a-aa7ccd1ed933_terseLabel_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual surcharge</link:label>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_label_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, New York, Annual Surcharge</link:label>
    <link:label id="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge_documentation_en-US" xlink:label="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, New York, Annual Surcharge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:href="mck-20230331.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:to="lab_mck_OpioidStewardshipActNewYorkAnnualSurcharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cb14d474-303d-448c-a62a-428ef2cb2dda_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_9f778ab2-8375-448e-8121-7d1d4fd5c569_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EPSBasicAndDilutedAbstract_ff666775-7663-4e43-8909-59a8dff69695_terseLabel_en-US" xlink:label="lab_mck_EPSBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson</link:label>
    <link:label id="lab_mck_EPSBasicAndDilutedAbstract_label_en-US" xlink:label="lab_mck_EPSBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS Basic and Diluted [Abstract]</link:label>
    <link:label id="lab_mck_EPSBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_mck_EPSBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EPSBasicAndDilutedAbstract" xlink:href="mck-20230331.xsd#mck_EPSBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EPSBasicAndDilutedAbstract" xlink:to="lab_mck_EPSBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LargestCustomerMember_b9953559-8ad8-498f-a6c1-7751c6949c5d_terseLabel_en-US" xlink:label="lab_mck_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS</link:label>
    <link:label id="lab_mck_LargestCustomerMember_label_en-US" xlink:label="lab_mck_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Customer [Member]</link:label>
    <link:label id="lab_mck_LargestCustomerMember_documentation_en-US" xlink:label="lab_mck_LargestCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Customer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LargestCustomerMember" xlink:href="mck-20230331.xsd#mck_LargestCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LargestCustomerMember" xlink:to="lab_mck_LargestCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_6137c7a9-e830-471a-84ed-e6f07c3cfb7e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_8e9c1a4c-16eb-455a-afbf-f774096b00b1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_288d2e64-f439-46b5-add7-6853bc3281af_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_86ca654d-edad-4338-be11-d460353f6e9c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFive_0d0874d9-7b7e-46c8-adc5-5cfd62932cfd_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2028</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFive_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearFive_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_WeightedAverageRemainingLeaseTermAbstract_9197b432-4a88-4211-a0f7-589d934239e8_terseLabel_en-US" xlink:label="lab_mck_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (years)</link:label>
    <link:label id="lab_mck_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_mck_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_mck_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_mck_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WeightedAverageRemainingLeaseTermAbstract" xlink:href="mck-20230331.xsd#mck_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_mck_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_d4def83a-436b-42ec-a0fc-1164d5c71088_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_00e22c9b-2854-4770-8cc8-dd60e4fbc881_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_a6e0c4fe-e347-4fb5-8f6a-23ee04a10d28_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_b3d1e173-beed-4498-a91b-7290ec03204b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_0b587f5d-165c-4a90-876d-312a874ddbe7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_e50eaa1a-7d6e-4c25-80b0-269ebf970636_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a99e185e-8686-4d2c-9fb9-68b0d25d629f_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilitiesPaymentsDueAbstract_ae805d51-690d-44ce-b1e4-ac2abf806a91_terseLabel_en-US" xlink:label="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_mck_LeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities Payments Due [Abstract]</link:label>
    <link:label id="lab_mck_LeaseLiabilitiesPaymentsDueAbstract_documentation_en-US" xlink:label="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities Payments Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:href="mck-20230331.xsd#mck_LeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_mck_LeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a17036d1-7902-4a14-bd2a-a5e099674896_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_efa891e6-dcda-4680-b23a-8795801fe345_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2028</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_8df2c10d-5a18-492c-8875-2ac85e21c764_verboseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liabilities derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_5ab77b8a-8e41-4c35-808e-dff3cc7a4873_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_c1d68973-7c2f-4b41-8e75-69456140ac54_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_9c4b648d-70fc-4243-b3ae-ee4e6da500da_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_9b8b4fd8-425f-4d95-8c5e-230504eb8cd0_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims and litigation charges, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_c4c6320a-7ee9-4bb5-b76d-b7ec7725ffc6_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_f0276d68-191e-4362-8489-4cda749b5124_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward</link:label>
    <link:label id="lab_us-gaap_CapitalLossCarryforwardMember_label_en-US" xlink:label="lab_us-gaap_CapitalLossCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Loss Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLossCarryforwardMember" xlink:to="lab_us-gaap_CapitalLossCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_001fd2f9-a58c-4245-b09c-a5f249dade0f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_c46c86f1-e2f6-458c-9eb2-cc11d4e6f6ad_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_72328e95-ccc1-43b0-8b76-35f9542a381d_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_35469d69-ff8c-42b3-8f2c-3e6e1267c79c_terseLabel_en-US" xlink:label="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future lease payments</link:label>
    <link:label id="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_label_en-US" xlink:label="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments</link:label>
    <link:label id="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_documentation_en-US" xlink:label="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:href="mck-20230331.xsd#mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:to="lab_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_05732ac9-e400-4877-adb0-4a52ececbc97_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_8ec09dc7-31a0-437a-9ab4-3bcb25ac6407_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of lease costs and supplemental cash flow information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2a0f8141-858d-4140-b4c3-dd5488173147_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_37082f21-74a3-4743-b309-34ac8a18f1e0_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_f2227a5d-d4ac-44ae-b40e-0dff340924b7_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_b74843e5-2749-41cd-ab9c-46359c2d30f1_terseLabel_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written-off</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_label_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowances And Reserves Deductions Written Off [Member]</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_documentation_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances and reserves, deductions written off [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:href="mck-20230331.xsd#mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:to="lab_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4869bfac-92a8-4d93-b140-48fc8223a531_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearTwo_7234b40f-0118-4881-8331-83b723feeb95_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_2a2dac11-3572-413d-81ad-554d615c5319_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_a448be66-94c7-4957-a8d4-714b39a7f908_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale of equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_357b8375-eaee-429e-b828-a8847a2b6de4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_2af47e91-2a0a-4147-a94a-0119d219b717_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European businesses held for sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1d385ff6-7148-4580-99a2-d1ed443abbbd_netLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European businesses, disposal group, losses (gains)</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_8be3ecfd-6c3c-40db-97f6-a09f280d5f1e_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge for remeasurement to fair value</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2b01a2a6-8538-4b4a-9719-76e42ef84276_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_03445edd-bd0d-4b2d-886a-7eb8394f77c9_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in net investment hedges, gains (losses)</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_e028535d-c13e-4b54-aa44-7a889ea0e45c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution expenses</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RealPropertyMember_4006c03a-eef6-4e3e-8134-0e4b0cfbdd3b_terseLabel_en-US" xlink:label="lab_mck_RealPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Property</link:label>
    <link:label id="lab_mck_RealPropertyMember_label_en-US" xlink:label="lab_mck_RealPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Property [Member]</link:label>
    <link:label id="lab_mck_RealPropertyMember_documentation_en-US" xlink:label="lab_mck_RealPropertyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RealPropertyMember" xlink:href="mck-20230331.xsd#mck_RealPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RealPropertyMember" xlink:to="lab_mck_RealPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_cfaaf38d-6b0e-4ddd-8435-e872762b4cfa_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_a801cebc-7d0b-4597-9cae-07337085d010_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Number of Shares Purchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7da1edd5-f353-4825-b591-bdb1ad70163a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfRelators_5798aaaf-df7b-4b3c-92b7-086b2c985a65_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfRelators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of relators</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfRelators_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfRelators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Relators</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfRelators_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfRelators" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Relators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfRelators" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfRelators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfRelators" xlink:to="lab_mck_LossContingencyNumberOfRelators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_127a2ebe-2bf8-4840-a51d-fd3ad8afc94e_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_4aa6722c-0d88-4b06-9db4-f80eca0044ea_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_8907f4b2-e8f3-4723-9ee1-3b2be6539112_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_69634a28-f903-4c32-a0f7-1eb4ae14557c_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_872134a6-08d9-4bbd-9107-d63227072219_terseLabel_en-US" xlink:label="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_label_en-US" xlink:label="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_documentation_en-US" xlink:label="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:href="mck-20230331.xsd#mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:to="lab_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_7e637dbd-27be-4821-904f-2794272bf2cd_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_82c4e99c-22cb-4ea0-a4ba-b4db085423df_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K.</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_64f79a17-5bf5-4a35-9b4c-d5b07cdecb27_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember_0d8e5f65-f27c-459d-b4f8-9b3dde4e5fea_terseLabel_en-US" xlink:label="lab_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims And Demands From Government Agencies, Environmental Conditions</link:label>
    <link:label id="lab_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember_label_en-US" xlink:label="lab_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims And Demands From Government Agencies, Environmental Conditions [Member]</link:label>
    <link:label id="lab_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember_documentation_en-US" xlink:label="lab_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims And Demands From Government Agencies, Environmental Conditions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember" xlink:href="mck-20230331.xsd#mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember" xlink:to="lab_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_1e379aa9-f2bb-4ac5-8dcd-292675b5ef35_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_label_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_documentation_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:href="mck-20230331.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:to="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_56cd1c66-47b8-47e9-9a0f-34b262eb1a68_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ecc02d0b-6852-4096-a827-8f0e5e515998_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccruedShareRepurchases_2c10b6ff-f387-4d01-8df0-ef3c593868ea_terseLabel_en-US" xlink:label="lab_mck_AccruedShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued shares repurchased</link:label>
    <link:label id="lab_mck_AccruedShareRepurchases_label_en-US" xlink:label="lab_mck_AccruedShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Share Repurchases</link:label>
    <link:label id="lab_mck_AccruedShareRepurchases_documentation_en-US" xlink:label="lab_mck_AccruedShareRepurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Share Repurchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccruedShareRepurchases" xlink:href="mck-20230331.xsd#mck_AccruedShareRepurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccruedShareRepurchases" xlink:to="lab_mck_AccruedShareRepurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember_bcb8b05a-de15-43ab-b900-3f4180be9308_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2022 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2022 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2022 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_0ee318ab-770d-44b9-bd0f-d882769c0b0b_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_5058ca67-1863-4c06-9704-d17f2564e0a9_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo_5c77318e-5007-4d7e-aa92-ef53ee2574e9_terseLabel_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee obligations, expiring in 2025</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo_label_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Two</link:label>
    <link:label id="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo_documentation_en-US" xlink:label="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee Obligations Exposure Expiring in Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:to="lab_mck_GuaranteeObligationsExposureExpiringinYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_a5e552ec-2578-4067-ac52-04d36746bc01_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParentAbstract_e746df62-1906-4bc7-8205-5a4673df6610_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossAttributableToParentAbstract" xlink:to="lab_us-gaap_IncomeLossAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_15f0cb6e-dac0-48a3-8dc3-0eb25f227698_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_c4817ca3-7123-45c0-bee5-a193829745b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, distribution, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_dde785bc-11f5-4e59-9f49-c3d5a789a8e9_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and handling costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_583c07e1-97e2-45ab-b324-2528605f3146_terseLabel_en-US" xlink:label="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software held for internal use, useful life</link:label>
    <link:label id="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_label_en-US" xlink:label="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Software Held for Internal Use, Useful Life</link:label>
    <link:label id="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_documentation_en-US" xlink:label="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Software Held for Internal Use, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:href="mck-20230331.xsd#mck_CapitalizedSoftwareHeldforInternalUseUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:to="lab_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_c2dbcbeb-8ccf-4e55-885e-4d011a11db95_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_d8f8e9a1-a548-405a-9487-b875392bc686_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_90e8f7af-2149-4d54-bfe7-792b7c472ee2_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_402d6df1-ae7f-4c3e-a591-687fa511073c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_c46406bf-55ef-4ff5-9517-6a01aad1bfe3_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_44a1d5ad-2173-44ed-a482-099c69a28fa4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_7302c6a8-6b29-4a03-a6f2-959961fdafed_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f89534ee-211c-41b7-9510-e487e93be13e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_a87a29b8-4898-4f83-b5e4-2991af8b3cf3_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected benefit payments in 2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_bab1227a-4057-454c-b867-3551d365b839_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_89e0107b-19b8-4a4a-8837-d569bd89aac1_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_4e1da5b7-3d7e-40ae-9faf-becbbf34ca8e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_cefc6e26-287d-4846-9d16-938f0b7ffb0e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_0ef18c6c-5b66-4869-b92a-7dcc0b8e297c_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f57a7f5d-1297-4670-90dd-7f7e702fcdbd_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_bef1d4c9-2cce-4b15-8d47-681914820690_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeasesTextBlock_45983339-8d23-4659-8456-57b999842f82_terseLabel_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorDirectFinancingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Direct Financing Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorDirectFinancingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:to="lab_us-gaap_LessorDirectFinancingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_9fbb4d84-fe64-408d-94e3-014dd2db2927_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_10e6ec17-5142-4cb4-b461-7e888b167c1c_terseLabel_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation and Project Consulting Fees</link:label>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_label_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]</link:label>
    <link:label id="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_documentation_en-US" xlink:label="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:href="mck-20230331.xsd#mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:to="lab_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_39242d7e-b642-44bf-9b7f-34f209ef3986_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current [Member]</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_ad43c0f9-c531-40a2-a0b4-2a851c43044e_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f6c4fc3f-abe1-49d2-8265-0783485625c7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_6ef7895d-e84a-476e-840f-cdeb3574d529_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_4d1e066e-2126-4b52-8788-254b52c18a53_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_af391bbf-6a04-4d50-85df-da91e3a0fe92_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of foreign operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ce104d5-e37f-43ce-8b7f-81fe807c3325_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A2022StockPlanMember_8b483d5f-b5e1-47c3-84e2-c7d9392e926d_terseLabel_en-US" xlink:label="lab_mck_A2022StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Stock Plan</link:label>
    <link:label id="lab_mck_A2022StockPlanMember_label_en-US" xlink:label="lab_mck_A2022StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Stock Plan [Member]</link:label>
    <link:label id="lab_mck_A2022StockPlanMember_documentation_en-US" xlink:label="lab_mck_A2022StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Stock Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2022StockPlanMember" xlink:href="mck-20230331.xsd#mck_A2022StockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A2022StockPlanMember" xlink:to="lab_mck_A2022StockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_30da739e-4801-4526-822b-5ea0583ef873_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherAllowancesMember_20d482f8-900a-4f15-919f-5d9b2e937b5d_terseLabel_en-US" xlink:label="lab_mck_OtherAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other allowances</link:label>
    <link:label id="lab_mck_OtherAllowancesMember_label_en-US" xlink:label="lab_mck_OtherAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Allowances [Member]</link:label>
    <link:label id="lab_mck_OtherAllowancesMember_documentation_en-US" xlink:label="lab_mck_OtherAllowancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Allowances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAllowancesMember" xlink:href="mck-20230331.xsd#mck_OtherAllowancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherAllowancesMember" xlink:to="lab_mck_OtherAllowancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_e740954d-5bdf-40a0-99ef-b9882dbf966c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SarahCannonResearchInstituteMember_c8d51cf1-fd38-47ee-b281-6555f251884f_terseLabel_en-US" xlink:label="lab_mck_SarahCannonResearchInstituteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCRI</link:label>
    <link:label id="lab_mck_SarahCannonResearchInstituteMember_label_en-US" xlink:label="lab_mck_SarahCannonResearchInstituteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sarah Cannon Research Institute [Member]</link:label>
    <link:label id="lab_mck_SarahCannonResearchInstituteMember_documentation_en-US" xlink:label="lab_mck_SarahCannonResearchInstituteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sarah Cannon Research Institute</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SarahCannonResearchInstituteMember" xlink:href="mck-20230331.xsd#mck_SarahCannonResearchInstituteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SarahCannonResearchInstituteMember" xlink:to="lab_mck_SarahCannonResearchInstituteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_5fd1cc9a-7cbe-4235-bfc7-1a52c04d7205_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_5ab2740c-e063-4dc1-ada7-d845da5dd631_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_39514daa-4f3c-4aea-8ff0-cd81a4bbed5b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_584efbf2-ca92-4c27-aca5-dce0bcf1f627_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f0eb15fe-5673-41cf-a4cc-cfd71819b2f1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_32a5a935-de2a-4fb3-b614-460b1a0586c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4ccc6b2e-12e3-4ccc-a006-6c33bc81b242_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_89a5c756-4091-4aa5-a02d-a9bd2826fc94_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_36f08227-207e-4893-bcc3-f90167d843b7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_1a74f72b-f542-4ff7-89e0-a7126ab16dff_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted balance</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_1e4eca58-ef50-48fa-b683-4b56f7e99225_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d3635190-2b83-4a6c-afe7-5c0d55f201ad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value on exercise</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_72f73853-aef2-434c-a324-d0d969e95980_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity method investment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_fb24814d-5e69-483e-8e86-31b0adbcf0a9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NotesDueNovember302020Member_a6fb777a-c1f9-4405-aa0b-c544ee34bee8_terseLabel_en-US" xlink:label="lab_mck_NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due November 30, 2020</link:label>
    <link:label id="lab_mck_NotesDueNovember302020Member_label_en-US" xlink:label="lab_mck_NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due November 30, 2020 [Member]</link:label>
    <link:label id="lab_mck_NotesDueNovember302020Member_documentation_en-US" xlink:label="lab_mck_NotesDueNovember302020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due November 30, 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueNovember302020Member" xlink:href="mck-20230331.xsd#mck_NotesDueNovember302020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NotesDueNovember302020Member" xlink:to="lab_mck_NotesDueNovember302020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b9ce61bc-9e2b-46e3-a015-272f33e2104e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_480b19de-8677-4e34-b314-5653f4ae641d_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsLineItems_775d1ce9-f9e4-4d6f-bb28-f6374e645a83_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations [Line Items]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsLineItems_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems" xlink:to="lab_us-gaap_GuaranteeObligationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_78a45347-33b6-402b-b853-00f499f3e644_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5a6c529e-3504-4403-8d81-e421aa6956d6_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_1af45f95-8054-42b0-bf02-9ed986851d1e_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_6bca194c-e682-4196-a764-bb15fd29c4b1_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_HeldforSalePolicyTextBlock_e096293c-9eb0-4456-a214-1b732537cb99_terseLabel_en-US" xlink:label="lab_mck_HeldforSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_mck_HeldforSalePolicyTextBlock_label_en-US" xlink:label="lab_mck_HeldforSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale [Policy Text Block]</link:label>
    <link:label id="lab_mck_HeldforSalePolicyTextBlock_documentation_en-US" xlink:label="lab_mck_HeldforSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldforSalePolicyTextBlock" xlink:href="mck-20230331.xsd#mck_HeldforSalePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_HeldforSalePolicyTextBlock" xlink:to="lab_mck_HeldforSalePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_aceb8163-3adc-492a-83f7-0515fa3fbb8d_negatedTerseLabel_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate expenses, net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_label_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_documentation_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:href="mck-20230331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:to="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_f7729b2d-0e09-4529-922b-8f2c335a86e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f194f65d-adf7-4189-a8bf-0d322985548f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_56d33585-32f4-4d44-b700-7e7b7aeca9b9_terseLabel_en-US" xlink:label="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated environmental assessment and cleanup costs</link:label>
    <link:label id="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_label_en-US" xlink:label="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Environmental Assessment And Cleanup Costs</link:label>
    <link:label id="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_documentation_en-US" xlink:label="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Environmental Assessment And Cleanup Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:href="mck-20230331.xsd#mck_EstimatedEnvironmentalAssessmentAndCleanupCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:to="lab_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_dd865879-2e0c-4e4c-be3b-343f472f67f9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_2e32aa69-5c1a-4bc6-bc15-56bfc88f0c6c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_f81b04af-b783-49f4-8df7-23f81a862a56_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1.500NotesDue2025Member_6d4d5880-e3e1-4720-baa6-2a0f211cc921_terseLabel_en-US" xlink:label="lab_mck_A1.500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes due 2025</link:label>
    <link:label id="lab_mck_A1.500NotesDue2025Member_label_en-US" xlink:label="lab_mck_A1.500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mck_A1.500NotesDue2025Member_documentation_en-US" xlink:label="lab_mck_A1.500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.500NotesDue2025Member" xlink:href="mck-20230331.xsd#mck_A1.500NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1.500NotesDue2025Member" xlink:to="lab_mck_A1.500NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_2f9ad678-0a7a-4fdf-aa7c-9563f3cb8a74_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_332b6635-c4f9-4bb9-b4ba-98dcfdaac568_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_fe85304c-8feb-488c-acf9-86957eb0de1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStates_7d022455-80c3-49ed-8d92-b10a93108f51_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberofStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStates" xlink:to="lab_mck_LossContingencyNumberofStates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CherokeeNationMember_6bb47e1e-959f-4f13-8bc9-085ba2560271_terseLabel_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation</link:label>
    <link:label id="lab_mck_CherokeeNationMember_label_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_CherokeeNationMember_documentation_en-US" xlink:label="lab_mck_CherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember" xlink:href="mck-20230331.xsd#mck_CherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CherokeeNationMember" xlink:to="lab_mck_CherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_90cebcdd-45fc-46c5-b364-2447a5fd3e42_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e82f0358-2832-41a8-baf7-1c884cb08c7c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d7bb247b-4054-4f5d-bfa1-b48c1ad0a8bf_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5a44878a-9098-4d90-82de-774af917ecec_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_3ce54d64-62e6-4396-b225-d1e6ace72c0f_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states filed on behalf of</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States Filed On Behalf Of</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States Filed On Behalf Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfStatesFiledOnBehalfOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:to="lab_mck_LossContingencyNumberOfStatesFiledOnBehalfOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_17fd9a7f-eb1f-4097-81b2-4288e69e931f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingent Liabilities</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7e4c27a6-299c-405c-b4e4-e8ed545bf6b9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuances of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_cdfa417f-b198-473a-abae-f70d48831da8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_af637e77-6ac8-490c-825c-cd718547dacc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_8e153c86-ab85-4f4a-b073-ce5e36fcd6d7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of investment in joint venture</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_14d9664d-f038-413e-889d-1058aca62b40_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of businesses and investments, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses and Interests in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_8aa93f09-c061-4614-8943-c603094170a5_terseLabel_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software</link:label>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_label_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software [Member]</link:label>
    <link:label id="lab_mck_InternallyDevelopedSoftwareMember_documentation_en-US" xlink:label="lab_mck_InternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember" xlink:href="mck-20230331.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternallyDevelopedSoftwareMember" xlink:to="lab_mck_InternallyDevelopedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_10ab7283-2d3c-4ea0-90a3-2db4f6edb795_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_911ee847-46fe-4ae7-9de2-d65709b62f08_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8e35ab9-bad7-4e1f-ab15-76312fc3606f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1f59090d-b7dc-4672-ab7c-fefeb198736e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_b84ddb98-bba1-42b7-9c57-9f9033f58b13_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_fedebf4b-c6b2-4c64-a259-1143c48f43bb_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_eaaa97b9-4994-4367-8b5e-2183cd9eac51_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_7e3e002a-c794-414e-a9e1-47a08d7b6c56_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_67d8b79f-3482-4332-9429-0a1ab0adf655_terseLabel_en-US" xlink:label="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Manchester v. Purdue Pharma, L.P., et al</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_label_en-US" xlink:label="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]</link:label>
    <link:label id="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_documentation_en-US" xlink:label="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:href="mck-20230331.xsd#mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:to="lab_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_14c0025e-92b1-4a83-b968-2a220045299a_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f37b0ad9-f20d-425f-8217-d08e3bdedef5_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of segment information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_17667cb5-97c6-46c5-9ef8-404b1cb363cc_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_c4877484-09f6-43f8-8325-a36a322e65e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BusinessCombinationConsiderationTransferredOwnershipInterest_8019386d-2162-4b17-afb0-ec542863cace_terseLabel_en-US" xlink:label="lab_mck_BusinessCombinationConsiderationTransferredOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution of USOR</link:label>
    <link:label id="lab_mck_BusinessCombinationConsiderationTransferredOwnershipInterest_label_en-US" xlink:label="lab_mck_BusinessCombinationConsiderationTransferredOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Ownership Interest</link:label>
    <link:label id="lab_mck_BusinessCombinationConsiderationTransferredOwnershipInterest_documentation_en-US" xlink:label="lab_mck_BusinessCombinationConsiderationTransferredOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationConsiderationTransferredOwnershipInterest" xlink:href="mck-20230331.xsd#mck_BusinessCombinationConsiderationTransferredOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BusinessCombinationConsiderationTransferredOwnershipInterest" xlink:to="lab_mck_BusinessCombinationConsiderationTransferredOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_1f564fac-6f70-4775-b895-b67eb661affb_terseLabel_en-US" xlink:label="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of data related to stock option activity</link:label>
    <link:label id="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_label_en-US" xlink:label="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award Data Related To Stock Option Activity [Table Text Block]</link:label>
    <link:label id="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_documentation_en-US" xlink:label="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share based compensation arrangements by share based payment award data related to stock option activity [table text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:href="mck-20230331.xsd#mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:to="lab_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_e43fadde-e91b-4863-a492-96d7fab4f694_terseLabel_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash classified within Assets held for sale</link:label>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_label_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</link:label>
    <link:label id="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:href="mck-20230331.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:to="lab_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d150915f-a06e-44fe-b605-269289910761_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_d8de7313-3585-4ff7-86e0-0e83f836992a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_998ecaaf-1c74-4afd-920b-0b9916c1cafb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory federal income tax rate (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DeferredTaxAssetLeaseObligations_becbdd37-26ae-476b-aa58-63da25bb26d5_terseLabel_en-US" xlink:label="lab_mck_DeferredTaxAssetLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligations</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLeaseObligations_label_en-US" xlink:label="lab_mck_DeferredTaxAssetLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Lease Obligations</link:label>
    <link:label id="lab_mck_DeferredTaxAssetLeaseObligations_documentation_en-US" xlink:label="lab_mck_DeferredTaxAssetLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLeaseObligations" xlink:href="mck-20230331.xsd#mck_DeferredTaxAssetLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DeferredTaxAssetLeaseObligations" xlink:to="lab_mck_DeferredTaxAssetLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_c2aa43b1-8758-4f61-a2ea-cf55654749e8_terseLabel_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax receivable agreement, percent of net cash tax savings realized</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_label_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</link:label>
    <link:label id="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_documentation_en-US" xlink:label="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:href="mck-20230331.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:to="lab_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e7d52298-ff12-4b6d-9d02-da85f0b8e44e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_7609534b-5a96-49ed-9776-09b61dcc68f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_b7cbfddc-2063-49d4-b7b6-d3e54f20befb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d936d122-fdba-43e4-b767-30acbff04987_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_273729e7-92a6-4056-8121-41023c503fc8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_fef74912-8310-4ac7-baf8-4ef7c19f80d9_terseLabel_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_label_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning [Member]</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_documentation_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:href="mck-20230331.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:to="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_472faadf-9e7e-4a64-b658-2a59dc88a406_terseLabel_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_EUBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_EUBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E.U. Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EUBusinessesDisposalGroupMember" xlink:to="lab_mck_EUBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_a7d0b5aa-af5c-4568-897d-fc6a611aaa25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3fea6484-670f-4160-b30b-1a2c6aaf2b82_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_14a3fc49-a632-4f6b-b211-5e3382194c9a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_60fff74a-8d16-4167-a2cd-1803d40063a4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e5fcc4eb-3e99-4f8c-a1e8-b2f7e7046d51_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_161a1075-961f-4bd2-a311-28066524d1e0_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_766ea7df-c683-4a3e-a0ae-4c0ca04b2d85_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_cf7e1546-2b6e-42b4-b985-ef0024ab03f9_terseLabel_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term assets</link:label>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_label_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan, Noncurrent</link:label>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_documentation_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:href="mck-20230331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:to="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_01e4edfd-55b2-4fe9-ac39-9175389bc705_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_aa341430-5cbf-4cc1-bb62-c2e431868fba_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_ad7ce419-713c-4c45-818c-8ce2c8f267b4_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_2d2c580b-67fd-413d-9b4e-d34c8ee74cda_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_ba5c5c62-2306-4910-84f2-ff0bbe5dade0_netLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_23d88e02-1c70-4238-a802-e233995d5827_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_8e50fbe0-9c8b-4b7c-9eb3-0865c4698bf9_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_78486aa6-c7e0-4669-824b-9402ce29aa73_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_20e6d9cb-95db-43ad-a00c-8ed15014c58a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment, and Related Charges, Net</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b109976b-bd05-4c05-a7d6-eff32887334f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital_8a9a5701-8069-45fb-abe3-5847a0350c7b_negatedTerseLabel_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital_label_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Additional-Paid-In Capital</link:label>
    <link:label id="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital_documentation_en-US" xlink:label="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Additional-Paid-In Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital" xlink:to="lab_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_66dff548-a6b4-4d9d-9e86-cdfb24fd076b_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:to="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_ef743c1a-bac0-4036-9fc4-86f3f0dcf24f_terseLabel_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_label_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:label id="lab_mck_RetailPharmacyReportingUnitMember_documentation_en-US" xlink:label="lab_mck_RetailPharmacyReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Pharmacy Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember" xlink:href="mck-20230331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RetailPharmacyReportingUnitMember" xlink:to="lab_mck_RetailPharmacyReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_17b35f16-dbdd-4c23-82ab-57f324a5b25f_terseLabel_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credited to other accounts and other</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_label_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowances And Reserves Deductions Credited To Other Accounts [Member]</link:label>
    <link:label id="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_documentation_en-US" xlink:label="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances and reserves, deductions credited to other accounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:href="mck-20230331.xsd#mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:to="lab_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_72bb92e8-fc76-4c8a-bf0d-55a188a40f24_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuropeanAssetsHeldForSaleMember_a61d7ecd-a8f7-4764-8cf2-4cebd2bfc0d9_terseLabel_en-US" xlink:label="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Assets Held for Sale</link:label>
    <link:label id="lab_mck_EuropeanAssetsHeldForSaleMember_label_en-US" xlink:label="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Assets Held for Sale [Member]</link:label>
    <link:label id="lab_mck_EuropeanAssetsHeldForSaleMember_documentation_en-US" xlink:label="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Assets Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanAssetsHeldForSaleMember" xlink:href="mck-20230331.xsd#mck_EuropeanAssetsHeldForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuropeanAssetsHeldForSaleMember" xlink:to="lab_mck_EuropeanAssetsHeldForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_baae6ffd-83f5-4711-a298-d5f3895d80e0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term rate of return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_99cb63ff-83ae-487d-9daa-5ba453cd931e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_c9908ca7-6594-4ca4-aa5b-7b2967a6bd4e_terseLabel_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes due February 16, 2028</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_label_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028 [Member]</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_documentation_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member" xlink:href="mck-20230331.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A395NotesDueFebruary162028Member" xlink:to="lab_mck_A395NotesDueFebruary162028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_9d65a094-2ad9-4650-a8f4-6e5aa0b7ceb3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFive_f1ae2a5c-7113-4b93-9cd4-68fe803fc963_totalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2028</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_mck_LeaseLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityPaymentsDueYearFive" xlink:to="lab_mck_LeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_e40fa718-8f14-40b5-bf52-83c4e7ef04d1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_81cfbebc-9e4f-4636-b9b8-80b3a8e74fa2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for legal settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_7277992e-c570-4b5b-83b3-03dead5c2fd4_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_e05845c8-3450-4cc6-909b-2bffd285e14c_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_a9e068b4-d557-4e07-9ae8-fb9729b1b2ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_22853eb6-078b-45ff-a235-aedc2aeb870b_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_d4d523d8-6435-4152-9fbe-20f1e79c5e73_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_e80e85aa-2206-414b-a7f2-e018f821bd51_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_4b884bd8-03ad-4c02-8a65-030e66ccb048_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_8fb467a1-a66e-4eae-986a-23d91cf375e6_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_5d116318-3c19-43ca-9d67-d309f39c1397_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_d306940f-ff9f-42f1-b5ec-7086cd46dd8b_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of segment assets and long-lived assets by net by geographic areas</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_6b18e2e7-227b-44ff-8a14-6b1acb849c4f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1e1021eb-e41e-4f8f-ba2d-4b4bfc0f4a5a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A525NotesDue2026Member_be9a4f0b-dd02-4a75-87f6-2d78ec8709a2_terseLabel_en-US" xlink:label="lab_mck_A525NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.25% Notes Due 2026</link:label>
    <link:label id="lab_mck_A525NotesDue2026Member_label_en-US" xlink:label="lab_mck_A525NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.25% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_mck_A525NotesDue2026Member_documentation_en-US" xlink:label="lab_mck_A525NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.25% Notes Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A525NotesDue2026Member" xlink:href="mck-20230331.xsd#mck_A525NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A525NotesDue2026Member" xlink:to="lab_mck_A525NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_ad0d3110-d15b-4e8d-98a6-8fa3ee50d574_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits realized related to exercise</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_dc52ed36-4540-493e-b1e5-77a9a88ef809_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2b12e42d-34de-467b-bbc2-92c90bd11bc6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_07792381-f8bd-46a5-9f85-3c5e6f1d1c98_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar notional amount, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusDomain_6cf429b0-6671-4a67-af9a-d861bbdde5ad_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Funding Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanFundingStatusDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funding Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain" xlink:to="lab_us-gaap_RetirementPlanFundingStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_d3b217b0-bfb0-493a-a9c0-e795891800e5_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_59cb815e-5ba1-4ce2-ad72-982e171c037b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiability_36aa64bb-822c-455b-b24f-b5a872c682b5_totalLabel_en-US" xlink:label="lab_mck_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_mck_LeaseLiability_label_en-US" xlink:label="lab_mck_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_mck_LeaseLiability_documentation_en-US" xlink:label="lab_mck_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability" xlink:href="mck-20230331.xsd#mck_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiability" xlink:to="lab_mck_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_9e84bbe7-9e42-4799-a57a-f54dca7ba9c2_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, settlement, installment payments, term (in years)</link:label>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_label_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Installment Payments, Term</link:label>
    <link:label id="lab_mck_LossContingencySettlementInstallmentPaymentsTerm_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement, Installment Payments, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:href="mck-20230331.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:to="lab_mck_LossContingencySettlementInstallmentPaymentsTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6def5460-653c-43b6-b1c0-a1f795a38314_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_924b9aca-ad55-4a1e-a8c6-ed91da35125a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_c9a7afb9-6c98-4ec8-b0a5-a35f75103ef7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of defined benefit plan amounts recognized in other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome_1e1f0540-a095-4028-83bb-36def0ac5e65_terseLabel_en-US" xlink:label="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating profit (loss)</link:label>
    <link:label id="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome_label_en-US" xlink:label="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit, Net of Expenses, Including Other Income</link:label>
    <link:label id="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome_documentation_en-US" xlink:label="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit, Net of Expenses, Including Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:href="mck-20230331.xsd#mck_GrossProfitNetofExpensesIncludingOtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:to="lab_mck_GrossProfitNetofExpensesIncludingOtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_fa348721-d3ca-432c-bd25-ee858e4397d0_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease receivable</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type and Direct Financing Leases, Lease Receivable, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_0c2f3946-e4f7-47e3-84fb-2c89c1b85b71_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_159f9502-022b-4190-a408-b4e1db579e69_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_1bd1290d-7db9-4446-b2eb-9587590bf4f9_terseLabel_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group) and Austrian Business</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_label_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group) and Austrian Business [Member]</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_documentation_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. and Austrian Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupAndAustrianBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:to="lab_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_6451f48b-fe2d-4e21-8175-e38ecf935324_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, repurchase amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ServicesBusinessMember_756fae3f-666e-48c9-a43b-48e668c73cc7_terseLabel_en-US" xlink:label="lab_mck_ServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Business</link:label>
    <link:label id="lab_mck_ServicesBusinessMember_label_en-US" xlink:label="lab_mck_ServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Business [Member]</link:label>
    <link:label id="lab_mck_ServicesBusinessMember_documentation_en-US" xlink:label="lab_mck_ServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ServicesBusinessMember" xlink:href="mck-20230331.xsd#mck_ServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ServicesBusinessMember" xlink:to="lab_mck_ServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_516f0f41-4ac7-4ca7-8ea5-c395ff539d23_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_16c0ed6a-19e8-4d31-9aa5-f0e7eca4e2cd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_331a83a2-07bf-4e58-9ae8-eb4f49aa39ea_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TenLargestCustomersMember_28d32666-25b2-4205-bf95-290c5aafba8c_terseLabel_en-US" xlink:label="lab_mck_TenLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ten Largest Customers</link:label>
    <link:label id="lab_mck_TenLargestCustomersMember_label_en-US" xlink:label="lab_mck_TenLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ten Largest Customers [Member]</link:label>
    <link:label id="lab_mck_TenLargestCustomersMember_documentation_en-US" xlink:label="lab_mck_TenLargestCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ten Largest Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenLargestCustomersMember" xlink:href="mck-20230331.xsd#mck_TenLargestCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TenLargestCustomersMember" xlink:to="lab_mck_TenLargestCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_34a14aac-22c2-475f-9542-3d7f547919f2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_56ca7751-9415-4154-82b6-29787c59dd82_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_eeba4bd6-ad7e-4d0d-af4b-9381b65b74f3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at Beginning of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_4112ceee-92b2-4bf6-ad49-107b9e148407_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_645c382e-313e-4117-9e87-afaf7b403b23_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember" xlink:href="mck-20230331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestMember" xlink:to="lab_mck_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_b4100210-482a-41de-9a24-55b358059fcb_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_317732f6-c976-4c5d-8b2a-4c370c003877_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_4b403935-151e-402c-9a56-29375749c45c_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_6d515432-134c-4faa-a959-d88d14861790_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_8e94f2b4-caf1-42b8-8cf9-85bb209f5bad_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of unrecognized actuarial loss and prior service costs</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:to="lab_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_6f9fe110-ea23-41fb-97f8-bfbbce912957_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021</link:label>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_label_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMarch12021Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMarch12021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due March 1, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member" xlink:href="mck-20230331.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMarch12021Member" xlink:to="lab_mck_A475NotesDueMarch12021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_97cb8761-94c4-400c-9659-e5362a789d41_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed income commingled funds</link:label>
    <link:label id="lab_us-gaap_FixedIncomeFundsMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeFundsMember" xlink:to="lab_us-gaap_FixedIncomeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f3339db7-b195-4f81-aa50-927651dd790b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_990a19f5-64d1-4901-bee6-921870c89856_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_1ff987a7-fd9d-45bc-944c-27f9d62faa18_terseLabel_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_UKBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_UKBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.K. Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_UKBusinessesDisposalGroupMember" xlink:to="lab_mck_UKBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_36dff156-e969-4062-852e-0b75cd53ddf3_negatedTerseLabel_en-US" xlink:label="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease right-of-use assets</link:label>
    <link:label id="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_label_en-US" xlink:label="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Lease Right-of-use Assets</link:label>
    <link:label id="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_documentation_en-US" xlink:label="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Lease Right-of-use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:href="mck-20230331.xsd#mck_DeferredTaxLiabilitiesLeaseRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:to="lab_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0148c42b-9307-4512-88fd-8d265fc593bd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_e831bff4-cbdc-4848-bdc9-aef008eef6ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_570ee117-ca26-4111-ad90-97c3ea44635a_terseLabel_en-US" xlink:label="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer and participant contributions</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_label_en-US" xlink:label="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Contributions by Employer and Plan Participants</link:label>
    <link:label id="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_documentation_en-US" xlink:label="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Contributions by Employer and Plan Participants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:to="lab_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_464e9c5b-9bb6-4ecc-a0b6-2d15c0d70337_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of other defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:to="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyClaimsSettledNumberOfSubdivisions_ae8208f3-abe8-4f93-8b3a-6fe7284b9f9e_terseLabel_en-US" xlink:label="lab_mck_LossContingencyClaimsSettledNumberOfSubdivisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of subdivisions</link:label>
    <link:label id="lab_mck_LossContingencyClaimsSettledNumberOfSubdivisions_label_en-US" xlink:label="lab_mck_LossContingencyClaimsSettledNumberOfSubdivisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number Of Subdivisions</link:label>
    <link:label id="lab_mck_LossContingencyClaimsSettledNumberOfSubdivisions_documentation_en-US" xlink:label="lab_mck_LossContingencyClaimsSettledNumberOfSubdivisions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number Of Subdivisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClaimsSettledNumberOfSubdivisions" xlink:href="mck-20230331.xsd#mck_LossContingencyClaimsSettledNumberOfSubdivisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyClaimsSettledNumberOfSubdivisions" xlink:to="lab_mck_LossContingencyClaimsSettledNumberOfSubdivisions" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_5b865700-be01-4253-8bf1-ad6d869e8c02_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites_272e81c4-38c2-408f-a715-8eea35165ed0_terseLabel_en-US" xlink:label="lab_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental loss contingency, agreed remediation, number of sites</link:label>
    <link:label id="lab_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites_label_en-US" xlink:label="lab_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Loss Contingency, Agreed Remediation, Number Of Sites</link:label>
    <link:label id="lab_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites_documentation_en-US" xlink:label="lab_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Loss Contingency, Agreed Remediation, Number Of Sites</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites" xlink:href="mck-20230331.xsd#mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites" xlink:to="lab_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_0a6399ed-156e-465e-8681-eec2edd79faa_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_7c64594c-2f70-479b-8ac0-ce3bf8cd47b0_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_2a8eb057-c31c-4fd4-a438-62767d3c5458_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges, net</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_f7b4a391-a56f-4427-9a2e-48525e4c9d9d_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated loss</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_7f886580-9476-4600-9a0f-1348808b4750_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a2540636-cf36-45d0-93ba-1ed6e6edfc07_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled principal payments of long-term debt in 2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_caddbe75-1e16-489f-ab5c-4179c7d131b7_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_c461fb16-4108-4b64-87f6-db02e7b15cfc_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_f455e165-7ade-4f19-8a21-c5bf735ebcfc_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_f9615e2c-54e2-4fdb-9efb-23f33bcfbede_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_2054abd7-e88a-4df2-ba21-fa514dc49617_terseLabel_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments and accelerated depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_label_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_documentation_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:href="mck-20230331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:to="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_8232dd6c-c35c-46a7-b14c-832771642e88_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_987de089-1b13-43e4-a9cf-648f45ee3593_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_28fb39f9-67c8-4d75-9a18-4f40d2e7a398_terseLabel_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue derived from services, percentage (less than)</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_label_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_documentation_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage" xlink:href="mck-20230331.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenueDerivedFromServicesPercentage" xlink:to="lab_mck_RevenueDerivedFromServicesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_baa8af8c-b511-48f6-9948-fc81330c9c3f_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_b9a75fe6-af55-42f4-9d91-86f94f1b6aee_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingent liabilities (Note 17)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_044288c0-eb82-4158-ac75-e981e5269b1f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dafbd718-6b88-4f13-b617-d561052e248e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_540d6c41-feee-4966-972e-c6193b065fae_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_5b6d0a13-afc3-4257-8917-096d47047660_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_efa0f7ac-7861-4f5e-abc2-33a5437cb210_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average life of intangibles</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNet_60749ec5-7634-4d94-bc7a-5c2a0233d8a2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets</link:label>
    <link:label id="lab_us-gaap_AssetsNet_label_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNet" xlink:to="lab_us-gaap_AssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_b45ead90-a8e0-4d80-8dd6-838e285409fd_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_6cdfc705-ab4b-42f9-a934-19c955d7a4f5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_a0d6c851-c89a-4f87-ae88-6c98ea11bccb_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_3132fdcd-426b-4973-a713-cf8ff7823917_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b09f5075-c269-4073-94ac-c39f3163aa18_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4beedb81-09ac-4f44-bf0a-6c4abd880c00_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_517f6d2f-24e7-4187-a364-95631553302c_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost - benefits earned during the year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_2205ed47-c31e-4a4d-ae40-d78003782802_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_81e55d2b-2569-45c6-a17c-72173b488180_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_95d6cc78-2c93-4a7b-b793-141ba8063981_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_d3640f78-af3c-4ab6-b2c2-8e12e15e47f2_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_d9a4b419-5e1f-4655-80b6-c914954c13c4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_bdc816e1-dcfd-4588-8841-d740d9f94516_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_efab26ba-70b0-45b4-bfd2-dd6a7f3d402f_terseLabel_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_label_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan, Current</link:label>
    <link:label id="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_documentation_en-US" xlink:label="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:href="mck-20230331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:to="lab_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DefinedContributionPlanMatchingDomain_9ca6b63b-34ba-4d4e-87aa-63e5fe4fe972_terseLabel_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Domain]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingDomain_label_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Matching [Domain]</link:label>
    <link:label id="lab_mck_DefinedContributionPlanMatchingDomain_documentation_en-US" xlink:label="lab_mck_DefinedContributionPlanMatchingDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Defined Contribution Plan Matching [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain" xlink:href="mck-20230331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain" xlink:to="lab_mck_DefinedContributionPlanMatchingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4dc59b45-6e87-4ee0-8579-c57e9e853847_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations Disclosures</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_745fb366-a90d-4122-94f0-39f05639ebac_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_37cb3ca5-813b-4912-bfdd-8994c31e4654_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings of foreign operations</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_edf65013-4db2-4744-a463-4433f26bfe6a_terseLabel_en-US" xlink:label="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of plan asset value</link:label>
    <link:label id="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_label_en-US" xlink:label="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value</link:label>
    <link:label id="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_documentation_en-US" xlink:label="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:href="mck-20230331.xsd#mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:to="lab_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c6488854-38de-4820-b8b3-3030539d3b80_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_63002d77-3d4c-45e7-bc1f-2a95d766ee80_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Reclassification to Liability</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Reclassification to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:to="lab_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_f5b3fdfb-1abc-41c8-ac6b-dd69d6c41d5a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_6762d913-d34b-4e4d-bfd6-b968ba14fc9e_negatedTerseLabel_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net tax benefit on intellectual property transfer</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_label_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit</link:label>
    <link:label id="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_documentation_en-US" xlink:label="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:to="lab_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_f79f34fc-8782-426c-9d5f-c95333cb2970_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_e8780deb-6900-4755-80f8-f838cf15c18c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_79d44e00-249a-485a-9425-36f72597d63f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_c366c559-f535-4258-99a5-ade32703382b_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_b13d416d-3064-4e22-81de-e75c0d9f9c6c_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rates (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_83fed35f-0096-469f-8258-f9b07165315c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_080a72b4-e148-46e6-8bb2-174950c6bfc4_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_79de7cb1-5d29-4e14-a8fb-57a8b201e01d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_72339276-246a-48e7-80ca-8d2c366fe7c5_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held at NAV practical expedient</link:label>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Other than Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_ae55fe9a-b5c1-4c31-b041-61bbd860b7f2_negatedTerseLabel_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges, net</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_23648e12-d229-4bdc-a2b7-24955e7a1c2b_terseLabel_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges, net</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_label_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_documentation_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:href="mck-20230331.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:to="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_f494dd7b-316f-4a53-a620-36df44356159_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_8570105f-2780-4d69-86c8-6f792212e624_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_3379f433-36c1-46ed-a635-790185c0854e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_0b04bfbc-2019-47e5-9357-790d50eae9e3_terseLabel_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation</link:label>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_label_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember_documentation_en-US" xlink:label="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Native American Tribes Other Than Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:href="mck-20230331.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:to="lab_mck_NativeAmericanTribesOtherThanCherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_a948baf0-06cf-4987-8461-df4cd1de349d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_cfec9bdd-7b9f-484a-9db0-9bf7a957cb00_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnfundedPlanMember_06c6dcf0-105f-46f9-b09d-1fd2e77ef7c0_terseLabel_en-US" xlink:label="lab_us-gaap_UnfundedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfunded plan</link:label>
    <link:label id="lab_us-gaap_UnfundedPlanMember_label_en-US" xlink:label="lab_us-gaap_UnfundedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Unfunded Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnfundedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnfundedPlanMember" xlink:to="lab_us-gaap_UnfundedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_b22c5feb-042f-4541-8457-65a0b405e334_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_a41952b0-dda1-490a-aae5-ab17d4361d20_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of income (loss) from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FormationOfBusiness_83d5e57c-49aa-4f0b-a041-ede39f5c502c_terseLabel_en-US" xlink:label="lab_mck_FormationOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Formation of SCRI Oncology, LLC</link:label>
    <link:label id="lab_mck_FormationOfBusiness_label_en-US" xlink:label="lab_mck_FormationOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Formation Of Business</link:label>
    <link:label id="lab_mck_FormationOfBusiness_documentation_en-US" xlink:label="lab_mck_FormationOfBusiness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Formation Of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FormationOfBusiness" xlink:href="mck-20230331.xsd#mck_FormationOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FormationOfBusiness" xlink:to="lab_mck_FormationOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_03cac0fb-a225-491a-8a2b-1f822357860f_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total settlement to be used to remediate damages (in percent)</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_label_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:href="mck-20230331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:to="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_2f9edf11-0ee6-45d2-937d-9f3f584c9714_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_0f8ae304-9c62-4cc2-aafa-a463f04373b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_61b07256-28ef-426b-a5fa-29396c1a7418_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0c9be9cb-b462-4ae9-9685-7b79a941676f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_311fcb11-ea4f-4186-8194-2c4bd07a4d7b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_d80b0a03-cf20-4b83-9caf-f7ef91862b97_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FinanceLeaseCost_3a76da2f-862a-45de-8b88-0af36da8504a_totalLabel_en-US" xlink:label="lab_mck_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease cost</link:label>
    <link:label id="lab_mck_FinanceLeaseCost_label_en-US" xlink:label="lab_mck_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_mck_FinanceLeaseCost_documentation_en-US" xlink:label="lab_mck_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost" xlink:href="mck-20230331.xsd#mck_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FinanceLeaseCost" xlink:to="lab_mck_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_4b75dffe-ee79-455d-b8fa-b9f454fe056b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_a62d736f-fee8-4858-85ba-84788d807860_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_895ba7ff-10fa-4582-899d-12372259aa83_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_cb7fabeb-0953-41cf-8b73-e6c8d610e069_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding common shares</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_0665a574-b31d-421a-9b11-3ebedfc44497_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6341b2f0-aa4d-45df-869d-2bfa33e3d81b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnContractTermination_17f26c2a-a229-4dc5-8760-ba8d3e54bd79_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnContractTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain for early termination of tax receivable agreement</link:label>
    <link:label id="lab_us-gaap_GainLossOnContractTermination_label_en-US" xlink:label="lab_us-gaap_GainLossOnContractTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Contract Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnContractTermination" xlink:to="lab_us-gaap_GainLossOnContractTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FirstPartOfPayContributionMember_98055bcc-a1aa-453b-929e-b1a255bfca5d_terseLabel_en-US" xlink:label="lab_mck_FirstPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Part Of Pay Contribution</link:label>
    <link:label id="lab_mck_FirstPartOfPayContributionMember_label_en-US" xlink:label="lab_mck_FirstPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Part Of Pay Contribution [Member]</link:label>
    <link:label id="lab_mck_FirstPartOfPayContributionMember_documentation_en-US" xlink:label="lab_mck_FirstPartOfPayContributionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Part Of Pay Contribution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FirstPartOfPayContributionMember" xlink:href="mck-20230331.xsd#mck_FirstPartOfPayContributionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FirstPartOfPayContributionMember" xlink:to="lab_mck_FirstPartOfPayContributionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EmployeeContributions_7c78ec95-e0a0-4481-9d3a-d2cd3f6e0c35_terseLabel_en-US" xlink:label="lab_mck_EmployeeContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions (as a percent)</link:label>
    <link:label id="lab_mck_EmployeeContributions_label_en-US" xlink:label="lab_mck_EmployeeContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Contributions</link:label>
    <link:label id="lab_mck_EmployeeContributions_documentation_en-US" xlink:label="lab_mck_EmployeeContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of contributions made by plan participants. This item represents a periodic increase to the plan obligation and a percentage increase to plan assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeContributions" xlink:href="mck-20230331.xsd#mck_EmployeeContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EmployeeContributions" xlink:to="lab_mck_EmployeeContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A2013StockPlanMember_41841729-050f-4f68-b474-93e404db9ac7_terseLabel_en-US" xlink:label="lab_mck_A2013StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Stock Plan</link:label>
    <link:label id="lab_mck_A2013StockPlanMember_label_en-US" xlink:label="lab_mck_A2013StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Stock Plan [Member]</link:label>
    <link:label id="lab_mck_A2013StockPlanMember_documentation_en-US" xlink:label="lab_mck_A2013StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Stock Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2013StockPlanMember" xlink:href="mck-20230331.xsd#mck_A2013StockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A2013StockPlanMember" xlink:to="lab_mck_A2013StockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_9ae1aa74-2081-4156-97fc-d07399b79149_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_e34eacf7-b2c4-4b5d-9030-6fe1b1c3e1e4_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_86279117-6032-4509-a9f0-84de19ad5999_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_7f7e9ce3-3c0c-4588-8df7-8da42563bc95_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits at end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_0ee9197a-fe66-4545-87cd-1d6452c5c6cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GainLossOnDerivativeTermination_8816a443-0c5d-4d46-85c3-86e6f276605f_terseLabel_en-US" xlink:label="lab_mck_GainLossOnDerivativeTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on derivative termination</link:label>
    <link:label id="lab_mck_GainLossOnDerivativeTermination_6319af16-e952-4dd9-8d58-0c27811dc687_negatedTerseLabel_en-US" xlink:label="lab_mck_GainLossOnDerivativeTermination" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on derivative termination</link:label>
    <link:label id="lab_mck_GainLossOnDerivativeTermination_label_en-US" xlink:label="lab_mck_GainLossOnDerivativeTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Derivative Termination</link:label>
    <link:label id="lab_mck_GainLossOnDerivativeTermination_documentation_en-US" xlink:label="lab_mck_GainLossOnDerivativeTermination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Derivative Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnDerivativeTermination" xlink:href="mck-20230331.xsd#mck_GainLossOnDerivativeTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GainLossOnDerivativeTermination" xlink:to="lab_mck_GainLossOnDerivativeTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_7c340330-2012-4b93-a99c-0fdc5301902e_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recognized on the balance sheet</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_bdde0f11-7e6c-40c6-a4dc-5830d675df93_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and long-lived asset impairment charges</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_d70fd6fb-9287-490f-bc20-ba54cf58af81_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4a57ff09-51e0-4e1d-b238-8a593ce98367_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_9367ecaf-a2e4-419d-86d4-1b4ff7fe1b0c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_7eaca0af-5f9e-4bb7-8d00-aed92c2171b4_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a7f7a053-6a79-4529-83e8-52833b4926b4_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening retained earnings adjustments: adoption of new accounting standards</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_246e9d76-a02f-4271-8ccb-cc4e9f01f5b2_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rates</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_474ebef8-7e42-486f-8ac1-d0e6333bea1a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_981e5420-33ab-4d62-ad31-c90eab3401b5_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_2cbc304d-fd83-4471-84ab-2508070068ac_terseLabel_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Joint Venture</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_label_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Pharmaceutical Wholesale Joint Venture [Member]</link:label>
    <link:label id="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember_documentation_en-US" xlink:label="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">German Wholesale Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:href="mck-20230331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:to="lab_mck_GermanPharmaceuticalWholesaleJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_22903c15-9920-46be-891e-0a5c3651e62a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_6c26c685-ac02-4de9-b138-87e1b2561bdd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_28ead31a-afdd-47dd-9cbd-9fdca9f36df7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_adf596c5-8db0-41bc-b971-81bf131856f1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_2ad13c6d-309c-4212-8497-a471ac58ffcc_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_baab589a-8604-4257-a4b9-2d73232d608c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a3af7b94-0ef4-4ca3-ac12-673a0d11d5a9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8aa51534-6ce9-4a9a-908d-71fbc04402a9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_44838e42-6683-401e-b9e0-bb6056725753_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeasesWeightedAverageDiscountRateAbstract_888e4f0d-6f9e-4009-8fb4-991ead1766bb_terseLabel_en-US" xlink:label="lab_mck_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_mck_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_mck_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_mck_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_mck_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeasesWeightedAverageDiscountRateAbstract" xlink:href="mck-20230331.xsd#mck_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_mck_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_f9919fb3-178e-4c4c-8c0f-63cf90088cd5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_54f71c75-9beb-4514-8823-83a2b60b36c8_terseLabel_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes due February 17, 2029</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_label_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029 [Member]</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_documentation_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:href="mck-20230331.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:to="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_7f7a7381-4cbf-4c88-8f59-9c8df48db67f_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_cb036f40-d727-4386-95b0-2ad6d7b5f53c_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan Relocation of Corporate Headquarters [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:href="mck-20230331.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_e77790d9-8ed3-487a-98c6-27e8cbb7a261_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreements</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimatedInsuranceRecoveries_3a83e84c-fa76-4380-abfa-04e48794100e_terseLabel_en-US" xlink:label="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probable loss recovery</link:label>
    <link:label id="lab_us-gaap_EstimatedInsuranceRecoveries_label_en-US" xlink:label="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Insurance Recoveries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimatedInsuranceRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimatedInsuranceRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimatedInsuranceRecoveries" xlink:to="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_c20555f7-6219-4ad1-8677-a89ab20dcf79_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DerivativeNotionalAmountTerminated_d73449a7-6f89-4269-b429-ca245f97a42c_terseLabel_en-US" xlink:label="lab_mck_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional mount, terminated</link:label>
    <link:label id="lab_mck_DerivativeNotionalAmountTerminated_label_en-US" xlink:label="lab_mck_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Terminated</link:label>
    <link:label id="lab_mck_DerivativeNotionalAmountTerminated_documentation_en-US" xlink:label="lab_mck_DerivativeNotionalAmountTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount, Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DerivativeNotionalAmountTerminated" xlink:href="mck-20230331.xsd#mck_DerivativeNotionalAmountTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DerivativeNotionalAmountTerminated" xlink:to="lab_mck_DerivativeNotionalAmountTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_3bb3a954-f700-499e-a0ed-4eca4b72fba9_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at end of period</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_3aa8bda8-8766-4437-b569-4a2982f10d1e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIFO reserve</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReserve_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReserve" xlink:to="lab_us-gaap_InventoryLIFOReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock_e3b281d1-b771-4e95-a759-c66cc1c22f79_terseLabel_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock_label_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantees And Warranties [Text Block]</link:label>
    <link:label id="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock_documentation_en-US" xlink:label="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial guarantees And warranties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:href="mck-20230331.xsd#mck_FinancialGuaranteesAndWarrantiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:to="lab_mck_FinancialGuaranteesAndWarrantiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_74555664-9ac5-42e6-bb78-879da5a25901_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LeaseLiabilityUndiscountedExcessAmount_e1a240b2-cc92-4b40-af4f-3d116c75b313_negatedTotalLabel_en-US" xlink:label="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_mck_LeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_mck_LeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_mck_LeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_8fe9e166-2456-418d-9a00-ef01140256b7_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_490c62f0-ed0b-4b29-9d75-75f430cf8e95_verboseLabel_en-US" xlink:label="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-lived assets</link:label>
    <link:label id="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_label_en-US" xlink:label="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Including Net Capitalized Software</link:label>
    <link:label id="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_documentation_en-US" xlink:label="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Including Net Capitalized Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:href="mck-20230331.xsd#mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:to="lab_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2021Member_686407c9-7a67-4bb1-90b0-9c577e3ea204_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2021</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2021Member_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2021 [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2021Member_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2021Member" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseMay2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseMay2021Member" xlink:to="lab_mck_AcceleratedShareRepurchaseMay2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_f83808a5-4936-4225-80ec-63d4a562083b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_315f7c9e-b8b6-43d9-a915-7db9df404118_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_1aa74144-662a-4913-a9eb-76bf6ab1591e_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_5bf415cc-179d-446a-85fe-308a15aeed08_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_04c819cb-490f-4b66-b833-fc77dac48ba5_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_7adeadb7-534b-44a5-847c-4bbe1086f71a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_632c033c-7eed-4cab-a63f-2817777159e2_terseLabel_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes due December 15, 2022</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_label_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022 [Member]</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_documentation_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member" xlink:href="mck-20230331.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A270NotesDueDecember152022Member" xlink:to="lab_mck_A270NotesDueDecember152022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_348dc3ef-4f09-4a41-b518-3f4e1c09f9e0_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_90cd1ce2-0cfd-4686-ae32-1e5b1577693e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_b28e0957-90ac-4331-ae73-98a13c1e96ea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_3b4a61df-d3bd-4736-b3bd-860f19eb531b_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DerecognitionOfNoncontrollingInterests_f61c2ff2-4904-4ddb-b088-230a3c09f040_negatedTerseLabel_en-US" xlink:label="lab_mck_DerecognitionOfNoncontrollingInterests" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derecognition of noncontrolling interests in McKesson Europe AG</link:label>
    <link:label id="lab_mck_DerecognitionOfNoncontrollingInterests_label_en-US" xlink:label="lab_mck_DerecognitionOfNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derecognition of Noncontrolling Interests</link:label>
    <link:label id="lab_mck_DerecognitionOfNoncontrollingInterests_documentation_en-US" xlink:label="lab_mck_DerecognitionOfNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DerecognitionOfNoncontrollingInterests" xlink:href="mck-20230331.xsd#mck_DerecognitionOfNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DerecognitionOfNoncontrollingInterests" xlink:to="lab_mck_DerecognitionOfNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_c1c531c8-acb6-4478-b935-5436b931a8f4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_7b7fd435-102d-4036-838d-3d788af889b3_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive gain (loss) derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:href="mck-20230331.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_016fcd31-6e19-4c55-8165-aaaa66a6b144_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_3e7eb1b8-55c1-4d6e-87eb-cde291b1c79e_terseLabel_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities and Cherokee Nation</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_label_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities and Cherokee Nation [Member]</link:label>
    <link:label id="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_documentation_en-US" xlink:label="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settling Governmental Entities and Cherokee Nation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:href="mck-20230331.xsd#mck_SettlingGovernmentalEntitiesAndCherokeeNationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:to="lab_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_5b4ded6b-cfb6-4041-940e-93a3adf40e2f_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_8fdacaf0-7e74-48fa-871d-f122b00e0130_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_bc12a187-6a35-4055-a5cb-220d637646cd_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_dc61fc01-5c37-4df9-898f-fa08e564900b_terseLabel_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_label_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021 [Member]</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_documentation_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member" xlink:href="mck-20230331.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A063EuroNotesDueAugust172021Member" xlink:to="lab_mck_A063EuroNotesDueAugust172021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfAdditionalDefendants_c2b906b3-0dbd-4975-854f-f27c513bfb5c_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfAdditionalDefendants_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional Defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfAdditionalDefendants_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfAdditionalDefendants" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfAdditionalDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfAdditionalDefendants" xlink:to="lab_mck_LossContingencyNumberOfAdditionalDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_01e49bd8-bd6c-44a4-b6e5-7fdefac16cc7_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EUR</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b4fa533f-390b-463f-a484-0ceff2bd08de_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberofSoftwareProducts_24385e18-87c7-4f33-8e2f-7cc0600b94ae_terseLabel_en-US" xlink:label="lab_mck_NumberofSoftwareProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of software products</link:label>
    <link:label id="lab_mck_NumberofSoftwareProducts_label_en-US" xlink:label="lab_mck_NumberofSoftwareProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Software Products</link:label>
    <link:label id="lab_mck_NumberofSoftwareProducts_documentation_en-US" xlink:label="lab_mck_NumberofSoftwareProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Software Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSoftwareProducts" xlink:href="mck-20230331.xsd#mck_NumberofSoftwareProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberofSoftwareProducts" xlink:to="lab_mck_NumberofSoftwareProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_fc52ab4a-891b-449b-8152-ba31e2c05d77_terseLabel_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business</link:label>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_label_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business [Member]</link:label>
    <link:label id="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_documentation_en-US" xlink:label="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Health Benefit Claims Management and Plan Administrative Services Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:href="mck-20230331.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:to="lab_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_91eca581-32dd-46a1-bff4-7f473e234b9e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2022Member_068b9c28-ec85-4d11-a083-197dec31028c_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2022</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2022Member_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2022 [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMay2022Member_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMay2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase, May 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2022Member" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseMay2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseMay2022Member" xlink:to="lab_mck_AcceleratedShareRepurchaseMay2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bb97a8fe-d252-4435-975e-b2eecba80e84_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_a4044cd0-0e6d-43c0-a6c3-722dbc8a701b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_d7b8ba8b-22b1-4296-a7ce-6d734008dcf5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual, payments</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_9a53ea5e-3150-4f55-abab-8faa4f72b8a8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_5bed6033-ca66-41e4-bb63-d6dea32aef94_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_a0a91a77-d791-41f3-94f3-f6fd6a7279f1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived asset impairment charges, before tax</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_fa9c255f-6595-4885-8e76-fa8de04f1e36_terseLabel_en-US" xlink:label="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evanston Police Pension Fund v. McKesson Corporation</link:label>
    <link:label id="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_label_en-US" xlink:label="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evanston Police Pension Fund v. McKesson Corporation [Member]</link:label>
    <link:label id="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_documentation_en-US" xlink:label="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evanston Police Pension Fund v. McKesson Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:href="mck-20230331.xsd#mck_EvanstonPolicePensionFundv.McKessonCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:to="lab_mck_EvanstonPolicePensionFundv.McKessonCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember_9a2b02cf-80c2-450a-8888-93c25b26fdff_terseLabel_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Operational Efficiencies and Cost Optimization</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember_label_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Operational Efficiencies and Cost Optimization [Member]</link:label>
    <link:label id="lab_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember_documentation_en-US" xlink:label="lab_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Growth Initiative Plan - Operational Efficiencies and Cost Optimization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember" xlink:href="mck-20230331.xsd#mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember" xlink:to="lab_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>mck-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:1eea9b32-7227-4c4c-b033-5c353ea41e5b,g:3de8d065-e076-4ee0-8f0c-2df01cc3ca1e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5c31f79f-7b35-4461-ad21-ff882f998826" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_bd0bb557-e128-4624-a6b1-f3a22a83be46" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c31f79f-7b35-4461-ad21-ff882f998826" xlink:to="loc_dei_EntitiesTable_bd0bb557-e128-4624-a6b1-f3a22a83be46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0a5f6628-9718-4086-9e41-176883b440a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_bd0bb557-e128-4624-a6b1-f3a22a83be46" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0a5f6628-9718-4086-9e41-176883b440a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0a5f6628-9718-4086-9e41-176883b440a1" xlink:to="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7d893635-43d5-4732-b267-e16ee1207e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:to="loc_us-gaap_CommonStockMember_7d893635-43d5-4732-b267-e16ee1207e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.500NotesDue2025Member_9a951edc-1ad8-4279-88ad-56366cfccc9d" xlink:href="mck-20230331.xsd#mck_A1.500NotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:to="loc_mck_A1.500NotesDue2025Member_9a951edc-1ad8-4279-88ad-56366cfccc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1.625NotesDue2026Member_190d0389-d164-4909-b3b1-5128d3e38fd6" xlink:href="mck-20230331.xsd#mck_A1.625NotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:to="loc_mck_A1.625NotesDue2026Member_190d0389-d164-4909-b3b1-5128d3e38fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3.125NotesDue2029Member_a682ae3a-ceed-4f7a-b805-c73966762ee4" xlink:href="mck-20230331.xsd#mck_A3.125NotesDue2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fb8c2d67-cef6-45b2-af9c-a1fadcc93c4c" xlink:to="loc_mck_A3.125NotesDue2029Member_a682ae3a-ceed-4f7a-b805-c73966762ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_bd0bb557-e128-4624-a6b1-f3a22a83be46" xlink:to="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4035fa61-e677-4b67-b3b4-09ab5ed56801" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentType_4035fa61-e677-4b67-b3b4-09ab5ed56801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_2ffb8436-f2ee-4bb6-baaa-d6f33f3e362f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentAnnualReport_2ffb8436-f2ee-4bb6-baaa-d6f33f3e362f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f3033b66-f638-4110-bc1c-d98144246969" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentPeriodEndDate_f3033b66-f638-4110-bc1c-d98144246969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4a75515b-9072-4e09-99e7-27e4be29ae32" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_CurrentFiscalYearEndDate_4a75515b-9072-4e09-99e7-27e4be29ae32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_48f0b1a8-0009-4eb5-97bc-58cb1d6a9a5a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentTransitionReport_48f0b1a8-0009-4eb5-97bc-58cb1d6a9a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_580f4bc7-8482-43c0-a536-6040d6497add" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityFileNumber_580f4bc7-8482-43c0-a536-6040d6497add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2256ff9f-95cf-4e98-9fd0-57489fbc896d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityRegistrantName_2256ff9f-95cf-4e98-9fd0-57489fbc896d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7771a1fe-ecfd-4ca1-baf0-1b2033de5327" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7771a1fe-ecfd-4ca1-baf0-1b2033de5327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_cad67c1d-3a2b-4ede-8044-4fd5e6062554" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityTaxIdentificationNumber_cad67c1d-3a2b-4ede-8044-4fd5e6062554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bc6e73f6-3715-49ab-ab71-acb558f43db6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityAddressAddressLine1_bc6e73f6-3715-49ab-ab71-acb558f43db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e5f4fb25-48cc-4029-b8f5-77dc74fbfdc8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityAddressCityOrTown_e5f4fb25-48cc-4029-b8f5-77dc74fbfdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a71cfd1f-5f2b-4310-817d-af66ebfea3b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityAddressStateOrProvince_a71cfd1f-5f2b-4310-817d-af66ebfea3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a369e87c-1da5-46b1-ba51-c229e6495350" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityAddressPostalZipCode_a369e87c-1da5-46b1-ba51-c229e6495350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a5b1f3d5-6097-4ad4-b0f3-3f8684b443b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_CityAreaCode_a5b1f3d5-6097-4ad4-b0f3-3f8684b443b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_19778895-555b-45a0-9d69-ece01a465c28" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_LocalPhoneNumber_19778895-555b-45a0-9d69-ece01a465c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b6e20d5a-de07-4976-883a-5669ea57df94" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_Security12bTitle_b6e20d5a-de07-4976-883a-5669ea57df94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4aa4d831-8bf6-478c-a737-83eda5837f2b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_TradingSymbol_4aa4d831-8bf6-478c-a737-83eda5837f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_153660a9-f511-4fe7-8a32-806165353608" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_SecurityExchangeName_153660a9-f511-4fe7-8a32-806165353608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_3530ecfd-7e8a-407f-9528-35d289a12924" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_3530ecfd-7e8a-407f-9528-35d289a12924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_c93a9cf9-c113-434f-aea5-1757ebe1620f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityVoluntaryFilers_c93a9cf9-c113-434f-aea5-1757ebe1620f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6c4772cc-278d-4729-9032-66c7747f254c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityCurrentReportingStatus_6c4772cc-278d-4729-9032-66c7747f254c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9be70cec-bfe1-4dea-ada7-54481d1ef18b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityInteractiveDataCurrent_9be70cec-bfe1-4dea-ada7-54481d1ef18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_3e2e5d48-751f-4aac-95a6-ea59ae08a0e6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityFilerCategory_3e2e5d48-751f-4aac-95a6-ea59ae08a0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f5db3b4c-78c7-445c-ad10-7ed56760a74f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntitySmallBusiness_f5db3b4c-78c7-445c-ad10-7ed56760a74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_2b65063a-535b-43b9-8d39-f97232dca689" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityEmergingGrowthCompany_2b65063a-535b-43b9-8d39-f97232dca689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_718f042e-6a14-4cf9-b77d-5126eeb64ac0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_IcfrAuditorAttestationFlag_718f042e-6a14-4cf9-b77d-5126eeb64ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_0ac3c77c-06eb-41db-b165-34d8e50fd32f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityShellCompany_0ac3c77c-06eb-41db-b165-34d8e50fd32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_75b0b9b0-6bda-4f15-a7e9-ec7a74ba0336" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityPublicFloat_75b0b9b0-6bda-4f15-a7e9-ec7a74ba0336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2df08074-0b91-43e3-b1a7-018676dcfe11" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2df08074-0b91-43e3-b1a7-018676dcfe11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_2f1ef158-1ba1-4af4-bf90-de07fce86fd0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_2f1ef158-1ba1-4af4-bf90-de07fce86fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_55e7b67d-be31-40d5-a981-6368ec3316e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_EntityCentralIndexKey_55e7b67d-be31-40d5-a981-6368ec3316e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_185c1b22-1286-4701-b109-600977874c7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_185c1b22-1286-4701-b109-600977874c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_68d307d4-6c03-4995-8047-976bcbabafa2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_DocumentFiscalYearFocus_68d307d4-6c03-4995-8047-976bcbabafa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_998b8780-da79-4f29-be4f-5e7906f47a68" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_11187f4f-9916-4de1-8d1a-edace0b9149c" xlink:to="loc_dei_AmendmentFlag_998b8780-da79-4f29-be4f-5e7906f47a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/AuditInformation" xlink:type="simple" xlink:href="mck-20230331.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_AuditorInformationAbstract_dc42aed7-fb94-42ad-a647-9503ef6904b6" xlink:href="mck-20230331.xsd#mck_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_e2595e6e-080c-4933-b065-a91a0215d646" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_AuditorInformationAbstract_dc42aed7-fb94-42ad-a647-9503ef6904b6" xlink:to="loc_dei_AuditorFirmId_e2595e6e-080c-4933-b065-a91a0215d646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_9867a310-4b90-47ee-b82f-53de8f18ff3e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_AuditorInformationAbstract_dc42aed7-fb94-42ad-a647-9503ef6904b6" xlink:to="loc_dei_AuditorLocation_9867a310-4b90-47ee-b82f-53de8f18ff3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_2fae72c9-b02f-4442-a189-8b755297701a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_AuditorInformationAbstract_dc42aed7-fb94-42ad-a647-9503ef6904b6" xlink:to="loc_dei_AuditorName_2fae72c9-b02f-4442-a189-8b755297701a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f50433d0-01d4-427a-8372-548407b6b206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f50433d0-01d4-427a-8372-548407b6b206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1721db3e-0d98-4a8a-bdd1-848b3e864e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1721db3e-0d98-4a8a-bdd1-848b3e864e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e716966f-33c6-4226-832f-144cc5eda022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_GrossProfit_e716966f-33c6-4226-832f-144cc5eda022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9a3603da-2896-4884-9945-686a6d9eb6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_9a3603da-2896-4884-9945-686a6d9eb6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_4cf456ba-d9e5-4c49-baa9-6b821ca8e2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_4cf456ba-d9e5-4c49-baa9-6b821ca8e2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_37fd7ef0-0b80-41b8-b773-faa7337b0c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_37fd7ef0-0b80-41b8-b773-faa7337b0c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_cecdccd9-16b5-4937-8872-8a75a94e5baa" xlink:href="mck-20230331.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_cecdccd9-16b5-4937-8872-8a75a94e5baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_632254b0-419c-48c7-a655-53e37ec08eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_OperatingExpenses_632254b0-419c-48c7-a655-53e37ec08eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4ea71cf8-a9ce-406b-a6e9-6810b7c14872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_OperatingIncomeLoss_4ea71cf8-a9ce-406b-a6e9-6810b7c14872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a12ecbcd-aad2-46f0-919a-69800a68d8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_a12ecbcd-aad2-46f0-919a-69800a68d8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ed7a3f72-68b8-4f9b-a1be-4aef14b390a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ed7a3f72-68b8-4f9b-a1be-4aef14b390a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_021e6b02-8265-4a2c-9fb5-00dfafa1417a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_InterestExpense_021e6b02-8265-4a2c-9fb5-00dfafa1417a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9e0aab08-c3d7-447a-8f94-0e4b476a20ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9e0aab08-c3d7-447a-8f94-0e4b476a20ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ea9ddbbe-0a3e-4dda-8267-8add4cd4b9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ea9ddbbe-0a3e-4dda-8267-8add4cd4b9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e453ca59-1869-4602-9dac-a441217e8fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e453ca59-1869-4602-9dac-a441217e8fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_c45ef234-3876-46fb-ba71-c445a26abc2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_c45ef234-3876-46fb-ba71-c445a26abc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d28e7f24-f78c-4b75-acf0-9c2dc0bf3278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_ProfitLoss_d28e7f24-f78c-4b75-acf0-9c2dc0bf3278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d267fc9c-d189-4fe6-88e4-f68686684861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d267fc9c-d189-4fe6-88e4-f68686684861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_67aa566d-bc78-4ff0-b013-767e24e8217f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_NetIncomeLoss_67aa566d-bc78-4ff0-b013-767e24e8217f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0129888b-7146-4f50-b33f-6211897104f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0129888b-7146-4f50-b33f-6211897104f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_101f5193-67d5-4e22-9990-f5b1a5bae511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0129888b-7146-4f50-b33f-6211897104f1" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_101f5193-67d5-4e22-9990-f5b1a5bae511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_ea358303-4166-4b32-9c13-e0b4e500e5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_101f5193-67d5-4e22-9990-f5b1a5bae511" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_ea358303-4166-4b32-9c13-e0b4e500e5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_4a8233e9-5f36-431e-8b9c-d68d588d6072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_101f5193-67d5-4e22-9990-f5b1a5bae511" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_4a8233e9-5f36-431e-8b9c-d68d588d6072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8c813ce0-bb05-46a1-bf5d-adcdcd18fbab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_101f5193-67d5-4e22-9990-f5b1a5bae511" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8c813ce0-bb05-46a1-bf5d-adcdcd18fbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_e962e71e-7f47-493f-bf96-3d24e9a13ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0129888b-7146-4f50-b33f-6211897104f1" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_e962e71e-7f47-493f-bf96-3d24e9a13ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_151d1b7d-31fb-4fd0-bc79-639d9d44d950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_e962e71e-7f47-493f-bf96-3d24e9a13ffa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_151d1b7d-31fb-4fd0-bc79-639d9d44d950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_2fb30639-5ac7-428a-ab67-e4a054b867b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_e962e71e-7f47-493f-bf96-3d24e9a13ffa" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_2fb30639-5ac7-428a-ab67-e4a054b867b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2a32a46b-c43a-442f-ac2d-64bf3c6ac697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_e962e71e-7f47-493f-bf96-3d24e9a13ffa" xlink:to="loc_us-gaap_EarningsPerShareBasic_2a32a46b-c43a-442f-ac2d-64bf3c6ac697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ec5379f7-c913-4768-af55-d24f944b2ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b66d4f46-c505-4c00-bdec-7fd48212166a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ec5379f7-c913-4768-af55-d24f944b2ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_948ebadb-6011-4ad5-9c32-adcb309d86d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ec5379f7-c913-4768-af55-d24f944b2ecd" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_948ebadb-6011-4ad5-9c32-adcb309d86d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1cf3fda5-d58f-4e58-a207-ec71e3ca5287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ec5379f7-c913-4768-af55-d24f944b2ecd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1cf3fda5-d58f-4e58-a207-ec71e3ca5287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4587530-c32e-449c-ad73-452c98d4d456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_227f0beb-77e9-4693-8d47-8a73abddd888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4587530-c32e-449c-ad73-452c98d4d456" xlink:to="loc_us-gaap_ProfitLoss_227f0beb-77e9-4693-8d47-8a73abddd888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f757d9a2-34e8-461f-b09a-2803d68711c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4587530-c32e-449c-ad73-452c98d4d456" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f757d9a2-34e8-461f-b09a-2803d68711c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f69d1de8-c5fe-496d-9e2c-dc6e0f8b46c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f757d9a2-34e8-461f-b09a-2803d68711c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f69d1de8-c5fe-496d-9e2c-dc6e0f8b46c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3b020548-0a3a-4874-9bef-fa8c0004bf64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f757d9a2-34e8-461f-b09a-2803d68711c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3b020548-0a3a-4874-9bef-fa8c0004bf64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_bf175d58-f8dd-4c49-8330-c9075860fab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f757d9a2-34e8-461f-b09a-2803d68711c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_bf175d58-f8dd-4c49-8330-c9075860fab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_375869e2-5007-4e21-98f4-40c6905bfe3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f757d9a2-34e8-461f-b09a-2803d68711c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_375869e2-5007-4e21-98f4-40c6905bfe3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_aed2971a-f320-4979-be59-3ae9bb698ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4587530-c32e-449c-ad73-452c98d4d456" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_aed2971a-f320-4979-be59-3ae9bb698ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c9ee8c88-fa23-4561-8990-28978ac8c149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4587530-c32e-449c-ad73-452c98d4d456" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c9ee8c88-fa23-4561-8990-28978ac8c149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_28fba97d-b15f-4d5f-8cac-49f4f9649592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4587530-c32e-449c-ad73-452c98d4d456" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_28fba97d-b15f-4d5f-8cac-49f4f9649592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4ea70115-13e7-4440-8cca-e37fed4fb391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b5d4d646-a7f3-4c46-80c2-267fe4bc2f16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4ea70115-13e7-4440-8cca-e37fed4fb391" xlink:to="loc_us-gaap_AssetsAbstract_b5d4d646-a7f3-4c46-80c2-267fe4bc2f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_13126cb9-d1f5-4c57-b060-90f3463ae10e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b5d4d646-a7f3-4c46-80c2-267fe4bc2f16" xlink:to="loc_us-gaap_AssetsCurrentAbstract_13126cb9-d1f5-4c57-b060-90f3463ae10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b3f10194-c804-462c-853a-f078ff466d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13126cb9-d1f5-4c57-b060-90f3463ae10e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b3f10194-c804-462c-853a-f078ff466d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_7a79f0f4-f4cb-436a-915d-2a45032a843a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13126cb9-d1f5-4c57-b060-90f3463ae10e" xlink:to="loc_us-gaap_ReceivablesNetCurrent_7a79f0f4-f4cb-436a-915d-2a45032a843a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e9b7a3db-4c3e-4cf4-98b5-0ff1ab401786" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13126cb9-d1f5-4c57-b060-90f3463ae10e" xlink:to="loc_us-gaap_InventoryNet_e9b7a3db-4c3e-4cf4-98b5-0ff1ab401786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_4ec8c171-6434-4c84-8104-92fdb1d66632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13126cb9-d1f5-4c57-b060-90f3463ae10e" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_4ec8c171-6434-4c84-8104-92fdb1d66632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_85cfe645-5fa8-4d50-b97c-9493c1c855cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13126cb9-d1f5-4c57-b060-90f3463ae10e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_85cfe645-5fa8-4d50-b97c-9493c1c855cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3a5523da-fdbd-4f73-9cdd-0e5ffbe1d8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13126cb9-d1f5-4c57-b060-90f3463ae10e" xlink:to="loc_us-gaap_AssetsCurrent_3a5523da-fdbd-4f73-9cdd-0e5ffbe1d8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_df059d9e-0350-4436-93cc-3496d1053234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b5d4d646-a7f3-4c46-80c2-267fe4bc2f16" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_df059d9e-0350-4436-93cc-3496d1053234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ab577a01-162f-420f-a06b-dc73d92dcbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b5d4d646-a7f3-4c46-80c2-267fe4bc2f16" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ab577a01-162f-420f-a06b-dc73d92dcbdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fc02786d-16fc-4b42-9ff6-1319684653fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b5d4d646-a7f3-4c46-80c2-267fe4bc2f16" xlink:to="loc_us-gaap_Goodwill_fc02786d-16fc-4b42-9ff6-1319684653fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3ba0dad7-5a83-422f-8978-50fcd341fc26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b5d4d646-a7f3-4c46-80c2-267fe4bc2f16" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3ba0dad7-5a83-422f-8978-50fcd341fc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_eb7e6691-e290-4288-bbbe-91b6cff3540a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b5d4d646-a7f3-4c46-80c2-267fe4bc2f16" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_eb7e6691-e290-4288-bbbe-91b6cff3540a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1af8db6c-0577-4748-a23e-33b80d0c9e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b5d4d646-a7f3-4c46-80c2-267fe4bc2f16" xlink:to="loc_us-gaap_Assets_1af8db6c-0577-4748-a23e-33b80d0c9e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12c640d0-6cdb-44b3-bbbe-2f0af1101114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4ea70115-13e7-4440-8cca-e37fed4fb391" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12c640d0-6cdb-44b3-bbbe-2f0af1101114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_fbd7c63c-7129-4692-b534-692828992352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12c640d0-6cdb-44b3-bbbe-2f0af1101114" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_fbd7c63c-7129-4692-b534-692828992352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_81809d7d-01dc-4d6d-bf41-817bad1eca4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fbd7c63c-7129-4692-b534-692828992352" xlink:to="loc_us-gaap_AccountsPayableCurrent_81809d7d-01dc-4d6d-bf41-817bad1eca4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f6333e2a-99ac-43ec-9a54-8c4b3d5a9b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fbd7c63c-7129-4692-b534-692828992352" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f6333e2a-99ac-43ec-9a54-8c4b3d5a9b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4a09c74a-b521-4af2-ae4f-45e6ef7c9482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fbd7c63c-7129-4692-b534-692828992352" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4a09c74a-b521-4af2-ae4f-45e6ef7c9482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_1857afc1-3f80-4f92-b721-66d43f39e0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fbd7c63c-7129-4692-b534-692828992352" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_1857afc1-3f80-4f92-b721-66d43f39e0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_401a52c4-0a46-4e17-a2b1-091cc6a6d389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fbd7c63c-7129-4692-b534-692828992352" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_401a52c4-0a46-4e17-a2b1-091cc6a6d389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1d810d1b-1b06-46a6-bcd2-39e038d5bf16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fbd7c63c-7129-4692-b534-692828992352" xlink:to="loc_us-gaap_LiabilitiesCurrent_1d810d1b-1b06-46a6-bcd2-39e038d5bf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_68143d0a-8dcd-4652-8337-5dbb766e305c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12c640d0-6cdb-44b3-bbbe-2f0af1101114" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_68143d0a-8dcd-4652-8337-5dbb766e305c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_75b8466c-ced1-4182-9b51-fe3b4175daf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12c640d0-6cdb-44b3-bbbe-2f0af1101114" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_75b8466c-ced1-4182-9b51-fe3b4175daf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1e91e6b7-a42c-4584-8408-1b9799a65e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12c640d0-6cdb-44b3-bbbe-2f0af1101114" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1e91e6b7-a42c-4584-8408-1b9799a65e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_4111a1df-43b8-45d1-9eb7-6b29d8793d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12c640d0-6cdb-44b3-bbbe-2f0af1101114" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_4111a1df-43b8-45d1-9eb7-6b29d8793d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e1085928-dc8e-4d9e-887c-67d968bc5090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12c640d0-6cdb-44b3-bbbe-2f0af1101114" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e1085928-dc8e-4d9e-887c-67d968bc5090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_06fcfdac-3d29-45a0-9cac-fbf00225af6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12c640d0-6cdb-44b3-bbbe-2f0af1101114" xlink:to="loc_us-gaap_CommitmentsAndContingencies_06fcfdac-3d29-45a0-9cac-fbf00225af6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a0e12dd2-6b8e-49b1-892a-260822da4fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12c640d0-6cdb-44b3-bbbe-2f0af1101114" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a0e12dd2-6b8e-49b1-892a-260822da4fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_509ae032-fb88-4dda-936f-6fbbee2b8e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e12dd2-6b8e-49b1-892a-260822da4fa0" xlink:to="loc_us-gaap_PreferredStockValue_509ae032-fb88-4dda-936f-6fbbee2b8e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8edf74e8-8100-45ad-b614-dda6e509cd74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e12dd2-6b8e-49b1-892a-260822da4fa0" xlink:to="loc_us-gaap_CommonStockValue_8edf74e8-8100-45ad-b614-dda6e509cd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_dd749ba4-cfca-4067-ad22-f0a7cdf2f39d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e12dd2-6b8e-49b1-892a-260822da4fa0" xlink:to="loc_us-gaap_AdditionalPaidInCapital_dd749ba4-cfca-4067-ad22-f0a7cdf2f39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_58b60e87-f774-4e34-a1b8-785a10546822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e12dd2-6b8e-49b1-892a-260822da4fa0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_58b60e87-f774-4e34-a1b8-785a10546822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_41893bb1-abd4-4ed9-acd0-cd6618fbf02a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e12dd2-6b8e-49b1-892a-260822da4fa0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_41893bb1-abd4-4ed9-acd0-cd6618fbf02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_fa71148e-00ae-4e0b-8057-3f0329ab32aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e12dd2-6b8e-49b1-892a-260822da4fa0" xlink:to="loc_us-gaap_TreasuryStockCommonValue_fa71148e-00ae-4e0b-8057-3f0329ab32aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ee37f57e-3940-48f9-93e9-13d426965d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e12dd2-6b8e-49b1-892a-260822da4fa0" xlink:to="loc_us-gaap_StockholdersEquity_ee37f57e-3940-48f9-93e9-13d426965d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_562efe25-e02e-4e32-9b65-db1c6aca6041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e12dd2-6b8e-49b1-892a-260822da4fa0" xlink:to="loc_us-gaap_MinorityInterest_562efe25-e02e-4e32-9b65-db1c6aca6041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6fdd93d5-b05c-4b68-a50e-6d370ad7063c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a0e12dd2-6b8e-49b1-892a-260822da4fa0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6fdd93d5-b05c-4b68-a50e-6d370ad7063c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a0267ffc-b4fd-4ad6-a789-ecce1a04aa8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_12c640d0-6cdb-44b3-bbbe-2f0af1101114" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a0267ffc-b4fd-4ad6-a789-ecce1a04aa8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_337e3c1e-afc9-4d6d-a946-aec4dc8e14ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4d05a3c3-4917-4320-81ba-1dcf1fe9d649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_337e3c1e-afc9-4d6d-a946-aec4dc8e14ed" xlink:to="loc_us-gaap_StatementTable_4d05a3c3-4917-4320-81ba-1dcf1fe9d649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e5411619-4414-4b6a-98bf-e1900085443e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4d05a3c3-4917-4320-81ba-1dcf1fe9d649" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e5411619-4414-4b6a-98bf-e1900085443e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_015c4c3f-c161-43e2-a53e-c496d53b19bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e5411619-4414-4b6a-98bf-e1900085443e" xlink:to="loc_us-gaap_EquityComponentDomain_015c4c3f-c161-43e2-a53e-c496d53b19bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_99b5ec42-0d48-46f0-8e60-4f00295e3e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_015c4c3f-c161-43e2-a53e-c496d53b19bb" xlink:to="loc_us-gaap_TreasuryStockCommonMember_99b5ec42-0d48-46f0-8e60-4f00295e3e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4d05a3c3-4917-4320-81ba-1dcf1fe9d649" xlink:to="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5716aec5-c3f1-4391-9b6a-1a8c817fcc2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5716aec5-c3f1-4391-9b6a-1a8c817fcc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_c6eba1fc-734a-424c-9682-1c0a2e667fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_c6eba1fc-734a-424c-9682-1c0a2e667fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_2c28b02e-11b2-4b89-ad21-c21fdf436c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_PreferredStockSharesIssued_2c28b02e-11b2-4b89-ad21-c21fdf436c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_87f6fc06-1587-4f1b-a3ca-d587ba6cd503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_87f6fc06-1587-4f1b-a3ca-d587ba6cd503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_a417599a-764e-49ef-8549-2111cc71fd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_a417599a-764e-49ef-8549-2111cc71fd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5f8a7423-7ace-4616-b50a-837efd0f6a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5f8a7423-7ace-4616-b50a-837efd0f6a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4e4ee3cb-1d3f-464a-8ce0-c5088253548d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_CommonStockSharesIssued_4e4ee3cb-1d3f-464a-8ce0-c5088253548d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_8bb97fe7-cb51-40ff-bc5e-46a640386071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ed82b05f-6b97-48aa-97d5-b128331c7b44" xlink:to="loc_us-gaap_TreasuryStockCommonShares_8bb97fe7-cb51-40ff-bc5e-46a640386071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a0ca7d9d-17f2-410a-a1f1-fbf077b51d93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5ee1dec8-05f2-4203-a2dc-1405db21abb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a0ca7d9d-17f2-410a-a1f1-fbf077b51d93" xlink:to="loc_us-gaap_StatementTable_5ee1dec8-05f2-4203-a2dc-1405db21abb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5bc0383f-6ddd-4fa2-9fc8-04e3a69fa15d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5ee1dec8-05f2-4203-a2dc-1405db21abb1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5bc0383f-6ddd-4fa2-9fc8-04e3a69fa15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_05e2b321-1531-4035-8ebd-99a12078932b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5bc0383f-6ddd-4fa2-9fc8-04e3a69fa15d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_05e2b321-1531-4035-8ebd-99a12078932b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e672ddfb-7005-4ac0-b9f1-e1fa645f212a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_05e2b321-1531-4035-8ebd-99a12078932b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e672ddfb-7005-4ac0-b9f1-e1fa645f212a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_7179d315-5064-4a1e-9b19-ac46a4f3dc9c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_05e2b321-1531-4035-8ebd-99a12078932b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_7179d315-5064-4a1e-9b19-ac46a4f3dc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9cecddcc-6d3c-4343-bc22-a8cb85037545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5ee1dec8-05f2-4203-a2dc-1405db21abb1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9cecddcc-6d3c-4343-bc22-a8cb85037545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9cecddcc-6d3c-4343-bc22-a8cb85037545" xlink:to="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_87ba05b8-c367-4dd7-a778-a22d893db28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_CommonStockMember_87ba05b8-c367-4dd7-a778-a22d893db28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c4259a2f-9208-488f-b398-2ace246e471d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c4259a2f-9208-488f-b398-2ace246e471d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3c36a4ee-6a44-4cd5-92a1-8ab655d52346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_RetainedEarningsMember_3c36a4ee-6a44-4cd5-92a1-8ab655d52346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d8a7ca25-e03c-4a7b-801a-222faa305d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d8a7ca25-e03c-4a7b-801a-222faa305d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_fed664e0-7368-4685-9b41-5a27f5eb9ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_TreasuryStockCommonMember_fed664e0-7368-4685-9b41-5a27f5eb9ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_fd6c69d6-e7f4-4b9e-8ee3-b796bd44274e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0fe3b2dc-a2d8-49ab-a11e-b7d27262df3c" xlink:to="loc_us-gaap_NoncontrollingInterestMember_fd6c69d6-e7f4-4b9e-8ee3-b796bd44274e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d064fd75-da1d-4215-a93a-829bf508f58e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5ee1dec8-05f2-4203-a2dc-1405db21abb1" xlink:to="loc_us-gaap_StatementLineItems_d064fd75-da1d-4215-a93a-829bf508f58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d064fd75-da1d-4215-a93a-829bf508f58e" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5a8c7184-5f86-466e-b101-85abb3a33afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_SharesOutstanding_5a8c7184-5f86-466e-b101-85abb3a33afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_f7acf3f9-b472-48a2-9eeb-e97484773fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_TreasuryStockCommonShares_f7acf3f9-b472-48a2-9eeb-e97484773fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc241ff7-38b1-492f-8c8a-0ad8a5634a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc241ff7-38b1-492f-8c8a-0ad8a5634a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures_2c0fcbee-2419-4e8a-a341-1a82efb433d5" xlink:href="mck-20230331.xsd#mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures_2c0fcbee-2419-4e8a-a341-1a82efb433d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures_bf3f8d49-9864-4774-b669-f16d6897d63f" xlink:href="mck-20230331.xsd#mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures_bf3f8d49-9864-4774-b669-f16d6897d63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2eb05c17-11e6-444e-bc92-9794304e0b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2eb05c17-11e6-444e-bc92-9794304e0b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_c0100a1e-416f-4abf-b4a1-c18fd2575d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_c0100a1e-416f-4abf-b4a1-c18fd2575d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_fd5b8e06-66fe-45b3-87f8-982680b8e168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_fd5b8e06-66fe-45b3-87f8-982680b8e168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_fc1f6423-27b5-4725-a62d-e3135cc65d72" xlink:href="mck-20230331.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_fc1f6423-27b5-4725-a62d-e3135cc65d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4b7b49d8-6c28-45f6-b48e-e662005eb1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4b7b49d8-6c28-45f6-b48e-e662005eb1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_45df1eea-5185-48f0-a674-217e99242371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_DividendsCommonStockCash_45df1eea-5185-48f0-a674-217e99242371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_5d879589-5013-4117-89d2-9834045b7702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_5d879589-5013-4117-89d2-9834045b7702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_c87d5c0e-200a-4148-92ea-e2b0dd2bcd2f" xlink:href="mck-20230331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_c87d5c0e-200a-4148-92ea-e2b0dd2bcd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_a303a3e1-764f-493e-a26d-f9e8e247c741" xlink:href="mck-20230331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_a303a3e1-764f-493e-a26d-f9e8e247c741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_ed0714e3-9ab9-4ab1-9c00-88c4ffa054ac" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestDecreaseFromReclassificationToLiability"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability_ed0714e3-9ab9-4ab1-9c00-88c4ffa054ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FormationOfBusiness_83ae2f9a-3ee3-491c-9d28-c2136acfe545" xlink:href="mck-20230331.xsd#mck_FormationOfBusiness"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_FormationOfBusiness_83ae2f9a-3ee3-491c-9d28-c2136acfe545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DerecognitionOfNoncontrollingInterests_75601163-1685-4f4f-9569-7bbb51ae46f6" xlink:href="mck-20230331.xsd#mck_DerecognitionOfNoncontrollingInterests"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_mck_DerecognitionOfNoncontrollingInterests_75601163-1685-4f4f-9569-7bbb51ae46f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_88d995bd-c68d-4dc1-8fad-24b55eb709eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_StockholdersEquityOther_88d995bd-c68d-4dc1-8fad-24b55eb709eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_c68206f9-5aa5-49b6-82ef-fe30dacf1ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_SharesOutstanding_c68206f9-5aa5-49b6-82ef-fe30dacf1ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_d97172fc-46cc-47a4-8cc0-c54299c20656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_TreasuryStockCommonShares_d97172fc-46cc-47a4-8cc0-c54299c20656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_253697da-7be8-4d7b-bfcc-4c1d87efdfb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_625c8508-e870-44c9-80c4-96f85ae7ed40" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_253697da-7be8-4d7b-bfcc-4c1d87efdfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParentheticals" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParentheticals"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_913c3622-cdf9-4eef-96cc-c099d7050866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_5d08222f-e4f9-49c2-b005-ab4d3152f42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_913c3622-cdf9-4eef-96cc-c099d7050866" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_5d08222f-e4f9-49c2-b005-ab4d3152f42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1ded64dd-8381-4c13-b971-3319b440c021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4a383b9d-2263-471d-8008-28320da9195e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1ded64dd-8381-4c13-b971-3319b440c021" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4a383b9d-2263-471d-8008-28320da9195e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bd594892-1ef7-45cc-98f9-ffddee704b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4a383b9d-2263-471d-8008-28320da9195e" xlink:to="loc_us-gaap_ProfitLoss_bd594892-1ef7-45cc-98f9-ffddee704b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4a383b9d-2263-471d-8008-28320da9195e" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a21923d7-8568-4806-a27b-eba849f571a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:to="loc_us-gaap_Depreciation_a21923d7-8568-4806-a27b-eba849f571a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_8fac5163-55f6-4eed-aeaf-a501adcde954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:to="loc_us-gaap_AdjustmentForAmortization_8fac5163-55f6-4eed-aeaf-a501adcde954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_bf55f46e-7b8b-4c26-b3c2-d43ab2d50724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_bf55f46e-7b8b-4c26-b3c2-d43ab2d50724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_7b966b5d-1b4c-4c22-aaba-2d59152e70df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_7b966b5d-1b4c-4c22-aaba-2d59152e70df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_a4f03aa4-e4e7-453c-8791-386783bf9829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_a4f03aa4-e4e7-453c-8791-386783bf9829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_07097ce6-c2f6-4fd6-8c8c-4e22ce95cbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:to="loc_us-gaap_OperatingLeaseExpense_07097ce6-c2f6-4fd6-8c8c-4e22ce95cbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_6bde4b21-f3e1-4b04-a0dc-cc1ece0736ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_6bde4b21-f3e1-4b04-a0dc-cc1ece0736ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_5cb562d8-ad87-4418-b3c0-294f5412468f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_5cb562d8-ad87-4418-b3c0-294f5412468f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_13da17ce-c073-44dd-a318-52fbd4593fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_13da17ce-c073-44dd-a318-52fbd4593fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e8e266-27f7-4b0f-9f66-50bae84bb532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_861fc883-be76-4ee4-8b4d-f37df1b8497b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e8e266-27f7-4b0f-9f66-50bae84bb532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_201e54a6-44a1-4e85-bdb9-64afc0a11d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e8e266-27f7-4b0f-9f66-50bae84bb532" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_201e54a6-44a1-4e85-bdb9-64afc0a11d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5f4304d9-ab1f-4a20-9a8e-7f67b2053518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e8e266-27f7-4b0f-9f66-50bae84bb532" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5f4304d9-ab1f-4a20-9a8e-7f67b2053518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9d955596-a61d-4112-a4d2-949b241230c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e8e266-27f7-4b0f-9f66-50bae84bb532" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9d955596-a61d-4112-a4d2-949b241230c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_3a781cba-10a4-476a-bf7b-8da4055d4b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e8e266-27f7-4b0f-9f66-50bae84bb532" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_3a781cba-10a4-476a-bf7b-8da4055d4b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_8776302c-3458-4660-9cc1-5e1bf07b0b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e8e266-27f7-4b0f-9f66-50bae84bb532" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_8776302c-3458-4660-9cc1-5e1bf07b0b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_20299b9d-64ba-41fc-969c-777066d03efc" xlink:href="mck-20230331.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e8e266-27f7-4b0f-9f66-50bae84bb532" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_20299b9d-64ba-41fc-969c-777066d03efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d599e5ce-016e-46f6-a959-28e5342b9787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e8e266-27f7-4b0f-9f66-50bae84bb532" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d599e5ce-016e-46f6-a959-28e5342b9787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e9bd8422-9d5c-4b4a-8e29-f2eb5536d86b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4a383b9d-2263-471d-8008-28320da9195e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e9bd8422-9d5c-4b4a-8e29-f2eb5536d86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eef45c89-642b-4bfb-bb9c-ea0421331f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1ded64dd-8381-4c13-b971-3319b440c021" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eef45c89-642b-4bfb-bb9c-ea0421331f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_aaac5f40-b3a1-4d2e-b5a2-0d86243a2158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eef45c89-642b-4bfb-bb9c-ea0421331f2b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_aaac5f40-b3a1-4d2e-b5a2-0d86243a2158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_29621737-03d4-4c2c-b3e8-763f6c0cf815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eef45c89-642b-4bfb-bb9c-ea0421331f2b" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_29621737-03d4-4c2c-b3e8-763f6c0cf815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_352dfa34-1b20-4edd-a966-eb4d4d67deee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eef45c89-642b-4bfb-bb9c-ea0421331f2b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_352dfa34-1b20-4edd-a966-eb4d4d67deee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_ff603123-5920-45c3-9730-50cca66507f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eef45c89-642b-4bfb-bb9c-ea0421331f2b" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_ff603123-5920-45c3-9730-50cca66507f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f342f634-3948-4af5-947c-012b5b27d0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eef45c89-642b-4bfb-bb9c-ea0421331f2b" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f342f634-3948-4af5-947c-012b5b27d0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ab4f4d8f-af84-4a1d-a2b6-7607ce4bfebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_eef45c89-642b-4bfb-bb9c-ea0421331f2b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ab4f4d8f-af84-4a1d-a2b6-7607ce4bfebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1ded64dd-8381-4c13-b971-3319b440c021" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_cb8a44e8-7fbc-4d70-8fa0-2da3eda1510a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_cb8a44e8-7fbc-4d70-8fa0-2da3eda1510a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_238f57c0-a49f-4238-ae8f-1985afa81fad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_238f57c0-a49f-4238-ae8f-1985afa81fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3864cab4-32db-4815-9e4b-f804aa41afd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3864cab4-32db-4815-9e4b-f804aa41afd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_1d40b081-0090-4863-8af4-d1ab4a25416f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_1d40b081-0090-4863-8af4-d1ab4a25416f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a994414b-ecc0-4de5-bcb8-2c83e714611f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a994414b-ecc0-4de5-bcb8-2c83e714611f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_7328b16e-0c22-419f-a9b3-e22b7957d1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepurchaseOfEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_7328b16e-0c22-419f-a9b3-e22b7957d1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9a8464f4-7538-4a87-9c62-2da82d783d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_7328b16e-0c22-419f-a9b3-e22b7957d1f2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9a8464f4-7538-4a87-9c62-2da82d783d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_17eb11f4-30c4-4fb3-a05e-809f2eb4edc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquityAbstract_7328b16e-0c22-419f-a9b3-e22b7957d1f2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_17eb11f4-30c4-4fb3-a05e-809f2eb4edc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_02be36f0-6297-4087-8ec0-d5a29978dcd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_02be36f0-6297-4087-8ec0-d5a29978dcd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_791e6903-07e8-4861-b83d-274741249440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_791e6903-07e8-4861-b83d-274741249440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9a468080-e88d-4604-9250-9693746aacde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9a468080-e88d-4604-9250-9693746aacde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4192c82a-27c3-4e28-b433-56cf95c2a7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b6611af9-6f3f-4beb-8c19-a480e38b75ad" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4192c82a-27c3-4e28-b433-56cf95c2a7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5c12c2e9-e4e2-43d7-97f0-e71668efc428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1ded64dd-8381-4c13-b971-3319b440c021" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5c12c2e9-e4e2-43d7-97f0-e71668efc428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_81020bf8-622e-4dfb-88f3-dd97f0d20c63" xlink:href="mck-20230331.xsd#mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1ded64dd-8381-4c13-b971-3319b440c021" xlink:to="loc_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease_81020bf8-622e-4dfb-88f3-dd97f0d20c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d4dc1d26-a8ef-40c3-b48f-a9da82e36bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1ded64dd-8381-4c13-b971-3319b440c021" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d4dc1d26-a8ef-40c3-b48f-a9da82e36bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e87facf-f4d7-492f-bfef-4bb429cd82b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1ded64dd-8381-4c13-b971-3319b440c021" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e87facf-f4d7-492f-bfef-4bb429cd82b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ecdcb75-68aa-4c2f-b577-84ddd10ba775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1ded64dd-8381-4c13-b971-3319b440c021" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1ecdcb75-68aa-4c2f-b577-84ddd10ba775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_af6701f1-f4af-4abd-b1e0-7183af842b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1ded64dd-8381-4c13-b971-3319b440c021" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_af6701f1-f4af-4abd-b1e0-7183af842b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_c4fafe6e-ee18-468c-acf3-88696cfe1013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_af6701f1-f4af-4abd-b1e0-7183af842b42" xlink:to="loc_us-gaap_RestrictedCashCurrent_c4fafe6e-ee18-468c-acf3-88696cfe1013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7c6d9007-de4a-41a8-bec2-5d97b08acdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_af6701f1-f4af-4abd-b1e0-7183af842b42" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7c6d9007-de4a-41a8-bec2-5d97b08acdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_10df9f46-0e9d-4523-bc5b-9cbf86ee784a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_af6701f1-f4af-4abd-b1e0-7183af842b42" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_10df9f46-0e9d-4523-bc5b-9cbf86ee784a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_ed7dccd8-d3ba-4d52-a391-503618fb732e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_10df9f46-0e9d-4523-bc5b-9cbf86ee784a" xlink:to="loc_us-gaap_InterestPaidNet_ed7dccd8-d3ba-4d52-a391-503618fb732e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_696714b6-a8c7-45a3-b4c6-1e3d2628d40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_10df9f46-0e9d-4523-bc5b-9cbf86ee784a" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_696714b6-a8c7-45a3-b4c6-1e3d2628d40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20230331.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ee7630f3-aaa2-465e-8f8c-8d7cc56175df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_4510e137-2b46-4ec2-9dd9-3fb359391ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee7630f3-aaa2-465e-8f8c-8d7cc56175df" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_4510e137-2b46-4ec2-9dd9-3fb359391ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestitures"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_673aa642-59fe-455b-8e36-58b3feb99653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_b292b28d-4c2e-473a-888a-dc110a512084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_673aa642-59fe-455b-8e36-58b3feb99653" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_b292b28d-4c2e-473a-888a-dc110a512084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet" xlink:type="simple" xlink:href="mck-20230331.xsd#RestructuringImpairmentandRelatedChargesNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7e47d481-7e70-44a2-9a3b-d38e7f849703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_38f775b7-e0fa-4e7c-ae08-b881912bd5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7e47d481-7e70-44a2-9a3b-d38e7f849703" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_38f775b7-e0fa-4e7c-ae08-b881912bd5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eaafdbec-0fc9-4390-b90b-ba6d89504712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a70309d2-a407-4e39-a0a0-bd4322192c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eaafdbec-0fc9-4390-b90b-ba6d89504712" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a70309d2-a407-4e39-a0a0-bd4322192c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNet" xlink:type="simple" xlink:href="mck-20230331.xsd#OtherIncomeNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/OtherIncomeNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_572e68fa-8dec-4594-b2e2-deb1969bf5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_b96dd211-23d9-4ac6-9024-8d573ec42243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_572e68fa-8dec-4594-b2e2-deb1969bf5b0" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_b96dd211-23d9-4ac6-9024-8d573ec42243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_16297f07-8ab5-49b8-b3b3-60c3dac132ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_10471158-9dfd-409d-a0dc-1f57e86238b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_16297f07-8ab5-49b8-b3b3-60c3dac132ba" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_10471158-9dfd-409d-a0dc-1f57e86238b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20230331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_a2134135-2fd3-408c-872b-60bf21957271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_ec33ab94-bde4-462a-898e-6ee560aeead2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_a2134135-2fd3-408c-872b-60bf21957271" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_ec33ab94-bde4-462a-898e-6ee560aeead2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="simple" xlink:href="mck-20230331.xsd#EarningsLossPerCommonShare"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8a5ae378-6e4a-45a4-aea2-47153190a6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_1808a3e3-426f-470b-b45b-6e4c5f88c1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8a5ae378-6e4a-45a4-aea2-47153190a6e0" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_1808a3e3-426f-470b-b45b-6e4c5f88c1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/Leases" xlink:type="simple" xlink:href="mck-20230331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0266be72-bdfd-4eb4-9413-8847200d152f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_953d5d3c-0dbf-44a5-94f9-4f4976e74efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0266be72-bdfd-4eb4-9413-8847200d152f" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_953d5d3c-0dbf-44a5-94f9-4f4976e74efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock_3ad72aac-685a-4185-b4f5-79fa10e4dcc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0266be72-bdfd-4eb4-9413-8847200d152f" xlink:to="loc_us-gaap_LessorSalesTypeLeasesTextBlock_3ad72aac-685a-4185-b4f5-79fa10e4dcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorDirectFinancingLeasesTextBlock_8bbad017-8574-4f6c-8d14-b422ce783163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LessorDirectFinancingLeasesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0266be72-bdfd-4eb4-9413-8847200d152f" xlink:to="loc_us-gaap_LessorDirectFinancingLeasesTextBlock_8bbad017-8574-4f6c-8d14-b422ce783163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20230331.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b80b681a-5669-4972-9883-d790f4065e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_9b839091-6f4e-415e-bf26-d68d30048b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b80b681a-5669-4972-9883-d790f4065e1a" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_9b839091-6f4e-415e-bf26-d68d30048b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c22ed81e-b437-4adc-9d26-82c0e3dc1393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_59a0307a-b934-46ee-9d31-fd3c988ca34b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c22ed81e-b437-4adc-9d26-82c0e3dc1393" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_59a0307a-b934-46ee-9d31-fd3c988ca34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="mck-20230331.xsd#VariableInterestEntities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/VariableInterestEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_b89e7350-f160-4cd6-befd-da27fc13894f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_ed2f30b5-6099-437b-8178-625425e2a1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_b89e7350-f160-4cd6-befd-da27fc13894f" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_ed2f30b5-6099-437b-8178-625425e2a1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefits"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_411650e6-4cba-4e24-bbf9-0d2b1e17b503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_0816f7cc-4e46-415e-b086-b7f4b2eabade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_411650e6-4cba-4e24-bbf9-0d2b1e17b503" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_0816f7cc-4e46-415e-b086-b7f4b2eabade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_83b95631-c500-47fd-a14b-07b6301dffe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_77f19f0e-56a7-4ed2-a862-caa8325c56df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_83b95631-c500-47fd-a14b-07b6301dffe8" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_77f19f0e-56a7-4ed2-a862-caa8325c56df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20230331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_51d3e415-fb43-4390-b6e3-460e6e6e6128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_4538f3c7-6ab0-4d4e-8d76-2b054a87f1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_51d3e415-fb43-4390-b6e3-460e6e6e6128" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_4538f3c7-6ab0-4d4e-8d76-2b054a87f1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarranties" xlink:type="simple" xlink:href="mck-20230331.xsd#FinancialGuaranteesandWarranties"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarranties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_fb5d91e6-9906-47c1-9659-050d9793d2bb" xlink:href="mck-20230331.xsd#mck_FinancialGuaranteesAndWarrantiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock_a0c5fdbd-73ea-4219-be63-cc30af1d2c70" xlink:href="mck-20230331.xsd#mck_FinancialGuaranteesAndWarrantiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_fb5d91e6-9906-47c1-9659-050d9793d2bb" xlink:to="loc_mck_FinancialGuaranteesAndWarrantiesTextBlock_a0c5fdbd-73ea-4219-be63-cc30af1d2c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20230331.xsd#CommitmentsandContingentLiabilities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f8325210-e401-4052-a305-3a6ae0b753f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_31991d7c-fbd1-4c20-bd06-14dc99614a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f8325210-e401-4052-a305-3a6ae0b753f5" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_31991d7c-fbd1-4c20-bd06-14dc99614a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="mck-20230331.xsd#StockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_af4bcb59-912e-4f25-9322-734bb17fe6a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_55ffbadf-95a2-41a2-94a3-c851ad8f5c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_af4bcb59-912e-4f25-9322-734bb17fe6a3" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_55ffbadf-95a2-41a2-94a3-c851ad8f5c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactions" xlink:type="simple" xlink:href="mck-20230331.xsd#RelatedPartyBalancesandTransactions"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_e03154eb-d20b-46a8-9776-d0f2e7b878d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_abf49d10-14d5-400c-8fd1-f196429bd175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_e03154eb-d20b-46a8-9776-d0f2e7b878d8" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_abf49d10-14d5-400c-8fd1-f196429bd175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20230331.xsd#SegmentsofBusiness"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d7139e43-0c91-440c-8faa-1ec104544fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_16587a42-8698-4223-9e50-7b6328851d29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d7139e43-0c91-440c-8faa-1ec104544fd2" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_16587a42-8698-4223-9e50-7b6328851d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="mck-20230331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_7eac34fc-6aef-49e3-a210-db644aad221f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_f2dc0920-71be-45a7-a5d6-7a1574902a7b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_7eac34fc-6aef-49e3-a210-db644aad221f" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_f2dc0920-71be-45a7-a5d6-7a1574902a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20230331.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_7ef14911-cd01-4934-bb61-addeac562623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_7ef14911-cd01-4934-bb61-addeac562623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_7c2b483a-5933-4dd8-b9cd-972283b7fe4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_FiscalPeriod_7c2b483a-5933-4dd8-b9cd-972283b7fe4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_ade81a8d-81bc-4657-9f61-d71737155f64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_ade81a8d-81bc-4657-9f61-d71737155f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a56c9347-9cc4-41ae-abd1-b701083abe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_UseOfEstimates_a56c9347-9cc4-41ae-abd1-b701083abe9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_87141f81-88ab-487d-875a-614059acff07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_87141f81-88ab-487d-875a-614059acff07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_dd91980c-d05c-4f6b-8319-e4a7fa73b697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_dd91980c-d05c-4f6b-8319-e4a7fa73b697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_2263e70a-2834-4f4e-876e-aa909c064c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_2263e70a-2834-4f4e-876e-aa909c064c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_0250fee4-e3e3-49d6-986c-e10dba053d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_0250fee4-e3e3-49d6-986c-e10dba053d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_01810355-6632-4f04-8017-4ebb0cf205c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_01810355-6632-4f04-8017-4ebb0cf205c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_76f09118-643b-4832-aaa6-4ca36965853d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_76f09118-643b-4832-aaa6-4ca36965853d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_f4beb2b7-b529-4191-b6b8-5e922b3d705d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_f4beb2b7-b529-4191-b6b8-5e922b3d705d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldforSalePolicyTextBlock_e007a046-d190-454c-bb65-6022ae935229" xlink:href="mck-20230331.xsd#mck_HeldforSalePolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_mck_HeldforSalePolicyTextBlock_e007a046-d190-454c-bb65-6022ae935229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_4cb21ddf-aec1-4420-9320-3fc810d8f72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_4cb21ddf-aec1-4420-9320-3fc810d8f72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_d360a998-5701-425b-80b2-2ddb7b65e9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_d360a998-5701-425b-80b2-2ddb7b65e9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_e52f1245-fd97-4017-b5cb-2b39a99cfccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_e52f1245-fd97-4017-b5cb-2b39a99cfccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_4da53439-1e79-4be2-9d20-3b488d37edc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_4da53439-1e79-4be2-9d20-3b488d37edc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_496f5a68-e626-420f-8a5b-9dfd0a8de82c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_496f5a68-e626-420f-8a5b-9dfd0a8de82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceProgramsPolicyTextBlock_b2c2d166-f042-49cf-8a3d-94fd44981bc7" xlink:href="mck-20230331.xsd#mck_InsuranceProgramsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_mck_InsuranceProgramsPolicyTextBlock_b2c2d166-f042-49cf-8a3d-94fd44981bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_c7b6ebbf-b843-4316-97a9-5ca177e7929e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_c7b6ebbf-b843-4316-97a9-5ca177e7929e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierIncentivesPolicyPolicyTextBlock_6673b654-e715-491f-a385-54b7973b9d4c" xlink:href="mck-20230331.xsd#mck_SupplierIncentivesPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_mck_SupplierIncentivesPolicyPolicyTextBlock_6673b654-e715-491f-a385-54b7973b9d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SupplierReservesPolicyTextBlock_b099cda8-b6d3-4629-be78-35eef13ac172" xlink:href="mck-20230331.xsd#mck_SupplierReservesPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_mck_SupplierReservesPolicyTextBlock_b099cda8-b6d3-4629-be78-35eef13ac172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_c4ca7f09-7fab-44a7-bd51-665ebb1d7ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_c4ca7f09-7fab-44a7-bd51-665ebb1d7ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpensePolicyTextBlock_8fadcd8b-46e0-4bad-9363-c3f3cf311536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpensePolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_InterestExpensePolicyTextBlock_8fadcd8b-46e0-4bad-9363-c3f3cf311536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_51f4abf6-8fd8-4e49-a950-8e35128a1ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_51f4abf6-8fd8-4e49-a950-8e35128a1ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_e25fea95-acf9-494d-b708-4f027c8011f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_e25fea95-acf9-494d-b708-4f027c8011f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_5ef4eb9a-350a-45a5-bdb0-03b17ea2ffe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_5ef4eb9a-350a-45a5-bdb0-03b17ea2ffe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_417e3cdd-5e49-4f35-aab2-71ebbbb1fab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_417e3cdd-5e49-4f35-aab2-71ebbbb1fab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_69a489c1-49e1-4c8f-a7f7-7a0bfebee32c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_69a489c1-49e1-4c8f-a7f7-7a0bfebee32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_b11f4940-9c6a-49eb-a2d0-3e2480976420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_b11f4940-9c6a-49eb-a2d0-3e2480976420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_59c39030-ffdf-4cbd-bcd1-1e96afedf8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_59c39030-ffdf-4cbd-bcd1-1e96afedf8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_97e0835a-701c-4cd5-bb26-d201d3bfdeef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_97e0835a-701c-4cd5-bb26-d201d3bfdeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TreasuryStockPolicyTextBlock_075b9420-44d2-43fa-965d-5d0335f2db2f" xlink:href="mck-20230331.xsd#mck_TreasuryStockPolicyTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_mck_TreasuryStockPolicyTextBlock_075b9420-44d2-43fa-965d-5d0335f2db2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_04699ce3-ca5f-4ae6-82cc-60560aa93788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e96142df-5847-482a-8934-c9f27e218280" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_04699ce3-ca5f-4ae6-82cc-60560aa93788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mck-20230331.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cecaaaaf-ab7a-4af8-9442-ee411331ac3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_f45f133a-1a2e-431b-8998-4e671569bbea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cecaaaaf-ab7a-4af8-9442-ee411331ac3d" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_f45f133a-1a2e-431b-8998-4e671569bbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_f38e78ae-a9a7-4669-abec-890e0503d504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cecaaaaf-ab7a-4af8-9442-ee411331ac3d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_f38e78ae-a9a7-4669-abec-890e0503d504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4e286686-72c2-44aa-a096-1ce2bb4cede9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6c77d961-4d47-4469-a804-e2d11b91a0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4e286686-72c2-44aa-a096-1ce2bb4cede9" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6c77d961-4d47-4469-a804-e2d11b91a0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_0beba914-fa1e-492b-bd5c-8a3de4ec57f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4e286686-72c2-44aa-a096-1ce2bb4cede9" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_0beba914-fa1e-492b-bd5c-8a3de4ec57f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables" xlink:type="simple" xlink:href="mck-20230331.xsd#RestructuringImpairmentandRelatedChargesNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1b2fa0d9-5acc-464b-9a86-58a9c9f0b4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_d2e47496-9a70-4d00-84cd-3a01663c4872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1b2fa0d9-5acc-464b-9a86-58a9c9f0b4dd" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_d2e47496-9a70-4d00-84cd-3a01663c4872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_32a54519-8f0d-49b7-bd21-ebd399446713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1b2fa0d9-5acc-464b-9a86-58a9c9f0b4dd" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_32a54519-8f0d-49b7-bd21-ebd399446713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33cfdec3-3ec0-4881-a2d1-c037809d398d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_b596ca05-e0c8-4401-a5d3-b0ecdf70e8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33cfdec3-3ec0-4881-a2d1-c037809d398d" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_b596ca05-e0c8-4401-a5d3-b0ecdf70e8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_fdcdcb1e-0e0c-4b53-a700-ac742dc308a4" xlink:href="mck-20230331.xsd#mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33cfdec3-3ec0-4881-a2d1-c037809d398d" xlink:to="loc_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock_fdcdcb1e-0e0c-4b53-a700-ac742dc308a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_02794dc4-8b45-4d95-841f-ea6fc81d2597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33cfdec3-3ec0-4881-a2d1-c037809d398d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_02794dc4-8b45-4d95-841f-ea6fc81d2597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DataRelatedtoRSUActivityTableTextBlock_f4e3a979-4ac4-4641-b801-d91b7e3896d5" xlink:href="mck-20230331.xsd#mck_DataRelatedtoRSUActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33cfdec3-3ec0-4881-a2d1-c037809d398d" xlink:to="loc_mck_DataRelatedtoRSUActivityTableTextBlock_f4e3a979-4ac4-4641-b801-d91b7e3896d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_0fcf64d3-65f3-487d-99d4-b8ca4100e7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33cfdec3-3ec0-4881-a2d1-c037809d398d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_0fcf64d3-65f3-487d-99d4-b8ca4100e7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5db470b3-a38a-4b8a-9334-aa6e84cb7631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33cfdec3-3ec0-4881-a2d1-c037809d398d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5db470b3-a38a-4b8a-9334-aa6e84cb7631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_9620cef5-fa7c-44c8-baf8-8dfec162796d" xlink:href="mck-20230331.xsd#mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_33cfdec3-3ec0-4881-a2d1-c037809d398d" xlink:to="loc_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock_9620cef5-fa7c-44c8-baf8-8dfec162796d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetTables" xlink:type="simple" xlink:href="mck-20230331.xsd#OtherIncomeNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/OtherIncomeNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_501aadd6-1bda-4ea3-8412-dab4eae60777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_a8ce23e3-fd89-4e5a-a1d5-9cad6c460981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_501aadd6-1bda-4ea3-8412-dab4eae60777" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_a8ce23e3-fd89-4e5a-a1d5-9cad6c460981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_52e85cb5-3f0e-4280-9e83-8d827c1d62ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_59926716-cb91-46ca-9ed2-1a0cf274682e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_52e85cb5-3f0e-4280-9e83-8d827c1d62ba" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_59926716-cb91-46ca-9ed2-1a0cf274682e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_20921efc-a36e-4385-b276-360fb23f2f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_52e85cb5-3f0e-4280-9e83-8d827c1d62ba" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_20921efc-a36e-4385-b276-360fb23f2f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1489e14f-cb9f-42b3-ad44-2ff001fb1610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_52e85cb5-3f0e-4280-9e83-8d827c1d62ba" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1489e14f-cb9f-42b3-ad44-2ff001fb1610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_7dd8d543-f1de-418d-b18a-e63e26f2fa01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_52e85cb5-3f0e-4280-9e83-8d827c1d62ba" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_7dd8d543-f1de-418d-b18a-e63e26f2fa01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_f81f787e-58ea-4ad3-9486-c245c05145c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_52e85cb5-3f0e-4280-9e83-8d827c1d62ba" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_f81f787e-58ea-4ad3-9486-c245c05145c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20230331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_93bad9ce-24b3-48c0-b6b8-51dc98cb258b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_4c12e9ad-8c79-4f5b-a2a3-8783a02e98f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_93bad9ce-24b3-48c0-b6b8-51dc98cb258b" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_4c12e9ad-8c79-4f5b-a2a3-8783a02e98f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="simple" xlink:href="mck-20230331.xsd#EarningsLossPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b551b5e9-f1b3-4b76-b3fa-e2c1b9784d52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_88d09cf9-5181-415d-8706-9a4fb9cffdad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b551b5e9-f1b3-4b76-b3fa-e2c1b9784d52" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_88d09cf9-5181-415d-8706-9a4fb9cffdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesTables" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8e9b9cd6-94a1-4a23-874b-2ac2418da484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock_227e7881-deb4-4ec9-ba5f-e133a3673397" xlink:href="mck-20230331.xsd#mck_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8e9b9cd6-94a1-4a23-874b-2ac2418da484" xlink:to="loc_mck_AssetsAndLiabilitiesLesseeTableTextBlock_227e7881-deb4-4ec9-ba5f-e133a3673397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_e690251a-4a09-4f8f-952f-4a7041883602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8e9b9cd6-94a1-4a23-874b-2ac2418da484" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_e690251a-4a09-4f8f-952f-4a7041883602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8cd37c9e-6786-4fb7-8d43-dcf3fa087074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8e9b9cd6-94a1-4a23-874b-2ac2418da484" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8cd37c9e-6786-4fb7-8d43-dcf3fa087074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_70132b9f-ad71-4926-84da-fa41bc900af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8e9b9cd6-94a1-4a23-874b-2ac2418da484" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_70132b9f-ad71-4926-84da-fa41bc900af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20230331.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a3add3aa-ff18-4abf-a590-34a132df8ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_8e02727a-99e1-435a-9591-92cafa28b2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a3add3aa-ff18-4abf-a590-34a132df8ad0" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_8e02727a-99e1-435a-9591-92cafa28b2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a117713e-f824-49a9-90fa-884a683df821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a3add3aa-ff18-4abf-a590-34a132df8ad0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a117713e-f824-49a9-90fa-884a683df821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d26a71f1-6357-4c46-b1a2-37e64b366313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_d0c25e82-bd5e-4e8c-993e-a9c341f6694e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d26a71f1-6357-4c46-b1a2-37e64b366313" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_d0c25e82-bd5e-4e8c-993e-a9c341f6694e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsTables" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a2c73c75-990c-4ddd-9aa9-08f745ec922d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_e5c098df-03b0-42c6-a572-d6dd493f6473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a2c73c75-990c-4ddd-9aa9-08f745ec922d" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_e5c098df-03b0-42c6-a572-d6dd493f6473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_a028307f-590b-46e9-bd01-cced6229b575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a2c73c75-990c-4ddd-9aa9-08f745ec922d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_a028307f-590b-46e9-bd01-cced6229b575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_2205f92f-c308-4712-8206-f2d9f1c5f46f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a2c73c75-990c-4ddd-9aa9-08f745ec922d" xlink:to="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_2205f92f-c308-4712-8206-f2d9f1c5f46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_4be87e6a-fb75-49e1-a8ae-38b2f397a616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a2c73c75-990c-4ddd-9aa9-08f745ec922d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_4be87e6a-fb75-49e1-a8ae-38b2f397a616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_f07e2ec7-2748-45ae-be17-a63505e53728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a2c73c75-990c-4ddd-9aa9-08f745ec922d" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_f07e2ec7-2748-45ae-be17-a63505e53728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_527efb3c-1673-4587-a5f8-4c77a44a34da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a2c73c75-990c-4ddd-9aa9-08f745ec922d" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_527efb3c-1673-4587-a5f8-4c77a44a34da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_6ffa2614-c168-40c9-9bb7-87ce50b024ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a2c73c75-990c-4ddd-9aa9-08f745ec922d" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_6ffa2614-c168-40c9-9bb7-87ce50b024ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_7f6afef2-bb6d-4498-9a21-d9b7077d6877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a2c73c75-990c-4ddd-9aa9-08f745ec922d" xlink:to="loc_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock_7f6afef2-bb6d-4498-9a21-d9b7077d6877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f094cf82-677c-4844-974c-d996e3efecbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1d80ab6f-8ad4-4223-b83d-8bf345b04f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f094cf82-677c-4844-974c-d996e3efecbe" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1d80ab6f-8ad4-4223-b83d-8bf345b04f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_af8ac024-df38-4922-b300-a7165c71a1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f094cf82-677c-4844-974c-d996e3efecbe" xlink:to="loc_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock_af8ac024-df38-4922-b300-a7165c71a1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_065e2b39-988e-4b55-9f38-ead20704be53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f094cf82-677c-4844-974c-d996e3efecbe" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_065e2b39-988e-4b55-9f38-ead20704be53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e17bedca-b457-4eea-8bf9-074ad3ccd389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f094cf82-677c-4844-974c-d996e3efecbe" xlink:to="loc_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e17bedca-b457-4eea-8bf9-074ad3ccd389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_1fd4c023-ddab-47f9-8adb-98e8c0a9dd98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f094cf82-677c-4844-974c-d996e3efecbe" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_1fd4c023-ddab-47f9-8adb-98e8c0a9dd98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mck-20230331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0825da27-50e4-4c0d-816b-639fe1751916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_1105a033-a56b-4d72-a548-c27f67bd444c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0825da27-50e4-4c0d-816b-639fe1751916" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_1105a033-a56b-4d72-a548-c27f67bd444c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables" xlink:type="simple" xlink:href="mck-20230331.xsd#CommitmentsandContingentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_aa9eee18-9aac-4e64-b327-6dce39f424ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_ffacaca3-e4e2-4068-a6ea-71a7fedfcf5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_aa9eee18-9aac-4e64-b327-6dce39f424ef" xlink:to="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_ffacaca3-e4e2-4068-a6ea-71a7fedfcf5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="simple" xlink:href="mck-20230331.xsd#StockholdersEquityDeficitTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_8f527199-0eac-474a-9900-97a4e682c54a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTextBlock_31d083f0-160b-40ad-9969-7d028e4f8f26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8f527199-0eac-474a-9900-97a4e682c54a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTextBlock_31d083f0-160b-40ad-9969-7d028e4f8f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4c55f6d0-853c-4da5-bb6d-fe4356b91b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8f527199-0eac-474a-9900-97a4e682c54a" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4c55f6d0-853c-4da5-bb6d-fe4356b91b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20230331.xsd#SegmentsofBusinessTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2e44041d-6a93-4637-882e-eb62c5c7bd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_48418df1-2879-494f-9121-f871dad91f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2e44041d-6a93-4637-882e-eb62c5c7bd6b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_48418df1-2879-494f-9121-f871dad91f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_0d713505-cd8a-494e-a15c-e98551bdd2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2e44041d-6a93-4637-882e-eb62c5c7bd6b" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_0d713505-cd8a-494e-a15c-e98551bdd2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_22e8b1cf-7f0e-467d-b04f-d9eb7ad66cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22e8b1cf-7f0e-467d-b04f-d9eb7ad66cbd" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e15be108-0fd8-4ce8-a355-7b7d5afefd83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e15be108-0fd8-4ce8-a355-7b7d5afefd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5e6d3e5b-c3b9-41e3-b0f0-628a7c5914d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e15be108-0fd8-4ce8-a355-7b7d5afefd83" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5e6d3e5b-c3b9-41e3-b0f0-628a7c5914d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_d821024e-d9cf-4473-bc5d-c8a772b0e221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5e6d3e5b-c3b9-41e3-b0f0-628a7c5914d8" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_d821024e-d9cf-4473-bc5d-c8a772b0e221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_de140be7-01a0-4574-911d-2a858e0a38ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5e6d3e5b-c3b9-41e3-b0f0-628a7c5914d8" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_de140be7-01a0-4574-911d-2a858e0a38ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d21a1735-c65f-4c1e-befb-33cc1d4e53ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d21a1735-c65f-4c1e-befb-33cc1d4e53ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ca98d759-d8a6-4c88-83ad-ff8451153846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d21a1735-c65f-4c1e-befb-33cc1d4e53ac" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ca98d759-d8a6-4c88-83ad-ff8451153846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_3187d042-4f0f-47ac-9ede-2795b8695de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ca98d759-d8a6-4c88-83ad-ff8451153846" xlink:to="loc_us-gaap_SalesRevenueNetMember_3187d042-4f0f-47ac-9ede-2795b8695de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_febf1f6f-7322-437b-abb8-b811f70df59e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ca98d759-d8a6-4c88-83ad-ff8451153846" xlink:to="loc_us-gaap_AccountsReceivableMember_febf1f6f-7322-437b-abb8-b811f70df59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_899c16b4-65d0-45d2-9cd2-6b9ac50903c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_srt_MajorCustomersAxis_899c16b4-65d0-45d2-9cd2-6b9ac50903c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f5b6d6b5-6d12-417b-a897-131b6acbd1e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_899c16b4-65d0-45d2-9cd2-6b9ac50903c1" xlink:to="loc_srt_NameOfMajorCustomerDomain_f5b6d6b5-6d12-417b-a897-131b6acbd1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenLargestCustomersMember_06fece1f-5909-4690-b6c8-9a5daa0e8162" xlink:href="mck-20230331.xsd#mck_TenLargestCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f5b6d6b5-6d12-417b-a897-131b6acbd1e5" xlink:to="loc_mck_TenLargestCustomersMember_06fece1f-5909-4690-b6c8-9a5daa0e8162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LargestCustomerMember_abb7db18-e88b-4d6d-9ab8-d25bf0e0a14c" xlink:href="mck-20230331.xsd#mck_LargestCustomerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f5b6d6b5-6d12-417b-a897-131b6acbd1e5" xlink:to="loc_mck_LargestCustomerMember_abb7db18-e88b-4d6d-9ab8-d25bf0e0a14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_884e77d2-15c6-48f5-8b47-574b4d24eb83" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_srt_ProductOrServiceAxis_884e77d2-15c6-48f5-8b47-574b4d24eb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f7b73ce5-7fb1-437f-af92-4f470a4babca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_884e77d2-15c6-48f5-8b47-574b4d24eb83" xlink:to="loc_srt_ProductsAndServicesDomain_f7b73ce5-7fb1-437f-af92-4f470a4babca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_dbf8b836-8e42-4a2e-897d-daec70152116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f7b73ce5-7fb1-437f-af92-4f470a4babca" xlink:to="loc_us-gaap_ShippingAndHandlingMember_dbf8b836-8e42-4a2e-897d-daec70152116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DistributionandRetailBusinessMember_efc99956-08f9-4b3b-a261-7172744c5816" xlink:href="mck-20230331.xsd#mck_DistributionandRetailBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f7b73ce5-7fb1-437f-af92-4f470a4babca" xlink:to="loc_mck_DistributionandRetailBusinessMember_efc99956-08f9-4b3b-a261-7172744c5816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ServicesBusinessMember_28d9d2d8-e9ec-4dab-a086-7d8b299c58d1" xlink:href="mck-20230331.xsd#mck_ServicesBusinessMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f7b73ce5-7fb1-437f-af92-4f470a4babca" xlink:to="loc_mck_ServicesBusinessMember_28d9d2d8-e9ec-4dab-a086-7d8b299c58d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a6578cc1-0696-45c4-8625-128a80018259" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_srt_RangeAxis_a6578cc1-0696-45c4-8625-128a80018259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19f08c2d-9029-4845-8b3f-ab76ff8793ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a6578cc1-0696-45c4-8625-128a80018259" xlink:to="loc_srt_RangeMember_19f08c2d-9029-4845-8b3f-ab76ff8793ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_908a0a74-a0d2-491a-b904-9b4e84e83fb9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_19f08c2d-9029-4845-8b3f-ab76ff8793ee" xlink:to="loc_srt_MinimumMember_908a0a74-a0d2-491a-b904-9b4e84e83fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5644a311-20c8-4b85-942a-16198310243f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_19f08c2d-9029-4845-8b3f-ab76ff8793ee" xlink:to="loc_srt_MaximumMember_5644a311-20c8-4b85-942a-16198310243f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_661fa294-eaf9-4b97-a6de-bc007ed36e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_661fa294-eaf9-4b97-a6de-bc007ed36e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_661fa294-eaf9-4b97-a6de-bc007ed36e63" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_8bf2dfef-23cd-4a15-bf47-39822362425b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_8bf2dfef-23cd-4a15-bf47-39822362425b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MachineryEquipmentAndOtherMember_feb776ca-c65c-47d9-a1e7-6c414741224b" xlink:href="mck-20230331.xsd#mck_MachineryEquipmentAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:to="loc_mck_MachineryEquipmentAndOtherMember_feb776ca-c65c-47d9-a1e7-6c414741224b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_bff59bb8-a7d9-4876-8fdf-c5d61f21ae52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:to="loc_us-gaap_BuildingMember_bff59bb8-a7d9-4876-8fdf-c5d61f21ae52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_03a64207-9e4a-445c-8110-64defd2805a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:to="loc_us-gaap_EquipmentMember_03a64207-9e4a-445c-8110-64defd2805a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RealPropertyMember_679b275e-9a76-4684-b037-6c9b9e81e69b" xlink:href="mck-20230331.xsd#mck_RealPropertyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_08678296-34f4-44bd-898e-563d40f1d698" xlink:to="loc_mck_RealPropertyMember_679b275e-9a76-4684-b037-6c9b9e81e69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_982fffe7-d990-41d7-8276-e9a6466f5ad9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_srt_LitigationCaseAxis_982fffe7-d990-41d7-8276-e9a6466f5ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_918df5f1-e4d0-4c2a-93c2-6525a6672137" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_982fffe7-d990-41d7-8276-e9a6466f5ad9" xlink:to="loc_srt_LitigationCaseTypeDomain_918df5f1-e4d0-4c2a-93c2-6525a6672137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_12d7b36e-4639-4d9e-98ae-de538e60d342" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_918df5f1-e4d0-4c2a-93c2-6525a6672137" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_12d7b36e-4639-4d9e-98ae-de538e60d342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_2c49ed03-db81-49a8-87dc-c20f819b18e6" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_76ba45f9-47a0-45b5-965c-8ea30f6b8b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_NumberOfReportableSegments_76ba45f9-47a0-45b5-965c-8ea30f6b8b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_88148526-782a-4950-98bf-f703fdae4506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_RestrictedCash_88148526-782a-4950-98bf-f703fdae4506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3129e5c1-67df-4d3e-b4df-7ab20479e6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3129e5c1-67df-4d3e-b4df-7ab20479e6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c1b63840-bf66-4686-9543-7cf49814f90d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c1b63840-bf66-4686-9543-7cf49814f90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_bc5ee66f-4632-404c-91b7-0270e67f9f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_InventoryNet_bc5ee66f-4632-404c-91b7-0270e67f9f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_e4868357-2488-4244-8216-6d422b4339b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_PercentageOfLIFOInventory_e4868357-2488-4244-8216-6d422b4339b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReserve_cf18b464-76bd-4235-8d3b-5aca4a0bb0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReserve"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_InventoryLIFOReserve_cf18b464-76bd-4235-8d3b-5aca4a0bb0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_6755ef0a-4b8e-48a9-9fa6-6cb85f017424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_6755ef0a-4b8e-48a9-9fa6-6cb85f017424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cf0637e6-dbc3-495f-9f72-1a9f2090e168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cf0637e6-dbc3-495f-9f72-1a9f2090e168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_83658a6f-3071-42f1-bbdd-8c272c5508da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_83658a6f-3071-42f1-bbdd-8c272c5508da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0a71b962-bf0f-4b90-812f-067a01864201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0a71b962-bf0f-4b90-812f-067a01864201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e6507280-6383-4587-a7e5-7fa18566bead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e6507280-6383-4587-a7e5-7fa18566bead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_3f005459-e841-4a06-817e-883ac4805156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_3f005459-e841-4a06-817e-883ac4805156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7220275a-ff48-48d9-99ce-3a71707a0a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7220275a-ff48-48d9-99ce-3a71707a0a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_688eed81-009d-45f3-b44c-309adfa61173" xlink:href="mck-20230331.xsd#mck_CapitalizedSoftwareHeldforInternalUseUsefulLife"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife_688eed81-009d-45f3-b44c-309adfa61173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_32cdf71d-c1fa-49fa-9f45-e6cd2657b972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_32cdf71d-c1fa-49fa-9f45-e6cd2657b972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_a3b5ef35-aab9-48fa-ac4a-6516baa77f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_a3b5ef35-aab9-48fa-ac4a-6516baa77f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_89f8d165-c1a9-49ea-9f4f-ecf0d000420e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_89f8d165-c1a9-49ea-9f4f-ecf0d000420e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_b0ed8955-90e3-41f2-b98d-cdb3f8a55775" xlink:href="mck-20230331.xsd#mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a1db555f-22d3-48fb-a36f-b3eb0458cc07" xlink:to="loc_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns_b0ed8955-90e3-41f2-b98d-cdb3f8a55775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SignificantAccountingPoliciesReceivablesNetDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7dfa9e57-9c4a-44c5-9836-642aca34cfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccountsReceivableCustomerAccountsGross_ed920a31-d1c2-4b4c-8de6-3e668d3c5743" xlink:href="mck-20230331.xsd#mck_AccountsReceivableCustomerAccountsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dfa9e57-9c4a-44c5-9836-642aca34cfc5" xlink:to="loc_mck_AccountsReceivableCustomerAccountsGross_ed920a31-d1c2-4b4c-8de6-3e668d3c5743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_20d3c81f-f657-411c-b606-7d2ca86ba9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dfa9e57-9c4a-44c5-9836-642aca34cfc5" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_20d3c81f-f657-411c-b606-7d2ca86ba9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_d0f2c1e7-12d1-416d-9901-76b29b140b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dfa9e57-9c4a-44c5-9836-642aca34cfc5" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_d0f2c1e7-12d1-416d-9901-76b29b140b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_15e8b4da-ff73-4758-9774-02e92f4c724f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dfa9e57-9c4a-44c5-9836-642aca34cfc5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_15e8b4da-ff73-4758-9774-02e92f4c724f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_2636efc3-990f-45f3-a685-273a9df6e1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dfa9e57-9c4a-44c5-9836-642aca34cfc5" xlink:to="loc_us-gaap_ReceivablesNetCurrent_2636efc3-990f-45f3-a685-273a9df6e1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6f0675d0-511e-4aea-9bcb-917bb8f3f8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_787694a2-b8f6-4de4-8b78-3dedd88ca944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f0675d0-511e-4aea-9bcb-917bb8f3f8fd" xlink:to="loc_us-gaap_Land_787694a2-b8f6-4de4-8b78-3dedd88ca944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_6cec49c9-8642-45f2-a5cd-39453fcecea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f0675d0-511e-4aea-9bcb-917bb8f3f8fd" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_6cec49c9-8642-45f2-a5cd-39453fcecea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOther_97dc0906-0511-4f29-b319-bb62a41456bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f0675d0-511e-4aea-9bcb-917bb8f3f8fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOther_97dc0906-0511-4f29-b319-bb62a41456bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_81b437fc-864e-4401-b1df-3426a7b5050c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f0675d0-511e-4aea-9bcb-917bb8f3f8fd" xlink:to="loc_us-gaap_ConstructionInProgressGross_81b437fc-864e-4401-b1df-3426a7b5050c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b7237e9b-1c2f-4251-8a66-a340f0610609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f0675d0-511e-4aea-9bcb-917bb8f3f8fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b7237e9b-1c2f-4251-8a66-a340f0610609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3d672944-ae0b-401e-a1c8-4ed755427c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f0675d0-511e-4aea-9bcb-917bb8f3f8fd" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3d672944-ae0b-401e-a1c8-4ed755427c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_de163090-f4bb-4083-a68b-ad7c910a67cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6f0675d0-511e-4aea-9bcb-917bb8f3f8fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_de163090-f4bb-4083-a68b-ad7c910a67cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4b101c05-6e41-4ec5-9e6f-0fd9573dac01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4b101c05-6e41-4ec5-9e6f-0fd9573dac01" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3da74409-8b9b-4dae-9718-609538fbf160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3da74409-8b9b-4dae-9718-609538fbf160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6532226-bd57-4d36-878d-47b71acb5cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3da74409-8b9b-4dae-9718-609538fbf160" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6532226-bd57-4d36-878d-47b71acb5cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxSavingsSolutionsLLCMember_815ace06-4c6f-4526-9c22-a4f829af86dc" xlink:href="mck-20230331.xsd#mck_RxSavingsSolutionsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6532226-bd57-4d36-878d-47b71acb5cff" xlink:to="loc_mck_RxSavingsSolutionsLLCMember_815ace06-4c6f-4526-9c22-a4f829af86dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SCRIOncologyLLCMember_9f6c24ea-2d9c-4b1e-81b0-070a945a01a4" xlink:href="mck-20230331.xsd#mck_SCRIOncologyLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6532226-bd57-4d36-878d-47b71acb5cff" xlink:to="loc_mck_SCRIOncologyLLCMember_9f6c24ea-2d9c-4b1e-81b0-070a945a01a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a7f33f3d-a92e-479e-8249-995b9e286c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a7f33f3d-a92e-479e-8249-995b9e286c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_79bf93d0-2f48-4f42-b2a6-1d137d94142b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7f33f3d-a92e-479e-8249-995b9e286c65" xlink:to="loc_us-gaap_SegmentDomain_79bf93d0-2f48-4f42-b2a6-1d137d94142b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxTsSegmentMember_04437abf-1066-454f-a2be-23b507578673" xlink:href="mck-20230331.xsd#mck_RxTsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_79bf93d0-2f48-4f42-b2a6-1d137d94142b" xlink:to="loc_mck_RxTsSegmentMember_04437abf-1066-454f-a2be-23b507578673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_98836257-c662-4871-a08e-a6157f2e920a" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_79bf93d0-2f48-4f42-b2a6-1d137d94142b" xlink:to="loc_mck_USPharmaceuticalSegmentMember_98836257-c662-4871-a08e-a6157f2e920a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5a24b614-533d-4fa5-bb56-90c4710808bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:to="loc_srt_OwnershipAxis_5a24b614-533d-4fa5-bb56-90c4710808bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_ec2d3251-3dcc-4a3d-a775-d3f6e0eadb81" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_5a24b614-533d-4fa5-bb56-90c4710808bb" xlink:to="loc_srt_OwnershipDomain_ec2d3251-3dcc-4a3d-a775-d3f6e0eadb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SarahCannonResearchInstituteMember_cf82c7e0-6051-4a16-b45a-5c9d7440680c" xlink:href="mck-20230331.xsd#mck_SarahCannonResearchInstituteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_ec2d3251-3dcc-4a3d-a775-d3f6e0eadb81" xlink:to="loc_mck_SarahCannonResearchInstituteMember_cf82c7e0-6051-4a16-b45a-5c9d7440680c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_McKessonUSOncologyResearchMember_877cb09f-4445-4192-b066-3d5bfeab1acb" xlink:href="mck-20230331.xsd#mck_McKessonUSOncologyResearchMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_ec2d3251-3dcc-4a3d-a775-d3f6e0eadb81" xlink:to="loc_mck_McKessonUSOncologyResearchMember_877cb09f-4445-4192-b066-3d5bfeab1acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5fda7fad-84b5-4d8c-8535-34307a779fce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:to="loc_srt_RangeAxis_5fda7fad-84b5-4d8c-8535-34307a779fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db68f474-3841-48eb-afd1-12587790bf25" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5fda7fad-84b5-4d8c-8535-34307a779fce" xlink:to="loc_srt_RangeMember_db68f474-3841-48eb-afd1-12587790bf25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_74febf1c-a1a5-4ec1-b652-faa9fbb73ca8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_db68f474-3841-48eb-afd1-12587790bf25" xlink:to="loc_srt_MaximumMember_74febf1c-a1a5-4ec1-b652-faa9fbb73ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_b2938860-9cab-4624-a7a6-af2048837dcd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b841de8e-7af3-4087-8a9a-d9e7b3fc47ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b841de8e-7af3-4087-8a9a-d9e7b3fc47ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6dde0b48-1813-4b5d-811a-922ba0bb45ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6dde0b48-1813-4b5d-811a-922ba0bb45ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6a1736ff-975e-419b-aa50-05ac2b6503e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6a1736ff-975e-419b-aa50-05ac2b6503e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_f96c0921-820e-4ea8-9148-0608a94b8c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_f96c0921-820e-4ea8-9148-0608a94b8c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_50386833-f29b-4a29-9cd7-65fded9c9e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_50386833-f29b-4a29-9cd7-65fded9c9e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_31cf7e95-3dbc-4139-be13-f0fb956500a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_31cf7e95-3dbc-4139-be13-f0fb956500a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_272b4038-f9fd-4de5-b82d-066821df2b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_272b4038-f9fd-4de5-b82d-066821df2b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d6e0ff25-d5a3-442b-abfc-3ccff0a1eb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_Goodwill_d6e0ff25-d5a3-442b-abfc-3ccff0a1eb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_0f455585-71a6-46ad-85de-7bcb4de6fe40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_0f455585-71a6-46ad-85de-7bcb4de6fe40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_e51e93e9-7efe-42d7-9b5e-3160dc024fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83e8b83e-7ed9-4358-bea8-1f698ff367f9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_e51e93e9-7efe-42d7-9b5e-3160dc024fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7c670b82-45fd-48d7-b36c-2ce86ffc5e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5761386f-0cf3-480c-8062-54cfcd5fbb84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7c670b82-45fd-48d7-b36c-2ce86ffc5e85" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5761386f-0cf3-480c-8062-54cfcd5fbb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4bd7f8b5-fd6d-459d-aebd-0158f64990a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5761386f-0cf3-480c-8062-54cfcd5fbb84" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4bd7f8b5-fd6d-459d-aebd-0158f64990a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b60ebcd-3fb8-40f5-9ccb-5585bab1974d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4bd7f8b5-fd6d-459d-aebd-0158f64990a6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b60ebcd-3fb8-40f5-9ccb-5585bab1974d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxSavingsSolutionsLLCMember_161c4b10-743d-4778-b091-93b859e6b5a0" xlink:href="mck-20230331.xsd#mck_RxSavingsSolutionsLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8b60ebcd-3fb8-40f5-9ccb-5585bab1974d" xlink:to="loc_mck_RxSavingsSolutionsLLCMember_161c4b10-743d-4778-b091-93b859e6b5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_db484178-4c84-4011-b314-db9ef6fbefe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5761386f-0cf3-480c-8062-54cfcd5fbb84" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_db484178-4c84-4011-b314-db9ef6fbefe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b1879294-e158-4371-b203-e7873cb5985c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_db484178-4c84-4011-b314-db9ef6fbefe6" xlink:to="loc_us-gaap_SegmentDomain_b1879294-e158-4371-b203-e7873cb5985c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RxTsSegmentMember_3c37738c-f22d-4736-b474-9083c8d04587" xlink:href="mck-20230331.xsd#mck_RxTsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b1879294-e158-4371-b203-e7873cb5985c" xlink:to="loc_mck_RxTsSegmentMember_3c37738c-f22d-4736-b474-9083c8d04587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1e5759ab-3221-4191-8023-21770ab7dcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_5761386f-0cf3-480c-8062-54cfcd5fbb84" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1e5759ab-3221-4191-8023-21770ab7dcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b0b852b3-2fad-46b4-a752-651c49c50480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1e5759ab-3221-4191-8023-21770ab7dcfd" xlink:to="loc_us-gaap_BusinessCombinationsAbstract_b0b852b3-2fad-46b4-a752-651c49c50480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a680f1fc-85a8-4a99-9da1-cf8196bc9553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b0b852b3-2fad-46b4-a752-651c49c50480" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a680f1fc-85a8-4a99-9da1-cf8196bc9553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a2a7ed0c-1338-45a3-a247-d69192f29cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b0b852b3-2fad-46b4-a752-651c49c50480" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a2a7ed0c-1338-45a3-a247-d69192f29cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c22fe971-e0cd-4d51-8a3d-4270a717ff81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b0b852b3-2fad-46b4-a752-651c49c50480" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c22fe971-e0cd-4d51-8a3d-4270a717ff81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_1e5759ab-3221-4191-8023-21770ab7dcfd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_6461ea96-cec6-4356-a4fd-75b6514bffc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_6461ea96-cec6-4356-a4fd-75b6514bffc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fbf3d3c6-f870-4aa6-ab1b-7089b27841be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fbf3d3c6-f870-4aa6-ab1b-7089b27841be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d1fd7c0e-21e6-46e6-b50d-d920a4e43182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d1fd7c0e-21e6-46e6-b50d-d920a4e43182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_15cd38b0-f602-484e-8738-33feceac8f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_15cd38b0-f602-484e-8738-33feceac8f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6bcdf4b0-16a3-47c3-be8c-19c5a3000ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6bcdf4b0-16a3-47c3-be8c-19c5a3000ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dbe669d6-40f7-485d-a70b-4e11846e9669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_Goodwill_dbe669d6-40f7-485d-a70b-4e11846e9669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_ec4f7705-b0aa-4039-9991-cadf197c1ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_13114df8-86f8-44eb-aa73-76aa2bf0481a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_ec4f7705-b0aa-4039-9991-cadf197c1ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4125abce-c3a5-4f8f-9b1d-40c9f83c3b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_0c79e6a2-10c6-4968-9604-4ff58868bd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4125abce-c3a5-4f8f-9b1d-40c9f83c3b26" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_0c79e6a2-10c6-4968-9604-4ff58868bd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0e9c6f48-62cd-411f-b73a-dad425c0eaad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_0c79e6a2-10c6-4968-9604-4ff58868bd24" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0e9c6f48-62cd-411f-b73a-dad425c0eaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_238ef117-530e-49b1-9c49-c6f579e7d45d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0e9c6f48-62cd-411f-b73a-dad425c0eaad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_238ef117-530e-49b1-9c49-c6f579e7d45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SCRIOncologyLLCMember_c6b266e1-70c1-4987-8f57-efc5611086ca" xlink:href="mck-20230331.xsd#mck_SCRIOncologyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_238ef117-530e-49b1-9c49-c6f579e7d45d" xlink:to="loc_mck_SCRIOncologyLLCMember_c6b266e1-70c1-4987-8f57-efc5611086ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d32de903-2ab5-4566-badf-f902eb37fd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_0c79e6a2-10c6-4968-9604-4ff58868bd24" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d32de903-2ab5-4566-badf-f902eb37fd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3fb31068-bead-4278-b91f-17e7972c552a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d32de903-2ab5-4566-badf-f902eb37fd15" xlink:to="loc_us-gaap_SegmentDomain_3fb31068-bead-4278-b91f-17e7972c552a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_20b6f727-2cdd-47d8-bbe9-7aaf903cd453" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3fb31068-bead-4278-b91f-17e7972c552a" xlink:to="loc_mck_USPharmaceuticalSegmentMember_20b6f727-2cdd-47d8-bbe9-7aaf903cd453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_908aa01c-eba8-46c3-859b-f92546603d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_0c79e6a2-10c6-4968-9604-4ff58868bd24" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_908aa01c-eba8-46c3-859b-f92546603d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_bb3eb254-943e-4ca1-a0e3-6f375f61b31e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_908aa01c-eba8-46c3-859b-f92546603d8b" xlink:to="loc_us-gaap_BusinessCombinationsAbstract_bb3eb254-943e-4ca1-a0e3-6f375f61b31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ca827260-4fc4-4466-8640-4ed21f996b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_bb3eb254-943e-4ca1-a0e3-6f375f61b31e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ca827260-4fc4-4466-8640-4ed21f996b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationConsiderationTransferredOwnershipInterest_1498a218-cc6a-413d-af78-b177e29bd7bd" xlink:href="mck-20230331.xsd#mck_BusinessCombinationConsiderationTransferredOwnershipInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_bb3eb254-943e-4ca1-a0e3-6f375f61b31e" xlink:to="loc_mck_BusinessCombinationConsiderationTransferredOwnershipInterest_1498a218-cc6a-413d-af78-b177e29bd7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4af8e2f0-59d1-425e-a22e-833cb5ca1b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_bb3eb254-943e-4ca1-a0e3-6f375f61b31e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_4af8e2f0-59d1-425e-a22e-833cb5ca1b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_908aa01c-eba8-46c3-859b-f92546603d8b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a1ab282c-6446-4c75-a9ab-34f9645d5d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a1ab282c-6446-4c75-a9ab-34f9645d5d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_6b5ce6fb-b0ac-44bb-8d9e-0f01cf533e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_6b5ce6fb-b0ac-44bb-8d9e-0f01cf533e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_6c20c7d4-9a8c-4ac4-82a8-abddea4744dc" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_6c20c7d4-9a8c-4ac4-82a8-abddea4744dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e8827df9-5394-4820-a9a4-7bda9e3b90f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e8827df9-5394-4820-a9a4-7bda9e3b90f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3df65082-556a-466c-bf36-f80f4440da0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_3df65082-556a-466c-bf36-f80f4440da0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities_6e2b9675-82e4-4549-8249-59b62909d278" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities_6e2b9675-82e4-4549-8249-59b62909d278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5ae8c779-440e-46d4-a0fb-f6762296d0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_5ae8c779-440e-46d4-a0fb-f6762296d0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a8ddc339-d1f0-46c1-b0f5-88df94cd2eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_a8ddc339-d1f0-46c1-b0f5-88df94cd2eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_4466f54d-7a67-41c6-a3bd-60f47f5b880b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_4466f54d-7a67-41c6-a3bd-60f47f5b880b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital_2381fbe8-dd51-447d-b1df-c32560c7ed64" xlink:href="mck-20230331.xsd#mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital_2381fbe8-dd51-447d-b1df-c32560c7ed64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_08ff1e4e-1692-4ff6-af0f-9b016dee23a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_Goodwill_08ff1e4e-1692-4ff6-af0f-9b016dee23a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_90bc61f0-64ec-4221-8849-5049df082564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_8b860474-97ba-40b9-b7a3-3f375c25ae25" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_90bc61f0-64ec-4221-8849-5049df082564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_85c7c82b-1c56-4936-8e36-feaa1beae928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_85c7c82b-1c56-4936-8e36-feaa1beae928" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ae0d953-77f6-4dba-b4c0-12ad042ae82e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ae0d953-77f6-4dba-b4c0-12ad042ae82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1ae0d953-77f6-4dba-b4c0-12ad042ae82e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_c2219ee3-1700-48ad-99ec-57eb80b6d86e" xlink:href="mck-20230331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_c2219ee3-1700-48ad-99ec-57eb80b6d86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_558e5759-f0c8-4c6a-b58f-be4c22e8bc70" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_558e5759-f0c8-4c6a-b58f-be4c22e8bc70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_4480b7c2-209b-4d7b-b004-04de7c69b73c" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_4480b7c2-209b-4d7b-b004-04de7c69b73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_1da4f393-248d-4f84-a7db-0a96ce0b07ee" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_InternationalSegmentMember_1da4f393-248d-4f84-a7db-0a96ce0b07ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember_d62d1705-4177-4f94-8e57-5adf96116b02" xlink:href="mck-20230331.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_AustrianBusinessOperationsMember_d62d1705-4177-4f94-8e57-5adf96116b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_04448bbf-2268-4bee-adaf-c092313f645c" xlink:href="mck-20230331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4728a7e2-5af8-4ac9-8fdb-31a65608f3ee" xlink:to="loc_mck_GermanWholesaleBusinessMember_04448bbf-2268-4bee-adaf-c092313f645c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4d123a2c-8dc0-4d0c-980c-00e74396d3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4d123a2c-8dc0-4d0c-980c-00e74396d3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7a1ebaf5-5fab-48e4-b530-99a1a2d2c0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4d123a2c-8dc0-4d0c-980c-00e74396d3a3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7a1ebaf5-5fab-48e4-b530-99a1a2d2c0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f23d07f5-08e9-4084-98bd-02c89b7f01c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7a1ebaf5-5fab-48e4-b530-99a1a2d2c0d1" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f23d07f5-08e9-4084-98bd-02c89b7f01c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_053e90c9-a94b-408b-a96d-cec60e96d187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7a1ebaf5-5fab-48e4-b530-99a1a2d2c0d1" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_053e90c9-a94b-408b-a96d-cec60e96d187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1752628a-ecab-41dc-8ad7-b1b3a0f11899" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_dei_LegalEntityAxis_1752628a-ecab-41dc-8ad7-b1b3a0f11899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_38bd4ea6-64d5-405f-915c-249a4f5f6ed9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1752628a-ecab-41dc-8ad7-b1b3a0f11899" xlink:to="loc_dei_EntityDomain_38bd4ea6-64d5-405f-915c-249a4f5f6ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AureliusElephantLimitedMember_570e0fc4-1258-4388-bbe1-506dac434a70" xlink:href="mck-20230331.xsd#mck_AureliusElephantLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_38bd4ea6-64d5-405f-915c-249a4f5f6ed9" xlink:to="loc_mck_AureliusElephantLimitedMember_570e0fc4-1258-4388-bbe1-506dac434a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9d9b2eb0-5b9f-47bc-bfa3-28c857d1eb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9d9b2eb0-5b9f-47bc-bfa3-28c857d1eb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9969b4dc-43d0-4b36-a7ce-0b9c6596d030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9d9b2eb0-5b9f-47bc-bfa3-28c857d1eb78" xlink:to="loc_us-gaap_SegmentDomain_9969b4dc-43d0-4b36-a7ce-0b9c6596d030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_e2e8753f-393b-4c39-a782-d5bdf78a1e5f" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9969b4dc-43d0-4b36-a7ce-0b9c6596d030" xlink:to="loc_mck_InternationalSegmentMember_e2e8753f-393b-4c39-a782-d5bdf78a1e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_22bca7c5-b058-4941-8555-dab01a13f4d1" xlink:href="mck-20230331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9969b4dc-43d0-4b36-a7ce-0b9c6596d030" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_22bca7c5-b058-4941-8555-dab01a13f4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a717a5da-c511-4890-bcc6-4c448c6c527a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a717a5da-c511-4890-bcc6-4c448c6c527a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7b136fd7-e8f4-4e8e-8079-8725684d0f43" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a717a5da-c511-4890-bcc6-4c448c6c527a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7b136fd7-e8f4-4e8e-8079-8725684d0f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_96a90704-b188-4feb-95b3-e428948d9f90" xlink:href="mck-20230331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7b136fd7-e8f4-4e8e-8079-8725684d0f43" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_96a90704-b188-4feb-95b3-e428948d9f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_3a19f3c1-8df6-431b-a4b4-dfaf5bff22ce" xlink:href="mck-20230331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7b136fd7-e8f4-4e8e-8079-8725684d0f43" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_3a19f3c1-8df6-431b-a4b4-dfaf5bff22ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6c8edf3a-020a-4ac7-b71f-23c47bb402c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_srt_ConsolidationItemsAxis_6c8edf3a-020a-4ac7-b71f-23c47bb402c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9cb214ff-bbb1-4096-b8dd-fc3589853663" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_6c8edf3a-020a-4ac7-b71f-23c47bb402c4" xlink:to="loc_srt_ConsolidationItemsDomain_9cb214ff-bbb1-4096-b8dd-fc3589853663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_bf324f01-fc13-41cd-b990-f9a760615977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9cb214ff-bbb1-4096-b8dd-fc3589853663" xlink:to="loc_us-gaap_OperatingSegmentsMember_bf324f01-fc13-41cd-b990-f9a760615977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_dffab505-0b17-4ebe-8305-e949e4c70751" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_866e4fda-e8c7-4923-879b-2470fe9f1c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_866e4fda-e8c7-4923-879b-2470fe9f1c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_caf2e0fa-bf57-44cd-bf28-dd0ad6614399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_caf2e0fa-bf57-44cd-bf28-dd0ad6614399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_72183b72-db27-446c-8b2f-ae5709ec84d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_72183b72-db27-446c-8b2f-ae5709ec84d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7942c516-cd6e-45d7-8e4f-4265ca6169e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7942c516-cd6e-45d7-8e4f-4265ca6169e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_6f7d8b72-3d64-46c6-a816-48a0493778fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_6f7d8b72-3d64-46c6-a816-48a0493778fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_1cfe5f52-e282-404e-b4d5-4f91eb5a1c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_1cfe5f52-e282-404e-b4d5-4f91eb5a1c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest_b220e193-0fee-4711-9207-e2220d7086f1" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest_b220e193-0fee-4711-9207-e2220d7086f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_b539ceb8-ee30-4c40-9ef0-86952f860110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_b539ceb8-ee30-4c40-9ef0-86952f860110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_d74fa97f-645f-4ad3-95e1-ae62454f03bb" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue_d74fa97f-645f-4ad3-95e1-ae62454f03bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_f637219e-930d-4633-92a2-2ed87266bceb" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_f637219e-930d-4633-92a2-2ed87266bceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_0963b204-ccfc-4817-aed9-51ecf8d448e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_0963b204-ccfc-4817-aed9-51ecf8d448e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c2f10cda-f3f5-4833-85c4-c3e7be3fc369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c2f10cda-f3f5-4833-85c4-c3e7be3fc369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_c6a1927a-c3bd-44a8-9c4e-0dbf0a748b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_AssetsNet_c6a1927a-c3bd-44a8-9c4e-0dbf0a748b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0885e630-0054-413a-95bd-4d9d29fd6f92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0885e630-0054-413a-95bd-4d9d29fd6f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_c9bec91b-1185-4db4-9a6e-3d486e2f756a" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable_c9bec91b-1185-4db4-9a6e-3d486e2f756a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_343feeac-5bec-4a23-a81d-a9cda98cc476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c486df83-4807-4267-9378-f1efc3acf59f" xlink:to="loc_us-gaap_EquityMethodInvestments_343feeac-5bec-4a23-a81d-a9cda98cc476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1f1d0e44-5a66-43ce-ab88-1dd63f08e69e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6a67f306-6bf2-4a49-976f-de8671424667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1f1d0e44-5a66-43ce-ab88-1dd63f08e69e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6a67f306-6bf2-4a49-976f-de8671424667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0570364b-6592-44f5-aed7-d56c0b470900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6a67f306-6bf2-4a49-976f-de8671424667" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0570364b-6592-44f5-aed7-d56c0b470900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5726ac85-56b9-44b9-9733-1a6fef3a57fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0570364b-6592-44f5-aed7-d56c0b470900" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5726ac85-56b9-44b9-9733-1a6fef3a57fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_37b7fa56-c973-4260-be88-cece83fc2032" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5726ac85-56b9-44b9-9733-1a6fef3a57fe" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_37b7fa56-c973-4260-be88-cece83fc2032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_6d0f432e-51fd-42d5-894e-d841ff8f9efc" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5726ac85-56b9-44b9-9733-1a6fef3a57fe" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_6d0f432e-51fd-42d5-894e-d841ff8f9efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternallyDevelopedSoftwareMember_bad45dbf-1352-4871-9cf5-d8231dc47988" xlink:href="mck-20230331.xsd#mck_InternallyDevelopedSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5726ac85-56b9-44b9-9733-1a6fef3a57fe" xlink:to="loc_mck_InternallyDevelopedSoftwareMember_bad45dbf-1352-4871-9cf5-d8231dc47988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b851ad6e-948c-41db-b062-8758b41e09f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6a67f306-6bf2-4a49-976f-de8671424667" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b851ad6e-948c-41db-b062-8758b41e09f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d4aeb144-1716-40a6-94f7-e582598b148c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b851ad6e-948c-41db-b062-8758b41e09f3" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d4aeb144-1716-40a6-94f7-e582598b148c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_326d9eae-4c16-4650-946b-6d0544ac4625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d4aeb144-1716-40a6-94f7-e582598b148c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_326d9eae-4c16-4650-946b-6d0544ac4625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_00822ae7-1b1c-4ef2-bd64-a9318202b76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6a67f306-6bf2-4a49-976f-de8671424667" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_00822ae7-1b1c-4ef2-bd64-a9318202b76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_00822ae7-1b1c-4ef2-bd64-a9318202b76c" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_4927c1c1-eb89-4d41-9c6b-f12923ce5d84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_4927c1c1-eb89-4d41-9c6b-f12923ce5d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_2d4c7e38-ea51-4047-bed5-f96fc2652def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_2d4c7e38-ea51-4047-bed5-f96fc2652def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_bcf31966-52b0-42be-87d3-10f24f4f3a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_bcf31966-52b0-42be-87d3-10f24f4f3a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_f1376e76-158e-416d-af08-5e8a8e7300c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_f1376e76-158e-416d-af08-5e8a8e7300c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_c2cb8713-fe8c-4f64-ad39-63aa52e16fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent_c2cb8713-fe8c-4f64-ad39-63aa52e16fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_21199e59-3ec1-4eab-a29b-7d72aeb763cc" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent_21199e59-3ec1-4eab-a29b-7d72aeb763cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_77057dd8-84a6-4aae-82f6-43b8eb8b16f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_77057dd8-84a6-4aae-82f6-43b8eb8b16f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_9038231e-53e1-4c95-a65f-b69f405a5f80" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent_9038231e-53e1-4c95-a65f-b69f405a5f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_9411c970-9ea2-4270-a6a6-42a792ac1306" xlink:href="mck-20230331.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1_9411c970-9ea2-4270-a6a6-42a792ac1306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_49277781-83f8-4dff-a62c-f71a5a7eb448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract_6fce76eb-c5ac-4a49-8ca9-cc4da8008fcd" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_49277781-83f8-4dff-a62c-f71a5a7eb448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_00822ae7-1b1c-4ef2-bd64-a9318202b76c" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_e5b87372-3895-4496-8e46-ee66f6c3b00d" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent_e5b87372-3895-4496-8e46-ee66f6c3b00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_52f73d8e-be07-44ea-b6da-b7e42710a43d" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_52f73d8e-be07-44ea-b6da-b7e42710a43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_cdd817e9-5d3a-41a3-834a-e48abeda7344" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent_cdd817e9-5d3a-41a3-834a-e48abeda7344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_17b56d89-d9fc-44e1-aaa1-c5079ff89d0c" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent_17b56d89-d9fc-44e1-aaa1-c5079ff89d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_f0bd8bc6-5a9f-4649-8e2d-b9fee348daba" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_f0bd8bc6-5a9f-4649-8e2d-b9fee348daba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_f08b94d0-5ed9-4cb1-8cb0-b4a685d4af49" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet_f08b94d0-5ed9-4cb1-8cb0-b4a685d4af49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_911a7116-6aa3-4374-9654-30314904555e" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent_911a7116-6aa3-4374-9654-30314904555e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_0908ec68-c07f-4e86-b49e-90c30b0a1d70" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent_0908ec68-c07f-4e86-b49e-90c30b0a1d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_3865ddd9-64a9-4865-ac70-7c0241c21b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract_31f513ef-aca3-4084-800a-844e82ce4b08" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_3865ddd9-64a9-4865-ac70-7c0241c21b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_171ec500-a845-48c9-a459-022dc2deb93d" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_00822ae7-1b1c-4ef2-bd64-a9318202b76c" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware_171ec500-a845-48c9-a459-022dc2deb93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RestructuringImpairmentandRelatedChargesNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_12991fe7-a039-4300-851a-3e14282212b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_12991fe7-a039-4300-851a-3e14282212b6" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_023a05c3-3470-4aad-9a78-7032dba4b7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:to="loc_us-gaap_RestructuringPlanAxis_023a05c3-3470-4aad-9a78-7032dba4b7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_023a05c3-3470-4aad-9a78-7032dba4b7ef" xlink:to="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember_c39e4fcd-7c4f-4672-986e-b8139572b95a" xlink:href="mck-20230331.xsd#mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:to="loc_mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember_c39e4fcd-7c4f-4672-986e-b8139572b95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_d2efee88-56b4-429d-8399-98198fea4e9a" xlink:href="mck-20230331.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_d2efee88-56b4-429d-8399-98198fea4e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_0cf6dde2-937a-4be8-b5d1-b26ded877007" xlink:href="mck-20230331.xsd#mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:to="loc_mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember_0cf6dde2-937a-4be8-b5d1-b26ded877007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_bac1ae23-df6f-4bcd-b151-cc2d4c62a4f2" xlink:href="mck-20230331.xsd#mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_a0b632a7-5853-47dc-96cc-646cca044382" xlink:to="loc_mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember_bac1ae23-df6f-4bcd-b151-cc2d4c62a4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5613d5e9-f6bf-4070-9f90-39e39d5838f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:to="loc_srt_StatementGeographicalAxis_5613d5e9-f6bf-4070-9f90-39e39d5838f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_17cd3730-6ad5-4288-9d7e-8f90e36d38bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_5613d5e9-f6bf-4070-9f90-39e39d5838f8" xlink:to="loc_srt_SegmentGeographicalDomain_17cd3730-6ad5-4288-9d7e-8f90e36d38bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_9c246d78-578f-4c6d-a03b-c898e3491a63" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_GB"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_17cd3730-6ad5-4288-9d7e-8f90e36d38bd" xlink:to="loc_country_GB_9c246d78-578f-4c6d-a03b-c898e3491a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_17cd7c0e-578c-45f6-9d9c-c6e432698af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_17cd7c0e-578c-45f6-9d9c-c6e432698af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cece0b82-b046-4085-bf60-bf683df519cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_17cd7c0e-578c-45f6-9d9c-c6e432698af6" xlink:to="loc_us-gaap_SegmentDomain_cece0b82-b046-4085-bf60-bf683df519cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_4790b66c-5c20-4b8c-a753-b7aa6dbe086b" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cece0b82-b046-4085-bf60-bf683df519cc" xlink:to="loc_mck_InternationalSegmentMember_4790b66c-5c20-4b8c-a753-b7aa6dbe086b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_bcfdc081-19a9-4a79-aebf-48b089e7ad82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_bcfdc081-19a9-4a79-aebf-48b089e7ad82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6c6a8d28-5339-4869-b149-705cc820d1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_bcfdc081-19a9-4a79-aebf-48b089e7ad82" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6c6a8d28-5339-4869-b149-705cc820d1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_26e259b2-7432-4c71-9c5a-8be4a84b6dd9" xlink:href="mck-20230331.xsd#mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6c6a8d28-5339-4869-b149-705cc820d1a7" xlink:to="loc_mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember_26e259b2-7432-4c71-9c5a-8be4a84b6dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_a364107b-1aea-4a60-855e-846c043fc0e8" xlink:href="mck-20230331.xsd#mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6c6a8d28-5339-4869-b149-705cc820d1a7" xlink:to="loc_mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember_a364107b-1aea-4a60-855e-846c043fc0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_940bf0b2-0d85-497b-9aef-5ec0aebfe339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:to="loc_us-gaap_ReportingUnitAxis_940bf0b2-0d85-497b-9aef-5ec0aebfe339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_993ee814-3d5a-48da-aeb8-26e8743fa8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_940bf0b2-0d85-497b-9aef-5ec0aebfe339" xlink:to="loc_us-gaap_ReportingUnitDomain_993ee814-3d5a-48da-aeb8-26e8743fa8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_f40734b9-6691-4a03-a23b-92c94354de86" xlink:href="mck-20230331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_993ee814-3d5a-48da-aeb8-26e8743fa8d6" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_f40734b9-6691-4a03-a23b-92c94354de86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c0ae6299-10be-4053-b95d-7b202595cb01" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_8b192483-9129-4302-923f-c0269aa536c0" xlink:href="mck-20230331.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_8b192483-9129-4302-923f-c0269aa536c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9416522d-bb8f-4ad2-b928-e7ab1e1f844a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_9416522d-bb8f-4ad2-b928-e7ab1e1f844a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_28de2de7-4575-4f3e-9d69-2d3d3a81f250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:to="loc_us-gaap_RestructuringCharges_28de2de7-4575-4f3e-9d69-2d3d3a81f250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_c6258f85-81de-49d9-a1f1-2fcde8f00d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_8e87b614-6012-4cf0-af92-651fb47d17b1" xlink:to="loc_us-gaap_AssetImpairmentCharges_c6258f85-81de-49d9-a1f1-2fcde8f00d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4b0b6397-b449-4475-be65-a04a9377c00d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9bbcca9e-8c62-4cb3-93e7-03857ccd989e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4b0b6397-b449-4475-be65-a04a9377c00d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9bbcca9e-8c62-4cb3-93e7-03857ccd989e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_120610ab-2747-4895-9266-7f79f9db0922" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9bbcca9e-8c62-4cb3-93e7-03857ccd989e" xlink:to="loc_srt_ConsolidationItemsAxis_120610ab-2747-4895-9266-7f79f9db0922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5ee27fd3-df88-4023-a2a3-ac193b7296ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_120610ab-2747-4895-9266-7f79f9db0922" xlink:to="loc_srt_ConsolidationItemsDomain_5ee27fd3-df88-4023-a2a3-ac193b7296ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f7f76ebc-aac5-451d-87e9-9b071d2f1b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_5ee27fd3-df88-4023-a2a3-ac193b7296ed" xlink:to="loc_us-gaap_OperatingSegmentsMember_f7f76ebc-aac5-451d-87e9-9b071d2f1b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_1df5fc11-4ad1-465e-b1c4-d21956681b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_5ee27fd3-df88-4023-a2a3-ac193b7296ed" xlink:to="loc_us-gaap_CorporateNonSegmentMember_1df5fc11-4ad1-465e-b1c4-d21956681b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_44db6021-4662-4b05-bd4e-55998bf186fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9bbcca9e-8c62-4cb3-93e7-03857ccd989e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_44db6021-4662-4b05-bd4e-55998bf186fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_44db6021-4662-4b05-bd4e-55998bf186fa" xlink:to="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_970d444e-2ac3-4826-a1e2-606d4a482642" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:to="loc_mck_USPharmaceuticalSegmentMember_970d444e-2ac3-4826-a1e2-606d4a482642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_06a28485-b687-4426-8d8b-743713603653" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_06a28485-b687-4426-8d8b-743713603653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_735aa27f-da37-488f-b937-2b6bc0ecdaba" xlink:href="mck-20230331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_735aa27f-da37-488f-b937-2b6bc0ecdaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_32b50e50-6e07-4981-b2ce-885ee9ad1135" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d2de36e3-95f6-480b-99be-a719146ea0b1" xlink:to="loc_mck_InternationalSegmentMember_32b50e50-6e07-4981-b2ce-885ee9ad1135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9bbcca9e-8c62-4cb3-93e7-03857ccd989e" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_df5045d8-3c16-4811-882a-895aa2819fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:to="loc_us-gaap_SeveranceCosts1_df5045d8-3c16-4811-882a-895aa2819fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_d8daedab-5d04-4f91-be39-dc6d17f1929e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:to="loc_us-gaap_BusinessExitCosts1_d8daedab-5d04-4f91-be39-dc6d17f1929e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_2b984efb-f20f-4f3c-9211-ae170a1036df" xlink:href="mck-20230331.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_2b984efb-f20f-4f3c-9211-ae170a1036df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_d7b741f5-caeb-4e85-9b7f-d2b2894b86dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f201025f-b66f-4041-91ed-50c5cc419024" xlink:to="loc_us-gaap_RestructuringCharges_d7b741f5-caeb-4e85-9b7f-d2b2894b86dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7bdcf07c-d2b6-4bac-bbc6-467808e466e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_316902db-0d83-4e4d-947b-1f0fe5306822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7bdcf07c-d2b6-4bac-bbc6-467808e466e0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_316902db-0d83-4e4d-947b-1f0fe5306822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_455ad681-ce15-4626-b012-7381f2f13ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_316902db-0d83-4e4d-947b-1f0fe5306822" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_455ad681-ce15-4626-b012-7381f2f13ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_455ad681-ce15-4626-b012-7381f2f13ee3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_53cac341-9a10-4c34-8889-8ce1801c01bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_53cac341-9a10-4c34-8889-8ce1801c01bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d79169f5-3aec-49ba-a009-c43580ed69a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d79169f5-3aec-49ba-a009-c43580ed69a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_fc94a519-50ec-41e2-977a-8c4ca826957c" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember_fc94a519-50ec-41e2-977a-8c4ca826957c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_47439937-80c3-476a-9109-f766f234f7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_76c767c0-0bd8-46bd-9934-2371db8117ec" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_47439937-80c3-476a-9109-f766f234f7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_03e195bd-d603-4a4e-bde5-390fc9a9eecd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_316902db-0d83-4e4d-947b-1f0fe5306822" xlink:to="loc_srt_ConsolidationItemsAxis_03e195bd-d603-4a4e-bde5-390fc9a9eecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_11deaf2f-65dc-4dcf-837a-cee2df6361b1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_03e195bd-d603-4a4e-bde5-390fc9a9eecd" xlink:to="loc_srt_ConsolidationItemsDomain_11deaf2f-65dc-4dcf-837a-cee2df6361b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_5b9d0f40-f756-4fff-b4bd-f4d94dc7281d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_11deaf2f-65dc-4dcf-837a-cee2df6361b1" xlink:to="loc_us-gaap_OperatingSegmentsMember_5b9d0f40-f756-4fff-b4bd-f4d94dc7281d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_833d1101-f87b-4750-9a80-6080b230ccc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_11deaf2f-65dc-4dcf-837a-cee2df6361b1" xlink:to="loc_us-gaap_CorporateNonSegmentMember_833d1101-f87b-4750-9a80-6080b230ccc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a40feedc-101b-49b3-ae98-2d536073fb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_316902db-0d83-4e4d-947b-1f0fe5306822" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a40feedc-101b-49b3-ae98-2d536073fb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a40feedc-101b-49b3-ae98-2d536073fb8a" xlink:to="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_cec004c5-ca2d-4588-a0d4-ed0f8d41b615" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:to="loc_mck_USPharmaceuticalSegmentMember_cec004c5-ca2d-4588-a0d4-ed0f8d41b615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_6e06cdf7-3542-41b6-81cb-5529efc525aa" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_6e06cdf7-3542-41b6-81cb-5529efc525aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_c4e5699e-6a9c-492d-83a3-7256f181d01a" xlink:href="mck-20230331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_c4e5699e-6a9c-492d-83a3-7256f181d01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_86d861ef-e60a-40b4-8ce3-0ff8ce0eb3b9" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e98b9d69-7284-4473-a86a-5f7190361b5f" xlink:to="loc_mck_InternationalSegmentMember_86d861ef-e60a-40b4-8ce3-0ff8ce0eb3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_735cf97c-11ef-4f7e-b290-69067a2ca13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_316902db-0d83-4e4d-947b-1f0fe5306822" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_735cf97c-11ef-4f7e-b290-69067a2ca13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_735cf97c-11ef-4f7e-b290-69067a2ca13b" xlink:to="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_913509a5-6f25-4af0-9d20-f6d57d443dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:to="loc_us-gaap_RestructuringReserve_913509a5-6f25-4af0-9d20-f6d57d443dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_846dade0-03bf-48ba-8463-9688dbd52eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:to="loc_us-gaap_RestructuringCharges_846dade0-03bf-48ba-8463-9688dbd52eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_4c1cc3af-652f-42b3-9ca3-287f8149aa75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_4c1cc3af-652f-42b3-9ca3-287f8149aa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_b77f1860-f5c3-4f2b-bcf6-dc25ad3b184c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:to="loc_us-gaap_PaymentsForRestructuring_b77f1860-f5c3-4f2b-bcf6-dc25ad3b184c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_b370e1ef-f322-4ba2-9f50-f8021bcc4118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_b370e1ef-f322-4ba2-9f50-f8021bcc4118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c98a5fb9-2479-42b6-938c-582e8266e437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_796e5703-0b27-4473-a2d5-1d2b46f512fb" xlink:to="loc_us-gaap_RestructuringReserve_c98a5fb9-2479-42b6-938c-582e8266e437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82291cf8-8a6c-4890-ab6b-d04c50b97510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0222964e-55f9-4b1f-a899-b6b8d16c443a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82291cf8-8a6c-4890-ab6b-d04c50b97510" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0222964e-55f9-4b1f-a899-b6b8d16c443a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e13dc520-103b-49b8-8e89-8b1aaf210c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0222964e-55f9-4b1f-a899-b6b8d16c443a" xlink:to="loc_us-gaap_AwardTypeAxis_e13dc520-103b-49b8-8e89-8b1aaf210c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ea2fd96-20f1-428a-ad27-ab918bf0cb24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e13dc520-103b-49b8-8e89-8b1aaf210c6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ea2fd96-20f1-428a-ad27-ab918bf0cb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6b0fa5a6-06b4-474f-bc61-e991d3132081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ea2fd96-20f1-428a-ad27-ab918bf0cb24" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6b0fa5a6-06b4-474f-bc61-e991d3132081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_37a1f30a-98a6-4185-a9d0-d0eb0d2188ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ea2fd96-20f1-428a-ad27-ab918bf0cb24" xlink:to="loc_us-gaap_StockOptionMember_37a1f30a-98a6-4185-a9d0-d0eb0d2188ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_9d99cfb3-283b-4c59-b2f8-d55e44a4dcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ea2fd96-20f1-428a-ad27-ab918bf0cb24" xlink:to="loc_us-gaap_EmployeeStockMember_9d99cfb3-283b-4c59-b2f8-d55e44a4dcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0222964e-55f9-4b1f-a899-b6b8d16c443a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_798807a6-2c79-4849-ab9a-c1d1a1f270ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_798807a6-2c79-4849-ab9a-c1d1a1f270ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_43696792-9fcb-4295-96ee-49688357871b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_43696792-9fcb-4295-96ee-49688357871b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_c9ffbacc-f62f-4aa3-94a0-f11d7278dc19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_c9ffbacc-f62f-4aa3-94a0-f11d7278dc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_81157b10-d26f-4e58-abef-1c97e050ca0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_389d80b0-a4a8-4160-91d7-eb28b295118f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_81157b10-d26f-4e58-abef-1c97e050ca0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4110b159-697e-48e1-bb74-1d6c35e1e740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4110b159-697e-48e1-bb74-1d6c35e1e740" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d7ed3530-5e3f-413f-a300-96feb2bbcfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:to="loc_us-gaap_PlanNameAxis_d7ed3530-5e3f-413f-a300-96feb2bbcfdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_17972fee-993c-42ab-bcff-73881a6c114f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d7ed3530-5e3f-413f-a300-96feb2bbcfdd" xlink:to="loc_us-gaap_PlanNameDomain_17972fee-993c-42ab-bcff-73881a6c114f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2022StockPlanMember_3b35120b-406d-47b7-8dd3-e54f53d3843d" xlink:href="mck-20230331.xsd#mck_A2022StockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_17972fee-993c-42ab-bcff-73881a6c114f" xlink:to="loc_mck_A2022StockPlanMember_3b35120b-406d-47b7-8dd3-e54f53d3843d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2013StockPlanMember_06be3d9c-99f5-45f5-953c-c2795df7e49e" xlink:href="mck-20230331.xsd#mck_A2013StockPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_17972fee-993c-42ab-bcff-73881a6c114f" xlink:to="loc_mck_A2013StockPlanMember_06be3d9c-99f5-45f5-953c-c2795df7e49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3218fba7-8f00-4c28-a164-acfcc3d6b82c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:to="loc_us-gaap_AwardTypeAxis_3218fba7-8f00-4c28-a164-acfcc3d6b82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3218fba7-8f00-4c28-a164-acfcc3d6b82c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fa81809b-827b-4fb2-ae22-afb54d1f7bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fa81809b-827b-4fb2-ae22-afb54d1f7bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PerformancebasedStockUnitsMember_ee91bbd7-c0b9-4e85-b577-be1417016755" xlink:href="mck-20230331.xsd#mck_PerformancebasedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:to="loc_mck_PerformancebasedStockUnitsMember_ee91bbd7-c0b9-4e85-b577-be1417016755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ddd314bd-5ee3-4052-92b3-015f61031654" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ddd314bd-5ee3-4052-92b3-015f61031654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d12337ee-6e94-4bfc-843c-2d4cb8f40973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cd39d2c-3f67-4ba0-b831-37eb2aef0267" xlink:to="loc_us-gaap_EmployeeStockMember_d12337ee-6e94-4bfc-843c-2d4cb8f40973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f8c34e49-b61a-4376-babd-2c140665cc10" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:to="loc_srt_RangeAxis_f8c34e49-b61a-4376-babd-2c140665cc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e2f780b9-5f04-498a-870e-0319b16f04fa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f8c34e49-b61a-4376-babd-2c140665cc10" xlink:to="loc_srt_RangeMember_e2f780b9-5f04-498a-870e-0319b16f04fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_27d725b3-c9a6-4b72-a191-602ffa099e9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e2f780b9-5f04-498a-870e-0319b16f04fa" xlink:to="loc_srt_MinimumMember_27d725b3-c9a6-4b72-a191-602ffa099e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5cea6cfd-40ab-4c50-9a5f-d67860332cf6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e2f780b9-5f04-498a-870e-0319b16f04fa" xlink:to="loc_srt_MaximumMember_5cea6cfd-40ab-4c50-9a5f-d67860332cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_d3585319-e634-4fe3-8eab-1de08ee362f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:to="loc_srt_TitleOfIndividualAxis_d3585319-e634-4fe3-8eab-1de08ee362f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e04497d0-f2e7-4727-a3bc-e15d3c0840ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_d3585319-e634-4fe3-8eab-1de08ee362f6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e04497d0-f2e7-4727-a3bc-e15d3c0840ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_60bb2d75-1aae-4b5e-88cd-539bd34eb783" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e04497d0-f2e7-4727-a3bc-e15d3c0840ee" xlink:to="loc_srt_DirectorMember_60bb2d75-1aae-4b5e-88cd-539bd34eb783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc6171ce-4037-45c0-8056-8b896d0506d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7d0f17d5-18ec-4f14-b426-7f115f83e5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7d0f17d5-18ec-4f14-b426-7f115f83e5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_86128ff8-9477-48b1-870c-b81af64f40d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_86128ff8-9477-48b1-870c-b81af64f40d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e2fd2e5e-33a9-4af6-9a27-0da11daf230e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e2fd2e5e-33a9-4af6-9a27-0da11daf230e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_6a8e73ab-71a4-4957-9656-74e5122476aa" xlink:href="mck-20230331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested_6a8e73ab-71a4-4957-9656-74e5122476aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_abff5d99-83d6-4cbe-8918-e64142aca4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_abff5d99-83d6-4cbe-8918-e64142aca4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_19ba857a-4da1-43c7-8cbc-eb68a6d61b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_19ba857a-4da1-43c7-8cbc-eb68a6d61b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00f3982d-700c-4c64-b7bb-73cad5f96ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00f3982d-700c-4c64-b7bb-73cad5f96ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_6d4c1d80-a064-4329-8c29-bc7aeb75c55c" xlink:href="mck-20230331.xsd#mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions_6d4c1d80-a064-4329-8c29-bc7aeb75c55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b7db8684-eabf-45f0-ab40-120af9ee2d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b7db8684-eabf-45f0-ab40-120af9ee2d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_f2ef890e-98ae-458b-be2a-2eacca12f086" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5450669b-cd67-46d7-b7e0-abe73902c6ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_f2ef890e-98ae-458b-be2a-2eacca12f086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eeedc0bb-0a41-407b-b349-852e093ae94a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7656d9df-fc65-46a7-89a4-cf2b65d47e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eeedc0bb-0a41-407b-b349-852e093ae94a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7656d9df-fc65-46a7-89a4-cf2b65d47e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_64afce61-8bde-4d0c-ad0a-362f1857f939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7656d9df-fc65-46a7-89a4-cf2b65d47e73" xlink:to="loc_us-gaap_AwardTypeAxis_64afce61-8bde-4d0c-ad0a-362f1857f939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a6d246cb-c17c-4209-9696-3d7ba384ea6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_64afce61-8bde-4d0c-ad0a-362f1857f939" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a6d246cb-c17c-4209-9696-3d7ba384ea6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_064f52ca-f459-48e9-b22d-a7e0e54177e6" xlink:href="mck-20230331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a6d246cb-c17c-4209-9696-3d7ba384ea6b" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_064f52ca-f459-48e9-b22d-a7e0e54177e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7656d9df-fc65-46a7-89a4-cf2b65d47e73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0ae2a002-5127-4bc9-938d-373dff2df4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0ae2a002-5127-4bc9-938d-373dff2df4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f41909e1-547c-4b3c-af49-9ec77145f7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f41909e1-547c-4b3c-af49-9ec77145f7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fd2d7d1-4437-44c7-94a6-271775543ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7fd2d7d1-4437-44c7-94a6-271775543ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f42a4d35-0858-420b-a792-0a2afb323a00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6f8ea71-a776-4580-81ac-af50d1d59b91" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f42a4d35-0858-420b-a792-0a2afb323a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_989ffae9-bcdc-4cb9-9ece-71422c4847f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eceb53b1-3674-4296-a16c-06936570cbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_989ffae9-bcdc-4cb9-9ece-71422c4847f1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eceb53b1-3674-4296-a16c-06936570cbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7fe94f0e-0e56-43f4-8382-bb8d1f6247cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eceb53b1-3674-4296-a16c-06936570cbb3" xlink:to="loc_us-gaap_AwardTypeAxis_7fe94f0e-0e56-43f4-8382-bb8d1f6247cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7331e782-8f0a-4a03-9608-4e5be235e178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7fe94f0e-0e56-43f4-8382-bb8d1f6247cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7331e782-8f0a-4a03-9608-4e5be235e178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_02e50a76-4fd4-4739-b6c2-79294a4be641" xlink:href="mck-20230331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7331e782-8f0a-4a03-9608-4e5be235e178" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_02e50a76-4fd4-4739-b6c2-79294a4be641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4396d691-60fc-4b89-95b7-518298d615ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eceb53b1-3674-4296-a16c-06936570cbb3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4396d691-60fc-4b89-95b7-518298d615ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4396d691-60fc-4b89-95b7-518298d615ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7c798371-10b0-43e4-9f22-8a8bc5f83766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7c798371-10b0-43e4-9f22-8a8bc5f83766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_342fbbd1-e004-4d1b-8c82-3e43aaff41f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_342fbbd1-e004-4d1b-8c82-3e43aaff41f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_92607fa6-b577-4b23-b2a0-7fa10fa6e803" xlink:href="mck-20230331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod_92607fa6-b577-4b23-b2a0-7fa10fa6e803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5f57eaac-2c85-4f73-98c1-981d6f10aa31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5f57eaac-2c85-4f73-98c1-981d6f10aa31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4d2f3903-2a91-4617-99d2-c843aec4c80a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_979459b6-ea83-49b9-9715-556ce4dd5f77" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4d2f3903-2a91-4617-99d2-c843aec4c80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4396d691-60fc-4b89-95b7-518298d615ee" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8bdc3c9e-ad1d-4279-b237-7a30fd6dc005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8bdc3c9e-ad1d-4279-b237-7a30fd6dc005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a7e789b9-d6d2-4da7-9ddc-9fd7dd54aef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a7e789b9-d6d2-4da7-9ddc-9fd7dd54aef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_17feceff-e437-4ec1-a484-26f0c6df6392" xlink:href="mck-20230331.xsd#mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:to="loc_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1_17feceff-e437-4ec1-a484-26f0c6df6392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e5e81d68-1cd6-4dfd-9adc-a31f1389f8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e5e81d68-1cd6-4dfd-9adc-a31f1389f8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ae64feb4-0079-4c11-8d14-629b1da47bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_5803ca28-e035-49bc-bff5-34c769eeb15d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ae64feb4-0079-4c11-8d14-629b1da47bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dbc00a88-12b5-44e6-9e08-d3201c37b44f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebffcdf3-8106-4c6b-a685-12b534fa794b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dbc00a88-12b5-44e6-9e08-d3201c37b44f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebffcdf3-8106-4c6b-a685-12b534fa794b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_512d8d61-2f59-41eb-85cf-d01630cfe576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebffcdf3-8106-4c6b-a685-12b534fa794b" xlink:to="loc_us-gaap_AwardTypeAxis_512d8d61-2f59-41eb-85cf-d01630cfe576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4af17af-ad00-43d8-91c8-c249fc5b2487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_512d8d61-2f59-41eb-85cf-d01630cfe576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4af17af-ad00-43d8-91c8-c249fc5b2487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_dbcb2eb7-5921-4437-936b-d4c82c42b3d4" xlink:href="mck-20230331.xsd#mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4af17af-ad00-43d8-91c8-c249fc5b2487" xlink:to="loc_mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember_dbcb2eb7-5921-4437-936b-d4c82c42b3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f511e23b-330b-4a0b-99a4-f5fd61934e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ebffcdf3-8106-4c6b-a685-12b534fa794b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f511e23b-330b-4a0b-99a4-f5fd61934e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a000b518-1e73-4997-b5f0-e63de9cbbf83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f511e23b-330b-4a0b-99a4-f5fd61934e2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a000b518-1e73-4997-b5f0-e63de9cbbf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f646bf06-d711-4a49-91f9-529bc942529b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f511e23b-330b-4a0b-99a4-f5fd61934e2d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f646bf06-d711-4a49-91f9-529bc942529b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d0bcb600-d145-4169-b38a-ee25e2ca1240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f511e23b-330b-4a0b-99a4-f5fd61934e2d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d0bcb600-d145-4169-b38a-ee25e2ca1240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationSummaryofStockOptionsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52448535-0346-4e0f-8c39-cb702ca63ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_943fb4bc-94f6-43f7-be94-e6c2d196ea9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52448535-0346-4e0f-8c39-cb702ca63ecd" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_943fb4bc-94f6-43f7-be94-e6c2d196ea9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_bf9b115e-c2c1-4907-b06b-3e8ee30c877d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52448535-0346-4e0f-8c39-cb702ca63ecd" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_bf9b115e-c2c1-4907-b06b-3e8ee30c877d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_16319cf4-90af-4c55-bb80-9eae8712bd42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52448535-0346-4e0f-8c39-cb702ca63ecd" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_16319cf4-90af-4c55-bb80-9eae8712bd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_9c6ef1ff-da33-4bad-9d90-100345ff4cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52448535-0346-4e0f-8c39-cb702ca63ecd" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_9c6ef1ff-da33-4bad-9d90-100345ff4cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_d14b2fad-7bfc-4603-91be-a51a6216bdd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52448535-0346-4e0f-8c39-cb702ca63ecd" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_d14b2fad-7bfc-4603-91be-a51a6216bdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_49fa2935-cb40-44b3-a4a1-2e29ef9fdd40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52448535-0346-4e0f-8c39-cb702ca63ecd" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_49fa2935-cb40-44b3-a4a1-2e29ef9fdd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_a4db12d8-6c0f-4808-bd1f-4b02d25a0a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52448535-0346-4e0f-8c39-cb702ca63ecd" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_a4db12d8-6c0f-4808-bd1f-4b02d25a0a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationScheduleofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3acac983-1c3d-4dcb-b366-ae952fbbe0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3acac983-1c3d-4dcb-b366-ae952fbbe0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_48195e9e-292f-4bc1-848e-bcca5e3a8db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3acac983-1c3d-4dcb-b366-ae952fbbe0f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_48195e9e-292f-4bc1-848e-bcca5e3a8db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_f1dec7fb-51e5-4842-bfe4-9043d49f6f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3acac983-1c3d-4dcb-b366-ae952fbbe0f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_f1dec7fb-51e5-4842-bfe4-9043d49f6f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d6182631-c395-4219-8704-5a5402727289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3acac983-1c3d-4dcb-b366-ae952fbbe0f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d6182631-c395-4219-8704-5a5402727289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_45ced03e-f18a-4bdb-980d-7f541bd6d2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3acac983-1c3d-4dcb-b366-ae952fbbe0f6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_45ced03e-f18a-4bdb-980d-7f541bd6d2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4655cc2a-7665-42d5-bc9c-ec03830e1432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3acac983-1c3d-4dcb-b366-ae952fbbe0f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4655cc2a-7665-42d5-bc9c-ec03830e1432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_f9726051-4d5e-4d44-9234-e31c1e0968a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_f9726051-4d5e-4d44-9234-e31c1e0968a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fec7e6ab-64d8-473c-b730-da5fa3bc11e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fec7e6ab-64d8-473c-b730-da5fa3bc11e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e14e55e0-bbbb-4f0d-8af1-b2f0cd13c621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e14e55e0-bbbb-4f0d-8af1-b2f0cd13c621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6e809c52-4596-496c-8109-c88e0a16cf35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e14e55e0-bbbb-4f0d-8af1-b2f0cd13c621" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6e809c52-4596-496c-8109-c88e0a16cf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3e070c0a-f788-4fac-ab2b-4df487ef0fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e14e55e0-bbbb-4f0d-8af1-b2f0cd13c621" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3e070c0a-f788-4fac-ab2b-4df487ef0fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2ff59b22-7d7b-4d63-b7bb-f1e26f2beea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e14e55e0-bbbb-4f0d-8af1-b2f0cd13c621" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2ff59b22-7d7b-4d63-b7bb-f1e26f2beea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4af1141b-0161-49a9-9d73-f5de78c44c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e14e55e0-bbbb-4f0d-8af1-b2f0cd13c621" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4af1141b-0161-49a9-9d73-f5de78c44c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e6a1a2a9-5c02-4998-9d55-7cddcb26f444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e14e55e0-bbbb-4f0d-8af1-b2f0cd13c621" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e6a1a2a9-5c02-4998-9d55-7cddcb26f444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a734e1fd-639e-464c-8a47-de88ce32b4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_a734e1fd-639e-464c-8a47-de88ce32b4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d22812e3-2ad1-4dc1-a431-81e641740de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d22812e3-2ad1-4dc1-a431-81e641740de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f67c0589-fc5b-422d-b17a-089dff6115b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f67c0589-fc5b-422d-b17a-089dff6115b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_84599502-2446-4b74-b758-514bb381401d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_f67c0589-fc5b-422d-b17a-089dff6115b2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_84599502-2446-4b74-b758-514bb381401d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_08b0fa93-7fa6-47f3-910d-e152e5b5897e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_08b0fa93-7fa6-47f3-910d-e152e5b5897e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_42c9d08b-5dfc-48f5-9fc3-776e01e8858b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_42c9d08b-5dfc-48f5-9fc3-776e01e8858b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_8ebc8725-8234-4393-909d-a76a629e2c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_8ebc8725-8234-4393-909d-a76a629e2c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f8665ea8-7127-46fe-abcf-e8cacf577bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_8ebc8725-8234-4393-909d-a76a629e2c94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f8665ea8-7127-46fe-abcf-e8cacf577bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_9e975755-a2ce-457e-86b5-f5b7cbae5cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_9e975755-a2ce-457e-86b5-f5b7cbae5cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_5438f5aa-e4a9-4b7b-b1e3-22efe5eef101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b8d647f2-5900-433b-854e-233ed6aedb93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_5438f5aa-e4a9-4b7b-b1e3-22efe5eef101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0297a125-ad3a-436e-85c8-2c9a08cdd636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fc46602-d7a4-4543-b249-eb8ccb338c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0297a125-ad3a-436e-85c8-2c9a08cdd636" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fc46602-d7a4-4543-b249-eb8ccb338c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_aa0aacb7-dc9a-4b39-bdc4-85f6168875a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fc46602-d7a4-4543-b249-eb8ccb338c3c" xlink:to="loc_us-gaap_AwardTypeAxis_aa0aacb7-dc9a-4b39-bdc4-85f6168875a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22e18a4e-32c1-4090-b22f-3df6d824a8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_aa0aacb7-dc9a-4b39-bdc4-85f6168875a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22e18a4e-32c1-4090-b22f-3df6d824a8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f06c97bc-28ca-4ba2-9b4b-2b989c5dc226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22e18a4e-32c1-4090-b22f-3df6d824a8a0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f06c97bc-28ca-4ba2-9b4b-2b989c5dc226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0fc46602-d7a4-4543-b249-eb8ccb338c3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9088e311-9f30-43bc-861f-c3e81d65e800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9088e311-9f30-43bc-861f-c3e81d65e800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_788be0cb-674f-469a-bc15-d9290377242e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_788be0cb-674f-469a-bc15-d9290377242e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e08f45e5-a964-4322-ab5f-ed476ceeee4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e08f45e5-a964-4322-ab5f-ed476ceeee4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_c6184dc1-0107-4efc-87eb-3667edb2d0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_c6184dc1-0107-4efc-87eb-3667edb2d0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_ca8f48f0-131e-4a45-b888-11fba81098bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_ca8f48f0-131e-4a45-b888-11fba81098bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c62c9926-4539-4e93-9614-81a70ee2ea07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c62c9926-4539-4e93-9614-81a70ee2ea07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2cc6616e-3869-41ce-8f39-c7ca506710e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_78e94b6c-68f3-4ab7-9ee1-5f0b35ef93db" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2cc6616e-3869-41ce-8f39-c7ca506710e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#OtherIncomeNetScheduleofOtherIncomeNetDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_f976ae69-1b57-4f5b-9037-f21adbe1a3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_f976ae69-1b57-4f5b-9037-f21adbe1a3d4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8a07048d-a11e-45e2-b267-96ae994d96d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8a07048d-a11e-45e2-b267-96ae994d96d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5561aff1-6cc8-44ab-a7cb-a75d91f2139c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8a07048d-a11e-45e2-b267-96ae994d96d7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5561aff1-6cc8-44ab-a7cb-a75d91f2139c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_e7158c61-2f36-4ffe-b9f6-dd1e3b7bddba" xlink:href="mck-20230331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5561aff1-6cc8-44ab-a7cb-a75d91f2139c" xlink:to="loc_mck_GermanWholesaleBusinessMember_e7158c61-2f36-4ffe-b9f6-dd1e3b7bddba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_80645b0f-c7ab-449d-8955-5b654358d77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_80645b0f-c7ab-449d-8955-5b654358d77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_efc4f275-835a-4d07-b547-39e12799745f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_80645b0f-c7ab-449d-8955-5b654358d77a" xlink:to="loc_us-gaap_RelatedPartyDomain_efc4f275-835a-4d07-b547-39e12799745f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_183fc3c5-5066-4ed6-a329-8c3731142453" xlink:href="mck-20230331.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_efc4f275-835a-4d07-b547-39e12799745f" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_183fc3c5-5066-4ed6-a329-8c3731142453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d81e1347-1163-43cf-8293-c15e981cc811" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:to="loc_srt_OwnershipAxis_d81e1347-1163-43cf-8293-c15e981cc811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_20c164cf-1ba7-417f-90ac-f2e7e74dc50f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_d81e1347-1163-43cf-8293-c15e981cc811" xlink:to="loc_srt_OwnershipDomain_20c164cf-1ba7-417f-90ac-f2e7e74dc50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_3deb3520-fa2a-4eaf-b696-c8e2e2d14baa" xlink:href="mck-20230331.xsd#mck_GermanPharmaceuticalWholesaleJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_20c164cf-1ba7-417f-90ac-f2e7e74dc50f" xlink:to="loc_mck_GermanPharmaceuticalWholesaleJointVentureMember_3deb3520-fa2a-4eaf-b696-c8e2e2d14baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b53a107f-492c-4045-b5b3-eddaf7af6c29" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:to="loc_srt_ConsolidationItemsAxis_b53a107f-492c-4045-b5b3-eddaf7af6c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a0ab65b3-7e07-46b0-ba4f-a1c5e454a575" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b53a107f-492c-4045-b5b3-eddaf7af6c29" xlink:to="loc_srt_ConsolidationItemsDomain_a0ab65b3-7e07-46b0-ba4f-a1c5e454a575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_be2138ee-00c5-44e6-ae66-063b70f5348d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a0ab65b3-7e07-46b0-ba4f-a1c5e454a575" xlink:to="loc_us-gaap_OperatingSegmentsMember_be2138ee-00c5-44e6-ae66-063b70f5348d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4cbbe365-f154-40bc-9507-7525c00d69da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4cbbe365-f154-40bc-9507-7525c00d69da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2c333d6a-d5e3-4fd4-992e-9bce88aeb5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4cbbe365-f154-40bc-9507-7525c00d69da" xlink:to="loc_us-gaap_SegmentDomain_2c333d6a-d5e3-4fd4-992e-9bce88aeb5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_270579b6-8fd7-40d8-9915-0014280919a1" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2c333d6a-d5e3-4fd4-992e-9bce88aeb5e0" xlink:to="loc_mck_USPharmaceuticalSegmentMember_270579b6-8fd7-40d8-9915-0014280919a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06cffb10-c9a6-4596-86ba-d44ac64b06b1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0a9c20e5-bf78-436e-94fd-d712d05765e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0a9c20e5-bf78-436e-94fd-d712d05765e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_75c4f654-7c7e-4f0a-a851-ce15b58af32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_75c4f654-7c7e-4f0a-a851-ce15b58af32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses_b091b1e5-341e-4e08-ae48-0a1ddb260ebc" xlink:href="mck-20230331.xsd#mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:to="loc_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses_b091b1e5-341e-4e08-ae48-0a1ddb260ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1339c964-4fc5-4d11-a321-f5b4ce198ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1339c964-4fc5-4d11-a321-f5b4ce198ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_67481f6b-f565-48fc-b4dc-2b47be0d0f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_236a17b5-a693-4527-be81-7fc7dd342430" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_67481f6b-f565-48fc-b4dc-2b47be0d0f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5b0b2013-ad99-4389-b2f6-705d7c0593ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5b0b2013-ad99-4389-b2f6-705d7c0593ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_1ea99464-006d-4dc0-9035-3c421f695fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_1ea99464-006d-4dc0-9035-3c421f695fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_ac06d3ec-4d87-4b95-a99f-7fb169e11146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_us-gaap_GainLossOnContractTermination_ac06d3ec-4d87-4b95-a99f-7fb169e11146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_6f5c109c-1e86-4bea-88af-8932aa486f2e" xlink:href="mck-20230331.xsd#mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized_6f5c109c-1e86-4bea-88af-8932aa486f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnDerivativeTermination_a703d1d8-7dd7-4b40-b689-b6efb64b7071" xlink:href="mck-20230331.xsd#mck_GainLossOnDerivativeTermination"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_mck_GainLossOnDerivativeTermination_a703d1d8-7dd7-4b40-b689-b6efb64b7071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_336b6d45-0d88-4d2d-92af-2ecd441ef80f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ddbf1a5a-00c4-4a3b-9a07-319eb36f5e1a" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_336b6d45-0d88-4d2d-92af-2ecd441ef80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_afa0daf4-cb34-43f7-ba5d-874614381b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_541fd76c-381e-495b-887f-2aa24d3fa35f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_afa0daf4-cb34-43f7-ba5d-874614381b3a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_541fd76c-381e-495b-887f-2aa24d3fa35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7b4a2b22-c633-4d49-8176-615217b5b862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_541fd76c-381e-495b-887f-2aa24d3fa35f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_7b4a2b22-c633-4d49-8176-615217b5b862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_41d53a80-5786-4790-996f-83a0b528fb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_541fd76c-381e-495b-887f-2aa24d3fa35f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_41d53a80-5786-4790-996f-83a0b528fb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cd51c972-1382-41c1-a2d0-abdca1aa9064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_541fd76c-381e-495b-887f-2aa24d3fa35f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cd51c972-1382-41c1-a2d0-abdca1aa9064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1b5748e7-8884-4e4c-bbeb-513ab333da8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a13e8fcc-0ddc-46f8-91ee-f7e621a11afa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b5748e7-8884-4e4c-bbeb-513ab333da8d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a13e8fcc-0ddc-46f8-91ee-f7e621a11afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_02b36ae4-8395-4f89-9323-8a7f05344d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a13e8fcc-0ddc-46f8-91ee-f7e621a11afa" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_02b36ae4-8395-4f89-9323-8a7f05344d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_52a23103-264f-4c93-a750-73df16a84277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a13e8fcc-0ddc-46f8-91ee-f7e621a11afa" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_52a23103-264f-4c93-a750-73df16a84277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c5b4563d-566c-4026-a384-31c356087732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a13e8fcc-0ddc-46f8-91ee-f7e621a11afa" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c5b4563d-566c-4026-a384-31c356087732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e8483acf-8362-45f3-9bd0-5fc50c1f385d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_a13e8fcc-0ddc-46f8-91ee-f7e621a11afa" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e8483acf-8362-45f3-9bd0-5fc50c1f385d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_54d20ff4-26c4-4bab-b2e1-a157ffefc34d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b5748e7-8884-4e4c-bbeb-513ab333da8d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_54d20ff4-26c4-4bab-b2e1-a157ffefc34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_9b6d8a13-c17a-4706-9f87-047cca34471f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_54d20ff4-26c4-4bab-b2e1-a157ffefc34d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_9b6d8a13-c17a-4706-9f87-047cca34471f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c524a255-52b3-4032-b317-91c92824297f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_54d20ff4-26c4-4bab-b2e1-a157ffefc34d" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c524a255-52b3-4032-b317-91c92824297f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_627fc569-7190-4ad0-af22-e0fe9e77cf8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_54d20ff4-26c4-4bab-b2e1-a157ffefc34d" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_627fc569-7190-4ad0-af22-e0fe9e77cf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6f33860e-2453-49d0-b7e3-ce4fecfc372a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_54d20ff4-26c4-4bab-b2e1-a157ffefc34d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6f33860e-2453-49d0-b7e3-ce4fecfc372a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e2686cd3-86b2-4e37-b378-c98be4d6055f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b5748e7-8884-4e4c-bbeb-513ab333da8d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e2686cd3-86b2-4e37-b378-c98be4d6055f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a2ec989e-05a5-4ab3-9ef2-4ae4c517f116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b5748e7-8884-4e4c-bbeb-513ab333da8d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a2ec989e-05a5-4ab3-9ef2-4ae4c517f116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_04b2e66f-ab93-4e25-b12e-1f6e81766591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_04b2e66f-ab93-4e25-b12e-1f6e81766591" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_6958da89-6035-4e75-b8c0-4ab74da5a32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_6958da89-6035-4e75-b8c0-4ab74da5a32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_e7e740ae-cb20-443d-9e2c-fb6b33eefb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_6958da89-6035-4e75-b8c0-4ab74da5a32d" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_e7e740ae-cb20-443d-9e2c-fb6b33eefb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLossCarryforwardMember_6057ee84-84da-4a10-adac-bfa50e8d0a36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLossCarryforwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_e7e740ae-cb20-443d-9e2c-fb6b33eefb72" xlink:to="loc_us-gaap_CapitalLossCarryforwardMember_6057ee84-84da-4a10-adac-bfa50e8d0a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d375e882-6eba-4fbc-ac6b-92e6007fec49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d375e882-6eba-4fbc-ac6b-92e6007fec49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_8586724e-5dbc-4aa8-9e2c-fa5011828190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d375e882-6eba-4fbc-ac6b-92e6007fec49" xlink:to="loc_us-gaap_LossContingencyNatureDomain_8586724e-5dbc-4aa8-9e2c-fa5011828190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_4db33021-4b1e-44ee-ab43-2fb76d1f161b" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8586724e-5dbc-4aa8-9e2c-fa5011828190" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_4db33021-4b1e-44ee-ab43-2fb76d1f161b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cc9a985b-7a78-4200-9e97-559ae7b89e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cc9a985b-7a78-4200-9e97-559ae7b89e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d2dab8e1-da2b-4656-8bb8-4b8bd8856682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cc9a985b-7a78-4200-9e97-559ae7b89e6a" xlink:to="loc_us-gaap_SegmentDomain_d2dab8e1-da2b-4656-8bb8-4b8bd8856682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_6736e5f6-15be-4a4a-bc96-21603855be52" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d2dab8e1-da2b-4656-8bb8-4b8bd8856682" xlink:to="loc_mck_InternationalSegmentMember_6736e5f6-15be-4a4a-bc96-21603855be52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_d5123484-05ba-4835-a523-bb3bd769b3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_d5123484-05ba-4835-a523-bb3bd769b3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_4bf6d0a0-979c-4134-beee-d8fccd8323dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_d5123484-05ba-4835-a523-bb3bd769b3c0" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_4bf6d0a0-979c-4134-beee-d8fccd8323dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_1abb979f-37aa-4177-b9fb-3471f90824c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4bf6d0a0-979c-4134-beee-d8fccd8323dc" xlink:to="loc_us-gaap_DomesticCountryMember_1abb979f-37aa-4177-b9fb-3471f90824c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_198e5737-20d4-49fc-93cc-6bb2178b87aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4bf6d0a0-979c-4134-beee-d8fccd8323dc" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_198e5737-20d4-49fc-93cc-6bb2178b87aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_8b7d7074-ddf0-456d-bf52-e640731fe2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4bf6d0a0-979c-4134-beee-d8fccd8323dc" xlink:to="loc_us-gaap_ForeignCountryMember_8b7d7074-ddf0-456d-bf52-e640731fe2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_255e7e80-ca59-444e-b8cc-0d3a8a5747fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_255e7e80-ca59-444e-b8cc-0d3a8a5747fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ae1ccd38-53be-4daf-ba55-d130788a1505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_255e7e80-ca59-444e-b8cc-0d3a8a5747fd" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ae1ccd38-53be-4daf-ba55-d130788a1505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_567a5c5e-13ff-4b61-918f-22437fa47526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ae1ccd38-53be-4daf-ba55-d130788a1505" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_567a5c5e-13ff-4b61-918f-22437fa47526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fac86b6b-548d-4a44-aceb-2e13a7becb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fac86b6b-548d-4a44-aceb-2e13a7becb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f3250c30-930b-4033-a406-8c4f7a619f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fac86b6b-548d-4a44-aceb-2e13a7becb5b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f3250c30-930b-4033-a406-8c4f7a619f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_191e7e61-3284-4b36-a5b4-c53cf824dd3f" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f3250c30-930b-4033-a406-8c4f7a619f69" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_191e7e61-3284-4b36-a5b4-c53cf824dd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_46f943f5-3d45-4d7e-8d80-cb8ec7a1e12e" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupAndAustrianBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f3250c30-930b-4033-a406-8c4f7a619f69" xlink:to="loc_mck_UKBusinessesDisposalGroupAndAustrianBusinessMember_46f943f5-3d45-4d7e-8d80-cb8ec7a1e12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_aee9060e-5852-479e-8beb-64a2f849fdfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_LitigationStatusAxis_aee9060e-5852-479e-8beb-64a2f849fdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_eddab60b-25a2-42f2-b0a4-043f2ea5eb50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_aee9060e-5852-479e-8beb-64a2f849fdfa" xlink:to="loc_us-gaap_LitigationStatusDomain_eddab60b-25a2-42f2-b0a4-043f2ea5eb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_1cffacd8-ed37-4813-84ff-15b65e6da8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_eddab60b-25a2-42f2-b0a4-043f2ea5eb50" xlink:to="loc_us-gaap_PendingLitigationMember_1cffacd8-ed37-4813-84ff-15b65e6da8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e9a91119-8bc1-4545-af8c-937e923cdaa0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_srt_RangeAxis_e9a91119-8bc1-4545-af8c-937e923cdaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16b830e8-b3a2-402b-893f-6ec1c07bf48a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e9a91119-8bc1-4545-af8c-937e923cdaa0" xlink:to="loc_srt_RangeMember_16b830e8-b3a2-402b-893f-6ec1c07bf48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_53abbe7e-83da-4f81-a25e-83ee3cb81128" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16b830e8-b3a2-402b-893f-6ec1c07bf48a" xlink:to="loc_srt_MinimumMember_53abbe7e-83da-4f81-a25e-83ee3cb81128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_fc7f5f6e-5bc9-44e9-bb56-a129f3ab385c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16b830e8-b3a2-402b-893f-6ec1c07bf48a" xlink:to="loc_srt_MaximumMember_fc7f5f6e-5bc9-44e9-bb56-a129f3ab385c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_34742123-9332-489a-a91b-01755163b1db" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_eeb549b6-2671-4f26-a9be-6ea3853380a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_eeb549b6-2671-4f26-a9be-6ea3853380a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_de15c2ba-b003-4cd7-8a61-877334ae9ac3" xlink:href="mck-20230331.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_de15c2ba-b003-4cd7-8a61-877334ae9ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount_1ebda689-169c-4c82-8c31-8544f80e23fe" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount_1ebda689-169c-4c82-8c31-8544f80e23fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ed3a3247-1001-4327-b2f7-d6db6f0ea5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ed3a3247-1001-4327-b2f7-d6db6f0ea5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_13311f7f-18f2-4050-855b-deef8d93c46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_13311f7f-18f2-4050-855b-deef8d93c46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_bd12d0d6-6755-40fc-b12a-e594cdffa5ec" xlink:href="mck-20230331.xsd#mck_IncomeTaxExpenseBenefitDiscreteItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_mck_IncomeTaxExpenseBenefitDiscreteItems_bd12d0d6-6755-40fc-b12a-e594cdffa5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_db9ed4fb-9bbd-4fe9-875e-8ebfa251ff3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_db9ed4fb-9bbd-4fe9-875e-8ebfa251ff3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1234dccd-3eb2-4679-a9b3-d86fde383ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1234dccd-3eb2-4679-a9b3-d86fde383ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_c5d81d1a-5e41-46cc-963f-90bd92c8b8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_OperatingLossCarryforwards_c5d81d1a-5e41-46cc-963f-90bd92c8b8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_743806bc-bf43-469b-8b39-6ca3de413cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_743806bc-bf43-469b-8b39-6ca3de413cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_40df03d4-3d15-4dab-9195-64abd6347f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_40df03d4-3d15-4dab-9195-64abd6347f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment_b7374629-ab7d-4256-8921-cc82c752f10a" xlink:href="mck-20230331.xsd#mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment_b7374629-ab7d-4256-8921-cc82c752f10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_98505e72-0780-43fa-b3ba-63238068dd22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_98505e72-0780-43fa-b3ba-63238068dd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_a63b9806-3f55-4aaf-b986-bd2a94f7f08c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_a63b9806-3f55-4aaf-b986-bd2a94f7f08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_05b03fbe-2c1d-4925-808f-1de93d79cfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a9cb8649-b083-4f0e-813c-036c677a0771" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_05b03fbe-2c1d-4925-808f-1de93d79cfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f97bdd32-ffae-4c52-89da-fa039372c5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_8f0ab0ac-cb84-40ee-8d62-eb460e3c61f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f97bdd32-ffae-4c52-89da-fa039372c5ed" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_8f0ab0ac-cb84-40ee-8d62-eb460e3c61f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f97bdd32-ffae-4c52-89da-fa039372c5ed" xlink:to="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e260a956-8a25-4b2b-8e9b-9b5096b466cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e260a956-8a25-4b2b-8e9b-9b5096b466cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_4c7e65a2-8f7b-431d-bf62-807aff362b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_4c7e65a2-8f7b-431d-bf62-807aff362b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_a2c79988-d9d3-4b18-9c3f-354929e8ea45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_a2c79988-d9d3-4b18-9c3f-354929e8ea45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_12589703-438c-4809-a154-16f29f1ec1ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_12589703-438c-4809-a154-16f29f1ec1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_79ca7558-d826-4760-bbb1-b5de6445c3ec" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims_79ca7558-d826-4760-bbb1-b5de6445c3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_0462ddd1-5167-4917-a7a2-fca43a17f439" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit_0462ddd1-5167-4917-a7a2-fca43a17f439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_506a0b50-719e-4b3d-bcbf-69350a9dcc20" xlink:href="mck-20230331.xsd#mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:to="loc_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount_506a0b50-719e-4b3d-bcbf-69350a9dcc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_43da7c8e-aabc-46ff-b625-2f5d0e568fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_43da7c8e-aabc-46ff-b625-2f5d0e568fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_d8d50f2f-9298-406a-8a5d-20d815f9d65c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_d8d50f2f-9298-406a-8a5d-20d815f9d65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_de756e9b-5dd2-40c7-bbe5-2084c2a69b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossAttributableToParentAbstract_e021465b-7626-43cf-ba82-685464bd44d1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_de756e9b-5dd2-40c7-bbe5-2084c2a69b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_fbedf584-bf75-4a40-b2c6-69e92fad623e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f97bdd32-ffae-4c52-89da-fa039372c5ed" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_fbedf584-bf75-4a40-b2c6-69e92fad623e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesComponentsOfDeferredTaxBalancesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b2a57a9c-8f6e-4aa3-9f5c-434dd55c1b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_19f35ba1-c960-4e77-bb1b-fca5513b9882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b2a57a9c-8f6e-4aa3-9f5c-434dd55c1b03" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_19f35ba1-c960-4e77-bb1b-fca5513b9882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_f3e34359-d49a-49f1-82ed-b45c9a2785af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_19f35ba1-c960-4e77-bb1b-fca5513b9882" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_f3e34359-d49a-49f1-82ed-b45c9a2785af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3c8141ed-ab6e-441b-b044-affbfa638043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f3e34359-d49a-49f1-82ed-b45c9a2785af" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3c8141ed-ab6e-441b-b044-affbfa638043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_544ad687-ea4a-42cf-8a14-a06524bff1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3c8141ed-ab6e-441b-b044-affbfa638043" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_544ad687-ea4a-42cf-8a14-a06524bff1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_19f35ba1-c960-4e77-bb1b-fca5513b9882" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:to="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_39f078bf-6364-4706-9b4c-b0b37fffa42a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_39f078bf-6364-4706-9b4c-b0b37fffa42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLitigationAndClaims_6a39afad-387b-428f-8441-3fdefa24bd04" xlink:href="mck-20230331.xsd#mck_DeferredTaxAssetLitigationAndClaims"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_mck_DeferredTaxAssetLitigationAndClaims_6a39afad-387b-428f-8441-3fdefa24bd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_b65a4b5b-a812-4dec-b57b-bab41f34a604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_b65a4b5b-a812-4dec-b57b-bab41f34a604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ae41be77-7c4a-4abd-9f17-e6abb124759c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ae41be77-7c4a-4abd-9f17-e6abb124759c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxAssetLeaseObligations_13771f70-6226-4955-99c3-70742b5a6149" xlink:href="mck-20230331.xsd#mck_DeferredTaxAssetLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_mck_DeferredTaxAssetLeaseObligations_13771f70-6226-4955-99c3-70742b5a6149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_af12fa1f-bc14-42a2-80ae-0f46bfeea6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_af12fa1f-bc14-42a2-80ae-0f46bfeea6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_694b7bc0-8d53-408c-bfaa-75be31a1b25f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_694b7bc0-8d53-408c-bfaa-75be31a1b25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9d77acca-af55-4bd0-a2f2-592998f29260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9d77acca-af55-4bd0-a2f2-592998f29260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_18079f16-a0ed-4db5-9df2-2c2d7b700bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6587c5c4-a981-4e7c-81ae-1095b0506a16" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_18079f16-a0ed-4db5-9df2-2c2d7b700bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:to="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_9df589fa-a78a-4681-bb4b-4c60912689d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_9df589fa-a78a-4681-bb4b-4c60912689d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_899b83b9-e046-4994-af17-7de205bd3bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_899b83b9-e046-4994-af17-7de205bd3bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_639298d9-b9b9-4242-97cf-040b9235b818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_639298d9-b9b9-4242-97cf-040b9235b818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_794a2a6d-cf52-4a48-b493-856057841d63" xlink:href="mck-20230331.xsd#mck_DeferredTaxLiabilitiesLeaseRightofuseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets_794a2a6d-cf52-4a48-b493-856057841d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_3b9405dd-68e3-4819-b2b9-0c5524044f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_3b9405dd-68e3-4819-b2b9-0c5524044f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e9ab76c5-57c1-45d5-ad0a-1152e3f7b509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_c6156156-4938-4450-a03a-335338cde79a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e9ab76c5-57c1-45d5-ad0a-1152e3f7b509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_d038e780-ba61-4a71-a518-294abc50cae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:to="loc_us-gaap_DeferredTaxLiabilities_d038e780-ba61-4a71-a518-294abc50cae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e78f2e9-bb40-43d4-b818-2d463266eba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5e78f2e9-bb40-43d4-b818-2d463266eba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fae46e14-1be6-4e5b-bdfb-bd661bc01528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_06510003-89bd-4fe7-99f2-244cc8e18497" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fae46e14-1be6-4e5b-bdfb-bd661bc01528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_db79bd0c-c545-4d47-999f-f04a28cea56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a7a39c45-52da-4964-8b41-0c96f339ae58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_db79bd0c-c545-4d47-999f-f04a28cea56f" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a7a39c45-52da-4964-8b41-0c96f339ae58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8ede02cd-1739-4ce5-b990-498863144041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a7a39c45-52da-4964-8b41-0c96f339ae58" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8ede02cd-1739-4ce5-b990-498863144041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_9965e7e6-c6c7-42f5-8ba6-def128adc270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a7a39c45-52da-4964-8b41-0c96f339ae58" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_9965e7e6-c6c7-42f5-8ba6-def128adc270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_8e9e16cd-c18d-4d20-a336-e33cd6aa596e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a7a39c45-52da-4964-8b41-0c96f339ae58" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_8e9e16cd-c18d-4d20-a336-e33cd6aa596e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_460e3353-861c-4588-a088-41d56c6aba9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a7a39c45-52da-4964-8b41-0c96f339ae58" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_460e3353-861c-4588-a088-41d56c6aba9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_ef3d48f9-f4c1-421a-b915-cb08bced66c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a7a39c45-52da-4964-8b41-0c96f339ae58" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_ef3d48f9-f4c1-421a-b915-cb08bced66c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_d6c2eeb6-0431-43a3-8468-e349cd4c268e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a7a39c45-52da-4964-8b41-0c96f339ae58" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_d6c2eeb6-0431-43a3-8468-e349cd4c268e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_6f467008-0452-4e18-8ce9-a631406b8c63" xlink:href="mck-20230331.xsd#mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a7a39c45-52da-4964-8b41-0c96f339ae58" xlink:to="loc_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation_6f467008-0452-4e18-8ce9-a631406b8c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_0d9237c3-58b4-46f8-9235-b0f001ccfd99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a7a39c45-52da-4964-8b41-0c96f339ae58" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_0d9237c3-58b4-46f8-9235-b0f001ccfd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_11befc3f-1a6b-4d2d-8e92-de8f1a647303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_79f8da15-ee21-4196-b7ad-9b8a19d9a518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_11befc3f-1a6b-4d2d-8e92-de8f1a647303" xlink:to="loc_us-gaap_MinorityInterestTable_79f8da15-ee21-4196-b7ad-9b8a19d9a518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_90a318d4-b27b-4cd8-9490-475e29f03bd2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_79f8da15-ee21-4196-b7ad-9b8a19d9a518" xlink:to="loc_dei_LegalEntityAxis_90a318d4-b27b-4cd8-9490-475e29f03bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5dae8dcc-b8c4-441f-8167-3e343bade2a0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_90a318d4-b27b-4cd8-9490-475e29f03bd2" xlink:to="loc_dei_EntityDomain_5dae8dcc-b8c4-441f-8167-3e343bade2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_e7959347-a28c-4699-87a0-8802ef7fa086" xlink:href="mck-20230331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5dae8dcc-b8c4-441f-8167-3e343bade2a0" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_e7959347-a28c-4699-87a0-8802ef7fa086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_8a9fc9b2-47cf-4b63-96a9-682c059f69f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_79f8da15-ee21-4196-b7ad-9b8a19d9a518" xlink:to="loc_srt_OwnershipAxis_8a9fc9b2-47cf-4b63-96a9-682c059f69f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_cb40f38d-ce02-4c62-96ad-4d4dd51e2254" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_8a9fc9b2-47cf-4b63-96a9-682c059f69f7" xlink:to="loc_srt_OwnershipDomain_cb40f38d-ce02-4c62-96ad-4d4dd51e2254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_b883b12c-f0e0-48c3-8169-c77d52cbfc80" xlink:href="mck-20230331.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_cb40f38d-ce02-4c62-96ad-4d4dd51e2254" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_b883b12c-f0e0-48c3-8169-c77d52cbfc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_98355d90-b9d9-4bf0-accc-74de599d5534" xlink:href="mck-20230331.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_cb40f38d-ce02-4c62-96ad-4d4dd51e2254" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_98355d90-b9d9-4bf0-accc-74de599d5534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_df892de1-be7e-4098-ab58-394e90186717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_79f8da15-ee21-4196-b7ad-9b8a19d9a518" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_df892de1-be7e-4098-ab58-394e90186717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0fc30b50-d0dd-4183-aa47-db8b5b2fd583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_df892de1-be7e-4098-ab58-394e90186717" xlink:to="loc_us-gaap_EquityComponentDomain_0fc30b50-d0dd-4183-aa47-db8b5b2fd583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_ec997bfc-c36f-4782-9a0f-c77b57eb662a" xlink:href="mck-20230331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0fc30b50-d0dd-4183-aa47-db8b5b2fd583" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_ec997bfc-c36f-4782-9a0f-c77b57eb662a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c124ecc0-699d-469a-8b39-e9b3cddb3a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0fc30b50-d0dd-4183-aa47-db8b5b2fd583" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c124ecc0-699d-469a-8b39-e9b3cddb3a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_4d936971-15c9-4628-8b38-be8892f06347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0fc30b50-d0dd-4183-aa47-db8b5b2fd583" xlink:to="loc_us-gaap_NoncontrollingInterestMember_4d936971-15c9-4628-8b38-be8892f06347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_79f8da15-ee21-4196-b7ad-9b8a19d9a518" xlink:to="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_00039828-3bf7-40eb-8bc7-a1c75b83ae9d" xlink:href="mck-20230331.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_00039828-3bf7-40eb-8bc7-a1c75b83ae9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_46dbd9f6-1d13-4f24-a65a-65d1bd610a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_46dbd9f6-1d13-4f24-a65a-65d1bd610a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_0fd27902-6cec-4682-ba6f-cc22ea8d7365" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_0fd27902-6cec-4682-ba6f-cc22ea8d7365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_e84589b0-5bb2-4114-9dd1-d5f52ce4543a" xlink:href="mck-20230331.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_PutRightValueInterestRateSpread_e84589b0-5bb2-4114-9dd1-d5f52ce4543a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_0b3fb824-b90a-4763-8216-a02c1d7790e7" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_0b3fb824-b90a-4763-8216-a02c1d7790e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_ff6746ef-5061-4aae-8e8b-fd14f58bc22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_ff6746ef-5061-4aae-8e8b-fd14f58bc22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_5d04d57f-7146-45a2-bd9f-f0af2d2917b7" xlink:href="mck-20230331.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_5d04d57f-7146-45a2-bd9f-f0af2d2917b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_a33ddaa5-c468-4e8f-9516-20ce67ac9f2c" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_a33ddaa5-c468-4e8f-9516-20ce67ac9f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_6fc8d6d8-edf6-40f5-84a3-11754d4b44dd" xlink:href="mck-20230331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_6fc8d6d8-edf6-40f5-84a3-11754d4b44dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_55b74e34-46dd-4f21-bfa9-18a3fb983772" xlink:href="mck-20230331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_55b74e34-46dd-4f21-bfa9-18a3fb983772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_373fd5c1-97cd-4cdf-9bcb-bccdd74ee746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_373fd5c1-97cd-4cdf-9bcb-bccdd74ee746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_4b75c299-d5ab-4b91-a9bb-98391fd7a2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_us-gaap_MinorityInterest_4b75c299-d5ab-4b91-a9bb-98391fd7a2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d807650f-a21c-4e37-aeaa-5af6c63fe292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_156bc1ac-da2b-4788-a295-f3d01417504a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d807650f-a21c-4e37-aeaa-5af6c63fe292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_4759c07e-67f0-44be-a354-cbaee04397b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_2ba1d655-86e7-40e7-b26e-b4bdc0321805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_4759c07e-67f0-44be-a354-cbaee04397b9" xlink:to="loc_us-gaap_MinorityInterestTable_2ba1d655-86e7-40e7-b26e-b4bdc0321805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_74a101fe-dfdd-45b8-a2f7-e2ce0f2ff4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_2ba1d655-86e7-40e7-b26e-b4bdc0321805" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_74a101fe-dfdd-45b8-a2f7-e2ce0f2ff4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_290ae2cf-8998-4c8b-8b6c-338fcdc49ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74a101fe-dfdd-45b8-a2f7-e2ce0f2ff4d2" xlink:to="loc_us-gaap_EquityComponentDomain_290ae2cf-8998-4c8b-8b6c-338fcdc49ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_4e46e8f5-c0db-496e-9c0b-79165acb6993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_290ae2cf-8998-4c8b-8b6c-338fcdc49ed1" xlink:to="loc_us-gaap_NoncontrollingInterestMember_4e46e8f5-c0db-496e-9c0b-79165acb6993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_f6c9cea1-f099-43df-ab7c-b1220f487953" xlink:href="mck-20230331.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_290ae2cf-8998-4c8b-8b6c-338fcdc49ed1" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_f6c9cea1-f099-43df-ab7c-b1220f487953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_5d772b89-38ef-47b5-9609-3cc2f28ec5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_2ba1d655-86e7-40e7-b26e-b4bdc0321805" xlink:to="loc_us-gaap_MinorityInterestLineItems_5d772b89-38ef-47b5-9609-3cc2f28ec5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_5d772b89-38ef-47b5-9609-3cc2f28ec5ed" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_772e82b4-283a-47f8-9315-f212548b1117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_MinorityInterest_772e82b4-283a-47f8-9315-f212548b1117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_7a1441fe-b7d9-4428-9380-80b1732f3b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_7a1441fe-b7d9-4428-9380-80b1732f3b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_efe698aa-3927-4fee-a620-c112a90cf071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_efe698aa-3927-4fee-a620-c112a90cf071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_06d44fc2-f3bc-40b7-a9d1-408e5bacb389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_06d44fc2-f3bc-40b7-a9d1-408e5bacb389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_45dd8fbf-0e48-4634-aefa-a997fff5b052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_45dd8fbf-0e48-4634-aefa-a997fff5b052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_94d8ae7d-0554-438b-accd-b2d3fcf5307e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_94d8ae7d-0554-438b-accd-b2d3fcf5307e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_b050cf6b-ab78-4bd9-b2af-914296d732e2" xlink:href="mck-20230331.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_b050cf6b-ab78-4bd9-b2af-914296d732e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_6a4a15ac-a8d0-4340-8664-2033602cac6d" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_6a4a15ac-a8d0-4340-8664-2033602cac6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_0b784432-3c8b-4747-852c-763735ef3dfc" xlink:href="mck-20230331.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_0b784432-3c8b-4747-852c-763735ef3dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FormationOfBusiness_45f51bdd-1177-4f6f-97bc-fa7808c348ff" xlink:href="mck-20230331.xsd#mck_FormationOfBusiness"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_FormationOfBusiness_45f51bdd-1177-4f6f-97bc-fa7808c348ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DerecognitionOfNoncontrollingInterests_03f56595-6b89-466e-adab-422dda20e87d" xlink:href="mck-20230331.xsd#mck_DerecognitionOfNoncontrollingInterests"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_DerecognitionOfNoncontrollingInterests_03f56595-6b89-466e-adab-422dda20e87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_5f457c48-977d-4bba-a001-d1c56e426e03" xlink:href="mck-20230331.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_5f457c48-977d-4bba-a001-d1c56e426e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_efe860c2-80df-4302-be80-962277b65e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_MinorityInterest_efe860c2-80df-4302-be80-962277b65e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_983195cd-9f20-4790-8bed-b2ec2bf7accd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_23df5d12-0fcb-4b64-b33a-cea77be0a82d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_983195cd-9f20-4790-8bed-b2ec2bf7accd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#EarningsLossPerCommonShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a6d7f800-2bc1-4df5-b551-c9a9678bfdf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1b96009d-6066-4b6a-9497-02e71a54bc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a6d7f800-2bc1-4df5-b551-c9a9678bfdf7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1b96009d-6066-4b6a-9497-02e71a54bc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6d3ac75f-6695-40a9-b10c-fc7822a1c2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf669a06-3fc8-4121-a6e8-88ad61605931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6d3ac75f-6695-40a9-b10c-fc7822a1c2fe" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf669a06-3fc8-4121-a6e8-88ad61605931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_53b0d331-a710-48c5-8681-0ccd41c884d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf669a06-3fc8-4121-a6e8-88ad61605931" xlink:to="loc_us-gaap_AwardTypeAxis_53b0d331-a710-48c5-8681-0ccd41c884d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01a3604b-a18e-4b21-bbe9-f436f2a6edb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_53b0d331-a710-48c5-8681-0ccd41c884d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01a3604b-a18e-4b21-bbe9-f436f2a6edb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4161447c-ccc8-4965-aec9-c5b1c8712e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01a3604b-a18e-4b21-bbe9-f436f2a6edb4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4161447c-ccc8-4965-aec9-c5b1c8712e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_cd550c85-c8c7-42c2-808b-15130b49e557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01a3604b-a18e-4b21-bbe9-f436f2a6edb4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_cd550c85-c8c7-42c2-808b-15130b49e557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf669a06-3fc8-4121-a6e8-88ad61605931" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2517d1fa-5b72-4d0f-a899-2c3a540db226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2517d1fa-5b72-4d0f-a899-2c3a540db226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f37c6fa6-b5b4-4bd0-8d4c-3d965b925a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f37c6fa6-b5b4-4bd0-8d4c-3d965b925a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_dd42e761-74c9-4918-a2c6-384e92b72093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_dd42e761-74c9-4918-a2c6-384e92b72093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3d8a3f38-571a-4c44-914f-8ef7b1e71eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3d8a3f38-571a-4c44-914f-8ef7b1e71eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0bc06f21-3094-4c1d-b911-2697b61eb309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_NetIncomeLoss_0bc06f21-3094-4c1d-b911-2697b61eb309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6af3b398-8781-4ae0-b5ec-53e208fd1422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6af3b398-8781-4ae0-b5ec-53e208fd1422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bcb4f145-d3d9-465e-a7a2-74ef23d046ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6af3b398-8781-4ae0-b5ec-53e208fd1422" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bcb4f145-d3d9-465e-a7a2-74ef23d046ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b9c90a86-dddc-4a10-87d6-68a748b23a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b9c90a86-dddc-4a10-87d6-68a748b23a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9f5024ae-02dc-47ac-8c5f-1f3dbb99fad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9f5024ae-02dc-47ac-8c5f-1f3dbb99fad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EPSBasicAndDilutedAbstract_9e0ec922-470a-4ff1-96f8-265c68727f2e" xlink:href="mck-20230331.xsd#mck_EPSBasicAndDilutedAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_88677e74-8f13-4fe9-976d-6e241223236f" xlink:to="loc_mck_EPSBasicAndDilutedAbstract_9e0ec922-470a-4ff1-96f8-265c68727f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_dbef0acd-6408-4dad-9056-5cb2c718343a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_9e0ec922-470a-4ff1-96f8-265c68727f2e" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_dbef0acd-6408-4dad-9056-5cb2c718343a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_873af286-09d9-4857-a2ac-c1711e35eb84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_dbef0acd-6408-4dad-9056-5cb2c718343a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_873af286-09d9-4857-a2ac-c1711e35eb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_515b6320-41f1-4978-a586-5e5796642153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_dbef0acd-6408-4dad-9056-5cb2c718343a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_515b6320-41f1-4978-a586-5e5796642153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8faf02f8-3525-42e1-9157-35e671160d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_dbef0acd-6408-4dad-9056-5cb2c718343a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8faf02f8-3525-42e1-9157-35e671160d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_0ee66093-1a4d-469c-836c-552d8f1e2ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_EPSBasicAndDilutedAbstract_9e0ec922-470a-4ff1-96f8-265c68727f2e" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_0ee66093-1a4d-469c-836c-552d8f1e2ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_32ca1807-9653-4591-bef6-84715547ca30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0ee66093-1a4d-469c-836c-552d8f1e2ba6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_32ca1807-9653-4591-bef6-84715547ca30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_ba266a7a-bdb1-41ed-865d-8672fe1bc9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0ee66093-1a4d-469c-836c-552d8f1e2ba6" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_ba266a7a-bdb1-41ed-865d-8672fe1bc9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d7a8ed82-092f-430c-809d-e3c1f9e09a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0ee66093-1a4d-469c-836c-552d8f1e2ba6" xlink:to="loc_us-gaap_EarningsPerShareBasic_d7a8ed82-092f-430c-809d-e3c1f9e09a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ed26fade-ff1f-422c-99ea-a3e3c12fb6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_8bf288b9-60f0-4f72-bd4c-6e6542a95d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ed26fade-ff1f-422c-99ea-a3e3c12fb6a9" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_8bf288b9-60f0-4f72-bd4c-6e6542a95d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_ae8792e6-1c93-4c22-a2d6-8dd7aef564b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_8bf288b9-60f0-4f72-bd4c-6e6542a95d6f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_ae8792e6-1c93-4c22-a2d6-8dd7aef564b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_732358aa-46ac-48bd-ae50-1cfce1f251dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_ae8792e6-1c93-4c22-a2d6-8dd7aef564b2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_732358aa-46ac-48bd-ae50-1cfce1f251dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4dbee5bd-1315-445d-aeb1-73d8152b4db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_732358aa-46ac-48bd-ae50-1cfce1f251dd" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4dbee5bd-1315-445d-aeb1-73d8152b4db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e9e40009-57cd-47c9-8571-b8c2493c60d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_8bf288b9-60f0-4f72-bd4c-6e6542a95d6f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e9e40009-57cd-47c9-8571-b8c2493c60d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_284622e2-8df2-4458-89b7-cdb3b274984b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e9e40009-57cd-47c9-8571-b8c2493c60d0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_284622e2-8df2-4458-89b7-cdb3b274984b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_5ed5cf9f-f80a-4515-a229-720d74c5e2e1" xlink:href="mck-20230331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_284622e2-8df2-4458-89b7-cdb3b274984b" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_5ed5cf9f-f80a-4515-a229-720d74c5e2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_8bf288b9-60f0-4f72-bd4c-6e6542a95d6f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e970d251-8ac0-4512-9d50-e01209637db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e970d251-8ac0-4512-9d50-e01209637db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0f5dac67-9dad-4304-8844-b8e79ce29317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0f5dac67-9dad-4304-8844-b8e79ce29317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e63d23b1-8d44-4d83-89cb-1478cc73f3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e63d23b1-8d44-4d83-89cb-1478cc73f3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_4f4ae5da-cea4-404d-a856-72ad3feebab0" xlink:href="mck-20230331.xsd#mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_4f4ae5da-cea4-404d-a856-72ad3feebab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fa1e2d64-1f47-41fc-982c-f5195082c984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_4f4ae5da-cea4-404d-a856-72ad3feebab0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fa1e2d64-1f47-41fc-982c-f5195082c984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_82f831ae-3bc2-4ad4-9a97-395d935b3ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_4f4ae5da-cea4-404d-a856-72ad3feebab0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_82f831ae-3bc2-4ad4-9a97-395d935b3ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1d407eba-c672-443c-bf97-222f972dd280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_4f4ae5da-cea4-404d-a856-72ad3feebab0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1d407eba-c672-443c-bf97-222f972dd280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b3ae8739-07f7-4f79-82cd-8efa7e5c6f44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_4f4ae5da-cea4-404d-a856-72ad3feebab0" xlink:to="loc_us-gaap_OperatingLeaseLiability_b3ae8739-07f7-4f79-82cd-8efa7e5c6f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:href="mck-20230331.xsd#mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_7f51f146-3ad5-458e-8429-4a0e9fc7986a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_7f51f146-3ad5-458e-8429-4a0e9fc7986a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f53ff49e-32cc-4144-8204-1526548348fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f53ff49e-32cc-4144-8204-1526548348fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_34ac1227-54ba-4a5c-a323-802231caf700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_34ac1227-54ba-4a5c-a323-802231caf700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_fb4b6a95-7c24-4bbd-ada8-306972cb2420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_fb4b6a95-7c24-4bbd-ada8-306972cb2420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5fd3b9fd-2b5e-4162-abb2-3a4ea6e9b424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5fd3b9fd-2b5e-4162-abb2-3a4ea6e9b424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_3d0c2e1d-d43d-4659-8dd6-9e68e35f73ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_3d0c2e1d-d43d-4659-8dd6-9e68e35f73ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_fdd24ff8-62c7-4d6c-9bae-9f61b9e64c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_40278b10-7ac9-4a64-bc9b-c6c53ac08b03" xlink:to="loc_us-gaap_FinanceLeaseLiability_fdd24ff8-62c7-4d6c-9bae-9f61b9e64c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WeightedAverageRemainingLeaseTermAbstract_074e50a9-82a0-4dcc-8106-14de6054ccac" xlink:href="mck-20230331.xsd#mck_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_mck_WeightedAverageRemainingLeaseTermAbstract_074e50a9-82a0-4dcc-8106-14de6054ccac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e72d75fa-b257-4495-9156-1c7b8f920693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_WeightedAverageRemainingLeaseTermAbstract_074e50a9-82a0-4dcc-8106-14de6054ccac" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e72d75fa-b257-4495-9156-1c7b8f920693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_34ffa244-b90f-480a-b3a8-45f215a32905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_WeightedAverageRemainingLeaseTermAbstract_074e50a9-82a0-4dcc-8106-14de6054ccac" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_34ffa244-b90f-480a-b3a8-45f215a32905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeasesWeightedAverageDiscountRateAbstract_d7fecf54-06fa-4ffa-bcfc-1fe5f75e708e" xlink:href="mck-20230331.xsd#mck_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_86c7ee3d-8ffa-4126-b12f-b10d4035c997" xlink:to="loc_mck_LeasesWeightedAverageDiscountRateAbstract_d7fecf54-06fa-4ffa-bcfc-1fe5f75e708e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fb7d827f-7498-4f98-99aa-15bb2a4c0e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeasesWeightedAverageDiscountRateAbstract_d7fecf54-06fa-4ffa-bcfc-1fe5f75e708e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fb7d827f-7498-4f98-99aa-15bb2a4c0e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_0c3d1422-73fe-4774-9716-4550d201c96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeasesWeightedAverageDiscountRateAbstract_d7fecf54-06fa-4ffa-bcfc-1fe5f75e708e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_0c3d1422-73fe-4774-9716-4550d201c96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesComponentsofLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_77243657-f339-495b-ad8a-f0f6ffdfef67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_a4661fbe-6660-4a9d-be62-3ef2eef0ce5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77243657-f339-495b-ad8a-f0f6ffdfef67" xlink:to="loc_us-gaap_ShortTermLeaseCost_a4661fbe-6660-4a9d-be62-3ef2eef0ce5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_e1afec94-e4b4-4cbc-8aec-f77f0cf7086f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77243657-f339-495b-ad8a-f0f6ffdfef67" xlink:to="loc_us-gaap_OperatingLeaseCost_e1afec94-e4b4-4cbc-8aec-f77f0cf7086f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_078fd1fc-8dd2-4305-8d9b-b7687b6d1182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77243657-f339-495b-ad8a-f0f6ffdfef67" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_078fd1fc-8dd2-4305-8d9b-b7687b6d1182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_65394d7d-fd0d-4693-8066-6806b7918d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77243657-f339-495b-ad8a-f0f6ffdfef67" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_65394d7d-fd0d-4693-8066-6806b7918d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinanceLeaseCost_fb1d8778-2686-40e6-be23-07bf05a743ce" xlink:href="mck-20230331.xsd#mck_FinanceLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77243657-f339-495b-ad8a-f0f6ffdfef67" xlink:to="loc_mck_FinanceLeaseCost_fb1d8778-2686-40e6-be23-07bf05a743ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_589f7a04-67c5-4ff9-822a-6e9d378a025f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77243657-f339-495b-ad8a-f0f6ffdfef67" xlink:to="loc_us-gaap_VariableLeaseCost_589f7a04-67c5-4ff9-822a-6e9d378a025f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_41b7754d-733f-448b-894e-df3d8af135dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77243657-f339-495b-ad8a-f0f6ffdfef67" xlink:to="loc_us-gaap_SubleaseIncome_41b7754d-733f-448b-894e-df3d8af135dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_ce3084cc-12b4-4033-bb04-9f2ceef35a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77243657-f339-495b-ad8a-f0f6ffdfef67" xlink:to="loc_us-gaap_LeaseCost_ce3084cc-12b4-4033-bb04-9f2ceef35a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c0047759-662a-4abe-8321-b048b3691d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_fa9f941e-2d54-4375-80cc-82eab17f5e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c0047759-662a-4abe-8321-b048b3691d75" xlink:to="loc_us-gaap_OperatingLeasePayments_fa9f941e-2d54-4375-80cc-82eab17f5e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_2879e6af-39af-4bc2-b609-44d0196798df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c0047759-662a-4abe-8321-b048b3691d75" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_2879e6af-39af-4bc2-b609-44d0196798df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_d0819433-4ee9-4d04-afd6-fe72e9a4cc58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c0047759-662a-4abe-8321-b048b3691d75" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_d0819433-4ee9-4d04-afd6-fe72e9a4cc58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0ca81124-e18b-47b3-8162-dfebad8e3d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c0047759-662a-4abe-8321-b048b3691d75" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0ca81124-e18b-47b3-8162-dfebad8e3d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_af7d0d90-da21-4d57-b209-40b7fd22d3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c0047759-662a-4abe-8321-b048b3691d75" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_af7d0d90-da21-4d57-b209-40b7fd22d3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_38273716-2808-430e-b570-cd1f81bf8b63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eacf80e3-89dd-4d8c-bcce-438f8216a88a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_38273716-2808-430e-b570-cd1f81bf8b63" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eacf80e3-89dd-4d8c-bcce-438f8216a88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8cc11ac3-62e9-49a1-bb57-c252a65b4af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eacf80e3-89dd-4d8c-bcce-438f8216a88a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8cc11ac3-62e9-49a1-bb57-c252a65b4af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fbe4ddf1-10ef-4530-844d-666c10ddb3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eacf80e3-89dd-4d8c-bcce-438f8216a88a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fbe4ddf1-10ef-4530-844d-666c10ddb3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b7ffe0d6-169f-47cb-932c-3d66a984941b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eacf80e3-89dd-4d8c-bcce-438f8216a88a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b7ffe0d6-169f-47cb-932c-3d66a984941b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_faf548c6-5ecc-4b31-b33d-4a49be64da53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eacf80e3-89dd-4d8c-bcce-438f8216a88a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_faf548c6-5ecc-4b31-b33d-4a49be64da53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_70e7e5d7-f8fb-4b95-9e11-094f1145b9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eacf80e3-89dd-4d8c-bcce-438f8216a88a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_70e7e5d7-f8fb-4b95-9e11-094f1145b9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3503ee95-b511-449f-9427-986387d4db69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eacf80e3-89dd-4d8c-bcce-438f8216a88a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3503ee95-b511-449f-9427-986387d4db69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_04379a9b-8cea-423e-924c-2b6e02781429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eacf80e3-89dd-4d8c-bcce-438f8216a88a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_04379a9b-8cea-423e-924c-2b6e02781429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6ae66a40-d834-4d01-806d-4df35cbb71f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eacf80e3-89dd-4d8c-bcce-438f8216a88a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6ae66a40-d834-4d01-806d-4df35cbb71f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_93ce2f3d-25d9-4748-9ba3-a540e943ba4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_eacf80e3-89dd-4d8c-bcce-438f8216a88a" xlink:to="loc_us-gaap_OperatingLeaseLiability_93ce2f3d-25d9-4748-9ba3-a540e943ba4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_90c31c15-aded-47cd-ad66-44ce88e043d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_38273716-2808-430e-b570-cd1f81bf8b63" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_90c31c15-aded-47cd-ad66-44ce88e043d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_576f70d3-c9c0-4df1-b01e-3ee7d889aa83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_90c31c15-aded-47cd-ad66-44ce88e043d1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_576f70d3-c9c0-4df1-b01e-3ee7d889aa83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_799bb1d7-10a5-4432-96db-ce42b54dc8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_90c31c15-aded-47cd-ad66-44ce88e043d1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_799bb1d7-10a5-4432-96db-ce42b54dc8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_64a63f03-c0e6-4025-ab1f-5da6d8de7f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_90c31c15-aded-47cd-ad66-44ce88e043d1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_64a63f03-c0e6-4025-ab1f-5da6d8de7f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_3b2b16bd-6561-45a6-952f-83506b635fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_90c31c15-aded-47cd-ad66-44ce88e043d1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_3b2b16bd-6561-45a6-952f-83506b635fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_fc6611c5-930f-448f-83b4-390807f32269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_90c31c15-aded-47cd-ad66-44ce88e043d1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_fc6611c5-930f-448f-83b4-390807f32269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_4697f02d-5611-446b-b816-44ce5a0c0ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_90c31c15-aded-47cd-ad66-44ce88e043d1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_4697f02d-5611-446b-b816-44ce5a0c0ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e76a026e-6564-4805-b168-418ab1057500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_90c31c15-aded-47cd-ad66-44ce88e043d1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_e76a026e-6564-4805-b168-418ab1057500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1f9fe822-0756-4827-a483-236f32140715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_90c31c15-aded-47cd-ad66-44ce88e043d1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1f9fe822-0756-4827-a483-236f32140715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_ef270405-21b9-4a2b-af1e-4d40015a494f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_90c31c15-aded-47cd-ad66-44ce88e043d1" xlink:to="loc_us-gaap_FinanceLeaseLiability_ef270405-21b9-4a2b-af1e-4d40015a494f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_578f6cae-8f53-4323-8904-d2e8b5d323b6" xlink:href="mck-20230331.xsd#mck_LeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_38273716-2808-430e-b570-cd1f81bf8b63" xlink:to="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_578f6cae-8f53-4323-8904-d2e8b5d323b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_a6b03c86-3eef-46bc-aee8-587a7a560237" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_578f6cae-8f53-4323-8904-d2e8b5d323b6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueNextTwelveMonths_a6b03c86-3eef-46bc-aee8-587a7a560237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearTwo_73a0d093-ce9a-4858-aa18-495b078b69c4" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_578f6cae-8f53-4323-8904-d2e8b5d323b6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearTwo_73a0d093-ce9a-4858-aa18-495b078b69c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearThree_89010a4a-8ac8-4193-a7e6-2f6b386dd06a" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_578f6cae-8f53-4323-8904-d2e8b5d323b6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearThree_89010a4a-8ac8-4193-a7e6-2f6b386dd06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFour_31d9957a-3d29-4669-bfc9-bbbdf1d8f06c" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_578f6cae-8f53-4323-8904-d2e8b5d323b6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFour_31d9957a-3d29-4669-bfc9-bbbdf1d8f06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueYearFive_a937555d-cba2-42ce-9f96-850e15ae23da" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_578f6cae-8f53-4323-8904-d2e8b5d323b6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueYearFive_a937555d-cba2-42ce-9f96-850e15ae23da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_5615c465-ce17-4644-b314-8da16337a047" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_578f6cae-8f53-4323-8904-d2e8b5d323b6" xlink:to="loc_mck_LeaseLiabilityPaymentsDueAfterYearFive_5615c465-ce17-4644-b314-8da16337a047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityPaymentsDue_d3669483-f6b0-4eec-8951-13cd1860072f" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_578f6cae-8f53-4323-8904-d2e8b5d323b6" xlink:to="loc_mck_LeaseLiabilityPaymentsDue_d3669483-f6b0-4eec-8951-13cd1860072f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiabilityUndiscountedExcessAmount_44888a5e-079e-4c73-9a5e-72e395f28698" xlink:href="mck-20230331.xsd#mck_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_578f6cae-8f53-4323-8904-d2e8b5d323b6" xlink:to="loc_mck_LeaseLiabilityUndiscountedExcessAmount_44888a5e-079e-4c73-9a5e-72e395f28698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseLiability_e307db4a-8a96-4e03-8a6e-eb5989b571fc" xlink:href="mck-20230331.xsd#mck_LeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_LeaseLiabilitiesPaymentsDueAbstract_578f6cae-8f53-4323-8904-d2e8b5d323b6" xlink:to="loc_mck_LeaseLiability_e307db4a-8a96-4e03-8a6e-eb5989b571fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorLeasePaymentstobeReceived_97d3da1e-ed23-4ea4-86be-8929e9a98ddc" xlink:href="mck-20230331.xsd#mck_LessorLeasePaymentstobeReceived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_38273716-2808-430e-b570-cd1f81bf8b63" xlink:to="loc_mck_LessorLeasePaymentstobeReceived_97d3da1e-ed23-4ea4-86be-8929e9a98ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_2"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_052e481e-4c5f-48a0-b05a-f9d0c87dc521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_84777c9b-a079-4e36-8852-6fcb874dea20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_052e481e-4c5f-48a0-b05a-f9d0c87dc521" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_84777c9b-a079-4e36-8852-6fcb874dea20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f129597b-cb85-4feb-ac9a-0d1c7d30a4c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_84777c9b-a079-4e36-8852-6fcb874dea20" xlink:to="loc_srt_RangeAxis_f129597b-cb85-4feb-ac9a-0d1c7d30a4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_18d91785-83bc-413c-9550-ca4cca3956a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f129597b-cb85-4feb-ac9a-0d1c7d30a4c2" xlink:to="loc_srt_RangeMember_18d91785-83bc-413c-9550-ca4cca3956a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d541ca3e-664f-4708-9f87-47ebb0cd69d9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_18d91785-83bc-413c-9550-ca4cca3956a2" xlink:to="loc_srt_MinimumMember_d541ca3e-664f-4708-9f87-47ebb0cd69d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ce40625a-bf38-4fc9-bba9-d248fa3e783b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_18d91785-83bc-413c-9550-ca4cca3956a2" xlink:to="loc_srt_MaximumMember_ce40625a-bf38-4fc9-bba9-d248fa3e783b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_84777c9b-a079-4e36-8852-6fcb874dea20" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_51c64d13-796b-4db7-8fef-ccacba54b1b9" xlink:href="mck-20230331.xsd#mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:to="loc_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments_51c64d13-796b-4db7-8fef-ccacba54b1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_59cc2458-e35d-4fb6-a4c3-0baf8a490254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_59cc2458-e35d-4fb6-a4c3-0baf8a490254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_c4859bba-96a0-49ee-b80a-b41e86316349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_c4859bba-96a0-49ee-b80a-b41e86316349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_361cf8fe-9d74-492c-bcb6-5a95366f76ec" xlink:href="mck-20230331.xsd#mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_3de77366-9519-4812-a59f-a8a03ae71459" xlink:to="loc_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm_361cf8fe-9d74-492c-bcb6-5a95366f76ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ffcd8cb6-57e1-417c-b403-1cf4b083c2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_46a9f8d7-2c2a-4181-9836-7431848ac403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ffcd8cb6-57e1-417c-b403-1cf4b083c2dd" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_46a9f8d7-2c2a-4181-9836-7431848ac403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a791d4ef-37c4-422b-8a96-b8cb45555cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_46a9f8d7-2c2a-4181-9836-7431848ac403" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a791d4ef-37c4-422b-8a96-b8cb45555cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a791d4ef-37c4-422b-8a96-b8cb45555cd3" xlink:to="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_781c8279-1e20-4d37-a55a-507c4a482e7a" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:to="loc_mck_USPharmaceuticalSegmentMember_781c8279-1e20-4d37-a55a-507c4a482e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_c5bc274a-1035-48b9-b215-875bc452d822" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_c5bc274a-1035-48b9-b215-875bc452d822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_e3f5743c-0a7a-4bc8-a674-e04b62ed27e9" xlink:href="mck-20230331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_e3f5743c-0a7a-4bc8-a674-e04b62ed27e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_f97f1c59-6737-4aff-8b71-2973c1d117dd" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ca2ae72e-c3a1-4238-a173-77fab2bccc96" xlink:to="loc_mck_InternationalSegmentMember_f97f1c59-6737-4aff-8b71-2973c1d117dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_4114639a-e381-481d-b9c2-e13077c773b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_46a9f8d7-2c2a-4181-9836-7431848ac403" xlink:to="loc_us-gaap_GoodwillLineItems_4114639a-e381-481d-b9c2-e13077c773b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4114639a-e381-481d-b9c2-e13077c773b4" xlink:to="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4eb4c339-cd0a-4e37-b7d2-2948bbbbb6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:to="loc_us-gaap_Goodwill_4eb4c339-cd0a-4e37-b7d2-2948bbbbb6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_388978bb-5a9f-4277-a4d2-0a2b021da068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_388978bb-5a9f-4277-a4d2-0a2b021da068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0e083dd0-2864-4bbb-a411-240f7a423888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0e083dd0-2864-4bbb-a411-240f7a423888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_497e0426-37aa-41c9-8c90-b446d6d3bad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_497e0426-37aa-41c9-8c90-b446d6d3bad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c75fe8a6-bb99-4556-aa1f-ef6673c92d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_70c89ede-f4f0-4ba3-aff2-ac09ece4294f" xlink:to="loc_us-gaap_Goodwill_c75fe8a6-bb99-4556-aa1f-ef6673c92d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f5352d5e-e9ae-45f9-b48f-bb46c6ef219a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_7238abab-a05b-4a98-9731-16252f11a6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f5352d5e-e9ae-45f9-b48f-bb46c6ef219a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_7238abab-a05b-4a98-9731-16252f11a6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_c8308110-36b6-4109-9dd2-90a0b35bd9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7238abab-a05b-4a98-9731-16252f11a6c3" xlink:to="loc_us-gaap_ReportingUnitAxis_c8308110-36b6-4109-9dd2-90a0b35bd9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_6917a62b-d4da-4a4f-8669-ad3ea9452ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_c8308110-36b6-4109-9dd2-90a0b35bd9a2" xlink:to="loc_us-gaap_ReportingUnitDomain_6917a62b-d4da-4a4f-8669-ad3ea9452ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RetailPharmacyReportingUnitMember_ede4b1e6-2e4c-43f0-9ee9-2507deaaec63" xlink:href="mck-20230331.xsd#mck_RetailPharmacyReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_6917a62b-d4da-4a4f-8669-ad3ea9452ae6" xlink:to="loc_mck_RetailPharmacyReportingUnitMember_ede4b1e6-2e4c-43f0-9ee9-2507deaaec63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_41854dae-7e0d-47c7-b2d2-0e73d2383acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7238abab-a05b-4a98-9731-16252f11a6c3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_41854dae-7e0d-47c7-b2d2-0e73d2383acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_34962155-775e-437a-9e58-4e34a1d2a881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_41854dae-7e0d-47c7-b2d2-0e73d2383acb" xlink:to="loc_us-gaap_SegmentDomain_34962155-775e-437a-9e58-4e34a1d2a881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_7f57970a-b6dd-469e-b9ab-f40a15fbc126" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_34962155-775e-437a-9e58-4e34a1d2a881" xlink:to="loc_mck_InternationalSegmentMember_7f57970a-b6dd-469e-b9ab-f40a15fbc126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_8deae261-c43e-4368-9370-40feaaa70f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_7238abab-a05b-4a98-9731-16252f11a6c3" xlink:to="loc_us-gaap_GoodwillLineItems_8deae261-c43e-4368-9370-40feaaa70f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_d4d5c965-1def-4a49-a554-f014bd2c9117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8deae261-c43e-4368-9370-40feaaa70f1b" xlink:to="loc_us-gaap_NumberOfReportableSegments_d4d5c965-1def-4a49-a554-f014bd2c9117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f8450270-bf77-47f7-818c-0e82e2295f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_8deae261-c43e-4368-9370-40feaaa70f1b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f8450270-bf77-47f7-818c-0e82e2295f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe3a8d9e-2fc2-4971-b0b4-12ebd87232d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6ea6c96-51fd-4471-89b5-bc0668e8ca02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe3a8d9e-2fc2-4971-b0b4-12ebd87232d1" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6ea6c96-51fd-4471-89b5-bc0668e8ca02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_264ce5a4-7f4c-4e95-9c8c-56c7da7b4027" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6ea6c96-51fd-4471-89b5-bc0668e8ca02" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_264ce5a4-7f4c-4e95-9c8c-56c7da7b4027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c133dedd-3953-4b42-adc1-e87912d4e77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_264ce5a4-7f4c-4e95-9c8c-56c7da7b4027" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c133dedd-3953-4b42-adc1-e87912d4e77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_606c77c7-cf6b-4fb2-8d13-57988cf5f8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c133dedd-3953-4b42-adc1-e87912d4e77c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_606c77c7-cf6b-4fb2-8d13-57988cf5f8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1bb92ebb-ac5d-4076-a6f3-10f2bf9cc49a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6ea6c96-51fd-4471-89b5-bc0668e8ca02" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1bb92ebb-ac5d-4076-a6f3-10f2bf9cc49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b2925b7-b670-4e73-9b78-9ec7342e967a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_1bb92ebb-ac5d-4076-a6f3-10f2bf9cc49a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b2925b7-b670-4e73-9b78-9ec7342e967a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanAssetsHeldForSaleMember_86c6a6a8-4429-48f3-a666-d005ce765830" xlink:href="mck-20230331.xsd#mck_EuropeanAssetsHeldForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4b2925b7-b670-4e73-9b78-9ec7342e967a" xlink:to="loc_mck_EuropeanAssetsHeldForSaleMember_86c6a6a8-4429-48f3-a666-d005ce765830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cb4ebac5-d297-4db3-8cc5-633925c2f117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6ea6c96-51fd-4471-89b5-bc0668e8ca02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cb4ebac5-d297-4db3-8cc5-633925c2f117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cb4ebac5-d297-4db3-8cc5-633925c2f117" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_020abbba-9e00-4ddf-b1e0-feafb017994d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:to="loc_us-gaap_CustomerRelationshipsMember_020abbba-9e00-4ddf-b1e0-feafb017994d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_8c01aa5d-7bd4-4810-b41b-f1a98fcb1f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:to="loc_us-gaap_ServiceAgreementsMember_8c01aa5d-7bd4-4810-b41b-f1a98fcb1f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_c4db0aee-af40-4d5e-bd54-7449b0db89e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_c4db0aee-af40-4d5e-bd54-7449b0db89e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cc87d62b-e6e0-4f96-9ca2-fcbe2791e392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_cc87d62b-e6e0-4f96-9ca2-fcbe2791e392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_9db7c429-df8f-4cf3-a457-834944ebbaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91281b58-0804-42bf-879f-181406296838" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_9db7c429-df8f-4cf3-a457-834944ebbaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e6ea6c96-51fd-4471-89b5-bc0668e8ca02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_bbbf215a-4746-44ae-aab1-81ec4730e5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_bbbf215a-4746-44ae-aab1-81ec4730e5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4ca620b4-5abf-4148-a4df-e2bd34df87d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4ca620b4-5abf-4148-a4df-e2bd34df87d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fa98449e-aec1-4ac2-a8b0-b05f52f103cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fa98449e-aec1-4ac2-a8b0-b05f52f103cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_00277201-3259-4747-a841-906f442c675b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_00277201-3259-4747-a841-906f442c675b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_a9040da6-8cdd-40fe-9327-b091180304b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7de39ca2-f256-40f6-9368-de2578ead56e" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_a9040da6-8cdd-40fe-9327-b091180304b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fcca00-362b-4ada-834a-64eb7af0aa76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2e409017-475e-4d42-8290-689a5d43b581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fcca00-362b-4ada-834a-64eb7af0aa76" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2e409017-475e-4d42-8290-689a5d43b581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_316cace7-fe73-486e-bf76-bbbd9b8ef246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fcca00-362b-4ada-834a-64eb7af0aa76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_316cace7-fe73-486e-bf76-bbbd9b8ef246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e8541a7f-b1b7-49d8-b4d2-ff0fc86495a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fcca00-362b-4ada-834a-64eb7af0aa76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e8541a7f-b1b7-49d8-b4d2-ff0fc86495a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b98e35c9-b778-47f3-85b2-37b0fe916c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fcca00-362b-4ada-834a-64eb7af0aa76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b98e35c9-b778-47f3-85b2-37b0fe916c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0d0bfe19-9d47-429a-ae57-e911b700e7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fcca00-362b-4ada-834a-64eb7af0aa76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0d0bfe19-9d47-429a-ae57-e911b700e7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1f0d1243-f334-47a6-9e0e-59caa1b9741c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fcca00-362b-4ada-834a-64eb7af0aa76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1f0d1243-f334-47a6-9e0e-59caa1b9741c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0c4e1482-9291-4e63-ae4a-f1e6bf0aea08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19fcca00-362b-4ada-834a-64eb7af0aa76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0c4e1482-9291-4e63-ae4a-f1e6bf0aea08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a3a9c5f8-1b18-4b7d-ad8a-a53a67969aab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a3a9c5f8-1b18-4b7d-ad8a-a53a67969aab" xlink:to="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_87fd35a0-6996-4775-9fde-98f872fc6ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_87fd35a0-6996-4775-9fde-98f872fc6ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_db84f911-0766-4cbe-b85c-7be364cb977e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_87fd35a0-6996-4775-9fde-98f872fc6ba9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_db84f911-0766-4cbe-b85c-7be364cb977e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b8e0b851-85f6-4050-bfca-b089d43d7403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_db84f911-0766-4cbe-b85c-7be364cb977e" xlink:to="loc_us-gaap_LoansPayableMember_b8e0b851-85f6-4050-bfca-b089d43d7403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LeaseandOtherObligationsMember_0aa4a9ec-8296-4b44-ae8f-3b5b4934f574" xlink:href="mck-20230331.xsd#mck_LeaseandOtherObligationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_db84f911-0766-4cbe-b85c-7be364cb977e" xlink:to="loc_mck_LeaseandOtherObligationsMember_0aa4a9ec-8296-4b44-ae8f-3b5b4934f574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4f327149-4999-44ec-8fe3-f76e419d1ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4f327149-4999-44ec-8fe3-f76e419d1ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5bf4a71c-95e9-4c53-8828-22937890a32a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4f327149-4999-44ec-8fe3-f76e419d1ea8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5bf4a71c-95e9-4c53-8828-22937890a32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_0c596556-ba90-4c55-9a85-9984c217fd89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_5bf4a71c-95e9-4c53-8828-22937890a32a" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_0c596556-ba90-4c55-9a85-9984c217fd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6c41efa3-9b17-49c2-86cc-0ca6bafe5f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6c41efa3-9b17-49c2-86cc-0ca6bafe5f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bed72a9-d9c6-4ec6-b643-208f146162fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6c41efa3-9b17-49c2-86cc-0ca6bafe5f3a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bed72a9-d9c6-4ec6-b643-208f146162fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_a1cb72c4-2216-41a5-8e39-77ac523638c7" xlink:href="mck-20230331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_0bed72a9-d9c6-4ec6-b643-208f146162fc" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_a1cb72c4-2216-41a5-8e39-77ac523638c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_81b4cac4-a140-458f-84e2-68bbeacb574b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:to="loc_us-gaap_DebtInstrumentAxis_81b4cac4-a140-458f-84e2-68bbeacb574b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_81b4cac4-a140-458f-84e2-68bbeacb574b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_24065b59-07c3-4712-a312-d68c86eda246" xlink:href="mck-20230331.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A270NotesDueDecember152022Member_24065b59-07c3-4712-a312-d68c86eda246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_d2710dde-adac-4dbd-bd62-6c7a17751f44" xlink:href="mck-20230331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A285NotesDueMarch152023Member_d2710dde-adac-4dbd-bd62-6c7a17751f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_aa75fc99-62fb-46df-9ee0-d3becbc64a22" xlink:href="mck-20230331.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A380NotesDueMarch152024Member_aa75fc99-62fb-46df-9ee0-d3becbc64a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_c076de99-617f-42c4-92fb-ed92a2975674" xlink:href="mck-20230331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A090NotesDueDecember32025Member_c076de99-617f-42c4-92fb-ed92a2975674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A525NotesDueFebruary152026Member_22fe1771-5528-4616-a4f9-948197efa5ff" xlink:href="mck-20230331.xsd#mck_A525NotesDueFebruary152026Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A525NotesDueFebruary152026Member_22fe1771-5528-4616-a4f9-948197efa5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_62f88e24-c8aa-41b4-8190-ca54f66a39ed" xlink:href="mck-20230331.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A130NotesDueAugust152026Member_62f88e24-c8aa-41b4-8190-ca54f66a39ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_5e9f40b2-0ba9-4926-a2f9-b61b274131ed" xlink:href="mck-20230331.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_5e9f40b2-0ba9-4926-a2f9-b61b274131ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_67e672df-7313-4601-9ee4-c4191a3e8b10" xlink:href="mck-20230331.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A395NotesDueFebruary162028Member_67e672df-7313-4601-9ee4-c4191a3e8b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_17f11119-48c9-4375-a4aa-f8b68f562a5a" xlink:href="mck-20230331.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A475NotesDueMay302029Member_17f11119-48c9-4375-a4aa-f8b68f562a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_bc9122da-be2f-45e8-ad17-b377df5feaad" xlink:href="mck-20230331.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A600NotesDueMarch12041Member_bc9122da-be2f-45e8-ad17-b377df5feaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_bf6d5820-255c-4964-86d8-7eabb5d40bdc" xlink:href="mck-20230331.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A488NotesDueMarch152044Member_bf6d5820-255c-4964-86d8-7eabb5d40bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_cc6ca79e-49f7-4363-b7bf-ecbff2a19993" xlink:href="mck-20230331.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_cc6ca79e-49f7-4363-b7bf-ecbff2a19993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_2186dfdc-8cbb-4735-bd00-09862f92b5e1" xlink:href="mck-20230331.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_2186dfdc-8cbb-4735-bd00-09862f92b5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_9f287b29-449c-4caf-851c-3ccad88ecd02" xlink:href="mck-20230331.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_360f346b-dafa-4b26-bc08-318cec32bce7" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_9f287b29-449c-4caf-851c-3ccad88ecd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_04f6ab57-2610-46d5-b6f1-7c1a6d37a341" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4491fae7-c4d7-46fd-9524-28f170626232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4491fae7-c4d7-46fd-9524-28f170626232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_52f43290-fdea-4c07-a1fa-68bc0a555f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_us-gaap_LongTermDebt_52f43290-fdea-4c07-a1fa-68bc0a555f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2467bc9b-76b3-4231-9a54-1e77151a7cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2467bc9b-76b3-4231-9a54-1e77151a7cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_af7f8899-a701-4b93-a5c3-3c779f697f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_af7f8899-a701-4b93-a5c3-3c779f697f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_fbf522bd-cd5e-488e-bf58-1cd6d721c11a" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities_fbf522bd-cd5e-488e-bf58-1cd6d721c11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_42ba34eb-a66f-4dbc-9c55-8f46886d4a34" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1e7bbc76-c7c6-4c66-9d4f-9c2ad60a7715" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities_42ba34eb-a66f-4dbc-9c55-8f46886d4a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ce348bd6-e7f5-4366-9f81-0a88325ffc70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_040d2baa-7ca9-4f6b-8bee-0798ddd354ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ce348bd6-e7f5-4366-9f81-0a88325ffc70" xlink:to="loc_us-gaap_DebtInstrumentTable_040d2baa-7ca9-4f6b-8bee-0798ddd354ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_49da40b4-5e05-42c3-83cf-0f57fed60e66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_040d2baa-7ca9-4f6b-8bee-0798ddd354ac" xlink:to="loc_us-gaap_DebtInstrumentAxis_49da40b4-5e05-42c3-83cf-0f57fed60e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_49da40b4-5e05-42c3-83cf-0f57fed60e66" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A525NotesDue2026Member_36079c11-5bda-45fd-bd6b-beecef7078be" xlink:href="mck-20230331.xsd#mck_A525NotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A525NotesDue2026Member_36079c11-5bda-45fd-bd6b-beecef7078be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A130NotesDueAugust152026Member_06e7383d-2fe0-4976-bdab-736d321a3ba9" xlink:href="mck-20230331.xsd#mck_A130NotesDueAugust152026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A130NotesDueAugust152026Member_06e7383d-2fe0-4976-bdab-736d321a3ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_d8309b56-5aaf-43c7-a1db-ee9800f2f263" xlink:href="mck-20230331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A285NotesDueMarch152023Member_d8309b56-5aaf-43c7-a1db-ee9800f2f263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_0414fcc9-bcac-4653-8877-97ea5198d13f" xlink:href="mck-20230331.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A270NotesDueDecember152022Member_0414fcc9-bcac-4653-8877-97ea5198d13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_505db7cb-f914-47d9-9f48-4f5c810d2a74" xlink:href="mck-20230331.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_505db7cb-f914-47d9-9f48-4f5c810d2a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMarch12021Member_e9fcac53-421c-4514-9f1e-83f807aef060" xlink:href="mck-20230331.xsd#mck_A475NotesDueMarch12021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A475NotesDueMarch12021Member_e9fcac53-421c-4514-9f1e-83f807aef060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NotesDueNovember302020Member_7515cc59-0b07-49f5-b0c3-4f8476190d0b" xlink:href="mck-20230331.xsd#mck_NotesDueNovember302020Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_NotesDueNovember302020Member_7515cc59-0b07-49f5-b0c3-4f8476190d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A525NotesDueFebruary152026Member_55feb7d2-3e1e-467d-8e51-c18e663e9b77" xlink:href="mck-20230331.xsd#mck_A525NotesDueFebruary152026Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A525NotesDueFebruary152026Member_55feb7d2-3e1e-467d-8e51-c18e663e9b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_c75bc5e0-b957-4ed0-bb96-640a5c2c3c59" xlink:href="mck-20230331.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6c8e034d-cc04-4551-93b4-d108a638cb0b" xlink:to="loc_mck_A090NotesDueDecember32025Member_c75bc5e0-b957-4ed0-bb96-640a5c2c3c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ddff147a-6715-458e-99c5-98d78a6970cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_040d2baa-7ca9-4f6b-8bee-0798ddd354ac" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ddff147a-6715-458e-99c5-98d78a6970cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_382652c4-f1e1-43cc-80b1-a4a04390197d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ddff147a-6715-458e-99c5-98d78a6970cc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_382652c4-f1e1-43cc-80b1-a4a04390197d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_5a576340-fdb3-4b4e-8574-dc879275a78b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_382652c4-f1e1-43cc-80b1-a4a04390197d" xlink:to="loc_us-gaap_LoansPayableMember_5a576340-fdb3-4b4e-8574-dc879275a78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_040d2baa-7ca9-4f6b-8bee-0798ddd354ac" xlink:to="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_3834fce7-ad17-4a31-9ed8-9030eed82fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_3834fce7-ad17-4a31-9ed8-9030eed82fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f87b872b-ad41-4242-aeec-7fc5c0cf2444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f87b872b-ad41-4242-aeec-7fc5c0cf2444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_027b568d-2ce9-4ac4-880c-89bf8c9e22dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_027b568d-2ce9-4ac4-880c-89bf8c9e22dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cb765caa-8b00-4ab0-a0cf-129a1e289a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cb765caa-8b00-4ab0-a0cf-129a1e289a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_69f168ca-199d-4b0c-aea9-f62b1bba70ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_69f168ca-199d-4b0c-aea9-f62b1bba70ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_ac766b03-affc-49d4-8ee5-0319205a5833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_ac766b03-affc-49d4-8ee5-0319205a5833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_1faa8a8a-3373-4fc7-9a8e-3826e856fbcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_db952ce3-a5dc-47ee-bf4f-089cc6667b72" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_1faa8a8a-3373-4fc7-9a8e-3826e856fbcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e53614c5-2ad3-49fe-8580-9a67c88053c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_70d1f41c-ae1e-40ad-ac02-17c83c632dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e53614c5-2ad3-49fe-8580-9a67c88053c0" xlink:to="loc_us-gaap_DebtInstrumentTable_70d1f41c-ae1e-40ad-ac02-17c83c632dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a2e4ecd9-e47f-4247-adf4-80b3908327eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_70d1f41c-ae1e-40ad-ac02-17c83c632dbb" xlink:to="loc_us-gaap_DebtInstrumentAxis_a2e4ecd9-e47f-4247-adf4-80b3908327eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a2e4ecd9-e47f-4247-adf4-80b3908327eb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_c7a23fb8-1399-4b10-b3d3-d9fbcd9a0578" xlink:href="mck-20230331.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A285NotesDueMarch152023Member_c7a23fb8-1399-4b10-b3d3-d9fbcd9a0578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_df2eac87-8a59-4ae1-a9b4-319498cfea1e" xlink:href="mck-20230331.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A380NotesDueMarch152024Member_df2eac87-8a59-4ae1-a9b4-319498cfea1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_2e760aee-5fcd-4c70-9c5d-21027f995a86" xlink:href="mck-20230331.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_2e760aee-5fcd-4c70-9c5d-21027f995a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_b3856e28-916a-4487-9dc3-d31e07c89806" xlink:href="mck-20230331.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A395NotesDueFebruary162028Member_b3856e28-916a-4487-9dc3-d31e07c89806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_ab94d528-7ccc-4173-8f48-3d07516e21a5" xlink:href="mck-20230331.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A475NotesDueMay302029Member_ab94d528-7ccc-4173-8f48-3d07516e21a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_44402ea9-4070-43f5-a6c6-8369e3fd6eed" xlink:href="mck-20230331.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A600NotesDueMarch12041Member_44402ea9-4070-43f5-a6c6-8369e3fd6eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_247ee048-5c74-4ba4-8d79-c1219ae8db8c" xlink:href="mck-20230331.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_A488NotesDueMarch152044Member_247ee048-5c74-4ba4-8d79-c1219ae8db8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_2bc0ab61-8c3e-47b2-aa91-a3ce3ede978e" xlink:href="mck-20230331.xsd#mck_TenderOfferNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8be987ea-c840-43ca-9e73-5ac720d6833d" xlink:to="loc_mck_TenderOfferNotesMember_2bc0ab61-8c3e-47b2-aa91-a3ce3ede978e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_27d3c654-e4d1-41a5-944a-aad70303c94e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_70d1f41c-ae1e-40ad-ac02-17c83c632dbb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_27d3c654-e4d1-41a5-944a-aad70303c94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_65536a46-f506-42ae-920a-46fa0e562554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_27d3c654-e4d1-41a5-944a-aad70303c94e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_65536a46-f506-42ae-920a-46fa0e562554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_63acdb6b-6220-45bc-8752-5fc8ec885d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_65536a46-f506-42ae-920a-46fa0e562554" xlink:to="loc_us-gaap_LoansPayableMember_63acdb6b-6220-45bc-8752-5fc8ec885d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_70d1f41c-ae1e-40ad-ac02-17c83c632dbb" xlink:to="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_086356f0-2796-4a46-aef0-e009190403e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_086356f0-2796-4a46-aef0-e009190403e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_50bff019-343b-494d-9904-4b4234186e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_50bff019-343b-494d-9904-4b4234186e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_be4baa42-14b5-4629-b884-c0e2a263105f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_be4baa42-14b5-4629-b884-c0e2a263105f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_bf2bc2ce-1193-4a73-ba96-8ff5236c16f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_bf2bc2ce-1193-4a73-ba96-8ff5236c16f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_20a2f078-f401-48c0-a2cc-2926ea5ada94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_20a2f078-f401-48c0-a2cc-2926ea5ada94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_24119d65-4c60-4ca8-913d-2be80e85486f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_InterestPaid_24119d65-4c60-4ca8-913d-2be80e85486f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f5847432-fe57-465e-a34c-063868259e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f5847432-fe57-465e-a34c-063868259e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_906ccfa0-3dfe-4338-9361-ae38184554f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_906ccfa0-3dfe-4338-9361-ae38184554f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_10af6d36-a1ed-49c4-8ab2-6ddf9f6b99bb" xlink:href="mck-20230331.xsd#mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts_10af6d36-a1ed-49c4-8ab2-6ddf9f6b99bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_04d4962e-3be8-4068-b242-9127c8026048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_04d4962e-3be8-4068-b242-9127c8026048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ef8ad88a-d71e-496a-b11a-53bc6c9edad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ef8ad88a-d71e-496a-b11a-53bc6c9edad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c5e8e462-4735-426c-af36-9d0c6e502533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c5e8e462-4735-426c-af36-9d0c6e502533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7705f0a8-a03a-4541-9023-dfedb5483705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7705f0a8-a03a-4541-9023-dfedb5483705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_019fc6a9-d162-4aa7-8f0b-018a2030edf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_019fc6a9-d162-4aa7-8f0b-018a2030edf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_665dafc6-d10c-4567-a647-621b31eab0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_054b1d14-cca7-4460-a778-59c32f52fa84" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_665dafc6-d10c-4567-a647-621b31eab0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ce1eed69-4e3f-4673-ab47-dd9595bfbb89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ce1eed69-4e3f-4673-ab47-dd9595bfbb89" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_04ac2c0a-1a79-4ae5-a058-abb303438cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:to="loc_us-gaap_DebtInstrumentAxis_04ac2c0a-1a79-4ae5-a058-abb303438cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_04ac2c0a-1a79-4ae5-a058-abb303438cbb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember_e599c8e5-1cb9-4ac3-b6ae-43bc040b4285" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:to="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember_e599c8e5-1cb9-4ac3-b6ae-43bc040b4285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember_b6bc4174-bff0-4eac-b4c4-76d958d5276c" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:to="loc_mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember_b6bc4174-bff0-4eac-b4c4-76d958d5276c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_5e7023e0-f1cd-4667-9d7c-170fa7849019" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_5e7023e0-f1cd-4667-9d7c-170fa7849019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_c6e8a388-4716-4b7f-a57f-33a4523126ec" xlink:href="mck-20230331.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_c6e8a388-4716-4b7f-a57f-33a4523126ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2022TermLoanCreditFacilityMember_cbd62ac3-749e-4664-98f9-ba286a2f488f" xlink:href="mck-20230331.xsd#mck_A2022TermLoanCreditFacilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_47320a3a-e612-43f9-a1b1-d78b0f5f80aa" xlink:to="loc_mck_A2022TermLoanCreditFacilityMember_cbd62ac3-749e-4664-98f9-ba286a2f488f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6dc64c8d-e92b-425f-95de-f2004242e4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6dc64c8d-e92b-425f-95de-f2004242e4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b13a4479-8eb1-40de-bcd7-75c25f93bb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6dc64c8d-e92b-425f-95de-f2004242e4c7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b13a4479-8eb1-40de-bcd7-75c25f93bb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_8073bc05-f788-47aa-ab62-cac84242304d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b13a4479-8eb1-40de-bcd7-75c25f93bb74" xlink:to="loc_us-gaap_UnsecuredDebtMember_8073bc05-f788-47aa-ab62-cac84242304d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_09953032-5588-4e2f-a82e-63013230b384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b13a4479-8eb1-40de-bcd7-75c25f93bb74" xlink:to="loc_us-gaap_LineOfCreditMember_09953032-5588-4e2f-a82e-63013230b384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TermLoanMember_c8a42f63-3707-4704-a0c8-1b40cad5b964" xlink:href="mck-20230331.xsd#mck_TermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b13a4479-8eb1-40de-bcd7-75c25f93bb74" xlink:to="loc_mck_TermLoanMember_c8a42f63-3707-4704-a0c8-1b40cad5b964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a0e6ed00-aaa5-48c1-ade3-d42bfb06c270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:to="loc_us-gaap_CreditFacilityAxis_a0e6ed00-aaa5-48c1-ade3-d42bfb06c270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_61b84fb2-b0c4-491a-9374-6bad3e9ef6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a0e6ed00-aaa5-48c1-ade3-d42bfb06c270" xlink:to="loc_us-gaap_CreditFacilityDomain_61b84fb2-b0c4-491a-9374-6bad3e9ef6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e7a1be3c-a345-4514-97f0-99743d81eb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_61b84fb2-b0c4-491a-9374-6bad3e9ef6fb" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e7a1be3c-a345-4514-97f0-99743d81eb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_596817ed-6855-4d04-9757-c14eadefea79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:to="loc_us-gaap_VariableRateAxis_596817ed-6855-4d04-9757-c14eadefea79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_104d3df8-c673-4b72-8e86-4203e24fc54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_596817ed-6855-4d04-9757-c14eadefea79" xlink:to="loc_us-gaap_VariableRateDomain_104d3df8-c673-4b72-8e86-4203e24fc54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecuredOvernightFinancingRateSOFRMember_dadbd9a3-f00d-4881-b793-394215d63016" xlink:href="mck-20230331.xsd#mck_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_104d3df8-c673-4b72-8e86-4203e24fc54b" xlink:to="loc_mck_SecuredOvernightFinancingRateSOFRMember_dadbd9a3-f00d-4881-b793-394215d63016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_7912fa0c-8ae5-4d6b-98a7-70335f9cd8f8" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ac58720e-1ddd-4ce8-a765-c2f3e1cc95be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ac58720e-1ddd-4ce8-a765-c2f3e1cc95be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c5b34a02-01f2-40a7-aa9d-c224fe0cc54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_DebtInstrumentTerm_c5b34a02-01f2-40a7-aa9d-c224fe0cc54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_39013df5-40dc-4e72-aeef-b1d002a445bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_39013df5-40dc-4e72-aeef-b1d002a445bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_ed1cf3a3-ed93-4a45-a212-f5ceb8fdde69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_LineOfCredit_ed1cf3a3-ed93-4a45-a212-f5ceb8fdde69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DebtInstrumentDaysAvailableForBorrowing_c35186d5-3ce4-4e80-a995-d72644087b00" xlink:href="mck-20230331.xsd#mck_DebtInstrumentDaysAvailableForBorrowing"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_mck_DebtInstrumentDaysAvailableForBorrowing_c35186d5-3ce4-4e80-a995-d72644087b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_00b2bd64-8a1e-4883-9cf6-1e912f3aaf4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_LongTermDebt_00b2bd64-8a1e-4883-9cf6-1e912f3aaf4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_542bb109-f4fd-4567-8953-e369ba01e483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_77b7997b-4d2d-46a5-9c85-50c5ad4abcdf" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_542bb109-f4fd-4567-8953-e369ba01e483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_356f8ab5-7806-4983-9307-36d53441c672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8319d0bf-5ede-44c7-8e2d-03ebeb2cbf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_356f8ab5-7806-4983-9307-36d53441c672" xlink:to="loc_us-gaap_DebtInstrumentTable_8319d0bf-5ede-44c7-8e2d-03ebeb2cbf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0e5c2daf-0ab3-4b52-a1eb-485b8a1d97bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8319d0bf-5ede-44c7-8e2d-03ebeb2cbf1a" xlink:to="loc_us-gaap_CreditFacilityAxis_0e5c2daf-0ab3-4b52-a1eb-485b8a1d97bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_51cc8df5-9845-463c-8a2a-423c28dc9f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_0e5c2daf-0ab3-4b52-a1eb-485b8a1d97bd" xlink:to="loc_us-gaap_CreditFacilityDomain_51cc8df5-9845-463c-8a2a-423c28dc9f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_accc5fee-4890-465b-b07e-e52476d406c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_51cc8df5-9845-463c-8a2a-423c28dc9f52" xlink:to="loc_us-gaap_CommercialPaperMember_accc5fee-4890-465b-b07e-e52476d406c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3937645b-962f-451a-a60b-3fb1f4128b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_51cc8df5-9845-463c-8a2a-423c28dc9f52" xlink:to="loc_us-gaap_LineOfCreditMember_3937645b-962f-451a-a60b-3fb1f4128b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8319d0bf-5ede-44c7-8e2d-03ebeb2cbf1a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_427f0e12-70cb-42c9-8b83-7d64deb90dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_427f0e12-70cb-42c9-8b83-7d64deb90dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_a6cb60f2-7fd3-47f3-81fc-c9df0c84ef7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_a6cb60f2-7fd3-47f3-81fc-c9df0c84ef7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5973b444-f822-4918-8863-0d4d345f97f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5973b444-f822-4918-8863-0d4d345f97f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_ddf75321-f092-4cfb-9f76-a3e04c88e390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_ddf75321-f092-4cfb-9f76-a3e04c88e390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_31c64c99-60dd-4e7c-9db3-f9aec0f1d807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_31c64c99-60dd-4e7c-9db3-f9aec0f1d807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_aceff82e-01ce-4f85-ae86-be841d99c718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b322feb2-23b0-498b-95f1-c9771c581327" xlink:to="loc_us-gaap_LongTermDebt_aceff82e-01ce-4f85-ae86-be841d99c718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#VariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/VariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_f9b69d7c-7542-4952-9915-163aab70b1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_470ec5bc-531f-4b17-9abc-a93ee6adb617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_f9b69d7c-7542-4952-9915-163aab70b1ed" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_470ec5bc-531f-4b17-9abc-a93ee6adb617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_eb01ae06-fa6c-4873-8a74-e85834a8d1c0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_470ec5bc-531f-4b17-9abc-a93ee6adb617" xlink:to="loc_srt_ConsolidatedEntitiesAxis_eb01ae06-fa6c-4873-8a74-e85834a8d1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_abaf97cf-41dc-47cb-a7ca-58a4029d8be1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_eb01ae06-fa6c-4873-8a74-e85834a8d1c0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_abaf97cf-41dc-47cb-a7ca-58a4029d8be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_db91fe45-d480-4f25-a00c-7b67383a810d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_abaf97cf-41dc-47cb-a7ca-58a4029d8be1" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_db91fe45-d480-4f25-a00c-7b67383a810d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_c9d2b5f1-0aad-4e28-beb7-5d313a1b37e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_470ec5bc-531f-4b17-9abc-a93ee6adb617" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_c9d2b5f1-0aad-4e28-beb7-5d313a1b37e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6641a147-d091-4fe6-bfb7-a54ac9fea195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_c9d2b5f1-0aad-4e28-beb7-5d313a1b37e8" xlink:to="loc_us-gaap_Assets_6641a147-d091-4fe6-bfb7-a54ac9fea195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4b783a01-17f4-4985-9dec-922127861d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_c9d2b5f1-0aad-4e28-beb7-5d313a1b37e8" xlink:to="loc_us-gaap_Liabilities_4b783a01-17f4-4985-9dec-922127861d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_5dc1e68c-b5b7-469f-9b00-79cf72d44807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_c9d2b5f1-0aad-4e28-beb7-5d313a1b37e8" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_5dc1e68c-b5b7-469f-9b00-79cf72d44807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c036708d-ac85-469f-a26b-e063305f34f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_c036708d-ac85-469f-a26b-e063305f34f0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_83f9bcf5-d8ef-41d7-a4f8-042e3e22c833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_83f9bcf5-d8ef-41d7-a4f8-042e3e22c833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_3247501a-d1c4-4a7b-91f8-dfeb7908eebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_83f9bcf5-d8ef-41d7-a4f8-042e3e22c833" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_3247501a-d1c4-4a7b-91f8-dfeb7908eebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_00c83a3c-2521-4bf3-8377-a3de0406dab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_3247501a-d1c4-4a7b-91f8-dfeb7908eebd" xlink:to="loc_us-gaap_DomesticPlanMember_00c83a3c-2521-4bf3-8377-a3de0406dab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5a43e022-8c67-47fa-bb02-0fcc5fa0bb59" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DomesticPlanMember_00c83a3c-2521-4bf3-8377-a3de0406dab8" xlink:to="loc_country_US_5a43e022-8c67-47fa-bb02-0fcc5fa0bb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_71142570-0135-4a00-8d1a-141c9d059c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_3247501a-d1c4-4a7b-91f8-dfeb7908eebd" xlink:to="loc_us-gaap_ForeignPlanMember_71142570-0135-4a00-8d1a-141c9d059c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_59b315b0-5fbf-4b2f-b43d-cba3bf4b28f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_59b315b0-5fbf-4b2f-b43d-cba3bf4b28f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3990fc81-8c1a-4bca-930b-2cc0d85c68ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_59b315b0-5fbf-4b2f-b43d-cba3bf4b28f0" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3990fc81-8c1a-4bca-930b-2cc0d85c68ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_45713756-1056-4d70-b93e-915c6300bca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3990fc81-8c1a-4bca-930b-2cc0d85c68ea" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_45713756-1056-4d70-b93e-915c6300bca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_0cf87071-d71d-439c-94b0-850ab14fe8c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3990fc81-8c1a-4bca-930b-2cc0d85c68ea" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_0cf87071-d71d-439c-94b0-850ab14fe8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusAxis_2f470e0d-4e5e-414c-8a80-fa9265054043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanFundingStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_RetirementPlanFundingStatusAxis_2f470e0d-4e5e-414c-8a80-fa9265054043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanFundingStatusDomain_87d0eb9b-7d8f-455d-abe6-ec71ce92b586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanFundingStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanFundingStatusAxis_2f470e0d-4e5e-414c-8a80-fa9265054043" xlink:to="loc_us-gaap_RetirementPlanFundingStatusDomain_87d0eb9b-7d8f-455d-abe6-ec71ce92b586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfundedPlanMember_c956b7e9-32fa-4d71-a68b-6c8500361da4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnfundedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanFundingStatusDomain_87d0eb9b-7d8f-455d-abe6-ec71ce92b586" xlink:to="loc_us-gaap_UnfundedPlanMember_c956b7e9-32fa-4d71-a68b-6c8500361da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b94b0540-d7ec-4415-942e-10051bafeb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b94b0540-d7ec-4415-942e-10051bafeb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ba9bb718-73e5-4d7d-b3c4-86f3ed80beae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b94b0540-d7ec-4415-942e-10051bafeb6e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ba9bb718-73e5-4d7d-b3c4-86f3ed80beae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2db43f86-5eb9-443b-84c8-86c613a5ac7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ba9bb718-73e5-4d7d-b3c4-86f3ed80beae" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_2db43f86-5eb9-443b-84c8-86c613a5ac7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6a2fdc41-6b00-4668-8f90-648d6bbe122a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ba9bb718-73e5-4d7d-b3c4-86f3ed80beae" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6a2fdc41-6b00-4668-8f90-648d6bbe122a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_f4cd4670-f896-42de-a5c4-598d17dcbddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_RetirementPlanNameAxis_f4cd4670-f896-42de-a5c4-598d17dcbddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_31c4c804-9ae6-42cc-8d7c-ba55000f54ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_f4cd4670-f896-42de-a5c4-598d17dcbddd" xlink:to="loc_us-gaap_RetirementPlanNameDomain_31c4c804-9ae6-42cc-8d7c-ba55000f54ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NorwegianPublicServicePensionFundSPKMember_009478f2-c73e-4ba9-ab5d-72df94b9a3de" xlink:href="mck-20230331.xsd#mck_NorwegianPublicServicePensionFundSPKMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_31c4c804-9ae6-42cc-8d7c-ba55000f54ba" xlink:to="loc_mck_NorwegianPublicServicePensionFundSPKMember_009478f2-c73e-4ba9-ab5d-72df94b9a3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingAxis_18384e00-f043-4ed0-8835-104d86153cab" xlink:href="mck-20230331.xsd#mck_DefinedContributionPlanMatchingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_mck_DefinedContributionPlanMatchingAxis_18384e00-f043-4ed0-8835-104d86153cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedContributionPlanMatchingDomain_e9ecf2b4-c34d-4e8c-abda-f398abab3376" xlink:href="mck-20230331.xsd#mck_DefinedContributionPlanMatchingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_DefinedContributionPlanMatchingAxis_18384e00-f043-4ed0-8835-104d86153cab" xlink:to="loc_mck_DefinedContributionPlanMatchingDomain_e9ecf2b4-c34d-4e8c-abda-f398abab3376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FirstPartOfPayContributionMember_1d02312f-2c89-455e-8cca-7a03683f5272" xlink:href="mck-20230331.xsd#mck_FirstPartOfPayContributionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_e9ecf2b4-c34d-4e8c-abda-f398abab3376" xlink:to="loc_mck_FirstPartOfPayContributionMember_1d02312f-2c89-455e-8cca-7a03683f5272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SecondPartOfPayContributionMember_ed5b34e5-0dc4-49d6-ac8c-9fc31b92614e" xlink:href="mck-20230331.xsd#mck_SecondPartOfPayContributionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_DefinedContributionPlanMatchingDomain_e9ecf2b4-c34d-4e8c-abda-f398abab3376" xlink:to="loc_mck_SecondPartOfPayContributionMember_ed5b34e5-0dc4-49d6-ac8c-9fc31b92614e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_30ec73cb-f51d-44ca-85e4-d6ce23113977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_30ec73cb-f51d-44ca-85e4-d6ce23113977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_30ec73cb-f51d-44ca-85e4-d6ce23113977" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_4740cf36-4191-4a1d-95b3-b969266501e5" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_4740cf36-4191-4a1d-95b3-b969266501e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_5b73ce59-4568-465d-b921-096afda031e7" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_5b73ce59-4568-465d-b921-096afda031e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AustrianBusinessOperationsMember_0b85eb82-b1b8-4cc6-9e60-1256004f4671" xlink:href="mck-20230331.xsd#mck_AustrianBusinessOperationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:to="loc_mck_AustrianBusinessOperationsMember_0b85eb82-b1b8-4cc6-9e60-1256004f4671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_9aa43867-7cdd-4554-9aba-ed24118ccb1f" xlink:href="mck-20230331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_29ab5a0a-19ee-474a-903a-9012c632b7bd" xlink:to="loc_mck_GermanWholesaleBusinessMember_9aa43867-7cdd-4554-9aba-ed24118ccb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2d3c4027-7713-4a43-b7f3-dde63062298b" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_67b3f133-ff4a-4525-882f-7aac21c9b879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation_67b3f133-ff4a-4525-882f-7aac21c9b879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_813b33e6-f825-4269-8ce0-89d3d968eeef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_813b33e6-f825-4269-8ce0-89d3d968eeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized_873f6742-6b83-4451-868a-62c9dcc71924" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized_873f6742-6b83-4451-868a-62c9dcc71924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_b90a9a65-1be4-47b7-b754-7352a3d6ab5d" xlink:href="mck-20230331.xsd#mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized_b90a9a65-1be4-47b7-b754-7352a3d6ab5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_fedba7e2-86ef-4d26-b36e-12895e99d6b8" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized_fedba7e2-86ef-4d26-b36e-12895e99d6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_ef5e9412-0865-46cd-a8f8-c647de694e04" xlink:href="mck-20230331.xsd#mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized_ef5e9412-0865-46cd-a8f8-c647de694e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_71e09cc6-0fd8-419e-9ff8-b25e7b8000c2" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets_71e09cc6-0fd8-419e-9ff8-b25e7b8000c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_5831aaf2-deaa-4648-9852-d379ed5a16ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_5831aaf2-deaa-4648-9852-d379ed5a16ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_249ef5fc-09a2-4d88-a6e7-29ee30cb88d0" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate_249ef5fc-09a2-4d88-a6e7-29ee30cb88d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8753bcc1-0c81-44e6-915f-9f960e69e4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8753bcc1-0c81-44e6-915f-9f960e69e4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_5aca2acb-bc76-41af-b9fa-ed85effbc56d" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges_5aca2acb-bc76-41af-b9fa-ed85effbc56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d15d5a7b-f7c8-4fd9-a6a9-7b0439a5c53f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_d15d5a7b-f7c8-4fd9-a6a9-7b0439a5c53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0fd18b7b-2b4f-4136-b121-161b71851ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_0fd18b7b-2b4f-4136-b121-161b71851ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_08447a4f-2796-4ab0-9207-3bd4a72e51d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_08447a4f-2796-4ab0-9207-3bd4a72e51d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_e3e1b9d8-ca0e-47ad-bbcb-ce9eed568fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_e3e1b9d8-ca0e-47ad-bbcb-ce9eed568fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_16341f5e-0845-41e3-a900-7529fbc2f85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_16341f5e-0845-41e3-a900-7529fbc2f85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_69f85d94-b58c-473c-a8e6-90b44768edce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_69f85d94-b58c-473c-a8e6-90b44768edce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_7d3f9a93-fa24-4cc0-b73d-31a7a8895689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_7d3f9a93-fa24-4cc0-b73d-31a7a8895689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d89b612e-d2fa-4d0e-8463-0b56af65ae4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_d89b612e-d2fa-4d0e-8463-0b56af65ae4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_cda22edf-4e99-46d4-8350-c7c8b66fee9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_cda22edf-4e99-46d4-8350-c7c8b66fee9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_cef31bb9-0fac-4344-85bc-2cf9db870025" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints_cef31bb9-0fac-4344-85bc-2cf9db870025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitValueOfCashAndCashEquivalents_bcf040eb-ae2d-41c8-b10c-5e88db6b0cf0" xlink:href="mck-20230331.xsd#mck_UnitValueOfCashAndCashEquivalents"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_UnitValueOfCashAndCashEquivalents_bcf040eb-ae2d-41c8-b10c-5e88db6b0cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_aab3969f-19fc-4fd6-8ea8-be61afad8ff4" xlink:href="mck-20230331.xsd#mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue_aab3969f-19fc-4fd6-8ea8-be61afad8ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_92ecd726-68a8-4638-ae6c-b0fc4927104f" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset_92ecd726-68a8-4638-ae6c-b0fc4927104f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_77b90202-9c3a-4251-9545-a94b822e4f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_77b90202-9c3a-4251-9545-a94b822e4f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MultiemployerPlanFundedStatusPercentage_817b0dd8-83f0-4cb4-82f4-954f8b39f4a9" xlink:href="mck-20230331.xsd#mck_MultiemployerPlanFundedStatusPercentage"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_MultiemployerPlanFundedStatusPercentage_817b0dd8-83f0-4cb4-82f4-954f8b39f4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlansWithdrawalObligation_1d1d5658-3832-4063-91e7-f88d4b2f3c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MultiemployerPlansWithdrawalObligation"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_MultiemployerPlansWithdrawalObligation_1d1d5658-3832-4063-91e7-f88d4b2f3c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_b6906cd4-8547-4dda-b33d-8db061a0ad9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_b6906cd4-8547-4dda-b33d-8db061a0ad9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_7cbe7a8c-5f02-4b99-bdae-45d030423443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_7cbe7a8c-5f02-4b99-bdae-45d030423443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EmployeeContributions_8eb3a7ed-ec5c-4767-b817-3ec889d394fd" xlink:href="mck-20230331.xsd#mck_EmployeeContributions"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_mck_EmployeeContributions_8eb3a7ed-ec5c-4767-b817-3ec889d394fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_3a797772-7838-4673-9ee2-0b5632986e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_3a797772-7838-4673-9ee2-0b5632986e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3eda58a7-64c9-453a-91d0-730515ec627d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_465a86a1-e003-4f21-bdc7-97e86b0684ab" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3eda58a7-64c9-453a-91d0-730515ec627d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_17641c53-80e7-48a5-92a6-3c836271c18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6b610e5d-e42d-4f49-92ca-a1cbfc3068c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_17641c53-80e7-48a5-92a6-3c836271c18c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6b610e5d-e42d-4f49-92ca-a1cbfc3068c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9e32db50-966f-48e3-b28c-33bd71a21a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6b610e5d-e42d-4f49-92ca-a1cbfc3068c9" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9e32db50-966f-48e3-b28c-33bd71a21a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a58f8a0a-303a-43df-881f-1beec72f35fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9e32db50-966f-48e3-b28c-33bd71a21a16" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a58f8a0a-303a-43df-881f-1beec72f35fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_a3c02e39-dc13-4c1c-99d4-229c2068a984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a58f8a0a-303a-43df-881f-1beec72f35fe" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_a3c02e39-dc13-4c1c-99d4-229c2068a984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fc0cb02-dbbc-42e8-a4c5-b196397a7938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6b610e5d-e42d-4f49-92ca-a1cbfc3068c9" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fc0cb02-dbbc-42e8-a4c5-b196397a7938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_4f905ede-9f8a-4e4a-90ea-042558a95df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_6fc0cb02-dbbc-42e8-a4c5-b196397a7938" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_4f905ede-9f8a-4e4a-90ea-042558a95df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_c5e7f586-4697-4caa-b742-4fec14307318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_4f905ede-9f8a-4e4a-90ea-042558a95df2" xlink:to="loc_us-gaap_ForeignPlanMember_c5e7f586-4697-4caa-b742-4fec14307318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6b610e5d-e42d-4f49-92ca-a1cbfc3068c9" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_73f40cf6-f7ae-45bf-a9bc-1fc143480b99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_73f40cf6-f7ae-45bf-a9bc-1fc143480b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_d4679e7c-6a8e-44b3-82ec-8ece59433f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_d4679e7c-6a8e-44b3-82ec-8ece59433f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2a7fbab1-d0e1-4d8b-939d-2a398bfef4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2a7fbab1-d0e1-4d8b-939d-2a398bfef4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_fc6d8450-6e41-44cb-a724-b2c165a941c7" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets_fc6d8450-6e41-44cb-a724-b2c165a941c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_712f385e-e8cb-4105-b51c-b3db34a71af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_712f385e-e8cb-4105-b51c-b3db34a71af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ed11d10a-0471-48ba-b4ed-ae3a63be6e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f88ae3d3-12d6-465a-8711-dcfb78fb7049" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ed11d10a-0471-48ba-b4ed-ae3a63be6e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d8885057-ccf0-4c8c-b763-dc5d8ca96fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d3bd1d70-8d77-4a0c-ad1a-2d62b8bee3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d8885057-ccf0-4c8c-b763-dc5d8ca96fe0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d3bd1d70-8d77-4a0c-ad1a-2d62b8bee3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c62dab85-475f-40f6-a304-7fa6a6149551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d3bd1d70-8d77-4a0c-ad1a-2d62b8bee3d6" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c62dab85-475f-40f6-a304-7fa6a6149551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_60e27c46-ed9d-4151-a7be-5a343e1a2c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c62dab85-475f-40f6-a304-7fa6a6149551" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_60e27c46-ed9d-4151-a7be-5a343e1a2c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_6e3b767f-e945-4833-8536-9c3c502987a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_60e27c46-ed9d-4151-a7be-5a343e1a2c5a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_6e3b767f-e945-4833-8536-9c3c502987a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_94a527fe-38bc-4170-9db8-5d623e7dfba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d3bd1d70-8d77-4a0c-ad1a-2d62b8bee3d6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_94a527fe-38bc-4170-9db8-5d623e7dfba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aa2974a5-bdd8-414f-a85d-06938d8b9db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_94a527fe-38bc-4170-9db8-5d623e7dfba3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aa2974a5-bdd8-414f-a85d-06938d8b9db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_ef67bfa9-39db-466c-b10d-3043d08a5ca0" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aa2974a5-bdd8-414f-a85d-06938d8b9db3" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_ef67bfa9-39db-466c-b10d-3043d08a5ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_d88f40dc-5ca0-4d6c-a951-6c8f7af22ecf" xlink:href="mck-20230331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aa2974a5-bdd8-414f-a85d-06938d8b9db3" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_d88f40dc-5ca0-4d6c-a951-6c8f7af22ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_087d9ec9-8338-4719-8509-dd3cfe225a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d3bd1d70-8d77-4a0c-ad1a-2d62b8bee3d6" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_087d9ec9-8338-4719-8509-dd3cfe225a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3acdfbb-0e8a-423d-8455-3f528a6f0746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_087d9ec9-8338-4719-8509-dd3cfe225a6c" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3acdfbb-0e8a-423d-8455-3f528a6f0746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_3c0eb4c1-e37e-4ca0-80b5-acb361651345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3acdfbb-0e8a-423d-8455-3f528a6f0746" xlink:to="loc_us-gaap_ForeignPlanMember_3c0eb4c1-e37e-4ca0-80b5-acb361651345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d3bd1d70-8d77-4a0c-ad1a-2d62b8bee3d6" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_1c9d0e58-3192-4cd5-aaa9-c8965c06890f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_1c9d0e58-3192-4cd5-aaa9-c8965c06890f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_7231bd23-4348-4b52-97a0-a9cb3e106e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_7231bd23-4348-4b52-97a0-a9cb3e106e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_48a76b45-9912-45e7-bed2-9a2b7ef798cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_48a76b45-9912-45e7-bed2-9a2b7ef798cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7eb5cf75-7d13-4e06-bd16-06ca75947f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7eb5cf75-7d13-4e06-bd16-06ca75947f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_a3013cc2-6d92-4588-8b8c-f8e2b36a2854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_a3013cc2-6d92-4588-8b8c-f8e2b36a2854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_c5d1d4b5-f25e-441e-b289-5c537090d698" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement_c5d1d4b5-f25e-441e-b289-5c537090d698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_84faa455-f9d7-402c-af21-2eba85cfdce8" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanBenefitObligationsExpensesPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid_84faa455-f9d7-402c-af21-2eba85cfdce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_fed08399-af2c-42c6-a50e-4da17411ce00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_fed08399-af2c-42c6-a50e-4da17411ce00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_0414c898-97c7-4e16-8b08-21cfe4196644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_0414c898-97c7-4e16-8b08-21cfe4196644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_85b1d488-c0c4-4370-8a37-256fd48d858c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ebdf299f-bdb8-4f1f-8715-05089c40cc84" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_85b1d488-c0c4-4370-8a37-256fd48d858c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1ad7ecf4-cc09-4e30-bab2-732a2c75e3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1ad7ecf4-cc09-4e30-bab2-732a2c75e3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_cee436fd-fd47-4971-9fe9-7b8d08e0dbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_cee436fd-fd47-4971-9fe9-7b8d08e0dbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_abfa3bbf-8e9c-40d9-950c-854c8ab4d4b8" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants_abfa3bbf-8e9c-40d9-950c-854c8ab4d4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_414bdf08-8dbf-48a3-9af9-51dafa513dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_414bdf08-8dbf-48a3-9af9-51dafa513dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_0afc857b-19fa-496f-90e4-7a37fe601d00" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanPlanAssetsExpensesPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_mck_DefinedBenefitPlanPlanAssetsExpensesPaid_0afc857b-19fa-496f-90e4-7a37fe601d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_b7aa9e3a-c6cf-4114-b8c1-bf20dbd1ac66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_b7aa9e3a-c6cf-4114-b8c1-bf20dbd1ac66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_e8763a77-044d-4cc1-a539-e565a99aa251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_e8763a77-044d-4cc1-a539-e565a99aa251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_3bb4e202-0a81-4f3c-a4ca-126dea573838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_3bb4e202-0a81-4f3c-a4ca-126dea573838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7e6f4fd6-d302-4bda-9db6-b731227939b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a6109ad5-2613-45b1-ac2e-9da152c35a07" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7e6f4fd6-d302-4bda-9db6-b731227939b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_137224d2-ba08-4360-a7e9-168e465a9771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_137224d2-ba08-4360-a7e9-168e465a9771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e805ba85-e137-42d2-a0a8-c6fe35aeddfe" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_42ac3172-2059-4d5d-92c8-8998e0a726b1" xlink:href="mck-20230331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent_42ac3172-2059-4d5d-92c8-8998e0a726b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_c3578ed8-1278-4b95-a7a0-19d9ea63c341" xlink:href="mck-20230331.xsd#mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:to="loc_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent_c3578ed8-1278-4b95-a7a0-19d9ea63c341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_39f04f80-46f4-42a9-ae66-f26af9242bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_39f04f80-46f4-42a9-ae66-f26af9242bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6bf5d05f-13c0-4984-af9f-f98a7a6102b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_6bf5d05f-13c0-4984-af9f-f98a7a6102b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_ed18d4b4-2166-4f62-8e1a-bc4e43c9b4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract_93372d83-00a2-4a65-958b-b049a4248253" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_ed18d4b4-2166-4f62-8e1a-bc4e43c9b4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f91b95e-f896-42ef-9b73-8ccfaf0c9bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_15cfbf95-bd44-427c-b11c-618d6cb2c415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0f91b95e-f896-42ef-9b73-8ccfaf0c9bc9" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_15cfbf95-bd44-427c-b11c-618d6cb2c415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_ca08e435-75bd-4eb4-b921-185be00f585b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_15cfbf95-bd44-427c-b11c-618d6cb2c415" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_ca08e435-75bd-4eb4-b921-185be00f585b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8fb1d67a-4e3a-4bae-9143-7af5c00ef5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_ca08e435-75bd-4eb4-b921-185be00f585b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8fb1d67a-4e3a-4bae-9143-7af5c00ef5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_384308b4-ee7f-4916-9b98-f2bd90423e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8fb1d67a-4e3a-4bae-9143-7af5c00ef5c3" xlink:to="loc_us-gaap_ForeignPlanMember_384308b4-ee7f-4916-9b98-f2bd90423e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_65210910-8f8c-4d74-824f-49d276234d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_15cfbf95-bd44-427c-b11c-618d6cb2c415" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_65210910-8f8c-4d74-824f-49d276234d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_cec284b0-1dfa-4f45-a002-ebabed3b8ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_65210910-8f8c-4d74-824f-49d276234d0a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_cec284b0-1dfa-4f45-a002-ebabed3b8ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f3808a0f-a9e4-4662-9dc7-33b8a7d282ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_cec284b0-1dfa-4f45-a002-ebabed3b8ef0" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f3808a0f-a9e4-4662-9dc7-33b8a7d282ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6420402f-d95d-40ae-b23c-cc1347e43801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_15cfbf95-bd44-427c-b11c-618d6cb2c415" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6420402f-d95d-40ae-b23c-cc1347e43801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ef0b61db-b9e7-4145-82ac-d0f2a5f0adc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6420402f-d95d-40ae-b23c-cc1347e43801" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_ef0b61db-b9e7-4145-82ac-d0f2a5f0adc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_c9da59c1-3d1a-4156-8d7d-c1ad2fb0cef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6420402f-d95d-40ae-b23c-cc1347e43801" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_c9da59c1-3d1a-4156-8d7d-c1ad2fb0cef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c8098287-ccd6-4c3b-a589-173a69a640c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6420402f-d95d-40ae-b23c-cc1347e43801" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c8098287-ccd6-4c3b-a589-173a69a640c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f428ff2c-e97d-43ec-a834-1cf69a15f2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_27cb10b2-de1d-4d17-b6e8-08c6fd6130b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f428ff2c-e97d-43ec-a834-1cf69a15f2bc" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_27cb10b2-de1d-4d17-b6e8-08c6fd6130b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_0813b917-0a64-4e37-898d-ab94e8e9440b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_27cb10b2-de1d-4d17-b6e8-08c6fd6130b3" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_0813b917-0a64-4e37-898d-ab94e8e9440b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3cab80d-c00b-468c-b91a-f5ec81a2d537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_0813b917-0a64-4e37-898d-ab94e8e9440b" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3cab80d-c00b-468c-b91a-f5ec81a2d537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_b5a254ed-7afc-4a2e-876b-6b4aacc05262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c3cab80d-c00b-468c-b91a-f5ec81a2d537" xlink:to="loc_us-gaap_ForeignPlanMember_b5a254ed-7afc-4a2e-876b-6b4aacc05262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_fb6bbb44-f944-4683-9ba7-4fd37c6c3a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_27cb10b2-de1d-4d17-b6e8-08c6fd6130b3" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_fb6bbb44-f944-4683-9ba7-4fd37c6c3a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5f4bea7c-c8d7-404b-8c83-cb53ccf4b9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_fb6bbb44-f944-4683-9ba7-4fd37c6c3a6b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5f4bea7c-c8d7-404b-8c83-cb53ccf4b9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_98a80870-b642-487e-bfbd-684e56398f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_5f4bea7c-c8d7-404b-8c83-cb53ccf4b9b0" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_98a80870-b642-487e-bfbd-684e56398f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_14be3be9-71fe-4f46-9f7f-85f650b3cf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_27cb10b2-de1d-4d17-b6e8-08c6fd6130b3" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_14be3be9-71fe-4f46-9f7f-85f650b3cf4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4da5a4f6-321c-4ebb-96b7-2b0600cc9d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_14be3be9-71fe-4f46-9f7f-85f650b3cf4b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_4da5a4f6-321c-4ebb-96b7-2b0600cc9d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_a4375cc8-4a4a-4020-9ce1-485eae4d26b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_14be3be9-71fe-4f46-9f7f-85f650b3cf4b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_a4375cc8-4a4a-4020-9ce1-485eae4d26b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_f5595a66-7c6a-4870-b03a-de440fde2299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_14be3be9-71fe-4f46-9f7f-85f650b3cf4b" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_f5595a66-7c6a-4870-b03a-de440fde2299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f05642f4-4a1b-485d-984b-d57ec40fab74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a14e3c8d-0a39-4eff-a32c-1ef1ad27ffaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f05642f4-4a1b-485d-984b-d57ec40fab74" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a14e3c8d-0a39-4eff-a32c-1ef1ad27ffaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_c35c9bbd-8e95-410c-a78a-159c2ec75591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a14e3c8d-0a39-4eff-a32c-1ef1ad27ffaa" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_c35c9bbd-8e95-410c-a78a-159c2ec75591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_c92550d4-c08e-479a-9f3f-19bf983cdb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_c35c9bbd-8e95-410c-a78a-159c2ec75591" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_c92550d4-c08e-479a-9f3f-19bf983cdb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_196ffaa5-4184-4d44-8e3d-0f60e26726ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_c92550d4-c08e-479a-9f3f-19bf983cdb1e" xlink:to="loc_us-gaap_ForeignPlanMember_196ffaa5-4184-4d44-8e3d-0f60e26726ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_9063a7c1-d071-4b1b-b472-354c5c2763a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a14e3c8d-0a39-4eff-a32c-1ef1ad27ffaa" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_9063a7c1-d071-4b1b-b472-354c5c2763a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d6bb72e7-5455-4e06-bd98-05d2f726c411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_9063a7c1-d071-4b1b-b472-354c5c2763a7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d6bb72e7-5455-4e06-bd98-05d2f726c411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f520d1e4-5711-4528-a370-9928cd1b7edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d6bb72e7-5455-4e06-bd98-05d2f726c411" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f520d1e4-5711-4528-a370-9928cd1b7edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a14e3c8d-0a39-4eff-a32c-1ef1ad27ffaa" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_096341c5-5c6a-4b88-8ccf-6012332b2d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_096341c5-5c6a-4b88-8ccf-6012332b2d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_48432e15-31e6-4961-b773-d5e503a9f4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_48432e15-31e6-4961-b773-d5e503a9f4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_9d79fda7-a523-4334-b507-c9f1617b14cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_9d79fda7-a523-4334-b507-c9f1617b14cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f8d6001f-466b-4963-b936-7c3c12ed4d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_9d79fda7-a523-4334-b507-c9f1617b14cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_f8d6001f-466b-4963-b936-7c3c12ed4d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_3668a52a-6de0-449b-b4ab-40804041ef5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract_9d79fda7-a523-4334-b507-c9f1617b14cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_3668a52a-6de0-449b-b4ab-40804041ef5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_27a3682c-b373-4bee-adfc-5f93f8e8879f" xlink:href="mck-20230331.xsd#mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:to="loc_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax_27a3682c-b373-4bee-adfc-5f93f8e8879f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_61df9b3e-4e6a-4296-a584-7fbd557b6b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_eec969f7-fabe-4103-9050-fa8cee98ade5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_61df9b3e-4e6a-4296-a584-7fbd557b6b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3c329d17-b841-4a37-956f-f68edae26400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_76fe2f9c-149a-4a04-b51b-1763f57c7755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3c329d17-b841-4a37-956f-f68edae26400" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_76fe2f9c-149a-4a04-b51b-1763f57c7755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_feaad9f6-6d54-4ca5-a934-763ae3d937c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_76fe2f9c-149a-4a04-b51b-1763f57c7755" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_feaad9f6-6d54-4ca5-a934-763ae3d937c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_efabf8f9-0a9b-4ce3-b432-bdcfcf72e809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_feaad9f6-6d54-4ca5-a934-763ae3d937c0" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_efabf8f9-0a9b-4ce3-b432-bdcfcf72e809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_534b767a-092f-42c6-803d-b0d54d516f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_efabf8f9-0a9b-4ce3-b432-bdcfcf72e809" xlink:to="loc_us-gaap_ForeignPlanMember_534b767a-092f-42c6-803d-b0d54d516f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_234ff75d-908f-4cb9-99d5-6558c105e075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_76fe2f9c-149a-4a04-b51b-1763f57c7755" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_234ff75d-908f-4cb9-99d5-6558c105e075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c04b0ea5-1e7e-4fab-b5f2-cafabe1baf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_234ff75d-908f-4cb9-99d5-6558c105e075" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c04b0ea5-1e7e-4fab-b5f2-cafabe1baf6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_43219deb-20eb-4b4b-8d52-a3fd019fcc25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_c04b0ea5-1e7e-4fab-b5f2-cafabe1baf6a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_43219deb-20eb-4b4b-8d52-a3fd019fcc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b3b60fcc-73b1-40fc-9f97-effc9834570a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_76fe2f9c-149a-4a04-b51b-1763f57c7755" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b3b60fcc-73b1-40fc-9f97-effc9834570a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_583172ad-fd71-4b0d-aa4d-f4a75b431619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b3b60fcc-73b1-40fc-9f97-effc9834570a" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_583172ad-fd71-4b0d-aa4d-f4a75b431619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_81bff4c4-805e-4a2a-8834-d2aa572df42a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_583172ad-fd71-4b0d-aa4d-f4a75b431619" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_81bff4c4-805e-4a2a-8834-d2aa572df42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_84e404c5-3995-40c0-aa97-fb3f6e412492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_583172ad-fd71-4b0d-aa4d-f4a75b431619" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_84e404c5-3995-40c0-aa97-fb3f6e412492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_249a5f30-204d-4895-8a95-dbeaf87f87ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_583172ad-fd71-4b0d-aa4d-f4a75b431619" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_249a5f30-204d-4895-8a95-dbeaf87f87ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_b2233ecf-9961-4230-8a9c-b3e72a999e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b3b60fcc-73b1-40fc-9f97-effc9834570a" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_b2233ecf-9961-4230-8a9c-b3e72a999e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_f9469ab3-437b-4857-9224-cf7091b553de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_b2233ecf-9961-4230-8a9c-b3e72a999e8e" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_f9469ab3-437b-4857-9224-cf7091b553de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_dadc18ad-2200-49ca-a308-51406952d6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_b2233ecf-9961-4230-8a9c-b3e72a999e8e" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_dadc18ad-2200-49ca-a308-51406952d6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1622b25d-b3bd-4cd2-b7af-3763d9ffb3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1622b25d-b3bd-4cd2-b7af-3763d9ffb3bd" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5ae87b59-6ff6-4bbf-a7e4-9693f3895f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5ae87b59-6ff6-4bbf-a7e4-9693f3895f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f4288907-d539-48b3-b806-dd3c412f1a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5ae87b59-6ff6-4bbf-a7e4-9693f3895f13" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f4288907-d539-48b3-b806-dd3c412f1a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_3378c89f-cb22-4d54-9526-0762bb18b983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_f4288907-d539-48b3-b806-dd3c412f1a63" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_3378c89f-cb22-4d54-9526-0762bb18b983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_4f5794b2-053f-46da-a4fb-06dec42710aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_4f5794b2-053f-46da-a4fb-06dec42710aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_8954b0b7-d7ef-428d-8415-d57d05b24448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_4f5794b2-053f-46da-a4fb-06dec42710aa" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_8954b0b7-d7ef-428d-8415-d57d05b24448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_729aac63-c184-4ea8-8268-aa14d2384289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_8954b0b7-d7ef-428d-8415-d57d05b24448" xlink:to="loc_us-gaap_ForeignPlanMember_729aac63-c184-4ea8-8268-aa14d2384289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7d5b6c4e-234a-40cd-8823-e94f64c40073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7d5b6c4e-234a-40cd-8823-e94f64c40073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_7d5b6c4e-234a-40cd-8823-e94f64c40073" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_33042ca0-a209-492c-a9e9-138fcac2a94f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_33042ca0-a209-492c-a9e9-138fcac2a94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_3cd58dc0-a11c-49d8-ab70-9e488c099e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_us-gaap_MutualFundMember_3cd58dc0-a11c-49d8-ab70-9e488c099e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_08312ee5-564f-48bb-b494-82f3297a6619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_08312ee5-564f-48bb-b494-82f3297a6619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_63eec949-46c7-4f60-8a03-8276e8c2d0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_63eec949-46c7-4f60-8a03-8276e8c2d0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeFundsMember_3d7b3780-0de8-4eed-9039-824a1ffff598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeFundsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_us-gaap_FixedIncomeFundsMember_3d7b3780-0de8-4eed-9039-824a1ffff598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanAnnuityContractsMember_757998df-f368-40f3-b734-497a31dd2dfe" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanAnnuityContractsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_mck_DefinedBenefitPlanAnnuityContractsMember_757998df-f368-40f3-b734-497a31dd2dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DefinedBenefitPlanOtherFundsMember_99e641bb-93e2-4b94-ab91-dc710b7a8c3e" xlink:href="mck-20230331.xsd#mck_DefinedBenefitPlanOtherFundsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f0f1d90b-a383-49d1-9963-9b7ae35723a6" xlink:to="loc_mck_DefinedBenefitPlanOtherFundsMember_99e641bb-93e2-4b94-ab91-dc710b7a8c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51a18a5d-ebdd-487a-b06e-5470701f484e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51a18a5d-ebdd-487a-b06e-5470701f484e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e4e5b46-0495-4e0c-a056-41c923cfbb54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_51a18a5d-ebdd-487a-b06e-5470701f484e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e4e5b46-0495-4e0c-a056-41c923cfbb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b2424b27-6b1e-42f7-9fe1-0b00f46af78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e4e5b46-0495-4e0c-a056-41c923cfbb54" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b2424b27-6b1e-42f7-9fe1-0b00f46af78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_39e490cb-0fa6-45be-950e-43300f2952d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e4e5b46-0495-4e0c-a056-41c923cfbb54" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_39e490cb-0fa6-45be-950e-43300f2952d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_051588f8-cdc5-40e6-962e-7332214894f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1e4e5b46-0495-4e0c-a056-41c923cfbb54" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_051588f8-cdc5-40e6-962e-7332214894f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_b31fc851-0081-4f77-a333-6a487ca5fe95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_b31fc851-0081-4f77-a333-6a487ca5fe95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b77bd817-513c-4f86-bec6-18af224148e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_b31fc851-0081-4f77-a333-6a487ca5fe95" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b77bd817-513c-4f86-bec6-18af224148e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_24ec8c01-5667-4852-8fbd-9a19689aa725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b77bd817-513c-4f86-bec6-18af224148e0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_24ec8c01-5667-4852-8fbd-9a19689aa725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_73e9d6fa-914f-46ba-9ffe-815ad1d934cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b77bd817-513c-4f86-bec6-18af224148e0" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_73e9d6fa-914f-46ba-9ffe-815ad1d934cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_6a1ffe5c-84bd-4703-8710-2c56256a2cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b77bd817-513c-4f86-bec6-18af224148e0" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_6a1ffe5c-84bd-4703-8710-2c56256a2cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e81f7c12-f9fd-44f0-ad27-cc104192dc20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_10e79281-3a36-476b-be68-3d3a048468f6" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e81f7c12-f9fd-44f0-ad27-cc104192dc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f41dffa8-efa2-4d0e-879a-f18fe95d871d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_e81f7c12-f9fd-44f0-ad27-cc104192dc20" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f41dffa8-efa2-4d0e-879a-f18fe95d871d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_40ed67c2-f5f8-423a-9cff-424f705eea29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_be4cc260-d5c3-4a86-b839-57fa89b9fe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_40ed67c2-f5f8-423a-9cff-424f705eea29" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_be4cc260-d5c3-4a86-b839-57fa89b9fe8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4c6457c-00ac-4f20-9d60-864f91f808d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_be4cc260-d5c3-4a86-b839-57fa89b9fe8a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4c6457c-00ac-4f20-9d60-864f91f808d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6dbc4cae-59e8-48aa-86e5-c6f370c4cfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4c6457c-00ac-4f20-9d60-864f91f808d6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6dbc4cae-59e8-48aa-86e5-c6f370c4cfe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8e86ce2d-5869-491b-a72d-f62f18ab8a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6dbc4cae-59e8-48aa-86e5-c6f370c4cfe6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8e86ce2d-5869-491b-a72d-f62f18ab8a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6e8cd0a2-b545-40cb-84c9-3099691c81f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_be4cc260-d5c3-4a86-b839-57fa89b9fe8a" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6e8cd0a2-b545-40cb-84c9-3099691c81f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_98cc7b83-3ed4-4555-9c3e-61b51326222e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_6e8cd0a2-b545-40cb-84c9-3099691c81f3" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_98cc7b83-3ed4-4555-9c3e-61b51326222e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e7440c72-24a2-42e9-aed6-012c89f764e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_98cc7b83-3ed4-4555-9c3e-61b51326222e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e7440c72-24a2-42e9-aed6-012c89f764e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_2b408edf-9b43-4cb4-b66d-3bf679153103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_98cc7b83-3ed4-4555-9c3e-61b51326222e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase_2b408edf-9b43-4cb4-b66d-3bf679153103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_04705fb8-62a7-4f93-9f23-ad7a1e0b9ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_98cc7b83-3ed4-4555-9c3e-61b51326222e" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_04705fb8-62a7-4f93-9f23-ad7a1e0b9ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_fa423b61-adad-4dcf-afb5-0d90084334f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward_98cc7b83-3ed4-4555-9c3e-61b51326222e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_fa423b61-adad-4dcf-afb5-0d90084334f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_95404290-4bd0-4372-b5e5-dd0c2cc0c110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_95404290-4bd0-4372-b5e5-dd0c2cc0c110" xlink:to="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_054c0089-e835-429f-81fb-c680c638aaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_DebtInstrumentAxis_054c0089-e835-429f-81fb-c680c638aaf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c9608b0f-138d-4336-8dca-c71be3db018d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_054c0089-e835-429f-81fb-c680c638aaf6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c9608b0f-138d-4336-8dca-c71be3db018d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_f68f5744-592b-4fc8-948c-d8969b5bf31d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9608b0f-138d-4336-8dca-c71be3db018d" xlink:to="loc_us-gaap_CurrencySwapMember_f68f5744-592b-4fc8-948c-d8969b5bf31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_cf914ccb-6f78-45be-bd89-3c092383ca2b" xlink:href="mck-20230331.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9608b0f-138d-4336-8dca-c71be3db018d" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_cf914ccb-6f78-45be-bd89-3c092383ca2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_836f6b5c-f9d3-4fc6-a0fa-645101af2533" xlink:href="mck-20230331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c9608b0f-138d-4336-8dca-c71be3db018d" xlink:to="loc_mck_EuroDenominatedNotesMember_836f6b5c-f9d3-4fc6-a0fa-645101af2533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f071dd62-f5e9-44bb-8f91-7c18071d7ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f071dd62-f5e9-44bb-8f91-7c18071d7ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c990940e-8335-4981-a033-68a038e853e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f071dd62-f5e9-44bb-8f91-7c18071d7ab9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c990940e-8335-4981-a033-68a038e853e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_2d978a46-59f9-4630-83a9-6aa33bb74942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c990940e-8335-4981-a033-68a038e853e0" xlink:to="loc_us-gaap_LoansPayableMember_2d978a46-59f9-4630-83a9-6aa33bb74942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61c50ea6-c8cc-496b-84b2-5378c8a4a2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61c50ea6-c8cc-496b-84b2-5378c8a4a2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3021baaa-924a-4ef7-8209-778366c5f2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_61c50ea6-c8cc-496b-84b2-5378c8a4a2f0" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3021baaa-924a-4ef7-8209-778366c5f2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_43816b00-3dfb-49ca-8fea-bbf518dc8061" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3021baaa-924a-4ef7-8209-778366c5f2f3" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_43816b00-3dfb-49ca-8fea-bbf518dc8061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_0ec6b4f2-8b12-4199-ba15-42f975d4ac26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3021baaa-924a-4ef7-8209-778366c5f2f3" xlink:to="loc_us-gaap_FairValueHedgingMember_0ec6b4f2-8b12-4199-ba15-42f975d4ac26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7e17079b-c7ae-463d-b159-865d6f52870a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3021baaa-924a-4ef7-8209-778366c5f2f3" xlink:to="loc_us-gaap_CashFlowHedgingMember_7e17079b-c7ae-463d-b159-865d6f52870a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f56de469-9b72-4fe6-8231-7afb8ffe87a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f56de469-9b72-4fe6-8231-7afb8ffe87a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f56de469-9b72-4fe6-8231-7afb8ffe87a8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_5e86f787-409f-4e29-a09f-d232d2cff013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:to="loc_us-gaap_CurrencySwapMember_5e86f787-409f-4e29-a09f-d232d2cff013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2069a9f1-5542-4c6c-bf5f-eb845beccb79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:to="loc_us-gaap_InterestRateSwapMember_2069a9f1-5542-4c6c-bf5f-eb845beccb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InterestRateSwapEnteredIntoYTDMember_030dbead-8d02-4321-91f0-69f3919d7781" xlink:href="mck-20230331.xsd#mck_InterestRateSwapEnteredIntoYTDMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:to="loc_mck_InterestRateSwapEnteredIntoYTDMember_030dbead-8d02-4321-91f0-69f3919d7781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_167089f5-2080-49ab-9241-2889a9a71ebb" xlink:href="mck-20230331.xsd#mck_FixedInterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b78ae82c-c6a8-4c40-988b-a2bc2d73c368" xlink:to="loc_mck_FixedInterestRateSwapMember_167089f5-2080-49ab-9241-2889a9a71ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b8a60e20-59e1-41c5-9af9-83466a161e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_HedgingDesignationAxis_b8a60e20-59e1-41c5-9af9-83466a161e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3802031a-197c-4a77-8254-e9dfc5fa7447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b8a60e20-59e1-41c5-9af9-83466a161e19" xlink:to="loc_us-gaap_HedgingDesignationDomain_3802031a-197c-4a77-8254-e9dfc5fa7447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_79c05604-d772-495c-9b1e-236d373ad4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_3802031a-197c-4a77-8254-e9dfc5fa7447" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_79c05604-d772-495c-9b1e-236d373ad4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_460b9022-8e63-42c0-aaab-12d24203664c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_460b9022-8e63-42c0-aaab-12d24203664c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6061bed5-4a0d-47b6-a9f7-4db00fa5d89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_460b9022-8e63-42c0-aaab-12d24203664c" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6061bed5-4a0d-47b6-a9f7-4db00fa5d89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8ee5790b-52b0-4d01-b60d-51be69b4858b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6061bed5-4a0d-47b6-a9f7-4db00fa5d89a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8ee5790b-52b0-4d01-b60d-51be69b4858b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6afa8a2e-28d9-4304-b28a-7ab715c74510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6afa8a2e-28d9-4304-b28a-7ab715c74510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b341554c-56b8-4145-bac0-034b972532d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6afa8a2e-28d9-4304-b28a-7ab715c74510" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b341554c-56b8-4145-bac0-034b972532d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_2f977980-74e9-4d1f-b277-6f0728ebc759" xlink:href="mck-20230331.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b341554c-56b8-4145-bac0-034b972532d2" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_2f977980-74e9-4d1f-b277-6f0728ebc759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_57c27a98-879c-4168-b4a4-ab6581d0cd7b" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b341554c-56b8-4145-bac0-034b972532d2" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_57c27a98-879c-4168-b4a4-ab6581d0cd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_a10e36be-1296-4ffe-9933-4b7eb371d8a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_srt_CurrencyAxis_a10e36be-1296-4ffe-9933-4b7eb371d8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_8e45b4c6-bba7-4259-aabf-a01fb1000725" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_a10e36be-1296-4ffe-9933-4b7eb371d8a5" xlink:to="loc_currency_AllCurrenciesDomain_8e45b4c6-bba7-4259-aabf-a01fb1000725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_d2027a1c-6cfa-482c-b546-af5054d98a02" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_8e45b4c6-bba7-4259-aabf-a01fb1000725" xlink:to="loc_currency_EUR_d2027a1c-6cfa-482c-b546-af5054d98a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_bb1fc3e4-2a27-41a4-920e-e4c52193fa69" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_8e45b4c6-bba7-4259-aabf-a01fb1000725" xlink:to="loc_currency_USD_bb1fc3e4-2a27-41a4-920e-e4c52193fa69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3472e5e8-8dcf-4040-9c9a-75792f29feb5" xlink:to="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9bf8f633-b5ed-4f0c-85d8-ba61a2ba7c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9bf8f633-b5ed-4f0c-85d8-ba61a2ba7c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_b35c3870-b7bc-4110-820f-bb767b826b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_b35c3870-b7bc-4110-820f-bb767b826b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_81c3b81c-814d-4b6d-8dac-94503b7cc538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_81c3b81c-814d-4b6d-8dac-94503b7cc538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f7472f0e-7fad-4ebe-866b-04f0196f7833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_us-gaap_LongTermDebt_f7472f0e-7fad-4ebe-866b-04f0196f7833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DerivativeNotionalAmountTerminated_43a67cc3-6c81-4f16-9b9e-afb766c8956b" xlink:href="mck-20230331.xsd#mck_DerivativeNotionalAmountTerminated"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_mck_DerivativeNotionalAmountTerminated_43a67cc3-6c81-4f16-9b9e-afb766c8956b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnDerivativeTermination_1da01921-4061-432b-a0d2-5577757dc8e2" xlink:href="mck-20230331.xsd#mck_GainLossOnDerivativeTermination"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5f5a6f5b-d0b3-44c2-a3e4-3ce6724ee7b8" xlink:to="loc_mck_GainLossOnDerivativeTermination_1da01921-4061-432b-a0d2-5577757dc8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_206e598f-286e-4c21-9d37-950d7896ff89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b3d59ae4-d337-43ff-9e1b-356050d70c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_206e598f-286e-4c21-9d37-950d7896ff89" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b3d59ae4-d337-43ff-9e1b-356050d70c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b68627fe-114e-418c-ad51-979a023db636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b3d59ae4-d337-43ff-9e1b-356050d70c78" xlink:to="loc_us-gaap_HedgingDesignationAxis_b68627fe-114e-418c-ad51-979a023db636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ea84b490-f1c4-424d-99ad-e55f4aca86d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b68627fe-114e-418c-ad51-979a023db636" xlink:to="loc_us-gaap_HedgingDesignationDomain_ea84b490-f1c4-424d-99ad-e55f4aca86d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4fcf5dc9-ff13-43ca-9dda-53c9d893475f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ea84b490-f1c4-424d-99ad-e55f4aca86d2" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4fcf5dc9-ff13-43ca-9dda-53c9d893475f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a174c3d1-fbfe-4d51-927e-105d09ccbec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b3d59ae4-d337-43ff-9e1b-356050d70c78" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a174c3d1-fbfe-4d51-927e-105d09ccbec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0a15b0a3-afae-4ad3-a3b7-3b7dece9e1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_a174c3d1-fbfe-4d51-927e-105d09ccbec6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0a15b0a3-afae-4ad3-a3b7-3b7dece9e1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_9c7b940c-c9ed-4be7-83d5-3af6ac81e695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0a15b0a3-afae-4ad3-a3b7-3b7dece9e1b7" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_9c7b940c-c9ed-4be7-83d5-3af6ac81e695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_faf79e45-3977-4da9-a9f6-1abc51b60953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b3d59ae4-d337-43ff-9e1b-356050d70c78" xlink:to="loc_us-gaap_DebtInstrumentAxis_faf79e45-3977-4da9-a9f6-1abc51b60953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1fe87d57-be33-4144-aaf7-4187f77d8600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_faf79e45-3977-4da9-a9f6-1abc51b60953" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1fe87d57-be33-4144-aaf7-4187f77d8600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_acd4aa40-bc9c-4448-8a1e-787a46fd0582" xlink:href="mck-20230331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1fe87d57-be33-4144-aaf7-4187f77d8600" xlink:to="loc_mck_EuroDenominatedNotesMember_acd4aa40-bc9c-4448-8a1e-787a46fd0582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_d53a83b5-c746-496a-a65a-bdb437bfcbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b3d59ae4-d337-43ff-9e1b-356050d70c78" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_d53a83b5-c746-496a-a65a-bdb437bfcbfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_3d1d5283-cd49-4fd2-b9ae-f223ea5f3003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d53a83b5-c746-496a-a65a-bdb437bfcbfd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_3d1d5283-cd49-4fd2-b9ae-f223ea5f3003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7f4fb4f0-3458-4878-bb37-1f1bf9e7ce41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_d53a83b5-c746-496a-a65a-bdb437bfcbfd" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7f4fb4f0-3458-4878-bb37-1f1bf9e7ce41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_24858807-5038-4b31-95ea-64855ec71d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_24858807-5038-4b31-95ea-64855ec71d85" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8de4c0d2-6616-4da0-987a-d87a83e1bed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:to="loc_us-gaap_HedgingDesignationAxis_8de4c0d2-6616-4da0-987a-d87a83e1bed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ee94152f-0e92-478a-99be-2031c46d9414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_8de4c0d2-6616-4da0-987a-d87a83e1bed1" xlink:to="loc_us-gaap_HedgingDesignationDomain_ee94152f-0e92-478a-99be-2031c46d9414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c64a24f4-9821-491a-80d3-d2cc54264e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ee94152f-0e92-478a-99be-2031c46d9414" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c64a24f4-9821-491a-80d3-d2cc54264e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fbbb6182-1ad8-4330-9615-40657fd0c20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fbbb6182-1ad8-4330-9615-40657fd0c20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9cc4bc2b-d43b-4bfd-8cbf-c5d6755f267a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fbbb6182-1ad8-4330-9615-40657fd0c20b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9cc4bc2b-d43b-4bfd-8cbf-c5d6755f267a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_311caa36-4e0e-4188-8dfc-bd131a04b793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9cc4bc2b-d43b-4bfd-8cbf-c5d6755f267a" xlink:to="loc_us-gaap_CurrencySwapMember_311caa36-4e0e-4188-8dfc-bd131a04b793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_671bdc2d-cd65-464d-b51f-8582909e0e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9cc4bc2b-d43b-4bfd-8cbf-c5d6755f267a" xlink:to="loc_us-gaap_InterestRateSwapMember_671bdc2d-cd65-464d-b51f-8582909e0e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_864743dd-c953-4302-8693-e8dbfc12aff8" xlink:href="mck-20230331.xsd#mck_FixedInterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9cc4bc2b-d43b-4bfd-8cbf-c5d6755f267a" xlink:to="loc_mck_FixedInterestRateSwapMember_864743dd-c953-4302-8693-e8dbfc12aff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1f1d4329-7499-4ed4-8b3a-6e79bd0385ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1f1d4329-7499-4ed4-8b3a-6e79bd0385ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_206d66a4-adf1-4f42-9720-a44a2a6554ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1f1d4329-7499-4ed4-8b3a-6e79bd0385ac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_206d66a4-adf1-4f42-9720-a44a2a6554ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_1e61607d-2421-4c78-a9ae-0322442ff325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_206d66a4-adf1-4f42-9720-a44a2a6554ad" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_1e61607d-2421-4c78-a9ae-0322442ff325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_9b0ea4cd-d611-4605-8154-b376a3a7463c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_206d66a4-adf1-4f42-9720-a44a2a6554ad" xlink:to="loc_us-gaap_FairValueHedgingMember_9b0ea4cd-d611-4605-8154-b376a3a7463c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_d99a0446-1b04-4825-beb0-4d8c24365345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_206d66a4-adf1-4f42-9720-a44a2a6554ad" xlink:to="loc_us-gaap_CashFlowHedgingMember_d99a0446-1b04-4825-beb0-4d8c24365345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8f56d302-ebd2-426c-ada1-542dc3846dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:to="loc_us-gaap_DebtInstrumentAxis_8f56d302-ebd2-426c-ada1-542dc3846dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f6b88a95-1939-4557-bbc9-0e199e0f24f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f56d302-ebd2-426c-ada1-542dc3846dfe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f6b88a95-1939-4557-bbc9-0e199e0f24f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_07a1c6ea-993a-432e-b8e1-ce10ddc0f169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f6b88a95-1939-4557-bbc9-0e199e0f24f6" xlink:to="loc_us-gaap_CurrencySwapMember_07a1c6ea-993a-432e-b8e1-ce10ddc0f169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_cbdb638a-7d62-4121-838a-34bc28d6fbe4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:to="loc_srt_CurrencyAxis_cbdb638a-7d62-4121-838a-34bc28d6fbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_cbdb638a-7d62-4121-838a-34bc28d6fbe4" xlink:to="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CAD_37597e98-ad53-4432-8e10-22b8902f36aa" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_CAD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:to="loc_currency_CAD_37597e98-ad53-4432-8e10-22b8902f36aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_GBP_792877aa-3ea5-481a-8019-3352bfc3dc29" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_GBP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:to="loc_currency_GBP_792877aa-3ea5-481a-8019-3352bfc3dc29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_a2307bbc-e6a3-498c-b460-e5d42e23e421" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:to="loc_currency_EUR_a2307bbc-e6a3-498c-b460-e5d42e23e421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_41b73c90-c408-47a7-897d-1d5c5cf45690" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_USD"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_2a3c3f86-a461-421b-99bc-3dafa74c0342" xlink:to="loc_currency_USD_41b73c90-c408-47a7-897d-1d5c5cf45690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_ec8daeb0-1e84-4eab-8917-66e6e491288c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_2776b36d-57fe-4eb1-9fbc-2100befb51a1" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_ec8daeb0-1e84-4eab-8917-66e6e491288c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6053055f-9994-4f5b-9ab4-a7cfd3f209ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ec8daeb0-1e84-4eab-8917-66e6e491288c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6053055f-9994-4f5b-9ab4-a7cfd3f209ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_168d7ef4-1ab3-4ba7-a7e0-82be2dfd1270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f33efa8-cb76-48de-bfc9-0707d3bca08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_168d7ef4-1ab3-4ba7-a7e0-82be2dfd1270" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f33efa8-cb76-48de-bfc9-0707d3bca08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c187067b-6c19-44f8-bb11-b3d6bcb5c83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f33efa8-cb76-48de-bfc9-0707d3bca08a" xlink:to="loc_us-gaap_HedgingDesignationAxis_c187067b-6c19-44f8-bb11-b3d6bcb5c83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_704225c8-7a74-4f6a-8a92-fb03b694a863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_c187067b-6c19-44f8-bb11-b3d6bcb5c83a" xlink:to="loc_us-gaap_HedgingDesignationDomain_704225c8-7a74-4f6a-8a92-fb03b694a863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_97153d59-8d89-46b5-ac13-6784a3d6fb65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_704225c8-7a74-4f6a-8a92-fb03b694a863" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_97153d59-8d89-46b5-ac13-6784a3d6fb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5c12ed1f-5a85-454f-bbc3-451a36946d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f33efa8-cb76-48de-bfc9-0707d3bca08a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5c12ed1f-5a85-454f-bbc3-451a36946d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_08acb4b0-9cab-4676-a9cd-4637a3de8b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5c12ed1f-5a85-454f-bbc3-451a36946d1d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_08acb4b0-9cab-4676-a9cd-4637a3de8b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_b66e1c4d-c34c-4f26-a07b-ff8a0edf21dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_08acb4b0-9cab-4676-a9cd-4637a3de8b2b" xlink:to="loc_us-gaap_CurrencySwapMember_b66e1c4d-c34c-4f26-a07b-ff8a0edf21dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FixedInterestRateSwapMember_f42d8437-9bd0-4d7f-b5c3-12945a363487" xlink:href="mck-20230331.xsd#mck_FixedInterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_08acb4b0-9cab-4676-a9cd-4637a3de8b2b" xlink:to="loc_mck_FixedInterestRateSwapMember_f42d8437-9bd0-4d7f-b5c3-12945a363487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_52ca8d30-f54b-436f-8d3c-bd9327279322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f33efa8-cb76-48de-bfc9-0707d3bca08a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_52ca8d30-f54b-436f-8d3c-bd9327279322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5cc74f49-53f2-4a4a-9af8-627f97280549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_52ca8d30-f54b-436f-8d3c-bd9327279322" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5cc74f49-53f2-4a4a-9af8-627f97280549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_45d03fde-d26d-4682-b3bd-4a06c0e898a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5cc74f49-53f2-4a4a-9af8-627f97280549" xlink:to="loc_us-gaap_CurrencySwapMember_45d03fde-d26d-4682-b3bd-4a06c0e898a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_4c2e0b01-7711-48e6-8436-4c9df124ee25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_4f33efa8-cb76-48de-bfc9-0707d3bca08a" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_4c2e0b01-7711-48e6-8436-4c9df124ee25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_2acb29d9-125d-42e6-8982-97752b9df2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4c2e0b01-7711-48e6-8436-4c9df124ee25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_2acb29d9-125d-42e6-8982-97752b9df2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_774b6115-6737-4a8b-a295-e55c8d2471bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_4c2e0b01-7711-48e6-8436-4c9df124ee25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_774b6115-6737-4a8b-a295-e55c8d2471bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_efadc014-e41b-4497-bdca-5c83121c2a33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71ae8800-51dc-479b-87a5-e01e5b225c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_efadc014-e41b-4497-bdca-5c83121c2a33" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71ae8800-51dc-479b-87a5-e01e5b225c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_78a5c8b8-4a12-4ba2-aec0-76a3fcbb1a31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71ae8800-51dc-479b-87a5-e01e5b225c3b" xlink:to="loc_us-gaap_HedgingDesignationAxis_78a5c8b8-4a12-4ba2-aec0-76a3fcbb1a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_774cbe50-d62c-48ae-90f3-de9a24b2bbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_78a5c8b8-4a12-4ba2-aec0-76a3fcbb1a31" xlink:to="loc_us-gaap_HedgingDesignationDomain_774cbe50-d62c-48ae-90f3-de9a24b2bbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d1cf6969-bdcd-4273-a9e5-58b92c8a61de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_774cbe50-d62c-48ae-90f3-de9a24b2bbda" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d1cf6969-bdcd-4273-a9e5-58b92c8a61de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fac76ce7-5d35-412a-88c4-c60c25be47d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71ae8800-51dc-479b-87a5-e01e5b225c3b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fac76ce7-5d35-412a-88c4-c60c25be47d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f49ce20f-539f-4a92-ae5a-d770c50255de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fac76ce7-5d35-412a-88c4-c60c25be47d0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f49ce20f-539f-4a92-ae5a-d770c50255de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_db40718f-b259-408e-82c7-1991e0324f5a" xlink:href="mck-20230331.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f49ce20f-539f-4a92-ae5a-d770c50255de" xlink:to="loc_mck_CurrentAssetLiabilityMember_db40718f-b259-408e-82c7-1991e0324f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember_572fb012-1ba0-413a-b9c6-6e69983ca93f" xlink:href="mck-20230331.xsd#mck_OtherNonCurrentAssetsAndLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f49ce20f-539f-4a92-ae5a-d770c50255de" xlink:to="loc_mck_OtherNonCurrentAssetsAndLiabilitiesMember_572fb012-1ba0-413a-b9c6-6e69983ca93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrepaidExpensesAndOtherMember_687aef0f-f43b-4695-a9b0-a1b4180afa78" xlink:href="mck-20230331.xsd#mck_PrepaidExpensesAndOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f49ce20f-539f-4a92-ae5a-d770c50255de" xlink:to="loc_mck_PrepaidExpensesAndOtherMember_687aef0f-f43b-4695-a9b0-a1b4180afa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2a165662-3a73-40e1-82e4-9d927daf358b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71ae8800-51dc-479b-87a5-e01e5b225c3b" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2a165662-3a73-40e1-82e4-9d927daf358b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5ed218a4-a654-471d-be66-cf9b4987ea09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2a165662-3a73-40e1-82e4-9d927daf358b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5ed218a4-a654-471d-be66-cf9b4987ea09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_ecf58977-e7e3-4e76-b9ad-d00bc5edc637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5ed218a4-a654-471d-be66-cf9b4987ea09" xlink:to="loc_us-gaap_CurrencySwapMember_ecf58977-e7e3-4e76-b9ad-d00bc5edc637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ae86e203-f2a2-4f23-b481-57763e96d801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5ed218a4-a654-471d-be66-cf9b4987ea09" xlink:to="loc_us-gaap_InterestRateSwapMember_ae86e203-f2a2-4f23-b481-57763e96d801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_71ae8800-51dc-479b-87a5-e01e5b225c3b" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_25a5eaf8-b13e-49af-8483-aafb4f80789b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_25a5eaf8-b13e-49af-8483-aafb4f80789b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9707c312-a468-4c3f-a0a3-146b70d73fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_9707c312-a468-4c3f-a0a3-146b70d73fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_d198ccae-c10a-4f59-9ab4-06b7469180ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_d198ccae-c10a-4f59-9ab4-06b7469180ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_151f9dbd-fe3d-4024-9cf1-2cbe4ca07d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_9587aa8a-135b-4b41-b8a1-a3e034c29bd5" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_151f9dbd-fe3d-4024-9cf1-2cbe4ca07d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_40b7ea46-9d97-44e0-8c83-c547e29e68db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_c7ec2c8a-80d6-4ad5-bf22-f29f46074ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_40b7ea46-9d97-44e0-8c83-c547e29e68db" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_c7ec2c8a-80d6-4ad5-bf22-f29f46074ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_efbe320a-92ba-414b-928b-3731aefcd4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_40b7ea46-9d97-44e0-8c83-c547e29e68db" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_efbe320a-92ba-414b-928b-3731aefcd4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_c44a6b98-c9dc-4a4e-b0ed-b8570bc8c457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_40b7ea46-9d97-44e0-8c83-c547e29e68db" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_c44a6b98-c9dc-4a4e-b0ed-b8570bc8c457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_15f7af36-0dc9-4531-9770-dffc95e8aab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_40b7ea46-9d97-44e0-8c83-c547e29e68db" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_15f7af36-0dc9-4531-9770-dffc95e8aab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b0611be3-1a32-4012-ac6d-5fa403f7e16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_be46631e-60b4-49eb-b541-16b4d457f8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b0611be3-1a32-4012-ac6d-5fa403f7e16d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_be46631e-60b4-49eb-b541-16b4d457f8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fba9b023-3ed6-48c6-8576-439c8f7c6bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_be46631e-60b4-49eb-b541-16b4d457f8e6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fba9b023-3ed6-48c6-8576-439c8f7c6bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be463c49-b157-437a-97aa-96aad6349217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fba9b023-3ed6-48c6-8576-439c8f7c6bd6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be463c49-b157-437a-97aa-96aad6349217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_00826310-6840-49a2-9953-6bdb1bd83f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_be463c49-b157-437a-97aa-96aad6349217" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_00826310-6840-49a2-9953-6bdb1bd83f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2fe0684c-baa6-4b2b-b4e2-b8939f2fc352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_be46631e-60b4-49eb-b541-16b4d457f8e6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2fe0684c-baa6-4b2b-b4e2-b8939f2fc352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b17b84d6-677a-467a-a6e3-3dc495c7d2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2fe0684c-baa6-4b2b-b4e2-b8939f2fc352" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b17b84d6-677a-467a-a6e3-3dc495c7d2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_757a44f0-4d6f-4deb-9af2-1f4b0d64bb93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b17b84d6-677a-467a-a6e3-3dc495c7d2c4" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_757a44f0-4d6f-4deb-9af2-1f4b0d64bb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a340ec8-58a1-4ed2-a58e-cf322e799965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_be46631e-60b4-49eb-b541-16b4d457f8e6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a340ec8-58a1-4ed2-a58e-cf322e799965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_774a853a-6c07-4cc8-92ed-8b3227d1c2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a340ec8-58a1-4ed2-a58e-cf322e799965" xlink:to="loc_us-gaap_LongTermDebt_774a853a-6c07-4cc8-92ed-8b3227d1c2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_472e7b4f-1e5a-4888-b0ae-6a4d421bb2be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a340ec8-58a1-4ed2-a58e-cf322e799965" xlink:to="loc_us-gaap_DebtInstrumentFairValue_472e7b4f-1e5a-4888-b0ae-6a4d421bb2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#FinancialGuaranteesandWarrantiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_e69b06f9-e4d2-4fc7-b29e-aee7b2823568" xlink:href="mck-20230331.xsd#mck_FinancialGuaranteesAndWarrantiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_e6a02a35-6448-48eb-a82c-f865fbfc34af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_FinancialGuaranteesAndWarrantiesAbstract_e69b06f9-e4d2-4fc7-b29e-aee7b2823568" xlink:to="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_e6a02a35-6448-48eb-a82c-f865fbfc34af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6c31c0a2-e01a-4581-a393-6eae2b6215ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_e6a02a35-6448-48eb-a82c-f865fbfc34af" xlink:to="loc_srt_RangeAxis_6c31c0a2-e01a-4581-a393-6eae2b6215ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_30250fca-d65e-4457-922c-3f1d3541c006" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6c31c0a2-e01a-4581-a393-6eae2b6215ce" xlink:to="loc_srt_RangeMember_30250fca-d65e-4457-922c-3f1d3541c006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1b6f5c42-31db-4bab-9b09-bcaac8d4562e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_30250fca-d65e-4457-922c-3f1d3541c006" xlink:to="loc_srt_MinimumMember_1b6f5c42-31db-4bab-9b09-bcaac8d4562e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_67d0c62a-5ad8-45e3-a957-036bea37e117" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_30250fca-d65e-4457-922c-3f1d3541c006" xlink:to="loc_srt_MaximumMember_67d0c62a-5ad8-45e3-a957-036bea37e117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_23eb383c-135e-44a9-ace2-bee539f12b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_e6a02a35-6448-48eb-a82c-f865fbfc34af" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_23eb383c-135e-44a9-ace2-bee539f12b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_5f447178-4b34-40a8-9ce6-32d96552890f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_23eb383c-135e-44a9-ace2-bee539f12b9a" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_5f447178-4b34-40a8-9ce6-32d96552890f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_d4a50e0c-b6d9-4039-a3eb-d85cc3b2fa5f" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5f447178-4b34-40a8-9ce6-32d96552890f" xlink:to="loc_mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember_d4a50e0c-b6d9-4039-a3eb-d85cc3b2fa5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsCustomersDebtMember_bae9a65c-2b8b-4caa-bf00-9b91dd5ef001" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsCustomersDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5f447178-4b34-40a8-9ce6-32d96552890f" xlink:to="loc_mck_GuaranteeObligationsCustomersDebtMember_bae9a65c-2b8b-4caa-bf00-9b91dd5ef001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_ff924d2d-46ad-41ef-a0f4-02ea231cffdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_5f447178-4b34-40a8-9ce6-32d96552890f" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_ff924d2d-46ad-41ef-a0f4-02ea231cffdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_e6a02a35-6448-48eb-a82c-f865fbfc34af" xlink:to="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuarantorObligationsPeriod_31802413-aedb-43c9-803c-b8ffad101e63" xlink:href="mck-20230331.xsd#mck_GuarantorObligationsPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuarantorObligationsPeriod_31802413-aedb-43c9-803c-b8ffad101e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_48ea9654-3928-414f-9c71-4d89607b69b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_48ea9654-3928-414f-9c71-4d89607b69b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_d32065ec-a317-44eb-a982-ddc4bd4db372" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearOne"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearOne_d32065ec-a317-44eb-a982-ddc4bd4db372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_ef0ed1ef-b29f-4e8d-b080-057b8f1b51b8" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearTwo_ef0ed1ef-b29f-4e8d-b080-057b8f1b51b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_27ba8f66-ca9e-444d-8b58-f8ca9c5b490e" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearThree"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearThree_27ba8f66-ca9e-444d-8b58-f8ca9c5b490e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_68a80b92-83e2-4465-a6f8-d32decc00615" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFour_68a80b92-83e2-4465-a6f8-d32decc00615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_aeb2a6de-db0e-4d3f-b01e-9591a12068d3" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFive_aeb2a6de-db0e-4d3f-b01e-9591a12068d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_a42f2a98-457a-4cb6-a9d7-46ab54232759" xlink:href="mck-20230331.xsd#mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter_a42f2a98-457a-4cb6-a9d7-46ab54232759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_fa2ecca6-2189-4cef-940a-4f69c2c5ab62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_60caf7eb-28ef-4a92-8944-b1d317665d7f" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_fa2ecca6-2189-4cef-940a-4f69c2c5ab62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#CommitmentsandContingentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_09951e14-0cb4-4ca6-a6db-ee58095a5c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_09951e14-0cb4-4ca6-a6db-ee58095a5c5e" xlink:to="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7a3ad31d-d225-4f51-89b2-1d0ea44e26ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_LitigationCaseAxis_7a3ad31d-d225-4f51-89b2-1d0ea44e26ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_7a3ad31d-d225-4f51-89b2-1d0ea44e26ca" xlink:to="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_501c7c74-ba10-4b48-8f5d-a583ffadafc7" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_501c7c74-ba10-4b48-8f5d-a583ffadafc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_90069f74-7574-4692-9349-8f85c3d5e2ea" xlink:href="mck-20230331.xsd#mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember_90069f74-7574-4692-9349-8f85c3d5e2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_4bf64df2-e654-4749-b0ba-05b87ce5b6e9" xlink:href="mck-20230331.xsd#mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member_4bf64df2-e654-4749-b0ba-05b87ce5b6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InsuranceCoverageLitigationMember_1bce6c57-4b1e-4b9b-bfa6-d6e2dc0d06ee" xlink:href="mck-20230331.xsd#mck_InsuranceCoverageLitigationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_InsuranceCoverageLitigationMember_1bce6c57-4b1e-4b9b-bfa6-d6e2dc0d06ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_e1ca692a-708a-46fd-b869-96cde23e850d" xlink:href="mck-20230331.xsd#mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember_e1ca692a-708a-46fd-b869-96cde23e850d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_2d3060c3-9f1b-4c34-a4fb-fe6341a6ac3a" xlink:href="mck-20230331.xsd#mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember_2d3060c3-9f1b-4c34-a4fb-fe6341a6ac3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_1878bb2b-87a1-4bd4-b79d-f8992d0fac42" xlink:href="mck-20230331.xsd#mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member_1878bb2b-87a1-4bd4-b79d-f8992d0fac42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_05442a56-3dda-4d92-9570-c7a57a90a91e" xlink:href="mck-20230331.xsd#mck_EvanstonPolicePensionFundv.McKessonCorporationMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_EvanstonPolicePensionFundv.McKessonCorporationMember_05442a56-3dda-4d92-9570-c7a57a90a91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_be713a61-43ed-44ff-879b-d8be6b01d6db" xlink:href="mck-20230331.xsd#mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember_be713a61-43ed-44ff-879b-d8be6b01d6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_0f397f15-9b51-453e-bcc9-3943e301a9a2" xlink:href="mck-20230331.xsd#mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember_0f397f15-9b51-453e-bcc9-3943e301a9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember_bba31fed-fa1b-4617-8bcc-b0ba28fd8bb9" xlink:href="mck-20230331.xsd#mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_aaf8048f-534d-4667-b736-90c7236f451f" xlink:to="loc_mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember_bba31fed-fa1b-4617-8bcc-b0ba28fd8bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_acd42dd1-39c2-475c-871a-61e10ddc7985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_us-gaap_LitigationStatusAxis_acd42dd1-39c2-475c-871a-61e10ddc7985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_4c198626-1ad7-427d-a10a-a41b8f5b506b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_acd42dd1-39c2-475c-871a-61e10ddc7985" xlink:to="loc_us-gaap_LitigationStatusDomain_4c198626-1ad7-427d-a10a-a41b8f5b506b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_7d8bffa6-3b84-4db0-878e-ff5b8a1e032f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_4c198626-1ad7-427d-a10a-a41b8f5b506b" xlink:to="loc_us-gaap_SettledLitigationMember_7d8bffa6-3b84-4db0-878e-ff5b8a1e032f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e74d15a4-154a-4272-b5fc-fa9c7230ec56" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_StatementGeographicalAxis_e74d15a4-154a-4272-b5fc-fa9c7230ec56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5eb5217b-abb2-450d-b430-3ba3a49e2706" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e74d15a4-154a-4272-b5fc-fa9c7230ec56" xlink:to="loc_srt_SegmentGeographicalDomain_5eb5217b-abb2-450d-b430-3ba3a49e2706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_b7b5b5f0-4b81-4814-8916-78c9b2af0689" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5eb5217b-abb2-450d-b430-3ba3a49e2706" xlink:to="loc_country_CA_b7b5b5f0-4b81-4814-8916-78c9b2af0689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_093a9b64-a3b4-43be-8430-d6bbd5da5363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_093a9b64-a3b4-43be-8430-d6bbd5da5363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_8dea9dc7-e262-406c-b4d2-4a67e2933677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_093a9b64-a3b4-43be-8430-d6bbd5da5363" xlink:to="loc_us-gaap_LossContingencyNatureDomain_8dea9dc7-e262-406c-b4d2-4a67e2933677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_3cb932b7-e818-4bcd-bc20-b8f93332b552" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8dea9dc7-e262-406c-b4d2-4a67e2933677" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_3cb932b7-e818-4bcd-bc20-b8f93332b552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_3e6bf945-c206-49f5-8e16-2e265f0b96e7" xlink:href="mck-20230331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8dea9dc7-e262-406c-b4d2-4a67e2933677" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_3e6bf945-c206-49f5-8e16-2e265f0b96e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLitigationMember_1fc539b3-2fea-4ab0-a9d3-f9bd8157835b" xlink:href="mck-20230331.xsd#mck_EnvironmentalLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_8dea9dc7-e262-406c-b4d2-4a67e2933677" xlink:to="loc_mck_EnvironmentalLitigationMember_1fc539b3-2fea-4ab0-a9d3-f9bd8157835b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_14a3d2c5-5362-411b-9884-17e73018ad9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_dei_LegalEntityAxis_14a3d2c5-5362-411b-9884-17e73018ad9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a0c7de9b-9829-42d4-92be-5455618ecb0f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_14a3d2c5-5362-411b-9884-17e73018ad9a" xlink:to="loc_dei_EntityDomain_a0c7de9b-9829-42d4-92be-5455618ecb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestUSPharmaceuticalDistributorsMember_57c53a66-cc93-4f64-9d5e-9dd6024f6947" xlink:href="mck-20230331.xsd#mck_ThreeLargestUSPharmaceuticalDistributorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a0c7de9b-9829-42d4-92be-5455618ecb0f" xlink:to="loc_mck_ThreeLargestUSPharmaceuticalDistributorsMember_57c53a66-cc93-4f64-9d5e-9dd6024f6947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_8e8b5a37-b045-4709-8220-4ad87bef61b0" xlink:href="mck-20230331.xsd#mck_ThreeNationalPharmaceuticalDistributorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a0c7de9b-9829-42d4-92be-5455618ecb0f" xlink:to="loc_mck_ThreeNationalPharmaceuticalDistributorsMember_8e8b5a37-b045-4709-8220-4ad87bef61b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7374fa08-7827-4201-9b4d-caee2a8decec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_RangeAxis_7374fa08-7827-4201-9b4d-caee2a8decec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_76a1c9d0-d88f-40db-b6d0-2743a402529c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7374fa08-7827-4201-9b4d-caee2a8decec" xlink:to="loc_srt_RangeMember_76a1c9d0-d88f-40db-b6d0-2743a402529c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d0bcf802-d43d-4bc1-bc29-e0e44c51aaa4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_76a1c9d0-d88f-40db-b6d0-2743a402529c" xlink:to="loc_srt_MinimumMember_d0bcf802-d43d-4bc1-bc29-e0e44c51aaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7a18aa4a-f835-417c-85dc-f9d3fcd6ac99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_76a1c9d0-d88f-40db-b6d0-2743a402529c" xlink:to="loc_srt_MaximumMember_7a18aa4a-f835-417c-85dc-f9d3fcd6ac99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_37827789-b480-4e80-b847-18d7f33d36af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_CounterpartyNameAxis_37827789-b480-4e80-b847-18d7f33d36af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_37827789-b480-4e80-b847-18d7f33d36af" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfAlabamaAndSubdivisionsMember_f7a0bca8-5a3a-4b92-8593-8a389554fa0d" xlink:href="mck-20230331.xsd#mck_StateOfAlabamaAndSubdivisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_StateOfAlabamaAndSubdivisionsMember_f7a0bca8-5a3a-4b92-8593-8a389554fa0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CherokeeNationMember_e485e55e-c1ab-4722-9d1f-55546dea1f08" xlink:href="mck-20230331.xsd#mck_CherokeeNationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_CherokeeNationMember_e485e55e-c1ab-4722-9d1f-55546dea1f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_68a0d3b6-0b96-4f97-ae7f-d0a230bfc77f" xlink:href="mck-20230331.xsd#mck_IndividualClaimantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_IndividualClaimantMember_68a0d3b6-0b96-4f97-ae7f-d0a230bfc77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_3c1d1740-56dd-4080-90a7-d0ca2c9dc687" xlink:href="mck-20230331.xsd#mck_StateOfWestVirginiaAndSubdivisionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_StateOfWestVirginiaAndSubdivisionsMember_3c1d1740-56dd-4080-90a7-d0ca2c9dc687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_b31ff106-eaa9-4798-a8ac-426a3e2c2b87" xlink:href="mck-20230331.xsd#mck_NativeAmericanTribesOtherThanCherokeeNationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_NativeAmericanTribesOtherThanCherokeeNationMember_b31ff106-eaa9-4798-a8ac-426a3e2c2b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_9f1b0f28-5543-4829-8a6f-dc34bc70d44b" xlink:href="mck-20230331.xsd#mck_SettlingGovernmentalEntitiesAndCherokeeNationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8f4ae0a8-600f-4dc3-a0ec-5e84a1773255" xlink:to="loc_mck_SettlingGovernmentalEntitiesAndCherokeeNationMember_9f1b0f28-5543-4829-8a6f-dc34bc70d44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_08bfe0f9-86f5-4860-8a97-0f14c0c3e9be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_08bfe0f9-86f5-4860-8a97-0f14c0c3e9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_be307432-42a6-4d2f-9b18-6393d6936b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_08bfe0f9-86f5-4860-8a97-0f14c0c3e9be" xlink:to="loc_us-gaap_SegmentDomain_be307432-42a6-4d2f-9b18-6393d6936b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_66ac5cdf-1723-4690-9bea-8d94b20585f3" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_be307432-42a6-4d2f-9b18-6393d6936b4d" xlink:to="loc_mck_USPharmaceuticalSegmentMember_66ac5cdf-1723-4690-9bea-8d94b20585f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0e59cd2b-515d-47cb-8baf-83bbed500b90" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_ConsolidationItemsAxis_0e59cd2b-515d-47cb-8baf-83bbed500b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_61428bff-cdc4-4da9-9ae4-dfb8ff375402" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_0e59cd2b-515d-47cb-8baf-83bbed500b90" xlink:to="loc_srt_ConsolidationItemsDomain_61428bff-cdc4-4da9-9ae4-dfb8ff375402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_8453ae3c-182d-48e0-a81c-0819d94b4375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_61428bff-cdc4-4da9-9ae4-dfb8ff375402" xlink:to="loc_us-gaap_OperatingSegmentsMember_8453ae3c-182d-48e0-a81c-0819d94b4375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_347cb80b-988c-485e-abbe-77389ccf1c6b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_srt_StatementScenarioAxis_347cb80b-988c-485e-abbe-77389ccf1c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a24fb5a3-c189-4698-88b6-9f7dbf6fd294" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_347cb80b-988c-485e-abbe-77389ccf1c6b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a24fb5a3-c189-4698-88b6-9f7dbf6fd294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_e4399533-46ea-442e-9f29-33b56ba746c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a24fb5a3-c189-4698-88b6-9f7dbf6fd294" xlink:to="loc_srt_ScenarioForecastMember_e4399533-46ea-442e-9f29-33b56ba746c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_882d9d0b-9dec-4b87-9eaf-34c2f21d4551" xlink:to="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_c0d4b82c-4652-4cc6-a2ac-ae6de074e3b0" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_c0d4b82c-4652-4cc6-a2ac-ae6de074e3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_aeaebf70-43df-4715-8436-8262ef43aae5" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberofStates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberofStates_aeaebf70-43df-4715-8436-8262ef43aae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_1d5145a6-2ebf-48e1-8bb2-4e6235a67036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_1d5145a6-2ebf-48e1-8bb2-4e6235a67036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0551acbf-6e80-4bf3-aeb1-6cac2fcf8370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_0551acbf-6e80-4bf3-aeb1-6cac2fcf8370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_08804423-f976-4118-8079-97cddfaf4ea9" xlink:href="mck-20230331.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_08804423-f976-4118-8079-97cddfaf4ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCasesDismissed_8c63c993-7c6f-4836-bb34-70564f7c6888" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfCasesDismissed"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfCasesDismissed_8c63c993-7c6f-4836-bb34-70564f7c6888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClaimsSettledNumberOfSubdivisions_d5637696-a90c-4383-986b-c8f0fac653f1" xlink:href="mck-20230331.xsd#mck_LossContingencyClaimsSettledNumberOfSubdivisions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyClaimsSettledNumberOfSubdivisions_d5637696-a90c-4383-986b-c8f0fac653f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_d6c1cdfe-e320-4185-8537-84f2e4b5abee" xlink:href="mck-20230331.xsd#mck_LossContingencySettlementInstallmentPaymentsTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencySettlementInstallmentPaymentsTerm_d6c1cdfe-e320-4185-8537-84f2e4b5abee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement_2c5a9ad7-9fbb-4f45-bfc5-a49fdd0cfa66" xlink:href="mck-20230331.xsd#mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement_2c5a9ad7-9fbb-4f45-bfc5-a49fdd0cfa66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_ccaa472f-6add-49bd-bcbf-a34f4942fa3b" xlink:href="mck-20230331.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages_ccaa472f-6add-49bd-bcbf-a34f4942fa3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_0675ef58-659e-435f-bba9-4dde18160e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_0675ef58-659e-435f-bba9-4dde18160e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_d5f800b8-875d-4d5f-87a0-dcff74ff8396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_d5f800b8-875d-4d5f-87a0-dcff74ff8396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_c037a138-9659-4229-9b32-a4eec67401f0" xlink:href="mck-20230331.xsd#mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal_c037a138-9659-4229-9b32-a4eec67401f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies_cdad91a3-d401-47fa-8c49-38cfbf24602f" xlink:href="mck-20230331.xsd#mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies_cdad91a3-d401-47fa-8c49-38cfbf24602f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofRelators_3bf36500-5e42-433b-a85a-bab964f5a947" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberofRelators"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberofRelators_3bf36500-5e42-433b-a85a-bab964f5a947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyDamagesSoughtPerViolationValue_1f5475d7-53b8-422c-a2f7-8a428a2b72a0" xlink:href="mck-20230331.xsd#mck_LossContingencyDamagesSoughtPerViolationValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyDamagesSoughtPerViolationValue_1f5475d7-53b8-422c-a2f7-8a428a2b72a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_3ef0187e-8b5f-4412-852e-68824549f09e" xlink:href="mck-20230331.xsd#mck_LossContingencyClassActionNumberofFaxesRemainingintheClass"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass_3ef0187e-8b5f-4412-852e-68824549f09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyClassActionNumberofFaxesReceived_dd455f75-6c56-4d46-8aa8-fd3270c31b56" xlink:href="mck-20230331.xsd#mck_LossContingencyClassActionNumberofFaxesReceived"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyClassActionNumberofFaxesReceived_dd455f75-6c56-4d46-8aa8-fd3270c31b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_d4ee4903-a437-4024-a4a7-34e345146a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_d4ee4903-a437-4024-a4a7-34e345146a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfRelators_bbb620cc-ab01-4639-ba57-be5e2a6239b4" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfRelators"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfRelators_bbb620cc-ab01-4639-ba57-be5e2a6239b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_6e0b84d4-71c8-467f-bde1-3d0f637f524c" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfCitiesFiledOnBehalfOf"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf_6e0b84d4-71c8-467f-bde1-3d0f637f524c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_b5b928cb-0d62-45af-939a-bbaad79f1f8d" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfStatesFiledOnBehalfOf"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfStatesFiledOnBehalfOf_b5b928cb-0d62-45af-939a-bbaad79f1f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfAdditionalDefendants_d6c9cd87-8c6e-4527-bcdd-85e6b430afe1" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberOfAdditionalDefendants"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberOfAdditionalDefendants_d6c9cd87-8c6e-4527-bcdd-85e6b430afe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofFormerOfficers_3c3d7e66-3576-4965-839d-d8336d259d54" xlink:href="mck-20230331.xsd#mck_LossContingencyNumberofFormerOfficers"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_LossContingencyNumberofFormerOfficers_3c3d7e66-3576-4965-839d-d8336d259d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimatedInsuranceRecoveries_52ad820e-784b-4ce8-910c-9866e5f4d826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimatedInsuranceRecoveries"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_EstimatedInsuranceRecoveries_52ad820e-784b-4ce8-910c-9866e5f4d826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberofSoftwareProducts_a19260dc-aba1-4596-8c4e-6a2ff5e6ebcc" xlink:href="mck-20230331.xsd#mck_NumberofSoftwareProducts"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_NumberofSoftwareProducts_a19260dc-aba1-4596-8c4e-6a2ff5e6ebcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_b85d13b4-5ac2-4a97-bfb1-c991c294bbc1" xlink:href="mck-20230331.xsd#mck_OpioidStewardshipActNewYorkAnnualSurcharge"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_OpioidStewardshipActNewYorkAnnualSurcharge_b85d13b4-5ac2-4a97-bfb1-c991c294bbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_39376d3f-9129-47a3-b37a-b25f2558fbba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_39376d3f-9129-47a3-b37a-b25f2558fbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_4ada03fc-72c2-4970-8ab0-70c89e272780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_4ada03fc-72c2-4970-8ab0-70c89e272780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites_9b9ea897-3758-4d5c-adc6-00eec7b117f5" xlink:href="mck-20230331.xsd#mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites_9b9ea897-3758-4d5c-adc6-00eec7b117f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_6fd6b2a9-f481-4ee9-81ac-e71d39cf2a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_6fd6b2a9-f481-4ee9-81ac-e71d39cf2a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_4c718dc5-3cee-4581-9dd7-32fc1f9c890d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_4c718dc5-3cee-4581-9dd7-32fc1f9c890d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSites_fedd820c-b636-4a6b-811e-6950c0b8fa18" xlink:href="mck-20230331.xsd#mck_HazardousSubstanceSites"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_HazardousSubstanceSites_fedd820c-b636-4a6b-811e-6950c0b8fa18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HazardousSubstanceSitesRecipientOfDirectives_c67e2d08-b028-45ea-9a15-4edd2ba67796" xlink:href="mck-20230331.xsd#mck_HazardousSubstanceSitesRecipientOfDirectives"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_HazardousSubstanceSitesRecipientOfDirectives_c67e2d08-b028-45ea-9a15-4edd2ba67796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_381c3656-2e9e-42b6-879b-e71e561da7ba" xlink:href="mck-20230331.xsd#mck_EstimatedEnvironmentalAssessmentAndCleanupCosts"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts_381c3656-2e9e-42b6-879b-e71e561da7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_cd50d9c6-1bf7-400b-b707-1a5218316899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_cd50d9c6-1bf7-400b-b707-1a5218316899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_317dcea8-1bfd-44af-8efe-0bc0d6148c60" xlink:href="mck-20230331.xsd#mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_7a04b08c-c2e2-4720-b974-3e834691e2a7" xlink:to="loc_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_317dcea8-1bfd-44af-8efe-0bc0d6148c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4f855d00-9812-498e-bcfd-96227e4a2887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_21d2ec2e-4b6d-4b86-bbe0-df29e5d10749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4f855d00-9812-498e-bcfd-96227e4a2887" xlink:to="loc_us-gaap_LossContingenciesTable_21d2ec2e-4b6d-4b86-bbe0-df29e5d10749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b9a770b0-e7ac-42d0-adc2-e8fd83c2387b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_21d2ec2e-4b6d-4b86-bbe0-df29e5d10749" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b9a770b0-e7ac-42d0-adc2-e8fd83c2387b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_0243f0dc-1cd3-479c-8e6c-c34729a9d53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_b9a770b0-e7ac-42d0-adc2-e8fd83c2387b" xlink:to="loc_us-gaap_LossContingencyNatureDomain_0243f0dc-1cd3-479c-8e6c-c34729a9d53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_0dc8b88e-5386-4a4a-9dae-abf6d6f980d7" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_0243f0dc-1cd3-479c-8e6c-c34729a9d53c" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_0dc8b88e-5386-4a4a-9dae-abf6d6f980d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_5e55248c-ea6f-45ad-b471-a8f59a1d69bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_21d2ec2e-4b6d-4b86-bbe0-df29e5d10749" xlink:to="loc_us-gaap_LossContingenciesLineItems_5e55248c-ea6f-45ad-b471-a8f59a1d69bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_17d0f0df-136e-4ae9-a143-48253e2097c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e55248c-ea6f-45ad-b471-a8f59a1d69bb" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_17d0f0df-136e-4ae9-a143-48253e2097c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_ff04a8b0-59f2-4c29-bff1-731e17c132af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e55248c-ea6f-45ad-b471-a8f59a1d69bb" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_ff04a8b0-59f2-4c29-bff1-731e17c132af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_ded498fb-8eff-4904-97c3-3a2faeb21078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5e55248c-ea6f-45ad-b471-a8f59a1d69bb" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_ded498fb-8eff-4904-97c3-3a2faeb21078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_c0aca684-a98d-4ca2-b231-732493644b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_f89e35b4-d583-4066-be66-b3e15e895659" xlink:href="mck-20230331.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c0aca684-a98d-4ca2-b231-732493644b9b" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_f89e35b4-d583-4066-be66-b3e15e895659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_4323bbd9-922a-4ffd-8b4d-435a762c6636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c0aca684-a98d-4ca2-b231-732493644b9b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_4323bbd9-922a-4ffd-8b4d-435a762c6636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#StockholdersEquityDeficitScheduleofShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1155770e-6868-4bf6-b8e0-31a2fbf62738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_36483b6c-dd09-4148-9fc5-6494c4164e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1155770e-6868-4bf6-b8e0-31a2fbf62738" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_36483b6c-dd09-4148-9fc5-6494c4164e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_d83ebfae-94a2-4d43-9ccf-75f635cf1609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_36483b6c-dd09-4148-9fc5-6494c4164e3a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_d83ebfae-94a2-4d43-9ccf-75f635cf1609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d83ebfae-94a2-4d43-9ccf-75f635cf1609" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpenMarketTransactionsMember_c53b36dc-e132-42fd-abe3-94072b08feb7" xlink:href="mck-20230331.xsd#mck_OpenMarketTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_OpenMarketTransactionsMember_c53b36dc-e132-42fd-abe3-94072b08feb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2021Member_4694d618-28b5-4446-8785-6cf3e9fcde60" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseMay2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_AcceleratedShareRepurchaseMay2021Member_4694d618-28b5-4446-8785-6cf3e9fcde60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseFebruary2022Member_0f4e3707-b944-4f4f-922b-116a4587eaea" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseFebruary2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_AcceleratedShareRepurchaseFebruary2022Member_0f4e3707-b944-4f4f-922b-116a4587eaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMay2022Member_3555594a-1bb8-41b2-85d6-ef4dab4826cd" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseMay2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_AcceleratedShareRepurchaseMay2022Member_3555594a-1bb8-41b2-85d6-ef4dab4826cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseDecember2022Member_937261a0-9d33-480e-b79e-4bdf04e64cb5" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseDecember2022Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_AcceleratedShareRepurchaseDecember2022Member_937261a0-9d33-480e-b79e-4bdf04e64cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_c688c9e6-3963-48f3-acfd-8e1871ea7e73" xlink:href="mck-20230331.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_637e01f8-233f-48e5-b3db-9806b3ea65d0" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_c688c9e6-3963-48f3-acfd-8e1871ea7e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_37b0236c-0299-4b3c-9ffb-d16c077e2b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_36483b6c-dd09-4148-9fc5-6494c4164e3a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_37b0236c-0299-4b3c-9ffb-d16c077e2b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_333495b0-6008-427e-b013-6da10826be2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_37b0236c-0299-4b3c-9ffb-d16c077e2b00" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_333495b0-6008-427e-b013-6da10826be2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_a460020a-0b3d-470b-ad98-2e811dc5a76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_333495b0-6008-427e-b013-6da10826be2b" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_a460020a-0b3d-470b-ad98-2e811dc5a76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_36483b6c-dd09-4148-9fc5-6494c4164e3a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9756032a-391b-4753-ad07-43c295116c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9756032a-391b-4753-ad07-43c295116c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_45e4d31c-80ae-49f3-a1dd-d998778ae609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_45e4d31c-80ae-49f3-a1dd-d998778ae609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_b9aa3e41-436c-49da-84de-c4ccf0896851" xlink:href="mck-20230331.xsd#mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:to="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_b9aa3e41-436c-49da-84de-c4ccf0896851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_25a86c86-76cf-467b-b6be-76210c2a3f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_b9aa3e41-436c-49da-84de-c4ccf0896851" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_25a86c86-76cf-467b-b6be-76210c2a3f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_45191d2e-4c6f-457b-9463-51c7585e685e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_b9aa3e41-436c-49da-84de-c4ccf0896851" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_45191d2e-4c6f-457b-9463-51c7585e685e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4f8e96b7-9a80-4206-9579-ee3c2e09cb81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_b9aa3e41-436c-49da-84de-c4ccf0896851" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4f8e96b7-9a80-4206-9579-ee3c2e09cb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_da898cf4-0d18-43c1-a6fa-caacfdd313f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward_b9aa3e41-436c-49da-84de-c4ccf0896851" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_da898cf4-0d18-43c1-a6fa-caacfdd313f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccruedShareRepurchases_66d9cb0c-dd3d-4368-a7db-9094b65a66f4" xlink:href="mck-20230331.xsd#mck_AccruedShareRepurchases"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:to="loc_mck_AccruedShareRepurchases_66d9cb0c-dd3d-4368-a7db-9094b65a66f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_b6298e0b-5c83-4b70-836f-42e35d62f7de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_95a2761e-6a1d-48b9-8844-193c23938ca6" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_b6298e0b-5c83-4b70-836f-42e35d62f7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0e1092e6-7c1c-4d79-b1b3-0dbf7915858b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0e1092e6-7c1c-4d79-b1b3-0dbf7915858b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_70f91ab7-8b7e-4253-a747-cc2c12b7ba00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_70f91ab7-8b7e-4253-a747-cc2c12b7ba00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e5201caa-9469-4e64-9e03-7c2327db170f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_70f91ab7-8b7e-4253-a747-cc2c12b7ba00" xlink:to="loc_us-gaap_EquityComponentDomain_e5201caa-9469-4e64-9e03-7c2327db170f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e5201caa-9469-4e64-9e03-7c2327db170f" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b8f0005b-7a58-4e1d-a331-b8c3c8bd94b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b8f0005b-7a58-4e1d-a331-b8c3c8bd94b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_91891783-dfda-4d54-b401-af7155b72504" xlink:href="mck-20230331.xsd#mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:to="loc_mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember_91891783-dfda-4d54-b401-af7155b72504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_84257210-ec32-42b3-8283-12401b7f6afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_84257210-ec32-42b3-8283-12401b7f6afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_31309e3c-15ce-41d0-9d72-a89b2bb7269a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f9b90426-65c5-412d-86b4-25c57e43d77a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_31309e3c-15ce-41d0-9d72-a89b2bb7269a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_780e1fb6-0ee2-434e-b50b-e8c3a9c71985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_780e1fb6-0ee2-434e-b50b-e8c3a9c71985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_133e0507-c7b9-4e79-bb9d-c022f6d26132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_780e1fb6-0ee2-434e-b50b-e8c3a9c71985" xlink:to="loc_us-gaap_HedgingRelationshipDomain_133e0507-c7b9-4e79-bb9d-c022f6d26132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_cb56f076-25e7-4ae0-9f78-a8d671390d94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_133e0507-c7b9-4e79-bb9d-c022f6d26132" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_cb56f076-25e7-4ae0-9f78-a8d671390d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_41f4c6b6-301a-495e-9e1b-380cfc7d89bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_133e0507-c7b9-4e79-bb9d-c022f6d26132" xlink:to="loc_us-gaap_CurrencySwapMember_41f4c6b6-301a-495e-9e1b-380cfc7d89bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_8bc6eb68-93f7-41b9-905c-6bf0889fad64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:to="loc_us-gaap_HedgingDesignationAxis_8bc6eb68-93f7-41b9-905c-6bf0889fad64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b43562bc-2aed-425b-a3bb-4bbb114d0c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_8bc6eb68-93f7-41b9-905c-6bf0889fad64" xlink:to="loc_us-gaap_HedgingDesignationDomain_b43562bc-2aed-425b-a3bb-4bbb114d0c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c78c040b-3694-41ac-a55e-a7d37cc2b414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b43562bc-2aed-425b-a3bb-4bbb114d0c51" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c78c040b-3694-41ac-a55e-a7d37cc2b414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5dbde897-1212-4ea8-9049-c352ebe89290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:to="loc_us-gaap_DebtInstrumentAxis_5dbde897-1212-4ea8-9049-c352ebe89290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a5f9897b-24bc-4b1d-a2d8-c30a980b000b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5dbde897-1212-4ea8-9049-c352ebe89290" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a5f9897b-24bc-4b1d-a2d8-c30a980b000b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_f0552909-8dc0-48b9-a5de-458e25fec77b" xlink:href="mck-20230331.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a5f9897b-24bc-4b1d-a2d8-c30a980b000b" xlink:to="loc_mck_EuroDenominatedNotesMember_f0552909-8dc0-48b9-a5de-458e25fec77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0d9ab8de-dffd-4adf-842e-3966bc790338" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20c91c9e-467c-4984-ae88-05ddfa6f700d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20c91c9e-467c-4984-ae88-05ddfa6f700d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b262f3ad-e286-4a81-9205-1ae2dedb1dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b262f3ad-e286-4a81-9205-1ae2dedb1dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ed9f4af9-e1bb-4f5b-a7f9-cac43ea5b7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ed9f4af9-e1bb-4f5b-a7f9-cac43ea5b7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2958439a-0480-49c0-a131-5a9d430cf7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2958439a-0480-49c0-a131-5a9d430cf7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2a8d1c30-ea93-4499-975e-f5c2b5f688a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2a8d1c30-ea93-4499-975e-f5c2b5f688a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_250bfcdf-72d2-48e1-befa-9650f3dd83a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_250bfcdf-72d2-48e1-befa-9650f3dd83a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_b61413a0-3e4e-48f5-a2f5-40135ad068e3" xlink:href="mck-20230331.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_b61413a0-3e4e-48f5-a2f5-40135ad068e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a49abbce-29d3-4c87-b1e3-c53d995fe076" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_c511c9a7-27db-4acc-b7f3-cadcb8099efc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a49abbce-29d3-4c87-b1e3-c53d995fe076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_f91d2e01-08f8-4688-860f-aadfd47430eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax_f91d2e01-08f8-4688-860f-aadfd47430eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_3b420f43-05f6-49d8-957e-d94bb0efb632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_3b420f43-05f6-49d8-957e-d94bb0efb632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_1adfea84-02c9-407a-ac4d-4f3ea38f77ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_1adfea84-02c9-407a-ac4d-4f3ea38f77ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_39ba1dbc-741a-41c2-b829-6ffbea8ca810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_69f7686e-7edc-4c31-9c86-b0931f93ca9b" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_39ba1dbc-741a-41c2-b829-6ffbea8ca810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#RelatedPartyBalancesandTransactionsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_8a04f183-4746-4fad-b0bb-2c03c3da0899" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c2b0a20c-7d41-4a0c-82e5-5b34d18ce09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_8a04f183-4746-4fad-b0bb-2c03c3da0899" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c2b0a20c-7d41-4a0c-82e5-5b34d18ce09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9212970f-30a2-4005-824d-77102da4909a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c2b0a20c-7d41-4a0c-82e5-5b34d18ce09b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9212970f-30a2-4005-824d-77102da4909a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_81299959-5bd9-4e5a-8c4c-0dbc430ec4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9212970f-30a2-4005-824d-77102da4909a" xlink:to="loc_us-gaap_RelatedPartyDomain_81299959-5bd9-4e5a-8c4c-0dbc430ec4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvesteeMember_7e9243b1-93a3-4359-8457-77863e763bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_81299959-5bd9-4e5a-8c4c-0dbc430ec4bc" xlink:to="loc_us-gaap_InvesteeMember_7e9243b1-93a3-4359-8457-77863e763bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_16cd94fc-21cf-4812-96cd-d43f904c8355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c2b0a20c-7d41-4a0c-82e5-5b34d18ce09b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_16cd94fc-21cf-4812-96cd-d43f904c8355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_77f6cabe-1fa3-4f9e-bc54-30254ad69146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_16cd94fc-21cf-4812-96cd-d43f904c8355" xlink:to="loc_us-gaap_SegmentDomain_77f6cabe-1fa3-4f9e-bc54-30254ad69146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_7d56b9f9-ddca-46db-b2a7-da7e2ba64e42" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_77f6cabe-1fa3-4f9e-bc54-30254ad69146" xlink:to="loc_mck_InternationalSegmentMember_7d56b9f9-ddca-46db-b2a7-da7e2ba64e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_32d6931a-fb59-42c5-b3c9-8b88634789db" xlink:href="mck-20230331.xsd#mck_U.S.PharmaceuticalandSpecialtySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_77f6cabe-1fa3-4f9e-bc54-30254ad69146" xlink:to="loc_mck_U.S.PharmaceuticalandSpecialtySolutionsMember_32d6931a-fb59-42c5-b3c9-8b88634789db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_98db8d31-e421-4df3-8766-4a743d15a5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c2b0a20c-7d41-4a0c-82e5-5b34d18ce09b" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_98db8d31-e421-4df3-8766-4a743d15a5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_b421a67c-2469-44b3-9209-56eac60bfab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_98db8d31-e421-4df3-8766-4a743d15a5f0" xlink:to="loc_us-gaap_RevenueFromRelatedParties_b421a67c-2469-44b3-9209-56eac60bfab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SegmentsofBusinessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f748e74d-de5f-45eb-bfb6-8af78466e92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_d1dda04a-ba03-4013-bf54-f1a46be11ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f748e74d-de5f-45eb-bfb6-8af78466e92c" xlink:to="loc_us-gaap_NumberOfReportableSegments_d1dda04a-ba03-4013-bf54-f1a46be11ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SegmentsofBusinessScheduleofSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e737ec61-5899-4cfd-afa2-0a3d5219d88e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e737ec61-5899-4cfd-afa2-0a3d5219d88e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d5e1ea90-cd4b-409d-8007-3e1e6485ec02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d5e1ea90-cd4b-409d-8007-3e1e6485ec02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d5e1ea90-cd4b-409d-8007-3e1e6485ec02" xlink:to="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_a147b04d-b84c-4bcc-89c4-43cbcd6449f8" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:to="loc_mck_USPharmaceuticalSegmentMember_a147b04d-b84c-4bcc-89c4-43cbcd6449f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e1b09591-e044-4595-a9ab-612ac609f8d8" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_e1b09591-e044-4595-a9ab-612ac609f8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_22b6275b-1e54-476c-8fc3-c9b5902e4cab" xlink:href="mck-20230331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_22b6275b-1e54-476c-8fc3-c9b5902e4cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_68202d81-f19d-431b-b26d-109215fff85c" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9ee4c64c-da18-4e6a-9b7b-9b7f3b36a9c8" xlink:to="loc_mck_InternationalSegmentMember_68202d81-f19d-431b-b26d-109215fff85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_167b0a9a-bba9-4daa-8a6a-ad489848e366" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_srt_ConsolidationItemsAxis_167b0a9a-bba9-4daa-8a6a-ad489848e366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a1f2dc79-7bde-4d3a-b236-86239ea9d725" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_167b0a9a-bba9-4daa-8a6a-ad489848e366" xlink:to="loc_srt_ConsolidationItemsDomain_a1f2dc79-7bde-4d3a-b236-86239ea9d725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2be3d4e0-6ff4-4052-92f1-f49b7bf245ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a1f2dc79-7bde-4d3a-b236-86239ea9d725" xlink:to="loc_us-gaap_OperatingSegmentsMember_2be3d4e0-6ff4-4052-92f1-f49b7bf245ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_112186df-9d23-4030-83c1-640b93ed2bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a1f2dc79-7bde-4d3a-b236-86239ea9d725" xlink:to="loc_us-gaap_CorporateNonSegmentMember_112186df-9d23-4030-83c1-640b93ed2bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_aa730f43-ec6e-401f-81ba-23ca3908b621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_aa730f43-ec6e-401f-81ba-23ca3908b621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_ead87b7a-094a-4ca3-b9d2-276ac9411349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_aa730f43-ec6e-401f-81ba-23ca3908b621" xlink:to="loc_us-gaap_LossContingencyNatureDomain_ead87b7a-094a-4ca3-b9d2-276ac9411349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NewYorkOpioidTaxSurchargeMember_cb1aa594-23ab-4b88-9649-bb272e873938" xlink:href="mck-20230331.xsd#mck_NewYorkOpioidTaxSurchargeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ead87b7a-094a-4ca3-b9d2-276ac9411349" xlink:to="loc_mck_NewYorkOpioidTaxSurchargeMember_cb1aa594-23ab-4b88-9649-bb272e873938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_07e9de4c-f148-418c-b885-6fb7ad55edb4" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_ead87b7a-094a-4ca3-b9d2-276ac9411349" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_07e9de4c-f148-418c-b885-6fb7ad55edb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_bcc931c4-5c1e-485c-ae4d-26a151833077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_bcc931c4-5c1e-485c-ae4d-26a151833077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e754dc32-fc8b-461d-9caa-d217d9dbc50e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_bcc931c4-5c1e-485c-ae4d-26a151833077" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e754dc32-fc8b-461d-9caa-d217d9dbc50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_508d7c62-3994-44f6-9350-24dd714d561f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e754dc32-fc8b-461d-9caa-d217d9dbc50e" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_508d7c62-3994-44f6-9350-24dd714d561f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_5420d8ab-3f38-4773-8e7a-f90438efb0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e754dc32-fc8b-461d-9caa-d217d9dbc50e" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_5420d8ab-3f38-4773-8e7a-f90438efb0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_de5a3901-2655-4b6e-9846-2fa8133cfbad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_de5a3901-2655-4b6e-9846-2fa8133cfbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_de5a3901-2655-4b6e-9846-2fa8133cfbad" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EUBusinessesDisposalGroupMember_c3dab798-ced6-4ea5-b7ee-43bea967b807" xlink:href="mck-20230331.xsd#mck_EUBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:to="loc_mck_EUBusinessesDisposalGroupMember_c3dab798-ced6-4ea5-b7ee-43bea967b807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_UKBusinessesDisposalGroupMember_f1d5aa5d-1d74-41b4-aadd-dcaac5ce9049" xlink:href="mck-20230331.xsd#mck_UKBusinessesDisposalGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:to="loc_mck_UKBusinessesDisposalGroupMember_f1d5aa5d-1d74-41b4-aadd-dcaac5ce9049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_dd7f11f2-f3ba-4c83-aef5-4136ae54e80d" xlink:href="mck-20230331.xsd#mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:to="loc_mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember_dd7f11f2-f3ba-4c83-aef5-4136ae54e80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_1d3bc7bb-100c-4a0d-a29b-b0d626a15a22" xlink:href="mck-20230331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4865bf58-c9f2-471f-ab6d-530d7e43b4ac" xlink:to="loc_mck_GermanWholesaleBusinessMember_1d3bc7bb-100c-4a0d-a29b-b0d626a15a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_94be5ecb-50cd-48d9-936b-ebd005834374" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_srt_OwnershipAxis_94be5ecb-50cd-48d9-936b-ebd005834374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_1c54d44a-3968-4682-9378-c422a6c2d606" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_94be5ecb-50cd-48d9-936b-ebd005834374" xlink:to="loc_srt_OwnershipDomain_1c54d44a-3968-4682-9378-c422a6c2d606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_WalgreensBootsAllianceJointVentureMember_06923fc8-1174-49de-916f-721a66c99b89" xlink:href="mck-20230331.xsd#mck_WalgreensBootsAllianceJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_1c54d44a-3968-4682-9378-c422a6c2d606" xlink:to="loc_mck_WalgreensBootsAllianceJointVentureMember_06923fc8-1174-49de-916f-721a66c99b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GermanWholesaleBusinessMember_8365fffe-c490-47bb-bb45-837df83c4655" xlink:href="mck-20230331.xsd#mck_GermanWholesaleBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_1c54d44a-3968-4682-9378-c422a6c2d606" xlink:to="loc_mck_GermanWholesaleBusinessMember_8365fffe-c490-47bb-bb45-837df83c4655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5eac1955-b946-47ff-ab8e-0d62b24219e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5eac1955-b946-47ff-ab8e-0d62b24219e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ea61065e-6a55-450a-b830-4194fbcd8ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5eac1955-b946-47ff-ab8e-0d62b24219e0" xlink:to="loc_us-gaap_RelatedPartyDomain_ea61065e-6a55-450a-b830-4194fbcd8ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TaxReceivableAgreementTRAMember_d2b7a603-98e3-49c8-adef-ab6ca108f60c" xlink:href="mck-20230331.xsd#mck_TaxReceivableAgreementTRAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_ea61065e-6a55-450a-b830-4194fbcd8ab4" xlink:to="loc_mck_TaxReceivableAgreementTRAMember_d2b7a603-98e3-49c8-adef-ab6ca108f60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_66b34c61-899b-4596-afdc-e46618e88d6c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_srt_LitigationCaseAxis_66b34c61-899b-4596-afdc-e46618e88d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_24b8a693-cf13-44fb-9f28-6a522aea82fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_66b34c61-899b-4596-afdc-e46618e88d6c" xlink:to="loc_srt_LitigationCaseTypeDomain_24b8a693-cf13-44fb-9f28-6a522aea82fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember_8f9a6716-87cb-4082-8f5a-a292e11905a5" xlink:href="mck-20230331.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_24b8a693-cf13-44fb-9f28-6a522aea82fc" xlink:to="loc_mck_ShareholderDerivativeActionMember_8f9a6716-87cb-4082-8f5a-a292e11905a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_63b6834f-c22f-47b3-8907-0add63b3bf58" xlink:href="mck-20230331.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_24b8a693-cf13-44fb-9f28-6a522aea82fc" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_63b6834f-c22f-47b3-8907-0add63b3bf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1e970704-ab2e-4216-8574-1b0756741cdf" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_98a6001b-d698-4d22-9b7a-de374648b60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_RevenuesAbstract_98a6001b-d698-4d22-9b7a-de374648b60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_59f48e03-8a82-42de-808f-01d32434bc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_98a6001b-d698-4d22-9b7a-de374648b60e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_59f48e03-8a82-42de-808f-01d32434bc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_b5ef3525-5022-43b4-979c-cb1dc1558d4d" xlink:href="mck-20230331.xsd#mck_GrossProfitNetofExpensesIncludingOtherIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:to="loc_mck_GrossProfitNetofExpensesIncludingOtherIncome_b5ef3525-5022-43b4-979c-cb1dc1558d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_d8039514-aca9-46c2-9b92-8475e0813ac0" xlink:href="mck-20230331.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_d8039514-aca9-46c2-9b92-8475e0813ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_24bc035a-e63f-487f-8d39-fb31f3e93a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_24bc035a-e63f-487f-8d39-fb31f3e93a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_72f8f25b-9f61-4c1c-9abf-967a50d3ac0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:to="loc_us-gaap_InterestExpense_72f8f25b-9f61-4c1c-9abf-967a50d3ac0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4bb97ee7-00b7-4a65-855c-6a29a7b423f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_80b9987e-db21-4dc8-afb1-f7cda04c8552" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4bb97ee7-00b7-4a65-855c-6a29a7b423f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract_19a962e2-886f-448c-ae9d-da6a5551b686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_DepreciationAndAmortizationAbstract_19a962e2-886f-448c-ae9d-da6a5551b686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_588d0b7a-e821-4b8c-975f-91d6ad0fcf9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract_19a962e2-886f-448c-ae9d-da6a5551b686" xlink:to="loc_us-gaap_DepreciationAndAmortization_588d0b7a-e821-4b8c-975f-91d6ad0fcf9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_f1058ecd-4ee8-460e-a06a-e57e1bdd1ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssetsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_f1058ecd-4ee8-460e-a06a-e57e1bdd1ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_2950a1fd-6630-44ae-872c-fc64e4df614b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssetsAbstract_f1058ecd-4ee8-460e-a06a-e57e1bdd1ea2" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_2950a1fd-6630-44ae-872c-fc64e4df614b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_ae855daf-9ade-4406-b057-027e97283f78" xlink:href="mck-20230331.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_ae855daf-9ade-4406-b057-027e97283f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_cc792c09-7e30-49f1-84cb-84015a94fec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_cc792c09-7e30-49f1-84cb-84015a94fec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_95166d19-3aa4-44d5-a63a-221f6ad68c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_95166d19-3aa4-44d5-a63a-221f6ad68c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_acfdb1e6-1970-46dd-85b5-eb6ebde1fcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_acfdb1e6-1970-46dd-85b5-eb6ebde1fcb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_72b43b6d-fbc0-4f38-b136-0cf119449fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_72b43b6d-fbc0-4f38-b136-0cf119449fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_646c08d5-fdda-44ac-b037-eea515ec7fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_646c08d5-fdda-44ac-b037-eea515ec7fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_9d904958-2faa-4104-9751-4c4b23a3f615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_InventoryWriteDown_9d904958-2faa-4104-9751-4c4b23a3f615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_cd82f084-b252-469f-a13c-f19e7f886590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_cd82f084-b252-469f-a13c-f19e7f886590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_86de9996-c60e-46d1-be7a-425b75b7343e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_86de9996-c60e-46d1-be7a-425b75b7343e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_2626542a-d8b1-43ec-85d7-05f89ed2010e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_2626542a-d8b1-43ec-85d7-05f89ed2010e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_331276e4-0251-4f0c-b21b-ec2dce2232d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_331276e4-0251-4f0c-b21b-ec2dce2232d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b0f8763f-fdb7-4e41-8e5e-48113ddc53a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_AssetImpairmentCharges_b0f8763f-fdb7-4e41-8e5e-48113ddc53a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_0eee04da-f35e-4565-8358-2dadd80196e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_GainLossOnContractTermination_0eee04da-f35e-4565-8358-2dadd80196e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GainLossOnDerivativeTermination_bec69ee7-2c6f-47b7-96ce-d9a1a4108597" xlink:href="mck-20230331.xsd#mck_GainLossOnDerivativeTermination"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_mck_GainLossOnDerivativeTermination_bec69ee7-2c6f-47b7-96ce-d9a1a4108597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_ae4987ac-6a5a-4cf9-8c2a-dc6d9375037a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_ae4987ac-6a5a-4cf9-8c2a-dc6d9375037a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_58c0a557-47b5-43c9-8906-d23f93cdcbae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_LitigationSettlementExpense_58c0a557-47b5-43c9-8906-d23f93cdcbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_97c04b50-3252-4147-99f8-065a66e2eb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_RestructuringCharges_97c04b50-3252-4147-99f8-065a66e2eb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_6436b13d-c3d8-4d5f-a71c-f989d866ee82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1e84ab5-87c7-44f3-bc2d-5205877852c4" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_6436b13d-c3d8-4d5f-a71c-f989d866ee82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_704610a3-6207-4581-88c3-709a20fafba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2fa321ee-f44e-4f6c-8c8e-c0096a54de2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_704610a3-6207-4581-88c3-709a20fafba9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2fa321ee-f44e-4f6c-8c8e-c0096a54de2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b7c3a125-f447-4f98-a498-8a405aea31e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2fa321ee-f44e-4f6c-8c8e-c0096a54de2f" xlink:to="loc_srt_ConsolidationItemsAxis_b7c3a125-f447-4f98-a498-8a405aea31e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_22b5070c-b3d2-4b5a-8eb1-7c82a6364303" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b7c3a125-f447-4f98-a498-8a405aea31e3" xlink:to="loc_srt_ConsolidationItemsDomain_22b5070c-b3d2-4b5a-8eb1-7c82a6364303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b0d1033f-7824-4ae1-815a-20f62e98aa1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_22b5070c-b3d2-4b5a-8eb1-7c82a6364303" xlink:to="loc_us-gaap_OperatingSegmentsMember_b0d1033f-7824-4ae1-815a-20f62e98aa1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_78248cc2-4bf6-4828-91d1-8c98cf7f5d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_22b5070c-b3d2-4b5a-8eb1-7c82a6364303" xlink:to="loc_us-gaap_CorporateNonSegmentMember_78248cc2-4bf6-4828-91d1-8c98cf7f5d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_68dfbcb6-8ce2-468c-adac-c1916111fb56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2fa321ee-f44e-4f6c-8c8e-c0096a54de2f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_68dfbcb6-8ce2-468c-adac-c1916111fb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_68dfbcb6-8ce2-468c-adac-c1916111fb56" xlink:to="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_583f40d2-a2f7-4d7c-8b5d-a529119164e4" xlink:href="mck-20230331.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:to="loc_mck_USPharmaceuticalSegmentMember_583f40d2-a2f7-4d7c-8b5d-a529119164e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsSegmentMember_fcc0c1d1-74a2-46f8-8d3d-3d5eea1ae8ed" xlink:href="mck-20230331.xsd#mck_PrescriptionTechnologySolutionsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:to="loc_mck_PrescriptionTechnologySolutionsSegmentMember_fcc0c1d1-74a2-46f8-8d3d-3d5eea1ae8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_44819e10-5e7c-4e10-a471-27aebdf615c8" xlink:href="mck-20230331.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_44819e10-5e7c-4e10-a471-27aebdf615c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_9ba5e453-ee10-4ab9-8b5f-f71459ec8eb4" xlink:href="mck-20230331.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_644dad42-9b12-4068-b2ef-e3d34d3e177c" xlink:to="loc_mck_InternationalSegmentMember_9ba5e453-ee10-4ab9-8b5f-f71459ec8eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c29bc1da-c406-4053-831c-e8c4e767f1a4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2fa321ee-f44e-4f6c-8c8e-c0096a54de2f" xlink:to="loc_srt_StatementGeographicalAxis_c29bc1da-c406-4053-831c-e8c4e767f1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8c549829-5bd5-4087-822d-f5b941bcd454" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c29bc1da-c406-4053-831c-e8c4e767f1a4" xlink:to="loc_srt_SegmentGeographicalDomain_8c549829-5bd5-4087-822d-f5b941bcd454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_1bf170ed-93e7-4ea4-8230-67461d705da0" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8c549829-5bd5-4087-822d-f5b941bcd454" xlink:to="loc_country_US_1bf170ed-93e7-4ea4-8230-67461d705da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_b0c0a96e-1842-42da-99af-a2c3378abac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8c549829-5bd5-4087-822d-f5b941bcd454" xlink:to="loc_us-gaap_NonUsMember_b0c0a96e-1842-42da-99af-a2c3378abac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e32f4f74-27e9-411c-a1b4-96e2001ed439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2fa321ee-f44e-4f6c-8c8e-c0096a54de2f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e32f4f74-27e9-411c-a1b4-96e2001ed439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0e6fcb75-a02e-42ae-8e79-e6639308c4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e32f4f74-27e9-411c-a1b4-96e2001ed439" xlink:to="loc_us-gaap_AssetsAbstract_0e6fcb75-a02e-42ae-8e79-e6639308c4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_27595d0d-1c85-4b22-8fd9-c25729b3c836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0e6fcb75-a02e-42ae-8e79-e6639308c4eb" xlink:to="loc_us-gaap_Assets_27595d0d-1c85-4b22-8fd9-c25729b3c836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5e5b13f8-f18f-4b24-abff-f15de9bee755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e32f4f74-27e9-411c-a1b4-96e2001ed439" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5e5b13f8-f18f-4b24-abff-f15de9bee755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_fca4b710-e01a-42fa-8620-f317262f3d6b" xlink:href="mck-20230331.xsd#mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5e5b13f8-f18f-4b24-abff-f15de9bee755" xlink:to="loc_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware_fca4b710-e01a-42fa-8620-f317262f3d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="mck-20230331.xsd#SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_c9114f9e-0de1-4fbc-a832-9e9419e9c3ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_dfee6288-fdd8-4caf-ab16-397392486727" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_c9114f9e-0de1-4fbc-a832-9e9419e9c3ee" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_dfee6288-fdd8-4caf-ab16-397392486727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_61a416b6-5ec7-4ea2-9056-847409310309" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_dfee6288-fdd8-4caf-ab16-397392486727" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_61a416b6-5ec7-4ea2-9056-847409310309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_61a416b6-5ec7-4ea2-9056-847409310309" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_ef0e22cb-33ee-49ce-9776-adb73090b89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_ef0e22cb-33ee-49ce-9776-adb73090b89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherAllowancesMember_badff502-f998-4657-8917-0e5cc0c40cae" xlink:href="mck-20230331.xsd#mck_OtherAllowancesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:to="loc_mck_OtherAllowancesMember_badff502-f998-4657-8917-0e5cc0c40cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_0ded01fe-e716-4e35-b36e-48c4b0169c73" xlink:href="mck-20230331.xsd#mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember_0ded01fe-e716-4e35-b36e-48c4b0169c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_0b705591-3a30-4790-83cf-d4f782811718" xlink:href="mck-20230331.xsd#mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_061005a4-2786-46f0-8f80-a967e7ef2f85" xlink:to="loc_mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember_0b705591-3a30-4790-83cf-d4f782811718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_630d1ace-224c-4057-94ae-264d3e932329" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_dfee6288-fdd8-4caf-ab16-397392486727" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_630d1ace-224c-4057-94ae-264d3e932329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_630d1ace-224c-4057-94ae-264d3e932329" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_14f9bbb8-9739-4301-b54b-23eb05b249bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_14f9bbb8-9739-4301-b54b-23eb05b249bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_5ae0bd7f-b0d9-4e7d-96dd-234b3e20aa56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_5ae0bd7f-b0d9-4e7d-96dd-234b3e20aa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_42de0552-8bb9-4f1a-b0fd-ffa7fd8d9d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_42de0552-8bb9-4f1a-b0fd-ffa7fd8d9d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d9a13203-a269-4053-8dca-ffa342ac8372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_d9a13203-a269-4053-8dca-ffa342ac8372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_37e291bb-fc3d-4985-85aa-a5d72672a343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_2bf62f0b-ec17-4df8-8ea5-ff710534d0b0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_37e291bb-fc3d-4985-85aa-a5d72672a343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_92906b46-22cf-42d0-a98c-c3351f24422c" xlink:href="mck-20230331.xsd#mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_630d1ace-224c-4057-94ae-264d3e932329" xlink:to="loc_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount_92906b46-22cf-42d0-a98c-c3351f24422c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>mck-20230331_g1.jpg
<TEXT>
begin 644 mck-20230331_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ^ 9@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]&_C!\5]*
M^"_@FY\3ZS#<SV,$B1LEJH9\L<#@D=_>OGS_ (>7?#;_ *!&O?\ ?B/_ .+K
MJO\ @H#_ ,FVZQ_U]6W_ *,%?E!Z5];E.64,91<ZN]SX?.LWQ.!Q"ITK6L?J
M?X+_ ."@GP[\;>+-(T"WL=7M+C4KE+6*:ZA18U9SA2Q#\#) Z5]/CGGM7X,6
M-]+IM];W<#%)X)%E1@<$,IR"#]17[:?!SQU%\2OAGX<\1PN'-]9QR2>TF,./
M^^@:YLWRV&"Y94MF=>1YK4Q_-"M\2.SXKYX^+G[;G@7X.^.+KPOJEKJ=[J%J
MB-*]E$C1J64,%R6'."/SKWO6-4@T32KS4+EO+MK6%II&/95!)_05^(GQ.\93
M?$#XA>(?$4S;FU&]DG'7A2QV@>V,5CE& CC:DO:?"C;/,RGE].*I?$S]#O\
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MOK:UCTK71)/(L2EH(P,DX!^_ZFOJ^&430I(O1E##Z&OPG\+C_BIM(_Z^XO\
MT,5^XUUK%GX?\.-J6H7$=K96MOYLTTAPJ*JY)-=>;X"E@W!45N<F1YE6QT9R
MKO8R?B9\2M#^$WA&]\1^(+G[-I]JN<+C?(QZ(@[L3T%?./\ P\N^&W_0)U['
M_7O'_P#%U\@_M:?M)7?Q\\;,EF\EOX4TUBFGVK$CS#G!G<?WF' '8<>N?(O!
MO@_6/'WB2RT'0K*2_P!3O)/+BB3Z\DGL .<GTKU,)DM%4/:8K1_D>/C.(*\L
M1[/!K3\S]1?AC^V_X4^+GB^S\.^'?#VOW-]<')9H(Q'$@ZN[;^%'>O2/CA\=
M-#^ OANVUO7K>[N;6XG%NJV:!FW$$]R..*P?V9_V<])_9]\&1VD82[\07:A]
M1U';S(_]Q?1%S@#OU->3?\%+O^2-Z/\ ]A1/_0&KP(4L/7QL:5)>XV?23KXO
M#X"5>LUSDO\ P\M^&Q_YA.O?^ \?_P 71_P\N^&__0)U[_OQ'_\ %U^97-=%
MIOPY\5:S8Q7MAX<U2]M)AF.>WLY'1L$C(8#U!'X5]=+),%!7EI\SXJ/$.83T
MC9_(_1/_ (>7?#?_ *!.O?\ ?B/_ .+H/_!2[X;_ /0)U[_P'C_^+K\]O^%2
M^-O^A2UK_P  )?\ XFC_ (5+XV_Z%+6O_ "7_P")K/\ LC+_ .;\33^W,S_E
M_ _6SX"_M%>'OVA-/U6[\/VM]:QZ;*L4HO4522P)!&&/I7J]?%__  37\*ZS
MX7\->-$U?2[S2WFO(&C6[@:(L C X!'2O</VI?C<GP(^%5[K<0635KAQ9Z?$
MW1IF!()'HH#-^&*^0Q&&BL6Z%#;H?<X3&2^I+$XC1VU-WXJ?'SP-\&;59/%.
MO6]E<2+NBL4/F7,ONL:_-C_:.!ZD5\U>(O\ @IYX7M;ADT;PEJ6H1 \37$R0
M9_X#\U?GWXD\3:IXQUR[UC6KV;4=2NG,DL\[%F)/;Z = /2K/A;P/XB\;71M
M_#^AZAK4XZI8VSRD?7:/YU]71R/#48<V(E=_@?$U^(L77J..&5E][/N:'_@J
M+8>8OG>!;KRR>2EZN1_X[7HG@W_@HO\ "_Q!)'#JW]I>')6X+W5N9(E_X$F3
M_P".U\#7/[,GQ7M83+)\/]>*CD[+)F/Y ?TKA=<\,ZOX9N&M]7TN\TN=>#'=
MP-$V?H16CRK+JVE-Z^3,UG6:4-:BT\T?MUX/^('AKXA:>;WPUKEAK=MQN>RN
M%DV$] P!RI]C@UT-?'/_  31\&G2?A;K?B&2/:^J7YBC8CGRXU X]LL?RKN?
MVU_VA+CX(_#V.TT698_$VM%H+63J;>,#YY<>HX ]S[5\=4P?^UO#4G?6Q]U2
MQ_\ L2Q==6TN=M\6?VGOAY\&&:#Q!KL;:F!D:99#SKG\5'W?^!$9KYXUK_@I
M_P"'[>X9-,\':A=0YXEN+E(R1_N@'^=?GM?7]SJ=[/>7D\MW=S,9)9IF+.[$
MY)))Y/UK=\)_#7Q9X\8CP[X<U36MIPS65J\JKGU(&!^)KZ^GD>%HP4J\K_@?
M#U>(<;B)\N'C9?>S[AM/^"HFFM,!<^!KM8NA:.]0D?AMKT_P5_P4(^%/BAXX
M=0O+WPW.W!_M"W)BS_OIN'XG%?GK??LU_%33H3+/X UX1C.2ED[X]S@=/K7!
M:IHM_H=P;?4;&XL)U)!CN(F1N.V"*;RG+ZZ_=2L_)B6=YG0:=6.GFC]R_#?B
MK1O&.FIJ.A:K9ZO8/PMQ8SK-'ZXW*2,\C\ZUOYU\Y_L#^"3X/_9UT>:1/+GU
MB>74W]PY"H?^_:)7L7Q/^(FE?"OP3JGB;6)-EG8Q%]H.&D8\*B^Y.!^-?#U:
M/+7=&GKK8_0Z&(Y\-&O5TTN7/&/CO0/A_HLVJ^(]6M=(T^,?--=2!0?8#JQ]
MADFOE[QG_P %*O >BW$D&@Z/J?B$*<>?@6\;>A7=\Q'U KX2^-GQN\1_'3Q=
M/K.N73FW#,+.P5B(;:/)PJKZXQECR:X&WMY;J98;>)YI6^['&NYC[ "OL<+D
M-*,%/$O4^%QG$E:<^3"JR/OR/_@J-9;QO\"7.SOMOE!_]!KU3X<?\% ?AAXX
MNH;+4KFX\*WDA"@ZH@$&2>GF@X ]VVBOS4U#X5^,M)T\7][X5UBULB,_:);&
M54^N=M<MTR,<UU2R7!5D_9[^3.&.?9A1DG4U7FC]Y[6\@O[9+BWE2>"0!DDC
M8,K ]"".U3U^5W['G[6&H_"+Q-8^'/$-[+<^"[V00D2DM]@=C@2+_L9^\H[$
MD5^IL,R7$*2QL'C<!E93D$'H:^+QV"G@JG)+;H?H&6YC3S"ESQW6Z/&/CO\
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M6=^U=\!E^/OPRETJV=(=;L9/M>G3/]WS ""C'L&!(]N#VKP\'..$QL7/9/\
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M1_>4?F,USYKE\<935:C\7YG5DV:2P%7V%;X7^!^P'\J^0?\ @I?_ ,D;T?\
M["B?^@-7U;H.NV/B;1K/5=,N8[RPNXEG@GB;<KHPR"#7RE_P4O\ ^2-Z/_V%
M$_\ 06KXW+4UC*:?<^\S:2E@*C78_,ZOOO\ 9U_8<^'?Q3^#/AKQ3K,NL+J6
MHPO),+:[5(\B1U&T;#CA1W]:^!*_2K]EO]J;X7^ _@/X3T+7?%EMI^JV=NZS
MV[0RDH3*[ 9"$=".AK[;.IXB%*/L+WOT/SW(88:=>7UFUK=3:_X=M_"C_GOK
M_P#X')_\;I/^';7PH_Y[Z_\ ^!R?_&Z[[_AM3X+_ /0]6G_@//\ _&Z/^&U/
M@O\ ]#U:?^ \_P#\;KX_VV9=Y?B?<_5\H[1/3/ /@G3_ (<>#M*\-:49FT[3
M(!! ;A]S[1_>.!D_A71=:XOX;_&#PA\7+6\N/"6M1:S#9NL<[11NH1F&0/F4
M=AVK!_:0^+S?!'X3ZKXGA2&:^A*16D,^=LDK,  0"#C&3QZ&O-5.I4J<C7O,
M]GVM*E1]HG[B1T?C_P"$_A#XI:?]C\4Z!9ZQ$!A6GC_>)[JX^9?P(KY>\??\
M$S?">JR23^$]?O\ 07;)%K=@74(/8!CAP/J6K<^%7_!13P)XMMXH/%<<OA34
MNCLZF6V)XR0PY'7N*][TWXX_#W6;<36GC;0)DV[L?VC$& ]2"V1^->C%X[ O
ME5U^1Y,EEN91YG9_F?FI\3?V#_B;\.[2>^M[2W\2:?"-S2:6Q,@'4GRR-W ]
M,U\Z,I5B&!!'!4\'Z8K]@?B-^V!\+?A_IL\DGB>SUFZ"DQV>E2K<M(>PRI*C
M\2*_)7QAKR^*/%NMZTEK'9)J5]-=K;1?=B$DC/L'L-V/PK[+*<5B<2G[>.G<
M^"SG!X3"2C]6G>_0^L_^";/Q*O\ 2_B-J?@R29I-+U&U:[CB;D1RQD D?53^
M@K])>*_,#_@F_P"%;O5OC=>:TBXL],TZ197Q_%(P"K^A-?9O[6'[0DO[/?@K
M3M4L;6"_U.\ODACM;@D*\8RTAR.AQ@=_O9P:^8S:C[7'^SHJ[9]ADF(]CEWM
M*S]U'9_$GX%^!OBW:M%XH\.6FHR8PMS@QSI_NR*0P_.OESQY_P $Q]#NO-F\
M'^*+O3G)RMKJB":/GL'4*P'U!->B_#'_ (* ?#7QM##%K-S)X4U%@ T5\I:+
M<>/ED7C'U KV>U^-?P_O;4W$/C;P_)"HW,_]IPX7Z_-Q^-<D:F/P,N571VSI
MY9F$>9\KO]Y^77Q:_8T^)/PCL;C4KS3H]8TB#)DO-,<R!%'\3*1N ]\5X6.3
MFOUB^-G[9GPS\%^%]3MK36;7Q/JDT#Q16.G,)D9F4@;G'R@<\\U^4-Q-]HN)
M9MBQ[W+[5Z#)S@#VS7V^5XK$8F#>(C:Q^>YQA,+A:B6&E?\ 0^__ /@F7\3+
MZ_L?$O@>\G:>VL0FH6"L<^4K,5E0>B[MAQZLWK7E'_!2+0Y--^/UK?%3Y&H:
M/!(K8XW*\B,,^N%4_P# A7=?\$P/"%Q)KGC+Q2T96TB@BTV.0YP[LPD=0?\
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M)?LB,Z_1F!(KNU4*-H  [ "N;$<0RE&U&%KG5A>%XQES8B=_)''?"/X6Z/\
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HTLX+"W2"UACMH%^['$H51WX Z45\G5G[6<I]V?:T:?L*4:6]E8__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>mck-20230331_g2.jpg
<TEXT>
begin 644 mck-20230331_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!"J,] !P!VKW'^SM/_Y\8?\ OT*\1_X)[_\ )$]6_P"Q[UG_ -*37NE $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%    , 8 Z 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%_P#!/?\
MY(GJW_8]ZS_Z4FO=*\+_ .">_P#R1/5O^Q[UG_TI->Z4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN+73(;JWA2TDER(WEE>?R5D^596(9>P_;Z_8A_X*#_&O4?A_\/OV+_CS\+O
M7PO\ 6UG)!X2\6^%[O5/[5O+4!;7[4H<));VVR)XH3E?-02OO9(O+^V** /C
M_P#97_9W_P""O>E_'W1_&W[;_P"W3X$\3^!]$M;J9/"?P\\$/I3ZE?O$883=
M2N2SP1K)+)Y8(!D6)B#L&/3OVO?V8/&O[3WQ(^"MN=;TNW\"^ OB7%XR\9Z?
M<R2"[U2XL+68Z5!"H0HT:7\D-S)O9<?98]NXDX]RHH \^_:I\(_M#^._V?\
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M/@#_ ))+#?\ ;_\ Z<F%%%%?+GV(4444 %%%% !1110 4444 %%%% !1110
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M*3TW/R+HK]=/^(5W_J^W_P QA_\ ?.C_ (A7?^K[?_,8?_?.OL?]<^&O^?\
M_P"2S_\ D3X/_4#BW_H&_P#)Z?\ \F'_  :N_P#-=O\ N5__ '+5^NE?(O\
MP2N_X)7?\.S?^$[_ .+[?\)M_P )M_9?_,K_ -F_8OL?VO\ Z>I_,W_:O]G;
MY??=Q]=5^2\38W#9AGE7$8>7-"7+9V:VC%/1I/='[=PAE^+ROAVAA<5'EG'F
MNKIVO.36J;6S74****\$^E"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KYK_ ."PGQP_:!_9M_X)E_&/XX_LMV4DOCKP[X2:XT6:
M&T$[V2F:)+B\5""&:WMWFN!N!7,.6!&17TI6-X[\;>#/ &@QZUX]U>"RT^[U
M2PTI);E"R275]=PV5K#@ \R7%Q#$,\9D&2!DT ?ES^R1\%?@'^W5\-OB9\;_
M /@GY^TEX\'C%? 'A:]\(_$.V^*.J/JA\0"SO));75S+<LLY>=!%<6]PC(BN
M3&J (1]J_MF_L6>,_P!N/Q78?#GQY\>O&O@OX4:9I'VC4=(^''B-M*U#Q-JD
MLCKY5W=1CS4L[>*-6$,94327.7.(%5OS6_;K_8]\=?\ !+?]H7XY_P#!2_\
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ML45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\
MP&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_
M ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_
M /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&
M_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q
M16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P#
M8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
MP&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\
M]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C_C1]B\;_
M /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%
M8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T&[+_ ,!C
M_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
M8_XT ;%%8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C0!L45C_8O&_P#T
M&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\ P&/^-'V+QO\
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M_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HI(PXC42L"VT;B!P32T %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P" QNTO-V7F?8LLL5O$T\\JHB*6=W; 4#J2>PKYJ^,W_!6/]D'X7^)3\-O
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MFEM[][A(W@2=9(S,<)^[8YVC- 'W112*6*@LN"1R,]*6@ HHHH \+_X)[_\
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M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
M4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ
M% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_
M]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__
M #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%
M']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]
M^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,
M/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__
M #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[Z
MJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/
M^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!
MJ#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'
M_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^
MJ/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:
M@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0
M:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ
M_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4
M_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C
M#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\
MSXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V
M=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_
M 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#S
MXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_
M ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V
M=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:
M@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_
MT&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ
M_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A
M,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@
M_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#
M'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?
M#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X
M3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?
MH4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SX
MP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_
M //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=
MI_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?
MH4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\
M^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I
M_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]
MG:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^
MJN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#
M'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3
M'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X
M3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_O
MJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'
M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
MA,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% 'Q
M[_P71\2Z%J'_  2P^*5I9:I%)*_]B;44\G&N6!/Z"OYWZ_?C_@X'^.7P7\ _
ML!^)_@?K_BNPM_%_C5]-'AS0XU#7-PEOJEK<33%5&8XA'!(-[84MA023BOP'
MK]G\/J<X9)-R5KS;7FN6*NOFFOD?@/B?4IU.(8*+3<:<4_)\TW9]G9I^C044
M45]R?G)_1!_P0N\2Z%I__!+#X6VE[JD4<J?VWN1CR,ZY?D?H:^MO^$Q\,?\
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M_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C
M#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M% &/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\
M 8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_
M  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_
M -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;
M_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XUL44
M 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\ T&[+_P !
MC_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\
M 8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\
MT&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_
M -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!
MC_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/
M^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !
MC_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0
M;LO_  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVH_"OXR?MR?"?PMXFT>18]5T#7_'UA:7EF[(LBK+%)*&0E'5@"!PP/>O _\
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M($H _:Q65U#J<@C(-+110 4444 >%_\ !/?_ )(GJW_8]ZS_ .E)KW2O"_\
M@GO_ ,D3U;_L>]9_]*37NE !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7&_'OX__  B_9D^&&H_&'XW^-;30M!TU,S75RV6E<@[88D'S2RM@
MA44%CZ<&N0_;"_;7^$G[&W@ZUU/QF+O6?$NN3?9?!W@;0HO/U37[PD*L,$2Y
M.W<5#2$;5R!RQ56\?^ G[%'Q;_:&^)^G?MB_\%)3::AXBL7\_P  _":UD\W1
M?!B$@J\B\K=WW"[I#E58<9VQ^7Z6&P4/9?6,4^6GT_FFUTC^LGHO-Z/R<7F%
M3VWU7!I2J];_  P3ZS:_"*]Z7DKR7-^&_@[\>/\ @JYK]G\4_P!JS0=5\!_
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MK?QQ8?\ (>_8]^)L>/O?V?I<5U^6UQFC_7+(E\;J0_Q4*\/_ $JF@_U8S9_
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M?&FN>#]+O=8T#S_["U:[T^.2YT[ST$<WD2LI>'S$ 5]A&Y1@Y% '+?'/XZ_
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
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MZ1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M_3RB@"GX?\/Z)X4T*S\,>&M*@L-.T^U2WL;*UB"1P1(H5$51P    /:KE%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M>)_\%&?VRM'_ ."?7[$GQ#_;$UKPG-KJ>"=%6XMM&AF\O[9=33Q6UO$SX/EH
M9IHP[@$JFX@'&#[97*_'#X)_"_\ :0^$/B+X#_&KPE;Z[X4\5Z5+IVNZ3=%@
MMQ!(,$!E(9&'#*ZD,K*K*00#0!\.6WQD_P""HOA^T^)OQW\%_'KX=?$"Z\*^
M!?#?BBX^'T?@JYBT?4K2XM+FZN+?2KB.^>>"7RHSY4LGGB=E3=&F[*_:7[2W
MB[XQ^ O@AXC\9? ;POX<U?Q+IFDW-U8V?BK5)[2S)CA=P6:"&5W^95&P;,@G
MYUQS^._@_5/VK_\ @VY_:&\??\(\NN?'']DK1QX>@\6W.I3!_$G@&RNC<+9&
M$[@L]M"6D0@*L;%U&+<D,W['>/?%.@>./V=-:\:^%-3CO=+UCP5<WVFWD6=L
M]O+:-)'(,\X96!'UH \8_P""-_[7/Q5_;P_X)M?#3]K3XVP:5%XG\90:I<:G
M#H=HT%I%Y6JWEO&D2,[L%6*&,?,S$XR22:Y/]LW]I3_@H'XX_:0?]D__ ()8
MZM\"E\3^#= M]8^)EW\:;S4?)A6]9Q8V=I%IP:5IA'!+/,7&U(YK;G,@KF_^
M#9W_ )0>? ?_ +!FM?\ I]U&HOV\_P#@WM_8E_;)\:Z]^TAX)N/%7PQ^.NHW
M7]HZ;\7/"?BS4!=P:BB!8)'A><QF-=B+MB$3A%"HZ8& #UJV_:0_:$_8B_X)
M\>*OVI/^"J'B+X?7?B;P7IU]JNNQ_".UO(]+>!7V6=G;&_/FR3RL8TW.$7S)
MPN-J[V\2^(W[=O[<G[+G[#_A'_@J7^T5/X7U#P9J1T;5?B/\)]#\-R1W'A?P
M_JDL,<4MG?&8R75[:?:;=IQ(@BFQ,$6 !6KXW_X*"?M!?M7_ +37_!K'\1I/
MVE_]*^(?PZ^)47@KXDZK9J!'JLFD>);>T:[PH .9!!O8  R1NV%!P/MS_@M9
M?>&;'_@@!\5KBU>+^S6^$VG1V!&-I#R6B08_%DQ^% 'W-H6N:/XGT2S\2^'M
M2AO-/U"UCN;&\MW#1SPR*'212.JLI!![@U:KQ#_@F58>(]*_X)N_L^Z9XP61
M=6M_@CX4BU-9L[Q<+I%J) V>=VX'/OFO;Z "BLGQUXAU3PIX1O\ Q'HGA6[U
MR[M(#)!I-BRB:Z;(^1"W&?KZ5Y#_ ,-8?&S_ *,?\=_^!5M_\50 ?\$]_P#D
MB>K?]CWK/_I2:]TKYP_X)X^*=9E^!NI2OX+OD9_&FJNR%ERA:;<5/NI)4^ZF
MO=_^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V
M**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$E
MU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (27
M5_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+
MW_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4
M+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^
MEH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:
M/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_
M (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?
M_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU
M?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]
M_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W
M_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -B
MBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^
M$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_
M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
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MT&TFC\-'0]"AUV]GBL["W%N8(V/E1R/((UVX3Y=V,;UZUZ!10!\P_P#!(?\
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M; DV]M]HN(YIVF\EMB0&0E?NFB@".UM;6QM8[*RMHX888PD,,2!510,!0!P
M!P *DHHH **** /"_P#@GO\ \D3U;_L>]9_]*37NE>%_\$]_^2)ZM_V/>L_^
ME)KW2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#;6L*QQQKZ*J@ #Z5S6XMS3=PP=-]K5:OWO]U!_*LO,VOPYE^REB9^=Z=/\
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M&W'G$WB#FRS#.JW/-)1BDK0BETC'97>KZM[]+?UT4445^*'])A1110 4444
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M0< F@#W.BJVBZUHWB31[3Q%X=U:VO]/O[9+BQOK*=98;B%U#))&ZDJZ,I!#
MD$$$5XO\2/\ @II_P3J^#WC_ %#X4_%;]N;X3>'/$VDW M]4\/ZUX^L+:\M)
M2H81R0O*'1L,IVD \B@#W&BD5E=0ZG((R#2T %%%% 'A?_!/?_DB>K?]CWK/
M_I2:]TKPO_@GO_R1/5O^Q[UG_P!*37NE !1110 4444 %%%% !1110 4444
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M;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
MP+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_
M  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH
MV**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_
M (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK
M'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_  +:C_A!
M](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A
M!](_Y^;W_P "VKQ3_AKS]G'_ (7O_P */_X2.]_YX?\ "0?;_P#0_MF['V?=
MG\-_W=WR^]>7F>=Y3DWLOKU>-/VDE"/,[<TGT7^>RZL]# 95F6:>T^J4I3Y(
MN4K*]DNO_ W?0^@Z*Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VKU#SS8HK'_
M .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](
M_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!]
M(_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GY
MO?\ P+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_G
MYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\
M"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P
M+:L3QEJ'PM^'GV#_ (3CQJ-+_M2]6TT_[9J13SYFZ*,_J>@R,D9K*M7H8:DZ
ME:2C%;MM)+IN]-S2E1JUZBA3BY2?1*[^Y'9T5C_\(/I'_/S>_P#@6U'_  @^
MD?\ /S>_^!;5J9FQ16/_ ,(/I'_/S>_^!;54UK1/!OAO3)=:\1>(FL+.!=TU
MW>ZGY448]69B /Q-3.<*<7*3LENV5&,IR48J[9T=%?/VL?M/?#G6]1E\-? #
MPAXH^(NJ1ML<Z&SQV,+?]-;N0!$'^T P]Z99? K]J7XKR?:?BA\58O VE2==
M"\&S-->%?[LEW(<(WO&"I]*^7GQ9@L1)T\KIRQ4MKTTO9I^=635/3JE*4E_*
MSWH\.XJC%3Q\XX>/]^_._2FDYZ]&XJ/]X]5^*'Q\^#OP9M3<?$GX@:?ILA7=
M'9O+YES(/]F%,R,/<+BO/!^T'^T%\7?W'[//P&FT^PDX3Q5X_8VD&/[\=LF9
M90>H8'''(KH?A[^QS\!OAK<C5= \+23:H6W2:SJ-RUQ=N_=O,?)4GOMVCVK@
M/C5^UY\*_!'BU_@Y\$]!UOXG?$-LJOA;PM>EX[-@<;KRZYCMD!X;.67C<H!S
M2^H\3YIKB\1'#P?V*/O3]'5G&W_@%.+72?4KZWD& _W:BZ\OYJONQ^5.#_\
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MO_!2#0OBSKMU\._^"=GP*\6_&O6H)3!<^([>X?3?#.G2=_.U"< 2$9W!$&'
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M^"_P=^">DRZ!\&OA/X:\(V$\OF3V7AC0K>PAD?\ O,D"*I/N1FNEHH ****
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M9PJE#%0H5*FLX.,VO\2Y(RY;]FM=T?1=%>*?\,Z_M*?]'MZW_P"$I9_XT?\
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M,UZ](^LG%'TQ\</VBO@7^S7X2;QS\>/BIHOA;3 #Y<^K7JH\[ 9*11\O,_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^H6L=S8WENX:.>&10Z2*1U5E((/<&K5 !1110!X7_P $]_\ DB>K?]CWK/\
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MRC\,?NDUTD+^SL;C-<;5]W^2G>,?G+XY?)Q3ZQ/%_P!F/_@GY^RC^R2[ZO\
M"3X76[>(;C<U_P",-<D-_K%X[??=[J;+KNZLJ;$)_AKVBBBO/KXBOB:CJ5I.
M4GU;NSU,/AL/A*2I4(*,5T2LOP"BBBL3<**** "BBB@ HHHH **** "BBB@
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M8"_X*J:_X5CG?PVW[8EFMPT )C<Q>(3]I/'!_>/9L3_NDU^L/_!:R^\,V/\
MP0 ^*UQ:O%_9K?";3H[ C&TAY+1(,?BR8_"O4O@)_P $J?V?OA-^P3XG_8.\
M<W%SXQTWXBC5KOXH>)+V%;>[\1ZMJ9+7FHE4R()-VSR@I)B6"$;F9-Q\T\1_
M\$R?VE?CM^RIX*_X)R_M0?&#PKJWP;\(W&DP>(->TB*Z77_'.D:5+')8:==0
M.HAL"3;VWVBXCFG:;R6V) 9"5 />O^"95AXCTK_@F[^S[IGC!9%U:W^"/A2+
M4UFSO%PND6HD#9YW;@<^^:]OJ.UM;6QM8[*RMHX888PD,,2!510,!0!P !P
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ME'E4=$KVO9ZW/B+PY^Q[^QG^T-XEN->\ ?M2ZYXCM[N7=;:?X4\;:1=^6O\
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M;8-(\56D\H)[&-)"RGV(!KT&N"I2JT9<LXM/S5CU*5:C7CS4Y*2[IW_(Q_\
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M7O\ WTM<7X^_;1_9"^%N]/B)^U#X T:6/.ZVO_%UFDQ]A&9-['V ->/>(O\
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M^$EU?_H4+W_OI:/^$EU?_H4+W_OI:V** ,?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EK8HH Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI:V** ,?_ (275_\
MH4+W_OI:/^$EU?\ Z%"]_P"^EK8HH Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI
M:V** ,?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EK8HH Q_^$EU?_H4+W_O
MI:/^$EU?_H4+W_OI:V** ,?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EK8H
MH Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI:V** ,?_ (275_\ H4+W_OI:/^$E
MU?\ Z%"]_P"^EK8HH Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI:V** ,?_ (27
M5_\ H4+W_OI:/^$EU?\ Z%"]_P"^EK8HH Q_^$EU?_H4+W_OI:/^$EU?_H4+
MW_OI:V** ,?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EK8HH Q_^$EU?_H4
M+W_OI:/^$EU?_H4+W_OI:V** $C8O&KLA4E02IZCVI:** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_P#@GO\
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MO;:]DKVN_O"BBBN4[ HHHH *S_$GA+PKXRTXZ1XO\,Z?JMHWWK74K*.>,_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
MC6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_
M\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P
M&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]
M!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&
M[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B
M\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+Q
MO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8
M_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-
M'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL
M44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8
M_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_
M (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;L
MO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_
M\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&_
M_0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]
M!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\
M8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B
M\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%%
M&/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\
MC1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-
M;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P
M&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8
M_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&
M[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;L
MO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+Q
MO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&_
M_0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_
M &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?
M8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q1
M0!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_
M (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
MC6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_
M\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P
M&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]
M!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&
M[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B
M\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+Q
MO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8
M_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-
M'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL
M44 )&'$:B5@6VC<0.":6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#PO\ X)[_ /)$]6_['O6?_2DU[I7A?_!/
M?_DB>K?]CWK/_I2:]TH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/>L_^E)KW2ODW]C?]J3]GOX6_"J_T+Q]\6=(TZ[NO%>J7MO%),7\RWEN&*2
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M  W=^R'_ -%XT3_OJ3_XB@#UJBO)?^&[OV0_^B\:)_WU)_\ $4?\-W?LA_\
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M/_B*/^&[OV0_^B\:)_WU)_\ $4 >M45Y+_PW=^R'_P!%XT3_ +ZD_P#B*/\
MAN[]D/\ Z+QHG_?4G_Q% 'K5%>2_\-W?LA_]%XT3_OJ3_P"(H_X;N_9#_P"B
M\:)_WU)_\10!ZU17DO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\
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M]D/_ *+QHG_?4G_Q%'_#=W[(?_1>-$_[ZD_^(H ]:HKR7_AN[]D/_HO&B?\
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MOV0_^B\:)_WU)_\ $4?\-W?LA_\ 1>-$_P"^I/\ XB@#UJBO)?\ AN[]D/\
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M:** (KZPL=4M)-/U.RBN+>5=LL$\8=''H5/!%8__  J[X9_]$[T+_P %$/\
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M <__ ,*F^%?_ $33P_\ ^":#_P"(H_X5-\*_^B:>'_\ P30?_$5T%% '/_\
M"IOA7_T33P__ .":#_XBO$_VI/AYX T[XR?!>UT_P-H\$5WXWECNHX=,B59D
M^S,=K@+AAGL:^C*YOQO\*?"/Q!\1>'/%'B.&=KOPMJ37VDF&<HJS%"A+#^(8
M/2@"3_A4WPK_ .B:>'__  30?_$4?\*F^%?_ $33P_\ ^":#_P"(KH** .?_
M .%3?"O_ *)IX?\ _!-!_P#$4?\ "IOA7_T33P__ .":#_XBN@HH Y__ (5-
M\*_^B:>'_P#P30?_ !%'_"IOA7_T33P__P"":#_XBN@HH Y__A4WPK_Z)IX?
M_P#!-!_\11_PJ;X5_P#1-/#_ /X)H/\ XBN@HH Y_P#X5-\*_P#HFGA__P $
MT'_Q%'_"IOA7_P!$T\/_ /@F@_\ B*Z"B@#G_P#A4WPK_P"B:>'_ /P30?\
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M$T\/_P#@F@_^(KH** .?_P"%3?"O_HFGA_\ \$T'_P 11_PJ;X5_]$T\/_\
M@F@_^(KH** .?_X5-\*_^B:>'_\ P30?_$4?\*F^%?\ T33P_P#^":#_ .(K
MH** .?\ ^%3?"O\ Z)IX?_\ !-!_\11_PJ;X5_\ 1-/#_P#X)H/_ (BN@HH
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MA_\ \$T'_P 17044 <__ ,*F^%?_ $33P_\ ^":#_P"(H_X5-\*_^B:>'_\
MP30?_$5T%% '/_\ "IOA7_T33P__ .":#_XBC_A4WPK_ .B:>'__  30?_$5
MT%% '/\ _"IOA7_T33P__P"":#_XBC_A4WPK_P"B:>'_ /P30?\ Q%=!10!S
M_P#PJ;X5_P#1-/#_ /X)H/\ XBC_ (5-\*_^B:>'_P#P30?_ !%=!10!S_\
MPJ;X5_\ 1-/#_P#X)H/_ (BC_A4WPK_Z)IX?_P#!-!_\17044 <__P *F^%?
M_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\17044 <_P#\*F^%?_1-/#__
M ()H/_B*/^%3?"O_ *)IX?\ _!-!_P#$5T%% '/_ /"IOA7_ -$T\/\ _@F@
M_P#B*/\ A4WPK_Z)IX?_ /!-!_\ $5T%% '/_P#"IOA7_P!$T\/_ /@F@_\
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MP!_P3-\/?&#PU*T/B#P1\;O#.N^&+J(D207\+SB-T(Y# ,W3FOHO_@MZ _\
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M#<G6]5^)?CS]M7XY>+96DUS7_P!J[6[*\>4Y>.WM$46\'/.R-)RBCL%Q5/\
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M1H-5U#QYXIT&]>$X-QI]W!IL$R/C[RJL\AP> 6)K]-* "BBB@ HHHH ****
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MBW611YR[G7H?I&OSL_X*A ?\/N/^"<S8Y_MGXE\_]P.QK]$Z "BBB@ HHHH
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M/"5SX<N?VBOC1K?Q"TKPO>6Q@GTG1KN7_B7Q3Q$?N[AX1]HD3@H;@(P5D84
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MPE\3/B)X>A@T][F3F);U$E9K$L,G:Q9E +.JJKLO"_\ !&:WTWQ#_P %(?\
M@HC\!=9TJ*]\*:/\>]"\4Z?I\Z;H(]6N9+VYFG"]/,$]A:R9_O1*3T%>O?\
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M#L;>_P!-2S\+Z0[ %85:0EKRY"(UQ<G!("0H%CC)D]5_;<_9A_:F_P""K/\
MP3)T/Q9XB^#MI\,?C;X9\:VOQ ^&W@G5M1$ITN_TZZE%I97MS\JF6XM6<,RA
M$CDN$!R(BS??5% 'Y]?ML_"SXE_\%A)?@G^SU-^SYXW\#>!?#?Q&T[QQ\:[[
MQWHC:>(5L(9?+\/VWF<:A+/--A[BVWVR1PEA*S,J-[)_P67T+QQ\0?\ @FO\
M7?@K\+/AKXC\6>*_''@B^T;P[HOAS1Y;EYKF9-@,CJ/+@0;MQ:1E! (&3Q7U
M#10!X=_P38'B'3?V#/A)X#\9^!O$'AG7_"?PWT+0?$&C>(M(EM)[6^M--MX9
ME7S!MF0.IQ+&61L<-D$#Y>_X)[?#/7OV-_V"=>_X)N?MJ_LN^-O'>IZ;J_B6
M"XOM&\%W&M:;\3+'4M1NKM+HW<2M;VTLJ70AD2_EMVC:/)8)AA^B5% 'S5_P
M1_\ V0_B%^PE_P $Y/AG^RW\5=42YU_PY87LNHQ17OVE+%KN_N;U;)9?^6H@
M6X6#>/E8Q$K\I KZ5HHH **** "BBB@ HHHH **** "BBB@ HHHH **** /S
M>_;<_;$_;%\4_M2S?"^/_@DG\:?B'\&O!=]'-;IHPLK:W\9ZO#+N2XN1-)E]
M.@=%DB@QB>4++)A(UC;VSX%_$SX^_P#!3+X5?%GX._M:_L)^)/@GX"USPI)X
M;AL?%VIPW&K:W]OM[B*\E18?W<$4,;1A2=[.\A.4\O#?6M% 'YF?##P;^VM\
M#?\ @DKK'_!)=/V?/$^M?%_3_"^J_#WPAXOL],9/#%_I-R9K>TU]]2),-K%!
M9SHTEK(WVKS;<HD+[E)^SOV._P!G+P7_ ,$]/V(_ O[-N@2WVIZ=\._"D%C<
M76G:5-<7&H7 ^>XN$MX5>0M+.\LFQ0<;_09KV6B@#\^_^" /@/XR?!;X;_&K
MX??'CX"^-/ ^J^*?V@_%'C308_$F@R10W>DWQM/)<3KNB67*L#"S!^"0I )'
MTQ^TK^T7\8_#NG:G\,OV4/@!K_C'XCSQFWTJXUO1[G3/#6F2NHVWM[J5PB13
M6\>[<T5F9YW*^6J*267VRB@#YV_X)I?\$_\ P_\ \$^?@5?>#;SQG-XO\>>,
M_$=UXI^*?CZ\@$<_B+7KMM]Q<;>?+B!^6.//RJ,G+.Y/T3110 4444 %%%%
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MHTNF7WB/Q+JBI#+(EC<!;B&UMH(8F\V9(S).%$:NBEZ^YZ** "BBB@ HHHH
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MY;*C]#+:XCNK>.ZB5PLB!U$D;(P!&>58 J?8@$=Z?10 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR6>HZ#X%NY[3QCY=C<I>Z-=0_?M;FQ>(745QD@"%HA(Q("J20*\/_P"";_\
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M$UI+BS\^^O<P2Q1WU^\TD:Q"4L4172)2Z2$?5O[*?[&OQ _99_;-^(&MZ/\
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MZN/BE\4+W0-1ELKS6=$\N1=,TP7$#+)!!+<)ON%1@TD91-P5F# 'Z%45\">
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MMT>S)G%S@XIVOU6Z\T?(O_"X_P#@L_\ ]&:_"+_PXDW_ ,11_P +C_X+/_\
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M9@ "37@/[27_  2L_9B_:*^.=I^U3IVI>,/AK\6+2R%DWQ,^%/B5]'U6\M0
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MPIHTFCZ#>0ZO;1V=MITA<RVAM5MO*D20R.69U:3)!#@HA4 ^@Z*** "BBB@
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M7?#XMHVCU#6_$CVLYE(^=2@4C .,'O7LE% 'S;_PL[_@J-_T;!\-O_"UE_\
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MT?X!^";;4I(=+\$RV*126M[?0Q'_ $N_N?-V32S!_*MYW6W6/>V6_P#!._\
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M8T3X _#OQGXDU3PQX9TV#3O#=GXEO8KF33;.%-D=NDRQ)(Z*H 'F,Y4*%!
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MW35UNK]5=-772Z?H73FJ=12:3L[V>S\G:SL_4\5_X3G]N[_HA?@G_P *=_\
MXFC_ (3G]N[_ *(7X)_\*=__ (FO:J*^;_U;Q?\ T,L1]]+_ .4GN_VYAO\
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M=!BT^2>^6(ZIIUV0L5]>.[+"4W&1BX?RP5R_VD_V1_\ @F!_P3?_ &5?VO\
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MX2U'^T?"]ZUWX4\6^&]3:PU?196*ES!<*#\K;$)1U=,HK;=RJPV_V)?^"?\
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MIN]=CT\/AL/A**I4(*$5LHI)*^NB6F^H4445D;!1110 4444 %%%% !1110
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MFVE?1-VNTMKNROZ(****U,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
,B@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156015063328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">McKESSON CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3207296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555 State Hwy 161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irving<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">446-4800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,602,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">DOCUMENTS INCORPORATED BY REFERENCEPortions of the registrant&#8217;s Proxy Statement for its calendar year 2023 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common stock, $0.01 par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1.500NotesDue2025Member', window );">1.500% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.500% Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1.625NotesDue2026Member', window );">1.625% Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Notes due 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A3.125NotesDue2029Member', window );">3.125% Notes due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1.500NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1.500NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1.625NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1.625NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A3.125NotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A3.125NotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156011173104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Dallas, Texas<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche LLP<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156016892720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 276,711<span></span>
</td>
<td class="nump">$ 263,966<span></span>
</td>
<td class="nump">$ 238,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(264,353)<span></span>
</td>
<td class="num">(250,836)<span></span>
</td>
<td class="num">(226,080)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">12,358<span></span>
</td>
<td class="nump">13,130<span></span>
</td>
<td class="nump">12,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, distribution, general, and administrative expenses</a></td>
<td class="num">(7,776)<span></span>
</td>
<td class="num">(10,537)<span></span>
</td>
<td class="num">(8,849)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Claims and litigation charges, net</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(274)<span></span>
</td>
<td class="num">(7,936)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RestructuringImpairmentandOtherRelatedCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="num">(209)<span></span>
</td>
<td class="num">(281)<span></span>
</td>
<td class="num">(334)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(7,977)<span></span>
</td>
<td class="num">(11,092)<span></span>
</td>
<td class="num">(17,188)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">4,381<span></span>
</td>
<td class="nump">2,038<span></span>
</td>
<td class="num">(5,040)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">497<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(248)<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="num">(217)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="nump">4,630<span></span>
</td>
<td class="nump">1,928<span></span>
</td>
<td class="num">(5,034)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(905)<span></span>
</td>
<td class="num">(636)<span></span>
</td>
<td class="nump">695<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">3,725<span></span>
</td>
<td class="nump">1,292<span></span>
</td>
<td class="num">(4,339)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">3,722<span></span>
</td>
<td class="nump">1,287<span></span>
</td>
<td class="num">(4,340)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(162)<span></span>
</td>
<td class="num">(173)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 3,560<span></span>
</td>
<td class="nump">$ 1,114<span></span>
</td>
<td class="num">$ (4,539)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 25.05<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">25.03<span></span>
</td>
<td class="nump">7.23<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">25.25<span></span>
</td>
<td class="nump">7.35<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 25.23<span></span>
</td>
<td class="nump">$ 7.32<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">142.2<span></span>
</td>
<td class="nump">154.1<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">141.1<span></span>
</td>
<td class="nump">152.3<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RestructuringImpairmentandOtherRelatedCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Impairment and Other Related Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RestructuringImpairmentandOtherRelatedCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156010290400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 3,722<span></span>
</td>
<td class="nump">$ 1,287<span></span>
</td>
<td class="num">$ (4,340)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">674<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized gains (losses) on cash flow and other hedges</a></td>
<td class="num">(63)<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Changes in retirement-related benefit plans</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">673<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">4,395<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
<td class="num">(4,170)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(206)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 4,189<span></span>
</td>
<td class="nump">$ 1,230<span></span>
</td>
<td class="num">$ (4,316)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156010416608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,678<span></span>
</td>
<td class="nump">$ 3,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">19,410<span></span>
</td>
<td class="nump">18,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">19,691<span></span>
</td>
<td class="nump">18,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">4,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">496<span></span>
</td>
<td class="nump">898<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">44,292<span></span>
</td>
<td class="nump">46,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">2,177<span></span>
</td>
<td class="nump">2,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,635<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,947<span></span>
</td>
<td class="nump">9,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">2,277<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">1,992<span></span>
</td>
<td class="nump">1,917<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">62,320<span></span>
</td>
<td class="nump">63,298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">42,490<span></span>
</td>
<td class="nump">38,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">968<span></span>
</td>
<td class="nump">799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">4,195<span></span>
</td>
<td class="nump">4,543<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">47,957<span></span>
</td>
<td class="nump">48,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">4,626<span></span>
</td>
<td class="nump">5,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">1,387<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,402<span></span>
</td>
<td class="nump">1,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">6,625<span></span>
</td>
<td class="nump">7,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,813<span></span>
</td>
<td class="nump">1,540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities (Note 17)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, 800 shares authorized, 277 and 275 shares issued at March 31, 2023 and 2022, respectively</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">7,747<span></span>
</td>
<td class="nump">7,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">12,295<span></span>
</td>
<td class="nump">9,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(905)<span></span>
</td>
<td class="num">(1,534)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury shares, at cost, 141 and 130 shares at March 31, 2023 and 2022, respectively</a></td>
<td class="num">(20,997)<span></span>
</td>
<td class="num">(17,045)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total McKesson Corporation stockholders&#8217; deficit</a></td>
<td class="num">(1,857)<span></span>
</td>
<td class="num">(2,272)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total deficit</a></td>
<td class="num">(1,490)<span></span>
</td>
<td class="num">(1,792)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and deficit</a></td>
<td class="nump">$ 62,320<span></span>
</td>
<td class="nump">$ 63,298<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156011212624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">277,000,000<span></span>
</td>
<td class="nump">275,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember', window );">Treasury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">141,000,000<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156008767920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
<th class="th"><div>Opening retained earnings adjustments: adoption of new accounting standards</div></th>
<th class="th">
<div>Opening retained earnings adjustments: adoption of new accounting standards </div>
<div>Retained Earnings</div>
</th>
<th class="th"><div>Adjusted balance</div></th>
<th class="th">
<div>Adjusted balance </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Additional Paid-in Capital</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Retained Earnings</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Accumulated Other Comprehensive Loss</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Treasury</div>
</th>
<th class="th">
<div>Adjusted balance </div>
<div>Noncontrolling Interests</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, common stock (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance, treasury common stock (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 13,022<span></span>
</td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 5,296<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 13,009<span></span>
</td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="num">(4,383)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance common stock (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury common stock (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,925<span></span>
</td>
<td class="nump">8,202<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
<td class="num">$ (13,670)<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(3,508)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,304)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">1,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance common stock (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury common stock (shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="num">(1,792)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">7,275<span></span>
</td>
<td class="nump">9,030<span></span>
</td>
<td class="num">(1,534)<span></span>
</td>
<td class="num">$ (17,045)<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures', window );">Issuance of shares under employee plans, net of forfeitures</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (160)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(3,665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,792)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income (loss)</a></td>
<td class="nump">3,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(296)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(296)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_FormationOfBusiness', window );">Formation of SCRI Oncology, LLC</a></td>
<td class="nump">247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DerecognitionOfNoncontrollingInterests', window );">Derecognition of noncontrolling interests in McKesson Europe AG</a></td>
<td class="num">(382)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(382)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance common stock (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury common stock (shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="num">$ (1,490)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 7,747<span></span>
</td>
<td class="nump">$ 12,295<span></span>
</td>
<td class="num">$ (905)<span></span>
</td>
<td class="num">$ (20,997)<span></span>
</td>
<td class="nump">$ 367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DerecognitionOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Divestiture of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DerecognitionOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FormationOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Formation Of Business</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FormationOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseFromReclassificationToLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease from Reclassification to Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseFromReclassificationToLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Employee Stock Plans Net of Forfeitures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Employee Stock Plans Net of Forfeitures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018872304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 1.83<span></span>
</td>
<td class="nump">$ 1.67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156009199104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 3,722<span></span>
</td>
<td class="nump">$ 1,287<span></span>
</td>
<td class="num">$ (4,340)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">360<span></span>
</td>
<td class="nump">481<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Goodwill and long-lived asset impairment charges</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="num">(20)<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="num">(908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Charges (credits) associated with last-in, first-out inventory method</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Gain from sales of businesses and investments</a></td>
<td class="num">(211)<span></span>
</td>
<td class="num">(132)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(1,082)<span></span>
</td>
<td class="num">(1,843)<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(1,259)<span></span>
</td>
<td class="num">(1,169)<span></span>
</td>
<td class="num">(2,276)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Drafts and accounts payable</a></td>
<td class="nump">3,788<span></span>
</td>
<td class="nump">2,802<span></span>
</td>
<td class="nump">1,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(338)<span></span>
</td>
<td class="num">(356)<span></span>
</td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Taxes</a></td>
<td class="nump">363<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="num">(166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_IncreaseDecreaseInLitigationReserve', window );">Litigation liabilities</a></td>
<td class="num">(1,088)<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="nump">8,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">5,159<span></span>
</td>
<td class="nump">4,434<span></span>
</td>
<td class="nump">4,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments for property, plant, and equipment</a></td>
<td class="num">(390)<span></span>
</td>
<td class="num">(388)<span></span>
</td>
<td class="num">(451)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireSoftware', window );">Capitalized software expenditures</a></td>
<td class="num">(168)<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="num">(190)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</a></td>
<td class="num">(867)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates', window );">Proceeds from sales of businesses and investments, net</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">578<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(194)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(542)<span></span>
</td>
<td class="num">(89)<span></span>
</td>
<td class="num">(415)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">8,450<span></span>
</td>
<td class="nump">11,192<span></span>
</td>
<td class="nump">6,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of short-term borrowings</a></td>
<td class="num">(8,450)<span></span>
</td>
<td class="num">(11,192)<span></span>
</td>
<td class="num">(6,323)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuances of long-term debt</a></td>
<td class="nump">997<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(1,274)<span></span>
</td>
<td class="num">(1,648)<span></span>
</td>
<td class="num">(1,040)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquityAbstract', window );"><strong>Common stock transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Issuances</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchases</a></td>
<td class="num">(3,638)<span></span>
</td>
<td class="num">(3,516)<span></span>
</td>
<td class="num">(742)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(292)<span></span>
</td>
<td class="num">(277)<span></span>
</td>
<td class="num">(276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(324)<span></span>
</td>
<td class="num">(383)<span></span>
</td>
<td class="num">(178)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(4,368)<span></span>
</td>
<td class="num">(6,321)<span></span>
</td>
<td class="num">(1,693)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease', window );">Cash, cash equivalents, and restricted cash classified within Assets held for sale</a></td>
<td class="nump">470<span></span>
</td>
<td class="num">(540)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">744<span></span>
</td>
<td class="num">(2,461)<span></span>
</td>
<td class="nump">2,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of year</a></td>
<td class="nump">3,935<span></span>
</td>
<td class="nump">6,396<span></span>
</td>
<td class="nump">4,023<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of year</a></td>
<td class="nump">4,679<span></span>
</td>
<td class="nump">3,935<span></span>
</td>
<td class="nump">6,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Less: Restricted cash at end of period included in Other Noncurrent Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Less: Restricted cash at end of year included in Prepaid expenses and other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(403)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">4,678<span></span>
</td>
<td class="nump">3,532<span></span>
</td>
<td class="nump">6,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>SUPPLEMENTAL CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest, net</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes, net of refunds</a></td>
<td class="nump">$ 562<span></span>
</td>
<td class="nump">$ 359<span></span>
</td>
<td class="nump">$ 379<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseInLitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Litigation Reserve</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseInLitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156019111776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson partners with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Refer to Financial Note 20, &#8220;Segments of Business,&#8221; for additional information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control, but instead has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Certain prior period amounts have been reclassified to conform to the current year presentation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;). Among other provisions, the IR Act includes a 15% corporate minimum tax, a 1% excise tax on certain repurchases of an entity&#8217;s own common stock after December 31, 2022, and various drug pricing reforms. Based on its preliminary assessment, the Company does not currently expect the IR Act to have a material impact on its results of operations, financial position, or cash flows in the foreseeable future. The Company will continue to evaluate the full impact of these legislative changes as they are implemented.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds, short-term deposits with financial institutions, and short-term commercial papers issued by non-financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#8217;s foreign subsidiaries, including Canadian dollars, Euro, and British pounds sterling. Deposits could exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#8220;Prepaid expenses and other&#8221; and &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. Restricted cash at</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2022 primarily consisted of $395&#160;million held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities and all amounts were released during fiscal 2023, as discussed in more detail in Financial Note 17, &#8220;Commitments and Contingent Liabilities.&#8221; Additionally, restricted cash at March 31, 2022 included funds temporarily held on behalf of unaffiliated medical practice groups related to their business continuity borrowings as a result of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;). These amounts were designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds were recorded by the Company within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets at March 31, 2022. These funds were fully disbursed during fiscal 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in business entities in which the Company does not have control, but instead has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that could have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables, Net and Allowances for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are presented net of an allowance for credit losses and primarily consist of trade accounts receivable from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings, collections on past due amounts, legal disputes, and bankruptcies, as well as reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $111 million and $89 million were included in &#8220;Receivables, net&#8221; in the Consolidated Balance Sheets as of March 31, 2023 and 2022, respectively. Changes in the allowance for the year ended March 31, 2023 were primarily within the U.S Pharmaceutical and Medical-Surgical Solutions segments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s receivables as of March 31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,410&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,583&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentrations of Credit Risk and Receivables: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During fiscal 2023, sales to the Company&#8217;s ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately 68% of its total consolidated revenues and approximately 42% of total trade accounts receivable at March 31, 2023. Sales to the Company&#8217;s largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 27% of its total consolidated revenues in fiscal 2023 and comprised approximately 21% of total trade accounts receivable at March 31, 2023. As a result, the Company&#8217;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies, and other healthcare providers, as well as with government entities and agencies. The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from GPOs or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#8217;s financial condition, results of operations, and liquidity. In addition, trade accounts receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy, changes in reimbursement policies, and other factors. This credit risk is mitigated by the size and diversity of the Company&#8217;s customer base as well as its geographic dispersion.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#8220;LIFO&#8221;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and 2022, total inventories, net were $19.7 billion and $18.7 billion, respectively, in the Company&#8217;s Consolidated Balance Sheets. The LIFO method was used to value approximately 64% and 63% of the Company&#8217;s inventories at March 31, 2023 and 2022, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $384&#160;million and $383&#160;million higher than the amounts reported at March 31, 2023 and 2022, respectively. These amounts are equivalent to the Company&#8217;s LIFO reserves. The Company&#8217;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized a LIFO charge of $1 million in fiscal 2023 and LIFO credits of $23 million and $38 million in fiscal 2022 and fiscal 2021, respectively, all within &#8220;Cost of sales&#8221; in its Consolidated Statements of Operations. The LIFO charge in fiscal 2023 compared to LIFO credits in fiscal 2022 and fiscal 2021 are primarily due to higher brand inflation and lower generics deflation, offset by significantly higher off patent launch activity in fiscal 2023. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March 31, 2023 and 2022, inventories at LIFO did not exceed market. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and Handling Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company includes costs to pack and deliver inventory to its customers in &#8220;Selling, distribution, general, and administrative expenses&#8221; in its Consolidated Statements of Operations. Shipping and handling costs of $1.2 billion, $1.1 billion, and $1.0 billion were recognized in fiscal 2023, fiscal 2022 and fiscal 2021, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Held for Sale: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed during each reporting period it remains classified as held for sale, and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and Equipment, Net: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzc5_434691cb-3c7b-46f0-b8e5-b9ad93bbc229">three</span> to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives of the right-of-use (&#8220;ROU&#8221;) asset or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s property, plant, and equipment, net as of March 31, 2023 and 2022:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total depreciation expense for property, plant, and equipment, net and amortization of the ROU assets of finance leases was $272&#160;million, $312&#160;million, and $344&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company leases facilities and equipment primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components, such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0MzI0_4fd24846-796a-4644-bf59-7de3fb2a6e2d">one</span>&#160;to 15 years, while remaining terms for equipment leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0NDA0_da16eb7b-c863-47a8-b5b6-560d55f8d8c1">one</span>&#160;to five years. Most real property leases contain renewal options (typically for five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating ROU assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#8217;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#8217;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. Operating lease liabilities are recorded in &#8220;Current portion of operating lease liabilities&#8221; and &#8220;Long-term operating lease liabilities,&#8221; and the corresponding lease assets are recorded in &#8220;Operating lease right-of-use assets&#8221; in the Company&#8217;s Consolidated Balance Sheets. Finance lease assets are included in &#8220;Property, plant, and equipment, net&#8221; and finance lease liabilities are included in &#8220;Current portion of long-term debt&#8221; and &#8220;Long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a lessor, the Company primarily leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 9, &#8220;Leases,&#8221; for additional information on the Company&#8217;s leases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment on an annual basis in the first fiscal quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#8220;DCF&#8221;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#8217; fair values to the Company&#8217;s market capitalization as further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline public companies for comparisons, and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently all of the Company&#8217;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE4NzYz_104a5783-416c-41d1-9774-e5859d78ef41">one</span> to 25 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from the use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair value.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitalized Software Held for Internal Use: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years. As of March 31, 2023 and 2022, capitalized software held for internal use was $353 million and $320 million, respectively, net of accumulated amortization of $1.5 billion and $1.4 billion, respectively, and is included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $101&#160;million, $116&#160;million, and $117&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Programs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#8220;Captives&#8221;) from which it obtains coverage for various exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company as discussed in more detail in Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; as well as those risks required to be insured by law or contract. It is the Company&#8217;s policy to retain a significant portion of certain losses, including those related to workers&#8217; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#8217;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#8217;s premium costs within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#8217;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#8217; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#8217;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 99% and 1% of total revenues, respectively, for the year ended March 31, 2023, and approximately 98% and 2% of total revenues, respectively, for each of the years ended March 31, 2022 and 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.1 billion, $3.2 billion, and $3.1 billion for fiscal 2023, fiscal 2022, and fiscal 2021, respectively. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March 31, 2023 and 2022. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#8217;s services arrangements and are recognized as revenues over the periods when services are performed. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March 31, 2023 and 2022. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Incentives:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Reserves: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims could be different than the Company&#8217;s estimate. The supplier reserves primarily pertain to the Company&#8217;s U.S. Pharmaceutical segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon effective settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Interest expense primarily includes interest for the Company&#8217;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#8217; deficit accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; deficit section of the Consolidated Balance Sheets. Gains and losses from currency exchange transactions are recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations and were not material for the years ended March 31, 2023, 2022, or 2021. The Company releases cumulative translation adjustments from stockholders&#8217; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro-rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Financial Instruments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company has used foreign currency-denominated notes and uses cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; deficit section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Any cash flows received or paid as part of the termination of derivative financial instruments are classified within the Consolidated Statements of Cash Flows in accordance with the nature of the hedged item. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings. Refer to Financial Note 14, &#8220;Hedging Activities,&#8221; for additional information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Income (Loss): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, as well as gains and losses that are recorded as an element of stockholders&#8217; deficit but are excluded from earnings. The Company&#8217;s other comprehensive income (loss) primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency, including gains and losses on net investment hedges, as well as unrealized gains and losses on cash flow hedges and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unrealized gains and losses on retirement-related benefit plans. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests and Redeemable Noncontrolling Interests: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income or loss that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes third-party equity interests in the Company&#8217;s consolidated entities, including: ClarusONE Sourcing Services LLP (&#8220;ClarusONE&#8221;), a joint venture established between McKesson and Walmart Inc. in fiscal 2017; Vantage Oncology Holdings, LLC (&#8220;Vantage&#8221;), a provider of integrated oncology and radiation services acquired in fiscal 2017; and SCRI Oncology, LLC (&#8220;SCRI Oncology&#8221;), an oncology research business formed in the third quarter of fiscal 2023 combining McKesson&#8217;s U.S. Oncology Research (&#8220;USOR&#8221;) and HCA Healthcare, Inc.&#8217;s (&#8220;HCA&#8221;) Sarah Cannon Research Institute (&#8220;SCRI&#8221;). Net income attributable to noncontrolling interests also included recurring compensation that the Company was obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. The Company&#8217;s noncontrolling interest in McKesson Europe was included in the divestiture of certain of the Company&#8217;s businesses in the European Union (&#8220;E.U.&#8221;) in October 2022. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#8217;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#8217; deficit in the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 7, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; for additional information on noncontrolling and redeemable noncontrolling interests, and Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for additional information on the acquisition and divestiture activity discussed above.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees. Refer to Financial Note 4, &#8220;Share-Based Compensation,&#8221; for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews all material contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; for additional information related to controlled substances claims to which the Company is a party.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at fair value at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are expensed as incurred. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; for additional information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, including contingent consideration, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a variation of the income approach, whereby a forecast of future cash flows attributable to the asset is discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#8217;s expected useful life.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration liabilities are measured at their fair value as of the acquisition date using unobservable inputs. These inputs include the estimated amount and timing of projected operational and financial information, the probability of achievement of performance milestones or other agreed-upon events, and the risk-adjusted discount rate used to calculate the present value of the probability-weighted projected financial information. Contingent liabilities are remeasured to fair value at each reporting date until the liability is resolved. Changes in any of the inputs could result in a significant adjustment to the fair value.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Treasury Stock:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> We record purchases of treasury stock at cost, which is reflected as a reduction to stockholders&#8217; equity in the Company&#8217;s Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock, including any excise tax recognized as a result of the IR Act, are included in the cost of the shares acquired. Treasury stock also includes shares withheld to satisfy the tax obligations of recipients of share-based compensation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adopted accounting standards during fiscal 2023 that had a material impact to the Company&#8217;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of such equity security, and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect that this guidance will have a material impact on its consolidated financial statements or related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156011258256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Business Acquisitions and Divestitures</a></td>
<td class="text">Business Acquisitions and Divestitures <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rx Savings Solutions, LLC</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, the Company completed its acquisition of 100% of the shares of Rx Savings Solutions, LLC (&#8220;RxSS&#8221;), a privately-owned company headquartered in Overland Park, Kansas, to further connect biopharma and payer services to patients. RxSS is a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers. The purchase consideration included a payment of $600&#160;million in cash made upon closing and a maximum of $275&#160;million of contingent consideration based on RxSS&#8217; operational and financial performance through calendar year 2025. The payment made upon closing was funded from cash on hand. The financial results of RxSS are included in the Company&#8217;s RxTS segment as of the acquisition date. The transaction was accounted for as a business combination.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a liability for the contingent consideration at its fair value of $92&#160;million as of the acquisition date. As of March 31, 2023, the current portion of $83&#160;million is included within &#8220;Other accrued liabilities&#8221; and the long-term portion of $9&#160;million is included within &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet. The fair value of the contingent consideration liability was estimated using a Monte Carlo simulation model, utilizing internal cash flow projections which are Level 3 inputs under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The contingent liability will be remeasured to fair value at each reporting date until the liability is resolved with changes in fair value being recognized within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Company&#8217;s Consolidated Statements of Operations. Recognition of the initial fair value of this contingent consideration is a non-cash investing activity.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation included acquired identifiable intangible assets of $229&#160;million, primarily representing customer relationships and technology with a weighted average amortization period of 12 years, and goodwill of $463&#160;million. Goodwill has been allocated to the Company&#8217;s RxTS segment, which reflects the expected future benefits from certain synergies and intangible assets that do not qualify for separate recognition. Goodwill attributable to the acquisition is deductible for tax purposes.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary purchase price allocation for this acquisition:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized<br/>as of Acquisition Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets acquired and liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable net assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SCRI Oncology, LLC</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, the Company completed a transaction with HCA to form SCRI Oncology, an oncology research business, combining McKesson&#8217;s USOR and HCA&#8217;s SCRI based in Nashville, Tennessee, to advance cancer care and increase access to oncology clinical research. Upon consummation of the transaction, McKesson owns a 51% controlling interest in the combined business, and the financial results are consolidated by the Company and reported within its U.S. Pharmaceutical segment as of the acquisition date. Transaction consideration included the transfer of full ownership interest in USOR to the combined business and $173&#160;million of cash paid to HCA, which was funded from cash on hand. The transaction was accounted for as a business combination.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation included acquired identifiable intangible assets of $177&#160;million, primarily representing customer relationships as well as trademarks and trade names with a weighted average amortization period of 17 years, and goodwill of $120&#160;million. Goodwill has been allocated to the Company&#8217;s U.S. Pharmaceutical segment, which reflects the expected future benefits from certain synergies and intangible assets that do not qualify for separate recognition. Goodwill attributable to the acquisition of $49&#160;million is deductible for tax purposes. The Company recorded noncontrolling interest of $225&#160;million as a component of equity, which includes HCA&#8217;s proportionate interest in the identifiable net assets of SCRI at fair value of $205&#160;million and its proportionate interest in the contributed net assets of USOR at carrying value of $20&#160;million. The difference between the fair value of the Company&#8217;s acquired interest in SCRI net assets and the $173&#160;million of cash paid to HCA was recognized as additional paid in capital, as well as the Company&#8217;s reduction in ownership interest in USOR net assets. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary purchase price allocation for this acquisition:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized<br/>as of Acquisition Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution of USOR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets acquired and liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable net assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the acquired identifiable intangible assets from the acquisitions discussed above were determined by applying the income approach, using a discounted cash flow model in which cash flows anticipated over several periods are discounted to their present value using an appropriate rate that is commensurate with the risk inherent with the transaction. These inputs are considered Level 3 inputs under the fair value measurements and disclosure guidance. Due to the recent timing of these acquisitions, the amounts presented above are subject to change as the Company&#8217;s fair value assessments are finalized. Pro forma financial information has not been provided as these acquisitions did not have a material impact, individually, or in the aggregate, to the Company&#8217;s consolidated results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestitures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the Company announced its intention to exit its businesses in Europe (&#8220;European Divestiture Activities&#8221;), as discussed in more detail below. Assets and liabilities of $4.5&#160;billion and $4.7&#160;billion, respectively as of March 31, 2022, met the criteria for classification as held for sale in the Company&#8217;s Consolidated Balance Sheet, primarily consisting of disposal groups related to the Company&#8217;s European Divestiture Activities within the International segment. At March 31, 2023, the Company had no assets or liabilities related to these divestiture activities that met the classification of held for sale and the decrease in these amounts during fiscal 2023 was driven by the divestiture of the Company&#8217;s E.U. disposal group (as defined below) in October 2022 and U.K. disposal group (as defined below) in April 2022, each as discussed in more detail below. During the year ended March 31, 2022, the Company recorded charges totaling $1.6&#160;billion primarily to remeasure the assets and liabilities of the disposal groups to fair value less costs to sell. These charges were largely driven by declines in the Euro and British pound sterling. Net gains and charges related to these divestiture activities during the years ended March 31, 2023 and 2021 were not material. The gains and charges for each year were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. The Company determined that the disposal groups did not meet the criteria for classification as discontinued operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Divestiture Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, the Company completed its previously announced transaction to sell certain of its businesses in the E.U. located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#8220;E.U. disposal group&#8221;) to the PHOENIX Group. As part of the transaction, the Company received cash proceeds of $892&#160;million and divested net assets of $1.3&#160;billion, including cash of $319&#160;million, derecognized the carrying value of its noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) of $382&#160;million, and released $153&#160;million of net accumulated other comprehensive loss.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended March 31, 2023 and 2022, the Company recorded net gains of $66&#160;million and net charges totaling $438&#160;million, respectively, to remeasure the E.U. disposal group to fair value less costs to sell. The charges for the year ended March 31, 2022 also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole and net losses of $151&#160;million related to the accumulated other comprehensive loss balances associated with the E.U. disposal group, driven by declines in the Euro. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. The Company&#8217;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet at March 31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges in fiscal 2022 related to the impairment of individual assets, including a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2022, the Company completed the previously announced sale of its retail and distribution businesses in the United Kingdom (&#8220;U.K. disposal group&#8221;) to Aurelius Elephant Limited for a purchase price of &#163;110&#160;million (or, approximately $144 million), including certain adjustments. As part of the transaction, the Company divested net assets of $615&#160;million and released $731&#160;million of accumulated other comprehensive loss and the buyer assumed and repaid a note payable to the Company of $118&#160;million. During the year ended March 31, 2022, the Company recorded charges totaling $1.2 billion, primarily consisting of adjustments to remeasure the U.K. disposal group to fair value less costs to sell. The remeasurement adjustments included a $734 million loss related to the accumulated other comprehensive loss balances associated with the U.K. disposal group, driven by declines in the British pound sterling. The charges were recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations. The Company&#8217;s measurement of the fair value of the U.K. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet at March 31, 2022 were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2022, the Company completed the sale of its Austrian business to Quadrifolia Management GmbH in a management-led buyout for a purchase price of &#8364;244&#160;million (or, approximately $276 million), including certain adjustments. The Company divested net assets of the Austrian business of $272 million and the buyer assumed a note payable to the Company of approximately $63 million which was paid to McKesson in the fourth quarter of fiscal 2022. During the year ended March 31, 2022, the Company recognized a loss of $32 million which was recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the divestiture activities discussed above, the Company&#8217;s European operations primarily consist of its retail and distribution businesses in Norway.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">German Pharmaceutical Wholesale Joint Venture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2020, the Company completed a transaction with Walgreens Boots Alliance (&#8220;WBA&#8221;) whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson had a 30% noncontrolling interest. Transaction consideration for the contribution included a receivable amount of $41 million, primarily related to working capital and net debt adjustments from WBA, which was received in the first quarter of fiscal 2022, and the 30% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was nil as of March 31, 2021. The Company accounted for its interest in the joint venture as an equity method investment within the International segment. The joint venture also assumed a note payable to the Company in the amount of approximately $291 million as of the transaction date, which was paid to the Company in fiscal 2021. In conjunction with the contribution, the Company recorded charges of $58 million in the year ended March 31, 2021, which included adjustments to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations. The Company&#8217;s measurement of the fair value of the German pharmaceutical wholesale business disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA. Refer to Financial Note 5, &#8220;Other Income, Net,&#8221; for information regarding the divestiture of this investment.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the periods presented, the Company also completed de minimis acquisitions and divestitures within its operating segments. Financial results for the Company&#8217;s business acquisitions have been included in its consolidated financial statements as of their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156016903888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring, Impairment, and Related Charges, Net</a></td>
<td class="text">Restructuring, Impairment, and Related Charges, Net <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges, net, of $209 million, $281 million, and $334 million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively. These charges are included in &#8220;Restructuring, impairment, and related charges, net&#8221; in the Consolidated Statements of Operations. </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, the Company approved a broad set of initiatives to drive operational efficiencies and increase cost optimization efforts, with the intent of simplifying its infrastructure and realizing long-term sustainable growth. These initiatives include headcount reductions and the exit or downsizing of certain facilities. The Company anticipates total charges of approximately $125&#160;million across its RxTS and U.S. Pharmaceutical segments as well as Corporate, consisting primarily of employee severance and other employee-related costs, facility and other exit-related costs, as well as long-lived asset impairments. The Company recorded charges of $60 million for the year ended March 31, 2023 related to this program, which reflects severance and other employee-related costs within its RxTS segment as well as asset impairments and accelerated depreciation, including certain asset impairments primarily within its U.S. Pharmaceutical segment and real estate charges within Corporate. This restructuring program is anticipated to be substantially complete by the end of fiscal 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#8217;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $124&#160;million for the year ended March 31, 2022, primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in fiscal 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2021, the Company committed to an initiative within the U.K., which was included in the Company&#8217;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative included reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Charges incurred for this initiative were not material for the year ended March 31, 2022 and were $57 million for the year ended March 31, 2021, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. This initiative was substantially complete in fiscal 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company implemented centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also included reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company recorded charges of $62 million for the year ended March 31, 2021, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. This initiative was substantially complete in fiscal 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. As a result, the Company recorded charges of $28 million for the year ended March 31, 2021, consisting primarily of employee retention expenses, severance, long-lived asset impairments, and accelerated depreciation. The relocation was substantially complete in January 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2023 </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2023 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to operational efficiencies and cost optimization efforts described above to support the Company&#8217;s technology solutions.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. Corporate includes costs for business transformation and optimization efforts related to the Company&#8217;s technology organization. The International segment includes costs related to the Company&#8217;s European divestitures. </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2022</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2022 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. For the Company&#8217;s International segment, costs primarily relate to optimization programs in Canada, exit-related actions for the Company&#8217;s European Divestiture Activities, and programs for operating model and cost optimization efforts in the U.K. as described above. For Corporate, primarily represents costs related to the transition to the partial remote work model described above and various other initiatives. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#8217;s headquarters described above in addition to various other initiatives.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the years ended March 31, 2023 and 2022: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Other primarily includes cumulative translation adjustments and transfers to certain other liabilities. For the Company&#8217;s International segment, other also includes a reduction to the liability for the divestitures of the E.U. disposal group and the U.K. disposal group in fiscal 2023, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#8220;Other accrued liabilities,&#8221; $36 million was recorded in &#8220;Liabilities held for sale,&#8221; and $36 million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets. </span></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;As of March 31, 2023, the total reserve balance was $92 million, of which $66 million was recorded in &#8220;Other accrued liabilities&#8221; and $26 million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2023</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material long-lived asset impairments recorded in fiscal 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2022</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2022, the Company recognized charges totaling $36 million to impair certain long-lived assets within the International segment related to the Company&#8217;s previous operations in Denmark and its retail pharmacy businesses in Canada. The Company used an income approach and a market approach to estimate the fair value of the long-lived assets. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span>fiscal 2021, the Company recognized charges of $115 million to impair certain long-lived assets within the Company&#8217;s International segment. These charges primarily related to long-lived assets associated with the Company&#8217;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach and a market approach to estimate the fair value of the long-lived assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156099269424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based CompensationThe Company provides share-based compensation to its employees, officers, and non-employee directors, including restricted stock units (&#8220;RSUs&#8221;), performance-based stock units (&#8220;PSUs&#8221;), stock options, and an employee stock purchase plan (&#8220;ESPP&#8221;) (collectively, &#8220;share-based awards&#8221;). Most of the share-based awards are granted in the first quarter of each fiscal year.<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest. The Company estimates the number of share-based awards that will ultimately vest primarily based on historical experience. The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur. The actual forfeitures in future reporting periods could be higher or lower than current estimates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact on Net Income</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of share-based compensation expense and related tax benefits were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit for share-based compensation expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes compensation expense recognized for RSUs and PSUs.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax benefit for fiscal 2023, fiscal 2022, and fiscal 2021 included discrete income tax benefit of $58 million and $10 million, and discrete income tax expense of $1 million, respectively. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the Company&#8217;s stockholders approved the McKesson Corporation 2022 Stock Plan (the &#8220;2022 Stock Plan&#8221;), to replace the McKesson Corporation 2013 Stock Plan (the &#8220;2013 Stock Plan&#8221;), which expired in 2023. The 2022 Stock Plan permits the grant of awards in the form of restricted stock, RSUs, PSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The shares previously reserved under the 2013 Stock Plan described below are no longer available for issuance pursuant to the 2022 Stock Plan. As of March 31, 2023, 4.9 million shares remain available for future grant under the 2022 Stock Plan.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2013, the Company&#8217;s stockholders approved the 2013 Stock Plan to replace the McKesson Corporation 2005 Stock Plan (the &#8220;2005 Stock Plan&#8221;), which expired in 2013. Under these stock plans, the Company issued restricted stock, RSUs, PSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The 2013 Stock Plan reserved 30.0 million shares plus unused reserved shares under the 2005 Stock Plan. As of March 31, 2023, no shares remain available for future grant under the 2013 Stock Plan.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Unit Awards</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs entitle the holder to receive a specified number of shares of the Company&#8217;s common stock which vest over a period of generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzIxMDA_29caba71-3a79-4459-a81e-59ee51b81951">three</span> to four years as determined by the Compensation Committee at the time of grant. The fair value of the award is determined based on the price of the Company&#8217;s common stock on the grant date and the related compensation expense is recognized over the vesting period on a straight-line basis. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-employee directors receive an annual grant of RSUs, which vest immediately and are expensed upon grant. The director may elect to receive the underlying shares immediately or defer receipt of the shares if they meet director stock ownership guidelines. The shares will be automatically deferred for those directors who do not meet the director stock ownership guidelines. At March 31, 2023, approximately 37,000 RSUs for the Company&#8217;s directors were vested.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSUs are conditional upon the attainment of market and performance objectives over a specified period. The number of vested PSUs is assessed at the end of a three-year performance period upon attainment of meeting certain earnings per share targets, average return on invested capital, and for certain participants, total shareholder return relative to a peer group of companies and, for special PSUs granted in 2019, meeting certain cumulative operating profit metrics. The Company uses the Monte Carlo simulation model to measure the fair value of the total shareholder return portion of the PSUs. The earnings per share portion of the PSUs is measured at the grant date market price. PSUs have a requisite service period of generally three years. Expense is attributed to the requisite service period on a straight-line basis based on the fair value of the PSUs, adjusted for the performance modifier at the end of each reporting period. For PSUs that are designated as equity awards, the fair value is measured at the grant date.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the Monte Carlo valuations were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></div></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity for restricted stock unit awards (RSUs and PSUs) during fiscal 2023:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.77&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts less than a million are shown as zero in the table above.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to restricted stock unit award activity: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted with an exercise price at no less than the fair market value and those options granted under the stock plans generally have a contractual term of seven years and follow a four-year vesting schedule. The Company did not grant any stock options during the years ended March 31, 2023, 2022, and 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for stock options is recognized on a straight-line basis over the requisite service period and is based on the grant-date fair value for the portion of the awards that is ultimately expected to vest. The Company uses the Black-Scholes options-pricing model to estimate the fair value of its stock options. Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock options outstanding at March 31, 2023:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range of Exercise<br/>Prices</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Outstanding<br/>at Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Exercisable at<br/>Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$123.98</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$182.78</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.36&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.36&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during fiscal 2023:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable, March 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.36&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of options expected to vest takes into account an estimate of expected forfeitures.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The intrinsic value is calculated as the difference between the period-end market price of the Company&#8217;s common stock and the exercise price of &#8220;in-the-money&#8221; options. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to stock option activity:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value on exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received upon exercise</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized related to exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of stock options vested</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which stock option compensation cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an ESPP under which 23.1 million shares have been authorized for issuance. The ESPP allows eligible employees to purchase shares of the Company&#8217;s common stock through payroll deductions. The deductions occur over three-month purchase periods and the shares are then purchased at 85% of the market price at the end of each purchase period. Employees are allowed to terminate their participation in the ESPP at any time during the purchase period prior to the purchase of the shares. The 15% discount provided to employees on these shares is included in compensation expense. The shares related to funds outstanding at the end of a quarter are included in the calculation of diluted weighted-average shares outstanding. These amounts have not been significant for all the years presented. The Company recognizes costs for employer matching contributions as ESPP expense over the relevant purchase period. Shares issued under the ESPP were not material in fiscal 2023, fiscal 2022, and fiscal 2021. At March 31, 2023, 3.6 million shares remain available for issuance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156099218288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other Income, Net</a></td>
<td class="text">Other Income, Net<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of the following:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains on investments in equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The increase in interest income for fiscal 2023 compared to fiscal 2022 and fiscal 2021 is primarily due to higher interest rates on certain cash balances.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily recorded within the Company&#8217;s International segment for fiscal 2022 and fiscal 2021. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents net realized and unrealized gains as well as impairment charges on the Company&#8217;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on the disposal of certain of these investments, including a gain of $142 million for the year ended March 31, 2023 related to the exit of one of the Company&#8217;s investments in equity securities in July 2022 for proceeds of $179 million. Refer to Financial Note 15, &#8220;Fair Value Measurements&#8221; for more information on these types of investments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other, net for year ended March 31, 2023 includes the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $126 million related to a cash payment received for the early termination of a tax receivable agreement (&#8220;TRA&#8221;) exercised by Change Healthcare Inc. (&#8220;Change&#8221;) in October 2022. The Company was a party to a TRA entered into as part of the formation of the joint venture with Change, from which McKesson has since exited. The TRA generally required Change to pay the Company 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the amortization allocated to Change by the joint venture. In October 2022, Change exercised its right pursuant to the TRA to terminate the agreement; and </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $97 million recognized from the termination of certain forward starting fixed interest rate swaps, as discussed in more detail in Financial Note 14, &#8220;Hedging Activities.&#8221;</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other, net for the year ended March 31, 2022 includes a gain of $42&#160;million as part of the completed sale of the Company&#8217;s previously held 30% interest in its German pharmaceutical wholesale joint venture to WBA. </span></div>Other, net for all periods presented also includes income recognized from finance charges to customers primarily for late fees.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI https://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI https://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156099340528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,630&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) related to continuing operations consists of the following: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except percentages)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(908)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the Company&#8217;s reported income tax rates are primarily due to non-cash charges related to remeasuring the value of the E.U. disposal group and U.K. disposal group held for sale to fair value less costs to sell in fiscal 2022, the impact of opioid-related claims, including charges of $8.1 billion ($6.8 billion after-tax) in fiscal 2021, changes in the mix of earnings between various taxing jurisdictions, and other discrete items recognized in each fiscal year.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21.0% to income before income taxes was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax benefit on intellectual property transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E.U. disposal transaction loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s effective tax rates were impacted by other favorable U.S. federal permanent differences, including research and development credits of $4 million in each of fiscal 2023 and fiscal 2022, and $5 million in fiscal 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2023, the Company recognized discrete tax benefits primarily consisting of $115 million related to statute of limitation expirations and tax settlements in various taxing jurisdictions and $58 million related to the tax impact of share-based compensation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2022, the Company recorded non-deductible, non-cash pre-tax charges of $438 million primarily to remeasure the E.U. disposal group to fair value less costs to sell, and $1.2 billion to remeasure the U.K. disposal group to fair value less costs to sell, as described in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rate for fiscal 2022 and fiscal 2021 was impacted by the charge for opioid-related claims of $274 million ($237 million after-tax) and $8.1 billion ($6.8 billion after-tax), respectively, as described in Financial Note 17, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reported income tax rate for fiscal 2021 was unfavorably impacted by a non-deductible, non-cash pre-tax charge of $58 million, primarily to remeasure the carrying value of assets and liabilities held for sale related to the formation of a German pharmaceutical wholesale joint venture, which the Company exited in fiscal 2022. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; and Financial Note 5, &#8220;Other Income, Net,&#8221; for more information. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gains were eliminated upon consolidation. The acquiring entities of the intellectual property were entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#8220;Intra-Entity Transfers of Assets Other Than Inventory,&#8221; discrete tax benefits of $105 million were recognized for fiscal 2021, with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#8217;s excess tax basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax balances consisted of the following:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable allowances</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefit related accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,607&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory valuation and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,079)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets and systems development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(401)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,809)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,828)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,221)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,221)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the available positive and negative evidence to determine whether deferred tax assets are more likely than not to be realized.&#160;As a result of this assessment, valuation allowances have been recorded on certain deferred tax assets in various tax jurisdictions.&#160;The valuation allowances were approximately $696 million and $726 million in fiscal 2023 and fiscal 2022, respectively, and primarily relate to net operating and capital losses incurred in certain tax jurisdictions for which no tax benefit was recognized. The decrease in the valuation allowance of $30 million in the current fiscal year relates primarily to the remeasurement of foreign loss carryforwards and their related valuation allowance for foreign exchange fluctuations, partially offset by the net operating losses incurred and deferred tax movements in certain tax jurisdictions for which no tax benefit was recognized. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has federal, state, and foreign net operating loss carryforwards of $49 million, $3.4 billion, and $2.0 billion at March 31, 2023, respectively. Federal and state net operating losses will expire at various dates from 2024 through 2043. Substantially all its foreign net operating losses have indefinite lives. In addition, the Company has foreign capital loss carryforwards of $701 million with indefinite lives. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits for the last three fiscal years:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on the lapse of the applicable statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company had $1.4 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate, if recognized. The decreases in unrecognized tax benefits in each fiscal year are primarily attributable to statute of limitation expirations in various taxing jurisdictions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the next twelve months, the Company does not expect any material reduction in its unrecognized tax benefits. However, this may change as the Company continues to have ongoing discussions with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 17, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2023, the Internal Revenue Service (&#8220;IRS&#8221;) communicated proposed adjustments to taxable income reported in the Company&#8217;s fiscal 2018 and fiscal 2019 U.S. Federal Corporate Income Tax returns. The adjustments would increase federal income tax liability in the range of $600&#160;million to $700&#160;million. The Company disagrees with the proposed adjustments and intends to pursue resolution through the administrative process with the IRS Independent Office of Appeals and, if necessary, through judicial remedies. The Company expects it could take several years to reach a final resolution on these matters. Although the final resolution of these matters is uncertain, the Company believes in the merits of its tax positions and believes that it has adequately reserved for any adjustments to the provision of income taxes that may ultimately result. However, if the IRS prevails in these matters, the assessed tax and interest, if any, could have a material adverse effect on the Company&#8217;s financial position, results of operations, and cash flows in the period of resolution.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports interest and penalties on income taxes as income tax expense. It recognized income tax expense of $31 million, $8 million, and $9 million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively, representing interest and penalties, in its Consolidated Statements of Operations. As of March 31, 2023 and 2022, the Company accrued cumulatively $138&#160;million and $108&#160;million, respectively, in interest and penalties on unrecognized tax benefits in its Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal 2015 through the current fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign operations of approximately $4.8 billion were considered indefinitely reinvested at March 31, 2023. Following the enactment of the 2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. However, the repatriation of cash held outside the U.S. could be subject to applicable foreign withholding taxes and state income taxes.&#160;The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so. It does not expect the tax impact from remitting these earnings to be material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156099218288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text">Redeemable Noncontrolling Interests and Noncontrolling Interests <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s previously recognized redeemable noncontrolling interests primarily related to its former consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;0.83 per share. The Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million and $43 million for the years ended March 31, 2022 and 2021, respectively. All amounts were recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Consolidated Statements of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Domination Agreement&#8217;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#8220;Appraisal Proceedings&#8221;) with the Stuttgart Regional Court to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified in the Domination Agreement. On September 19, 2018, that court ruled that the Put Amount shall be increased by &#8364;0.51 resulting in an adjusted Put Amount of &#8364;23.50. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount remained at &#8364;22.99, thereby rejecting the lower court&#8217;s increase, and the recurring compensation remained at &#8364;0.83 per share.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercises of the Put Right reduced the balance of redeemable noncontrolling interests. The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income or loss, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2022 and fiscal 2021, the Company paid $1.0 billion and $49 million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the redeemable noncontrolling interests by $983 million and $49&#160;million, respectively, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $178 million and $3 million, respectively, as an increase to McKesson stockholders&#8217; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; in the Consolidated Balance Sheet.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE, Vantage, and SCRI Oncology. As discussed above, after June 15, 2021, noncontrolling interests also represented minority shareholder equity interests in McKesson Europe and at March 31, 2022, the Company owned approximately 95% of McKesson Europe&#8217;s outstanding common shares. The Company&#8217;s noncontrolling interest in McKesson Europe was included in the divestiture of the E.U. disposal group in October 2022, as discussed in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests in the Company&#8217;s Consolidated Balance Sheets were $367 million and $480 million at March 31, 2023 and 2022, respectively. For the years ended March 31, 2023, 2022, and 2021, the Company allocated a total of $162 million, $165 million, and $156 million of net income to noncontrolling interests, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March 31, 2023, 2022, and 2021 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Formation of SCRI Oncology</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derecognition of noncontrolling interests in McKesson Europe</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156099340528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Common Share</a></td>
<td class="text">Earnings (Loss) Per Common Share<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted loss per common share for the year ended March 31, 2021 was calculated by excluding all dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Less than 1&#160;million of potentially dilutive securities for fiscal 2023 and fiscal 2022 were excluded from the computation of diluted earnings (loss) per common share as they were anti-dilutive.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share were as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,538)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,539)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.32&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div>(2)Certain computations may reflect rounding adjustments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020816112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2cb43d7d-4dbe-40be-891b-5b154c0f7e7e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2e8bafc9-a699-4ad1-a382-140d4fabd947">Property, plant, and equipment, net</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_481d8594-6d0e-48c4-a516-41181b6ee1a8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_b132aa89-d101-44a4-8856-5a1aefc7a3ca">Current portion of long-term debt</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_9a3e0520-2b32-4c2a-8b14-f87e23310cf5"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_fbb0bd27-adff-497f-b17f-ffe770574fee">Long-term debt</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.66&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; in fiscal 2022, the Company rationalized its office space, including certain property leases in North America, and in fiscal 2023, management approved further changes to its real estate footprint as part of a broader set of initiatives. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. These initiatives did not have a material financial impact to the Company&#8217;s operating lease ROU assets and liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes operating lease right-of-use assets of approximately $494&#160;million, as well as current and long-term operating lease liabilities of approximately $83&#160;million and $442&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included under the caption &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of the assets ceased upon classification as held for sale.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2023 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by future minimum sublease income&#160;of $191 million which is due under noncancellable subleases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $98 million that are not reflected in the table above. These operating leases will commence in calendar year 2023 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM2MjQ_b3387c7e-31d8-45e1-b5f8-dc61fc04b015">two</span> to ten years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2023 and 2022, the total lease receivable was $342 million and $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2023, 2022, and 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorSalesTypeLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2cb43d7d-4dbe-40be-891b-5b154c0f7e7e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2e8bafc9-a699-4ad1-a382-140d4fabd947">Property, plant, and equipment, net</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_481d8594-6d0e-48c4-a516-41181b6ee1a8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_b132aa89-d101-44a4-8856-5a1aefc7a3ca">Current portion of long-term debt</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_9a3e0520-2b32-4c2a-8b14-f87e23310cf5"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_fbb0bd27-adff-497f-b17f-ffe770574fee">Long-term debt</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.66&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; in fiscal 2022, the Company rationalized its office space, including certain property leases in North America, and in fiscal 2023, management approved further changes to its real estate footprint as part of a broader set of initiatives. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. These initiatives did not have a material financial impact to the Company&#8217;s operating lease ROU assets and liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes operating lease right-of-use assets of approximately $494&#160;million, as well as current and long-term operating lease liabilities of approximately $83&#160;million and $442&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included under the caption &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of the assets ceased upon classification as held for sale.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2023 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by future minimum sublease income&#160;of $191 million which is due under noncancellable subleases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $98 million that are not reflected in the table above. These operating leases will commence in calendar year 2023 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM2MjQ_b3387c7e-31d8-45e1-b5f8-dc61fc04b015">two</span> to ten years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2023 and 2022, the total lease receivable was $342 million and $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2023, 2022, and 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorDirectFinancingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2cb43d7d-4dbe-40be-891b-5b154c0f7e7e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2e8bafc9-a699-4ad1-a382-140d4fabd947">Property, plant, and equipment, net</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_481d8594-6d0e-48c4-a516-41181b6ee1a8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_b132aa89-d101-44a4-8856-5a1aefc7a3ca">Current portion of long-term debt</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_9a3e0520-2b32-4c2a-8b14-f87e23310cf5"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_fbb0bd27-adff-497f-b17f-ffe770574fee">Long-term debt</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.66&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; in fiscal 2022, the Company rationalized its office space, including certain property leases in North America, and in fiscal 2023, management approved further changes to its real estate footprint as part of a broader set of initiatives. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. These initiatives did not have a material financial impact to the Company&#8217;s operating lease ROU assets and liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes operating lease right-of-use assets of approximately $494&#160;million, as well as current and long-term operating lease liabilities of approximately $83&#160;million and $442&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included under the caption &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of the assets ceased upon classification as held for sale.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2023 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by future minimum sublease income&#160;of $191 million which is due under noncancellable subleases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $98 million that are not reflected in the table above. These operating leases will commence in calendar year 2023 with noncancellable lease terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM2MjQ_b3387c7e-31d8-45e1-b5f8-dc61fc04b015">two</span> to ten years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2023 and 2022, the total lease receivable was $342 million and $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2023, 2022, and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorDirectFinancingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorDirectFinancingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorSalesTypeLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's sales-type leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorSalesTypeLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156016821968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text">Goodwill and Intangible Assets, Net <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.941%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,451&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,947&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment Charges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill for impairment on an annual basis and at an interim date, if indicators of potential impairment exist. Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit. During the first quarter of fiscal 2023, the Company voluntarily changed its annual goodwill impairment testing date from October 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to April 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to align with a change in the timing of the Company&#8217;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from April 1, 2022, as a retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#8217;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the reporting units is determined using a combination of an income approach based on a DCF model and a market approach based on appropriate valuation multiples observed for the reporting unit&#8217;s guideline public companies. Fair value estimates result from a complex series of judgments about future events and uncertainties and relies heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date. Any material changes in key assumptions, including failure to improve operations of certain retail pharmacy stores, additional government reimbursement reductions, deterioration in the financial markets, an increase in interest rates, or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances, may affect such estimates. The discount rates are the weighted-average cost of capital measuring the reporting unit&#8217;s cost of debt and equity financing weighted by the percentage of debt and percentage of equity in a company&#8217;s target capital. The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit&#8217;s future cash flow projections. Fair value assessments of the reporting unit are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual impairment testing performed for fiscal 2023, fiscal 2022, and fiscal 2021 did not indicate any impairment of goodwill. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of fiscal 2021, the Company implemented a new segment reporting structure which resulted in the Company&#8217;s current four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a goodwill impairment charge of $69 million in fiscal 2021 as the estimated fair value of the former Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This charge was recorded in &#8220;Goodwill impairment charges&#8221; in the Consolidated Statements of Operations. At March 31, 2023 and 2022, the balance of goodwill in the International segment primarily relates to the Company&#8217;s McKesson Canada reporting unit. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 15, &#8220;Fair Value Measurements,&#8221; for more information on this nonrecurring fair value measurement. As of March 31, 2023 and 2022, accumulated goodwill impairment losses in the Company&#8217;s International segment were approximately $700 million. Most of the goodwill impairment for these reporting units was generally not deductible for income tax purposes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:22.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,765)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,691)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,398&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,121)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,277&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,996&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,937)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes net intangible assets of approximately $384 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; This amount was included under the caption &#8220;Assets held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of fiscal 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intangible assets were subject to amortization as of March 31, 2023 and 2022. Amortization expense of intangible assets was $236 million, $332 million, and $422 million for fiscal 2023, fiscal 2022, and fiscal 2021, respectively. Estimated annual amortization expense of intangible assets was as follows: $246 million, $240 million, $208 million, $201 million, and $197 million for fiscal 2024 through fiscal 2028, respectively, and $1.2 billion thereafter. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for a description of the goodwill and intangible assets recognized as part of the RxSS acquisition and formation of SCRI Oncology.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; for more information on intangible asset impairment charges recorded in fiscal 2022 and fiscal 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156111342768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt and Financing Activities</a></td>
<td class="text">Debt and Financing Activities<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.25% Notes due February 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,626&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,080&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these U.S. dollar notes is payable semi-annually.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term debt of approximately $4&#160;million and $11&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. At March 31, 2023 and 2022, $5.6 billion and $5.9 billion, respectively, of total debt was outstanding, of which $968 million and $799 million, respectively, was included in &#8220;Current portion of long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2023, the Company completed a public offering of 5.25% Notes due 2026 (the &#8220;February 2026 Notes&#8221;) in a principal amount of $500 million. Interest on the February 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on August 15, 2023. Proceeds received from this note issuance, net of discounts and offering expenses, were $497 million. The Company utilized the net proceeds from this note issuance to repay existing debt. On or after February 15, 2024, the Company may redeem the February 2026 Notes at its option, in whole or in part, at any time and from time to time, for cash at a redemption price equal to 100% of the principal amount of the notes being redeemed plus accrued and unpaid interest thereon to, but not including, the redemption date.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021, the Company completed a public offering of 1.30% Notes due August 15, 2026 (the &#8220;August 2026 Notes&#8221;) in a principal amount of $500&#160;million. Interest on the August 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on February 15, 2022. Proceeds received from this note issuance, net of discounts and offering expenses, were $495&#160;million. The Company utilized the net proceeds from this note issuance for general corporate purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2020, the Company completed a public offering of 0.90% Notes due December 3, 2025 (the &#8220;2025 Notes&#8221;) in a principal amount of $500&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $496&#160;million. The Company utilized the net proceeds from this note issuance for general corporate purposes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each note, which constitutes a &#8220;Series,&#8221; is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#8217;s existing, and from time-to-time, future unsecured and unsubordinated indebtedness outstanding. Each Series is governed by materially similar indentures and officers&#8217; certificates as those of other Series issued by the Company. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#8217;s Certificate) within a specified period, an offer must be made to purchase that Series from the holders at a price equal to 101% of the then outstanding principal amount of that Series, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#8217; certificate for each Series, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without the lenders&#8217; consent. The indentures also contain customary events of default provisions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 15, 2023, the Company retired its $360&#160;million outstanding principal amount of 2.85% Notes due 2023 upon maturity. On December 15, 2022, the Company retired its $400&#160;million outstanding principal amount of 2.70% Notes due 2022 upon maturity. On July 17, 2021, the Company redeemed its &#8364;600 million (or, approximately $709 million) outstanding principal amount of Euro-denominated 0.63% Notes due 2021, prior to maturity at par value. On December 1, 2020, the Company redeemed its $323&#160;million outstanding principal amount of 4.75% Notes due 2021 prior to maturity. On November 30, 2020, the Company retired its $700&#160;million outstanding principal amount of 3.65% Notes due 2020 upon maturity. All of these notes were repaid or redeemed using cash on hand.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tender Offer</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) 2.85% Notes due 2023, (ii) 3.80% Notes due 2024, (iii) 7.65% Debentures due 2027, (iv) 3.95% Notes due 2028, (v) 4.75% Notes due 2029, (vi) 6.00% Notes due 2041, and (vii) 4.88% Notes due 2044 (collectively referred to herein as the &#8220;Tender Offer Notes&#8221;). In connection with the tender offer, the Company paid an aggregate consideration of $1.1 billion to redeem $922 million principal amount of the Tender Offer Notes at a redemption price equal to 100% of the principal amount and premiums of $182 million, plus accrued and unpaid interest of $14 million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $191 million for the year ended March 31, 2022, which included premiums of $182&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $9 million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments of long-term debt are $968&#160;million, $39&#160;million, $1.7&#160;billion, $1.2&#160;billion, and $376 million for fiscal 2024 through fiscal 2028, respectively, and $1.3&#160;billion thereafter.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 7, 2022, the Company entered into a Credit Agreement (the &#8220;2022 Credit Facility&#8221;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. The 2022 Credit Facility replaced the Company&#8217;s previous syndicated $4.0 billion five-year senior unsecured credit facility, dated as of September 25, 2019, as amended (the &#8220;2020 Credit Facility&#8221;), which was scheduled to mature in September 2024. The 2020 Credit Facility was terminated in connection with the execution of the 2022 Credit Facility. There were no borrowings under the 2020 Credit Facility during the years ended March 31, 2023, 2022, and 2021, and no amounts outstanding at the time of its termination. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2022 Credit Facility bear interest based upon the Term Secured Overnight Financing Rate (&#8220;SOFR&#8221;) for credit extensions denominated in U.S. dollars, the Sterling Overnight Index Average Reference Rate for credit extensions denominated in British pound sterling, the Euro Interbank Offered Rate for credit extensions denominated in Euros, the Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates, as applicable, plus agreed upon margins. The 2022 Credit Facility contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the 2022 Credit Facility. If the Company does not comply with these covenants, its ability to use the 2022 Credit Facility may be suspended and repayment of any outstanding balances under the 2022 Credit Facility may be required. At March 31, 2023, the Company was in compliance with all covenants under the 2022 Credit Facility. The 2022 Credit Facility also permits the Company to establish key performance indicators with respect to certain sustainability targets of the Company in consultation with certain sustainability coordinators. The Company may enter into an amendment to the 2022 Credit Facility to provide for certain adjustments to the otherwise applicable facility fee and margins based on the Company&#8217;s performance against any established key performance indicators. The 2022 Credit Facility is scheduled to mature in November 2027. The remaining terms and conditions of the 2022 Credit Facility are substantially similar to those previously in place under the 2020 Credit Facility. The Company can use funds obtained under the 2022 Credit Facility for general corporate purposes. There were no borrowings under the 2022 Credit Facility during the year ended March 31, 2023 and no amounts outstanding at March 31, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Term Loan Credit Facility </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 7, 2022, the Company entered into a Credit Agreement (the &#8220;2022 Term Loan Credit Facility&#8221;) pursuant to which the Company had an unsecured delayed draw term loan facility up to $500&#160;million which was available for borrowing for 90 days after the closing date in up to three separate borrowings. During the third quarter of fiscal 2023, the Company borrowed $500&#160;million under the 2022 Term Loan Credit Facility at an interest rate of three-month Term SOFR plus 110 basis points, which was payable quarterly and had an original maturity date of November 7, 2025. The funds obtained were used for general corporate purposes. In February 2023, the Company repaid all borrowings outstanding under the 2022 Term Loan Credit Facility, at which point this facility was terminated in its entirety.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Facilities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintained bilateral credit facilities primarily denominated in Euros with a committed amount of $7&#160;million and an uncommitted amount of $111&#160;million as of March 31, 2022, which were transferred as part of the divestiture of the E.U. disposal group in October 2022. Borrowings and repayments were not material during the years ended March 31, 2023, 2022, and 2021, and amounts outstanding under these credit lines were not material at March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0&#160;billion in outstanding commercial paper notes. During the years ended March 31, 2023, 2022, and 2021, the Company borrowed $8.5&#160;billion, $11.2&#160;billion, and $6.3&#160;billion, respectively, and repaid $8.5&#160;billion, $11.2&#160;billion, and $6.3&#160;billion, respectively, under the program. At March 31, 2023 and 2022, there were no commercial paper notes outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156016821968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract', window );"><strong>Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities</a></td>
<td class="text">Variable Interest Entities <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs if it has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates a VIE when it has the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE and, as a result, is considered the primary beneficiary of the VIE. It consolidates certain single-lessee leasing entities where it, as the lessee, has the majority risk of the leased assets due to its minimum lease payment obligations to these leasing entities. As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity. Consolidated VIEs do not have a material impact on the Company&#8217;s Consolidated Statements of Operations or Consolidated Statements of Cash Flows. Total assets and liabilities included in its Consolidated Balance Sheets for these VIEs were $621 million and $53 million, respectively, at March 31, 2023, and $660 million and $65&#160;million, respectively, at March 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Unconsolidated Variable Interest Entities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved with VIEs which it does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Its relationships include equity method investments and lending, leasing, contractual, or other relationships with the VIEs. The Company&#8217;s most significant VIE relationships are with oncology and other specialty practices. Under these practice arrangements, the Company generally owns or leases all of the real estate and equipment used by the practices and manages the practices&#8217; administrative functions. Prior to the divestment of the Austrian business in the fourth quarter of fiscal 2022, the Company had relationships with certain pharmacies in Europe with whom it provided financing, had equity ownership, and/or had a supply agreement whereby it supplied the vast majority of the pharmacies&#8217; purchases. The Company&#8217;s maximum exposure to loss (regardless of probability) as a result of all unconsolidated VIEs was $1.4 billion at March 31, 2023 and 2022, which primarily represents the value of intangible assets related to service agreements, equity investments, and lease and loan receivables. This amount excludes the customer loan guarantees discussed in Financial Note 16, &#8220;Financial Guarantees and Warranties.&#8221; The Company believes there is no material loss exposure on these assets or from these relationships.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156014644528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Benefits</a></td>
<td class="text">Pension Benefits<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a number of qualified and nonqualified defined benefit pension plans and defined contribution plans for eligible employees.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-U.S. Defined Benefit Pension Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the Company&#8217;s non-U.S. defined benefit pension plans cover eligible employees located predominantly in Norway and Canada. Benefits for these plans are based primarily on each employee&#8217;s final salary, with annual adjustments for inflation. The obligations in Norway are largely related to the state-regulated pension plan which is managed by the Norwegian Public Service Pension Fund (&#8220;SPK&#8221;). According to the terms of the SPK, the plan assets of state regulated plans in Norway must correspond very closely to the pension obligation calculated using the principles codified in Norwegian law.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; pension liabilities of $85&#160;million, as part of the E.U. disposal group, and pension assets of $49&#160;million, as part of the U.K. disposal group, were included under the captions &#8220;Liabilities held for sale&#8221; and &#8220;Assets held for sale,&#8221; respectively, in the Consolidated Balance Sheet as of March 31, 2022. During the third quarter of fiscal 2023, the Company divested pension liabilities totaling $75&#160;million and released $13&#160;million of gains from accumulated other comprehensive loss related to the divestiture of the E.U. disposal group. During the first quarter of fiscal 2023, the Company divested pension assets of $49&#160;million and released $30&#160;million of accumulated other comprehensive loss related to the divestiture of the U.K. disposal group.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2022, the Company divested $43&#160;million of pension liabilities and released $11&#160;million of accumulated other comprehensive loss related to the sale of its Austrian business. During the third quarter of fiscal 2021, the Company divested $187&#160;million of pension liabilities and released $33&#160;million of accumulated other comprehensive loss related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defined benefit plan assets and obligations are measured as of the Company&#8217;s fiscal year-end. The net periodic expense for the Company&#8217;s pension plans were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost - benefits earned during the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized actuarial loss and prior service costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service period of active employees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the changes in benefit obligations and plan assets for the Company&#8217;s pension plans was as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer and participant contributions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on the balance sheet</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The benefit obligation is the projected benefit obligation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Relates to the completed divestitures of the E.U. disposal group and U.K. disposal group in fiscal 2023 and the completed divestiture of the Company&#8217;s Austrian business in fiscal 2022 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Current assets at March 31, 2022 include $49&#160;million reclassified from long-term assets to assets held for sale as part of the Company&#8217;s U.K. disposal group, which was divested in fiscal 2023. Current liabilities at March 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$85&#160;million reclassified from long-term liabilities to liabilities held for sale as part of the Company&#8217;s E.U. disposal group, which was divested in fiscal 2023. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures&#8221; for additional information.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial gain of $65 million in fiscal 2023 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates ($69&#160;million gain):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> The weighted average discount rate for Non-U.S. plans increased to 4.54% as of March 31, 2023 from 2.67% as of March 31, 2022. </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes ($4&#160;million loss):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actuarial gain of $55 million in fiscal 2022 was primarily attributable to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Discount rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">($69&#160;million gain):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> The weighted average discount rate for Non-U.S plans increased to 2.67% as of March 31, 2022 from 1.89% as of March 31, 2021.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt">Demographic and assumption changes ($14&#160;million loss):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the European divestitures in fiscal 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#8217;s pension plans, including accumulated benefit obligation in excess of plan assets:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in accumulated other comprehensive loss consist of: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other changes in accumulated other comprehensive loss were as follows: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.058%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive income </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2023, the Company recognized $17&#160;million in actuarial losses for pension plans to stockholders&#8217; deficit as a result of the sale of its E.U. disposal group and U.K. disposal group. In fiscal 2022, the Company recognized $11&#160;million in actuarial losses for pension plans to stockholders&#8217; deficit as a result of the sale of its Austrian business. In fiscal 2021, the Company recognized $33&#160;million in actuarial losses for pension plans to stockholders&#8217; equity as a result of the contribution of its German pharmaceutical wholesale business to a joint venture. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for more information on the Company&#8217;s European divestiture activities. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projected benefit obligations related to the Company&#8217;s unfunded plans were $18 million and $101 million at March 31, 2023 and 2022, respectively. Funding obligations for its plans vary based on the laws of each jurisdiction.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected benefit payments for the Company&#8217;s pension plans were as follows: $8 million, $9 million, $9 million, $9 million, and $9 million for fiscal 2024 to fiscal 2028, respectively, and $50 million for fiscal 2029 through fiscal 2033. Expected benefit payments are based on the same assumptions used to measure the benefit obligations and include estimated future employee service. Expected contributions to be made for the Company&#8217;s pension plans are $3 million for fiscal 2024.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:55.140%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.532%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic pension expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.67&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s defined benefit pension plan liabilities are valued using a discount rate based on a yield curve developed from a portfolio of high quality corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans. The Company&#8217;s defined benefit pension plan liabilities are valued using a weighted-average discount rate of 4.54%, which represents an increase of 187 basis points from its fiscal 2022 weighted-average discount rate of 2.67%.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Assets </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Strategy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For plan assets, the investment strategies are subject to local regulations and the asset/liability profiles of the plans in each individual country. Plan assets are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans. Plan assets are primarily invested in high-quality corporate and government bond funds and equity securities. Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops the expected long-term rate of return assumption based on the projected performance of the asset classes in which plan assets are invested. The target asset allocation was determined based on the liability and risk tolerance characteristics of the plans and at times may be adjusted to achieve overall investment objectives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on unadjusted quoted prices in active markets for identical assets. Level&#160;2 refers to fair values estimated using significant other observable inputs and Level 3 includes fair values estimated using significant unobservable inputs. The following tables represent the Company&#8217;s plan assets as of March&#160;31, 2023 and 2022, using the fair value hierarchy by asset class:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held at NAV practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents - Cash and cash equivalents include short-term investment funds that maintain daily liquidity and aim to have constant unit values of $1.00. The funds invest in short-term fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and high credit quality. Directly held cash and cash equivalents are classified as Level 1 investments. Cash and cash equivalents include money market funds and other commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity commingled funds - Some equity investments are held in commingled funds, which have daily net asset values derived from quoted prices for the underlying securities in active markets; these are classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income securities - Government securities consist of bonds and debentures issued by central governments or federal agencies; corporate bonds consist of bonds and debentures issued by corporations. Inputs to the valuation methodology include quoted prices for similar assets in active markets, and inputs that are observable for the asset, either directly or indirectly, for substantially the full term of the asset. Multiple prices and price types are obtained from pricing vendors whenever possible, enabling cross-provider price validations. Fixed income securities are generally classified as Level 1 or Level 2 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed income commingled funds - Some fixed income investments are held in exchange traded or commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1, 2, or 3 investments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annuity contracts - The value of the annuity contracts is reported by the Trustee and is based on a valuation of the remaining contracted cash flow of the contract. Inputs in the valuation include discounted future cash flows; these are classified as Level 3 investments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real estate funds - The value of the real estate funds is reported by the fund manager and is based on a valuation of the underlying properties. Inputs used in the valuation include items such as cost, discounted future cash flows, independent appraisals, and market based comparable data. The real estate funds are classified as Level 1, 2, or 3 investments.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other - At March 31, 2023 and 2022, this includes $30 million and $35 million, respectively, of plan asset value relating to the SPK. In principle, the SPK is organized as a pay-as-you-go system guaranteed by the Norwegian government as it holds no Company-owned assets to back the pension liabilities. The Company pays a pension premium used to fund the plan, which is paid directly to the Norwegian government who establishes an account for each participating employer to keep track of the financial status of the plan, including managing the contributions and the payments. Further, the investment return credited to this account is determined annually by the SPK based on the performance of long-term government bonds.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the Level 3 plan assets measured on a recurring basis for the years ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover union-represented employees in the U.S. In 2017, it also contributed to the Pensjonsordningen for Apoteketaten (&#8220;POA&#8221;), a mandatory multiemployer pension scheme for its pharmacy employees in Norway, managed by the association of Norwegian Pharmacies.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks of participating in these multiemployer plans are different from single-employer pension plans in the following aspects: (i)&#160;assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers; (ii)&#160;if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers; and (iii)&#160;if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability. Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company&#8217;s withdrawal liability and contributions may increase.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contributions and amounts accrued for U.S. multiemployer pension plans were not material for the years ended March 31, 2023, 2022, and 2021. Contributions to the POA for non-U.S. plans exceeding 5% of total plan contributions were&#160;$19 million, $20 million, and&#160;$22 million for the years ended March 31, 2023, 2022, and 2021, respectively. Based on actuarial calculations, the Company estimates the funded status for its non-U.S. Plans to be approximately 85% as of March 31, 2023. No amounts were accrued for liability associated with the POA as the Company has no intention to withdraw from the plan.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Defined Contribution Plans </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a contributory retirement savings plan (&#8220;RSP&#8221;) for U.S. eligible employees. Eligible employees may contribute to the RSP up to 75% of their eligible compensation on a pre-tax or post-tax basis not to exceed IRS limits. The Company makes matching contributions in an amount equal to 100% of the employee&#8217;s first 3% of pay contributed and 50% for the next 2% of pay contributed. The Company also may make an additional annual matching contribution for each plan year to enable participants to receive a full match based on their annual contribution. The Company also contributed to non-U.S. plans that are available in certain countries. Contribution expenses for the RSP and non-U.S. plans were $125 million, $116 million, and $102 million for the years ended March 31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Postretirement Benefits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a number of postretirement benefit plans, primarily consisting of healthcare and life insurance (&#8220;welfare&#8221;) benefits, for certain eligible U.S. employees. Eligible employees consist of those who retired before March 31, 1999 and those who retired after March 31, 1999, but were an active employee as of that date, after meeting other age-related criteria. It also provides postretirement benefits for certain U.S. executives. Defined benefit plan obligations are measured as of the Company&#8217;s fiscal year-end. The net periodic (credit) expense for the Company&#8217;s postretirement welfare benefits was not material for the years ended March 31, 2023, 2022, and 2021. The benefit obligation at March 31, 2023 and 2022 was $45 million and $56 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018514880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Hedging Activities</a></td>
<td class="text">Hedging Activities <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives as described below. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. The Company uses different counterparties for its derivative contracts to minimize the exposure to credit risk but does not anticipate non-performance by these parties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Canadian dollars, Euro, and British pounds sterling. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, the Company had &#8364;1.1 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges were utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that were designated as net investment hedges and met effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates were recorded as foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency-denominated notes designated as net investment hedges were ineffective, changes in carrying value attributable to the change in spot rates were recorded in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the E.U. disposal group in October 2022, the Company reclassified $112 million of gains from accumulated other comprehensive loss to</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2023. This amount related to the &#8364;1.1&#160;billion of Euro-denominated notes described above, along with certain other Euro-denominated notes which were previously accounted for as net investment hedges and matured in prior periods, and was included in the fiscal 2023 and fiscal 2022 calculations of charges to remeasure the assets and liabilities of the disposal group to fair value less costs to sell.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale of the U.K. disposal group in April 2022, the Company reclassified $26 million of gains from accumulated other comprehensive loss to &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2023. This amount related to the Company&#8217;s &#163;450 million of British pound sterling-denominated notes, which were previously accounted for as net investment hedges until de-designated in fiscal 2020, and was included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities of the disposal group to fair value less costs to sell.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the years ended March 31, 2023, 2022 and 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the year ended March 31, 2023, includes amounts reclassified to earnings of $112&#160;million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023 and 2022, the notional amounts of the Company&#8217;s outstanding derivatives were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-24 to Mar-25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as fair value hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-28</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aug-25 to Jul-26</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feb-26 to Sep-29</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan-24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jun-33</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The maturity date reflected is for outstanding derivatives as of March 31, 2023.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the years ended March 31, 2023, 2022, and 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In fiscal 2023, represents cross-currency fixed-to-fixed interest rate swaps to mitigate the foreign currency exchange fluctuations on its foreign currency-denominated notes. In fiscal 2022, represents fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread.  </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in accumulated other comprehensive loss and offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses cross-currency swaps to hedge the changes in the fair value of its foreign currency notes resulting from changes in benchmark interest rates and foreign currency exchange rates. In February 2023, &#163;450&#160;million of cross-currency swaps matured and the Company executed new cross-currency swaps with similar terms to continue to mitigate interest rate and foreign exchange rate risks. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2023, the Company entered into cross-currency fixed-to-fixed interest rate swaps with a total notional amount of &#8364;1.1 billion to hedge the changes in the fair value of its underlying Euro-denominated notes resulting from changes in benchmark interest rates and foreign currency exchange rates.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2023, the Company also entered into floating interest rate swaps to convert $1.3&#160;billion of its fixed rate debt to floating interest rate in order to hedge the changes in fair value caused by fluctuations in the benchmark interest rate. The changes in the fair value of these derivatives are recorded in &#8220;Interest expense&#8221; in the Consolidated Statements of Operations. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the fair value of these derivatives and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from the changes in the Company&#8217;s fair value hedges recorded in earnings were largely offset by the losses recorded in earnings on the hedged item. For components excluded from the assessment of hedge effectiveness, the initial value of the excluded component is recognized in accumulated other comprehensive income (loss) and then released into earnings over the life of the hedging instrument. The difference between the change in the fair value of the excluded component and the amount amortized into earnings during the period is recorded in other comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies to reduce the income statement effects arising from fluctuations in foreign currency rates and also enters into forward contracts to hedge the variability of future benchmark interest rates on planned bond issuances. The effective portion of changes in the fair value&#160;of these hedges is recorded in accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. Gains or losses reclassified from accumulated other comprehensive loss and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations were not material for the years ended March 31, 2023, 2022, and 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended March 31, 2023, the Company terminated its $500&#160;million</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">notional forward starting fixed interest rate swaps and recognized a gain of $97 million within &#8220;Other income, net&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2023, the Company also entered into forward starting fixed interest rate swaps designated as cash flow hedges, with a combined notional amount of $450&#160;million, to hedge the variability of future benchmark interest rates on a planned bond issuance. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings. Prior to the divestitures of the E.U. disposal group and U.K. disposal group, the Company had entered into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. Changes in the fair values for contracts not designated as hedges were recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. Changes in the fair values were not material for the years ended March 31, 2022 and 2021, and the Company did not have any outstanding derivative instruments not designated as hedges during fiscal 2023. Gains or losses from these contracts were largely offset by changes in the value of the underlying intercompany obligations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Information on Derivative Instruments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains (losses) from derivatives included in other comprehensive income (loss) in the Consolidated Statements of Comprehensive Income (Loss) were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow and other hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes other comprehensive income related to the excluded component of certain fair value hedges.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated for hedge accounting:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 15, &#8220;Fair Value Measurements,&#8221; for more information on these recurring fair value measurements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156014519664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with ASC Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at March 31, 2023 and 2022 included investments in money market funds of $1.4 billion and $981 million, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. The fair values for the Company&#8217;s marketable securities were not material at March 31, 2022, and were liquidated during fiscal 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 14, &#8220;Hedging Activities,&#8221; for fair values and other information on the Company&#8217;s derivatives.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $237&#160;million and $346&#160;million at March 31, 2023 and 2022, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. During fiscal 2023, the Company recognized impairment charges and realized gains on the exit of certain investments. During fiscal 2022, certain of the Company&#8217;s investments in equity securities without readily determinable fair values were remeasured to fair value based on transactions which resulted in changes in the observable price of those securities. During fiscal 2021, certain of the Company&#8217;s investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. The Company exited most of its investments in publicly traded shares in the fourth quarter of fiscal 2021. The Company recognized net losses of $36 million, including impairments of $59&#160;million, for the year ended March 31, 2023, and recognized net gains of $98 million and $133 million for the years ended March 31, 2022 and 2021, respectively. These amounts were recorded in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges, including long-lived assets associated with the Company&#8217;s restructuring initiatives as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; or as a result of charges to remeasure assets classified as held for sale to fair value less costs to sell.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023, the contingent consideration liability related to the Company&#8217;s acquisition of RxSS in November 2022 was measured at fair value on a nonrecurring basis. At March 31, 2022, the assets and liabilities associated with the E.U. disposal group and U.K. disposal group classified as held for sale were measured at the lower of carrying value or fair value less costs to sell. The E.U. disposal group was divested in October 2022 and the U.K. disposal group was divested in April 2022. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures" for more information on these transactions. Additionally, at March 31, 2022, assets measured at fair value on a nonrecurring basis included certain long-lived assets within the International segment related to the Company&#8217;s previous operations in Denmark and its retail pharmacy businesses in Canada, as discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs related to changes in observable price are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Inputs related to impairments of investments are generally considered Level 3 fair value measurements due to their inherently unobservable nature based on significant assumptions by management and use of company-specific information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other material assets or liabilities measured at fair value on a nonrecurring basis at March 31, 2023 and 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023 and 2022, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short-term maturity of these financial instruments.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,594&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,386&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 10, &#8220;Goodwill and Intangible Assets, Net,&#8221; for more information regarding goodwill impairment charges recorded for certain reporting units during fiscal 2021. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net&#8221; under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Lived Asset Impairments&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156014644528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Guarantees and Warranties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_FinancialGuaranteesAndWarrantiesAbstract', window );"><strong>Financial Guarantees And Warranties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_FinancialGuaranteesAndWarrantiesTextBlock', window );">Financial Guarantees And Warranties</a></td>
<td class="text">Financial Guarantees and Warranties<div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Guarantees</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with certain of its customers&#8217; financial institutions, primarily in its International segment, under which it has guaranteed the repurchase of its customers&#8217; inventory or its customers&#8217; debt in the event these customers are unable to meet their obligations to those financial institutions. For the Company&#8217;s inventory repurchase agreements, among other requirements, inventories must be in a resalable condition and any repurchase would be at a discount. The inventory repurchase agreements mostly relate to certain Canadian customers and generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzYyMA_f70be4f2-8308-4872-ada2-b3f0a675b674">one</span> to two years. Customers&#8217; debt guarantees generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzY3OA_6036989f-413d-4a9a-9e98-c93fb0ca4aa4">one</span> to five years and are primarily provided to facilitate financing for certain customers. The majority of the Company&#8217;s customers&#8217; debt guarantees are secured by certain assets of the customer. At March 31, 2023, the maximum amounts of inventory repurchase guarantees and customers&#8217; debt guarantees were $343 million and $17 million, respectively, of which the Company has not accrued any material amounts. The expirations of these financial guarantees were as follows: $18 million, $108 million, $195 million, $10 million, and $8 million&#160;from fiscal 2024 through fiscal 2028, respectively, and $21 million thereafter.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023, the Company&#8217;s banks and insurance companies have issued $206 million of standby letters of credit and surety bonds, which were issued on the Company&#8217;s behalf primarily related to its customer contracts and in order to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, pension obligations in Europe, and its workers&#8217; compensation and automotive liability programs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s software license agreements generally include certain provisions for indemnifying customers against liabilities if its software products infringe a third party&#8217;s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnification agreements and has not accrued any liabilities related to such obligations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with certain transactions, primarily divestitures, the Company may provide routine indemnification agreements (such as retention of previously existing environmental, tax, and employee liabilities) whose terms vary in duration and often are not explicitly defined. Where appropriate, obligations for such indemnifications are recorded as liabilities. Because the amounts of these indemnification obligations often are not explicitly stated, the overall maximum amount of these commitments cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of divestiture, the Company has historically not made material payments as a result of these indemnification provisions.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services. For example, the Company provides warranties that the pharmaceutical and medical-surgical products it distributes are in compliance with the U.S. Food, Drug, and Cosmetic Act and other applicable laws and regulations. It has received the same warranties from its suppliers, which customarily are the manufacturers of the products. In addition, the Company has indemnity obligations to its customers for these products, which have also been provided from its suppliers, either through express agreement or by operation of law. Accrued warranty costs were not material to the Consolidated Balance Sheets as of March 31, 2023 and 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FinancialGuaranteesAndWarrantiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Guarantees And Warranties [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FinancialGuaranteesAndWarrantiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FinancialGuaranteesAndWarrantiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial guarantees And warranties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FinancialGuaranteesAndWarrantiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018741184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingent Liabilities</a></td>
<td class="text">Commitments and Contingent Liabilities<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#8220;Claims and litigation charges, net&#8221; in the Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacies. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They have sought monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes. Because of the many uncertainties associated with opioid-related litigation matters, the Company is not able to conclude that a liability is probable or to reasonably estimate a range of ultimate possible loss for opioid-related litigation matters other than those for which an accrual is described below. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State and Local Government Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of these cases were brought by state and local government entities in the U.S. The Company and two other national pharmaceutical distributors (collectively &#8220;Distributors&#8221;) entered into a settlement agreement (the &#8220;Settlement&#8221;) with 48 states and their participating subdivisions, as well as the District of Columbia and all eligible territories (the &#8220;Settling Governmental Entities&#8221;). The Company has paid the Settling Governmental Entities approximately $1.0&#160;billion as of March 31, 2023, and, under the Settlement, will pay the Settling Governmental Entities additional amounts up to approximately $6.8&#160;billion through 2038. A minimum of 85% of the Settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and is payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Distributors do not admit liability or wrongdoing and do not waive any defenses pursuant to the Settlement. Consent judgments have been entered in all participating states and territories, and approximately 2,300 cases have been dismissed pursuant to the Settlement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alabama and West Virginia did not participate in the Settlement. Under a separate agreement with Alabama and its subdivisions, the Company has paid approximately $42&#160;million as of March 31, 2023, and will pay additional amounts totaling approximately $132&#160;million through 2031. The Company previously settled with the state of West Virginia in 2018, and West Virginia and its subdivisions were not eligible to participate in the Settlement. After a trial, the claims of two West Virginia subdivisions, Cabell County and the City of Huntington, were decided in the Company&#8217;s favor on July 4, 2022. That decision is under appeal. The claims of certain other West Virginia subdivisions were settled pursuant to an agreement requiring the Company to pay approximately $152&#160;million over 11 years. The Company has paid the settling subdivisions $38&#160;million as of March 31, 2023, and will pay additional amounts totaling approximately $114&#160;million through 2033. All participating litigating subdivisions have dismissed their claims against the Company, but the agreement does not include school districts or the claims of Cabell County and the City of Huntington. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some subdivisions did not participate in the Settlement, including certain municipal governments, government hospitals, school districts, and government-affiliated third-party payors. The Company contends these claims are foreclosed by the Settlement or otherwise subject to strong defenses, while the non-participating subdivisions assert that they are not bound by the Settlement for a variety of reasons. The Company intends to defend itself vigorously in these matters. The City of Baltimore, Maryland, is one jurisdiction that did not participate in the settlement. Trial of the City of Baltimore&#8217;s claims is currently scheduled to begin September 26, 2024. The Company&#8217;s loss contingency accruals for these subdivisions are reflected in the estimated liability for opioid-related claims consistent with what would be allocated under the framework of the Settlement.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Native American Tribe Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the claims of Native American tribes, the Company has reached agreements that achieve a broad resolution of opioid-related claims brought by federally recognized Native American tribes. Under the agreements, the Company will pay approximately $196&#160;million over 6.5 years to resolve the claims of participating Native American tribes. The Company has paid the settling Native American tribes $56&#160;million as of March 31, 2023, and will pay additional amounts totaling approximately $140&#160;million through 2027. Under these agreements, a minimum of 85% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for the opioid-related claims of U.S. governmental entities, including Native American tribes, was as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,173&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These amounts, recorded in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2023 and fiscal 2022, the Company paid $1.1&#160;billion and $74&#160;million, respectively, associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes. In conjunction with the payments made in fiscal 2023, all funds have been released from escrow.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Governmental Plaintiff Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Though the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals. These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One such case was brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court seeking to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CE19-00472. On March 1, 2023, the jury in that case returned a verdict in favor of the defendants, including the Company. That verdict is now the subject of post-trial motions, including a plaintiffs&#8217; motion for a new trial.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In another, several hospitals brought suit in the Circuit Court of Conecuh County, Alabama; trial on the claims of eight of these hospitals is currently scheduled for July 24, 2023. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fort Payne Hospital Corporation et al. v. McKesson Corp., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CV-2021-900016. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Plaintiff Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition to the opioid-related claims brought in the U.S., the Company and its Canadian affiliate are also defendants in four cases pending in Canada. These cases involve the claims of the provincial governments, a group representing indigenous people, as well as one case brought by an individual. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Qui Tam Litigation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2018, the Company was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint pending in the United States District Court for the District of Massachusetts alleging that the Company violated the federal False Claims Act and various state false claims acts due to the alleged failure of the Company and other defendants to report providers who were engaged in diversion of controlled substances. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Manchester v. Purdue Pharma, L.P., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 1-16-cv-10947. On August 22, 2018, the United States filed a motion to dismiss. The relator died, and on February 25, 2019 the court entered an order staying the matter until a proper party can be substituted, and providing that if no party is substituted within 90 days of February 25, 2019, the case would be dismissed. In April 2019, the widow of the relator filed a motion to substitute their daughter as the relator; the United States and defendants opposed this substitution request. The motion remains pending and the case remains stayed.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company was served with two </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by the same two relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 19-cv-2233, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State of California ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit, which affirmed the dismissal on March 10, 2022. On June 28, 2021, the court in the state action dismissed the complaint with prejudice, and the relators appealed the dismissal to the California Court of Appeal, which affirmed the dismissal on February 24, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Coverage Litigation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two cases pending in the Northern District of California were filed against McKesson by its liability umbrella insurers about policies they issued to the Company for the period 1999-2017, AIU Insurance Company and National Union Fire Insurance Company of Pittsburgh, Pa. (together "AIG") and ACE Property and Casualty Insurance Company ("ACE"). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AIU Insurance Company et al. v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-07469 (N.D. Cal.) was initiated by AIG in the Northern District of California on October 23, 2020. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ace Property and Casualty Insurance Company v. McKesson Corporation et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:20-cv-09356 (N.D. Cal.) was brought by ACE in California state court on November 2, 2020, and was removed by McKesson to federal court, transferred to the Northern District of California, and designated as related to the AIU action. AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits filed in federal and state courts related to opioids. In both actions, McKesson has asserted claims under the AIG and ACE policies seeking declarations and damages for past and future defense and indemnity costs. On April 5, 2022, the court issued an order granting partial summary judgment to the insurers that the Company&#8217;s defense costs in certain opioid-related litigation were not covered by two of the insurance policies, which the Company has appealed to the U.S. Court of Appeals for the Ninth Circuit.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#8220;TCPA&#8221;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$500&#160;to&#160;$1,500&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On August 13, 2019, the court granted plaintiffs&#8217; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On October 8, 2021, the court de-certified the class citing the plaintiffs lacked class-wide proof identifying the manner of receipt, thus leaving two named Plaintiffs remaining in the case. On April 27, 2022, the Court found that the named Plaintiffs had failed to meet their burden to show Defendants willfully or knowingly violated the TCPA and therefore were not entitled to treble damages. The Court found McKesson liable for statutory damages in the amount of $6,500. The Company appealed the finding of liability and the plaintiffs cross-appealed the denial of class certification and the ruling denying treble damages.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2013, the Company&#8217;s subsidiary, U.S. Oncology, Inc. (&#8220;USON&#8221;), was served with a third amended qui tam complaint filed in the United States District Court for the Eastern District of New York by two relators, purportedly on behalf of the United States, 21 states and the District of Columbia, against USON and five other defendants, alleging that USON solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Piacentile v. Amgen Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al., CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On November 16, 2018, the relators filed a fourth amended complaint; that complaint was dismissed with prejudice on December 1, 2021. On March 28, 2023, the Court of Appeals for the Second Circuit affirmed dismissal.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2014, U.S. Oncology Specialty, LP (&#8220;USOS&#8221;) was served with a fifth amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Eastern District of New York by a relator alleging that USOS, among others, solicited and received illegal &#8220;kickbacks&#8221; from Amgen in violation of the Anti-Kickback Statute, the federal False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hanks v. Amgen, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CV-08-03096 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 17, 2018, the court granted USOS&#8217;s motion to dismiss. Following the relator&#8217;s appeal, the United States Court of Appeals for the Second Circuit vacated the district court&#8217;s order and remanded the suit to the district court, directing it to consider the question of whether the suit should be dismissed for lack of jurisdiction. The district court granted the relator leave to amend the complaint for a seventh time. The relator filed the seventh amended complaint on November 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or about April 25, 2018, a second amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint filed in the U.S. District Court for the Eastern District of New York was served on McKesson Corporation, McKesson Specialty Care Distribution Corporation, McKesson Specialty Distribution LLC, McKesson Specialty Care Distribution Joint Venture, L.P., Oncology Therapeutics Network Corporation, Oncology Therapeutics Network Joint Venture, L.P., US Oncology, Inc., and US Oncology Specialty, L.P. by Omni Healthcare, Inc. as relator, purportedly on behalf of the United States and 33 cities and states alleging that from 2001 through 2010 the defendants repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#8217; fees and costs of suit, all in unspecified amounts. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America ex rel. Omni Healthcare, Inc. v. McKesson Corp., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 1:12-cv-06440 (E.D.N.Y.). The United States and the other governmental plaintiffs declined to intervene in the suit. In February 2019, the court dismissed all of the defendants except McKesson Corporation and Oncology Therapeutics Network Corp. On February 2, 2022, the court entered a scheduling order under which non-government fact discovery was set to close on June 15, 2022. On June 14, 2022, relator moved for additional discovery and an extension of the discovery schedule. On October 13, 2022, the Court granted relator permission to take certain additional discovery, directed relator to move for leave to amend its complaint, and otherwise denied relator's motion without prejudice. On November 14, 2022, relator served its motion for leave to amend its complaint, which remains pending.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or about March 2, 2020, another </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complaint filed in the U.S. District Court for the Eastern District of New York was served on US Oncology, Inc. by the same relator purportedly on behalf of the United States and 33 cities and states alleging the same misconduct and seeking the same relief. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Civil Action No. 1:19-cv-05125. The United States and the other governmental plaintiffs declined to intervene in the suit. On July 21, 2022, the Court granted defendant&#8217;s motion to dismiss without prejudice. Relator subsequently filed an amended complaint. On October 21, 2022, defendant moved to dismiss the amended complaint and that motion remains pending.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, a group of independent pharmacies and a hospital filed a purported class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reliable Pharmacy, et al. v. Actavis Holdco US, et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. On May 25, 2022, the district court granted distributor defendants&#8217; motion to dismiss the complaint, but granted the plaintiffs leave to amend the complaint. Plaintiffs filed an amended complaint on July 1, 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, the Company received a purported class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and two&#160;of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evanston Police Pension Fund v. McKesson Corporation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. In October 2022, the parties reached an agreement in principle to settle this class action lawsuit for an amount covered in full by the Company&#8217;s insurance policy. The settlement is subject to, among other things, final approval by the court. This settlement does not include any admission of liability, and defendants expressly deny wrongdoing. The Company&#8217;s estimated probable loss, entirely offset by probable loss recovery from the Company&#8217;s insurers, was $141&#160;million, both of which were recognized in the Condensed Consolidated Balance Sheet as of September 30, 2022 within &#8220;Other accrued liabilities&#8221; and &#8220;Prepaid expenses and other.&#8221; In February 2023, the insurance carriers funded the settlement, and the probable loss and loss recovery of $141&#160;million have been reversed in the Consolidated Balance Sheet as of March 31, 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2015, The Great Atlantic &amp; Pacific Tea Company (&#8220;A&amp;P&#8221;), a former customer of the Company, filed for reorganization in bankruptcy under Chapter 11 of the United States Bankruptcy Code in the Bankruptcy Court for the Southern District of New York. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re The Great Atlantic &amp; Pacific Tea Company, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;Case No. 15-23007. A suit filed in 2017 against the Company in this bankruptcy case seeks to recover alleged preferential transfers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Official Committee of Unsecured Creditors on behalf of the bankruptcy estate of The Great Atlantic &amp; Pacific Tea Company, Inc., et al. v. McKesson Corporation d/b/a McKesson Drug Co.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Adv. Proc. No. 17-08264.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company was served with a first amended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., 27 states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Hart v. McKesson Corporation, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. On May 5, 2022, the district court granted the Company&#8217;s motion to dismiss the complaint, but granted the plaintiff leave to amend the complaint. The relator filed the second amended complaint on June 7, 2022, which was dismissed again on March 28, 2023, but the district court granted the plaintiff leave to amend. On April 7, 2023, Plaintiff advised the court he would not amend and asked the court to enter the final judgment dismissing the complaint. Once the court issues the final judgment, that decision will be appealable to the Second Circuit Court of Appeals.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">III.&#160;Government Subpoenas and Investigations </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough, and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. The following are examples of the type of subpoenas or requests the Company receives from time to time.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017 and August 2018, respectively, the Company was served with&#160;two&#160;separate Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York relating to the certification the Company obtained for two software products under the U.S. Department of Health and Human Services&#8217; Electronic Health Record Incentive Program. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the United States Attorney&#8217;s Office for the District of Massachusetts served a Civil Investigative Demand on the Company seeking documents related to certain discounts and rebates paid to physician practice customers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2021, the Norwegian Competition Authority carried out an inspection of Norsk Medisinaldepot AS regarding its and its competitors alleged sharing of competitively sensitive information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the United States Department of Justice served a Civil Investigative Demand on the Company seeking documents related to distribution arrangements for ophthalmology products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IV. State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, the State of New York Opioid Stewardship Act (&#8220;OSA&#8221;) imposed an aggregate $100&#160;million annual surcharge for 2017 and 2018 on all manufacturers and distributors licensed to sell or distribute opioids in New York. Pending resolution of a challenge to the OSA filed by the Healthcare Distribution Alliance (&#8220;HDA&#8221;), the Company accrued its estimated OSA surcharges as a $50&#160;million provision in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet as of March 31, 2021. In December 2021, after the HDA challenge was dismissed, the Company paid $26&#160;million for the 2017 OSA surcharge assessment. On May 18, 2022, the Company filed a lawsuit in New York state court challenging the constitutionality of the OSA. In November 2022, the Company received a 2018 OSA surcharge assessment of approximately $42&#160;million, and therefore the Company accrued an additional $18&#160;million provision in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2023. On December 14, 2022, the state court ruled that the OSA is constitutional. In December 2022, the Company paid $11&#160;million as the first installment of the 2018 OSA surcharge assessment, and in March 2023, the Company paid another $11&#160;million as the second installment. The Company&#8217;s OSA challenge is pending before the New York Supreme Court Appellate Division. The Company reserves its rights and intends to vigorously challenge the OSA and the OSA surcharge assessments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">V.&#160;Environmental Matters</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primarily as a result of the operation of the Company&#8217;s former chemical businesses, which were fully divested by 1987, the Company is involved in various matters pursuant to environmental laws and regulations. The Company has received claims and demands from governmental agencies relating to investigative and remedial actions purportedly required to address environmental conditions alleged to exist at four sites where it, or entities acquired by it, formerly conducted operations and the Company, by administrative order or otherwise, has agreed to take certain actions at those sites, including soil and groundwater remediation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on a determination by the Company&#8217;s environmental staff, in consultation with outside environmental specialists and counsel, the current estimate of the Company&#8217;s probable loss associated with the remediation costs for these four sites is $24&#160;million, net of amounts anticipated from third parties. The $24&#160;million is expected to be paid out between April 2023 and March 2053. The Company has accrued $24&#160;million for the estimated probable loss for these environmental matters in its Consolidated Balance Sheet as of March 31, 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been designated as a Potentially Responsible Party (&#8220;PRP&#8221;) under the Superfund law for environmental assessment and cleanup costs as the result of its alleged disposal of hazardous substances at 14 sites. With respect to these sites, numerous other PRPs have similarly been designated and while the current state of the law potentially imposes joint and several liabilities upon PRPs, as a practical matter, costs of these sites are typically shared with other PRPs. For one such site, the Company was one of multiple recipients of a New Jersey Department of Environmental Protection directive and a separate U.S. Environmental Protection Agency (&#8220;EPA&#8221;) directive concerning natural resources damages to the Passaic River associated with the Company&#8217;s Newark, New Jersey facility.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2016, the EPA selected a preferred remedy for this Lower Passaic River site with an estimated cost of approximately $1.4 billion. In December 2022, the Company entered into a Consent Decree with the EPA that is currently pending approval by the U.S. District Court for the District of New Jersey and requires the Company to pay $3&#160;million, which had already been accrued for in the Consolidated Balance Sheets based on past estimated probable loss. Accordingly, the Company&#8217;s estimated probable loss at the remaining 13 sites is approximately $23&#160;million, which has been accrued for in the Consolidated Balance Sheets as of March 31, 2023. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">VI. Value Added Tax Assessments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in various countries outside the U.S. which collect value added taxes (&#8220;VAT&#8221;). The determination of the manner in which a VAT applies to the Company&#8217;s foreign operations is subject to varying interpretations arising from the complex nature of the tax laws. The Company has received assessments for VAT which are in various stages of appeal. The Company disagrees with these assessments and believes that it has a strong legal argument to defend its tax positions. Certain VAT assessments relate to years covered by an indemnification agreement. Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters. However, based on currently available information, the Company believes the ultimate outcome of these matters will not have a material adverse effect on its financial position, cash flows or results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">VII.&#160;Antitrust Settlements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous lawsuits have been filed against certain brand pharmaceutical manufacturers alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. These lawsuits are typically brought as class actions. The Company has not been named a plaintiff in any of these class action lawsuits, but has been a member of the class of those who purchased directly from the pharmaceutical manufacturers. Some of these class action lawsuits have settled in the past with the Company receiving proceeds, including $129 million, $46&#160;million, and $181&#160;million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively, which were included in &#8220;Cost of sales&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">VIII. Other Matters </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in various other litigation, governmental proceedings, and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings, or claims, the Company believes, based on current knowledge and the advice of counsel, that such litigation, proceedings, and claims will not have a material impact on the Company&#8217;s financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156008750064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity (Deficit)</a></td>
<td class="text">Stockholders' Equity (Deficit) <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to participate equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, the Company&#8217;s quarterly dividend was raised from $0.47 to $0.54 per common share for dividends declared on or after such date by the Board. The Company declared regular cash dividends of $2.09, $1.83, and $1.67 per share for the years ended March 31, 2023, 2022, and 2021, respectively. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company&#8217;s future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has authorized the repurchase of McKesson&#8217;s common stock. Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, tax implications, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions. During the last three fiscal years, the Company&#8217;s share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding share repurchase activity over the last three fiscal years were as follows:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.449%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2021 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2022 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - December 2022 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,693)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $8&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet as of March 31, 2021, included in the Company&#8217;s Annual Report on Form 10-K for the year ended March 31, 2022,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for share repurchases that were executed in late March 2021 and settled in early April 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.1&#160;million shares at an average price per share of $295.16. The Company received 4.8&#160;million shares as the initial share settlement in the fourth quarter of fiscal 2022 based on an initial share purchase price, and in May 2022, it received an additional 0.3&#160;million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $27 million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet as of March 31, 2023 for share repurchases that were executed in late March 2023 and settled in early April 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Loss</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s accumulated other comprehensive loss by component were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow and Other Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling<br/>shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,504)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,534)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(847)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts before reclassifications recorded in fiscal 2023, fiscal 2022, and fiscal 2021 include gains (losses) of $7&#160;million, $73&#160;million, and $(118)&#160;million, respectively, related to net investment hedges from Euro-denominated notes and gains (losses) of $28&#160;million, $(4)&#160;million, and $(119)&#160;million, respectively, related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit (expense) of $(33)&#160;million, $(23)&#160;million, and $62&#160;million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures&#8221; and Financial Note 5, &#8220;Other Income, Net.&#8221; These amounts were included in the fiscal 2021 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the Company&#8217;s Austrian business, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the divestitures of the E.U. disposal group in October 2022, including the impact of amounts previously attributed to the noncontrolling interest in McKesson Europe, and the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included in the fiscal 2023 and fiscal 2022 calculations of charges to remeasure the assets and liabilities of the disposal groups to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. Amounts reclassified to earnings and other includes a net income tax impact of $6&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156014519664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Balances and Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Balances and Transactions</a></td>
<td class="text">Related Party Balances and Transactions<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Europe had investments in pharmacies located across Europe that were accounted for under the equity method. McKesson Europe maintained distribution arrangements with these pharmacies for the sale of related goods and services under which revenues of $137 million and $178 million are included in the Consolidated Statements of Operations for the years ended March 31, 2022 and 2021, respectively, and receivables related to these transactions included in the Consolidated Balance Sheet were not material as of March 31, 2022. Predominately all of these pharmacies were divested from the Company in the fourth quarter of fiscal 2022 as part of the completed divestiture of the Company&#8217;s Austrian business, and in fiscal 2023 as part of the completed divestitures of the E.U. disposal group and U.K. disposal group. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for additional information on the Company&#8217;s European divestiture activities.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended March 31, 2022 and 2021, the Company&#8217;s pharmaceutical sales to one of its equity method investees in the U.S. Pharmaceutical segment totaled $100 million and $111 million, respectively. During fiscal 2022, the Company&#8217;s investment in this investee was no longer accounted for using the equity method and is not considered a related party as of March 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018491168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments of Business</a></td>
<td class="text">Segments of Business <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. RxTS serves our biopharma and life sciences partners, delivering innovative solutions that help people get the medicine they need to live healthier lives. RxTS also offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers national brand medical-surgical products as well as McKesson&#8217;s own line of high-quality products through a network of distribution centers within the U.S.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company completed the divestitures of its Austrian business in January 2022, the U.K. disposal group in April 2022, and the E.U. disposal group in October 2022. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for more information. The Company&#8217;s remaining operations in Europe provide distribution and services to wholesale, institutional, and retail customers in Norway where it owns, partners, or franchises with retail pharmacies. The Company&#8217;s Canadian operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the consolidated totals was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,966&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,025&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment expenditures for long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenditures for long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 40% of the RxTS segment&#8217;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than 8% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit includes the following: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">cash receipts for the Company&#8217;s share of antitrust legal settlements were $129 million, $46 million, and $181 million for the years ended March 31, 2023, 2022, 2021, respectively;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a charge of $1 million for the year ended March 31, 2023 and credits of $23 million and $38 million for the years ended March 31, 2022 and 2021, respectively, related to the LIFO method of accounting for inventories;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $142 million for the year ended March 31, 2023 related to the exit of one of the Company&#8217;s investments in equity securities in July 2022 for proceeds of $179 million, which is reflected within &#8220;Other income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in the Company&#8217;s Consolidated Statement of Operations; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $18&#160;million and $50 million for fiscal 2023 and fiscal 2021, respectively, recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in Financial Note 17, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s RxTS segment&#8217;s operating profit for fiscal 2023 includes restructuring charges of $43&#160;million primarily for severance and employee-related costs, as well as asset impairments and accelerated depreciation. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net&#8221; for further information. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for fiscal 2022 and fiscal 2021 includes inventory charges of $164 million and $136&#160;million, respectively, on certain personal protective equipment and other related products.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating profit (loss) includes the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $240 million and $383 million for the years ended March 31, 2023 and 2022, respectively, to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell and, in fiscal 2022, to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a charge of $1.1 billion for the year ended March 31, 2022 to remeasure the assets and liabilities of the U.K. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $59 million for the year ended March 31, 2022 related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $42 million for the year ended March 31, 2022 related to the sale of the Company&#8217;s previously held </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> interest in its German pharmaceutical wholesale joint venture to WBA. See Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; and Financial Note 5, &#8220;Other Income, Net,&#8221; for further details;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a goodwill impairment charge of $69 million for the year ended March 31, 2021 related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 10, &#8220;Goodwill and Intangible Assets, Net;&#8221; and</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a long-lived asset impairment charge of $115 million for the year ended March 31, 2021 primarily related to the retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net, includes the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $126 million for the year ended March 31, 2023 related to a cash payment received for the early termination of a TRA exercised by Change in October 2022 and was recorded within &#8220;Other income, net&#8221; in the Consolidated Statement of Operations, as discussed in more detail in Financial Note 5, &#8220;Other Income, Net;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $306 million in fiscal 2023 and a charge of $55 million in fiscal 2022 primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $97 million for the year ended March 31, 2023 from the termination of certain forward starting fixed interest rate swaps, as discussed in more detail in Financial Note 14, &#8220;Hedging Activities;&#8221;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a charge of $42 million in fiscal 2022 primarily related to the effect of accumulated other comprehensive loss components from the U.K. disposal group, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a credit of $8 million, and charges of $274 million and $8.1 billion for the years ended March 31, 2023, 2022, and 2021, respectively, related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 17, &#8220;Commitments and Contingent Liabilities;" </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $36&#160;million, $130&#160;million, and $153&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively, of opioid-related costs, primarily litigation expenses; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $83 million, $100 million, and $105 million for the years ended March 31, 2023, 2022, and 2021, respectively, for restructuring initiatives as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a net loss of $36 million, and net gains of $98 million and $133 million for the years ended March 31, 2023, 2022, and 2021, respectively, associated with certain of the Company&#8217;s equity investments, as discussed in more detail in Financial Note 15, &#8220;Fair Value Measurements;&#8221; and</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a net gain of $131 million in fiscal 2021 recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for fiscal 2022 consists of a charge of $191 million related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 11, &#8220;Debt and Financing Activities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment assets and long-lived assets by geographic areas were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The decrease in assets within the International segment is due to the completed divestitures of the U.K. disposal group in April 2022 and the E.U. disposal group in October 2022. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for more information.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software and fiscal 2022 excludes amounts classified as assets held for sale.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018596160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:34.635%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Costs and Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Charged to Other Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions From Allowance Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at End of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:2.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:55.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written-off</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credited to other accounts and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts shown as deductions from current and non-current receivables (current allowances were $158 million, $144 million, and $250 million at March 31, 2023, 2022, and 2021, respectively)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primarily represents reclassifications to other balance sheet accounts.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156006723632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;GAAP&#8221;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.</span>The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control, but instead has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Period</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Period: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Certain prior period amounts have been reclassified to conform to the current year presentation.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds, short-term deposits with financial institutions, and short-term commercial papers issued by non-financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#8217;s foreign subsidiaries, including Canadian dollars, Euro, and British pounds sterling. Deposits could exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#8220;Prepaid expenses and other&#8221; and &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. Restricted cash at</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2022 primarily consisted of $395&#160;million held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities and all amounts were released during fiscal 2023, as discussed in more detail in Financial Note 17, &#8220;Commitments and Contingent Liabilities.&#8221; Additionally, restricted cash at March 31, 2022 included funds temporarily held on behalf of unaffiliated medical practice groups related to their business continuity borrowings as a result of the pandemic caused by the SARS-CoV-2 coronavirus (&#8220;COVID-19&#8221;). These amounts were designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds were recorded by the Company within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets at March 31, 2022. These funds were fully disbursed during fiscal 2023.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text">Equity Method Investments: Investments in business entities in which the Company does not have control, but instead has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that could have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables, Net and Allowances for Credit Losses</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables, Net and Allowances for Credit Losses: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are presented net of an allowance for credit losses and primarily consist of trade accounts receivable from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings, collections on past due amounts, legal disputes, and bankruptcies, as well as reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $111 million and $89 million were included in &#8220;Receivables, net&#8221; in the Consolidated Balance Sheets as of March 31, 2023 and 2022, respectively. Changes in the allowance for the year ended March 31, 2023 were primarily within the U.S Pharmaceutical and Medical-Surgical Solutions segments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk and Receivables</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentrations of Credit Risk and Receivables: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During fiscal 2023, sales to the Company&#8217;s ten largest customers, including group purchasing organizations (&#8220;GPOs&#8221;), accounted for approximately 68% of its total consolidated revenues and approximately 42% of total trade accounts receivable at March 31, 2023. Sales to the Company&#8217;s largest customer, CVS Health Corporation (&#8220;CVS&#8221;), accounted for approximately 27% of its total consolidated revenues in fiscal 2023 and comprised approximately 21% of total trade accounts receivable at March 31, 2023. As a result, the Company&#8217;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies, and other healthcare providers, as well as with government entities and agencies. The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from GPOs or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#8217;s financial condition, results of operations, and liquidity. In addition, trade accounts receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy, changes in reimbursement policies, and other factors. This credit risk is mitigated by the size and diversity of the Company&#8217;s customer base as well as its geographic dispersion.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#8220;LIFO&#8221;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#8220;FIFO&#8221;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023 and 2022, total inventories, net were $19.7 billion and $18.7 billion, respectively, in the Company&#8217;s Consolidated Balance Sheets. The LIFO method was used to value approximately 64% and 63% of the Company&#8217;s inventories at March 31, 2023 and 2022, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $384&#160;million and $383&#160;million higher than the amounts reported at March 31, 2023 and 2022, respectively. These amounts are equivalent to the Company&#8217;s LIFO reserves. The Company&#8217;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized a LIFO charge of $1 million in fiscal 2023 and LIFO credits of $23 million and $38 million in fiscal 2022 and fiscal 2021, respectively, all within &#8220;Cost of sales&#8221; in its Consolidated Statements of Operations. The LIFO charge in fiscal 2023 compared to LIFO credits in fiscal 2022 and fiscal 2021 are primarily due to higher brand inflation and lower generics deflation, offset by significantly higher off patent launch activity in fiscal 2023. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. </span></div>The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#8220;market&#8221;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March 31, 2023 and 2022, inventories at LIFO did not exceed market.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Shipping and Handling Costs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shipping and Handling Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company includes costs to pack and deliver inventory to its customers in &#8220;Selling, distribution, general, and administrative expenses&#8221; in its Consolidated Statements of Operations. Shipping and handling costs of $1.2 billion, $1.1 billion, and $1.0 billion were recognized in fiscal 2023, fiscal 2022 and fiscal 2021, respectively.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_HeldforSalePolicyTextBlock', window );">Held for Sale</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Held for Sale: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are classified as &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed during each reporting period it remains classified as held for sale, and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for additional information.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">Property, Plant, and Equipment, Net: Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzc5_434691cb-3c7b-46f0-b8e5-b9ad93bbc229">three</span> to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives of the right-of-use (&#8220;ROU&#8221;) asset or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company leases facilities and equipment primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components, such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0MzI0_4fd24846-796a-4644-bf59-7de3fb2a6e2d">one</span>&#160;to 15 years, while remaining terms for equipment leases generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0NDA0_da16eb7b-c863-47a8-b5b6-560d55f8d8c1">one</span>&#160;to five years. Most real property leases contain renewal options (typically for five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating ROU assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#8217;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#8217;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. Operating lease liabilities are recorded in &#8220;Current portion of operating lease liabilities&#8221; and &#8220;Long-term operating lease liabilities,&#8221; and the corresponding lease assets are recorded in &#8220;Operating lease right-of-use assets&#8221; in the Company&#8217;s Consolidated Balance Sheets. Finance lease assets are included in &#8220;Property, plant, and equipment, net&#8221; and finance lease liabilities are included in &#8220;Current portion of long-term debt&#8221; and &#8220;Long-term debt&#8221; in the Company&#8217;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a lessor, the Company primarily leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 9, &#8220;Leases,&#8221; for additional information on the Company&#8217;s leases.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment on an annual basis in the first fiscal quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#8220;DCF&#8221;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#8217; fair values to the Company&#8217;s market capitalization as further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline public companies for comparisons, and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently all of the Company&#8217;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE4NzYz_104a5783-416c-41d1-9774-e5859d78ef41">one</span> to 25 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from the use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair value.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Capitalized Software Held for Internal Use</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitalized Software Held for Internal Use: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years. As of March 31, 2023 and 2022, capitalized software held for internal use was $353 million and $320 million, respectively, net of accumulated amortization of $1.5 billion and $1.4 billion, respectively, and is included in &#8220;Other non-current assets&#8221; in the Consolidated Balance Sheets. Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $101&#160;million, $116&#160;million, and $117&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_InsuranceProgramsPolicyTextBlock', window );">Insurance Programs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance Programs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#8220;Captives&#8221;) from which it obtains coverage for various exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company as discussed in more detail in Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; as well as those risks required to be insured by law or contract. It is the Company&#8217;s policy to retain a significant portion of certain losses, including those related to workers&#8217; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#8217;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#8217;s premium costs within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#8217;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#8217; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#8217;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 99% and 1% of total revenues, respectively, for the year ended March 31, 2023, and approximately 98% and 2% of total revenues, respectively, for each of the years ended March 31, 2022 and 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.1 billion, $3.2 billion, and $3.1 billion for fiscal 2023, fiscal 2022, and fiscal 2021, respectively. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March 31, 2023 and 2022. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#8217;s services arrangements and are recognized as revenues over the periods when services are performed. </span></div>The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March 31, 2023 and 2022. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_SupplierIncentivesPolicyPolicyTextBlock', window );">Supplier Incentives</a></td>
<td class="text">Supplier Incentives: Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_SupplierReservesPolicyTextBlock', window );">Supplier Reserves</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplier Reserves: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims could be different than the Company&#8217;s estimate. The supplier reserves primarily pertain to the Company&#8217;s U.S. Pharmaceutical segment.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon effective settlement.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpensePolicyTextBlock', window );">Interest Expense</a></td>
<td class="text">Interest Expense: Interest expense primarily includes interest for the Company&#8217;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Translation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#8217; deficit accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; deficit section of the Consolidated Balance Sheets. Gains and losses from currency exchange transactions are recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations and were not material for the years ended March 31, 2023, 2022, or 2021. The Company releases cumulative translation adjustments from stockholders&#8217; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro-rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments: Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company has used foreign currency-denominated notes and uses cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#8220;Other comprehensive income, net of tax&#8221; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#8217; deficit section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Any cash flows received or paid as part of the termination of derivative financial instruments are classified within the Consolidated Statements of Cash Flows in accordance with the nature of the hedged item. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings. Refer to Financial Note 14, &#8220;Hedging Activities,&#8221; for additional information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Income (Loss): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, as well as gains and losses that are recorded as an element of stockholders&#8217; deficit but are excluded from earnings. The Company&#8217;s other comprehensive income (loss) primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency, including gains and losses on net investment hedges, as well as unrealized gains and losses on cash flow hedges and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span>unrealized gains and losses on retirement-related benefit plans.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Noncontrolling Interests and Redeemable Noncontrolling Interests</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests and Redeemable Noncontrolling Interests: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income or loss that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes third-party equity interests in the Company&#8217;s consolidated entities, including: ClarusONE Sourcing Services LLP (&#8220;ClarusONE&#8221;), a joint venture established between McKesson and Walmart Inc. in fiscal 2017; Vantage Oncology Holdings, LLC (&#8220;Vantage&#8221;), a provider of integrated oncology and radiation services acquired in fiscal 2017; and SCRI Oncology, LLC (&#8220;SCRI Oncology&#8221;), an oncology research business formed in the third quarter of fiscal 2023 combining McKesson&#8217;s U.S. Oncology Research (&#8220;USOR&#8221;) and HCA Healthcare, Inc.&#8217;s (&#8220;HCA&#8221;) Sarah Cannon Research Institute (&#8220;SCRI&#8221;). Net income attributable to noncontrolling interests also included recurring compensation that the Company was obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. The Company&#8217;s noncontrolling interest in McKesson Europe was included in the divestiture of certain of the Company&#8217;s businesses in the European Union (&#8220;E.U.&#8221;) in October 2022. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#8217;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#8217; deficit in the Company&#8217;s Consolidated Balance Sheets. Refer to Financial Note 7, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; for additional information on noncontrolling and redeemable noncontrolling interests, and Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for additional information on the acquisition and divestiture activity discussed above.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#8217;s employees. Refer to Financial Note 4, &#8220;Share-Based Compensation,&#8221; for additional information.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Loss Contingencies</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews all material contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 17, &#8220;Commitments and Contingent Liabilities,&#8221; for additional information related to controlled substances claims to which the Company is a party.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Restructuring Charges</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at fair value at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are expensed as incurred. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; for additional information.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, including contingent consideration, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a variation of the income approach, whereby a forecast of future cash flows attributable to the asset is discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#8217;s expected useful life.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration liabilities are measured at their fair value as of the acquisition date using unobservable inputs. These inputs include the estimated amount and timing of projected operational and financial information, the probability of achievement of performance milestones or other agreed-upon events, and the risk-adjusted discount rate used to calculate the present value of the probability-weighted projected financial information. Contingent liabilities are remeasured to fair value at each reporting date until the liability is resolved. Changes in any of the inputs could result in a significant adjustment to the fair value.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_TreasuryStockPolicyTextBlock', window );">Treasury Stock</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Treasury Stock:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> We record purchases of treasury stock at cost, which is reflected as a reduction to stockholders&#8217; equity in the Company&#8217;s Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock, including any excise tax recognized as a result of the IR Act, are included in the cost of the shares acquired. Treasury stock also includes shares withheld to satisfy the tax obligations of recipients of share-based compensation.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no adopted accounting standards during fiscal 2023 that had a material impact to the Company&#8217;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of such equity security, and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect that this guidance will have a material impact on its consolidated financial statements or related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_HeldforSalePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Held for Sale [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_HeldforSalePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_InsuranceProgramsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of our insurance programs, we seek to obtain coverage for catastrophic exposures as well as those risks required to be insured by law or contract. [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_InsuranceProgramsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SupplierIncentivesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplier Incentives, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SupplierIncentivesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SupplierReservesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reserves against amounts due from suppliers relating to various price and rebate incentives, including deductions or billings taken against payments otherwise due to them. [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SupplierReservesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_TreasuryStockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_TreasuryStockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing interest expense, including the method of amortizing debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 10<br> -Section 05<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=28365394&amp;loc=d3e23770-108382<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19379-109286<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156016877104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of receivables</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s receivables as of March 31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer accounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total receivables</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,410&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,583&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property, plant and equipment, net</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of the Company&#8217;s property, plant, and equipment, net as of March 31, 2023 and 2022:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156009181888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary purchase price allocation for this acquisition:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized<br/>as of Acquisition Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets acquired and liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable net assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary purchase price allocation for this acquisition:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized<br/>as of Acquisition Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchase consideration:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution of USOR</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets acquired and liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable net assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Assets and Liabilities Held for Sale</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the E.U. disposal group that met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet at March 31, 2022 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Excludes charges in fiscal 2022 related to the impairment of individual assets, including a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#8217;s Consolidated Balance Sheet at March 31, 2022 were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of assets of businesses held for sale to fair value less costs to sell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities held for sale</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156014463120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of details for charges recorded</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2023 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes costs related to operational efficiencies and cost optimization efforts described above to support the Company&#8217;s technology solutions.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. Corporate includes costs for business transformation and optimization efforts related to the Company&#8217;s technology organization. The International segment includes costs related to the Company&#8217;s European divestitures. </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2022</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2022 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. For the Company&#8217;s International segment, costs primarily relate to optimization programs in Canada, exit-related actions for the Company&#8217;s European Divestiture Activities, and programs for operating model and cost optimization efforts in the U.K. as described above. For Corporate, primarily represents costs related to the transition to the partial remote work model described above and various other initiatives. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges, net for the year ended March 31, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended March 31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the operating model and cost optimization efforts described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#8217;s headquarters described above in addition to various other initiatives.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the years ended March 31, 2023 and 2022: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Other primarily includes cumulative translation adjustments and transfers to certain other liabilities. For the Company&#8217;s International segment, other also includes a reduction to the liability for the divestitures of the E.U. disposal group and the U.K. disposal group in fiscal 2023, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#8220;Other accrued liabilities,&#8221; $36 million was recorded in &#8220;Liabilities held for sale,&#8221; and $36 million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets. </span></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;As of March 31, 2023, the total reserve balance was $92 million, of which $66 million was recorded in &#8220;Other accrued liabilities&#8221; and $26 million was recorded in &#8220;Other non-current liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156014137392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of components of share-based compensation expense and related tax benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of share-based compensation expense and related tax benefits were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit for share-based compensation expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense, net of tax</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes compensation expense recognized for RSUs and PSUs.</span></div>(2)Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax benefit for fiscal 2023, fiscal 2022, and fiscal 2021 included discrete income tax benefit of $58 million and $10 million, and discrete income tax expense of $1 million, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used to estimate fair value of PSUs</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average assumptions used in the Monte Carlo valuations were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></div></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of restricted stock unit award activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity for restricted stock unit awards (RSUs and PSUs) during fiscal 2023:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date Fair<br/>Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested, March 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.77&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts less than a million are shown as zero in the table above.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DataRelatedtoRSUActivityTableTextBlock', window );">Schedule of data related to restricted stock unit award activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to restricted stock unit award activity: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of shares vested</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of options outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of stock options outstanding at March 31, 2023:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.560%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Range of Exercise<br/>Prices</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Outstanding<br/>at Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options<br/>Exercisable at<br/>Year End<br/>(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$123.98</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$182.78</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.36&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.36&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of stock option activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during fiscal 2023:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding, March 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable, March 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.36&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of options expected to vest takes into account an estimate of expected forfeitures.</span></div>(2)The intrinsic value is calculated as the difference between the period-end market price of the Company&#8217;s common stock and the exercise price of &#8220;in-the-money&#8221; options.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock', window );">Summary of data related to stock option activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides data related to stock option activity:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per stock option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value on exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received upon exercise</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized related to exercise</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value of stock options vested</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average period in years over which stock option compensation cost is expected to be recognized</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DataRelatedtoRSUActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Data Related to RSU Activity [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DataRelatedtoRSUActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of share based compensation arrangements by share based payment award data related to stock option activity [table text block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156014462272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock', window );">Schedule of other income, net</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of the following:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gains on investments in equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The increase in interest income for fiscal 2023 compared to fiscal 2022 and fiscal 2021 is primarily due to higher interest rates on certain cash balances.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily recorded within the Company&#8217;s International segment for fiscal 2022 and fiscal 2021. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents net realized and unrealized gains as well as impairment charges on the Company&#8217;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on the disposal of certain of these investments, including a gain of $142 million for the year ended March 31, 2023 related to the exit of one of the Company&#8217;s investments in equity securities in July 2022 for proceeds of $179 million. Refer to Financial Note 15, &#8220;Fair Value Measurements&#8221; for more information on these types of investments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other, net for year ended March 31, 2023 includes the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $126 million related to a cash payment received for the early termination of a tax receivable agreement (&#8220;TRA&#8221;) exercised by Change Healthcare Inc. (&#8220;Change&#8221;) in October 2022. The Company was a party to a TRA entered into as part of the formation of the joint venture with Change, from which McKesson has since exited. The TRA generally required Change to pay the Company 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the amortization allocated to Change by the joint venture. In October 2022, Change exercised its right pursuant to the TRA to terminate the agreement; and </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $97 million recognized from the termination of certain forward starting fixed interest rate swaps, as discussed in more detail in Financial Note 14, &#8220;Hedging Activities.&#8221;</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other, net for the year ended March 31, 2022 includes a gain of $42&#160;million as part of the completed sale of the Company&#8217;s previously held 30% interest in its German pharmaceutical wholesale joint venture to WBA. </span></div>Other, net for all periods presented also includes income recognized from finance charges to customers primarily for late fees.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the detailed components of other nonoperating income. May include methodology, assumptions and amounts for: (a) dividends, (b) interest on securities, (c) profits on securities (net of losses), and (d) miscellaneous other income items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156006338320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of income (loss) from continuing operations before income taxes</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,630&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of income tax expense (benefit) related to continuing operations</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) related to continuing operations consists of the following: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except percentages)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(908)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation between effective tax rate on income from continuing operations and statutory tax rate</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21.0% to income before income taxes was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of foreign operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tax benefit on intellectual property transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E.U. disposal transaction loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1)The Company&#8217;s effective tax rates were impacted by other favorable U.S. federal permanent differences, including research and development credits of $4 million in each of fiscal 2023 and fiscal 2022, and $5 million in fiscal 2021.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax balances</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax balances consisted of the following:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable allowances</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opioid-related litigation and claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefit related accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,329&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,607&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory valuation and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,079)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets and systems development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(401)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,809)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,828)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,221)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,221)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of gross unrecognized tax benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits for the last three fiscal years:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions based on the lapse of the applicable statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange rate fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized tax benefits at end of period</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,754&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018741184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Schedule of Changes in Noncontrolling Interest</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March 31, 2023, 2022, and 2021 were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable<br/>Noncontrolling<br/>Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Formation of SCRI Oncology</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derecognition of noncontrolling interests in McKesson Europe</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></div></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018481760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted earnings per common share</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share were as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,725&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to McKesson Corporation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,538)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to McKesson Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,539)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.32&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.26)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units and performance-based stock units.</span></div>(2)Certain computations may reflect rounding adjustments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020746336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Supplemental balance sheet information</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except lease term and discount rate)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2cb43d7d-4dbe-40be-891b-5b154c0f7e7e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2e8bafc9-a699-4ad1-a382-140d4fabd947">Property, plant, and equipment, net</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_481d8594-6d0e-48c4-a516-41181b6ee1a8"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_b132aa89-d101-44a4-8856-5a1aefc7a3ca">Current portion of long-term debt</span></span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_9a3e0520-2b32-4c2a-8b14-f87e23310cf5"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_fbb0bd27-adff-497f-b17f-ffe770574fee">Long-term debt</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.66&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As discussed in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net,&#8221; in fiscal 2022, the Company rationalized its office space, including certain property leases in North America, and in fiscal 2023, management approved further changes to its real estate footprint as part of a broader set of initiatives. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. These initiatives did not have a material financial impact to the Company&#8217;s operating lease ROU assets and liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes operating lease right-of-use assets of approximately $494&#160;million, as well as current and long-term operating lease liabilities of approximately $83&#160;million and $442&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included under the caption &#8220;Assets held for sale&#8221; and &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of the assets ceased upon classification as held for sale.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of lease costs and supplemental cash flow information</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease cost were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of lease liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2023 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by future minimum sublease income&#160;of $191 million which is due under noncancellable subleases.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Maturities of lease liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2023 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Total lease payments are not reduced by future minimum sublease income&#160;of $191 million which is due under noncancellable subleases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156021067056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of changes in the carrying amount of goodwill</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.941%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,533&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,451&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,947&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of information regarding intangible assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:22.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,765)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,691)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(623)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,398&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,121)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,277&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,996&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,937)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes net intangible assets of approximately $384 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; This amount was included under the caption &#8220;Assets held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of fiscal 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018601760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.25% Notes due February 15, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30% Notes due August 15, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,626&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,080&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these U.S. dollar notes is payable semi-annually.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Excludes current and long-term debt of approximately $4&#160;million and $11&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included under the caption &#8220;Liabilities held for sale&#8221; in the Consolidated Balance Sheet as of March 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156010328208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of net periodic expense for pension plans</a></td>
<td class="text">The net periodic expense for the Company&#8217;s pension plans were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost - benefits earned during the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of unrecognized actuarial loss and prior service costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of changes in benefit obligations and plan assets for pension plans</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the changes in benefit obligations and plan assets for the Company&#8217;s pension plans was as follows: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Curtailment/settlement</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer and participant contributions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses paid</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status at end of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on the balance sheet</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The benefit obligation is the projected benefit obligation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Relates to the completed divestitures of the E.U. disposal group and U.K. disposal group in fiscal 2023 and the completed divestiture of the Company&#8217;s Austrian business in fiscal 2022 as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221;</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Current assets at March 31, 2022 include $49&#160;million reclassified from long-term assets to assets held for sale as part of the Company&#8217;s U.K. disposal group, which was divested in fiscal 2023. Current liabilities at March 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$85&#160;million reclassified from long-term liabilities to liabilities held for sale as part of the Company&#8217;s E.U. disposal group, which was divested in fiscal 2023. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures&#8221; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Schedule of projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#8217;s pension plans, including accumulated benefit obligation in excess of plan assets:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated benefit obligation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of defined benefit plan amounts recognized in other comprehensive loss</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts recognized in accumulated other comprehensive loss consist of: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.495%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of other changes in plan assets and benefit obligations recognized in other comprehensive income</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other changes in accumulated other comprehensive loss were as follows: </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:55.058%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.656%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service credit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange impact and other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recognized in other comprehensive income </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of weighted-average assumptions used to estimate net periodic pension expense and actuarial present value of benefit obligations</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:55.140%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.528%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.532%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net periodic pension expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benefit obligation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of increase in compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.21&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.67&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.20&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Summary of pension plan assets using fair value hierarchy by asset class</a></td>
<td class="text">The following tables represent the Company&#8217;s plan assets as of March&#160;31, 2023 and 2022, using the fair value hierarchy by asset class:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.655%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed income commingled funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuity contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate funds and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held at NAV practical expedient </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total plan assets</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock', window );">Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the Level 3 plan assets measured on a recurring basis for the years ended March 31, 2023 and 2022:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.298%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in plan assets and benefit obligations recognized in other comprehensive income (loss) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020822864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Consolidated Statements of Comprehensive Income were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro-denominated notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the years ended March 31, 2023, 2022 and 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the year ended March 31, 2023, includes amounts reclassified to earnings of $112&#160;million.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock', window );">Schedule of Notional Amounts of Outstanding Derivative Positions</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2023 and 2022, the notional amounts of the Company&#8217;s outstanding derivatives were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-24 to Mar-25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as fair value hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nov-28</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#163;</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EUR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aug-25 to Jul-26</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8364;</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Floating interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feb-26 to Sep-29</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jan-24</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jun-33</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The maturity date reflected is for outstanding derivatives as of March 31, 2023.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">There was no ineffectiveness in these hedges for the years ended March 31, 2023, 2022, and 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In fiscal 2023, represents cross-currency fixed-to-fixed interest rate swaps to mitigate the foreign currency exchange fluctuations on its foreign currency-denominated notes. In fiscal 2022, represents fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread.  </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains (losses) from derivatives included in other comprehensive income (loss) in the Consolidated Statements of Comprehensive Income (Loss) were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow and other hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes other comprehensive income related to the excluded component of certain fair value hedges.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains (losses) from derivatives included in other comprehensive income (loss) in the Consolidated Statements of Comprehensive Income (Loss) were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow and other hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes other comprehensive income related to the excluded component of certain fair value hedges.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis were as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated for hedge accounting:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the notional amounts of outstanding derivative positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018508720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,594&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,386&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,879&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018561760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock', window );">Schedule of Estimated Accrual Liability</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimated accrued liability for the opioid-related claims of U.S. governmental entities, including Native American tribes, was as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,173&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These amounts, recorded in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020905776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesTextBlock', window );">Schedule of shares repurchased over last three years</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding share repurchase activity over the last three fiscal years were as follows:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.449%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price <br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate <br/>Dollar Value of <br/>Shares that May <br/>Yet Be Purchased <br/>Under the <br/>Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2021 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - February 2022 ASR </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - May 2022 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase authorization increase in fiscal 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - December 2022 ASR</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased - Open market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,693)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The number of shares purchased reflects rounding adjustments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $8&#160;million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet as of March 31, 2021, included in the Company&#8217;s Annual Report on Form 10-K for the year ended March 31, 2022,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for share repurchases that were executed in late March 2021 and settled in early April 2021.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#8217;s common stock. The total number of shares repurchased under this ASR program was 5.1&#160;million shares at an average price per share of $295.16. The Company received 4.8&#160;million shares as the initial share settlement in the fourth quarter of fiscal 2022 based on an initial share purchase price, and in May 2022, it received an additional 0.3&#160;million shares upon the completion of this ASR program.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Of the total dollar value, $27 million was accrued within &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Consolidated Balance Sheet as of March 31, 2023 for share repurchases that were executed in late March 2023 and settled in early April 2023.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of accumulated other comprehensive income (loss)</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s accumulated other comprehensive loss by component were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net of Tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow and Other Hedges, <br/>Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling<br/>shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,504)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,534)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(847)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(905)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#8217;s operations in Europe and Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts before reclassifications recorded in fiscal 2023, fiscal 2022, and fiscal 2021 include gains (losses) of $7&#160;million, $73&#160;million, and $(118)&#160;million, respectively, related to net investment hedges from Euro-denominated notes and gains (losses) of $28&#160;million, $(4)&#160;million, and $(119)&#160;million, respectively, related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit (expense) of $(33)&#160;million, $(23)&#160;million, and $62&#160;million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the contribution of the Company&#8217;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures&#8221; and Financial Note 5, &#8220;Other Income, Net.&#8221; These amounts were included in the fiscal 2021 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the sale of the Company&#8217;s Austrian business, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily includes adjustments for amounts related to the divestitures of the E.U. disposal group in October 2022, including the impact of amounts previously attributed to the noncontrolling interest in McKesson Europe, and the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures.&#8221; These amounts were included in the fiscal 2023 and fiscal 2022 calculations of charges to remeasure the assets and liabilities of the disposal groups to fair value less costs to sell recorded within &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statements of Operations. Amounts reclassified to earnings and other includes a net income tax impact of $6&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020483024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of segment information</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the consolidated totals was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,711&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,966&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,228&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,025&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,073)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt extinguishment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,034)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(9) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment expenditures for long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(10) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenditures for long-lived assets</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, less than 40% of the RxTS segment&#8217;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#8217;s total revenues, and less than 8% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for the Company&#8217;s reportable segments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit includes the following: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">cash receipts for the Company&#8217;s share of antitrust legal settlements were $129 million, $46 million, and $181 million for the years ended March 31, 2023, 2022, 2021, respectively;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a charge of $1 million for the year ended March 31, 2023 and credits of $23 million and $38 million for the years ended March 31, 2022 and 2021, respectively, related to the LIFO method of accounting for inventories;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $142 million for the year ended March 31, 2023 related to the exit of one of the Company&#8217;s investments in equity securities in July 2022 for proceeds of $179 million, which is reflected within &#8220;Other income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in the Company&#8217;s Consolidated Statement of Operations; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $18&#160;million and $50 million for fiscal 2023 and fiscal 2021, respectively, recorded in connection with the Company&#8217;s estimated liability under the State of New York&#8217;s OSA, as further discussed in Financial Note 17, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s RxTS segment&#8217;s operating profit for fiscal 2023 includes restructuring charges of $43&#160;million primarily for severance and employee-related costs, as well as asset impairments and accelerated depreciation. Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net&#8221; for further information. </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for fiscal 2022 and fiscal 2021 includes inventory charges of $164 million and $136&#160;million, respectively, on certain personal protective equipment and other related products.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s International segment&#8217;s operating profit (loss) includes the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $240 million and $383 million for the years ended March 31, 2023 and 2022, respectively, to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell and, in fiscal 2022, to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a charge of $1.1 billion for the year ended March 31, 2022 to remeasure the assets and liabilities of the U.K. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $59 million for the year ended March 31, 2022 related to the sale of the Company&#8217;s Canadian health benefit claims management and plan administrative services business;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $42 million for the year ended March 31, 2022 related to the sale of the Company&#8217;s previously held </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> interest in its German pharmaceutical wholesale joint venture to WBA. See Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; and Financial Note 5, &#8220;Other Income, Net,&#8221; for further details;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a goodwill impairment charge of $69 million for the year ended March 31, 2021 related to one of the Company&#8217;s reporting units in Europe, as discussed in more detail in Financial Note 10, &#8220;Goodwill and Intangible Assets, Net;&#8221; and</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a long-lived asset impairment charge of $115 million for the year ended March 31, 2021 primarily related to the retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net.&#8221; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net, includes the following:</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $126 million for the year ended March 31, 2023 related to a cash payment received for the early termination of a TRA exercised by Change in October 2022 and was recorded within &#8220;Other income, net&#8221; in the Consolidated Statement of Operations, as discussed in more detail in Financial Note 5, &#8220;Other Income, Net;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $306 million in fiscal 2023 and a charge of $55 million in fiscal 2022 primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a gain of $97 million for the year ended March 31, 2023 from the termination of certain forward starting fixed interest rate swaps, as discussed in more detail in Financial Note 14, &#8220;Hedging Activities;&#8221;</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a charge of $42 million in fiscal 2022 primarily related to the effect of accumulated other comprehensive loss components from the U.K. disposal group, as discussed in more detail in Financial Note 2, &#8220;Business Acquisitions and Divestitures;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a credit of $8 million, and charges of $274 million and $8.1 billion for the years ended March 31, 2023, 2022, and 2021, respectively, related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 17, &#8220;Commitments and Contingent Liabilities;" </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $36&#160;million, $130&#160;million, and $153&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively, of opioid-related costs, primarily litigation expenses; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">charges of $83 million, $100 million, and $105 million for the years ended March 31, 2023, 2022, and 2021, respectively, for restructuring initiatives as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges, Net;&#8221; </span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a net loss of $36 million, and net gains of $98 million and $133 million for the years ended March 31, 2023, 2022, and 2021, respectively, associated with certain of the Company&#8217;s equity investments, as discussed in more detail in Financial Note 15, &#8220;Fair Value Measurements;&#8221; and</span></div><div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a net gain of $131 million in fiscal 2021 recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Loss on debt extinguishment for fiscal 2022 consists of a charge of $191 million related to the Company&#8217;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 11, &#8220;Debt and Financing Activities.&#8221;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Schedule of segment assets and long-lived assets by net by geographic areas</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment assets and long-lived assets by geographic areas were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The decrease in assets within the International segment is due to the completed divestitures of the U.K. disposal group in April 2022 and the E.U. disposal group in October 2022. Refer to Financial Note 2, &#8220;Business Acquisitions and Divestitures,&#8221; for more information.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Long-lived assets consist of property, plant, and equipment, net and capitalized software and fiscal 2022 excludes amounts classified as assets held for sale.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156009296848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,691<span></span>
</td>
<td class="nump">$ 18,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PercentageOfLIFOInventory', window );">LIFO inventory (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">LIFO reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 384<span></span>
</td>
<td class="nump">$ 383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Charges (credits) associated with last-in, first-out inventory method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">$ (38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Shipping and handling costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,776<span></span>
</td>
<td class="nump">10,537<span></span>
</td>
<td class="nump">8,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation expense for property, plant, and equipment, and amortization of finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized software held for internal use, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">353<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization', window );">Capitalized software held for internal use, accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Capitalized software held for internal use, amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns', window );">Sales returns from customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_RealPropertyMember', window );">Real Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal option increments for leases (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Machinery, equipment, and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife', window );">Capitalized software held for internal use, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Machinery, equipment, and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Shipping and handling costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Sales Revenue, Net | Ten Largest Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Sales Revenue, Net | CVS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable | Ten Largest Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable | CVS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk | Sales Revenue, Net | Distribution and Retail Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.00%<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Product Concentration Risk | Sales Revenue, Net | Services Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of total consolidated revenues (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CapitalizedSoftwareHeldforInternalUseUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Software Held for Internal Use, Useful Life</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CapitalizedSoftwareHeldforInternalUseUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfLIFOInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfLIFOInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_RealPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_RealPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_MachineryEquipmentAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mck_MachineryEquipmentAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mck_TenLargestCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mck_TenLargestCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mck_LargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mck_LargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mck_DistributionandRetailBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mck_DistributionandRetailBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mck_ServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mck_ServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156014428928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Receivables, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AccountsReceivableCustomerAccountsGross', window );">Customer accounts</a></td>
<td class="nump">$ 17,160<span></span>
</td>
<td class="nump">$ 16,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesGrossCurrent', window );">Other</a></td>
<td class="nump">2,408<span></span>
</td>
<td class="nump">2,289<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Total receivables</a></td>
<td class="nump">19,568<span></span>
</td>
<td class="nump">18,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowances</a></td>
<td class="num">(158)<span></span>
</td>
<td class="num">(144)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">$ 19,410<span></span>
</td>
<td class="nump">$ 18,583<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AccountsReceivableCustomerAccountsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Customer Accounts, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AccountsReceivableCustomerAccountsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156009164336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Property, Plant and Equipment, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 109<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building and improvements</a></td>
<td class="nump">1,413<span></span>
</td>
<td class="nump">1,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Machinery, equipment, and other</a></td>
<td class="nump">2,603<span></span>
</td>
<td class="nump">2,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">283<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, plant, and equipment</a></td>
<td class="nump">4,408<span></span>
</td>
<td class="nump">4,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(2,231)<span></span>
</td>
<td class="num">(1,994)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">$ 2,177<span></span>
</td>
<td class="nump">$ 2,092<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156008969200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures - Acquisitions (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Nov. 01, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,947<span></span>
</td>
<td class="nump">$ 9,451<span></span>
</td>
<td class="nump">$ 9,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,050<span></span>
</td>
<td class="nump">$ 3,923<span></span>
</td>
<td class="nump">$ 3,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mck_RxSavingsSolutionsLLCMember', window );">Rx Savings Solutions, LLC | RxTs Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition, percentage of controlling interest in combined business</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payment to acquire business</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired identifiable intangible assets</a></td>
<td class="nump">$ 229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average life of intangibles</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mck_RxSavingsSolutionsLLCMember', window );">Rx Savings Solutions, LLC | RxTs Segment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mck_SCRIOncologyLLCMember', window );">SCRI Oncology, LLC | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition, percentage of controlling interest in combined business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payment to acquire business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired identifiable intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average life of intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill, expected tax deductible amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mck_SCRIOncologyLLCMember', window );">SCRI Oncology, LLC | U.S. Pharmaceutical | SCRI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mck_SCRIOncologyLLCMember', window );">SCRI Oncology, LLC | U.S. Pharmaceutical | USOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mck_RxSavingsSolutionsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mck_RxSavingsSolutionsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_RxTsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_RxTsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mck_SCRIOncologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mck_SCRIOncologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_SarahCannonResearchInstituteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_SarahCannonResearchInstituteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_McKessonUSOncologyResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_McKessonUSOncologyResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156008780704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Rx Savings Solutions) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Nov. 01, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Identifiable assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,947<span></span>
</td>
<td class="nump">$ 9,451<span></span>
</td>
<td class="nump">$ 9,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mck_RxSavingsSolutionsLLCMember', window );">Rx Savings Solutions, LLC | RxTs Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Purchase consideration:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase consideration</a></td>
<td class="nump">692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Identifiable assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest', window );">Net assets acquired</a></td>
<td class="nump">$ 692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mck_RxSavingsSolutionsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mck_RxSavingsSolutionsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_RxTsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_RxTsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156006420384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Oncology Research) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Identifiable assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,947<span></span>
</td>
<td class="nump">$ 9,451<span></span>
</td>
<td class="nump">$ 9,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Identifiable assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,050<span></span>
</td>
<td class="nump">$ 3,923<span></span>
</td>
<td class="nump">$ 3,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mck_SCRIOncologyLLCMember', window );">SCRI Oncology, LLC | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Purchase consideration:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="nump">$ 173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_BusinessCombinationConsiderationTransferredOwnershipInterest', window );">Contribution of USOR</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase consideration</a></td>
<td class="nump">213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Identifiable assets acquired and liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Receivables</a></td>
<td class="nump">224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant, and equipment</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities', window );">Long-term operating lease liabilities</a></td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other non-current liabilities</a></td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets</a></td>
<td class="nump">340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Noncontrolling interest</a></td>
<td class="num">(225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest', window );">Net assets acquired</a></td>
<td class="nump">$ 213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_BusinessCombinationConsiderationTransferredOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Ownership Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_BusinessCombinationConsiderationTransferredOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Additional-Paid-In Capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mck_SCRIOncologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mck_SCRIOncologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156007584784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures - Divestitures and Other (Details)<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 06, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 06, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Nov. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 4,516<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 4,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4,741<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses, disposal group, losses (gains)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Accumulated other comprehensive loss adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember', window );">German Pharmaceutical Wholesale Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Carrying value of investment in joint venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses, disposal group, losses (gains)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | German Pharmaceutical Wholesale Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses, disposal group, losses (gains)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses, disposal group, losses (gains)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses, disposal group, losses (gains)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue', window );">Accumulated other comprehensive loss in charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group) | Held-for-sale | International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses, disposal group, losses (gains)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group) | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses, disposal group, losses (gains)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (66)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Cash proceeds from divestiture</a></td>
<td class="nump">$ 892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net assets</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Divested cash</a></td>
<td class="nump">319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest', window );">Divested carrying value of noncontrolling interest held by minority shareholders</a></td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Accumulated other comprehensive loss adjustment</a></td>
<td class="nump">$ 153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Businesses (Disposal Group) | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses, disposal group, losses (gains)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Divested cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue', window );">Accumulated other comprehensive loss in charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected', window );">Gross purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Businesses (Disposal Group) | Held-for-sale | International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses, disposal group, losses (gains)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Businesses (Disposal Group) | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from collection of notes receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternationalSegmentMember', window );">International | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Aurelius Elephant Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Divested net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Accumulated other comprehensive loss adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember', window );">Austrian Business Operations | Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses, disposal group, losses (gains)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from collection of notes receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Consideration agreed upon for sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">&#8364; 244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from collection of notes receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable', window );">Consideration receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business | Held-for-sale | International | Walgreens Boots Alliance Joint Venture | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Discontinued Operations Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest in Joint Venture (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Carrying Value Of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Expected</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_AureliusElephantLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_AureliusElephantLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_WalgreensBootsAllianceJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mck_WalgreensBootsAllianceJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156007544864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (E.U. and U.K. Disposal Groups) (Details) - Held-for-sale<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember', window );">E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net</a></td>
<td class="nump">$ 1,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="nump">809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant, and equipment, net</a></td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent', window );">Operating lease right-of-use assets</a></td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent', window );">Other non-current assets</a></td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of businesses held for sale to fair value less costs to sell</a></td>
<td class="num">(302)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held for sale</a></td>
<td class="nump">3,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">1,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities', window );">Current portion of long-term debt</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities', window );">Long-term debt</a></td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent', window );">Other non-current liabilities</a></td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held for sale</a></td>
<td class="nump">2,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember', window );">U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net</a></td>
<td class="nump">931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent', window );">Property, plant, and equipment, net</a></td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent', window );">Operating lease right-of-use assets</a></td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent', window );">Other non-current assets</a></td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1', window );">Remeasurement of assets of businesses held for sale to fair value less costs to sell</a></td>
<td class="num">(1,159)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets held for sale</a></td>
<td class="nump">1,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">1,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent', window );">Other non-current liabilities</a></td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities held for sale</a></td>
<td class="nump">2,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember', window );">Internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware', window );">Impairment charge</a></td>
<td class="nump">$ 113<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_InternallyDevelopedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156006301344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges, Net - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RestructuringImpairmentandOtherRelatedCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">$ 281<span></span>
</td>
<td class="nump">$ 334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Retail Pharmacy Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">U.K. | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember', window );">Strategic Growth Initiative Plan - Operational Efficiencies and Cost Optimization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring costs, anticipated total charges</a></td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember', window );">Restructuring Plan, Remote Work Transitioning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember', window );">Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs | Employee Severance, Accelerated Depreciation and Project Consulting Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember', window );">Strategic Growth Initiative Plan - Relocation of Corporate Headquarters | Employee Retention Expenses, Asset Impairments and Accelerated Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RestructuringImpairmentandOtherRelatedCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Impairment and Other Related Charges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RestructuringImpairmentandOtherRelatedCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156011229264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges, Net - Summary of Details for Charges Recorded (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges, Including Accelerated Depreciation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetImpairmentChargesIncludingAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156013818128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges, Net - Summary of Activity Related to Restructuring Liability (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">$ 219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(115)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges, net</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(86)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember', window );">Disposal Group, Including Discontinued Operation, Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Cost Alignment Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020281856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Components of Share-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 162<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit for share-based compensation expense</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense, net of tax</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Tax expense (benefit), share-based payment arrangement</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock unit awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156010429664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested', window );">Vested RSUs (in shares)</a></td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mck_PerformancebasedStockUnitsMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Requisite service period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock award contractual term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (shares)</a></td>
<td class="nump">23,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (shares)</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions', window );">Period over which payroll is deducted to purchase shares</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of market price for share purchase</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate', window );">Percentage of market price deduction for share purchases</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mck_A2022StockPlanMember', window );">2022 Stock Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (shares)</a></td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mck_A2013StockPlanMember', window );">2013 Stock Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee service share based compensation period to purchase shares through payroll deductions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on offering date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_PerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_PerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mck_A2022StockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mck_A2022StockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mck_A2013StockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mck_A2013StockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156014023712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details) - RSUs and PSUs<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156011136544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details) - RSUs and PSUs<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod', window );">Cancelled (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted- Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per shares) | $ / shares</a></td>
<td class="nump">$ 160.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">332.86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1', window );">Cancelled (in dollars per share) | $ / shares</a></td>
<td class="nump">201.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">149.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per shares) | $ / shares</a></td>
<td class="nump">$ 238.77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156008302944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details) - RSUs and PSUs - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax</a></td>
<td class="nump">$ 192<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which restricted stock unit award cost is expected to be recognized</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020803968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Summary of Stock Options Outstanding (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise prices lower limit (in dollars per share)</a></td>
<td class="nump">$ 123.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise prices upper limit (in dollars per share)</a></td>
<td class="nump">$ 182.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding at Year End (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted- Average Remaining Contractual Life (Years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Weighted- Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 154.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable at Year End (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted- Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 154.36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156006271744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Stock options vested and expected to vest (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 175.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in dollars per share)</a></td>
<td class="nump">125.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">191.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">154.36<span></span>
</td>
<td class="nump">$ 175.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest (in dollars per share)</a></td>
<td class="nump">154.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Vested and exercisable (in dollars per share)</a></td>
<td class="nump">$ 154.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted- Average Remaining Contractual Term (Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Vested and exercisable</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Vested and exercisable</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156011138720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details) - Stock options - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value per stock option (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value on exercise</a></td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received upon exercise</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Tax benefits realized related to exercise</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of stock options vested</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period in years over which stock option compensation cost is expected to be recognized</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">0 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156008867872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net - Schedule of Other Income, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses', window );">Net gains on investments in equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
<td class="nump">$ 223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GainLossOnDerivativeTermination', window );">Gain on derivative termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity method investment</a></td>
<td class="nump">$ 179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember', window );">German Pharmaceutical Wholesale Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_TaxReceivableAgreementTRAMember', window );">Tax Receivable Agreement (&#8220;TRA&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnContractTermination', window );">Gain for early termination of tax receivable agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized', window );">Tax receivable agreement, percent of net cash tax savings realized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Gain (Loss), Excluding Impairment Losses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GainLossOnDerivativeTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Derivative Termination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GainLossOnDerivativeTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_GermanPharmaceuticalWholesaleJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_TaxReceivableAgreementTRAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_TaxReceivableAgreementTRAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156007399712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Income (loss) from continuing operations before income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
<td class="nump">$ 3,308<span></span>
</td>
<td class="nump">$ 1,944<span></span>
</td>
<td class="num">$ (6,019)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">1,322<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">985<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="nump">$ 4,630<span></span>
</td>
<td class="nump">$ 1,928<span></span>
</td>
<td class="num">$ (5,034)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156011090432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 619<span></span>
</td>
<td class="nump">$ 233<span></span>
</td>
<td class="num">$ (15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">180<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">925<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(46)<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="num">(562)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">36<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(204)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(20)<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="num">(908)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 905<span></span>
</td>
<td class="nump">$ 636<span></span>
</td>
<td class="num">$ (695)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax expense (benefit) rates (percent)</a></td>
<td class="nump">19.50%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="num">(13.80%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156008414000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount', window );">Discrete tax benefits related to statute of limitation expirations and tax settlements</a></td>
<td class="nump">$ 115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Tax expense (benefit), share-based payment arrangement</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_IncomeTaxExpenseBenefitDiscreteItems', window );">Net discrete tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">696<span></span>
</td>
<td class="nump">726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">1,399<span></span>
</td>
<td class="nump">1,523<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
<td class="nump">$ 958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would Impact income tax expense and the effective tax rate</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income tax expense (benefit), before any tax effect, related to accrued interest and penalties</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued', window );">Accrued interest and penalties on unrecognized tax benefits</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed earnings of foreign operations</a></td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment', window );">Tax liability increase due to proposed adjustment to taxable income</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment', window );">Tax liability increase due to proposed adjustment to taxable income</a></td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupAndAustrianBusinessMember', window );">U.K. Businesses (Disposal Group) and Austrian Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="nump">3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">European businesses held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Loss contingency accrual, period increase (decrease)</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="nump">8,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax', window );">Loss contingency accrual, period increase (decrease), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Loss contingency accrual, period increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember', window );">Capital Loss Carryforward | Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="nump">$ 701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Lapse Of Applicable Statute Of Limitations And Tax Settlement, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Examination, Estimate Of Possible Liability Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncomeTaxExpenseBenefitDiscreteItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit) Discrete Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncomeTaxExpenseBenefitDiscreteItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126928070&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense accrued for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupAndAustrianBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupAndAustrianBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_CapitalLossCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156011196976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate (percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParentAbstract', window );"><strong>Income (Loss) Attributable to Parent, before Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax expense (benefit) at federal statutory rate</a></td>
<td class="nump">$ 972<span></span>
</td>
<td class="nump">$ 405<span></span>
</td>
<td class="num">$ (1,057)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="num">(206)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Tax effect of foreign operations</a></td>
<td class="num">(145)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Unrecognized tax benefits and settlements</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims', window );">Opioid-related litigation and claims</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit', window );">Net tax benefit on intellectual property transfer</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount', window );">E.U. disposal transaction loss</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Share-based compensation</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other, net</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">905<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="num">(695)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credit</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Litigation and Claims</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156007572928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Components Of Deferred Tax Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Receivable allowances</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DeferredTaxAssetLitigationAndClaims', window );">Opioid-related litigation and claims</a></td>
<td class="nump">699<span></span>
</td>
<td class="nump">755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Compensation and benefit related accruals</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Net operating loss and credit carryforwards</a></td>
<td class="nump">760<span></span>
</td>
<td class="nump">739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DeferredTaxAssetLeaseObligations', window );">Lease obligations</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Subtotal</a></td>
<td class="nump">2,329<span></span>
</td>
<td class="nump">2,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(696)<span></span>
</td>
<td class="num">(726)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total assets</a></td>
<td class="nump">1,633<span></span>
</td>
<td class="nump">1,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts', window );">Inventory valuation and other assets</a></td>
<td class="num">(2,079)<span></span>
</td>
<td class="num">(1,993)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets and systems development costs</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(267)<span></span>
</td>
<td class="num">(233)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets', window );">Lease right-of-use assets</a></td>
<td class="num">(412)<span></span>
</td>
<td class="num">(401)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total liabilities</a></td>
<td class="num">(2,809)<span></span>
</td>
<td class="num">(2,828)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="num">(1,176)<span></span>
</td>
<td class="num">(1,221)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Long-term deferred tax asset</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liability</a></td>
<td class="num">$ (1,387)<span></span>
</td>
<td class="num">$ (1,418)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DeferredTaxAssetLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Lease Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DeferredTaxAssetLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DeferredTaxAssetLitigationAndClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Litigation and Claims</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DeferredTaxAssetLitigationAndClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DeferredTaxLiabilitiesLeaseRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Lease Right-of-use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DeferredTaxLiabilitiesLeaseRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020149648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Gross Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at beginning of period</a></td>
<td class="nump">$ 1,523<span></span>
</td>
<td class="nump">$ 1,754<span></span>
</td>
<td class="nump">$ 958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions based on tax positions related to prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions based on tax positions related to prior years</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(131)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to current year</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Reductions based on settlements</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions based on the lapse of the applicable statutes of limitations</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(102)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation', window );">Exchange rate fluctuations</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at end of period</a></td>
<td class="nump">$ 1,399<span></span>
</td>
<td class="nump">$ 1,523<span></span>
</td>
<td class="nump">$ 1,754<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156008442848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 19, 2018 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 12, 2021 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right (in euro per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 23.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_PutRightValueInterestRateSpread', window );">Annual increase in interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePriceIncrease', window );">Put Right increase (euros per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 0.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments to purchase shares of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,031<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">367<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income (loss) attributable to redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercise of put right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">983<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercise of put right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">367<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income (loss) attributable to redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments to purchase shares of McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased', window );">Shares purchased (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.5<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of outstanding common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember', window );">Vantage and ClarusOne Sourcing Services LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests', window );">Annual recurring compensation (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual Recurring Compensation Per Share to Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price, Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PutRightValueInterestRateSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Put Right Value, Interest Rate Spread</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PutRightValueInterestRateSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156010791216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_FormationOfBusiness', window );">Formation of SCRI Oncology, LLC</a></td>
<td class="nump">247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DerecognitionOfNoncontrollingInterests', window );">Derecognition of noncontrolling interests in McKesson Europe AG</a></td>
<td class="num">(382)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercise of put right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_FormationOfBusiness', window );">Formation of SCRI Oncology, LLC</a></td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DerecognitionOfNoncontrollingInterests', window );">Derecognition of noncontrolling interests in McKesson Europe AG</a></td>
<td class="num">(382)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income (loss) attributable to redeemable noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercise of put right</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(983)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe AG redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_FormationOfBusiness', window );">Formation of SCRI Oncology, LLC</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DerecognitionOfNoncontrollingInterests', window );">Derecognition of noncontrolling interests in McKesson Europe AG</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable Noncontrolling Interest, Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,271<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DerecognitionOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Divestiture of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DerecognitionOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FormationOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Formation Of Business</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FormationOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) Due to Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestIncreaseDecreaseDuetoOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationofTemporaryEquitytoLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationofTemporaryEquitytoLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018759248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share - Narrative (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from diluted earnings per share (less than)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156007510944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">$ 3,725<span></span>
</td>
<td class="nump">$ 1,292<span></span>
</td>
<td class="num">$ (4,339)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(162)<span></span>
</td>
<td class="num">(173)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations attributable to McKesson Corporation</a></td>
<td class="nump">3,563<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
<td class="num">(4,538)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to McKesson Corporation</a></td>
<td class="nump">$ 3,560<span></span>
</td>
<td class="nump">$ 1,114<span></span>
</td>
<td class="num">$ (4,539)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">141.1<span></span>
</td>
<td class="nump">152.3<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">142.2<span></span>
</td>
<td class="nump">154.1<span></span>
</td>
<td class="nump">160.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 25.05<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">25.03<span></span>
</td>
<td class="nump">7.23<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">25.25<span></span>
</td>
<td class="nump">7.35<span></span>
</td>
<td class="num">(28.26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.02)<span></span>
</td>
<td class="num">(0.03)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 25.23<span></span>
</td>
<td class="nump">$ 7.32<span></span>
</td>
<td class="num">$ (28.26)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock unit awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156010766944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 1,635<span></span>
</td>
<td class="nump">$ 1,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,402<span></span>
</td>
<td class="nump">1,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,635<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,402<span></span>
</td>
<td class="nump">1,366<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">1,701<span></span>
</td>
<td class="nump">1,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Finance leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Property, plant, and equipment, net</a></td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property, plant, and equipment, net<span></span>
</td>
<td class="text">Property, plant, and equipment, net<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Less: Current portion<span></span>
</td>
<td class="text">Less: Current portion<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">$ 185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term debt<span></span>
</td>
<td class="text">Long-term debt<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 202<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted-average remaining lease term (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">8 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Weighted-average discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">3.03%<span></span>
</td>
<td class="nump">2.47%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">2.66%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | European Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 442<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leases, Weighted Average Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156021099200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of Lease Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">384<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 529<span></span>
</td>
<td class="nump">$ 598<span></span>
</td>
<td class="nump">$ 615<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156009071632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="num">$ (338)<span></span>
</td>
<td class="num">$ (356)<span></span>
</td>
<td class="num">$ (362)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance leases</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020349792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Fiscal 2024</a></td>
<td class="nump">$ 340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Fiscal 2025</a></td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Fiscal 2026</a></td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Fiscal 2027</a></td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Fiscal 2028</a></td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">1,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(193)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">1,701<span></span>
</td>
<td class="nump">$ 1,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Fiscal 2024</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Fiscal 2025</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Fiscal 2026</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Fiscal 2027</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">Fiscal 2028</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueNextTwelveMonths', window );">Fiscal 2024</a></td>
<td class="nump">373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearTwo', window );">Fiscal 2025</a></td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearThree', window );">Fiscal 2026</a></td>
<td class="nump">302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearFour', window );">Fiscal 2027</a></td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueYearFive', window );">Fiscal 2028</a></td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">2,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">1,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LessorLeasePaymentstobeReceived', window );">Minimum sublease income</a></td>
<td class="nump">$ 191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities Payments Due [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LessorLeasePaymentstobeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessor, Lease, Payments to be Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LessorLeasePaymentstobeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020214928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments', window );">Future lease payments</a></td>
<td class="nump">$ 98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived', window );">Total lease receivable</a></td>
<td class="nump">$ 342<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Noncancelable lease terms</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Noncancelable lease terms</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156010874384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 9,451<span></span>
</td>
<td class="nump">$ 9,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">628<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(120)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">9,947<span></span>
</td>
<td class="nump">9,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">3,923<span></span>
</td>
<td class="nump">3,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">4,050<span></span>
</td>
<td class="nump">3,923<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">1,542<span></span>
</td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">2,005<span></span>
</td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">2,453<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">2,453<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">1,533<span></span>
</td>
<td class="nump">1,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="num">(99)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 1,439<span></span>
</td>
<td class="nump">$ 1,533<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020333152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember', window );">Retail Pharmacy Reporting Unit | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=mck_RetailPharmacyReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156010799328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 5,398<span></span>
</td>
<td class="nump">$ 4,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(3,121)<span></span>
</td>
<td class="num">(2,937)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 2,277<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,971<span></span>
</td>
<td class="nump">2,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,765)<span></span>
</td>
<td class="num">(1,691)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,206<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Service agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,137<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(623)<span></span>
</td>
<td class="num">(573)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 514<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 833<span></span>
</td>
<td class="nump">819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(430)<span></span>
</td>
<td class="num">(386)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 403<span></span>
</td>
<td class="nump">433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(129)<span></span>
</td>
<td class="num">(116)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(174)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | European Assets Held for Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets, net</a></td>
<td class="nump">$ 384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanAssetsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanAssetsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020388080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible assets</a></td>
<td class="nump">$ 236<span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
<td class="nump">$ 422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2024</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2025</a></td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2026</a></td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2027</a></td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated annual amortization expense, 2028</a></td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Estimated annual amortization expense, after 2028</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156010452128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 15, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Aug. 12, 2021</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
<th class="th"><div>Dec. 03, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 5,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current portion</a></td>
<td class="nump">968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">$ 4,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | European Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 2.70% Notes due December 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 2.85% Notes due March 15, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 3.80% Notes due March 15, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 0.90% Notes due December 3, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 5.25% Notes due February 15, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 1.30% Notes due August 15, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 7.65% Debentures due March 1, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 3.95% Notes due February 16, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 4.75% Notes due May 30, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 6.00% Notes due March 1, 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 4.88% Notes due March 15, 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 1.50% Euro Notes due November 17, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 1.63% Euro Notes due October 30, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">1.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable | 3.13% Sterling Notes due February 17, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">3.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mck_LeaseandOtherObligationsMember', window );">Lease and other obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A525NotesDueFebruary152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A525NotesDueFebruary152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mck_LeaseandOtherObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mck_LeaseandOtherObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156015424512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Long-Term Debt (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 15, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 13, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 15, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 12, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 17, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 17, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 03, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jul. 23, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600,000,000<span></span>
</td>
<td class="nump">$ 5,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">968,000,000<span></span>
</td>
<td class="nump">799,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Retired and redeemed outstanding principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,274,000,000<span></span>
</td>
<td class="nump">$ 1,648,000,000<span></span>
</td>
<td class="nump">$ 1,040,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A525NotesDue2026Member', window );">5.25% Notes Due 2026 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from issuance, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 497,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member', window );">1.30% Notes due August 15, 2026 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from issuance, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Retired and redeemed outstanding principal amount</a></td>
<td class="nump">$ 360,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member', window );">2.70% Notes due December 15, 2022 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Retired and redeemed outstanding principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member', window );">0.63% Euro Notes Due August 17, 2021 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Retired and redeemed outstanding principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 709,000,000<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member', window );">4.75% Notes Due March 1, 2021 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Retired and redeemed outstanding principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 323,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_NotesDueNovember302020Member', window );">Notes Due November 30, 2020 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Retired and redeemed outstanding principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A525NotesDueFebruary152026Member', window );">5.25% Notes due February 15, 2026 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member', window );">0.90% Notes due December 3, 2025 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from issuance, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A525NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A525NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A130NotesDueAugust152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMarch12021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_NotesDueNovember302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_NotesDueNovember302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A525NotesDueFebruary152026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A525NotesDueFebruary152026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156007409776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Tender Offer and Other Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 23, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Scheduled principal payments of long-term debt in 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Scheduled principal payments of long-term debt in 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Scheduled principal payments of long-term debt in 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Scheduled principal payments of long-term debt in 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Scheduled principal payments of long-term debt in 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Scheduled principal payments of long-term debt, thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instruments (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember', window );">Tender Offer Notes | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt instrument, repurchase amount</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt Instrument, repurchased face amount</a></td>
<td class="nump">$ 922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payments for debt extinguishments</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Accrued and unpaid interest</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts', window );">Write-off of unamortized debt issuance costs and transaction fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of Deferred Debt Issuance Cost and Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156013791360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Revolving Credit Facilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 07, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,594,000,000<span></span>
</td>
<td class="nump">$ 5,879,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mck_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=mck_TermLoanMember', window );">Term Loan | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember', window );">Senior Unsecured Credit Facility (the 2022 Credit Facility) | Unsecured debt | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of facility</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember', window );">Senior Unsecured Credit Facility (the 2022 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit | Unsecured debt | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember', window );">Senior Unsecured Credit Facility (the 2020 Credit Facility) | Unsecured debt | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of facility</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember', window );">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit | Unsecured debt | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Amount borrowed under facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facility outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A2022TermLoanCreditFacilityMember', window );">2022 Term Loan Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DebtInstrumentDaysAvailableForBorrowing', window );">Debt instrument, days available for borrowing</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DebtInstrumentDaysAvailableForBorrowing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Days Available For Borrowing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DebtInstrumentDaysAvailableForBorrowing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mck_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mck_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=mck_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=mck_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A2022TermLoanCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A2022TermLoanCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156009282688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Other Facilities and Commercial Paper (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Commercial paper issuances</a></td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="nump">$ 11,200<span></span>
</td>
<td class="nump">$ 6,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Commercial paper repaid</a></td>
<td class="nump">8,500<span></span>
</td>
<td class="nump">11,200<span></span>
</td>
<td class="nump">$ 6,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">5,594<span></span>
</td>
<td class="nump">5,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity (up to)</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases', window );">Committed balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Uncommitted balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020267824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">VIE consolidated assets</a></td>
<td class="nump">$ 62,320<span></span>
</td>
<td class="nump">$ 63,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Unconsolidated VIE maximum exposure to loss</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Consolidated Variable Interest Entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">VIE consolidated assets</a></td>
<td class="nump">621<span></span>
</td>
<td class="nump">660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">VIE consolidated liabilities</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156006831616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Percentage of eligible compensation (up to percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Contribution expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="nump">$ 116,000,000<span></span>
</td>
<td class="nump">$ 102,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedContributionPlanMatchingAxis=mck_FirstPartOfPayContributionMember', window );">First Part Of Pay Contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Company match employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EmployeeContributions', window );">Employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedContributionPlanMatchingAxis=mck_SecondPartOfPayContributionMember', window );">Second Part Of Pay Contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Company match employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EmployeeContributions', window );">Employee contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Pension assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,024,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,024,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Pension assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,482,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,482,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | Austrian Business Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized', window );">Accumulated other comprehensive gain (loss) derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17,000,000)<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized', window );">Accumulated other comprehensive gain (loss) derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (33,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized', window );">Pension liabilities derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Pension assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized', window );">Disposal group, including discontinued operations, pension plan obligation derecognized</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized', window );">Accumulated other comprehensive gain (loss) derecognized</a></td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized', window );">Accumulated other comprehensive gain (loss) derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets', window );">Unexpected actuarial losses (as a percent) (exceeding)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Expected benefit payments in 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Expected benefit payments in 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Expected benefit payments in 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Expected benefit payments in 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Expected benefit payments in 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Expected benefit payments in 2029 through 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected contributions in next fiscal year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_UnitValueOfCashAndCashEquivalents', window );">Unit value of cash and cash equivalents (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation', window );">Pension liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Held-for-sale | U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Pension assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Held-for-sale | Austrian Business Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized', window );">Pension liabilities derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Disposal Group, Disposed of by Sale, Not Discontinued Operations | U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized', window );">Disposal group, including discontinued operations, pension plan assets derecognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="nump">56,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">UNITED STATES | Pension Plans, Defined Benefit | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans | Pension Plans, Defined Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000,000<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate', window );">Actuarial loss resulting from discount rate changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="nump">$ 69,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rates (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.54%<span></span>
</td>
<td class="nump">2.67%<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges', window );">Actuarial gain (loss), demographic and assumption changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,000,000)<span></span>
</td>
<td class="num">$ (14,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Actuarial loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 701,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172,000,000<span></span>
</td>
<td class="nump">701,000,000<span></span>
</td>
<td class="nump">875,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints', window );">Increase (decrease) in basis points</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset', window );">Percentage of total plan contribution - exceeding (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Amounts of plan exceeding total plan contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_MultiemployerPlanFundedStatusPercentage', window );">Funded status (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MultiemployerPlansWithdrawalObligation', window );">Amounts accrued for liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">$ 19,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans | Pension Plans, Defined Benefit | Norwegian Public Service Pension Fund (SPK)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue', window );">Amount of plan asset value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">Non-U.S. Plans | Pension Plans, Defined Benefit | Unfunded plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000,000<span></span>
</td>
<td class="nump">$ 101,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Pension Plan Obligation Derecognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EmployeeContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contributions made by plan participants. This item represents a periodic increase to the plan obligation and a percentage increase to plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EmployeeContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_MultiemployerPlanFundedStatusPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Multiemployer Plan, Funded Status, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_MultiemployerPlanFundedStatusPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_UnitValueOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unit value of cash and cash equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_UnitValueOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as defined benefit plan benefit obligations attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlansWithdrawalObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the obligation recognized by withdrawing from a pension or postretirement benefit plan to which two or more unrelated employers contribute where assets contributed by one participating employer may be used to provide benefits to employees of other participating employers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlansWithdrawalObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedContributionPlanMatchingAxis=mck_FirstPartOfPayContributionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedContributionPlanMatchingAxis=mck_FirstPartOfPayContributionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedContributionPlanMatchingAxis=mck_SecondPartOfPayContributionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedContributionPlanMatchingAxis=mck_SecondPartOfPayContributionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_AustrianBusinessOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=mck_NorwegianPublicServicePensionFundSPKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=mck_NorwegianPublicServicePensionFundSPKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanFundingStatusAxis=us-gaap_UnfundedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanFundingStatusAxis=us-gaap_UnfundedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156007401088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details) - Pension Plans, Defined Benefit - Non-U.S. Plans - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost - benefits earned during the year</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost on projected benefit obligation</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on assets</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets', window );">Amortization of unrecognized actuarial loss and prior service costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Curtailment/settlement gain</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156010839728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of period</a></td>
<td class="nump">$ 701<span></span>
</td>
<td class="nump">875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement', window );">Curtailment/settlement</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid', window );">Expenses paid</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation', window );">Divestitures</a></td>
<td class="num">(408)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign exchange impact and other</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of period</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">701<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">681<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants', window );">Employer and participant contributions</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DefinedBenefitPlanPlanAssetsExpensesPaid', window );">Expenses paid</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresPlanAssets', window );">Divestitures</a></td>
<td class="num">(393)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign exchange impact and other</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="nump">$ 735<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at end of period</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract', window );"><strong>Amounts recognized on the balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent', window );">Current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent', window );">Long-term assets</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Total</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | European Businesses (Disposal Group) | Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract', window );"><strong>Amounts recognized on the balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets for Plan Benefits, Defined Benefit Plan, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets for Plan Benefits, Defined Benefit Plan, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment and Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanBenefitObligationsExpensesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligations, Expenses Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanBenefitObligationsExpensesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Contributions by Employer and Plan Participants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DefinedBenefitPlanPlanAssetsExpensesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Plan Assets, Expenses Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DefinedBenefitPlanPlanAssetsExpensesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(9)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDivestituresBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDivestituresPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in plan assets of defined benefit plan from disposal or classification as held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDivestituresPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156021077984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details) - Non-U.S. Plans - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 701<span></span>
</td>
<td class="nump">$ 875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 681<span></span>
</td>
<td class="nump">$ 735<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156018433744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details) - Non-U.S. Plans - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net actuarial loss</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service cost (credit)</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Total</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156011125312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details) - Non-U.S. Plans - Pension Plans, Defined Benefit - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net actuarial gain</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (32)<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Prior service cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract', window );"><strong>Amortization of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Net actuarial loss</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Prior service credit</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax', window );">Foreign exchange impact and other</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Total recognized in other comprehensive income</a></td>
<td class="num">$ (18)<span></span>
</td>
<td class="num">$ (50)<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020456640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details) - Non-U.S. Plans - Pension Plans, Defined Benefit<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic pension expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rates</a></td>
<td class="nump">2.67%<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of increase in compensation</a></td>
<td class="nump">3.67%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on plan assets</a></td>
<td class="nump">1.63%<span></span>
</td>
<td class="nump">2.56%<span></span>
</td>
<td class="nump">2.56%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Benefit obligation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rates</a></td>
<td class="nump">4.54%<span></span>
</td>
<td class="nump">2.67%<span></span>
</td>
<td class="nump">1.89%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of increase in compensation</a></td>
<td class="nump">3.21%<span></span>
</td>
<td class="nump">3.67%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156010251840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="nump">$ 735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Cash and cash equivalents | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Cash and cash equivalents | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Cash and cash equivalents | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Cash and cash equivalents | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Equity commingled funds | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Equity commingled funds | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Equity commingled funds | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Equity commingled funds | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Government securities | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Government securities | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Government securities | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Government securities | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Corporate bonds | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Corporate bonds | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Corporate bonds | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Corporate bonds | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Fixed income commingled funds | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Fixed income commingled funds | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Fixed income commingled funds | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Fixed income commingled funds | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Annuity contracts | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Annuity contracts | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Annuity contracts | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Annuity contracts | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Real estate funds and Other | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Real estate funds and Other | Assets held at NAV practical expedient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Real estate funds and Other | Level 1 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Real estate funds and Other | Level 2 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plans, Defined Benefit | Non-U.S. Plans | Real estate funds and Other | Level 3 | Investment Assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mck_DefinedBenefitPlanAnnuityContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mck_DefinedBenefitPlanAnnuityContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mck_DefinedBenefitPlanOtherFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mck_DefinedBenefitPlanOtherFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156009288976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Schedule of Investments Measured at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward', window );"><strong>Defined Benefit Plan, Level 3 [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Return on assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward', window );"><strong>Defined Benefit Plan, Level 3 [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase', window );">Purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Return on assets</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable input, of increase in plan asset of defined benefit plan from purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(B)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156009260544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Narrative (Details)<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 5,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GainLossOnDerivativeTermination', window );">Gain on derivative termination</a></td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | European Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification from AOCI, current period, before tax</a></td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Reclassification from AOCI, current period, before tax, attributable to parent</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedges | Interest Rate Swap | Derivatives Designated for Hedge Accounting | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedges | Interest Rate Swap Entered Into YTD | Derivatives Designated for Hedge Accounting | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest Rate Swap | Derivatives Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Fixed interest rate swaps | Derivatives Designated for Hedge Accounting | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_DerivativeNotionalAmountTerminated', window );">Derivative, notional mount, terminated</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Net Investment Hedging | Derivatives Designated for Hedge Accounting | EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Fair Value Hedges | Derivatives Designated for Hedge Accounting | EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Net Investment Hedging | Derivatives Designated for Hedge Accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification from AOCI, current period, before tax</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DerivativeNotionalAmountTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Notional Amount, Terminated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DerivativeNotionalAmountTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GainLossOnDerivativeTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Derivative Termination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GainLossOnDerivativeTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_InterestRateSwapEnteredIntoYTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_InterestRateSwapEnteredIntoYTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156016974960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details) - Derivatives designated for hedge accounting: - Net Investment Hedges - Euro Denominated Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as net investment hedges:</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="num">$ (118)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification from AOCI, current period, before tax</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156015443808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details) - Derivatives designated for hedge accounting:<br> &#8364; in Millions, &#163; in Millions, $ in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Net Investment Hedges | Currency Swap | EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative | &#8364;</a></td>
<td class="nump">&#8364; 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fair Value Hedges | Currency Swap | GBP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fair Value Hedges | Currency Swap | EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="nump">&#8364; 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Currency Swap | Net Investment Hedges | CAD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Currency Swap | Cash Flow Hedging | CAD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Interest Rate Swap | Fair Value Hedges | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Interest Rate Swap | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fixed interest rate swaps | Cash Flow Hedging | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156007554208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details) - Derivatives designated for hedge accounting: - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as net investment hedges:</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">$ (119)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as cash flow and other hedges:</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Fixed interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as cash flow and other hedges:</a></td>
<td class="num">$ (30)<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_FixedInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020353616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details) - Derivatives designated for hedge accounting: - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Prepaid expenses and other/Other accrued liabilities | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">1,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Other non-current assets/liabilities | Currency Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">2,760<span></span>
</td>
<td class="nump">679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Other non-current assets/liabilities | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar notional amount, liability</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Prepaid expenses and other | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar notional amount, liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_OtherNonCurrentAssetsAndLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_OtherNonCurrentAssetsAndLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_PrepaidExpensesAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_PrepaidExpensesAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156019391472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Investments in money market funds</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">$ 981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities of growth stage companies</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment loss</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Net gain (loss) on equity securities</a></td>
<td class="num">$ (36)<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156021023648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">$ 5,594<span></span>
</td>
<td class="nump">$ 5,879<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">5,594<span></span>
</td>
<td class="nump">5,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value</a></td>
<td class="nump">$ 5,386<span></span>
</td>
<td class="nump">$ 5,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156014072496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Guarantees and Warranties (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearOne', window );">Guarantee obligations, expiring in 2024</a></td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearTwo', window );">Guarantee obligations, expiring in 2025</a></td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearThree', window );">Guarantee obligations, expiring in 2026</a></td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearFour', window );">Guarantee obligations, expiring in 2027</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearFive', window );">Guarantee obligations, expiring in 2028</a></td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter', window );">Guarantee obligations, expiring after 2028</a></td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember', window );">Guarantee Obligations Inventory Repurchase Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsCustomersDebtMember', window );">Guarantee Obligations Customers Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="nump">$ 206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Guarantee Obligations Inventory Repurchase Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Guarantee Obligations Customers Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Guarantee Obligations Inventory Repurchase Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Guarantee Obligations Customers Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GuarantorObligationsPeriod', window );">Debt guarantee period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Five Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuaranteeObligationsExposureExpiringinYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantee Obligations Exposure Expiring in Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuaranteeObligationsExposureExpiringinYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GuarantorObligationsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GuarantorObligationsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsCustomersDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=mck_GuaranteeObligationsCustomersDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140155995343536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 24, 2023 </div>
<div>plaintiff</div>
</th>
<th class="th">
<div>Apr. 27, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 08, 2021 </div>
<div>plaintiff</div>
</th>
<th class="th"><div>Feb. 25, 2019</div></th>
<th class="th">
<div>May 17, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 16, 2013 </div>
<div>state </div>
<div>defendant </div>
<div>relator</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>distributor </div>
<div>case </div>
<div>jurisdiction </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>complaint </div>
<div>relator</div>
</th>
<th class="th">
<div>Mar. 31, 2016 </div>
<div>USD ($) </div>
<div>site</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>distributor </div>
<div>site </div>
<div>case </div>
<div>jurisdiction </div>
<div>state</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 04, 2022 </div>
<div>subdivision</div>
</th>
<th class="th">
<div>Apr. 05, 2022 </div>
<div>policy</div>
</th>
<th class="th">
<div>Oct. 23, 2020 </div>
<div>case</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>state</div>
</th>
<th class="th">
<div>Mar. 02, 2020 </div>
<div>state </div>
<div>city</div>
</th>
<th class="th">
<div>Aug. 13, 2019 </div>
<div>faxNumber </div>
<div>fax</div>
</th>
<th class="th">
<div>Dec. 12, 2018 </div>
<div>officer</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>softwareProduct </div>
<div>case</div>
</th>
<th class="th">
<div>Apr. 25, 2018 </div>
<div>city </div>
<div>state</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>softwareProduct </div>
<div>case</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_OpioidStewardshipActNewYorkAnnualSurcharge', window );">Annual surcharge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag', window );">Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Consolidated Balance Sheet<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Net cash proceeds from settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 129,000,000<span></span>
</td>
<td class="nump">$ 46,000,000<span></span>
</td>
<td class="nump">$ 181,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember', window );">New York Opioid Tax Surcharge | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Loss contingency accrual, payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="nump">$ 26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember', window );">New York Opioid Tax Surcharge | U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_EnvironmentalLitigationMember', window );">Environmental Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Estimated loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_HazardousSubstanceSites', window );">Hazardous substance sites | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_HazardousSubstanceSitesRecipientOfDirectives', window );">Hazardous substance sites, number | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts', window );">Estimated environmental assessment and cleanup costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opiate Litigation | Individual Claimant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other defendants | distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberofStates', window );">Number of states | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment', window );">Litigation settlement, award amount to be used by state and local government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfCasesDismissed', window );">Loss contingency, number of cases dismissed | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement', window );">Number of jurisdictions that did not participate in settlement | jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | State of Alabama and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Native American Tribes Other Than Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages', window );">Percentage of total settlement to be used to remediate damages (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Three Largest U.S. Pharmaceutical Distributors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Three National Pharmaceutical Distributors | Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencySettlementInstallmentPaymentsTerm', window );">Loss contingency, settlement, installment payments, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Three National Pharmaceutical Distributors | State of West Virginia and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Three National Pharmaceutical Distributors | Native American Tribes Other Than Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Settled Litigation | State of West Virginia and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyClaimsSettledNumberOfSubdivisions', window );">Number of subdivisions | subdivision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Settled Litigation | Settling Governmental Entities and Cherokee Nation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000,000<span></span>
</td>
<td class="nump">$ 74,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation | Settled Litigation | Three National Pharmaceutical Distributors | State of West Virginia and Subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Aggregate amount expected to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencySettlementInstallmentPaymentsTerm', window );">Loss contingency, settlement, installment payments, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember', window );">United States ex rel. Manchester v. Purdue Pharma, L.P., et al</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal', window );">Period within which party can be substituted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member', window );">United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberofRelators', window );">Number of relators alleging violations | relator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_InsuranceCoverageLitigationMember', window );">Insurance Coverage Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies', window );">Loss Contingency, Number of Insurance Policies | policy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass', window );">Number of faxes remaining in class | faxNumber</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyClassActionNumberofFaxesReceived', window );">Number of faxes received | fax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Loss contingency, statutory damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Damages sought per violation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember', window );">True Health Chiropractic Inc., et al. v. McKesson Corporation, et al | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyDamagesSoughtPerViolationValue', window );">Damages sought per violation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember', window );">United States ex rel. Piacentile v. Amgen Inc., et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfRelators', window );">Number of relators | relator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfStatesFiledOnBehalfOf', window );">Number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfAdditionalDefendants', window );">Number of additional defendants | defendant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member', window );">United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf', window );">Number of cities filed on behalf of | city</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfStatesFiledOnBehalfOf', window );">Number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_EvanstonPolicePensionFundv.McKessonCorporationMember', window );">Evanston Police Pension Fund v. McKesson Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberofFormerOfficers', window );">Number of former officers | officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EstimatedInsuranceRecoveries', window );">Probable loss recovery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss contingency, estimate of possible loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 141,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember', window );">United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_LossContingencyNumberOfStatesFiledOnBehalfOf', window );">Number of states filed on behalf of | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember', window );">Civil Investigative Demands by the U.S. Attorney&#8217;s Office for the Eastern District of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of complaints served | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_NumberofSoftwareProducts', window );">Number of software products | softwareProduct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember', window );">Claims And Demands From Government Agencies, Environmental Conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites', window );">Environmental loss contingency, agreed remediation, number of sites | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss contingency, estimate of possible loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Estimated loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Environmental Loss Contingency, Agreed Remediation, Number Of Sites</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_EstimatedEnvironmentalAssessmentAndCleanupCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated Environmental Assessment And Cleanup Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_EstimatedEnvironmentalAssessmentAndCleanupCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_HazardousSubstanceSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of sites that hazardous substances were allegedly disposed at.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_HazardousSubstanceSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:positiveIntegerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_HazardousSubstanceSitesRecipientOfDirectives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of sites that hazardous substances were allegedly disposed at.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_HazardousSubstanceSitesRecipientOfDirectives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:positiveIntegerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Award Amount To Be Used by State and Local Government</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Settled, Number Of Jurisdictions Not Participating In Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClaimsSettledNumberOfSubdivisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Settled, Number Of Subdivisions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClaimsSettledNumberOfSubdivisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyClassActionNumberofFaxesRemainingintheClass">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action, Number of Faxes Remaining in the Class</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyClassActionNumberofFaxesRemainingintheClass</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyDamagesSoughtPerViolationValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Damages Sought Per Violation, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyDamagesSoughtPerViolationValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Insufficient Coverage, Number Of Insurance Policies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfAdditionalDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Additional Defendants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfAdditionalDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfCasesDismissed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Cases Dismissed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfCasesDismissed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfCitiesFiledOnBehalfOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfCitiesFiledOnBehalfOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfOtherDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Other Defendants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfOtherDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfRelators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Relators</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfRelators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfStatesFiledOnBehalfOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States Filed On Behalf Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfStatesFiledOnBehalfOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofFormerOfficers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Former Officers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofFormerOfficers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofRelators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number of Relators</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofRelators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Party Substitution Period to Prevent Case Dismissal</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementInstallmentPaymentsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement, Installment Payments, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementInstallmentPaymentsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberofSoftwareProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Software Products</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberofSoftwareProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OpioidStewardshipActNewYorkAnnualSurcharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Opioid Stewardship Act, New York, Annual Surcharge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OpioidStewardshipActNewYorkAnnualSurcharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs accrued as of the balance sheet date for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13237-110859<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13237-110859<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 55<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=6571209&amp;loc=d3e13703-110860<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EstimatedInsuranceRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts expected to be recovered under the terms of insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EstimatedInsuranceRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_EnvironmentalLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_EnvironmentalLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_IndividualClaimantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_IndividualClaimantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfAlabamaAndSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfAlabamaAndSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeLargestUSPharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeLargestUSPharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_CherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_CherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfWestVirginiaAndSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfWestVirginiaAndSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesAndCherokeeNationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesAndCherokeeNationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_InsuranceCoverageLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_InsuranceCoverageLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_EvanstonPolicePensionFundv.McKessonCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_EvanstonPolicePensionFundv.McKessonCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156015061856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details) - National Prescription Opiate Litigation - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueCurrent', window );">Current litigation liabilities</a></td>
<td class="nump">$ 548<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">6,625<span></span>
</td>
<td class="nump">7,220<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Total litigation liabilities</a></td>
<td class="nump">$ 7,173<span></span>
</td>
<td class="nump">$ 8,266<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156011295856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>vote </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare', window );">Number of votes per share of common stock permitted on proposals presented to stockholders (vote) | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.54<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 1.83<span></span>
</td>
<td class="nump">$ 1.67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockVotingRightsNumberofVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156015395664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Schedule of Share Repurchases (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,278<span></span>
</td>
<td class="nump">$ 2,785<span></span>
</td>
<td class="nump">$ 1,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase authorization increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,278<span></span>
</td>
<td class="nump">$ 3,613<span></span>
</td>
<td class="nump">$ 3,278<span></span>
</td>
<td class="nump">2,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AccruedShareRepurchases', window );">Accrued shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketTransactionsMember', window );">Open Market Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average Price Paid Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363.24<span></span>
</td>
<td class="nump">$ 217.73<span></span>
</td>
<td class="nump">$ 160.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,693)<span></span>
</td>
<td class="num">$ (1,007)<span></span>
</td>
<td class="num">$ (750)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketTransactionsMember', window );">Open Market Transactions | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2021Member', window );">Accelerated Share Repurchase, May 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average Price Paid Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseFebruary2022Member', window );">Accelerated Share Repurchase, February 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average Price Paid Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 295.16<span></span>
</td>
<td class="nump">$ 265.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2022Member', window );">Accelerated Share Repurchase, May 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average Price Paid Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 321.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseDecember2022Member', window );">Accelerated Share Repurchase, December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average Price Paid Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 369.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember', window );">Accelerated Share Repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total Number of Shares Purchased (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average Price Paid Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 295.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward', window );"><strong>Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AccruedShareRepurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Share Repurchases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AccruedShareRepurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_OpenMarketTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseFebruary2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseFebruary2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMay2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156008534160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,792)<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 5,309<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">673<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">673<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (1,490)<span></span>
</td>
<td class="num">(1,490)<span></span>
</td>
<td class="num">(1,792)<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassification to income statement, tax expense</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Derivatives designated for hedge accounting: | Euro Denominated Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as net investment hedges:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="num">(118)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember', window );">Currency Swap | Derivatives designated for hedge accounting:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax', window );">Derivatives designated as net investment hedges:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Derivatives used in net investment hedges, gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Total Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,534)<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(179)<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amount reclassified to earnings and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">852<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">673<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(905)<span></span>
</td>
<td class="num">(905)<span></span>
</td>
<td class="num">(1,534)<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,504)<span></span>
</td>
<td class="num">(1,361)<span></span>
</td>
<td class="num">(1,780)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(329)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amount reclassified to earnings and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,027<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">698<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">657<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(847)<span></span>
</td>
<td class="num">(847)<span></span>
</td>
<td class="num">(1,504)<span></span>
</td>
<td class="num">(1,361)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amount reclassified to earnings and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="num">(174)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Unrealized gain (loss) on net investment hedges, tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Cash Flow and Other Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amount reclassified to earnings and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amount reclassified to earnings and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (8)<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
<td class="num">$ (67)<span></span>
</td>
<td class="num">$ (96)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156009201056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Balances and Transactions (Details) - Investee - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember', window );">U.S. Pharmaceutical and Specialty Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_U.S.PharmaceuticalandSpecialtySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_U.S.PharmaceuticalandSpecialtySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156020866736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Narrative (Details) - segment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156008273872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business - Schedule of Segment Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 276,711<span></span>
</td>
<td class="nump">$ 263,966<span></span>
</td>
<td class="nump">$ 238,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Total operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,025<span></span>
</td>
<td class="nump">3,370<span></span>
</td>
<td class="nump">3,828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(147)<span></span>
</td>
<td class="num">(1,073)<span></span>
</td>
<td class="num">(8,645)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="num">(217)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) from continuing operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,630<span></span>
</td>
<td class="nump">1,928<span></span>
</td>
<td class="num">(5,034)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">608<span></span>
</td>
<td class="nump">760<span></span>
</td>
<td class="nump">887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">558<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Charges (credits) associated with last-in, first-out inventory method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GainLossOnDerivativeTermination', window );">Gain on derivative termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Net gains (losses) on investments in equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember', window );">Shareholder Derivative Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(131)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_TaxReceivableAgreementTRAMember', window );">Tax Receivable Agreement (&#8220;TRA&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnContractTermination', window );">Gain for early termination of tax receivable agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember', window );">German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale | U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Loss contingency accrual, period increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">$ 274<span></span>
</td>
<td class="nump">8,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | German Wholesale Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | National Prescription Opiate Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation settlement payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate | Held-for-sale | U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,616<span></span>
</td>
<td class="nump">212,149<span></span>
</td>
<td class="nump">189,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | New York Opioid Tax Surcharge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Total operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,206<span></span>
</td>
<td class="nump">2,879<span></span>
</td>
<td class="nump">2,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Net cash proceeds from settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Charges (credits) associated with last-in, first-out inventory method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity method investment</a></td>
<td class="nump">$ 179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical | Operating Segments | New York Opioid Tax Surcharge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Charge recorded related to Company's share of the litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,387<span></span>
</td>
<td class="nump">3,864<span></span>
</td>
<td class="nump">2,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember', window );">Prescription Technology Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Total operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,110<span></span>
</td>
<td class="nump">11,608<span></span>
</td>
<td class="nump">10,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Total operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="nump">959<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,598<span></span>
</td>
<td class="nump">36,345<span></span>
</td>
<td class="nump">35,965<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_GrossProfitNetofExpensesIncludingOtherIncome', window );">Total operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="num">(968)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Segment depreciation and amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Total depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Total expenditures for long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 177<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments | Held-for-sale | E.U. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments | Held-for-sale | U.K. Businesses (Disposal Group)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Charge for remeasurement to fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments | Held-for-sale | German Wholesale Business | Walgreens Boots Alliance Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain from sale of equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Operating Segments | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Canadian Health Benefit Claims Management and Plan Administrative Services Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract', window );"><strong>Segment expenditures for long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Pre-tax gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CorporateOperatingExpenseandOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expense and Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CorporateOperatingExpenseandOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GainLossOnDerivativeTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Derivative Termination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GainLossOnDerivativeTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_GrossProfitNetofExpensesIncludingOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Profit, Net of Expenses, Including Other Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_GrossProfitNetofExpensesIncludingOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenueDerivedFromServicesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue Derived From Services, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenueDerivedFromServicesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_TaxReceivableAgreementTRAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mck_TaxReceivableAgreementTRAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EUBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_UKBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_GermanWholesaleBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_GermanWholesaleBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_WalgreensBootsAllianceJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156009250864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 62,320<span></span>
</td>
<td class="nump">$ 63,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware', window );">Total long-lived assets</a></td>
<td class="nump">2,530<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware', window );">Total long-lived assets</a></td>
<td class="nump">2,207<span></span>
</td>
<td class="nump">2,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-lived assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware', window );">Total long-lived assets</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">41,793<span></span>
</td>
<td class="nump">38,346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">4,168<span></span>
</td>
<td class="nump">3,528<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">5,780<span></span>
</td>
<td class="nump">5,830<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,226<span></span>
</td>
<td class="nump">13,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Segment assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 4,353<span></span>
</td>
<td class="nump">$ 1,877<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property, Plant and Equipment, Including Net Capitalized Software</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140156005803728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 261<span></span>
</td>
<td class="nump">$ 282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to Other Accounts</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount', window );">Current allowances</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowances for credit losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to Other Accounts</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_OtherAllowancesMember', window );">Other allowances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Charged to Other Accounts</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember', window );">Written-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember', window );">Credited to other accounts and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions From Allowance Accounts</a></td>
<td class="num">$ (8)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_OtherAllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_OtherAllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>mck-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:currency="http://xbrl.sec.gov/currency/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mck="http://mckesson123.com/20230331"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mck-20230331.xsd" xlink:type="simple"/>
    <context id="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4a1cd3cc23a14e3c8567f6f5021d4d29_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib4d9c8c16b9c41c79238cd17c37cf884_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.500NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i35936bfe99754ea0b2d8151940f323d5_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1.625NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0407835b367a4e4ea273bf9f6036ebaa_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3.125NotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i399f6860da294568aba7949399d70dcc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1da02b0e502e472ba1f749732b72467c_I20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2ff10e823cba4f38b2c4399434a229ba_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i24ea2536cc79402c87a81416ae3171dd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3bc582f275f5403289fded6bcb155630_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia6a1485449e34a8ea1bffd8f744aa580_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0a1422fa33ff4ef8be96240fe701c4a8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2c7ce235f09242b1a7dd13dd1873da14_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6b4ad18ecc1b43159d4657ee792f26c1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i14f8bb56f1e4471588d3ee861bf56425_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia09f86adf45346869fdfd6e2c5e84729_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i28949ffb8bb2424c94e02d81ae0b5d27_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i56ca92db1bf347039646a68953e87fed_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i37de8b6ee05745e3861fbe7542070721_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i60a6fff3dabd4c79b50c2bf8f6f2c365_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idbe6a88a06904b1cab91937548e19519_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8ab59611846a49f2b03ee48497e3100f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i16ef48415e2d41019530a2f69364659e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib06de7ab957b4a4d88a689f7f6a590e7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3fda731c4c8243d8b5bf494fa64e80af_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic4b8982f387147d193c2d960f77258b8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="icef2c063f0184f93894500720ce4015e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8551607689bb4731bc5de364f262218e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4f30127a64d74d9e8d4865e42e4cbf4c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if49d7008347c45e9a5c3670667639536_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6de2dc307ac14073bdb93ae09a60b176_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3c3e18a28c2e4303a930bfe449b415f1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icd2b75e00f334c31915664ac94e7674e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i73dc7887d5ec4c559ba7ed149b2a2e5c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i47e91f2d45c04afe94f7d67b691dde7e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib6e648d6891241edbef964d4d9ee910a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i05b7ccb4f8144bea8f3d6c3af844c49d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7f45287ebbdd4148b5e154a230ab10c8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i183ca81b5799440d9119d0fe988e65c3_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4def4e91aef84e1483b875342987eb63_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i45aab0fb88544a5484bbea268be3db79_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i243683b0717241af93096502d0de6cfd_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i018191f728124dca8ee428ea5cf8cef8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5ddf4f8a62464df1938e09cf326c73ea_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i229bafbff863466083e1c27c4d7dfc34_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iff055f45df5945548e9f06839bf74bac_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iea824d5b394948b6bd119948e0fe3df9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i967edbc39aee4ecb80a07170518c493d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3ace641432ca4f1aab983fa4bd125d85_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i06314da3128a4c098170cd700e3e914e_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i52d6cbef9c014a779d83f8e789f001b6_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i284da6d569754ff58e9c0e3c01fd1f5a_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id8a72099ceda422ba14d79222a77f39e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3ebb46144e314022b145d5a691b3751b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8f0fe405ebb24cc3b0ba09f049f2c10b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i389a9bd705fb43da948f7f435028f032_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icf262331a9f54dcaa1ab7d2f24876767_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1dcb8f3258544de983570a2447cfa80a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7264b2fb579741cdab359e1aba22aede_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:TenLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic04e9e22dc634dfca9e2377700f0d82f_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:TenLargestCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i932aecaa6796433d9fa0f50f4ddd4f32_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibfb139caacd149a5b3fdff785111e258_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mck:LargestCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3969df882b2a4177a8ac36cb92b0b6c7_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i515e802e55bc4ca1b11dd1a584ef8dde_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i223505a11e384113a49c9b97f61ec445_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibc4a0c9d2b824683901b0907b93e42dd_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i655245d8cb514931a14931cc038eb490_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2a4af360e7154c9e8ccdf22798b63fbb_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie30f2480525c49ada9cabfe8e2d20354_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:MachineryEquipmentAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id5e672e286474d2e9f8e1f5fe1e234e0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1aaff57b7c384456ab86bd2b5fccb87a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i78c87aed7caa4ad198dca1602c85ed23_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia26faef7d39742839185203bac54e495_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic711bd1052674b80ad0f571918f35552_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mck:RealPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7385cd355dd4468ba773e9d23bf40348_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5a7c37dc0f5d4bfb9f78bc365e926644_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie56d43006f754d499f7e19cd5720562c_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i22171c2b91104f3f9aae6c7df97e030e_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i915d437ab7bb4f499b0ca40841b44528_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib344714960c14cd0aaa14d648eb58138_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:DistributionandRetailBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i63f0fcb2e0aa4013b42d29b5ade1e28b_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if322074120a140808e8c82b1bed2d7ec_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mck:ServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9641805d39b54755bb865f24f51f1b5d_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="ia4dd209b573244c7881d99fe517c75d8_D20221101-20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="i59947628e39647249591b0cbaa3bf334_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="if401780d59f34141aabbaf7ca4d032ab_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:RxSavingsSolutionsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:RxTsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icf8aef407b7f488e85c6b12526cca4c8_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:SCRIOncologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:SCRIOncologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-31</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i9259fb307c6141ab8b52ca6d3a1907c8_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:SarahCannonResearchInstituteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:SCRIOncologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i625dd0b0aa6e4e8d97d061d0a70a7e97_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:McKessonUSOncologyResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mck:SCRIOncologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i7746d7d6c7f74bd5a522363e31a8b366_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i260e787e79514142b7c391cce58ca8d4_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i54bfea324a094e7f996dd8a56ee105f4_D20221031-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-31</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i522ab9fff9ee4ecb8c2fbd1f12f1d934_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i9b9815e733a0475592cd7fada3bced42_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifc7a65af5b26474e8427ff7f8bd6ce64_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibe5a2e65fb56419382b72990eee9a1e3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i382c204f13554d4e8ece4058bc5b69c6_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib62a5923230c46c49e36098ccca7369e_I20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-06</instant>
        </period>
    </context>
    <context id="i4c4a29b7f1134f299939b7067a5bbc68_I20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-06</instant>
        </period>
    </context>
    <context id="ia42344bf1adb4cdeb5624c43ce11a349_D20220406-20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:AureliusElephantLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <context id="ie11de948c9444efb94e5917cae16710f_D20220406-20220406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <context id="i58454d4bece0446ab49687291c0c1cd5_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c359290f5374ebcb781e2a05480221e_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i85ba3e843a814a899aaf3a87e8422f9d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i10dc0fc369ee4d088df51fef92fe40e1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie4656299b20c436497390a7e79147f34_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7351ec7b72b6422a82ab0afffdd65c27_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="ifd040622e9b1489ba2addf0494df3a62_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i2646e19a2c8440d08bc15a4216ccadaf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if02745e482324982aa1ae5309d602ded_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if2e3b761b77d4b7cbc297831b399408a_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9c75333b88e542c4ba71e94b1d28056e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibfc71eef9d254de48d739e651f3d7561_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7a6fc260a6de4b629a6b4970e20fe6aa_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7a4a0202812f4880a82a0487047cc47f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifa888a5ec0d944f1a58684506e131405_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia88c62cc31154e05941895097f4eb653_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9f3eb833b0314352811520832d05703c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id62c43649df1424688c3e5137b75b17a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ica9a08587ca04030b0e7cc35fa7d526b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i663d657bf1e24bbcb2dbc5356bd8a9d7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0450b305293d4d12a476155c59674aac_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icf0b80c33ebe40fbb027ad323e881fa7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i842e5c3e1d294131aa2e71ec30e3c3e1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i948e2e219f854ac082a3c472c583fe7d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie936d943185b4ffbb312cec2d0a11ea1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56dc2bee6bfd4893aaf3550953e9f904_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3977781f98d2482e9204ee3df23b62ef_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0ca2257eaa5a4089b39072f8a37a459e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i493ee32637374fef85bb13b3cde7de11_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifbec207732c741a7b5cd533ccd6d7102_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iab47b293b1e6457e9220acf589c14011_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1d3e584c30524ea7abc9a6d31589fd8b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifd5164d3ebc94282adf69fe3daa1dd18_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8e022c6735f44aafbc94894561402456_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3947bd9bcc904e12bbce546550846178_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8be50c56aed545d6a05664ecf4cd0520_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9271e52fbc4b4051bc42f5edf6a60c46_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i196be4042ab946ffab53968cba582319_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if642126ed2f24282b10b29e0c453e35e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie1ad9e5e8f13437e83ec2ed5b6ca20ee_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7f6f943ac64c470b961d73cf2c5fbcf3_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic06aa85305f44c8fbb86fb2d2319293a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9556991f875d4713b5b62bb435eaf7d2_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia9cc1088918d4bdf9fec9c448e29978f_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id4e58f11e8ff4837b70351c42fecfe2a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i83d13ad17dcb49b4899c2f0e3cc432d9_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ife447a3b57f0484f98349ca82b7c8778_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i15f030c588ac48cfbb2352300d303adb_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6e22ae69db0e4c909043949b0bf363e3_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1f18df5cf4f04ff894901fbf46e6dba6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2022StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaa24a0cfb242478997ad1819397e47c8_I20130731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-07-31</instant>
        </period>
    </context>
    <context id="i9a10efc6895245d08afc780fe46cc0c0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mck:A2013StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4a39186a14424d8bafc2b9cf028fffd8_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia330d79374df4f04b29816d2c53ad7e3_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i19acbfe54421472fb6c6c57213d527bf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia89b0a5df63447d995cd0a4593059729_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:PerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i194bfd7f58694118b6608f52ec99adf8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i022f37e081eb4c90b78d43940f46aff4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i289228fb848b4f3baeb89b15df8f45fa_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mck:RestrictedStockUnitsandPerformancebasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1369c60e05b34b468652499b286a05d6_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id0c1b4f588c94865ab50e59ee67700cb_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icd1fd6d108f04354be5ba6979cfef798_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i280391a88a5f4cfc9ae3305390b982af_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9d695f8e4fe74cf68dd4c19a1015fbad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5042c611135944438746cce257499d4f_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="ibee85f1796ce4da18771743ac93a0bf7_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i79fd2475cde549da9b49f44a3b1d5fa7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mck:TaxReceivableAgreementTRAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idf485190a9674be1a5f6e8cc04f2de3a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie9363c5254cf4b7b9d31529bc982ca01_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:GermanPharmaceuticalWholesaleJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7d4a1d2617604c3abf9cdc6b550d8e12_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupAndAustrianBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibeefc9d1d76042fbbba383f76527d7a5_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id73f9b34f34c41d6ad73b7db3ed24dfd_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie2c162cb2b9c417883dd91ccec907c32_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibf6fd4d81f1f416290d250974ba098e2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3d415447fbd94360ba64460c62a0a537_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3a85db8cbb4b46c1b80086fe84b2ad90_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3af290b74f9b45468794a2c3907f33d0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:CapitalLossCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i925b096ac7224e21909543318e72b500_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ied7b454e7843455ab8ab7494918c2873_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia0d9f68e5c994bf59aeea678b50b65af_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i85eec0525fe24f99b37fe1b51e6c5a23_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3133b1be91fc45ce9e09a9108d5d72ff_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id814aee4543a4f3b8149ab5107886aa3_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i629eed48f7a6425b99da3d0911202452_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i64073e3798b24140a877b78902322039_D20180919-20180919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2018-09-19</startDate>
            <endDate>2018-09-19</endDate>
        </period>
    </context>
    <context id="i1f2d9133245747b1a400a98a3daea68f_I20180919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2018-09-19</instant>
        </period>
    </context>
    <context id="i42752d505455466fbf8fbf4f49c40afc_I20210412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-04-12</instant>
        </period>
    </context>
    <context id="i9dc0714e08b14ba2814d733ed7fd0102_I20210412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-12</instant>
        </period>
    </context>
    <context id="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i702ec37556b84e119a5f3bb8522ed174_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idbd55a5a04e24729999d4fa3eb8ae352_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if79bf94dc2504cb2a88b82abdd979b19_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icf838c191f224e90921deb0c9dd4d8b0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1c0a87d5a109411fae8be9b302d9a229_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i60796f3f508f4327a4e738afb42dcf8b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6bf2274fbdb7410f92df8d07c6a7f201_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i45f0ee99639740adb0c22db01af096ac_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i58348ef8cf7b4b6faf2cce35de2978c5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie9e8557376044f0fa6608b862b7e25c2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2c04e8513e99429391fedba4d6dad8af_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3119e2458b4d43bd8aac84c146e9a100_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2799afba52094088a0aec4099f2cd4f8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id1ceabaf0dff4adc9d75414a157e0e6f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i80ef17e0a1714077b0570474802db35d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i849ee3b7fa1d4cb8ba90315b84e6817c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i76fe5a1e46444faa97974d14a8212357_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie36e6e5e651d4dac8a530797e7a70c18_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i62db101872a24148a919c634afca4814_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i888e928ebad143cbb7a499ff02241d61_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6ac9479cfdf4484f9e8701e0f82d2e4c_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i19b668b117b34adcb089b01f3153c8f0_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i969dadb6a5014e4e97c0701a8fa71817_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i716b019882fd4fceb551ac9e5a422c18_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i06c8b950234148b09f83c9527bf5b802_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ief5e2ae4563940bf95c8d1d8e28f2353_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic03f6f90300b411c9d23b5538357dc9b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2fb6e5f190e74ccdae10ef40017a5792_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia73bbbf5c3f94136997b8becbe0d75fb_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">mck:RetailPharmacyReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i51a5d02d9bff429da29560b39c8f2ff3_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if336d47d141c481c95e420c0cf744a34_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i460359d3c86945e3bca1ddec5b04da33_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i64e47ed80ef449548b1acb824907d26d_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i444f9a88357b4522a70b67e00782860a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie7c8512e869e4882979001a21c27cc1a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ice102114e53046c0990a7f9b97933076_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i26dce1de93254045b3bf97178b2dd2bf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibf6e4b73c21f44648aa84b01813ff828_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib3aea8ed8bb64f248ee3ba0de12e5974_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibddbc2840c8d47d1a8b3d4d03ad88e0e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i58d94f46b8eb44d5abcdcf4c68ffd4af_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icfb74fdbaafc42b5bc38853f2956af25_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8e7a74f1e4ec41a08eb7da7766828283_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i618590d34e9e40beaae759c50efa5248_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0496c19ac0ab424285907e4b8bdfd63c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanAssetsHeldForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i202cd9cf62f0431e8d01300563014a7d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1765debe58fa477bb60f4fa358d03763_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibae09054075242708b4f1b92c5ad9435_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idf954d0b17fa4afcbd832a5b25242889_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i74f232fbbdd542a68a67aac5bb01a3ad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6020b3dcea424492aa70f65876ac2906_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i768c441bead74af990375d494dcd615f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i46014a69e7bb46d7804f90bfac7336a1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id6a8fb9420154ab99c47ee021794a752_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A525NotesDueFebruary152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i15a119cca4d54ce1b9e9b15b07ecb555_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A525NotesDueFebruary152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia67ce7e8257446a8a749a51dd4e61f1e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6923623dff6a4c21af62ba66950bbca1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i836c135ad296412391b52c76ec2d65af_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i584398e2f2774124928de1b3733debf3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icc18546dd5254ad9bc27e6a28551e869_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibf67d81b73484a2ab862ae6562f12c8f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib792f01cad394fa9a6b5b6007690d92d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i22b455fe9626429d82d1312274a08717_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6305f106d8224c67a7f1f4f9d248c6ee_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i00eb8e4aa01348e88c908410c24dbed9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2db8c6c2c8154fc292aa5199f298a4cd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0ded6a5da3964377b85a8496b7db3a17_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib30972cf50704e17b9605f2bd2f62293_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i215f3153999b49f994c67efb2f5ca414_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i844ae52bcc2545d293dac8695661ad1c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if363f9768e7c4dfda22b43256fce94cf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5694cf86b13649b19e91a4472f2dd301_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i35cacf2366014f2ea0f9ac27e0b29d39_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieea3066b4198415db491f3e894ce0b14_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6f1b5510456d4c02b2ecb86d2a690ce1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:LeaseandOtherObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i976e4c827b4549e1961c10a386b91abb_I20230213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A525NotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-13</instant>
        </period>
    </context>
    <context id="ifa0ffbdeacb64a09986b957e9f96a042_D20230213-20230213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A525NotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-13</startDate>
            <endDate>2023-02-13</endDate>
        </period>
    </context>
    <context id="i535b3f0e572b482a8d1a1dedf038fe50_I20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="i78a368c4b72d42cf8b1a224dc65b0f47_D20210812-20210812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A130NotesDueAugust152026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="i2a24f716c6be4a4696ca08b8cc9d7ad8_I20201203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-03</instant>
        </period>
    </context>
    <context id="i11be422271b0497c8bb2cbf054b40bdd_D20201203-20201203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-03</startDate>
            <endDate>2020-12-03</endDate>
        </period>
    </context>
    <context id="i772fb832f6354412ad17d3bfd7fe6b1d_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icac00852e08b4922ad11b375efe1e1b0_D20230315-20230315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-15</endDate>
        </period>
    </context>
    <context id="ia19e57b1a46b4e69ae2d79da972f650a_I20221215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="i3851e69ede76406a8a5a4117e99d5ec4_D20221215-20221215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-15</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <context id="ib44bfb223bc14e29aeac77c05bbc39d7_I20221215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-15</instant>
        </period>
    </context>
    <context id="i453005c054c0476fbb9853e512d6bd28_D20210717-20210717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-17</startDate>
            <endDate>2021-07-17</endDate>
        </period>
    </context>
    <context id="ie0e1375f02f24ba79ea97f55a3b99d89_I20210717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-17</instant>
        </period>
    </context>
    <context id="ic756400c1f7e46c38b850bd10c43a377_D20201201-20201201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-01</endDate>
        </period>
    </context>
    <context id="i3f46bdc3df244190a4f3caa01c5eccdd_I20201201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMarch12021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-01</instant>
        </period>
    </context>
    <context id="i7fd03415c82341b0bcd801b36c1a28fe_D20201130-20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-30</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="i1f7ee8f00bf1412e813d7abd850dc07b_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:NotesDueNovember302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="i4592baf7793041fa8e76756aac03670e_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ib143d3ffb79a4cc4bd2ad4ebae133edc_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i34d77590b6c24730802120c45ff43aa6_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ia499a63a8849486aa054b9140660701a_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ic327cefb81b34e5a82369680f27dfba6_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i2959faada6aa43a892063ae50e28b434_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ida05874ce18a4f4fb630c33eac2a3138_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i9c2fdc8cd1ed4cabbe44be3bfdd3a3f2_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ie691f38e48be4843a3fd39459645f39b_D20210723-20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="i5bdacb5a0bcc4ad480dec225518c10c8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7cc5f04c5c2d4d70aa2d95e18cd6bef4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0de40eac191846698bafb26987f8db02_I20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="id2939e16a3a648eeadc8fe5b14335874_D20221107-20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-07</startDate>
            <endDate>2022-11-07</endDate>
        </period>
    </context>
    <context id="id005fd4ac6fa46378f61401585bd1f21_I20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="ic980d09285fc4708a8a6eafe8b8a5655_I20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="i6df2825430ea48468dedc27f049659e5_D20221107-20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-07</startDate>
            <endDate>2022-11-07</endDate>
        </period>
    </context>
    <context id="i63af9e33b0074a89b174bb79dc0563a6_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i34acb3e619be4e479ffc9dd6d3c2637e_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ieffd80ee181540709a1840aa1e6b331a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i37179d6482964d95b578a69074ef0010_I20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="i3ded1a9c1439414ab4b7d6ef1c80ea50_I20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A2022TermLoanCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="i7ea2abb1609b4016be9ea5ea390f3ddb_D20221107-20221107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A2022TermLoanCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-07</startDate>
            <endDate>2022-11-07</endDate>
        </period>
    </context>
    <context id="ib8c8b37718a34ccf97efe28b40fa8b98_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i86beb9ab012e4ab98ab444ffd6a60f1d_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2fc646c92280442fa50dc0dd90fd3b8f_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mck:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mck:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie365f78409fa4f7c8fab2a443f6508cb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i764185698f6248c8a59dd7255743615b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia236aca49f824360a041b24156a09309_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9be4134ad35a4d88b4b59aff8d5eb2fc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7bf2f9269b0245f082bf1b61c46287fc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icf74b96be12f4a219ff712ac02236787_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0d0480bcc6d3431ab87336fe586f8dd4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i725249281f6448479928864a02cfeb84_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9285759f0f7e48fc96862d938f16f2c4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibd224bce6d5d4f0ebf52968e5025d793_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i29ce9dc1593049718fe7bb3e0475e10e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2ac7e4d1dc5b4f05b72d3e857f067e82_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib91bd719aec14a16b34e473ef04b8e30_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaebb395b037444299908403308be0b79_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i513eafe450024d3a99fd378acb5c768e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6c2b6a539b6d496b8795e813d345ea7c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8526b8b91b7b41a8b075fd3451c4af50_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iba0180b4473b4cc5ada51da9d6909ece_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6af7427ba4784b7fab08180a13ff9b1c_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:AustrianBusinessOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i10bcba3ec49146f58e7e91f9b293ca33_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i722584ad23f0453f86285951f75a1700_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i205b3862163e4e678a0394523279c14a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i51610f05cd18459b963569b57c8bbbe1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i71bf1a36819e476c85f3a6d8663bdea3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i45ba471960e744afa8691f9d48e62f13_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ida7184b50fa64a8dbc5cde66e602da28_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i994dc07d79bd4a03a6631b10f5eceac2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie758338a330442f68f01dd372842ee71_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7b161706e1cc4841adfb4249122e7e93_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id9871350b1e94507bc4d2b7948cd34e2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i125e3486c8434dc7b093af7f724a9223_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i77514bdd2d89462c9211465f0a766ec7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic8973019f6d64483a30bda7006efbc09_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1e169cd345664994a6d79eea226c19b3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic6b05b2e1ce7435294b2dbf7fb0aae99_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if8307fb561294672b090c1bb5d05d513_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib3f1ee10031041a3af07110ab4849733_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i72ad2547012c48f4936cd2741754a6d9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifc7ed483c5154a59a6c8c3b34afc8b2c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0a004834e91942e79a1a035a54eb8430_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i24fb96b7e1ad440a909f91f9f5db78a3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0efc094e70304787b594a72d0060b612_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4f2387351c284073a3585ae340c96f38_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic30de0ea7dbf4ca294f03806a898ccb9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i657e7112d45443199c58b406acf29838_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5327b1083ed94e798541f3da89104dc9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i39dae6d084c84047aa582ca074a0d078_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia46e3fa973c947b48594cb4ab31a9c66_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i13d1edaf8e3f4acab8850b098880754d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i227439bd64d1487db0754f92fbcd1a4f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i759d43483f4048ec80ee7227fa0f70f5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i62410ab1336048ada10bb12a73da0a7c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i28cf440d298c42adb27df58f03c66fea_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia4193615347d4fe29a971e9dd9b5227f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i918e287d03514df6b3bfe695542d3887_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia011b94ec27b40e8b51a633a0bcbd4a5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idb1fcabf197142b5bd6d52bf694fa67b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i43e7a92a6d5e4ada8cc90026e6b3229d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idd1cb19b0477476cb20d2a0e4982c520_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iac3be98a2bbc4274ace7d610d1288ff9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia3f016b2ef3e440eb97d4400be55876f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i41a1d6ce3a444d7e82696c5f8ff77d6d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i81ad37783f6e4af8b246e63c8f3a99c0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ica1476e409e7402b9a147a0ba6312dff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5f69217e7cff424dbb573dfbe087faa5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie63109b7002f4f4f93a996b521f5b59e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i829df4d042954ba09a94b3ab60df2ee6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i94b0345b6b1d434596b0988c93100635_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i38c1211ca3bd47ccaa63f4d573ef3eb9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8613bd2d24b24d0c91d02304e304ef0e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanAnnuityContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i999721f0f4df4c2db0a933b5978923b6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i18b9e6dc3e4246a78043d39c8c8a997d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic1ce3ce209624caf96b787927d453e69_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i846de7923abc4c97892d8ae4ffa6a848_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i087f9375fa6f4e85b3f512df46958583_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i03a25adf74c747e3af066921668300d8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic2c7699ae1b14f20a774af95b9906d4e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1da20a00fd7c41bf882c2c4b0fca97bc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifd8f41a67f1d4ac6bcd66decef5d2d36_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib77b1393ed7f4e1cb5cdf0a8cceb3947_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6cb089efc1bd4c339e696998159d126a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i736fe7819f714241ad16df84489ece06_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i403dc252a03943a08391aee80b76db38_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4e959507a65a46d4953fdcacc156df2a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic2c0f39a48f745c181b6f5d69c3f1b19_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4aff01889e07438fb29743fe2ba9c669_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i22203a08a73a45f287b95b3462d5d578_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1a7ce7882d7346b99cf64d531cb03268_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mck:DefinedBenefitPlanOtherFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i548b65f153fe455fb735edc18c43071c_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib463cce9887841b580560f381cb2da5b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i320f8fd67c4948f0a308006480a2c5ad_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">mck:NorwegianPublicServicePensionFundSPKMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iedac49b197d6406986b0d015faf7d0db_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if6665b3b43b04da588b52399a7fe54b5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9a7df9519bd34e78875fe27cd2ff763e_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie7a9b9f544264510b97f94b12eb3d7b2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if513543f51ba4b0d91334260d63c6376_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:FirstPartOfPayContributionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i957a9c83570946a8bff0405f80b94b7f_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mck:DefinedContributionPlanMatchingAxis">mck:SecondPartOfPayContributionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ica96366b6bcf4de3a3a5a18786d44260_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idb54d0a7ddd04860a8ac09f3e04418f4_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i942e6213795a47479851045f390d686e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i570d5007fbb6461f83baab05592c1bd4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6581ce23346b4adc8afb8d7c98565984_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i61ed85ae587d438299585235a376442d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if95560d064ba4166a3331f01665e7c28_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7f756df8d9cf4ff5bf43b455279a736b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i377c89ac0f94417ab6e32711608e6849_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7746cd80fb0e4dba825522f21e14c35c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icde86b5b9cf640a3857b79b2a12f38f7_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5bf4620f35c94ffe8b0ced9de2482405_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib5ed5bad9fbc48a79bf500f2ea6d7a22_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5ff470a2b6a24f96a0586ed7a59b7b7b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifd33b3ebae6e4d2496772717c3f8c273_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i451f85a810074a318c6fdba6392654ed_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie46f20f9252c435eb905f97640abaa6c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie365683768f34533b940d20aee5be735_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9d0ea17b2eb84516bc5d182b18413d90_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8d2f247e11ef4383a78c76952ded2871_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i012704ce27234402832a8bc9c0017988_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8ff7efcd13d54a859f0cdcd3c236d712_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i58eb9e87b3f1463fbab075c07679076d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i18e62823c6c34113847dd36bdd196aee_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icc76b912e3064681bcafdf4fb127e946_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6b463726a6524dd3ba88c8289035c4c4_I20230228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="i1212e8cf47b1431fba4fec0f85eaa49f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:InterestRateSwapEnteredIntoYTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5b574ca5d25e4e77b9ac4175842add0c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4e74926dad464e94bdc3f1c87eb5109a_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9a201725780545cb9926c7c283f7d7d0_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie12bcf044f834b0ebb0a13192a63245b_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie8dab7068d7b4998b54b905773776649_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i94135546f3234d41991f401e92d4d4d6_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4e3950dedac64c34a7acce736f0bc228_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i42e31d06ed3643fbae42793a45735ac5_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i69be7012e79640bfb23e05de78108936_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaa333c469edc4e739ef41e09656c0dfe_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:FixedInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iae39c5b703e44224ad9561aadf22dcaa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i08578346a1c640a69d5c8c9dbc6cef2f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib89a2c4aa24f415ebad33a8ffc064667_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9ab3273dc18846c0891c616e297f96e1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i570b23d2fb4f453cb4925aebe582d8f1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie5af88ef9b934cc4a000f911d7bc1a8c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:PrepaidExpensesAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i27091f652077438a88c26df46b3f0175_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i96f88968ebe444dd9eb39629b0d33d5c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:OtherNonCurrentAssetsAndLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9919373fdaa44e9488d392bca8c37b57_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i72369ee3bdc242a584b516b6b0220cd3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i193367ab1bd147669e6aa97c4b68b27c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9ed31f2e5a9e4fa5b8dcaf9650e3ac4c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i04f759a37fee446ab4c24b7a4aa7fd2c_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia4296c0b84d346e4b89b55d58821c05d_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibb01f985e84846568b14aa2b0bf489e5_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9d14a00ce32c46e7b5068767e2553b8b_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7c2dfca8ca434187bc4a0181f1cd5d18_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsInventoryRepurchaseGuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1be6be612b674d65a670c15307e93ab4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">mck:GuaranteeObligationsCustomersDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ied8ab1ea89bb4a8492bbac67f1f3dd79_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3b2d6726cb4b46f2902ab30560ff644c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if0f3c705d63d43aaae784ab3543e3e80_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestUSPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7e87a690a6d84ef49943e4b9a57bf486_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfAlabamaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if55961281a7144958d26ffefe3ca4b9b_I20220704">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-04</instant>
        </period>
    </context>
    <context id="ia95d07e149ed453ca958daff0b5e82b2_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i129e51149a384d2ca3e97d96fc3cd639_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfWestVirginiaAndSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifc24b7896b6c4e3e9686133fcdf77aaf_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:CherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1db22ae3a3cb4da3b2e5eb909147033a_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeNationalPharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4deb4bb0d31640d6839b768c83fb82d3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:NativeAmericanTribesOtherThanCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0140a17cab884d1492bcaa9df5a4d5a3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2b22d4f28fe34a62b1126f5d988f8052_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i634cecdea7c5420991fa07409e24bae9_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i480f6acdd20745c3951ffb01a8a1f2fd_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:SettlingGovernmentalEntitiesAndCherokeeNationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia186f3731bcd4bec9362d4010651c39a_D20230724-20230724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-24</startDate>
            <endDate>2023-07-24</endDate>
        </period>
    </context>
    <context id="i7ba50f0dfc7944c88deff9f8478101c4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3930fd7ff02f439e9ab59431524b3678_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i88153d2f52214fe0a9768ef8344eaabd_D20190225-20190225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-25</startDate>
            <endDate>2019-02-25</endDate>
        </period>
    </context>
    <context id="i88a1d24ff9dc4dde993d7cc58d70cee1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i33396fbf2486428a890309fa325b4aaa_D20191201-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i76d4bda7231445d895623496e61e3afe_I20201023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InsuranceCoverageLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-23</instant>
        </period>
    </context>
    <context id="i8fe1c6d47bac41768956c525d9da297c_I20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:InsuranceCoverageLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-05</instant>
        </period>
    </context>
    <context id="if37f55f8d74d4f7e856241b5044f79a1_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="ifa4d87725ecc4620b0b0c4339cac0d54_D20130517-20130517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-05-17</startDate>
            <endDate>2013-05-17</endDate>
        </period>
    </context>
    <context id="i590634e41f954ae590139d3aba0164cd_I20190813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-13</instant>
        </period>
    </context>
    <context id="icf72768e9e58489a9cfe3dcada7cea25_D20211008-20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-10-08</startDate>
            <endDate>2021-10-08</endDate>
        </period>
    </context>
    <context id="i604155abded247ec9c473e57fc99aa9b_D20220427-20220427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-27</startDate>
            <endDate>2022-04-27</endDate>
        </period>
    </context>
    <context id="ic6909fc49de54c13a5acf0f3f0cd933d_D20130416-20130416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelPiacentileVAmgenIncEtAlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-04-16</startDate>
            <endDate>2013-04-16</endDate>
        </period>
    </context>
    <context id="i24b5bf7bd68d425d9982f2b10d0f20f4_I20130416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelPiacentileVAmgenIncEtAlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-04-16</instant>
        </period>
    </context>
    <context id="i2f35dd91b0344cb6ba1c6fc2ce024afc_I20180425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-25</instant>
        </period>
    </context>
    <context id="i057d846c99e24512ad9cb275e0ad3de8_I20200302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-02</instant>
        </period>
    </context>
    <context id="iddc589cd657a4746a04bdd0a051ab071_I20181212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:EvanstonPolicePensionFundv.McKessonCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-12</instant>
        </period>
    </context>
    <context id="i3b893491327d4a5081fd775de27171a8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:EvanstonPolicePensionFundv.McKessonCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i23f831232dbf484481fae3a05bce6513_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="ia91da99152ad44428ddb96bcf738d999_I20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="i9fa7ddfc765f423794371f1af3723e4f_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="icf0b205ff8cb4fe6bbf197d316b47f43_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="i20873e9ecf6d4345bd56d1540cbbe862_I20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2018-03-31</instant>
        </period>
    </context>
    <context id="id1aa84dc10f44e2ea8914b72f7921ce2_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7dea821e32924b6585e37a6e0736d3bc_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibee4b1dcd2594498a8e665ad78a26929_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i9b320ce88af7493b8137e9d513e29859_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7989fb6981db44d6a082cf3c02a024b6_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7403b5a9a1b84b5cb7c8a882d6a51fd2_D20230301-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idc03527a8d334d539c474fe9c3791d14_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9db2aeb8a3924ed5bd9d03fb72c6cd8d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iddb1a3b6365b4643bd368941bb1a62c9_D20160301-20160331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-01</startDate>
            <endDate>2016-03-31</endDate>
        </period>
    </context>
    <context id="i219f752cc9d64079a2574ee8f7108652_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia153892cce85447fb85d9233bdf56fff_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2c415789acee4283a6ed5420c5137fc9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:EnvironmentalLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i71dc2fb8cd8f4fab8df832f11c64c6e4_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idf21b957ae1643249d6ecd39408dd77d_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="ic9446f02c71545a69aa3169ca6418b21_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3376bdc454704e8a84932b1b7dd33e89_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMay2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9218dd12bc66496ba1bcdebfe2a9ca2b_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9cde46cdcba64ab9acfd06498904f049_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseFebruary2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i20292928a6df4630869820c5c913bbdb_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseFebruary2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i45ac0ae0f55f4a1db80ab683ab3f7655_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMay2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i96f090a3fbc74514b59f02f20a563b79_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseDecember2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i32ef665f7e9f47f8a52f2b7ccd1c1642_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i62b31f8221c34827bfa4b4c4223aef53_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if81af84863b849ee84346934e78dd3d1_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseFebruary2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="i4b81b5ce8e3946c486bacd3228a6502d_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="i609db64ab4224f9ab5523d7c2bb0d613_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id1c0f65c88014f1ca2d67069e57a5ee6_D20220501-20220531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="i831c04a5da8247afbc87577d86b34cfe_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:OpenMarketTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i606c3a6a2202458da025615d9b410a00_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i074564bccb7c4a93a2b47e7194a97423_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8a12d8177d3a4bca8f20394c549b2ba4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia24155bbe2b64b13a5839bc953e73126_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia06fe5f5c08242e7988383eb561e7daf_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i541d58c4043e481c86a354b16272d39f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ief34de8c02864055a306f0805902d830_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2ab34673c6cd4865a1526b689d28d9e5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4de62b174ea943d98bbc5ea010c68a3b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idebabd22268d4aa5be5fdcb7615dcb80_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ica7e852a88784746894a205a0250f9e2_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i996effba6e534e53953b29d2c0934e15_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ide3cc36767984833bee114be85420104_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2c2e1ec251cb4ae3beaeb30c7c423caf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie30cfb911148404bb4945fff687165b3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i36eca1d194984dd68f29ddaa4c2a05f9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i124bd77619314a38a6b7cf276d1570cd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia7f24a9d3204464d821c538c01648b18_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4cf65ea6698449018a0c90a7c5bde4ab_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icebbfa315f6f4c3badea80ba552d9fb3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9073522e455946228d949f1757f5c414_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9ab73b88a84e4a3399c2d709d8b90830_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaa875c8421764c2c97f433701036010f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia639b6ffb08b44728499feae92d1c0c8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia0d5849c66ff44049855a2ac70d7759e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iceb7460499a94969a987f6e8ded5348e_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i710b6d1dd56e4af4adf0dcdc5a56ecad_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if772d42044f24743833c57e3767d2780_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvesteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:U.S.PharmaceuticalandSpecialtySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4a2892fe126a4d66a63dd15b65453356_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id978da015466413b89b3f2baa572ef6d_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib8b0a03505314b06b91188743cad0dec_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i29863184fd5348ff9a2a8abf0a0f8828_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic0df62424e8a4e62973e47b8bfd93a08_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic7a2b38fb7fa4ffd985ec84c91b96f08_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6f27de4692d94ce8a48a3d7cc406987a_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NewYorkOpioidTaxSurchargeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia7674cea30624b1d8ca527142731b3ad_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idfa165efd60744789333c4342a1321b6_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib04ea519904c428dbf874fb64037adad_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i05710b61fa6a461a86f2ce635e26e4b7_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i49a0432e3a7549c3a03b803ce21875b6_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:WalgreensBootsAllianceJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id5247400d4124ca0b0a07ce0631d83e8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:GermanWholesaleBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56f911c056b9484b92530a2457c3bafb_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic3df0606471a49beaeceeaa20d347abb_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EUBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibd7c7850d8804f519104e7d06502da80_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:UKBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia92f8f2aaaa94d78b491c9cdf4615c44_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic465b0622cf24cb28f75710b46a76fb2_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id2e8b60c81a24e6fb0f18c0151fbdea0_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1f0021b2207044be8e84e8be9891a203_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i264e209968434d6cab289a945e761bb9_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ShareholderDerivativeActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie4d3a7b2492845f594e7eb9cb4d9ba34_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i27b479eb9b0a4205ac5ae85acf2eab9f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1f12ecf10c5748808acbd2a3b98687df_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1892be5575524f3e9fca14e45be67594_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1a645887208e4db486fb4c28bf9e9789_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3437a5a1fdb04c6e8b55de243f4372f2_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i63e0cc8c15f34a96905c888bc0341914_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i900587631c7346db9cea5a03126cc912_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia7384817abd64241a01371e5ab5d3497_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibb89c7229e47468d9dc24fe8eae25115_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia81ff60f8db142b3b909cdcd9740380f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8940a83e694049a79488bf11a8ab865b_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2cd212f902f34f7f840d70349edad45f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4edda4c7cace4760a6ee6c90e9c98795_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6ed2dcfef9ef48c5bb328cf03b40b504_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3bde156294a94d568921fd8650774394_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i759399c0e9f1473c9e22bd29f133ffe0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4b8997759ac04bec85bf84dabe68cba0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:OtherAllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3a62067dd1e740e787533693c47c4cad_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5a3854feff1f4556b7bc99ddcbb54572_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i57b78c8af30b448bbccd7dfac95d2712_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsWrittenOffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5e0851153ff84a2cb14ce3cf28fc235d_D20220401-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i19cf323fe7a0413b901a209d2006acbe_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0f46ce261be141779d217de93096c2dc_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mck:ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>mck:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="distributor">
        <measure>mck:distributor</measure>
    </unit>
    <unit id="state">
        <measure>mck:state</measure>
    </unit>
    <unit id="case">
        <measure>mck:case</measure>
    </unit>
    <unit id="subdivision">
        <measure>mck:subdivision</measure>
    </unit>
    <unit id="jurisdiction">
        <measure>mck:jurisdiction</measure>
    </unit>
    <unit id="plaintiff">
        <measure>mck:plaintiff</measure>
    </unit>
    <unit id="complaint">
        <measure>mck:complaint</measure>
    </unit>
    <unit id="relator">
        <measure>mck:relator</measure>
    </unit>
    <unit id="policy">
        <measure>mck:policy</measure>
    </unit>
    <unit id="faxnumber">
        <measure>mck:faxNumber</measure>
    </unit>
    <unit id="fax">
        <measure>mck:fax</measure>
    </unit>
    <unit id="defendant">
        <measure>mck:defendant</measure>
    </unit>
    <unit id="city">
        <measure>mck:city</measure>
    </unit>
    <unit id="officer">
        <measure>mck:officer</measure>
    </unit>
    <unit id="softwareproduct">
        <measure>mck:softwareProduct</measure>
    </unit>
    <unit id="site">
        <measure>mck:site</measure>
    </unit>
    <unit id="vote">
        <measure>mck:vote</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl80L2ZyYWc6OTk5ZDg4MzYzZTUyNDA1ZTkzNjVjZGIzZTM2MmU0YzIvdGFibGU6OTE1OGUzNGE1NGI5NDBhY2EwOTFiOGVkNzQwYjM0NDcvdGFibGVyYW5nZTo5MTU4ZTM0YTU0Yjk0MGFjYTA5MWI4ZWQ3NDBiMzQ0N18zLTItMS0xLTIxODc0OA_7db1adf8-2aa9-4428-b564-47369d992357">0000927653</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl80L2ZyYWc6OTk5ZDg4MzYzZTUyNDA1ZTkzNjVjZGIzZTM2MmU0YzIvdGFibGU6OTE1OGUzNGE1NGI5NDBhY2EwOTFiOGVkNzQwYjM0NDcvdGFibGVyYW5nZTo5MTU4ZTM0YTU0Yjk0MGFjYTA5MWI4ZWQ3NDBiMzQ0N181LTItMS0xLTIxODc0OA_eb5d471d-be84-4676-aff0-33b29276d929">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl80L2ZyYWc6OTk5ZDg4MzYzZTUyNDA1ZTkzNjVjZGIzZTM2MmU0YzIvdGFibGU6OTE1OGUzNGE1NGI5NDBhY2EwOTFiOGVkNzQwYjM0NDcvdGFibGVyYW5nZTo5MTU4ZTM0YTU0Yjk0MGFjYTA5MWI4ZWQ3NDBiMzQ0N182LTItMS0xLTIxODc0OA_7d855d96-cb8e-4386-bef6-f3a0747e0ae0">2023</dei:DocumentFiscalYearFocus>
    <dei:AmendmentFlag
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl80L2ZyYWc6OTk5ZDg4MzYzZTUyNDA1ZTkzNjVjZGIzZTM2MmU0YzIvdGFibGU6OTE1OGUzNGE1NGI5NDBhY2EwOTFiOGVkNzQwYjM0NDcvdGFibGVyYW5nZTo5MTU4ZTM0YTU0Yjk0MGFjYTA5MWI4ZWQ3NDBiMzQ0N183LTItMS0xLTIxODc0OA_ba0ca071-01f5-4a21-977b-b4a2787b1a04">false</dei:AmendmentFlag>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2a4af360e7154c9e8ccdf22798b63fbb_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzc5_434691cb-3c7b-46f0-b8e5-b9ad93bbc229">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="id5e672e286474d2e9f8e1f5fe1e234e0_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0MzI0_4fd24846-796a-4644-bf59-7de3fb2a6e2d">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i78c87aed7caa4ad198dca1602c85ed23_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0NDA0_da16eb7b-c863-47a8-b5b6-560d55f8d8c1">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7385cd355dd4468ba773e9d23bf40348_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE4NzYz_104a5783-416c-41d1-9774-e5859d78ef41">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i4a39186a14424d8bafc2b9cf028fffd8_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzIxMDA_29caba71-3a79-4459-a81e-59ee51b81951">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2cb43d7d-4dbe-40be-891b-5b154c0f7e7e">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2e8bafc9-a699-4ad1-a382-140d4fabd947">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_481d8594-6d0e-48c4-a516-41181b6ee1a8">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_b132aa89-d101-44a4-8856-5a1aefc7a3ca">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_9a3e0520-2b32-4c2a-8b14-f87e23310cf5">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_fbb0bd27-adff-497f-b17f-ffe770574fee">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="i925b096ac7224e21909543318e72b500_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM2MjQ_b3387c7e-31d8-45e1-b5f8-dc61fc04b015">P2Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <mck:GuarantorObligationsPeriod
      contextRef="i04f759a37fee446ab4c24b7a4aa7fd2c_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzYyMA_f70be4f2-8308-4872-ada2-b3f0a675b674">P1Y</mck:GuarantorObligationsPeriod>
    <mck:GuarantorObligationsPeriod
      contextRef="ibb01f985e84846568b14aa2b0bf489e5_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzY3OA_6036989f-413d-4a9a-9e98-c93fb0ca4aa4">P1Y</mck:GuarantorObligationsPeriod>
    <mck:LossContingencyNumberOfStatesFiledOnBehalfOf
      contextRef="i057d846c99e24512ad9cb275e0ad3de8_I20200302"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNjU4L2ZyYWc6MTM4N2FlNGFkNmEwNDFjZjg4YTk3MTFlNDlmMDMwMmQvdGFibGU6NTg3OTcxYjNkZjc3NDI3ODllZDU1YjMzYTc4ZDJiYzgvdGFibGVyYW5nZTo1ODc5NzFiM2RmNzc0Mjc4OWVkNTViMzNhNzhkMmJjOF8wLTEtMS0xLTI2NDkzMw_e2c0a557-44e4-419c-adcd-c9a6adfec990"
      unitRef="state">33</mck:LossContingencyNumberOfStatesFiledOnBehalfOf>
    <mck:LossContingencyNumberOfStatesFiledOnBehalfOf
      contextRef="i2f35dd91b0344cb6ba1c6fc2ce024afc_I20180425"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNjU4L2ZyYWc6MTM4N2FlNGFkNmEwNDFjZjg4YTk3MTFlNDlmMDMwMmQvdGFibGU6NTg3OTcxYjNkZjc3NDI3ODllZDU1YjMzYTc4ZDJiYzgvdGFibGVyYW5nZTo1ODc5NzFiM2RmNzc0Mjc4OWVkNTViMzNhNzhkMmJjOF8wLTEtMS0xLTI2NDkzMw_f561e2f4-a11d-4e05-8b0b-50ee3b97bd51"
      unitRef="state">33</mck:LossContingencyNumberOfStatesFiledOnBehalfOf>
    <dei:DocumentType
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl84NA_b24d6a7b-c12f-4f3d-ae56-190c06cdaa21">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6OTExODI0M2FmNjFiNGFlY2I3NzVlNmE0YzdhNjcyNmUvdGFibGVyYW5nZTo5MTE4MjQzYWY2MWI0YWVjYjc3NWU2YTRjN2E2NzI2ZV8wLTAtMS0xLTIxODc0OA_89915ee8-4470-4785-a39b-883e69ed4da0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8xNjQ5MjY3NDUyODI4_08a4d4c4-9cbd-4e0e-8210-fdd540c59baa">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8xNjQ5MjY3NDUyODI4_467b6b2b-44b1-415d-a9f9-715b0489ecf4">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6ZDdlZDk4ZDI0OTZiNDlkYWFmOWJiMWRmZTdiYjllMTYvdGFibGVyYW5nZTpkN2VkOThkMjQ5NmI0OWRhYWY5YmIxZGZlN2JiOWUxNl8wLTAtMS0xLTIxODc0OA_63687bd2-bfd0-43a6-863e-859dceebc1fe">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yMDU_ed6526ef-9f37-4fb1-8dbe-5f557cc94f2d">1-13252</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yMTA_027685a4-cc7d-4a40-9e78-6c49b4c846dc">McKESSON CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6ZDRkNDUyNjRlYWQ0NDQyN2I3YTM1OThjOGI1YWQwZmMvdGFibGVyYW5nZTpkNGQ0NTI2NGVhZDQ0NDI3YjdhMzU5OGM4YjVhZDBmY18wLTAtMS0xLTIxODc0OA_ff306fff-4c41-4c9e-b942-89f9fc83f101">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6ZDRkNDUyNjRlYWQ0NDQyN2I3YTM1OThjOGI1YWQwZmMvdGFibGVyYW5nZTpkNGQ0NTI2NGVhZDQ0NDI3YjdhMzU5OGM4YjVhZDBmY18wLTItMS0xLTIxODc0OA_1236edea-87bb-400c-afac-1a647fc008c5">94-3207296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yNzI_d2f28bb2-3038-4562-a394-4246827c4c52">6555 State Hwy 161</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yNzc_5813e2ba-2e64-491f-8934-0c858e7c0ec4">Irving</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yODE_0f3ab321-e367-4afe-9658-356a47c00d7c">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yODQ_fd5f790c-dc04-4eeb-8e28-73eaad28a0ac">75039</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8zNTA_af4393e8-c7a4-4a2c-96e2-29bebc231a95">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8zNTQ_f13a6785-eb15-4ae3-af15-a02dd878eb4c">446-4800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i4a1cd3cc23a14e3c8567f6f5021d4d29_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8xLTAtMS0xLTIxODc0OA_d71195de-7911-4d8a-9fd2-6ea2019d3043">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4a1cd3cc23a14e3c8567f6f5021d4d29_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8xLTEtMS0xLTIxODc0OA_2ac21fef-92b1-40d8-a594-7328bf0614fe">MCK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4a1cd3cc23a14e3c8567f6f5021d4d29_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8xLTItMS0xLTIxODc0OA_5b903727-2a45-42d3-9c7e-21b1d8812e10">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib4d9c8c16b9c41c79238cd17c37cf884_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8yLTAtMS0xLTIxODc0OA_1ff61c0e-4737-419c-b323-4c652c589dde">1.500% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib4d9c8c16b9c41c79238cd17c37cf884_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8yLTEtMS0xLTIxODc0OA_5cdf12cd-e144-4d1d-a786-745c46c923bb">MCK25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib4d9c8c16b9c41c79238cd17c37cf884_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8yLTItMS0xLTIxODc0OA_baa90745-51e1-4af2-b171-d1fbb00e4649">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i35936bfe99754ea0b2d8151940f323d5_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8zLTAtMS0xLTIxODc0OA_73f51f98-f065-461f-868e-d612ec03d4ad">1.625% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i35936bfe99754ea0b2d8151940f323d5_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8zLTEtMS0xLTIxODc0OA_dcce9c94-1892-4585-ab0b-a0558684ae53">MCK26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i35936bfe99754ea0b2d8151940f323d5_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF8zLTItMS0xLTIxODc0OA_d7f14c7b-0ee5-497c-9f13-4ac62336acce">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0407835b367a4e4ea273bf9f6036ebaa_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF80LTAtMS0xLTIxODc0OA_3d2afcc3-7485-491c-9d89-3f62eb0331d4">3.125% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0407835b367a4e4ea273bf9f6036ebaa_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF80LTEtMS0xLTIxODc0OA_5bad6052-4727-4274-be18-3a9b7b3760b0">MCK29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0407835b367a4e4ea273bf9f6036ebaa_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6YzgxYzhlNmI1N2RmNGU3Mzg1NzMzYTExMTE0Zjc2NmQvdGFibGVyYW5nZTpjODFjOGU2YjU3ZGY0ZTczODU3MzNhMTExMTRmNzY2ZF80LTItMS0xLTIxODc0OA_a6c4df23-92d7-4bbb-8905-1b1bf3e02b77">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl82NTk_21f7fd07-f78c-4f4c-9a4d-aedc48ce3846">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl84MDI_778d4acd-2195-457c-be16-82cd3236e60d">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8xMTU0_86e56c52-1709-42e9-ae4c-10a1750be65f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8xNDc5_4623b291-a072-4fa8-83e3-95b9f69b9f0f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6MjJiYzQ5Y2Q0MDlkNDU0OTlkNWJjMmMwMWMwNjVhM2MvdGFibGVyYW5nZToyMmJjNDljZDQwOWQ0NTQ5OWQ1YmMyYzAxYzA2NWEzY18wLTAtMS0xLTIxODc0OA_a7536f05-77d0-4c98-83fa-48847c84ed8b">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6MjJiYzQ5Y2Q0MDlkNDU0OTlkNWJjMmMwMWMwNjVhM2MvdGFibGVyYW5nZToyMmJjNDljZDQwOWQ0NTQ5OWQ1YmMyYzAxYzA2NWEzY18xLTYtMS0xLTIxODc0OA_a64a382d-162a-4877-be95-127a82a71d6d">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGFibGU6MjJiYzQ5Y2Q0MDlkNDU0OTlkNWJjMmMwMWMwNjVhM2MvdGFibGVyYW5nZToyMmJjNDljZDQwOWQ0NTQ5OWQ1YmMyYzAxYzA2NWEzY18yLTYtMS0xLTIxODc0OA_f3d998c1-b8d7-4830-aaaa-afbc11f20708">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8zMTAx_bdfb9197-f001-4208-9669-276b43c2bdaa">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yNTQ2_f8f2c45b-95a0-4a13-ba9d-909ca4b0d3c3">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i399f6860da294568aba7949399d70dcc_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yODMw_3f49b33b-a5ba-45bf-9333-6570f1e1aad8"
      unitRef="usd">48200000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1da02b0e502e472ba1f749732b72467c_I20230428"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8yODk2_7a46cbac-8824-4d30-b804-3b73e668280d"
      unitRef="shares">135602262</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xL2ZyYWc6NTAyYWM1YzUzYTQ1NGQ0ZmI0NDQ2M2Q4ZTQyM2EzYmIvdGV4dHJlZ2lvbjo1MDJhYzVjNTNhNDU0ZDRmYjQ0NDYzZDhlNDIzYTNiYl8zMTAy_8a4b75fb-1a86-43c5-aa06-30e7457c3ee9">DOCUMENTS INCORPORATED BY REFERENCEPortions of the registrant&#x2019;s Proxy Statement for its calendar year 2023 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDAvZnJhZzpkMzU1YTMxMzNjOTE0ZDE0YTViYTAzNmExMmFjNDVjZS90YWJsZTo2ZWM1MzVjZDliZTE0NGQ2YjcxMDQzYzcwNzdmMzAwMC90YWJsZXJhbmdlOjZlYzUzNWNkOWJlMTQ0ZDZiNzEwNDNjNzA3N2YzMDAwXzEtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246ZDNkNDkzZDZhMTllNGNkMGE0ZDJlNmRlMjJjODhmMWFfOQ_2ed2d760-f222-4372-8605-2b3d0ce0a36c">Deloitte &amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDAvZnJhZzpkMzU1YTMxMzNjOTE0ZDE0YTViYTAzNmExMmFjNDVjZS90YWJsZTo2ZWM1MzVjZDliZTE0NGQ2YjcxMDQzYzcwNzdmMzAwMC90YWJsZXJhbmdlOjZlYzUzNWNkOWJlMTQ0ZDZiNzEwNDNjNzA3N2YzMDAwXzItMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246YTBhMjU3ZGMwMmUwNDE2MWJiN2FjOWM4N2YxODQ2MjlfNA_2975ed31-36f0-4690-b696-49c49dccdb4d">Dallas, Texas</dei:AuditorLocation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzItMS0xLTEtMjE4NzQ4_88ad45eb-6172-453c-b924-2fa60d56ce15"
      unitRef="usd">276711000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzItMy0xLTEtMjE4NzQ4_51a066b3-9dd8-4f28-96c0-b8ed3d64b3c2"
      unitRef="usd">263966000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzItNS0xLTEtMjE4NzQ4_67e8791f-023a-4994-a327-4d33b4c7bca8"
      unitRef="usd">238228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMtMS0xLTEtMjE4NzQ4_93d57cac-d6c1-46b9-a7bc-8a0e3292b4ff"
      unitRef="usd">264353000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMtMy0xLTEtMjE4NzQ4_bc26cedf-3004-4855-9831-ae0639399dc8"
      unitRef="usd">250836000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMtNS0xLTEtMjE4NzQ4_867ccbb8-737d-4ac3-8651-67c56f9700d8"
      unitRef="usd">226080000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzQtMS0xLTEtMjE4NzQ4_8cd15df2-ab89-4a01-8b19-0cfe08ad37de"
      unitRef="usd">12358000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzQtMy0xLTEtMjE4NzQ4_e163edb3-edf5-4a0c-b197-f4c84887dff6"
      unitRef="usd">13130000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzQtNS0xLTEtMjE4NzQ4_147a4c73-3ede-44a1-93e7-9ecd512e1ccf"
      unitRef="usd">12148000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzUtMS0xLTEtMjE4NzQ4_74283a64-83de-4959-9a9c-d8e6c0e0e734"
      unitRef="usd">7776000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzUtMy0xLTEtMjE4NzQ4_b18e4f18-4f00-4d64-9ec6-bc6034b34933"
      unitRef="usd">10537000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzUtNS0xLTEtMjE4NzQ4_fff63f52-08a2-441b-907d-d6174a8360b6"
      unitRef="usd">8849000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzYtMS0xLTEtMjE4NzQ4_8a243802-134b-4c26-a45e-6106d26b5315"
      unitRef="usd">8000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzYtMy0xLTEtMjE4NzQ4_505a4b3f-88e4-4d54-ac7d-bfac338d7179"
      unitRef="usd">-274000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzYtNS0xLTEtMjE4NzQ4_7d55d540-c3d9-40e0-86c2-1f859b2b5141"
      unitRef="usd">-7936000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzctMS0xLTEtMjE4NzQ4_a26993b0-0be6-4d21-8f50-6b6481469a9b"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzctMy0xLTEtMjE4NzQ4_732730ee-b81b-42c7-bd43-f2dd57956208"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzctNS0xLTEtMjE4NzQ4_d64bebe3-2215-4ad9-8df7-11f508435f6c"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzgtMS0xLTEtMjE4NzQ4_9a1a7f9c-a530-488d-b156-8bef65c7c809"
      unitRef="usd">209000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzgtMy0xLTEtMjE4NzQ4_3c23df35-0ea0-4fbc-a3db-4122cc9c1bb4"
      unitRef="usd">281000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzgtNS0xLTEtMjE4NzQ4_5f8322bb-de00-462a-a18a-289b1dc9734e"
      unitRef="usd">334000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <us-gaap:OperatingExpenses
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzktMS0xLTEtMjE4NzQ4_956bf118-f3e9-42c4-91f7-a5525b947a2f"
      unitRef="usd">7977000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzktMy0xLTEtMjE4NzQ4_52dce289-4e9f-4e66-894c-219e6e80b047"
      unitRef="usd">11092000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzktNS0xLTEtMjE4NzQ4_ffa03781-1537-44a9-8402-4f86d5dc0879"
      unitRef="usd">17188000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEwLTEtMS0xLTIxODc0OA_a7994695-1529-46bb-ba1e-5fb6c0d72c2f"
      unitRef="usd">4381000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEwLTMtMS0xLTIxODc0OA_d46bd1d4-89e8-4646-8a30-6576fc818d1a"
      unitRef="usd">2038000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEwLTUtMS0xLTIxODc0OA_5ca81391-3cda-4b38-80b2-ffb4387093f3"
      unitRef="usd">-5040000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzExLTEtMS0xLTIxODc0OA_2964803a-e0d0-4b6a-8aac-28cb8a14d980"
      unitRef="usd">497000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzExLTMtMS0xLTIxODc0OA_04b3f4ef-e537-4993-8078-8b354e039c55"
      unitRef="usd">259000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzExLTUtMS0xLTIxODc0OA_4a623e7d-74ac-4b19-9667-4c6e08f96a5f"
      unitRef="usd">223000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEzLTEtMS0xLTIxODc0OA_94fbea38-f61e-49d3-aa8c-8c372cb72392"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEzLTMtMS0xLTIxODc0OA_b35c1d20-febf-4c6a-bbdf-6cba12a8aaa5"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzEzLTUtMS0xLTIxODc0OA_baf7144f-de34-4606-83ea-28ff71600f5f"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE0LTEtMS0xLTIxODc0OA_275929f9-bb84-4749-b24f-89cef19e738a"
      unitRef="usd">248000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE0LTMtMS0xLTIxODc0OA_34bda097-28a8-49d1-b7ab-b465aaa446d6"
      unitRef="usd">178000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE0LTUtMS0xLTIxODc0OA_5e079b1d-6b7b-4b43-80fb-9c1813b534fb"
      unitRef="usd">217000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE1LTEtMS0xLTIxODc0OA_1da40179-f804-42b7-8b6f-dbcfd008f53b"
      unitRef="usd">4630000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE1LTMtMS0xLTIxODc0OA_27e0309c-1a33-44fb-afd4-7903655274ee"
      unitRef="usd">1928000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE1LTUtMS0xLTIxODc0OA_cd391289-128c-4ccf-96ea-e1962ef25855"
      unitRef="usd">-5034000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE2LTEtMS0xLTIxODc0OA_2e90d1d8-a5b7-45cc-b0d5-c47856b716f3"
      unitRef="usd">905000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE2LTMtMS0xLTIxODc0OA_35ce6d27-00b3-488a-862a-bee02489a05c"
      unitRef="usd">636000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE2LTUtMS0xLTIxODc0OA_f36ed28c-0b7f-4f4d-9b9b-181d51d2b8fa"
      unitRef="usd">-695000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE3LTEtMS0xLTIxODc0OA_429ec7ce-04a7-4d48-bc10-accacd17c346"
      unitRef="usd">3725000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE3LTMtMS0xLTIxODc0OA_34fe81a3-ef24-4151-a569-986bfeab7b46"
      unitRef="usd">1292000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE3LTUtMS0xLTIxODc0OA_a9ac4a1c-055f-48f2-b452-4a0896353692"
      unitRef="usd">-4339000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE4LTEtMS0xLTIxODc0OA_7f3a0b73-9a8e-4fb7-a398-2c9588526095"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE4LTMtMS0xLTIxODc0OA_97173305-9bac-4d9b-ab7f-48137d0c7c16"
      unitRef="usd">-5000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE4LTUtMS0xLTIxODc0OA_30ed9553-003b-4aac-8dd4-b554564c528e"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE5LTEtMS0xLTIxODc0OA_9ed33e9e-5942-48df-9158-733b0d9758f1"
      unitRef="usd">3722000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE5LTMtMS0xLTIxODc0OA_1a24b173-3137-478a-9985-4382a65aa4fd"
      unitRef="usd">1287000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzE5LTUtMS0xLTIxODc0OA_65529e24-3270-483b-b6b3-b431ba2e2600"
      unitRef="usd">-4340000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIwLTEtMS0xLTIxODc0OA_11cf3b64-3304-4f97-9742-212467431764"
      unitRef="usd">162000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIwLTMtMS0xLTIxODc0OA_b23a6f63-5964-4717-aa95-1e6923defafd"
      unitRef="usd">173000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIwLTUtMS0xLTIxODc0OA_859f820f-b73a-4a4f-9fbc-c237b74d5e11"
      unitRef="usd">199000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIxLTEtMS0xLTIxODc0OA_19ca6810-45e1-4b02-a7b7-7082e9a3b237"
      unitRef="usd">3560000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIxLTMtMS0xLTIxODc0OA_df15a823-c6dd-425b-8732-d4b3a2940549"
      unitRef="usd">1114000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzIxLTUtMS0xLTIxODc0OA_f5b828ba-aed0-4af8-a423-4ff9679e7d3a"
      unitRef="usd">-4539000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI1LTEtMS0xLTIxODc0OA_f0fca01a-812f-4773-9fd0-1c8d98163cb4"
      unitRef="usdPerShare">25.05</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI1LTMtMS0xLTIxODc0OA_8489e818-f235-4dab-b8f5-43cb0b02356a"
      unitRef="usdPerShare">7.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI1LTUtMS0xLTIxODc0OA_5f9e78be-948e-4885-b9df-045102f4e900"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI2LTEtMS0xLTIxODc0OA_503ddbe6-5856-4515-adbc-a77525bafc87"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI2LTMtMS0xLTIxODc0OA_e07aa815-0f46-455b-84f7-5ab8ff9e5f87"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI2LTUtMS0xLTIxODc0OA_a021036c-47c1-49ac-b8e1-b300c8f67656"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI3LTEtMS0xLTIxODc0OA_a91c4e85-4eeb-461e-a2e6-ae798f4bc53c"
      unitRef="usdPerShare">25.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI3LTMtMS0xLTIxODc0OA_62e6866c-7bda-4285-b413-89f2ce76e5fa"
      unitRef="usdPerShare">7.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI3LTUtMS0xLTIxODc0OA_532c80de-f0a5-47ef-a2c2-c7423b9f4fb9"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI5LTEtMS0xLTIxODc0OA_3f22a7d9-407b-4477-b013-ae4f36ccc42a"
      unitRef="usdPerShare">25.25</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI5LTMtMS0xLTIxODc0OA_dd5c5345-c1ed-4edb-846c-7cef9a643652"
      unitRef="usdPerShare">7.35</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzI5LTUtMS0xLTIxODc0OA_ec49d15c-c9f7-438d-938f-b720e412ceae"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMwLTEtMS0xLTIxODc0OA_7ec3a040-6f6d-4d13-b9e8-a3bffa6c0647"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMwLTMtMS0xLTIxODc0OA_e6c69636-47cb-4689-b041-b9a27fe64537"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMwLTUtMS0xLTIxODc0OA_a4798472-8d5a-442e-b07e-24c2383c47ee"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMxLTEtMS0xLTIxODc0OA_036130da-dcf1-4657-8a22-edc90daf9ea9"
      unitRef="usdPerShare">25.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMxLTMtMS0xLTIxODc0OA_17955968-617e-4ff7-99a2-569b9a0c94df"
      unitRef="usdPerShare">7.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzMxLTUtMS0xLTIxODc0OA_9deaff92-127e-4fe6-98e7-172c3bf45de5"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM0LTEtMS0xLTIxODc0OA_533850be-162e-48c8-a604-8f52154f7f3a"
      unitRef="shares">142200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM0LTMtMS0xLTIxODc0OA_27aa7b0d-e640-452b-a85e-d51ef4cb0b46"
      unitRef="shares">154100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM0LTUtMS0xLTIxODc0OA_6f73424d-fff4-443f-bf9d-b635c2379a68"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM1LTEtMS0xLTIxODc0OA_09368807-73fc-4118-96fa-684eb38b87fa"
      unitRef="shares">141100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM1LTMtMS0xLTIxODc0OA_78226c0e-1b2e-4fc1-aaf2-19749fbd8f99"
      unitRef="shares">152300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDMvZnJhZzplODU4YWFhMzVkNTg0MzFkYjFkYWJlOTM5YWM5Y2M1YS90YWJsZTplMzdkMTcwNmE5NzY0Yjk5YTViNDhiNjY3NGUxNjZmOC90YWJsZXJhbmdlOmUzN2QxNzA2YTk3NjRiOTlhNWI0OGI2Njc0ZTE2NmY4XzM1LTUtMS0xLTIxODc0OA_271d3647-613d-4a70-b9d6-fc398850407c"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzItMS0xLTEtMjE4NzQ4_bfeee902-5edd-48d6-b2a1-40819e9da6f7"
      unitRef="usd">3722000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzItMy0xLTEtMjE4NzQ4_cf788c6c-9096-43e8-8ce3-c5a8d21d25bb"
      unitRef="usd">1287000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzItNS0xLTEtMjE4NzQ4_415d239a-511d-438b-be5b-da6f1b45cf3c"
      unitRef="usd">-4340000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzUtMS0xLTEtMjE4NzQ4_4142ca3c-f91e-43f6-b92a-57414364ef4d"
      unitRef="usd">674000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzUtMy0xLTEtMjE4NzQ4_6a5dd140-115c-475b-8a86-7f81023430be"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzUtNS0xLTEtMjE4NzQ4_c981900e-5a7e-4e4b-9112-7430e3417912"
      unitRef="usd">184000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzYtMS0xLTEtMjE4NzQ4_3fdeb3c6-e556-4c54-b0aa-e792c58fc46f"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzYtMy0xLTEtMjE4NzQ4_b11e2b1d-b852-4d27-a592-798ab2bb25b3"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzYtNS0xLTEtMjE4NzQ4_3b040794-edcd-4255-8f4b-2017260948ae"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzctMS0xLTEtMjE4NzQ4_cc5d8c29-1953-46d7-b391-497a7e36deb4"
      unitRef="usd">-62000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzctMy0xLTEtMjE4NzQ4_caad97f0-9f33-4ae9-9211-c9f8e6afd496"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzctNS0xLTEtMjE4NzQ4_da1d649f-6de3-40ab-b63a-d13c5d7032b1"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzgtMS0xLTEtMjE4NzQ4_7e98a942-1337-4919-95fd-2a3ba3690187"
      unitRef="usd">673000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzgtMy0xLTEtMjE4NzQ4_bd01910e-4646-4278-8f79-7b58d9c1a383"
      unitRef="usd">115000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzgtNS0xLTEtMjE4NzQ4_8ab6007e-d319-4d2f-b390-9508ee703812"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEwLTEtMS0xLTIxODc0OA_4fa9834d-de0e-4102-81b0-02afe41c7c28"
      unitRef="usd">4395000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEwLTMtMS0xLTIxODc0OA_3a7629a2-dbf5-462e-ae2a-79e4f4fd24e2"
      unitRef="usd">1402000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEwLTUtMS0xLTIxODc0OA_23f34e91-4cfa-43ff-afdc-b4457ca09b66"
      unitRef="usd">-4170000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzExLTEtMS0xLTIxODc0OA_d12b930e-632a-4f84-aab1-09c96ab7d7e1"
      unitRef="usd">206000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzExLTMtMS0xLTIxODc0OA_654cde86-39fb-48f5-95c0-9f936003308a"
      unitRef="usd">172000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzExLTUtMS0xLTIxODc0OA_8503db74-3166-48a1-acf5-8a44a7f41686"
      unitRef="usd">146000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEyLTEtMS0xLTIxODc0OA_e3d7a598-efc6-493a-a352-e71b9d47dcca"
      unitRef="usd">4189000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEyLTMtMS0xLTIxODc0OA_5ee6e9b8-540e-4cf3-b6ff-90b5f5ea3d78"
      unitRef="usd">1230000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDYvZnJhZzoyOTMzODUxMzc2ZmY0NThiYjZmMTZmNmY4MGUzOTIxOC90YWJsZTozYmRkYjA1YWViYzA0OWQwYTU2MjUwMjVlNzVmMmE0ZS90YWJsZXJhbmdlOjNiZGRiMDVhZWJjMDQ5ZDBhNTYyNTAyNWU3NWYyYTRlXzEyLTUtMS0xLTIxODc0OA_68da7ccb-ef48-4a50-9500-e08e9f142add"
      unitRef="usd">-4316000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQtMS0xLTEtMjE4NzQ4_9a4cbc8a-9671-4bd1-b980-fbbb2c5afd9c"
      unitRef="usd">4678000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQtMy0xLTEtMjE4NzQ4_a3ad3aaf-cf92-410a-8488-b65b58e248e5"
      unitRef="usd">3532000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzUtMS0xLTEtMjE4NzQ4_0e88cbd8-3e2d-4a5c-81d7-8002c218ccd4"
      unitRef="usd">19410000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzUtMy0xLTEtMjE4NzQ4_793f2684-b60f-4caf-a31e-077add2dbe6d"
      unitRef="usd">18583000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzYtMS0xLTEtMjE4NzQ4_f758d0ef-a496-46f9-b141-49e83812d0b6"
      unitRef="usd">19691000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzYtMy0xLTEtMjE4NzQ4_85258063-516a-4bbf-9a88-db8a5af01fc6"
      unitRef="usd">18702000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzctMS0xLTEtMjE4NzQ4_ae6db0ba-37ad-4519-9737-665629459956"
      unitRef="usd">17000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzctMy0xLTEtMjE4NzQ4_f1312ce9-0416-4d8f-afe3-9fb44af8f991"
      unitRef="usd">4516000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzgtMS0xLTEtMjE4NzQ4_3e32bb19-60e4-48d8-a8ea-4c781bed5511"
      unitRef="usd">496000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzgtMy0xLTEtMjE4NzQ4_f833d8be-4825-4899-b26f-481ef0101689"
      unitRef="usd">898000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzktMS0xLTEtMjE4NzQ4_447f7b88-02a8-482f-82e6-c2df663f64e1"
      unitRef="usd">44292000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzktMy0xLTEtMjE4NzQ4_8b4e6070-5b9b-475d-a02d-f9e391572042"
      unitRef="usd">46231000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEwLTEtMS0xLTIxODc0OA_01755b96-1055-42e1-be9f-40a97529281b"
      unitRef="usd">2177000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEwLTMtMS0xLTIxODc0OA_3bb157a6-64ab-4532-b87d-cd19d627c5fc"
      unitRef="usd">2092000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzExLTEtMS0xLTIxODc0OA_479429e8-b537-46d4-9b56-c6ea84549275"
      unitRef="usd">1635000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzExLTMtMS0xLTIxODc0OA_386c0a3e-eb58-48c0-9dac-ae7f15629f23"
      unitRef="usd">1548000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEyLTEtMS0xLTIxODc0OA_0995da66-8d3e-4837-8073-d07d92d7d58f"
      unitRef="usd">9947000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEyLTMtMS0xLTIxODc0OA_54dde658-d362-4f40-83f7-855d36ed4620"
      unitRef="usd">9451000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEzLTEtMS0xLTIxODc0OA_fbab9d1e-c824-4ffc-993e-d23e62e6ac52"
      unitRef="usd">2277000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzEzLTMtMS0xLTIxODc0OA_56d3db69-fea6-4344-9582-4253c3e62176"
      unitRef="usd">2059000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE0LTEtMS0xLTIxODc0OA_0282e379-0428-4018-89dc-c1a32b105b6a"
      unitRef="usd">1992000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE0LTMtMS0xLTIxODc0OA_06a429e4-5a9f-4c0e-bb6d-93b9ccc2a6a7"
      unitRef="usd">1917000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE1LTEtMS0xLTIxODc0OA_9c47650d-797e-49f6-88d8-8977bb9ac4c0"
      unitRef="usd">62320000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE1LTMtMS0xLTIxODc0OA_f5e46338-377b-4da9-8552-5da5c9a11498"
      unitRef="usd">63298000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE4LTEtMS0xLTIxODc0OA_52c3393f-6484-4623-8170-644dfaf1b89c"
      unitRef="usd">42490000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzE4LTMtMS0xLTIxODc0OA_120a0b1e-220d-4a7d-9965-f5faefdb9915"
      unitRef="usd">38086000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIwLTEtMS0xLTIxODc0OA_3d2b959d-2aa1-4cfa-9f5f-fd0212984b3f"
      unitRef="usd">968000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIwLTMtMS0xLTIxODc0OA_59a5a071-d34c-4b7a-aa1d-8ed83ebee136"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIxLTEtMS0xLTIxODc0OA_40497ea8-0ca2-4c2a-bdeb-4c08508f91ca"
      unitRef="usd">299000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIxLTMtMS0xLTIxODc0OA_2422f37b-7613-4576-a6b9-67bd2df88541"
      unitRef="usd">297000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIyLTEtMS0xLTIxODc0OA_00110dc1-d48d-400c-b05e-c9ba3a8a5f01"
      unitRef="usd">5000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIyLTMtMS0xLTIxODc0OA_df9e6645-2138-45b1-a304-1316015387c1"
      unitRef="usd">4741000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIzLTEtMS0xLTIxODc0OA_b8cc4a99-aced-40a5-a937-f766007b247e"
      unitRef="usd">4195000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzIzLTMtMS0xLTIxODc0OA_c9cf0593-f053-4f3d-b4e4-a8cb77e8d5d9"
      unitRef="usd">4543000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI0LTEtMS0xLTIxODc0OA_e997b700-5538-42b1-be99-4d6d8c97a3d3"
      unitRef="usd">47957000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI0LTMtMS0xLTIxODc0OA_e68f9ff2-7130-4995-8d62-5938911d4d45"
      unitRef="usd">48466000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI1LTEtMS0xLTIxODc0OA_2cfdf8ed-87ac-40e3-af71-a0bc53542f12"
      unitRef="usd">4626000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI1LTMtMS0xLTIxODc0OA_3d74699e-46db-4273-a91e-aab49d38aab8"
      unitRef="usd">5080000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI2LTEtMS0xLTIxODc0OA_685a7dff-3cbc-4e2f-b4e3-197bc95c0a5b"
      unitRef="usd">1387000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI2LTMtMS0xLTIxODc0OA_d890faf2-22fb-4956-bac2-ec7465450def"
      unitRef="usd">1418000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI3LTEtMS0xLTIxODc0OA_3bb443b2-5445-4163-83fe-7a74254fbd70"
      unitRef="usd">1402000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI3LTMtMS0xLTIxODc0OA_0b2e5384-969d-44f7-80e7-fc8c081f3bb5"
      unitRef="usd">1366000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI4LTEtMS0xLTIxODc0OA_560379b0-a46e-4f3f-b8d1-715bc172a237"
      unitRef="usd">6625000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI4LTMtMS0xLTIxODc0OA_bc164b80-c6fb-41fa-b1fa-fd68f04e0590"
      unitRef="usd">7220000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI5LTEtMS0xLTIxODc0OA_095d97b0-057a-4ac2-9c9f-207a7ec888be"
      unitRef="usd">1813000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzI5LTMtMS0xLTIxODc0OA_3e5db2eb-aa18-425a-bbb9-53c72e61af1e"
      unitRef="usd">1540000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMwLTEtMS0xLTIxODc0OA_246ba068-a88c-4f1f-816a-09a5e62068cc"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMwLTMtMS0xLTIxODc0OA_e61a75f0-6e41-4a4b-96e0-59fb173a84e4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzIx_6a21a9b7-18b9-4ca6-aee3-ce09b40e17b5"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzIx_ed755c36-6eee-4b74-968b-3ba545c479aa"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzM1_7e4fbc58-93af-45e1-8710-6a2c987f5b8e"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzM1_be35ffb6-aafa-42e1-a9c0-9d04ee02f506"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzU3_1483ae8b-7788-42d3-abcc-026c04c234ca"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzU3_aab1cc53-0aec-4dff-ae9e-6be0b4be9d3a"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzU3_b8bccd9b-4f5a-4a48-94e0-6ed11e2bb71b"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjE1Y2MyN2VhYzlhMzQ5NzI4NWJhNTIyZDJlZmZiYmI2XzU3_dce8669f-4860-4bd2-9ca5-b97c6d7b07d9"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTEtMS0xLTIxODc0OA_ee49b595-6464-4f2d-ab3a-12c696304f5d"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzMzLTMtMS0xLTIxODc0OA_cfb697bc-7540-489d-ac1b-876f0b8b6cd4"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzE4_7ca49d84-6322-41e8-9ed5-4ce6b0249b67"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzE4_d6cd490e-9886-4023-a30b-5c558f18f017"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzMy_908a1048-8275-479e-8233-c3c15e9cd22a"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzMy_9e2f847c-d198-45bb-93f3-3ac11ccdf9e6"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzU0_ff12431c-ce38-425c-9d38-ec20e778b2b6"
      unitRef="shares">277000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc1MWE2YTYyZWI2ZDRlYTU5MTk2NDA5OGJjYmI0MmMyXzYx_8f21e05a-2108-44b4-a035-20a94de78819"
      unitRef="shares">275000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTEtMS0xLTIxODc0OA_0b678abe-487e-41d0-8da5-215b6a0897e2"
      unitRef="usd">3000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM0LTMtMS0xLTIxODc0OA_371bb4bc-bdd1-433e-ba33-ab82fc3e60ff"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM1LTEtMS0xLTIxODc0OA_a004af86-0c7d-4698-bfea-9c5854cfc69e"
      unitRef="usd">7747000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM1LTMtMS0xLTIxODc0OA_ff1f435c-8180-4a28-a347-e24f50e5e2ee"
      unitRef="usd">7275000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM2LTEtMS0xLTIxODc0OA_5b4fff3d-1800-436e-a909-9f461123db5b"
      unitRef="usd">12295000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM2LTMtMS0xLTIxODc0OA_797dbf64-ca6c-41c1-9574-4371f8d31be3"
      unitRef="usd">9030000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM3LTEtMS0xLTIxODc0OA_675b4744-8064-45dd-a490-072bd5589702"
      unitRef="usd">-905000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM3LTMtMS0xLTIxODc0OA_fe26442c-85c8-41a9-a18d-22cb91f8223f"
      unitRef="usd">-1534000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i3bc582f275f5403289fded6bcb155630_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM5LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjgxODIzZGNiZmY1ODQwY2ViYzEyNGI4Yjk3OTllODU0XzMw_a2f6a21f-3c55-47d5-9345-2d1828d74286"
      unitRef="shares">141000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia6a1485449e34a8ea1bffd8f744aa580_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM5LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjgxODIzZGNiZmY1ODQwY2ViYzEyNGI4Yjk3OTllODU0XzM3_cb4e13ed-3326-4f7a-9437-3933ffffc927"
      unitRef="shares">130000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM5LTEtMS0xLTIxODc0OA_c6f20479-62d0-4aa4-85f0-855217a6c70a"
      unitRef="usd">20997000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzM5LTMtMS0xLTIxODc0OA_a9fce8ce-3670-4fad-a034-d4133654e862"
      unitRef="usd">17045000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQwLTEtMS0xLTIxODc0OA_77d02d91-bb8e-4e57-921f-7803d9a1c47b"
      unitRef="usd">-1857000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQwLTMtMS0xLTIxODc0OA_cf2abfa0-4ed8-4cc0-be4d-444068da7a2f"
      unitRef="usd">-2272000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQxLTEtMS0xLTIxODc0OA_4b8ac458-9934-4c78-a19c-988b29904ac5"
      unitRef="usd">367000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQxLTMtMS0xLTIxODc0OA_d11cf834-ae48-46e9-995b-68179adccdfc"
      unitRef="usd">480000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQyLTEtMS0xLTIxODc0OA_ba14187f-d0e2-4ee2-90b5-79e64e4d3eec"
      unitRef="usd">-1490000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQyLTMtMS0xLTIxODc0OA_8fa93d90-2991-4839-8282-057532989bb8"
      unitRef="usd">-1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQzLTEtMS0xLTIxODc0OA_73c76140-58c5-414e-a975-046c1cbbd4b6"
      unitRef="usd">62320000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMDkvZnJhZzo2NWUwZDI4NjQ5MmE0NDQxYWRiM2VjYTFkY2FhODc2OC90YWJsZTpmMTZkZWYwMmQwZjc0YzQyYTUzZWFhYTY3YjEzNDUzMS90YWJsZXJhbmdlOmYxNmRlZjAyZDBmNzRjNDJhNTNlYWFhNjdiMTM0NTMxXzQzLTMtMS0xLTIxODc0OA_3aac8c1c-bd23-4c6d-ba2f-48de6f34accf"
      unitRef="usd">63298000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i0a1422fa33ff4ef8be96240fe701c4a8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMS0xLTEtMjE4NzQ4_40b661af-3de8-4926-a834-59862ab71a8a"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0a1422fa33ff4ef8be96240fe701c4a8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMy0xLTEtMjE4NzQ4_8181029f-425a-49e9-bb6d-7b9ced3a8d06"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c7ce235f09242b1a7dd13dd1873da14_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtNS0xLTEtMjE4NzQ4_70a9ac42-e679-44bf-8b63-0a4dfdba3d33"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b4ad18ecc1b43159d4657ee792f26c1_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtOS0xLTEtMjE4NzQ4_03efd11f-def0-4ded-81c7-09a4b76305de"
      unitRef="usd">13022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i14f8bb56f1e4471588d3ee861bf56425_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMTEtMS0xLTIxODc0OA_470f33fa-4eee-400c-a80a-4521d411df45"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia09f86adf45346869fdfd6e2c5e84729_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMTMtMS0xLTIxODc0OA_708ea203-6db8-46ba-be09-7c7fb52c2d0e"
      unitRef="shares">110000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia09f86adf45346869fdfd6e2c5e84729_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMTUtMS0xLTIxODc0OA_9b2656b0-cd2f-4485-b95c-1143936e63a9"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28949ffb8bb2424c94e02d81ae0b5d27_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMTctMS0xLTIxODc0OA_e99ccf1e-426f-4b94-89ca-5dc89e5b844e"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56ca92db1bf347039646a68953e87fed_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMtMTktMS0xLTIxODc0OA_b9251ba3-760f-48cf-ba68-5ae3c90241c0"
      unitRef="usd">5309000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i37de8b6ee05745e3861fbe7542070721_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzQtOS0xLTEtMjE4NzQ4_6ca2e692-11e3-42ee-b4e8-971c03748d09"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i60a6fff3dabd4c79b50c2bf8f6f2c365_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzQtMTktMS0xLTIxODc0OA_716d6ae5-e9d5-436a-83e8-b27aae35af7d"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="idbe6a88a06904b1cab91937548e19519_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMS0xLTEtMjE4NzQ4_38315c6b-57aa-4fe6-9726-8e49be7aa48d"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idbe6a88a06904b1cab91937548e19519_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMy0xLTEtMjE4NzQ4_744a929c-17e3-4477-a984-21b85bf34011"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ab59611846a49f2b03ee48497e3100f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtNS0xLTEtMjE4NzQ4_b1b6e92b-e1cd-4ea7-9bf7-1f85f4d3f071"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16ef48415e2d41019530a2f69364659e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtOS0xLTEtMjE4NzQ4_c7308e61-3e94-46fb-bdf2-fe71de39a36e"
      unitRef="usd">13009000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib06de7ab957b4a4d88a689f7f6a590e7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMTEtMS0xLTIxODc0OA_fdac3293-518a-4a59-8edd-3001d992bb6e"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i3fda731c4c8243d8b5bf494fa64e80af_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMTMtMS0xLTIxODc0OA_d586fb26-8b80-4741-9a9f-2f56dcde1f27"
      unitRef="shares">110000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3fda731c4c8243d8b5bf494fa64e80af_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMTUtMS0xLTIxODc0OA_40902453-f597-4ac0-866e-89470e353c24"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic4b8982f387147d193c2d960f77258b8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMTctMS0xLTIxODc0OA_adefdf00-6e3e-4992-a493-9d72fcfdaebe"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icef2c063f0184f93894500720ce4015e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzUtMTktMS0xLTIxODc0OA_9ff9a0d8-fadd-4c74-86d8-c4f455082d1d"
      unitRef="usd">5296000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mck:StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures
      contextRef="i8551607689bb4731bc5de364f262218e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzYtMS0xLTEtMjE4NzQ4_9f17dc81-1617-4df3-b835-5c2a63b19812"
      unitRef="shares">1000000</mck:StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures
      contextRef="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzYtNS0xLTEtMjE4NzQ4_b59c4d38-6575-43ea-931d-9714ee33fb70"
      unitRef="usd">92000000</mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures
      contextRef="i4f30127a64d74d9e8d4865e42e4cbf4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzYtMTUtMS0xLTIxODc0OA_e3df3648-d2f9-4be9-87ba-be253bcda46b"
      unitRef="usd">-28000000</mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzYtMTktMS0xLTIxODc0OA_402d6c36-88c5-4bf3-bcb9-bb1a6a6f164d"
      unitRef="usd">64000000</mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzctNS0xLTEtMjE4NzQ4_20b8cc47-1a6d-4234-8f03-76f140c1eb38"
      unitRef="usd">151000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzctMTktMS0xLTIxODc0OA_897c08ea-5698-47e5-8021-1c269915593c"
      unitRef="usd">151000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i4f30127a64d74d9e8d4865e42e4cbf4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzgtMTMtMS0xLTI0MDc2Ng_297971bf-3b9d-46b7-8dc0-3d01943c6de6"
      unitRef="shares">5000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i4f30127a64d74d9e8d4865e42e4cbf4c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzgtMTUtMS0xLTI0MDc2Ng_a5a59bc7-6cdf-4575-b6f0-663cb753af1d"
      unitRef="usd">750000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzgtMTktMS0xLTI0MDc2Ng_6a9a51d2-c1f8-472c-b0dc-4474d8087bf1"
      unitRef="usd">750000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="if49d7008347c45e9a5c3670667639536_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzktOS0xLTEtMjQwNzc1_23bb877d-42ce-43d7-afbc-ead223744a4d"
      unitRef="usd">-4539000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzktMTctMS0xLTI0MDc3NQ_9b447542-c10f-4d60-93c5-1b732758ee24"
      unitRef="usd">156000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzktMTktMS0xLTI0MDc3NQ_b7a14094-dd79-4f25-ab72-ae4a710a58d5"
      unitRef="usd">-4383000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6de2dc307ac14073bdb93ae09a60b176_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzEwLTExLTEtMS0yNDA3ODQ_15b36d3e-b201-4bdf-aee3-4a19e5ae30c1"
      unitRef="usd">223000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzEwLTE5LTEtMS0yNDA3ODQ_18b65ccc-36dc-42d6-a931-2a3448ba3f8f"
      unitRef="usd">223000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzExLTAtMS0xLTI0MDc5MS90ZXh0cmVnaW9uOjYyYjYwNzlmM2YwMTRmMmQ4NzE1MTgxMDM4YmQ2YjBiXzI5_4881de47-8beb-4b30-b3ea-eef5b2d5cdfe"
      unitRef="usdPerShare">1.67</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="if49d7008347c45e9a5c3670667639536_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzExLTktMS0xLTI0MDc5MQ_2fbe4747-f689-4f8e-9f51-387550df3fd5"
      unitRef="usd">270000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzExLTE5LTEtMS0yNDA3OTE_adf574e1-db34-4859-ba2a-26b56e071cdc"
      unitRef="usd">270000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzgtMTctMS0xLTIxODc0OA_ab0787dd-e5f6-459e-ad32-0e3cef81cbd2"
      unitRef="usd">177000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzgtMTktMS0xLTIxODc0OA_73e8195a-865a-4177-ba96-d35d8a4b81be"
      unitRef="usd">177000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzExLTUtMS0xLTIyOTg2OQ_cf225fb0-b4e1-41a9-9af2-76ee8849165f"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzExLTE5LTEtMS0yMjk4Njk_8dd910d7-c6ee-45e1-b0ef-d4b27efbcb88"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockholdersEquityOther
      contextRef="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzEzLTUtMS0xLTIxODc0OA_690a4731-739e-4fed-ae43-6f399eca8726"
      unitRef="usd">-16000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="if49d7008347c45e9a5c3670667639536_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzEzLTktMS0xLTIxODc0OA_6e18e60f-b2bc-4874-9615-e207846e3bc8"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzEzLTE5LTEtMS0yMTg3NDg_1d813921-1b05-46a6-9fa5-86e6c8a253b9"
      unitRef="usd">-18000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i3c3e18a28c2e4303a930bfe449b415f1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTEtMS0xLTIxODc0OA_e9d06063-8937-4bef-9e46-7d3509528278"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c3e18a28c2e4303a930bfe449b415f1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTMtMS0xLTIxODc0OA_7d18c0f6-1dbf-4de0-9999-9063f69b3a5a"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icd2b75e00f334c31915664ac94e7674e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTUtMS0xLTIxODc0OA_32f4e5c8-e689-4045-b2e1-9952ac1795e2"
      unitRef="usd">6925000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73dc7887d5ec4c559ba7ed149b2a2e5c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTktMS0xLTIxODc0OA_8ac1622d-b8d4-46b9-9e6f-b3143385489f"
      unitRef="usd">8202000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i47e91f2d45c04afe94f7d67b691dde7e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTExLTEtMS0yMTg3NDg_b76d4059-ce3c-409d-85ff-20340c7d41dd"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ib6e648d6891241edbef964d4d9ee910a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTEzLTEtMS0yMTg3NDg_1fd74746-ce6e-4c6f-8fab-e777387749ec"
      unitRef="shares">115000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib6e648d6891241edbef964d4d9ee910a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTE1LTEtMS0yMTg3NDg_74e45f6e-8024-4b57-8f8f-4ebf37c31f62"
      unitRef="usd">-13670000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i05b7ccb4f8144bea8f3d6c3af844c49d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTE3LTEtMS0yMTg3NDg_8bec0339-29d3-476c-9cc6-3c59aff38461"
      unitRef="usd">196000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE0LTE5LTEtMS0yMTg3NDg_4b34dc21-6f82-457d-b444-b826c4a535ba"
      unitRef="usd">175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mck:StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures
      contextRef="i183ca81b5799440d9119d0fe988e65c3_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE1LTEtMS0xLTIxODc0OA_9e718dbb-7349-4dcb-a4f3-6b8b15f9fce6"
      unitRef="shares">2000000</mck:StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures
      contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE1LTUtMS0xLTIxODc0OA_d7032f8c-d58f-4cb6-8256-cbb0643657b6"
      unitRef="usd">220000000</mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures
      contextRef="i4def4e91aef84e1483b875342987eb63_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE1LTE1LTEtMS0yMTg3NDg_4954f00a-7cc3-458f-a796-6525a4258a5b"
      unitRef="usd">-71000000</mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE1LTE5LTEtMS0yMTg3NDg_2f967fe9-feac-4633-be55-23cd56ef50fa"
      unitRef="usd">149000000</mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE2LTUtMS0xLTIxODc0OA_cf68c940-bbe7-4798-b70d-3db1a8c978eb"
      unitRef="usd">154000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE2LTE5LTEtMS0yMTg3NDg_f1a5c28a-d1df-4329-b0ea-4f88b5c0847b"
      unitRef="usd">154000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTUtMS0xLTI0MDgwMg_38add395-8ed2-4bea-bce9-d1d86a7cc5b3"
      unitRef="usd">204000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i4def4e91aef84e1483b875342987eb63_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTEzLTEtMS0yNDA4MDI_6708cf22-e59a-43c6-9ba2-779d560cba73"
      unitRef="shares">15000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i4def4e91aef84e1483b875342987eb63_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTE1LTEtMS0yNDA4MDI_c60620e2-6db0-45dc-af3a-65f9bae8f151"
      unitRef="usd">3304000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTE5LTEtMS0yNDA4MDI_cfd0f24d-5d7e-4acd-b907-42374b1f8ca6"
      unitRef="usd">3508000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i45aab0fb88544a5484bbea268be3db79_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE5LTktMS0xLTI0MDgwNQ_5bd0b612-1ff4-4695-a06c-48fe5c612fc0"
      unitRef="usd">1114000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE5LTE3LTEtMS0yNDA4MDU_134e6b9b-f063-4d22-a55d-f576fc4a17b5"
      unitRef="usd">165000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE5LTE5LTEtMS0yNDA4MDU_d1cc03c8-b547-4997-870e-686e970ac551"
      unitRef="usd">1279000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i018191f728124dca8ee428ea5cf8cef8_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIwLTExLTEtMS0yNDA4MDg_5a8071c2-819e-47c8-b540-5e2bf00e6eff"
      unitRef="usd">116000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIwLTE3LTEtMS0yNDA4MDg_ddb7e835-8a45-4be4-adb9-c1d687e78154"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIwLTE5LTEtMS0yNDA4MDg_b0eca1e3-2343-48ac-90d9-668f234daa45"
      unitRef="usd">112000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIxLTAtMS0xLTI0MDgxMi90ZXh0cmVnaW9uOmM2MTBjZWZhMWE5MTRmM2Q5ZDc0OTZjMjNjMDlkYjRlXzI5_548196c8-c5e1-4fd1-ae10-c48d308b4901"
      unitRef="usdPerShare">1.83</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i45aab0fb88544a5484bbea268be3db79_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIxLTktMS0xLTI0MDgxMg_00bb0661-bab7-472a-9cd4-722dc9bcf8c9"
      unitRef="usd">279000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIxLTE5LTEtMS0yNDA4MTI_847c0a73-337a-47f5-9689-8a144b097af3"
      unitRef="usd">279000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE3LTE3LTEtMS0yMTg3NDg_79933832-6750-467d-a067-d2c82035cead"
      unitRef="usd">155000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE3LTE5LTEtMS0yMTg3NDg_2d9ff000-7459-4146-8b89-a449d5799bc6"
      unitRef="usd">155000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTUtMS0xLTI0MDgyNQ_768289ad-ae4f-43a4-8cd1-29ac124be9e8"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i018191f728124dca8ee428ea5cf8cef8_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTExLTEtMS0yNDA4MjU_57e92414-cec3-4967-a505-c68c8b5e1d82"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTE5LTEtMS0yNDA4MjU_ae30dcef-57e2-4043-be64-5a9df114af0d"
      unitRef="usd">8000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTE3LTEtMS0yNDA4MzM_11da9b54-4cbd-4eac-9e90-029969c39f6a"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTE5LTEtMS0yNDA4MzM_de438ec7-fdc1-48e4-9b31-ea2d4c61f645"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTE3LTEtMS0yMTg3NDg_6e1088cf-d8de-42d9-a980-523ec1339e77"
      unitRef="usd">7000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzE4LTE5LTEtMS0yMTg3NDg_0fd4f48d-769e-4798-8035-33ae67867793"
      unitRef="usd">7000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <us-gaap:StockholdersEquityOther
      contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTUtMS0xLTIxODc0OA_5fd2a01d-3db0-47d7-86b7-d25b5e2cade9"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i45aab0fb88544a5484bbea268be3db79_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTktMS0xLTIxODc0OA_58d867cd-7e57-4b11-a913-c2dd8c1aad7c"
      unitRef="usd">7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTE3LTEtMS0yMTg3NDg_e0398f85-9bbe-41e1-9c0f-1d875dec257d"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzIzLTE5LTEtMS0yMTg3NDg_fb4e0be9-c104-4ae2-9d3c-94745095998b"
      unitRef="usd">7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i5ddf4f8a62464df1938e09cf326c73ea_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTEtMS0xLTIxODc0OA_ec1ff7e4-78a5-4b21-9df7-df55763aae3d"
      unitRef="shares">275000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ddf4f8a62464df1938e09cf326c73ea_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTMtMS0xLTIxODc0OA_d8064fdb-5086-4399-acae-ae1282c1e49a"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i229bafbff863466083e1c27c4d7dfc34_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTUtMS0xLTIxODc0OA_6ddf95a0-9ed9-4ece-a7df-8457dfdeeb0b"
      unitRef="usd">7275000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff055f45df5945548e9f06839bf74bac_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTktMS0xLTIxODc0OA_019b78b8-11a1-4456-86bb-db6dc338545f"
      unitRef="usd">9030000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea824d5b394948b6bd119948e0fe3df9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTExLTEtMS0yMTg3NDg_17937b89-d67e-4acd-96d6-0225ebc86b8a"
      unitRef="usd">-1534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia6a1485449e34a8ea1bffd8f744aa580_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTEzLTEtMS0yMTg3NDg_518c914f-ca30-4d53-8ba8-979234e8d8f7"
      unitRef="shares">130000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6a1485449e34a8ea1bffd8f744aa580_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTE1LTEtMS0yMTg3NDg_65f067c1-7313-4930-817d-5d467f8556bd"
      unitRef="usd">-17045000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i967edbc39aee4ecb80a07170518c493d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTE3LTEtMS0yMTg3NDg_83a1e93f-48fb-42fb-a20b-c4be8162b579"
      unitRef="usd">480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI0LTE5LTEtMS0yMTg3NDg_e35aabac-e793-406a-b728-66da8f111f26"
      unitRef="usd">-1792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mck:StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures
      contextRef="i3ace641432ca4f1aab983fa4bd125d85_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI1LTEtMS0xLTIxODc0OA_acb400b0-3fe8-4192-98d5-34465056eedb"
      unitRef="shares">2000000</mck:StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures
      contextRef="i3ace641432ca4f1aab983fa4bd125d85_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI1LTMtMS0xLTIxODc0OA_394f8b60-0908-4664-a6c5-4dc505cedafd"
      unitRef="usd">1000000</mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures
      contextRef="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI1LTUtMS0xLTIxODc0OA_d3f25020-325f-4e1c-863f-c25a8d7ec1a7"
      unitRef="usd">163000000</mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures
      contextRef="i06314da3128a4c098170cd700e3e914e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI1LTE1LTEtMS0yMTg3NDg_be3a4c34-1536-497c-8ba2-9bf8bdc2a6fe"
      unitRef="usd">-160000000</mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures>
    <mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI1LTE5LTEtMS0yMTg3NDg_73987a1c-4d07-4d69-9137-e35013d47378"
      unitRef="usd">4000000</mck:StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI2LTUtMS0xLTIxODc0OA_70b60515-48f0-4de1-9448-fa952aace841"
      unitRef="usd">161000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI2LTE5LTEtMS0yMTg3NDg_00709498-013a-481f-9ceb-5f2bedf0f8fa"
      unitRef="usd">161000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMwLTUtMS0xLTI0MDg0MA_f7c12ade-5efe-4284-bd4c-94809f1644ce"
      unitRef="usd">-127000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i06314da3128a4c098170cd700e3e914e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMwLTEzLTEtMS0yNDA4NDA_073c7dd8-7b3a-4611-9063-16ff99e85588"
      unitRef="shares">11000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i06314da3128a4c098170cd700e3e914e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMwLTE1LTEtMS0yNDA4NDA_a91e1d79-09b3-4fa8-b64f-9c3371cd0359"
      unitRef="usd">3792000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMwLTE5LTEtMS0yNDA4NDA_4a11e74b-fdf5-4a43-90e6-0dbfcee9ee1f"
      unitRef="usd">3665000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i52d6cbef9c014a779d83f8e789f001b6_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMxLTktMS0xLTI0MDg0Nw_83079c98-7eaa-4a8a-8742-5818e5297135"
      unitRef="usd">3560000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMxLTE3LTEtMS0yNDA4NDc_d39c3ccf-6ae1-4679-91a9-09439dfc18f3"
      unitRef="usd">162000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMxLTE5LTEtMS0yNDA4NDc_13ca4161-491d-4521-b127-417a21231b1e"
      unitRef="usd">3722000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i284da6d569754ff58e9c0e3c01fd1f5a_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMyLTExLTEtMS0yNDA4NTQ_5e27d2a8-1d6b-4a8c-ba80-4ac918ad9c7b"
      unitRef="usd">629000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMyLTE3LTEtMS0yNDA4NTQ_0b8e4746-b285-42a5-82e7-e2c0d66633c9"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMyLTE5LTEtMS0yNDA4NTQ_e6025318-a247-420d-9592-05eb6815ba53"
      unitRef="usd">673000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMzLTAtMS0xLTI0MDg2MS90ZXh0cmVnaW9uOjM4NjFhYzBlMTk2NDRkODk4ZDQzN2JhNGFiMWU0YzdiXzMw_7dc11172-0710-4406-b02c-a917c9bc80a2"
      unitRef="usdPerShare">2.09</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i52d6cbef9c014a779d83f8e789f001b6_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMzLTktMS0xLTI0MDg2MQ_a060341e-2364-4cf6-9169-b1781161791d"
      unitRef="usd">296000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMzLTE5LTEtMS0yNDA4NjE_2e2f9cd2-b522-4ac1-b492-2423cdc950fc"
      unitRef="usd">296000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI3LTE3LTEtMS0yMTg3NDg_250688e8-425c-4eb1-90fc-a94140726c53"
      unitRef="usd">150000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzI3LTE5LTEtMS0yMTg3NDg_c54e2a11-e656-4666-8ccb-0a8bfe165ba1"
      unitRef="usd">150000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMzLTE3LTEtMS0yMTg3NDg_8b297925-8e7c-4e93-bf90-06cd2bdfde4f"
      unitRef="usd">5000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <mck:NoncontrollingInterestDecreaseFromReclassificationToLiability
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzMzLTE5LTEtMS0yMTg3NDg_c11165cb-1fdb-4536-bd96-257a75b6ca96"
      unitRef="usd">5000000</mck:NoncontrollingInterestDecreaseFromReclassificationToLiability>
    <mck:FormationOfBusiness
      contextRef="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM4LTUtMS0xLTIyOTk2MA_d360ca65-551e-4684-b117-39f6f1df594d"
      unitRef="usd">22000000</mck:FormationOfBusiness>
    <mck:FormationOfBusiness
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM4LTE3LTEtMS0yMjk5NjA_29e3f87e-0887-41bb-972d-a33f63e97d1c"
      unitRef="usd">225000000</mck:FormationOfBusiness>
    <mck:FormationOfBusiness
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM4LTE5LTEtMS0yMjk5NjA_bd9cd0d8-7235-4ff7-b764-8df5f45d0d8f"
      unitRef="usd">247000000</mck:FormationOfBusiness>
    <mck:DerecognitionOfNoncontrollingInterests
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM5LTE3LTEtMS0yMjk5NjA_0ed7b278-d37e-4bc6-8365-dbb3476a11af"
      unitRef="usd">382000000</mck:DerecognitionOfNoncontrollingInterests>
    <mck:DerecognitionOfNoncontrollingInterests
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM5LTE5LTEtMS0yMjk5NjA_b71689de-86e9-48ee-84f8-cf0279639c30"
      unitRef="usd">382000000</mck:DerecognitionOfNoncontrollingInterests>
    <us-gaap:StockholdersEquityOther
      contextRef="i3ead13a541084c91b9dddba0a7aef574_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM1LTUtMS0xLTIxODc0OA_22cb2e9c-9b9c-4e0b-bfea-cde59a9ccde9"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i52d6cbef9c014a779d83f8e789f001b6_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM1LTktMS0xLTIxODc0OA_710076a0-3f82-4031-a63f-9fb6edfac1ea"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM1LTE3LTEtMS0yMTg3NDg_b0300ac8-523a-41d9-80d5-666b5172dd09"
      unitRef="usd">7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM1LTE5LTEtMS0yMTg3NDg_09f5a147-9c14-4089-9858-9082b7900c57"
      unitRef="usd">7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="id8a72099ceda422ba14d79222a77f39e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTEtMS0xLTIxODc0OA_e4f1c849-ce03-4531-ab4a-2428379ea369"
      unitRef="shares">277000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id8a72099ceda422ba14d79222a77f39e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTMtMS0xLTIxODc0OA_04ef7eb6-24e7-416b-b72e-adf5a0627e2a"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ebb46144e314022b145d5a691b3751b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTUtMS0xLTIxODc0OA_e0402492-04c1-49a5-8986-f5cf707fc667"
      unitRef="usd">7747000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f0fe405ebb24cc3b0ba09f049f2c10b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTktMS0xLTIxODc0OA_28b51499-b08c-4b58-8bb9-53787aa74121"
      unitRef="usd">12295000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i389a9bd705fb43da948f7f435028f032_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTExLTEtMS0yMTg3NDg_41892315-1c24-4e00-8fad-c479ae42a0e9"
      unitRef="usd">-905000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i3bc582f275f5403289fded6bcb155630_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTEzLTEtMS0yMTg3NDg_df6753e9-6451-4df2-83ec-a17243287c09"
      unitRef="shares">141000000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3bc582f275f5403289fded6bcb155630_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTE1LTEtMS0yMTg3NDg_07a8a1d7-2217-4c67-98c3-5d54a2b4d602"
      unitRef="usd">-20997000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icf262331a9f54dcaa1ab7d2f24876767_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTE3LTEtMS0yMTg3NDg_b5510654-489c-489a-acb2-7383f7399f71"
      unitRef="usd">367000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTIvZnJhZzowNDZhZjRiMjIyY2E0ZWYwOGE0ZGZmNTM3MmM3YTdiYy90YWJsZTphMTJlNzNmYTJiZWY0MjM2YWUxM2YxNmU0Njg0NjY3ZS90YWJsZXJhbmdlOmExMmU3M2ZhMmJlZjQyMzZhZTEzZjE2ZTQ2ODQ2NjdlXzM2LTE5LTEtMS0yMTg3NDg_7e375f59-2266-4c06-8cc7-a1cf8a789fe6"
      unitRef="usd">-1490000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMtMS0xLTEtMjE4NzQ4_d88c252c-de3e-4c03-9b94-438a756251b5"
      unitRef="usd">3722000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMtMy0xLTEtMjE4NzQ4_44a4a69c-1ebe-4fbc-9fb0-3c6fa4eb85ad"
      unitRef="usd">1287000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMtNS0xLTEtMjE4NzQ4_a1ea6081-53dc-44fb-a3e1-956886b215bc"
      unitRef="usd">-4340000000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUtMS0xLTEtMjE4NzQ4_e16ca416-aea7-4ea8-8077-6738f3825168"
      unitRef="usd">248000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUtMy0xLTEtMjE4NzQ4_f9d0cb99-38fd-4d40-8b13-8f9dd33859e1"
      unitRef="usd">279000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUtNS0xLTEtMjE4NzQ4_b235ab6d-2c5d-4541-9fab-52e188f33054"
      unitRef="usd">321000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzYtMS0xLTEtMjE4NzQ4_faf82b73-520b-4507-9762-9218f2bd37d4"
      unitRef="usd">360000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzYtMy0xLTEtMjE4NzQ4_fe1d4b6c-8897-4971-b303-9edc29cf569a"
      unitRef="usd">481000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzYtNS0xLTEtMjE4NzQ4_f87e595f-f11b-4d6d-b5ad-1267ea493484"
      unitRef="usd">566000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzctMS0xLTEtMjE4NzQ4_d743960d-be0a-4208-9228-57b26cd1aaad"
      unitRef="usd">72000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzctMy0xLTEtMjE4NzQ4_0ac1318d-d00e-4a5c-8664-1847c969a29d"
      unitRef="usd">175000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzctNS0xLTEtMjE4NzQ4_06277085-a77c-4b97-a0d8-76ff85e9672e"
      unitRef="usd">242000000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzktMS0xLTEtMjE4NzQ4_7e692a44-2ed5-4a3e-a396-ec55b191db7b"
      unitRef="usd">20000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzktMy0xLTEtMjE4NzQ4_c71642cc-c773-4d54-acad-9ba0b790b62e"
      unitRef="usd">-34000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzktNS0xLTEtMjE4NzQ4_684f3a60-ca47-4710-b615-5d41eaa2b2e6"
      unitRef="usd">908000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEwLTEtMS0xLTIxODc0OA_c24f16a8-9190-4ef5-a1a2-cd29ced175f2"
      unitRef="usd">1000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEwLTMtMS0xLTIxODc0OA_bb47e749-6717-4750-b720-d73e3e96647d"
      unitRef="usd">-23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEwLTUtMS0xLTIxODc0OA_01a5e6e7-824c-4a71-8a4a-02df4ecaf491"
      unitRef="usd">-38000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:OperatingLeaseExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzExLTEtMS0xLTIxODc0OA_bf764cd2-2d4c-420b-9d62-a3d297fd1e5a"
      unitRef="usd">249000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzExLTMtMS0xLTIxODc0OA_65ba7a7d-811e-40d8-8d31-4bef02a44f66"
      unitRef="usd">241000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzExLTUtMS0xLTIxODc0OA_6a235ca7-8991-41c7-b191-d0d115145676"
      unitRef="usd">334000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEyLTEtMS0xLTIxODc0OA_a40fde1a-8070-4c02-9603-a2a616dbb447"
      unitRef="usd">211000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEyLTMtMS0xLTIxODc0OA_1a6d08e3-e497-4bbf-b61c-07242c697729"
      unitRef="usd">132000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEyLTUtMS0xLTIxODc0OA_4a84fd51-7489-444e-831f-14175b81b889"
      unitRef="usd">9000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEzLTEtMS0xLTIxODc0OA_09c828c5-8fde-4bde-99f0-c735e559b9ed"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEzLTMtMS0xLTIxODc0OA_0980e3f5-005f-4e56-8c04-afe5a57b6353"
      unitRef="usd">1509000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzEzLTUtMS0xLTIxODc0OA_04555632-685a-4d89-b0d5-6dd08c2efd53"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE0LTEtMS0xLTIxODc0OA_a245c69e-f43b-45c1-ac73-0ec774e66272"
      unitRef="usd">-298000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE0LTMtMS0xLTIxODc0OA_241203d9-3ada-4822-aef5-a7e259e059e6"
      unitRef="usd">-501000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE0LTUtMS0xLTIxODc0OA_6d174d93-fb49-4fe0-84d0-f7aa7baa32ea"
      unitRef="usd">-188000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE2LTEtMS0xLTIxODc0OA_f7767a3b-e863-4e96-bc42-8174b9bfc7ed"
      unitRef="usd">1082000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE2LTMtMS0xLTIxODc0OA_e8f433c1-553f-43d1-a36a-406767e198d5"
      unitRef="usd">1843000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE2LTUtMS0xLTIxODc0OA_28c595ec-aae5-4ec6-8e06-9ced08ae6b9d"
      unitRef="usd">-1145000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE3LTEtMS0xLTIxODc0OA_d8f0d1fb-4332-4abb-a1ce-3e6f955d70fd"
      unitRef="usd">1259000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE3LTMtMS0xLTIxODc0OA_eadfcb37-01ac-4241-876e-01a350b35111"
      unitRef="usd">1169000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE3LTUtMS0xLTIxODc0OA_013f6cb1-05fd-4de6-9077-e2834e001a5f"
      unitRef="usd">2276000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE4LTEtMS0xLTIxODc0OA_2c8794d5-44f0-43c9-a865-746e371767f0"
      unitRef="usd">3788000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE4LTMtMS0xLTIxODc0OA_ed233475-3326-41ff-a359-10f5cd662919"
      unitRef="usd">2802000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE4LTUtMS0xLTIxODc0OA_3d6088ca-6a19-4ed1-94c9-436c85471bd7"
      unitRef="usd">1267000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE5LTEtMS0xLTIxODc0OA_1fbf2aa1-490a-48c2-a567-9fbd2823281f"
      unitRef="usd">-338000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE5LTMtMS0xLTIxODc0OA_f409f7be-5a58-4922-a70e-546b07ebf9b8"
      unitRef="usd">-356000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzE5LTUtMS0xLTIxODc0OA_525d433c-16c7-481d-84a4-714b39986cfb"
      unitRef="usd">-362000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIwLTEtMS0xLTIxODc0OA_1659978b-09ab-4811-8db9-b704ffd12b17"
      unitRef="usd">363000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIwLTMtMS0xLTIxODc0OA_ddaa2ccc-8086-44d3-9431-16bae62c936d"
      unitRef="usd">243000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIwLTUtMS0xLTIxODc0OA_10b69cdf-92b2-4aa2-8f40-6ee8c06adc6c"
      unitRef="usd">-166000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIxLTEtMS0xLTIxODc0OA_f2186e29-b1b6-4a89-b260-fd8f4e661661"
      unitRef="usd">-1088000000</mck:IncreaseDecreaseInLitigationReserve>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIxLTMtMS0xLTIxODc0OA_63160e85-63da-4cbf-a745-1624debcd197"
      unitRef="usd">199000000</mck:IncreaseDecreaseInLitigationReserve>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIxLTUtMS0xLTIxODc0OA_075c3b6e-710f-4050-ab0a-29b2683ac25b"
      unitRef="usd">8067000000</mck:IncreaseDecreaseInLitigationReserve>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIyLTEtMS0xLTIxODc0OA_a973c7ae-208a-4220-960f-87ba1a4ae8a5"
      unitRef="usd">-56000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIyLTMtMS0xLTIxODc0OA_b664fb1d-afca-47ed-a33e-9db0343d1e26"
      unitRef="usd">-206000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIyLTUtMS0xLTIxODc0OA_3b60e46e-4e84-4f2c-9ce1-8691e821f31b"
      unitRef="usd">-511000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIzLTEtMS0xLTIxODc0OA_7ba85f74-b46e-4593-8f02-b41871396b78"
      unitRef="usd">5159000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIzLTMtMS0xLTIxODc0OA_c717cb1f-4375-421a-8e02-debc3a8268dd"
      unitRef="usd">4434000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzIzLTUtMS0xLTIxODc0OA_3609a9d6-ac70-4def-9d46-c55f2dbc0654"
      unitRef="usd">4542000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI2LTEtMS0xLTIxODc0OA_34f8241f-9f34-4694-9fef-0291097b7aee"
      unitRef="usd">390000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI2LTMtMS0xLTIxODc0OA_4d2e95f4-3081-40bc-9599-9bd2c1c71172"
      unitRef="usd">388000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI2LTUtMS0xLTIxODc0OA_28d0a5c8-50b5-42f0-934d-d57fa94fb1d1"
      unitRef="usd">451000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI3LTEtMS0xLTIxODc0OA_ed7ea2f1-afbc-459e-8ad2-32307f275111"
      unitRef="usd">168000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI3LTMtMS0xLTIxODc0OA_ba09415c-901f-46d0-b09d-ff1fba4d31f9"
      unitRef="usd">147000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI3LTUtMS0xLTIxODc0OA_61710bda-869c-43f6-ab17-de425043a25f"
      unitRef="usd">190000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI4LTEtMS0xLTIxODc0OA_6bae67cf-2009-4be4-8d69-b58c782fc2b0"
      unitRef="usd">867000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI4LTMtMS0xLTIxODc0OA_f6f0809b-fad3-482f-bdbc-625ec4c84b8a"
      unitRef="usd">6000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI4LTUtMS0xLTIxODc0OA_856a08f9-a8bf-42bd-8ae2-a72a7044ad09"
      unitRef="usd">35000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI5LTEtMS0xLTIxODc0OA_12ad615d-83d5-4b75-996c-b5af18559c19"
      unitRef="usd">1077000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI5LTMtMS0xLTIxODc0OA_a504a515-0e34-458d-82dd-bbb7b7f28be1"
      unitRef="usd">578000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzI5LTUtMS0xLTIxODc0OA_20b36861-fcd0-4fca-8618-d547761298ef"
      unitRef="usd">400000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMwLTEtMS0xLTIxODc0OA_484c19a0-a0a4-43bc-b8c9-d2ddcaccb9f4"
      unitRef="usd">194000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMwLTMtMS0xLTIxODc0OA_b2f86877-0a3e-46f7-aab1-53c2d8e2c794"
      unitRef="usd">126000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMwLTUtMS0xLTIxODc0OA_e3312af9-43dc-4989-9e6b-192598e6e70d"
      unitRef="usd">139000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMxLTEtMS0xLTIxODc0OA_4311a248-9dc1-481e-964b-19745c8a7124"
      unitRef="usd">-542000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMxLTMtMS0xLTIxODc0OA_63cdf8a4-63e5-445c-8c9e-e37a0b122903"
      unitRef="usd">-89000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzMxLTUtMS0xLTIxODc0OA_32ecc65d-963e-4e19-82b6-9d813a1205a4"
      unitRef="usd">-415000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM0LTEtMS0xLTIxODc0OA_ae7eda42-166e-4187-ba54-8f164446dc58"
      unitRef="usd">8450000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM0LTMtMS0xLTIxODc0OA_043fd378-b860-45e4-a05f-5870a596b895"
      unitRef="usd">11192000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM0LTUtMS0xLTIxODc0OA_01a61ffd-1066-4cd2-af5d-bf420d058a0b"
      unitRef="usd">6323000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM1LTEtMS0xLTIxODc0OA_8997378c-fc4e-4e46-a020-1cb224970a81"
      unitRef="usd">8450000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM1LTMtMS0xLTIxODc0OA_a91d775b-613e-4dd0-9580-3d274ac8cdb6"
      unitRef="usd">11192000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM1LTUtMS0xLTIxODc0OA_f5f59712-cdfb-40b5-bec0-f567bf8dfa31"
      unitRef="usd">6323000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM2LTEtMS0xLTIxODc0OA_3fe8bb72-b5f6-4a12-b999-cd223fe49a4f"
      unitRef="usd">997000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM2LTMtMS0xLTIxODc0OA_a59331d8-4a30-4c4c-a8f3-f17d26e7aa5d"
      unitRef="usd">498000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM2LTUtMS0xLTIxODc0OA_18df11f5-e242-4ee7-9c8c-3b24713f6c91"
      unitRef="usd">500000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM3LTEtMS0xLTIxODc0OA_a43a0bb6-727f-44ad-862f-7f4ba81bf6b2"
      unitRef="usd">1274000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM3LTMtMS0xLTIxODc0OA_e2f71874-8e37-484c-b7fa-d17a2780e5cd"
      unitRef="usd">1648000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM3LTUtMS0xLTIxODc0OA_5cb59487-f092-4275-bb2d-41a51344b86e"
      unitRef="usd">1040000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM4LTEtMS0xLTIxODc0OA_1b136f0d-0e0e-4dde-84a6-1561fe894e8e"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM4LTMtMS0xLTIxODc0OA_ebcef6d9-e63c-4dbf-adf5-cd5916031e94"
      unitRef="usd">184000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzM4LTUtMS0xLTIxODc0OA_1f3ea4cf-08ac-47a8-a60e-35d3b87f0f30"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQwLTEtMS0xLTIxODc0OA_73550085-5f45-4892-b7bb-044daa2ff511"
      unitRef="usd">163000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQwLTMtMS0xLTIxODc0OA_db25c7a3-c31a-4913-a894-b4dd94b17243"
      unitRef="usd">220000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQwLTUtMS0xLTIxODc0OA_31eed7a5-9c29-4871-af8a-355112792fec"
      unitRef="usd">92000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQxLTEtMS0xLTIxODc0OA_220506b5-811c-4ad3-a7f9-6a02aa98a6f1"
      unitRef="usd">3638000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQxLTMtMS0xLTIxODc0OA_442768a4-2df7-4898-a9e8-b6c1e1fecefa"
      unitRef="usd">3516000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQxLTUtMS0xLTIxODc0OA_62f07ce8-164d-4ba2-80c6-6b9c578e4072"
      unitRef="usd">742000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQyLTEtMS0xLTIxODc0OA_afddb713-9096-40b1-93bc-39d6a90fe110"
      unitRef="usd">292000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQyLTMtMS0xLTIxODc0OA_53c492e9-19cf-4822-8b96-79df79d0f462"
      unitRef="usd">277000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQyLTUtMS0xLTIxODc0OA_14802659-eaed-4307-9a3a-10b6698e8556"
      unitRef="usd">276000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQzLTEtMS0xLTIxODc0OA_0e1c6dbd-0a64-404e-bcc0-e78f750b1ebd"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQzLTMtMS0xLTIxODc0OA_1af9ad66-2839-46c4-86e8-59787efb9210"
      unitRef="usd">1031000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQzLTUtMS0xLTIxODc0OA_7dbb9538-55b2-4b82-90a2-f119a287a05b"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ0LTEtMS0xLTIxODc0OA_6fe3e27b-a671-42a9-ae64-1b219cef6ed7"
      unitRef="usd">-324000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ0LTMtMS0xLTIxODc0OA_323303fb-fcf4-422d-9cb9-0c5bdc70c88d"
      unitRef="usd">-383000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ0LTUtMS0xLTIxODc0OA_71454ddc-6c02-419e-b3df-0f8687a13502"
      unitRef="usd">-178000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ1LTEtMS0xLTIxODc0OA_efaec1dc-3863-4739-a663-068e409562bc"
      unitRef="usd">-4368000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ1LTMtMS0xLTIxODc0OA_b941a87a-9de0-43c7-931b-aa2ff10382b0"
      unitRef="usd">-6321000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ1LTUtMS0xLTIxODc0OA_bd76297a-0f3e-4eff-84a8-3e6b4cee8bad"
      unitRef="usd">-1693000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ2LTEtMS0xLTIxODc0OA_38ec464e-144d-4ccd-b581-2b1b83f075c4"
      unitRef="usd">25000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ2LTMtMS0xLTIxODc0OA_d0d1c16e-16ef-4360-b32f-27d2aed68552"
      unitRef="usd">55000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ2LTUtMS0xLTIxODc0OA_6340a5ac-4d92-4434-9ae4-8af8270902b5"
      unitRef="usd">-61000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ3LTEtMS0xLTIxODc0OA_feb0daab-0162-4f45-8aa9-43a9ed6f96c3"
      unitRef="usd">470000000</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ3LTMtMS0xLTIxODc0OA_abb94914-6e08-4068-b625-7045cfc11a3e"
      unitRef="usd">-540000000</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ3LTUtMS0xLTIxODc0OA_7bf40982-3e05-46a2-b700-dad0e6b5931e"
      unitRef="usd">0</mck:CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ4LTEtMS0xLTIxODc0OA_dd1d9a8b-eefc-463b-9a0d-a0e87531ee9a"
      unitRef="usd">744000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ4LTMtMS0xLTIxODc0OA_08ad9438-7324-407a-934e-679533dafceb"
      unitRef="usd">-2461000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ4LTUtMS0xLTIxODc0OA_935e43e0-d704-4440-8c6d-3c5c57254455"
      unitRef="usd">2373000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ5LTEtMS0xLTIxODc0OA_a48ea3e3-51b9-42b8-9952-d1e160cc5abb"
      unitRef="usd">3935000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ5LTMtMS0xLTIxODc0OA_a5740763-2889-44a3-81f7-3717ff987d7d"
      unitRef="usd">6396000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i56ca92db1bf347039646a68953e87fed_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzQ5LTUtMS0xLTIxODc0OA_d6c39dd4-2949-44d3-b0d1-310a1f7344a6"
      unitRef="usd">4023000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUwLTEtMS0xLTIxODc0OA_78225560-b673-4a68-a969-9c0c68815486"
      unitRef="usd">4679000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUwLTMtMS0xLTIxODc0OA_6ecbe39d-1263-4223-81e9-ff6c2974f4be"
      unitRef="usd">3935000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUwLTUtMS0xLTIxODc0OA_e26262b7-2fce-40fa-bf96-b2c2f5aa2435"
      unitRef="usd">6396000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUxLTEtMS0xLTIxODc0OA_8054d5dd-07a8-4aa2-be13-b48008a0340f"
      unitRef="usd">1000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUxLTMtMS0xLTIxODc0OA_1566b8b9-e80b-40ad-8097-f4cbcb51a17e"
      unitRef="usd">403000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUxLTUtMS0xLTIxODc0OA_afdf631f-2a86-4a56-a08f-fe1210b4268c"
      unitRef="usd">118000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUzLTEtMS0xLTIxODc0OA_d5008e4d-7e88-463e-9262-5c8849397b48"
      unitRef="usd">4678000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUzLTMtMS0xLTIxODc0OA_3152903f-852c-4ab2-86c4-c1fdb021f44d"
      unitRef="usd">3532000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzUzLTUtMS0xLTIxODc0OA_26879216-61d2-4ea5-a1cd-53791d92da48"
      unitRef="usd">6278000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU3LTEtMS0xLTIxODc0OA_1aa53046-f2fe-48e7-ac43-87aff0609300"
      unitRef="usd">224000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU3LTMtMS0xLTIxODc0OA_af97bdca-a8e3-47a9-88e7-de6c14eac0f0"
      unitRef="usd">186000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU3LTUtMS0xLTIxODc0OA_d19d4039-e9ea-4e4d-8b9f-e8dbc406e5cc"
      unitRef="usd">220000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU4LTEtMS0xLTIxODc0OA_16cac791-f0ec-4f2e-ab0a-5e2bde0f1435"
      unitRef="usd">562000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU4LTMtMS0xLTIxODc0OA_d1b5b165-5b0c-47b1-9d21-4d67bdeda5ec"
      unitRef="usd">359000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMTUvZnJhZzozOTc0ZGFkNjE2OWM0NWNmYWMyMWUyOTk4MTc0ZDBmOC90YWJsZToyYWQwNDhkYTM3ZmM0ZGRmYWViNzU3Nzk1Y2QwNjAyYi90YWJsZXJhbmdlOjJhZDA0OGRhMzdmYzRkZGZhZWI3NTc3OTVjZDA2MDJiXzU4LTUtMS0xLTIxODc0OA_1965e80d-a4ff-43e2-96ba-4d592afc0b9d"
      unitRef="usd">379000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDEy_df886772-4b56-4c64-9135-592e7b8e84be">Significant Accounting Policies &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: McKesson Corporation (&#x201c;McKesson,&#x201d; or the &#x201c;Company,&#x201d;) is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson partners with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#x201c;RxTS&#x201d;), Medical-Surgical Solutions, and International. Refer to Financial Note 20, &#x201c;Segments of Business,&#x201d; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;GAAP&#x201d;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control, but instead has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal Period: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Certain prior period amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (the &#x201c;IR Act&#x201d;). Among other provisions, the IR Act includes a 15% corporate minimum tax, a 1% excise tax on certain repurchases of an entity&#x2019;s own common stock after December 31, 2022, and various drug pricing reforms. Based on its preliminary assessment, the Company does not currently expect the IR Act to have a material impact on its results of operations, financial position, or cash flows in the foreseeable future. The Company will continue to evaluate the full impact of these legislative changes as they are implemented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds, short-term deposits with financial institutions, and short-term commercial papers issued by non-financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#x2019;s foreign subsidiaries, including Canadian dollars, Euro, and British pounds sterling. Deposits could exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#x201c;Prepaid expenses and other&#x201d; and &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. Restricted cash at&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 31, 2022 primarily consisted of $395&#160;million held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities and all amounts were released during fiscal 2023, as discussed in more detail in Financial Note 17, &#x201c;Commitments and Contingent Liabilities.&#x201d; Additionally, restricted cash at March 31, 2022 included funds temporarily held on behalf of unaffiliated medical practice groups related to their business continuity borrowings as a result of the pandemic caused by the SARS-CoV-2 coronavirus (&#x201c;COVID-19&#x201d;). These amounts were designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds were recorded by the Company within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets at March 31, 2022. These funds were fully disbursed during fiscal 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Method Investments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Investments in business entities in which the Company does not have control, but instead has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that could have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables, Net and Allowances for Credit Losses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables are presented net of an allowance for credit losses and primarily consist of trade accounts receivable from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings, collections on past due amounts, legal disputes, and bankruptcies, as well as reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $111 million and $89 million were included in &#x201c;Receivables, net&#x201d; in the Consolidated Balance Sheets as of March 31, 2023 and 2022, respectively. Changes in the allowance for the year ended March 31, 2023 were primarily within the U.S Pharmaceutical and Medical-Surgical Solutions segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company&#x2019;s receivables as of March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentrations of Credit Risk and Receivables: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During fiscal 2023, sales to the Company&#x2019;s ten largest customers, including group purchasing organizations (&#x201c;GPOs&#x201d;), accounted for approximately 68% of its total consolidated revenues and approximately 42% of total trade accounts receivable at March 31, 2023. Sales to the Company&#x2019;s largest customer, CVS Health Corporation (&#x201c;CVS&#x201d;), accounted for approximately 27% of its total consolidated revenues in fiscal 2023 and comprised approximately 21% of total trade accounts receivable at March 31, 2023. As a result, the Company&#x2019;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies, and other healthcare providers, as well as with government entities and agencies. The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from GPOs or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#x2019;s financial condition, results of operations, and liquidity. In addition, trade accounts receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy, changes in reimbursement policies, and other factors. This credit risk is mitigated by the size and diversity of the Company&#x2019;s customer base as well as its geographic dispersion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#x201c;LIFO&#x201d;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#x201c;FIFO&#x201d;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023 and 2022, total inventories, net were $19.7 billion and $18.7 billion, respectively, in the Company&#x2019;s Consolidated Balance Sheets. The LIFO method was used to value approximately 64% and 63% of the Company&#x2019;s inventories at March 31, 2023 and 2022, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $384&#160;million and $383&#160;million higher than the amounts reported at March 31, 2023 and 2022, respectively. These amounts are equivalent to the Company&#x2019;s LIFO reserves. The Company&#x2019;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized a LIFO charge of $1 million in fiscal 2023 and LIFO credits of $23 million and $38 million in fiscal 2022 and fiscal 2021, respectively, all within &#x201c;Cost of sales&#x201d; in its Consolidated Statements of Operations. The LIFO charge in fiscal 2023 compared to LIFO credits in fiscal 2022 and fiscal 2021 are primarily due to higher brand inflation and lower generics deflation, offset by significantly higher off patent launch activity in fiscal 2023. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#x201c;market&#x201d;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March 31, 2023 and 2022, inventories at LIFO did not exceed market. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shipping and Handling Costs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company includes costs to pack and deliver inventory to its customers in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in its Consolidated Statements of Operations. Shipping and handling costs of $1.2 billion, $1.1 billion, and $1.0 billion were recognized in fiscal 2023, fiscal 2022 and fiscal 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Held for Sale: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are classified as &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed during each reporting period it remains classified as held for sale, and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant, and Equipment, Net: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzc5_434691cb-3c7b-46f0-b8e5-b9ad93bbc229"&gt;three&lt;/span&gt; to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives of the right-of-use (&#x201c;ROU&#x201d;) asset or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company&#x2019;s property, plant, and equipment, net as of March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total depreciation expense for property, plant, and equipment, net and amortization of the ROU assets of finance leases was $272&#160;million, $312&#160;million, and $344&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company leases facilities and equipment primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components, such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0MzI0_4fd24846-796a-4644-bf59-7de3fb2a6e2d"&gt;one&lt;/span&gt;&#160;to 15 years, while remaining terms for equipment leases generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0NDA0_da16eb7b-c863-47a8-b5b6-560d55f8d8c1"&gt;one&lt;/span&gt;&#160;to five years. Most real property leases contain renewal options (typically for five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#x2019;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating ROU assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#x2019;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#x2019;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. Operating lease liabilities are recorded in &#x201c;Current portion of operating lease liabilities&#x201d; and &#x201c;Long-term operating lease liabilities,&#x201d; and the corresponding lease assets are recorded in &#x201c;Operating lease right-of-use assets&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. Finance lease assets are included in &#x201c;Property, plant, and equipment, net&#x201d; and finance lease liabilities are included in &#x201c;Current portion of long-term debt&#x201d; and &#x201c;Long-term debt&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a lessor, the Company primarily leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 9, &#x201c;Leases,&#x201d; for additional information on the Company&#x2019;s leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment on an annual basis in the first fiscal quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#x201c;DCF&#x201d;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#x2019; fair values to the Company&#x2019;s market capitalization as further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline public companies for comparisons, and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currently all of the Company&#x2019;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE4NzYz_104a5783-416c-41d1-9774-e5859d78ef41"&gt;one&lt;/span&gt; to 25 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from the use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Capitalized Software Held for Internal Use: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years. As of March 31, 2023 and 2022, capitalized software held for internal use was $353 million and $320 million, respectively, net of accumulated amortization of $1.5 billion and $1.4 billion, respectively, and is included in &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $101&#160;million, $116&#160;million, and $117&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance Programs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#x201c;Captives&#x201d;) from which it obtains coverage for various exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company as discussed in more detail in Financial Note 17, &#x201c;Commitments and Contingent Liabilities,&#x201d; as well as those risks required to be insured by law or contract. It is the Company&#x2019;s policy to retain a significant portion of certain losses, including those related to workers&#x2019; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#x2019;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#x2019;s premium costs within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#x2019;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#x2019; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#x2019;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 99% and 1% of total revenues, respectively, for the year ended March 31, 2023, and approximately 98% and 2% of total revenues, respectively, for each of the years ended March 31, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.1 billion, $3.2 billion, and $3.1 billion for fiscal 2023, fiscal 2022, and fiscal 2021, respectively. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March 31, 2023 and 2022. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#x2019;s services arrangements and are recognized as revenues over the periods when services are performed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March 31, 2023 and 2022. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Supplier Incentives:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Supplier Reserves: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims could be different than the Company&#x2019;s estimate. The supplier reserves primarily pertain to the Company&#x2019;s U.S. Pharmaceutical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon effective settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Interest expense primarily includes interest for the Company&#x2019;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Translation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#x2019; deficit accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#x201c;Other comprehensive income, net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; deficit section of the Consolidated Balance Sheets. Gains and losses from currency exchange transactions are recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations and were not material for the years ended March 31, 2023, 2022, or 2021. The Company releases cumulative translation adjustments from stockholders&#x2019; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro-rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivative Financial Instruments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company has used foreign currency-denominated notes and uses cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#x201c;Other comprehensive income, net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; deficit section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Any cash flows received or paid as part of the termination of derivative financial instruments are classified within the Consolidated Statements of Cash Flows in accordance with the nature of the hedged item. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings. Refer to Financial Note 14, &#x201c;Hedging Activities,&#x201d; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Comprehensive Income (Loss): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, as well as gains and losses that are recorded as an element of stockholders&#x2019; deficit but are excluded from earnings. The Company&#x2019;s other comprehensive income (loss) primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency, including gains and losses on net investment hedges, as well as unrealized gains and losses on cash flow hedges and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;unrealized gains and losses on retirement-related benefit plans. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests and Redeemable Noncontrolling Interests: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income or loss that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes third-party equity interests in the Company&#x2019;s consolidated entities, including: ClarusONE Sourcing Services LLP (&#x201c;ClarusONE&#x201d;), a joint venture established between McKesson and Walmart Inc. in fiscal 2017; Vantage Oncology Holdings, LLC (&#x201c;Vantage&#x201d;), a provider of integrated oncology and radiation services acquired in fiscal 2017; and SCRI Oncology, LLC (&#x201c;SCRI Oncology&#x201d;), an oncology research business formed in the third quarter of fiscal 2023 combining McKesson&#x2019;s U.S. Oncology Research (&#x201c;USOR&#x201d;) and HCA Healthcare, Inc.&#x2019;s (&#x201c;HCA&#x201d;) Sarah Cannon Research Institute (&#x201c;SCRI&#x201d;). Net income attributable to noncontrolling interests also included recurring compensation that the Company was obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. The Company&#x2019;s noncontrolling interest in McKesson Europe was included in the divestiture of certain of the Company&#x2019;s businesses in the European Union (&#x201c;E.U.&#x201d;) in October 2022. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#x2019;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#x2019; deficit in the Company&#x2019;s Consolidated Balance Sheets. Refer to Financial Note 7, &#x201c;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#x201d; for additional information on noncontrolling and redeemable noncontrolling interests, and Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; for additional information on the acquisition and divestiture activity discussed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Compensation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#x2019;s employees. Refer to Financial Note 4, &#x201c;Share-Based Compensation,&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loss Contingencies:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews all material contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 17, &#x201c;Commitments and Contingent Liabilities,&#x201d; for additional information related to controlled substances claims to which the Company is a party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at fair value at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are expensed as incurred. Refer to Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, including contingent consideration, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a variation of the income approach, whereby a forecast of future cash flows attributable to the asset is discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#x2019;s expected useful life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration liabilities are measured at their fair value as of the acquisition date using unobservable inputs. These inputs include the estimated amount and timing of projected operational and financial information, the probability of achievement of performance milestones or other agreed-upon events, and the risk-adjusted discount rate used to calculate the present value of the probability-weighted projected financial information. Contingent liabilities are remeasured to fair value at each reporting date until the liability is resolved. Changes in any of the inputs could result in a significant adjustment to the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Treasury Stock:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; We record purchases of treasury stock at cost, which is reflected as a reduction to stockholders&#x2019; equity in the Company&#x2019;s Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock, including any excise tax recognized as a result of the IR Act, are included in the cost of the shares acquired. Treasury stock also includes shares withheld to satisfy the tax obligations of recipients of share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no adopted accounting standards during fiscal 2023 that had a material impact to the Company&#x2019;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of such equity security, and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect that this guidance will have a material impact on its consolidated financial statements or related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzQ2MQ_2b2b6b16-36aa-4ce0-8614-9beac4f018e8"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDkw_c0df4c6a-3c42-4afd-a6f9-c3f2c2975368">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements and accompanying notes are prepared in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;GAAP&#x201d;). The consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation, including the intercompany portion of transactions with equity method investees.&lt;/span&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control, but instead has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:FiscalPeriod
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDMy_4a9bfe77-02e1-4195-8b28-2bbc30645c26">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal Period: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;</us-gaap:FiscalPeriod>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzM1_9f0bac32-10eb-470e-a0a0-5f28edb1aa12">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Certain prior period amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDM1_f4058709-b745-477f-8472-42955cbae9ec">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimated amounts.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzAy_75b1dedb-9d95-4d5c-894b-7e5d14f0f8ac">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: All highly liquid debt and money market instruments purchased with an original maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Cash equivalents are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds, short-term deposits with financial institutions, and short-term commercial papers issued by non-financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of the Company&#x2019;s foreign subsidiaries, including Canadian dollars, Euro, and British pounds sterling. Deposits could exceed the amounts insured by the Federal Deposit Insurance Corporation in the U.S. and similar deposit insurance programs in other jurisdictions. The Company mitigates the risk of its short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzk4_e1de4980-bf6d-43ce-8c06-d71320121142">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Cash that is subject to legal restrictions or is unavailable for general operating purposes is classified as restricted cash and is included in &#x201c;Prepaid expenses and other&#x201d; and &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. Restricted cash at&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 31, 2022 primarily consisted of $395&#160;million held in escrow related to obligations under settlement agreements for opioid-related claims of governmental entities and all amounts were released during fiscal 2023, as discussed in more detail in Financial Note 17, &#x201c;Commitments and Contingent Liabilities.&#x201d; Additionally, restricted cash at March 31, 2022 included funds temporarily held on behalf of unaffiliated medical practice groups related to their business continuity borrowings as a result of the pandemic caused by the SARS-CoV-2 coronavirus (&#x201c;COVID-19&#x201d;). These amounts were designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds were recorded by the Company within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets at March 31, 2022. These funds were fully disbursed during fiscal 2023.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCash
      contextRef="i1dcb8f3258544de983570a2447cfa80a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzQzNjQ_39d19f6b-8626-4d32-85a2-f95def89ef15"
      unitRef="usd">395000000</us-gaap:RestrictedCash>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NTAw_67aff153-6ca4-4483-8c38-238f217c44d9">Equity Method Investments: Investments in business entities in which the Company does not have control, but instead has the ability to exercise significant influence over operating and financial policies, are accounted for using the equity method. The Company evaluates its equity method investments for impairment whenever an event or change in circumstances occurs that could have a significant adverse impact on the carrying value of the investment. If a loss in value has occurred that is deemed to be other-than-temporary, an impairment loss is recorded.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDU5_61a0e884-802b-4407-b8ef-fb4e6bdae9d1">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Receivables, Net and Allowances for Credit Losses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables are presented net of an allowance for credit losses and primarily consist of trade accounts receivable from customers that result from the sale of goods and services. Receivables, net also includes other receivables, which primarily represent amounts due from suppliers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to credit losses on accounts receivable balances. The Company estimates credit losses by considering historical credit losses, the current economic environment, customer credit ratings, collections on past due amounts, legal disputes, and bankruptcies, as well as reasonable and supportable forecasts to develop its allowance for credit losses. Management reviews these factors quarterly to determine if any adjustments are needed to the allowance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade accounts receivable represent the majority of the Company's financial assets, for which an allowance for credit losses of $111 million and $89 million were included in &#x201c;Receivables, net&#x201d; in the Consolidated Balance Sheets as of March 31, 2023 and 2022, respectively. Changes in the allowance for the year ended March 31, 2023 were primarily within the U.S Pharmaceutical and Medical-Surgical Solutions segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzY1MTk_70ba7072-570b-40fc-9414-fc5b6fdedb03"
      unitRef="usd">111000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzY1MjY_fb5233dd-e938-40e9-a28b-59c9b9084e4e"
      unitRef="usd">89000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDU2_a0fb7157-a4d6-4d7a-a980-9e16f18eb9fa">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company&#x2019;s receivables as of March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <mck:AccountsReceivableCustomerAccountsGross
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzItMS0xLTEtMjE4NzQ4_e11be425-bd35-438e-9284-07d786577c57"
      unitRef="usd">17160000000</mck:AccountsReceivableCustomerAccountsGross>
    <mck:AccountsReceivableCustomerAccountsGross
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzItMy0xLTEtMjE4NzQ4_f0856881-a7f1-425f-93da-8f6f2f51b87e"
      unitRef="usd">16438000000</mck:AccountsReceivableCustomerAccountsGross>
    <us-gaap:OtherReceivablesGrossCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzMtMS0xLTEtMjE4NzQ4_729a029f-14b1-452b-84ab-76f832a863d5"
      unitRef="usd">2408000000</us-gaap:OtherReceivablesGrossCurrent>
    <us-gaap:OtherReceivablesGrossCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzMtMy0xLTEtMjE4NzQ4_5bbc4dd0-983f-4b87-a7de-d64d0c10f4b2"
      unitRef="usd">2289000000</us-gaap:OtherReceivablesGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzQtMS0xLTEtMjE4NzQ4_a3b5a77c-6025-496a-b3f5-66b06de12484"
      unitRef="usd">19568000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzQtMy0xLTEtMjE4NzQ4_98e09775-ff63-409e-994f-40912d294363"
      unitRef="usd">18727000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzUtMS0xLTEtMjE4NzQ4_cf7272a1-0aca-481d-a014-61a733d21833"
      unitRef="usd">158000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzUtMy0xLTEtMjE4NzQ4_d42e577a-f620-45b3-9108-76d9d62f9d78"
      unitRef="usd">144000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzYtMS0xLTEtMjE4NzQ4_67f318ab-b392-4410-a655-b796b784526c"
      unitRef="usd">19410000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTpmNDEyOTQ1YTYxYzQ0MTY0YjExNjkxMzI0ZmNiMzZjNi90YWJsZXJhbmdlOmY0MTI5NDVhNjFjNDQxNjRiMTE2OTEzMjRmY2IzNmM2XzYtMy0xLTEtMjE4NzQ4_595bf35b-ab76-4400-b0e8-2319fd5ec303"
      unitRef="usd">18583000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzA1_fdac7b9d-538f-4b7a-83ee-c85fb6998c4c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentrations of Credit Risk and Receivables: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s trade accounts receivable are subject to concentrations of credit risk with customers primarily in its U.S. Pharmaceutical segment. During fiscal 2023, sales to the Company&#x2019;s ten largest customers, including group purchasing organizations (&#x201c;GPOs&#x201d;), accounted for approximately 68% of its total consolidated revenues and approximately 42% of total trade accounts receivable at March 31, 2023. Sales to the Company&#x2019;s largest customer, CVS Health Corporation (&#x201c;CVS&#x201d;), accounted for approximately 27% of its total consolidated revenues in fiscal 2023 and comprised approximately 21% of total trade accounts receivable at March 31, 2023. As a result, the Company&#x2019;s sales and credit concentration is significant. The Company has agreements with GPOs, each of which functions as a purchasing agent on behalf of member hospitals, pharmacies, and other healthcare providers, as well as with government entities and agencies. The accounts receivable balances are with individual members of the GPOs, and therefore no significant concentration of credit risk exists. A material default in payment, a material reduction in purchases from GPOs or any other large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company&#x2019;s financial condition, results of operations, and liquidity. In addition, trade accounts receivables are subject to concentrations of credit risk with customers in the institutional, retail, and healthcare provider sectors, which can be affected by a downturn in the economy, changes in reimbursement policies, and other factors. This credit risk is mitigated by the size and diversity of the Company&#x2019;s customer base as well as its geographic dispersion.&lt;/span&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7264b2fb579741cdab359e1aba22aede_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzcxNjA_efbd257c-bac1-426a-91a2-01771b088e02"
      unitRef="number">0.68</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic04e9e22dc634dfca9e2377700f0d82f_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzcyMTY_949022db-7b56-4f5c-af68-4ab66dfa7a58"
      unitRef="number">0.42</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i932aecaa6796433d9fa0f50f4ddd4f32_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzczNjI_feda8f0c-4df3-44fb-ba5a-016a100bea8a"
      unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibfb139caacd149a5b3fdff785111e258_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzc0MzQ_771260eb-ebef-4715-a4cb-b0c19dc220bf"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzA2_744717a0-6463-4d60-86e7-4bbf8d7d3966">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inventories: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of merchandise held for resale. The Company reports inventories at the lower of cost or net realizable value, except for inventories determined using the last-in, first-out (&#x201c;LIFO&#x201d;) method which are valued at the lower of LIFO cost or market. The LIFO method presumes that the most recent inventory purchases are the first items sold and the inventory cost under LIFO approximates market. The majority of the cost of domestic inventories is determined using the LIFO method. The majority of the cost of inventories held in foreign and certain domestic locations is based on the first-in, first-out (&#x201c;FIFO&#x201d;) method and weighted-average purchase prices. Rebates, cash discounts, and other incentives received from vendors are recognized in cost of sales upon the sale of the related inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023 and 2022, total inventories, net were $19.7 billion and $18.7 billion, respectively, in the Company&#x2019;s Consolidated Balance Sheets. The LIFO method was used to value approximately 64% and 63% of the Company&#x2019;s inventories at March 31, 2023 and 2022, respectively. If the Company had used the moving average method of inventory valuation, inventories would have been approximately $384&#160;million and $383&#160;million higher than the amounts reported at March 31, 2023 and 2022, respectively. These amounts are equivalent to the Company&#x2019;s LIFO reserves. The Company&#x2019;s LIFO valuation amount includes both pharmaceutical and non-pharmaceutical products. The Company recognized a LIFO charge of $1 million in fiscal 2023 and LIFO credits of $23 million and $38 million in fiscal 2022 and fiscal 2021, respectively, all within &#x201c;Cost of sales&#x201d; in its Consolidated Statements of Operations. The LIFO charge in fiscal 2023 compared to LIFO credits in fiscal 2022 and fiscal 2021 are primarily due to higher brand inflation and lower generics deflation, offset by significantly higher off patent launch activity in fiscal 2023. A LIFO charge is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. &lt;/span&gt;&lt;/div&gt;The Company believes that the moving average inventory costing method provides a reasonable estimation of the current cost of replacing inventory (i.e., &#x201c;market&#x201d;).&#160;As such, its LIFO inventory is valued at the lower of LIFO cost or market. As of March 31, 2023 and 2022, inventories at LIFO did not exceed market.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryNet
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk0Mjc_4b74cb02-fa1f-4f17-85b9-9b992f5b2179"
      unitRef="usd">19700000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk0MzQ_e08fefb1-deda-4782-b3b4-af7442d14e85"
      unitRef="usd">18700000000</us-gaap:InventoryNet>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk1NDY_577c3b96-fb77-4f27-b777-929065d4a99b"
      unitRef="number">0.64</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk1NTM_17cdd363-0509-4e2a-9560-60f10e38953f"
      unitRef="number">0.63</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:InventoryLIFOReserve
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk3Mjk_746cdb13-c5d3-4f01-89e4-fee5231c5024"
      unitRef="usd">384000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReserve
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk3MzY_c4790ece-12de-49ff-8641-1eee72ba934b"
      unitRef="usd">383000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzk5OTg_b9e903e0-3bb3-4cbc-9ad3-314ba14fb134"
      unitRef="usd">1000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEwMDAy_0dc03165-e3a6-4c66-b1a5-e3a648041d30"
      unitRef="usd">-23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEwMDEw_e87ede39-7295-4f6b-90e3-56af0ee5e731"
      unitRef="usd">-38000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mjcx_dbf64ea9-52e5-4345-bd5e-b2ab79208c04">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shipping and Handling Costs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company includes costs to pack and deliver inventory to its customers in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in its Consolidated Statements of Operations. Shipping and handling costs of $1.2 billion, $1.1 billion, and $1.0 billion were recognized in fiscal 2023, fiscal 2022 and fiscal 2021, respectively.&lt;/span&gt;</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3969df882b2a4177a8ac36cb92b0b6c7_D20220401-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzExMTg1_993c2a42-872c-4ebf-8ff8-43c03b44e535"
      unitRef="usd">1200000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i515e802e55bc4ca1b11dd1a584ef8dde_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzExMjE0_38c4caf7-a33b-4e58-b5fd-d7c7f35a9bfa"
      unitRef="usd">1100000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i223505a11e384113a49c9b97f61ec445_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE2NDkyNjc0ODE3MDA_fa85e1eb-443f-47d7-b85a-b8a2b56f8774"
      unitRef="usd">1000000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <mck:HeldforSalePolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mjg3_98629df8-7145-46a9-a2ba-25fae5a84c8c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Held for Sale: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are classified as &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The classification occurs when the disposal group is available for immediate sale and the sale is probable. These criteria are generally met when management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell, and long-lived assets included within the disposal group are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed during each reporting period it remains classified as held for sale, and any remeasurement to the lower of carrying value or fair value less costs to sell is reported as an adjustment to the carrying value of the disposal group. When the net realizable value of a disposal group increases during a period, a gain can be recognized to the extent that it does not increase the value of the disposal group beyond its original carrying value when the disposal group was reclassified as held for sale. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; for additional information.&lt;/span&gt;</mck:HeldforSalePolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzQ4_84f7f6fa-0e3b-4973-8767-fed23ba4b4be">Property, Plant, and Equipment, Net: Property, plant, and equipment, net is stated at historical cost and depreciated under the straight-line method over the estimated useful life of each asset, which ranges from 15 to 30 years for building and improvements and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzc5_434691cb-3c7b-46f0-b8e5-b9ad93bbc229"&gt;three&lt;/span&gt; to 15 years for machinery, equipment, and other. Leasehold improvements and property, plant, and equipment, net under finance leases are amortized over their respective useful lives of the right-of-use (&#x201c;ROU&#x201d;) asset or over the term of the lease, whichever is shorter. Depreciation and amortization begins when an asset is placed in service and ready for its intended use. Repairs and maintenance costs are expensed as incurred. When certain events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable, an impairment assessment may be performed on the recoverability of the carrying amounts.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ibc4a0c9d2b824683901b0907b93e42dd_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzM2_0d414740-241f-4c76-8404-ef21c6eec225">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i655245d8cb514931a14931cc038eb490_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzQy_e49e4979-7c43-4fc5-95aa-d7cb17b9d12d">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie30f2480525c49ada9cabfe8e2d20354_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEyNzg1_e2ec2299-9262-4010-9bf6-46e046b1983a">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzg3_00a787dc-c79d-4121-ac07-877450f07ddd">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company&#x2019;s property, plant, and equipment, net as of March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzItMS0xLTEtMjE4NzQ4_40128617-58f6-46a9-84ab-c94ae8f0b83e"
      unitRef="usd">109000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzItMy0xLTEtMjE4NzQ4_685892e7-0d11-42d7-a978-240a8b536a4c"
      unitRef="usd">104000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzMtMS0xLTEtMjE4NzQ4_19b95c7c-973b-4e3d-8327-eac03cacc42d"
      unitRef="usd">1413000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzMtMy0xLTEtMjE4NzQ4_daeebd07-a3e3-46f2-a0ce-bf35e5b282d3"
      unitRef="usd">1331000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzQtMS0xLTEtMjE4NzQ4_54344579-9d5e-494e-be05-2a6e85214798"
      unitRef="usd">2603000000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzQtMy0xLTEtMjE4NzQ4_391f50fb-9b30-4b11-ba63-7d9b997eac5b"
      unitRef="usd">2338000000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:ConstructionInProgressGross
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzUtMS0xLTEtMjE4NzQ4_30ca322b-9a77-4421-a4c9-ef8f09bb4bad"
      unitRef="usd">283000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzUtMy0xLTEtMjE4NzQ4_46c88839-2dda-4115-aa00-44c2d865a8cc"
      unitRef="usd">313000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzYtMS0xLTEtMjE4NzQ4_73c4902b-7422-40b1-82a5-1e5ec4a3420a"
      unitRef="usd">4408000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzYtMy0xLTEtMjE4NzQ4_09cef1c4-41a7-411b-a3ad-96bec7bb2f43"
      unitRef="usd">4086000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzctMS0xLTEtMjE4NzQ4_ff242647-66a9-431e-ad85-229ec9d2777f"
      unitRef="usd">2231000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzctMy0xLTEtMjE4NzQ4_065fc4f9-9509-4338-b109-b9eca269d0c4"
      unitRef="usd">1994000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzgtMS0xLTEtMjE4NzQ4_d654eced-ecf9-440f-8724-d920eadf73c1"
      unitRef="usd">2177000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90YWJsZTo5MmY1YzU4ZDllOWU0NTk1OGNkNzEyZmY2MTM0NjYyZi90YWJsZXJhbmdlOjkyZjVjNThkOWU5ZTQ1OTU4Y2Q3MTJmZjYxMzQ2NjJmXzgtMy0xLTEtMjE4NzQ4_3bc0163a-659d-4457-9b4d-1459e47aa1dc"
      unitRef="usd">2092000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEzNjY4_d0a33df7-ddfc-4718-b807-80bbe6c3b625"
      unitRef="usd">272000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEzNjcy_59318fd8-6149-410a-8107-8c277aa93bd4"
      unitRef="usd">312000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEzNjgw_cbc27261-713e-4065-94e9-8d3e7ad19ee2"
      unitRef="usd">344000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDQ1_6c56efaf-2a00-42d1-bab0-d400bfd5c41a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company leases facilities and equipment primarily under operating leases. The Company recognizes lease expense on a straight-line basis over the term of the lease, taking into account, when applicable, lessor incentives for tenant improvements, periods where no rent payment is required, and escalations in rent payments over the term of the lease. As a practical expedient, the Company does not separate lease components from non-lease components, such as common area maintenance, utilities, and repairs and maintenance. Remaining terms for facility leases generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0MzI0_4fd24846-796a-4644-bf59-7de3fb2a6e2d"&gt;one&lt;/span&gt;&#160;to 15 years, while remaining terms for equipment leases generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0NDA0_da16eb7b-c863-47a8-b5b6-560d55f8d8c1"&gt;one&lt;/span&gt;&#160;to five years. Most real property leases contain renewal options (typically for five-year increments). Generally, the renewal option periods are not included within the lease term as the Company is not reasonably certain to exercise that right at lease commencement. The Company&#x2019;s lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating ROU assets and operating lease liabilities are recognized at the lease commencement date. ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and operating lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term, discounted at the Company&#x2019;s incremental borrowing rate as the implicit rate in the lease is not readily determinable for most of the Company&#x2019;s leases. The Company estimates the discount rate as its incremental borrowing rate based on qualitative factors including Company specific credit rating, lease term, general economics, and the interest rate environment. Operating lease liabilities are recorded in &#x201c;Current portion of operating lease liabilities&#x201d; and &#x201c;Long-term operating lease liabilities,&#x201d; and the corresponding lease assets are recorded in &#x201c;Operating lease right-of-use assets&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. Finance lease assets are included in &#x201c;Property, plant, and equipment, net&#x201d; and finance lease liabilities are included in &#x201c;Current portion of long-term debt&#x201d; and &#x201c;Long-term debt&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. As a practical expedient, short-term leases with an initial term of 12 months or less are excluded from the Consolidated Balance Sheets and charges from these leases are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a lessor, the Company primarily leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 9, &#x201c;Leases,&#x201d; for additional information on the Company&#x2019;s leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i1aaff57b7c384456ab86bd2b5fccb87a_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEzNzQzODk1NDI4MTg2_d1c7ed3c-2703-4f3f-99fb-6b03398fb806">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ia26faef7d39742839185203bac54e495_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE0NDEw_751319e9-e9d0-45d1-a7d3-1823b7d96541">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ic711bd1052674b80ad0f571918f35552_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDA4_2ab78e94-6ecf-45eb-a66d-84a052db1570">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDA5_6822d60b-1e9d-4184-b923-d725cb5061de">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment on an annual basis in the first fiscal quarter and more frequently if indicators of potential impairment exist. Impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the goodwill impairment test by comparing the estimated fair value of a reporting unit to its carrying value and recording an impairment charge equal to the amount of excess carrying value above the estimated fair value, if any, but not to exceed the amount of goodwill allocated to the reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To estimate the fair value of its reporting units, the Company generally uses a combination of the market approach and the income approach. Under the market approach, it estimates fair value by comparing the business to similar businesses, or guideline companies whose securities are actively traded in public markets. Under the income approach, it uses a discounted cash flow (&#x201c;DCF&#x201d;) model in which cash flows anticipated over future periods, plus a terminal value at the end of that time horizon, are discounted to their present value using an appropriate rate that is commensurate with the risk inherent within the reporting unit. Other estimates inherent in both the market and income approaches include long-term growth rates, projected revenues, and earnings and cash flow forecasts for the reporting units. In addition, the Company compares the aggregate of the reporting units&#x2019; fair values to the Company&#x2019;s market capitalization as further corroboration of the fair values. Goodwill testing requires a complex series of assumptions and judgments by management in projecting future operating results, selecting guideline public companies for comparisons, and assessing risks. The use of alternative assumptions and estimates could affect the fair values and change the impairment determinations.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzQ2_aec65f8e-3382-4063-af81-66ebd5daa9c2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currently all of the Company&#x2019;s intangible assets are subject to amortization and are amortized based on the pattern of their economic consumption or on a straight-line basis over their estimated useful lives, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE4NzYz_104a5783-416c-41d1-9774-e5859d78ef41"&gt;one&lt;/span&gt; to 25 years. The Company reviews intangible assets for impairment at an asset group level whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated future undiscounted cash flows resulting from the use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset group over its estimated fair value.&lt;/span&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5a7c37dc0f5d4bfb9f78bc365e926644_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzEzNzQzODk1NDI4MTg1_797e51db-af71-44a4-8e6f-8bf22c69de55">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:InternalUseSoftwarePolicy
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzk2_85ad870c-45fa-4db4-83aa-79fd46e5a767">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Capitalized Software Held for Internal Use: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes costs of software held for internal use during the application development stage of a project and amortizes those costs using the straight-line method over their estimated useful lives, not to exceed 10 years. As of March 31, 2023 and 2022, capitalized software held for internal use was $353 million and $320 million, respectively, net of accumulated amortization of $1.5 billion and $1.4 billion, respectively, and is included in &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. Costs incurred during the preliminary project and post-implementation stages are expensed as incurred. Amortization expense for capitalized software held for internal use was $101&#160;million, $116&#160;million, and $117&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively.&lt;/span&gt;</us-gaap:InternalUseSoftwarePolicy>
    <mck:CapitalizedSoftwareHeldforInternalUseUsefulLife
      contextRef="i5a7c37dc0f5d4bfb9f78bc365e926644_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE5NTU2_5660e8f4-ec35-401a-a5ee-e3c10810f835">P10Y</mck:CapitalizedSoftwareHeldforInternalUseUsefulLife>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE5NjI0_8a91cacb-f936-4a59-b250-24993778a6ba"
      unitRef="usd">353000000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzE5NjMx_a2215203-ae9d-4bf7-86d9-cd51ddec913e"
      unitRef="usd">320000000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzYwNDczMTQwMDEyNzM_f05628ce-cf32-4739-b0fd-acbad24675a2"
      unitRef="usd">1500000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzU0OTc1NTkwMzYzNg_8f721276-7795-45fc-b74b-7fc8923eacb3"
      unitRef="usd">1400000000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIwMjQ0_fb0532a0-7115-4157-a9a1-b7100f5aba18"
      unitRef="usd">101000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIwMjQ4_2f6ccc40-f61a-448e-aa1c-06505be636ba"
      unitRef="usd">116000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIwMjU2_5bd9e64e-860b-4a4a-a0f7-0bfaf91fa5ba"
      unitRef="usd">117000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <mck:InsuranceProgramsPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzI1_8e54b1d2-86c0-42b7-8ffd-373318538a66">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance Programs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company maintains insurance programs through its wholly-owned captive insurance subsidiaries (&#x201c;Captives&#x201d;) from which it obtains coverage for various exposures, including certain exposures arising from the opioid-related claims of governmental entities against the Company as discussed in more detail in Financial Note 17, &#x201c;Commitments and Contingent Liabilities,&#x201d; as well as those risks required to be insured by law or contract. It is the Company&#x2019;s policy to retain a significant portion of certain losses, including those related to workers&#x2019; compensation and comprehensive general, product, and vehicle liability. Provisions for losses expected under insurance programs are recorded based on the Company&#x2019;s estimate of the aggregate liability for claims incurred as well as for claims incurred but not yet reported. Such estimates utilize certain actuarial assumptions followed in the insurance industry. The Captives receive direct premiums, which are eliminated on consolidation against the Company&#x2019;s premium costs within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;</mck:InsuranceProgramsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDA1_13c484bf-37a2-48a6-91d9-21b371ca045c">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenue is recognized when an entity satisfies a performance obligation by transferring control of a promised good or service to a customer in an amount that reflects the consideration to which the entity expects to be entitled for that good or service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues generated from the distribution of pharmaceutical and medical products represent the majority of the Company&#x2019;s revenues. The Company orders product from the manufacturer, receives and carries the product at its central distribution facilities, and delivers the product directly to its customers&#x2019; warehouses, hospitals, or retail pharmacies. The distribution business primarily generates revenue from a contract related to a confirmed purchase order with a customer in a distribution arrangement. Revenue is recognized when control of goods is transferred to the customer which occurs upon the Company&#x2019;s delivery to the customer or upon customer pick-up. The Company also earns revenues from a variety of other sources including its retail, services, and technology businesses. Retail revenues are recognized at the point of sale. Service revenues, including technology service revenues, are recognized when services are rendered. Revenues derived from distribution and retail business at the point of sale, and revenues derived from services represent approximately 99% and 1% of total revenues, respectively, for the year ended March 31, 2023, and approximately 98% and 2% of total revenues, respectively, for each of the years ended March 31, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recorded gross when the Company is the principal in the transaction, has the ability to direct the use of the goods or services prior to transfer to a customer, is responsible for fulfilling the promise to its customer, has latitude in establishing prices, and controls the relationship with the customer. The Company records its revenues net of sales taxes. Revenues are measured based on the amount of consideration that the Company expects to receive, reduced by estimates for return allowances, discounts, and rebates using historical data. Sales returns from customers were approximately $3.1 billion, $3.2 billion, and $3.1 billion for fiscal 2023, fiscal 2022, and fiscal 2021, respectively. Assets for the right to recover products from customers and the associated refund liabilities for return allowances were not material as of March 31, 2023 and 2022. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as fulfillment costs. The Company records deferred revenues when payments are received or due in advance of its performance. Deferred revenues are primarily from the Company&#x2019;s services arrangements and are recognized as revenues over the periods when services are performed. &lt;/span&gt;&lt;/div&gt;The Company had no material contract assets, contract liabilities, or deferred contract costs recorded in its Consolidated Balance Sheets as of March 31, 2023 and 2022. The Company generally expenses costs to obtain a contract as incurred when the amortization period is less than one year.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie56d43006f754d499f7e19cd5720562c_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIyNzE4_05114ae9-18ee-4665-b468-721ebdd30344"
      unitRef="number">0.99</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i22171c2b91104f3f9aae6c7df97e030e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIyNzI1_30dac889-986f-498b-acd2-710130057f77"
      unitRef="number">0.01</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i915d437ab7bb4f499b0ca40841b44528_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM4NDgyOTA3ODc0ODY_62ca3aa8-a14f-4934-83f6-2c929f0fd4e6"
      unitRef="number">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib344714960c14cd0aaa14d648eb58138_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM4NDgyOTA3ODc0ODY_75cc1105-e67e-4f92-ad15-fcef0af31a48"
      unitRef="number">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i63f0fcb2e0aa4013b42d29b5ade1e28b_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM4NDgyOTA3ODc0OTA_45183bbe-f4c3-45d2-8e17-e1b2bac322a0"
      unitRef="number">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if322074120a140808e8c82b1bed2d7ec_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM4NDgyOTA3ODc0OTA_cec8f472-7550-4e29-9370-405ff1615b57"
      unitRef="number">0.02</us-gaap:ConcentrationRiskPercentage1>
    <mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzIzMzk3_5a68dc96-b2c5-455d-9031-bbf298d6b9eb"
      unitRef="usd">3100000000</mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns>
    <mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzcxNDY4MjU2MjUyMjE_2172f643-31b9-4d52-8fe4-3d463178ad0c"
      unitRef="usd">3200000000</mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns>
    <mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzcxNDY4MjU2MjUyMjk_92a845d3-2112-4913-82f0-496d04cb7c5d"
      unitRef="usd">3100000000</mck:RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns>
    <mck:SupplierIncentivesPolicyPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDg0_67d5ce7a-62ee-40a7-b8dd-741c4153cf89">Supplier Incentives: Fees for services and other incentives received from suppliers, relating to the purchase or distribution of inventory, are considered product discounts and are generally reported as a reduction to cost of sales.</mck:SupplierIncentivesPolicyPolicyTextBlock>
    <mck:SupplierReservesPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mjgx_7f73fb18-f557-4f0d-9ca0-4914d00ecee7">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Supplier Reserves: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes reserves against amounts due from suppliers relating to various fees for services and price and rebate incentives, including deductions taken against payments otherwise due to it. These reserve estimates are established based on judgment after considering the status of current outstanding claims, historical experience with the suppliers, the specific incentive programs, and any other pertinent information available. The Company evaluates the amounts due from suppliers on a continual basis and adjusts the reserve estimates when appropriate based on changes in facts and circumstances. Adjustments to supplier reserves are generally included in cost of sales unless consideration from the vendor is in exchange for distinct goods or services or for pass-through rebate purchases. The ultimate outcome of any outstanding claims could be different than the Company&#x2019;s estimate. The supplier reserves primarily pertain to the Company&#x2019;s U.S. Pharmaceutical segment.&lt;/span&gt;</mck:SupplierReservesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDcw_984e3b79-5694-4a80-b29a-c54e47fbbf1e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or the tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The amount recognized is measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon effective settlement.&lt;/span&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:InterestExpensePolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDcx_0dd98cb1-98df-417b-ad89-524dca82299d">Interest Expense: Interest expense primarily includes interest for the Company&#x2019;s long-term debt obligations, commercial paper, net interest settlements of interest rate swaps, and the amortization of deferred issuance costs and original issue discounts on debt.</us-gaap:InterestExpensePolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mjg0_6a97ab20-4bea-483e-8e4c-c26b9c40145c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Translation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The reporting currency of the Company and its subsidiaries is the U.S. dollar. Its foreign subsidiaries generally consider their local currency to be their functional currency. Foreign currency-denominated assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates, while revenues and expenses are translated at average exchange rates during the corresponding period and stockholders&#x2019; deficit accounts are primarily translated at historical exchange rates. Foreign currency translation adjustments are included in &#x201c;Other comprehensive income, net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; deficit section of the Consolidated Balance Sheets. Gains and losses from currency exchange transactions are recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations and were not material for the years ended March 31, 2023, 2022, or 2021. The Company releases cumulative translation adjustments from stockholders&#x2019; equity into earnings as a gain or loss only upon a complete or substantially complete liquidation of a controlling interest in a subsidiary or a group of assets within a foreign entity.&#160;It also releases all or a pro-rata portion of the cumulative translation adjustments into earnings upon the sale of an equity method investment that is a foreign entity or has a foreign component.&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzY5_b14ac114-99a3-40fa-accf-589a41280571">Derivative Financial Instruments: Derivative financial instruments are used principally in the management of foreign currency exchange and interest rate exposures and are recorded in the Consolidated Balance Sheets at fair value. If a derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. The Company has used foreign currency-denominated notes and uses cross-currency swaps to hedge a portion of its net investment in its foreign subsidiaries.&#160;It uses cash flow hedges primarily to reduce the effects of foreign currency exchange rate risk related to intercompany loans denominated in non-functional currencies. If the financial instrument is designated as a cash flow hedge or net investment hedge, the effective portions of changes in the fair value of the derivative are included in &#x201c;Other comprehensive income, net of tax&#x201d; in the Consolidated Statements of Comprehensive Income (Loss), and the cumulative effect is included in the stockholders&#x2019; deficit section of the Consolidated Balance Sheets. The cumulative changes in fair value are reclassified to the same line as the hedged item in the Consolidated Statements of Operations when the hedged item affects earnings. The Company evaluates hedge effectiveness at inception and on an ongoing basis, and ineffective portions of changes in the fair value of cash flow hedges and net investment hedges are recognized in earnings following the date when ineffectiveness was identified. Any cash flows received or paid as part of the termination of derivative financial instruments are classified within the Consolidated Statements of Cash Flows in accordance with the nature of the hedged item. Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change included in earnings. Refer to Financial Note 14, &#x201c;Hedging Activities,&#x201d; for additional information.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDU3_23f46fc9-25dd-4e45-83a0-3418259efd1b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Comprehensive Income (Loss): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) consists of two components: net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, as well as gains and losses that are recorded as an element of stockholders&#x2019; deficit but are excluded from earnings. The Company&#x2019;s other comprehensive income (loss) primarily consists of foreign currency translation adjustments from those subsidiaries where the local currency is the functional currency, including gains and losses on net investment hedges, as well as unrealized gains and losses on cash flow hedges and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;unrealized gains and losses on retirement-related benefit plans.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mjkx_965c1e4e-0e6d-4b42-a549-a6a72e5ee83e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests and Redeemable Noncontrolling Interests: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent the portion of profit or loss, net assets, and comprehensive income or loss that is not allocable to McKesson Corporation. Net income attributable to noncontrolling interests includes third-party equity interests in the Company&#x2019;s consolidated entities, including: ClarusONE Sourcing Services LLP (&#x201c;ClarusONE&#x201d;), a joint venture established between McKesson and Walmart Inc. in fiscal 2017; Vantage Oncology Holdings, LLC (&#x201c;Vantage&#x201d;), a provider of integrated oncology and radiation services acquired in fiscal 2017; and SCRI Oncology, LLC (&#x201c;SCRI Oncology&#x201d;), an oncology research business formed in the third quarter of fiscal 2023 combining McKesson&#x2019;s U.S. Oncology Research (&#x201c;USOR&#x201d;) and HCA Healthcare, Inc.&#x2019;s (&#x201c;HCA&#x201d;) Sarah Cannon Research Institute (&#x201c;SCRI&#x201d;). Net income attributable to noncontrolling interests also included recurring compensation that the Company was obligated to pay to the noncontrolling shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;), formerly known as Celesio AG, under the domination and profit and loss transfer agreement. The Company&#x2019;s noncontrolling interest in McKesson Europe was included in the divestiture of certain of the Company&#x2019;s businesses in the European Union (&#x201c;E.U.&#x201d;) in October 2022. Noncontrolling interests with redemption features, such as put rights, that are not solely within the Company&#x2019;s control are considered redeemable noncontrolling interests. Redeemable noncontrolling interests are presented outside of stockholders&#x2019; deficit in the Company&#x2019;s Consolidated Balance Sheets. Refer to Financial Note 7, &#x201c;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#x201d; for additional information on noncontrolling and redeemable noncontrolling interests, and Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; for additional information on the acquisition and divestiture activity discussed above.&lt;/span&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MzEz_cb746396-9de3-4d3c-99de-62a8380a5568">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Compensation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for all share-based compensation transactions at fair value. The share-based compensation expense, for the portion of the awards that is ultimately expected to vest, is recognized on a straight-line basis over the requisite service period. The share-based compensation expense recognized is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#x2019;s employees. Refer to Financial Note 4, &#x201c;Share-Based Compensation,&#x201d; for additional information.&lt;/span&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzg4_b42e195d-c9d7-46f9-9835-b573d90b86ca">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Loss Contingencies:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company is subject to various claims, including, but not limited to, claims with customers and vendors, pending and potential legal actions for damages, investigations relating to governmental laws and regulations, and other matters arising out of the normal conduct of its business. When a loss is considered probable and reasonably estimable, the Company records a liability in the amount of its best estimate for the ultimate loss. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be reevaluated at least quarterly to determine both the likelihood of potential loss and whether it is possible to reasonably estimate the loss or a range of possible loss. When a material loss is reasonably possible or probable, but a reasonable estimate cannot be made, disclosure of the proceeding is provided. The Company recognizes legal fees as incurred when the legal services are provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews all material contingencies at least quarterly to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or a range of the loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system, and other interested parties. Refer to Financial Note 17, &#x201c;Commitments and Contingent Liabilities,&#x201d; for additional information related to controlled substances claims to which the Company is a party.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3MjY4_81cf0fcd-a814-4d15-9041-5b09c7cd4e25">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Employee severance costs are generally recognized when payments are probable and amounts are reasonably estimable. Costs related to contracts without future benefit or contract termination are recognized at fair value at the earlier of the contract termination or the cease-use dates.&#160;Other exit-related costs are expensed as incurred. Refer to Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; for additional information.&lt;/span&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3NDg1_937c2c66-2f10-4695-bd44-cf3bf1cf509e">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company accounts for business combinations using the acquisition method of accounting whereby the identifiable assets and liabilities of the acquired business, including contingent consideration, as well as any noncontrolling interest in the acquired business, are recorded at their estimated fair values as of the date that the Company obtains control of the acquired business. Any purchase consideration in excess of the estimated fair values of the net assets acquired is recorded as goodwill. Acquisition-related expenses and related restructuring costs are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Several valuation methods may be used to determine the fair value of assets acquired and liabilities assumed. For intangible assets, the Company typically uses a variation of the income approach, whereby a forecast of future cash flows attributable to the asset is discounted to present value using a risk-adjusted discount rate. Some of the more significant estimates and assumptions inherent in the income approach include the amount and timing of projected future cash flows, the discount rate selected to measure the risks inherent in the future cash flows, and the assessment of the asset&#x2019;s expected useful life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration liabilities are measured at their fair value as of the acquisition date using unobservable inputs. These inputs include the estimated amount and timing of projected operational and financial information, the probability of achievement of performance milestones or other agreed-upon events, and the risk-adjusted discount rate used to calculate the present value of the probability-weighted projected financial information. Contingent liabilities are remeasured to fair value at each reporting date until the liability is resolved. Changes in any of the inputs could result in a significant adjustment to the fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <mck:TreasuryStockPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzg5_584d15c5-5bd6-47c3-8c8e-72b4d5d3d212">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Treasury Stock:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; We record purchases of treasury stock at cost, which is reflected as a reduction to stockholders&#x2019; equity in the Company&#x2019;s Consolidated Balance Sheets. Incremental direct costs to purchase treasury stock, including any excise tax recognized as a result of the IR Act, are included in the cost of the shares acquired. Treasury stock also includes shares withheld to satisfy the tax obligations of recipients of share-based compensation.&lt;/span&gt;</mck:TreasuryStockPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjEvZnJhZzo0Yzk1OGQzZjkwYjc0ZWU4YWMwZjZhM2RiMzViYzU5Yi90ZXh0cmVnaW9uOjRjOTU4ZDNmOTBiNzRlZThhYzBmNmEzZGIzNWJjNTliXzM3Mzk0_7c766e90-2620-458e-bc08-53d0660869fd">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no adopted accounting standards during fiscal 2023 that had a material impact to the Company&#x2019;s results of operations, financial position, cash flows, or notes to the financial statements upon their adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which clarifies the guidance when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of such equity security, and requires additional disclosure requirements. ASU 2022-03 is effective for the Company on a prospective basis for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect that this guidance will have a material impact on its consolidated financial statements or related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjQvZnJhZzpjZTA2NzAzZGUwYjc0YmM2YjEzMjQ0NWRhNWJiMzZkNy90ZXh0cmVnaW9uOmNlMDY3MDNkZTBiNzRiYzZiMTMyNDQ1ZGE1YmIzNmQ3XzcyMzI_05a75fae-7f17-44a5-82f8-3cbdd6b677b3">Business Acquisitions and Divestitures &lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rx Savings Solutions, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, the Company completed its acquisition of 100% of the shares of Rx Savings Solutions, LLC (&#x201c;RxSS&#x201d;), a privately-owned company headquartered in Overland Park, Kansas, to further connect biopharma and payer services to patients. RxSS is a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers. The purchase consideration included a payment of $600&#160;million in cash made upon closing and a maximum of $275&#160;million of contingent consideration based on RxSS&#x2019; operational and financial performance through calendar year 2025. The payment made upon closing was funded from cash on hand. The financial results of RxSS are included in the Company&#x2019;s RxTS segment as of the acquisition date. The transaction was accounted for as a business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a liability for the contingent consideration at its fair value of $92&#160;million as of the acquisition date. As of March 31, 2023, the current portion of $83&#160;million is included within &#x201c;Other accrued liabilities&#x201d; and the long-term portion of $9&#160;million is included within &#x201c;Other non-current liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheet. The fair value of the contingent consideration liability was estimated using a Monte Carlo simulation model, utilizing internal cash flow projections which are Level 3 inputs under Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The contingent liability will be remeasured to fair value at each reporting date until the liability is resolved with changes in fair value being recognized within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Company&#x2019;s Consolidated Statements of Operations. Recognition of the initial fair value of this contingent consideration is a non-cash investing activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purchase price allocation included acquired identifiable intangible assets of $229&#160;million, primarily representing customer relationships and technology with a weighted average amortization period of 12 years, and goodwill of $463&#160;million. Goodwill has been allocated to the Company&#x2019;s RxTS segment, which reflects the expected future benefits from certain synergies and intangible assets that do not qualify for separate recognition. Goodwill attributable to the acquisition is deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the preliminary purchase price allocation for this acquisition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized&lt;br/&gt;as of Acquisition Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase consideration:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Identifiable assets acquired and liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total identifiable net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;SCRI Oncology, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2022, the Company completed a transaction with HCA to form SCRI Oncology, an oncology research business, combining McKesson&#x2019;s USOR and HCA&#x2019;s SCRI based in Nashville, Tennessee, to advance cancer care and increase access to oncology clinical research. Upon consummation of the transaction, McKesson owns a 51% controlling interest in the combined business, and the financial results are consolidated by the Company and reported within its U.S. Pharmaceutical segment as of the acquisition date. Transaction consideration included the transfer of full ownership interest in USOR to the combined business and $173&#160;million of cash paid to HCA, which was funded from cash on hand. The transaction was accounted for as a business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purchase price allocation included acquired identifiable intangible assets of $177&#160;million, primarily representing customer relationships as well as trademarks and trade names with a weighted average amortization period of 17 years, and goodwill of $120&#160;million. Goodwill has been allocated to the Company&#x2019;s U.S. Pharmaceutical segment, which reflects the expected future benefits from certain synergies and intangible assets that do not qualify for separate recognition. Goodwill attributable to the acquisition of $49&#160;million is deductible for tax purposes. The Company recorded noncontrolling interest of $225&#160;million as a component of equity, which includes HCA&#x2019;s proportionate interest in the identifiable net assets of SCRI at fair value of $205&#160;million and its proportionate interest in the contributed net assets of USOR at carrying value of $20&#160;million. The difference between the fair value of the Company&#x2019;s acquired interest in SCRI net assets and the $173&#160;million of cash paid to HCA was recognized as additional paid in capital, as well as the Company&#x2019;s reduction in ownership interest in USOR net assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the preliminary purchase price allocation for this acquisition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized&lt;br/&gt;as of Acquisition Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase consideration:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution of USOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Identifiable assets acquired and liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total identifiable net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the acquired identifiable intangible assets from the acquisitions discussed above were determined by applying the income approach, using a discounted cash flow model in which cash flows anticipated over several periods are discounted to their present value using an appropriate rate that is commensurate with the risk inherent with the transaction. These inputs are considered Level 3 inputs under the fair value measurements and disclosure guidance. Due to the recent timing of these acquisitions, the amounts presented above are subject to change as the Company&#x2019;s fair value assessments are finalized. Pro forma financial information has not been provided as these acquisitions did not have a material impact, individually, or in the aggregate, to the Company&#x2019;s consolidated results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the Company announced its intention to exit its businesses in Europe (&#x201c;European Divestiture Activities&#x201d;), as discussed in more detail below. Assets and liabilities of $4.5&#160;billion and $4.7&#160;billion, respectively as of March 31, 2022, met the criteria for classification as held for sale in the Company&#x2019;s Consolidated Balance Sheet, primarily consisting of disposal groups related to the Company&#x2019;s European Divestiture Activities within the International segment. At March 31, 2023, the Company had no assets or liabilities related to these divestiture activities that met the classification of held for sale and the decrease in these amounts during fiscal 2023 was driven by the divestiture of the Company&#x2019;s E.U. disposal group (as defined below) in October 2022 and U.K. disposal group (as defined below) in April 2022, each as discussed in more detail below. During the year ended March 31, 2022, the Company recorded charges totaling $1.6&#160;billion primarily to remeasure the assets and liabilities of the disposal groups to fair value less costs to sell. These charges were largely driven by declines in the Euro and British pound sterling. Net gains and charges related to these divestiture activities during the years ended March 31, 2023 and 2021 were not material. The gains and charges for each year were recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations. The Company determined that the disposal groups did not meet the criteria for classification as discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;European Divestiture Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2022, the Company completed its previously announced transaction to sell certain of its businesses in the E.U. located in France, Italy, Ireland, Portugal, Belgium, and Slovenia, along with its German headquarters and wound-care business, part of a shared services center in Lithuania, and its ownership stake in a joint venture in the Netherlands (&#x201c;E.U. disposal group&#x201d;) to the PHOENIX Group. As part of the transaction, the Company received cash proceeds of $892&#160;million and divested net assets of $1.3&#160;billion, including cash of $319&#160;million, derecognized the carrying value of its noncontrolling interest held by minority shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;) of $382&#160;million, and released $153&#160;million of net accumulated other comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended March 31, 2023 and 2022, the Company recorded net gains of $66&#160;million and net charges totaling $438&#160;million, respectively, to remeasure the E.U. disposal group to fair value less costs to sell. The charges for the year ended March 31, 2022 also included impairments of individual assets, such as certain internal-use software that will not be utilized in the future, prior to adjusting the E.U. disposal group as a whole and net losses of $151&#160;million related to the accumulated other comprehensive loss balances associated with the E.U. disposal group, driven by declines in the Euro. The charges were recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations. The Company&#x2019;s measurement of the fair value of the E.U. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the E.U. disposal group that met the classification of held for sale in the Company&#x2019;s Consolidated Balance Sheet at March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Excludes charges in fiscal 2022 related to the impairment of individual assets, including a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 6, 2022, the Company completed the previously announced sale of its retail and distribution businesses in the United Kingdom (&#x201c;U.K. disposal group&#x201d;) to Aurelius Elephant Limited for a purchase price of &#xa3;110&#160;million (or, approximately $144 million), including certain adjustments. As part of the transaction, the Company divested net assets of $615&#160;million and released $731&#160;million of accumulated other comprehensive loss and the buyer assumed and repaid a note payable to the Company of $118&#160;million. During the year ended March 31, 2022, the Company recorded charges totaling $1.2 billion, primarily consisting of adjustments to remeasure the U.K. disposal group to fair value less costs to sell. The remeasurement adjustments included a $734 million loss related to the accumulated other comprehensive loss balances associated with the U.K. disposal group, driven by declines in the British pound sterling. The charges were recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations. The Company&#x2019;s measurement of the fair value of the U.K. disposal group was based on the total consideration expected to be received by the Company as outlined in the transaction agreement. Certain components of the total consideration included fair value measurements that fall within Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#x2019;s Consolidated Balance Sheet at March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 31, 2022, the Company completed the sale of its Austrian business to Quadrifolia Management GmbH in a management-led buyout for a purchase price of &#x20ac;244&#160;million (or, approximately $276 million), including certain adjustments. The Company divested net assets of the Austrian business of $272 million and the buyer assumed a note payable to the Company of approximately $63 million which was paid to McKesson in the fourth quarter of fiscal 2022. During the year ended March 31, 2022, the Company recognized a loss of $32 million which was recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the divestiture activities discussed above, the Company&#x2019;s European operations primarily consist of its retail and distribution businesses in Norway.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;German Pharmaceutical Wholesale Joint Venture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2020, the Company completed a transaction with Walgreens Boots Alliance (&#x201c;WBA&#x201d;) whereby the majority of its German pharmaceutical wholesale business was contributed to a newly formed joint venture in which McKesson had a 30% noncontrolling interest. Transaction consideration for the contribution included a receivable amount of $41 million, primarily related to working capital and net debt adjustments from WBA, which was received in the first quarter of fiscal 2022, and the 30% interest in the newly formed joint venture. At the transaction date, the carrying value of the equity investment in the joint venture was recorded at its fair value, which was measured using inputs that fell within Level 3 of the fair value hierarchy. The carrying value of the investment in the joint venture was nil as of March 31, 2021. The Company accounted for its interest in the joint venture as an equity method investment within the International segment. The joint venture also assumed a note payable to the Company in the amount of approximately $291 million as of the transaction date, which was paid to the Company in fiscal 2021. In conjunction with the contribution, the Company recorded charges of $58 million in the year ended March 31, 2021, which included adjustments to remeasure the assets and liabilities held for sale to fair value less costs to sell. These charges were included within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations. The Company&#x2019;s measurement of the fair value of the German pharmaceutical wholesale business disposal group was based on estimates of total consideration to be received by the Company as outlined in the contribution agreement between the Company and WBA. Refer to Financial Note 5, &#x201c;Other Income, Net,&#x201d; for information regarding the divestiture of this investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the periods presented, the Company also completed de minimis acquisitions and divestitures within its operating segments. Financial results for the Company&#x2019;s business acquisitions have been included in its consolidated financial statements as of their respective acquisition dates. Purchase prices for business acquisitions have been allocated based on estimated fair values at the respective acquisition dates.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xMDc_0de768c9-8e4f-4253-900a-40e3f894d498"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia4dd209b573244c7881d99fe517c75d8_D20221101-20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF80OTU_b6beb293-6b0a-444c-9f60-42517048ae18"
      unitRef="usd">600000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i59947628e39647249591b0cbaa3bf334_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF81NDE_70393261-0407-493a-89d3-f74340fc6131"
      unitRef="usd">275000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF85NjI_efa3a44a-845c-4358-99be-6052e144fcfe"
      unitRef="usd">92000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="if401780d59f34141aabbaf7ca4d032ab_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF80OTQ3ODAyMzQ1MzQ5_f59d2c7d-a774-4149-8e2c-0524e141aed4"
      unitRef="usd">83000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="if401780d59f34141aabbaf7ca4d032ab_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF80OTQ3ODAyMzQ1MzY1_239d8e73-3405-4032-a520-5fb44b2c14f4"
      unitRef="usd">9000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xNzc4_3961ea80-7503-4737-97e3-077be9e9d41e"
      unitRef="usd">229000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia4dd209b573244c7881d99fe517c75d8_D20221101-20221101"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xMzc0Mzg5NTM2NjgwMA_41d044b0-872e-4d56-adcd-af89daf3fae4">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xOTE2_75afd898-ca40-419b-a990-a5531921d5b6"
      unitRef="usd">463000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xMzc0Mzg5NTM2NjgwMQ_e509485c-6f83-4689-ad51-c8303eccb016">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the preliminary purchase price allocation for this acquisition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized&lt;br/&gt;as of Acquisition Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase consideration:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Identifiable assets acquired and liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total identifiable net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the preliminary purchase price allocation for this acquisition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized&lt;br/&gt;as of Acquisition Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchase consideration:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution of USOR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Identifiable assets acquired and liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total identifiable net assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additional paid-in capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia4dd209b573244c7881d99fe517c75d8_D20221101-20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8yLTEtMS0xLTIyMjcxNQ_b6beb293-6b0a-444c-9f60-42517048ae18"
      unitRef="usd">600000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8zLTEtMS0xLTIyMjcxNQ_efa3a44a-845c-4358-99be-6052e144fcfe"
      unitRef="usd">92000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia4dd209b573244c7881d99fe517c75d8_D20221101-20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF80LTEtMS0xLTIyMjcxNQ_8cf13244-94c0-4d0d-a4d0-3147e0bdb36a"
      unitRef="usd">692000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF83LTEtMS0xLTIyMjcxNQ_eaafc9e0-6df7-4d4f-a79e-f4c5f2aebf46"
      unitRef="usd">5000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF84LTEtMS0xLTIyMjcxNQ_3961ea80-7503-4737-97e3-077be9e9d41e"
      unitRef="usd">229000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF85LTEtMS0xLTIyMjcxNQ_6f0b5421-154a-4344-8ebc-6db23386093e"
      unitRef="usd">3000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8xMC0xLTEtMS0yMjI3MTU_6a663247-2f20-4d8a-be98-e2c69c1db6b2"
      unitRef="usd">8000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8xMi0xLTEtMS0yMjI3MTU_7aadfc89-6da4-4b4e-bd6b-39e8c1fb65d4"
      unitRef="usd">229000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8xMy0xLTEtMS0yMjI3MTU_75afd898-ca40-419b-a990-a5531921d5b6"
      unitRef="usd">463000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
      contextRef="i9641805d39b54755bb865f24f51f1b5d_I20221101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6MjY2MDlmMTBlNDc4NDMzNzgxYjBiMzMyYzQyMDhiNTQvdGFibGVyYW5nZToyNjYwOWYxMGU0Nzg0MzM3ODFiMGIzMzJjNDIwOGI1NF8xNC0xLTEtMS0yMjI3MTU_d33af551-02f5-42b2-85e0-e0eccae0d074"
      unitRef="usd">692000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8yNzA0_678f8a24-571a-4767-bcf3-e3e95c920e9a"
      unitRef="number">0.51</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zMDA1_4b961137-026c-49ee-904c-9f09183e2874"
      unitRef="usd">173000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zMjA4_8c956e0e-7597-4131-92e0-f7ec019eb17a"
      unitRef="usd">177000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8xMzc0Mzg5NTM2NjgwMg_04a00163-7bf7-4a81-853a-09be0d8bd16e">P17Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zMzY5_3b126107-3e1c-4b3b-93ed-3aa6b0b225f8"
      unitRef="usd">120000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zNjI2_6dc4904a-aae9-4bfe-8711-0cd4a7822e5d"
      unitRef="usd">49000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zNzA5_340969bf-5c19-4a1f-b50c-aeb687f91b40"
      unitRef="usd">225000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i9259fb307c6141ab8b52ca6d3a1907c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zODM4_59d3d014-f284-444f-9589-89311462c583"
      unitRef="usd">205000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i625dd0b0aa6e4e8d97d061d0a70a7e97_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF8zOTMx_c0e5db4e-f315-455e-88bb-9bd61608490c"
      unitRef="usd">20000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGV4dHJlZ2lvbjowNzU2OTZkOWEzNDk0MWVmOTM5ZjA5ZDNmYTlmZGI0OF80MDM1_4b961137-026c-49ee-904c-9f09183e2874"
      unitRef="usd">173000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8yLTEtMS0xLTIyMjcxNQ_4b961137-026c-49ee-904c-9f09183e2874"
      unitRef="usd">173000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <mck:BusinessCombinationConsiderationTransferredOwnershipInterest
      contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8zLTEtMS0xLTIyMjcxNQ_51cc7deb-590b-4863-9375-d9cedcd0ed46"
      unitRef="usd">40000000</mck:BusinessCombinationConsiderationTransferredOwnershipInterest>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV80LTEtMS0xLTIyMjcxNQ_b2f26eb6-64de-4fd2-8f96-6b41598fa31c"
      unitRef="usd">213000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV83LTEtMS0xLTIyMjcxNQ_a9d4f468-8edf-4585-bfbe-ed0ea01dc7cd"
      unitRef="usd">224000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV85LTEtMS0xLTIyMjcxNQ_2b7d9fdf-d716-4028-b32b-775dbce5171b"
      unitRef="usd">22000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xMC0xLTEtMS0yMjI3MTU_e94fb0ae-5a1a-4fbe-ad20-68f8477d3dbc"
      unitRef="usd">31000000</mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xMS0xLTEtMS0yMjI3MTU_8c956e0e-7597-4131-92e0-f7ec019eb17a"
      unitRef="usd">177000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xMy0xLTEtMS0yMjI3MTU_ed20a7a0-00c4-4167-8ef4-d91024ca171d"
      unitRef="usd">42000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xNC0xLTEtMS0yMjI3MTU_75de5cc0-6c63-4672-bd3f-0eaab69952d9"
      unitRef="usd">29000000</mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xNS0xLTEtMS0yMjI3MTU_6ff33e18-e996-4a23-a1cf-6ccd09790da3"
      unitRef="usd">43000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xNi0xLTEtMS0yMjI3MTU_6cfba9af-3a4d-4ee0-9e30-f4e108f5e3f3"
      unitRef="usd">340000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xNy0xLTEtMS0yMjI3MTU_340969bf-5c19-4a1f-b50c-aeb687f91b40"
      unitRef="usd">225000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xOC0xLTEtMS0yMjI3MTU_6407e30a-eb69-4755-bed6-cd633fc4740d"
      unitRef="usd">22000000</mck:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital>
    <us-gaap:Goodwill
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8xOS0xLTEtMS0yMjI3MTU_3b126107-3e1c-4b3b-93ed-3aa6b0b225f8"
      unitRef="usd">120000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
      contextRef="icf8aef407b7f488e85c6b12526cca4c8_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMzc4L2ZyYWc6MDc1Njk2ZDlhMzQ5NDFlZjkzOWYwOWQzZmE5ZmRiNDgvdGFibGU6Y2FjYjIxOTc4NDNhNGU2YmJlMWNiM2ZiNmI2NzcxNDEvdGFibGVyYW5nZTpjYWNiMjE5Nzg0M2E0ZTZiYmUxY2IzZmI2YjY3NzE0MV8yMC0xLTEtMS0yMjI3MTU_98c1ef5f-1097-427d-b6d2-421e9abe884e"
      unitRef="usd">213000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i7746d7d6c7f74bd5a522363e31a8b366_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8zOTU_b9670dc6-bb76-41b6-bc28-5c53dbd38b65"
      unitRef="usd">4500000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i7746d7d6c7f74bd5a522363e31a8b366_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF80MDI_67d34130-ef3c-4b5f-b850-a7e0cd88b873"
      unitRef="usd">4700000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i260e787e79514142b7c391cce58ca8d4_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF83MDU_9c43cbd4-f534-434a-9f87-32ab991bdc01"
      unitRef="usd">1600000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i54bfea324a094e7f996dd8a56ee105f4_D20221031-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTM4_0a6f8390-4130-42e2-8eff-1baa9953e9b6"
      unitRef="usd">892000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i522ab9fff9ee4ecb8c2fbd1f12f1d934_I20221031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTQz_3f524a0e-5769-4504-8152-5e273568af99"
      unitRef="usd">1300000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i522ab9fff9ee4ecb8c2fbd1f12f1d934_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTUw_6cc76c7d-3203-40fd-a3a3-61473b6dfb09"
      unitRef="usd">319000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <mck:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest
      contextRef="i522ab9fff9ee4ecb8c2fbd1f12f1d934_I20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTU0_e1edec51-e543-4329-866f-aa0a1ba098f2"
      unitRef="usd">382000000</mck:DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i54bfea324a094e7f996dd8a56ee105f4_D20221031-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTY1_759278f0-480e-4c7e-89d0-0361c5d4bf95"
      unitRef="usd">153000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i9b9815e733a0475592cd7fada3bced42_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjM5ODE2_c28dd133-1ef5-4011-801d-e1e86feb1ff8"
      unitRef="usd">-66000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ifc7a65af5b26474e8427ff7f8bd6ce64_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8yMjgz_a9e26b09-ebf0-4d7a-9d0e-5ed844493030"
      unitRef="usd">438000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue
      contextRef="ifc7a65af5b26474e8427ff7f8bd6ce64_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8yNjA1_9a78e85a-5184-4963-aa43-711e78c66333"
      unitRef="usd">151000000</mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF83MjM1_aa6c8085-9bb5-465e-a33c-269f2ab4b3da">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the E.U. disposal group that met the classification of held for sale in the Company&#x2019;s Consolidated Balance Sheet at March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Excludes charges in fiscal 2022 related to the impairment of individual assets, including a $113 million impairment of internally developed software recorded directly against the gross value of the assets impacted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total assets and liabilities of the U.K. disposal group that met the classification of held for sale in the Company&#x2019;s Consolidated Balance Sheet at March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remeasurement of assets of businesses held for sale to fair value less costs to sell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Drafts and accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities held for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18zLTEtMS0xLTIyMjczNA_1a994681-aee6-42fd-b423-2c6a7ffe1715"
      unitRef="usd">1322000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y180LTEtMS0xLTIyMjczNA_574529ea-efe5-4a5c-8f5c-0d4bd90cd85b"
      unitRef="usd">809000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y181LTEtMS0xLTIyMjczNA_fddf1e4d-01fb-4837-98eb-0efdb9137144"
      unitRef="usd">72000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y182LTEtMS0xLTIyMjczNA_82f61da0-b415-4f50-b387-e8eee6b2bdd9"
      unitRef="usd">304000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y183LTEtMS0xLTIyMjczNA_311efa28-1860-4042-b6bc-6cd5aecfbc54"
      unitRef="usd">224000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y184LTEtMS0xLTIyMjczNA_2d27d4a6-5a33-4cb3-8776-d38893c35263"
      unitRef="usd">267000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y185LTEtMS0xLTIyMjczNA_d8c3ee53-3882-498e-ab2c-16b5665b1724"
      unitRef="usd">328000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xMC0xLTEtMS0yMjI3MzQ_3b5bc39f-e8fe-4182-a86c-6a37d216b30d"
      unitRef="usd">302000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xMS0xLTEtMS0yMjI3MzQ_45da52ac-153c-45ac-a5c1-d43a55e0287a"
      unitRef="usd">3024000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xNS0xLTEtMS0yMjI3MzQ_5dfcdf16-1c32-483c-9fef-cbe68b35a614"
      unitRef="usd">1826000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xNi0xLTEtMS0yMjI3MzQ_769ac0bd-bb1f-413d-9fef-d7ca31bcb544"
      unitRef="usd">4000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xNy0xLTEtMS0yMjI3MzQ_1afed3f1-5691-4e62-9226-44610d27d6ca"
      unitRef="usd">33000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xOC0xLTEtMS0yMjI3MzQ_d75bc6ed-07cd-4dff-8c05-d57f47a79cf6"
      unitRef="usd">473000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18xOS0xLTEtMS0yMjI3MzQ_6fdcce88-a1d5-4ffd-8d86-88f04ac5576c"
      unitRef="usd">11000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18yMC0xLTEtMS0yMjI3MzQ_28f3fbd1-c855-40c2-9ed3-8f775a4c8345"
      unitRef="usd">55000000</mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18yMS0xLTEtMS0yMjI3MzQ_2aec0820-45c2-406a-94ac-81d0d1091811"
      unitRef="usd">180000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18yMi0xLTEtMS0yMjI3MzQ_f47c06a3-9a95-431a-b447-46f73e6b5c1c"
      unitRef="usd">138000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="ibe5a2e65fb56419382b72990eee9a1e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6ZmYwOTZlYmEwZGQzNDZiODgwZjE4YTUyZGQwNTgxNGMvdGFibGVyYW5nZTpmZjA5NmViYTBkZDM0NmI4ODBmMThhNTJkZDA1ODE0Y18yMy0xLTEtMS0yMjI3MzQ_6725a2c7-58cf-49f1-b06f-5691732cf10a"
      unitRef="usd">2720000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware
      contextRef="i382c204f13554d4e8ece4058bc5b69c6_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8zNDIx_ea8f3847-c531-4904-aac3-cd27d90292e5"
      unitRef="usd">113000000</mck:DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="ib62a5923230c46c49e36098ccca7369e_I20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8zODA3_b9450423-42a7-4441-830b-e5bd4064f00b"
      unitRef="gbp">110000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="ib62a5923230c46c49e36098ccca7369e_I20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8zODI5_29826d81-bd26-45e8-abd9-9bb86d0c9df7"
      unitRef="usd">144000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i4c4a29b7f1134f299939b7067a5bbc68_I20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTc5_758a10b9-9d7c-44b9-a79a-644a2a117edb"
      unitRef="usd">615000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia42344bf1adb4cdeb5624c43ce11a349_D20220406-20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTg2_104ee135-a39b-438b-a95b-f2feea770217"
      unitRef="usd">731000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="ie11de948c9444efb94e5917cae16710f_D20220406-20220406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8xMDk5NTExNjQxOTc1_497d6306-27cb-4f5a-8de0-de29614a438a"
      unitRef="usd">118000000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i58454d4bece0446ab49687291c0c1cd5_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF8zOTI5_cd34ab3e-88ac-4ba1-bf34-c92068366294"
      unitRef="usd">1200000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue
      contextRef="i58454d4bece0446ab49687291c0c1cd5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF80MDgw_487ce79d-5c29-4329-8af5-19149a00bd7c"
      unitRef="usd">734000000</mck:DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8zLTEtMS0xLTIyMjczNA_bc03964b-6b20-4aa4-ad8e-e384237b03b1"
      unitRef="usd">531000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl80LTEtMS0xLTIyMjczNA_bccf5e43-a083-44c2-b386-a14492073743"
      unitRef="usd">931000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl81LTEtMS0xLTIyMjczNA_725c8db8-b341-4537-9f81-24ba3e280d08"
      unitRef="usd">563000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl82LTEtMS0xLTIyMjczNA_c9cb00f0-09dd-4630-8259-c8482a04b018"
      unitRef="usd">50000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl83LTEtMS0xLTIyMjczNA_8527fc19-eea8-4be8-b433-cfef9b6795a1"
      unitRef="usd">91000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl84LTEtMS0xLTIyMjczNA_5c9c04ea-484f-44eb-bc3d-3a16b95c3c55"
      unitRef="usd">270000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl85LTEtMS0xLTIyMjczNA_fcff1731-4582-4e61-a395-2f019098a743"
      unitRef="usd">117000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xMC0xLTEtMS0yMjI3MzQ_40a4c848-aafe-4d5b-8d08-670055d3cda8"
      unitRef="usd">88000000</mck:DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xMS0xLTEtMS0yMjI3MzQ_5eff57bf-f12f-4b81-965c-3d92610b04b5"
      unitRef="usd">1159000000</mck:DisposalGroupNotDiscontinuedOperationLossGainonWritedown1>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xMi0xLTEtMS0yMjI3MzQ_5515d16e-f119-44ca-8c9f-b5e55038b932"
      unitRef="usd">1482000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xNi0xLTEtMS0yMjI3MzQ_b17ac424-f3d1-4a81-9d75-9a9ef4bed510"
      unitRef="usd">1593000000</mck:DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xOC0xLTEtMS0yMjI3MzQ_f3a4da1a-6b55-43c8-981d-6d38a9a8a27a"
      unitRef="usd">50000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8xOS0xLTEtMS0yMjI3MzQ_f3203f25-5c2b-49a6-a556-27edcb1bf21b"
      unitRef="usd">59000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8yMS0xLTEtMS0yMjI3MzQ_2ffc1fe6-cf6c-43bf-971a-876f0ffedebf"
      unitRef="usd">16000000</mck:DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet>
    <mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8yMi0xLTEtMS0yMjI3MzQ_928abdd6-3265-4c04-8671-a492e4c4dc41"
      unitRef="usd">262000000</mck:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8yMy0xLTEtMS0yMjI3MzQ_7dab4953-9439-4421-b8ff-a58ffb1bbae8"
      unitRef="usd">38000000</mck:DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i1def0e3a8d774f6b89cf0c1afaf9db22_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGFibGU6MzZjMjM2NDVjNGUyNGNmZWJhOGRmNTRiN2RkMzE3OTYvdGFibGVyYW5nZTozNmMyMzY0NWM0ZTI0Y2ZlYmE4ZGY1NGI3ZGQzMTc5Nl8yNC0xLTEtMS0yMjI3MzQ_2d110ee8-1b17-4d7d-ba6b-7597ebeb12b3"
      unitRef="usd">2018000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i4c359290f5374ebcb781e2a05480221e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81MTE0_ba4d2f00-2ccf-4c9b-aa78-30ef57dd87ea"
      unitRef="eur">244000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i4c359290f5374ebcb781e2a05480221e_I20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81MTM2_27e0866c-197c-46ff-8cb3-637cb3085295"
      unitRef="usd">276000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:AssetsNet
      contextRef="i85ba3e843a814a899aaf3a87e8422f9d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81MjMy_8eb0a8f4-65e1-48a9-8fc8-3a4ed174c1fc"
      unitRef="usd">272000000</us-gaap:AssetsNet>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="i10dc0fc369ee4d088df51fef92fe40e1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81MzQ5_29260afb-67ed-4f21-a1dd-fffc445cf39a"
      unitRef="usd">63000000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ie4656299b20c436497390a7e79147f34_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81NDY5_c7d3a9ed-aa7c-4394-b597-c4280e86b810"
      unitRef="usd">32000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i7351ec7b72b6422a82ab0afffdd65c27_I20201101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81ODAx_a8a27c37-6652-4ff0-a17d-906c02cd40bc"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable
      contextRef="ifd040622e9b1489ba2addf0494df3a62_I20201101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF81OTA4_373c3e97-a904-4bf2-86e7-8fc67b30ecaa"
      unitRef="usd">41000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i7351ec7b72b6422a82ab0afffdd65c27_I20201101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF82MDQx_a8a27c37-6652-4ff0-a17d-906c02cd40bc"
      unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i2646e19a2c8440d08bc15a4216ccadaf_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF82MzU4_77fde351-5b5a-44af-b871-41e82b301846"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="if02745e482324982aa1ae5309d602ded_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF82NTg4_88bd520c-af8e-4326-941a-3ba93c4a087b"
      unitRef="usd">291000000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="if2e3b761b77d4b7cbc297831b399408a_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDA1L2ZyYWc6ODBhNWY2NjllZjA2NDZkYTg0YmJlOWE2NTdlZDkyMDAvdGV4dHJlZ2lvbjo4MGE1ZjY2OWVmMDY0NmRhODRiYmU5YTY1N2VkOTIwMF82NzI3_45ffbf42-dfbd-406c-982d-2137a3ac6ac0"
      unitRef="usd">58000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3NDU_e7369fcc-d723-4d99-9465-eebaffd1ebf7">Restructuring, Impairment, and Related Charges, Net &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded restructuring, impairment, and related charges, net, of $209 million, $281 million, and $334 million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively. These charges are included in &#x201c;Restructuring, impairment, and related charges, net&#x201d; in the Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restructuring Initiatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of fiscal 2023, the Company approved a broad set of initiatives to drive operational efficiencies and increase cost optimization efforts, with the intent of simplifying its infrastructure and realizing long-term sustainable growth. These initiatives include headcount reductions and the exit or downsizing of certain facilities. The Company anticipates total charges of approximately $125&#160;million across its RxTS and U.S. Pharmaceutical segments as well as Corporate, consisting primarily of employee severance and other employee-related costs, facility and other exit-related costs, as well as long-lived asset impairments. The Company recorded charges of $60 million for the year ended March 31, 2023 related to this program, which reflects severance and other employee-related costs within its RxTS segment as well as asset impairments and accelerated depreciation, including certain asset impairments primarily within its U.S. Pharmaceutical segment and real estate charges within Corporate. This restructuring program is anticipated to be substantially complete by the end of fiscal 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily included the rationalization of the Company&#x2019;s office space in North America. Where the Company ceased using office space, it exited the portion of the facility no longer used. It also retained and repurposed certain other office locations. The Company recorded charges of $124&#160;million for the year ended March 31, 2022, primarily related to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. This initiative was substantially complete in fiscal 2022 after which immaterial charges will continue to be incurred through the termination date of certain leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal 2021, the Company committed to an initiative within the U.K., which was included in the Company&#x2019;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative included reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. Charges incurred for this initiative were not material for the year ended March 31, 2022 and were $57 million for the year ended March 31, 2021, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. This initiative was substantially complete in fiscal 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of fiscal 2019, the Company committed to certain programs to continue its operating model and cost optimization efforts. The Company implemented centralization of certain functions and outsourcing through an expanded arrangement with a third-party vendor to achieve operational efficiency. The programs also included reorganization and consolidation of business operations, related headcount reductions, the further closures of retail pharmacy stores in Europe, and closures of other facilities. The Company recorded charges of $62 million for the year ended March 31, 2021, consisting primarily of employee severance, accelerated depreciation expense, and project consulting fees. This initiative was substantially complete in fiscal 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously announced on November 30, 2018, the Company relocated its corporate headquarters, effective April 1, 2019, from San Francisco, California to Irving, Texas to improve efficiency, collaboration, and cost competitiveness. As a result, the Company recorded charges of $28 million for the year ended March 31, 2021, consisting primarily of employee retention expenses, severance, long-lived asset impairments, and accelerated depreciation. The relocation was substantially complete in January 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2023 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2023 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to operational efficiencies and cost optimization efforts described above to support the Company&#x2019;s technology solutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. Corporate includes costs for business transformation and optimization efforts related to the Company&#x2019;s technology organization. The International segment includes costs related to the Company&#x2019;s European divestitures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2022 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. For the Company&#x2019;s International segment, costs primarily relate to optimization programs in Canada, exit-related actions for the Company&#x2019;s European Divestiture Activities, and programs for operating model and cost optimization efforts in the U.K. as described above. For Corporate, primarily represents costs related to the transition to the partial remote work model described above and various other initiatives. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Costs primarily relate to the transition to the partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#x2019;s headquarters described above in addition to various other initiatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the years ended March 31, 2023 and 2022: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Other primarily includes cumulative translation adjustments and transfers to certain other liabilities. For the Company&#x2019;s International segment, other also includes a reduction to the liability for the divestitures of the E.U. disposal group and the U.K. disposal group in fiscal 2023, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $36 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $36 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;As of March 31, 2023, the total reserve balance was $92 million, of which $66 million was recorded in &#x201c;Other accrued liabilities&#x201d; and $26 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Asset Impairments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2023&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no material long-lived asset impairments recorded in fiscal 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2022, the Company recognized charges totaling $36 million to impair certain long-lived assets within the International segment related to the Company&#x2019;s previous operations in Denmark and its retail pharmacy businesses in Canada. The Company used an income approach and a market approach to estimate the fair value of the long-lived assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;fiscal 2021, the Company recognized charges of $115 million to impair certain long-lived assets within the Company&#x2019;s International segment. These charges primarily related to long-lived assets associated with the Company&#x2019;s retail pharmacy businesses in Canada and Europe and were due to declines in estimated future cash flows partially driven by a revised outlook regarding the impacts of COVID-19. The Company used both an income approach and a market approach to estimate the fair value of the long-lived assets.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzkw_9a1a7f9c-a530-488d-b156-8bef65c7c809"
      unitRef="usd">209000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzk0_3c23df35-0ea0-4fbc-a3db-4122cc9c1bb4"
      unitRef="usd">281000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzEwMg_5f8322bb-de00-462a-a18a-289b1dc9734e"
      unitRef="usd">334000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i9c75333b88e542c4ba71e94b1d28056e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3OTYwOTMwNDgxNDY_f42f5f29-574c-47e9-8556-340526fe747b"
      unitRef="usd">125000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringCharges
      contextRef="ibfc71eef9d254de48d739e651f3d7561_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgzOTUyNg_e0872bc8-377e-479e-8735-795329f92c33"
      unitRef="usd">60000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7a6fc260a6de4b629a6b4970e20fe6aa_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzYwNDczMTM5NjM3ODA_83553d8b-563f-479b-8fbe-7785f4706fe6"
      unitRef="usd">124000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7a4a0202812f4880a82a0487047cc47f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3OTYwOTMwNDQ4ODQ_c5656c7c-01e2-4b49-994a-3b4ef08e5dc9"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ifa888a5ec0d944f1a58684506e131405_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgyNTA5MQ_79197b9e-7194-41e0-8abc-0bc03b23d4af"
      unitRef="usd">57000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia88c62cc31154e05941895097f4eb653_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgyNTcwNg_54bda34b-1d25-4a6c-b0ee-8b1fb3e82b63"
      unitRef="usd">62000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9f3eb833b0314352811520832d05703c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgyNjI2Nw_81600214-2019-4a6b-b40f-0664e2865306"
      unitRef="usd">28000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3NTA_ce5e4e70-3b78-4db5-9d67-51189aac7d1e">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2023 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes costs related to operational efficiencies and cost optimization efforts described above to support the Company&#x2019;s technology solutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. Corporate includes costs for business transformation and optimization efforts related to the Company&#x2019;s technology organization. The International segment includes costs related to the Company&#x2019;s European divestitures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2022 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred. For the Company&#x2019;s International segment, costs primarily relate to optimization programs in Canada, exit-related actions for the Company&#x2019;s European Divestiture Activities, and programs for operating model and cost optimization efforts in the U.K. as described above. For Corporate, primarily represents costs related to the transition to the partial remote work model described above and various other initiatives. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Costs primarily relate to the transition to the partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges, net for the year ended March 31, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the operating model and cost optimization efforts described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents costs associated with the operating model cost optimization efforts and the relocation of the Company&#x2019;s headquarters described above in addition to various other initiatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItMS0xLTEtMjE4NzQ4_67c3ca33-9ec8-4400-85a7-96b53ebdf100"
      unitRef="usd">6000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItMy0xLTEtMjE4NzQ4_894c3aca-ef63-4e4e-940e-be0cf2092f44"
      unitRef="usd">23000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItNS0xLTEtMjE4NzQ4_1d1f245a-f0f0-488f-a2b8-706b6f81bd5b"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItNy0xLTEtMjE4NzQ4_fd267ce9-d40b-48f6-aa7a-082c41d8eec9"
      unitRef="usd">4000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItOS0xLTEtMjE4NzQ4_3d78b770-3c56-47f4-818c-e391207f6aa0"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzItMTEtMS0xLTIxODc0OA_282f7db0-438e-46c0-a60a-e8e6a7a1a1ba"
      unitRef="usd">35000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtMS0xLTEtMjE4NzQ4_96e0c371-81ed-4ae4-ba7a-efb9bf12ae9e"
      unitRef="usd">7000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtMy0xLTEtMjE4NzQ4_7776767a-61b2-4774-938a-98aec9754e96"
      unitRef="usd">7000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtNS0xLTEtMjE4NzQ4_778d52fa-d644-40c1-b6d4-5a9a7fa74db6"
      unitRef="usd">3000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtNy0xLTEtMjE4NzQ4_f59f76d3-b0b3-4bf8-b7e9-e688c465d0c6"
      unitRef="usd">21000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtOS0xLTEtMjE4NzQ4_bbbc42cd-4319-4286-ac51-d7ff4a2912ae"
      unitRef="usd">64000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzMtMTEtMS0xLTIxODc0OA_26f4023b-6059-4947-b401-f369b01781ea"
      unitRef="usd">102000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtMS0xLTEtMjE4NzQ4_2988d6ad-f248-4863-bf57-d80597715b82"
      unitRef="usd">25000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtMy0xLTEtMjE4NzQ4_39a1446a-52d7-4572-a724-9de35a7ed7ab"
      unitRef="usd">13000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtNS0xLTEtMjE4NzQ4_a1e1f614-e6c0-4b8d-ac77-4b32bc524029"
      unitRef="usd">5000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtNy0xLTEtMjE4NzQ4_441a8bc9-0a59-4eb9-8d7e-85c9de7f46f1"
      unitRef="usd">10000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtOS0xLTEtMjE4NzQ4_ed3ae0ce-8967-4cf3-82a7-1780a1588c5e"
      unitRef="usd">19000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzQtMTEtMS0xLTIxODc0OA_1d8eacbb-dd95-43ba-9ca0-1f31b82677a7"
      unitRef="usd">72000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtMS0xLTEtMjE4NzQ4_9c83d7bf-864d-437e-ba1b-bb1719428e4e"
      unitRef="usd">38000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtMy0xLTEtMjE4NzQ4_038535f4-5c99-49c9-9385-8f3bfa78048d"
      unitRef="usd">43000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtNS0xLTEtMjE4NzQ4_ddb2fef9-b2b2-4aba-b0a3-50a3a0bb517c"
      unitRef="usd">10000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtNy0xLTEtMjE4NzQ4_04663a3e-ccde-4470-a342-ba7c6432c841"
      unitRef="usd">35000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtOS0xLTEtMjE4NzQ4_e966d969-dbd6-4339-a320-cc8eb75618f9"
      unitRef="usd">83000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5MGJkOTdiMGY5OWI0NjY1ODVjZmYzNmU4OWRhZjZhMC90YWJsZXJhbmdlOjkwYmQ5N2IwZjk5YjQ2NjU4NWNmZjM2ZTg5ZGFmNmEwXzUtMTEtMS0xLTIxODc0OA_b1d1a2dc-7470-4585-95b5-c3244f91d9b6"
      unitRef="usd">209000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItMS0xLTEtMjE4NzQ4_f9ed6fe0-6deb-4218-9b48-33223912793e"
      unitRef="usd">8000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItMy0xLTEtMjE4NzQ4_9dbbc1cc-0207-4690-9933-f6f23d725c6f"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItNS0xLTEtMjE4NzQ4_0777a5f1-60b3-41e6-93d5-87d0c478e68a"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItNy0xLTEtMjE4NzQ4_81f528a3-bfca-4b27-a48f-62c8c7591254"
      unitRef="usd">8000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItOS0xLTEtMjE4NzQ4_0913ace5-b272-400b-a1a7-263ebfd30362"
      unitRef="usd">-7000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzItMTEtMS0xLTIxODc0OA_de639d83-68c4-44d7-8a53-fe6c0556c2df"
      unitRef="usd">9000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtMS0xLTEtMjE4NzQ4_ef42fb05-52b5-47b8-8508-9f41408bc7ce"
      unitRef="usd">9000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtMy0xLTEtMjE4NzQ4_3e2a8ed5-5111-4d51-9b47-9e3cd8c7d7ae"
      unitRef="usd">4000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtNS0xLTEtMjE4NzQ4_30fc74d4-7ecf-448b-ac77-1c37c37ab78b"
      unitRef="usd">5000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtNy0xLTEtMjE4NzQ4_b717f76f-7161-43df-becd-bb6cc93156ff"
      unitRef="usd">33000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtOS0xLTEtMjE4NzQ4_5657485b-a129-4054-8af0-e39d0b09db62"
      unitRef="usd">46000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzMtMTEtMS0xLTIxODc0OA_a4ded195-075b-4779-a850-82ef78800c9b"
      unitRef="usd">97000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtMS0xLTEtMjE4NzQ4_dc51a33a-51ea-4087-86d6-42d1a96d2f8d"
      unitRef="usd">18000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtMy0xLTEtMjE4NzQ4_89db1188-fd79-44ac-a5d0-858cbcf05231"
      unitRef="usd">20000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtNS0xLTEtMjE4NzQ4_7851ee50-3db2-47d5-a15f-8d38915f93bd"
      unitRef="usd">5000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtNy0xLTEtMjE4NzQ4_2cf883e4-735f-463b-b034-d86e04ec3c63"
      unitRef="usd">35000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtOS0xLTEtMjE4NzQ4_961bc2d0-8c62-4119-8f3b-e4a7bd3c2b3a"
      unitRef="usd">61000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzQtMTEtMS0xLTIxODc0OA_947280fe-4421-4505-b2d7-09cdece13659"
      unitRef="usd">139000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtMS0xLTEtMjE4NzQ4_48de05e8-0f08-4cbf-947a-1e0c75b97a7e"
      unitRef="usd">35000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtMy0xLTEtMjE4NzQ4_478b4967-e0d8-4f8b-bfa4-88ab0cfa7ce4"
      unitRef="usd">25000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtNS0xLTEtMjE4NzQ4_97b0cbed-d186-45b0-9ee4-1ba73cfce8ec"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtNy0xLTEtMjE4NzQ4_dde76f4c-2c69-408b-a24b-b51b68446607"
      unitRef="usd">76000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtOS0xLTEtMjE4NzQ4_199793ae-9c2b-40c4-8558-0d7756f1b8d6"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo5YTU5MjNkNzUzZTA0ZDVmOGVmYTAwMjNiMGNmZWY3ZS90YWJsZXJhbmdlOjlhNTkyM2Q3NTNlMDRkNWY4ZWZhMDAyM2IwY2ZlZjdlXzUtMTEtMS0xLTIxODc0OA_617696ea-1773-43d0-bd3e-5866e472cc1c"
      unitRef="usd">245000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItMS0xLTEtMjM1MjUz_86032241-dc96-49b2-8b87-c15ce56ccabc"
      unitRef="usd">10000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItMy0xLTEtMjM1MjUz_e22ad945-1301-41e2-9b5e-1c06eec0a620"
      unitRef="usd">4000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItNS0xLTEtMjM1MjUz_a4103037-37d8-47b9-9a1a-3bcadd330e7a"
      unitRef="usd">-1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItNy0xLTEtMjM1MjUz_2ae67b2a-0ca5-4d3d-8a94-01a03e1908a1"
      unitRef="usd">22000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItOS0xLTEtMjM1MjUz_d4f18335-1920-4627-b4b5-9e3465d0aa86"
      unitRef="usd">69000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzItMTEtMS0xLTIzNTI1Mw_3e0ea8c6-3960-4e8f-b832-19b19c33b304"
      unitRef="usd">104000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtMS0xLTEtMjM1MjUz_d50a92f4-f877-48d6-8ba3-e800a69faebf"
      unitRef="usd">11000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtMy0xLTEtMjM1MjUz_29d7c08c-e141-40c7-ae82-d0a9317feee0"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtNS0xLTEtMjM1MjUz_49ac6572-7f0c-4315-8949-dac0b06db87b"
      unitRef="usd">4000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtNy0xLTEtMjM1MjUz_3dfa5a48-1721-4a2b-a45d-be015faa076f"
      unitRef="usd">17000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtOS0xLTEtMjM1MjUz_e9e7540e-19c1-4781-a01f-71121930c324"
      unitRef="usd">27000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzMtMTEtMS0xLTIzNTI1Mw_80439d6d-77a7-4974-91a1-5418e0517ac0"
      unitRef="usd">59000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtMS0xLTEtMjM1MjUz_dbac34c4-7f2f-4981-a76f-1268b9c10f6c"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtMy0xLTEtMjM1MjUz_bc859aea-66b9-44be-96c9-0a1e86dfc902"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtNS0xLTEtMjM1MjUz_6c73182b-9fc8-498c-aed8-d9034c8f3721"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtNy0xLTEtMjM1MjUz_99b9366c-1c69-467b-b00d-86bf42264681"
      unitRef="usd">46000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtOS0xLTEtMjM1MjUz_9df35b4a-4e68-4247-86dc-cf428b9f122e"
      unitRef="usd">9000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzQtMTEtMS0xLTIzNTI1Mw_1cdd8872-5a35-414c-82d2-6bb9accd1587"
      unitRef="usd">56000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtMS0xLTEtMjM1MjUz_78aafa78-2e98-40f8-99ee-ee8ec8760607"
      unitRef="usd">21000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtMy0xLTEtMjM1MjUz_a158d998-218c-45b8-9792-6d8d28a0b263"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtNS0xLTEtMjM1MjUz_4008fa5c-307a-4716-82d6-5d6b2699a54f"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtNy0xLTEtMjM1MjUz_fee68f92-4eae-4e2b-988b-78dbec03ad94"
      unitRef="usd">85000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtOS0xLTEtMjM1MjUz_db22c55a-35ac-4db2-a813-55d9ec1bcc7a"
      unitRef="usd">105000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTowNzhlYjM3MmZhYjI0MjQ5YjdhZjkxMTkyZGI0Yzk2Zi90YWJsZXJhbmdlOjA3OGViMzcyZmFiMjQyNDliN2FmOTExOTJkYjRjOTZmXzUtMTEtMS0xLTIzNTI1Mw_d8f86498-6fa1-4714-8c4e-175c940cb587"
      unitRef="usd">219000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3NDQ_49c00ec9-cf3f-4479-a790-0848bd725e59">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the years ended March 31, 2023 and 2022: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Other primarily includes cumulative translation adjustments and transfers to certain other liabilities. For the Company&#x2019;s International segment, other also includes a reduction to the liability for the divestitures of the E.U. disposal group and the U.K. disposal group in fiscal 2023, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;As of March 31, 2022, the total reserve balance was $130 million, of which $58 million was recorded in &#x201c;Other accrued liabilities,&#x201d; $36 million was recorded in &#x201c;Liabilities held for sale,&#x201d; and $36 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&#160;&#160;&#160;&#160;As of March 31, 2023, the total reserve balance was $92 million, of which $66 million was recorded in &#x201c;Other accrued liabilities&#x201d; and $26 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="ica9a08587ca04030b0e7cc35fa7d526b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtMS0xLTEtMjE4NzQ4_a77059e1-f6d8-4ff9-bce0-5540a5c8bc95"
      unitRef="usd">19000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i663d657bf1e24bbcb2dbc5356bd8a9d7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtMy0xLTEtMjE4NzQ4_15f7ed5e-5a02-48de-88fd-3128998f7161"
      unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0450b305293d4d12a476155c59674aac_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtNS0xLTEtMjE4NzQ4_732acdf6-728d-4a5d-a7fd-181872afadd4"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="icf0b80c33ebe40fbb027ad323e881fa7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtNy0xLTEtMjE4NzQ4_59b88ace-86d9-419a-b5bc-7060075b2f6c"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i842e5c3e1d294131aa2e71ec30e3c3e1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtOS0xLTEtMjE4NzQ4_0b4dce1d-36fc-4531-910b-8701d88c7788"
      unitRef="usd">59000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEtMTEtMS0xLTIxODc0OA_4a93fae4-1bc5-493e-a5dc-3515bec96942"
      unitRef="usd">151000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItMS0xLTEtMjE4NzQ4_f698b501-dd5b-4898-9cb0-723cdd933076"
      unitRef="usd">35000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItMy0xLTEtMjE4NzQ4_91340250-21c7-4b49-8968-e8dd64cf14a4"
      unitRef="usd">25000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItNS0xLTEtMjE4NzQ4_fd4eaa9d-7520-458b-87b3-04f7280d70a3"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItNy0xLTEtMjE4NzQ4_45a96a86-cba7-4ee1-9ee6-7c987078b031"
      unitRef="usd">76000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItOS0xLTEtMjE4NzQ4_c1a1385a-9d55-4b9b-8857-55db03ff1245"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzItMTEtMS0xLTIxODc0OA_f509ac17-9c99-4d76-995c-dc6a9740e922"
      unitRef="usd">245000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtMS0xLTEtMjE4NzQ4_94f0aabc-6dad-4c4a-931b-f3dc38991180"
      unitRef="usd">18000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtMy0xLTEtMjE4NzQ4_db4edd8b-d3d0-465e-bb75-c97d4859d095"
      unitRef="usd">20000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtNS0xLTEtMjE4NzQ4_dd15853d-7c28-42ce-b9ed-32983de3e4fd"
      unitRef="usd">5000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtNy0xLTEtMjE4NzQ4_d53aa838-3cc0-4678-9579-5ddf9775ff89"
      unitRef="usd">35000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtOS0xLTEtMjE4NzQ4_82b547c4-7db5-4100-8c47-282ea83371f5"
      unitRef="usd">61000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzMtMTEtMS0xLTIxODc0OA_d3a4a288-8ff1-42d7-81bb-e26943957847"
      unitRef="usd">139000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtMS0xLTEtMjE4NzQ4_e8053886-eea4-4ef5-be5f-cabcb9c195d7"
      unitRef="usd">18000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtMy0xLTEtMjE4NzQ4_4807facf-374a-4d24-8c69-b46893b9f8b5"
      unitRef="usd">6000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtNS0xLTEtMjE4NzQ4_bfa7f849-5da2-44d1-b61d-54ac2f6b68a4"
      unitRef="usd">6000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtNy0xLTEtMjE4NzQ4_5b160ba4-323e-409e-ab33-a5865efa7a67"
      unitRef="usd">28000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtOS0xLTEtMjE4NzQ4_9189a3a1-3c15-4e7e-9604-6c43f50ef3b7"
      unitRef="usd">29000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzQtMTEtMS0xLTIxODc0OA_a0726802-cab2-45e8-a70b-50e2b2ea12ec"
      unitRef="usd">87000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtMS0xLTEtMjE4NzQ4_e58e0310-e1cf-46c6-81d9-876a69fa799b"
      unitRef="usd">-7000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtMy0xLTEtMjE4NzQ4_79c4799d-99c4-4cd2-be94-f0cb6fd3b3b3"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtNS0xLTEtMjE4NzQ4_a8119eab-e567-4ab4-bdcf-ae10c3b49601"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtNy0xLTEtMjE4NzQ4_63f6ed8a-c63a-4005-855f-a78cd775b63a"
      unitRef="usd">-23000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtOS0xLTEtMjE4NzQ4_53297414-27b2-4d12-ab00-59bdac396ebc"
      unitRef="usd">-10000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzUtMTEtMS0xLTIxODc0OA_f840d422-edeb-4517-b57d-2186fd305a37"
      unitRef="usd">-40000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i948e2e219f854ac082a3c472c583fe7d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtMS0xLTEtMjE4NzQ4_d140ba62-2a18-460b-9ae9-84033a63514f"
      unitRef="usd">11000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie936d943185b4ffbb312cec2d0a11ea1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtMy0xLTEtMjE4NzQ4_076c3a75-b4e7-4e61-9d93-e539c9450480"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i56dc2bee6bfd4893aaf3550953e9f904_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtNS0xLTEtMjE4NzQ4_420fa12f-aa50-4a63-855e-6f826b87ee0c"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3977781f98d2482e9204ee3df23b62ef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtNy0xLTEtMjE4NzQ4_67734c1a-147d-46d5-a706-83622bea7755"
      unitRef="usd">56000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0ca2257eaa5a4089b39072f8a37a459e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtOS0xLTEtMjE4NzQ4_6e539c38-a609-40ad-80cc-fc4b6c0439dc"
      unitRef="usd">59000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzYtMTEtMS0xLTIxODc0OA_7ddc78b9-f6c4-44b7-b6cf-e28b7073edd5"
      unitRef="usd">130000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctMS0xLTEtMjE4NzQ4_3016d79f-7e57-41a4-8ceb-5dfe40829cec"
      unitRef="usd">38000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctMy0xLTEtMjE4NzQ4_5171b3e5-6b7b-450d-a210-19b444193367"
      unitRef="usd">43000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctNS0xLTEtMjE4NzQ4_5705d0a9-7e0e-4926-8d40-fbff2b3c43f3"
      unitRef="usd">10000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctNy0xLTEtMjE4NzQ4_09e23ddb-de68-426f-ba77-fddc866594ab"
      unitRef="usd">35000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctOS0xLTEtMjE4NzQ4_e0f8e16f-c660-4184-8db6-9116bbd3cf08"
      unitRef="usd">83000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzctMTEtMS0xLTIxODc0OA_d69c1781-5496-4c9c-a21c-37435b3ee929"
      unitRef="usd">209000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtMS0xLTEtMjE4NzQ4_6ea1a4b8-970c-4f6f-bf22-c7a8f3f87d98"
      unitRef="usd">25000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtMy0xLTEtMjE4NzQ4_1dbe79e3-54a4-4820-a37e-d5616d837dde"
      unitRef="usd">13000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtNS0xLTEtMjE4NzQ4_d4b2309d-1c02-4619-bcdd-1f8ade3cc2f1"
      unitRef="usd">5000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtNy0xLTEtMjE4NzQ4_8e1bbaa1-cde1-4b3b-8ea2-599d6d56044e"
      unitRef="usd">10000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtOS0xLTEtMjE4NzQ4_a1885e86-9951-4eda-bc26-48b5449d4452"
      unitRef="usd">19000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzgtMTEtMS0xLTIxODc0OA_83f9525e-1bff-4b2d-a6c6-40890e0955c2"
      unitRef="usd">72000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktMS0xLTEtMjE4NzQ4_dda2d26a-7471-4759-8cd5-bfcccb594697"
      unitRef="usd">9000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktMy0xLTEtMjE4NzQ4_03fdf1ab-4576-4c77-9406-71643061585c"
      unitRef="usd">7000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktNS0xLTEtMjE4NzQ4_2b063fe0-bd13-4425-8627-092245789b6b"
      unitRef="usd">3000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktNy0xLTEtMjE4NzQ4_383766f1-2b45-41f2-97f6-bbdc5d0f3477"
      unitRef="usd">10000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktOS0xLTEtMjE4NzQ4_d2c49557-ac7a-4e39-8e64-8c5587e229e6"
      unitRef="usd">86000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzktMTEtMS0xLTIxODc0OA_260a21df-dba2-4103-b0d7-4339c64c6df0"
      unitRef="usd">115000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTEtMS0xLTIxODc0OA_45edb7ba-7835-472c-841d-263cf550bd77"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTMtMS0xLTIxODc0OA_74d03256-fdbd-4774-ac12-0b2488225bc5"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTUtMS0xLTIxODc0OA_78a86cb4-8fa5-459f-89b0-5a63842f1447"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTctMS0xLTIxODc0OA_8be82976-30c1-40b3-8089-7159479a0764"
      unitRef="usd">-58000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTktMS0xLTIxODc0OA_5c02d23b-f69c-4b61-91f2-7f90a713b13d"
      unitRef="usd">-2000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzEwLTExLTEtMS0yMTg3NDg_d12f50fc-ff22-4b1b-8aaf-304bfdb44535"
      unitRef="usd">-60000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i493ee32637374fef85bb13b3cde7de11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTEtMS0xLTIxODc0OA_7b3c4d42-717d-4d97-84ce-51a5c27b658d"
      unitRef="usd">15000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ifbec207732c741a7b5cd533ccd6d7102_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTMtMS0xLTIxODc0OA_9967a56e-6934-45b5-b065-4143901ff38e"
      unitRef="usd">26000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iab47b293b1e6457e9220acf589c14011_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTUtMS0xLTIxODc0OA_8d724b54-93e6-4327-8192-f771ee12c0d8"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1d3e584c30524ea7abc9a6d31589fd8b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTctMS0xLTIxODc0OA_8a2aba23-dc27-46ff-aadd-43788d300dfd"
      unitRef="usd">13000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ifd5164d3ebc94282adf69fe3daa1dd18_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTktMS0xLTIxODc0OA_80877ca4-9c92-4580-bfcb-6261a53e0e6a"
      unitRef="usd">35000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90YWJsZTo4YzRhNzE1YWJlNzQ0ODhiYTljNjg5OWQ1ODk0Y2ZlNC90YWJsZXJhbmdlOjhjNGE3MTVhYmU3NDQ4OGJhOWM2ODk5ZDU4OTRjZmU0XzExLTExLTEtMS0yMTg3NDg_648f1911-8207-43ab-b0d5-a8d94edf70b4"
      unitRef="usd">92000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzYzNjg_7248e279-e9dc-4092-8bb8-272049f77a32"
      unitRef="usd">130000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8e022c6735f44aafbc94894561402456_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzYzODE_94d5296b-cd51-42fe-abe5-cde0d7711769"
      unitRef="usd">58000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3947bd9bcc904e12bbce546550846178_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgzMzA0Nw_06d85a9f-fc04-42c2-9313-95c81eadd397"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8be50c56aed545d6a05664ecf4cd0520_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzY0MDk_663fed10-a54e-403b-a3ab-65a688503723"
      unitRef="usd">36000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzY1MjQ_435c1902-cd04-4915-9d3e-669135401445"
      unitRef="usd">92000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9271e52fbc4b4051bc42f5edf6a60c46_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzY1Mzc_780bcb43-99e6-47b7-85a6-ce28eed21167"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i196be4042ab946ffab53968cba582319_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzY1OTE_15688f78-14ba-4384-9c2f-08842916409e"
      unitRef="usd">26000000</us-gaap:RestructuringReserve>
    <us-gaap:AssetImpairmentCharges
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2Xzg3OTYwOTMwNTI4NzU_0150df67-d94f-4409-9c0b-78efb877d0b9"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if642126ed2f24282b10b29e0c453e35e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgzNDM4OA_48b68db6-a1e5-4a7c-a8e4-f6a66cb76a07"
      unitRef="usd">36000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ie1ad9e5e8f13437e83ec2ed5b6ca20ee_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMjcvZnJhZzoxZGQ4MTIyYWVmMzU0YTY0YWIwYTRkMGZhMGM0NzRmNi90ZXh0cmVnaW9uOjFkZDgxMjJhZWYzNTRhNjRhYjBhNGQwZmEwYzQ3NGY2XzU0OTc1NTgzNDM5NQ_a197f91b-f9ba-41a8-ae06-26162e1c286c"
      unitRef="usd">115000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0OTc_ab82ab34-2888-454a-9858-23f9e67ed906">Share-Based CompensationThe Company provides share-based compensation to its employees, officers, and non-employee directors, including restricted stock units (&#x201c;RSUs&#x201d;), performance-based stock units (&#x201c;PSUs&#x201d;), stock options, and an employee stock purchase plan (&#x201c;ESPP&#x201d;) (collectively, &#x201c;share-based awards&#x201d;). Most of the share-based awards are granted in the first quarter of each fiscal year.&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense for the share-based awards is recognized for the portion of awards ultimately expected to vest. The Company estimates the number of share-based awards that will ultimately vest primarily based on historical experience. The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period and is adjusted when actual forfeitures occur. The actual forfeitures in future reporting periods could be higher or lower than current estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense is classified in the Consolidated Statements of Operations in the same manner as cash compensation paid to the Company&#x2019;s employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impact on Net Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of share-based compensation expense and related tax benefits were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock unit awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit for share-based compensation expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes compensation expense recognized for RSUs and PSUs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax benefit for fiscal 2023, fiscal 2022, and fiscal 2021 included discrete income tax benefit of $58 million and $10 million, and discrete income tax expense of $1 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2022, the Company&#x2019;s stockholders approved the McKesson Corporation 2022 Stock Plan (the &#x201c;2022 Stock Plan&#x201d;), to replace the McKesson Corporation 2013 Stock Plan (the &#x201c;2013 Stock Plan&#x201d;), which expired in 2023. The 2022 Stock Plan permits the grant of awards in the form of restricted stock, RSUs, PSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The shares previously reserved under the 2013 Stock Plan described below are no longer available for issuance pursuant to the 2022 Stock Plan. As of March 31, 2023, 4.9 million shares remain available for future grant under the 2022 Stock Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2013, the Company&#x2019;s stockholders approved the 2013 Stock Plan to replace the McKesson Corporation 2005 Stock Plan (the &#x201c;2005 Stock Plan&#x201d;), which expired in 2013. Under these stock plans, the Company issued restricted stock, RSUs, PSUs, stock options, and other share-based awards to selected employees, officers, and non-employee directors. The 2013 Stock Plan reserved 30.0 million shares plus unused reserved shares under the 2005 Stock Plan. As of March 31, 2023, no shares remain available for future grant under the 2013 Stock Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Unit Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs entitle the holder to receive a specified number of shares of the Company&#x2019;s common stock which vest over a period of generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzIxMDA_29caba71-3a79-4459-a81e-59ee51b81951"&gt;three&lt;/span&gt; to four years as determined by the Compensation Committee at the time of grant. The fair value of the award is determined based on the price of the Company&#x2019;s common stock on the grant date and the related compensation expense is recognized over the vesting period on a straight-line basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-employee directors receive an annual grant of RSUs, which vest immediately and are expensed upon grant. The director may elect to receive the underlying shares immediately or defer receipt of the shares if they meet director stock ownership guidelines. The shares will be automatically deferred for those directors who do not meet the director stock ownership guidelines. At March 31, 2023, approximately 37,000 RSUs for the Company&#x2019;s directors were vested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PSUs are conditional upon the attainment of market and performance objectives over a specified period. The number of vested PSUs is assessed at the end of a three-year performance period upon attainment of meeting certain earnings per share targets, average return on invested capital, and for certain participants, total shareholder return relative to a peer group of companies and, for special PSUs granted in 2019, meeting certain cumulative operating profit metrics. The Company uses the Monte Carlo simulation model to measure the fair value of the total shareholder return portion of the PSUs. The earnings per share portion of the PSUs is measured at the grant date market price. PSUs have a requisite service period of generally three years. Expense is attributed to the requisite service period on a straight-line basis based on the fair value of the PSUs, adjusted for the performance modifier at the end of each reporting period. For PSUs that are designated as equity awards, the fair value is measured at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average assumptions used in the Monte Carlo valuations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity for restricted stock unit awards (RSUs and PSUs) during fiscal 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts less than a million are shown as zero in the table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to restricted stock unit award activity: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which restricted stock unit award cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options are granted with an exercise price at no less than the fair market value and those options granted under the stock plans generally have a contractual term of seven years and follow a four-year vesting schedule. The Company did not grant any stock options during the years ended March 31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation expense for stock options is recognized on a straight-line basis over the requisite service period and is based on the grant-date fair value for the portion of the awards that is ultimately expected to vest. The Company uses the Black-Scholes options-pricing model to estimate the fair value of its stock options. Once the fair value of an employee stock option is determined, current accounting practices do not permit it to be changed, even if the estimates used are different from actual. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of stock options outstanding at March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range of Exercise&lt;br/&gt;Prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;br/&gt;at Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Exercisable at&lt;br/&gt;Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$123.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$182.78&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity during fiscal 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and exercisable, March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of options expected to vest takes into account an estimate of expected forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The intrinsic value is calculated as the difference between the period-end market price of the Company&#x2019;s common stock and the exercise price of &#x201c;in-the-money&#x201d; options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to stock option activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value per stock option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value on exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received upon exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized related to exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of stock options vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which stock option compensation cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an ESPP under which 23.1 million shares have been authorized for issuance. The ESPP allows eligible employees to purchase shares of the Company&#x2019;s common stock through payroll deductions. The deductions occur over three-month purchase periods and the shares are then purchased at 85% of the market price at the end of each purchase period. Employees are allowed to terminate their participation in the ESPP at any time during the purchase period prior to the purchase of the shares. The 15% discount provided to employees on these shares is included in compensation expense. The shares related to funds outstanding at the end of a quarter are included in the calculation of diluted weighted-average shares outstanding. These amounts have not been significant for all the years presented. The Company recognizes costs for employer matching contributions as ESPP expense over the relevant purchase period. Shares issued under the ESPP were not material in fiscal 2023, fiscal 2022, and fiscal 2021. At March 31, 2023, 3.6 million shares remain available for issuance.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0NzQ_1efca864-9cc7-425e-9e35-976c0c105a9d">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of share-based compensation expense and related tax benefits were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock unit awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit for share-based compensation expense &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes compensation expense recognized for RSUs and PSUs.&lt;/span&gt;&lt;/div&gt;(2)Income tax benefit is computed using the tax rates of applicable tax jurisdictions. Additionally, a portion of compensation expense is not tax-deductible. Income tax benefit for fiscal 2023, fiscal 2022, and fiscal 2021 included discrete income tax benefit of $58 million and $10 million, and discrete income tax expense of $1 million, respectively.</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7f6f943ac64c470b961d73cf2c5fbcf3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzItMS0xLTEtMjE4NzQ4_5b7bb67e-67e3-49af-b126-d8fe74c08067"
      unitRef="usd">149000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic06aa85305f44c8fbb86fb2d2319293a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzItMy0xLTEtMjE4NzQ4_6e281a31-0236-4618-9b29-3cd3560eb1d2"
      unitRef="usd">148000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9556991f875d4713b5b62bb435eaf7d2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzItNS0xLTEtMjE4NzQ4_07d104d1-e44f-42b9-a4a5-0d16c470ae2f"
      unitRef="usd">137000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia9cc1088918d4bdf9fec9c448e29978f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzMtMS0xLTEtMjE4NzQ4_4c79d9e2-e341-4266-bfc0-c01e85ac110e"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id4e58f11e8ff4837b70351c42fecfe2a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzMtMy0xLTEtMjE4NzQ4_24bf8934-ead6-48ec-b006-7747de3200b6"
      unitRef="usd">2000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i83d13ad17dcb49b4899c2f0e3cc432d9_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzMtNS0xLTEtMjE4NzQ4_0be90235-8eec-4472-bc88-e643459589e0"
      unitRef="usd">4000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ife447a3b57f0484f98349ca82b7c8778_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzQtMS0xLTEtMjE4NzQ4_6a8c27da-6029-407a-9437-7efd200d5fd9"
      unitRef="usd">13000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i15f030c588ac48cfbb2352300d303adb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzQtMy0xLTEtMjE4NzQ4_bef95f0a-3082-4743-ad39-33069398b289"
      unitRef="usd">11000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6e22ae69db0e4c909043949b0bf363e3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzQtNS0xLTEtMjE4NzQ4_6893696b-6ed2-470b-b60b-f675d21d4747"
      unitRef="usd">10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzUtMS0xLTEtMjE4NzQ4_303c971f-fc70-4e91-b8a4-2fb40bca2bc3"
      unitRef="usd">162000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzUtMy0xLTEtMjE4NzQ4_c059d17b-fabc-48c2-ae48-01a242d2771b"
      unitRef="usd">161000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzUtNS0xLTEtMjE4NzQ4_94ce3ee9-8f35-4a28-b4bf-bd5361f2ec5a"
      unitRef="usd">151000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzYtMS0xLTEtMjE4NzQ4_af46fc4b-991f-4336-87cd-d2836d9063c2"
      unitRef="usd">87000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzYtMy0xLTEtMjE4NzQ4_f45a219c-398e-4fb6-a20f-238072fa17df"
      unitRef="usd">35000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzYtNS0xLTEtMjE4NzQ4_a42a910a-6a6c-4ad0-ad46-be9e4fe01270"
      unitRef="usd">23000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzctMS0xLTEtMjE4NzQ4_f4810e6f-f224-4a04-8f9e-23291dffba3d"
      unitRef="usd">75000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzctMy0xLTEtMjE4NzQ4_881f205e-85a2-49f9-b323-2f501ffa1734"
      unitRef="usd">126000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5YmMzM2NjZjQ4Yjk0M2JkODQzNmI4YmI4OTczM2NiYi90YWJsZXJhbmdlOjliYzMzY2NmNDhiOTQzYmQ4NDM2YjhiYjg5NzMzY2JiXzctNS0xLTEtMjE4NzQ4_5b948a5d-6ccb-4783-a4ed-a5143f5d5322"
      unitRef="usd">128000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzE0Mzc_34c87311-3946-4e2f-b0bd-389c8b8a9457"
      unitRef="usd">-58000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzE0NDE_b6b23b4d-2eb7-4b4f-a061-f220bd8754d0"
      unitRef="usd">-10000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzE0NDk_b22ef7eb-6c67-416b-977e-2fb3d9b5cf5b"
      unitRef="usd">1000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i1f18df5cf4f04ff894901fbf46e6dba6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzYwNDczMTM5NjU3MjQ_1c28f78e-d1af-4452-9699-f1a04af000e5"
      unitRef="shares">4900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="iaa24a0cfb242478997ad1819397e47c8_I20130731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzE3OTM_f253721d-9bf5-4251-b1e1-b20d63fa8f87"
      unitRef="shares">30000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i9a10efc6895245d08afc780fe46cc0c0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzE4Njg_e2857738-4836-469d-a5c0-625c239f9f0b"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia330d79374df4f04b29816d2c53ad7e3_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzIxMDY_c9ba5e24-bae9-4dfb-9ac5-96d39a94df1f">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested
      contextRef="i19acbfe54421472fb6c6c57213d527bf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzI3ODM_ae2d8e31-4886-444c-9f94-2a9509f6c371"
      unitRef="shares">37000</mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia89b0a5df63447d995cd0a4593059729_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0NzE_c21a8fa6-93f8-48b4-afe7-925c9d35cd20">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="ia89b0a5df63447d995cd0a4593059729_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzM1NjU_3afe3786-661b-45cd-b1a4-849b2870687f">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0Njg_86faf531-9ef4-4fa1-b435-85dfb95dc695">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average assumptions used in the Monte Carlo valuations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzItMS0xLTEtMjE4NzQ4_86912f36-98bf-4bbd-8805-7d69c5e3160d"
      unitRef="number">0.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzItMy0xLTEtMjE4NzQ4_85a8ac89-b8c9-4648-8b01-d1020e8d69b9"
      unitRef="number">0.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzItNS0xLTEtMjE4NzQ4_a991ee7d-39f5-4fa4-9c21-f60814286c3e"
      unitRef="number">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzMtMS0xLTEtMjE4NzQ4_b37aa0d2-c22c-453f-a43b-edc90fff88c4"
      unitRef="number">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzMtMy0xLTEtMjE4NzQ4_beb42e00-ad32-4d90-a33f-675d3d869980"
      unitRef="number">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzMtNS0xLTEtMjE4NzQ4_382e8d26-5318-4a3d-981b-466f73c02f6d"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzQtMS0xLTEtMjE4NzQ4_e91bf8d5-9a1e-4228-aa4c-361a0713b41a"
      unitRef="number">0.027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzQtMy0xLTEtMjE4NzQ4_bcb56217-d004-46c1-af1e-e869a9f1775a"
      unitRef="number">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzQtNS0xLTEtMjE4NzQ4_dd7f6600-8f46-4d52-b0ed-8ac8369d2998"
      unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzUtMS0xLTEtMjE4NzQ4_97353a81-3a69-495e-9b63-12b023bbf65c">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzUtMy0xLTEtMjE4NzQ4_4e143a71-c466-4226-af98-2dc4923b90c3">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo1NTk5MzgxMGEwM2I0MzQ1OGVjYjkxMGVhMWIyMzg4YS90YWJsZXJhbmdlOjU1OTkzODEwYTAzYjQzNDU4ZWNiOTEwZWExYjIzODhhXzUtNS0xLTEtMjE4NzQ4_42024dd3-30d1-44bc-a525-da589096cdb8">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY1MjE_ef97c2f9-6237-4f99-b75e-954d617cea00">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity for restricted stock unit awards (RSUs and PSUs) during fiscal 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested, March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts less than a million are shown as zero in the table above.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i194bfd7f58694118b6608f52ec99adf8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzEtMS0xLTEtMjE4NzQ4_bf95756c-fc57-4f6d-8cc4-28d939ccdbb7"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i194bfd7f58694118b6608f52ec99adf8_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzEtMy0xLTEtMjE4NzQ4_4f8ddf5e-381d-4496-83f3-f4b4ed005667"
      unitRef="usdPerShare">160.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzItMS0xLTEtMjE4NzQ4_b8398e91-7c8c-4705-bbce-6b9ab614469f"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzItMy0xLTEtMjE4NzQ4_f23c0703-e61e-448a-a357-873d5358382b"
      unitRef="usdPerShare">332.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzMtMS0xLTEtMjE4NzQ4_3547b215-6c5c-4840-b101-c27a0c3d9a11"
      unitRef="shares">0</mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod>
    <mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzMtMy0xLTEtMjE4NzQ4_9d7bfe65-64fb-4daf-8813-4cdf7bcdae42"
      unitRef="usdPerShare">201.79</mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzQtMS0xLTEtMjE4NzQ4_6a8df46a-7a7d-48af-8c25-7a862a6ecabd"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzQtMy0xLTEtMjE4NzQ4_bb7e55cc-07a2-4de8-ab1b-4fb5f91060b2"
      unitRef="usdPerShare">149.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i022f37e081eb4c90b78d43940f46aff4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzUtMS0xLTEtMjE4NzQ4_34d5e4d7-12e7-454e-89a7-b778bf3ac870"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i022f37e081eb4c90b78d43940f46aff4_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmYmVmMjIwYTVlYjI0OWQyOTQ2NjhiZmZhNWQ4OTg0Zi90YWJsZXJhbmdlOmZiZWYyMjBhNWViMjQ5ZDI5NDY2OGJmZmE1ZDg5ODRmXzUtMy0xLTEtMjE4NzQ4_ab0d07f3-7eda-4b7e-beb7-30caf1083b4a"
      unitRef="usdPerShare">238.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <mck:DataRelatedtoRSUActivityTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0NTg_1caf09bb-8923-49c7-8f50-890fd61f651b">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to restricted stock unit award activity: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of shares vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which restricted stock unit award cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mck:DataRelatedtoRSUActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzItMS0xLTEtMjE4NzQ4_f68c4deb-903e-4bb5-be73-0b37b5eb53c8"
      unitRef="usd">200000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzItMy0xLTEtMjE4NzQ4_1abe0346-a992-425b-acfc-62e364ed9823"
      unitRef="usd">144000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzItNS0xLTEtMjE4NzQ4_0c719c19-b1f6-4832-bfa1-102cf3f0ca19"
      unitRef="usd">79000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i022f37e081eb4c90b78d43940f46aff4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzMtMS0xLTEtMjE4NzQ4_4c81908d-bbe0-4dba-a2d9-ab79cd50fc18"
      unitRef="usd">192000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i194bfd7f58694118b6608f52ec99adf8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzMtMy0xLTEtMjE4NzQ4_5b6c9b86-697c-4b9b-b398-e57e46ac1340"
      unitRef="usd">165000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i289228fb848b4f3baeb89b15df8f45fa_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzMtNS0xLTEtMjE4NzQ4_02b5f7d2-98ad-4e14-bc2c-907d80801b5d"
      unitRef="usd">147000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzQtMS0xLTEtMjE4NzQ4_0a829fc9-5647-4790-b91d-17db3d37e30b">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i2feda4fcaba44ad898703021c0da5f3e_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzQtMy0xLTEtMjE4NzQ4_421c93cd-17f5-4b36-8c59-2c4e3b1ccea7">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i40d46e125b2642e6aaffc337caaea7e6_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo3MGY4MzhhMDg0MmY0ODcxYTgyNmQxOGFjNGQzNDNiNC90YWJsZXJhbmdlOjcwZjgzOGEwODQyZjQ4NzFhODI2ZDE4YWM0ZDM0M2I0XzQtNS0xLTEtMjE4NzQ4_938d9b08-8024-4abc-b4f2-b919c2f41082">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzQzMTM_f1decab9-5486-488b-a921-32beb6f9a07e">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY1MDI_5ef01145-ea5e-45a2-85f2-a42a481894ad">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY1MTc_3594b682-559b-4e28-b9af-1ade5fd4180f"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY1MTc_91d8c1ed-63cd-4676-913e-3e11871d840a"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY1MTc_f7f56b6a-68a8-4b9e-b087-d451384a54a7"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0OTA_d717990b-24f0-4ff6-83eb-6f2968f633cd">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of stock options outstanding at March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.560%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Range of Exercise&lt;br/&gt;Prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;br/&gt;at Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;br/&gt;Exercisable at&lt;br/&gt;Year End&lt;br/&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$123.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$182.78&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtMC0xLTEtMjE4NzQ4_d3e543d4-1f3e-4fe4-a364-d69c15729122"
      unitRef="usdPerShare">123.98</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtMi0xLTEtMjE4NzQ4_31115c9e-fc06-4d57-9f3f-6c635a07b847"
      unitRef="usdPerShare">182.78</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtNC0xLTEtMjE4NzQ4_b3d67635-5c70-4c2c-987c-970953eca110"
      unitRef="shares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtNi0xLTEtMjE4NzQ4_56bbaed1-09cb-4264-9afb-e2320b75f18f">P1Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtOC0xLTEtMjE4NzQ4_bfc93310-80c7-438a-a1e1-d8c4951b42d4"
      unitRef="usdPerShare">154.36</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtMTAtMS0xLTIxODc0OA_08ed511c-5a44-4df2-a2fa-1bc08b0b72cb"
      unitRef="shares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTo5ZGM2ZWYxMTMxNTg0MjgxODM2ODQ3MGQwNGFjYTBjYy90YWJsZXJhbmdlOjlkYzZlZjExMzE1ODQyODE4MzY4NDcwZDA0YWNhMGNjXzMtMTItMS0xLTIxODc0OA_e53ea7f3-f02c-44a4-a95c-f041397058bc"
      unitRef="usdPerShare">154.36</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0OTE_8aa457d8-b06e-4e6c-b2ab-dce9a72505e7">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity during fiscal 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding, March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and exercisable, March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of options expected to vest takes into account an estimate of expected forfeitures.&lt;/span&gt;&lt;/div&gt;(2)The intrinsic value is calculated as the difference between the period-end market price of the Company&#x2019;s common stock and the exercise price of &#x201c;in-the-money&#x201d; options.</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzEtMS0xLTEtMjE4NzQ4_2ccf8483-163e-438c-84bc-125fdff91f0e"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzEtMy0xLTEtMjE4NzQ4_df754bb4-ebd7-4139-849f-754b6459a97c"
      unitRef="usdPerShare">175.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzEtNS0xLTEtMjE4NzQ4_4a424a95-0d4f-4465-b5fe-e75b77706ea7">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzEtNy0xLTEtMjE4NzQ4_b5b0ed60-2947-4ece-bc92-fffd920572e6"
      unitRef="usd">114000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzItMS0xLTEtMjE4NzQ4_1ed2f10b-1f40-462a-82c6-e046e1efca35"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzItMy0xLTEtMjE4NzQ4_4974cfc2-edfd-4975-b9ee-2f0d0e36653c"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzMtMS0xLTEtMjE4NzQ4_38948a97-40e9-40f1-a825-bffa517ac899"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzMtMy0xLTEtMjE4NzQ4_11751373-e7e3-4da2-a48a-ef9626f41969"
      unitRef="usdPerShare">125.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzQtMS0xLTEtMjE4NzQ4_cc86b615-ebd8-4f1d-975d-f88527df18b8"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzQtMy0xLTEtMjE4NzQ4_0fa85cb1-7d3b-46a2-a066-4018c9f31dcf"
      unitRef="usdPerShare">191.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzUtMS0xLTEtMjE4NzQ4_8258d09a-9958-46e2-9b0f-968b0001582c"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzUtMy0xLTEtMjE4NzQ4_a72fdac3-c79b-42ef-9e31-0f58b8fb1880"
      unitRef="usdPerShare">154.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzUtNS0xLTEtMjE4NzQ4_6d2e1d89-cd90-4bf9-829a-285d4b5d42f2">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzUtNy0xLTEtMjE4NzQ4_55696bd0-bb53-4ab4-aa6c-6df4b7163416"
      unitRef="usd">73000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzYtMS0xLTEtMjE4NzQ4_f49936d0-3d00-4f3f-b598-91a74f31b5cc"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzYtMy0xLTEtMjE4NzQ4_ba3a4d46-d502-46a8-ba5c-0c5d892c56e7"
      unitRef="usdPerShare">154.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzYtNS0xLTEtMjE4NzQ4_18e0da3c-7dcb-45b1-a262-c13b9f78c464">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzYtNy0xLTEtMjE4NzQ4_b1c20a1f-ab97-48b7-9903-37844334bccc"
      unitRef="usd">73000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzctMS0xLTEtMjE4NzQ4_16f17f00-1ef1-4319-8d92-fe52f52294dd"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzctMy0xLTEtMjE4NzQ4_92b66ea3-b62c-4334-ba6f-bc0d52eb765d"
      unitRef="usdPerShare">154.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzctNS0xLTEtMjE4NzQ4_2deb4017-426d-4938-ba9f-500a86c21aa3">P1Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpjOTYyZWY5Zjk1YjU0ZmE1ODMwMTNkYjFkNDk1NjBmNC90YWJsZXJhbmdlOmM5NjJlZjlmOTViNTRmYTU4MzAxM2RiMWQ0OTU2MGY0XzctNy0xLTEtMjE4NzQ4_a041a5e5-f500-4528-afb8-78c2775c43f1"
      unitRef="usd">73000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0ODU_c219d9a2-26df-4020-a07b-4eae934f571f">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides data related to stock option activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value per stock option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value on exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received upon exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized related to exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value of stock options vested&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average period in years over which stock option compensation cost is expected to be recognized&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzItMS0xLTEtMjE4NzQ4_c1a10991-79bb-4f57-a598-233aedacbcf1"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzItMy0xLTEtMjE4NzQ4_7ea0d15f-4a72-4c98-a43e-fc6a4be63f0a"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzItNS0xLTEtMjE4NzQ4_bbbe1067-87c2-49ae-b18e-aa8e32d9242d"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzMtMS0xLTEtMjE4NzQ4_c7fb8cb7-4c47-42a1-b6a2-e635eeaf1ef2"
      unitRef="usd">69000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzMtMy0xLTEtMjE4NzQ4_21e48707-cbbf-4809-8c49-4f5b40b1a65c"
      unitRef="usd">28000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzMtNS0xLTEtMjE4NzQ4_87b49db7-10ca-4d73-a57e-7bd5f6dfa9aa"
      unitRef="usd">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzQtMS0xLTEtMjE4NzQ4_66e1bbc7-6d4e-47f1-9b3d-9873c8013b86"
      unitRef="usd">93000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzQtMy0xLTEtMjE4NzQ4_ecc08565-31a3-428e-a0be-6f2469539aeb"
      unitRef="usd">157000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzQtNS0xLTEtMjE4NzQ4_b70ea88d-8583-46ef-9b42-580355411c06"
      unitRef="usd">38000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzUtMS0xLTEtMjE4NzQ4_28ecf438-1e50-4d3b-b3e0-7935f594262d"
      unitRef="usd">4000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzUtMy0xLTEtMjE4NzQ4_344a7c1b-cc2b-4437-92fe-e2050f6c20f9"
      unitRef="usd">5000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzUtNS0xLTEtMjE4NzQ4_97911f25-e660-44f2-b004-f87323b84613"
      unitRef="usd">4000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzYtMS0xLTEtMjE4NzQ4_b2369ca7-3dc2-42eb-b67a-0020fecdbf0d"
      unitRef="usd">1000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzYtMy0xLTEtMjE4NzQ4_ecba71aa-be75-429e-bd47-902fbc738bd4"
      unitRef="usd">5000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzYtNS0xLTEtMjE4NzQ4_b8802b92-c225-4512-b43b-165dbbc85189"
      unitRef="usd">10000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="id0c1b4f588c94865ab50e59ee67700cb_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzctMS0xLTEtMjE4NzQ4_3c62140a-8b51-4b6f-997c-e8a58987bfcf"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="icd1fd6d108f04354be5ba6979cfef798_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzctMy0xLTEtMjE4NzQ4_a15d2866-2b67-4985-b55e-b4903ff90ef3"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i280391a88a5f4cfc9ae3305390b982af_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzctNS0xLTEtMjE4NzQ4_d7aa53a3-c32e-4ce3-8533-f4691d6bcdda"
      unitRef="usd">2000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzgtMS0xLTEtMjE4NzQ4_8c02117a-3d1e-45e4-aed1-31359eb879fe">P0Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzgtMy0xLTEtMjE4NzQ4_6839e499-8ae9-475c-be6b-3c48cef31a3a">P0Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90YWJsZTpmNDJkY2Y1MDBhYjA0OWM1YjU3MmUxN2I3MTBmZDAzOS90YWJsZXJhbmdlOmY0MmRjZjUwMGFiMDQ5YzViNTcyZTE3YjcxMGZkMDM5XzgtNS0xLTEtMjE4NzQ4_414ac21d-dff1-45f0-ba38-f87e9787d422">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i9d695f8e4fe74cf68dd4c19a1015fbad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzU0NzU_ef55acc4-fd48-466e-8b5a-b5f6dfd0b7f9"
      unitRef="shares">23100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <mck:EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions
      contextRef="ife447a3b57f0484f98349ca82b7c8778_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0NjA_912ba7b7-8332-4580-aa1f-a1b2752fbcb8">P3M</mck:EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ife447a3b57f0484f98349ca82b7c8778_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzU3MjE_0aed9bc4-8a18-43cd-b6c8-9d7a91e9f00f"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
      contextRef="ife447a3b57f0484f98349ca82b7c8778_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzU5Mjc_3ac04325-da5d-4358-aa3f-dd3d55a08e86"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i9d695f8e4fe74cf68dd4c19a1015fbad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzMvZnJhZzowMjk4ZDkyNmIyZmU0N2VjOGFmMDI3MGJjN2IxODJiYS90ZXh0cmVnaW9uOjAyOThkOTI2YjJmZTQ3ZWM4YWYwMjcwYmM3YjE4MmJhXzY0MTY_27ea7e0e-79b3-4e5c-af4e-9d4fde9cfd27"
      unitRef="shares">3600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzExNDA_e654b142-8c33-4f3a-8824-425129a32241">Other Income, Net&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income, net consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gains on investments in equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The increase in interest income for fiscal 2023 compared to fiscal 2022 and fiscal 2021 is primarily due to higher interest rates on certain cash balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily recorded within the Company&#x2019;s International segment for fiscal 2022 and fiscal 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents net realized and unrealized gains as well as impairment charges on the Company&#x2019;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on the disposal of certain of these investments, including a gain of $142 million for the year ended March 31, 2023 related to the exit of one of the Company&#x2019;s investments in equity securities in July 2022 for proceeds of $179 million. Refer to Financial Note 15, &#x201c;Fair Value Measurements&#x201d; for more information on these types of investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other, net for year ended March 31, 2023 includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $126 million related to a cash payment received for the early termination of a tax receivable agreement (&#x201c;TRA&#x201d;) exercised by Change Healthcare Inc. (&#x201c;Change&#x201d;) in October 2022. The Company was a party to a TRA entered into as part of the formation of the joint venture with Change, from which McKesson has since exited. The TRA generally required Change to pay the Company 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the amortization allocated to Change by the joint venture. In October 2022, Change exercised its right pursuant to the TRA to terminate the agreement; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $97 million recognized from the termination of certain forward starting fixed interest rate swaps, as discussed in more detail in Financial Note 14, &#x201c;Hedging Activities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other, net for the year ended March 31, 2022 includes a gain of $42&#160;million as part of the completed sale of the Company&#x2019;s previously held 30% interest in its German pharmaceutical wholesale joint venture to WBA. &lt;/span&gt;&lt;/div&gt;Other, net for all periods presented also includes income recognized from finance charges to customers primarily for late fees.</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzExNDE_ea1a4f93-a35a-4db2-9bde-cd4f4ad6bc8c">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income, net consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gains on investments in equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The increase in interest income for fiscal 2023 compared to fiscal 2022 and fiscal 2021 is primarily due to higher interest rates on certain cash balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily recorded within the Company&#x2019;s International segment for fiscal 2022 and fiscal 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Represents net realized and unrealized gains as well as impairment charges on the Company&#x2019;s investments in equity securities of certain U.S. growth stage companies in the healthcare industry. These net gains primarily relate to mark-to-market adjustments for investments which are measured at fair value based on changes in the observable price of the securities and realized gains on the disposal of certain of these investments, including a gain of $142 million for the year ended March 31, 2023 related to the exit of one of the Company&#x2019;s investments in equity securities in July 2022 for proceeds of $179 million. Refer to Financial Note 15, &#x201c;Fair Value Measurements&#x201d; for more information on these types of investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other, net for year ended March 31, 2023 includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $126 million related to a cash payment received for the early termination of a tax receivable agreement (&#x201c;TRA&#x201d;) exercised by Change Healthcare Inc. (&#x201c;Change&#x201d;) in October 2022. The Company was a party to a TRA entered into as part of the formation of the joint venture with Change, from which McKesson has since exited. The TRA generally required Change to pay the Company 85% of the net cash tax savings realized, or deemed to be realized, by Change resulting from the amortization allocated to Change by the joint venture. In October 2022, Change exercised its right pursuant to the TRA to terminate the agreement; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $97 million recognized from the termination of certain forward starting fixed interest rate swaps, as discussed in more detail in Financial Note 14, &#x201c;Hedging Activities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other, net for the year ended March 31, 2022 includes a gain of $42&#160;million as part of the completed sale of the Company&#x2019;s previously held 30% interest in its German pharmaceutical wholesale joint venture to WBA. &lt;/span&gt;&lt;/div&gt;Other, net for all periods presented also includes income recognized from finance charges to customers primarily for late fees.</us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzItMS0xLTEtMjE4NzQ4_8b1d1cc0-e32b-47b3-b345-c6b79d6e58a8"
      unitRef="usd">107000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzItMy0xLTEtMjE4NzQ4_c70a979d-02be-4101-a9f0-f901a019db44"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzItNS0xLTEtMjE4NzQ4_4d33c569-36b7-48dc-9417-24c2e1e612e5"
      unitRef="usd">12000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzMtMS0xLTEtMjE4NzQ4_3d565f6a-1393-4024-9b25-266c758c4024"
      unitRef="usd">5000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzMtMy0xLTEtMjE4NzQ4_360c3ee6-a6ee-45d8-ac3e-72742635c964"
      unitRef="usd">43000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzMtNS0xLTEtMjE4NzQ4_dd1e4eff-0244-452c-adf6-c59fd625e090"
      unitRef="usd">48000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <mck:EquitySecuritiesFVNIGainLossExcludingImpairmentLosses
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzQtMS0xLTEtMjE4NzQ4_0835701b-8f15-40d7-ac2e-9dcd60caf125"
      unitRef="usd">106000000</mck:EquitySecuritiesFVNIGainLossExcludingImpairmentLosses>
    <mck:EquitySecuritiesFVNIGainLossExcludingImpairmentLosses
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzQtMy0xLTEtMjE4NzQ4_fa700308-aff8-4ae9-a386-3b13611a614d"
      unitRef="usd">98000000</mck:EquitySecuritiesFVNIGainLossExcludingImpairmentLosses>
    <mck:EquitySecuritiesFVNIGainLossExcludingImpairmentLosses
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzQtNS0xLTEtMjE4NzQ4_56dee12c-bb7d-44e0-b0b2-07be9edf601d"
      unitRef="usd">133000000</mck:EquitySecuritiesFVNIGainLossExcludingImpairmentLosses>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzYtMS0xLTEtMjE4NzQ4_168dbfdc-6d7c-419a-8bde-7cecd3c61476"
      unitRef="usd">279000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzYtMy0xLTEtMjE4NzQ4_2443df1d-b7d6-4cf4-ae8c-a44be8023a98"
      unitRef="usd">108000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzYtNS0xLTEtMjE4NzQ4_7ddc2f81-85e2-406a-a4f1-1943fe38c299"
      unitRef="usd">30000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzctMS0xLTEtMjE4NzQ4_b090377c-3709-4a55-bbc8-e78014d25c64"
      unitRef="usd">497000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzctMy0xLTEtMjE4NzQ4_4a605399-3a6b-4123-81b6-6652080a07da"
      unitRef="usd">259000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90YWJsZTpkNzNlMjA1ODY5MjQ0ZDg0YWFjYTExYjI3M2QzYzIyNS90YWJsZXJhbmdlOmQ3M2UyMDU4NjkyNDRkODRhYWNhMTFiMjczZDNjMjI1XzctNS0xLTEtMjE4NzQ4_fee7f93c-a6c1-4b15-acea-d135cb003343"
      unitRef="usd">223000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzU0OTc1NTgxNzI2Nw_b6e0d868-e1ef-40c1-959f-74f2734ad126"
      unitRef="usd">142000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i5042c611135944438746cce257499d4f_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzU0OTc1NTgxNzM5MA_107ba45d-634f-4c9d-a932-449a7d528b96"
      unitRef="usd">179000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:GainLossOnContractTermination
      contextRef="ibee85f1796ce4da18771743ac93a0bf7_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzU0OTc1NTgxNTgwOQ_62ff2e1a-4b34-47a8-9244-867614d53ddf"
      unitRef="usd">126000000</us-gaap:GainLossOnContractTermination>
    <mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized
      contextRef="i79fd2475cde549da9b49f44a3b1d5fa7_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4Xzg3OTYwOTMwMjU3NzY_9029da24-b907-4323-908c-069837954752"
      unitRef="number">0.85</mck:TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized>
    <mck:GainLossOnDerivativeTermination
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzU0OTc1NTgxNjkwMA_fe9c6f0a-a441-4aef-bf86-36e70f4f5a5d"
      unitRef="usd">97000000</mck:GainLossOnDerivativeTermination>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="idf485190a9674be1a5f6e8cc04f2de3a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4Xzg2Ng_1736194b-eff7-46d0-86b2-a09f3207edc4"
      unitRef="usd">42000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="ie9363c5254cf4b7b9d31529bc982ca01_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzYvZnJhZzpmZjg5NzhkYzYzOWQ0NWYxYmIwZjYyNDUwOTlhZGU0OC90ZXh0cmVnaW9uOmZmODk3OGRjNjM5ZDQ1ZjFiYjBmNjI0NTA5OWFkZTQ4XzkzOA_ede4c4d2-2ec5-4208-80d3-f00de9419367"
      unitRef="number">0.30</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MTg_faf85a8c-7824-4a00-bbc6-1e3c2d0aba41">Income Taxes&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense (benefit) related to continuing operations consists of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fluctuations in the Company&#x2019;s reported income tax rates are primarily due to non-cash charges related to remeasuring the value of the E.U. disposal group and U.K. disposal group held for sale to fair value less costs to sell in fiscal 2022, the impact of opioid-related claims, including charges of $8.1 billion ($6.8 billion after-tax) in fiscal 2021, changes in the mix of earnings between various taxing jurisdictions, and other discrete items recognized in each fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21.0% to income before income taxes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit) at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net tax benefit on intellectual property transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E.U. disposal transaction loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s effective tax rates were impacted by other favorable U.S. federal permanent differences, including research and development credits of $4 million in each of fiscal 2023 and fiscal 2022, and $5 million in fiscal 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended March 31, 2023, the Company recognized discrete tax benefits primarily consisting of $115 million related to statute of limitation expirations and tax settlements in various taxing jurisdictions and $58 million related to the tax impact of share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended March 31, 2022, the Company recorded non-deductible, non-cash pre-tax charges of $438 million primarily to remeasure the E.U. disposal group to fair value less costs to sell, and $1.2 billion to remeasure the U.K. disposal group to fair value less costs to sell, as described in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reported income tax rate for fiscal 2022 and fiscal 2021 was impacted by the charge for opioid-related claims of $274 million ($237 million after-tax) and $8.1 billion ($6.8 billion after-tax), respectively, as described in Financial Note 17, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reported income tax rate for fiscal 2021 was unfavorably impacted by a non-deductible, non-cash pre-tax charge of $58 million, primarily to remeasure the carrying value of assets and liabilities held for sale related to the formation of a German pharmaceutical wholesale joint venture, which the Company exited in fiscal 2022. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; and Financial Note 5, &#x201c;Other Income, Net,&#x201d; for more information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, the Company sold intellectual property between wholly-owned legal entities within McKesson that are based in different tax jurisdictions. The transferor entity recognized a gain on the sale of assets which was not subject to income tax in its local jurisdiction; such gains were eliminated upon consolidation. The acquiring entities of the intellectual property were entitled to amortize the purchase price of the assets for tax purposes. In accordance with ASU 2016-16, &#x201c;Intra-Entity Transfers of Assets Other Than Inventory,&#x201d; discrete tax benefits of $105 million were recognized for fiscal 2021, with a corresponding increase to a deferred tax asset for the temporary difference arising from the buyer&#x2019;s excess tax basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax balances consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivable allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefit related accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory valuation and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets and systems development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,809)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses the available positive and negative evidence to determine whether deferred tax assets are more likely than not to be realized.&#160;As a result of this assessment, valuation allowances have been recorded on certain deferred tax assets in various tax jurisdictions.&#160;The valuation allowances were approximately $696 million and $726 million in fiscal 2023 and fiscal 2022, respectively, and primarily relate to net operating and capital losses incurred in certain tax jurisdictions for which no tax benefit was recognized. The decrease in the valuation allowance of $30 million in the current fiscal year relates primarily to the remeasurement of foreign loss carryforwards and their related valuation allowance for foreign exchange fluctuations, partially offset by the net operating losses incurred and deferred tax movements in certain tax jurisdictions for which no tax benefit was recognized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has federal, state, and foreign net operating loss carryforwards of $49 million, $3.4 billion, and $2.0 billion at March 31, 2023, respectively. Federal and state net operating losses will expire at various dates from 2024 through 2043. Substantially all its foreign net operating losses have indefinite lives. In addition, the Company has foreign capital loss carryforwards of $701 million with indefinite lives. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s gross unrecognized tax benefits for the last three fiscal years:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on the lapse of the applicable statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange rate fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, the Company had $1.4 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate, if recognized. The decreases in unrecognized tax benefits in each fiscal year are primarily attributable to statute of limitation expirations in various taxing jurisdictions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the next twelve months, the Company does not expect any material reduction in its unrecognized tax benefits. However, this may change as the Company continues to have ongoing discussions with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in opioid-related litigation and claims, as discussed in Financial Note 17, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of fiscal 2023, the Internal Revenue Service (&#x201c;IRS&#x201d;) communicated proposed adjustments to taxable income reported in the Company&#x2019;s fiscal 2018 and fiscal 2019 U.S. Federal Corporate Income Tax returns. The adjustments would increase federal income tax liability in the range of $600&#160;million to $700&#160;million. The Company disagrees with the proposed adjustments and intends to pursue resolution through the administrative process with the IRS Independent Office of Appeals and, if necessary, through judicial remedies. The Company expects it could take several years to reach a final resolution on these matters. Although the final resolution of these matters is uncertain, the Company believes in the merits of its tax positions and believes that it has adequately reserved for any adjustments to the provision of income taxes that may ultimately result. However, if the IRS prevails in these matters, the assessed tax and interest, if any, could have a material adverse effect on the Company&#x2019;s financial position, results of operations, and cash flows in the period of resolution.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports interest and penalties on income taxes as income tax expense. It recognized income tax expense of $31 million, $8 million, and $9 million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively, representing interest and penalties, in its Consolidated Statements of Operations. As of March 31, 2023 and 2022, the Company accrued cumulatively $138&#160;million and $108&#160;million, respectively, in interest and penalties on unrecognized tax benefits in its Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal 2015 through the current fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Undistributed earnings of the Company&#x2019;s foreign operations of approximately $4.8 billion were considered indefinitely reinvested at March 31, 2023. Following the enactment of the 2017 Tax Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. However, the repatriation of cash held outside the U.S. could be subject to applicable foreign withholding taxes and state income taxes.&#160;The Company may remit foreign earnings to the U.S. to the extent it is tax efficient to do so. It does not expect the tax impact from remitting these earnings to be material.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MjM_76c5df74-1bf6-4de9-afa8-fb4b31f22d33">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzMtMS0xLTEtMjE4NzQ4_6b0d25c6-dd3b-4beb-8f12-954487de8b98"
      unitRef="usd">3308000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzMtMy0xLTEtMjE4NzQ4_b159efef-1530-4036-810a-5b742c1876d0"
      unitRef="usd">1944000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzMtNS0xLTEtMjE4NzQ4_d79d0320-fd48-4977-a376-ee63a3b28d75"
      unitRef="usd">-6019000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzQtMS0xLTEtMjE4NzQ4_e1f07082-7274-49af-bea9-4f54e81773cd"
      unitRef="usd">1322000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzQtMy0xLTEtMjE4NzQ4_eef34eb2-46d5-45d0-8aa7-ce0309b6a798"
      unitRef="usd">-16000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzQtNS0xLTEtMjE4NzQ4_78bc64f6-a33b-4f70-9e64-29eb07bb3d5f"
      unitRef="usd">985000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzUtMS0xLTEtMjE4NzQ4_86259e68-210c-4f97-8bcd-8480f093c441"
      unitRef="usd">4630000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzUtMy0xLTEtMjE4NzQ4_56b85967-8105-4e53-9e91-846d690df6da"
      unitRef="usd">1928000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0NDUwNjVjODk5MWQ0ZmI2ODM0ODY2MTEzZDQ0YTFlZS90YWJsZXJhbmdlOjQ0NTA2NWM4OTkxZDRmYjY4MzQ4NjYxMTNkNDRhMWVlXzUtNS0xLTEtMjE4NzQ4_202c1742-a142-4f6e-ab17-c53b5f4db6f1"
      unitRef="usd">-5034000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MDA_f9338723-d32a-4b91-bea8-1b139ade9ee0">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense (benefit) related to continuing operations consists of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzMtMS0xLTEtMjE4NzQ4_fa0539fd-ec0f-44d4-b849-5547f3a3f8bd"
      unitRef="usd">619000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzMtMy0xLTEtMjE4NzQ4_27932efa-7a1c-48b5-b527-596830e7fc67"
      unitRef="usd">233000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzMtNS0xLTEtMjE4NzQ4_862b5a35-9102-4bbc-a1fd-7d28fc0c8cfa"
      unitRef="usd">-15000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzQtMS0xLTEtMjE4NzQ4_1bc1d0c0-c9b6-4202-8be2-ee90ad5acad9"
      unitRef="usd">126000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzQtMy0xLTEtMjE4NzQ4_de8533f8-ce48-4fcb-bf73-ef7f42af3615"
      unitRef="usd">129000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzQtNS0xLTEtMjE4NzQ4_f1060d4e-545f-4c5e-a686-e7009eafd650"
      unitRef="usd">47000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzUtMS0xLTEtMjE4NzQ4_96c1d762-6a0e-4062-9532-679a12c15e43"
      unitRef="usd">180000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzUtMy0xLTEtMjE4NzQ4_19eaa021-4578-48a1-8f96-ef082c35e543"
      unitRef="usd">240000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzUtNS0xLTEtMjE4NzQ4_3b5e09bb-f3c0-45b5-b0c2-6c0ec83ac4ed"
      unitRef="usd">181000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzYtMS0xLTEtMjE4NzQ4_7eecb405-54ce-4964-b789-918e83b4ad98"
      unitRef="usd">925000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzYtMy0xLTEtMjE4NzQ4_dd024b1c-e8b4-43d7-8a45-6123aea21190"
      unitRef="usd">602000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzYtNS0xLTEtMjE4NzQ4_9d91b22b-4dc2-4d33-9eb3-1defc9ac86e6"
      unitRef="usd">213000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzktMS0xLTEtMjE4NzQ4_c3d6d819-974f-47cf-a245-d7939bea22b7"
      unitRef="usd">-46000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzktMy0xLTEtMjE4NzQ4_95c826fe-fd73-4360-a946-26a64beeeb70"
      unitRef="usd">88000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzktNS0xLTEtMjE4NzQ4_db721849-612d-47dd-ad11-4825dac10b4a"
      unitRef="usd">-562000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEwLTEtMS0xLTIxODc0OA_c5bef177-a729-45ed-ab19-b370279f0326"
      unitRef="usd">36000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEwLTMtMS0xLTIxODc0OA_bdc01e64-cfc8-40d7-a992-791061f61696"
      unitRef="usd">-16000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEwLTUtMS0xLTIxODc0OA_53886e95-72bf-4ec5-ac3a-bed8db28fe6e"
      unitRef="usd">-204000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzExLTEtMS0xLTIxODc0OA_e6d863e1-ab01-4f50-bb64-256de52a3cfb"
      unitRef="usd">-10000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzExLTMtMS0xLTIxODc0OA_ab0e1bd1-486d-4516-9c04-80edd46488c7"
      unitRef="usd">-38000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzExLTUtMS0xLTIxODc0OA_a859d794-dc99-4d14-bf6c-17158556abdf"
      unitRef="usd">-142000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEyLTEtMS0xLTIxODc0OA_700cb5ac-d46d-4f4c-a07d-b4d8345d491e"
      unitRef="usd">-20000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEyLTMtMS0xLTIxODc0OA_cea64ac9-a5e6-48ba-be09-490173ac7aa2"
      unitRef="usd">34000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEyLTUtMS0xLTIxODc0OA_54718d47-8db3-429f-9dca-fd4ac227df60"
      unitRef="usd">-908000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEzLTEtMS0xLTIxODc0OA_ed57b9e1-a4ce-4be7-afde-f3ebfbe98aae"
      unitRef="usd">905000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEzLTMtMS0xLTIxODc0OA_06040098-0d12-4f62-a255-fada4b355529"
      unitRef="usd">636000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzEzLTUtMS0xLTIxODc0OA_08d15625-1468-470c-9d48-03457bdf5b65"
      unitRef="usd">-695000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzE0LTEtMS0xLTIzOTU2Ng_d965e5b5-44c2-4b9e-b7a3-e546ecd382b0"
      unitRef="number">0.195</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzE0LTMtMS0xLTIzOTU3Nw_5720e447-8cb0-414b-9a28-0dcc456a1543"
      unitRef="number">0.330</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxOTdjZjk4MmJiMWM0OGM4YjJmY2Q0MTE5NTkxNTNhNC90YWJsZXJhbmdlOjE5N2NmOTgyYmIxYzQ4YzhiMmZjZDQxMTk1OTE1M2E0XzE0LTUtMS0xLTIzOTU4OA_f19f9b37-2922-41d1-9784-bd0eee039d47"
      unitRef="number">-0.138</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzcxNDY4MjU1ODgxNzU_1c07c8a7-f068-4909-91d0-299ecfd7b07b"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzcxNDY4MjU1ODgxODA_e7f6302a-2481-4a99-85c4-2fd000ddaacb"
      unitRef="usd">6800000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MDE_e116a96c-1728-44fc-90cc-da81dff67f81">&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21.0% to income before income taxes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit) at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net tax benefit on intellectual property transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E.U. disposal transaction loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1)The Company&#x2019;s effective tax rates were impacted by other favorable U.S. federal permanent differences, including research and development credits of $4 million in each of fiscal 2023 and fiscal 2022, and $5 million in fiscal 2021.</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2NQ_2dcdd17e-c9c8-43cb-a8c6-97fc7c3dd35d"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2NQ_43f79519-69c8-4770-8331-09886fa4a43f"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2NQ_54985641-269e-4daa-a236-5e325ea70465"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzItMS0xLTEtMjE4NzQ4_527002ff-7f92-4902-842d-6898ba2fd583"
      unitRef="usd">972000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzItMy0xLTEtMjE4NzQ4_4f24f8ed-b611-415a-9609-5eb0b6bef747"
      unitRef="usd">405000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzItNS0xLTEtMjE4NzQ4_d5378366-06ad-435f-abfa-d588e686260a"
      unitRef="usd">-1057000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzMtMS0xLTEtMjE4NzQ4_9c127168-850d-479e-8275-596f4b001702"
      unitRef="usd">134000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzMtMy0xLTEtMjE4NzQ4_987670fd-b9d6-4541-856b-f62b85c8ea42"
      unitRef="usd">85000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzMtNS0xLTEtMjE4NzQ4_0498f273-8696-42ed-a05f-4f40ac96b081"
      unitRef="usd">-206000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzQtMS0xLTEtMjE4NzQ4_12f7e0a7-7a99-4da5-bce3-c22800471b95"
      unitRef="usd">-145000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzQtMy0xLTEtMjE4NzQ4_2e045e74-9bbb-4397-9b3c-2ffbbd5f65e0"
      unitRef="usd">-186000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzQtNS0xLTEtMjE4NzQ4_79e28580-f740-4f7e-bf47-d45aa5d4536a"
      unitRef="usd">-77000000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzUtMS0xLTEtMjE4NzQ4_92d1f507-ca88-48a9-b351-075b4cc700d7"
      unitRef="usd">6000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzUtMy0xLTEtMjE4NzQ4_b6499a35-4d2a-47b8-bca9-fd5c74e886fe"
      unitRef="usd">-26000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzUtNS0xLTEtMjE4NzQ4_a0b93ed6-a1cb-4a30-891b-5a9b2165cac5"
      unitRef="usd">41000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzctMS0xLTEtMjE4NzQ4_23c419db-b9ea-4869-b455-155131f09f34"
      unitRef="usd">9000000</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzctMy0xLTEtMjE4NzQ4_020b3d3f-66b5-4fdb-a2df-0ec83601000e"
      unitRef="usd">38000000</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims>
    <mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzctNS0xLTEtMjE4NzQ4_c6a9b98a-7fa3-4cfe-b832-8a6cdd9f7897"
      unitRef="usd">715000000</mck:EffectiveIncomeTaxRateReconciliationLitigationAndClaims>
    <mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzgtMS0xLTEtMjE4NzQ4_b44ccf36-4805-49d3-87f5-5c6628527e9e"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit>
    <mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzgtMy0xLTEtMjE4NzQ4_0fe24583-736f-4b9c-8551-5439732ee1fc"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit>
    <mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzgtNS0xLTEtMjE4NzQ4_a28ce4d8-07fd-46cf-8068-13251b2262d3"
      unitRef="usd">105000000</mck:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit>
    <mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEwLTEtMS0xLTIxODc0OA_259a2efe-1b07-4c8b-a853-43cd750f083a"
      unitRef="usd">-8000000</mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount>
    <mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEwLTMtMS0xLTIxODc0OA_dacb2261-3daf-41e3-9c36-887627deb91d"
      unitRef="usd">345000000</mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount>
    <mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEwLTUtMS0xLTIxODc0OA_565732cc-baf9-4c7b-81d6-0b3d4c6e6dc7"
      unitRef="usd">0</mck:EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEyLTEtMS0xLTIxODc0OA_de50e0c2-9891-4d63-aa43-1a6adb6c39af"
      unitRef="usd">-58000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEyLTMtMS0xLTIxODc0OA_5b6d95bd-f2f0-4796-8034-7593d8c777fb"
      unitRef="usd">-10000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEyLTUtMS0xLTIxODc0OA_86eb9788-de65-4a79-8ced-3590cb4581b9"
      unitRef="usd">1000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEzLTEtMS0xLTIxODc0OA_f154a53a-c43a-4941-b28b-2064d9b03cc7"
      unitRef="usd">-5000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEzLTMtMS0xLTIxODc0OA_7a2344cf-17d7-4915-bc70-2ef9b6be78db"
      unitRef="usd">-15000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzEzLTUtMS0xLTIxODc0OA_64534376-b0de-441c-a0d6-626fab5a12f7"
      unitRef="usd">-7000000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzE0LTEtMS0xLTIxODc0OA_12aef5e9-7495-4649-8902-81f4e6618415"
      unitRef="usd">905000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzE0LTMtMS0xLTIxODc0OA_8a485c42-605b-4043-9b87-bb57270e3dbf"
      unitRef="usd">636000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo0ZGIyYjhkNDExMGQ0ZTM3OGU5MzAwMTZkMjBlODRlYy90YWJsZXJhbmdlOjRkYjJiOGQ0MTEwZDRlMzc4ZTkzMDAxNmQyMGU4NGVjXzE0LTUtMS0xLTIxODc0OA_2877e035-03ad-490a-a325-197bb6e3e69b"
      unitRef="usd">-695000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzEwNzQ_2e1e9d80-545d-475d-92f0-8ec92fbf20c9"
      unitRef="usd">4000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzEwNzQ_4442f6ce-ff19-4b74-be08-6a160253f9c4"
      unitRef="usd">4000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzEwODY_868c1d2d-ea19-4ac3-b17a-c4ab6202aa98"
      unitRef="usd">5000000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <mck:EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYwNDczMTM5NzE2MTQ_8b6966c3-7003-480d-a3d8-6e114ee87572"
      unitRef="usd">-115000000</mck:EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYwNDczMTM5NzE2MzA_e3d3f9d7-d2ff-4e15-bc9f-b265d55ccd18"
      unitRef="usd">-58000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ifc7a65af5b26474e8427ff7f8bd6ce64_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzEyMDA_a9e26b09-ebf0-4d7a-9d0e-5ed844493030"
      unitRef="usd">438000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i7d4a1d2617604c3abf9cdc6b550d8e12_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzEyODg_79acfd5c-0c19-4cac-b959-496f101f123c"
      unitRef="usd">1200000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="ibeefc9d1d76042fbbba383f76527d7a5_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzU0OTc1NTgzMTkxMQ_7adb4d7c-a8d2-4ed6-8684-c7d8758dc39f"
      unitRef="usd">274000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="id73f9b34f34c41d6ad73b7db3ed24dfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzU0OTc1NTgzMTkxNg_bab1e474-60ec-4213-bafe-00700876943f"
      unitRef="usd">237000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzU0OTc1NTgzMTkzNQ_1c07c8a7-f068-4909-91d0-299ecfd7b07b"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzU0OTc1NTgzMTk0MA_e7f6302a-2481-4a99-85c4-2fd000ddaacb"
      unitRef="usd">6800000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ie2c162cb2b9c417883dd91ccec907c32_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzE0OTE_b654fa5a-964d-4382-8ca7-76c8768d9653"
      unitRef="usd">58000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mck:IncomeTaxExpenseBenefitDiscreteItems
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzU0OTc1NTgzMTExNw_69356793-4fc2-47d0-b528-5565206b0765"
      unitRef="usd">-105000000</mck:IncomeTaxExpenseBenefitDiscreteItems>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MTI_3ab5056d-c951-4325-88a7-0b87731bb7d6">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax balances consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivable allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Opioid-related litigation and claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and benefit related accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory valuation and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets and systems development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,809)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzMtMS0xLTEtMjE4NzQ4_f46d154e-cfd8-42f4-89ab-af19e0100dc3"
      unitRef="usd">51000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzMtMy0xLTEtMjE4NzQ4_4a49bdf9-881d-4f4e-a223-8f2fe71cefd8"
      unitRef="usd">49000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <mck:DeferredTaxAssetLitigationAndClaims
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzQtMS0xLTEtMjE4NzQ4_c154f190-1e28-40b0-9533-7da222557949"
      unitRef="usd">699000000</mck:DeferredTaxAssetLitigationAndClaims>
    <mck:DeferredTaxAssetLitigationAndClaims
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzQtMy0xLTEtMjE4NzQ4_a4bbb230-5595-4996-ad64-067b61415bb2"
      unitRef="usd">755000000</mck:DeferredTaxAssetLitigationAndClaims>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzUtMS0xLTEtMjE4NzQ4_5d3578c7-d43c-4de4-98b5-a954c1893cc8"
      unitRef="usd">265000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzUtMy0xLTEtMjE4NzQ4_ded1af54-c5be-42cb-8288-042f38d7b8b9"
      unitRef="usd">285000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzYtMS0xLTEtMjE4NzQ4_7a04175a-67f6-4973-a4e3-3586e67ea75f"
      unitRef="usd">760000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzYtMy0xLTEtMjE4NzQ4_5c4f41f5-803e-4008-a096-dfd83858032c"
      unitRef="usd">739000000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <mck:DeferredTaxAssetLeaseObligations
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzctMS0xLTEtMjE4NzQ4_51ec98e9-f1fe-44e3-a518-c4db65e6a24e"
      unitRef="usd">427000000</mck:DeferredTaxAssetLeaseObligations>
    <mck:DeferredTaxAssetLeaseObligations
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzctMy0xLTEtMjE4NzQ4_5f8142c4-dabc-404f-b79b-e3ac677e9b47"
      unitRef="usd">422000000</mck:DeferredTaxAssetLeaseObligations>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzgtMS0xLTEtMjE4NzQ4_fddf3868-4e3d-4617-b25d-18eca8a379b8"
      unitRef="usd">127000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzgtMy0xLTEtMjE4NzQ4_f1a06df9-37c9-474d-8f6a-20e569c7a7db"
      unitRef="usd">83000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzktMS0xLTEtMjE4NzQ4_28be4e55-f217-4066-9119-74120e1105a8"
      unitRef="usd">2329000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzktMy0xLTEtMjE4NzQ4_5a2ef36b-97ac-4cfc-8678-8815c7991c05"
      unitRef="usd">2333000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzEwLTEtMS0xLTIxODc0OA_14380c0e-8d87-4b39-8bad-c1fd3ed75436"
      unitRef="usd">696000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzEwLTMtMS0xLTIxODc0OA_128204a3-50d1-4276-85df-828edfcc9c8d"
      unitRef="usd">726000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzExLTEtMS0xLTIxODc0OA_11b14126-c059-4ed4-bf2a-65f0d7914a11"
      unitRef="usd">1633000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzExLTMtMS0xLTIxODc0OA_ca30b610-d0b9-43af-b18c-eccf681d69f5"
      unitRef="usd">1607000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzEzLTEtMS0xLTIxODc0OA_1c224bb4-b3bb-4477-b24a-7394186ef523"
      unitRef="usd">2079000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzEzLTMtMS0xLTIxODc0OA_cc9d4842-dc8a-447f-bdf8-8309fd51a1d9"
      unitRef="usd">1993000000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE0LTEtMS0xLTIxODc0OA_83fbcbc9-c51c-49ea-9b0d-25611849db6e"
      unitRef="usd">32000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE0LTMtMS0xLTIxODc0OA_74d91ee7-f6f1-4903-87a1-05366490d3f1"
      unitRef="usd">184000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE1LTEtMS0xLTIxODc0OA_c9437577-a979-4c8e-a53a-feede0ec9382"
      unitRef="usd">267000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE1LTMtMS0xLTIxODc0OA_1f0bcb44-020e-4cbd-b527-a28269312ffa"
      unitRef="usd">233000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <mck:DeferredTaxLiabilitiesLeaseRightofuseAssets
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE2LTEtMS0xLTIxODc0OA_294e7212-e6ea-40ac-b1c7-362e686307c3"
      unitRef="usd">412000000</mck:DeferredTaxLiabilitiesLeaseRightofuseAssets>
    <mck:DeferredTaxLiabilitiesLeaseRightofuseAssets
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE2LTMtMS0xLTIxODc0OA_8e491c05-0a8a-4e2c-90fc-139596b0f4fc"
      unitRef="usd">401000000</mck:DeferredTaxLiabilitiesLeaseRightofuseAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE3LTEtMS0xLTIxODc0OA_c7226bab-7003-4cb5-934d-fa6db0462699"
      unitRef="usd">19000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE3LTMtMS0xLTIxODc0OA_52e43a59-b28a-43e9-a7dd-7f294cf2c95a"
      unitRef="usd">17000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE4LTEtMS0xLTIxODc0OA_0c9094b0-b546-41f4-b255-c1ebaf9beb6b"
      unitRef="usd">2809000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE4LTMtMS0xLTIxODc0OA_9c4b7f13-dc81-407b-829e-45cc07bff7ff"
      unitRef="usd">2828000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE5LTEtMS0xLTIxODc0OA_6ab69a97-0abf-4b8d-9331-7e54a3a5fbab"
      unitRef="usd">1176000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzE5LTMtMS0xLTIxODc0OA_0604ba6a-a41f-4c73-a477-6a9826f92632"
      unitRef="usd">1221000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIxLTEtMS0xLTIxODc0OA_8902e9cb-139b-4255-b822-56dc1b5b7291"
      unitRef="usd">211000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIxLTMtMS0xLTIxODc0OA_d4ef5749-0acd-4127-bd58-8e42803335d4"
      unitRef="usd">197000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIyLTEtMS0xLTIxODc0OA_3f178217-4ff0-4556-9c7c-77650bfd8b7a"
      unitRef="usd">1387000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIyLTMtMS0xLTIxODc0OA_337e8208-ae79-432a-bb1b-7a8ce3582e89"
      unitRef="usd">1418000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIzLTEtMS0xLTIxODc0OA_3df564a5-9265-4d18-82fd-d7f4385c0abd"
      unitRef="usd">1176000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZToxNDQwMTFlZDE2NTk0N2Y4OGNkZjY2YWNhNTZjOWY5MC90YWJsZXJhbmdlOjE0NDAxMWVkMTY1OTQ3Zjg4Y2RmNjZhY2E1NmM5ZjkwXzIzLTMtMS0xLTIxODc0OA_ce516a60-8344-42fd-a1db-c35bc583e3b6"
      unitRef="usd">1221000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzM3NzI_14380c0e-8d87-4b39-8bad-c1fd3ed75436"
      unitRef="usd">696000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzM3Nzk_128204a3-50d1-4276-85df-828edfcc9c8d"
      unitRef="usd">726000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzM5ODk_fa25ed50-80ee-46a8-b5c0-40cf2b9e9fce"
      unitRef="usd">30000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ibf6fd4d81f1f416290d250974ba098e2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQzODU_092a0cd9-361e-43bc-9c47-cc9da7f44b77"
      unitRef="usd">49000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i3d415447fbd94360ba64460c62a0a537_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQzODk_38e55c17-f94f-4826-84f4-a70d244f4eb4"
      unitRef="usd">3400000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i3a85db8cbb4b46c1b80086fe84b2ad90_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQzOTc_3614f840-b373-42f5-bbcc-8865934370a7"
      unitRef="usd">2000000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i3af290b74f9b45468794a2c3907f33d0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQ2NTA_7c329120-a5b6-44d1-8c43-626dadb228e8"
      unitRef="usd">701000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzc2MDg_68ba88e7-ca4a-4cab-912c-bf8ae93200ef">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s gross unrecognized tax benefits for the last three fiscal years:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions based on the lapse of the applicable statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exchange rate fluctuations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized tax benefits at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzItMS0xLTEtMjE4NzQ4_be343d98-0bf4-418d-a02d-33ae48d1b660"
      unitRef="usd">1523000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzItMy0xLTEtMjE4NzQ4_464f3e12-36ae-4a23-91ea-72357d602f6d"
      unitRef="usd">1754000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i56ca92db1bf347039646a68953e87fed_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzItNS0xLTEtMjE4NzQ4_2afc828d-f87d-4dc9-832a-7237f355edab"
      unitRef="usd">958000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzMtMS0xLTEtMjE4NzQ4_34412307-c339-4489-8e0b-cebbb5a20651"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzMtMy0xLTEtMjE4NzQ4_7490362e-7c95-404d-b139-48085d3bd04c"
      unitRef="usd">14000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzMtNS0xLTEtMjE4NzQ4_07760c3a-4095-4a71-9bb2-635378bc562e"
      unitRef="usd">53000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzQtMS0xLTEtMjE4NzQ4_f641a64e-2748-44fc-ba1c-da9c01bc8f3a"
      unitRef="usd">26000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzQtMy0xLTEtMjE4NzQ4_0f9c3557-774a-42d2-afbf-33e2393aaee7"
      unitRef="usd">131000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzQtNS0xLTEtMjE4NzQ4_475877da-9298-46b9-9460-edfe98781fc2"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzUtMS0xLTEtMjE4NzQ4_4973b827-caa7-4adb-92e2-998a5d4af2ef"
      unitRef="usd">21000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzUtMy0xLTEtMjE4NzQ4_0aaaf7cb-dc6b-4b42-a544-1bd303804267"
      unitRef="usd">14000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzUtNS0xLTEtMjE4NzQ4_008482a7-5f15-41d0-85e5-d62c9abd23b0"
      unitRef="usd">755000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzYtMS0xLTEtMjE4NzQ4_19fc333a-adf6-48ee-b2ac-08a2fc4d12b9"
      unitRef="usd">96000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzYtMy0xLTEtMjE4NzQ4_0d1c0216-6b64-490a-a4cd-0b56520abf65"
      unitRef="usd">20000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzYtNS0xLTEtMjE4NzQ4_34a4d57c-bf0a-435b-857a-013a7543772d"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzctMS0xLTEtMjE4NzQ4_7c0dd5f1-0625-4624-ae3c-8058f220d06f"
      unitRef="usd">16000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzctMy0xLTEtMjE4NzQ4_c8b61c5e-3ef6-4dd2-9403-b2f6e9c5dda7"
      unitRef="usd">102000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzctNS0xLTEtMjE4NzQ4_22997d88-4ea6-4b8b-8f9f-ef0806c1d2e2"
      unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzgtMS0xLTEtMjE4NzQ4_ae952341-3681-4a53-bbe1-c44a145791f3"
      unitRef="usd">-7000000</mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation>
    <mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzgtMy0xLTEtMjE4NzQ4_1f4d882d-baf7-4af8-8336-be9a52771a40"
      unitRef="usd">-6000000</mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation>
    <mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzgtNS0xLTEtMjE4NzQ4_46cc73f3-2119-4347-a2d7-80f33d58cde2"
      unitRef="usd">13000000</mck:UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzktMS0xLTEtMjE4NzQ4_8f8cf1b4-ff54-430a-bd4f-a844e7c9437a"
      unitRef="usd">1399000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzktMy0xLTEtMjE4NzQ4_38bdf6e0-559b-4862-be05-bbc8de7adac2"
      unitRef="usd">1523000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90YWJsZTo1NmE1MDVjZjQ3NzE0M2RmYjcyMDdkZTk2OTM4ZWU4Mi90YWJsZXJhbmdlOjU2YTUwNWNmNDc3MTQzZGZiNzIwN2RlOTY5MzhlZTgyXzktNS0xLTEtMjE4NzQ4_9f9ec11f-9e8b-46a1-954b-9c75e84f39c4"
      unitRef="usd">1754000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQ4MzI_46383c3a-9ec0-4cc0-9202-31c3bcf95dff"
      unitRef="usd">1400000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzQ4NzQ_c2561315-ff03-4c96-a085-a99074b7692b"
      unitRef="usd">1300000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <mck:IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment
      contextRef="i925b096ac7224e21909543318e72b500_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYwNDczMTM5ODMzMjE_a531c79c-0b34-4f32-9d38-d14276d093ce"
      unitRef="usd">600000000</mck:IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment>
    <mck:IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment
      contextRef="ied7b454e7843455ab8ab7494918c2873_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYwNDczMTM5ODMzMjg_aff10fa6-4327-4420-8efa-ec05f208a675"
      unitRef="usd">700000000</mck:IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYzMTk_4c327115-6c48-4c3e-acdb-c4eb3d129a9a"
      unitRef="usd">31000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYzMjM_60252a06-58cd-440f-bec8-b9ae99bb4771"
      unitRef="usd">8000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzYzMzE_8fd23c07-c245-492d-8c09-3470f1001c53"
      unitRef="usd">9000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzY0Nzg_fd944c49-6257-419a-8273-ada89dd01fcd"
      unitRef="usd">138000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzY0ODU_74ecc0b7-b5b5-423c-ba80-af73987b0133"
      unitRef="usd">108000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xMzkvZnJhZzo4MzgwODkxYTVhZTA0OTVhYWY3MGE1YTQ2NmRjYzM5Mi90ZXh0cmVnaW9uOjgzODA4OTFhNWFlMDQ5NWFhZjcwYTVhNDY2ZGNjMzkyXzcwNzM_226b9d32-3bf0-4c96-b5be-2814a3e34574"
      unitRef="usd">4800000000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQ3NDY_f8fd2272-554c-4a20-971f-d2ad2a02ed7e">Redeemable Noncontrolling Interests and Noncontrolling Interests &lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s previously recognized redeemable noncontrolling interests primarily related to its former consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. The Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million and $43 million for the years ended March 31, 2022 and 2021, respectively. All amounts were recorded in &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Company&#x2019;s Consolidated Statements of Operations and the corresponding liability balance was recorded in &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the Domination Agreement&#x2019;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#x201c;Appraisal Proceedings&#x201d;) with the Stuttgart Regional Court to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified in the Domination Agreement. On September 19, 2018, that court ruled that the Put Amount shall be increased by &#x20ac;0.51 resulting in an adjusted Put Amount of &#x20ac;23.50. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount remained at &#x20ac;22.99, thereby rejecting the lower court&#x2019;s increase, and the recurring compensation remained at &#x20ac;0.83 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercises of the Put Right reduced the balance of redeemable noncontrolling interests. The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income or loss, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2022 and fiscal 2021, the Company paid $1.0 billion and $49 million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the redeemable noncontrolling interests by $983 million and $49&#160;million, respectively, and the Company recorded the associated effect of the increase in the Company&#x2019;s ownership interest of $178 million and $3 million, respectively, as an increase to McKesson stockholders&#x2019; additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#x201c;Redeemable noncontrolling interests&#x201d; to &#x201c;Noncontrolling interests&#x201d; in the Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE, Vantage, and SCRI Oncology. As discussed above, after June 15, 2021, noncontrolling interests also represented minority shareholder equity interests in McKesson Europe and at March 31, 2022, the Company owned approximately 95% of McKesson Europe&#x2019;s outstanding common shares. The Company&#x2019;s noncontrolling interest in McKesson Europe was included in the divestiture of the E.U. disposal group in October 2022, as discussed in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests in the Company&#x2019;s Consolidated Balance Sheets were $367 million and $480 million at March 31, 2023 and 2022, respectively. For the years ended March 31, 2023, 2022, and 2021, the Company allocated a total of $162 million, $165 million, and $156 million of net income to noncontrolling interests, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March 31, 2023, 2022, and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Formation of SCRI Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derecognition of noncontrolling interests in McKesson Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="ia0d9f68e5c994bf59aeea678b50b65af_I20141231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzM4OA_94271ac1-eef6-4e2e-a18c-5e9af814abbe"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i85eec0525fe24f99b37fe1b51e6c5a23_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzE2NDkyNjc0NDY0MTc_2ef3578e-9625-4f40-b35c-1ef396d4fce9"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i3133b1be91fc45ce9e09a9108d5d72ff_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzU2Mg_467e21af-5582-4af5-9ba2-240e348bf127"
      unitRef="usd">43000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="id814aee4543a4f3b8149ab5107886aa3_I20141231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzkyMw_4f042bbe-b62f-4ecd-9b87-82adb1363035"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:PutRightValueInterestRateSpread
      contextRef="i629eed48f7a6425b99da3d0911202452_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1Xzk4Ng_d07fba94-7030-4cba-8b15-f337d838755d"
      unitRef="number">0.05</mck:PutRightValueInterestRateSpread>
    <mck:NoncontrollingInterestsPutRightExercisePriceIncrease
      contextRef="i64073e3798b24140a877b78902322039_D20180919-20180919"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzE3MjE_178538c9-67a1-450a-a1ac-182c87d32c36"
      unitRef="eurPerShare">0.51</mck:NoncontrollingInterestsPutRightExercisePriceIncrease>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i1f2d9133245747b1a400a98a3daea68f_I20180919"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzE3NjM_6df47f5f-7e82-4c69-b4e6-b659e2067639"
      unitRef="eurPerShare">23.50</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i42752d505455466fbf8fbf4f49c40afc_I20210412"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzIxMjE_7a588282-e5e9-4243-baae-6b82afdacd20"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="i9dc0714e08b14ba2814d733ed7fd0102_I20210412"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzIyMTQ_125d2378-03b1-4b67-a8c6-4c68036de74f"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i85eec0525fe24f99b37fe1b51e6c5a23_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI1ODI_c4413d65-37be-4457-9502-9d7bcb1bb503"
      unitRef="usd">1000000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i3133b1be91fc45ce9e09a9108d5d72ff_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI1ODk_c7e699d2-294e-43ca-b3b5-838dbfa51e2e"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="i85eec0525fe24f99b37fe1b51e6c5a23_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI2MTk_3002bbe7-2875-427a-8960-5965f8007800"
      unitRef="shares">34500000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="i3133b1be91fc45ce9e09a9108d5d72ff_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI2MjY_9a8b0f43-1191-49b8-9992-45a2b6a8e78b"
      unitRef="shares">1800000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzE2NDkyNjc0NDY0NjE_6ff86b03-d0b5-44f3-b909-cbf28d8f0c4d"
      unitRef="usd">983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI4MTc_ba24af5d-463a-40ad-823e-7dbf6f587341"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i233e0cb7214540f3be4be81f87c8120d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI5Mzc_8e065323-9008-4162-ad90-5b1e418b3f88"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i141c56cba3134f8b9ca6b4a9945134b2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzI5NDQ_a37434a5-89d7-4ce6-a530-03807de4e94d"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzE2NDkyNjc0NDY0NzA_57382aa4-92e5-4c86-bb39-86418eafc691"
      unitRef="usd">287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i702ec37556b84e119a5f3bb8522ed174_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzU0OTc1NTgyMDg1MQ_eb0828d3-3e0c-45c2-9bf7-68465ac8d2bd"
      unitRef="number">0.95</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterest
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQxOTY_4b8ac458-9934-4c78-a19c-988b29904ac5"
      unitRef="usd">367000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQyMDM_d11cf834-ae48-46e9-995b-68179adccdfc"
      unitRef="usd">480000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="idbd55a5a04e24729999d4fa3eb8ae352_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQ1MzA_90248959-15e8-4ff7-9e35-f1e4863f566b"
      unitRef="usd">162000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if79bf94dc2504cb2a88b82abdd979b19_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQ1MzQ_7a9b0941-baa2-46f5-b3a8-32ea53e688e8"
      unitRef="usd">165000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="icf838c191f224e90921deb0c9dd4d8b0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQ1NDI_f31831f2-039d-4db4-adca-45d8edcca1ed"
      unitRef="usd">156000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90ZXh0cmVnaW9uOjMxYmY3N2ZmODM1MzQwMjY5ZDNiNzQ2MjdkMjVlOGM1XzQ3NDU_9adae30f-a965-464b-a202-421ff2fecba9">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the years ended March 31, 2023, 2022, and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;Noncontrolling&lt;br/&gt;Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Formation of SCRI Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derecognition of noncontrolling interests in McKesson Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <us-gaap:MinorityInterest
      contextRef="i28949ffb8bb2424c94e02d81ae0b5d27_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEtMi0xLTEtMjE4NzQ4_0148e247-109e-4962-9fc0-0213d827d15a"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i1c0a87d5a109411fae8be9b302d9a229_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEtNC0xLTEtMjE4NzQ4_1ba084e7-5cc8-4c02-bb98-17257fb3c82f"
      unitRef="usd">1402000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzItMi0xLTEtMjE4NzQ4_9169b96a-c2ad-4f26-9ef8-70a95cbbf9db"
      unitRef="usd">156000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzItNC0xLTEtMjE4NzQ4_210541cc-5572-4286-afce-612d0a513570"
      unitRef="usd">43000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzMtMi0xLTEtMjQzMDU4_b256cb28-75d1-4b5f-874e-d5bb7e6f2273"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzMtNC0xLTEtMjQzMDU4_2fc82789-43f2-4a9f-9263-e6ec49488596"
      unitRef="usd">-79000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzMtMi0xLTEtMjQzMDM2_2bbaa97e-286e-4824-85db-90ed7dd3b949"
      unitRef="usd">177000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzMtNC0xLTEtMjQzMDM2_5725cf7d-cb41-46f3-acee-42652f9a9358"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzQtMi0xLTEtMjQzMDQ2_530bcbc7-99b8-4976-979f-99305ad21392"
      unitRef="usd">0</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzQtNC0xLTEtMjQzMDQ2_bc69704a-d921-4948-9104-6c97749dabb9"
      unitRef="usd">43000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzYtMi0xLTEtMjIzOTIz_b6bc48c5-9fb9-4eb9-b738-777a6ec2a85a"
      unitRef="usd">0</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzYtNC0xLTEtMjIzOTMx_fe55a433-8888-43ad-96c9-992b4c7aa863"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="id8135dd2e23c4d28bcd19344d76fb69b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzYtMi0xLTEtMjE4NzQ4_8b03d5cb-bd9e-4060-acf6-92e4f6ebd692"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="ib8415ab4ce474dd0a8f6093e06c86d8f_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzYtNC0xLTEtMjE4NzQ4_5a1c852b-37de-47b4-8ca0-01675729d9de"
      unitRef="usd">-3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i05b7ccb4f8144bea8f3d6c3af844c49d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzctMi0xLTEtMjE4NzQ4_18f5fb41-fa1c-48e9-951c-f6ad22534ee0"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i60796f3f508f4327a4e738afb42dcf8b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzctNC0xLTEtMjE4NzQ4_2923d1f0-83ef-45cd-91e3-15deb9d4f319"
      unitRef="usd">1271000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzgtMi0xLTEtMjE4NzQ4_eb1fbe94-dc6a-414f-9629-85a287f6b0aa"
      unitRef="usd">165000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzgtNC0xLTEtMjE4NzQ4_2d80a004-f326-43f0-8ca6-c07d3944a438"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzktMi0xLTEtMjE4NzQ4_a40feb1d-a44e-4cb8-8d45-2fdd154b75de"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzktNC0xLTEtMjE4NzQ4_9d9827d5-0461-4414-aeb9-c920f205d499"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzExLTItMS0xLTI0MzA3MA_0e095fd2-5935-4c97-bedf-5ac1306aa8c6"
      unitRef="usd">155000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzExLTQtMS0xLTI0MzA3MA_3baf23ab-bff6-4f16-a1ee-55f367eb6600"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEwLTItMS0xLTIxODc0OA_510b81aa-b6d4-4599-ae78-30ae254e5f5e"
      unitRef="usd">7000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEwLTQtMS0xLTIxODc0OA_efa681e6-835f-45e3-896c-ee8b47750ba5"
      unitRef="usd">8000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEyLTItMS0xLTIxODc0OA_7d11c343-c36d-4c14-9cf7-dd3b849c8024"
      unitRef="usd">0</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEyLTQtMS0xLTIxODc0OA_6ff86b03-d0b5-44f3-b909-cbf28d8f0c4d"
      unitRef="usd">983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE0LTItMS0xLTI0MjgzOQ_82962702-166b-4f2a-9f78-34a79c6d6172"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE0LTQtMS0xLTI0Mjg0Mg_57382aa4-92e5-4c86-bb39-86418eafc691"
      unitRef="usd">287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i243683b0717241af93096502d0de6cfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEzLTItMS0xLTIxODc0OA_3aff9a70-8206-4762-b0fe-bc609bc02840"
      unitRef="usd">-2000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i17b08c3e4f614f85baf52b57f9c67cf4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzEzLTQtMS0xLTIxODc0OA_947aa2b3-8c61-4bcb-8727-e3b6f6c85d82"
      unitRef="usd">-4000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i967edbc39aee4ecb80a07170518c493d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE0LTItMS0xLTIxODc0OA_91396ce9-42e5-48fa-9be8-f38c4ac044e5"
      unitRef="usd">480000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i6bf2274fbdb7410f92df8d07c6a7f201_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE0LTQtMS0xLTIxODc0OA_c4c3804c-6ecd-4966-8dce-f8d75904e0ef"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE1LTItMS0xLTIxODc0OA_de18768f-fd7e-4efd-8e50-8b2993c89700"
      unitRef="usd">162000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE1LTQtMS0xLTIxODc0OA_6524eb31-b5ce-4b15-8029-bc37f966ac16"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE2LTItMS0xLTIxODc0OA_473d3db5-1e12-46e7-9938-d06e73dc5ffb"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE2LTQtMS0xLTIxODc0OA_afb4fa37-da3a-4072-b5b3-983cefd553dc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE5LTItMS0xLTI0MzA3NQ_ef20441d-d6d6-489e-939d-7a9c3ac4d01a"
      unitRef="usd">150000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE5LTQtMS0xLTI0MzA3NQ_2637678c-a406-4ccf-82ab-387a7b58bb7d"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE3LTItMS0xLTIxODc0OA_59bef57a-ef5a-4e41-97e2-a8064dc636f5"
      unitRef="usd">5000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE3LTQtMS0xLTIxODc0OA_19800b2b-9119-494a-a6f0-013a6735252c"
      unitRef="usd">0</mck:ReclassificationofTemporaryEquitytoLiability>
    <mck:FormationOfBusiness
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE4LTItMS0xLTIxODc0OA_ceaa4f74-0a2f-4806-9dc1-e96c3de24254"
      unitRef="usd">225000000</mck:FormationOfBusiness>
    <mck:FormationOfBusiness
      contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzE4LTQtMS0xLTIxODc0OA_6e330c5d-9ced-45fd-888b-fcabfe05de22"
      unitRef="usd">0</mck:FormationOfBusiness>
    <mck:DerecognitionOfNoncontrollingInterests
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIyLTItMS0xLTI0MzYzNA_2e8a98ad-35b7-4008-bf4b-f4a1993d8747"
      unitRef="usd">382000000</mck:DerecognitionOfNoncontrollingInterests>
    <mck:DerecognitionOfNoncontrollingInterests
      contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIyLTQtMS0xLTI0MzYzOA_2ee31d7e-9040-4490-9325-17a08c220742"
      unitRef="usd">0</mck:DerecognitionOfNoncontrollingInterests>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIxLTItMS0xLTIxODc0OA_1992b068-39e1-4cda-8350-73cf47524037"
      unitRef="usd">-7000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i1bf679ac096c4aa691178bb332cacedd_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIxLTQtMS0xLTIxODc0OA_39c6b3c1-6a69-46d6-806e-186c208df7c2"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="icf262331a9f54dcaa1ab7d2f24876767_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIyLTItMS0xLTIxODc0OA_7ab34ffe-6f2f-49db-9a2c-3e2d9c8e73d3"
      unitRef="usd">367000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i45f0ee99639740adb0c22db01af096ac_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDIvZnJhZzozMWJmNzdmZjgzNTM0MDI2OWQzYjc0NjI3ZDI1ZThjNS90YWJsZTo3N2YxZGVmZjZlMjc0NGNiYWUwZGQ4ZjBjNDdjM2YxZC90YWJsZXJhbmdlOjc3ZjFkZWZmNmUyNzQ0Y2JhZTBkZDhmMGM0N2MzZjFkXzIyLTQtMS0xLTIxODc0OA_d39e9229-d7f8-477d-97e6-597e15dc2cb9"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90ZXh0cmVnaW9uOjI4NzdjYjI1NTYzNjRlY2FiYTA2Nzc1N2NlMDA5ODk2XzEyNjI_98e6cef4-ce7e-4c30-b249-2711885c67e6">Earnings (Loss) Per Common Share&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock. Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted loss per common share for the year ended March 31, 2021 was calculated by excluding all dilutive securities from the denominator of the share computation due to their anti-dilutive effects. Less than 1&#160;million of potentially dilutive securities for fiscal 2023 and fiscal 2022 were excluded from the computation of diluted earnings (loss) per common share as they were anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson Corporation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units and performance-based stock units.&lt;/span&gt;&lt;/div&gt;(2)Certain computations may reflect rounding adjustments.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90ZXh0cmVnaW9uOjI4NzdjYjI1NTYzNjRlY2FiYTA2Nzc1N2NlMDA5ODk2Xzg3OTYwOTMwMjM2Njc_2f6f60ce-b918-4886-a339-d767253f5179"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90ZXh0cmVnaW9uOjI4NzdjYjI1NTYzNjRlY2FiYTA2Nzc1N2NlMDA5ODk2Xzg3OTYwOTMwMjM2Njc_b81bbeb4-810c-47e2-9e4f-ddeec604f053"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90ZXh0cmVnaW9uOjI4NzdjYjI1NTYzNjRlY2FiYTA2Nzc1N2NlMDA5ODk2XzEyNTI_9d05a324-b288-45a3-acb5-3ca25431736d">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson Corporation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units and performance-based stock units.&lt;/span&gt;&lt;/div&gt;(2)Certain computations may reflect rounding adjustments.</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzItMS0xLTEtMjE4NzQ4_77827422-81b3-43b7-8f57-68ca9128ea54"
      unitRef="usd">3725000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzItMy0xLTEtMjE4NzQ4_b76e4c3f-0b78-482c-a428-a67d1ec059d2"
      unitRef="usd">1292000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzItNS0xLTEtMjE4NzQ4_0b6785f6-f895-40ee-9f70-a5ad87010a57"
      unitRef="usd">-4339000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzMtMS0xLTEtMjE4NzQ4_125d6867-c7bb-49eb-a1a3-370037d0d389"
      unitRef="usd">162000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzMtMy0xLTEtMjE4NzQ4_6fddf77f-7142-4171-bfb6-0aa54453eb2b"
      unitRef="usd">173000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzMtNS0xLTEtMjE4NzQ4_03216d8f-2668-4e3d-904b-0b8233224654"
      unitRef="usd">199000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzQtMS0xLTEtMjE4NzQ4_1540e0f1-012e-40d3-9800-2a33fbb21cf5"
      unitRef="usd">3563000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzQtMy0xLTEtMjE4NzQ4_677a09c5-2d5d-48e8-ae46-4bd522dd624a"
      unitRef="usd">1119000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzQtNS0xLTEtMjE4NzQ4_3cf876f8-2b96-46d2-b517-575f830acb5d"
      unitRef="usd">-4538000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzUtMS0xLTEtMjE4NzQ4_bf6e8281-791f-48b6-92da-3bbfeecff5d9"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzUtMy0xLTEtMjE4NzQ4_2a6f8af8-6a4f-4b36-ab0a-b9f5183256fc"
      unitRef="usd">-5000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzUtNS0xLTEtMjE4NzQ4_5703f260-7d58-4984-82a0-99b3f1ce1903"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzYtMS0xLTEtMjE4NzQ4_dabfd3ed-9f3f-4a68-8f63-293f28b55741"
      unitRef="usd">3560000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzYtMy0xLTEtMjE4NzQ4_c04d4ff7-f4bf-43c7-ac9d-fe6c550e06f2"
      unitRef="usd">1114000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzYtNS0xLTEtMjE4NzQ4_3ea5a8de-dd83-4ad6-b6f0-e172454c8c72"
      unitRef="usd">-4539000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzktMS0xLTEtMjE4NzQ4_63987e7e-c5a2-4f4b-a4af-8c940f776771"
      unitRef="shares">141100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzktMy0xLTEtMjE4NzQ4_346cfb52-4e12-4801-80a3-d63b13be8f7a"
      unitRef="shares">152300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzktNS0xLTEtMjE4NzQ4_dab16532-d183-4129-968f-232acc0c7989"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzExLTEtMS0xLTIxODc0OA_fc5b0d2e-aa75-4d2f-a543-e7ba301b92d2"
      unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i56a1b9bdafc8406590f07b100fb712f5_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzExLTMtMS0xLTIxODc0OA_6c53e621-313f-4fb2-b36b-cfd3fa9ec6b0"
      unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1369c60e05b34b468652499b286a05d6_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzExLTUtMS0xLTIxODc0OA_46a49c21-7c3e-46df-a1da-3abc1806e71b"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7f6f943ac64c470b961d73cf2c5fbcf3_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEyLTEtMS0xLTIxODc0OA_e0466eb3-5c7c-4d36-b07d-a683756dbf4b"
      unitRef="shares">900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic06aa85305f44c8fbb86fb2d2319293a_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEyLTMtMS0xLTIxODc0OA_af4b09e2-958b-465d-a353-adf56679b409"
      unitRef="shares">1600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9556991f875d4713b5b62bb435eaf7d2_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEyLTUtMS0xLTIxODc0OA_b2c3a809-badf-4e92-a03d-ccd3951d580d"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEzLTEtMS0xLTIxODc0OA_bfcd4b07-ffc3-4422-ada5-4fae475a0281"
      unitRef="shares">142200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEzLTMtMS0xLTIxODc0OA_54025fc7-b541-4741-bf9d-f75d468b261a"
      unitRef="shares">154100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzEzLTUtMS0xLTIxODc0OA_ba2a0d45-238f-49e6-8642-c65cdaa829a4"
      unitRef="shares">160600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE3LTEtMS0xLTIxODc0OA_f1ed569b-4874-4e3f-b940-86d5d8dec1c9"
      unitRef="usdPerShare">25.05</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE3LTMtMS0xLTIxODc0OA_c421eb54-8a09-4220-902c-21f1fedbf7ac"
      unitRef="usdPerShare">7.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE3LTUtMS0xLTIxODc0OA_0342bc02-10b4-4eeb-a410-3073a6edeaef"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE4LTEtMS0xLTIxODc0OA_dc922598-b165-4f22-b0ed-b6cd609ff0ed"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE4LTMtMS0xLTIxODc0OA_420f25bf-dbf4-40a0-9b1b-20c08ccfbe9a"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE4LTUtMS0xLTIxODc0OA_5e9b3a26-0cb1-4311-b816-de34bccd174e"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE5LTEtMS0xLTIxODc0OA_bd53816f-9e27-4cd9-847a-36ee9464f721"
      unitRef="usdPerShare">25.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE5LTMtMS0xLTIxODc0OA_91cac982-269f-444a-8af3-3ca10397e0cb"
      unitRef="usdPerShare">7.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzE5LTUtMS0xLTIxODc0OA_d4363379-8562-4757-85e6-a1c09d2a815e"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIxLTEtMS0xLTIxODc0OA_8ec39aef-fb9d-446c-af89-b5723d47cee9"
      unitRef="usdPerShare">25.25</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIxLTMtMS0xLTIxODc0OA_e35aed27-656c-4e40-a1e8-afcf5ed43773"
      unitRef="usdPerShare">7.35</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIxLTUtMS0xLTIxODc0OA_6779aee3-1575-47ad-b080-a7237553ee0a"
      unitRef="usdPerShare">-28.26</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIyLTEtMS0xLTIxODc0OA_034f36e8-a968-4143-8766-d299bb1dfde9"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIyLTMtMS0xLTIxODc0OA_715f2c38-d396-4876-b3b9-c6a8a1b06422"
      unitRef="usdPerShare">-0.03</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIyLTUtMS0xLTIxODc0OA_27e53612-a19a-4b05-98b0-024a2838b851"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIzLTEtMS0xLTIxODc0OA_6d497f9e-7796-4496-978a-43861e9aab22"
      unitRef="usdPerShare">25.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIzLTMtMS0xLTIxODc0OA_ac2153d3-530a-481a-9809-180ccb991b3e"
      unitRef="usdPerShare">7.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDUvZnJhZzoyODc3Y2IyNTU2MzY0ZWNhYmEwNjc3NTdjZTAwOTg5Ni90YWJsZTozNjA1OWI2NjdlN2Q0ZjU1ODFiOWUzYmQ1NWY3ZTJkMi90YWJsZXJhbmdlOjM2MDU5YjY2N2U3ZDRmNTU4MWI5ZTNiZDU1ZjdlMmQyXzIzLTUtMS0xLTIxODc0OA_a587512c-2dfe-4d6e-9f5a-c1cc4eba518f"
      unitRef="usdPerShare">-28.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5OTg_720ee3ae-bc02-4f44-8462-ddcbff3bc399">Leases&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2cb43d7d-4dbe-40be-891b-5b154c0f7e7e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2e8bafc9-a699-4ad1-a382-140d4fabd947"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_481d8594-6d0e-48c4-a516-41181b6ee1a8"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_b132aa89-d101-44a4-8856-5a1aefc7a3ca"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_9a3e0520-2b32-4c2a-8b14-f87e23310cf5"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_fbb0bd27-adff-497f-b17f-ffe770574fee"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (years) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As discussed in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; in fiscal 2022, the Company rationalized its office space, including certain property leases in North America, and in fiscal 2023, management approved further changes to its real estate footprint as part of a broader set of initiatives. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. These initiatives did not have a material financial impact to the Company&#x2019;s operating lease ROU assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes operating lease right-of-use assets of approximately $494&#160;million, as well as current and long-term operating lease liabilities of approximately $83&#160;million and $442&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included under the caption &#x201c;Assets held for sale&#x201d; and &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of the assets ceased upon classification as held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by future minimum sublease income&#160;of $191 million which is due under noncancellable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $98 million that are not reflected in the table above. These operating leases will commence in calendar year 2023 with noncancellable lease terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM2MjQ_b3387c7e-31d8-45e1-b5f8-dc61fc04b015"&gt;two&lt;/span&gt; to ten years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2023 and 2022, the total lease receivable was $342 million and $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LessorDirectFinancingLeasesTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5OTk_541cee0b-724d-4531-973f-d8efff948390">Leases&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2cb43d7d-4dbe-40be-891b-5b154c0f7e7e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2e8bafc9-a699-4ad1-a382-140d4fabd947"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_481d8594-6d0e-48c4-a516-41181b6ee1a8"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_b132aa89-d101-44a4-8856-5a1aefc7a3ca"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_9a3e0520-2b32-4c2a-8b14-f87e23310cf5"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_fbb0bd27-adff-497f-b17f-ffe770574fee"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (years) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As discussed in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; in fiscal 2022, the Company rationalized its office space, including certain property leases in North America, and in fiscal 2023, management approved further changes to its real estate footprint as part of a broader set of initiatives. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. These initiatives did not have a material financial impact to the Company&#x2019;s operating lease ROU assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes operating lease right-of-use assets of approximately $494&#160;million, as well as current and long-term operating lease liabilities of approximately $83&#160;million and $442&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included under the caption &#x201c;Assets held for sale&#x201d; and &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of the assets ceased upon classification as held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by future minimum sublease income&#160;of $191 million which is due under noncancellable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $98 million that are not reflected in the table above. These operating leases will commence in calendar year 2023 with noncancellable lease terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM2MjQ_b3387c7e-31d8-45e1-b5f8-dc61fc04b015"&gt;two&lt;/span&gt; to ten years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2023 and 2022, the total lease receivable was $342 million and $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorDirectFinancingLeasesTextBlock>
    <us-gaap:LessorSalesTypeLeasesTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5OTk_97f21d53-016b-489a-b9da-d3f33e0f66ab">Leases&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2cb43d7d-4dbe-40be-891b-5b154c0f7e7e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2e8bafc9-a699-4ad1-a382-140d4fabd947"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_481d8594-6d0e-48c4-a516-41181b6ee1a8"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_b132aa89-d101-44a4-8856-5a1aefc7a3ca"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_9a3e0520-2b32-4c2a-8b14-f87e23310cf5"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_fbb0bd27-adff-497f-b17f-ffe770574fee"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (years) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As discussed in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; in fiscal 2022, the Company rationalized its office space, including certain property leases in North America, and in fiscal 2023, management approved further changes to its real estate footprint as part of a broader set of initiatives. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. These initiatives did not have a material financial impact to the Company&#x2019;s operating lease ROU assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes operating lease right-of-use assets of approximately $494&#160;million, as well as current and long-term operating lease liabilities of approximately $83&#160;million and $442&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included under the caption &#x201c;Assets held for sale&#x201d; and &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of the assets ceased upon classification as held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by future minimum sublease income&#160;of $191 million which is due under noncancellable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, the Company entered into additional leases primarily for facilities that have not yet commenced with future lease payments of $98 million that are not reflected in the table above. These operating leases will commence in calendar year 2023 with noncancellable lease terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM2MjQ_b3387c7e-31d8-45e1-b5f8-dc61fc04b015"&gt;two&lt;/span&gt; to ten years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain owned equipment, classified as direct financing or sales-type leases, to physician practices. As of March 31, 2023 and 2022, the total lease receivable was $342 million and $298 million, respectively, with a weighted-average remaining lease term of approximately seven years. Interest income from these leases was not material for the years ended March 31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorSalesTypeLeasesTextBlock>
    <mck:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5ODc_a95e1e01-dc37-40ff-97c4-c0c9ce415a4d">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except lease term and discount rate)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2cb43d7d-4dbe-40be-891b-5b154c0f7e7e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTAtMS0xLTIxODc0OA_2e8bafc9-a699-4ad1-a382-140d4fabd947"&gt;Property, plant, and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_481d8594-6d0e-48c4-a516-41181b6ee1a8"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTAtMS0xLTIxODc0OA_b132aa89-d101-44a4-8856-5a1aefc7a3ca"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_9a3e0520-2b32-4c2a-8b14-f87e23310cf5"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTAtMS0xLTIxODc0OA_fbb0bd27-adff-497f-b17f-ffe770574fee"&gt;Long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average remaining lease term (years) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average discount rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As discussed in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; in fiscal 2022, the Company rationalized its office space, including certain property leases in North America, and in fiscal 2023, management approved further changes to its real estate footprint as part of a broader set of initiatives. Where the Company ceased using office space, it exited the portion of the facility no longer used and repurposed other office locations which resulted in changes to certain lease agreements. These initiatives did not have a material financial impact to the Company&#x2019;s operating lease ROU assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes operating lease right-of-use assets of approximately $494&#160;million, as well as current and long-term operating lease liabilities of approximately $83&#160;million and $442&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included under the caption &#x201c;Assets held for sale&#x201d; and &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of the assets ceased upon classification as held for sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Lease terms and discount rates as of March 31, 2022 exclude leases classified as held for sale in the Consolidated Balance Sheet related to the European divestiture activities completed in fiscal 2023 as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;</mck:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzQtMS0xLTEtMjE4NzQ4_4f3a6730-5e46-40a1-b983-e0e76d41221b"
      unitRef="usd">1635000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzQtMy0xLTEtMjE4NzQ4_16b6c587-ad9a-4d0d-99cc-af8ae1328e0a"
      unitRef="usd">1548000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzYtMS0xLTEtMjE4NzQ4_99f6e103-ecaa-4cef-89d4-a295d7fea2a6"
      unitRef="usd">299000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzYtMy0xLTEtMjE4NzQ4_7f868f31-7581-4479-834e-24155d9596a8"
      unitRef="usd">297000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzctMS0xLTEtMjE4NzQ4_aba8b46f-8953-4752-9861-f9089d4cc9c8"
      unitRef="usd">1402000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzctMy0xLTEtMjE4NzQ4_5fd6e441-adba-4cbb-a24b-33e01305da57"
      unitRef="usd">1366000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzgtMS0xLTEtMjE4NzQ4_e677a168-03ef-490b-b383-bd6eebe4a79e"
      unitRef="usd">1701000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzgtMy0xLTEtMjE4NzQ4_8a1ae4d5-41b8-4e7b-838e-7b6135ebf470"
      unitRef="usd">1663000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTEtMS0xLTIxODc0OA_54df4485-9b1c-48bc-8dd0-9635f7543637"
      unitRef="usd">180000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzExLTMtMS0xLTIxODc0OA_419d4bcb-abe5-4764-a88a-64ea7ae16846"
      unitRef="usd">206000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTEtMS0xLTIxODc0OA_e17218b0-b189-4b7e-a067-e3eb0f5d5cad"
      unitRef="usd">29000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzEzLTMtMS0xLTIxODc0OA_1d61c22c-0f88-40e0-aa3b-c28ac0d3e22e"
      unitRef="usd">25000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTEtMS0xLTIxODc0OA_88ff613e-4419-4974-b7c2-7b3e13a16667"
      unitRef="usd">173000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE0LTMtMS0xLTIxODc0OA_c1545082-b685-497f-8338-b77305a33674"
      unitRef="usd">185000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE1LTEtMS0xLTIxODc0OA_43e3353c-3d75-41a5-b32d-62ab680e6103"
      unitRef="usd">202000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE1LTMtMS0xLTIxODc0OA_351dc062-64cf-4d9a-b4d0-c7918b359a0c"
      unitRef="usd">210000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE4LTEtMS0xLTIxODc0OA_271ed771-f1e8-4b90-a606-42e37994ae1f">P6Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE4LTMtMS0xLTIxODc0OA_cf7b5bdb-813e-400f-924e-41628cccc2d7">P6Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE5LTEtMS0xLTIxODc0OA_31acdf98-a313-446a-9655-b05df63210db">P7Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzE5LTMtMS0xLTIxODc0OA_addeb603-69cf-4ece-a2ea-b4f9b55113c3">P8Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzIyLTEtMS0xLTIxODc0OA_b4188887-cf1a-42e3-a229-1d7454b4d2ea"
      unitRef="number">0.0303</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzIyLTMtMS0xLTIxODc0OA_bbcf2e02-c56f-44a3-acad-8a3f7cf38e99"
      unitRef="number">0.0247</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzIzLTEtMS0xLTIxODc0OA_410dd78e-1a94-4dcd-b4a3-6f8b4189aa50"
      unitRef="number">0.0266</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTo0ODEzZDU2ZjRmNTY0ZWQ3OTJiZDczNjQ2MTkwZjE0NS90YWJsZXJhbmdlOjQ4MTNkNTZmNGY1NjRlZDc5MmJkNzM2NDYxOTBmMTQ1XzIzLTMtMS0xLTIxODc0OA_adf3e18d-bb5b-4e29-a872-d6e8560a86b2"
      unitRef="number">0.0250</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzg3OTYwOTMwMzI3ODI_99e83c3f-dc2b-4a35-a40a-0b9ca54a6338"
      unitRef="usd">494000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzU0OTc1NTgyNjU5NQ_abb8a2a5-bfe7-4ea8-a8ea-fd4bfd830ba4"
      unitRef="usd">83000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzU0OTc1NTgyNjYwMw_8a7c1c27-b151-4d0c-86dd-e5ec8e328983"
      unitRef="usd">442000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5OTQ_5f50fac5-7bd8-4001-b18d-691f865d79c0">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease cost were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;These amounts include payments for maintenance, taxes, payments affected by the consumer price index, and other similar metrics and payments contingent on usage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;These amounts were primarily recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:ShortTermLeaseCost
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzItMS0xLTEtMjE4NzQ4_b718dce5-72bf-47cc-89e2-849f28d82926"
      unitRef="usd">20000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzItMy0xLTEtMjE4NzQ4_1a9539d4-8910-4d44-82a4-0358f39af872"
      unitRef="usd">43000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzItNS0xLTEtMjE4NzQ4_d6b17196-4720-4d88-bebf-7c8bb24c3ecc"
      unitRef="usd">32000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzMtMS0xLTEtMjE4NzQ4_1884faa0-64dd-4858-8e4d-77f78e1aeb10"
      unitRef="usd">384000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzMtMy0xLTEtMjE4NzQ4_e9e4134c-53e3-4565-8ef9-de5ad9e5966a"
      unitRef="usd">431000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzMtNS0xLTEtMjE4NzQ4_a5296440-6822-499a-807c-4fc09dd91f52"
      unitRef="usd">465000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzYtMS0xLTEtMjE4NzQ4_50d6f60b-48a6-4401-9ccf-49caa2b31535"
      unitRef="usd">24000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzYtMy0xLTEtMjE4NzQ4_54cb7baf-e373-469d-a0f9-dfc6654867bd"
      unitRef="usd">33000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzYtNS0xLTEtMjE4NzQ4_ea221d4d-aa53-4c8d-ad20-9cee512b07e7"
      unitRef="usd">23000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzctMS0xLTEtMjE4NzQ4_a990274f-0a9c-400b-87fc-6a69f9e932a7"
      unitRef="usd">6000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzctMy0xLTEtMjE4NzQ4_e7789e1e-fff3-4ab1-be47-bce936eb73f0"
      unitRef="usd">5000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzctNS0xLTEtMjE4NzQ4_12d8221d-b360-4788-b657-324bd80c235b"
      unitRef="usd">6000000</us-gaap:FinanceLeaseInterestExpense>
    <mck:FinanceLeaseCost
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzgtMS0xLTEtMjE4NzQ4_1da509b4-03bd-4bbc-9b05-134d417ad981"
      unitRef="usd">30000000</mck:FinanceLeaseCost>
    <mck:FinanceLeaseCost
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzgtMy0xLTEtMjE4NzQ4_f5f30a1c-11bc-4bb0-b8bd-2e15c385ca40"
      unitRef="usd">38000000</mck:FinanceLeaseCost>
    <mck:FinanceLeaseCost
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzgtNS0xLTEtMjE4NzQ4_521e9a8c-7792-4346-b218-3bafc1b9c2ab"
      unitRef="usd">29000000</mck:FinanceLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEwLTEtMS0xLTIxODc0OA_9f322afc-8fe8-4d60-b3ba-bf79cc8aab7f"
      unitRef="usd">128000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEwLTMtMS0xLTIxODc0OA_fc9fadfe-5119-4a55-8361-ec7876fd39b2"
      unitRef="usd">127000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEwLTUtMS0xLTIxODc0OA_955a5e59-967b-4f30-8436-9fe382a934c2"
      unitRef="usd">125000000</us-gaap:VariableLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzExLTEtMS0xLTIxODc0OA_b12da451-9af9-4954-a39a-2ded14188af8"
      unitRef="usd">33000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzExLTMtMS0xLTIxODc0OA_f7123f56-a840-4778-bc3e-f3c4ac2b0767"
      unitRef="usd">41000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzExLTUtMS0xLTIxODc0OA_370cc3ed-8e2e-4fd0-b99c-935f0fb35147"
      unitRef="usd">36000000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEyLTEtMS0xLTIxODc0OA_a562412c-27e3-4700-abdf-f758ef2d30f3"
      unitRef="usd">529000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEyLTMtMS0xLTIxODc0OA_18316c87-1fe3-42ca-b3d4-44b251c5899d"
      unitRef="usd">598000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTozYTkwMDcwMGE3ODA0YzBkOGE5YzhlOTU5OTM1NDRmMS90YWJsZXJhbmdlOjNhOTAwNzAwYTc4MDRjMGQ4YTljOGU5NTk5MzU0NGYxXzEyLTUtMS0xLTIxODc0OA_7563b959-70c5-4183-90c0-dc7d60c1a248"
      unitRef="usd">615000000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzMtMS0xLTEtMjE4NzQ4_871b6b02-d2ec-407c-a2c6-4d920de97736"
      unitRef="usd">338000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzMtMy0xLTEtMjE4NzQ4_1c3cde57-417b-48ed-acec-f52efba85d33"
      unitRef="usd">356000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzMtNS0xLTEtMjE4NzQ4_ce1fd9aa-4781-44ab-83ce-f989119c4377"
      unitRef="usd">362000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzQtMS0xLTEtMjE4NzQ4_0aeb7f3e-fb5c-4341-9a92-766b26058d57"
      unitRef="usd">1000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzQtMy0xLTEtMjE4NzQ4_50ad5af3-4c65-4480-8a57-179e8f24295f"
      unitRef="usd">0</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzQtNS0xLTEtMjE4NzQ4_ff7d4935-d9f0-44e7-9cef-82636941b324"
      unitRef="usd">4000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzUtMS0xLTEtMjE4NzQ4_920dc048-af3e-40cf-adc3-c753e91047ac"
      unitRef="usd">29000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzUtMy0xLTEtMjE4NzQ4_aa7bcb53-5baa-4f7c-aed3-fc7c9cdbe9cd"
      unitRef="usd">31000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzUtNS0xLTEtMjE4NzQ4_a11ad591-114b-4e38-8d56-77df552aa12a"
      unitRef="usd">31000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzctMS0xLTEtMjE4NzQ4_8f0ea54e-bab3-4cf1-b4e5-175d4eb994a8"
      unitRef="usd">462000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzctMy0xLTEtMjE4NzQ4_e6c13464-d191-491d-bec6-11b7334b0630"
      unitRef="usd">286000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzctNS0xLTEtMjE4NzQ4_c04da261-0db1-48f7-bba3-e997fd79bbf1"
      unitRef="usd">321000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzgtMS0xLTEtMjE4NzQ4_ca29d5e7-0842-484b-afe9-1ca60f797487"
      unitRef="usd">17000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzgtMy0xLTEtMjE4NzQ4_820e3d34-3933-42b6-a625-dc5337656e5d"
      unitRef="usd">32000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZToxZjNjOTRjNGFlOWY0NmY0ODc5MDVkMWY4YzIxNTE3YS90YWJsZXJhbmdlOjFmM2M5NGM0YWU5ZjQ2ZjQ4NzkwNWQxZjhjMjE1MTdhXzgtNS0xLTEtMjE4NzQ4_d8254e06-31ec-4f39-9437-03e4c7360f8a"
      unitRef="usd">75000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM5ODk_d319d4ae-525f-4a0d-9b16-f496f91b9182">&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by future minimum sublease income&#160;of $191 million which is due under noncancellable subleases.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzQwMDE_0a9acc00-e22f-41a3-bf71-5d57d9a33251">&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Total lease payments are not reduced by future minimum sublease income&#160;of $191 million which is due under noncancellable subleases.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzItMS0xLTEtMjE4NzQ4_9d40caf3-6086-483a-8236-5c9cb6fc6083"
      unitRef="usd">340000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzItMy0xLTEtMjE4NzQ4_8cdb8cc1-9f32-4d21-9e5a-ea76c91f0996"
      unitRef="usd">33000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <mck:LeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzItNS0xLTEtMjE4NzQ4_6549121e-d026-4183-95f1-ed60fa9993e5"
      unitRef="usd">373000000</mck:LeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzMtMS0xLTEtMjE4NzQ4_be61be3d-a820-4ff7-aeb0-aee76bda732f"
      unitRef="usd">321000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzMtMy0xLTEtMjE4NzQ4_e6e49ae9-9689-4484-b072-28d14130fcf1"
      unitRef="usd">31000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <mck:LeaseLiabilityPaymentsDueYearTwo
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzMtNS0xLTEtMjE4NzQ4_dab78d6e-fcb8-4f73-a2ee-13a54abd07da"
      unitRef="usd">352000000</mck:LeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzQtMS0xLTEtMjE4NzQ4_d588c1a8-6a07-4d8b-a195-e54f4e940aee"
      unitRef="usd">273000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzQtMy0xLTEtMjE4NzQ4_e1c693bb-1521-4ff4-87a1-04cde190c526"
      unitRef="usd">29000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <mck:LeaseLiabilityPaymentsDueYearThree
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzQtNS0xLTEtMjE4NzQ4_90932fd5-e784-4ab1-be71-228ff34be467"
      unitRef="usd">302000000</mck:LeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzUtMS0xLTEtMjE4NzQ4_26edd7cc-d4fd-441a-8931-e611d89fe091"
      unitRef="usd">230000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzUtMy0xLTEtMjE4NzQ4_85172460-b75f-4185-9326-8f1dfc60b568"
      unitRef="usd">28000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <mck:LeaseLiabilityPaymentsDueYearFour
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzUtNS0xLTEtMjE4NzQ4_5fc7e314-3d9d-4e9e-ab77-2638a6deb57b"
      unitRef="usd">258000000</mck:LeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzYtMS0xLTEtMjE4NzQ4_e756fdab-bbc8-44d8-993c-e1156ff76b77"
      unitRef="usd">183000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzYtMy0xLTEtMjE4NzQ4_c5f4c321-dce0-40ed-b0d9-42349c5b1a0e"
      unitRef="usd">26000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <mck:LeaseLiabilityPaymentsDueYearFive
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzYtNS0xLTEtMjE4NzQ4_cc3167f1-95fb-421b-97b1-345aa072e5a6"
      unitRef="usd">209000000</mck:LeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzctMS0xLTEtMjE4NzQ4_67fa5b16-bf98-4434-bedb-2721d8d689b1"
      unitRef="usd">547000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzctMy0xLTEtMjE4NzQ4_796ea07f-b2a8-4aa6-b7a4-9ce3af22db3a"
      unitRef="usd">79000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <mck:LeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzctNS0xLTEtMjE4NzQ4_44a3983f-e89c-46f0-81e7-ec9777017e44"
      unitRef="usd">626000000</mck:LeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzgtMS0xLTEtMjE4NzQ4_6cd5fdf9-f435-4832-83bb-1624dc14685f"
      unitRef="usd">1894000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzgtMy0xLTEtMjE4NzQ4_afdccfb8-9c11-4b6c-b564-0c9e50077ac0"
      unitRef="usd">226000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <mck:LeaseLiabilityPaymentsDue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzgtNS0xLTEtMjE4NzQ4_8fe19c1c-552b-46cf-953d-90c09a085899"
      unitRef="usd">2120000000</mck:LeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzktMS0xLTEtMjE4NzQ4_6f14bedf-7bd4-4614-992d-91cfb3d140ce"
      unitRef="usd">193000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzktMy0xLTEtMjE4NzQ4_2bf6011c-9ca2-48fa-a0c6-aac5c71ecb0c"
      unitRef="usd">24000000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <mck:LeaseLiabilityUndiscountedExcessAmount
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzktNS0xLTEtMjE4NzQ4_fea9f32a-4022-4d1e-a75d-ad3e8c7c4033"
      unitRef="usd">217000000</mck:LeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzEwLTEtMS0xLTIxODc0OA_79b3f467-681f-4f7d-bcec-a2b0009c4f03"
      unitRef="usd">1701000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzEwLTMtMS0xLTIxODc0OA_dd124c76-b5eb-4854-83c2-24e27d0a97f4"
      unitRef="usd">202000000</us-gaap:FinanceLeaseLiability>
    <mck:LeaseLiability
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90YWJsZTplOGM4MmExYmM0ZjM0M2IzYTg4MWM0Y2ExZjFmNDY1MS90YWJsZXJhbmdlOmU4YzgyYTFiYzRmMzQzYjNhODgxYzRjYTFmMWY0NjUxXzEwLTUtMS0xLTIxODc0OA_f3f692f1-5def-4219-939d-500470b32755"
      unitRef="usd">1903000000</mck:LeaseLiability>
    <mck:LessorLeasePaymentstobeReceived
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzMyOTY_23f061f2-9a7f-420f-8dc0-56b158f7868c"
      unitRef="usd">191000000</mck:LessorLeasePaymentstobeReceived>
    <mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM0ODg_edc1db31-96ff-4fa9-843c-9cdcaf6712cf"
      unitRef="usd">98000000</mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="ied7b454e7843455ab8ab7494918c2873_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzg3OTYwOTMwMjkzNTU_de1a1485-d885-4d8c-b595-fbabe8230a45">P10Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzU0OTc1NTgyNTUyMw_3fe26ac6-cee0-4aa0-9736-fc679c0d05cc"
      unitRef="usd">342000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzM4MTY_67faf532-0b3d-4724-a21a-73c6b3403615"
      unitRef="usd">298000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived>
    <mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzg3OTYwOTMwMzUzMjI_cbad47da-6d94-4f17-bc83-f335e0b401c2">P7Y</mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm>
    <mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNDgvZnJhZzpiYmE1Mzg0OWNmNDc0M2YwYTU1MTFmMTlmNWRlYjcwYi90ZXh0cmVnaW9uOmJiYTUzODQ5Y2Y0NzQzZjBhNTUxMWYxOWY1ZGViNzBiXzg3OTYwOTMwMzUzMjI_ea5f975e-bc9e-424a-8b94-a3dab43420ea">P7Y</mck:LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTEvZnJhZzpmZGI5ZDBhODY1MzI0YmI3ODZhZTk2NzQxMWNhOGMxMy90ZXh0cmVnaW9uOmZkYjlkMGE4NjUzMjRiYjc4NmFlOTY3NDExY2E4YzEzXzQ0NTk_8a1af392-6517-44f0-8695-fc863b69e851">Goodwill and Intangible Assets, Net &lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill Impairment Charges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates goodwill for impairment on an annual basis and at an interim date, if indicators of potential impairment exist. Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit. During the first quarter of fiscal 2023, the Company voluntarily changed its annual goodwill impairment testing date from October 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to April 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to align with a change in the timing of the Company&#x2019;s annual long-term planning process. Accordingly, management determined that the change in accounting principle is preferable under the circumstance. This change has been applied prospectively from April 1, 2022, as a retrospective application is deemed impracticable due to the inability to objectively determine the assumptions and significant estimates used in earlier periods without the benefit of hindsight. This change was not material to the Company&#x2019;s consolidated financial statements as it did not delay, accelerate, or avoid any potential goodwill impairment charge. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the reporting units is determined using a combination of an income approach based on a DCF model and a market approach based on appropriate valuation multiples observed for the reporting unit&#x2019;s guideline public companies. Fair value estimates result from a complex series of judgments about future events and uncertainties and relies heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date. Any material changes in key assumptions, including failure to improve operations of certain retail pharmacy stores, additional government reimbursement reductions, deterioration in the financial markets, an increase in interest rates, or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances, may affect such estimates. The discount rates are the weighted-average cost of capital measuring the reporting unit&#x2019;s cost of debt and equity financing weighted by the percentage of debt and percentage of equity in a company&#x2019;s target capital. The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit&#x2019;s future cash flow projections. Fair value assessments of the reporting unit are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual impairment testing performed for fiscal 2023, fiscal 2022, and fiscal 2021 did not indicate any impairment of goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of fiscal 2021, the Company implemented a new segment reporting structure which resulted in the Company&#x2019;s current four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. These reportable segments encompass all operating segments of the Company. This segment change prompted changes in multiple reporting units across the Company. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach and assessed for impairment both before and after the reallocation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a goodwill impairment charge of $69 million in fiscal 2021 as the estimated fair value of the former Europe Retail Pharmacy reporting unit was lower than its reassigned carrying value based on changes in the composition of the Europe Retail Pharmacy reporting unit within the International segment. This charge was recorded in &#x201c;Goodwill impairment charges&#x201d; in the Consolidated Statements of Operations. At March 31, 2023 and 2022, the balance of goodwill in the International segment primarily relates to the Company&#x2019;s McKesson Canada reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 15, &#x201c;Fair Value Measurements,&#x201d; for more information on this nonrecurring fair value measurement. As of March 31, 2023 and 2022, accumulated goodwill impairment losses in the Company&#x2019;s International segment were approximately $700 million. Most of the goodwill impairment for these reporting units was generally not deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes net intangible assets of approximately $384 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; This amount was included under the caption &#x201c;Assets held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of fiscal 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intangible assets were subject to amortization as of March 31, 2023 and 2022. Amortization expense of intangible assets was $236 million, $332 million, and $422 million for fiscal 2023, fiscal 2022, and fiscal 2021, respectively. Estimated annual amortization expense of intangible assets was as follows: $246 million, $240 million, $208 million, $201 million, and $197 million for fiscal 2024 through fiscal 2028, respectively, and $1.2 billion thereafter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; for a description of the goodwill and intangible assets recognized as part of the RxSS acquisition and formation of SCRI Oncology.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; for more information on intangible asset impairment charges recorded in fiscal 2022 and fiscal 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGV4dHJlZ2lvbjoxNTJlNmMxZWMxYjc0NTU2ODBhOTI4NGZmYjc3MTgxYl80NDU3_e80e7ad2-891b-44ce-bc8a-d794024d6531">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i58348ef8cf7b4b6faf2cce35de2978c5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xLTEtMS0xLTIyMjc1Mg_07508008-9f08-40af-b4ad-3eed4a0eac52"
      unitRef="usd">3963000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie9e8557376044f0fa6608b862b7e25c2_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xLTMtMS0xLTIyMjc1Mg_30d60406-b657-4816-9632-d72bbb2ee6bd"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2c04e8513e99429391fedba4d6dad8af_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xLTUtMS0xLTIyMjc1Mg_9f028525-30d4-4fd1-9aec-f25614ad3db6"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3119e2458b4d43bd8aac84c146e9a100_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xLTctMS0xLTIyMjc1Mg_9e90f0a8-02aa-46a6-9ce0-6fb95712cbde"
      unitRef="usd">1535000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xLTktMS0xLTIyMjc1Mg_57f46b7e-c475-4d51-9358-ab8e9f776644"
      unitRef="usd">9493000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i2799afba52094088a0aec4099f2cd4f8_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8yLTEtMS0xLTIyMjc1Mg_7740139d-d1bd-405f-badd-bbb1b68cd181"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id1ceabaf0dff4adc9d75414a157e0e6f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8yLTMtMS0xLTIyMjc1Mg_5ea4a37d-bea7-4bd9-973a-2f01e6109a71"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i80ef17e0a1714077b0570474802db35d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8yLTUtMS0xLTIyMjc1Mg_49bf6dd1-9106-498b-9b43-3c638fb579ec"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="if642126ed2f24282b10b29e0c453e35e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8yLTctMS0xLTIyMjc1Mg_05f8679f-683c-481f-b8c9-eea21e686272"
      unitRef="usd">5000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8yLTktMS0xLTIyMjc1Mg_ae9d6e61-f811-4c34-bc6c-9a0a9153b570"
      unitRef="usd">5000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i2799afba52094088a0aec4099f2cd4f8_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl82LTEtMS0xLTIyMjc1Mg_5ddcda40-f3f7-4091-9e1f-cb9a013c1fb1"
      unitRef="usd">-40000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="id1ceabaf0dff4adc9d75414a157e0e6f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl82LTMtMS0xLTIyMjc1Mg_b4d34f63-ea0e-4468-86f4-69bccb2fa9ab"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i80ef17e0a1714077b0570474802db35d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl82LTUtMS0xLTIyMjc1Mg_9a04192c-3087-44b0-9739-f264ecf254a0"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="if642126ed2f24282b10b29e0c453e35e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl82LTctMS0xLTIyMjc1Mg_2a053b3c-c12b-4381-9910-290e107e3783"
      unitRef="usd">-7000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl82LTktMS0xLTIyMjc1Mg_dadca23c-92dc-4a2c-9b14-d0120cbfc869"
      unitRef="usd">-47000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i849ee3b7fa1d4cb8ba90315b84e6817c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl83LTEtMS0xLTIyMjc1Mg_3f7d3855-a9e7-4b8f-baa9-fd3387b19e96"
      unitRef="usd">3923000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i76fe5a1e46444faa97974d14a8212357_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl83LTMtMS0xLTIyMjc1Mg_2ac6146b-a9c4-4023-baf3-e0e4a7961ef6"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie36e6e5e651d4dac8a530797e7a70c18_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl83LTUtMS0xLTIyMjc1Mg_70a3e9a0-34c1-4e43-80a6-470d33e87025"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i62db101872a24148a919c634afca4814_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl83LTctMS0xLTIyMjc1Mg_350d75bb-0030-4ac1-9743-8fb8cde8103b"
      unitRef="usd">1533000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl83LTktMS0xLTIyMjc1Mg_3b70e6a8-fdc9-4889-be7a-09c9d0498982"
      unitRef="usd">9451000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i888e928ebad143cbb7a499ff02241d61_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl84LTEtMS0xLTIyMjc1Mg_5e9d9ca3-56d8-4926-b10b-1cf881e939c3"
      unitRef="usd">160000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6ac9479cfdf4484f9e8701e0f82d2e4c_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl84LTMtMS0xLTIyMjc1Mg_5066b789-b6fb-4c72-8251-ce28b36cd063"
      unitRef="usd">463000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i19b668b117b34adcb089b01f3153c8f0_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl84LTUtMS0xLTIyMjc1Mg_304875a8-e9d3-4db3-bc26-48c499a6d6dd"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i969dadb6a5014e4e97c0701a8fa71817_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl84LTctMS0xLTIyMjc1Mg_5e6fc8ba-37ec-46a5-a4b5-906351c7b21a"
      unitRef="usd">5000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl84LTktMS0xLTIyMjc1Mg_bb9dfd85-f683-469a-a102-f20f2ba37027"
      unitRef="usd">628000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i888e928ebad143cbb7a499ff02241d61_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMi0xLTEtMS0yMjI3NTI_db346ec8-8bac-4f2d-acf5-be651615f6c7"
      unitRef="usd">-21000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6ac9479cfdf4484f9e8701e0f82d2e4c_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMi0zLTEtMS0yMjI3NTI_8537a69c-dfd8-4a37-9c7f-79146d34ea41"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i19b668b117b34adcb089b01f3153c8f0_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMi01LTEtMS0yMjI3NTI_576406ff-841d-4ad5-a590-09ced5f7a8a1"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i969dadb6a5014e4e97c0701a8fa71817_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMi03LTEtMS0yMjI3NTI_d0f940e2-d157-4fe4-b838-4f093770f755"
      unitRef="usd">-99000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMi05LTEtMS0yMjI3NTI_297b14fc-d7f2-4449-a7f5-d4a924583de5"
      unitRef="usd">-120000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i888e928ebad143cbb7a499ff02241d61_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy0xLTEtMS0yMzU5NjQ_a6e066bc-367b-4dab-946d-3b52d43c1139"
      unitRef="usd">-12000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i6ac9479cfdf4484f9e8701e0f82d2e4c_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy0zLTEtMS0yMzU5NjQ_703ec1f8-61c7-4f2a-b377-2c8229ac699a"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i19b668b117b34adcb089b01f3153c8f0_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy01LTEtMS0yMzU5NjQ_5812a7a4-6afd-4766-a447-e030b45cefb7"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i969dadb6a5014e4e97c0701a8fa71817_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy03LTEtMS0yMzU5NjQ_e8c48b23-4d13-4e85-966f-81db67565e50"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy05LTEtMS0yMzU5NjQ_e5bce742-c120-46d7-95b9-92fa0ec4845d"
      unitRef="usd">-12000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i716b019882fd4fceb551ac9e5a422c18_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy0xLTEtMS0yMjI3NTI_174283f7-7b1d-4dd6-bd11-55a214d39253"
      unitRef="usd">4050000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i06c8b950234148b09f83c9527bf5b802_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy0zLTEtMS0yMjI3NTI_833cc8d9-73de-42ef-8caf-36429b8fde7b"
      unitRef="usd">2005000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ief5e2ae4563940bf95c8d1d8e28f2353_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy01LTEtMS0yMjI3NTI_49e4e831-6916-4d00-a45c-0d1e8577411f"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic03f6f90300b411c9d23b5538357dc9b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy03LTEtMS0yMjI3NTI_ad7096da-39a3-47e0-b545-8013ccb56ada"
      unitRef="usd">1439000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGFibGU6YTY0YmE5Nzg1Y2Q0NDIxZDlkODAzZmQ0NzRhYzdiZWYvdGFibGVyYW5nZTphNjRiYTk3ODVjZDQ0MjFkOWQ4MDNmZDQ3NGFjN2JlZl8xMy05LTEtMS0yMjI3NTI_0af6740d-dde3-48e5-b145-9d36bafca24b"
      unitRef="usd">9947000000</us-gaap:Goodwill>
    <us-gaap:NumberOfReportableSegments
      contextRef="i2fb6e5f190e74ccdae10ef40017a5792_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGV4dHJlZ2lvbjoxNTJlNmMxZWMxYjc0NTU2ODBhOTI4NGZmYjc3MTgxYl8yMjUw_d9f5c56a-d4b8-4edc-b2e3-b21af8ea205f"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ie1ad9e5e8f13437e83ec2ed5b6ca20ee_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGV4dHJlZ2lvbjoxNTJlNmMxZWMxYjc0NTU2ODBhOTI4NGZmYjc3MTgxYl81NDk3NTU4Mjk2ODQ_7c3d0f23-270a-4902-a345-0121e267e886"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia73bbbf5c3f94136997b8becbe0d75fb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDMxL2ZyYWc6MTUyZTZjMWVjMWI3NDU1NjgwYTkyODRmZmI3NzE4MWIvdGV4dHJlZ2lvbjoxNTJlNmMxZWMxYjc0NTU2ODBhOTI4NGZmYjc3MTgxYl81NDk3NTU4MzA3MzE_0ec5a8c6-5f5b-4c1f-ba5a-722a3b305e7d"
      unitRef="usd">700000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN184NTE_3cec2f28-f047-4eab-b68f-4dc49ec18668">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(623)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes net intangible assets of approximately $384 million related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; This amount was included under the caption &#x201c;Assets held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022. Amortization of these assets ceased upon classification as held for sale in the second and third quarters of fiscal 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i51a5d02d9bff429da29560b39c8f2ff3_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTEtMS0xLTIyMjc3Mg_0a01ab5a-0677-4c0f-ae00-4d347cc42453">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if336d47d141c481c95e420c0cf744a34_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTMtMS0xLTIyMjc3Mg_187c5d24-c830-416c-bd6e-86b04eee6c0c"
      unitRef="usd">2971000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if336d47d141c481c95e420c0cf744a34_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTUtMS0xLTIyMjc3Mg_c60af8c1-9e22-4039-b5c4-3df2c0e9008d"
      unitRef="usd">1765000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if336d47d141c481c95e420c0cf744a34_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTctMS0xLTIyMjc3Mg_c474e9fc-340f-4f28-9987-e519c86783d4"
      unitRef="usd">1206000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i460359d3c86945e3bca1ddec5b04da33_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTktMS0xLTIyMjc3Mg_f0072eff-7a38-48b9-a07a-e9417c618dc6"
      unitRef="usd">2777000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i460359d3c86945e3bca1ddec5b04da33_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTExLTEtMS0yMjI3NzI_619867b8-75f3-45c6-a8d9-c1a5b94542cd"
      unitRef="usd">1691000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i460359d3c86945e3bca1ddec5b04da33_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8yLTEzLTEtMS0yMjI3NzI_7afe6f8f-5fa3-4156-a25c-1ac4989aba4f"
      unitRef="usd">1086000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i64e47ed80ef449548b1acb824907d26d_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTEtMS0xLTIyMjc3Mg_917a081c-78ea-4093-bf35-da248d82d77e">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i444f9a88357b4522a70b67e00782860a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTMtMS0xLTIyMjc3Mg_5c612d3f-745f-498d-bf2e-db21a0b923b4"
      unitRef="usd">1137000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i444f9a88357b4522a70b67e00782860a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTUtMS0xLTIyMjc3Mg_6f4c5bec-14bd-43b2-b2f4-3bfdcefa8c40"
      unitRef="usd">623000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i444f9a88357b4522a70b67e00782860a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTctMS0xLTIyMjc3Mg_0d0480cc-c4ea-4423-b1c9-fe96120f0fe1"
      unitRef="usd">514000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie7c8512e869e4882979001a21c27cc1a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTktMS0xLTIyMjc3Mg_c30ab9eb-6f5c-46a3-8a16-45bf95230d8d"
      unitRef="usd">1085000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie7c8512e869e4882979001a21c27cc1a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTExLTEtMS0yMjI3NzI_fb5d2f66-a148-4d01-9bcb-cacc86a926e5"
      unitRef="usd">573000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie7c8512e869e4882979001a21c27cc1a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV8zLTEzLTEtMS0yMjI3NzI_4669f314-63c3-4bb4-b9a7-9a510eeea5e9"
      unitRef="usd">512000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ice102114e53046c0990a7f9b97933076_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTEtMS0xLTIyMjc3Mg_9d99cc7a-b93e-4117-9213-4cb4fbbd075b">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i26dce1de93254045b3bf97178b2dd2bf_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTMtMS0xLTIyMjc3Mg_534d2f87-dd42-47f0-b1fb-51f397a1153f"
      unitRef="usd">833000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i26dce1de93254045b3bf97178b2dd2bf_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTUtMS0xLTIyMjc3Mg_efcd8799-5cad-400a-bb54-3d46d8a799cf"
      unitRef="usd">430000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i26dce1de93254045b3bf97178b2dd2bf_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTctMS0xLTIyMjc3Mg_c5c1d06a-9f2a-43b4-a6c5-ffb942b5330f"
      unitRef="usd">403000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibf6e4b73c21f44648aa84b01813ff828_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTktMS0xLTIyMjc3Mg_a63f2a5c-4cbf-4664-87c9-359c0d7ca099"
      unitRef="usd">819000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibf6e4b73c21f44648aa84b01813ff828_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTExLTEtMS0yMjI3NzI_d00a7400-00bb-4d48-b99b-c128381a45c7"
      unitRef="usd">386000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibf6e4b73c21f44648aa84b01813ff828_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV81LTEzLTEtMS0yMjI3NzI_f9e68d41-8bae-4013-9688-e8a2bc83b59e"
      unitRef="usd">433000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ib3aea8ed8bb64f248ee3ba0de12e5974_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTEtMS0xLTIyMjc3Mg_74e7139d-759e-417c-8b21-9c1d2e364377">P11Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibddbc2840c8d47d1a8b3d4d03ad88e0e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTMtMS0xLTIyMjc3Mg_e4ac0eb9-27dd-44dc-80f6-c973ccb9b12a"
      unitRef="usd">264000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibddbc2840c8d47d1a8b3d4d03ad88e0e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTUtMS0xLTIyMjc3Mg_d1e97158-4afb-4972-9962-0d08327275b7"
      unitRef="usd">129000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibddbc2840c8d47d1a8b3d4d03ad88e0e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTctMS0xLTIyMjc3Mg_ff77cbe9-ce7f-4508-90c5-6af865d6a578"
      unitRef="usd">135000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i58d94f46b8eb44d5abcdcf4c68ffd4af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTktMS0xLTIyMjc3Mg_ba6ebeef-537e-476c-bfd3-33e35264038f"
      unitRef="usd">128000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i58d94f46b8eb44d5abcdcf4c68ffd4af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTExLTEtMS0yMjI3NzI_3cc9f907-a5d3-475a-8a69-98d04cd3c24c"
      unitRef="usd">116000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i58d94f46b8eb44d5abcdcf4c68ffd4af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV82LTEzLTEtMS0yMjI3NzI_91010dba-071d-4c07-8d23-1264a186bf23"
      unitRef="usd">12000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="icfb74fdbaafc42b5bc38853f2956af25_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTEtMS0xLTIyMjc3Mg_a0e743da-cfc6-4011-8e16-1fb8da9f2561">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8e7a74f1e4ec41a08eb7da7766828283_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTMtMS0xLTIyMjc3Mg_a91d6fbb-441b-4e53-98cd-c1fbfa1adbb7"
      unitRef="usd">193000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8e7a74f1e4ec41a08eb7da7766828283_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTUtMS0xLTIyMjc3Mg_d00adb8b-79ae-48a3-94af-8370322f182b"
      unitRef="usd">174000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8e7a74f1e4ec41a08eb7da7766828283_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTctMS0xLTIyMjc3Mg_eca8a34a-6cf9-410c-a5b1-60404307a216"
      unitRef="usd">19000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i618590d34e9e40beaae759c50efa5248_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTktMS0xLTIyMjc3Mg_0649edba-2e11-4178-8c9f-bc4711f6b6a3"
      unitRef="usd">187000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i618590d34e9e40beaae759c50efa5248_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTExLTEtMS0yMjI3NzI_1987af2d-f411-48b4-adaa-addf131c742f"
      unitRef="usd">171000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i618590d34e9e40beaae759c50efa5248_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV83LTEzLTEtMS0yMjI3NzI_6daaeddb-72e3-4c16-95ad-f7e06565c94d"
      unitRef="usd">16000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTMtMS0xLTIyMjc3Mg_5c82a768-1bd7-44ff-b8a3-991ff4fa2cd0"
      unitRef="usd">5398000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTUtMS0xLTIyMjc3Mg_2f03446c-b48b-42b5-8b53-9174d9375492"
      unitRef="usd">3121000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTctMS0xLTIyMjc3Mg_a1ab24ff-fa3c-4371-a9f3-488c97df1477"
      unitRef="usd">2277000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTktMS0xLTIyMjc3Mg_ca5fdd4d-1558-40f0-9992-8c30fdb698e7"
      unitRef="usd">4996000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTExLTEtMS0yMjI3NzI_eb21b0e0-d123-4c1f-90f1-7b703b847442"
      unitRef="usd">2937000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGFibGU6YTE2N2EwNDJjZTA4NDMwMTljYmQ5OWVkYzk5YThhMzUvdGFibGVyYW5nZTphMTY3YTA0MmNlMDg0MzAxOWNiZDk5ZWRjOTlhOGEzNV84LTEzLTEtMS0yMjI3NzI_1fa4dd3f-a270-4931-809d-f7487b1f31a1"
      unitRef="usd">2059000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i0496c19ac0ab424285907e4b8bdfd63c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN181NDk3NTU4MTQ4Nzc_e7205849-7b5e-42ad-9ac2-7892ef0e5024"
      unitRef="usd">384000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN181NDg_a3de599e-36a3-4267-b42c-b9a705cbf1d4"
      unitRef="usd">236000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN181NTM_d9129445-7bc8-472a-ac21-10f8b02b6436"
      unitRef="usd">332000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN181NjE_5bd640db-3916-413d-83f2-135b08787189"
      unitRef="usd">422000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN182NzM_14311356-2196-4bff-a5b8-11319e80e6fd"
      unitRef="usd">246000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN182Nzc_d972efa1-1e02-4075-826f-bc224c23248b"
      unitRef="usd">240000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN182ODE_b42261d8-dc7f-4a6c-99a7-ff9310b03dfa"
      unitRef="usd">208000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN182ODU_ee840b88-7bb3-413d-97f4-2b39ab7c5822"
      unitRef="usd">201000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN182OTM_5de7c8d5-4cee-45b7-ae03-dfe20e90b3f0"
      unitRef="usd">197000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDU4L2ZyYWc6MTNlYzk2ODE3MjdmNDA5ZGE0NGZjZDdmNzNmZDkzMzcvdGV4dHJlZ2lvbjoxM2VjOTY4MTcyN2Y0MDlkYTQ0ZmNkN2Y3M2ZkOTMzN183MTk_8816d24c-4ee8-49de-8642-3d892dc5f1fd"
      unitRef="usd">1200000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzc0NDc_688c5df9-1c9d-4481-8032-30b7955485b5">Debt and Financing Activities&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.25% Notes due February 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30% Notes due August 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these U.S. dollar notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes current and long-term debt of approximately $4&#160;million and $11&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included under the caption &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. At March 31, 2023 and 2022, $5.6 billion and $5.9 billion, respectively, of total debt was outstanding, of which $968 million and $799 million, respectively, was included in &#x201c;Current portion of long-term debt&#x201d; in the Company&#x2019;s Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 15, 2023, the Company completed a public offering of 5.25% Notes due 2026 (the &#x201c;February 2026 Notes&#x201d;) in a principal amount of $500 million. Interest on the February 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on August 15, 2023. Proceeds received from this note issuance, net of discounts and offering expenses, were $497 million. The Company utilized the net proceeds from this note issuance to repay existing debt. On or after February 15, 2024, the Company may redeem the February 2026 Notes at its option, in whole or in part, at any time and from time to time, for cash at a redemption price equal to 100% of the principal amount of the notes being redeemed plus accrued and unpaid interest thereon to, but not including, the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 12, 2021, the Company completed a public offering of 1.30% Notes due August 15, 2026 (the &#x201c;August 2026 Notes&#x201d;) in a principal amount of $500&#160;million. Interest on the August 2026 Notes is payable semi-annually on February 15th and August 15th of each year, commencing on February 15, 2022. Proceeds received from this note issuance, net of discounts and offering expenses, were $495&#160;million. The Company utilized the net proceeds from this note issuance for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 3, 2020, the Company completed a public offering of 0.90% Notes due December 3, 2025 (the &#x201c;2025 Notes&#x201d;) in a principal amount of $500&#160;million. Interest on the 2025 Notes is payable semi-annually on June 3rd and December 3rd of each year, commencing on June 3, 2021. Proceeds received from this note issuance, net of discounts and offering expenses, were $496&#160;million. The Company utilized the net proceeds from this note issuance for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each note, which constitutes a &#x201c;Series,&#x201d; is an unsecured and unsubordinated obligation of the Company and ranks equally with all of the Company&#x2019;s existing, and from time-to-time, future unsecured and unsubordinated indebtedness outstanding. Each Series is governed by materially similar indentures and officers&#x2019; certificates as those of other Series issued by the Company. Upon required notice to holders of notes with fixed interest rates, the Company may redeem those notes at any time prior to maturity, in whole or in part, for cash at redemption prices. In the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of a Series below an investment grade rating by each of the Ratings Agencies (as defined in the applicable Officer&#x2019;s Certificate) within a specified period, an offer must be made to purchase that Series from the holders at a price equal to 101% of the then outstanding principal amount of that Series, plus accrued and unpaid interest to, but not including, the date of repurchase. The indenture and the related officers&#x2019; certificate for each Series, subject to the exceptions and in compliance with the conditions as applicable, specify that the Company may not consolidate, merge or sell all or substantially all of its assets, incur liens, or enter into sale-leaseback transactions exceeding specific terms, without the lenders&#x2019; consent. The indentures also contain customary events of default provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 15, 2023, the Company retired its $360&#160;million outstanding principal amount of 2.85% Notes due 2023 upon maturity. On December 15, 2022, the Company retired its $400&#160;million outstanding principal amount of 2.70% Notes due 2022 upon maturity. On July 17, 2021, the Company redeemed its &#x20ac;600 million (or, approximately $709 million) outstanding principal amount of Euro-denominated 0.63% Notes due 2021, prior to maturity at par value. On December 1, 2020, the Company redeemed its $323&#160;million outstanding principal amount of 4.75% Notes due 2021 prior to maturity. On November 30, 2020, the Company retired its $700&#160;million outstanding principal amount of 3.65% Notes due 2020 upon maturity. All of these notes were repaid or redeemed using cash on hand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tender Offer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) 2.85% Notes due 2023, (ii) 3.80% Notes due 2024, (iii) 7.65% Debentures due 2027, (iv) 3.95% Notes due 2028, (v) 4.75% Notes due 2029, (vi) 6.00% Notes due 2041, and (vii) 4.88% Notes due 2044 (collectively referred to herein as the &#x201c;Tender Offer Notes&#x201d;). In connection with the tender offer, the Company paid an aggregate consideration of $1.1 billion to redeem $922 million principal amount of the Tender Offer Notes at a redemption price equal to 100% of the principal amount and premiums of $182 million, plus accrued and unpaid interest of $14 million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment. As a result of the redemption, the Company incurred a pre-tax loss on debt extinguishment of $191 million for the year ended March 31, 2022, which included premiums of $182&#160;million as well as the write-off of unamortized debt issuance costs and transaction fees incurred totaling $9 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled principal payments of long-term debt are $968&#160;million, $39&#160;million, $1.7&#160;billion, $1.2&#160;billion, and $376 million for fiscal 2024 through fiscal 2028, respectively, and $1.3&#160;billion thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 7, 2022, the Company entered into a Credit Agreement (the &#x201c;2022 Credit Facility&#x201d;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. The 2022 Credit Facility replaced the Company&#x2019;s previous syndicated $4.0 billion five-year senior unsecured credit facility, dated as of September 25, 2019, as amended (the &#x201c;2020 Credit Facility&#x201d;), which was scheduled to mature in September 2024. The 2020 Credit Facility was terminated in connection with the execution of the 2022 Credit Facility. There were no borrowings under the 2020 Credit Facility during the years ended March 31, 2023, 2022, and 2021, and no amounts outstanding at the time of its termination. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the 2022 Credit Facility bear interest based upon the Term Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;) for credit extensions denominated in U.S. dollars, the Sterling Overnight Index Average Reference Rate for credit extensions denominated in British pound sterling, the Euro Interbank Offered Rate for credit extensions denominated in Euros, the Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates, as applicable, plus agreed upon margins. The 2022 Credit Facility contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the 2022 Credit Facility. If the Company does not comply with these covenants, its ability to use the 2022 Credit Facility may be suspended and repayment of any outstanding balances under the 2022 Credit Facility may be required. At March 31, 2023, the Company was in compliance with all covenants under the 2022 Credit Facility. The 2022 Credit Facility also permits the Company to establish key performance indicators with respect to certain sustainability targets of the Company in consultation with certain sustainability coordinators. The Company may enter into an amendment to the 2022 Credit Facility to provide for certain adjustments to the otherwise applicable facility fee and margins based on the Company&#x2019;s performance against any established key performance indicators. The 2022 Credit Facility is scheduled to mature in November 2027. The remaining terms and conditions of the 2022 Credit Facility are substantially similar to those previously in place under the 2020 Credit Facility. The Company can use funds obtained under the 2022 Credit Facility for general corporate purposes. There were no borrowings under the 2022 Credit Facility during the year ended March 31, 2023 and no amounts outstanding at March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Term Loan Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 7, 2022, the Company entered into a Credit Agreement (the &#x201c;2022 Term Loan Credit Facility&#x201d;) pursuant to which the Company had an unsecured delayed draw term loan facility up to $500&#160;million which was available for borrowing for 90 days after the closing date in up to three separate borrowings. During the third quarter of fiscal 2023, the Company borrowed $500&#160;million under the 2022 Term Loan Credit Facility at an interest rate of three-month Term SOFR plus 110 basis points, which was payable quarterly and had an original maturity date of November 7, 2025. The funds obtained were used for general corporate purposes. In February 2023, the Company repaid all borrowings outstanding under the 2022 Term Loan Credit Facility, at which point this facility was terminated in its entirety.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintained bilateral credit facilities primarily denominated in Euros with a committed amount of $7&#160;million and an uncommitted amount of $111&#160;million as of March 31, 2022, which were transferred as part of the divestiture of the E.U. disposal group in October 2022. Borrowings and repayments were not material during the years ended March 31, 2023, 2022, and 2021, and amounts outstanding under these credit lines were not material at March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0&#160;billion in outstanding commercial paper notes. During the years ended March 31, 2023, 2022, and 2021, the Company borrowed $8.5&#160;billion, $11.2&#160;billion, and $6.3&#160;billion, respectively, and repaid $8.5&#160;billion, $11.2&#160;billion, and $6.3&#160;billion, respectively, under the program. At March 31, 2023 and 2022, there were no commercial paper notes outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzc0NTY_3e3f516f-31cb-463c-80ec-87b59e7a78fd">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.25% Notes due February 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30% Notes due August 15, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these U.S. dollar notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Excludes current and long-term debt of approximately $4&#160;million and $11&#160;million, respectively, as of March 31, 2022 related to the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included under the caption &#x201c;Liabilities held for sale&#x201d; in the Consolidated Balance Sheet as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i202cd9cf62f0431e8d01300563014a7d_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzMtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246NjRkYWMyMTgzODdlNDllOWFmNGI4Y2IwOGIyNzBlNWRfNA_87a8a339-6867-4e16-8c74-4bb266157df9"
      unitRef="number">0.0270</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i202cd9cf62f0431e8d01300563014a7d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzMtMS0xLTEtMjE4NzQ4_ffb44435-3808-42e5-9b00-1b0a1943ace5"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1765debe58fa477bb60f4fa358d03763_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzMtMy0xLTEtMjE4NzQ4_c0612b22-52e4-4773-affb-f1cfbcbe8e18"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibae09054075242708b4f1b92c5ad9435_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzQtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246MTRiMThjM2NjYTQyNGVlYzhjODc1MzJhN2FjMjNmNDlfNA_d0aba5cf-8ef7-4fa6-a50a-44c515905e3f"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ibae09054075242708b4f1b92c5ad9435_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzQtMS0xLTEtMjE4NzQ4_d215abd5-27d3-4a4a-88f4-a094682da017"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="idf954d0b17fa4afcbd832a5b25242889_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzQtMy0xLTEtMjE4NzQ4_31b38b8b-bf26-4480-9cad-b2a32d56b6ac"
      unitRef="usd">360000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i74f232fbbdd542a68a67aac5bb01a3ad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzUtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246ZmQxMTZiZTEyNjUwNDZiMThkZGU4NDUzODRjMDRlYTJfNA_f38706f3-09e9-4202-b9b3-e453e6333578"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i74f232fbbdd542a68a67aac5bb01a3ad_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzUtMS0xLTEtMjE4NzQ4_119055cc-2a2b-481a-836e-30b8397a273b"
      unitRef="usd">918000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6020b3dcea424492aa70f65876ac2906_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzUtMy0xLTEtMjE4NzQ4_d68f1287-502f-48a2-b67c-b5342e922ad4"
      unitRef="usd">918000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i768c441bead74af990375d494dcd615f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzYtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246MDcyMjM3ZDEwMWVjNGEyOTkwMjg3ODNiMmQ4NTJhMzVfNA_7f43654f-633a-4a22-a459-3a765e2016bf"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i768c441bead74af990375d494dcd615f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzYtMS0xLTEtMjE4NzQ4_7df7dd87-74a5-491c-8caf-f99d44d326e6"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i46014a69e7bb46d7804f90bfac7336a1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzYtMy0xLTEtMjE4NzQ4_0c0b0988-1a99-4c10-9d8f-66acb8cc637a"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id6a8fb9420154ab99c47ee021794a752_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMC0xLTEtMjQzNjY3L3RleHRyZWdpb246YmNhNGVmYmIyZGQ0NGE0MjgxOWYwNDhjYjI3MTM0NDFfMTY0OTI2NzQ0MTcwNg_0ea110ba-fe70-4c8c-b578-79ef134715e9"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id6a8fb9420154ab99c47ee021794a752_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMS0xLTEtMjIzNzcx_2db25fda-2a1a-4e66-9fa4-65dc351b9110"
      unitRef="usd">499000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i15a119cca4d54ce1b9e9b15b07ecb555_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMy0xLTEtMjIzNzcx_f48964c4-9edf-4fcb-8e58-8226362882f1"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia67ce7e8257446a8a749a51dd4e61f1e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246Njk2NGM3MTAxMTdkNDVlZjg2NjA2ZDE2YjRlMDViOGFfNA_e152d987-7e17-4507-8228-d0aae529bf42"
      unitRef="number">0.0130</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia67ce7e8257446a8a749a51dd4e61f1e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMS0xLTEtMjE4NzQ4_57325a0f-925e-4cb5-8aa8-f2335429529d"
      unitRef="usd">498000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6923623dff6a4c21af62ba66950bbca1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzctMy0xLTEtMjE4NzQ4_1e673a98-d055-4903-a04e-ad359b4759c1"
      unitRef="usd">498000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i836c135ad296412391b52c76ec2d65af_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzgtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246NmI0M2QyZDI3MWU5NDg0OWE4Y2YzMzQzNTg3OTFmOGRfNA_f8a1ba5a-2894-421c-8e23-5bf427ba2059"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i836c135ad296412391b52c76ec2d65af_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzgtMS0xLTEtMjE4NzQ4_d83b4664-d4ab-4e85-8556-42c6550ca33f"
      unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i584398e2f2774124928de1b3733debf3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzgtMy0xLTEtMjE4NzQ4_09f46535-eb08-487f-b148-815a833336f5"
      unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icc18546dd5254ad9bc27e6a28551e869_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzktMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246OGE1NTdlMDc2N2Q2NGFlMDgxZjgxYjcwNDI5NTVlNTBfNA_3656891e-7672-47bd-afe9-81d2fd6bd150"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="icc18546dd5254ad9bc27e6a28551e869_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzktMS0xLTEtMjE4NzQ4_ce5e6ba5-1e3d-4e87-80c0-e641f31b874b"
      unitRef="usd">343000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibf67d81b73484a2ab862ae6562f12c8f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzktMy0xLTEtMjE4NzQ4_7185ff50-abd8-487a-ba95-963e87f71349"
      unitRef="usd">343000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib792f01cad394fa9a6b5b6007690d92d_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEwLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjMzNzhmNDQzYTM3MzQ2ZTI4YTQ2MjFiN2NmMjdlYTM5XzQ_286bcc2e-5d7a-4375-9ab6-615c2e61d1aa"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib792f01cad394fa9a6b5b6007690d92d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEwLTEtMS0xLTIxODc0OA_ecc0f169-3486-4997-abc6-8cd549b21a25"
      unitRef="usd">196000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i22b455fe9626429d82d1312274a08717_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEwLTMtMS0xLTIxODc0OA_0c299901-8532-4be2-86f9-aaf8e10c3055"
      unitRef="usd">196000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6305f106d8224c67a7f1f4f9d248c6ee_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzExLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjBmYzllYWQyZjgxZDQ4MDlhZDk0YzNlMWU3ODE0NzRiXzQ_e260fee0-aa34-4d84-845a-184c20e85182"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i6305f106d8224c67a7f1f4f9d248c6ee_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzExLTEtMS0xLTIxODc0OA_1a7118a5-6dd4-4581-b626-a0c14e98da13"
      unitRef="usd">218000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i00eb8e4aa01348e88c908410c24dbed9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzExLTMtMS0xLTIxODc0OA_5af8653e-a02a-401d-b78c-f713574f3a75"
      unitRef="usd">217000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2db8c6c2c8154fc292aa5199f298a4cd_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEyLTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOmY3MzYwNDhmYWE1ODQ2YzJiYjY3NWFkN2E5ODZkZDgzXzQ_53ed88af-528f-4b5d-9fe9-280769a9594c"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i2db8c6c2c8154fc292aa5199f298a4cd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEyLTEtMS0xLTIxODc0OA_77b48336-6618-4343-87bd-76c3cdb87784"
      unitRef="usd">255000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0ded6a5da3964377b85a8496b7db3a17_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzEyLTMtMS0xLTIxODc0OA_8c5c1402-9d0d-464c-a323-8fc0b62c3281"
      unitRef="usd">255000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib30972cf50704e17b9605f2bd2f62293_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE1LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjc5NjExZGFjOTA1ODQzNzA5MTU5MzQ1MzFjYzA1ZjU2XzQ_726da56e-ed0c-46df-a9cf-071e8614b069"
      unitRef="number">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib30972cf50704e17b9605f2bd2f62293_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE1LTEtMS0xLTIxODc0OA_708ec2c2-1ce3-41a8-ba6b-396f0f4f59ba"
      unitRef="usd">649000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i215f3153999b49f994c67efb2f5ca414_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE1LTMtMS0xLTIxODc0OA_d8985fdf-afb8-4443-b32e-d6a46d3e8cc9"
      unitRef="usd">662000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i844ae52bcc2545d293dac8695661ad1c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE2LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOjQ3MjNkNmU4ODc4OTQ2MGY5Y2VlYmZkZDNkNzc0OWRkXzQ_92858a7e-42dc-410d-9880-c6aa7bb0462d"
      unitRef="number">0.0163</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i844ae52bcc2545d293dac8695661ad1c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE2LTEtMS0xLTIxODc0OA_fe1f6d50-09fb-44a8-b920-2a911cd31535"
      unitRef="usd">542000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if363f9768e7c4dfda22b43256fce94cf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE2LTMtMS0xLTIxODc0OA_2402f814-8645-498e-baca-fe1ac1239d05"
      unitRef="usd">554000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5694cf86b13649b19e91a4472f2dd301_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE3LTAtMS0xLTIxODc0OC90ZXh0cmVnaW9uOmJmNTdiYmMyOTFkMTRjZjY5YTQ3NTJkMDdjOThjY2E0XzQ_df7bbe9f-2691-4a25-a393-9cbf0df162d5"
      unitRef="number">0.0313</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5694cf86b13649b19e91a4472f2dd301_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE3LTEtMS0xLTIxODc0OA_a70dea57-3af4-49b3-be65-f6ba50c3ecc4"
      unitRef="usd">555000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i35cacf2366014f2ea0f9ac27e0b29d39_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE3LTMtMS0xLTIxODc0OA_9861a5a7-6f88-44a2-9f03-d680c58a41d1"
      unitRef="usd">582000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ieea3066b4198415db491f3e894ce0b14_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE5LTEtMS0xLTIxODc0OA_ad8b8bba-65a1-40a9-a03a-89e40bba1f76"
      unitRef="usd">271000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6f1b5510456d4c02b2ecb86d2a690ce1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzE5LTMtMS0xLTIxODc0OA_91caf450-34f5-4c2e-bafe-7acf693cc62b"
      unitRef="usd">244000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIwLTEtMS0xLTIxODc0OA_ad4ca98a-c92f-4f51-8593-2e0d35facf60"
      unitRef="usd">5594000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIwLTMtMS0xLTIxODc0OA_38fb3b98-2e27-453c-8f57-3469673a476c"
      unitRef="usd">5879000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIxLTEtMS0xLTIxODc0OA_0444af75-2ebb-468d-9187-c570729cca93"
      unitRef="usd">968000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIxLTMtMS0xLTIxODc0OA_9eec57b0-b645-45b6-9573-8da75e8d3023"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIyLTEtMS0xLTIxODc0OA_fc796c24-8e2f-4234-ac5e-8a11fbb7240d"
      unitRef="usd">4626000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90YWJsZTo3NjgwOTAyYzkyYWE0NWQ0YjIzZjg2NWY4ZjgyYjRjYS90YWJsZXJhbmdlOjc2ODA5MDJjOTJhYTQ1ZDRiMjNmODY1ZjhmODJiNGNhXzIyLTMtMS0xLTIxODc0OA_638644a0-af45-40f0-8948-62b41cf12d1e"
      unitRef="usd">5080000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities
      contextRef="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg2ODc_1e333c8a-912d-4484-b7fd-3ec4d85b6385"
      unitRef="usd">4000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities>
    <mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities
      contextRef="iaa923d2ce3d540a0acb1c546c38a17c5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg2OTk_d048256b-a148-4030-afe7-80be15034ec9"
      unitRef="usd">11000000</mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzY2MQ_fe7f691b-ddab-45bb-b2fd-ef2edb573937"
      unitRef="usd">5600000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzY2OA_7d5a5315-16ec-4ed3-89da-ed67dfc07974"
      unitRef="usd">5900000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzcyNg_2e384163-e6ab-4ae5-b491-574b57b0e805"
      unitRef="usd">968000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczMw_8b95d84e-b703-4f07-a083-f351802b07ff"
      unitRef="usd">799000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i976e4c827b4549e1961c10a386b91abb_I20230213"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE1NzE_22ba0850-77af-4977-a871-cd2d82c73b8e"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i976e4c827b4549e1961c10a386b91abb_I20230213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE1ODY_4472bd89-59a9-4f43-9444-e9519e384cae"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="ifa0ffbdeacb64a09986b957e9f96a042_D20230213-20230213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE2MDg_05e0e940-fae7-407c-80ec-7189f59154b1"
      unitRef="usd">497000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ifa0ffbdeacb64a09986b957e9f96a042_D20230213-20230213"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNjMwMjg_72b340c2-043b-4394-8a91-84337fcc0201"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i535b3f0e572b482a8d1a1dedf038fe50_I20210812"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg4Mg_f7754e82-628e-4263-bacf-701e40c1d475"
      unitRef="number">0.0130</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i535b3f0e572b482a8d1a1dedf038fe50_I20210812"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzk1NQ_9cc269c8-21ea-4133-85ab-1c60866d0fdc"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i78a368c4b72d42cf8b1a224dc65b0f47_D20210812-20210812"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzExNzk_059732c9-d6d3-445e-baaf-ea2c49a12dc0"
      unitRef="usd">495000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2a24f716c6be4a4696ca08b8cc9d7ad8_I20201203"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3MTI_8ce25eef-d27a-43ec-b90f-0d6547c3fde7"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2a24f716c6be4a4696ca08b8cc9d7ad8_I20201203"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3MTk_9e88ac22-26bb-4d3b-8459-b46815c70e43"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i11be422271b0497c8bb2cbf054b40bdd_D20201203-20201203"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3MzM_4b6fdb44-45c0-4010-9e09-946ead7e9490"
      unitRef="usd">496000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i772fb832f6354412ad17d3bfd7fe6b1d_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg0ODg3Ng_4f0d09f1-c40f-4c86-b0a6-16a0fbd24e10"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="icac00852e08b4922ad11b375efe1e1b0_D20230315-20230315"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0Nzg3NTk_f84fea45-b3b1-4173-bb41-c414ad5b8a45"
      unitRef="usd">360000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia19e57b1a46b4e69ae2d79da972f650a_I20221215"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0Nzg3Njc_0a2e71b4-c67f-466a-8ca3-2d84daf8f193"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i3851e69ede76406a8a5a4117e99d5ec4_D20221215-20221215"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg0OTY2MQ_672db05e-e009-4960-880c-e8c834e49d40"
      unitRef="usd">400000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib44bfb223bc14e29aeac77c05bbc39d7_I20221215"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg0OTY5Nw_34333bec-4541-4b43-b1c7-cea02d6ddc5d"
      unitRef="number">0.0270</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i453005c054c0476fbb9853e512d6bd28_D20210717-20210717"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzMxODM_0e7fdb33-53f7-49df-abdd-f46e520fc28a"
      unitRef="eur">600000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i453005c054c0476fbb9853e512d6bd28_D20210717-20210717"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzMyMDU_04260e15-5937-480c-8077-b4767f4df6c1"
      unitRef="usd">709000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie0e1375f02f24ba79ea97f55a3b99d89_I20210717"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg1NjI0Nw_2e740a34-6780-481f-b873-bccd68f43680"
      unitRef="number">0.0063</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic756400c1f7e46c38b850bd10c43a377_D20201201-20201201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM0MDk_505838de-2a55-4df5-926a-63424998e685"
      unitRef="usd">323000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3f46bdc3df244190a4f3caa01c5eccdd_I20201201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg1NjMzMg_2e503813-09ec-45c5-8b6e-8a033099797b"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i7fd03415c82341b0bcd801b36c1a28fe_D20201130-20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM1MjY_96e13712-d68b-4892-944a-403f22861435"
      unitRef="usd">700000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1f7ee8f00bf1412e813d7abd850dc07b_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzU0OTc1NTg1NjM3Nw_d70f3584-af2a-4341-95a4-1f5d7584c3e8"
      unitRef="number">0.0365</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4592baf7793041fa8e76756aac03670e_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM4ODQ_ee0e5fbc-a826-43a0-82fa-771281832584"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib143d3ffb79a4cc4bd2ad4ebae133edc_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM5MDg_66304062-ea79-4bcb-acd7-69b0e03bc244"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i34d77590b6c24730802120c45ff43aa6_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM5MzM_a8f202b6-6dc4-4d52-bc76-9c9a14e16a9a"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia499a63a8849486aa054b9140660701a_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM5NjI_f4fc1367-d1ee-4157-bfe1-5dd561ba2faa"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic327cefb81b34e5a82369680f27dfba6_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzM5ODU_e0872f41-c6ba-4eca-acf2-0184967c91ce"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2959faada6aa43a892063ae50e28b434_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQwMDk_8fbbf4a8-f4bb-4665-b363-374fccfb1eaa"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ida05874ce18a4f4fb630c33eac2a3138_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQwMzg_99ad85b4-2521-4f4b-a522-d36a356872e7"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i9c2fdc8cd1ed4cabbe44be3bfdd3a3f2_I20210723"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQyMDM_ff5de359-b4c0-477c-996e-f9c48a5e6133"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i9c2fdc8cd1ed4cabbe44be3bfdd3a3f2_I20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQyMTY_dbfb663b-f9d9-430f-9a88-6e6af61f7c28"
      unitRef="usd">922000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ie691f38e48be4843a3fd39459645f39b_D20210723-20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQyODA_92ccc99f-019a-4fad-afa5-b89e8911be7a"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ie691f38e48be4843a3fd39459645f39b_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQzMjM_5fecef03-06a9-435e-b4ff-11803bb3684a"
      unitRef="usd">182000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:InterestPaid
      contextRef="ie691f38e48be4843a3fd39459645f39b_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQzNjM_dcef01e4-2c3c-488c-a6ad-d5311aeed6c4"
      unitRef="usd">14000000</us-gaap:InterestPaid>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5bdacb5a0bcc4ad480dec225518c10c8_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ1NDU_e0802ddb-feda-4b0c-8523-232fd2945f95"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i7cc5f04c5c2d4d70aa2d95e18cd6bef4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ1OTc_1f4ae9d0-22e7-4fd9-8031-ee8a78454589"
      unitRef="usd">182000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts
      contextRef="i5bdacb5a0bcc4ad480dec225518c10c8_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ2OTk_a1658042-ba9d-43de-b0b1-d931e760fa84"
      unitRef="usd">9000000</mck:WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ3NzI_947aea02-94f8-4dcf-8fac-202746e0c84c"
      unitRef="usd">968000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ3ODI_af083832-4675-4eb8-b7ef-7db63b79613a"
      unitRef="usd">39000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ3OTI_2467e8f0-d28c-4261-88d5-6a079348b91b"
      unitRef="usd">1700000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ4MDI_db27afc4-9eea-4c13-8888-29e183713676"
      unitRef="usd">1200000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ4MTI_b1d958ee-ed59-45f9-9fa6-235d252c1a00"
      unitRef="usd">376000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzQ4MjY_5098e4c6-cbcf-4a0e-ada4-febbfca3f044"
      unitRef="usd">1300000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0de40eac191846698bafb26987f8db02_I20221107"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE2ODI_414c33dd-ca9d-467a-ab3b-f4e6eb5933c2"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="id2939e16a3a648eeadc8fe5b14335874_D20221107-20221107"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTI1Mzc_9f6c9f21-90bd-4571-8cf5-034dadb0f765">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id005fd4ac6fa46378f61401585bd1f21_I20221107"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE2OTE_617ee65d-19ad-420a-91e4-831c9d0f5498"
      unitRef="usd">3600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic980d09285fc4708a8a6eafe8b8a5655_I20221107"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE2OTY_f8c152bd-0b87-4bdf-a4d0-5eec337fcd98"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i6df2825430ea48468dedc27f049659e5_D20221107-20221107"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTI1Mzg_d138d68c-f14b-4c1e-827d-5a0ed3755ff7">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i63af9e33b0074a89b174bb79dc0563a6_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NTU5MzE_17266d10-7451-4812-a8ce-c00eebb5e6ef"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i34acb3e619be4e479ffc9dd6d3c2637e_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NTU5MzE_2ff15a40-9543-4990-bc66-04c655d76c7c"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ieffd80ee181540709a1840aa1e6b331a_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NTU5MzE_b60c044b-d7d0-4df0-a33c-f350d5215336"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i37179d6482964d95b578a69074ef0010_I20221107"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NTYwMDk_0e3dbf90-b407-4697-9692-5a9ccdabc600"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3ded1a9c1439414ab4b7d6ef1c80ea50_I20221107"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE4Nzc_1a3648e4-8558-41d7-a213-d6e76d3a4739"
      unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <mck:DebtInstrumentDaysAvailableForBorrowing
      contextRef="i7ea2abb1609b4016be9ea5ea390f3ddb_D20221107-20221107"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTI1Mzk_74026532-0335-4b70-894c-4d8356771c77">P90D</mck:DebtInstrumentDaysAvailableForBorrowing>
    <us-gaap:LongTermDebt
      contextRef="ib8c8b37718a34ccf97efe28b40fa8b98_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3NzQ_fd1592dd-ed30-4d60-a1af-2bd525a06b8a"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentTerm
      contextRef="i86beb9ab012e4ab98ab444ffd6a60f1d_D20221001-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3NDY_564fe6af-f14a-434b-8680-eaecc75d6716">P3M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2fc646c92280442fa50dc0dd90fd3b8f_D20221001-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzE2NDkyNjc0NzE5MTI_8748c174-e22f-44f3-8692-0ccf2d7563f6"
      unitRef="number">0.0110</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
      contextRef="ie365f78409fa4f7c8fab2a443f6508cb_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3NDg_ad45825f-2be3-4d73-9a0c-1e58895690bd"
      unitRef="usd">7000000</us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="ie365f78409fa4f7c8fab2a443f6508cb_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3Xzg3OTYwOTMwNTg3NjA_66d9be05-870e-4449-931c-55f51f2e2c4b"
      unitRef="usd">111000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i764185698f6248c8a59dd7255743615b_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzcxOTc_5e6c3707-0fb9-4d6d-88ff-e52aec6b150a"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzcyODM_c8b179bf-0b05-4b5a-99ee-24dc9c3cdd83"
      unitRef="usd">8500000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzcyODc_fb9969f5-a7b2-44fd-a4e7-8d9731ba7bcb"
      unitRef="usd">11200000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzcyOTU_872136a0-a0d7-4884-92f1-5bf053900f7e"
      unitRef="usd">6300000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczMjQ_40117c93-cbb3-4771-a849-42e84e4ad9bf"
      unitRef="usd">8500000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczMjg_b8d49c8c-fe9d-484b-beab-a107bab3aa80"
      unitRef="usd">11200000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczMzY_5b8f5b0b-29b2-49ef-a231-a2bac73aa6c5"
      unitRef="usd">6300000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:LongTermDebt
      contextRef="ia236aca49f824360a041b24156a09309_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczOTg_c114cdad-c1ca-4947-b717-252a10fd3020"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i764185698f6248c8a59dd7255743615b_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTQvZnJhZzo2ZDQ4Yjg3NTg5NWU0NGI2ODJlODhmYTM0MzgxZTgwNy90ZXh0cmVnaW9uOjZkNDhiODc1ODk1ZTQ0YjY4MmU4OGZhMzQzODFlODA3XzczOTg_dd85673e-9bb8-4081-a64c-2ad8fce5e517"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzMwNDA_52fb3039-9dc3-4efe-acbc-7ef619cf0be6">Variable Interest Entities &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs if it has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidated Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company consolidates a VIE when it has the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE and, as a result, is considered the primary beneficiary of the VIE. It consolidates certain single-lessee leasing entities where it, as the lessee, has the majority risk of the leased assets due to its minimum lease payment obligations to these leasing entities. As a result of absorbing this risk, the leases provide the Company with the power to direct the operations of the leased properties and the obligation to absorb losses or the right to receive benefits of the entity. Consolidated VIEs do not have a material impact on the Company&#x2019;s Consolidated Statements of Operations or Consolidated Statements of Cash Flows. Total assets and liabilities included in its Consolidated Balance Sheets for these VIEs were $621 million and $53 million, respectively, at March 31, 2023, and $660 million and $65&#160;million, respectively, at March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Unconsolidated Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved with VIEs which it does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Its relationships include equity method investments and lending, leasing, contractual, or other relationships with the VIEs. The Company&#x2019;s most significant VIE relationships are with oncology and other specialty practices. Under these practice arrangements, the Company generally owns or leases all of the real estate and equipment used by the practices and manages the practices&#x2019; administrative functions. Prior to the divestment of the Austrian business in the fourth quarter of fiscal 2022, the Company had relationships with certain pharmacies in Europe with whom it provided financing, had equity ownership, and/or had a supply agreement whereby it supplied the vast majority of the pharmacies&#x2019; purchases. The Company&#x2019;s maximum exposure to loss (regardless of probability) as a result of all unconsolidated VIEs was $1.4 billion at March 31, 2023 and 2022, which primarily represents the value of intangible assets related to service agreements, equity investments, and lease and loan receivables. This amount excludes the customer loan guarantees discussed in Financial Note 16, &#x201c;Financial Guarantees and Warranties.&#x201d; The Company believes there is no material loss exposure on these assets or from these relationships.&lt;/span&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:Assets
      contextRef="i9be4134ad35a4d88b4b59aff8d5eb2fc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzE1MDI_e6d3807a-e407-44bf-9ff4-626ad158e62e"
      unitRef="usd">621000000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i9be4134ad35a4d88b4b59aff8d5eb2fc_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzE1MDk_3654e044-2acb-4fd2-9cb5-452a544eaa56"
      unitRef="usd">53000000</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="i7bf2f9269b0245f082bf1b61c46287fc_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzE1Mzg_dc25cf54-ad62-4d48-8f77-abe3492db024"
      unitRef="usd">660000000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i7bf2f9269b0245f082bf1b61c46287fc_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzE1NDU_b7db5c44-3bc8-4184-89af-4bdf7949725e"
      unitRef="usd">65000000</us-gaap:Liabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzI2NzE_760a3d96-ecef-44fe-a675-220c780542c9"
      unitRef="usd">1400000000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNTcvZnJhZzpkN2NmYzUyZmE5OWU0NTlmOGY0YmExMmY5M2RiM2UzYy90ZXh0cmVnaW9uOmQ3Y2ZjNTJmYTk5ZTQ1OWY4ZjRiYTEyZjkzZGIzZTNjXzI2NzE_ad483107-9e90-49e9-b8e1-2fc60d8a2747"
      unitRef="usd">1400000000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzYy_46ecffca-c733-4098-b4ad-55fd8eb44254">Pension Benefits&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a number of qualified and nonqualified defined benefit pension plans and defined contribution plans for eligible employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-U.S. Defined Benefit Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2023, the Company&#x2019;s non-U.S. defined benefit pension plans cover eligible employees located predominantly in Norway and Canada. Benefits for these plans are based primarily on each employee&#x2019;s final salary, with annual adjustments for inflation. The obligations in Norway are largely related to the state-regulated pension plan which is managed by the Norwegian Public Service Pension Fund (&#x201c;SPK&#x201d;). According to the terms of the SPK, the plan assets of state regulated plans in Norway must correspond very closely to the pension obligation calculated using the principles codified in Norwegian law.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the European divestiture activities discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; pension liabilities of $85&#160;million, as part of the E.U. disposal group, and pension assets of $49&#160;million, as part of the U.K. disposal group, were included under the captions &#x201c;Liabilities held for sale&#x201d; and &#x201c;Assets held for sale,&#x201d; respectively, in the Consolidated Balance Sheet as of March 31, 2022. During the third quarter of fiscal 2023, the Company divested pension liabilities totaling $75&#160;million and released $13&#160;million of gains from accumulated other comprehensive loss related to the divestiture of the E.U. disposal group. During the first quarter of fiscal 2023, the Company divested pension assets of $49&#160;million and released $30&#160;million of accumulated other comprehensive loss related to the divestiture of the U.K. disposal group.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of fiscal 2022, the Company divested $43&#160;million of pension liabilities and released $11&#160;million of accumulated other comprehensive loss related to the sale of its Austrian business. During the third quarter of fiscal 2021, the Company divested $187&#160;million of pension liabilities and released $33&#160;million of accumulated other comprehensive loss related to its German pharmaceutical wholesale business contributed to a joint venture, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Defined benefit plan assets and obligations are measured as of the Company&#x2019;s fiscal year-end. The net periodic expense for the Company&#x2019;s pension plans were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost - benefits earned during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized actuarial loss and prior service costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#x2019; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service period of active employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the changes in benefit obligations and plan assets for the Company&#x2019;s pension plans was as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer and participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The benefit obligation is the projected benefit obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Relates to the completed divestitures of the E.U. disposal group and U.K. disposal group in fiscal 2023 and the completed divestiture of the Company&#x2019;s Austrian business in fiscal 2022 as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Current assets at March 31, 2022 include $49&#160;million reclassified from long-term assets to assets held for sale as part of the Company&#x2019;s U.K. disposal group, which was divested in fiscal 2023. Current liabilities at March 31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; include &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$85&#160;million reclassified from long-term liabilities to liabilities held for sale as part of the Company&#x2019;s E.U. disposal group, which was divested in fiscal 2023. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The actuarial gain of $65 million in fiscal 2023 was primarily attributable to:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Discount rates ($69&#160;million gain):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; The weighted average discount rate for Non-U.S. plans increased to 4.54% as of March 31, 2023 from 2.67% as of March 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Demographic and assumption changes ($4&#160;million loss):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The actuarial gain of $55 million in fiscal 2022 was primarily attributable to:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Discount rates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;($69&#160;million gain):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; The weighted average discount rate for Non-U.S plans increased to 2.67% as of March 31, 2022 from 1.89% as of March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%;padding-left:14.5pt"&gt;Demographic and assumption changes ($14&#160;million loss):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; This represents the difference between actual and estimated participant data and demographic factors, including items such as inflation assumption, compensation changes, mortality, and other changes including losses related to the European divestitures in fiscal 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#x2019;s pension plans, including accumulated benefit obligation in excess of plan assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in accumulated other comprehensive loss consist of: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other changes in accumulated other comprehensive loss were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2023, the Company recognized $17&#160;million in actuarial losses for pension plans to stockholders&#x2019; deficit as a result of the sale of its E.U. disposal group and U.K. disposal group. In fiscal 2022, the Company recognized $11&#160;million in actuarial losses for pension plans to stockholders&#x2019; deficit as a result of the sale of its Austrian business. In fiscal 2021, the Company recognized $33&#160;million in actuarial losses for pension plans to stockholders&#x2019; equity as a result of the contribution of its German pharmaceutical wholesale business to a joint venture. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; for more information on the Company&#x2019;s European divestiture activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Projected benefit obligations related to the Company&#x2019;s unfunded plans were $18 million and $101 million at March 31, 2023 and 2022, respectively. Funding obligations for its plans vary based on the laws of each jurisdiction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected benefit payments for the Company&#x2019;s pension plans were as follows: $8 million, $9 million, $9 million, $9 million, and $9 million for fiscal 2024 to fiscal 2028, respectively, and $50 million for fiscal 2029 through fiscal 2033. Expected benefit payments are based on the same assumptions used to measure the benefit obligations and include estimated future employee service. Expected contributions to be made for the Company&#x2019;s pension plans are $3 million for fiscal 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s defined benefit pension plan liabilities are valued using a discount rate based on a yield curve developed from a portfolio of high quality corporate bonds rated AA or better whose maturities are aligned with the expected benefit payments of its plans. The Company&#x2019;s defined benefit pension plan liabilities are valued using a weighted-average discount rate of 4.54%, which represents an increase of 187 basis points from its fiscal 2022 weighted-average discount rate of 2.67%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plan Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment Strategy&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: For plan assets, the investment strategies are subject to local regulations and the asset/liability profiles of the plans in each individual country. Plan assets are broadly invested in a manner appropriate to the nature and duration of the expected future retirement benefits payable under the plans. Plan assets are primarily invested in high-quality corporate and government bond funds and equity securities. Assets are properly diversified to avoid excessive reliance on any particular asset, issuer, or group of undertakings so as to avoid accumulations of risk in the portfolio as a whole.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops the expected long-term rate of return assumption based on the projected performance of the asset classes in which plan assets are invested. The target asset allocation was determined based on the liability and risk tolerance characteristics of the plans and at times may be adjusted to achieve overall investment objectives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on unadjusted quoted prices in active markets for identical assets. Level&#160;2 refers to fair values estimated using significant other observable inputs and Level 3 includes fair values estimated using significant unobservable inputs. The following tables represent the Company&#x2019;s plan assets as of March&#160;31, 2023 and 2022, using the fair value hierarchy by asset class:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity commingled funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income commingled funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate funds and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held at NAV practical expedient &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents - Cash and cash equivalents include short-term investment funds that maintain daily liquidity and aim to have constant unit values of $1.00. The funds invest in short-term fixed income securities and other securities with debt-like characteristics emphasizing short-term maturities and high credit quality. Directly held cash and cash equivalents are classified as Level 1 investments. Cash and cash equivalents include money market funds and other commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity commingled funds - Some equity investments are held in commingled funds, which have daily net asset values derived from quoted prices for the underlying securities in active markets; these are classified as Level 1 or Level 2 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed income securities - Government securities consist of bonds and debentures issued by central governments or federal agencies; corporate bonds consist of bonds and debentures issued by corporations. Inputs to the valuation methodology include quoted prices for similar assets in active markets, and inputs that are observable for the asset, either directly or indirectly, for substantially the full term of the asset. Multiple prices and price types are obtained from pricing vendors whenever possible, enabling cross-provider price validations. Fixed income securities are generally classified as Level 1 or Level 2 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed income commingled funds - Some fixed income investments are held in exchange traded or commingled funds, which have daily net asset values derived from the underlying securities; these are classified as Level 1, 2, or 3 investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Annuity contracts - The value of the annuity contracts is reported by the Trustee and is based on a valuation of the remaining contracted cash flow of the contract. Inputs in the valuation include discounted future cash flows; these are classified as Level 3 investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Real estate funds - The value of the real estate funds is reported by the fund manager and is based on a valuation of the underlying properties. Inputs used in the valuation include items such as cost, discounted future cash flows, independent appraisals, and market based comparable data. The real estate funds are classified as Level 1, 2, or 3 investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other - At March 31, 2023 and 2022, this includes $30 million and $35 million, respectively, of plan asset value relating to the SPK. In principle, the SPK is organized as a pay-as-you-go system guaranteed by the Norwegian government as it holds no Company-owned assets to back the pension liabilities. The Company pays a pension premium used to fund the plan, which is paid directly to the Norwegian government who establishes an account for each participating employer to keep track of the financial status of the plan, including managing the contributions and the payments. Further, the investment return credited to this account is determined annually by the SPK based on the performance of long-term government bonds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the Level 3 plan assets measured on a recurring basis for the years ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Multiemployer Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover union-represented employees in the U.S. In 2017, it also contributed to the Pensjonsordningen for Apoteketaten (&#x201c;POA&#x201d;), a mandatory multiemployer pension scheme for its pharmacy employees in Norway, managed by the association of Norwegian Pharmacies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risks of participating in these multiemployer plans are different from single-employer pension plans in the following aspects: (i)&#160;assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers; (ii)&#160;if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers; and (iii)&#160;if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the plan, referred to as a withdrawal liability. Actions taken by other participating employers may lead to adverse changes in the financial condition of a multiemployer benefit plan and the Company&#x2019;s withdrawal liability and contributions may increase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contributions and amounts accrued for U.S. multiemployer pension plans were not material for the years ended March 31, 2023, 2022, and 2021. Contributions to the POA for non-U.S. plans exceeding 5% of total plan contributions were&#160;$19 million, $20 million, and&#160;$22 million for the years ended March 31, 2023, 2022, and 2021, respectively. Based on actuarial calculations, the Company estimates the funded status for its non-U.S. Plans to be approximately 85% as of March 31, 2023. No amounts were accrued for liability associated with the POA as the Company has no intention to withdraw from the plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Defined Contribution Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a contributory retirement savings plan (&#x201c;RSP&#x201d;) for U.S. eligible employees. Eligible employees may contribute to the RSP up to 75% of their eligible compensation on a pre-tax or post-tax basis not to exceed IRS limits. The Company makes matching contributions in an amount equal to 100% of the employee&#x2019;s first 3% of pay contributed and 50% for the next 2% of pay contributed. The Company also may make an additional annual matching contribution for each plan year to enable participants to receive a full match based on their annual contribution. The Company also contributed to non-U.S. plans that are available in certain countries. Contribution expenses for the RSP and non-U.S. plans were $125 million, $116 million, and $102 million for the years ended March 31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Postretirement Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a number of postretirement benefit plans, primarily consisting of healthcare and life insurance (&#x201c;welfare&#x201d;) benefits, for certain eligible U.S. employees. Eligible employees consist of those who retired before March 31, 1999 and those who retired after March 31, 1999, but were an active employee as of that date, after meeting other age-related criteria. It also provides postretirement benefits for certain U.S. executives. Defined benefit plan obligations are measured as of the Company&#x2019;s fiscal year-end. The net periodic (credit) expense for the Company&#x2019;s postretirement welfare benefits was not material for the years ended March 31, 2023, 2022, and 2021. The benefit obligation at March 31, 2023 and 2022 was $45 million and $56 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation
      contextRef="icf74b96be12f4a219ff712ac02236787_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1Mjg_c3d482d2-4ac9-4a8d-849c-f2a4f1d8b33e"
      unitRef="usd">85000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i0d0480bcc6d3431ab87336fe586f8dd4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1Njc_0e145f5b-8aa0-4a7b-a134-9607a745a082"
      unitRef="usd">49000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized
      contextRef="i725249281f6448479928864a02cfeb84_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1NDE_834618a8-c075-49d8-ba4f-0363e5e05e28"
      unitRef="usd">75000000</mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="i725249281f6448479928864a02cfeb84_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1NTQ_c56e9556-5c67-4dbe-b370-701275f577ef"
      unitRef="usd">13000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized
      contextRef="i9285759f0f7e48fc96862d938f16f2c4_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1OTM_997577ef-f78e-40e2-bfab-900aea2344e3"
      unitRef="usd">49000000</mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="ibd224bce6d5d4f0ebf52968e5025d793_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTI1ODA_24b7b452-1cd2-4a82-a2f0-820b250c7481"
      unitRef="usd">30000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized
      contextRef="i29ce9dc1593049718fe7bb3e0475e10e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzI2Njc_33d2f98c-9873-4d39-b884-8df93d67ef68"
      unitRef="usd">43000000</mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="i10dc0fc369ee4d088df51fef92fe40e1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzI3MzU_71c9351c-14f8-480d-8c5f-74ea0103bea6"
      unitRef="usd">-11000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized
      contextRef="i2ac7e4d1dc5b4f05b72d3e857f067e82_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzI4ODM_d6dc8b67-57f5-4d4e-b461-8e2fb315c68f"
      unitRef="usd">187000000</mck:DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="ib91bd719aec14a16b34e473ef04b8e30_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzI5NTE_a490d58b-f165-4cc6-859c-421e8d529bbb"
      unitRef="usd">-33000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzI4_6153170f-fd2d-4481-8182-91e1e2e5d51b">The net periodic expense for the Company&#x2019;s pension plans were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost - benefits earned during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of unrecognized actuarial loss and prior service costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzMtNy0xLTEtMjE4NzQ4_5d72a6b0-5cc4-4da5-8a1f-05f45f5fbfe2"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzMtOS0xLTEtMjE4NzQ4_a4186391-0f41-4bb6-a0b4-da1bade14abd"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzMtMTEtMS0xLTIxODc0OA_0aa5f719-9a1a-4d2b-b3ee-b6f1f856d153"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzQtNy0xLTEtMjE4NzQ4_7373a51b-20ea-46bf-ae5e-00d5c7da097c"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzQtOS0xLTEtMjE4NzQ4_5bb79775-b330-45a7-97c6-0a3f0e72689a"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzQtMTEtMS0xLTIxODc0OA_7433ed80-2310-4de5-a2ac-43eb7051c2e4"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzUtNy0xLTEtMjE4NzQ4_ae2fb120-9223-4b5a-8070-252c41aad7d0"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzUtOS0xLTEtMjE4NzQ4_5687d56a-e67e-4aa9-8d22-25f158c1cdf5"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzUtMTEtMS0xLTIxODc0OA_263e51ce-7453-44b4-8029-8ad7e6f615ed"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzYtNy0xLTEtMjE4NzQ4_1bd90461-cb5c-4b97-b7e7-a7a1bab3f7d8"
      unitRef="usd">1000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzYtOS0xLTEtMjE4NzQ4_7c83dc50-b4b1-4611-ada6-deb52a7021a5"
      unitRef="usd">3000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzYtMTEtMS0xLTIxODc0OA_c8be42e6-fc3a-4b16-a9fb-a429316e2334"
      unitRef="usd">5000000</mck:DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzctNy0xLTEtMjE4NzQ4_712649c0-cab6-4bb0-b48a-8ed8e1608d85"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzctOS0xLTEtMjE4NzQ4_c9287b6e-fdca-45c8-be94-ae4ac65f1e5b"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzctMTEtMS0xLTIxODc0OA_946ca1a7-45d4-4ac2-9f4e-126910a5fb1b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzktNy0xLTEtMjE4NzQ4_c5a3e808-20e1-43af-87fb-fb5ebf106ef4"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzktOS0xLTEtMjE4NzQ4_06e16a55-d89e-472a-8789-44020a2fd015"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmQwZGQ2YjQ3NjA0NzE0YWVhMjE5Yzk5ZDFlYjFjMi90YWJsZXJhbmdlOmMyZDBkZDZiNDc2MDQ3MTRhZWEyMTljOTlkMWViMWMyXzktMTEtMS0xLTIxODc0OA_7ff6dc92-8d4d-4382-862c-6ec3c7d13535"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <mck:DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets
      contextRef="iaebb395b037444299908403308be0b79_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzM0ODU_122f0e58-cff2-4493-be1f-b112192d2a14"
      unitRef="number">0.10</mck:DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzU5_8409d61e-22c7-4485-8b08-0aa95f2f8d45">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the changes in benefit obligations and plan assets for the Company&#x2019;s pension plans was as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Curtailment/settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer and participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized on the balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The benefit obligation is the projected benefit obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Relates to the completed divestitures of the E.U. disposal group and U.K. disposal group in fiscal 2023 and the completed divestiture of the Company&#x2019;s Austrian business in fiscal 2022 as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Current assets at March 31, 2022 include $49&#160;million reclassified from long-term assets to assets held for sale as part of the Company&#x2019;s U.K. disposal group, which was divested in fiscal 2023. Current liabilities at March 31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; include &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$85&#160;million reclassified from long-term liabilities to liabilities held for sale as part of the Company&#x2019;s E.U. disposal group, which was divested in fiscal 2023. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzQtNS0xLTEtMjE4NzQ4_190d8aea-9b13-4ced-809c-ee626ce75d53"
      unitRef="usd">701000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6c2b6a539b6d496b8795e813d345ea7c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzQtNy0xLTEtMjE4NzQ4_d07d90bf-6e00-4680-85d5-ca76589503f8"
      unitRef="usd">875000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzUtNS0xLTEtMjE4NzQ4_7a53d485-9b97-4981-97db-c9f639fcd4d3"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzUtNy0xLTEtMjE4NzQ4_c3ccbf57-f134-4209-a285-e6e932def0d5"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzYtNS0xLTEtMjE4NzQ4_818af69d-a74c-45ad-a918-2548e08e8561"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzYtNy0xLTEtMjE4NzQ4_40892cd8-6e7a-4a7b-9c45-3768079adb08"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzctNS0xLTEtMjE4NzQ4_0cd38f01-8214-4968-8320-2fb5f9dfa98e"
      unitRef="usd">65000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzctNy0xLTEtMjE4NzQ4_f6395a65-667e-4e90-9e01-f748c5dcb38b"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzgtNS0xLTEtMjE4NzQ4_1b135ad1-8034-4792-97fd-8b6636058351"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzgtNy0xLTEtMjE4NzQ4_bade7adc-99c7-44bb-8523-de75c514600b"
      unitRef="usd">35000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzktNS0xLTEtMjE4NzQ4_bf7e78fd-c680-4e69-8ca4-55e0df780921"
      unitRef="usd">3000000</mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement>
    <mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzktNy0xLTEtMjE4NzQ4_73677dd9-51c2-4db8-9616-95d5ba1105bd"
      unitRef="usd">32000000</mck:DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement>
    <mck:DefinedBenefitPlanBenefitObligationsExpensesPaid
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzEwLTUtMS0xLTIxODc0OA_e33a159a-78e5-438a-aed3-77d7ee9e1197"
      unitRef="usd">1000000</mck:DefinedBenefitPlanBenefitObligationsExpensesPaid>
    <mck:DefinedBenefitPlanBenefitObligationsExpensesPaid
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzEwLTctMS0xLTIxODc0OA_53c51194-b0a2-42d1-9fbd-ffe125924e98"
      unitRef="usd">1000000</mck:DefinedBenefitPlanBenefitObligationsExpensesPaid>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzExLTUtMS0xLTIxODc0OA_611131e9-1027-4aac-a1b1-df3f31de6e99"
      unitRef="usd">408000000</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzExLTctMS0xLTIxODc0OA_d65c5c94-ba66-4dbc-b4b6-c2f2aa9f2a30"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzEzLTUtMS0xLTIxODc0OA_cb21a14f-e475-41c0-b61b-8ec3e8481e5c"
      unitRef="usd">-53000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzEzLTctMS0xLTIxODc0OA_10b1f0ee-984a-4e32-accf-0714e9312b4f"
      unitRef="usd">-33000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE0LTUtMS0xLTIxODc0OA_cad0b3df-82aa-4360-b3d3-49fd99811962"
      unitRef="usd">172000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE0LTctMS0xLTIxODc0OA_dcb31106-fff5-4a91-a9fb-8908451c0d57"
      unitRef="usd">701000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE3LTUtMS0xLTIxODc0OA_7c663faf-6a67-49e3-8c9d-6a1b61750d4b"
      unitRef="usd">681000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6c2b6a539b6d496b8795e813d345ea7c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE3LTctMS0xLTIxODc0OA_1232240e-b18c-409a-85f3-3512abac1000"
      unitRef="usd">735000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE4LTUtMS0xLTIxODc0OA_a0672e53-75d7-454d-8299-ee30c953b7f9"
      unitRef="usd">-51000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE4LTctMS0xLTIxODc0OA_eb5ede18-fc0f-480b-8187-c7c577dcf621"
      unitRef="usd">-4000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE5LTUtMS0xLTIxODc0OA_940bf2fc-98d8-47c3-b506-3861f74c38e0"
      unitRef="usd">7000000</mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants>
    <mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzE5LTctMS0xLTIxODc0OA_076b3b8d-97c9-4533-947e-90e59945a5b1"
      unitRef="usd">43000000</mck:DefinedBenefitPlanContributionsbyEmployerandPlanParticipants>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIwLTUtMS0xLTIxODc0OA_6b7368de-90eb-4da1-b02c-8413055963f5"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIwLTctMS0xLTIxODc0OA_367d18a6-5bcb-400b-a537-ceb2043dc161"
      unitRef="usd">35000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <mck:DefinedBenefitPlanPlanAssetsExpensesPaid
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIyLTUtMS0xLTIxODc0OA_50d20d90-b6f5-4ffc-91c7-d703e81c40e3"
      unitRef="usd">1000000</mck:DefinedBenefitPlanPlanAssetsExpensesPaid>
    <mck:DefinedBenefitPlanPlanAssetsExpensesPaid
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIyLTctMS0xLTIxODc0OA_1deb64c6-f032-43dc-9fe4-bc072920cc1c"
      unitRef="usd">1000000</mck:DefinedBenefitPlanPlanAssetsExpensesPaid>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIzLTQtMS0xLTI2MTU0NQ_09f71681-49a3-458c-9b8f-9a93a09e55a7"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIzLTYtMS0xLTI2MTQ4Mg_835d8f25-2b33-4c37-96d0-e5de16f85c1e"
      unitRef="usd">24000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanDivestituresPlanAssets
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIzLTUtMS0xLTIxODc0OA_a19cb55b-6047-4905-b259-5a10ac3dd68c"
      unitRef="usd">393000000</us-gaap:DefinedBenefitPlanDivestituresPlanAssets>
    <us-gaap:DefinedBenefitPlanDivestituresPlanAssets
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzIzLTctMS0xLTIxODc0OA_956092bf-9bd8-43d0-836c-53e635b7d399"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI0LTUtMS0xLTIxODc0OA_9082fba1-f79e-4c33-a3f5-0c865a25ccf6"
      unitRef="usd">-55000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI0LTctMS0xLTIxODc0OA_a5efc28b-5339-4df4-bc18-093ba38ea2b1"
      unitRef="usd">-33000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI1LTUtMS0xLTIxODc0OA_b65dc237-afec-4ae1-a937-8aeab0e92f21"
      unitRef="usd">174000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI1LTctMS0xLTIxODc0OA_5abd09ba-d500-4c50-a192-e11b81deea50"
      unitRef="usd">681000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI3LTUtMS0xLTIxODc0OA_50068207-185c-4bf3-9b9f-2aaf8755e52c"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzI3LTctMS0xLTIxODc0OA_1ef26022-038a-40b4-bc52-84497631f419"
      unitRef="usd">-20000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMwLTUtMS0xLTIxODc0OA_f30181f9-4d8d-4537-aac1-6ccdb182b632"
      unitRef="usd">0</mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMwLTctMS0xLTIxODc0OA_165cce2a-83de-4655-b183-70b0dd0999f0"
      unitRef="usd">49000000</mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMxLTUtMS0xLTIxODc0OA_5a6e6460-e43c-406e-bc63-227d024c4d0f"
      unitRef="usd">24000000</mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMxLTctMS0xLTIxODc0OA_cbe1b553-68e4-4a4e-8f59-ce4c03335a6d"
      unitRef="usd">40000000</mck:AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMyLTUtMS0xLTIxODc0OA_54a3bf9d-d922-4521-aee7-e1e3db89584b"
      unitRef="usd">1000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMyLTctMS0xLTIxODc0OA_7668c0ad-383f-4534-beeb-9a957a01d7df"
      unitRef="usd">90000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMzLTUtMS0xLTIxODc0OA_33daea70-3288-4421-aca9-358079e80f74"
      unitRef="usd">21000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzMzLTctMS0xLTIxODc0OA_aed05859-c996-4957-b2c6-747209a76a48"
      unitRef="usd">19000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzM0LTUtMS0xLTIxODc0OA_b54aa2f1-c6b4-456a-874e-2f124dad8dfa"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo1NmE5MDM2NGM1YWQ0ZDM3ODk2NmExMTc0NDQ0MGZiMy90YWJsZXJhbmdlOjU2YTkwMzY0YzVhZDRkMzc4OTY2YTExNzQ0NDQwZmIzXzM0LTctMS0xLTIxODc0OA_dbb81dfe-1114-4212-9662-7d7ae7e0d590"
      unitRef="usd">-20000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent
      contextRef="iba0180b4473b4cc5ada51da9d6909ece_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQxMjA_67e667cc-5df3-4c4b-bb97-d445d964dbe6"
      unitRef="usd">49000000</mck:AssetsForPlanBenefitsDefinedBenefitPlanCurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="iba0180b4473b4cc5ada51da9d6909ece_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQyNjI_7fae7d2d-6616-44c3-ad97-b731f0b02835"
      unitRef="usd">85000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ0NTg_0cd38f01-8214-4968-8320-2fb5f9dfa98e"
      unitRef="usd">65000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ1MTQ_65893957-2f80-4d9c-8de4-e9f52793e6eb"
      unitRef="usd">69000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ1OTE_c0d55ec2-2651-43cd-856a-77327821a0b3"
      unitRef="number">0.0454</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ2MDg_8f70c292-9dd9-4182-8f84-35eec2383de8"
      unitRef="number">0.0267</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ2NTg_57faaab3-1194-4ceb-ad73-18e3246f92c1"
      unitRef="usd">-4000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzQ5NDM_f6395a65-667e-4e90-9e01-f748c5dcb38b"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzcxNDY4MjU2MDQxNzA_b5d011f5-6913-44f4-9e49-507963c22405"
      unitRef="usd">69000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzUwNzY_e4d9ff37-555b-4183-aaef-b4ba309c8eec"
      unitRef="number">0.0267</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i6c2b6a539b6d496b8795e813d345ea7c_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzUwOTM_395becc6-bf4b-40c4-9c26-04e8068f5b2f"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzUxNDI_218dfafc-9d69-4a24-a70c-2bf508fb7848"
      unitRef="usd">-14000000</mck:DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges>
    <us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzA5_9b0c3d7e-db40-41db-92bf-a5f5cac64c0a">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the projected benefit obligation, accumulated benefit obligation, and fair value of plan assets for all the Company&#x2019;s pension plans, including accumulated benefit obligation in excess of plan assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzMtNS0xLTEtMjE4NzQ4_1324cea0-47f5-417d-b083-79f39705691f"
      unitRef="usd">172000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzMtNy0xLTEtMjE4NzQ4_8e81fb23-48c2-4633-a279-b5edc9c4a589"
      unitRef="usd">701000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzQtNS0xLTEtMjE4NzQ4_9bd6c590-6588-4cf7-b32c-33e287f0f77a"
      unitRef="usd">171000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzQtNy0xLTEtMjE4NzQ4_7c121d26-3276-4393-ad56-ddeb5d28eaf1"
      unitRef="usd">689000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzUtNS0xLTEtMjE4NzQ4_896eaf5f-c827-4ccc-a37b-7c481b2b946f"
      unitRef="usd">174000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiOTAzNjI5MjgyOWU0MmNhOTM1YjFmNjcxZWI5YTQwMi90YWJsZXJhbmdlOmI5MDM2MjkyODI5ZTQyY2E5MzViMWY2NzFlYjlhNDAyXzUtNy0xLTEtMjE4NzQ4_571a5c7b-9f35-497b-bf81-602d086e3e77"
      unitRef="usd">681000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzM1_34083610-abee-4164-a399-450a94114ce6">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts recognized in accumulated other comprehensive loss consist of: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzMtNS0xLTEtMjE4NzQ4_21e1439d-397d-4ce3-83a2-eb3b44909cfd"
      unitRef="usd">-49000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzMtNy0xLTEtMjE4NzQ4_8d0119af-a37b-4814-b2a5-4ab6bc957225"
      unitRef="usd">-70000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzQtNS0xLTEtMjE4NzQ4_d645b675-6ed7-41ce-9f8b-edab5ed2c986"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzQtNy0xLTEtMjE4NzQ4_b95cc9ca-a6cb-4d15-a8a5-b8ae38f2f3e9"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzUtNS0xLTEtMjE4NzQ4_38d13c41-1f82-4da3-bca1-3878b47fa5d7"
      unitRef="usd">50000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTo3MDY0ZGY2ODc0ODI0YzQ0YjQxNDY3MTVhNDg0Yjg0Ni90YWJsZXJhbmdlOjcwNjRkZjY4NzQ4MjRjNDRiNDE0NjcxNWE0ODRiODQ2XzUtNy0xLTEtMjE4NzQ4_d4e1dc10-df49-4ac9-ba59-b98d86ca823c"
      unitRef="usd">68000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2Nzc0_288417c5-1ad4-4fcf-af9a-edd031cd9ac8">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other changes in accumulated other comprehensive loss were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total recognized in other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzMtNy0xLTEtMjE4NzQ4_7831899f-6730-4bdd-a537-b56e12012609"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzMtOS0xLTEtMjE4NzQ4_cbe49db5-2069-4aaa-a1f6-9bb3c8f8e22f"
      unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzMtMTEtMS0xLTIxODc0OA_84b46a53-1cf2-4720-9085-247be3d6f9ac"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzQtNy0xLTEtMjE4NzQ4_023c3e1f-2f2a-4347-9d86-086b912e179b"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzQtOS0xLTEtMjE4NzQ4_7a9f8aeb-1e4c-4bd4-a061-f761ca0f74e0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzQtMTEtMS0xLTIxODc0OA_10af6ad9-122e-4ebd-960e-eede4ae0f218"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzYtNy0xLTEtMjE4NzQ4_0d042e49-614f-4fb1-8239-9214b8c723d6"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzYtOS0xLTEtMjE4NzQ4_b35e39f1-5503-4165-aeeb-b6ef31d2ca36"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzYtMTEtMS0xLTIxODc0OA_d744487d-7ade-40e8-ae15-536366d49cbb"
      unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzctNy0xLTEtMjE4NzQ4_72844934-d87d-4bf0-851c-3649a91b0bc9"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzctOS0xLTEtMjE4NzQ4_14d75292-3517-4c1d-ba99-dfbabf82a96d"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzctMTEtMS0xLTIxODc0OA_dcbcc820-9416-4620-ad77-27ff23361eff"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzgtNy0xLTEtMjE4NzQ4_eb2a8104-33f3-4627-830f-fdd50af29e18"
      unitRef="usd">5000000</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzgtOS0xLTEtMjE4NzQ4_b5ef3232-59e4-44fb-9a7f-4648e7c9540b"
      unitRef="usd">5000000</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzgtMTEtMS0xLTIxODc0OA_f909f583-a2b9-4c0b-ba5c-d15831fb1fe5"
      unitRef="usd">-15000000</mck:OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzktNy0xLTEtMjE4NzQ4_dfe95f21-40dc-49e2-8adb-f1b4982076e7"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzktOS0xLTEtMjE4NzQ4_43d1ff57-937b-415b-bcd8-a3d956cef096"
      unitRef="usd">-50000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiYTFhZWIzZjQwOTA0YTY4YmFiZTYyYzFmOTUwMDdjYi90YWJsZXJhbmdlOmJhMWFlYjNmNDA5MDRhNjhiYWJlNjJjMWY5NTAwN2NiXzktMTEtMS0xLTIxODc0OA_11488063-9647-42f4-9c3c-2e98348e6f49"
      unitRef="usd">-28000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="i6af7427ba4784b7fab08180a13ff9b1c_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4Xzg3OTYwOTMwNTY0Mjg_a11fdeb8-d08d-4f98-8383-be6e8d4a5b5d"
      unitRef="usd">-17000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized
      contextRef="ie4656299b20c436497390a7e79147f34_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzU4MTc_64967f61-8c9f-4e14-90b3-d107910d4a30"
      unitRef="usd">-11000000</mck:DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i10bcba3ec49146f58e7e91f9b293ca33_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzU5NjQ_2efe816b-b907-469f-bf7c-a4696ef37e4c"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i722584ad23f0453f86285951f75a1700_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY3NDU_c7a72152-f83f-4e71-b45e-b7ab2fdea8b1"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i205b3862163e4e678a0394523279c14a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY3NTI_4c84db06-0338-465b-bb70-282d736a1f1e"
      unitRef="usd">101000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="iaebb395b037444299908403308be0b79_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY5NTQ_d04f3fb4-d76f-4e3e-84c9-de3ab19e4e61"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="iaebb395b037444299908403308be0b79_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY5NTg_50105e44-abf6-49d7-aa81-faaad199e775"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="iaebb395b037444299908403308be0b79_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY5NjI_cbc01c3a-40b8-46d5-8ceb-3fb76c997ab6"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="iaebb395b037444299908403308be0b79_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY5NjY_577c3a5d-08a2-4e4e-94ca-874c66692f6d"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="iaebb395b037444299908403308be0b79_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzY5NzQ_ed5fcfeb-5aab-4d74-a409-e1fd6b2274fb"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="iaebb395b037444299908403308be0b79_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzcwMDk_24128585-4256-4ec9-914e-081a0058dcf8"
      unitRef="usd">50000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="iaebb395b037444299908403308be0b79_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzcyNDg_ee56c216-2893-4720-8467-7f777466dccd"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2Nzg2_06031851-b9a0-44c8-95a4-0d12f23ca105">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average assumptions used to estimate the net periodic pension expense and the actuarial present value of benefit obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.528%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of increase in compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzQtNy0xLTEtMjE4NzQ4_e5b7d63e-5134-45a7-bfe0-463f81a2e9ab"
      unitRef="number">0.0267</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzQtOS0xLTEtMjE4NzQ4_fd42174f-a2bb-40c7-9313-00e6c4164265"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzQtMTEtMS0xLTIxODc0OA_bbddac2b-776f-4152-a34a-f45571cc3c98"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzUtNy0xLTEtMjE4NzQ4_aa2bff21-7b01-45e7-ab21-91edf8b1a675"
      unitRef="number">0.0367</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzUtOS0xLTEtMjE4NzQ4_b45d7cc4-cb8a-4d58-83bb-ed36fa5ed61b"
      unitRef="number">0.0320</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzUtMTEtMS0xLTIxODc0OA_4dfa621a-6288-4666-b9d6-b13f80ecc731"
      unitRef="number">0.0320</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzYtNy0xLTEtMjE4NzQ4_5050ddf9-3cf6-4610-828c-52edafaaea41"
      unitRef="number">0.0163</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzYtOS0xLTEtMjE4NzQ4_491d4d6c-c948-4b48-b746-be2e7abff6fc"
      unitRef="number">0.0256</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzYtMTEtMS0xLTIxODc0OA_8f3984fa-7255-4bda-ac31-4275d23f3a1a"
      unitRef="number">0.0256</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzgtNy0xLTEtMjE4NzQ4_efb43441-3273-4bec-a641-1b388712739b"
      unitRef="number">0.0454</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzgtOS0xLTEtMjE4NzQ4_b57ba9b2-fe55-40aa-a587-22294281da54"
      unitRef="number">0.0267</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i6c2b6a539b6d496b8795e813d345ea7c_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzgtMTEtMS0xLTIxODc0OA_b0a31a0b-2086-457e-bb93-eb4d96aea0f3"
      unitRef="number">0.0189</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzktNy0xLTEtMjE4NzQ4_2ae680c9-0a11-44aa-911a-028aba334896"
      unitRef="number">0.0321</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzktOS0xLTEtMjE4NzQ4_327af806-6eea-457e-9307-cd6dfab80a9b"
      unitRef="number">0.0367</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i6c2b6a539b6d496b8795e813d345ea7c_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpjMmJmMmE0ODRhZmU0ZjZkOGZlZDMxNmY4NDU2YTI1OC90YWJsZXJhbmdlOmMyYmYyYTQ4NGFmZTRmNmQ4ZmVkMzE2Zjg0NTZhMjU4XzktMTEtMS0xLTIxODc0OA_8e074e71-2c56-43ad-9086-84ebb7dfbf2b"
      unitRef="number">0.0320</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzgxNTc_376ec830-76b2-4adb-9319-2a380ca71a74"
      unitRef="number">0.0454</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzgxOTM_c89066a1-d3b2-407c-8bc6-7052bb3f7f80"
      unitRef="number">0.0187</mck:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzgyNTU_3ccad312-1060-41e2-8124-91863a00f2ae"
      unitRef="number">0.0267</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzQy_a36b94f8-5a6b-49be-9c36-f741d82360bf">The following tables represent the Company&#x2019;s plan assets as of March&#160;31, 2023 and 2022, using the fair value hierarchy by asset class:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity commingled funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed income commingled funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuity contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate funds and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets held at NAV practical expedient &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Equity commingled funds, fixed income commingled funds, real estate funds, and other investments for which fair value is measured using the NAV per share as a practical expedient are not leveled within the fair value hierarchy and are included as a reconciling item to total investments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i51610f05cd18459b963569b57c8bbbe1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtMS0xLTEtMjE4NzQ4_12c1756d-8b7e-4f05-88d1-988300ef0f60"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i71bf1a36819e476c85f3a6d8663bdea3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtMy0xLTEtMjE4NzQ4_1129e770-4405-44f1-aa7c-2021afe6e873"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i45ba471960e744afa8691f9d48e62f13_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtNS0xLTEtMjE4NzQ4_3afc80e7-ef84-4c8d-b140-e4a06d3eac64"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ida7184b50fa64a8dbc5cde66e602da28_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtNy0xLTEtMjE4NzQ4_0d42e1ed-bd77-44be-9831-137d18b1e54b"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i994dc07d79bd4a03a6631b10f5eceac2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtOS0xLTEtMjE4NzQ4_284dce55-a2d4-47c4-8a79-e063a0b8075b"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie758338a330442f68f01dd372842ee71_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtMTEtMS0xLTIxODc0OA_732ebae3-ff01-4387-aea8-455723b5bc13"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7b161706e1cc4841adfb4249122e7e93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtMTMtMS0xLTIxODc0OA_55b8515c-9a16-408d-8f4b-10a137eb91f9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id9871350b1e94507bc4d2b7948cd34e2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzMtMTUtMS0xLTIxODc0OA_85b3c8a5-4012-4317-a8ca-5000e0c6dd6b"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i125e3486c8434dc7b093af7f724a9223_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtMS0xLTEtMjE4NzQ4_df6dd9dd-51c7-4c63-ac8c-809564711c10"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i77514bdd2d89462c9211465f0a766ec7_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtMy0xLTEtMjE4NzQ4_e916d783-791e-4df7-bb1f-bee40710902a"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic8973019f6d64483a30bda7006efbc09_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtNS0xLTEtMjE4NzQ4_60cd9cb0-15ce-4b80-bf31-0e4ad7c72e66"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1e169cd345664994a6d79eea226c19b3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtNy0xLTEtMjE4NzQ4_a065e872-ddc3-4403-84e9-657a93f92234"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic6b05b2e1ce7435294b2dbf7fb0aae99_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtOS0xLTEtMjE4NzQ4_1f3abf07-568d-4733-ab87-a46db647271d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if8307fb561294672b090c1bb5d05d513_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtMTEtMS0xLTIxODc0OA_6e59cf05-14ff-453f-a7a2-06748bb4ee99"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib3f1ee10031041a3af07110ab4849733_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtMTMtMS0xLTIxODc0OA_e79c491a-e73f-4a0c-8c49-ac3e2beea70b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i72ad2547012c48f4936cd2741754a6d9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzYtMTUtMS0xLTIxODc0OA_c564da9b-1de4-4ac6-9620-865f62385a7c"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifc7ed483c5154a59a6c8c3b34afc8b2c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtMS0xLTEtMjE4NzQ4_f3a6c43d-6dd0-45c8-bc04-99c3d9430f79"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0a004834e91942e79a1a035a54eb8430_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtMy0xLTEtMjE4NzQ4_962e11e7-c7a7-4dc7-a9da-50ea7f9bd2cd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i24fb96b7e1ad440a909f91f9f5db78a3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtNS0xLTEtMjE4NzQ4_864b7b58-2a21-4e28-aff2-f98288823218"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0efc094e70304787b594a72d0060b612_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtNy0xLTEtMjE4NzQ4_475099d8-212f-4fca-9a6d-e50d13e4d2ce"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4f2387351c284073a3585ae340c96f38_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtOS0xLTEtMjE4NzQ4_9f8a4ee6-b477-468f-8676-0a62895dbe4f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic30de0ea7dbf4ca294f03806a898ccb9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtMTEtMS0xLTIxODc0OA_9d24fadf-f8e7-4081-af18-8a6ffeb41b8d"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i657e7112d45443199c58b406acf29838_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtMTMtMS0xLTIxODc0OA_468f97db-3239-447c-895e-b89cca88c0e4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5327b1083ed94e798541f3da89104dc9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzgtMTUtMS0xLTIxODc0OA_a6a41b12-9315-44cd-b46e-16fb2e843e33"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i39dae6d084c84047aa582ca074a0d078_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktMS0xLTEtMjE4NzQ4_1238975a-8a58-40be-91cb-f4471ce00399"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia46e3fa973c947b48594cb4ab31a9c66_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktMy0xLTEtMjE4NzQ4_7d1f610b-2452-4648-8a85-aa0a126e4e15"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i13d1edaf8e3f4acab8850b098880754d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktNS0xLTEtMjE4NzQ4_acebd463-31a4-4186-8b71-5d75e342507c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i227439bd64d1487db0754f92fbcd1a4f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktNy0xLTEtMjE4NzQ4_8ebaf7b8-c0e3-49ad-be81-021709c4f360"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i759d43483f4048ec80ee7227fa0f70f5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktOS0xLTEtMjE4NzQ4_7ff3bcbc-8083-4f34-9eb4-526d5e6280b6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i62410ab1336048ada10bb12a73da0a7c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktMTEtMS0xLTIxODc0OA_209c4018-5513-4bc4-a84a-70d611be7188"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i28cf440d298c42adb27df58f03c66fea_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktMTMtMS0xLTIxODc0OA_8176a1d5-2a01-45a6-9ecf-1c64f773c216"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia4193615347d4fe29a971e9dd9b5227f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzktMTUtMS0xLTIxODc0OA_1a2c1d5e-dc38-4359-84e1-5abc388f001a"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i918e287d03514df6b3bfe695542d3887_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTEtMS0xLTIxODc0OA_588e25c3-09f5-4fe6-ab93-caf2d7f64bfc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia011b94ec27b40e8b51a633a0bcbd4a5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTMtMS0xLTIxODc0OA_9b33fad5-1780-40af-8c1b-1247e921cf57"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idb1fcabf197142b5bd6d52bf694fa67b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTUtMS0xLTIxODc0OA_23133e48-c747-45a4-bd82-5286f6756b46"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i43e7a92a6d5e4ada8cc90026e6b3229d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTctMS0xLTIxODc0OA_fea1e548-f394-49d5-ad63-48df8b6067ef"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idd1cb19b0477476cb20d2a0e4982c520_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTktMS0xLTIxODc0OA_11c16751-e2af-4f1e-92d3-40e6a0f019da"
      unitRef="usd">336000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iac3be98a2bbc4274ace7d610d1288ff9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTExLTEtMS0yMTg3NDg_3e9e4bf3-f0cf-4d1c-8ee1-4540c89b874b"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia3f016b2ef3e440eb97d4400be55876f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTEzLTEtMS0yMTg3NDg_d6686150-bcf8-4954-9240-6c4487afd444"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i41a1d6ce3a444d7e82696c5f8ff77d6d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzEyLTE1LTEtMS0yMTg3NDg_0c796fd4-afd6-46a8-a02e-6300eb6cb802"
      unitRef="usd">361000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i81ad37783f6e4af8b246e63c8f3a99c0_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTEtMS0xLTIxODc0OA_ac9c1a69-b038-4ee2-9cc1-4b156ac5f5df"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ica1476e409e7402b9a147a0ba6312dff_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTMtMS0xLTIxODc0OA_aacd07a1-4268-4edd-92d4-1671ef13525a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5f69217e7cff424dbb573dfbe087faa5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTUtMS0xLTIxODc0OA_b73501b4-e944-489a-8ce6-b9f88cf523a0"
      unitRef="usd">110000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie63109b7002f4f4f93a996b521f5b59e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTctMS0xLTIxODc0OA_4b4608aa-d7ce-4f19-813b-742e962e23c0"
      unitRef="usd">110000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i829df4d042954ba09a94b3ab60df2ee6_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTktMS0xLTIxODc0OA_6b62b234-610c-4f4b-acc9-9e90410e566f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i94b0345b6b1d434596b0988c93100635_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTExLTEtMS0yMTg3NDg_f7f35706-f5d4-4385-b608-cbf8a2ef071f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i38c1211ca3bd47ccaa63f4d573ef3eb9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTEzLTEtMS0yMTg3NDg_ffcf88b8-2f36-4948-8205-dc558e67c1bd"
      unitRef="usd">173000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8613bd2d24b24d0c91d02304e304ef0e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE0LTE1LTEtMS0yMTg3NDg_dd1cfa3d-5f94-4ef7-aa01-3e4c1f324cb8"
      unitRef="usd">173000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i999721f0f4df4c2db0a933b5978923b6_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTEtMS0xLTIxODc0OA_022941cb-ac86-4323-ade1-dde0f894cc9f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i18b9e6dc3e4246a78043d39c8c8a997d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTMtMS0xLTIxODc0OA_1586bd56-77d9-45d6-bbae-eef207686acc"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic1ce3ce209624caf96b787927d453e69_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTUtMS0xLTIxODc0OA_359efc59-cc7d-4bb1-9f5d-d90d850449e2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i846de7923abc4c97892d8ae4ffa6a848_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTctMS0xLTIxODc0OA_523687d0-77b5-491c-901c-b1fd351a04de"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i087f9375fa6f4e85b3f512df46958583_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTktMS0xLTIxODc0OA_83892178-fa7d-4e3b-8cd6-c32df66c2ad2"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i03a25adf74c747e3af066921668300d8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTExLTEtMS0yMTg3NDg_50530fda-9faa-4a43-8a09-810698c6d62e"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic2c7699ae1b14f20a774af95b9906d4e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTEzLTEtMS0yMTg3NDg_d4cb1f35-1024-40cf-a331-709e3187a33a"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1da20a00fd7c41bf882c2c4b0fca97bc_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE1LTE1LTEtMS0yMTg3NDg_cf605dc9-5b94-49ba-85df-3e14f714ea62"
      unitRef="usd">37000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifd8f41a67f1d4ac6bcd66decef5d2d36_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTEtMS0xLTIxODc0OA_4909eeb9-7b62-4760-9291-3b1668d2b253"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib77b1393ed7f4e1cb5cdf0a8cceb3947_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTMtMS0xLTIxODc0OA_57abc6d5-8081-4149-8dc7-edf4c09f77fa"
      unitRef="usd">27000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6cb089efc1bd4c339e696998159d126a_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTUtMS0xLTIxODc0OA_4b47ac39-cf9c-4e4b-a573-ff6785e8c2af"
      unitRef="usd">110000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i736fe7819f714241ad16df84489ece06_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTctMS0xLTIxODc0OA_1ca626fa-1e0d-4d1a-976d-a02159e31659"
      unitRef="usd">144000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i403dc252a03943a08391aee80b76db38_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTktMS0xLTIxODc0OA_3581a896-a281-4dba-b5f7-fd6730f73ae1"
      unitRef="usd">382000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4e959507a65a46d4953fdcacc156df2a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTExLTEtMS0yMTg3NDg_0340ce8c-74d5-4d0e-8885-e764a69861ab"
      unitRef="usd">84000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic2c0f39a48f745c181b6f5d69c3f1b19_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTEzLTEtMS0yMTg3NDg_9ce82ebc-3559-4332-b9f1-ec587a083d4e"
      unitRef="usd">175000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4aff01889e07438fb29743fe2ba9c669_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzE2LTE1LTEtMS0yMTg3NDg_0b2993e8-ca67-4fe6-a7ef-e7db2eefe6fd"
      unitRef="usd">641000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i22203a08a73a45f287b95b3462d5d578_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzIyLTctMS0xLTIxODc0OA_c507449f-10d2-45e3-94d1-0776bf2eba1c"
      unitRef="usd">30000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1a7ce7882d7346b99cf64d531cb03268_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzIyLTE1LTEtMS0yMTg3NDg_8172c30d-8a7a-4151-96a2-2319dce38edb"
      unitRef="usd">40000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzIzLTctMS0xLTIxODc0OA_c9acce3b-c973-4c11-8095-ab7598a3159d"
      unitRef="usd">174000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i513eafe450024d3a99fd378acb5c768e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZTpiNmU4YzEwOTVkZDE0MDgxYWFlYjBiZDRiYjNkZGJkNC90YWJsZXJhbmdlOmI2ZThjMTA5NWRkMTQwODFhYWViMGJkNGJiM2RkYmQ0XzIzLTE1LTEtMS0yMTg3NDg_b3838930-6978-463a-972e-ad6eb41f986b"
      unitRef="usd">681000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <mck:UnitValueOfCashAndCashEquivalents
      contextRef="i548b65f153fe455fb735edc18c43071c_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzEwMjc0_0eb605d0-3d11-4edf-8c60-767d61a59cf1"
      unitRef="usdPerShare">1.00</mck:UnitValueOfCashAndCashEquivalents>
    <mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue
      contextRef="ib463cce9887841b580560f381cb2da5b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzEyNTEy_85e8b271-8e21-4b48-8d56-8bfe4d23c125"
      unitRef="usd">30000000</mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue>
    <mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue
      contextRef="i320f8fd67c4948f0a308006480a2c5ad_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzEyNTE5_327427b7-0957-4c6a-86c2-76384eda3779"
      unitRef="usd">35000000</mck:PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue>
    <us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NzI2_0493a587-e8dc-41e5-be05-b760c5f0880c">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the Level 3 plan assets measured on a recurring basis for the years ended March 31, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return on assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iedac49b197d6406986b0d015faf7d0db_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzEtMS0xLTEtMjM5NzQ3_7fe585c9-86b1-4db7-a982-aae46ad5b860"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzItMS0xLTEtMjM5NzQ3_83f14599-ef40-4d72-b428-75ee4abc8a6d"
      unitRef="usd">196000000</us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzMtMS0xLTEtMjM5NzQ3_fe47a707-88af-4592-8f05-dd22e4e0318e"
      unitRef="usd">-25000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if6665b3b43b04da588b52399a7fe54b5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzEtMS0xLTEtMjE4NzQ4_f7094046-6506-484c-8344-37ac11404628"
      unitRef="usd">175000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase
      contextRef="i9a7df9519bd34e78875fe27cd2ff763e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzItMS0xLTEtMjE4NzQ4_cf90d92c-da77-4535-89ef-a4f24383b2f9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i9a7df9519bd34e78875fe27cd2ff763e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzMtMS0xLTEtMjE4NzQ4_583f6be2-6a4a-46e3-b829-1cbdeccd5087"
      unitRef="usd">-65000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie7a9b9f544264510b97f94b12eb3d7b2_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90YWJsZToxYzAxMDkyMWM5Yzk0ODE0ODc4YTVkMmU2MDQxZmMyNi90YWJsZXJhbmdlOjFjMDEwOTIxYzljOTQ4MTQ4NzhhNWQyZTYwNDFmYzI2XzUtMS0xLTEtMjE4NzQ4_2538ddcb-437e-4b72-80ae-ecac72ffe53f"
      unitRef="usd">110000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <mck:DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE0ODA3_34ec3a72-0c07-41d8-926a-7735116aaf14"
      unitRef="number">0.05</mck:DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE0ODQz_17ec697d-5586-4b7e-b587-3e8ab57d4aac"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i1a04154ea67a4b55a4728d50b3210b1c_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE0ODQ3_64cd40ce-7cdd-4e11-ab4a-39de61135c0e"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i6b00f907b06c4f09bf53f0dc391be45e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE0ODU1_dce7b4bb-be24-4700-9a90-7b74b96f91cb"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <mck:MultiemployerPlanFundedStatusPercentage
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1MDA3_1f1191c4-c5e0-43a3-89a8-bca2c8eb8c78"
      unitRef="number">0.85</mck:MultiemployerPlanFundedStatusPercentage>
    <us-gaap:MultiemployerPlansWithdrawalObligation
      contextRef="i8526b8b91b7b41a8b075fd3451c4af50_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1MDIw_1012ff5f-83a1-4baa-904a-f4803f265cb5"
      unitRef="usd">0</us-gaap:MultiemployerPlansWithdrawalObligation>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1MzEy_2ed07781-6afa-4e71-b4e9-fcd515f85be1"
      unitRef="number">0.75</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="if513543f51ba4b0d91334260d63c6376_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1NDY2_d10d3b52-3d58-48ad-a78a-43ae01d6cee4"
      unitRef="number">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <mck:EmployeeContributions
      contextRef="if513543f51ba4b0d91334260d63c6376_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1NDkz_e9911970-f154-4ab7-b263-567d0bab4515"
      unitRef="number">0.03</mck:EmployeeContributions>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i957a9c83570946a8bff0405f80b94b7f_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1NTE5_711e6faf-2f78-42d2-92c1-8197620ffed9"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <mck:EmployeeContributions
      contextRef="i957a9c83570946a8bff0405f80b94b7f_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1NTM1_815126b0-0f74-4f11-9dfc-cb216141a3da"
      unitRef="number">0.02</mck:EmployeeContributions>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1ODc1_50af9dd3-cba5-47a2-9a63-5839ed1285bc"
      unitRef="usd">125000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE1OTA0_8d66fb07-f776-425e-a43b-178f3c418d80"
      unitRef="usd">116000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzU0OTc1NTg0NzgzOA_70bf8f05-f945-4bb5-b8ba-c9208583ad73"
      unitRef="usd">102000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ica96366b6bcf4de3a3a5a18786d44260_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NTg5_81546fc3-876f-40b0-88e9-4747b826c99e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="idb54d0a7ddd04860a8ac09f3e04418f4_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NTg5_d505276a-b98b-44af-ae47-6ad9f39cea02"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i942e6213795a47479851045f390d686e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2NTg5_e11f9926-0e52-4cd2-917c-d0feb6c3eeba"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i570d5007fbb6461f83baab05592c1bd4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2Njc4_86d29928-ee10-493b-a521-199ac79d60cc"
      unitRef="usd">45000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6581ce23346b4adc8afb8d7c98565984_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjAvZnJhZzoxZjNkMzQyMzVmMjU0YmE3Yjk1NWVjNmQyZTBmN2U0OC90ZXh0cmVnaW9uOjFmM2QzNDIzNWYyNTRiYTdiOTU1ZWM2ZDJlMGY3ZTQ4XzE2Njg1_64e950e4-52eb-491b-943e-a81e8e3d0011"
      unitRef="usd">56000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzExNTk2_87ab95d2-3109-4052-95bc-9067b0f525e6">Hedging Activities &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives as described below. In accordance with the Company&#x2019;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. The Company uses different counterparties for its derivative contracts to minimize the exposure to credit risk but does not anticipate non-performance by these parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Exchange Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Canadian dollars, Euro, and British pounds sterling. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#x2019;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Derivative Instruments Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2022, the Company had &#x20ac;1.1 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges were utilized to hedge portions of the Company&#x2019;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that were designated as net investment hedges and met effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates were recorded as foreign currency translation adjustments in &#x201c;Accumulated other comprehensive loss&#x201d; in the Consolidated Statements of Stockholders&#x2019; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments.&#160;To the extent foreign currency-denominated notes designated as net investment hedges were ineffective, changes in carrying value attributable to the change in spot rates were recorded in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the sale of the E.U. disposal group in October 2022, the Company reclassified $112 million of gains from accumulated other comprehensive loss to&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations for the year ended March 31, 2023. This amount related to the &#x20ac;1.1&#160;billion of Euro-denominated notes described above, along with certain other Euro-denominated notes which were previously accounted for as net investment hedges and matured in prior periods, and was included in the fiscal 2023 and fiscal 2022 calculations of charges to remeasure the assets and liabilities of the disposal group to fair value less costs to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the sale of the U.K. disposal group in April 2022, the Company reclassified $26 million of gains from accumulated other comprehensive loss to &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations for the year ended March 31, 2023. This amount related to the Company&#x2019;s &#xa3;450 million of British pound sterling-denominated notes, which were previously accounted for as net investment hedges until de-designated in fiscal 2020, and was included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities of the disposal group to fair value less costs to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro-denominated notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the years ended March 31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the year ended March 31, 2023, includes amounts reclassified to earnings of $112&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2023 and 2022, the notional amounts of the Company&#x2019;s outstanding derivatives were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nov-24 to Mar-25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as fair value hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nov-28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aug-25 to Jul-26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Feb-26 to Sep-29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jan-24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jun-33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The maturity date reflected is for outstanding derivatives as of March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the years ended March 31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;In fiscal 2023, represents cross-currency fixed-to-fixed interest rate swaps to mitigate the foreign currency exchange fluctuations on its foreign currency-denominated notes. In fiscal 2022, represents fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses cross-currency swaps to hedge portions of the Company&#x2019;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in accumulated other comprehensive loss and offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses cross-currency swaps to hedge the changes in the fair value of its foreign currency notes resulting from changes in benchmark interest rates and foreign currency exchange rates. In February 2023, &#xa3;450&#160;million of cross-currency swaps matured and the Company executed new cross-currency swaps with similar terms to continue to mitigate interest rate and foreign exchange rate risks. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended March 31, 2023, the Company entered into cross-currency fixed-to-fixed interest rate swaps with a total notional amount of &#x20ac;1.1 billion to hedge the changes in the fair value of its underlying Euro-denominated notes resulting from changes in benchmark interest rates and foreign currency exchange rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2023, the Company also entered into floating interest rate swaps to convert $1.3&#160;billion of its fixed rate debt to floating interest rate in order to hedge the changes in fair value caused by fluctuations in the benchmark interest rate. The changes in the fair value of these derivatives are recorded in &#x201c;Interest expense&#x201d; in the Consolidated Statements of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the fair value of these derivatives and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from the changes in the Company&#x2019;s fair value hedges recorded in earnings were largely offset by the losses recorded in earnings on the hedged item. For components excluded from the assessment of hedge effectiveness, the initial value of the excluded component is recognized in accumulated other comprehensive income (loss) and then released into earnings over the life of the hedging instrument. The difference between the change in the fair value of the excluded component and the amount amortized into earnings during the period is recorded in other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies to reduce the income statement effects arising from fluctuations in foreign currency rates and also enters into forward contracts to hedge the variability of future benchmark interest rates on planned bond issuances. The effective portion of changes in the fair value&#160;of these hedges is recorded in accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. Gains or losses reclassified from accumulated other comprehensive loss and recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations were not material for the years ended March 31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended March 31, 2023, the Company terminated its $500&#160;million&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;notional forward starting fixed interest rate swaps and recognized a gain of $97 million within &#x201c;Other income, net&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2023, the Company also entered into forward starting fixed interest rate swaps designated as cash flow hedges, with a combined notional amount of $450&#160;million, to hedge the variability of future benchmark interest rates on a planned bond issuance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Not Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings. Prior to the divestitures of the E.U. disposal group and U.K. disposal group, the Company had entered into forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. Changes in the fair values for contracts not designated as hedges were recorded directly into earnings in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations. Changes in the fair values were not material for the years ended March 31, 2022 and 2021, and the Company did not have any outstanding derivative instruments not designated as hedges during fiscal 2023. Gains or losses from these contracts were largely offset by changes in the value of the underlying intercompany obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Information on Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains (losses) from derivatives included in other comprehensive income (loss) in the Consolidated Statements of Comprehensive Income (Loss) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow and other hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes other comprehensive income related to the excluded component of certain fair value hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated for hedge accounting:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 15, &#x201c;Fair Value Measurements,&#x201d; for more information on these recurring fair value measurements.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i61ed85ae587d438299585235a376442d_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzYwNDczMTM5NzAyNzc_02505b1c-e216-406f-9b94-f985fe6cb014"
      unitRef="eur">1100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="if95560d064ba4166a3331f01665e7c28_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzYwNDczMTM5NzE1MzM_669726e1-7a64-4995-b80a-8efeecaf7b56"
      unitRef="usd">112000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7f756df8d9cf4ff5bf43b455279a736b_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNjc_45233a0e-01fd-44c5-90cf-15175c4ad037"
      unitRef="eur">1100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i61ed85ae587d438299585235a376442d_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNjc_9e4e397d-37c9-4350-803c-31faca784be2"
      unitRef="eur">1100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i377c89ac0f94417ab6e32711608e6849_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzYwNDczMTM5NzE1NTk_dd559eb3-c412-4e57-8091-6f2774c2b840"
      unitRef="usd">26000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:LongTermDebt
      contextRef="i7746cd80fb0e4dba825522f21e14c35c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzYwNDczMTM5Njk5MTI_eddf9df1-894a-440a-87f7-5c841399e17a"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNDk_3b2d918d-590f-412c-bc1c-ee0b693cf451">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency gains (losses) from non-derivative instruments included in other comprehensive income in the Consolidated Statements of Comprehensive Income were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro-denominated notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the years ended March 31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the year ended March 31, 2023, includes amounts reclassified to earnings of $112&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="icde86b5b9cf640a3857b79b2a12f38f7_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpmZmY4OGQxYTYxZmU0NmNhYjFmZWNiYjY2MzFhNDQ2Ni90YWJsZXJhbmdlOmZmZjg4ZDFhNjFmZTQ2Y2FiMWZlY2JiNjYzMWE0NDY2XzMtMS0xLTEtMjM3NzM4_cf1e6c3c-1915-4823-8bde-a60e02404f35"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i5bf4620f35c94ffe8b0ced9de2482405_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpmZmY4OGQxYTYxZmU0NmNhYjFmZWNiYjY2MzFhNDQ2Ni90YWJsZXJhbmdlOmZmZjg4ZDFhNjFmZTQ2Y2FiMWZlY2JiNjYzMWE0NDY2XzMtMy0xLTEtMjM3NzM4_aa4ae77f-4e68-4240-9ae4-0fbc0dacbac8"
      unitRef="usd">73000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ib5ed5bad9fbc48a79bf500f2ea6d7a22_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpmZmY4OGQxYTYxZmU0NmNhYjFmZWNiYjY2MzFhNDQ2Ni90YWJsZXJhbmdlOmZmZjg4ZDFhNjFmZTQ2Y2FiMWZlY2JiNjYzMWE0NDY2XzMtNS0xLTEtMjM3NzM4_be2847bf-f99d-4a76-b57c-1cdda8936431"
      unitRef="usd">-118000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="icde86b5b9cf640a3857b79b2a12f38f7_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzYwNDczMTM5NzE4NTg_9dc4afd3-f70c-4974-b104-80892e04cabd"
      unitRef="usd">112000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNTA_bc6477a5-3c4a-4c66-a81d-002aa3010907">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2023 and 2022, the notional amounts of the Company&#x2019;s outstanding derivatives were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity Date &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nov-24 to Mar-25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as fair value hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nov-28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#xa3;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aug-25 to Jul-26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x20ac;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Floating interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Feb-26 to Sep-29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow hedges: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CAD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jan-24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jun-33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The maturity date reflected is for outstanding derivatives as of March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;There was no ineffectiveness in these hedges for the years ended March 31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company agreed with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;In fiscal 2023, represents cross-currency fixed-to-fixed interest rate swaps to mitigate the foreign currency exchange fluctuations on its foreign currency-denominated notes. In fiscal 2022, represents fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into fixed-to-floating interest rate swaps to hedge the changes in fair value caused by fluctuations in the benchmark interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company entered into agreements with financial institutions to lock into the fixed benchmark interest rates for future bond issuance.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5ff470a2b6a24f96a0586ed7a59b7b7b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzMtNS0xLTEtMjM4MDk3_5def9f4b-205b-47a3-8690-55f1d0451a0b"
      unitRef="cad">1500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ifd33b3ebae6e4d2496772717c3f8c273_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzMtNy0xLTEtMjM4MDk3_42067552-e74f-4f1c-b72d-369ee139dc0e"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i451f85a810074a318c6fdba6392654ed_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzYtNS0xLTEtMjM4MDk3_84db09c7-8fe7-4070-a590-cfa435da539d"
      unitRef="gbp">450000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie46f20f9252c435eb905f97640abaa6c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzYtNy0xLTEtMjM4MDk3_b4008b9a-84c8-4efd-99d1-a1edfdb36fdb"
      unitRef="gbp">450000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie365683768f34533b940d20aee5be735_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzctNS0xLTEtMjM4MDk3_bc40573c-7d72-4b50-b372-232f1c442add"
      unitRef="eur">1100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9d0ea17b2eb84516bc5d182b18413d90_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzctNy0xLTEtMjM4MDk3_71dd676f-f4c6-4f7d-a70a-072af0c036b5"
      unitRef="eur">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8d2f247e11ef4383a78c76952ded2871_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzgtNS0xLTEtMjM4MDk3_9939640c-2d19-40df-a141-0eb295f3b1b9"
      unitRef="usd">1250000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i012704ce27234402832a8bc9c0017988_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzgtNy0xLTEtMjM4MDk3_530ff181-1b70-464f-b10d-6c1461af62c4"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8ff7efcd13d54a859f0cdcd3c236d712_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzExLTUtMS0xLTIzODA5Nw_a5eda248-83a1-4ff1-a0e8-bc1c03c2222b"
      unitRef="cad">400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i58eb9e87b3f1463fbab075c07679076d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzExLTctMS0xLTIzODA5Nw_89630ebf-8dab-4e4c-8c33-8c3abbf2ffcc"
      unitRef="cad">1678000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i18e62823c6c34113847dd36bdd196aee_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzEyLTUtMS0xLTIzODA5Nw_cf5cf608-389e-428e-87b6-4a7dc933e382"
      unitRef="usd">450000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icc76b912e3064681bcafdf4fb127e946_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo4YWY3ZmViYjVhZTc0MzRlYjcyMDAwNWQ5Njc1M2UwMC90YWJsZXJhbmdlOjhhZjdmZWJiNWFlNzQzNGViNzIwMDA1ZDk2NzUzZTAwXzEyLTctMS0xLTIzODA5Nw_7221dec5-9e0e-4864-aee8-f4e08a0b870c"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6b463726a6524dd3ba88c8289035c4c4_I20230228"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNzQyNTU_fa0e7922-c9ec-48f6-8575-642748ed7ffd"
      unitRef="gbp">450000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie365683768f34533b940d20aee5be735_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzcxNDY4MjU2MTEzOTg_df9b5d33-6547-4881-8568-60d9fc57d341"
      unitRef="eur">1100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1212e8cf47b1431fba4fec0f85eaa49f_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzcxNDY4MjU2MTE0Nzc_0d143ec0-af53-4903-b916-ffd96596e27e"
      unitRef="usd">1300000000</us-gaap:DerivativeNotionalAmount>
    <mck:DerivativeNotionalAmountTerminated
      contextRef="i18e62823c6c34113847dd36bdd196aee_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzcxNDY4MjU2MDQ1ODg_60ff5614-706c-40f7-9df0-787dca5c02d5"
      unitRef="usd">500000000</mck:DerivativeNotionalAmountTerminated>
    <mck:GainLossOnDerivativeTermination
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzcxNDY4MjU2MDQ2NTI_84ff939f-432e-4922-a9a0-a8beb2833e65"
      unitRef="usd">97000000</mck:GainLossOnDerivativeTermination>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5b574ca5d25e4e77b9ac4175842add0c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNzQyNjk_b9979882-bdbb-42b5-a3d5-4982df69582b"
      unitRef="usd">450000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNTE_2c2baeb0-38fc-4112-8cd3-513c3fd9ed44">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains (losses) from derivatives included in other comprehensive income (loss) in the Consolidated Statements of Comprehensive Income (Loss) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow and other hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes other comprehensive income related to the excluded component of certain fair value hedges.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzg3OTYwOTMwNjMzNTE_2d56452b-d800-4e79-b964-84354d587588">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains (losses) from derivatives included in other comprehensive income (loss) in the Consolidated Statements of Comprehensive Income (Loss) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as net investment hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated as cash flow and other hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes other comprehensive income related to the excluded component of certain fair value hedges.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i4e74926dad464e94bdc3f1c87eb5109a_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzMtMS0xLTEtMjM4NDk5_b0c56d2a-9eec-4855-839b-c768c08f4318"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i9a201725780545cb9926c7c283f7d7d0_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzMtMy0xLTEtMjM4NDk5_42de335e-1174-4eca-9abd-35ef23acefcc"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ie12bcf044f834b0ebb0a13192a63245b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzMtNS0xLTEtMjM4NDk5_d66afda2-c97b-4312-861f-02d059ad2c9b"
      unitRef="usd">-119000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ie8dab7068d7b4998b54b905773776649_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzYtMS0xLTEtMjM4NDk5_f3255c35-4fae-4158-a5f7-37d9664a506c"
      unitRef="usd">-54000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i94135546f3234d41991f401e92d4d4d6_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzYtMy0xLTEtMjM4NDk5_e14eebed-3385-4c93-a73c-c3620cc2813c"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i4e3950dedac64c34a7acce736f0bc228_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzYtNS0xLTEtMjM4NDk5_438bf000-0351-40fa-ae01-e7aa5065dbda"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i42e31d06ed3643fbae42793a45735ac5_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzctMS0xLTEtMjM4NDk5_ca2e54f7-c376-49f0-9c23-ba9ecbfc66be"
      unitRef="usd">-30000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i69be7012e79640bfb23e05de78108936_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzctMy0xLTEtMjM4NDk5_1ba0f53f-d252-453d-bdbd-25117976a02c"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iaa333c469edc4e739ef41e09656c0dfe_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTo2MTMzODc4MTE1ZTc0NjllODk0ZjExMGVmYTdmNGVmNi90YWJsZXJhbmdlOjYxMzM4NzgxMTVlNzQ2OWU4OTRmMTEwZWZhN2Y0ZWY2XzctNS0xLTEtMjM4NDk5_9d0ab03c-3cac-4feb-8bb6-fbbfc8db0688"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90ZXh0cmVnaW9uOjA0MzU0YjA1NDk2YzQxZTQ4MThjMDIwZjMzMWExMDczXzExNTk3_5ddee9a5-9200-4271-a813-659de97c7506">&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives designated for hedge accounting:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 3.25pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iae39c5b703e44224ad9561aadf22dcaa_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtMi0xLTEtMjE4NzQ4_6ab8368e-667f-453a-bc1f-68643f69f81a"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iae39c5b703e44224ad9561aadf22dcaa_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtNC0xLTEtMjE4NzQ4_780a58c9-9edf-43b4-802b-b4a2147e6cf3"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="iae39c5b703e44224ad9561aadf22dcaa_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtNi0xLTEtMjE4NzQ4_7e7e9b19-ddca-44f9-9e25-61e8fd97b412"
      unitRef="usd">301000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i08578346a1c640a69d5c8c9dbc6cef2f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtOC0xLTEtMjE4NzQ4_8d2e2c4d-a19c-4b54-866e-3639e629b2f1"
      unitRef="usd">30000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i08578346a1c640a69d5c8c9dbc6cef2f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtMTAtMS0xLTIxODc0OA_64ffe065-fc9d-455c-a339-ab0fd0421116"
      unitRef="usd">39000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i08578346a1c640a69d5c8c9dbc6cef2f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzUtMTItMS0xLTIxODc0OA_e58b905b-1320-4c49-ac9a-4647eba5ca0a"
      unitRef="usd">1537000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib89a2c4aa24f415ebad33a8ffc064667_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtMi0xLTEtMjE4NzQ4_96189d3a-d138-4dcd-9be0-9e117bbb3093"
      unitRef="usd">74000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib89a2c4aa24f415ebad33a8ffc064667_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtNC0xLTEtMjE4NzQ4_af12577b-e2db-4b9a-8f5f-352d13d9dc05"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib89a2c4aa24f415ebad33a8ffc064667_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtNi0xLTEtMjE4NzQ4_0451f7cb-aebc-40e0-b056-23ec301e9cce"
      unitRef="usd">2760000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9ab3273dc18846c0891c616e297f96e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtOC0xLTEtMjE4NzQ4_68726062-de17-404a-8ec8-fa8bbb099529"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9ab3273dc18846c0891c616e297f96e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtMTAtMS0xLTIxODc0OA_8c1c7ea0-394f-4a85-8553-c97d2b43415a"
      unitRef="usd">36000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i9ab3273dc18846c0891c616e297f96e1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzYtMTItMS0xLTIxODc0OA_d39ac54c-79a3-4f39-b226-54094054266e"
      unitRef="usd">679000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i570b23d2fb4f453cb4925aebe582d8f1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctMi0xLTEtMjE4NzQ4_463526e1-401e-47cf-af00-c1ab03866c7c"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i570b23d2fb4f453cb4925aebe582d8f1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctNC0xLTEtMjE4NzQ4_2cecbc9c-a3be-4ec0-a1ed-0c36a23b0f89"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i570b23d2fb4f453cb4925aebe582d8f1_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctNi0xLTEtMjE4NzQ4_ecab0a8a-4f46-4674-8cc1-763ea3d56eb7"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie5af88ef9b934cc4a000f911d7bc1a8c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctOC0xLTEtMjE4NzQ4_f6c1c215-0236-4bcd-9a2d-e12ef2f47ac9"
      unitRef="usd">31000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie5af88ef9b934cc4a000f911d7bc1a8c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctMTAtMS0xLTIxODc0OA_d44ad424-9cb2-48a3-b82a-a01562d3b864"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ie5af88ef9b934cc4a000f911d7bc1a8c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzctMTItMS0xLTIxODc0OA_58117bbd-d42d-43d1-8c4d-1a49fc3d1264"
      unitRef="usd">500000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i27091f652077438a88c26df46b3f0175_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtMi0xLTEtMjE4NzQ4_10a35188-9697-480b-be62-f6666a583004"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i27091f652077438a88c26df46b3f0175_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtNC0xLTEtMjE4NzQ4_4188014a-5134-4484-9db8-e40913ad31fe"
      unitRef="usd">15000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i27091f652077438a88c26df46b3f0175_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtNi0xLTEtMjE4NzQ4_bfa52b6e-b7e7-46cc-a3c0-22a17f7e628e"
      unitRef="usd">1700000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i96f88968ebe444dd9eb39629b0d33d5c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtOC0xLTEtMjE4NzQ4_0e5cbaf4-fd85-459d-9147-8073d84524d2"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i96f88968ebe444dd9eb39629b0d33d5c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtMTAtMS0xLTIxODc0OA_f87d0d60-acaa-485f-8a69-4ada697901a7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i96f88968ebe444dd9eb39629b0d33d5c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzgtMTItMS0xLTIxODc0OA_fafa2ec5-80ce-4b8f-a26e-da2f6e58a8df"
      unitRef="usd">0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9919373fdaa44e9488d392bca8c37b57_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzktMi0xLTEtMjE4NzQ4_d7cfb8f3-1ff6-4b18-9c42-c6a0d112a6c3"
      unitRef="usd">80000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9919373fdaa44e9488d392bca8c37b57_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzktNC0xLTEtMjE4NzQ4_21dbcbed-4d94-4aed-b897-6e7aaf487b2b"
      unitRef="usd">17000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i72369ee3bdc242a584b516b6b0220cd3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzktOC0xLTEtMjE4NzQ4_46b39a23-f50e-41a0-8139-b4eb860c1c59"
      unitRef="usd">61000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i72369ee3bdc242a584b516b6b0220cd3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjMvZnJhZzowNDM1NGIwNTQ5NmM0MWU0ODE4YzAyMGYzMzFhMTA3My90YWJsZTpjMTMwYjQyNzQ1MjE0Njc0ODBmNzA3NGVlMzU4N2JmYy90YWJsZXJhbmdlOmMxMzBiNDI3NDUyMTQ2NzQ4MGY3MDc0ZWUzNTg3YmZjXzktMTAtMS0xLTIxODc0OA_4a0920fe-be75-4a5a-aa57-bbba73e2c563"
      unitRef="usd">75000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1Xzc3MDk_2812925c-6292-47f3-8aac-f5180e19a619">Fair Value Measurements&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain assets and liabilities at fair value in accordance with ASC Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - significant other observable market-based inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents at March 31, 2023 and 2022 included investments in money market funds of $1.4 billion and $981 million, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. The fair values for the Company&#x2019;s marketable securities were not material at March 31, 2022, and were liquidated during fiscal 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of the Company&#x2019;s interest rate swaps and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 14, &#x201c;Hedging Activities,&#x201d; for fair values and other information on the Company&#x2019;s derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds investments in equity securities of U.S. growth stage companies that address both current and emerging business challenges in the healthcare industry and which had carrying values of $237&#160;million and $346&#160;million at March 31, 2023 and 2022, respectively. These investments primarily consist of equity securities without readily determinable fair values and are included in &#x201c;Other non-current assets&#x201d; in the Consolidated Balance Sheets. During fiscal 2023, the Company recognized impairment charges and realized gains on the exit of certain investments. During fiscal 2022, certain of the Company&#x2019;s investments in equity securities without readily determinable fair values were remeasured to fair value based on transactions which resulted in changes in the observable price of those securities. During fiscal 2021, certain of the Company&#x2019;s investments in equity securities were converted into shares of public common stock through initial public offerings and an acquisition. The Company exited most of its investments in publicly traded shares in the fourth quarter of fiscal 2021. The Company recognized net losses of $36 million, including impairments of $59&#160;million, for the year ended March 31, 2023, and recognized net gains of $98 million and $133 million for the years ended March 31, 2022 and 2021, respectively. These amounts were recorded in &#x201c;Other income, net&#x201d; in the Consolidated Statements of Operations. The carrying value of publicly traded investments was determined using quoted prices for identical investments in active markets and are considered to be Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#x2019;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges, including long-lived assets associated with the Company&#x2019;s restructuring initiatives as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net,&#x201d; or as a result of charges to remeasure assets classified as held for sale to fair value less costs to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2023, the contingent consideration liability related to the Company&#x2019;s acquisition of RxSS in November 2022 was measured at fair value on a nonrecurring basis. At March 31, 2022, the assets and liabilities associated with the E.U. disposal group and U.K. disposal group classified as held for sale were measured at the lower of carrying value or fair value less costs to sell. The E.U. disposal group was divested in October 2022 and the U.K. disposal group was divested in April 2022. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures" for more information on these transactions. Additionally, at March 31, 2022, assets measured at fair value on a nonrecurring basis included certain long-lived assets within the International segment related to the Company&#x2019;s previous operations in Denmark and its retail pharmacy businesses in Canada, as discussed in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aforementioned investments in equity securities of U.S. growth stage companies include the carrying value of investments without readily determinable fair values, which were determined using a measurement alternative and are recorded at cost less impairment, plus or minus any changes in observable price from orderly transactions of the same or similar security of the same issuer. These inputs related to changes in observable price are considered Level 2 under the fair value measurements and disclosure guidance and may not be representative of actual values that could have been realized or that will be realized in the future. Inputs related to impairments of investments are generally considered Level 3 fair value measurements due to their inherently unobservable nature based on significant assumptions by management and use of company-specific information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no other material assets or liabilities measured at fair value on a nonrecurring basis at March 31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Fair Value Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2023 and 2022, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short-term maturity of these financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a DCF model to determine the fair value of each reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Financial Note 10, &#x201c;Goodwill and Intangible Assets, Net,&#x201d; for more information regarding goodwill impairment charges recorded for certain reporting units during fiscal 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value. Refer to Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net&#x201d; under the heading &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Lived Asset Impairments&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1Xzc2Nw_9cd0795f-55f4-4c62-ac70-5f90608cb382"
      unitRef="usd">1400000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1Xzc3NA_1469e6bf-0ae7-4f60-8be3-90089b535c2b"
      unitRef="usd">981000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzIxNDM_49c6539d-01c5-4c69-88ff-4503b1914561"
      unitRef="usd">237000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzIxNTA_7ff81cea-c8a7-4b2a-bf63-6e04d48e0e29"
      unitRef="usd">346000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzI5Mjg_b0c64079-cbba-4b3a-bbd9-e2097347a55b"
      unitRef="usd">-36000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzU0OTc1NTgyNjUzMw_79d309dd-32c7-4da1-b68d-3e196ca628ea"
      unitRef="usd">59000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzI5MzU_17f06690-f741-484c-b344-f762f561b345"
      unitRef="usd">98000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1XzU0OTc1NTgyMjUzMQ_c7532c18-be6d-4bef-a725-304a1128602d"
      unitRef="usd">133000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90ZXh0cmVnaW9uOjg0MGJiZGNiODU1NjRiY2M4MTZlOTUxYWExOTJiMTY1Xzc3MTA_62c95a99-7e4e-4eab-8d3d-4c0ffd089f68">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i193367ab1bd147669e6aa97c4b68b27c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90YWJsZTo4Y2UyZDNhYjU0Mzc0Y2IxYWVhNGRkNjZhODlkMjJiZS90YWJsZXJhbmdlOjhjZTJkM2FiNTQzNzRjYjFhZWE0ZGQ2NmE4OWQyMmJlXzItMS0xLTEtMjE4NzQ4_db2b3ee8-e1fc-4126-ae44-e216fe88562d"
      unitRef="usd">5594000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i193367ab1bd147669e6aa97c4b68b27c_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90YWJsZTo4Y2UyZDNhYjU0Mzc0Y2IxYWVhNGRkNjZhODlkMjJiZS90YWJsZXJhbmdlOjhjZTJkM2FiNTQzNzRjYjFhZWE0ZGQ2NmE4OWQyMmJlXzItMy0xLTEtMjE4NzQ4_04014798-e194-4213-89af-f4b85fb0ddc4"
      unitRef="usd">5386000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="i9ed31f2e5a9e4fa5b8dcaf9650e3ac4c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90YWJsZTo4Y2UyZDNhYjU0Mzc0Y2IxYWVhNGRkNjZhODlkMjJiZS90YWJsZXJhbmdlOjhjZTJkM2FiNTQzNzRjYjFhZWE0ZGQ2NmE4OWQyMmJlXzItNS0xLTEtMjE4NzQ4_04b6e4ce-236b-4f0c-a3c5-de22d641d3ea"
      unitRef="usd">5879000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i9ed31f2e5a9e4fa5b8dcaf9650e3ac4c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjYvZnJhZzo4NDBiYmRjYjg1NTY0YmNjODE2ZTk1MWFhMTkyYjE2NS90YWJsZTo4Y2UyZDNhYjU0Mzc0Y2IxYWVhNGRkNjZhODlkMjJiZS90YWJsZXJhbmdlOjhjZTJkM2FiNTQzNzRjYjFhZWE0ZGQ2NmE4OWQyMmJlXzItNy0xLTEtMjE4NzQ4_aeec0bcd-e5fd-4d4b-a64d-736847f82c1a"
      unitRef="usd">5999000000</us-gaap:DebtInstrumentFairValue>
    <mck:FinancialGuaranteesAndWarrantiesTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzM0Mzg_b3186142-7a51-4687-a7a6-a868cbfa1a79">Financial Guarantees and Warranties&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreements with certain of its customers&#x2019; financial institutions, primarily in its International segment, under which it has guaranteed the repurchase of its customers&#x2019; inventory or its customers&#x2019; debt in the event these customers are unable to meet their obligations to those financial institutions. For the Company&#x2019;s inventory repurchase agreements, among other requirements, inventories must be in a resalable condition and any repurchase would be at a discount. The inventory repurchase agreements mostly relate to certain Canadian customers and generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzYyMA_f70be4f2-8308-4872-ada2-b3f0a675b674"&gt;one&lt;/span&gt; to two years. Customers&#x2019; debt guarantees generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzY3OA_6036989f-413d-4a9a-9e98-c93fb0ca4aa4"&gt;one&lt;/span&gt; to five years and are primarily provided to facilitate financing for certain customers. The majority of the Company&#x2019;s customers&#x2019; debt guarantees are secured by certain assets of the customer. At March 31, 2023, the maximum amounts of inventory repurchase guarantees and customers&#x2019; debt guarantees were $343 million and $17 million, respectively, of which the Company has not accrued any material amounts. The expirations of these financial guarantees were as follows: $18 million, $108 million, $195 million, $10 million, and $8 million&#160;from fiscal 2024 through fiscal 2028, respectively, and $21 million thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March 31, 2023, the Company&#x2019;s banks and insurance companies have issued $206 million of standby letters of credit and surety bonds, which were issued on the Company&#x2019;s behalf primarily related to its customer contracts and in order to meet the security requirements for statutory licenses and permits, court and fiduciary obligations, pension obligations in Europe, and its workers&#x2019; compensation and automotive liability programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s software license agreements generally include certain provisions for indemnifying customers against liabilities if its software products infringe a third party&#x2019;s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnification agreements and has not accrued any liabilities related to such obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with certain transactions, primarily divestitures, the Company may provide routine indemnification agreements (such as retention of previously existing environmental, tax, and employee liabilities) whose terms vary in duration and often are not explicitly defined. Where appropriate, obligations for such indemnifications are recorded as liabilities. Because the amounts of these indemnification obligations often are not explicitly stated, the overall maximum amount of these commitments cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of divestiture, the Company has historically not made material payments as a result of these indemnification provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company provides certain warranties and indemnification protection for its products and services. For example, the Company provides warranties that the pharmaceutical and medical-surgical products it distributes are in compliance with the U.S. Food, Drug, and Cosmetic Act and other applicable laws and regulations. It has received the same warranties from its suppliers, which customarily are the manufacturers of the products. In addition, the Company has indemnity obligations to its customers for these products, which have also been provided from its suppliers, either through express agreement or by operation of law. Accrued warranty costs were not material to the Consolidated Balance Sheets as of March 31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</mck:FinancialGuaranteesAndWarrantiesTextBlock>
    <mck:GuarantorObligationsPeriod
      contextRef="ia4296c0b84d346e4b89b55d58821c05d_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzYyNg_8ae3d152-07df-4e7b-a266-9ed2fc58669c">P2Y</mck:GuarantorObligationsPeriod>
    <mck:GuarantorObligationsPeriod
      contextRef="i9d14a00ce32c46e7b5068767e2553b8b_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzg3OTYwOTMwMjU4OTU_15b3436c-fa15-4ee3-a14b-0df6cbc7d3db">P5Y</mck:GuarantorObligationsPeriod>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i7c2dfca8ca434187bc4a0181f1cd5d18_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzk2Mw_2acf2ab8-86d2-4eb5-920d-b4d10fce1413"
      unitRef="usd">343000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i1be6be612b674d65a670c15307e93ab4_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzk3MA_e21fda29-d9f7-468e-ac43-719d41aa1501"
      unitRef="usd">17000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <mck:GuaranteeObligationsExposureExpiringinYearOne
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExMDk_9896434a-f86d-4aa8-b25a-82db10e1d9e5"
      unitRef="usd">18000000</mck:GuaranteeObligationsExposureExpiringinYearOne>
    <mck:GuaranteeObligationsExposureExpiringinYearTwo
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExMTM_ba038e5c-e088-4371-aba6-ef4ac7baff6a"
      unitRef="usd">108000000</mck:GuaranteeObligationsExposureExpiringinYearTwo>
    <mck:GuaranteeObligationsExposureExpiringinYearThree
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExMTc_1b2ff040-699b-40ac-b2cf-3782c73b9a1d"
      unitRef="usd">195000000</mck:GuaranteeObligationsExposureExpiringinYearThree>
    <mck:GuaranteeObligationsExposureExpiringinYearFour
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExMjE_b8b50b32-b151-47a2-9145-36a24f22d4de"
      unitRef="usd">10000000</mck:GuaranteeObligationsExposureExpiringinYearFour>
    <mck:GuaranteeObligationsExposureExpiringinYearFive
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExMjk_44a41915-05e3-4eb7-89b8-8b0615740a8e"
      unitRef="usd">8000000</mck:GuaranteeObligationsExposureExpiringinYearFive>
    <mck:GuaranteeObligationsExposureExpiringinYearFiveThereafter
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzExNzA_bfe9825f-3e6f-41bd-a6f2-ca2dbf143349"
      unitRef="usd">21000000</mck:GuaranteeObligationsExposureExpiringinYearFiveThereafter>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ied8ab1ea89bb4a8492bbac67f1f3dd79_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNjkvZnJhZzo0MWQwNjZkNGI4NWM0YzBhOWU3YmVmODgxYWY4NTUyZi90ZXh0cmVnaW9uOjQxZDA2NmQ0Yjg1YzRjMGE5ZTdiZWY4ODFhZjg1NTJmXzEyNDg_6b951148-33c1-430d-942a-ffedb361372a"
      unitRef="usd">206000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzM4MTc0_08d40ea5-8f53-4123-ae48-096f076c80ee">Commitments and Contingent Liabilities&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability, or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. Amounts included within &#x201c;Claims and litigation charges, net&#x201d; in the Consolidated Statements of Operations consist of estimated loss contingencies related to opioid-related litigation matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;I. Litigation and Claims Involving Distribution of Controlled Substances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its affiliates have been sued as defendants in many cases asserting claims related to distribution of controlled substances. They have been named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacies. The plaintiffs in these actions have included state attorneys general, county and municipal governments, school districts, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They have sought monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), state and federal controlled substances laws, and other statutes. Because of the many uncertainties associated with opioid-related litigation matters, the Company is not able to conclude that a liability is probable or to reasonably estimate a range of ultimate possible loss for opioid-related litigation matters other than those for which an accrual is described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;State and Local Government Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of these cases were brought by state and local government entities in the U.S. The Company and two other national pharmaceutical distributors (collectively &#x201c;Distributors&#x201d;) entered into a settlement agreement (the &#x201c;Settlement&#x201d;) with 48 states and their participating subdivisions, as well as the District of Columbia and all eligible territories (the &#x201c;Settling Governmental Entities&#x201d;). The Company has paid the Settling Governmental Entities approximately $1.0&#160;billion as of March 31, 2023, and, under the Settlement, will pay the Settling Governmental Entities additional amounts up to approximately $6.8&#160;billion through 2038. A minimum of 85% of the Settlement payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#x2019; attorneys&#x2019; fees and costs, and is payable over a shorter time period. Under the Settlement, the Distributors will establish a clearinghouse to consolidate their controlled-substance distribution data, which will be available to the settling U.S. states to use as part of their anti-diversion efforts. The Distributors do not admit liability or wrongdoing and do not waive any defenses pursuant to the Settlement. Consent judgments have been entered in all participating states and territories, and approximately 2,300 cases have been dismissed pursuant to the Settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Alabama and West Virginia did not participate in the Settlement. Under a separate agreement with Alabama and its subdivisions, the Company has paid approximately $42&#160;million as of March 31, 2023, and will pay additional amounts totaling approximately $132&#160;million through 2031. The Company previously settled with the state of West Virginia in 2018, and West Virginia and its subdivisions were not eligible to participate in the Settlement. After a trial, the claims of two West Virginia subdivisions, Cabell County and the City of Huntington, were decided in the Company&#x2019;s favor on July 4, 2022. That decision is under appeal. The claims of certain other West Virginia subdivisions were settled pursuant to an agreement requiring the Company to pay approximately $152&#160;million over 11 years. The Company has paid the settling subdivisions $38&#160;million as of March 31, 2023, and will pay additional amounts totaling approximately $114&#160;million through 2033. All participating litigating subdivisions have dismissed their claims against the Company, but the agreement does not include school districts or the claims of Cabell County and the City of Huntington. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some subdivisions did not participate in the Settlement, including certain municipal governments, government hospitals, school districts, and government-affiliated third-party payors. The Company contends these claims are foreclosed by the Settlement or otherwise subject to strong defenses, while the non-participating subdivisions assert that they are not bound by the Settlement for a variety of reasons. The Company intends to defend itself vigorously in these matters. The City of Baltimore, Maryland, is one jurisdiction that did not participate in the settlement. Trial of the City of Baltimore&#x2019;s claims is currently scheduled to begin September 26, 2024. The Company&#x2019;s loss contingency accruals for these subdivisions are reflected in the estimated liability for opioid-related claims consistent with what would be allocated under the framework of the Settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Native American Tribe Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to the claims of Native American tribes, the Company has reached agreements that achieve a broad resolution of opioid-related claims brought by federally recognized Native American tribes. Under the agreements, the Company will pay approximately $196&#160;million over 6.5 years to resolve the claims of participating Native American tribes. The Company has paid the settling Native American tribes $56&#160;million as of March 31, 2023, and will pay additional amounts totaling approximately $140&#160;million through 2027. Under these agreements, a minimum of 85% of the settlement payments must be used by the Native American tribes to remediate the opioid epidemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimated accrued liability for the opioid-related claims of U.S. governmental entities, including Native American tribes, was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These amounts, recorded in &#x201c;Other accrued liabilities&#x201d; in the Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2023 and fiscal 2022, the Company paid $1.1&#160;billion and $74&#160;million, respectively, associated with the Settlement and separate settlement agreements of opioid-related claims of participating states, subdivisions, and Native American tribes. In conjunction with the payments made in fiscal 2023, all funds have been released from escrow.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Governmental Plaintiff Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Though the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals. These claims, and those of private entities generally, are not included in the Settlement or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;One such case was brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court seeking to recover for damages allegedly arising from their family members&#x2019; abuse of prescription opioids. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Poppell v. Cardinal Health, Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CE19-00472. On March 1, 2023, the jury in that case returned a verdict in favor of the defendants, including the Company. That verdict is now the subject of post-trial motions, including a plaintiffs&#x2019; motion for a new trial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In another, several hospitals brought suit in the Circuit Court of Conecuh County, Alabama; trial on the claims of eight of these hospitals is currently scheduled for July 24, 2023. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fort Payne Hospital Corporation et al. v. McKesson Corp., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CV-2021-900016. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Canadian Plaintiff Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In addition to the opioid-related claims brought in the U.S., the Company and its Canadian affiliate are also defendants in four cases pending in Canada. These cases involve the claims of the provincial governments, a group representing indigenous people, as well as one case brought by an individual. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. The Company has not concluded a loss is probable in any of these matters; nor is any possible loss or range of loss reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#x2019;s financial position, cash flows or liquidity, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Qui Tam Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 8, 2018, the Company was served with a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint pending in the United States District Court for the District of Massachusetts alleging that the Company violated the federal False Claims Act and various state false claims acts due to the alleged failure of the Company and other defendants to report providers who were engaged in diversion of controlled substances. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Manchester v. Purdue Pharma, L.P., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Case No. 1-16-cv-10947. On August 22, 2018, the United States filed a motion to dismiss. The relator died, and on February 25, 2019 the court entered an order staying the matter until a proper party can be substituted, and providing that if no party is substituted within 90 days of February 25, 2019, the case would be dismissed. In April 2019, the widow of the relator filed a motion to substitute their daughter as the relator; the United States and defendants opposed this substitution request. The motion remains pending and the case remains stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Company was served with two &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaints filed by the same two relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Kelley&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 19-cv-2233, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;State of California ex rel. Kelley&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit, which affirmed the dismissal on March 10, 2022. On June 28, 2021, the court in the state action dismissed the complaint with prejudice, and the relators appealed the dismissal to the California Court of Appeal, which affirmed the dismissal on February 24, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance Coverage Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Two cases pending in the Northern District of California were filed against McKesson by its liability umbrella insurers about policies they issued to the Company for the period 1999-2017, AIU Insurance Company and National Union Fire Insurance Company of Pittsburgh, Pa. (together "AIG") and ACE Property and Casualty Insurance Company ("ACE"). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AIU Insurance Company et al. v. McKesson Corporation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 3:20-cv-07469 (N.D. Cal.) was initiated by AIG in the Northern District of California on October 23, 2020. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ace Property and Casualty Insurance Company v. McKesson Corporation et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 3:20-cv-09356 (N.D. Cal.) was brought by ACE in California state court on November 2, 2020, and was removed by McKesson to federal court, transferred to the Northern District of California, and designated as related to the AIU action. AIG and ACE are seeking declarations that they have no duty to defend or indemnify McKesson in the thousands of lawsuits filed in federal and state courts related to opioids. In both actions, McKesson has asserted claims under the AIG and ACE policies seeking declarations and damages for past and future defense and indemnity costs. On April 5, 2022, the court issued an order granting partial summary judgment to the insurers that the Company&#x2019;s defense costs in certain opioid-related litigation were not covered by two of the insurance policies, which the Company has appealed to the U.S. Court of Appeals for the Ninth Circuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;II. Other Litigation and Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 17, 2013, the Company was served with a complaint filed in the United States District Court for the Northern District of California by True Health Chiropractic Inc., alleging that McKesson sent unsolicited marketing faxes in violation of the Telephone Consumer Protection Act of 1991 (&#x201c;TCPA&#x201d;), as amended by the Junk Fax Protection Act of 2005 or JFPA,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;True Health Chiropractic Inc., et al. v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;No. CV-13-02219 (HG). Plaintiffs seek statutory damages from&#160;$500&#160;to&#160;$1,500&#160;per violation plus injunctive relief. True Health Chiropractic later amended its complaint, adding McLaughlin Chiropractic Associates as an additional named plaintiff and McKesson Technologies Inc. as a defendant. Both plaintiffs alleged that defendants violated the TCPA by sending faxes that did not contain notices regarding how to opt out of receiving the faxes. On August 13, 2019, the court granted plaintiffs&#x2019; renewed motion for class certification. After class notice and the opt-out period, 9,490 fax numbers remain in the class, representing 48,769 faxes received. On October 8, 2021, the court de-certified the class citing the plaintiffs lacked class-wide proof identifying the manner of receipt, thus leaving two named Plaintiffs remaining in the case. On April 27, 2022, the Court found that the named Plaintiffs had failed to meet their burden to show Defendants willfully or knowingly violated the TCPA and therefore were not entitled to treble damages. The Court found McKesson liable for statutory damages in the amount of $6,500. The Company appealed the finding of liability and the plaintiffs cross-appealed the denial of class certification and the ruling denying treble damages.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 16, 2013, the Company&#x2019;s subsidiary, U.S. Oncology, Inc. (&#x201c;USON&#x201d;), was served with a third amended qui tam complaint filed in the United States District Court for the Eastern District of New York by two relators, purportedly on behalf of the United States, 21 states and the District of Columbia, against USON and five other defendants, alleging that USON solicited and received illegal &#x201c;kickbacks&#x201d; from Amgen in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Piacentile v. Amgen Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, et al., CV 04-3983 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On November 16, 2018, the relators filed a fourth amended complaint; that complaint was dismissed with prejudice on December 1, 2021. On March 28, 2023, the Court of Appeals for the Second Circuit affirmed dismissal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 17, 2014, U.S. Oncology Specialty, LP (&#x201c;USOS&#x201d;) was served with a fifth amended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed in the United States District Court for the Eastern District of New York by a relator alleging that USOS, among others, solicited and received illegal &#x201c;kickbacks&#x201d; from Amgen in violation of the Anti-Kickback Statute, the federal False Claims Act, and various state false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Hanks v. Amgen, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CV-08-03096 (SJ). Previously, the United States declined to intervene in the case as to all allegations and defendants except for Amgen. On September 17, 2018, the court granted USOS&#x2019;s motion to dismiss. Following the relator&#x2019;s appeal, the United States Court of Appeals for the Second Circuit vacated the district court&#x2019;s order and remanded the suit to the district court, directing it to consider the question of whether the suit should be dismissed for lack of jurisdiction. The district court granted the relator leave to amend the complaint for a seventh time. The relator filed the seventh amended complaint on November 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or about April 25, 2018, a second amended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;complaint filed in the U.S. District Court for the Eastern District of New York was served on McKesson Corporation, McKesson Specialty Care Distribution Corporation, McKesson Specialty Distribution LLC, McKesson Specialty Care Distribution Joint Venture, L.P., Oncology Therapeutics Network Corporation, Oncology Therapeutics Network Joint Venture, L.P., US Oncology, Inc., and US Oncology Specialty, L.P. by Omni Healthcare, Inc. as relator, purportedly on behalf of the United States and 33 cities and states alleging that from 2001 through 2010 the defendants repackaged and sold single-dose syringes of oncology medications in a manner that violated the federal False Claims Act and various state and local false claims statutes, and seeking damages, treble damages, civil penalties, attorneys&#x2019; fees and costs of suit, all in unspecified amounts. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States of America ex rel. Omni Healthcare, Inc. v. McKesson Corp., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Case No. 1:12-cv-06440 (E.D.N.Y.). The United States and the other governmental plaintiffs declined to intervene in the suit. In February 2019, the court dismissed all of the defendants except McKesson Corporation and Oncology Therapeutics Network Corp. On February 2, 2022, the court entered a scheduling order under which non-government fact discovery was set to close on June 15, 2022. On June 14, 2022, relator moved for additional discovery and an extension of the discovery schedule. On October 13, 2022, the Court granted relator permission to take certain additional discovery, directed relator to move for leave to amend its complaint, and otherwise denied relator's motion without prejudice. On November 14, 2022, relator served its motion for leave to amend its complaint, which remains pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or about March 2, 2020, another &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;complaint filed in the U.S. District Court for the Eastern District of New York was served on US Oncology, Inc. by the same relator purportedly on behalf of the United States and 33 cities and states alleging the same misconduct and seeking the same relief. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Civil Action No. 1:19-cv-05125. The United States and the other governmental plaintiffs declined to intervene in the suit. On July 21, 2022, the Court granted defendant&#x2019;s motion to dismiss without prejudice. Relator subsequently filed an amended complaint. On October 21, 2022, defendant moved to dismiss the amended complaint and that motion remains pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2019, a group of independent pharmacies and a hospital filed a purported class action complaint alleging that the Company and other distributors violated the Sherman Act by colluding with manufacturers to restrain trade in the sale of generic drugs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reliable Pharmacy, et al. v. Actavis Holdco US, et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., No. 2:19-cv-6044; MDL No. 16-MD-2724. The complaint seeks relief including treble damages, disgorgement, attorney fees, and costs in unspecified amounts. On May 25, 2022, the district court granted distributor defendants&#x2019; motion to dismiss the complaint, but granted the plaintiffs leave to amend the complaint. Plaintiffs filed an amended complaint on July 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 12, 2018, the Company received a purported class action complaint in the United States District Court for the Northern District of California, alleging that McKesson and two&#160;of its former officers, CEO John Hammergren and CFO James Beer, violated the Securities Exchange Act of 1934 by reporting profits and revenues from 2013 until early 2017 that were false and misleading, due to an alleged undisclosed conspiracy to fix the prices of generic drugs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Evanston Police Pension Fund v. McKesson Corporation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 3:18-06525. The complaint seeks relief including damages, attorney fees, and costs in unspecified amounts. On April 10, 2019, the lead plaintiff filed an amended complaint that added insider trading allegations against defendant Hammergren. In October 2022, the parties reached an agreement in principle to settle this class action lawsuit for an amount covered in full by the Company&#x2019;s insurance policy. The settlement is subject to, among other things, final approval by the court. This settlement does not include any admission of liability, and defendants expressly deny wrongdoing. The Company&#x2019;s estimated probable loss, entirely offset by probable loss recovery from the Company&#x2019;s insurers, was $141&#160;million, both of which were recognized in the Condensed Consolidated Balance Sheet as of September 30, 2022 within &#x201c;Other accrued liabilities&#x201d; and &#x201c;Prepaid expenses and other.&#x201d; In February 2023, the insurance carriers funded the settlement, and the probable loss and loss recovery of $141&#160;million have been reversed in the Consolidated Balance Sheet as of March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2015, The Great Atlantic &amp;amp; Pacific Tea Company (&#x201c;A&amp;amp;P&#x201d;), a former customer of the Company, filed for reorganization in bankruptcy under Chapter 11 of the United States Bankruptcy Code in the Bankruptcy Court for the Southern District of New York. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re The Great Atlantic &amp;amp; Pacific Tea Company, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;Case No. 15-23007. A suit filed in 2017 against the Company in this bankruptcy case seeks to recover alleged preferential transfers. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;The Official Committee of Unsecured Creditors on behalf of the bankruptcy estate of The Great Atlantic &amp;amp; Pacific Tea Company, Inc., et al. v. McKesson Corporation d/b/a McKesson Drug Co.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Adv. Proc. No. 17-08264.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the Company was served with a first amended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed in the United States District Court for the Southern District of New York by a relator on behalf of the U.S., 27 states and the District of Columbia against McKesson Corporation, McKesson Specialty Distribution LLC, and McKesson Specialty Care Distribution Corporation, alleging that defendants violated the Anti-Kickback Statute, federal False Claims Act, and various state false claims statutes by providing certain business analytical tools to oncology practice customers, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Hart v. McKesson Corporation, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 15-cv-00903-RA. The U.S. and the named states have declined to intervene in the case. The complaint seeks relief including damages, treble damages, civil penalties, attorney fees, and costs of suit, all in unspecified amounts. On May 5, 2022, the district court granted the Company&#x2019;s motion to dismiss the complaint, but granted the plaintiff leave to amend the complaint. The relator filed the second amended complaint on June 7, 2022, which was dismissed again on March 28, 2023, but the district court granted the plaintiff leave to amend. On April 7, 2023, Plaintiff advised the court he would not amend and asked the court to enter the final judgment dismissing the complaint. Once the court issues the final judgment, that decision will be appealable to the Second Circuit Court of Appeals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;III.&#160;Government Subpoenas and Investigations &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough, and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. The following are examples of the type of subpoenas or requests the Company receives from time to time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017 and August 2018, respectively, the Company was served with&#160;two&#160;separate Civil Investigative Demands by the U.S. Attorney&#x2019;s Office for the Eastern District of New York relating to the certification the Company obtained for two software products under the U.S. Department of Health and Human Services&#x2019; Electronic Health Record Incentive Program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the United States Attorney&#x2019;s Office for the District of Massachusetts served a Civil Investigative Demand on the Company seeking documents related to certain discounts and rebates paid to physician practice customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 19, 2021, the Norwegian Competition Authority carried out an inspection of Norsk Medisinaldepot AS regarding its and its competitors alleged sharing of competitively sensitive information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the United States Department of Justice served a Civil Investigative Demand on the Company seeking documents related to distribution arrangements for ophthalmology products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;IV. State Opioid Statutes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2018, the State of New York Opioid Stewardship Act (&#x201c;OSA&#x201d;) imposed an aggregate $100&#160;million annual surcharge for 2017 and 2018 on all manufacturers and distributors licensed to sell or distribute opioids in New York. Pending resolution of a challenge to the OSA filed by the Healthcare Distribution Alliance (&#x201c;HDA&#x201d;), the Company accrued its estimated OSA surcharges as a $50&#160;million provision in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#x201c;Other accrued liabilities&#x201d; in the Consolidated Balance Sheet as of March 31, 2021. In December 2021, after the HDA challenge was dismissed, the Company paid $26&#160;million for the 2017 OSA surcharge assessment. On May 18, 2022, the Company filed a lawsuit in New York state court challenging the constitutionality of the OSA. In November 2022, the Company received a 2018 OSA surcharge assessment of approximately $42&#160;million, and therefore the Company accrued an additional $18&#160;million provision in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations for the year ended March 31, 2023. On December 14, 2022, the state court ruled that the OSA is constitutional. In December 2022, the Company paid $11&#160;million as the first installment of the 2018 OSA surcharge assessment, and in March 2023, the Company paid another $11&#160;million as the second installment. The Company&#x2019;s OSA challenge is pending before the New York Supreme Court Appellate Division. The Company reserves its rights and intends to vigorously challenge the OSA and the OSA surcharge assessments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;V.&#160;Environmental Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Primarily as a result of the operation of the Company&#x2019;s former chemical businesses, which were fully divested by 1987, the Company is involved in various matters pursuant to environmental laws and regulations. The Company has received claims and demands from governmental agencies relating to investigative and remedial actions purportedly required to address environmental conditions alleged to exist at four sites where it, or entities acquired by it, formerly conducted operations and the Company, by administrative order or otherwise, has agreed to take certain actions at those sites, including soil and groundwater remediation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on a determination by the Company&#x2019;s environmental staff, in consultation with outside environmental specialists and counsel, the current estimate of the Company&#x2019;s probable loss associated with the remediation costs for these four sites is $24&#160;million, net of amounts anticipated from third parties. The $24&#160;million is expected to be paid out between April 2023 and March 2053. The Company has accrued $24&#160;million for the estimated probable loss for these environmental matters in its Consolidated Balance Sheet as of March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been designated as a Potentially Responsible Party (&#x201c;PRP&#x201d;) under the Superfund law for environmental assessment and cleanup costs as the result of its alleged disposal of hazardous substances at 14 sites. With respect to these sites, numerous other PRPs have similarly been designated and while the current state of the law potentially imposes joint and several liabilities upon PRPs, as a practical matter, costs of these sites are typically shared with other PRPs. For one such site, the Company was one of multiple recipients of a New Jersey Department of Environmental Protection directive and a separate U.S. Environmental Protection Agency (&#x201c;EPA&#x201d;) directive concerning natural resources damages to the Passaic River associated with the Company&#x2019;s Newark, New Jersey facility.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2016, the EPA selected a preferred remedy for this Lower Passaic River site with an estimated cost of approximately $1.4 billion. In December 2022, the Company entered into a Consent Decree with the EPA that is currently pending approval by the U.S. District Court for the District of New Jersey and requires the Company to pay $3&#160;million, which had already been accrued for in the Consolidated Balance Sheets based on past estimated probable loss. Accordingly, the Company&#x2019;s estimated probable loss at the remaining 13 sites is approximately $23&#160;million, which has been accrued for in the Consolidated Balance Sheets as of March 31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;VI. Value Added Tax Assessments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in various countries outside the U.S. which collect value added taxes (&#x201c;VAT&#x201d;). The determination of the manner in which a VAT applies to the Company&#x2019;s foreign operations is subject to varying interpretations arising from the complex nature of the tax laws. The Company has received assessments for VAT which are in various stages of appeal. The Company disagrees with these assessments and believes that it has a strong legal argument to defend its tax positions. Certain VAT assessments relate to years covered by an indemnification agreement. Due to the complex nature of the tax laws, it is not possible to estimate the outcome of these matters. However, based on currently available information, the Company believes the ultimate outcome of these matters will not have a material adverse effect on its financial position, cash flows or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;VII.&#160;Antitrust Settlements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Numerous lawsuits have been filed against certain brand pharmaceutical manufacturers alleging that the manufacturer, by itself or in concert with others, took improper actions to delay or prevent generic drugs from entering the market. These lawsuits are typically brought as class actions. The Company has not been named a plaintiff in any of these class action lawsuits, but has been a member of the class of those who purchased directly from the pharmaceutical manufacturers. Some of these class action lawsuits have settled in the past with the Company receiving proceeds, including $129 million, $46&#160;million, and $181&#160;million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively, which were included in &#x201c;Cost of sales&#x201d; in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;VIII. Other Matters &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in various other litigation, governmental proceedings, and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings, or claims, the Company believes, based on current knowledge and the advice of counsel, that such litigation, proceedings, and claims will not have a material impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="i3b2d6726cb4b46f2902ab30560ff644c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NTk3MTkxOQ_551b388d-eb9f-4967-88dc-a85079f86bc2"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <mck:LossContingencyNumberofStates
      contextRef="i3b2d6726cb4b46f2902ab30560ff644c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzQwMDY_2b3e6d70-7745-4dfa-95ab-07566b420330"
      unitRef="state">48</mck:LossContingencyNumberofStates>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="if0f3c705d63d43aaae784ab3543e3e80_D20220401-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzQ3NjM_e2dc1565-3ad0-44c9-8cf2-67a02952053e"
      unitRef="usd">1000000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="if0f3c705d63d43aaae784ab3543e3e80_D20220401-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzQ4MDA_1a5e2454-e61e-44b1-a3b7-0f0491ba7a75"
      unitRef="usd">6800000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment
      contextRef="i3b2d6726cb4b46f2902ab30560ff644c_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzQ4ODQ_90375260-4928-43b5-94ef-9e03b78a136a"
      unitRef="number">0.85</mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment>
    <mck:LossContingencyNumberOfCasesDismissed
      contextRef="i3b2d6726cb4b46f2902ab30560ff644c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE1ODE_372c67b3-722f-48bb-865e-56cbda7a358f"
      unitRef="case">2300</mck:LossContingencyNumberOfCasesDismissed>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i7e87a690a6d84ef49943e4b9a57bf486_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyNDI_97d18bc9-606f-4047-8681-f703c6d81e7f"
      unitRef="usd">42000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i7e87a690a6d84ef49943e4b9a57bf486_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzYzMzY_e3caf258-0f2d-4ead-9863-509921ddf1ca"
      unitRef="usd">132000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencyClaimsSettledNumberOfSubdivisions
      contextRef="if55961281a7144958d26ffefe3ca4b9b_I20220704"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyNjg_15c6dea6-d3ae-4bf9-85b4-990bd3d5641b"
      unitRef="subdivision">2</mck:LossContingencyClaimsSettledNumberOfSubdivisions>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ia95d07e149ed453ca958daff0b5e82b2_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE2MzY_1e82148e-0749-42d3-b14f-3d533720a09e"
      unitRef="usd">152000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementInstallmentPaymentsTerm
      contextRef="ia95d07e149ed453ca958daff0b5e82b2_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyNTQ_556165f8-011f-42fe-8d45-c6c0ed08ca34">P11Y</mck:LossContingencySettlementInstallmentPaymentsTerm>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i129e51149a384d2ca3e97d96fc3cd639_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyNTY_866fe4b2-0365-4070-ad88-ef9f91ab34b8"
      unitRef="usd">38000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i129e51149a384d2ca3e97d96fc3cd639_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyMjg_a117bb18-c70e-46be-9446-2903489d7002"
      unitRef="usd">114000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement
      contextRef="i3b2d6726cb4b46f2902ab30560ff644c_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzOTM_49f0b0fa-6e0b-469b-8633-33887012bd96"
      unitRef="jurisdiction">1</mck:LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ifc24b7896b6c4e3e9686133fcdf77aaf_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg2Mzk_0621ba9c-337f-40e1-908b-93d8637b1dbe"
      unitRef="usd">196000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementInstallmentPaymentsTerm
      contextRef="ifc24b7896b6c4e3e9686133fcdf77aaf_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg2NDc_fa829046-069d-4a0b-a8cf-f3ae21cdb52f">P6Y6M</mck:LossContingencySettlementInstallmentPaymentsTerm>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="ifc24b7896b6c4e3e9686133fcdf77aaf_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAyNzA_b0e58e91-0cc5-4dfc-a4b3-ca41e8fe2713"
      unitRef="usd">56000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i1db22ae3a3cb4da3b2e5eb909147033a_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzcxNDY4MjU2NDM2MjY_94508926-e6fd-4db1-979d-d58f0b480330"
      unitRef="usd">140000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages
      contextRef="i4deb4bb0d31640d6839b768c83fb82d3_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE3MTE_73a4d7bb-f50e-4be0-af2f-9cb97cd8a629"
      unitRef="number">0.85</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzM4MTc1_57516c88-b5f8-4750-8c27-0138ac03a576">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimated accrued liability for the opioid-related claims of U.S. governmental entities, including Native American tribes, was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These amounts, recorded in &#x201c;Other accrued liabilities&#x201d; in the Consolidated Balance Sheets, are the amounts estimated to be paid within the next twelve months following each respective period end date.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="i0140a17cab884d1492bcaa9df5a4d5a3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzEtMS0xLTEtMjE4NzQ4_e98018fd-9471-4230-aae1-ef0cd739962e"
      unitRef="usd">548000000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="i2b22d4f28fe34a62b1126f5d988f8052_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzEtMy0xLTEtMjE4NzQ4_c3cea26f-2b04-4fd6-8f6a-a8209daf1456"
      unitRef="usd">1046000000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="i0140a17cab884d1492bcaa9df5a4d5a3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzItMS0xLTEtMjE4NzQ4_50ecebbf-63fc-495c-bfb6-c38bc1ff12f8"
      unitRef="usd">6625000000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="i2b22d4f28fe34a62b1126f5d988f8052_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzItMy0xLTEtMjE4NzQ4_8b2294ed-95ec-4655-89ae-26fad2756c9a"
      unitRef="usd">7220000000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i0140a17cab884d1492bcaa9df5a4d5a3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzQtMS0xLTEtMjE4NzQ4_1aa07118-d382-413d-addb-0fd0eefb37a4"
      unitRef="usd">7173000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i2b22d4f28fe34a62b1126f5d988f8052_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90YWJsZTpkZGExOGZjMWU5MTc0Y2VkODU2YzViZGRhMTE5ZGQwMC90YWJsZXJhbmdlOmRkYTE4ZmMxZTkxNzRjZWQ4NTZjNWJkZGExMTlkZDAwXzQtMy0xLTEtMjE4NzQ4_8bd580bd-d7c7-4716-b44a-45aba7a2e764"
      unitRef="usd">8266000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i634cecdea7c5420991fa07409e24bae9_D20220401-20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjAxMTIyOA_76bf43a4-0a25-4b40-abce-a4ddbf9c9fa9"
      unitRef="usd">1100000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i480f6acdd20745c3951ffb01a8a1f2fd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjAxMTI2OQ_ee72655a-e13c-428a-a155-4af403d5802f"
      unitRef="usd">74000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="ia186f3731bcd4bec9362d4010651c39a_D20230724-20230724"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjIxOTE_2a15d4ea-147f-42d8-bc3d-8cfb024e67d9"
      unitRef="plaintiff">8</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7ba50f0dfc7944c88deff9f8478101c4_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzEyMDg2_70f9a429-df5d-425c-90ad-6ed2c7e10c3b"
      unitRef="case">4</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i3930fd7ff02f439e9ab59431524b3678_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzEyMTU2_4cb92e7a-5b79-4b92-acb9-3faca7f7239d"
      unitRef="case">1</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal
      contextRef="i88153d2f52214fe0a9768ef8344eaabd_D20190225-20190225"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE0MDUz_3c689113-c34f-49b1-b6f9-b717a6f9514a">P90D</mck:LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i88a1d24ff9dc4dde993d7cc58d70cee1_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE0Mzc3_b98023a6-101f-4132-8816-2f2cfbb543f8"
      unitRef="complaint">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofRelators
      contextRef="i33396fbf2486428a890309fa325b4aaa_D20191201-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE0NDE3_64123a88-304d-47e0-b996-fdead9c6585a"
      unitRef="relator">2</mck:LossContingencyNumberofRelators>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i76d4bda7231445d895623496e61e3afe_I20201023"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE1MzU5_d2895edf-d253-4bcc-9292-b6c2ad0217cf"
      unitRef="case">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyInsufficientCoverageNumberOfInsurancePolicies
      contextRef="i8fe1c6d47bac41768956c525d9da297c_I20220405"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjIyMDE_c39fbd5a-b0b4-487d-bf11-5a19f2c37715"
      unitRef="policy">2</mck:LossContingencyInsufficientCoverageNumberOfInsurancePolicies>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="if37f55f8d74d4f7e856241b5044f79a1_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE3MjU4_eea136d9-148f-4410-9ebb-3f858aac1023"
      unitRef="usd">500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyDamagesSoughtPerViolationValue
      contextRef="ifa4d87725ecc4620b0b0c4339cac0d54_D20130517-20130517"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE3MjY0_b404470c-c812-4478-b433-45645dacc6c2"
      unitRef="usd">1500</mck:LossContingencyDamagesSoughtPerViolationValue>
    <mck:LossContingencyClassActionNumberofFaxesRemainingintheClass
      contextRef="i590634e41f954ae590139d3aba0164cd_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE3NzY3_03a642dd-4386-459b-ba3d-7389e715320c"
      unitRef="faxnumber">9490</mck:LossContingencyClassActionNumberofFaxesRemainingintheClass>
    <mck:LossContingencyClassActionNumberofFaxesReceived
      contextRef="i590634e41f954ae590139d3aba0164cd_I20190813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE3ODE2_44fb3b72-fa23-4e4f-8c25-4f9b16568a10"
      unitRef="fax">48769</mck:LossContingencyClassActionNumberofFaxesReceived>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="icf72768e9e58489a9cfe3dcada7cea25_D20211008-20211008"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNzQwODE_37dabf64-116b-4f05-8f9f-bf02af2dc36b"
      unitRef="plaintiff">2</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i604155abded247ec9c473e57fc99aa9b_D20220427-20220427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE4MzAx_fd65507a-32be-4481-b873-8d1ef94ac972"
      unitRef="usd">6500</us-gaap:LossContingencyDamagesAwardedValue>
    <mck:LossContingencyNumberOfRelators
      contextRef="ic6909fc49de54c13a5acf0f3f0cd933d_D20130416-20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE4NTEy_8b38c511-a7b9-4c4b-bd78-13be0e3cf15e"
      unitRef="relator">2</mck:LossContingencyNumberOfRelators>
    <mck:LossContingencyNumberOfStatesFiledOnBehalfOf
      contextRef="i24b5bf7bd68d425d9982f2b10d0f20f4_I20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE4NTY5_82a05f52-b2ce-4446-b80e-199631674b8f"
      unitRef="state">21</mck:LossContingencyNumberOfStatesFiledOnBehalfOf>
    <mck:LossContingencyNumberOfAdditionalDefendants
      contextRef="ic6909fc49de54c13a5acf0f3f0cd933d_D20130416-20130416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzE4NjI2_aad8f446-e1ac-48b6-b302-544e87bce1cf"
      unitRef="defendant">5</mck:LossContingencyNumberOfAdditionalDefendants>
    <mck:LossContingencyNumberOfCitiesFiledOnBehalfOf
      contextRef="i2f35dd91b0344cb6ba1c6fc2ce024afc_I20180425"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNzQwNzg_f9449915-8c3c-4ea7-a1b6-faa31951b576"
      unitRef="city">33</mck:LossContingencyNumberOfCitiesFiledOnBehalfOf>
    <mck:LossContingencyNumberOfCitiesFiledOnBehalfOf
      contextRef="i057d846c99e24512ad9cb275e0ad3de8_I20200302"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNzQwOTA_e9d73c7d-dd7f-4ad0-b412-6d02576e4f0e"
      unitRef="city">33</mck:LossContingencyNumberOfCitiesFiledOnBehalfOf>
    <mck:LossContingencyNumberofFormerOfficers
      contextRef="iddc589cd657a4746a04bdd0a051ab071_I20181212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI0Nzg2_ae5eff53-ce00-4b3c-843f-3cf585110ca5"
      unitRef="officer">2</mck:LossContingencyNumberofFormerOfficers>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i3b893491327d4a5081fd775de27171a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0MTI_267486ff-5ee8-4175-9b17-819dcca06fe4"
      unitRef="usd">141000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:EstimatedInsuranceRecoveries
      contextRef="i3b893491327d4a5081fd775de27171a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0MTI_38570e68-4477-42f2-9eba-5f518bc84243"
      unitRef="usd">141000000</us-gaap:EstimatedInsuranceRecoveries>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i3b893491327d4a5081fd775de27171a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0MjY_0aa41d2e-fcb0-4bf9-88b9-23bbe2435539"
      unitRef="usd">141000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:EstimatedInsuranceRecoveries
      contextRef="i3b893491327d4a5081fd775de27171a8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0MjY_5d5319ce-5600-4998-96ab-61af7c53ea63"
      unitRef="usd">141000000</us-gaap:EstimatedInsuranceRecoveries>
    <mck:LossContingencyNumberOfStatesFiledOnBehalfOf
      contextRef="i23f831232dbf484481fae3a05bce6513_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI4MDM2_30388ce5-f2f5-40ac-b9c9-5cd14eb374b3"
      unitRef="state">27</mck:LossContingencyNumberOfStatesFiledOnBehalfOf>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ia91da99152ad44428ddb96bcf738d999_I20170531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI5NzE3_3e1c4f45-d2e3-4728-985b-bcd834802b4b"
      unitRef="case">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i9fa7ddfc765f423794371f1af3723e4f_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI5NzE3_855cca28-be6c-4f83-b91f-3c69614767ab"
      unitRef="case">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:NumberofSoftwareProducts
      contextRef="i9fa7ddfc765f423794371f1af3723e4f_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI5ODc5_0aa091a2-1cdb-42f4-b285-f4f13bd4cb4c"
      unitRef="softwareproduct">2</mck:NumberofSoftwareProducts>
    <mck:NumberofSoftwareProducts
      contextRef="ia91da99152ad44428ddb96bcf738d999_I20170531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzI5ODc5_6b48a21f-fd16-4a8b-ae0b-47248239452f"
      unitRef="softwareproduct">2</mck:NumberofSoftwareProducts>
    <mck:OpioidStewardshipActNewYorkAnnualSurcharge
      contextRef="icf0b205ff8cb4fe6bbf197d316b47f43_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzMxODk1_0955e2ec-37eb-4a02-8eb8-e74feefca9a1"
      unitRef="usd">100000000</mck:OpioidStewardshipActNewYorkAnnualSurcharge>
    <mck:OpioidStewardshipActNewYorkAnnualSurcharge
      contextRef="i20873e9ecf6d4345bd56d1540cbbe862_I20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzMxODk1_c49705ba-4d0e-4369-9299-b1b62ff779b2"
      unitRef="usd">100000000</mck:OpioidStewardshipActNewYorkAnnualSurcharge>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="id1aa84dc10f44e2ea8914b72f7921ce2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzMyNzAx_58667d5e-6558-46ab-998e-051e24f5a8e1"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i7dea821e32924b6585e37a6e0736d3bc_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE3MTY_9921cce0-0d94-49c9-99a9-44bc9879f198"
      unitRef="usd">26000000</us-gaap:LossContingencyAccrualPayments>
    <mck:OpioidStewardshipActNewYorkAnnualSurcharge
      contextRef="ibee4b1dcd2594498a8e665ad78a26929_I20221130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE3Mjk_88059a1a-2aff-4d19-9acb-22a9988bc938"
      unitRef="usd">42000000</mck:OpioidStewardshipActNewYorkAnnualSurcharge>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i9b320ce88af7493b8137e9d513e29859_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE3NDI_c653cbb2-2573-42f0-8844-d946d1919988"
      unitRef="usd">18000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i7989fb6981db44d6a082cf3c02a024b6_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMyNTE3NTU_b385038f-4eea-4104-a5e5-07c1bb0dbe9c"
      unitRef="usd">11000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i7403b5a9a1b84b5cb7c8a882d6a51fd2_D20230301-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0NDA_d1d3aa8b-6498-49a8-ae4a-e100f973a63d"
      unitRef="usd">11000000</us-gaap:LossContingencyAccrualPayments>
    <mck:EnvironmentalLossContingencyAgreedRemediationNumberOfSites
      contextRef="idc03527a8d334d539c474fe9c3791d14_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzODQ_5008dc56-1c73-4cc0-afbb-9c1404341ac2"
      unitRef="site">4</mck:EnvironmentalLossContingencyAgreedRemediationNumberOfSites>
    <mck:EnvironmentalLossContingencyAgreedRemediationNumberOfSites
      contextRef="idc03527a8d334d539c474fe9c3791d14_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzNjA_ae1037ac-380a-463d-8ad0-3506308bb0d0"
      unitRef="site">4</mck:EnvironmentalLossContingencyAgreedRemediationNumberOfSites>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i9db2aeb8a3924ed5bd9d03fb72c6cd8d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzNDg_cf11d824-bdc3-42f8-b56c-90b2973c668f"
      unitRef="usd">24000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i9db2aeb8a3924ed5bd9d03fb72c6cd8d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzMDM_af947080-c551-439f-9113-663c0af94684"
      unitRef="usd">24000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i9db2aeb8a3924ed5bd9d03fb72c6cd8d_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzMTY_e88e8d64-4ad4-4783-89de-4b175ca023e7"
      unitRef="usd">24000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <mck:EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjIyMTA_a8c4c602-98b3-499d-a7a2-ee7af8805ca7">Consolidated Balance Sheet</mck:EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag>
    <mck:HazardousSubstanceSites
      contextRef="iddb1a3b6365b4643bd368941bb1a62c9_D20160301-20160331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzM1MjAw_3676f36b-064e-4cd3-a033-4d1af6e7638f"
      unitRef="site">14</mck:HazardousSubstanceSites>
    <mck:HazardousSubstanceSitesRecipientOfDirectives
      contextRef="iddb1a3b6365b4643bd368941bb1a62c9_D20160301-20160331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjA0MDI_e5913c0e-1a1f-4c47-af88-fa82e8b09ddb"
      unitRef="site">1</mck:HazardousSubstanceSitesRecipientOfDirectives>
    <mck:EstimatedEnvironmentalAssessmentAndCleanupCosts
      contextRef="iddb1a3b6365b4643bd368941bb1a62c9_D20160301-20160331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzM1NjE2_03196b19-5d6c-4c4d-8246-6bc9f3880343"
      unitRef="usd">1400000000</mck:EstimatedEnvironmentalAssessmentAndCleanupCosts>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i219f752cc9d64079a2574ee8f7108652_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjAxMzE3Ng_87baa105-f501-4f7a-92cf-c47994d318c3"
      unitRef="usd">3000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <mck:HazardousSubstanceSitesRecipientOfDirectives
      contextRef="ia153892cce85447fb85d9233bdf56fff_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzNDQ_04ac47cb-e991-4de0-ade0-31fd511f0398"
      unitRef="site">13</mck:HazardousSubstanceSitesRecipientOfDirectives>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i2c415789acee4283a6ed5420c5137fc9_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4Xzg3OTYwOTMzNjAzMzA_fcfc62a1-b79d-47ca-9910-c37505c9574d"
      unitRef="usd">23000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjA0MzA5NA_7145bd41-57ff-425d-8568-cafad874ee2f"
      unitRef="usd">129000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjA0MzEwMA_afdb7aba-91ed-40a7-9b0a-b1c9cfc0f00f"
      unitRef="usd">46000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzIvZnJhZzoyMjAyYzU1YjZlMTc0NWY4OTFjYTk0MTlmMTU3ZGVjOC90ZXh0cmVnaW9uOjIyMDJjNTViNmUxNzQ1Zjg5MWNhOTQxOWYxNTdkZWM4XzU0OTc1NjA0MzEwOQ_2b79bcfd-6673-4f47-a445-81e89d6de041"
      unitRef="usd">181000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzUyMzg_d4489b7a-6bf8-439a-b59a-7136810fa0e2">Stockholders' Equity (Deficit) &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of the Company&#x2019;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to participate equally in any dividends declared by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2022, the Company&#x2019;s quarterly dividend was raised from $0.47 to $0.54 per common share for dividends declared on or after such date by the Board. The Company declared regular cash dividends of $2.09, $1.83, and $1.67 per share for the years ended March 31, 2023, 2022, and 2021, respectively. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company&#x2019;s future earnings, financial condition, capital requirements, and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Board has authorized the repurchase of McKesson&#x2019;s common stock. Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#x201c;ASR&#x201d;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#x2019;s stock price, corporate and regulatory requirements, tax implications, restrictions under the Company&#x2019;s debt obligations, and other market and economic conditions. During the last three fiscal years, the Company&#x2019;s share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions. The ASR programs discussed below were designed to comply with Rule 10b5-1(c).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding share repurchase activity over the last three fiscal years were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Share Repurchases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except price per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchased &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average Price &lt;br/&gt;Paid Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Approximate &lt;br/&gt;Dollar Value of &lt;br/&gt;Shares that May &lt;br/&gt;Yet Be Purchased &lt;br/&gt;Under the &lt;br/&gt;Programs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase authorization increase in fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - May 2021 ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase authorization increase in fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - February 2022 ASR &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - February 2022 ASR &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - May 2022 ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase authorization increase in fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - December 2022 ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of shares purchased reflects rounding adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Of the total dollar value, $8&#160;million was accrued within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheet as of March 31, 2021, included in the Company&#x2019;s Annual Report on Form 10-K for the year ended March 31, 2022,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;for share repurchases that were executed in late March 2021 and settled in early April 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#x2019;s common stock. The total number of shares repurchased under this ASR program was 5.1&#160;million shares at an average price per share of $295.16. The Company received 4.8&#160;million shares as the initial share settlement in the fourth quarter of fiscal 2022 based on an initial share purchase price, and in May 2022, it received an additional 0.3&#160;million shares upon the completion of this ASR program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Of the total dollar value, $27 million was accrued within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheet as of March 31, 2023 for share repurchases that were executed in late March 2023 and settled in early April 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s accumulated other comprehensive loss by component were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.419%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow and Other Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling&lt;br/&gt;shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts before reclassifications recorded in fiscal 2023, fiscal 2022, and fiscal 2021 include gains (losses) of $7&#160;million, $73&#160;million, and $(118)&#160;million, respectively, related to net investment hedges from Euro-denominated notes and gains (losses) of $28&#160;million, $(4)&#160;million, and $(119)&#160;million, respectively, related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit (expense) of $(33)&#160;million, $(23)&#160;million, and $62&#160;million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures&#x201d; and Financial Note 5, &#x201c;Other Income, Net.&#x201d; These amounts were included in the fiscal 2021 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the sale of the Company&#x2019;s Austrian business, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the divestitures of the E.U. disposal group in October 2022, including the impact of amounts previously attributed to the noncontrolling interest in McKesson Europe, and the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included in the fiscal 2023 and fiscal 2022 calculations of charges to remeasure the assets and liabilities of the disposal groups to fair value less costs to sell recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations. Amounts reclassified to earnings and other includes a net income tax impact of $6&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <mck:CommonStockVotingRightsNumberofVotesPerCommonShare
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0Xzc5_23b03a88-24b4-4984-b2c8-98d99e50a043"
      unitRef="vote">1</mck:CommonStockVotingRightsNumberofVotesPerCommonShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i71dc2fb8cd8f4fab8df832f11c64c6e4_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzI1Mw_17a4f875-4550-404b-bb43-342352f491e8"
      unitRef="usdPerShare">0.47</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="idf21b957ae1643249d6ecd39408dd77d_D20220701-20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzI1OQ_5f2b94de-11c8-4d2a-9511-3dd9e25dbf4a"
      unitRef="usdPerShare">0.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzM1Mw_7dc11172-0710-4406-b02c-a917c9bc80a2"
      unitRef="usdPerShare">2.09</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzM3Mw_548196c8-c5e1-4fd1-ae10-c48d308b4901"
      unitRef="usdPerShare">1.83</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzUvZnJhZzoyOGRjYTExNDM0ZTk0YjAzODM4Y2M1YWVjNDQ1YmJmNC90ZXh0cmVnaW9uOjI4ZGNhMTE0MzRlOTRiMDM4MzhjYzVhZWM0NDViYmY0XzM5Nw_4881de47-8beb-4b30-b3ea-eef5b2d5cdfe"
      unitRef="usdPerShare">1.67</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:AcceleratedShareRepurchasesTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV80NTM0_1dda83c3-581d-429a-80c2-279754ea85ed">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding share repurchase activity over the last three fiscal years were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Share Repurchases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except price per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchased &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average Price &lt;br/&gt;Paid Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Approximate &lt;br/&gt;Dollar Value of &lt;br/&gt;Shares that May &lt;br/&gt;Yet Be Purchased &lt;br/&gt;Under the &lt;br/&gt;Programs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase authorization increase in fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - May 2021 ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase authorization increase in fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - February 2022 ASR &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - February 2022 ASR &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - May 2022 ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase authorization increase in fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - December 2022 ASR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased - Open market &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The number of shares purchased reflects rounding adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Of the total dollar value, $8&#160;million was accrued within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheet as of March 31, 2021, included in the Company&#x2019;s Annual Report on Form 10-K for the year ended March 31, 2022,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;for share repurchases that were executed in late March 2021 and settled in early April 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5&#160;billion of the Company&#x2019;s common stock. The total number of shares repurchased under this ASR program was 5.1&#160;million shares at an average price per share of $295.16. The Company received 4.8&#160;million shares as the initial share settlement in the fourth quarter of fiscal 2022 based on an initial share purchase price, and in May 2022, it received an additional 0.3&#160;million shares upon the completion of this ASR program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;padding-right:9pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Of the total dollar value, $27 million was accrued within &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Consolidated Balance Sheet as of March 31, 2023 for share repurchases that were executed in late March 2023 and settled in early April 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:AcceleratedShareRepurchasesTextBlock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i56ca92db1bf347039646a68953e87fed_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18yLTYtMS0xLTIyMjc4Nw_e5f0d458-7206-4169-8667-611ae468e54e"
      unitRef="usd">1535000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18zLTYtMS0xLTIyMjc4Nw_b0be8a57-5d5d-4d8a-98db-7ce099c220f2"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ic9446f02c71545a69aa3169ca6418b21_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY180LTItMS0xLTIyMjc4Nw_84a8596c-3ef8-481e-aba1-55bb56dbee80"
      unitRef="shares">4700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ic9446f02c71545a69aa3169ca6418b21_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY180LTQtMS0xLTIyMjc4Nw_5ba22329-320c-4eac-8257-e8883b27365b"
      unitRef="usdPerShare">160.33</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic9446f02c71545a69aa3169ca6418b21_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY180LTYtMS0xLTIyMjc4Nw_184598aa-e272-4066-a195-49ca4df74f58"
      unitRef="usd">750000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY181LTYtMS0xLTIyMjc4Nw_32741208-cd27-40e9-a954-f6f6e642586b"
      unitRef="usd">2785000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i3376bdc454704e8a84932b1b7dd33e89_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY182LTItMS0xLTIzNDMxNw_5e7c7ce9-13bc-4313-b85e-99d7b333e80d"
      unitRef="shares">5200000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i3376bdc454704e8a84932b1b7dd33e89_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY182LTQtMS0xLTIzNDMyMQ_ad77a244-92b9-46a8-b3c9-2d71a31bc157"
      unitRef="usdPerShare">193.22</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i3376bdc454704e8a84932b1b7dd33e89_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY182LTYtMS0xLTIyMjc4Nw_6c6cbd3b-12ef-4afa-8082-c887753be7e8"
      unitRef="usd">1000000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i9218dd12bc66496ba1bcdebfe2a9ca2b_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY183LTItMS0xLTIyMjc4Nw_8005cd3e-b048-4984-92f4-a433dd567202"
      unitRef="shares">4600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i9218dd12bc66496ba1bcdebfe2a9ca2b_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY183LTQtMS0xLTIyMjc4Nw_044ad54b-4968-4a9b-baed-63ae3def96ff"
      unitRef="usdPerShare">217.73</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9218dd12bc66496ba1bcdebfe2a9ca2b_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY183LTYtMS0xLTIyMjc4Nw_1cfc7f96-c535-446f-8dc3-99d47080c9ab"
      unitRef="usd">1007000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY184LTYtMS0xLTIyNDUyOA_c2b79a7c-66f9-4ff5-b9ba-abd6a74cc2bc"
      unitRef="usd">4000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i9cde46cdcba64ab9acfd06498904f049_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTItMS0xLTIyNDUxNA_8fd6debb-2c7d-4a9e-84df-a73f1e186da0"
      unitRef="shares">4800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i9cde46cdcba64ab9acfd06498904f049_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTQtMS0xLTIyNDUxNA_35790583-cb55-42c7-948f-d21fb4c62d6a"
      unitRef="usdPerShare">265.56</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9cde46cdcba64ab9acfd06498904f049_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTYtMS0xLTIyNDUyOA_de9c2216-967d-497d-a24c-965eec1dc21e"
      unitRef="usd">1500000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY184LTYtMS0xLTIyMjc4Nw_178dfb1a-457a-4956-accb-e4c40624f8da"
      unitRef="usd">3278000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i20292928a6df4630869820c5c913bbdb_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMS0yLTEtMS0yMzYyMDY_9e01b99c-bab5-412d-9048-a1498a307ccb"
      unitRef="shares">300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i20292928a6df4630869820c5c913bbdb_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMS00LTEtMS0yMzYyMDY_4e6de2e8-ab9e-488a-a54c-94ba230b55ea"
      unitRef="usdPerShare">295.16</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i20292928a6df4630869820c5c913bbdb_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMS02LTEtMS0yMzYyMDY_2f7e75c7-b396-480d-a2d6-389026a1a34b"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i45ac0ae0f55f4a1db80ab683ab3f7655_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTItMS0xLTIyMjc4Nw_281ae973-5bed-4a70-bac8-277511c5ccac"
      unitRef="shares">3100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i45ac0ae0f55f4a1db80ab683ab3f7655_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTQtMS0xLTIyMjc4Nw_d3e50e5d-d125-474e-975f-a2c8f02568bc"
      unitRef="usdPerShare">321.05</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i45ac0ae0f55f4a1db80ab683ab3f7655_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY185LTYtMS0xLTIyMjc4Nw_10b80101-772b-441a-9762-45ebad8e5854"
      unitRef="usd">1000000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMS02LTEtMS0yMjI3ODc_0c5f7965-692c-4068-85e3-42cd492a4dd1"
      unitRef="usd">4000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i96f090a3fbc74514b59f02f20a563b79_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMi0yLTEtMS0yMjI3ODc_d50d40cf-cb21-48c0-a084-06874624e23f"
      unitRef="shares">2600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i96f090a3fbc74514b59f02f20a563b79_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMi00LTEtMS0yMjI3ODc_19ff9bdf-efbe-4796-94bb-3b196f3bc6db"
      unitRef="usdPerShare">369.20</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i96f090a3fbc74514b59f02f20a563b79_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMi02LTEtMS0yMjI3ODc_a154f659-969a-4428-9a1a-389071855bf7"
      unitRef="usd">972000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i32ef665f7e9f47f8a52f2b7ccd1c1642_D20220401-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xNi0yLTEtMS0yMzYyMTA_2f735ec1-58a3-459a-81d5-e67198b1a160"
      unitRef="shares">4700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i32ef665f7e9f47f8a52f2b7ccd1c1642_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xNi00LTEtMS0yMzYyMTA_ffff8665-c582-4b68-9ed5-44482717f16d"
      unitRef="usdPerShare">363.24</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i32ef665f7e9f47f8a52f2b7ccd1c1642_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xNi02LTEtMS0yMzYyMTA_7a230aa0-8298-4f7e-9a56-b0383b54e234"
      unitRef="usd">1693000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGFibGU6NzFmZjMyZDk3OGEwNDM5YmI5ZDlmMTA3OTQ3ODFiZWMvdGFibGVyYW5nZTo3MWZmMzJkOTc4YTA0MzliYjlkOWYxMDc5NDc4MWJlY18xMy02LTEtMS0yMjI3ODc_9fc9735d-f3db-40fc-a614-6d4feb4bc149"
      unitRef="usd">3613000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <mck:AccruedShareRepurchases
      contextRef="i62b31f8221c34827bfa4b4c4223aef53_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV8xMjU5_6cea931d-3516-415a-9141-df2e8bb8a06b"
      unitRef="usd">8000000</mck:AccruedShareRepurchases>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if81af84863b849ee84346934e78dd3d1_D20220201-20220228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV84Nzk2MDkzMDMxMzg3_f6ffe804-2907-45db-bc3a-46bf9ba5ba0c"
      unitRef="usd">1500000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i4b81b5ce8e3946c486bacd3228a6502d_D20220201-20220228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV84Nzk2MDkzMDMxMTU0_942134b8-9f6e-4ab5-967d-8deecc3dc023"
      unitRef="shares">5100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i4b81b5ce8e3946c486bacd3228a6502d_D20220201-20220228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV84Nzk2MDkzMDMxMTgw_1a90c2d6-9d6a-43aa-9504-78bc84071ee7"
      unitRef="usdPerShare">295.16</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i609db64ab4224f9ab5523d7c2bb0d613_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV84Nzk2MDkzMDMxMTY3_74d8600d-53a0-4020-bee7-551043af4efe"
      unitRef="shares">4800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id1c0f65c88014f1ca2d67069e57a5ee6_D20220501-20220531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV84Nzk2MDkzMDMxMTg5_88ed9204-aab1-409c-83de-6eba12d55a3b"
      unitRef="shares">300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i831c04a5da8247afbc87577d86b34cfe_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNDg0L2ZyYWc6NGM2NjBlN2VmNjdhNDkxYWJlMmI0NzhjZTZhZDkzNTkvdGV4dHJlZ2lvbjo0YzY2MGU3ZWY2N2E0OTFhYmUyYjQ3OGNlNmFkOTM1OV8xNjQ5MjY3NDUwMzk5_1df5136d-e077-4993-a1f5-810ab3261b79"
      unitRef="usd">27000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl8xODAz_0ab6f428-18cf-47de-b15f-4114da445dae">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s accumulated other comprehensive loss by component were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.419%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net of Tax &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow and Other Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling&lt;br/&gt;shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(847)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily results from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s operations in Europe and Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts before reclassifications recorded in fiscal 2023, fiscal 2022, and fiscal 2021 include gains (losses) of $7&#160;million, $73&#160;million, and $(118)&#160;million, respectively, related to net investment hedges from Euro-denominated notes and gains (losses) of $28&#160;million, $(4)&#160;million, and $(119)&#160;million, respectively, related to net investment hedges from cross-currency swaps. These amounts are net of income tax benefit (expense) of $(33)&#160;million, $(23)&#160;million, and $62&#160;million in fiscal 2023, fiscal 2022, and fiscal 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the contribution of the Company&#x2019;s German pharmaceutical wholesale business to a joint venture, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures&#x201d; and Financial Note 5, &#x201c;Other Income, Net.&#x201d; These amounts were included in the fiscal 2021 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the sale of the Company&#x2019;s Austrian business, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included in the fiscal 2022 calculation of charges to remeasure the assets and liabilities held for sale to fair value less costs to sell recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily includes adjustments for amounts related to the divestitures of the E.U. disposal group in October 2022, including the impact of amounts previously attributed to the noncontrolling interest in McKesson Europe, and the U.K. disposal group in April 2022, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures.&#x201d; These amounts were included in the fiscal 2023 and fiscal 2022 calculations of charges to remeasure the assets and liabilities of the disposal groups to fair value less costs to sell recorded within &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statements of Operations. Amounts reclassified to earnings and other includes a net income tax impact of $6&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i606c3a6a2202458da025615d9b410a00_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yLTEtMS0xLTIyMjgwNg_0a2fad01-4ff5-47f7-860f-be697bf0cf5b"
      unitRef="usd">-1780000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i074564bccb7c4a93a2b47e7194a97423_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yLTMtMS0xLTIyMjgwNg_b9578c81-68b4-4ddf-9294-d4b9f38ba49c"
      unitRef="usd">138000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8a12d8177d3a4bca8f20394c549b2ba4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yLTUtMS0xLTIyMjgwNg_6f1e9ed3-c9e4-4dfe-b242-3220ca076aff"
      unitRef="usd">49000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia24155bbe2b64b13a5839bc953e73126_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yLTctMS0xLTIyMjgwNg_56ca6ca1-5d07-499a-9198-53549a88d92a"
      unitRef="usd">-110000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia06fe5f5c08242e7988383eb561e7daf_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yLTktMS0xLTIyMjgwNg_2551b108-718f-40b7-8118-5363f7f99eaa"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18zLTEtMS0xLTIyMjgwNg_ed91af41-8f46-4086-870e-54d7579e1327"
      unitRef="usd">312000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18zLTMtMS0xLTIyMjgwNg_61964087-2056-467f-83ee-d7865a535521"
      unitRef="usd">-175000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18zLTUtMS0xLTIyMjgwNg_ca06b039-58cf-4694-829c-fb3834a9aa93"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18zLTctMS0xLTIyMjgwNg_7b7c8afa-1885-4895-a8b0-222445d20213"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18zLTktMS0xLTIyMjgwNg_7a40d41f-aff9-4088-ba5e-590ffc70ec85"
      unitRef="usd">99000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM180LTEtMS0xLTIyMjgwNg_1c5443cb-622c-4fde-bdfe-4844ba4b8165"
      unitRef="usd">-47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM180LTMtMS0xLTIyMjgwNg_1b99a2b3-554d-44e7-ab91-ee6c7411e0c3"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM180LTUtMS0xLTIyMjgwNg_f34153d7-2333-4b86-9fa9-b8b8fc38cbd5"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM180LTctMS0xLTIyMjgwNg_5711a0a0-35d3-4ae8-b93e-0970afd378f1"
      unitRef="usd">-24000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM180LTktMS0xLTIyMjgwNg_b1ac0d5f-9709-4866-b0c5-039a04995c93"
      unitRef="usd">-71000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM181LTEtMS0xLTIyMjgwNg_d5bbb26b-f868-4899-8323-c456261ec237"
      unitRef="usd">359000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM181LTMtMS0xLTIyMjgwNg_90d04605-2cc7-400b-a746-eb52728350e9"
      unitRef="usd">-175000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM181LTUtMS0xLTIyMjgwNg_15538e0b-b939-42d3-8832-c3136bc9e14f"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM181LTctMS0xLTIyMjgwNg_76d409dd-8e59-4765-998c-9eb768bd2c39"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM181LTktMS0xLTIyMjgwNg_955a6097-e525-4067-8911-e824c1420d33"
      unitRef="usd">170000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM182LTEtMS0xLTIyMjgwNg_adb42812-dc5d-43bc-87f8-6effd6ca5b2f"
      unitRef="usd">-60000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM182LTMtMS0xLTIyMjgwNg_98209968-e688-43c1-9646-63a3408e6eb5"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM182LTUtMS0xLTIyMjgwNg_01a56520-dd3e-42cb-aba1-ce9497bf34f2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM182LTctMS0xLTIyMjgwNg_2fc67287-b06b-4ace-9245-e516402abc8f"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM182LTktMS0xLTIyMjgwNg_2fc43944-5351-4908-8640-cad1f8ca57d4"
      unitRef="usd">-53000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia95e60fc042e4ccf882a47f06cd90ac2_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM183LTEtMS0xLTIyMjgwNg_4e6b04d0-7386-4e17-810b-f9ebc9ef5638"
      unitRef="usd">419000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM183LTMtMS0xLTIyMjgwNg_69cc76f5-973a-49e7-ac7e-516a3e21115d"
      unitRef="usd">-174000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i004200dc35774145a24e67c9aa0d7d7c_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM183LTUtMS0xLTIyMjgwNg_1f2b0c25-61d2-4ec6-94b9-90c26dd54a5a"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8012e531211c45a4a7c61287c1ea69f1_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM183LTctMS0xLTIyMjgwNg_fff319dc-335a-4f96-a8f3-6723ad151451"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i33e8532d25b4408d9df12f488888cc91_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM183LTktMS0xLTIyMjgwNg_aeb5a083-7809-4ff2-9320-146dbc21ef92"
      unitRef="usd">223000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i541d58c4043e481c86a354b16272d39f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM184LTEtMS0xLTIyMjgwNg_9d888582-20f9-45e4-bade-8b60aa5eb46d"
      unitRef="usd">-1361000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief34de8c02864055a306f0805902d830_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM184LTMtMS0xLTIyMjgwNg_b62936f8-2767-4565-a34b-e57a67666f61"
      unitRef="usd">-36000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2ab34673c6cd4865a1526b689d28d9e5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM184LTUtMS0xLTIyMjgwNg_6f9005b6-2d44-479d-b767-cbb2b97293b0"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4de62b174ea943d98bbc5ea010c68a3b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM184LTctMS0xLTIyMjgwNg_9391e79b-9ef1-4687-9f00-d9b7a6d972ce"
      unitRef="usd">-96000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idebabd22268d4aa5be5fdcb7615dcb80_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM184LTktMS0xLTIyMjgwNg_492afa5a-4a0f-4fa0-b01e-da9e96d0634b"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ica7e852a88784746894a205a0250f9e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM185LTEtMS0xLTIyMjgwNg_c6a920ff-64b1-45aa-b163-f10401b384b7"
      unitRef="usd">-51000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM185LTMtMS0xLTIyMjgwNg_d7927d33-da48-418d-bfed-1a84473af835"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM185LTUtMS0xLTIyMjgwNg_346de2cc-9853-425f-a00d-08ea05c3feba"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM185LTctMS0xLTIyMjgwNg_ad36dbde-febb-41a9-97a0-192d97a70e8e"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM185LTktMS0xLTIyMjgwNg_962e5348-f103-43de-aa10-f4848a41df4a"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ica7e852a88784746894a205a0250f9e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMC0xLTEtMS0yMjI4MDY_9d72ce7b-62cc-4c57-baac-263cd88c1be3"
      unitRef="usd">-71000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMC0zLTEtMS0yMjI4MDY_fe830a62-27f8-4390-b253-8adcecab1805"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMC01LTEtMS0yMjI4MDY_f52d221a-659a-47c2-9326-2095732e6796"
      unitRef="usd">4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMC03LTEtMS0yMjI4MDY_6b9e4bfc-14a6-467f-b9c4-3a0a061b7c6a"
      unitRef="usd">-10000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMC05LTEtMS0yMjI4MDY_901a73f7-26df-43ac-9459-152015d27f7e"
      unitRef="usd">-76000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ica7e852a88784746894a205a0250f9e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMS0xLTEtMS0yMjI4MDY_ad6fb346-7e2a-4e5c-a741-fe9cd7cdd9bf"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMS0zLTEtMS0yMjI4MDY_30efa56e-f651-4401-a63b-ad6c24acc600"
      unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMS01LTEtMS0yMjI4MDY_5b5fde1f-7de7-4690-bfd1-42f65cc0de6b"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMS03LTEtMS0yMjI4MDY_b47af9e0-931c-40c6-92da-12c2f96fcc01"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMS05LTEtMS0yMjI4MDY_0e3a1963-3e73-4131-ad89-8612d208f6b0"
      unitRef="usd">115000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ica7e852a88784746894a205a0250f9e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMi0xLTEtMS0yMjI4MDY_ed71dc2c-c1bf-4bbb-a8e3-d7bfc9423f00"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMi0zLTEtMS0yMjI4MDY_6574715d-3e11-40dd-9aab-c62a66cc2619"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMi01LTEtMS0yMjI4MDY_9616e35e-3169-4751-bdef-791473d10308"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMi03LTEtMS0yMjI4MDY_d38b1d05-4f42-4dd1-828c-732a2190ecb0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMi05LTEtMS0yMjI4MDY_27daae3d-eb9e-4e3d-b0d1-5b79c369b2c2"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ica7e852a88784746894a205a0250f9e2_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMy0xLTEtMS0yMjI4MDY_e7b214b8-1541-4ffa-b45e-9a29c3028816"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMy0zLTEtMS0yMjI4MDY_114cbd2e-bb88-4c94-87b0-3d29d800ec45"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ife0d5391f6a34c348cc06c3c76d0321f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMy01LTEtMS0yMjI4MDY_4628de81-89d7-48d3-82cf-f21406398841"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i959d1bb706fa4661a1b1a57884406b29_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMy03LTEtMS0yMjI4MDY_0a9e5cb8-060d-44e4-ab0b-b0ac5b5a9006"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib589f13c250b40b2a2b1a3e3d28ecf30_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xMy05LTEtMS0yMjI4MDY_90bb14c4-bdf1-42f8-b298-d99d3ce6e8d5"
      unitRef="usd">116000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC0xLTEtMS0yNDEzMzQ_f4611816-8a63-42a4-b71a-ead01bde4235"
      unitRef="usd">-158000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC0zLTEtMS0yNDEzMzg_3b861f5c-7e7a-450f-bb44-8fa761ad9374"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC01LTEtMS0yNDEzNDI_a40a5fa7-42d5-4402-ab07-663b670134cf"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC03LTEtMS0yNDM3OTM_83f93b12-dab6-4081-86af-f76f4fa58bda"
      unitRef="usd">-12000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC05LTEtMS0yNDEzNDg_90b79d48-dde5-4418-92b4-37a55012bd66"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c2e1ec251cb4ae3beaeb30c7c423caf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC0xLTEtMS0yMjI4MDY_cb2bb5b9-8f78-4c1f-9a1a-227a96ba6a48"
      unitRef="usd">-1504000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie30cfb911148404bb4945fff687165b3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC0zLTEtMS0yMjI4MDY_a46b319e-f4b0-40c0-aafc-7540dbe75eac"
      unitRef="usd">10000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36eca1d194984dd68f29ddaa4c2a05f9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC01LTEtMS0yMjI4MDY_35ce15c5-01bb-4ab2-842e-4c4e476b3130"
      unitRef="usd">27000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i124bd77619314a38a6b7cf276d1570cd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC03LTEtMS0yMjI4MDY_59433e03-f107-4bde-af50-c574062caef6"
      unitRef="usd">-67000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7f24a9d3204464d821c538c01648b18_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNC05LTEtMS0yMjI4MDY_26249fe6-e0fb-4bb2-9658-96d925ba310f"
      unitRef="usd">-1534000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNS0xLTEtMS0yMjI4MDY_d8a95817-a533-4ed4-8484-53b6088cbdb2"
      unitRef="usd">-329000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNS0zLTEtMS0yMjI4MDY_a8d69f06-6266-4749-aa7c-8a5899d3aa05"
      unitRef="usd">112000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNS01LTEtMS0yMjI4MDY_fdca13f2-7fd8-4794-a4aa-03dbfd765f4c"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNS03LTEtMS0yMjI4MDY_13886464-f273-4d92-8dd0-1427fbc41a37"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNS05LTEtMS0yMjI4MDY_ce5ea564-00c5-4e1e-88ed-335593d07a9a"
      unitRef="usd">-179000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNi0xLTEtMS0yMjI4MDY_ffaa655b-400d-4370-a938-e2cc28433c65"
      unitRef="usd">-1027000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNi0zLTEtMS0yMjI4MDY_19f2f5af-ca14-4bef-a586-1b1afaedd561"
      unitRef="usd">136000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNi01LTEtMS0yMjI4MDY_433567f0-ddb0-4a6f-b2d7-334fb98b3fe3"
      unitRef="usd">73000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNi03LTEtMS0yMjI4MDY_21a2e4e5-2771-4c98-a786-d47253c0f100"
      unitRef="usd">-34000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNi05LTEtMS0yMjI4MDY_3c67fb25-2a5c-4455-be8a-f1dc3c7d7133"
      unitRef="usd">-852000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNy0xLTEtMS0yMjI4MDY_92ed015a-ae63-4508-bab7-4a10ea1ac609"
      unitRef="usd">698000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNy0zLTEtMS0yMjI4MDY_b8e0d5cb-38bc-4b43-9753-62baab8b55e2"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNy01LTEtMS0yMjI4MDY_63dac46a-607a-4ebf-a5c3-cb334b02d488"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNy03LTEtMS0yMjI4MDY_8cd5a771-7249-4639-9206-dc2164cb75f7"
      unitRef="usd">62000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xNy05LTEtMS0yMjI4MDY_b5b3c29e-602e-401b-8db4-70b8c566d41a"
      unitRef="usd">673000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOC0xLTEtMS0yMjI4MDY_65835a57-05e0-4572-a780-453fdd93f1a1"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOC0zLTEtMS0yMjI4MDY_b3f6ee1a-91cd-409d-8bbf-7fda04a70627"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOC01LTEtMS0yMjI4MDY_27ad8ecd-20ab-484e-9a10-5b4c52fc66c1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOC03LTEtMS0yMjI4MDY_c4af22a2-972c-44fb-a827-1b055f6f8e40"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOC05LTEtMS0yMjI4MDY_592df65d-1ea3-4016-baa9-b318e2805887"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i54464f5e54b54b12b9be685c8464bc3e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOS0xLTEtMS0yMjI4MDY_f35aba77-6749-4fdd-b825-daa1ec42f890"
      unitRef="usd">657000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOS0zLTEtMS0yMjI4MDY_4961c8af-9213-4ee9-a4fa-618d448e6d64"
      unitRef="usd">-24000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i996effba6e534e53953b29d2c0934e15_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOS01LTEtMS0yMjI4MDY_faddcce3-dcbb-4ef7-81f6-319d41cdb9fc"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ide3cc36767984833bee114be85420104_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOS03LTEtMS0yMjI4MDY_9aaebe12-24d0-42f2-a35a-14f0e0adc9f1"
      unitRef="usd">59000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iae11c8d101d3469b944d08b7b49ff0e0_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18xOS05LTEtMS0yMjI4MDY_b7295c3f-2da1-47ae-a761-d607383fee68"
      unitRef="usd">629000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4cf65ea6698449018a0c90a7c5bde4ab_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yMS0xLTEtMS0yMjI4MDY_2009105b-5b7d-4c09-9de2-217ea68944a2"
      unitRef="usd">-847000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icebbfa315f6f4c3badea80ba552d9fb3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yMS0zLTEtMS0yMjI4MDY_fc1fac6f-7c91-4dfb-a79a-df64af0add2a"
      unitRef="usd">-14000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9073522e455946228d949f1757f5c414_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yMS01LTEtMS0yMjI4MDY_7037f4c6-a947-47d3-8ae0-cfc425da36ef"
      unitRef="usd">-36000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ab73b88a84e4a3399c2d709d8b90830_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yMS03LTEtMS0yMjI4MDY_dfd60132-c9f2-4689-8454-365d7d43d027"
      unitRef="usd">-8000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa875c8421764c2c97f433701036010f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGFibGU6N2IyZjg4NDYzZjY5NGY4Mzg2N2I2YmQ0MGQ4ODYwYzMvdGFibGVyYW5nZTo3YjJmODg0NjNmNjk0ZjgzODY3YjZiZDQwZDg4NjBjM18yMS05LTEtMS0yMjI4MDY_9607aa6c-b2d4-4536-a5e5-db38e0b28294"
      unitRef="usd">-905000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="icde86b5b9cf640a3857b79b2a12f38f7_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl80NDE_cf1e6c3c-1915-4823-8bde-a60e02404f35"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="i5bf4620f35c94ffe8b0ced9de2482405_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl80NDU_aa4ae77f-4e68-4240-9ae4-0fbc0dacbac8"
      unitRef="usd">73000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax
      contextRef="ib5ed5bad9fbc48a79bf500f2ea6d7a22_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl80NTM_ba3e2618-94e2-4b81-8301-1e78fe714682"
      unitRef="usd">-118000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i4e74926dad464e94bdc3f1c87eb5109a_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl81NTQ_a6a8fe12-4665-4b62-8078-57f8392d5799"
      unitRef="usd">28000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="i9a201725780545cb9926c7c283f7d7d0_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl81NTg_ffc0a7d3-8e94-4b0b-b4fb-f19c4897ffe7"
      unitRef="usd">-4000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ie12bcf044f834b0ebb0a13192a63245b_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl81NjY_704a2d12-eadc-4c9c-a1d1-bc13a00ebae3"
      unitRef="usd">-119000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i2d68c16d5cd0403fa55f35c5a3f08ca6_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl80OTQ3ODAyMzI5OTI0_377f1882-84d9-48ed-a08b-5755fdc39d25"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i35ce052be7d44a28902bc287f3ca2b72_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl83MDU_976f091d-1206-437f-8445-27d6c1a36123"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i5b87be284c8740248b2f191fbb0da757_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl83MTM_5e8f89a6-ef40-4484-a776-11c67fb8b9ff"
      unitRef="usd">62000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ia639b6ffb08b44728499feae92d1c0c8_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yNTExL2ZyYWc6MTk4YjFiN2EwOGRjNDdiMGE2YmZjYTMwZGMyMDMwNTYvdGV4dHJlZ2lvbjoxOThiMWI3YTA4ZGM0N2IwYTZiZmNhMzBkYzIwMzA1Nl84Nzk2MDkzMDI3MTY4_e19a9fdb-86e5-4904-9639-cc29e34c2e82"
      unitRef="usd">6000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzgvZnJhZzo4NGNkOGFhMzc4YjU0N2E5YjFlMWEyZmI1YzMzMjJjMS90ZXh0cmVnaW9uOjg0Y2Q4YWEzNzhiNTQ3YTliMWUxYTJmYjVjMzMyMmMxXzE0MDY_3db760a4-55ff-4996-a336-54fc185d6b97">Related Party Balances and Transactions&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;McKesson Europe had investments in pharmacies located across Europe that were accounted for under the equity method. McKesson Europe maintained distribution arrangements with these pharmacies for the sale of related goods and services under which revenues of $137 million and $178 million are included in the Consolidated Statements of Operations for the years ended March 31, 2022 and 2021, respectively, and receivables related to these transactions included in the Consolidated Balance Sheet were not material as of March 31, 2022. Predominately all of these pharmacies were divested from the Company in the fourth quarter of fiscal 2022 as part of the completed divestiture of the Company&#x2019;s Austrian business, and in fiscal 2023 as part of the completed divestitures of the E.U. disposal group and U.K. disposal group. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; for additional information on the Company&#x2019;s European divestiture activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended March 31, 2022 and 2021, the Company&#x2019;s pharmaceutical sales to one of its equity method investees in the U.S. Pharmaceutical segment totaled $100 million and $111 million, respectively. During fiscal 2022, the Company&#x2019;s investment in this investee was no longer accounted for using the equity method and is not considered a related party as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ia0d5849c66ff44049855a2ac70d7759e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzgvZnJhZzo4NGNkOGFhMzc4YjU0N2E5YjFlMWEyZmI1YzMzMjJjMS90ZXh0cmVnaW9uOjg0Y2Q4YWEzNzhiNTQ3YTliMWUxYTJmYjVjMzMyMmMxXzI3Mw_2ff77713-f99e-477c-89a2-7b84670c8cee"
      unitRef="usd">137000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="iceb7460499a94969a987f6e8ded5348e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzgvZnJhZzo4NGNkOGFhMzc4YjU0N2E5YjFlMWEyZmI1YzMzMjJjMS90ZXh0cmVnaW9uOjg0Y2Q4YWEzNzhiNTQ3YTliMWUxYTJmYjVjMzMyMmMxXzI4MQ_b2fa46eb-c182-47d7-b1d5-7712b164546e"
      unitRef="usd">178000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i710b6d1dd56e4af4adf0dcdc5a56ecad_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzgvZnJhZzo4NGNkOGFhMzc4YjU0N2E5YjFlMWEyZmI1YzMzMjJjMS90ZXh0cmVnaW9uOjg0Y2Q4YWEzNzhiNTQ3YTliMWUxYTJmYjVjMzMyMmMxXzk4NA_27a5901c-0902-4af8-888b-1e100e0c5038"
      unitRef="usd">100000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="if772d42044f24743833c57e3767d2780_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xNzgvZnJhZzo4NGNkOGFhMzc4YjU0N2E5YjFlMWEyZmI1YzMzMjJjMS90ZXh0cmVnaW9uOjg0Y2Q4YWEzNzhiNTQ3YTliMWUxYTJmYjVjMzMyMmMxXzk5Mg_2c5f423d-56ba-4d40-aded-70c62117f1ab"
      unitRef="usd">111000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzkzNDQ_3bf396a1-d26e-45f9-b0f7-f1d71b108636">Segments of Business &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit (loss) before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RxTS segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. RxTS serves our biopharma and life sciences partners, delivering innovative solutions that help people get the medicine they need to live healthier lives. RxTS also offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution support across various therapeutic categories and temperature ranges to biopharma customers throughout the product lifecycle.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers national brand medical-surgical products as well as McKesson&#x2019;s own line of high-quality products through a network of distribution centers within the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The International segment includes the Company&#x2019;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company completed the divestitures of its Austrian business in January 2022, the U.K. disposal group in April 2022, and the E.U. disposal group in October 2022. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; for more information. The Company&#x2019;s remaining operations in Europe provide distribution and services to wholesale, institutional, and retail customers in Norway where it owns, partners, or franchises with retail pharmacies. The Company&#x2019;s Canadian operations deliver vital medicines, supplies, and information technology solutions throughout Canada and includes Rexall Health retail pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the consolidated totals was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(9) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment expenditures for long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(10) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total expenditures for long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 40% of the RxTS segment&#x2019;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and less than 8% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for the Company&#x2019;s reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit includes the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;cash receipts for the Company&#x2019;s share of antitrust legal settlements were $129 million, $46 million, and $181 million for the years ended March 31, 2023, 2022, 2021, respectively;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a charge of $1 million for the year ended March 31, 2023 and credits of $23 million and $38 million for the years ended March 31, 2022 and 2021, respectively, related to the LIFO method of accounting for inventories;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $142 million for the year ended March 31, 2023 related to the exit of one of the Company&#x2019;s investments in equity securities in July 2022 for proceeds of $179 million, which is reflected within &#x201c;Other income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; in the Company&#x2019;s Consolidated Statement of Operations; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $18&#160;million and $50 million for fiscal 2023 and fiscal 2021, respectively, recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s OSA, as further discussed in Financial Note 17, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s RxTS segment&#x2019;s operating profit for fiscal 2023 includes restructuring charges of $43&#160;million primarily for severance and employee-related costs, as well as asset impairments and accelerated depreciation. Refer to Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net&#x201d; for further information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for fiscal 2022 and fiscal 2021 includes inventory charges of $164 million and $136&#160;million, respectively, on certain personal protective equipment and other related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating profit (loss) includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $240 million and $383 million for the years ended March 31, 2023 and 2022, respectively, to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell and, in fiscal 2022, to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a charge of $1.1 billion for the year ended March 31, 2022 to remeasure the assets and liabilities of the U.K. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $59 million for the year ended March 31, 2022 related to the sale of the Company&#x2019;s Canadian health benefit claims management and plan administrative services business;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $42 million for the year ended March 31, 2022 related to the sale of the Company&#x2019;s previously held &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;30%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; interest in its German pharmaceutical wholesale joint venture to WBA. See Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; and Financial Note 5, &#x201c;Other Income, Net,&#x201d; for further details;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a goodwill impairment charge of $69 million for the year ended March 31, 2021 related to one of the Company&#x2019;s reporting units in Europe, as discussed in more detail in Financial Note 10, &#x201c;Goodwill and Intangible Assets, Net;&#x201d; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a long-lived asset impairment charge of $115 million for the year ended March 31, 2021 primarily related to the retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net, includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $126 million for the year ended March 31, 2023 related to a cash payment received for the early termination of a TRA exercised by Change in October 2022 and was recorded within &#x201c;Other income, net&#x201d; in the Consolidated Statement of Operations, as discussed in more detail in Financial Note 5, &#x201c;Other Income, Net;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $306 million in fiscal 2023 and a charge of $55 million in fiscal 2022 primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $97 million for the year ended March 31, 2023 from the termination of certain forward starting fixed interest rate swaps, as discussed in more detail in Financial Note 14, &#x201c;Hedging Activities;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a charge of $42 million in fiscal 2022 primarily related to the effect of accumulated other comprehensive loss components from the U.K. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a credit of $8 million, and charges of $274 million and $8.1 billion for the years ended March 31, 2023, 2022, and 2021, respectively, related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 17, &#x201c;Commitments and Contingent Liabilities;" &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $36&#160;million, $130&#160;million, and $153&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively, of opioid-related costs, primarily litigation expenses; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $83 million, $100 million, and $105 million for the years ended March 31, 2023, 2022, and 2021, respectively, for restructuring initiatives as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a net loss of $36 million, and net gains of $98 million and $133 million for the years ended March 31, 2023, 2022, and 2021, respectively, associated with certain of the Company&#x2019;s equity investments, as discussed in more detail in Financial Note 15, &#x201c;Fair Value Measurements;&#x201d; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a net gain of $131 million in fiscal 2021 recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Loss on debt extinguishment for fiscal 2022 consists of a charge of $191 million related to the Company&#x2019;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 11, &#x201c;Debt and Financing Activities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(9)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(10)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment assets and long-lived assets by geographic areas were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The decrease in assets within the International segment is due to the completed divestitures of the U.K. disposal group in April 2022 and the E.U. disposal group in October 2022. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software and fiscal 2022 excludes amounts classified as assets held for sale.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzkx_5d0ec1b4-0a40-4457-afb2-75749bb147b5"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzkzMDg_be3cd915-841d-4ec2-ba47-6c4363365e54">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the consolidated totals was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,073)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(9) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment expenditures for long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(10) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total expenditures for long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, less than 40% of the RxTS segment&#x2019;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and less than 8% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit (loss) includes gross profit, net of total operating expenses, as well as other income (expense), net, for the Company&#x2019;s reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit includes the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;cash receipts for the Company&#x2019;s share of antitrust legal settlements were $129 million, $46 million, and $181 million for the years ended March 31, 2023, 2022, 2021, respectively;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a charge of $1 million for the year ended March 31, 2023 and credits of $23 million and $38 million for the years ended March 31, 2022 and 2021, respectively, related to the LIFO method of accounting for inventories;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $142 million for the year ended March 31, 2023 related to the exit of one of the Company&#x2019;s investments in equity securities in July 2022 for proceeds of $179 million, which is reflected within &#x201c;Other income, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; in the Company&#x2019;s Consolidated Statement of Operations; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $18&#160;million and $50 million for fiscal 2023 and fiscal 2021, respectively, recorded in connection with the Company&#x2019;s estimated liability under the State of New York&#x2019;s OSA, as further discussed in Financial Note 17, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s RxTS segment&#x2019;s operating profit for fiscal 2023 includes restructuring charges of $43&#160;million primarily for severance and employee-related costs, as well as asset impairments and accelerated depreciation. Refer to Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net&#x201d; for further information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for fiscal 2022 and fiscal 2021 includes inventory charges of $164 million and $136&#160;million, respectively, on certain personal protective equipment and other related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s International segment&#x2019;s operating profit (loss) includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $240 million and $383 million for the years ended March 31, 2023 and 2022, respectively, to remeasure the assets and liabilities of the E.U. disposal group to fair value less costs to sell and, in fiscal 2022, to impair certain assets, including internal-use software that will not be utilized in the future, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a charge of $1.1 billion for the year ended March 31, 2022 to remeasure the assets and liabilities of the U.K. disposal group to fair value less costs to sell, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $59 million for the year ended March 31, 2022 related to the sale of the Company&#x2019;s Canadian health benefit claims management and plan administrative services business;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $42 million for the year ended March 31, 2022 related to the sale of the Company&#x2019;s previously held &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;30%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; interest in its German pharmaceutical wholesale joint venture to WBA. See Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; and Financial Note 5, &#x201c;Other Income, Net,&#x201d; for further details;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a goodwill impairment charge of $69 million for the year ended March 31, 2021 related to one of the Company&#x2019;s reporting units in Europe, as discussed in more detail in Financial Note 10, &#x201c;Goodwill and Intangible Assets, Net;&#x201d; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a long-lived asset impairment charge of $115 million for the year ended March 31, 2021 primarily related to the retail pharmacy businesses in Canada and Europe, as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net, includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $126 million for the year ended March 31, 2023 related to a cash payment received for the early termination of a TRA exercised by Change in October 2022 and was recorded within &#x201c;Other income, net&#x201d; in the Consolidated Statement of Operations, as discussed in more detail in Financial Note 5, &#x201c;Other Income, Net;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $306 million in fiscal 2023 and a charge of $55 million in fiscal 2022 primarily related to the effect of accumulated other comprehensive loss components from the E.U. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a gain of $97 million for the year ended March 31, 2023 from the termination of certain forward starting fixed interest rate swaps, as discussed in more detail in Financial Note 14, &#x201c;Hedging Activities;&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a charge of $42 million in fiscal 2022 primarily related to the effect of accumulated other comprehensive loss components from the U.K. disposal group, as discussed in more detail in Financial Note 2, &#x201c;Business Acquisitions and Divestitures;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a credit of $8 million, and charges of $274 million and $8.1 billion for the years ended March 31, 2023, 2022, and 2021, respectively, related to the estimated liability for opioid-related claims, as discussed in more detail in Financial Note 17, &#x201c;Commitments and Contingent Liabilities;" &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $36&#160;million, $130&#160;million, and $153&#160;million for the years ended March 31, 2023, 2022, and 2021, respectively, of opioid-related costs, primarily litigation expenses; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;charges of $83 million, $100 million, and $105 million for the years ended March 31, 2023, 2022, and 2021, respectively, for restructuring initiatives as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges, Net;&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a net loss of $36 million, and net gains of $98 million and $133 million for the years ended March 31, 2023, 2022, and 2021, respectively, associated with certain of the Company&#x2019;s equity investments, as discussed in more detail in Financial Note 15, &#x201c;Fair Value Measurements;&#x201d; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;a net gain of $131 million in fiscal 2021 recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Loss on debt extinguishment for fiscal 2022 consists of a charge of $191 million related to the Company&#x2019;s July 2021 tender offer to redeem a portion of its existing debt, as discussed in more detail in Financial Note 11, &#x201c;Debt and Financing Activities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(9)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Amounts primarily consist of amortization of acquired intangible assets purchased in connection with business acquisitions and capitalized software for internal use as well as depreciation and amortization of property, plant, and equipment, net. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(10)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software.&lt;/span&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i888e928ebad143cbb7a499ff02241d61_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMtMS0xLTEtMjE4NzQ4_509b9f64-d427-4d20-b40c-4725931f42d1"
      unitRef="usd">240616000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2799afba52094088a0aec4099f2cd4f8_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMtMy0xLTEtMjE4NzQ4_541e769a-a9b7-47ca-8751-a0389a08930b"
      unitRef="usd">212149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a2892fe126a4d66a63dd15b65453356_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMtNS0xLTEtMjE4NzQ4_07d84bd1-f938-49c6-b379-d58fa0195dad"
      unitRef="usd">189274000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id978da015466413b89b3f2baa572ef6d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzQtMS0xLTEtMjE4NzQ4_8a227fec-53ea-466e-b646-36007439b35b"
      unitRef="usd">4387000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8b0a03505314b06b91188743cad0dec_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzQtMy0xLTEtMjE4NzQ4_ca4d8187-fa68-45c1-8464-a90fb1833d88"
      unitRef="usd">3864000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29863184fd5348ff9a2a8abf0a0f8828_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzQtNS0xLTEtMjE4NzQ4_31f453eb-175f-4e31-8a5d-4e01cb8531f6"
      unitRef="usd">2890000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19b668b117b34adcb089b01f3153c8f0_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzUtMS0xLTEtMjE4NzQ4_9a8d554f-68f2-4f4b-b721-232c08e52445"
      unitRef="usd">11110000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80ef17e0a1714077b0570474802db35d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzUtMy0xLTEtMjE4NzQ4_aa2a94c2-d2f6-48c8-b53a-28723a9a5aaf"
      unitRef="usd">11608000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0df62424e8a4e62973e47b8bfd93a08_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzUtNS0xLTEtMjE4NzQ4_e0d0a50f-2dbe-4a6d-b150-a6c93ee8636b"
      unitRef="usd">10099000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i969dadb6a5014e4e97c0701a8fa71817_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzYtMS0xLTEtMjE4NzQ4_2554925f-5630-43f2-8f0a-b42a4e11cc96"
      unitRef="usd">20598000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if642126ed2f24282b10b29e0c453e35e_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzYtMy0xLTEtMjE4NzQ4_b9c55873-2b1b-4ba7-bd6e-1618d336a5ad"
      unitRef="usd">36345000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2c162cb2b9c417883dd91ccec907c32_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzYtNS0xLTEtMjE4NzQ4_35419cf1-d5fa-4f53-9e02-52b29c75378b"
      unitRef="usd">35965000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzctMS0xLTEtMjE4NzQ4_ee4d6b1d-4d48-4f7b-a94e-84812717d022"
      unitRef="usd">276711000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzctMy0xLTEtMjE4NzQ4_f847d0c2-1c0b-42f4-9e31-90508570f0ea"
      unitRef="usd">263966000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzctNS0xLTEtMjE4NzQ4_d5443662-2689-4949-83b3-7883e24da051"
      unitRef="usd">238228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEwLTEtMS0xLTIxODc0OA_2db929aa-2759-48ef-a5a5-2f4bd9bdd5be"
      unitRef="usd">3206000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEwLTMtMS0xLTIxODc0OA_73ed13ed-adaa-4a07-a432-999818e1d3b4"
      unitRef="usd">2879000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEwLTUtMS0xLTIxODc0OA_f5cf5106-8bd1-4bc0-a051-ccd7a9eab65b"
      unitRef="usd">2763000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzExLTEtMS0xLTIxODc0OA_ac69cb54-2927-4660-a8f7-d8c7da36c079"
      unitRef="usd">566000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzExLTMtMS0xLTIxODc0OA_a5221928-8953-470b-ac1b-6a6b42b6a813"
      unitRef="usd">500000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzExLTUtMS0xLTIxODc0OA_3bf7ff69-9381-4c42-bcea-784efa68acd2"
      unitRef="usd">395000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEyLTEtMS0xLTIxODc0OA_b9b6a2a3-617f-43e2-a263-035fc651fb2d"
      unitRef="usd">1117000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEyLTMtMS0xLTIxODc0OA_24f52fbd-e270-4443-b0d2-c897e619750c"
      unitRef="usd">959000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEyLTUtMS0xLTIxODc0OA_a94bf807-3c97-42a4-ad9f-0ea017581926"
      unitRef="usd">707000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEzLTEtMS0xLTIxODc0OA_03c6609d-2ade-49e1-b898-7c0ac9d6e792"
      unitRef="usd">136000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEzLTMtMS0xLTIxODc0OA_b04806b1-b8ce-4807-8c53-f21cb9bb45d2"
      unitRef="usd">-968000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzEzLTUtMS0xLTIxODc0OA_90c6ef01-e9c9-4084-a70a-52e609e9317d"
      unitRef="usd">-37000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE1LTEtMS0xLTIxODc0OA_74a85ad4-f878-4f2b-bdeb-076c2dd4201a"
      unitRef="usd">5025000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE1LTMtMS0xLTIxODc0OA_29f264e7-9264-4924-b15b-d560a45be18a"
      unitRef="usd">3370000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:GrossProfitNetofExpensesIncludingOtherIncome
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE1LTUtMS0xLTIxODc0OA_896ddc14-ab7a-4070-8453-e18fe07153fc"
      unitRef="usd">3828000000</mck:GrossProfitNetofExpensesIncludingOtherIncome>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE2LTEtMS0xLTIxODc0OA_c5180f17-dcc4-4d8c-a59a-9db8c2752927"
      unitRef="usd">147000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE2LTMtMS0xLTIxODc0OA_465417ca-5f2b-4b41-9240-17a575d84538"
      unitRef="usd">1073000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE2LTUtMS0xLTIxODc0OA_06c15acf-ca79-4ad2-a7a1-d952f3631bc7"
      unitRef="usd">8645000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE3LTEtMS0xLTIxODc0OA_b2bff6d3-1620-40e6-bb4e-6424c87a241a"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE3LTMtMS0xLTIxODc0OA_1cd2006a-5431-46e2-ac30-cfb6035fab07"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE3LTUtMS0xLTIxODc0OA_6f6d4d90-2934-4f19-b85b-b021eb1c45a9"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE4LTEtMS0xLTIxODc0OA_c3b991a2-6aaa-4627-9195-e1c12831b181"
      unitRef="usd">248000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE4LTMtMS0xLTIxODc0OA_2ba7679c-89d6-4d42-a226-f1a890afc285"
      unitRef="usd">178000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE4LTUtMS0xLTIxODc0OA_d8cea6c4-55c9-4016-8bed-5c1a638c4942"
      unitRef="usd">217000000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE5LTEtMS0xLTIxODc0OA_cd548eda-bdd6-4f81-8556-3010923fd4ab"
      unitRef="usd">4630000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE5LTMtMS0xLTIxODc0OA_206fab7b-bb16-449b-8ff4-b8e35ff0df25"
      unitRef="usd">1928000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzE5LTUtMS0xLTIxODc0OA_448d66ff-04fe-477d-95e2-60fdbe11585f"
      unitRef="usd">-5034000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DepreciationAndAmortization
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIyLTEtMS0xLTIxODc0OA_7e97abbd-4130-400f-8252-bd3bb3dc0f9c"
      unitRef="usd">212000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIyLTMtMS0xLTIxODc0OA_8ed8d24e-4266-44e1-8085-a585d73a5c9d"
      unitRef="usd">228000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIyLTUtMS0xLTIxODc0OA_025012f8-71cb-452b-bb56-8d01104d4694"
      unitRef="usd">211000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIzLTEtMS0xLTIxODc0OA_b5c79d93-e70d-4aab-b8d8-a9325deafe07"
      unitRef="usd">77000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIzLTMtMS0xLTIxODc0OA_99441495-de27-45e6-b2b1-c7d254e04218"
      unitRef="usd">82000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzIzLTUtMS0xLTIxODc0OA_d550b389-84c4-442c-b8a2-eb688af7abd7"
      unitRef="usd">87000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI0LTEtMS0xLTIxODc0OA_2440526d-13cb-4545-a70e-a73702be570a"
      unitRef="usd">80000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI0LTMtMS0xLTIxODc0OA_11530316-ceb9-48ff-804f-e68e190e1dd9"
      unitRef="usd">129000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI0LTUtMS0xLTIxODc0OA_838e35d9-27a0-45a1-9c6c-5bc554534da2"
      unitRef="usd">130000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI1LTEtMS0xLTIxODc0OA_b75e432d-98c2-47fd-90ab-cd5efd0ed364"
      unitRef="usd">115000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI1LTMtMS0xLTIxODc0OA_221563c6-95e8-4618-b63c-50fb67de3b07"
      unitRef="usd">204000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI1LTUtMS0xLTIxODc0OA_cbd7f133-5f2a-4e38-87dc-b06ee3a57c36"
      unitRef="usd">334000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI2LTEtMS0xLTIxODc0OA_5e9b1f14-408d-4675-bbaa-fdded1352b12"
      unitRef="usd">124000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI2LTMtMS0xLTIxODc0OA_e13a299f-f66d-4e9f-a37c-55bb701db8c1"
      unitRef="usd">117000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI2LTUtMS0xLTIxODc0OA_e09e0844-ef88-4267-8f44-7f69b57c56b8"
      unitRef="usd">125000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI3LTEtMS0xLTIxODc0OA_889546c4-4dbc-44e1-a5df-b5cc6f541f54"
      unitRef="usd">608000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI3LTMtMS0xLTIxODc0OA_59b47c62-b4ed-4b50-bec4-32cf0e0c557d"
      unitRef="usd">760000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzI3LTUtMS0xLTIxODc0OA_1e0d3318-51cd-4aa8-8f60-6541da589ae3"
      unitRef="usd">887000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMwLTEtMS0xLTIxODc0OA_2b5281bb-7138-457c-9eee-42dd21362ffe"
      unitRef="usd">154000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMwLTMtMS0xLTIxODc0OA_41890426-a2c9-47bd-a594-79c79cb70420"
      unitRef="usd">137000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMwLTUtMS0xLTIxODc0OA_e9e612dd-6a95-4a40-ac73-b5e36556f576"
      unitRef="usd">246000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMxLTEtMS0xLTIxODc0OA_86aefca4-a44a-4a85-a1e6-ef8e2d1de6d1"
      unitRef="usd">35000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMxLTMtMS0xLTIxODc0OA_9cf4d93a-ca8e-4007-b597-d1f2f99361ee"
      unitRef="usd">10000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMxLTUtMS0xLTIxODc0OA_96e4d2b6-d19e-4949-9387-9c9a3d434419"
      unitRef="usd">22000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMyLTEtMS0xLTIxODc0OA_ea06ba8f-b2f1-4ed8-ab65-5d2df40ea2d0"
      unitRef="usd">117000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMyLTMtMS0xLTIxODc0OA_603b7bed-e77e-48a1-92cb-f06ca9117688"
      unitRef="usd">74000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMyLTUtMS0xLTIxODc0OA_0a83232f-8347-4c95-abbb-d184d915fcfd"
      unitRef="usd">57000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMzLTEtMS0xLTIxODc0OA_bce8585d-c666-4ed3-8ce6-b0eeeeb8a121"
      unitRef="usd">79000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMzLTMtMS0xLTIxODc0OA_d0da8309-c64f-49c7-8440-53a208285b67"
      unitRef="usd">177000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzMzLTUtMS0xLTIxODc0OA_1102c9a7-6691-4cee-992c-7aaef903e809"
      unitRef="usd">212000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM0LTEtMS0xLTIxODc0OA_58afe414-5dad-44f3-a414-7f9c48b2a2a2"
      unitRef="usd">173000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM0LTMtMS0xLTIxODc0OA_efac513b-08cc-48d3-9ce8-f31edfec1589"
      unitRef="usd">137000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM0LTUtMS0xLTIxODc0OA_15e088f8-b2ed-4159-9248-97d46e64b27a"
      unitRef="usd">104000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM1LTEtMS0xLTIxODc0OA_3ecc9f46-bae6-4a16-9e71-6e95e396dbe2"
      unitRef="usd">558000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM1LTMtMS0xLTIxODc0OA_091440d1-cc96-49a9-9bfe-2e1fb4a2e711"
      unitRef="usd">535000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZTpmZTZmNDllODJmYmM0OTg0YTM3NjBhZGU2ODNmNjQ4OC90YWJsZXJhbmdlOmZlNmY0OWU4MmZiYzQ5ODRhMzc2MGFkZTY4M2Y2NDg4XzM1LTUtMS0xLTIxODc0OA_9b9200e9-dc11-4f97-bf08-a9819b065d7d"
      unitRef="usd">641000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5MDI_471a868c-0f0b-4a55-a68f-0523c01c3174"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5MDI_6053b534-fcee-4453-abef-418722f65cee"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5MDI_96e5b227-faeb-46a3-932d-3e250e6cc68a"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ic792a7859a654eb9aabfd88841ce87f4_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5Njg_20b77280-a9e7-4e11-8dc6-e527ca96eb15"
      unitRef="number">0.40</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5Njg_3aa9d296-4323-4d9f-ab03-50a1da8025f9"
      unitRef="number">0.40</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i4d08fce5558d42deaa9c7ec067b0d1e8_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzM5Njg_49cfc1f5-1e41-4bbb-96c1-f4b94fe689e9"
      unitRef="number">0.40</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i52e8647b58614506afee4fe62d2ff63a_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwMTk_9438e27a-1f3f-4688-bc0a-c728c3fd2493"
      unitRef="number">0.02</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ifbc2bf31404649628c3f5153557874bc_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwMTk_a2cce488-db73-4ed6-ae51-0968bc8f988d"
      unitRef="number">0.02</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i7c29fe312f6f4f499677052f6fadabf0_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwMTk_eca48fff-9099-4a6f-8a65-2a0b32c1da10"
      unitRef="number">0.02</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwOTY_a23e1029-2520-4191-9c2e-cb38923db6bc"
      unitRef="number">0.08</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="id62c43649df1424688c3e5137b75b17a_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwOTY_bda2fe69-d1de-4b2f-9c8d-7b5450ad8d40"
      unitRef="number">0.08</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="ie75c96baa9fb488b97ba1450a8e0a3d3_D20220401-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQwOTY_c785f27b-cac5-4978-a458-3ac987a0a39e"
      unitRef="number">0.08</mck:RevenueDerivedFromServicesPercentage>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjM5NzI_7145bd41-57ff-425d-8568-cafad874ee2f"
      unitRef="usd">129000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjQwNDY_afdb7aba-91ed-40a7-9b0a-b1c9cfc0f00f"
      unitRef="usd">46000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjQwOTk_2b79bcfd-6673-4f47-a445-81e89d6de041"
      unitRef="usd">181000000</us-gaap:ProceedsFromLegalSettlements>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjU5ODg_a6315e91-a5a1-4d13-b613-011da5dac7bc"
      unitRef="usd">-1000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i262d3be2189e44f4807846229b5b7b2f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjYwMDQ_cd5976b7-ba9e-47a6-99b6-f6f57521e950"
      unitRef="usd">23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ic28fd885d09449f4ab0e43b69b9c2bc3_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjYwODM_0839877c-2e7d-403f-8c78-51422b48deab"
      unitRef="usd">38000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="id7079e78125c4ce2bc548c0fe9d88736_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjYzMDE_b6e0d868-e1ef-40c1-959f-74f2734ad126"
      unitRef="usd">142000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i5042c611135944438746cce257499d4f_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjYzNTU_107ba45d-634f-4c9d-a932-449a7d528b96"
      unitRef="usd">179000000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ic7a2b38fb7fa4ffd985ec84c91b96f08_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzg3OTYwOTMwNDU3NTQ_59f8688f-c863-4b4d-a36c-ab70fc54a54c"
      unitRef="usd">18000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i6f27de4692d94ce8a48a3d7cc406987a_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk5NjE_1e04d104-96cc-4f66-9812-26c119ee8b86"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:RestructuringCharges
      contextRef="i74f77caf1abc49cfbdfd66d5d4657f82_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzYwMDk_038535f4-5c99-49c9-9385-8f3bfa78048d"
      unitRef="usd">43000000</us-gaap:RestructuringCharges>
    <us-gaap:InventoryWriteDown
      contextRef="i80ef17e0a1714077b0570474802db35d_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzUzNDM_80e22ef8-6cf4-409a-8875-436988e885ef"
      unitRef="usd">164000000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="ic0df62424e8a4e62973e47b8bfd93a08_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzg3OTYwOTMwNDgxMjA_ef6f491b-663f-4391-94df-cb87c947d60a"
      unitRef="usd">136000000</us-gaap:InventoryWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ia7674cea30624b1d8ca527142731b3ad_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjU2NzE_8fa42341-eae7-43fc-8721-46a862826598"
      unitRef="usd">240000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="idfa165efd60744789333c4342a1321b6_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjU2NzU_13cc5028-33f7-4357-9f85-01e946e26e14"
      unitRef="usd">383000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ib04ea519904c428dbf874fb64037adad_D20210401-20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjU3MDU_f22d4b8e-42f5-4f98-9122-dd4ca1a7e7bb"
      unitRef="usd">1100000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i05710b61fa6a461a86f2ce635e26e4b7_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5Nzc4MTA_0df30f87-f15c-4a98-8571-9c228daaf855"
      unitRef="usd">59000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i49a0432e3a7549c3a03b803ce21875b6_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5Nzc5MzM_6ebf7b0a-d5dc-475b-bf05-13c8a7010477"
      unitRef="usd">42000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="id5247400d4124ca0b0a07ce0631d83e8_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYxNjA_f3367985-d20f-4c3e-8ec1-e26eddd25db5"
      unitRef="number">0.30</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzgwMTA_c6c6856e-ae92-4e53-ac97-f60d6777a603"
      unitRef="usd">69000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:AssetImpairmentCharges
      contextRef="i15c1c350057d46098ad022832c0ae00e_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzgwODY_45a2d6ee-1657-4046-8cee-83a19152bd64"
      unitRef="usd">115000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainLossOnContractTermination
      contextRef="ibee85f1796ce4da18771743ac93a0bf7_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzU0OTc1NTgyNTI2MA_62ff2e1a-4b34-47a8-9244-867614d53ddf"
      unitRef="usd">126000000</us-gaap:GainLossOnContractTermination>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i56f911c056b9484b92530a2457c3bafb_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjkzNDQ_a1f37bb7-efe5-4b22-867d-9a00094de2f5"
      unitRef="usd">-306000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ic3df0606471a49beaeceeaa20d347abb_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjkzNDg_720cf83a-aeb7-44de-b9f7-2b47f2801ab0"
      unitRef="usd">55000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <mck:GainLossOnDerivativeTermination
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjkzNjM_fe9c6f0a-a441-4aef-bf86-36e70f4f5a5d"
      unitRef="usd">97000000</mck:GainLossOnDerivativeTermination>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="ibd7c7850d8804f519104e7d06502da80_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk0MzY_26a36eb0-dd40-4533-ae21-51245da61f96"
      unitRef="usd">42000000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="ia92f8f2aaaa94d78b491c9cdf4615c44_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk0NjM_e5179c50-f054-49eb-b741-abe424ec0506"
      unitRef="usd">-8000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="id73f9b34f34c41d6ad73b7db3ed24dfd_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk0Njc_952a9cca-8afb-40fe-be5c-fc89db8ca426"
      unitRef="usd">274000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="ib85a539d993f44df8a7f58db53244cd0_D20200401-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk0NzA_c8600d0f-ec4e-4bb4-b543-d129b2bfb084"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:LitigationSettlementExpense
      contextRef="ic465b0622cf24cb28f75710b46a76fb2_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzU4ODI_1689860d-a8be-4b38-9181-e3d26a115c69"
      unitRef="usd">36000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="id2e8b60c81a24e6fb0f18c0151fbdea0_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzU4Mjk_990b4d0b-3416-4b34-8ce0-538b663b88b8"
      unitRef="usd">130000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i1f0021b2207044be8e84e8be9891a203_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzU4NjM_f3efc08f-d4a1-4770-8253-2329f2461c79"
      unitRef="usd">153000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:RestructuringCharges
      contextRef="i08d5a7879c7842858f44ba47201dae9f_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5Nzg0Nzk_e966d969-dbd6-4339-a320-cc8eb75618f9"
      unitRef="usd">83000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic5ffbe0971d844779efce51fa5cf228f_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk2Mzg_199793ae-9c2b-40c4-8558-0d7756f1b8d6"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iff00fa96170f49e9b8f3a1224da8c25d_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5Nzg0OTA_db22c55a-35ac-4db2-a813-55d9ec1bcc7a"
      unitRef="usd">105000000</us-gaap:RestructuringCharges>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzcyOTg_405af7ac-6be9-4c6d-8b95-afd38146bbce"
      unitRef="usd">-36000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzczMjA_5fda44b1-0216-486e-9be7-272d3c44b01e"
      unitRef="usd">98000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzYwNDczMTM5NzczMjg_1b258187-c3fd-4193-853a-f07df93304bb"
      unitRef="usd">133000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i264e209968434d6cab289a945e761bb9_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1Mjk2ODQ_21730d9a-2c6e-42b0-8a08-935152d34dae"
      unitRef="usd">131000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzQzOTgwNDY1MjkxMjA_f9ec6911-7a98-486a-a493-4e3b43d73848"
      unitRef="usd">-191000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90ZXh0cmVnaW9uOjg4N2M4YjQyNjI0ZTRiZmE4Mjc2MDIxYjAyMzBlZGZmXzkzMTI_9e637055-b4b6-498a-a0d7-4143bd7fdb60">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment assets and long-lived assets by geographic areas were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The decrease in assets within the International segment is due to the completed divestitures of the U.K. disposal group in April 2022 and the E.U. disposal group in October 2022. Refer to Financial Note 2, &#x201c;Business Acquisitions and Divestitures,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Long-lived assets consist of property, plant, and equipment, net and capitalized software and fiscal 2022 excludes amounts classified as assets held for sale.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="i493ee32637374fef85bb13b3cde7de11_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzMtMS0xLTEtMjE4NzQ4_de885df0-ef04-4c3a-bec8-ed09f6d75b6c"
      unitRef="usd">41793000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i948e2e219f854ac082a3c472c583fe7d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzMtMy0xLTEtMjE4NzQ4_617a26ed-afd0-4945-823c-a1a651977bbc"
      unitRef="usd">38346000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ifbec207732c741a7b5cd533ccd6d7102_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzQtMS0xLTEtMjE4NzQ4_512a0c8b-a799-44c4-bffc-f0d442040f3e"
      unitRef="usd">4168000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie936d943185b4ffbb312cec2d0a11ea1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzQtMy0xLTEtMjE4NzQ4_9d6c8bf9-f079-4461-ae86-27f2e4c412d7"
      unitRef="usd">3528000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iab47b293b1e6457e9220acf589c14011_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzUtMS0xLTEtMjE4NzQ4_52c89e2a-8cc2-4f96-a7d6-bc8bfc601f20"
      unitRef="usd">5780000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i56dc2bee6bfd4893aaf3550953e9f904_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzUtMy0xLTEtMjE4NzQ4_5366435b-0099-48a6-9fb4-9e26e4a0fc4d"
      unitRef="usd">5830000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1d3e584c30524ea7abc9a6d31589fd8b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzYtMS0xLTEtMjE4NzQ4_b66a2b79-2b30-4a93-9d91-62158e269bbf"
      unitRef="usd">6226000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i3977781f98d2482e9204ee3df23b62ef_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzYtMy0xLTEtMjE4NzQ4_fc74d1ca-e713-44ce-8bb7-cdfefd89bc20"
      unitRef="usd">13717000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ifd5164d3ebc94282adf69fe3daa1dd18_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzgtMS0xLTEtMjE4NzQ4_9b3fbf63-0a9c-4547-8998-464d6c018ce5"
      unitRef="usd">4353000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0ca2257eaa5a4089b39072f8a37a459e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzgtMy0xLTEtMjE4NzQ4_fd0831a1-1746-4d84-9e96-51f6a54936a5"
      unitRef="usd">1877000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzktMS0xLTEtMjE4NzQ4_b06608ba-1606-44b9-b7f2-3ccfc39971eb"
      unitRef="usd">62320000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzktMy0xLTEtMjE4NzQ4_3b69114c-3304-4f0e-a8d7-1a6fda57c4ee"
      unitRef="usd">63298000000</us-gaap:Assets>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="ie4d3a7b2492845f594e7eb9cb4d9ba34_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzEyLTEtMS0xLTIxODc0OA_3ce087ff-2a8e-4c31-8e24-40cd874f73c3"
      unitRef="usd">2207000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i27b479eb9b0a4205ac5ae85acf2eab9f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzEyLTMtMS0xLTIxODc0OA_9633eee7-af5a-4dbe-9279-fd1678da0839"
      unitRef="usd">2060000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i1f12ecf10c5748808acbd2a3b98687df_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzEzLTEtMS0xLTIxODc0OA_7ff15151-ba5e-4f27-b050-823d8bd32c59"
      unitRef="usd">323000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i1892be5575524f3e9fca14e45be67594_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzEzLTMtMS0xLTIxODc0OA_03217ac3-3284-4e48-8cba-b6ea5d9f34aa"
      unitRef="usd">352000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzE0LTEtMS0xLTIxODc0OA_2a6d58ba-4a6c-4fa8-b4f2-8c31f6a73e9e"
      unitRef="usd">2530000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8xODEvZnJhZzo4ODdjOGI0MjYyNGU0YmZhODI3NjAyMWIwMjMwZWRmZi90YWJsZToxNDNkYzA4YzJlNzA0YzM5YWE4NTRmYTRjNjRlMzk5NS90YWJsZXJhbmdlOjE0M2RjMDhjMmU3MDRjMzlhYTg1NGZhNGM2NGUzOTk1XzE0LTMtMS0xLTIxODc0OA_d7fad197-70d1-46d0-94ed-02742e1aabf7"
      unitRef="usd">2412000000</mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware>
    <dei:AuditorFirmId
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMTcvZnJhZzo0ZjE5OTBiZmE2ODQ0N2FiODhhNzVkZTZjMjFkMjMyYS90YWJsZTo5NGNhZTU2NDdmNTI0NDg1YjE2ZTk4MDc2Zjk5OTUwZC90YWJsZXJhbmdlOjk0Y2FlNTY0N2Y1MjQ0ODViMTZlOTgwNzZmOTk5NTBkXzMtMC0xLTEtMjE4NzQ4L3RleHRyZWdpb246MTY5ZTNiMzgyZjcxNDc1YmI4Mzc5YWIyM2ZlZGJmMDFfOTQ_bcc81310-2281-4c3d-be02-9a8e182abf9b">34</dei:AuditorFirmId>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90ZXh0cmVnaW9uOmE4OTJkNjFjYjJlMDQxOTFhZDUyYWQ0MDg0YzBmMjIzXzEyOA_3b665675-9b65-4b94-9576-e047482b46d3">&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at Beginning of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Charged to Costs and Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Charged to Other Accounts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deductions From Allowance Accounts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at End of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowances for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Written-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credited to other accounts and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts shown as deductions from current and non-current receivables (current allowances were $158 million, $144 million, and $250 million at March 31, 2023, 2022, and 2021, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Primarily represents reclassifications to other balance sheet accounts.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i1a645887208e4db486fb4c28bf9e9789_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzMtMS0xLTEtMjE4NzQ4_77a1e0bd-cd7b-4014-ab4f-5847a16784f9"
      unitRef="usd">99000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i3437a5a1fdb04c6e8b55de243f4372f2_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzMtMy0xLTEtMjE4NzQ4_911e20b4-9e96-40ca-b00c-606c83a9136e"
      unitRef="usd">45000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i3437a5a1fdb04c6e8b55de243f4372f2_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzMtNS0xLTEtMjE4NzQ4_75f102ff-d4f7-4769-aaf6-60efd49e1f79"
      unitRef="usd">5000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i3437a5a1fdb04c6e8b55de243f4372f2_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzMtNy0xLTEtMjE4NzQ4_47cbdc21-7c68-4140-91e5-1f2b4665fc17"
      unitRef="usd">35000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i63e0cc8c15f34a96905c888bc0341914_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzMtOS0xLTEtMjE4NzQ4_fae76b55-b4a3-431e-8f3b-a57cf580f1d7"
      unitRef="usd">114000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i900587631c7346db9cea5a03126cc912_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzQtMS0xLTEtMjE4NzQ4_56e06cc4-d5e6-4206-8b1c-2e851cac47ba"
      unitRef="usd">52000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ia7384817abd64241a01371e5ab5d3497_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzQtMy0xLTEtMjE4NzQ4_a8c7c9f4-2124-4197-aaf1-a48fe4012853"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ia7384817abd64241a01371e5ab5d3497_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzQtNS0xLTEtMjE4NzQ4_fcbfad29-1ac6-4f6c-8159-75b06e2c3be3"
      unitRef="usd">4000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ia7384817abd64241a01371e5ab5d3497_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzQtNy0xLTEtMjE4NzQ4_c0e7d7aa-3086-4e12-ab71-819166c935ac"
      unitRef="usd">10000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibb89c7229e47468d9dc24fe8eae25115_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzQtOS0xLTEtMjE4NzQ4_50381511-f56f-4925-ae48-6235928fd1c8"
      unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzUtMS0xLTEtMjE4NzQ4_809f9c8f-fbb7-4867-a6cf-f671caee3317"
      unitRef="usd">151000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzUtMy0xLTEtMjE4NzQ4_33bebc42-a59a-4db7-889e-e64b010477cb"
      unitRef="usd">45000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzUtNS0xLTEtMjE4NzQ4_1b300556-510e-44ad-9547-6560a781ab25"
      unitRef="usd">9000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzUtNy0xLTEtMjE4NzQ4_0e7a2fed-9504-417c-ad67-db2f6e91e364"
      unitRef="usd">45000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzUtOS0xLTEtMjE4NzQ4_dfd3e3ac-d26f-49a4-b7c6-a5e33f6aac20"
      unitRef="usd">160000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia81ff60f8db142b3b909cdcd9740380f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzgtMS0xLTEtMjE4NzQ4_283b1e48-dbf6-41c0-840e-220e882a7d35"
      unitRef="usd">211000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i8940a83e694049a79488bf11a8ab865b_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzgtMy0xLTEtMjE4NzQ4_0f2b0037-847b-4235-a209-b2708e439f6f"
      unitRef="usd">29000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i8940a83e694049a79488bf11a8ab865b_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzgtNS0xLTEtMjE4NzQ4_575cdca3-4c03-4eaf-8222-3757b41b96dc"
      unitRef="usd">-35000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i8940a83e694049a79488bf11a8ab865b_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzgtNy0xLTEtMjE4NzQ4_ae6aba33-106d-4e48-aa38-40cc5cda5806"
      unitRef="usd">106000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i1a645887208e4db486fb4c28bf9e9789_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzgtOS0xLTEtMjE4NzQ4_7e286698-ee68-4c48-837f-e3b3a9a7c35f"
      unitRef="usd">99000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2cd212f902f34f7f840d70349edad45f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzktMS0xLTEtMjE4NzQ4_10a4c33c-ea1d-42f0-ae81-e42351aead84"
      unitRef="usd">50000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i4edda4c7cace4760a6ee6c90e9c98795_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzktMy0xLTEtMjE4NzQ4_233faff4-1902-46b5-bbbe-4f3e648d3dbf"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i4edda4c7cace4760a6ee6c90e9c98795_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzktNS0xLTEtMjE4NzQ4_ec5802cf-fa2d-4778-86eb-92d66477f7e5"
      unitRef="usd">4000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i4edda4c7cace4760a6ee6c90e9c98795_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzktNy0xLTEtMjE4NzQ4_236d2c47-777b-4b5d-8d1f-d8b9c2f0d8e1"
      unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i900587631c7346db9cea5a03126cc912_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzktOS0xLTEtMjE4NzQ4_1382b11c-0de8-4c7d-a99b-45df55916e42"
      unitRef="usd">52000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEwLTEtMS0xLTIxODc0OA_a151c76e-822c-4d7c-82d7-aa0546d6a5c7"
      unitRef="usd">261000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEwLTMtMS0xLTIxODc0OA_0bf745c9-4096-4e18-9fe8-11dfd948fae3"
      unitRef="usd">29000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEwLTUtMS0xLTIxODc0OA_93a7dd31-bb0b-483f-9d9d-e805ca4b0afb"
      unitRef="usd">-31000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEwLTctMS0xLTIxODc0OA_c717db85-ef20-4159-bc06-a2ce124ba00e"
      unitRef="usd">108000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEwLTktMS0xLTIxODc0OA_2d7cef6e-225d-46de-b6a9-34b3fe6bf143"
      unitRef="usd">151000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i6ed2dcfef9ef48c5bb328cf03b40b504_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEzLTEtMS0xLTIxODc0OA_d2aac13a-32cf-4a3b-99ba-287380855c5d"
      unitRef="usd">252000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i3bde156294a94d568921fd8650774394_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEzLTMtMS0xLTIxODc0OA_1fa31185-59cf-4ebe-a29d-76a301b623ce"
      unitRef="usd">4000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i3bde156294a94d568921fd8650774394_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEzLTUtMS0xLTIxODc0OA_a276c6ad-e856-4a67-8782-a63af52cce0f"
      unitRef="usd">1000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i3bde156294a94d568921fd8650774394_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEzLTctMS0xLTIxODc0OA_883ebbc7-005c-40fe-a8d4-e59ed4e90020"
      unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia81ff60f8db142b3b909cdcd9740380f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzEzLTktMS0xLTIxODc0OA_34cbd522-5ac8-4bf6-be54-86f31ce40fe2"
      unitRef="usd">211000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i759399c0e9f1473c9e22bd29f133ffe0_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE0LTEtMS0xLTIxODc0OA_cd2e4a69-d588-4958-9e2f-532f90e5a57c"
      unitRef="usd">30000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i4b8997759ac04bec85bf84dabe68cba0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE0LTMtMS0xLTIxODc0OA_f078ad61-dab9-4450-83e1-e068d2fbc16d"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="i4b8997759ac04bec85bf84dabe68cba0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE0LTUtMS0xLTIxODc0OA_519487a5-83ae-4c33-a018-cec546439975"
      unitRef="usd">9000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i4b8997759ac04bec85bf84dabe68cba0_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE0LTctMS0xLTIxODc0OA_a40f6732-9c40-476b-9859-3d39c8954d6c"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2cd212f902f34f7f840d70349edad45f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE0LTktMS0xLTIxODc0OA_3bef2193-aede-4b95-9756-9caea4e09bdf"
      unitRef="usd">50000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i56ca92db1bf347039646a68953e87fed_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE1LTEtMS0xLTIxODc0OA_1ac5ee5e-1414-407a-b8ff-ef3fe89e11ad"
      unitRef="usd">282000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE1LTMtMS0xLTIxODc0OA_f8c0a7e8-9ae7-4a66-b453-c44dd5ed120b"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE1LTUtMS0xLTIxODc0OA_369c8b15-acd6-4bff-a5a9-e4b9bbf41053"
      unitRef="usd">10000000</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE1LTctMS0xLTIxODc0OA_11af3c48-ea30-4124-a571-ed23088a38ca"
      unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpiY2M2NmY2NWNmOTA0MmI0OGJjNjcxNjU1NGYwNmQ3NC90YWJsZXJhbmdlOmJjYzY2ZjY1Y2Y5MDQyYjQ4YmM2NzE2NTU0ZjA2ZDc0XzE1LTktMS0xLTIxODc0OA_020cd77a-1bd6-4602-b9fd-5be0aecaeebd"
      unitRef="usd">261000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i3a62067dd1e740e787533693c47c4cad_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzItMy0xLTEtMjE4NzQ4_a7638cc5-b55d-4108-bf13-8e2922a77a8b"
      unitRef="usd">37000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i5a3854feff1f4556b7bc99ddcbb54572_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzItNS0xLTEtMjE4NzQ4_857650d2-707b-41be-9b33-3b6541279217"
      unitRef="usd">106000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i57b78c8af30b448bbccd7dfac95d2712_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzItNy0xLTEtMjE4NzQ4_82115d3d-ea16-432d-a46c-832279f144ff"
      unitRef="usd">40000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i5e0851153ff84a2cb14ce3cf28fc235d_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzMtMy0xLTEtMjE4NzQ4_6c26f486-f703-4a68-9c77-2f388ea2974b"
      unitRef="usd">8000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i19cf323fe7a0413b901a209d2006acbe_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzMtNS0xLTEtMjE4NzQ4_350d3698-9beb-4a18-87d0-a330a84aad25"
      unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i0f46ce261be141779d217de93096c2dc_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzMtNy0xLTEtMjE4NzQ4_74879245-1a4d-4cf7-8a47-709d3480098e"
      unitRef="usd">6000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzQtMy0xLTEtMjE4NzQ4_490ba6bf-c8ff-4aff-824a-7bc8a0e3f74e"
      unitRef="usd">45000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzQtNS0xLTEtMjE4NzQ4_2e549488-89f8-41e3-b038-6ad72a8ec984"
      unitRef="usd">108000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="iaa4ea9efa04447b4bb42310d2d4c64ae_D20200401-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzQtNy0xLTEtMjE4NzQ4_6e483ef9-154c-4f7a-a1c4-ce2a673ce17c"
      unitRef="usd">46000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtMS0xLTEtMjE4NzQ4L3RleHRyZWdpb246YjcwNGNlOGY2OGIxNGI3NDg1ZTdlMmZhY2U3NmMwODhfOTg_810fb33e-72a1-4f33-85fe-eca896f97d6e"
      unitRef="usd">158000000</mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount>
    <mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtMS0xLTEtMjE4NzQ4L3RleHRyZWdpb246YjcwNGNlOGY2OGIxNGI3NDg1ZTdlMmZhY2U3NmMwODhfMTAy_0ea0be9d-4192-46b1-afa7-64c015b4461a"
      unitRef="usd">144000000</mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount>
    <mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtMS0xLTEtMjE4NzQ4L3RleHRyZWdpb246YjcwNGNlOGY2OGIxNGI3NDg1ZTdlMmZhY2U3NmMwODhfMTEw_cb812a57-2829-4297-9ea6-db6b8d28b475"
      unitRef="usd">250000000</mck:SECSchedule1209ValuationAllowancesandReservesCurrentAmount>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i2ff10e823cba4f38b2c4399434a229ba_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtMy0xLTEtMjE4NzQ4_c9542ab0-a760-403d-8940-ce2238c22270"
      unitRef="usd">160000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i24ea2536cc79402c87a81416ae3171dd_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtNS0xLTEtMjE4NzQ4_99aa69d4-09f5-4f82-9a79-09f83a59ec5e"
      unitRef="usd">151000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i7f45287ebbdd4148b5e154a230ab10c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA0MzM1ZDAxOGRhOTQwNzZiMGFjZjIxZTgxYWM4ODZiL3NlYzowNDMzNWQwMThkYTk0MDc2YjBhY2YyMWU4MWFjODg2Yl8yMjAvZnJhZzphODkyZDYxY2IyZTA0MTkxYWQ1MmFkNDA4NGMwZjIyMy90YWJsZTpkYzk2Y2MyNDNkZWU0YmQ4YmM1NzIyYmE1NTczOThkNC90YWJsZXJhbmdlOmRjOTZjYzI0M2RlZTRiZDhiYzU3MjJiYTU1NzM5OGQ0XzYtNy0xLTEtMjE4NzQ4_2947d390-c9e3-40fd-8a1b-b7404732c79a"
      unitRef="usd">261000000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>136
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M(UZ:;EM%:UA5^?+<*HO%[J<E=E?0S@'W=TK9D^$.Z/IU]A=02P,$%     @
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M'<'<.F*'B-"->A?W*62:(KG**[\5JI;W@&JJ)QJ1#-,$@44550[<I(JAXIZ
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M8C<76JWK8]U[I;7*ZJ\K*1:RJ #P^X-2^OFB>L#V7PDF_P%02P,$%     @
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M,EW6]ZCBP+1(&DH=B>EH"3?],5[/NI.H,8TZD%U64=B3!GB+#K$7\U]"%(]
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M*'7EWEG;;2GH#!V.MF&@FHUJ#JJYJ.:AFH]J :J%J!:A6HQJ":JEJ)916CM
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M3!K _)12L>I(!^7SR/D/4$L#!!0    ( ,^-J%8;F%O&D@H  $HT   8
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MY:0/'WT<TEIR*&O[3=AA%?5CE1'$"R'K?LWE$MT+J8RI40*/#9N5!BPTYQQ
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M3T*\LCS^04>!K=5OC/II;!?C#9 N1P8$YEW PUECZW@(2MH*LR$17!,6;<;
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M7*:WG&<3^@LH3LG,^D]2*M(XX )!(SSJJ4L0OY'!,D_FH?C,^ _&098=1M9
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M0H7 $S5CAW%O@L3(,N1X!]_&T?H;33SL]P?U+TP6;"9-PC,;-YW@2^Q&KW]
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MEBJW'ZD1%9H&X/E, 3[]%V+07"@^^R]02P,$%     @ SXVH5MS?["LY#@
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M1O,3OIZQ$-YQ2%9N?,FM&$)AF95&L7;*# 7E)]IC.P6QEB3?.O(#,B<:83F
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M,L8^X49NKAQ1X^$\3!G4[X5Q3=>A&.OVN4FZFSI*>;=%$9RX \V^=S&AFNO
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MZQ[_NT'<#/_R_C0P="[C:2"W7-.4C:?DNO1%08!>G@5D@&R[&\O0ZYK\4+8
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MK"L$NT&_M8NO6U. ?Y]Z,X40K%@HHI7H8H$2EX!N(7$(!8N")^Y@&7<RPSV
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MURED8"S/H3-[ -[=I W:-,%ZMT51] =*0UG<C(;*<,:R^]?W>X^<2QIYG3;
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M>A)RO\^>:@-:>'I5FN));'PD'#L>3HJC<?@-V<)_-X0V!PEWLAX,[$N@X!S
MGA&H;#AL>68&$4;SF-".@VD4!>%T7H=PE\5 Y(K=I:9#!WGZ(D+( G 1O0AX
M2HAJLU'.NS8^\#L0B,B?4OPO"!WF..USWK%AAZYE0UA5EADB)\=G8$J,79-(
M_-3WVDR7^MX9E_8X)Q9+D2S$/)J*OX'W+L-8IO,2L:$H_C.$,?%7/@FD[MP"
MC 3'?_RJ>0=P@>E^D/)BZ6I 2C)BM"#TFC:;[A YZII*NY2="%9Q/(ZFC(
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MT:R#+&7K<P8'\0FTC:;R?HL/DV1,N0<D<V\324-65PB=$;4.>8WV>Z-S5.?
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M9?=_HX0F'6*U=FE)47[6?*=D4$$+:QCGCFOIHRM]'COPJ:4W$*%\Y]R5:K+
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M'0[8;0U(<B^O7'KYIZQ]?'+([O@Z>VFQCV.[?WQ\6-+=BR#"<,6))N %(FL
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M" ZL0ANP/E,8O/D-"2B_?U[\#U!+ P04    " #/C:A6[0/]= P%  !4#0
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ML&2 [Q<&I;U[H GZ#ZG9OU!+ P04    " #/C:A6(A@85(0)  !N/@  &0
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MTDJO@46%=R_D<G%(> SIR!WDSQ=)<JD-.QM?CFO$[9/7UNA2Z#.JT,'N^2I
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M)+]W"F0TRBF!71$R-K;PW("RA=SU('4F"3/(<8WX7!;H\?RG4:LJDP:Z&_5
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M&)J ]\L2_JP?:(/V?P6X_@]02P,$%     @ SXVH5L-;P'R-$   KS,  !D
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MU\GMC G&W]"5N>5&]*-$;6PU #HTNMX\8>&6%Z+$H\--*6>X8DLH*_L/?9W
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MQ (X7WD V#VP@>%O+I?_ E!+ P04    " #/C:A6Q-VX:9<7   +4   &0
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MBQ_RK%J5XMLL44D;P"70:7 :.YQ>CX]"_$$60S&)!F(\&D^.P)LT-$X8WN0
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M8-]I7N0RX?DKW]R2-*&449]^@P4V\"WDCTRPS:0)UAEO<C:;C"T5L9ZV\,.
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M:2"D%QPG>KUB65$_WWLT'X6,"S3AWTXWA)NZ@:-T2,_S J18B?E$ZB!RY!"
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M/6>^(!OFU[W-\ZK*U_P1YH4LE6[ ]46..LU^H06:]_^]^C]02P,$%     @
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M_#"0D, G3^\%&HJ$DR<6X-**KJE4(%6\'JP$H@8BF5L"F!;+7%O 5T,H=62
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MV\\MO"":H>)[#S$:4<5Y7+Q#HKP-YSF-G:=G6YCL!?L#IG:QL17RS#)["L8
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MX*1T8_"=Z\>B["(W8Y<=,-XFP C1S1$A2="1>=F-R!IC9+5A5QQ"R:ZY+4A
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M?,X*7FU$7(!:[A'1ERI 8;+M^@$8(^O]:?QY[9"Y,90K2D"LI)4CX! 4,]=
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MC1,&%SS&TQ!P7_B"&[0_^+OX/U!+ P04    " #/C:A6B.VM)[@&  "$$
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MK:?SYT]GN?4--]&UZ3MSY2)"GRYKALR]+,#[M8."^ALY8/S'P_7?4$L#!!0
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M@6N%)TRQT75CUSK@Q<,B*A#4IH')ALF7>$D;LRBKLJWS+6H0F=PTH*SFB5J
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M']RZALF47JK%7L+?[@S(4Y'\Z=_.)Y/1\\O R!IKX_!,*^+L0C?TX/BYM>R
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M6/8;<2%LYY/Q<)0 -^=D6$G:/ZH*.,H&9$@$49MD@@;]I@T8AZ#']YAY):*
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M^H^R,L>C'BLS.0LVL(ZW4.UQH>I'N%#XW)XE/NPW]<EC$'-'0=R1*#]0EZ^
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M\W57F, #.#0YW[MHJ7KH6_(?ML: 0SHK?7A)7OLY//V^J-N*(D^7"!6QI"+
M E] CG? *.TEV#JP@45<?.-)(\,G2E%R9PZ/@Z) X?'!QW8U@\7GF!BNJ602
M_>X6;&F9&ZI>I0P-K*+E\%>HHNSA2DAK?'%Q 3!_? ;.R/N?H]5Y\_W)ED&!
ME.*N&*!U]TE8T+4!_#%KJP7XAM< OY\VY8(+KP^F[W\\^(Y&FUZ^ 4V#=DL2
M>&!^ 1C##[MC/CV IP^^&^XA;H_S8GV; 1GUH^\G(]0>H[/CTXODZ:?A:_1E
M\N%WI*X-*!X&H+#-0.1C#PR!7]J49 >.B#E&0"70]MBE[2/:H9*(]HNCD],=
MV@,? S>5_!Y'(,L6BQL,^PFXE:T6$RM1?4JHK,H-K]\1!$P359MB!:PJZKFN
M*L]2#VS10,QR;18%1]&C(F0< 4^5I7](>V_90U%.G@,=F0;<:<NW??Z1O #
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M]Q:?SELIJ<Y5X;0IA%6+9R<7X>,70WJ?7_B'5C>N<RU(D[DQG^G#F_39R8
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M=F*M;*[+4J7"%$I<DV7Q>&W-VCB9X3G9IZ#GI?&K:B0" DD 'NHR\\_7TI8
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M7L,&'1SL!%U_X^GZFTF"?%NT&6#>>]<4=3Y&SP]XG>EXB#YK?N36I2##W*:
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MQI0C2SK(N38.?=I[V!MIE3C2=#QQ$1)B%I,9+"_1>*]01SXBL1^1_V*&9.>
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MF*$R=S24OJ^+RN>R@V 1 @^N(2.KPSSMP6.#T>D4=)GR(\I8%%Z>>+'C@J^
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MNR#"B#HWL<Z#RS(E/#@'7E^T+]2'>\P_/(E3H<SI=+I&Z0-=*@VB[SRO]W@
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M!.(#\/NZ!K*7#S@!]L&DY;W\?U!+ P04    " #/C:A6L"CBWVP#  !D"
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MN> LXHHFX/N9E*:\(075U\S)?U!+ P04    " #/C:A6HO^!C2L&  !8#@
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MJ4A9A,.KSDAC?R]"+2/G&$ =*%" W':RBH/=5RL 8;]C 9A0)^]X[VDJ;T=
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M&I\4$9APE(<'I]?^^)QKAX>QOUWAUX\P- '_7VCMM@^48/<]-?L'4$L#!!0
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MC?<H-6]0&JXD:%Q>!E?QV77F[+W!7QPWYN =7"0+I7ZXR<?Z,H@<(11868?
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M3=="U,Z _E\JTGJ8N 7V%\W9?U!+ P04    " #/C:A6X(=Y-YH)   /(
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M/Q0*OA6I6$EKV-EGOHR%Z5^.+,C3H%%8D+K-2?DG2'D^^UFE=F/8?1J)Z)#
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M>X" 6UO+^X3-6>6R\>!M/=/^NC3JQ);RMRHI'Z#DJ"J2$DS1Q7]4Z8,1F3B
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M10MP?Z&@EOH/;="^8'OQ7U!+ P04    " #/C:A6^4IN_9,+  #3=   &0
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MAD"HYG"DJ]0E<FA'.(IF^\2H#OZK5(<C%XAH2&_;0P4(*(VC:+8[C #AGU:
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MM!W&H'D^BF8[PN3YXR-;VO4/B]>_W7?Z BH$0&DAE,91-'N_4*,-!*?=1B&
MB@I06@BE<13-=J01%0+ZW@50$*1;Z>TOIRL(NI/V#K%040!%LQUA1('@R,:
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M%WE90'^_R#+U\J9L8/L<T\N_ %!+ P04    " #/C:A62@VCA*@"  "$!P
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MDE>;&P1%B2,[B.,K0OC;CGQUWWX,"G\"4$L#!!0    ( ,^-J%9M44C9>P4
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MHII M0C5)*6I2>T;2U/].9\./&2C5T8G$6THH9H[W7/>I.EPGYJ'CND?-&:
MCAFBFD"U"-4DI:D)ZQM%4WVCZ,5#,?KE1V<+[0JAFMMIRBEX;7,8+7)(_Y A
M W3($-4$JD6H)BE-359? 9KJ*T#'_Z:Y?@5&1Q/M%J&:BVH>JOF=]CS#9_;P
M;!'HD"&J"52+4$U2FIKAOC(TU5>&_+(-Z7I3-B&M$F-=IHO]243/C-1IRB&9
MZ> 5Y:!#NJCFH9J/:@&JA9W67M:[_UV9@T^? ATS0C5):6K"^BK05%\%&GMP
MY/]]+@?]>HR.*-H]0C47U3Q4\U$M0+40U02J1:@F*4W-?-\]FIX?Y0@*>F(E
M5'-0S44U#]5\5 M0+40U@6H1JDE*4Q/<]XZF+YR!"3J"@IY?"=4<5'-1S4,U
MO].4_;OF[A$4M'R$:@+5(E23E*8D==:7CV8_7#XZQED?]&LU-MFHYJ":BVH>
MJOFH%J!:B&H"U2)4DY2FO@/T?:794?I*,[2OA&H.JKFHYJ&:CVH!JH6H)E M
M0C5):6J"^[[23-]7^J!\CWQ19%FR:#/\^&6=NMFJE\DB21_BS_O+PWI^=)3W
M%&[,P?GG'71(%]4\5/-1+4"U$-4$JD6H)BE-36C?4YKI>TK#7=(_.J5NB/?-
MACE+-Y7A9LEZ&>>U(=-56B>W>Q..%J!0S4$U%]4\5/-1+4"U$-4$JD6H)BE-
M?2OH"U6SZ5&FVVC-"M4<5'-1S4,U']4"5 M13:!:A&J2TM0$]\6MF;ZX=6#I
M6*^,3NQNBVANSH:S:K14A6H>JOFH%J!:B&H"U2)4DY2F!K%O7\WT[2O@V^WZ
M$4:'=+>8=3:LZSKHD"ZJ>:CFHUJ :B&J"52+4$U2FAK2OL UTQ>XWC?I*],X
M?SK(I'Z,??&;[7I^=$+17A:JN:CFH9J/:@&JA:@F4"U"-4EI:I3[7M;L*+VL
M&=K+0C4'U5Q4\U#-1[4 U4)4$Z@6H9JD-#7!?2]K]K?TLO2CC$XTVLM"-1?5
M/%3S9[N]+'OXK5MTQ!#5!*I%J"8I3<GIO&]ES?6MK!\]HJOGQP84U1Q4<SM-
MV2\V.#N=AX[HHUJ :B&J"52+4$U2FAK0OC0UUU^L[J:9]Z:WW0S8B._+)JW&
M9MW\W'Y/=_M%I/90;K>5W1M1M#^%:@ZJN:CFH9J/:@&JA:@F.NWYODGK;'!M
MDJA[D&D_?]3PJZ626C$U>WW=::ZO._VJ/>RB7WATKM"S+J&:VVGJ;W1XJA=T
M2/^0(0-TR!#5!*I%J"8I38U5WU&:ZSM*?E*NFD^&?RZ++-ENP*YU6R^T4(1J
M#JJYJ.:AFH]J :J%J"90+4(U26EJ;OM"T?PHA:(Y6BA"-0?57%3S4,U'M0#5
M0E03J!:AFJ0T-<%]H6BN+Q3]\-X>M&F$:@ZJN:CFH9J/:L%\]W)_UL6@2A*B
M0PI4BU!-4IJ:T+YI--<WC=3=/2^D$:T4H9J#:BZJ>:CFHUJ :B&J"52+4$W.
M=PMQT_Y-3 UCWRB:ZQM%W_V@>L"YH/Z,LW9?;3,]OBZ*NC+>9UD:YXO$$$6:
MU\8?2=Y>?_7@DT;IUW1TUM%R$JJYJ.:AFH]J :J%J"90+4(U26GJNT)?3IH?
MI9PT1\M)J.:@FHMJ'JKYJ!:@6HAJ M4B5).4IB:X+R?-]>6DW[[D25DMTW5_
M2<DT'VR87S7!7C0_[ZTEZ?W1649K2:CFHIJ':CZJ!:@6HII M0C59*>9YK.I
M]^2-/9A[GU;+)*F=N(ZO+E=)>9_<)%E6&8MBD]?MJCR[M_G4>]=DV'S[WCHY
MW;G?,=^ZYI[[/?-ML.]^8;Z-MO>?]L->7:[C^^27N+Q/F^UVEMPUJS!Y<]9\
M\B_3^^73C;I8-\_KQ/A<U'6QVOZX3.+FPWG[@.;?[YJ)_;<;[0!?BO*O[=.\
M^C]02P,$%     @ SXVH5DU&QZ_A!0  -1P  !D   !X;"]W;W)K<VAE971S
M+W-H965T-38N>&ULO9EM;]LV$,>_"N$50PK$MDC*#^D< TG3K<4:+&B6[34M
MT;90251)RDZ^_8ZR8CJ52,5ILS>)9(EW?Q[)'^_$V5;(KVK-N4;W69JK\]Y:
MZ^+=<*BB-<^8&HB"Y_!D*63&--S*U5 5DK.X:I2E0Q($XV'&DKPWGU6_W<CY
M3)0Z37)^(Y$JLXS)ATN>BNUY#_<>?_B2K-;:_#"<SPJVXK=<WQ4W$NZ&>RMQ
MDO%<)2)'DB_/>Q?XW64X-@VJ-_Y)^%8=7"/3E8407\W-I_B\%QA%/.61-B88
M_-OP]SQ-C270\:TVVMO[- T/KQ^M_UYU'CJS8(J_%^F_2:S7Y[UI#\5\R<I4
M?Q';C[SNT,C8BT2JJK]H6[\;]%!4*BVRNC$HR))\]Y_=UX$X:$"(HP&I&Y!*
M]\Y1I?**:3:?2;%%TKP-ULQ%U=6J-8A+<C,JMUK"TP3:Z?EEJ> 7I=!%]*U,
M5&)"I1#+8W0%T5(ZT:7D"O71A5)<[YY\3M@B2>%5>/"1IS&"R8%N6<K1R8?!
MW:!ZYV[PYP!,J$(HEJ(_I"@+]1:=7''-DA2N^E7+/K3L*]/R#4IR=)VDJ?$_
M&VKHFA$XC.IN7.ZZ01S=P 1=BURO%?J0QSQ^:F (,=D'ACP&YI)X+5XS.4 4
MGR(2$(+N;J_0R9NW'KMT'W!:V0T==JL(/48= GCR-$AOV_KNM6C6[3M5L(B?
M]V!A*BXWO#?_]1<\#G[SZ WW>L/*.G7HW8U[FZKP%52-]JI&WBA^X1%/-FR1
M<G6*<J[;].TL3"H+!DZ;.::$S(:;%K_CO=^QU^^G?,-S+63B\;NS,#[P.PW.
MVMU.]FXG7K<WDA<LB1&_!QJ;66.6F-!K+ML$3!H")HYN3_?^IQW^81N0^N$4
M%2G+]6GEGP,P"@"T=D9BVA!"@[!=R=E>R9E7R5^@@^DD7Z&4 XR1--3MBV6_
MA!OFG*MG#26$.)3@P*(SZ)@,FN6K!"9A[=D9B-K0$__CB</_ ;JQ/Q9F J!<
MY/VHE!(&PA. VM23L2!3AP)B%9".99C!*, .8:8!$LM:@+E:6,2M'_>(BO1:
MH"5+)-JPM.0PBK#W1$)!(W@ NW7:JIXTU/=IX)C4V*(8^UG\M]# W5KS$Y6M
M(FC+=';.(LM7[ ?LP6[:ZO4U,(LM9[$?M%>2+>MMGT61*'.X*=B#(6^KVE$C
M1GA*QHX86>IB/W;?U_.[$++*Y6!^I2)?]367&>1@B_9%UP2Q:[ LA[$?Q"U"
MQ'=$2CO&LTEG2AVR+)ZQG\\[$L  R9+'G0J:6 XG+@F6R]@/YL_=X]&$,,;M
M;HEE,/$S^-#MDL/@Q$BS^ZX0D":/1R.'%(MCXL>QE7+DE"!--N-IX)!CV4S\
M;&[N#ETRFI#%U+%%$,M8\AS&'KCN!BUI@I9,B"L@%K3$B\IY59(<F7G[3;Z0
MOL32EXQ>F'P3+[9?*LP"F70 F:EUM2E$YL)D@K"=PQQKU]H$\8BZ5KY%,?&C
M^#DE &G"]LSIV=*6^&G[G"* -"$[&CL@2RQDB1^RQ]4!I G<D6,540M<Z@?N
M"TL!VB3NF6,@J"4N[4B 7U8,T"9OR<05&,M;ZN?M\ZL!V@):[*@&Z,%W!3]H
MCZD&:).P4P?IJ>4K]?/U_RH&:AE/B@&,1XX2FUK84G^J>UPU0%LRW7#J*$FH
M!2L=_T@U0+U8?B'VJ64N]3/WR&J -O$+X^2@(+7\I7[^_G@23EOH[ * A3/M
M^#1Q3!).6]CLF,&A97/X&LEPV$0S=E1LH45S^$K)<-@"Y[%C6846SN%/3H;#
M)J-=N7!H$1W^]%PX;,F% ^Q2<O!1U\]JV*RXS%F:/L!4V? 4!BE&2BSUELEV
M':^1"(>6S:$_$>[ 8O@:V7!HH1UV?!7.("N3U;87K9E<M4=PW/P>C;]GX?#@
M)"?C8,F<5YD]$5"[.]39_[H_$[O8G039UW<':M<@),D5K+HE- T&$XB1W)U1
M[6ZT**ISH8706F35Y9JSF$OS CQ?"J$?;XR#_4GA_#]02P,$%     @ SXVH
M5M?"<$K&!0  AB4  !D   !X;"]W;W)K<VAE971S+W-H965T-3<N>&ULM5I=
M;]LV%/TKA%<,+9#&%NTX3N882,RT#=:T@;.L#\,>&(FVN4JD2M+Y&/;C=RDI
MDF4KG(71#XGUP7O(>\A[=8_$\:-4W_62,8.>DECHL\[2F/2TV]7ADB54'\J4
M";@SERJA!D[5HJM3Q6B4&25Q%_=ZPVY"N>A,QMFU&S49RY6)N6 W"NE5DE#U
M?,%B^7C6"3HO%V9\L33V0G<R3NF"W3)SE]XH..N6*!%/F-!<"J38_*QS'IP2
M/+(&68O?.7O4:\?(NG(OY7=[<A6==7IV1"QFH;$0%'X>V)3%L46"<?PH0#ME
MG]9P_?@%_4/F/#AS3S6;RO@;C\SRK#/JH(C-Z2HV,_GXB14.'5F\4,8Z^X\>
MB[:]#@I7VLBD,(81)%SDO_2I(&+-(!B^8H + [QI,'C%H%\8]'<U&!0&@XR9
MW)6,!T(-G8R5?$3*M@8T>Y"1F5F#^US8>;\U"NYRL#.3&=-&K4*S4EPL#M!5
MDE*N8%[- :(B0C,64\,B-%U2M6#Z 'V!I?@>?:%*43MAZ"UAAO)8OX.K=[<$
MO7WS#KU!7*!K'L<PL7K<-3!,VUDW+(9TD0\)OS*D *-K*<Q2HTL1L:@.T 7_
M2B?QBY,7V(EX3=4AZ@<'"/=POV% T]W-<8,YV=T\<'C3+Z>LG^'U=YDR-)7:
M%%.EF8(9^>,SM$=7AB7ZSR;R<_!!,[A-,Z<ZI2$[ZT >R1 [DY]_"H:]7YJ(
M\PE&/('52!V4I Y<Z)MQP#?B0!5Q$+[$@6"FB=R\D^.L$YMR'R:X=S+N/JQS
MUM!F%-3;D.TV_?Z@;%/S\*CT\&AW#U\<:?(AAQDZ?6AH,SC:\*&A37#2[,.P
M]&'H].&S%(OW,>2="%&M(155\U1-S3V#QR%#ACXU>3?<&E5OPS?G$-JN:4]@
M-;:.2[:.G6Q="<.4H/;Y2N,F+ISF;5.!3S#B":Q&VZBD;;3/_#KR2:I/,.()
MK$;J24GJR;XCU]E!6V)/MM) ?[B1OSSU5Z,KZ%5U66_WX$7_P/*S=1:Z :X2
M&C[#>2J5L2OT3O#&9Y&[@[:$>44COM#JY*X5O<$^0[Q ]\6L3S3B"ZW.+*Z8
MQ?N.<W</K=GUB48*M/6\$01'S45-4!7T@;.TG=P=_GH((?Z?SVLW3&MFO!;O
MOM#J%%;E>S#8:T0[U4%K9GVB$5]H=68KV1!XT@UNG-8<;LN'C4*=-#0Y.GXE
M%BN%$;@E!AR#TEOP$'T$6[.$J.2&YR\[;F(JT'OT-67JY<%\.9_SD#,!?SI;
M<=G2^YH:GO"_LT:-5/G4&%.O:,076IW_2K,$QWL-9*^:QBL:\8569[:2-8&S
MP-\,9&!6VY<;!M9OFKW<,-+ BG9%^&C[Z8<W9/_4/8K6G.U#M 25:@G<LF7W
MY'>R]<9FN/EBP=U7:V;VH4]PI4^P6Y_4F;&9\0""-)&&H6]2?4>_*2HTMPD0
M[C<QYL9O&ZE>T8@OM#JWE3S!>Y4GV*L\\8I&?*'5F:WD"7;+DYWCV8W3FD.\
ME1T"/-@H9WQU6:>F$B'8+4)V*'S.HX@7=<_'6-[#SXQ)M:"B*'6R57JQTH"L
M-:Q;H67,H_S6C9(+11,-.N<R26/YS!BZ90]028F0':#S,&2Q+:O@.408.!CR
M"A)L_V*AR1!7<?;2XP-[9=Z\2B2O:,076GV"*XF$]RJ1L%>)Y!6-^$*K,UM)
M).Q)(KEQ6G/H$XW@;34UQ,UJ"E=J"O]O-35CL0SS6)=S6)8JE=8&?6(T^K&B
MRC!52QHS9IC(FE\^I4QH^T+I/'O55'V\SJ78:SFE<6:\*C*O:,076GT.*T6&
M]ZK(L%=%YA6-^$*K,ULI,MQ*D3GRAM>/2E[12(%6_YZ]D3>Z:QM4$@9>VHT^
M&C3H2IA\&T=YM=Q,=)YMH=FX?A&<DGQ+4 63[U"Z!O*XT"AF<X#L'1Y#.E/Y
MII_\Q,@TVP9S+XV127:XA!3#E&T ]^<2M$MQ8CLHMUY-_@502P,$%     @
MSXVH5KK'A;XJ!@  M"8  !D   !X;"]W;W)K<VAE971S+W-H965T-3@N>&UL
MM5I=;]LV%/TKA%<,+9#$(FG+=N88:*P6"[!L0=QN#\,>5)FQA4JB1]))"^S'
MC_J(:)$4%R_T2V+)YQ[=>RD>'9.:/U'VE6\)$>!;GA7\:K 58G<Y'/)D2_*8
M7] =*>0W#Y3EL9"';#/D.T;B=1649T,4!.$PC]-BL)A7Y^[88D[W(DL+<L<
MW^=YS+Y?DXP^70W@X/G$?;K9BO+$<#'?Q1NR(N+S[H[)HV'+LDYS4O"4%H"1
MAZO!>W@9X4D94"%^3\D3/_@,RE*^4/JU/+A97PV",B.2D424%+'\]TB6),M*
M)IG'WPWIH+UF&7CX^9G]8U6\+.9+S,F29G^D:[&]&DP'8$T>XGTF[NG3SZ0I
M:%SR)33CU5_PU&"# 4CV7-"\"989Y&E1_X^_-8TX"(!A3P!J I >,.H)P$T
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M_3LJ]A^DV#9O;7@64HI-\^N:QTM>U ;5WU^$D&\?Z@,<WA0R_QM02P,$%
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M6C?OVRVX4BA2MPZRI+JK9(0_4(G67-MZW4U*.1IU.F6I^)ZW.['G['SPLI.
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M%M=5&Y*MR]5C<R8ER\J/*TIBRO4!ZOL%8_)Y0Y^@6>(X^1=02P,$%     @
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ME]#OG8/O^?V6!=U^W-UO<5]^W+W70=,OD]RW\?J=25XWD[R0DF41TC[6L#Y
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M! *IF3?.=JJ)J*E<BER@0BI!HRV/94R-H[,5WU>D<:=^GCMNR=1-<SIMR63
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MZ3%BERO]90#"&.C[!>=JOS$.FF^-Y#]02P,$%     @ SXVH5KB2EO/2 P
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;+5<6V_C-AK]*X1;+"9
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M$R1J@@P:) Y1T!B;INC8?-KW/T%[ W2GUR#M.NZ,O>^(O1ZZ0Q,T!L$A.K+
M!?O>)FC=U5OW72?-H+D&U+?.N4,TC.HKFT/4&4Z.S9)]'Q&T-Q(/V)I0F:SM
M6I;",Q[D"[-&DT1"ZMY2 T<[4"?Z4!([)'68WL&Q- >YLL=[A=6_X;H\AU5/
MJT\(E_;@7'M^93XMV./NWDWY70*/22N&!\T,ENC2[XXPR[(\ZI<W6A3V\+L0
M&H_2]G(-%%L/(\#?ET+HMQOS@NJ#R^Q_4$L#!!0    ( ,^-J%9MMK0S<@0
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M;!Y*LZ$T!TISH30/2J,HFJIBF<V;^JOESW7A@[[9UJI"LWOS^*7R#45JUTA
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ME3U<<K;@<5I OO\416+[)&U@M[KW[%]02P,$%     @ SXVH5A5NOCQK!@
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M8@*=4U9C9;70HK2#UEIH&-OLXQY&<2(- -YOA="/"^.@&>ZS7U!+ P04
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M>$U*=8(\OF%,O#;48DVS.)?\!U!+ P04    " #/C:A6_#G502$#  #>#
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M7*L/$.!Z@GJ^9$SN.GJ!XI,F^ M02P,$%     @ SXVH5A0?&#5D!0  ,AX
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M 'E_S9AX/LDZJ+:)Y_\#4$L#!!0    ( ,^-J%8XC!MT0@,  +X-   9
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M%-H*@93L6PA(S"0QB\1L$G-(S"4QC\1\$@L.V/CDZ+X>7[76@9=+3JZO6\L
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M,A/9;H'RWQ_2M'A^L>O@*<U^WV_.[?\ 4$L#!!0    ( ,^-J%8G,.>99@@
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MC:N7.QYL>%86D)]OTU3<ORD;.*R7N?H74$L#!!0    ( ,^-J%8P<F_2:08
M *DZ   9    >&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;,6;6V_;-AB&_PKA
M#4,*9+$D'W*88R"Q1+1 NP;QNET,NZ!MVA8JB1E%.PW0'S]*5B33D1FK>8WE
M(M'I>TCQE?B);\C!HY!?TR7GBGR+HR2];BV5>KAJM]/IDL<L/1,//-%GYD+&
M3.E=N6BG#Y*S61X41VW/<?KMF(5):SC(C]W)X4"L5!0F_$Z2=!7'3#[=\D@\
M7K?<UO.!^W"Q5-F!]G#PP!9\S-67ASNI]]HE91;&/$E#D1#)Y]>M&_>*=IPL
M(+_BSY _IEO;)+N5B1!?LYT/L^N6D]6(1WRJ,@33?]9\Q*,H(^EZ_%M 6V69
M6>#V]C.=YC>O;V;"4CX2T5_A3"VO6Q<M,N-SMHK4O7A\SXL;ZF6\J8C2_#=Y
M+*YU6F2Z2I6(BV!=@SA,-G_9MZ(AM@(TIS[ *P*\0P,Z14!G-Z"_)Z!;!'0/
M+:%7!/1V [I[ OI%0#]O^TUCY2WM,\6& RD>B<RNUK1L(Y<KC]8-'";9DS56
M4I\-=9P:^GRB"$MFA(8)2Z9ALB WF=BA"GE*?B7W?"VB=79X)/DL5(2R:1AM
MSI[X7+$P2M_IZ[Z,?7+R\[M!6^E*9>CVM*C :%,!;T\%.N232-0R)4$RX[.:
M>-\>[WH60%NW1MDDWG.3W'I6XN]B?4:<\U/B.9Y7=T/V<)]/STC'W1ONV\,_
M,5F&=VK"@\/#ZTJGAX>[EK;LE(]7)^=U]O ^ZGTBYCL/SQ/Y.S_Q0?$X_:>F
MEK<;:K>>FO6V5^D#F_+KENY.4R[7O#7\Y2>W[_Q6IQ<2YB-A 1)&03!#YVZI
M<]=&'_XA%(MTCSY1=6I:8YNJB83Y&]AY#LN2\'K8ZUUVG?QGT%YO:U5SZ<7Y
M9=VE%%1%0XE>J43/K@27,?DH6%(GA#6TJ1!(F(^$!4@8!<$,,?NEF/VC=)]]
MI,Y(F(^$!4@8!<$,G<]+G<]??VFUSO-"X#I-K82FFMJKTR%Q_DE5)R"R&@$2
M1D$P0\"+4L"+-^0_:VQ3Z2Y>YB''J4M#/K+8  FC()@AU64IU>5A"9)\)V,^
M7>FNE7Q><YED8]"M8= ]4YR<C#_3^[I1S:VUD*::(F$^$A8@810$,V1WG6JD
MZQPEF198D-10F@^E!5 :1=%,N;>,#=?ZGN?.1IBD2JYBGJC3S( *4[(QX(A(
MR)K)D$TB3J1^TVN%MQ;06/C"B.EN]=S.F>.Z.[TVM-0 2J,HFBFI5TGJ624=
M\R04DGQ)TJ+?WGV53]22Y\['[IEWNK.OPK(\K0_L\[9J/[_L56O\,"!I/I06
M0&D413,?F<I_<H]C0+E0!PI*\Z&T $JC*)HI=V5#N78?JI#Y>1Q%)D)J1O:*
M3YDN=M^[_=+;Z3KU']4C>P4:2XFD!5 :1=%,*2L?RSW R'IE3/P*HD>>.)-U
MP]B1/;*QC%#["DJC*)HI8^5@N5;CY"TY^Y2,6,)FH1ZJ^2**F#PEMS)48;HD
M=V*5S,A8<:G+6YSF_\$*5E*D9+R:1&$<JK<G?*B)!J7Y4%H I5$4S7S>*B?-
M/3].PH?Z:U":#Z4%4!I%T4RY*]_-M1MO/YCP7YIHG?Z^A(]TOGPH+8#2*(IF
M2EGY<J[=F#LX4SA'&-U![3PHS8?2 BB-HFCF1(W*TO..8^EY4$L/2O.AM !*
MHRB:*7=EZ7EV2^_'.OL">M#HSEZ!QE)"K3PHC:)HII25E>?9K;Q#1G>O("RC
M.WMD8QFA]AJ41E$T4\;*7O.L?LY;<O;_.[JSWU?C# #U]Z"T $JC*)KYO%7^
MGM<]3L*'3D&#TGPH+8#2*(IFREUY@)[=P+N)=4^@BCROWW3=+7!ISQG0*6Y0
MFE_0MC]$=B<9OGX)M5YBMG-ETGEVDV[WPTJL5*ITKZL[T]I&[K]6RY&]P,8M
M!_6[H#2*HIG257Z79Y^KE3NGU9R6W8[Q.S&[S%HYH=87E.9#:0&41E$T4_G*
M^O(NCI,+H=/1H#0?2@N@-(JBF7)7]IAGM\=^</![>>ATP9&]_,9*0ETK*(VB
M:.:2F,JUZEAMDI<SDV;L*25LS<(HGX\TUR.J4MTZ45_A7SHYL>YMM4<V7@L#
MM:J@-(JB;31N;ZVPB[E<Y&LA4S+-/D\W*\O*H^5ZRYM\E>'.<=^]HIM5DQ5F
MLXCS$Y,+_5"0B,\UTCD[U]]Y<K,N<K.CQ$.^CF\BE!)QOKGD3'\09Q?H\W,A
MU/-.5D"Y.G7X'U!+ P04    " #/C:A698_\,[H#  "P$0  &0   'AL+W=O
M<FMS:&5E=',O<VAE970Y,BYX;6RU6-MNXS80_15"710)T(TNMF4[M04D48,&
M:+#!IFD?BC[0TM@FEB)5DHYW_[XDI<BRK0CVEGVQ16KF<,XA.1IRMN7BBUP#
M*/2UH$S.O;52Y;7ORVP-!997O 2FWRRY*+#23;'R92D Y]:IH'X4!+%?8,*\
M9&;[GD0RXQM%"8,G@>2F*+#X=@N4;^=>Z+UU?":KM3(=?C(K\0J>0;V43T*W
M_ 8E)P4P23A# I9S[R:\3L.A<; 6?Q#8RM8S,E06G'\QC8=\[@4F(J"0*0.!
M]=\KW &E!DG'\4\-ZC5C&L?V\QOZO26OR2RPA#M._R2Y6L^]B8=R6.(-59_Y
M]E>H"8T,7L:IM+]H6]L&'LHV4O&B=M81%(15__AK+43+(8S?<8AJA^C08?B.
MPZ!V&)SJ,*P=K-1^1<7JD&*%DYG@6R2,M48S#U9,ZZWI$V;F_5D)_99H/Y6D
ML% (LQS=$X991M@*W9BI((J 1!_1)[4&@>YQ1FC596SO>%& R BFZ F7^OU%
M"@H3*B^UQ\MSBBX^7*(/B##T2"C5TRMGOM+!FB']K [LM@HL>B>P,$*/G*FU
M1+^P'/)] %^S;*A&;U1OHU[$1RRNT"#\"45!-.@(Z.YT]ZC#/3W=/>QA,V@F
M;F#Q!GT3]\"D$AN]#17ZZS=M@!X4%/+O+K4KM&$WFLDNU[+$&<P]G3XDB%?P
MDA]_"./@YRZE7(*ECL#V5!PV*@[[T)/62B[M2B92;O0^@,X56V&-+99)J*_)
M9!0$,_^UK<VQ41A&AU;IL54\:!GMD1DU9$;GD1%08I)W,:F XGXFQT9=3$9G
M,(D;)G$OD]^YTB1RO<2[@H^/XAJ-IL.#X#N,)N/I0>R]47SGTALW',>GSI9-
MHEU,>Q'.W;0NP5)'8'O*31KE)DY3W\2EBB[!4D=@>RI.&Q6G_>M/0$X46E:?
M]F]HP85&, 5 AO6@INMB4R+%+[LTG1YMKV%PE$!Z SA7*T=@>UJ%P:Y,"OY#
M1JJ=VTGP4(O:)'[?).T/X7LIMBK!L)>BW45\B:J%T4FS%^#<G>04+76%MB]>
MM!,O<IJ3:CA74KI$2UVA[4NY*VS#WHK/?AB)4I#K QTUM5BG?D[KV1JMO3G'
MAYOS_RA3PUV=&O87JB\L.TF67I2S9>FJ9<-#81P-60GCMXZRNCQ:V2L!B3*^
M8:HZZC6]S;7#C3UL'_3?FNL(>T3>P51W&?HDMB),(@I+#1E<C74%*ZKK@:JA
M>&D/S NN]/';/JX!YR",@7Z_Y%R]-<P S25-\B]02P,$%     @ SXVH5I[L
M2_^N @  %@D  !D   !X;"]W;W)K<VAE971S+W-H965T.3,N>&ULM59=3]LP
M%/TK5H8FD#;RU:8=2R.- EJE(2$0[&':@YO<MA9VG-FW+?S[V4F(FI)V('4O
MB>W<<WS.M6_L>"W5HUX ('D2/-<C9X%8G+FN3A<@J#Z5!>3FRTPJ0=%TU=S5
MA0*:E2#!W<#S(E=0ECM)7([=J"262^0LAQM%]%((JI[/@<OUR/&=EX%;-E^@
M'7"3N*!SN .\+VZ4Z;D-2\8$Y)K)G"B8C9QO_MEX:./+@ <&:[W1)M;)5,I'
MVYED(\>S@H!#BI:!FM<*QL"Y)3(R_M2<3C.E!6ZV7]BO2N_&RY1J&$O^DV6X
M&#E#AV0PHTN.MW+]'6H_?<N72J[+)UE7L9&9,5UJE*(&F[Y@>?6F3W4>-@!^
M;P<@J '!6P%A#0A+HY6RTM8%19K$2JZ)LM&&S3;*W)1HXX;E=A7O4)FOS. P
M>:"*T2D',LD1%&@DESDR9*#)\04@95R?D,_D_NZ"'!^=D"/"<G+-.#=+H&,7
MC0++XZ;U;.?5;,&.V:ZI.B6A_XD$7A!VP,=OAP=MN&M\-^:#QGQ0\H7O,_],
M?OTPD62"(/3O+I<5;:^;UA;>F2YH"B/'5)8&M0(G^?C!C[RO79X/1-;*0-AD
M(-S'GCQ,+DEJEE)REE&$C%"M 3M7MB(:E$3VW[!*HB ,O-A=;9KIB J#+\,F
MJJ6RUZCL[55YG[<T6M&F!)A8"@)/A=1+!00EX5)W*J_(HPU-?L_;%OZ/H);N
M?J.[OU?WN*5Z9Z5U:=Y+_-X==B"R5@ZB)@?1_ZFQZ) 9.!!9*P.#)@.#0]78
MX-4FC )_:Z-VQ$0[]NFP43A\GT)NEHSQG9MS^*K(^^&6RM<A47]+I+MQ:MD;
M@_F[SUFN"8>9 7FG [-M574*5QV417F0326:8[%L+LS%!90-,-]G4N)+QYZ-
MS54H^0M02P,$%     @ SXVH5J:S,VH8$0  6>@  !D   !X;"]W;W)K<VAE
M971S+W-H965T.30N>&ULQ=U;<]NX 07@OX)Q=SK.3&*+U-6IXYDX  ATNXEG
MO>X^=/I 2[#$+D5J22J.._OC2U*T($@0)*9'[3YL?"$_D,F1!.F(T/5SFOV6
MSY0JR+=YG.0?SF9%L7A_>9F/9VH>YA?I0B7E;Y[2;!X6Y;?9]#)?9"J<U#O-
MXTN_TQE<SL,H.;NYKG]VE]U<I\LBCA)UEY%\.9^'V<NMBM/G#V?>V>L/?HZF
MLZ+ZP>7-]2*<JGM5/"SNLO*[R[4RB>8JR:,T(9EZ^G#VT7LO1[UJAWJ+OT?J
M.=_XFE2G\IBFOU7?R,F'LTYU1"I6XZ(BPO*/K^J3BN-**H_C]P8]6X]9[;CY
M]:O.ZY,O3^8QS-6G-/XUFA2S#V>C,S)13^$R+GY.GX5J3JA?>>,TSNO_D^=F
MV\X9&2_S(ITW.Y=',(^2U9_AM^8O8F,'W]^S@]_LX!^[0[?9H7OL#KUFA]ZQ
M._2;'?I;.W2[>W88-#L,CAUAV.PP/':'4;/#Z-@=KIH=KNHXK/[]ZG]\&A;A
MS766/I.LVKK4JB_J!-5[E__F45*%_;[(RM]&Y7[%S5V3VUN5J*>HR,D[\CG,
MLK"*(#FGJ@BC.']S?5F48U5[7(X;]W;E^GO<+ODI38I93E@R41/+_MR]O^<[
M@,OR)-=GZK^>Z:WO%*D:7Y"N]Y;X'=\G#_>4G/]@.[%/;N:ORZ1D.@<9ZF9^
M"K.CCH8=?U(=!\.//YKN*T-^()<DGX69RBUB@#D_<3SC.1CI9KZ,BT-'8V2J
MN[[U=&NWN_>O_ZG\R>3UUD/NXC A-,K'<9HO,T7^\;?RUT06:I[_TW8;6ND]
MNUX]SKW/%^%8?3@K'\ARE7U59S=__I,WZ/S%EELD1I$80V(<B05(3" Q"<*,
M6/?6L>ZY]/)!(1NKI"@G.R1](BJ.IM%CK,@XG9=SK#RL9RGGRP4I4K)8;6I]
MA' .TC;=2(PB,8;$^ KS5@_7U4SUZTWG8MB_OORZ&5ODD *)21!FQ+:_CFW?
M&=M/Y80ABQZ7=3[5MRJKUH>N6R?3-IA(C"(QAL3X"AMNY-+S^YWZOZUP6K8L
M4<N6PK)E.8VQ;"E!IV+$:K".U< 9*QYE>?G0'F8%^?)4_OE"-H-FRY?3:YLO
M)$:1&$-B'(D%2$P@,0G"C" /UT$>GG2V.D3&&HE1),:0&$=B 1(32$R","/6
MHW6L1P<>]N>+,'DA\[ 8SXB:+^+T156S57TGG9/S,">A<[;J'*1MNI$816(,
MB?'1[FS5VYH-(,<32$R",".S5^O,7CDSR[XWI4ZV;4J1&$5B#(GQ*]MSJDYW
M*ZC((042DR#,"*K7T2\0=YQ1O5=E1B>MYK]NL6U*H1J%:@RJ<:@60#4!U21*
M,S.]47IX)YT)-SPJX$B-0C4&U3A4"Z":@&H2I9D!]W7 _?_%G-@]2NN<(S4*
MU1A4XXVV->78?A47.J: :A*EF?G5O9KG[#>^?W[L=ELG%MJI034&U7BC;4^2
M_>W(0@LSJ"91FAE9W9EY[M),J'CR[BG-WN5AK,@?A%T\7)#;95YNEN>JS&XY
MOUBDY2])D*7+A3V]T,H,JE&HQJ :AVH!5!-03:(T,^2Z8?/ZIYTX0ZLWJ$:A
M&H-J'*H%4$U -8G2S(#KKL]SEWVO[X<+R_OLPEH>NX'6$8;6>XVVV:AV.W[/
M5JDRZ,@<J@6--CCB/ 1T9(G2S/CIALYS-B4[DXB'BQ_;3R*@/1U4HU"-034.
MU0*H)J":1&EFR'5?YXU..XF 5G50C4(U!M4X5 N@FH!J$J69 =?EGN=N]XZ8
M1$![/*A&&VWSP=?KC:SORV+0D3E4"UJ<AX".+%&:>9V#;NQ\=V.W/8GXN,R+
M+"KO8U\G$N3+0F7UVWBMX73S;<,)U2A48U"-0[4 J@FH)E&:&7!=W_FGK>]\
M:'T'U2A48U"-0[4 J@FH)E&:&7!=W_GN^N[C>+R<+^.P*$.>%C.5U==>9&I6
M32R^*C(-HX2<EVG/WY")RM0XG2;1OZW7V=VZAVH==FB'UVB;#]'O/,\ZTX .
MS!MM: P\M+Z=_?AC%-!CE"C-S*"NX'QW!;<]BPA4-B_O9G^=I;&J?_0ZF["&
M#EK#034*U1A4XU M@&H"JDF49J9;MW5^[[13"&A3!]4H5&-0C4.U *H)J"91
MFAEPW=3Y[HOAH%,(:&L'U2A48_[N)6GONEW;@SV'#AQ -0'5)$HSDZPK.?^X
M2BZ.PL<HCHI(Y8<3"RWIH!J%:LS?K?R\D74FRZ$#!U!-0#6)TLS$ZA;/=[=X
M9DGWEJR^K^Z(G\CC"[DO9\]OR>>TJ"<<:5)$R;+\I7Y1[CO?/>0^JM:AAQ9_
M4(U!-0[5 J@FH)I$:>;M0A=__FF+/Q]:_$$U"M485.-0+8!J JI)E&8&7!=_
M_G];_+F!UA&&%G]0C4$U#M4"J":@FFPT8T+7/ /9F-&9RU7I:K#KK@;7LXCI
M:F82)>-X.8F2*9EL3D72]53D+5DTF5Y4=];I8QQ-5PL '9J"-T>R>1Y#ZX(A
MG]S'W#;%4(U!-0[5 J@FH)I$:6;.=4/8=18TT%<_FJ%L-\CM($.;0*C&H!J'
M:@%4$U!-HC0SR+H)[+J;0,!3R>]Y#ZG[J-I.4Z :A6H,JG&H%D U =4D2C-O
M%QL+;YYXY4WLTIO8M3>QBV]B5]_$+K^)77\3NP#G*0K*KBXHN\Y^"#N#@9:5
MC69>9&*;#U'HN RJ<:@60#4!U21*,X.LB\BNNXA\?4VDNH<NGTYNW7%;XPJM
M&Z$:A6H,JG&H%D U =4D2C,CK1O)[N"TDP]H.PG5*%1C4(U#M0"J":@F49H9
M<%U@=MT%YD-2+9\\KN8>X;A8AEE4/ENLYAIJ>PT.<JZ^C96J7D*T/Y&$=I)0
MC4(U!M5XHVVMQ[&]N")T3 '5)$HS(ZR[QJY[55#V&N#'YDYZ$;[,R\3FI)PW
M^QV_9TTKM&"$:A2J,:C&&VWS*<'(^F9JZ+ "JDF49@96=X?= TN"'@ALWQI8
M:)T(U2A48U"-=W>O#;RR!Q;:%$(UB=+,SPC176+/W24>"NS %EBWV3:P4(U"
M-0;5>*,=#BQT6 '5)$HS ZM+P9Z[%#P4V*$UL-!K!:$:A6H,JO%&.R*PT/(/
MJDF49@96EW\]=_EW*+ C:V"AU1U4HU"-037>V[W.;T]@H:T<5),HS0RL;N5Z
M!Y;M/!#8*U+,LG0YG97?=+O6]$)[.:A&H1J#:KS1-M/;MY8R 71< =4D2C/C
MN_&Q=^[.;1U?<]79,KN)^E:0IR@?AS%Y46%FC2ZT98-J%*HQJ,9[>_O$[>1"
M2S:H)E&:F5Q=LO7<)=M#4M[9?@WC9?V)C>,PGY$PF:R^4+\OH_)7]=WP>9GE
M21K'8997+^&N/M[U#?G#_5FOM^[16T<;VLA!-0;5>,_R"7?;H8;6;%!-HC0S
MU+IFZQUWX9^].2Y#BUARV7T,K:,-[>*@&H-J'*H%4$U -8G2S%N![N)ZI_W4
MOAZT@8-J%*HQJ,:A6@#5!%23*,T,N&[J>NZFSG)]MS7'T&X.JM%&VWSV-;)>
MZ\*@XW*H%AQ]%@(ZKD1I9OYT\=8[[J*]HZ<9W_.&>O<QM$XOM*B#:@RJ<:@6
M0#4!U21*,S\Z7;=Y_<Y)IQE]:+$'U2A48U"-0[4 J@FH)E&:&7#=_O7=[=_A
M:[/=0.L(0ZN^_FZ=UK/6$PPZ+H=JP=%G(:#C2I1F1D_W>'UWC]=ZAM%VQ6;W
M^*V3"^W\H!J#:ARJ!5!-0#6)TLQ;@"X&^Z>]7*\/K06A&H5J#*IQJ!9 -0'5
M)$HS ZZKP[Z[.OR>1>K<9.M00PO#1C,>J:VM'(..RZ%:</19".BX$J698=1M
M8/^_N>2NG%_\GU85<!]VZ\!#:T2HQJ :AVH!5!-03:(T\X:C&\?^:2_LZT/+
M1*A&H1J#:ARJ!5!-0#6)TLR ZS*Q?^3*I-^Y_M?JQ9/#,QMHY]AHF^^BL+]J
M0*'C,JC&H5H U014DRC-S+CN$_ON/O%+O5K&79H7F2JB3%5O0'V]1\_KNW1K
M9*'U(E2C4(U!-0[5 J@FH)I$:6:L=4W9OSKMW 3:0$(U"M485.-0+8!J JI)
ME&8$?* ;R('[>L*[+/V7>?6 7FW4%F@WUS;04(T.=A<_[0^L+Y] Q^66<7O6
MMW $@]T+"NU'**!'*%&:&3+= @[<+>!G551O?([2231>3VVKQ2Z27%E#!NT$
MH1J%:@RJ\<%NT[>3P(.;B,.;2-1AFWG2U=[ 7>T]?):_,$KN?_GX"[LG?Y"#
M+[VU^A@U]^"MTP?M]: :@VH<J@5034 UB=+,^.M>;W#:7F\ [?6@&H5J#*IQ
MJ!9 -0'5)$HS ZY[O8&[U_MH+']EC3"TQ8-J%*HQJ,:A6@#51*,9ER1:>T.)
M&M>,IV[Z!NZF[W.:O'NXN+]8S3<.SC^L^866<E"-0C4&U3A4"Z":@&H2I9D9
MUZ7<X+2EW !:RD$U"M485.-0+8!J JI)E&8&7)=R W<II^<8&XMZ6Y,,K=6@
M&H5J#*KQ1MM\&6&PYU6QW2W[]DN@H$<H49J90%V9#=R5F3G+)>40R[BH6N&G
M+)VOJN%E4I L+!09S\)D:K]$SSU*ZWQ".S2HQJ :'^PNGSFPKSUT])8">H02
MI9GYU-W7P'V)'MU,8$[.7U<?MH80VG-!-=IH7F_S!<V+CC\8;K<"T IKS["]
M?F\[7D<>G]BSH3>ZVGY^=(I.::@[I:&[4[(^M+XE$S5/IUFXF$7C>IV4,,^7
M\T7]L7:.NS?W6&V3!=4H5&-0C0]W2ZEW/>O=FVU+S[JI@!ZB1&EF3'4K-3ST
M<76'7F5R ZVS!^VAH!J#:GQX[#*4E@WW)6_W\P"[UCFB1)V*F2K=30T/7';6
MLE!W<ZTS!FV;&LWX--&.9VW4H0-SR\#>T+=':'<%R3W'*"R;CNR?CBI1IV.&
M2#<\0_>2CC(99RK,%3F?J-57;ZH%\1[#/,K)(HT2^[6T;K5UEJ#%#E1C4(TW
MFF=4WM7$:K@=-FAG ]4D2C,CJSN;H;NSN5L].PBG]6)X15J4CZOUNY<WEW4D
M[\CZDTO<3RC<H[6.,K3@@6H,JO%&V_H(DTY_.\C0Y@:J291F!EFW.T-WN_-Q
M7CWIS:L4U_G5@=T3:FM\H?T.5*-0C4$U/K2LW;AGZMC?>3#WK6OO"MN6UKF$
M1)V+F3S=N0S=2R_R93(IYXUY$1;+[8]\LH8,VK% -0K5&%3CC;9U'SG:N8^$
MEB=03:(T,ZFZ/!D>*$^:^\AP/,ZJ2Y>>TFQ]$?:+-:K0$@6J4:C&H!H?[EZ%
MM7-'"+TH":I)E&;&5#<L0W?#TO9]QVZN=4JA50I48U"-#W?7,!S:'[1W-]SS
M<L]NY6*?!TC4F9@1TR7)T%V2M'PO4+G!YS1[5M-JG:&[Y6-<!O.^/*AHK-9[
M5M, <GY_]Z/]01_:M$ U"M485.-0+8!J JI)E&;<(D:Z_1F==DW#$;3P@6H4
MJC&HQJ%: -4$5),HS0RX[HU&!WJC>O*[?GV@OCI_]3$0UCA#.R2H1D>[]8N]
M5&'0<;EM7.MS]^#H(Q30(Y0HS8R8+I%&[A*I_:SB(7E:O7JPV'.IO7O$UCF$
M]DQ0C4$U#M4"J":@FD1I9N9UYS4Z[55-(VCY!=4H5&-0C4.U *H)J"91FAEP
MW9"-#C1D+=\9X.9:!QI:@36:\?Q\SSL#H -SV\#V3ST__A %]! E2EO%[#*?
M*570L AOKN<JFZI/*HYS4K\SL[HSW?@IR=13&4/O_4?_['+GY[?>>^99?LZ]
M]Z+^^:7F;ZX7X53]%&;3J)Q^Q.JI'*IS4=4C632=K;\ITL6'LW*F])@613JO
MOYRI<**R:H/R]T]I6KQ^4PWPG&:_U:=S\Q]02P,$%     @ SXVH5C73=BN>
M P  (0L  !D   !X;"]W;W)K<VAE971S+W-H965T.34N>&ULK99MC]HX$,>_
MBI6K3JW4)22PL.Q!I&73ZE:ZK5#17E]4]\(D0_#5L7.VLVS[Z6^<A!02@_9%
MWX ?9O[Q;\8/,]]+]4WO  QYR;G0"V]G3''K^SK904[U0!8@<&8K54X-=E7F
MZT(!32NGG/OA<#CQ<\J$%\VKL96*YK(TG E8*:++/*?J^Q*XW"^\P#L,?&;9
MSM@!/YH7-(,UF*=BI;#GMRHIRT%H)@51L%UX=\%M/+/VE<'?#/;ZJ$TLR4;*
M;[;SD"Z\H5T0<$B,5:#X]PSWP+D5PF7\UVAZ[2>MXW'[H/ZQ8D>6#=5P+_D7
MEIK=PKOQ2 I;6G+S6>[_A(;GVNHEDNOJE^P;VZ%'DE(;F3?.N(*<B?J?OC1Q
M.'(()F<<PL8A[#J,SSB,&H?1:QW&C<.XBDR-4L4AIH9&<R7W1%EK5+.-*IB5
M-^(S8=.^-@IG&?J9:-5D< D"MLQH<D76N+72D@.16_()-]X*%),I2\B'%]QL
M&@AN-G+P6W$J-'D;@Z&,ZW?H?C+SGL0H*R ]?  -/DEQ]318#QK?*_*TCLG;
M-^_(&\($>62<H[N>^P;Q["+]I$%9UBCA&90@)(]2F)TF'T0*Z:F CW%I@Q,>
M@K,,+RH^4C4@H^ ]"8?AR+&@^]>[AP[W^/7NP06:49OJ4:4W.J/7S80-/XF9
M3KC4I0+R]2^<)@\&<OV/*_JU^MBM;J^G6UW0!!8>WC\:U#-XT>^_!9/A'Z[(
M_4JQ^!>)G41UW$9U?$D]6J,>2X D4MO-O3F<(Z#*!CLM%1,9,3L@WW'(%==:
M?UKIVUOZ.;J>^\_'P>I;!,&I2>PP^:ER G;=@EU?!'L0!C!<IB;# UTH^2_>
MU@C50!*YX2RC]OYV<=7RDZ,E33M<?8M@W.%RF,S<7).6:W*1R]YB%84"4RIA
MR:C68)PWSJ3W^:MN<APF1TNL*1PVX="-,6TQIA<Q[G*I#/M11=_>U*50D,A,
ML!^(AJ]I216CG.#9UH2*%+/'\-K61[O5"3SMQ[O#V[<8=6C[%F>VXDW+>G.1
M];Y4]GG!:L/XF"G#P39)AE6-B^'&D9$.A,.DD]>X;W(F8[.68G:1PKZEQ>$M
M+9I7$NHWU84QZQWI[OGI6W2/3]^B=WS\H^(A!Y5519C&'5(*4S^5[6A;Y]U5
MY4UG?(GU7UVN_92IBT=\R3*&3SV'+4H.!U,\U:HNR.J.D455HFRDP8*G:NZP
MA@5E#7!^*Z4Y=.P'VJHX^A]02P,$%     @ SXVH5JG\(J*@!@  /"@  !D
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M4IIM_N.7RHBM!M%H1P-8-8!V@\&.!JAJ@ YM,*@:#$IG-E)*'V(L\?22LV?
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M.>A+7'P$L;K^,[*L9X+_P&\LZWX]>SC;1/C\"I[@K7ZUF2QN*5G#V%%M[.C
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M0N-389M+?/U!F@"<GPNA-QWS7M3_)\*_4$L#!!0    ( ,^-J%8E32J_K@(
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M8N^3U41:+;38V!GM66B<^.QCAE,\2 / ]RLA]'YA#FC^%TS_ U!+ P04
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M5?OP9-GAWU?UGX??<?5_4$L#!!0    ( ,^-J%:.W#0,, ,  *(+   :
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MKM%$ATJ<4D!\CA[8&J32SZ9WAH!E*B!&6*%[3 1ZPC0%=#D A0F5G[3IXV2
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M_FF1P-F;M_ &B.Z!%P5M!3WQ#05FI^>G=1"W51#1D2#""!ZD,+F&7T6&69O
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MQ6K^0-981C;\*Z82?,=LE\3<$$GWV#X/!>RC ;]+H12XQHHJ\/&&:$R9^F2
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M!Y:-#H6/_E&&I@]4DU!-1C4%U514TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4
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MFHYJ!JJ9J&:AFHUJ#JJYJ.:AFH]J :J%J!:A6HQJ":JEJ):A6HYJ!:J)1Q+
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MIIKN:OP>RGIZ,,^@A<.H)J&:C&H*JJFHIJ&:CFH&JIFH9J&:O=/V\\SH])5
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MM?[5T^,.IA^T#QG5)%2344U!-175-%334<U -1/5+%2S4<U!-1?5/%3S42U
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M4GRD+.?PH<9H"3*J2:@FHYJ":BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ
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MFFGGSC102Q1*HU :JVC&W. >5!=0MQ-%,Q6@_4[GI.%YU+WX6!Y?#A=!5*J
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M.@3"&.CO2\[5=F)^T%ZPDM]02P,$%     @ SXVH5H^,>A=- @  RP4  !H
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MY"UY8%HS=\#DU2U8QH5YC5[3!B?48F:'IUF79=UFB9[)$I-[)6UIR$>90SZ
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M#/CG]WR,NO^C:^"IJO_<?.WK_P=02P,$%     @ SXVH5G^EVZE4!   C1@
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MR,+5[=VD+O+V4"0:*/(!LQ'PX2\ ><C7I-^]/QWUTUW9KJ9GJ.D9JO!\<\\
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M@/Q\PYAXN8B_(#^>G_X/4$L#!!0    ( ,^-J%9RMQ:D?@,  *L7   -
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( ,^-J%9*((0W\@<  "I/   /
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MR^]6OWM=)LG I,VRB>*KW5%ONV/J/O\'4$L#!!0    ( ,^-J%9L\H9[3 ,
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M5>\*T+NJWA6@=U6]*T#OJGI7@-[5/"P(T+NJWA6@=U6]*T#OIGHW@-Y-]6X
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M4^_Y_+/CY_>_7WZ\:7Z'?&27P]<9T\U?4$L#!!0    ( ,^-J%:#_[!:EP(
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
MSXVH5K@!UG#O    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ SXVH5IE<G",0!@  G"<  !,
M ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #/C:A6]?7
M&1\)   ]1   &               @($."   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ SXVH5@6O'9LZ @  NP4  !@
M ("!8Q$  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( ,^-
MJ%9CMS+<_P8  %8@   8              " @=,3  !X;"]W;W)K<VAE971S
M+W-H965T,RYX;6Q02P$"% ,4    " #/C:A67BP4KAH$   A#@  &
M        @($(&P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%
M  @ SXVH5N)Z5T_L!@  (AX  !@              ("!6!\  'AL+W=O<FMS
M:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( ,^-J%:#PM#?X0(  "T*   8
M              " @7HF  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"
M% ,4    " #/C:A6SYV%T?@1  "8"0$ &               @(&1*0  >&PO
M=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ SXVH5KE>&#,( P
M*@D  !@              ("!OSL  'AL+W=O<FMS:&5E=',O<VAE970X+GAM
M;%!+ 0(4 Q0    ( ,^-J%8;F%O&D@H  $HT   8              " @?T^
M  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #/C:A6.YW8
M@^,I   ]B   &0              @('%20  >&PO=V]R:W-H965T<R]S:&5E
M=#$P+GAM;%!+ 0(4 Q0    ( ,^-J%;WT>(EFQ,  /5%   9
M  " @=]S  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @
MSXVH5F0SL>?E#   7"P  !D              ("!L8<  'AL+W=O<FMS:&5E
M=',O<VAE970Q,BYX;6Q02P$"% ,4    " #/C:A6W-_L*SD.  !**@  &0
M            @('-E   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4
M Q0    ( ,^-J%8W23M7&08  %4.   9              " @3VC  !X;"]W
M;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ SXVH5M3AV*0R$
M(BX  !D              ("!C:D  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX
M;6Q02P$"% ,4    " #/C:A6/]KIK%X)   +'0  &0              @('V
MN0  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( ,^-J%;M
M _UT# 4  %0-   9              " @8O#  !X;"]W;W)K<VAE971S+W-H
M965T,3<N>&UL4$L! A0#%     @ SXVH5B(8&%2$"0  ;CX  !D
M     ("!SL@  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,^-J%9]3ZJR!P\  #DW   9              "
M@=<. 0!X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ SXVH
M5F.X,,U!#   _"<  !D              ("!%1X! 'AL+W=O<FMS:&5E=',O
M<VAE970R-"YX;6Q02P$"% ,4    " #/C:A6B.VM)[@&  "$$   &0
M        @(&-*@$ >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0
M   ( ,^-J%9=S^URTRD  +&&   9              " @7PQ 0!X;"]W;W)K
M<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ SXVH5DR^_L;F#   ;B<
M !D              ("!AEL! 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q0
M2P$"% ,4    " #/C:A6;:1CFSP$  !2"@  &0              @(&C: $
M>&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( ,^-J%;9C&9X
M4Q$  *8W   9              " @19M 0!X;"]W;W)K<VAE971S+W-H965T
M,CDN>&UL4$L! A0#%     @ SXVH5CWE0FX:!   W@D  !D
M ("!H'X! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " #/
MC:A6Q8$^[',O  !_IP  &0              @('Q@@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( ,^-J%:P*.+?; ,  &0(   9
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M970S-BYX;6Q02P$"% ,4    " #/C:A6]- UTA '  !:$P  &0
M    @(&9T0$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    (
M ,^-J%;GR_.&H0,  $,*   9              " @>#8 0!X;"]W;W)K<VAE
M971S+W-H965T,S@N>&UL4$L! A0#%     @ SXVH5ND]U@C[ P  6PD  !D
M             ("!N-P! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"
M% ,4    " #/C:A6?\'":EH(  #+&   &0              @('JX $ >&PO
M=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( ,^-J%;^1AM2+P4
M .D+   9              " @7OI 0!X;"]W;W)K<VAE971S+W-H965T-#$N
M>&UL4$L! A0#%     @ SXVH5AR:JQ2Z!   = H  !D              ("!
MX>X! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " #/C:A6
MX(=Y-YH)   /(   &0              @('2\P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0S+GAM;%!+ 0(4 Q0    ( ,^-J%8D+@BN@@<  ' 8   9
M      " @:/] 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%
M  @ SXVH5J.T;]C& @  -08  !D              ("!7 4" 'AL+W=O<FMS
M:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " #/C:A6A1,(=DP#   &!P
M&0              @(%9" ( >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+
M 0(4 Q0    ( ,^-J%9[YGDM40H  'L@   9              " @=P+ @!X
M;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ SXVH5NEIZ.P$
M#0  ;"L  !D              ("!9!8" 'AL+W=O<FMS:&5E=',O<VAE970T
M."YX;6Q02P$"% ,4    " #/C:A6^4IN_9,+  #3=   &0
M@(&?(P( >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( ,^-
MJ%9*#:.$J (  (0'   9              " @6DO @!X;"]W;W)K<VAE971S
M+W-H965T-3 N>&UL4$L! A0#%     @ SXVH5B?<Q<X@ P  *PD  !D
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M=#4U+GAM;%!+ 0(4 Q0    ( ,^-J%9-1L>OX04  #4<   9
M  " @6Q7 @!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @
MSXVH5M?"<$K&!0  AB4  !D              ("!A%T" 'AL+W=O<FMS:&5E
M=',O<VAE970U-RYX;6Q02P$"% ,4    " #/C:A6NL>%OBH&  "T)@  &0
M            @(&!8P( >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4
M Q0    ( ,^-J%84EDA-M@@  #5$   9              " @>)I @!X;"]W
M;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ SXVH5I(*Z[$$!
M0Q0  !D              ("!SW(" 'AL+W=O<FMS:&5E=',O<VAE970V,"YX
M;6Q02P$"% ,4    " #/C:A6-[%E5$0&  #N.   &0              @($*
M=P( >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( ,^-J%9_
MC\(H,@,  ,L)   9              " @85] @!X;"]W;W)K<VAE971S+W-H
M965T-C(N>&UL4$L! A0#%     @ SXVH5D\\LVXY P  R H  !D
M     ("![H " 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,^-J%80FAQXB@4  %HC   9              "
M@=B4 @!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @ SXVH
M5BOV>]W4 @  =P@  !D              ("!F9H" 'AL+W=O<FMS:&5E=',O
M<VAE970V.2YX;6Q02P$"% ,4    " #/C:A6N)*6\](#  "T#@  &0
M        @(&DG0( >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0
M   ( ,^-J%;+3+2JW@@  -A*   9              " @:VA @!X;"]W;W)K
M<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ SXVH5OD6/BC'!   ?!$
M !D              ("!PJH" 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q0
M2P$"% ,4    " #/C:A6;;:T,W($   )$0  &0              @(' KP(
M>&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( ,^-J%81YW;Z
MUP,  "P-   9              " @6FT @!X;"]W;W)K<VAE971S+W-H965T
M-S0N>&UL4$L! A0#%     @ SXVH5FD.BK+2"   Z5L  !D
M ("!=[@" 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4    " #/
MC:A6%6Z^/&L&  ![*   &0              @(& P0( >&PO=V]R:W-H965T
M<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( ,^-J%91&X4,?@(  /D%   9
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M970X,2YX;6Q02P$"% ,4    " #/C:A6L/O:!'$$  "H&P  &0
M    @(%9W0( >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0    (
M ,^-J%;\.=5!(0,  -X,   9              " @0'B @!X;"]W;W)K<VAE
M971S+W-H965T.#,N>&UL4$L! A0#%     @ SXVH5A0?&#5D!0  ,AX  !D
M             ("!6>4" 'AL+W=O<FMS:&5E=',O<VAE970X-"YX;6Q02P$"
M% ,4    " #/C:A6.(P;=$(#  "^#0  &0              @('TZ@( >&PO
M=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    ( ,^-J%:B<Q$>XP4
M +XB   9              " @6WN @!X;"]W;W)K<VAE971S+W-H965T.#8N
M>&UL4$L! A0#%     @ SXVH5J9.AM%) P  \ T  !D              ("!
MA_0" 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"% ,4    " #/C:A6
M%U^9@I\+   7D   &0              @($'^ ( >&PO=V]R:W-H965T<R]S
M:&5E=#@X+GAM;%!+ 0(4 Q0    ( ,^-J%:9AQ!*X0P  #C-   9
M      " @=T# P!X;"]W;W)K<VAE971S+W-H965T.#DN>&UL4$L! A0#%
M  @ SXVH5B<PYYEF"   .U,  !D              ("!]1 # 'AL+W=O<FMS
M:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4    " #/C:A6,')OTFD&  "I.@
M&0              @(&2&0, >&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+
M 0(4 Q0    ( ,^-J%9EC_PSN@,  + 1   9              " @3(@ P!X
M;"]W;W)K<VAE971S+W-H965T.3(N>&UL4$L! A0#%     @ SXVH5I[L2_^N
M @  %@D  !D              ("!(R0# 'AL+W=O<FMS:&5E=',O<VAE970Y
M,RYX;6Q02P$"% ,4    " #/C:A6IK,S:A@1  !9Z   &0
M@($()P, >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;%!+ 0(4 Q0    ( ,^-
MJ%8UTW8KG@,  "$+   9              " @5<X P!X;"]W;W)K<VAE971S
M+W-H965T.34N>&UL4$L! A0#%     @ SXVH5JG\(J*@!@  /"@  !D
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M=#$P,"YX;6Q02P$"% ,4    " #/C:A6J %VLU8+  !HC   &@
M    @(%M4 , >&PO=V]R:W-H965T<R]S:&5E=#$P,2YX;6Q02P$"% ,4
M" #/C:A6CMPT## #  "B"P  &@              @('[6P, >&PO=V]R:W-H
M965T<R]S:&5E=#$P,BYX;6Q02P$"% ,4    " #/C:A66/UJXNH'  #$4
M&@              @(%C7P, >&PO=V]R:W-H965T<R]S:&5E=#$P,RYX;6Q0
M2P$"% ,4    " #/C:A60RP::QP#  ")"   &@              @(&%9P,
M>&PO=V]R:W-H965T<R]S:&5E=#$P-"YX;6Q02P$"% ,4    " #/C:A66>Z^
MH<(&  !34   &@              @('9:@, >&PO=V]R:W-H965T<R]S:&5E
M=#$P-2YX;6Q02P$"% ,4    " #/C:A6N^2DJ7T#   ?#P  &@
M    @('3<0, >&PO=V]R:W-H965T<R]S:&5E=#$P-BYX;6Q02P$"% ,4
M" #/C:A670)/QU\$  #*%@  &@              @(&(=0, >&PO=V]R:W-H
M965T<R]S:&5E=#$P-RYX;6Q02P$"% ,4    " #/C:A6I&)VX1 #  "_"0
M&@              @($?>@, >&PO=V]R:W-H965T<R]S:&5E=#$P."YX;6Q0
M2P$"% ,4    " #/C:A64OSR!L4"  #M"   &@              @(%G?0,
M>&PO=V]R:W-H965T<R]S:&5E=#$P.2YX;6Q02P$"% ,4    " #/C:A6CM#T
ML1X$  #,%0  &@              @(%D@ , >&PO=V]R:W-H965T<R]S:&5E
M=#$Q,"YX;6Q02P$"% ,4    " #/C:A6DTBWI;PR  !P(P0 &@
M    @(&ZA , >&PO=V]R:W-H965T<R]S:&5E=#$Q,2YX;6Q02P$"% ,4
M" #/C:A66L9L")4"  "Y!@  &@              @(&NMP, >&PO=V]R:W-H
M965T<R]S:&5E=#$Q,BYX;6Q02P$"% ,4    " #/C:A6?6! 42T#  !#"P
M&@              @(%[N@, >&PO=V]R:W-H965T<R]S:&5E=#$Q,RYX;6Q0
M2P$"% ,4    " #/C:A6O/[/<%<)  "+:   &@              @('@O0,
M>&PO=V]R:W-H965T<R]S:&5E=#$Q-"YX;6Q02P$"% ,4    " #/C:A6&?"\
MY1<+  "47   &@              @(%OQP, >&PO=V]R:W-H965T<R]S:&5E
M=#$Q-2YX;6Q02P$"% ,4    " #/C:A68.JQR]@"  !L"0  &@
M    @(&^T@, >&PO=V]R:W-H965T<R]S:&5E=#$Q-BYX;6Q02P$"% ,4
M" #/C:A6CXQZ%TT"  #+!0  &@              @('.U0, >&PO=V]R:W-H
M965T<R]S:&5E=#$Q-RYX;6Q02P$"% ,4    " #/C:A6'>:<!/,3  !9R@
M&@              @(%3V , >&PO=V]R:W-H965T<R]S:&5E=#$Q."YX;6Q0
M2P$"% ,4    " #/C:A6?Z7;J50$  "-&   &@              @(%^[ ,
M>&PO=V]R:W-H965T<R]S:&5E=#$Q.2YX;6Q02P$"% ,4    " #/C:A6T;UD
MCY8%  "J'P  &@              @($*\0, >&PO=V]R:W-H965T<R]S:&5E
M=#$R,"YX;6Q02P$"% ,4    " #/C:A6<K<6I'X#  "K%P  #0
M    @ '8]@, >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ,^-J%:7BKL<P
M !,"   +              "  8'Z P!?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M ,^-J%9*((0W\@<  "I/   /              "  6K[ P!X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " #/C:A6;/*&>TP#  !K1@  &@
M@ &) P0 >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #/
MC:A6@_^P6I<"  "+0P  $P              @ $-!P0 6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     @ "  $PC  #5"00    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>645</ContextCount>
  <ElementCount>758</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>217</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>26</UnitCount>
  <MyReports>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParentheticals</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (DEFICIT) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Business Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestitures</Role>
      <ShortName>Business Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Restructuring, Impairment, and Related Charges, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet</Role>
      <ShortName>Restructuring, Impairment, and Related Charges, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Other Income, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/OtherIncomeNet</Role>
      <ShortName>Other Income, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Earnings (Loss) Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShare</Role>
      <ShortName>Earnings (Loss) Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Debt and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivities</Role>
      <ShortName>Debt and Financing Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Pension Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefits</Role>
      <ShortName>Pension Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivities</Role>
      <ShortName>Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Financial Guarantees and Warranties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FinancialGuaranteesandWarranties</Role>
      <ShortName>Financial Guarantees and Warranties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficit</Role>
      <ShortName>Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Related Party Balances and Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RelatedPartyBalancesandTransactions</Role>
      <ShortName>Related Party Balances and Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Segments of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusiness</Role>
      <ShortName>Segments of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS</Role>
      <ShortName>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Business Acquisitions and Divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables</Role>
      <ShortName>Business Acquisitions and Divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/BusinessAcquisitionsandDivestitures</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Restructuring, Impairment, and Related Charges, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables</Role>
      <ShortName>Restructuring, Impairment, and Related Charges, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/ShareBasedCompensation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Other Income, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/OtherIncomeNetTables</Role>
      <ShortName>Other Income, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/OtherIncomeNet</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/IncomeTaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Earnings (Loss) Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareTables</Role>
      <ShortName>Earnings (Loss) Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShare</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/Leases</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Debt and Financing Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesTables</Role>
      <ShortName>Debt and Financing Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/DebtandFinancingActivities</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Pension Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsTables</Role>
      <ShortName>Pension Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/PensionBenefits</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesTables</Role>
      <ShortName>Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HedgingActivities</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FairValueMeasurements</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Commitments and Contingent Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables</Role>
      <ShortName>Commitments and Contingent Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/CommitmentsandContingentLiabilities</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Stockholders' Equity (Deficit) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitTables</Role>
      <ShortName>Stockholders' Equity (Deficit) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficit</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Segments of Business (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessTables</Role>
      <ShortName>Segments of Business (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusiness</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Significant Accounting Policies - Receivables, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails</Role>
      <ShortName>Significant Accounting Policies - Receivables, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Significant Accounting Policies - Property, Plant and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails</Role>
      <ShortName>Significant Accounting Policies - Property, Plant and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Business Acquisitions and Divestitures - Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails</Role>
      <ShortName>Business Acquisitions and Divestitures - Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Rx Savings Solutions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails</Role>
      <ShortName>Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Rx Savings Solutions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Oncology Research) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails</Role>
      <ShortName>Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Oncology Research) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Business Acquisitions and Divestitures - Divestitures and Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails</Role>
      <ShortName>Business Acquisitions and Divestitures - Divestitures and Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (E.U. and U.K. Disposal Groups) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails</Role>
      <ShortName>Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (E.U. and U.K. Disposal Groups) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Details for Charges Recorded (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges, Net - Summary of Details for Charges Recorded (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Activity Related to Restructuring Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges, Net - Summary of Activity Related to Restructuring Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Share-Based Compensation - Components of Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation - Components of Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Share-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails</Role>
      <ShortName>Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Share-Based Compensation - Summary of Stock Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails</Role>
      <ShortName>Share-Based Compensation - Summary of Stock Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Other Income, Net - Schedule of Other Income, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails</Role>
      <ShortName>Other Income, Net - Schedule of Other Income, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails</Role>
      <ShortName>Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Income Taxes - Components Of Deferred Tax Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails</Role>
      <ShortName>Income Taxes - Components Of Deferred Tax Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Gross Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Earnings (Loss) Per Common Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareNarrativeDetails</Role>
      <ShortName>Earnings (Loss) Per Common Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShareTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Earnings (Loss) Per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails</Role>
      <ShortName>Earnings (Loss) Per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShareTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Leases - Components of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails</Role>
      <ShortName>Leases - Components of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Debt and Financing Activities - Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Debt and Financing Activities - Tender Offer and Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails</Role>
      <ShortName>Debt and Financing Activities - Tender Offer and Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails</Role>
      <ShortName>Debt and Financing Activities - Revolving Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Debt and Financing Activities - Other Facilities and Commercial Paper (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails</Role>
      <ShortName>Debt and Financing Activities - Other Facilities and Commercial Paper (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/VariableInterestEntitiesDetails</Role>
      <ShortName>Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/VariableInterestEntities</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - Pension Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsNarrativeDetails</Role>
      <ShortName>Pension Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails</Role>
      <ShortName>Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails</Role>
      <ShortName>Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails</Role>
      <ShortName>Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails</Role>
      <ShortName>Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails</Role>
      <ShortName>Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0000102 - Disclosure - Pension Benefits - Schedule of Investments Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails</Role>
      <ShortName>Pension Benefits - Schedule of Investments Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0000103 - Disclosure - Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesNarrativeDetails</Role>
      <ShortName>Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0000104 - Disclosure - Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails</Role>
      <ShortName>Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>0000105 - Disclosure - Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails</Role>
      <ShortName>Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>0000106 - Disclosure - Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails</Role>
      <ShortName>Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>0000107 - Disclosure - Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails</Role>
      <ShortName>Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>0000108 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>0000109 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>0000110 - Disclosure - Financial Guarantees and Warranties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails</Role>
      <ShortName>Financial Guarantees and Warranties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FinancialGuaranteesandWarranties</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>0000111 - Disclosure - Commitments and Contingent Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingent Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>0000112 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>0000113 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>0000114 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Schedule of Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>0000115 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>0000116 - Disclosure - Related Party Balances and Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails</Role>
      <ShortName>Related Party Balances and Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RelatedPartyBalancesandTransactions</ParentRole>
      <Position>116</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>0000117 - Disclosure - Segments of Business - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails</Role>
      <ShortName>Segments of Business - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>0000118 - Disclosure - Segments of Business - Schedule of Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails</Role>
      <ShortName>Segments of Business - Schedule of Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>0000119 - Disclosure - Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails</Role>
      <ShortName>Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="mck-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>0000120 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails</Role>
      <ShortName>SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS</ParentRole>
      <Position>120</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RevenueFromRelatedParties in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. mck-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 10 fact(s) appearing in ix:hidden were eligible for transformation: mck:GuarantorObligationsPeriod, mck:LossContingencyNumberOfStatesFiledOnBehalfOf, us-gaap:FiniteLivedIntangibleAssetUsefulLife, us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1, us-gaap:LesseeOperatingLeaseTermOfContract, us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  mck-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="mck-20230331.htm">mck-20230331.htm</File>
    <File>mck-20230331.xsd</File>
    <File>mck-20230331_cal.xml</File>
    <File>mck-20230331_def.xml</File>
    <File>mck-20230331_lab.xml</File>
    <File>mck-20230331_pre.xml</File>
    <File>mck_exhibit21x3312023.htm</File>
    <File>mck_exhibit23x3312023.htm</File>
    <File>mck_exhibit311x3312023.htm</File>
    <File>mck_exhibit312x3312023.htm</File>
    <File>mck_exhibit32x3312023.htm</File>
    <File>mck_exhibit415x3312023.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mck-20230331_g1.jpg</File>
    <File>mck-20230331_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="2101">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="46">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>142
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mck-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 54,
   "baseTaxonomies": {
    "http://fasb.org/srt/2022": 1,
    "http://fasb.org/us-gaap/2022": 2101,
    "http://xbrl.sec.gov/dei/2022": 46
   },
   "contextCount": 645,
   "dts": {
    "calculationLink": {
     "local": [
      "mck-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mck-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mck-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mck-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mck-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mck-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 1216,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 12,
    "http://mckesson123.com/20230331": 4,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 20
   },
   "keyCustom": 148,
   "keyStandard": 610,
   "memberCustom": 121,
   "memberStandard": 84,
   "nsprefix": "mck",
   "nsuri": "http://mckesson123.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://mckesson123.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://mckesson123.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
     "shortName": "Pension Benefits - Schedule of Weighted-Average Assumptions Used to Estimate Net Periodic Pension Expense and Actuarial Present Value of Benefit Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ie7a9b9f544264510b97f94b12eb3d7b2_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails",
     "shortName": "Pension Benefits - Summary of Pension Plan Assets Using Fair Value Hierarchy by Asset Class (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i736fe7819f714241ad16df84489ece06_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - Pension Benefits - Schedule of Investments Measured at Fair Value (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
     "shortName": "Pension Benefits - Schedule of Investments Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - Hedging Activities - Narrative (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
     "shortName": "Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "if95560d064ba4166a3331f01665e7c28_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "icde86b5b9cf640a3857b79b2a12f38f7_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
     "shortName": "Hedging Activities - Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i7f756df8d9cf4ff5bf43b455279a736b_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "eur",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000105 - Disclosure - Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)",
     "menuCat": "Details",
     "order": "105",
     "role": "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
     "shortName": "Hedging Activities - Schedule of Notional Amounts of Outstanding Derivative Positions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i451f85a810074a318c6fdba6392654ed_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "gbp",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i4e74926dad464e94bdc3f1c87eb5109a_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000106 - Disclosure - Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)",
     "menuCat": "Details",
     "order": "106",
     "role": "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
     "shortName": "Hedging Activities - Summary of Derivative Instruments Gain (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ie8dab7068d7b4998b54b905773776649_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i9919373fdaa44e9488d392bca8c37b57_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000107 - Disclosure - Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)",
     "menuCat": "Details",
     "order": "107",
     "role": "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
     "shortName": "Hedging Activities - Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i9919373fdaa44e9488d392bca8c37b57_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MoneyMarketFundsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000108 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "menuCat": "Details",
     "order": "108",
     "role": "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MoneyMarketFundsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000109 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)",
     "menuCat": "Details",
     "order": "109",
     "role": "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
     "shortName": "Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i193367ab1bd147669e6aa97c4b68b27c_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Business Acquisitions and Divestitures",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestitures",
     "shortName": "Business Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:GuaranteeObligationsExposureExpiringinYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000110 - Disclosure - Financial Guarantees and Warranties (Details)",
     "menuCat": "Details",
     "order": "110",
     "role": "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
     "shortName": "Financial Guarantees and Warranties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:GuaranteeObligationsExposureExpiringinYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "icf72768e9e58489a9cfe3dcada7cea25_D20211008-20211008",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNumberOfPlaintiffs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "plaintiff",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000111 - Disclosure - Commitments and Contingent Liabilities (Details)",
     "menuCat": "Details",
     "order": "111",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
     "shortName": "Commitments and Contingent Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "icf72768e9e58489a9cfe3dcada7cea25_D20211008-20211008",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNumberOfPlaintiffs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "plaintiff",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i0140a17cab884d1492bcaa9df5a4d5a3_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000112 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "menuCat": "Details",
     "order": "112",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
     "shortName": "Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i0140a17cab884d1492bcaa9df5a4d5a3_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000113 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)",
     "menuCat": "Details",
     "order": "113",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails",
     "shortName": "Stockholders' Equity (Deficit) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AcceleratedShareRepurchasesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i24ea2536cc79402c87a81416ae3171dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000114 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Share Repurchases (Details)",
     "menuCat": "Details",
     "order": "114",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails",
     "shortName": "Stockholders' Equity (Deficit) - Schedule of Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AcceleratedShareRepurchasesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i56ca92db1bf347039646a68953e87fed_I20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i24ea2536cc79402c87a81416ae3171dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000115 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)",
     "menuCat": "Details",
     "order": "115",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails",
     "shortName": "Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i4e74926dad464e94bdc3f1c87eb5109a_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ia0d5849c66ff44049855a2ac70d7759e_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000116 - Disclosure - Related Party Balances and Transactions (Details)",
     "menuCat": "Details",
     "order": "116",
     "role": "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
     "shortName": "Related Party Balances and Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ia0d5849c66ff44049855a2ac70d7759e_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2fb6e5f190e74ccdae10ef40017a5792_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000117 - Disclosure - Segments of Business - Narrative (Details)",
     "menuCat": "Details",
     "order": "117",
     "role": "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
     "shortName": "Segments of Business - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000118 - Disclosure - Segments of Business - Schedule of Segment Information (Details)",
     "menuCat": "Details",
     "order": "118",
     "role": "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
     "shortName": "Segments of Business - Schedule of Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:GrossProfitNetofExpensesIncludingOtherIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000119 - Disclosure - Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details)",
     "menuCat": "Details",
     "order": "119",
     "role": "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails",
     "shortName": "Segments of Business - Segment Assets and Long-lived Assets by Geographical Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Restructuring, Impairment, and Related Charges, Net",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet",
     "shortName": "Restructuring, Impairment, and Related Charges, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i24ea2536cc79402c87a81416ae3171dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000120 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "menuCat": "Details",
     "order": "120",
     "role": "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails",
     "shortName": "SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i56ca92db1bf347039646a68953e87fed_I20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Share-Based Compensation",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://mckesson123.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Other Income, Net",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://mckesson123.com/role/OtherIncomeNet",
     "shortName": "Other Income, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://mckesson123.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Earnings (Loss) Per Common Share",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShare",
     "shortName": "Earnings (Loss) Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://mckesson123.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Goodwill and Intangible Assets, Net",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://mckesson123.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Debt and Financing Activities",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://mckesson123.com/role/DebtandFinancingActivities",
     "shortName": "Debt and Financing Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Variable Interest Entities",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://mckesson123.com/role/VariableInterestEntities",
     "shortName": "Variable Interest Entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Pension Benefits",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://mckesson123.com/role/PensionBenefits",
     "shortName": "Pension Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Hedging Activities",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://mckesson123.com/role/HedgingActivities",
     "shortName": "Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://mckesson123.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:FinancialGuaranteesAndWarrantiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Financial Guarantees and Warranties",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://mckesson123.com/role/FinancialGuaranteesandWarranties",
     "shortName": "Financial Guarantees and Warranties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:FinancialGuaranteesAndWarrantiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Commitments and Contingent Liabilities",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Stockholders' Equity (Deficit)",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficit",
     "shortName": "Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Related Party Balances and Transactions",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://mckesson123.com/role/RelatedPartyBalancesandTransactions",
     "shortName": "Related Party Balances and Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Segments of Business",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://mckesson123.com/role/SegmentsofBusiness",
     "shortName": "Segments of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS",
     "shortName": "SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "31",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Business Acquisitions and Divestitures (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables",
     "shortName": "Business Acquisitions and Divestitures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Restructuring, Impairment, and Related Charges, Net (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables",
     "shortName": "Restructuring, Impairment, and Related Charges, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Share-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://mckesson123.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Other Income, Net (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://mckesson123.com/role/OtherIncomeNetTables",
     "shortName": "Other Income, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://mckesson123.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Earnings (Loss) Per Common Share (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareTables",
     "shortName": "Earnings (Loss) Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://mckesson123.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mck:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Debt and Financing Activities (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesTables",
     "shortName": "Debt and Financing Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Pension Benefits (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://mckesson123.com/role/PensionBenefitsTables",
     "shortName": "Pension Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Hedging Activities (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://mckesson123.com/role/HedgingActivitiesTables",
     "shortName": "Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://mckesson123.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Commitments and Contingent Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables",
     "shortName": "Commitments and Contingent Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Stockholders' Equity (Deficit) (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitTables",
     "shortName": "Stockholders' Equity (Deficit) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Segments of Business (Tables)",
     "menuCat": "Tables",
     "order": "48",
     "role": "http://mckesson123.com/role/SegmentsofBusinessTables",
     "shortName": "Segments of Business (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2fb6e5f190e74ccdae10ef40017a5792_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ReceivablesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:AccountsReceivableCustomerAccountsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Significant Accounting Policies - Receivables, Net (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails",
     "shortName": "Significant Accounting Policies - Receivables, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:AccountsReceivableCustomerAccountsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Significant Accounting Policies - Property, Plant and Equipment, Net (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails",
     "shortName": "Significant Accounting Policies - Property, Plant and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Business Acquisitions and Divestitures - Acquisitions (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
     "shortName": "Business Acquisitions and Divestitures - Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i9641805d39b54755bb865f24f51f1b5d_I20221101",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Rx Savings Solutions) (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails",
     "shortName": "Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Rx Savings Solutions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ia4dd209b573244c7881d99fe517c75d8_D20221101-20221101",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Oncology Research) (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
     "shortName": "Business Acquisitions and Divestitures - Identified Assets Acquired and Liabilities Assumed (Oncology Research) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i3d3c088aa81a474f85344b4391dd1c61_D20221031-20221031",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:BusinessCombinationConsiderationTransferredOwnershipInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Business Acquisitions and Divestitures - Divestitures and Other (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
     "shortName": "Business Acquisitions and Divestitures - Divestitures and Other (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2646e19a2c8440d08bc15a4216ccadaf_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ibe5a2e65fb56419382b72990eee9a1e3_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (E.U. and U.K. Disposal Groups) (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
     "shortName": "Business Acquisitions and Divestitures - Assets and Liabilities Held for Sale (E.U. and U.K. Disposal Groups) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ibe5a2e65fb56419382b72990eee9a1e3_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:RestructuringImpairmentandOtherRelatedCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Narrative (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
     "shortName": "Restructuring, Impairment, and Related Charges, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ie1ad9e5e8f13437e83ec2ed5b6ca20ee_D20200401-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Details for Charges Recorded (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
     "shortName": "Restructuring, Impairment, and Related Charges, Net - Summary of Details for Charges Recorded (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i24ea2536cc79402c87a81416ae3171dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Restructuring, Impairment, and Related Charges, Net - Summary of Activity Related to Restructuring Liability (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
     "shortName": "Restructuring, Impairment, and Related Charges, Net - Summary of Activity Related to Restructuring Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserveSettledWithoutCash2",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Share-Based Compensation - Components of Share-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
     "shortName": "Share-Based Compensation - Components of Share-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Share-Based Compensation - Narrative (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i19acbfe54421472fb6c6c57213d527bf_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "mck:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
     "shortName": "Share-Based Compensation - Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of RSUs and PSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i194bfd7f58694118b6608f52ec99adf8_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
     "shortName": "Share-Based Compensation - Schedule of RSUs and PSUs Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i194bfd7f58694118b6608f52ec99adf8_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:DataRelatedtoRSUActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails",
     "shortName": "Share-Based Compensation - Summary of Data Related to RSUs and PSUs Award Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:DataRelatedtoRSUActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i696b2d9c0b2e43f9b7343ede4c0a0f03_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Share-Based Compensation - Summary of Stock Options Outstanding (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails",
     "shortName": "Share-Based Compensation - Summary of Stock Options Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i24ea2536cc79402c87a81416ae3171dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails",
     "shortName": "Share-Based Compensation - Schedule of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
     "shortName": "Share-Based Compensation - Schedule of Data Related to Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ie47b6c58fa514cdcb04039f5c38ed249_D20220401-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Other Income, Net - Schedule of Other Income, Net (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
     "shortName": "Other Income, Net - Schedule of Other Income, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Schedule of Income from Continuing Operations Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i0a1422fa33ff4ef8be96240fe701c4a8_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i0a1422fa33ff4ef8be96240fe701c4a8_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails",
     "shortName": "Income Taxes - Components Of Provision For Income Taxes Related To Continuing Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails",
     "shortName": "Income Taxes - Reconciliation Between Effective Tax Rate On Income From Continuing Operations And Statutory Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Income Taxes - Components Of Deferred Tax Balances (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
     "shortName": "Income Taxes - Components Of Deferred Tax Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i24ea2536cc79402c87a81416ae3171dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Income Taxes - Gross Unrecognized Tax Benefits (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Gross Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i1f2d9133245747b1a400a98a3daea68f_I20180919",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i1f2d9133245747b1a400a98a3daea68f_I20180919",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i24ea2536cc79402c87a81416ae3171dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i0cc8f77e582c44e08a058298c7783eaa_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Earnings (Loss) Per Common Share - Narrative (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareNarrativeDetails",
     "shortName": "Earnings (Loss) Per Common Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Earnings (Loss) Per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
     "shortName": "Earnings (Loss) Per Common Share - Schedule of Basic and Diluted Earnings per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mck:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "idf21b957ae1643249d6ecd39408dd77d_D20220701-20220731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Parentheticals)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParentheticals",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (DEFICIT) (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Leases - Components of Lease Costs (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails",
     "shortName": "Leases - Components of Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://mckesson123.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Leases - Maturities of Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://mckesson123.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mck:LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i24ea2536cc79402c87a81416ae3171dd_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2fb6e5f190e74ccdae10ef40017a5792_D20200701-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Goodwill Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ia73bbbf5c3f94136997b8becbe0d75fb_D20210401-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Intangible Assets Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "iaa923d2ce3d540a0acb1c546c38a17c5_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Debt and Financing Activities - Long-Term Debt (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfDebtExtinguishmentCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Debt and Financing Activities - Tender Offer and Other Information (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails",
     "shortName": "Debt and Financing Activities - Tender Offer and Other Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
     "shortName": "Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i86beb9ab012e4ab98ab444ffd6a60f1d_D20221001-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfCommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Debt and Financing Activities - Other Facilities and Commercial Paper (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails",
     "shortName": "Debt and Financing Activities - Other Facilities and Commercial Paper (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfCommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Variable Interest Entities (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://mckesson123.com/role/VariableInterestEntitiesDetails",
     "shortName": "Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i2ff10e823cba4f38b2c4399434a229ba_I20230331",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Pension Benefits - Narrative (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
     "shortName": "Pension Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i61a2e448f9a94c9a9fe929868d65511e_D20220401-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
     "shortName": "Pension Benefits - Schedule of Net Periodic Expense for Pension Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "ia784a6947b0a4723826434b0538ae8e9_D20210401-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
     "shortName": "Pension Benefits - Schedule of Changes in Benefit Obligations and Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i8526b8b91b7b41a8b075fd3451c4af50_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
     "shortName": "Pension Benefits - Schedule of Projected Benefit Obligation, Accumulated Benefit Obligation and Fair Value of Plan Assets for Pension Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i8526b8b91b7b41a8b075fd3451c4af50_I20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i8526b8b91b7b41a8b075fd3451c4af50_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Pension Benefits - Schedule of Amounts Recognized in Accumulated Other Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i8526b8b91b7b41a8b075fd3451c4af50_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Pension Benefits - Schedule of Other Changes in Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20230331.htm",
      "contextRef": "i816b059163a54e5bb0203bcaacbe1d3d_D20220401-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 217,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_GB": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "U.K."
       }
      }
     },
     "localname": "GB",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CAD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada, Dollars",
        "terseLabel": "CAD"
       }
      }
     },
     "localname": "CAD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "EUR"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "GBP"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "USD"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r1074",
      "r1075",
      "r1076"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r1074",
      "r1075",
      "r1076"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r1074",
      "r1075",
      "r1076"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r1074",
      "r1075",
      "r1076"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r1077"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r1078"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r1079"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r1074",
      "r1075",
      "r1076"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1070"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mck_A063EuroNotesDueAugust172021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.63% Euro Notes Due August 17, 2021",
        "label": "0.63% Euro Notes Due August 17, 2021 [Member]",
        "terseLabel": "0.63% Euro Notes Due August 17, 2021"
       }
      }
     },
     "localname": "A063EuroNotesDueAugust172021Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A090NotesDueDecember32025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.90% Notes Due December 3, 2025",
        "label": "0.90% Notes Due December 3, 2025 [Member]",
        "terseLabel": "0.90% Notes due December 3, 2025"
       }
      }
     },
     "localname": "A090NotesDueDecember32025Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1.500NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.500% Notes Due 2025 [Member]",
        "label": "1.500% Notes Due 2025 [Member]",
        "terseLabel": "1.500% Notes due 2025"
       }
      }
     },
     "localname": "A1.500NotesDue2025Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1.625NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.625% Notes Due 2026 [Member]",
        "label": "1.625% Notes Due 2026 [Member]",
        "terseLabel": "1.625% Notes due 2026"
       }
      }
     },
     "localname": "A1.625NotesDue2026Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A130NotesDueAugust152026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.30% Notes Due August 15, 2026",
        "label": "1.30% Notes Due August 15, 2026 [Member]",
        "terseLabel": "1.30% Notes due August 15, 2026"
       }
      }
     },
     "localname": "A130NotesDueAugust152026Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A150EuroNotesDueNovember172025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.50% Euro Notes Due November 17, 2025",
        "label": "1.50% Euro Notes Due November 17, 2025 [Member]",
        "terseLabel": "1.50% Euro Notes due November 17, 2025"
       }
      }
     },
     "localname": "A150EuroNotesDueNovember172025Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A163EuroNotesDueOctober302026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.63% Euro Notes Due October 30, 2026",
        "label": "1.63% Euro Notes Due October 30, 2026 [Member]",
        "terseLabel": "1.63% Euro Notes due October 30, 2026"
       }
      }
     },
     "localname": "A163EuroNotesDueOctober302026Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A2013StockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2013 Stock Plan [Member]",
        "label": "2013 Stock Plan [Member]",
        "terseLabel": "2013 Stock Plan"
       }
      }
     },
     "localname": "A2013StockPlanMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A2022StockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Stock Plan",
        "label": "2022 Stock Plan [Member]",
        "terseLabel": "2022 Stock Plan"
       }
      }
     },
     "localname": "A2022StockPlanMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A2022TermLoanCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Term Loan Credit Facility",
        "label": "2022 Term Loan Credit Facility [Member]",
        "terseLabel": "2022 Term Loan Credit Facility"
       }
      }
     },
     "localname": "A2022TermLoanCreditFacilityMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A270NotesDueDecember152022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.70% Notes Due December 15, 2022",
        "label": "2.70% Notes Due December 15, 2022 [Member]",
        "terseLabel": "2.70% Notes due December 15, 2022"
       }
      }
     },
     "localname": "A270NotesDueDecember152022Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A285NotesDueMarch152023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.85% Notes Due March 15, 2023",
        "label": "2.85% Notes Due March 15, 2023 [Member]",
        "terseLabel": "2.85% Notes due March 15, 2023"
       }
      }
     },
     "localname": "A285NotesDueMarch152023Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A3.125NotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125% Notes Due 2029 [Member]",
        "label": "3.125% Notes Due 2029 [Member]",
        "terseLabel": "3.125% Notes due 2029"
       }
      }
     },
     "localname": "A3.125NotesDue2029Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A313SterlingNotesDueFebruary172029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.13% Sterling Notes Due February 17, 2029",
        "label": "3.13% Sterling Notes Due February 17, 2029 [Member]",
        "terseLabel": "3.13% Sterling Notes due February 17, 2029"
       }
      }
     },
     "localname": "A313SterlingNotesDueFebruary172029Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A380NotesDueMarch152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.80% Notes Due March 15, 2024",
        "label": "3.80% Notes Due March 15, 2024 [Member]",
        "terseLabel": "3.80% Notes due March 15, 2024"
       }
      }
     },
     "localname": "A380NotesDueMarch152024Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A395NotesDueFebruary162028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.95% Notes Due February 16, 2028",
        "label": "3.95% Notes Due February 16, 2028 [Member]",
        "terseLabel": "3.95% Notes due February 16, 2028"
       }
      }
     },
     "localname": "A395NotesDueFebruary162028Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMarch12021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.75% Notes Due March 1, 2021",
        "label": "4.75% Notes Due March 1, 2021 [Member]",
        "terseLabel": "4.75% Notes Due March 1, 2021"
       }
      }
     },
     "localname": "A475NotesDueMarch12021Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMay302029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.75% Notes Due May 30, 2029",
        "label": "4.75% Notes Due May 30, 2029 [Member]",
        "terseLabel": "4.75% Notes due May 30, 2029"
       }
      }
     },
     "localname": "A475NotesDueMay302029Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A488NotesDueMarch152044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.88% Notes Due March 15, 2044",
        "label": "4.88% Notes Due March 15, 2044 [Member]",
        "terseLabel": "4.88% Notes due March 15, 2044"
       }
      }
     },
     "localname": "A488NotesDueMarch152044Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A525NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.25% Notes Due 2026",
        "label": "5.25% Notes Due 2026 [Member]",
        "terseLabel": "5.25% Notes Due 2026"
       }
      }
     },
     "localname": "A525NotesDue2026Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A525NotesDueFebruary152026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.25% Notes Due February 15, 2026",
        "label": "5.25% Notes Due February 15, 2026 [Member]",
        "terseLabel": "5.25% Notes due February 15, 2026"
       }
      }
     },
     "localname": "A525NotesDueFebruary152026Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A600NotesDueMarch12041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.00% Notes Due March 1, 2041",
        "label": "6.00% Notes Due March 1, 2041 [Member]",
        "terseLabel": "6.00% Notes due March 1, 2041"
       }
      }
     },
     "localname": "A600NotesDueMarch12041Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A765DebenturesDueMarch12027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "7.65% Debentures Due March 1, 2027",
        "label": "7.65% Debentures Due March 1, 2027 [Member]",
        "terseLabel": "7.65% Debentures due March 1, 2027"
       }
      }
     },
     "localname": "A765DebenturesDueMarch12027Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest",
        "label": "AOCI, Accumulated Gain (Loss), Net Investment Hedges, Including Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains (Losses) on Net Investment Hedges, Net of Tax"
       }
      }
     },
     "localname": "AOCIAccumulatedGainLossNetInvestmentHedgesIncludingNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase, December 2022",
        "label": "Accelerated Share Repurchase, December 2022 [Member]",
        "terseLabel": "Accelerated Share Repurchase, December 2022"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseDecember2022Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseFebruary2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase, February 2022",
        "label": "Accelerated Share Repurchase, February 2022 [Member]",
        "terseLabel": "Accelerated Share Repurchase, February 2022"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseFebruary2022Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseMay2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase, May 2021",
        "label": "Accelerated Share Repurchase, May 2021 [Member]",
        "terseLabel": "Accelerated Share Repurchase, May 2021"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseMay2021Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseMay2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase, May 2022",
        "label": "Accelerated Share Repurchase, May 2022 [Member]",
        "terseLabel": "Accelerated Share Repurchase, May 2022"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseMay2022Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase [Member]",
        "label": "Accelerated Share Repurchase [Member]",
        "terseLabel": "Accelerated Share Repurchase"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccountsReceivableCustomerAccountsGross": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Customer Accounts, Gross",
        "label": "Accounts Receivable, Customer Accounts, Gross",
        "terseLabel": "Customer accounts"
       }
      }
     },
     "localname": "AccountsReceivableCustomerAccountsGross",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AccruedShareRepurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Share Repurchases",
        "label": "Accrued Share Repurchases",
        "terseLabel": "Accrued shares repurchased"
       }
      }
     },
     "localname": "AccruedShareRepurchases",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "label": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "terseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "label": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "terseLabel": "Annual recurring compensation (in euro per share)"
       }
      }
     },
     "localname": "AnnualRecurringCompensationPerSharetoNoncontrollingInterests",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_AssetImpairmentChargesIncludingAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment Charges, Including Accelerated Depreciation",
        "label": "Asset Impairment Charges, Including Accelerated Depreciation",
        "terseLabel": "Asset impairments and accelerated depreciation"
       }
      }
     },
     "localname": "AssetImpairmentChargesIncludingAcceleratedDepreciation",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Supplemental balance sheet information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_AssetsForPlanBenefitsDefinedBenefitPlanCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets for Plan Benefits, Defined Benefit Plan, Current",
        "label": "Assets for Plan Benefits, Defined Benefit Plan, Current",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsForPlanBenefitsDefinedBenefitPlanCurrent",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets for Plan Benefits, Defined Benefit Plan, Noncurrent",
        "label": "Assets for Plan Benefits, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "AssetsForPlanBenefitsDefinedBenefitPlanNoncurrent",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information [Abstract]",
        "label": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://mckesson123.com/20230331",
     "xbrltype": "stringItemType"
    },
    "mck_AureliusElephantLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aurelius Elephant Limited",
        "label": "Aurelius Elephant Limited [Member]",
        "terseLabel": "Aurelius Elephant Limited"
       }
      }
     },
     "localname": "AureliusElephantLimitedMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AustrianBusinessOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Austrian Business Operations",
        "label": "Austrian Business Operations [Member]",
        "terseLabel": "Austrian Business Operations"
       }
      }
     },
     "localname": "AustrianBusinessOperationsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_BritishPoundSterlingDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "British Pound Sterling Denominated Notes [Member]",
        "label": "British Pound Sterling Denominated Notes [Member]",
        "terseLabel": "British Pound Sterling Denominated Notes"
       }
      }
     },
     "localname": "BritishPoundSterlingDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_BusinessCombinationConsiderationTransferredOwnershipInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Ownership Interest",
        "label": "Business Combination, Consideration Transferred, Ownership Interest",
        "terseLabel": "Contribution of USOR"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredOwnershipInterest",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Additional-Paid-In Capital",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Additional-Paid-In Capital",
        "negatedTerseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdditionalPaidInCapital",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Operating Lease Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Operating Lease Liabilities",
        "negatedTerseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermOperatingLeaseLiabilities",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canadian Health Benefit Claims Management and Plan Administrative Services Business",
        "label": "Canadian Health Benefit Claims Management and Plan Administrative Services Business [Member]",
        "terseLabel": "Canadian Health Benefit Claims Management and Plan Administrative Services Business"
       }
      }
     },
     "localname": "CanadianHealthBenefitClaimsManagementAndPlanAdministrativeServicesBusinessMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CapitalizedSoftwareHeldforInternalUseUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized Software Held for Internal Use, Useful Life",
        "label": "Capitalized Software Held for Internal Use, Useful Life",
        "terseLabel": "Capitalized software held for internal use, useful life"
       }
      }
     },
     "localname": "CapitalizedSoftwareHeldforInternalUseUsefulLife",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)",
        "label": "Cash, Cash Equivalents, Restricted Cash Classified within Assets Held for Sale, Period Increase (Decrease)",
        "terseLabel": "Cash, cash equivalents, and restricted cash classified within Assets held for sale"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashClassifiedWithinAssetsHeldForSalePeriodIncreaseDecrease",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cherokee Nation",
        "label": "Cherokee Nation [Member]",
        "terseLabel": "Cherokee Nation"
       }
      }
     },
     "localname": "CherokeeNationMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Civil Investigative Demands by the U.S. Attorney\u2019s Office for the Eastern District of New York [Member]",
        "label": "Civil Investigative Demands by the U.S. Attorney\u2019s Office for the Eastern District of New York [Member]",
        "terseLabel": "Civil Investigative Demands by the U.S. Attorney\u2019s Office for the Eastern District of New York"
       }
      }
     },
     "localname": "CivilInvestigativeDemandsbytheU.S.AttorneysOfficefortheEasternDistrictofNewYorkMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Claims And Demands From Government Agencies, Environmental Conditions",
        "label": "Claims And Demands From Government Agencies, Environmental Conditions [Member]",
        "terseLabel": "Claims And Demands From Government Agencies, Environmental Conditions"
       }
      }
     },
     "localname": "ClaimsAndDemandsFromGovernmentAgenciesEnvironmentalConditionsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CommonStockVotingRightsNumberofVotesPerCommonShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "label": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "terseLabel": "Number of votes per share of common stock permitted on proposals presented to stockholders (vote)"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberofVotesPerCommonShare",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_CorporateOperatingExpenseandOtherIncomeNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Operating Expense and Other Income, Net",
        "label": "Corporate Operating Expense and Other Income, Net",
        "negatedTerseLabel": "Corporate expenses, net"
       }
      }
     },
     "localname": "CorporateOperatingExpenseandOtherIncomeNet",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CurrentAssetLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Asset / Liability [Member]",
        "label": "Current Asset / Liability [Member]",
        "terseLabel": "Prepaid expenses and other/Other accrued liabilities"
       }
      }
     },
     "localname": "CurrentAssetLiabilityMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DataRelatedtoRSUActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Data Related to RSU Activity [Table Text Block]",
        "label": "Data Related to RSU Activity [Table Text Block]",
        "terseLabel": "Schedule of data related to restricted stock unit award activity"
       }
      }
     },
     "localname": "DataRelatedtoRSUActivityTableTextBlock",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_DebtInstrumentDaysAvailableForBorrowing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Days Available For Borrowing",
        "label": "Debt Instrument, Days Available For Borrowing",
        "terseLabel": "Debt instrument, days available for borrowing"
       }
      }
     },
     "localname": "DebtInstrumentDaysAvailableForBorrowing",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_DeferredTaxAssetLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Lease Obligations",
        "label": "Deferred Tax Asset, Lease Obligations",
        "terseLabel": "Lease obligations"
       }
      }
     },
     "localname": "DeferredTaxAssetLeaseObligations",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DeferredTaxAssetLitigationAndClaims": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Litigation and Claims",
        "label": "Deferred Tax Asset, Litigation and Claims",
        "terseLabel": "Opioid-related litigation and claims"
       }
      }
     },
     "localname": "DeferredTaxAssetLitigationAndClaims",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DeferredTaxLiabilitiesLeaseRightofuseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Lease Right-of-use Assets",
        "label": "Deferred Tax Liabilities, Lease Right-of-use Assets",
        "negatedTerseLabel": "Lease right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeaseRightofuseAssets",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized straight-line over the average remaining future service periods.",
        "label": "Defined Benefit Plan, Actuarial Losses, Percentage Exceeding Greater Of Projected Benefit Obligation Or Market Value of Assets",
        "terseLabel": "Unexpected actuarial losses (as a percent) (exceeding)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialLossesPercentageExceedingGreaterOfProjectedBenefitObligationOrMarketValueOfAssets",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)",
        "label": "Defined Benefit Plan, Amortization of Gains (Losses), Prior Service Cost (Credit) and Transition Obligations (Assets)",
        "terseLabel": "Amortization of unrecognized actuarial loss and prior service costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationofGainsLossesPriorServiceCostCreditandTransitionObligationsAssets",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanAnnuityContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Annuity Contracts",
        "label": "Defined Benefit Plan, Annuity Contracts [Member]",
        "terseLabel": "Annuity contracts"
       }
      }
     },
     "localname": "DefinedBenefitPlanAnnuityContractsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation, Change In Rate, Basis Points",
        "terseLabel": "Increase (decrease) in basis points"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationChangeInRateBasisPoints",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Demographic and Assumption Changes",
        "terseLabel": "Actuarial gain (loss), demographic and assumption changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationActuarialGainLossDemographicAndAssumptionChanges",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Discount Rate",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss), Discount Rate",
        "terseLabel": "Actuarial loss resulting from discount rate changes"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationActuarialGainLossDiscountRate",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment and Settlement",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment and Settlement",
        "negatedTerseLabel": "Curtailment/settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationIncreaseDecreaseForCurtailmentAndSettlement",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanBenefitObligationsExpensesPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Benefit Obligations, Expenses Paid",
        "label": "Defined Benefit Plan, Benefit Obligations, Expenses Paid",
        "negatedTerseLabel": "Expenses paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationsExpensesPaid",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanContributionsbyEmployerandPlanParticipants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Contributions by Employer and Plan Participants",
        "label": "Defined Benefit Plan, Contributions by Employer and Plan Participants",
        "terseLabel": "Employer and participant contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsbyEmployerandPlanParticipants",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset",
        "label": "Defined Benefit Plan, Employer Contributions Percent Exceed Plan Asset",
        "terseLabel": "Percentage of total plan contribution - exceeding (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanEmployerContributionsPercentExceedPlanAsset",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_DefinedBenefitPlanOtherFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Other Funds [Member]",
        "label": "Defined Benefit Plan, Other Funds [Member]",
        "terseLabel": "Real estate funds and Other"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherFundsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DefinedBenefitPlanPlanAssetsExpensesPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Plan Assets, Expenses Paid",
        "label": "Defined Benefit Plan, Plan Assets, Expenses Paid",
        "negatedTerseLabel": "Expenses paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsExpensesPaid",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DefinedContributionPlanMatchingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan Matching [Axis]",
        "label": "Defined Contribution Plan Matching [Axis]",
        "terseLabel": "Defined Contribution Plan Matching [Axis]"
       }
      }
     },
     "localname": "DefinedContributionPlanMatchingAxis",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_DefinedContributionPlanMatchingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Defined Contribution Plan Matching [Axis]",
        "label": "Defined Contribution Plan Matching [Domain]",
        "terseLabel": "Defined Contribution Plan Matching [Domain]"
       }
      }
     },
     "localname": "DefinedContributionPlanMatchingDomain",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DerecognitionOfNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture of Noncontrolling Interest",
        "label": "Derecognition of Noncontrolling Interests",
        "negatedTerseLabel": "Derecognition of noncontrolling interests in McKesson Europe AG"
       }
      }
     },
     "localname": "DerecognitionOfNoncontrollingInterests",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DerivativeNotionalAmountTerminated": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Notional Amount, Terminated",
        "label": "Derivative, Notional Amount, Terminated",
        "terseLabel": "Derivative, notional mount, terminated"
       }
      }
     },
     "localname": "DerivativeNotionalAmountTerminated",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Gain (Loss) in Charge for Remeasurement to Fair Value",
        "label": "Disposal Group, Including Discontinued Operation, Accumulated Other Comprehensive Loss in Charge for Remeasurement to Fair Value",
        "terseLabel": "Accumulated other comprehensive loss in charge for remeasurement to fair value"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccumulatedOtherComprehensiveLossInChargeForRemeasurementToFairValue",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Carrying Value Of Noncontrolling Interest",
        "label": "Disposal Group, Including Discontinued Operation, Carrying Value Of Noncontrolling Interest",
        "terseLabel": "Divested carrying value of noncontrolling interest held by minority shareholders"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCarryingValueOfNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "terseLabel": "Gross purchase price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationExpected",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration Receivable",
        "label": "Disposal Group, Including Discontinued Operation, Consideration Receivable",
        "terseLabel": "Consideration receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationReceivable",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net",
        "label": "Disposal Group, Including Discontinued Operation, Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "label": "Disposal Group, Including Discontinued Operation, Drafts and Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDraftsandAccountsPayableCurrent",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software",
        "label": "Disposal Group Including Discontinued Operation, Impairment Charge Related To Internally Developed Software",
        "terseLabel": "Impairment charge"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationImpairmentChargeRelatedToInternallyDevelopedSoftware",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Member]",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities, Current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLiabilitiesCurrentMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities",
        "label": "Disposal Group, Including Discontinued Operation, Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLongTermDebtCurrentMaturities",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities",
        "label": "Disposal Group, Including Discontinued Operation, Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationLongTermDebtExcludingCurrentMaturities",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityCurrent",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent",
        "label": "Disposal Group, Including Discontinued Operation, Operating Lease. Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current",
        "label": "Disposal Group Including Discontinued Operation, Operating Lease, Right-of-Use Assets, Current",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current",
        "label": "Disposal Group, Including Discontinued Operation, Other Non-current Liabilities, Current",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNonCurrentLiabilitiesCurrent",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Assets Derecognized",
        "terseLabel": "Disposal group, including discontinued operations, pension plan assets derecognized"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanAssetsDerecognized",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation Derecognized",
        "verboseLabel": "Pension liabilities derecognized"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligationDerecognized",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Pension Plan Obligation Derecognized",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Obligation Derecognized",
        "terseLabel": "Disposal group, including discontinued operations, pension plan obligation derecognized"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanObligationDerecognized",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current",
        "label": "Disposal Group, Including Discontinued Operation, Reclassified Other Non-current Assets, Current",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReclassifiedOtherNonCurrentAssetsCurrent",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized",
        "label": "Disposal Group, Not Discontinued Operation, Accumulated Gain (Loss) Derecognized",
        "terseLabel": "Accumulated other comprehensive gain (loss) derecognized"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationAccumulatedGainLossDerecognized",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationLossGainonWritedown1": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down1",
        "negatedTerseLabel": "Remeasurement of assets of businesses held for sale to fair value less costs to sell"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainonWritedown1",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DistributionandRetailBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distribution and Retail Business [Member]",
        "label": "Distribution and Retail Business [Member]",
        "terseLabel": "Distribution and Retail Business"
       }
      }
     },
     "localname": "DistributionandRetailBusinessMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EPSBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EPS Basic and Diluted",
        "label": "EPS Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson"
       }
      }
     },
     "localname": "EPSBasicAndDilutedAbstract",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_EUBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E.U. Businesses (Disposal Group)",
        "label": "E.U. Businesses (Disposal Group) [Member]",
        "terseLabel": "E.U. Businesses (Disposal Group)"
       }
      }
     },
     "localname": "EUBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Disposal Transaction Loss, Amount",
        "terseLabel": "E.U. disposal transaction loss"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDisposalTransactionLossAmount",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit",
        "label": "Effective Income Tax Rate Reconciliation,Intellectual Property Transfer, Net Tax Benefit",
        "negatedTerseLabel": "Net tax benefit on intellectual property transfer"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransferNetTaxBenefit",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Lapse Of Applicable Statute Of Limitations And Tax Settlement, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Lapse Of Applicable Statute Of Limitations And Tax Settlement, Amount",
        "negatedTerseLabel": "Discrete tax benefits related to statute of limitation expirations and tax settlements"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationLapseOfApplicableStatuteOfLimitationsAndTaxSettlementAmount",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EffectiveIncomeTaxRateReconciliationLitigationAndClaims": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Litigation and Claims",
        "label": "Effective Income Tax Rate Reconciliation, Litigation and Claims",
        "terseLabel": "Opioid-related litigation and claims"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationLitigationAndClaims",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EmployeeContributions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of contributions made by plan participants. This item represents a periodic increase to the plan obligation and a percentage increase to plan assets.",
        "label": "Employee Contributions",
        "terseLabel": "Employee contributions (as a percent)"
       }
      }
     },
     "localname": "EmployeeContributions",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]",
        "label": "Employee Retention Expenses, Asset Impairments and Accelerated Depreciation [Member]",
        "terseLabel": "Employee Retention Expenses, Asset Impairments and Accelerated Depreciation"
       }
      }
     },
     "localname": "EmployeeRetentionExpensesAssetImpairmentsandAcceleratedDepreciationMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee service share based compensation period to purchase shares through payroll deductions",
        "label": "Employee Service Share Based Compensation Period To Purchase Shares Through Payroll Deductions",
        "terseLabel": "Period over which payroll is deducted to purchase shares"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationPeriodToPurchaseSharesThroughPayrollDeductions",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]",
        "label": "Employee Severance, Accelerated Depreciation and Project Consulting Fees [Member]",
        "terseLabel": "Employee Severance, Accelerated Depreciation and Project Consulting Fees"
       }
      }
     },
     "localname": "EmployeeSeveranceAcceleratedDepreciationandProjectConsultingFeesMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EnvironmentalLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environmental Litigation [Member]",
        "label": "Environmental Litigation [Member]",
        "terseLabel": "Environmental Litigation"
       }
      }
     },
     "localname": "EnvironmentalLitigationMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EnvironmentalLossContingencyAgreedRemediationNumberOfSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environmental Loss Contingency, Agreed Remediation, Number Of Sites",
        "label": "Environmental Loss Contingency, Agreed Remediation, Number Of Sites",
        "terseLabel": "Environmental loss contingency, agreed remediation, number of sites"
       }
      }
     },
     "localname": "EnvironmentalLossContingencyAgreedRemediationNumberOfSites",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "label": "Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "terseLabel": "Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag"
       }
      }
     },
     "localname": "EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_EquitySecuritiesFVNIGainLossExcludingImpairmentLosses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Gain (Loss), Excluding Impairment Losses",
        "label": "Equity Securities, FV-NI, Gain (Loss), Excluding Impairment Losses",
        "terseLabel": "Net gains on investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIGainLossExcludingImpairmentLosses",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EstimatedEnvironmentalAssessmentAndCleanupCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Environmental Assessment And Cleanup Costs",
        "label": "Estimated Environmental Assessment And Cleanup Costs",
        "terseLabel": "Estimated environmental assessment and cleanup costs"
       }
      }
     },
     "localname": "EstimatedEnvironmentalAssessmentAndCleanupCosts",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EuroDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Notes [Member]",
        "label": "Euro Denominated Notes [Member]",
        "terseLabel": "Euro Denominated Notes"
       }
      }
     },
     "localname": "EuroDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EuropeanAssetsHeldForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Assets Held for Sale",
        "label": "European Assets Held for Sale [Member]",
        "terseLabel": "European Assets Held for Sale"
       }
      }
     },
     "localname": "EuropeanAssetsHeldForSaleMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EuropeanBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Businesses (Disposal Group)",
        "label": "European Businesses (Disposal Group) [Member]",
        "terseLabel": "European Businesses (Disposal Group)"
       }
      }
     },
     "localname": "EuropeanBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EvanstonPolicePensionFundv.McKessonCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evanston Police Pension Fund v. McKesson Corporation [Member]",
        "label": "Evanston Police Pension Fund v. McKesson Corporation [Member]",
        "terseLabel": "Evanston Police Pension Fund v. McKesson Corporation"
       }
      }
     },
     "localname": "EvanstonPolicePensionFundv.McKessonCorporationMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Assets And Liabilities, Lessee",
        "label": "Finance Lease, Assets And Liabilities, Lessee [Abstract]",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_FinancialGuaranteesAndWarrantiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Guarantees And Warranties [Abstract]",
        "label": "Financial Guarantees And Warranties [Abstract]",
        "terseLabel": "Financial Guarantees And Warranties [Abstract]"
       }
      }
     },
     "localname": "FinancialGuaranteesAndWarrantiesAbstract",
     "nsuri": "http://mckesson123.com/20230331",
     "xbrltype": "stringItemType"
    },
    "mck_FinancialGuaranteesAndWarrantiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial guarantees And warranties.",
        "label": "Financial Guarantees And Warranties [Text Block]",
        "terseLabel": "Financial Guarantees And Warranties"
       }
      }
     },
     "localname": "FinancialGuaranteesAndWarrantiesTextBlock",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarranties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_FirstPartOfPayContributionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Part Of Pay Contribution [Member]",
        "label": "First Part Of Pay Contribution [Member]",
        "terseLabel": "First Part Of Pay Contribution"
       }
      }
     },
     "localname": "FirstPartOfPayContributionMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FixedInterestRateSwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Interest Rate Swap",
        "label": "Fixed Interest Rate Swap [Member]",
        "terseLabel": "Fixed interest rate swaps"
       }
      }
     },
     "localname": "FixedInterestRateSwapMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FormationOfBusiness": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Formation Of Business",
        "label": "Formation Of Business",
        "terseLabel": "Formation of SCRI Oncology, LLC"
       }
      }
     },
     "localname": "FormationOfBusiness",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GainLossOnDerivativeTermination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Derivative Termination",
        "label": "Gain (Loss) On Derivative Termination",
        "negatedTerseLabel": "Gain on derivative termination",
        "terseLabel": "Gain on derivative termination"
       }
      }
     },
     "localname": "GainLossOnDerivativeTermination",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GermanPharmaceuticalWholesaleJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "German Wholesale Joint Venture [Member]",
        "label": "German Pharmaceutical Wholesale Joint Venture [Member]",
        "terseLabel": "German Pharmaceutical Wholesale Joint Venture"
       }
      }
     },
     "localname": "GermanPharmaceuticalWholesaleJointVentureMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GermanWholesaleBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "German Wholesale Business [Member]",
        "label": "German Wholesale Business [Member]",
        "terseLabel": "German Wholesale Business"
       }
      }
     },
     "localname": "GermanWholesaleBusinessMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GrossProfitNetofExpensesIncludingOtherIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Profit, Net of Expenses, Including Other Income",
        "label": "Gross Profit, Net of Expenses, Including Other Income",
        "terseLabel": "Total operating profit (loss)"
       }
      }
     },
     "localname": "GrossProfitNetofExpensesIncludingOtherIncome",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsCustomersDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Customers Debt [Member]",
        "label": "Guarantee Obligations Customers Debt [Member]",
        "terseLabel": "Guarantee Obligations Customers Debt"
       }
      }
     },
     "localname": "GuaranteeObligationsCustomersDebtMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Five",
        "label": "Guarantee Obligations Exposure Expiring in Year Five",
        "terseLabel": "Guarantee obligations, expiring in 2028"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearFive",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearFiveThereafter": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Five Thereafter",
        "label": "Guarantee Obligations Exposure Expiring in Year Five Thereafter",
        "terseLabel": "Guarantee obligations, expiring after 2028"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearFiveThereafter",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Four",
        "label": "Guarantee Obligations Exposure Expiring in Year Four",
        "terseLabel": "Guarantee obligations, expiring in 2027"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearFour",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year One",
        "label": "Guarantee Obligations Exposure Expiring in Year One",
        "terseLabel": "Guarantee obligations, expiring in 2024"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearOne",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Three",
        "label": "Guarantee Obligations Exposure Expiring in Year Three",
        "terseLabel": "Guarantee obligations, expiring in 2026"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearThree",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsExposureExpiringinYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee Obligations Exposure Expiring in Year Two",
        "label": "Guarantee Obligations Exposure Expiring in Year Two",
        "terseLabel": "Guarantee obligations, expiring in 2025"
       }
      }
     },
     "localname": "GuaranteeObligationsExposureExpiringinYearTwo",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_GuaranteeObligationsInventoryRepurchaseGuaranteesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GuaranteeObligationsInventoryRepurchaseGuaranteesMember",
        "label": "Guarantee Obligations Inventory Repurchase Guarantees [Member]",
        "terseLabel": "Guarantee Obligations Inventory Repurchase Guarantees"
       }
      }
     },
     "localname": "GuaranteeObligationsInventoryRepurchaseGuaranteesMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GuarantorObligationsPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor Obligations, Period",
        "label": "Guarantor Obligations, Period",
        "terseLabel": "Debt guarantee period"
       }
      }
     },
     "localname": "GuarantorObligationsPeriod",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_HazardousSubstanceSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of sites that hazardous substances were allegedly disposed at.",
        "label": "Hazardous substance sites",
        "terseLabel": "Hazardous substance sites"
       }
      }
     },
     "localname": "HazardousSubstanceSites",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "positiveIntegerItemType"
    },
    "mck_HazardousSubstanceSitesRecipientOfDirectives": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of sites that hazardous substances were allegedly disposed at.",
        "label": "Hazardous Substance Sites, Recipient Of Directives",
        "terseLabel": "Hazardous substance sites, number"
       }
      }
     },
     "localname": "HazardousSubstanceSitesRecipientOfDirectives",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "positiveIntegerItemType"
    },
    "mck_HeldforSalePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Held for Sale [Policy Text Block]",
        "label": "Held for Sale [Policy Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "HeldforSalePolicyTextBlock",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Examination, Estimate Of Possible Liability Adjustment",
        "label": "Income Tax Examination, Estimate Of Possible Liability Adjustment",
        "terseLabel": "Tax liability increase due to proposed adjustment to taxable income"
       }
      }
     },
     "localname": "IncomeTaxExaminationEstimateOfPossibleLiabilityAdjustment",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncomeTaxExpenseBenefitDiscreteItems": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit) Discrete Items",
        "label": "Income Tax Expense (Benefit) Discrete Items",
        "negatedLabel": "Net discrete tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitDiscreteItems",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IncreaseDecreaseInLitigationReserve": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Litigation Reserve",
        "label": "Increase (Decrease) in Litigation Reserve",
        "terseLabel": "Litigation liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLitigationReserve",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IndividualClaimantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Claimant",
        "label": "Individual Claimant [Member]",
        "terseLabel": "Individual Claimant"
       }
      }
     },
     "localname": "IndividualClaimantMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InsuranceCoverageLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Coverage Litigation",
        "label": "Insurance Coverage Litigation [Member]",
        "terseLabel": "Insurance Coverage Litigation"
       }
      }
     },
     "localname": "InsuranceCoverageLitigationMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InsuranceProgramsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of our insurance programs, we seek to obtain coverage for catastrophic exposures as well as those risks required to be insured by law or contract. [Policy Text Block]",
        "label": "Insurance Programs [Policy Text Block]",
        "terseLabel": "Insurance Programs"
       }
      }
     },
     "localname": "InsuranceProgramsPolicyTextBlock",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_InterestRateSwapEnteredIntoYTDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Entered Into YTD",
        "label": "Interest Rate Swap Entered Into YTD [Member]",
        "terseLabel": "Interest Rate Swap Entered Into YTD"
       }
      }
     },
     "localname": "InterestRateSwapEnteredIntoYTDMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternallyDevelopedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software",
        "label": "Internally developed software [Member]",
        "terseLabel": "Internally developed software"
       }
      }
     },
     "localname": "InternallyDevelopedSoftwareMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternationalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment [Member]",
        "label": "International Segment [Member]",
        "terseLabel": "International",
        "verboseLabel": "International"
       }
      }
     },
     "localname": "InternationalSegmentMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Largest Customer [Member]",
        "label": "Largest Customer [Member]",
        "terseLabel": "CVS"
       }
      }
     },
     "localname": "LargestCustomerMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities Payments Due [Abstract]",
        "label": "Lease Liabilities Payments Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due",
        "label": "Lease, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDue",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due After Year Five",
        "label": "Lease, Liability, Payments, Due After Year Five",
        "totalLabel": "Thereafter"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Next Twelve Months",
        "label": "Lease, Liability, Payments, Due Next Twelve Months",
        "totalLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Five",
        "label": "Lease, Liability, Payments, Due Year Five",
        "totalLabel": "Fiscal 2028"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Four",
        "label": "Lease, Liability, Payments, Due Year Four",
        "totalLabel": "Fiscal 2027"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Three",
        "label": "Lease, Liability, Payments, Due Year Three",
        "totalLabel": "Fiscal 2026"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payments, Due Year Two",
        "label": "Lease, Liability, Payments, Due Year Two",
        "totalLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_2": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Undiscounted Excess Amount",
        "label": "Lease, Liability, Undiscounted Excess Amount",
        "negatedTotalLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LeaseandOtherObligationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease and Other Obligations [Member]",
        "label": "Lease and Other Obligations [Member]",
        "terseLabel": "Lease and other obligations"
       }
      }
     },
     "localname": "LeaseandOtherObligationsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LeasesWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Weighted Average Discount Rate",
        "label": "Leases, Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Future Lease Payments",
        "terseLabel": "Future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotyetCommencedFutureLeasePayments",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LessorLeasePaymentstobeReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Lease, Payments to be Received",
        "label": "Lessor, Lease, Payments to be Received",
        "terseLabel": "Minimum sublease income"
       }
      }
     },
     "localname": "LessorLeasePaymentstobeReceived",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term",
        "label": "Lessor, Sales-type and Direct Financing Leases, Weighted Average Remaining Lease Term",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LessorSalestypeandDirectFinancingLeasesWeightedAverageRemainingLeaseTerm",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages",
        "terseLabel": "Percentage of total settlement to be used to remediate damages (in percent)"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "label": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "terseLabel": "Litigation settlement, award amount to be used by state and local government"
       }
      }
     },
     "localname": "LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Accrual, Period Increase (Decrease), Net of Tax",
        "label": "Loss Contingency Accrual, Period Increase (Decrease), Net of Tax",
        "terseLabel": "Loss contingency accrual, period increase (decrease), net of tax"
       }
      }
     },
     "localname": "LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Settled, Number Of Jurisdictions Not Participating In Settlement",
        "label": "Loss Contingency, Claims Settled, Number Of Jurisdictions Not Participating In Settlement",
        "terseLabel": "Number of jurisdictions that did not participate in settlement"
       }
      }
     },
     "localname": "LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyClaimsSettledNumberOfSubdivisions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Settled, Number Of Subdivisions",
        "label": "Loss Contingency, Claims Settled, Number Of Subdivisions",
        "terseLabel": "Number of subdivisions"
       }
      }
     },
     "localname": "LossContingencyClaimsSettledNumberOfSubdivisions",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Received",
        "label": "Loss Contingency, Class Action, Number of Faxes Received",
        "terseLabel": "Number of faxes received"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesReceived",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyClassActionNumberofFaxesRemainingintheClass": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "label": "Loss Contingency, Class Action, Number of Faxes Remaining in the Class",
        "terseLabel": "Number of faxes remaining in class"
       }
      }
     },
     "localname": "LossContingencyClassActionNumberofFaxesRemainingintheClass",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyDamagesSoughtPerViolationValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Damages Sought Per Violation, Value",
        "label": "Loss Contingency, Damages Sought Per Violation, Value",
        "terseLabel": "Damages sought per violation"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtPerViolationValue",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyInsufficientCoverageNumberOfInsurancePolicies": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Insufficient Coverage, Number Of Insurance Policies",
        "label": "Loss Contingency, Insufficient Coverage, Number Of Insurance Policies",
        "terseLabel": "Loss Contingency, Number of Insurance Policies"
       }
      }
     },
     "localname": "LossContingencyInsufficientCoverageNumberOfInsurancePolicies",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfAdditionalDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Additional Defendants",
        "label": "Loss Contingency, Number of Additional Defendants",
        "terseLabel": "Number of additional defendants"
       }
      }
     },
     "localname": "LossContingencyNumberOfAdditionalDefendants",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfCasesDismissed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Cases Dismissed",
        "label": "Loss Contingency, Number Of Cases Dismissed",
        "terseLabel": "Loss contingency, number of cases dismissed"
       }
      }
     },
     "localname": "LossContingencyNumberOfCasesDismissed",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfCitiesFiledOnBehalfOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cities",
        "label": "Loss Contingency, Number of Cities Filed On Behalf Of",
        "terseLabel": "Number of cities filed on behalf of"
       }
      }
     },
     "localname": "LossContingencyNumberOfCitiesFiledOnBehalfOf",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfOtherDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Other Defendants",
        "label": "Loss Contingency, Number of Other Defendants",
        "terseLabel": "Number of other defendants"
       }
      }
     },
     "localname": "LossContingencyNumberOfOtherDefendants",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfRelators": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Relators",
        "label": "Loss Contingency, Number of Relators",
        "terseLabel": "Number of relators"
       }
      }
     },
     "localname": "LossContingencyNumberOfRelators",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberOfStatesFiledOnBehalfOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States Filed On Behalf Of",
        "label": "Loss Contingency, Number of States Filed On Behalf Of",
        "terseLabel": "Number of states filed on behalf of"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesFiledOnBehalfOf",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofFormerOfficers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Former Officers",
        "label": "Loss Contingency, Number of Former Officers",
        "terseLabel": "Number of former officers"
       }
      }
     },
     "localname": "LossContingencyNumberofFormerOfficers",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofRelators": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Number of Relators",
        "label": "Loss Contingency Number of Relators",
        "terseLabel": "Number of relators alleging violations"
       }
      }
     },
     "localname": "LossContingencyNumberofRelators",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States",
        "label": "Loss Contingency, Number of States",
        "terseLabel": "Number of states"
       }
      }
     },
     "localname": "LossContingencyNumberofStates",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Party Substitution Period to Prevent Case Dismissal",
        "label": "Loss Contingency, Party Substitution Period to Prevent Case Dismissal",
        "terseLabel": "Period within which party can be substituted"
       }
      }
     },
     "localname": "LossContingencyPartySubstitutionPeriodtoPreventCaseDismissal",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_LossContingencySettlementInstallmentPaymentsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement, Installment Payments, Term",
        "label": "Loss Contingency, Settlement, Installment Payments, Term",
        "terseLabel": "Loss contingency, settlement, installment payments, term (in years)"
       }
      }
     },
     "localname": "LossContingencySettlementInstallmentPaymentsTerm",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_MachineryEquipmentAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Machinery, Equipment, and Other",
        "label": "Machinery, Equipment, and Other [Member]",
        "terseLabel": "Machinery, equipment, and other"
       }
      }
     },
     "localname": "MachineryEquipmentAndOtherMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_McKessonUSOncologyResearchMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "McKesson U.S. Oncology Research",
        "label": "McKesson U.S. Oncology Research [Member]",
        "terseLabel": "USOR"
       }
      }
     },
     "localname": "McKessonUSOncologyResearchMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MckessonEuropeSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mckesson Europe Subsidiary [Member]",
        "label": "Mckesson Europe Subsidiary [Member]",
        "terseLabel": "McKesson Europe"
       }
      }
     },
     "localname": "MckessonEuropeSubsidiaryMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MedicalSurgicalSolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical-Surgical Solutions Segment [Member]",
        "label": "Medical-Surgical Solutions Segment [Member]",
        "terseLabel": "Medical-Surgical Solutions"
       }
      }
     },
     "localname": "MedicalSurgicalSolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MultiemployerPlanFundedStatusPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Multiemployer Plan, Funded Status, Percentage",
        "label": "Multiemployer Plan, Funded Status, Percentage",
        "terseLabel": "Funded status (as a percent)"
       }
      }
     },
     "localname": "MultiemployerPlanFundedStatusPercentage",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_NationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In re: National Prescription Opiate Litigation [Member]",
        "label": "National Prescription Opiate Litigation [Member]",
        "terseLabel": "National Prescription Opiate Litigation"
       }
      }
     },
     "localname": "NationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NativeAmericanTribesOtherThanCherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Native American Tribes Other Than Cherokee Nation",
        "label": "Native American Tribes Other Than Cherokee Nation [Member]",
        "terseLabel": "Native American Tribes Other Than Cherokee Nation"
       }
      }
     },
     "localname": "NativeAmericanTribesOtherThanCherokeeNationMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NewYorkOpioidTaxSurchargeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New York Opioid Tax Surcharge",
        "label": "New York Opioid Tax Surcharge [Member]",
        "terseLabel": "New York Opioid Tax Surcharge"
       }
      }
     },
     "localname": "NewYorkOpioidTaxSurchargeMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NoncontrollingInterestDecreaseForExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "label": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "negatedTerseLabel": "Exercise of put right",
        "terseLabel": "Exercise of put right"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseForExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestDecreaseFromReclassificationToLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease from Reclassification to Liability",
        "label": "Noncontrolling Interest, Decrease from Reclassification to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromReclassificationToLiability",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestIncreaseDecreaseDuetoOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "label": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDecreaseDuetoOther",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price",
        "label": "Noncontrolling Interests, Put Right, Exercise Price",
        "terseLabel": "Put right (in euro per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePrice",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePriceIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price, Increase",
        "label": "Noncontrolling Interests, Put Right, Exercise Price, Increase",
        "terseLabel": "Put Right increase (euros per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePriceIncrease",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NorwegianPublicServicePensionFundSPKMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Norwegian Public Service Pension Fund (SPK) [Member]",
        "label": "Norwegian Public Service Pension Fund (SPK) [Member]",
        "terseLabel": "Norwegian Public Service Pension Fund (SPK)"
       }
      }
     },
     "localname": "NorwegianPublicServicePensionFundSPKMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NotesDueNovember302020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Due November 30, 2020 [Member]",
        "label": "Notes Due November 30, 2020 [Member]",
        "terseLabel": "Notes Due November 30, 2020"
       }
      }
     },
     "localname": "NotesDueNovember302020Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NumberofSoftwareProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Software Products",
        "label": "Number of Software Products",
        "terseLabel": "Number of software products"
       }
      }
     },
     "localname": "NumberofSoftwareProducts",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_OpenMarketTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Transactions [Member]",
        "label": "Open Market Transactions [Member]",
        "terseLabel": "Open Market Transactions"
       }
      }
     },
     "localname": "OpenMarketTransactionsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Assets And Liabilities, Lessee",
        "label": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_OpioidStewardshipActNewYorkAnnualSurcharge": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Stewardship Act, New York, Annual Surcharge",
        "label": "Opioid Stewardship Act, New York, Annual Surcharge",
        "terseLabel": "Annual surcharge"
       }
      }
     },
     "localname": "OpioidStewardshipActNewYorkAnnualSurcharge",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherAllowancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Allowances [Member]",
        "label": "Other Allowances [Member]",
        "terseLabel": "Other allowances"
       }
      }
     },
     "localname": "OtherAllowancesMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax",
        "label": "Other Comprehensive Income Defined Benefit Plans Net Translation Gain Loss Arising During Period Before Tax",
        "negatedTerseLabel": "Foreign exchange impact and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetTranslationGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherNonCurrentAssetsAndLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Non-Current Assets and Liabilities",
        "label": "Other Non-Current Assets and Liabilities [Member]",
        "terseLabel": "Other non-current assets/liabilities"
       }
      }
     },
     "localname": "OtherNonCurrentAssetsAndLiabilitiesMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value",
        "label": "Pension And Other Postretirement Defined Benefit Plans, Plan Asset Value",
        "terseLabel": "Amount of plan asset value"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansPlanAssetValue",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_PerformancebasedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-based Stock Units [Member]",
        "label": "Performance-based Stock Units [Member]",
        "terseLabel": "PSUs"
       }
      }
     },
     "localname": "PerformancebasedStockUnitsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrepaidExpensesAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Expenses and Other",
        "label": "Prepaid Expenses and Other [Member]",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrescriptionTechnologySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment [Member]",
        "label": "Prescription Technology Solutions [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "PrescriptionTechnologySolutionsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrescriptionTechnologySolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prescription Technology Solutions Segment",
        "label": "Prescription Technology Solutions Segment [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "PrescriptionTechnologySolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant and Equipment, Including Net Capitalized Software",
        "label": "Property, Plant and Equipment, Including Net Capitalized Software",
        "verboseLabel": "Total long-lived assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentIncludingNetCapitalizedSoftware",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_PutRightValueInterestRateSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Put Right Value, Interest Rate Spread",
        "label": "Put Right Value, Interest Rate Spread",
        "terseLabel": "Annual increase in interest (percent)"
       }
      }
     },
     "localname": "PutRightValueInterestRateSpread",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_RealPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real Property [Member]",
        "label": "Real Property [Member]",
        "terseLabel": "Real Property"
       }
      }
     },
     "localname": "RealPropertyMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "label": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "negatedTerseLabel": "Reclassification of McKesson Europe AG redeemable noncontrolling interests",
        "verboseLabel": "Reclassification of McKesson Europe AG redeemable noncontrolling interests"
       }
      }
     },
     "localname": "ReclassificationOfTemporaryEquityToNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ReclassificationofTemporaryEquitytoLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Liability",
        "label": "Reclassification of Temporary Equity to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "ReclassificationofTemporaryEquitytoLiability",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RedeemableNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Member]",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "terseLabel": "Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "label": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "terseLabel": "Shares purchased (shares)"
       }
      }
     },
     "localname": "RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_RestrictedStockUnitsandPerformancebasedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units and Performance-based Stock Units [Member]",
        "label": "Restricted Stock Units and Performance-based Stock Units [Member]",
        "terseLabel": "RSUs and PSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsandPerformancebasedStockUnitsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RestructuringImpairmentandOtherRelatedCharges": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, Impairment and Other Related Charges",
        "label": "Restructuring, Impairment and Other Related Charges",
        "negatedTerseLabel": "Restructuring, impairment, and related charges, net",
        "terseLabel": "Restructuring, impairment, and related charges, net"
       }
      }
     },
     "localname": "RestructuringImpairmentandOtherRelatedCharges",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RestructuringPlanRemoteWorkTransitioningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Plan, Remote Work Transitioning",
        "label": "Restructuring Plan, Remote Work Transitioning [Member]",
        "terseLabel": "Restructuring Plan, Remote Work Transitioning"
       }
      }
     },
     "localname": "RestructuringPlanRemoteWorkTransitioningMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RetailPharmacyReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail Pharmacy Reporting Unit [Member]",
        "label": "Retail Pharmacy Reporting Unit [Member]",
        "terseLabel": "Retail Pharmacy Reporting Unit"
       }
      }
     },
     "localname": "RetailPharmacyReportingUnitMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RevenueDerivedFromServicesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Derived From Services, Percentage",
        "label": "Revenue Derived From Services, Percentage",
        "terseLabel": "Revenue derived from services, percentage (less than)"
       }
      }
     },
     "localname": "RevenueDerivedFromServicesPercentage",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax, Sales Returns",
        "terseLabel": "Sales returns from customers"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerExcludingAssessedTaxSalesReturns",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RxSavingsSolutionsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rx Savings Solutions, LLC",
        "label": "Rx Savings Solutions, LLC [Member]",
        "terseLabel": "Rx Savings Solutions, LLC"
       }
      }
     },
     "localname": "RxSavingsSolutionsLLCMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RxTsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RxTs Segment",
        "label": "RxTs Segment [Member]",
        "terseLabel": "RxTs Segment"
       }
      }
     },
     "localname": "RxTsSegmentMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SCRIOncologyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SCRI Oncology, LLC",
        "label": "SCRI Oncology, LLC [Member]",
        "terseLabel": "SCRI Oncology, LLC"
       }
      }
     },
     "localname": "SCRIOncologyLLCMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SECSchedule1209ValuationAllowancesandReservesCurrentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Current, Amount",
        "terseLabel": "Current allowances"
       }
      }
     },
     "localname": "SECSchedule1209ValuationAllowancesandReservesCurrentAmount",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_SarahCannonResearchInstituteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sarah Cannon Research Institute",
        "label": "Sarah Cannon Research Institute [Member]",
        "terseLabel": "SCRI"
       }
      }
     },
     "localname": "SarahCannonResearchInstituteMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share based compensation arrangements by share based payment award data related to stock option activity [table text block]",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award Data Related To Stock Option Activity [Table Text Block]",
        "terseLabel": "Summary of data related to stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardDataRelatedToStockOptionActivityTableTextBlock",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]",
        "label": "Schedule of Share-based Payment Award, Other Than Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of assumptions used to estimate fair value of PSUs"
       }
      }
     },
     "localname": "ScheduleofSharebasedPaymentAwardOtherThanOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_SecondPartOfPayContributionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Part Of Pay Contribution [Member]",
        "label": "Second Part Of Pay Contribution [Member]",
        "terseLabel": "Second Part Of Pay Contribution"
       }
      }
     },
     "localname": "SecondPartOfPayContributionMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SecuredOvernightFinancingRateSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSOFRMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2022 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit",
        "label": "Senior Unsecured Credit Facility (the 2022 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "terseLabel": "Senior Unsecured Credit Facility (the 2022 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilityThe2022CreditFacilityCanadianDollarBritishPoundSterlingAndEurosSublimitMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2022 Credit Facility)",
        "label": "Senior Unsecured Credit Facility (the 2022 Credit Facility) [Member]",
        "terseLabel": "Senior Unsecured Credit Facility (the 2022 Credit Facility)"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilityThe2022CreditFacilityMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "terseLabel": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "terseLabel": "Senior Unsecured Credit Facility (the 2020 Credit Facility)"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Services Business [Member]",
        "label": "Services Business [Member]",
        "terseLabel": "Services Business"
       }
      }
     },
     "localname": "ServicesBusinessMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SettlingGovernmentalEntitiesAndCherokeeNationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Settling Governmental Entities and Cherokee Nation",
        "label": "Settling Governmental Entities and Cherokee Nation [Member]",
        "terseLabel": "Settling Governmental Entities and Cherokee Nation"
       }
      }
     },
     "localname": "SettlingGovernmentalEntitiesAndCherokeeNationMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]",
        "label": "Share Repurchases, Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs [Roll Forward]",
        "terseLabel": "Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs"
       }
      }
     },
     "localname": "ShareRepurchasesApproximateDollarValueofSharesthatMayYetBePurchasedUndertheProgramsRollForward",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period",
        "negatedTerseLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled in Period1",
        "terseLabel": "Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCancelledinPeriod1",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested",
        "verboseLabel": "Vested RSUs (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsVested",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_ShareholderDerivativeActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder Derivative Action",
        "label": "Shareholder Derivative Action [Member]",
        "terseLabel": "Shareholder Derivative Action"
       }
      }
     },
     "localname": "ShareholderDerivativeActionMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfAlabamaAndSubdivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of Alabama and Subdivisions",
        "label": "State of Alabama and Subdivisions [Member]",
        "terseLabel": "State of Alabama and Subdivisions"
       }
      }
     },
     "localname": "StateOfAlabamaAndSubdivisionsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfWestVirginiaAndSubdivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of West Virginia and Subdivisions",
        "label": "State of West Virginia and Subdivisions [Member]",
        "terseLabel": "State of West Virginia and Subdivisions"
       }
      }
     },
     "localname": "StateOfWestVirginiaAndSubdivisionsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Employee Stock Plans Net of Forfeitures",
        "label": "Stock Issued During Period, Shares, Employee Stock Plans Net of Forfeitures",
        "terseLabel": "Issuance of shares under employee plans, net of forfeitures (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPlansNetOfForfeitures",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Employee Stock Plans Net of Forfeitures",
        "label": "Stock Issued During Period, Value, Employee Stock Plans Net of Forfeitures",
        "terseLabel": "Issuance of shares under employee plans, net of forfeitures"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPlansNetOfForfeitures",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]",
        "label": "Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs [Member]",
        "terseLabel": "Strategic Growth Initiative Plan - Additional Global Reorganization and Business Consolidation Programs"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanAdditionalGlobalReorganizationandBusinessConsolidationProgramsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan - Operational Efficiencies and Cost Optimization",
        "label": "Strategic Growth Initiative Plan - Operational Efficiencies and Cost Optimization [Member]",
        "terseLabel": "Strategic Growth Initiative Plan - Operational Efficiencies and Cost Optimization"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanOperationalEfficienciesAndCostOptimizationMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Growth Initiative Plan Relocation of Corporate Headquarters [Member]",
        "label": "Strategic Growth Initiative Plan - Relocation of Corporate Headquarters [Member]",
        "terseLabel": "Strategic Growth Initiative Plan - Relocation of Corporate Headquarters"
       }
      }
     },
     "localname": "StrategicGrowthInitiativePlanRelocationofCorporateHeadquartersMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SupplierIncentivesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Incentives, Policy [Policy Text Block]",
        "label": "Supplier Incentives, Policy [Policy Text Block]",
        "terseLabel": "Supplier Incentives"
       }
      }
     },
     "localname": "SupplierIncentivesPolicyPolicyTextBlock",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_SupplierReservesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reserves against amounts due from suppliers relating to various price and rebate incentives, including deductions or billings taken against payments otherwise due to them. [Policy Text Block]",
        "label": "Supplier Reserves [Policy Text Block]",
        "terseLabel": "Supplier Reserves"
       }
      }
     },
     "localname": "SupplierReservesPolicyTextBlock",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized",
        "label": "Tax Receivable Agreement, Percent of Net Cash Tax Savings Realized",
        "terseLabel": "Tax receivable agreement, percent of net cash tax savings realized"
       }
      }
     },
     "localname": "TaxReceivableAgreementPercentOfNetCashTaxSavingsRealized",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_TaxReceivableAgreementTRAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "label": "Tax Receivable Agreement (\u201cTRA\u201d) [Member]",
        "terseLabel": "Tax Receivable Agreement (\u201cTRA\u201d)"
       }
      }
     },
     "localname": "TaxReceivableAgreementTRAMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TenLargestCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ten Largest Customers",
        "label": "Ten Largest Customers [Member]",
        "terseLabel": "Ten Largest Customers"
       }
      }
     },
     "localname": "TenLargestCustomersMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TenderOfferNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tender Offer Notes",
        "label": "Tender Offer Notes [Member]",
        "terseLabel": "Tender Offer Notes"
       }
      }
     },
     "localname": "TenderOfferNotesMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeLargestUSPharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Largest U.S. Pharmaceutical Distributors",
        "label": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "terseLabel": "Three Largest U.S. Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeLargestUSPharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeNationalPharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three National Pharmaceutical Distributors",
        "label": "Three National Pharmaceutical Distributors [Member]",
        "terseLabel": "Three National Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeNationalPharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_TreasuryStockPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock",
        "label": "Treasury Stock [Policy Text Block]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockPolicyTextBlock",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "label": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al [Member]",
        "terseLabel": "True Health Chiropractic Inc., et al. v. McKesson Corporation, et al"
       }
      }
     },
     "localname": "TrueHealthChiropracticInc.etal.v.McKessonCorporationetalMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_U.S.PharmaceuticalandSpecialtySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Pharmaceutical and Specialty Solutions [Member]",
        "label": "U.S. Pharmaceutical and Specialty Solutions [Member]",
        "terseLabel": "U.S. Pharmaceutical and Specialty Solutions"
       }
      }
     },
     "localname": "U.S.PharmaceuticalandSpecialtySolutionsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UKBusinessesDisposalGroupAndAustrianBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. and Austrian Businesses (Disposal Group)",
        "label": "U.K. Businesses (Disposal Group) and Austrian Business [Member]",
        "terseLabel": "U.K. Businesses (Disposal Group) and Austrian Business"
       }
      }
     },
     "localname": "UKBusinessesDisposalGroupAndAustrianBusinessMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UKBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.K. Businesses (Disposal Group)",
        "label": "U.K. Businesses (Disposal Group) [Member]",
        "terseLabel": "U.K. Businesses (Disposal Group)"
       }
      }
     },
     "localname": "UKBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_USPharmaceuticalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Pharmaceutical Segment [Member]",
        "label": "U.S. Pharmaceutical Segment [Member]",
        "terseLabel": "U.S. Pharmaceutical"
       }
      }
     },
     "localname": "USPharmaceuticalSegmentMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitValueOfCashAndCashEquivalents": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unit value of cash and cash equivalents",
        "label": "Unit Value Of Cash And Cash Equivalents",
        "terseLabel": "Unit value of cash and cash equivalents (in dollars per share)"
       }
      }
     },
     "localname": "UnitValueOfCashAndCashEquivalents",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA",
        "label": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA [Member]",
        "terseLabel": "United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA"
       }
      }
     },
     "localname": "UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesExRelPiacentileVAmgenIncEtAlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Piacentile v. Amgen Inc., et al.",
        "label": "United States ex rel. Piacentile v. Amgen Inc., et al. [Member]",
        "terseLabel": "United States ex rel. Piacentile v. Amgen Inc., et al."
       }
      }
     },
     "localname": "UnitedStatesExRelPiacentileVAmgenIncEtAlMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]",
        "label": "United States ex rel. Manchester v. Purdue Pharma, L.P., et al [Member]",
        "terseLabel": "United States ex rel. Manchester v. Purdue Pharma, L.P., et al"
       }
      }
     },
     "localname": "UnitedStatesexrel.Manchesterv.PurduePharmaL.P.etalMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]",
        "label": "United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al. [Member]",
        "terseLabel": "United States ex rel. Omni Healthcare Inc. v. McKesson Corporation, et al."
       }
      }
     },
     "localname": "UnitedStatesexrel.OmniHealthcareInc.v.McKessonCorporationetal.Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]",
        "label": "United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931 [Member]",
        "terseLabel": "United States of America, ex rel. Carl Kelley and Michael McElligott, 19-cv-2233, and State of California, ex rel. Carl Kelley and Michael McElligott, CGC-19-576931"
       }
      }
     },
     "localname": "UnitedStatesofAmericaexrel.CarlKelleyandMichaelMcElligott19cv2233andStateofCaliforniaexrel.CarlKelleyandMichaelMcElligottCGC19576931Member",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation",
        "label": "Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation",
        "terseLabel": "Exchange rate fluctuations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowances and reserves, deductions credited to other accounts [Member]",
        "label": "Valuation Allowances And Reserves Deductions Credited To Other Accounts [Member]",
        "terseLabel": "Credited to other accounts and other"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductionsCreditedToOtherAccountsMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ValuationAllowancesAndReservesDeductionsWrittenOffMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowances and reserves, deductions written off [Member]",
        "label": "Valuation Allowances And Reserves Deductions Written Off [Member]",
        "terseLabel": "Written-off"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductionsWrittenOffMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_VantageandClarusOneSourcingServicesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "label": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "terseLabel": "Vantage and ClarusOne Sourcing Services LLC"
       }
      }
     },
     "localname": "VantageandClarusOneSourcingServicesLLCMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_WalgreensBootsAllianceJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Walgreens Boots Alliance Joint Venture",
        "label": "Walgreens Boots Alliance Joint Venture [Member]",
        "terseLabel": "Walgreens Boots Alliance Joint Venture"
       }
      }
     },
     "localname": "WalgreensBootsAllianceJointVentureMember",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted-average remaining lease term (years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mck_WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of Deferred Debt Issuance Cost and Transaction Costs",
        "label": "Write-off of Deferred Debt Issuance Cost and Transaction Costs",
        "terseLabel": "Write-off of unamortized debt issuance costs and transaction fees"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCostAndTransactionCosts",
     "nsuri": "http://mckesson123.com/20230331",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r423",
      "r823",
      "r824",
      "r830",
      "r831",
      "r920",
      "r996",
      "r1002",
      "r1159",
      "r1162",
      "r1163",
      "r1317",
      "r1320",
      "r1321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r423",
      "r823",
      "r824",
      "r830",
      "r831",
      "r920",
      "r996",
      "r1002",
      "r1159",
      "r1162",
      "r1163",
      "r1317",
      "r1320",
      "r1321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r423",
      "r478",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r496",
      "r500",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576",
      "r577",
      "r579",
      "r581",
      "r582",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1160",
      "r1161",
      "r1318",
      "r1319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r423",
      "r478",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r496",
      "r500",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576",
      "r577",
      "r579",
      "r581",
      "r582",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1160",
      "r1161",
      "r1318",
      "r1319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r420",
      "r421",
      "r587",
      "r614",
      "r1022",
      "r1027",
      "r1029"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r1085",
      "r1120",
      "r1121",
      "r1135",
      "r1261",
      "r1262",
      "r1263",
      "r1271",
      "r1272",
      "r1282",
      "r1283",
      "r1284",
      "r1296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount after cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Adjusted balance"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r359",
      "r435",
      "r442",
      "r448",
      "r519",
      "r768",
      "r769",
      "r770",
      "r801",
      "r802",
      "r840",
      "r843",
      "r845",
      "r846",
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Opening retained earnings adjustments: adoption of new accounting standards"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r359",
      "r435",
      "r442",
      "r448",
      "r519",
      "r768",
      "r769",
      "r770",
      "r801",
      "r802",
      "r840",
      "r843",
      "r845",
      "r846",
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r359",
      "r435",
      "r442",
      "r448",
      "r519",
      "r768",
      "r769",
      "r770",
      "r801",
      "r802",
      "r840",
      "r843",
      "r845",
      "r846",
      "r911"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by currency.",
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r1128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]",
        "terseLabel": "Directors"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r506",
      "r1047",
      "r1167",
      "r1312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r564",
      "r565",
      "r567",
      "r568",
      "r720",
      "r928",
      "r967",
      "r997",
      "r998",
      "r1044",
      "r1058",
      "r1069",
      "r1164",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r564",
      "r565",
      "r567",
      "r568",
      "r720",
      "r928",
      "r967",
      "r997",
      "r998",
      "r1044",
      "r1058",
      "r1069",
      "r1164",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r506",
      "r1047",
      "r1167",
      "r1312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r502",
      "r933",
      "r1045",
      "r1067",
      "r1156",
      "r1157",
      "r1167",
      "r1311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r502",
      "r933",
      "r1045",
      "r1067",
      "r1156",
      "r1157",
      "r1167",
      "r1311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r564",
      "r565",
      "r567",
      "r568",
      "r663",
      "r720",
      "r758",
      "r759",
      "r760",
      "r924",
      "r928",
      "r967",
      "r997",
      "r998",
      "r1044",
      "r1058",
      "r1069",
      "r1148",
      "r1164",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r564",
      "r565",
      "r567",
      "r568",
      "r663",
      "r720",
      "r758",
      "r759",
      "r760",
      "r924",
      "r928",
      "r967",
      "r997",
      "r998",
      "r1044",
      "r1058",
      "r1069",
      "r1148",
      "r1164",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r420",
      "r421",
      "r587",
      "r614",
      "r1028",
      "r1029"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r725",
      "r1122",
      "r1316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r448",
      "r725",
      "r1083",
      "r1122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r431",
      "r1012"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SUPPLEMENTARY CONSOLIDATED FINANCIAL STATEMENT SCHEDULE VALUATION AND QUALIFYING ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r503",
      "r504",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r1001",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1046",
      "r1068",
      "r1167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r503",
      "r504",
      "r981",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r1001",
      "r1003",
      "r1046",
      "r1068",
      "r1167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r448",
      "r725",
      "r1083",
      "r1084",
      "r1122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r1128",
      "r1297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r429",
      "r430",
      "r1012"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Change, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTextBlock": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs. An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program. ASRs can be disclosed as part of stockholders' equity.",
        "label": "Accelerated Share Repurchases [Table Text Block]",
        "terseLabel": "Schedule of shares repurchased over last three years"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r34",
      "r1066"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r379",
      "r508",
      "r509",
      "r1025"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "totalLabel": "Total receivables"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingencies": {
     "auth_ref": [
      "r566",
      "r1038",
      "r1081",
      "r1082",
      "r1149",
      "r1152"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies",
        "terseLabel": "Estimated loss"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "verboseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "verboseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r50",
      "r57",
      "r254",
      "r398",
      "r1094",
      "r1095"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains (Losses) and Other Components of Benefit Plans, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r136",
      "r370"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r49",
      "r57",
      "r254",
      "r398",
      "r1094",
      "r1095"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r389",
      "r398",
      "r828",
      "r1094",
      "r1095"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains (Losses) on Cash Flow and Other Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r54",
      "r56",
      "r57",
      "r381",
      "r960",
      "r975",
      "r979"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r53",
      "r57",
      "r254",
      "r913",
      "r970",
      "r971",
      "r1093",
      "r1094",
      "r1095",
      "r1117",
      "r1118",
      "r1119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average life of intangibles"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Less: Restricted cash at end of period included in Other Noncurrent Assets"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r29",
      "r1066"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r768",
      "r769",
      "r770",
      "r1117",
      "r1118",
      "r1119",
      "r1283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r90",
      "r125"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r203",
      "r204",
      "r729"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r762"
     ],
     "calculation": {
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Share-based compensation expense, net of tax"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "Allowances for credit losses"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r382",
      "r510",
      "r522",
      "r523",
      "r524"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r382",
      "r510",
      "r522"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedTerseLabel": "Allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r90",
      "r120",
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Potentially dilutive securities excluded from diluted earnings per share (less than)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r53",
      "r57",
      "r254",
      "r1093",
      "r1094",
      "r1095"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Total Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r90",
      "r131"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Long-lived asset impairment charges, before tax"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r312",
      "r332",
      "r374",
      "r416",
      "r486",
      "r492",
      "r498",
      "r515",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r578",
      "r580",
      "r582",
      "r583",
      "r823",
      "r830",
      "r859",
      "r1066",
      "r1160",
      "r1161",
      "r1299"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets",
        "verboseLabel": "VIE consolidated assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails",
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "netLabel": "Assets",
        "terseLabel": "ASSETS",
        "verboseLabel": "Segment assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r365",
      "r385",
      "r416",
      "r515",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r578",
      "r580",
      "r582",
      "r583",
      "r823",
      "r830",
      "r859",
      "r1066",
      "r1160",
      "r1161",
      "r1299"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNet": {
     "auth_ref": [
      "r20",
      "r349",
      "r350",
      "r353",
      "r354"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Net Assets",
        "terseLabel": "Net assets"
       }
      }
     },
     "localname": "AssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r13",
      "r139",
      "r363",
      "r364"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "netLabel": "Pension assets",
        "totalLabel": "Total assets held for sale",
        "verboseLabel": "Divested net assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r13",
      "r133",
      "r139",
      "r363",
      "r364"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale",
        "verboseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r733",
      "r734",
      "r735",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r279",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r816",
      "r1052",
      "r1055"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r224",
      "r225",
      "r816",
      "r1052",
      "r1055"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business acquisition, percentage of controlling interest in combined business"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r240"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill, expected tax deductible amount"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r228"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "negatedTerseLabel": "Noncontrolling interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r235",
      "r236",
      "r239"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r234",
      "r237",
      "r821"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "totalLabel": "Contingent consideration",
        "verboseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r234",
      "r238"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationContingentConsiderationLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r234",
      "r238"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationContingentConsiderationLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "negatedTerseLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r226",
      "r227"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Acquired identifiable intangible assets",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "Identifiable assets acquired and liabilities assumed:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r226",
      "r227"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total identifiable net assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r226",
      "r227"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Purchase consideration:"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Exit and other-related costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLossCarryforwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deductions derived from capital losses that cannot be utilized on the tax return during a period that have been carried forward to reduce taxable income or taxes payable in a future year.",
        "label": "Capital Loss Carryforward [Member]",
        "terseLabel": "Capital Loss Carryforward"
       }
      }
     },
     "localname": "CapitalLossCarryforwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization": {
     "auth_ref": [
      "r1315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.",
        "label": "Capitalized Computer Software, Accumulated Amortization",
        "terseLabel": "Capitalized software held for internal use, accumulated amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r355",
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Capitalized software held for internal use, amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "auth_ref": [
      "r999"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.",
        "label": "Capitalized Computer Software, Net",
        "terseLabel": "Capitalized software held for internal use, net"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r92",
      "r368",
      "r1023"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents at end of year"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r93",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r85",
      "r92",
      "r95"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of year",
        "totalLabel": "Cash, cash equivalents, and restricted cash at end of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r85",
      "r301"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r416",
      "r451",
      "r455",
      "r457",
      "r459",
      "r467",
      "r468",
      "r515",
      "r571",
      "r574",
      "r575",
      "r576",
      "r582",
      "r583",
      "r612",
      "r613",
      "r616",
      "r620",
      "r626",
      "r859",
      "r1000",
      "r1080",
      "r1108",
      "r1123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r42",
      "r319",
      "r339"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingent liabilities (Note 17)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r151",
      "r561",
      "r562",
      "r983",
      "r1158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingent Liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r157",
      "r984"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParentheticals",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r1117",
      "r1118",
      "r1283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "verboseLabel": "Common stock, $0.01 par value"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r28",
      "r1066"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value, 800 shares authorized, 277 and 275 shares issued at March 31, 2023 and 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r59",
      "r394",
      "r396",
      "r405",
      "r955",
      "r964"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r249",
      "r250",
      "r266",
      "r394",
      "r396",
      "r404",
      "r954",
      "r963"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r248",
      "r266",
      "r394",
      "r396",
      "r403",
      "r953",
      "r962"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r102",
      "r103",
      "r298",
      "r299",
      "r506",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r102",
      "r103",
      "r298",
      "r299",
      "r506",
      "r980",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r102",
      "r103",
      "r298",
      "r299",
      "r506",
      "r982",
      "r1314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r329",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk and Receivables"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r102",
      "r103",
      "r298",
      "r299",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of total consolidated revenues (percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r102",
      "r103",
      "r298",
      "r299",
      "r506",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "auth_ref": [
      "r255",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]",
        "terseLabel": "Schedule of Changes in Noncontrolling Interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r251",
      "r1030"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Noncontrolling Interests and Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r1048",
      "r1050",
      "r1313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r112",
      "r491",
      "r492",
      "r493",
      "r494",
      "r500",
      "r1127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r70",
      "r933"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r145",
      "r146",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap",
        "verboseLabel": "Currency Swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r1111",
      "r1269",
      "r1273"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r1111",
      "r1269"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r220",
      "r796",
      "r806",
      "r1111"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r1111",
      "r1269",
      "r1273"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r100",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r318",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Debt outstanding"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r164",
      "r414",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r600",
      "r607",
      "r608",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt and Financing Activities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r313",
      "r315",
      "r331",
      "r423",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r590",
      "r596",
      "r597",
      "r598",
      "r599",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r880",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r304",
      "r306",
      "r584",
      "r880",
      "r1040",
      "r1041"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r598",
      "r858",
      "r1040",
      "r1041"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r39",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on debt instruments (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r40",
      "r423",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r590",
      "r596",
      "r597",
      "r598",
      "r599",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r880",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price (percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Debt instrument, repurchase amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt Instrument, repurchased face amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r40",
      "r170",
      "r171",
      "r172",
      "r173",
      "r303",
      "r304",
      "r306",
      "r327",
      "r423",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r590",
      "r596",
      "r597",
      "r598",
      "r599",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r609",
      "r880",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of facility"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r303",
      "r306",
      "r1165"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premiums"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r1111",
      "r1270",
      "r1273"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r220",
      "r1111",
      "r1270"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r777",
      "r778"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Long-term deferred tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r90",
      "r220",
      "r797",
      "r805",
      "r806",
      "r1111"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r25",
      "r26",
      "r314",
      "r330",
      "r790"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r777",
      "r778"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedTerseLabel": "Long-term deferred tax liability",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r1111",
      "r1270",
      "r1273"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r791"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Subtotal"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r1267"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r217",
      "r1268"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r215",
      "r217",
      "r1268"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Net operating loss and credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r217",
      "r1268"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Compensation and benefit related accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r217",
      "r1268"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Receivable allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r792"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r207",
      "r1267"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts": {
     "auth_ref": [
      "r217",
      "r1268"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.",
        "label": "Deferred Tax Liabilities, Inventory",
        "negatedTerseLabel": "Inventory valuation and other assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r217",
      "r1268"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedTerseLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r217",
      "r1268"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r217",
      "r1268"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Fixed assets and systems development costs"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r672"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r51",
      "r57",
      "r1211"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r57",
      "r684"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "negatedTerseLabel": "Net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r57",
      "r684"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "verboseLabel": "Prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r654",
      "r1050"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets",
        "verboseLabel": "Return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r647"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial gain",
        "terseLabel": "Actuarial gain (loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r182",
      "r183"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rates",
        "verboseLabel": "Discount rates (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of increase in compensation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "verboseLabel": "Discount rates"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r688",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Expected long-term rate of return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of increase in compensation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r642"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Benefit obligation at end of period",
        "periodStartLabel": "Benefit obligation at beginning of period",
        "terseLabel": "Projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r649",
      "r713"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r691",
      "r1048",
      "r1049",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r1048"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Level 3 [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r656",
      "r666",
      "r709",
      "r1048",
      "r1049",
      "r1050",
      "r1051"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Amounts of plan exceeding total plan contribution"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanDivestituresBenefitObligation": {
     "auth_ref": [
      "r652"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.",
        "label": "Defined Benefit Plan, Benefit Obligation, Divestiture",
        "negatedTerseLabel": "Divestitures"
       }
      }
     },
     "localname": "DefinedBenefitPlanDivestituresBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDivestituresPlanAssets": {
     "auth_ref": [
      "r660"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in plan assets of defined benefit plan from disposal or classification as held-for-sale.",
        "label": "Defined Benefit Plan, Plan Assets, Divestiture",
        "negatedTerseLabel": "Divestitures"
       }
      }
     },
     "localname": "DefinedBenefitPlanDivestituresPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "verboseLabel": "Expected benefit payments in 2029 through 2033"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "verboseLabel": "Expected benefit payments in 2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "verboseLabel": "Expected benefit payments in 2028"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "verboseLabel": "Expected benefit payments in 2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "Expected benefit payments in 2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "verboseLabel": "Expected benefit payments in 2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r674",
      "r1051"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "verboseLabel": "Expected contributions in next fiscal year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r641",
      "r678",
      "r704",
      "r1050",
      "r1051"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r653",
      "r664",
      "r666",
      "r667",
      "r1048",
      "r1049",
      "r1050"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets at end of period",
        "periodStartLabel": "Fair value of plan assets at beginning of period",
        "verboseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r648"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange impact and other"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r639",
      "r662",
      "r1050"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status at end of period"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r641",
      "r645",
      "r677",
      "r703",
      "r1050",
      "r1051"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost",
        "verboseLabel": "Interest cost on projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r675",
      "r701",
      "r1050",
      "r1051"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Net periodic pension expense",
        "totalLabel": "Net periodic pension expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r658",
      "r1231"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r655"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange impact and other"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase": {
     "auth_ref": [
      "r1196"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable input, of increase in plan asset of defined benefit plan from purchase.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase for Purchase",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsLevel3ReconciliationIncreaseForPurchase",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r1169",
      "r1209",
      "r1228"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedTerseLabel": "Curtailment/settlement gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r643",
      "r676",
      "r702",
      "r1050",
      "r1051"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost",
        "verboseLabel": "Service cost - benefits earned during the year"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r661"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Net periodic pension expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r714"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Contribution expenses"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Company match employee contributions (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Percentage of eligible compensation (up to percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r90",
      "r134"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r90",
      "r134"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Total depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization [Abstract]",
        "terseLabel": "Segment depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortizationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r90",
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation expense for property, plant, and equipment, and amortization of finance leases"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r1277",
      "r1278",
      "r1279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "U.S. Dollar notional amount, asset"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r47",
      "r281",
      "r309",
      "r386",
      "r1029"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Fair value of derivative, asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r47",
      "r281",
      "r309",
      "r386",
      "r1029"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Fair value of derivative, liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r280",
      "r282",
      "r287",
      "r288",
      "r1029"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r294",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r277",
      "r280",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r1277",
      "r1278",
      "r1279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "U.S. Dollar notional amount, liability"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r1278",
      "r1279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amounts of derivative"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r270",
      "r272",
      "r273",
      "r277",
      "r278",
      "r284",
      "r287",
      "r289",
      "r291",
      "r293",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r270",
      "r272",
      "r277",
      "r278",
      "r290",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated for hedge accounting:",
        "verboseLabel": "Derivatives Designated for Hedge Accounting"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r732",
      "r763",
      "r764",
      "r766",
      "r772",
      "r1059"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r132",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r130",
      "r140",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r13",
      "r139"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r0",
      "r1",
      "r13",
      "r139"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Divested cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Consideration agreed upon for sale of business"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r13",
      "r139"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r13",
      "r133",
      "r139"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation": {
     "auth_ref": [
      "r1",
      "r13",
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as defined benefit plan benefit obligations attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Pension Plan Benefit Obligation",
        "terseLabel": "Pension liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPensionPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r13",
      "r133",
      "r139"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r13",
      "r133",
      "r139"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": {
     "auth_ref": [
      "r90",
      "r132",
      "r138"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down",
        "netLabel": "European businesses, disposal group, losses (gains)",
        "terseLabel": "European businesses held for sale",
        "verboseLabel": "Charge for remeasurement to fair value"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r1052",
      "r1055"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r174"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r1232",
      "r1233",
      "r1234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson Corporation"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r406",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r449",
      "r451",
      "r457",
      "r458",
      "r459",
      "r463",
      "r846",
      "r847",
      "r956",
      "r965",
      "r1034"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r406",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r451",
      "r457",
      "r458",
      "r459",
      "r463",
      "r846",
      "r847",
      "r956",
      "r965",
      "r1034"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted",
        "verboseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Loss) Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r868"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Income tax expense (benefit) rates (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r418",
      "r780",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory federal income tax rate (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r1264",
      "r1265"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Tax expense (benefit), share-based payment arrangement"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails",
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r765"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total compensation cost, net of estimated forfeitures, related to unvested stock options not yet recognized, pre-tax",
        "verboseLabel": "Total compensation cost, net of estimated forfeitures, related to nonvested restricted stock unit awards not yet recognized, pre-tax"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period in years over which restricted stock unit award cost is expected to be recognized",
        "verboseLabel": "Weighted-average period in years over which stock option compensation cost is expected to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r762"
     ],
     "calculation": {
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "negatedTerseLabel": "Tax benefit for share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r767"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Tax benefits realized related to exercise"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee stock purchase plan",
        "verboseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r169",
      "r359",
      "r398",
      "r399",
      "r400",
      "r432",
      "r433",
      "r434",
      "r437",
      "r445",
      "r447",
      "r466",
      "r519",
      "r627",
      "r768",
      "r769",
      "r770",
      "r801",
      "r802",
      "r845",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r875",
      "r913",
      "r970",
      "r971",
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest in Joint Venture (percent)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r1096",
      "r1097",
      "r1105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "terseLabel": "Gain from sale of equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r115",
      "r487",
      "r1088"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Carrying value of investment in joint venture"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r84",
      "r117",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r375",
      "r856",
      "r1026"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Investments in equity securities of growth stage companies"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r1133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Net gains (losses) on investments in equity securities",
        "verboseLabel": "Net gain (loss) on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": {
     "auth_ref": [
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount",
        "terseLabel": "Impairment loss"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r598",
      "r858",
      "r1040",
      "r1041"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Investment Assets at Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimatedInsuranceRecoveries": {
     "auth_ref": [
      "r1090"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts expected to be recovered under the terms of insurance contracts.",
        "label": "Estimated Insurance Recoveries",
        "terseLabel": "Probable loss recovery"
       }
      }
     },
     "localname": "EstimatedInsuranceRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r849",
      "r850",
      "r854"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r295",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Information Regarding Fair Value of Derivatives on a Gross Basis"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r598",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r850",
      "r921",
      "r922",
      "r923",
      "r1040",
      "r1041",
      "r1048",
      "r1049",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r295",
      "r296",
      "r598",
      "r1040",
      "r1041"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r849",
      "r850",
      "r851",
      "r852",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r598",
      "r1040",
      "r1041"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedges"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r598",
      "r666",
      "r671",
      "r850",
      "r921",
      "r1048",
      "r1049",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r598",
      "r666",
      "r671",
      "r850",
      "r922",
      "r1040",
      "r1041",
      "r1048",
      "r1049",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r598",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r850",
      "r923",
      "r1040",
      "r1041",
      "r1048",
      "r1049",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r598",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r921",
      "r922",
      "r923",
      "r1040",
      "r1041",
      "r1048",
      "r1049",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r853",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r279",
      "r284",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r888",
      "r894",
      "r1065"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "mck_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r890",
      "r899"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "negatedTerseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r886",
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiability",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r886"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r886"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueNextTwelveMonths",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Fiscal 2028"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Fiscal 2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Fiscal 2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "mck_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r889",
      "r899"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r885"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r888",
      "r894",
      "r1065"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "mck_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r902",
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r901",
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible assets, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r372",
      "r545"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Estimated annual amortization expense, after 2028"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated annual amortization expense, 2028"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r543",
      "r544",
      "r545",
      "r546",
      "r934",
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r124",
      "r938"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r121",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r124",
      "r934"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Period"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FixedIncomeFundsMember": {
     "auth_ref": [
      "r1192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that pools funds from investors to invest in a combination of underlying investments, primarily fixed income investments.",
        "label": "Fixed Income Funds [Member]",
        "terseLabel": "Fixed income commingled funds"
       }
      }
     },
     "localname": "FixedIncomeFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r1232",
      "r1233",
      "r1234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Non-U.S. Plans"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnContractTermination": {
     "auth_ref": [
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.",
        "label": "Gain (Loss) on Contract Termination",
        "terseLabel": "Gain for early termination of tax receivable agreement"
       }
      }
     },
     "localname": "GainLossOnContractTermination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r829",
      "r1105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "verboseLabel": "Pre-tax gain on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r1105"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedLabel": "Gain from sales of businesses and investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r1152"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "terseLabel": "Claims and litigation charges, net"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r90",
      "r162",
      "r163"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on debt extinguishment",
        "terseLabel": "Loss on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r371",
      "r529",
      "r951",
      "r1037",
      "r1066",
      "r1136",
      "r1143"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails",
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r532",
      "r1037"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r541",
      "r542",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "verboseLabel": "Foreign currency translation adjustments, net"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r90",
      "r530",
      "r535",
      "r541",
      "r1037"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill impairment charges",
        "terseLabel": "Goodwill impairment charge"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r222",
      "r1142"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "verboseLabel": "Other adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r67",
      "r416",
      "r486",
      "r491",
      "r497",
      "r500",
      "r515",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r578",
      "r580",
      "r582",
      "r583",
      "r859",
      "r1036",
      "r1160"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsByNatureAxis": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of guarantee.",
        "label": "Guarantor Obligations, Nature [Axis]",
        "terseLabel": "Guarantor Obligations, Nature [Axis]"
       }
      }
     },
     "localname": "GuaranteeObligationsByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteeObligationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Guarantor Obligations [Line Items]",
        "terseLabel": "Guarantor Obligations [Line Items]"
       }
      }
     },
     "localname": "GuaranteeObligationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Guarantor obligations, maximum exposure"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsNatureDomain": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Nature [Domain]",
        "terseLabel": "Guarantor Obligations, Nature [Domain]"
       }
      }
     },
     "localname": "GuaranteeObligationsNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r277",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) Attributable to Parent, before Tax [Abstract]",
        "terseLabel": "Income (Loss) Attributable to Parent, before Tax [Abstract]"
       }
      }
     },
     "localname": "IncomeLossAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r68",
      "r91",
      "r247",
      "r440",
      "r441",
      "r442",
      "r443",
      "r456",
      "r459"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income (loss) from continuing operations attributable to McKesson Corporation"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r417",
      "r807"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r310",
      "r322",
      "r346",
      "r486",
      "r491",
      "r497",
      "r500",
      "r957",
      "r1036"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income (loss) from continuing operations before income taxes",
        "totalLabel": "Income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r417",
      "r807"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]",
        "terseLabel": "Income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesScheduleofIncomefromContinuingOperationsBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r248",
      "r416",
      "r436",
      "r486",
      "r491",
      "r497",
      "r500",
      "r515",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r578",
      "r580",
      "r582",
      "r583",
      "r847",
      "r859",
      "r1036",
      "r1160"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Income (loss) from continuing operations",
        "verboseLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r61",
      "r320",
      "r323",
      "r342",
      "r406",
      "r436",
      "r440",
      "r441",
      "r442",
      "r443",
      "r451",
      "r457",
      "r458",
      "r847",
      "r956"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r61",
      "r342",
      "r345",
      "r406",
      "r436",
      "r440",
      "r441",
      "r442",
      "r443",
      "r451",
      "r457",
      "r458",
      "r459",
      "r847",
      "r956",
      "r965"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r15",
      "r343",
      "r364",
      "r811"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Loss from discontinued operations, net of tax",
        "verboseLabel": "Loss from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r64",
      "r343",
      "r345",
      "r406",
      "r455",
      "r457",
      "r458",
      "r1308",
      "r1310"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r268",
      "r455",
      "r457",
      "r458"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r63",
      "r90",
      "r115",
      "r321",
      "r341",
      "r483"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "verboseLabel": "Equity in earnings, net"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r1052",
      "r1055"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Discontinued Operations Disclosures"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r14",
      "r16",
      "r17",
      "r18",
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r418",
      "r781",
      "r788",
      "r795",
      "r803",
      "r809",
      "r812",
      "r813",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r1266"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "terseLabel": "Income tax expense (benefit), before any tax effect, related to accrued interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r419",
      "r446",
      "r447",
      "r484",
      "r779",
      "r804",
      "r810",
      "r966"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)",
        "totalLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesComponentsOfProvisionForIncomeTaxesRelatedToContinuingOperationsDetails",
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r397",
      "r775",
      "r776",
      "r788",
      "r789",
      "r794",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r1265"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Tax effect of foreign operations"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r780"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax expense (benefit) at federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r1265"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r1265"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "auth_ref": [
      "r1265"
     ],
     "calculation": {
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "terseLabel": "Unrecognized tax benefits and settlements"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r1265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "terseLabel": "Research and development credit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesReconciliationBetweenEffectiveTaxRateOnIncomeFromContinuingOperationsAndStatutoryTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r1104"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "terseLabel": "Taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedTerseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in assets and liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r1104",
      "r1293"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r452",
      "r453",
      "r454",
      "r459",
      "r731"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "verboseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r123",
      "r930",
      "r931",
      "r932",
      "r934",
      "r1031"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r305",
      "r325",
      "r401",
      "r480",
      "r879"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpensePolicyTextBlock": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing interest expense, including the method of amortizing debt issuance costs.",
        "label": "Interest Expense, Policy [Policy Text Block]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpensePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r1106"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Accrued and unpaid interest"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r409",
      "r412",
      "r413"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest, net"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r1064"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofInformationRegardingFairValueofDerivativesonaGrossBasisDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "auth_ref": [
      "r127",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "terseLabel": "Capitalized Software Held for Internal Use"
       }
      }
     },
     "localname": "InternalUseSoftwarePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryLIFOReserve": {
     "auth_ref": [
      "r1091"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.",
        "label": "Inventory, LIFO Reserve",
        "terseLabel": "LIFO reserve"
       }
      }
     },
     "localname": "InventoryLIFOReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory, LIFO Reserve, Period Charge",
        "terseLabel": "Charges (credits) associated with last-in, first-out inventory method"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r384",
      "r1024",
      "r1066"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory, net",
        "verboseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r367",
      "r383",
      "r465",
      "r525",
      "r527",
      "r528",
      "r929",
      "r1032"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down charges"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvesteeMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A corporation that issued voting stock held by an investor.",
        "label": "Investee [Member]",
        "terseLabel": "Investee"
       }
      }
     },
     "localname": "InvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r72",
      "r479"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r1089"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r903",
      "r1065"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r1294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of lease costs and supplemental cash flow information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r893"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r1292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Noncancelable lease terms"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityPaymentsDueNextTwelveMonths",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Fiscal 2028"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Fiscal 2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Fiscal 2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r904"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r1291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal option increments for leases (in years)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r1291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term (in years)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorDirectFinancingLeasesTextBlock": {
     "auth_ref": [
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of lessor's direct financing leases.",
        "label": "Lessor, Direct Financing Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorDirectFinancingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorSalesTypeLeasesTextBlock": {
     "auth_ref": [
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of lessor's sales-type leases.",
        "label": "Lessor, Sales-type Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorSalesTypeLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r36",
      "r416",
      "r515",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r578",
      "r580",
      "r582",
      "r583",
      "r824",
      "r830",
      "r831",
      "r859",
      "r1035",
      "r1160",
      "r1299",
      "r1300"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "VIE consolidated liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesComponentsOfDeferredTaxBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r317",
      "r336",
      "r1066",
      "r1110",
      "r1134",
      "r1285"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r38",
      "r366",
      "r416",
      "r515",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r578",
      "r580",
      "r582",
      "r583",
      "r824",
      "r830",
      "r831",
      "r859",
      "r1066",
      "r1160",
      "r1299",
      "r1300"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r13",
      "r139",
      "r363",
      "r364"
     ],
     "calculation": {
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Total liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAssetsandLiabilitiesHeldforSaleEUandUKDisposalGroupsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r13",
      "r133",
      "r139",
      "r363",
      "r364"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r23",
      "r315",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "verboseLabel": "Credit facility outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.",
        "label": "Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases",
        "terseLabel": "Committed balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r35"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility borrowing capacity",
        "verboseLabel": "Credit facility borrowing capacity (up to)"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r35"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Uncommitted balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r35",
      "r1109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r42",
      "r1152"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Aggregate amount expected to be paid"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation settlement payments"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r1152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r1152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Loans payable"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r23",
      "r315",
      "r333",
      "r597",
      "r611",
      "r1040",
      "r1041"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "netLabel": "Carrying Value",
        "terseLabel": "Total debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/FairValueMeasurementsScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "terseLabel": "Less: Current portion",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r160",
      "r423",
      "r1166"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Scheduled principal payments of long-term debt, thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r160",
      "r423",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Scheduled principal payments of long-term debt in 2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r160",
      "r423",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "Scheduled principal payments of long-term debt in 2028"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r160",
      "r423",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "Scheduled principal payments of long-term debt in 2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r160",
      "r423",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Scheduled principal payments of long-term debt in 2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r160",
      "r423",
      "r602"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Scheduled principal payments of long-term debt in 2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r40",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r152",
      "r153",
      "r563",
      "r564",
      "r565",
      "r1153",
      "r1155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r152",
      "r153",
      "r563",
      "r564",
      "r565",
      "r1153",
      "r1155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r563",
      "r1083"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "totalLabel": "Total litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueCurrent": {
     "auth_ref": [
      "r563"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Current",
        "verboseLabel": "Current litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": {
     "auth_ref": [
      "r563"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Noncurrent",
        "terseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": {
     "auth_ref": [
      "r1152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in loss contingency liability.",
        "label": "Loss Contingency Accrual, Period Increase (Decrease)",
        "terseLabel": "Loss contingency accrual, period increase (decrease)"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r1152"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "terseLabel": "Loss contingency accrual, payments"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r1152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Charge recorded related to Company's share of the litigation settlement"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r1152",
      "r1153",
      "r1155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Loss contingency, statutory damages"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r564",
      "r565",
      "r570"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Loss contingency, estimate of possible loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r152",
      "r153",
      "r563",
      "r564",
      "r565",
      "r1153",
      "r1155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [
      "r1153",
      "r1155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r1153",
      "r1155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of complaints served"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r19",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Business Acquisitions and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r46",
      "r316",
      "r335",
      "r416",
      "r515",
      "r571",
      "r574",
      "r575",
      "r576",
      "r582",
      "r583",
      "r859"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Noncontrolling interests",
        "verboseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r174"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Payments to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Noncontrolling interest (percent)"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "verboseLabel": "Percentage of outstanding common shares"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r46",
      "r69",
      "r246",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interests [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Investments in money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MultiemployerPlansWithdrawalObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the obligation recognized by withdrawing from a pension or postretirement benefit plan to which two or more unrelated employers contribute where assets contributed by one participating employer may be used to provide benefits to employees of other participating employers.",
        "label": "Multiemployer Plans, Withdrawal Obligation",
        "terseLabel": "Amounts accrued for liability"
       }
      }
     },
     "localname": "MultiemployerPlansWithdrawalObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r1192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Equity commingled funds"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r411"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r85",
      "r88",
      "r91"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r65",
      "r91",
      "r324",
      "r344",
      "r364",
      "r392",
      "r395",
      "r400",
      "r416",
      "r436",
      "r440",
      "r441",
      "r442",
      "r443",
      "r446",
      "r447",
      "r456",
      "r486",
      "r491",
      "r497",
      "r500",
      "r515",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r578",
      "r580",
      "r582",
      "r583",
      "r847",
      "r859",
      "r1036",
      "r1160"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to McKesson Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r252",
      "r265",
      "r392",
      "r395",
      "r446",
      "r447",
      "r1095"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net income attributable to noncontrolling interests",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Net income (loss) attributable to redeemable noncontrolling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging",
        "verboseLabel": "Net Investment Hedges"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesScheduleofNotionalAmountsofOutstandingDerivativePositionsDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r97",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r442",
      "r448",
      "r463",
      "r511",
      "r512",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r768",
      "r769",
      "r770",
      "r799",
      "r800",
      "r801",
      "r802",
      "r817",
      "r818",
      "r819",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r877",
      "r878",
      "r881",
      "r882",
      "r883",
      "r884",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r935",
      "r936",
      "r937",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r245",
      "r627",
      "r1117",
      "r1118",
      "r1119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "netLabel": "Noncontrolling Interests",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total",
        "verboseLabel": "Other income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r1126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessNarrativeDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r486",
      "r491",
      "r497",
      "r500",
      "r1036"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment operating profit (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r895",
      "r1065"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r1290"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r886"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "mck_LeaseLiability",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r886"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r886"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r891",
      "r899"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "negatedTerseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r885"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r902",
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r901",
      "r1065"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Federal, state and foreign net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r1105",
      "r1147"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Goodwill and long-lived asset impairment charges"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r52",
      "r54",
      "r683"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax",
        "terseLabel": "Prior service cost"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r54",
      "r58",
      "r391",
      "r683"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "negatedLabel": "Prior service credit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r57",
      "r60",
      "r399",
      "r869",
      "r871",
      "r875",
      "r1093"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r55",
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "terseLabel": "Unrealized gain (loss) on net investment hedges, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r387",
      "r388"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Unrealized gains (losses) on cash flow and other hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r388",
      "r390",
      "r832"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "verboseLabel": "Derivatives designated as cash flow and other hedges:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r833"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Derivatives designated as net investment hedges:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesSummaryofDerivativeInstrumentsGainLossDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r60",
      "r169",
      "r393",
      "r396",
      "r402",
      "r869",
      "r874",
      "r875",
      "r952",
      "r961",
      "r1093",
      "r1094"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r248",
      "r249",
      "r253",
      "r393",
      "r396"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Other comprehensive income",
        "verboseLabel": "Less: amounts attributable to noncontrolling and redeemable noncontrolling interests"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r248",
      "r249",
      "r253",
      "r393",
      "r396"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss) attributable to McKesson"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r51",
      "r54",
      "r1050",
      "r1210"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "totalLabel": "Total recognized in other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r51",
      "r54"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r50",
      "r54",
      "r186"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "negatedTerseLabel": "Net actuarial gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r54",
      "r58",
      "r391",
      "r683"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedLabel": "Actuarial loss",
        "terseLabel": "Net actuarial loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax [Abstract]",
        "terseLabel": "Amortization of:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other Income, Net"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r179",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Other Income, Net"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "verboseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r181",
      "r639",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r688",
      "r689",
      "r691",
      "r694",
      "r697",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r714",
      "r715",
      "r716",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits Plan"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesGrossCurrent": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableGrossCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Gross, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherReceivablesGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Payments for legal settlements"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r1098",
      "r1099"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Share repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r1101"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "negatedTerseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG",
        "terseLabel": "Payments to purchase shares of McKesson Europe"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r550",
      "r1103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Payments for debt extinguishments",
        "terseLabel": "Payments for debt extinguishments"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesTenderOfferandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedTerseLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r77",
      "r820"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash payment to acquire business",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash, cash equivalents, and restricted cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r407",
      "r1274",
      "r1275",
      "r1276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Total expenditures for long-lived assets"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Productive Assets [Abstract]",
        "terseLabel": "Segment expenditures for long-lived assets"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Payments for property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireSoftware": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Acquire Software",
        "negatedLabel": "Capitalized software expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireSoftware",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r1152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r663",
      "r665",
      "r671",
      "r690",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r711",
      "r712",
      "r714",
      "r727",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r22",
      "r639",
      "r640",
      "r662",
      "r1050"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r24",
      "r639",
      "r640",
      "r662",
      "r1050"
     ],
     "calculation": {
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Long-term liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability, Defined Benefit Plan [Abstract]",
        "terseLabel": "Amounts recognized on the balance sheet"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansNoncurrentLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r180",
      "r639",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r688",
      "r689",
      "r691",
      "r694",
      "r697",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r714",
      "r715",
      "r726",
      "r1050",
      "r1051",
      "r1055",
      "r1056",
      "r1057"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plans, Defined Benefit"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PercentageOfLIFOInventory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.",
        "label": "Percentage of LIFO Inventory",
        "terseLabel": "LIFO inventory (percentage)"
       }
      }
     },
     "localname": "PercentageOfLIFOInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r691",
      "r1048",
      "r1049",
      "r1050"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Not measured at fair value.",
        "label": "Portion at Other than Fair Value Measurement [Member]",
        "terseLabel": "Assets held at NAV practical expedient"
       }
      }
     },
     "localname": "PortionAtOtherThanFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r27",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r27",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r27",
      "r1066"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r1092"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r1086"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Collection of Notes Receivable",
        "terseLabel": "Proceeds from collection of notes receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from issuance, net"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Cash proceeds from divestiture"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Proceeds from Divestiture of Businesses and Interests in Affiliates",
        "terseLabel": "Proceeds from sales of businesses and investments, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from borrowing by issuing commercial paper.",
        "label": "Proceeds from Issuance of Commercial Paper",
        "terseLabel": "Commercial paper issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from issuances of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r79",
      "r202"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for the settlement of litigation during the current period.",
        "label": "Proceeds from Legal Settlements",
        "terseLabel": "Net cash proceeds from settlements"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r80",
      "r1109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "verboseLabel": "Amount borrowed under facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r1100",
      "r1102"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepurchaseOfEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from (Repurchase of) Equity [Abstract]",
        "terseLabel": "Common stock transactions:"
       }
      }
     },
     "localname": "ProceedsFromRepurchaseOfEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from sale of equity method investment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-Term Debt",
        "verboseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r79",
      "r202"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Cash received upon exercise"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r364",
      "r392",
      "r395",
      "r410",
      "r416",
      "r436",
      "r446",
      "r447",
      "r486",
      "r491",
      "r497",
      "r500",
      "r515",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r578",
      "r580",
      "r582",
      "r583",
      "r822",
      "r826",
      "r827",
      "r847",
      "r859",
      "r957",
      "r1036",
      "r1062",
      "r1063",
      "r1095",
      "r1160"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r135",
      "r369"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Total property, plant, and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r137",
      "r338",
      "r959",
      "r1066"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net",
        "totalLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOther": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Other, Gross",
        "terseLabel": "Machinery, equipment, and other"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r137",
      "r985",
      "r986"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r337",
      "r351",
      "r1066"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "totalLabel": "Receivables, net",
        "verboseLabel": "Receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/SignificantAccountingPoliciesReceivablesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r1129",
      "r1130",
      "r1131",
      "r1132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivables, Net and Allowances for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r57",
      "r399",
      "r869",
      "r873",
      "r875",
      "r1093"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "terseLabel": "Reclassification from AOCI, current period, before tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/HedgingActivitiesSummaryofForeignCurrencyGainsandLossesfromNonDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r57",
      "r60",
      "r399",
      "r869",
      "r873",
      "r875",
      "r1093"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amount reclassified to earnings and other"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "terseLabel": "Reclassification from AOCI, current period, before tax, attributable to parent"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r55",
      "r391",
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Reclassification to income statement, tax expense",
        "verboseLabel": "Accumulated other comprehensive loss adjustment"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r109",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of segment assets and long-lived assets by net by geographic areas"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount",
        "periodEndLabel": "Redeemable Noncontrolling Interest, Ending balance",
        "periodStartLabel": "Redeemable Noncontrolling Interest, Beginning balance"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r691",
      "r916",
      "r917"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r691",
      "r916",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r1298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r914",
      "r915",
      "r917",
      "r918",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Balances and Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "terseLabel": "Commercial paper repaid"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesOtherFacilitiesandCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Repayments of long-term debt",
        "terseLabel": "Retired and redeemed outstanding principal amount"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-Term Debt",
        "negatedTerseLabel": "Repayments of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r540",
      "r541",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [
      "r540",
      "r541",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r1087",
      "r1107",
      "r1307",
      "r1309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r1087",
      "r1107"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "negatedTerseLabel": "Less: Restricted cash at end of year included in Prepaid expenses and other"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock unit awards",
        "verboseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r548",
      "r550",
      "r553",
      "r559",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring, Impairment, and Related Charges, Net"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r549",
      "r552",
      "r556",
      "r558"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring costs, anticipated total charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r90",
      "r554",
      "r556",
      "r1150"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring, impairment, and related charges, net",
        "totalLabel": "Total",
        "verboseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r549",
      "r550",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r550",
      "r555"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Cost Alignment Plan"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r550",
      "r557"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r147",
      "r1151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r30",
      "r174",
      "r334",
      "r974",
      "r979",
      "r1066"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r359",
      "r432",
      "r433",
      "r434",
      "r437",
      "r445",
      "r447",
      "r519",
      "r768",
      "r769",
      "r770",
      "r801",
      "r802",
      "r845",
      "r970",
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanFundingStatusAxis": {
     "auth_ref": [
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Axis]",
        "terseLabel": "Retirement Plan Funding Status [Axis]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanFundingStatusDomain": {
     "auth_ref": [
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of funding for defined benefit plan designed to provide retirement benefits.",
        "label": "Defined Benefit Plan, Funding Status [Domain]",
        "terseLabel": "Retirement Plan Funding Status [Domain]"
       }
      }
     },
     "localname": "RetirementPlanFundingStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r1058",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r1058",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r687",
      "r688",
      "r689",
      "r691",
      "r694",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r1232",
      "r1233",
      "r1234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r687",
      "r688",
      "r689",
      "r691",
      "r694",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r1232",
      "r1233",
      "r1234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r180",
      "r181",
      "r639",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r688",
      "r689",
      "r691",
      "r694",
      "r697",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r714",
      "r715",
      "r716",
      "r726",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r180",
      "r181",
      "r639",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r688",
      "r689",
      "r691",
      "r694",
      "r697",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r714",
      "r715",
      "r716",
      "r726",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r477",
      "r478",
      "r490",
      "r495",
      "r496",
      "r502",
      "r503",
      "r506",
      "r636",
      "r637",
      "r933"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r638",
      "r1033"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r66",
      "r352",
      "r573",
      "r574",
      "r575",
      "r581",
      "r582",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Revenue from related parties"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Segment revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r900",
      "r1065"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r900",
      "r1065"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r506",
      "r1125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Sales Revenue, Net"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived": {
     "auth_ref": [
      "r906"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.",
        "label": "Sales-Type and Direct Financing Leases, Lease Receivable, Payments to be Received",
        "terseLabel": "Total lease receivable"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of receivables"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r1050",
      "r1219",
      "r1220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r57",
      "r1288",
      "r1289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Summary of pension plan assets using fair value hierarchy by asset class"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of other changes in plan assets and benefit obligations recognized in other comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of weighted-average assumptions used to estimate net periodic pension expense and actuarial present value of benefit obligations"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "verboseLabel": "Schedule of components of share-based compensation expense and related tax benefits"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of income tax expense (benefit) related to continuing operations"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax balances"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in plan assets and benefit obligations recognized in other comprehensive income (loss) during the period.",
        "label": "Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of defined benefit plan amounts recognized in other comprehensive loss"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r190",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofAmountsRecognizedinAccumulatedOtherComprehensiveLossDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofChangesinBenefitObligationsandPlanAssetsDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofInvestmentsMeasuredatFairValueDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofNetPeriodicExpenseforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofOtherChangesinAccumulatedOtherComprehensiveIncomeDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofProjectedBenefitObligationAccumulatedBenefitObligationandFairValueofPlanAssetsforPensionPlansDetails",
      "http://mckesson123.com/role/PensionBenefitsScheduleofWeightedAverageAssumptionsUsedtoEstimateNetPeriodicPensionExpenseandActuarialPresentValueofBenefitObligationsDetails",
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r190",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of changes in benefit obligations and plan assets for pension plans"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r14",
      "r16",
      "r17",
      "r18",
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Assets and Liabilities Held for Sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r1124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of basic and diluted earnings per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r98",
      "r99",
      "r451",
      "r455",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r1194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of fair value measurements using significant unobservable inputs (Level 3) on changes in plan assets of pension plans and/or other employee benefit plans for the period.",
        "label": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfEffectOfSignificantUnobservableInputsChangesInPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of reconciliation between effective tax rate on income from continuing operations and statutory tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r121",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of information regarding intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r1037"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r1037",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of changes in the carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGuaranteeObligationsTable": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the type or nature of guarantees, for example performance, indemnification, payment and other guarantees, and related information such as term, origin and purpose, triggering event, maximum exposure, and carrying value. Represents the guarantor's disclosures which include the information about each guarantee, or each group of similar guarantees, even if the likelihood of the guarantor's need to make any payments under the guarantee is remote. This excludes disclosures for product warranties.",
        "label": "Schedule of Guarantor Obligations [Table]",
        "terseLabel": "Schedule of Guarantor Obligations [Table]"
       }
      }
     },
     "localname": "ScheduleOfGuaranteeObligationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r1111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of income (loss) from continuing operations before income taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": {
     "auth_ref": [
      "r152",
      "r153",
      "r1152",
      "r1154",
      "r1156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.",
        "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]",
        "terseLabel": "Schedule of Estimated Accrual Liability"
       }
      }
     },
     "localname": "ScheduleOfLossContingenciesByContingencyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of net periodic expense for pension plans"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r1281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.",
        "label": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.",
        "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]",
        "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions"
       }
      }
     },
     "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r286",
      "r1280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Summary of Foreign Currency Gains and (Losses) from Non-Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the detailed components of other nonoperating income. May include methodology, assumptions and amounts for: (a) dividends, (b) interest on securities, (c) profits on securities (net of losses), and (d) miscellaneous other income items.",
        "label": "Schedule of Other Nonoperating Income, by Component [Table Text Block]",
        "terseLabel": "Schedule of other income, net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeByComponentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r307",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r549",
      "r550",
      "r551",
      "r552",
      "r556",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r143",
      "r144",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Summary of details for charges recorded"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r142",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r107",
      "r108",
      "r110",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r107",
      "r108",
      "r110",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Schedule of segment information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r728",
      "r730",
      "r733",
      "r734",
      "r735",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation Arrangements [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of restricted stock unit award activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Summary of options outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r192",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r257",
      "r259",
      "r260",
      "r262",
      "r263",
      "r823",
      "r824",
      "r830",
      "r831",
      "r925",
      "r926",
      "r927"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r474",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r506",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r552",
      "r558",
      "r1037",
      "r1311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r474",
      "r475",
      "r476",
      "r486",
      "r489",
      "r494",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segments of Business"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "negatedTerseLabel": "Selling, distribution, general, and administrative expenses",
        "terseLabel": "Shipping and handling costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "Shipping and Handling Costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Service agreements"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [
      "r1152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance and employee-related costs, net"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r1059"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period",
        "terseLabel": "Requisite service period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r1059"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Stock award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on offering date that participants pay for shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date",
        "terseLabel": "Percentage of market price deduction for share purchases"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r748"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r745",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r745",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per shares)",
        "periodStartLabel": "Beginning balance (in dollars per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r752"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r1061"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted- Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Stock options vested and exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Vested and exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r752"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value on exercise"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value per stock option (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r201"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r754"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Vested and exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r753"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "verboseLabel": "Stock options vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r733",
      "r734",
      "r735",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails",
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails",
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails",
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails",
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofDataRelatedtoRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r736",
      "r755",
      "r756",
      "r757",
      "r758",
      "r761",
      "r771",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Range of exercise prices lower limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Number of Options Exercisable at Year End (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Number of Options Outstanding at Year End (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Range of exercise prices upper limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r1060"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Stock award contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofWeightedAverageAssumptionsUsedtoEstimateFairValueofRSUsandPSUsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted- Average Grant Date Fair Value Per Share"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofRSUsandPSUsAwardActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r752"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of stock options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofDataRelatedtoStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Percentage of market price for share purchase"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted- Average Remaining Contractual Life (Years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationSummaryofStockOptionsOutstandingDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance common stock (in shares)",
        "periodStartLabel": "Beginning balance, common stock (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r1168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Shipping and Handling"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r896",
      "r1065"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "auth_ref": [
      "r158",
      "r243",
      "r348",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.",
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letters of Credit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/FinancialGuaranteesandWarrantiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r362",
      "r474",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r500",
      "r506",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r547",
      "r552",
      "r558",
      "r1037",
      "r1311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresAcquisitionsDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresDivestituresandOtherDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedOncologyResearchDetails",
      "http://mckesson123.com/role/BusinessAcquisitionsandDivestituresIdentifiedAssetsAcquiredandLiabilitiesAssumedRxSavingsSolutionsDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetGoodwillNarrativeDetails",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails",
      "http://mckesson123.com/role/OtherIncomeNetScheduleofOtherIncomeNetDetails",
      "http://mckesson123.com/role/RelatedPartyBalancesandTransactionsDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofActivityRelatedtoRestructuringLiabilityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetSummaryofDetailsforChargesRecordedDetails",
      "http://mckesson123.com/role/SegmentsofBusinessScheduleofSegmentInformationDetails",
      "http://mckesson123.com/role/SegmentsofBusinessSegmentAssetsandLonglivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r416",
      "r451",
      "r455",
      "r457",
      "r459",
      "r467",
      "r468",
      "r515",
      "r571",
      "r574",
      "r575",
      "r576",
      "r582",
      "r583",
      "r612",
      "r613",
      "r616",
      "r620",
      "r626",
      "r859",
      "r1000",
      "r1080",
      "r1108",
      "r1123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r43",
      "r169",
      "r359",
      "r398",
      "r399",
      "r400",
      "r432",
      "r433",
      "r434",
      "r437",
      "r445",
      "r447",
      "r466",
      "r519",
      "r627",
      "r768",
      "r769",
      "r770",
      "r801",
      "r802",
      "r845",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r875",
      "r913",
      "r970",
      "r971",
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinNoncontrollingInterestsandRedeemableNoncontrollingInterestDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r466",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r27",
      "r28",
      "r169",
      "r174",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/ShareBasedCompensationComponentsofShareBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "verboseLabel": "Share repurchase authorization increase"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r27",
      "r28",
      "r169",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedLabel": "Repurchase of common stock (in shares)",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r27",
      "r28",
      "r169",
      "r174"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r28",
      "r31",
      "r32",
      "r113",
      "r1066",
      "r1110",
      "r1134",
      "r1285"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r245",
      "r246",
      "r264",
      "r359",
      "r360",
      "r399",
      "r432",
      "r433",
      "r434",
      "r437",
      "r445",
      "r519",
      "r627",
      "r768",
      "r769",
      "r770",
      "r801",
      "r802",
      "r845",
      "r869",
      "r870",
      "r875",
      "r913",
      "r971",
      "r972",
      "r1110",
      "r1134",
      "r1285"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total deficit"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r178",
      "r415",
      "r613",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r627",
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r898",
      "r1065"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r209",
      "r212",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of gross unrecognized tax benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and trade names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax": {
     "auth_ref": [
      "r1286",
      "r1287"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "terseLabel": "Derivatives used in net investment hedges, gains (losses)"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomebyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average Price Paid Per Share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Ending balance, treasury common stock (shares)",
        "negatedPeriodStartLabel": "Beginning balance, treasury common stock (shares)",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r45",
      "r176",
      "r177"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedTerseLabel": "Treasury shares, at cost, 141 and 130 shares at March 31, 2023 and 2022, respectively"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r28",
      "r169",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "verboseLabel": "Total Number of Shares Purchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r169",
      "r174",
      "r176"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r549",
      "r550",
      "r556",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r958",
      "r1048",
      "r1313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "Government securities"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsSummaryofPensionPlanAssetsUsingFairValueHierarchybyAssetClassDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r328",
      "r347",
      "r773",
      "r814"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed earnings of foreign operations"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnfundedPlanMember": {
     "auth_ref": [
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan in which retirement benefits are payable directly from general assets of employer sponsoring plan.",
        "label": "Defined Benefit Plan, Unfunded Plan [Member]",
        "terseLabel": "Unfunded plan"
       }
      }
     },
     "localname": "UnfundedPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r774",
      "r782"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits at end of period",
        "periodStartLabel": "Unrecognized tax benefits at beginning of period",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails",
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r783"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions based on tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r785"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Reductions based on settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r784"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r783"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": {
     "auth_ref": [
      "r1266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense accrued for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued",
        "verboseLabel": "Accrued interest and penalties on unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r786"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Reductions based on the lapse of the applicable statutes of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesGrossUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r787"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "verboseLabel": "Unrecognized tax benefits that would Impact income tax expense and the effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r104",
      "r105",
      "r106",
      "r469",
      "r470",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r793"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "verboseLabel": "Increase (decrease) in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r424",
      "r430"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Year",
        "periodStartLabel": "Balance at Beginning of Year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to Costs and Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account",
        "terseLabel": "Charged to Other Accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r429"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "Deductions From Allowance Accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r429",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r429",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/SUPPLEMENTARYCONSOLIDATEDFINANCIALSTATEMENTSCHEDULEVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "auth_ref": [
      "r258",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "terseLabel": "Unconsolidated VIE maximum exposure to loss"
       }
      }
     },
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract]"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r257",
      "r823",
      "r824",
      "r830",
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Consolidated Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r897",
      "r1065"
     ],
     "calculation": {
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/LeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r450",
      "r459"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average common shares outstanding:",
        "verboseLabel": "Weighted-average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r449",
      "r459"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://mckesson123.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareScheduleofBasicandDilutedEarningsperCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 26
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1001": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1002": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1003": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1004": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1005": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1006": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1007": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1008": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1009": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1011": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1012": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1013": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1014": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1015": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1016": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1017": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1018": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1019": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1021": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1022": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13703-110860",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1040": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1041": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1042": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1043": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1044": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1045": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1046": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1047": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1048": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1049": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1050": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1051": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1052": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1053": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1054": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1055": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1056": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1057": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1058": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1059": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1060": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1061": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1062": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1063": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1064": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1065": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1066": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1067": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1068": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r1069": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1070": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1071": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1072": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1073": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1074": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1075": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1076": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1077": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1078": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1079": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1080": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1081": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(1)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1082": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(3)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1083": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1084": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r1085": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1086": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1087": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1088": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1089": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1090": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1091": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1092": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1093": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1094": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1095": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1096": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1097": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1098": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1099": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126960272&loc=d3e32006-111567",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1158": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19379-109286",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1316": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1317": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1318": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1319": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1320": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1321": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e12803-110250",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "https://asc.fasb.org/topic&trid=49130413",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "https://asc.fasb.org/topic&trid=2122503",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5291-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=28365394&loc=d3e23770-108382",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q1)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28200-109314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919391-209981",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888252",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>143
<FILENAME>0000927653-23-000038-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927653-23-000038-xbrl.zip
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M5P6&Y.EWCN<'D^GP/'L_?W]+WIU)$G!O<CR>3T]ZDK?; MH!A$JM'XY7A![
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M- QA0#H?-40.UL32WQ2R$]F'R!%R"^P6V'4'=EVP9)2+(,&2BV1@4[ L)4,
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MGTP&G4#"<0*,:$-PC F=B'\+X=J,BQ;1]45T74 4(P^>.\_ &# Z>,&B0);
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M'',),BIO8\#LM&))8H &,(=6@19J@1ADHQQ*DQ-Q3XT>R%]X@X!H<A2A 2E
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MQ@&-;DQ:_&[UQ=DHGJ7IS.SOJR]6$]''^W5TW%6]$-4M'-WGI_X 7;+$]Z,
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M^@^<E+FVF @/[1=D!5I7G]!62Y8?1C<VP=A\EA<GNNC:."MZ!1$TE>+ED4+
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MW;G_H;O^LL/[L1M[4T[VHX\\V9\@X#?OV/\>I_V3KHQ;*G6'#W=2=\%E\Z'
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M!@VI6Y= 3O_HC(+PN= QTT# ? #\]3/!L']MAQIP4Y*9A5LRV;*5Z"Z,CE$
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MV_AT=:GU4Y6K4@+M@WB!..K3,4?8U&GPS;Q+M;!]C)C5!:<HN^S.JEEXHFV
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M6#II0_@O;]E3])GL+K29UV:67,C&\4C_"HZ=C78AFD@Q+#BEK\'6DQ@QTG#
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M2+>1"C$V[1*+$Y!6II8)!/ZX0/\2.!KIZXN)(F.RQ1#4G1(TI_RO1;,Q3BR
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MC9/Z@%!]D_O(;?0Y-X;###$+;1..,KUA8$Q$DV:!*7=IY/3W(HF</'%T)"(
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M! ;0:ZR8F5*=HT[O 6?FW?+R!R<+Q;AU;:CZ%A131CB/ Y,^9NC$)8OM@Y^
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MGT.ZCH+LUD7<;79Z.\]T>RX77K4;AR?=G<I1DD0*@>+O["%@Y69>HS7)<P^
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M(Z/D/(5:L4P#>YPY+6%;/P*-!-%"#:+=FR =YFF*Z(>H;I]&?CA/ T(%?V=
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MN7:A77S[<JD]9PWO RFLX<%E#N1#GX'Y :M_Y\B(7%WAAZR?QLD5:*#_D<^
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MQ=M;";G6*&*NW0D0V%V5YEM<6;0%Q0=54Z@N/GAWUX8(/*55EMF>Q^<;%F-
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MEV0,C?B-=&0Q;!."3;_Q9ZE6N&WR+9VMF ]-Z=P_)8U/CK:"Q+70V3NA ZK
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M>9U!D BV*V63B,:E9VW75-^##7"<NF@@8WUFYG_#7I#MOWGJVQ"[OF*.*_4
M9P^!Z]'C#',T\3/K\\+V$$6_%^JJUL]LJV*0RZ_]A"(MU.49,3@9* RKVM*F
M][/N;BA1F3# /#RP*1%T,4V1>.P6B E<6MSY8 ]C6'F8N0O''H\^<!E6HL)\
MT#YD8U(/[[2_<\U)_,KIGRCV"'7&);?H&,P? ]<*TU:I4J21,*PUN>4)_5H;
MO91.C%BU2'7&OP[M7#2$5.@<#(&3$L-ZSHWY,/2/ZP<C>D]E SIDSPU9S+F@
M[0?.^26,![ C;Z_W2%XX3@VG47@E7ZZ H2=\PK)E,/<&2>R//%#+HEB\,*-
MMVS6\+5)D!9Z Z!L2!'?5JC?<$"PT &D,BXE)T<2-A+-&AKN,\EGKK=0/%7
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MOJ@7IZCU(Z!S@HCBP <36X5F^BQA<%(E G!^C<%"%?%5K75?9B!LBQ-'HX5
MBCDSIHV'A-7._,@?2<^FP+02,DU?RKCD<I"I.)[,X<7&"=P.Z"9.OA+6#,+R
MTPUM(G*D#L7(Y];8PF,*&L,P4*F>RPB["LP-HA%)F4A:3L Y]*_](&2'.7)$
MP/J0%B%P_%-Z&1A<&?<)HL*(6:$.\//GMV[#P9$WQ?L<PWJ@H@PG155 G^X
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M]F'/8F-$;CC228359+7&T>H![S\EG2/SOR)6!W>U91T5=)XKS!Q(@O0K,Y)
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M0?2_2OQINH)$I)%AE7IP_,F5NXDRQ <U(JWX,@=NQ-]?HJ%-[]<CT3R<?0M
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MW-PTA?GA09DMN4E<Y39!8ERDW?I3D)J4$N4-TL0//-R3!'5INV] 3Y3CI]W
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MP':PIUF5.!Z=B!@<^3TM8&9"7_2[K0%7<H$13];[QY!4G31O)'K@C/!:DEN
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MNBY&V^J7[@;K_JU.9U6,X]=7_]\8=.317F.7OT6[?/,]@*]_[6Z=R5NN@-K
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M@1D&1@'Z <D/MST9I?I*N#P_!M40=(63L1]?-3K@JQW^T<'#S[YRKMH:@'%
M_\=D%#_EX$5X2TJ_: !TO60W_C2;?^RRACXF/<[B<M^$03Z67!CW+:&27?N*
M/\C0K3;_%8=VA@IG^/(I/40I_7X%1=SYOV.#-3,%17IGD"K_^XX_@LG^Y$<W
M_EWV[G_*/ ,,(X,?,/9Y=?6__$6R!/2^41H.K#6"4U$_Z?_X66?+A#'-F%[Z
MN<R2->#HM*?\LWSYZ*A]L'N 'Y=L6?FPS*M-\ZHD,?%O_</VT>[\GW?;G;F_
M/=&P]R3Y/D<KF]'H22BM#@.%YQ>H8<*@BS\5P.@I0]G_Q5^;N7CC5(W^^NZ_
MPMU^K[<7['8. _^HOWNP/]CUAZ-N1QUV_.'AX?[@_S]X]\LET3)(H!/XH*+$
M)_^7>T#YG^0 :X0(Y<C-ER'-R2Y_LOW>NU]^^_C?_F3Z\[%W"@/<SCG7Q?E[
M+R_A9W:$)/QOPW]^NK@X^^J=G)U_.SL_OCP]^WJ?VH,IAI6\_^=90U69J%_"
MY].OQU]/3H^_/(M"L^0^>N>?_G7ZZ0_O W)[&!<JJ#;@:'3(%] AYT>V'7<V
M^;=!(#RM/2KQ2795XXC::^CE*:P2_C)AI91BG-,\G(3_RW\ TS5)\ZRJR)Z
MB>K'=]32Y.!G&,;B!23IE1_KUW$\4GSQ,Z1@X@@^V#]P18 AFZI) KKM39)^
M]R9)H"*:G=:+=13_X?D<#:4^A%+1?X6>""'/7MEQ@K^B-<0_'AT^!:GZ699@
MI@6\04:NI@ Q?B7!QTG[:>S?5PO'K>3K?DZ?6$U0MR&+UXO2'O0?%@,A!H?=
MGM ?HM ?A!%R.V5H3,,D#&P6%\7'FD-^O32,7KUF4G_(*+TK!\AI>%8JP$F'
M5Z)J2/SD49',=8]?':Q;_&I1;\'[3WB8@(S..,+BBT[+A'+4,80R9_2*"/A'
M >0 @W9 F43;%X89P?^E)(U J0EJC:"*.BYQ=0N?1ET:1[]7110HY?G%9[_\
M99#^SR]+$M[^DH3W?*8SC?A3B-F+PR6,P$5 HXN7VNG>SU+/P5%+^H%G$OS"
M>)@J/W."*O/]\ZA6^*G52D PP3OT_(SU! K&#:BFH)6BY@K6"]Q1Y6A\UG(^
MC@U;TG @&:I&:;E2,:QS2#5M5ZD_P:1D#BZD:IA<Q93N0T\_,/<=_ZAY"?1L
MU+C'L%VH5E'D*4V&2@69#3VEF.:<*2Z;6+:,I^U=CL/,N_$S;<O!%X%C,:=Z
M< =OFIV@_(694CU*F"JFR-%Z>M=)5$RHB _SL(&I[?L4-W/VTV[GR=F_3C_N
M=(Z\:U C@390'[2/R1XO:S[6UZ:^(*&OR-/+0_8U'+Z8PU/@A!@)UPXMY,CV
M: PKX3QNN7*&L$7)1*79K'1 LL0R@@Q)&=TG@6BT0MD!$+O"0H5,'].VTN<2
M0%T-82YS]8S\ZR35=I&0V! ;?_&3=R#:X1_:J=>2Y".*)/.;$8C1*"*/7P83
M1#><8D)&DLQ@O"'] QTR=(LPK3ISLK4-QAY8MCRB57M%1,F-XJQ:TAZ-(,>)
M22V./#,K^;^'N9E\2>#3I36$I>*FX/T2X8V(AU&]*+:6Z>I1A;:+SYB[PN4+
M?\KLYKL:";F7]/L.P9-J8QC11X=E$9$R)OJ*R1VG&6BN0"TN#6S*MC-BQ>"!
MTT >Q'1-X@!\FEQ:2-4U^5[,%/CF<8$D#ZNP'.\4MC'3E*,-1NUBIXKCX-=J
M*,Z7TI+]^U2[&6UU=J5&?WWFI.=MY6&35+HIZUO(OO-29+6&_\2WY>;EV"ZY
MC\_I'UQJ"C,.0O(/XB'L)-<JW6'>=W45$@0LD)RZF;+D] /<: ,.8;)=40K4
MN/BS$BTX=3:;YQ;>[',7Y<S<>V_)H;_9)V>N\.=(3'XP?%)SF$]XF,^8:=P<
MX_,<H^OP?$C8K#FP%SVPDF%7E]FE)><C<Y\H'+JL4)T)2S6'^T!N=!QGH&T.
M<\;W,"69A"I(VJUX THBM.0<DWN2KM>!'R%&3;;0GH%E),&RINV:NVXNQPHD
M&BB*JM:9X&2:F9#.;+)7:;=L^MFLW^&^K7M[13)[\XMD<+IA\-=W]^>5[Q^\
M:RIKFLJ:IOZBJ:QYHR?;5-8TE37/4%DS1WE[):KX?';^Z?1O7[VS;Y^8)"ZV
M0P<] Z423"OXDXG[84J6R7L"O=*?3M/DECR6H)\>_$ V5Z?_@U'>X07$V2=K
M/%77"LXZ*^,\<7%#"??)K7%H>Y]GIX!1^ZP8_*G8OM 60QIFWTM1_&&18LK(
MG3>*T,SDM]O>N9(,R=-<3;S.L;?CG<.KWF>P5Y*4YO<-E&[OE,.+8>8=QW$!
MTSLGV'.R-WWZ&I@[^(KK17(_Y;'KB*9OYJ)NA^3Q8XNG[?VAP(R-PUR ]=QE
M4MI+@LT*,)2GKD(&^IPFG.&/2Z>AC$X/TCI.)N&00X$)NCMP6U5\':9)+!!]
MGO*'8QTY)>#?5/+?;L8A_'*C9!**)@=#8CH"3<[4/X'U'06@:)'7)4KP([)
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M3\L*W));<)&7VSJXS5#PT^++NW(5TCA!&$AB(4HEXZ;>&%)8,?9BJEQ/DLE
MH.-?.??W#^->YFB@GN'0F:'C]_<MPH&C@SA%<831!%*&[A<\ 1 UG&B4@?S)
M)+>#<;1"B_Y#XZ* K&NP-B1M]XI)GGUY(M7<\'Y\A_*%&IDE4<3<8+"DYWU$
M.\@I'X%)/70[:]B.*I2<)+,-3&DDXI\-.$N7/SQW01@AMJ&=\D((:(U=DTFY
M2K4\ _D1+WB]G?HSH9-7 1/%Y.H;N![;+B:%P;HWJ1B<11M)DED)83W)M'+&
M#].P<"8H>[8%.?M"75-:M+W)F*9-X%AK^S8YE )1MLT.$G_E)*H43C7%L&58
MV(XDZ<=7H64(!O"ZF^)E&#& FT]!AY+$%S!T4MU]%-F:S7P3$2#8L8*0[RB2
M-0*)C8*6@T_$@CIU%3],D3V)-/$:-4@:+XQ9GI$+=S@55@7F#8\1_RYP4C+%
M&0>_=8Y3),JIK'8K3VM6I_4(Q\[@>&<XD<I=>.Y/3D2863&G>93F:=,6L,R;
MNR)QIA)B0,[,IF9('6VMI!#IO31ILIP?3X%2-2HB((.16G.,J7H F0K:DB/U
MMT91.Y' <_V-!\I*$DE"VS0A'#0IGQ#RD*S+C/,-7%E.]X+@K\BM1; !?"N,
M4374%"1 @N1T@"7"22<QY]EQX)F29X,=>AU3@+53HMSO26?%U5V1.!$A>;K?
MT.9PQ)=?OH#E8J?KC05 $2<#-,*Y2T,\+7(3$^-_E9C5WEKWL*W)]A3#P%*O
M0X0MG:TT<& W'[V#EIL7B#8+7NE'PR+2]3%E$2D[YTQP1Z<;N!*J;FEU&M_
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M,K0JHD/-$0IPJC?'/M6QM"8?DBN%NF?+&!B50Q^BJ3_2-=KWFD?HT,B-#S*
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M7HVY<@Y[:65J6*0V!N.+PY*!" +&E1E$8,;R]#)WQK/I"DIVQ$DY, %V;Y+
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M><CZ%MPO;$IA^SUX#(0(T 39<Y0G@O-68S\:D385^Z,14!()D@E'R('^<&I
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M?C,.QPV4D=T?O:4MXM>6"&O8\/88)N-?*>\;"=F_#-+_^>4;1OZ^ 8L1_6Z
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M;L-*#2LUK/0$K+0ZP,:ZL-+BCLA.<V%L(E6*5F'_I/MZ+.T\1Y.E:@?B^C9
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M^I=M87MTU#[8/7A(!]O^8?OH&;J!KC#LTS:K!!G/AS.7 $>C)R' .BP,GEP
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M*XS)P>;1)@\M)^.N\92EY-.YY(BQT(//M\Y ><!\5SC99#3*V/>-K\ 5BLM
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MB1]"3M$%N<3@G9M!$,&[</!>M068I<SE+$78:P!O;@#&S(%50"BU5ED"*B&
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M%ZFU#;G,\;A;K+BADSNNMB=<;9_Q/R!?RAFQR/JR%G]J42B B;REV&<9"-S
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M/Z'B7-)K0HE0ZLBI.K<7<065G[<_6&G TW>>K%\&/!T^>:0.GNR_-I:Y5(0
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MXS">0'^PVRO]4?UJ>-:F,7S P60X.N^=X.3M,%,.Y/X<A<L[_]/^LZ,76-_
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MC&RSME(L$*S2U3T0*F-,F?M6=>!I*.\6\W95Q41T$J^%U+/="58G&0V"Y:R
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MS!1D\_4,7YJ0B\X^9"9>V<7*;&C5)@:62$Y 1(;"3 032<(XRLQJ8D;YV%O
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M\&USO=Z:2I!7P%H<I.8_L!C/83LJ>.-6,!^\V U.@DC0C/(")#$+"04Y3/)
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M5LWV@</,('-O:_(M#Q?'=,;ZW^-:5=.M:7=OZMP+! %AO03#7UI?NWH?G_"
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M'7>_>330\;LISL2MSLN==SLM@<"EAV)><55;9+.-#%?'2.!X*=,UT2N4CMS
M<6ZPYR)&EQ9S X2H83JL?Q(Y*; LK"T9A(Q6^)J&&5Q",:H[\;2)\';Z,FPS
M=>H,2"TOD),LYOB&FYRD&\9Z;>1T4XRHZU-Z"Y&K*6W3C[<(*&D/Y_!V Q=S
MXT(9$;DT]K =^^^._>TBKVV+K."6%QVMWG:$.O^_>X[I(M8C>69B:)>]?K",
M5Y_4=TA.^[::^!%RLM^QW.MYCSD>ZF.U.Y4M(-I?Z-3\=?7NJY=7)X*G-(GR
MA.12183*2) </I(D9%F4^2R.D^R1ZMUZEXG>9J^_SP^?VK^VIA:35+6():80
M<2BW!_G+PQPNC;>SZ48;S.J:(2UEOK(+AJ"O3NUVX$#CRT'A)_*$T5)O/9WV
MBYG0.#NBTTUL7:K#7]7%OL!;5-LBSD3[;S?DI2K+7N;#G5)87&(.YL3 [DV5
MQL+5T:/!6W6&Q@9((I"XX^I2J6O$2Y>!L(GL;I>'\'#]?GOMNX$'MLV[1;E-
MG45>>$I/. U5D,>2B%RFA"8%-BV+8L+C-)*YS[-$L)^X=R\F$'@#NG@\G+34
M55#GNF-)!]_GP.U:ZWS4-BW'YN"&N8T<VIG6KX= X0:*#9X IU@Z+6Y68<@!
M3_Y8G2(&N&7+&J&-3=BI<0AH/<J6; [ !4^104[QH.$CV$5C=</3Q=@5>';I
M#< 8YGHT=:F+^D%S=JQ[BFQ#PS)KH%&;J>JLD!WO'PUV9PRFLNEK]6!.<:V%
MFA<S,(/@3]=YA(]M_N8R,CCKP3J4RSU/]+MUT:OK-N\D3@LXAR/9\?ZL+A!&
MP+Q"%[V79[HO<>$&:PT=C?9N@,W11U,*6)_:.H9/7?I!5<!F:- "_%U?#F:&
M+,7<-L4U679Z[[!2'S\5BW$W2KN8IJ %:T0TT#A^K;^:@#F,],+1?,&=-@ZI
M 5; 6F##-F^T(Q>;-HK>"8-:81$JS$ %;#"2"G:2UMX,/6F7::)A$%H<B>&Z
M=J ';3U+MT@[WGY5JTJO>-FZUA;H7)A8#'YM/CI",Z5^^I$Z=_&3)D*@ EV0
M-'(U<18P @ZT+K/YQ*:8$_A)C:M9AU<QA9/>7YP)'"[S=)<EJBO@L$IG[IPW
M)C&ZFREPR[,UI-([A+A-NI;J3!F,7SW+&7Q=6I_)"HG/U:9-;V\SQ&K/4%N=
MY0Y3[XGM'57='BS#9UAW60="":K'U!+4A$EENOF,=4:_VSV-2:%,H]_&.>/D
M*EJ_5HX:RX4T5.E:;'/S^Q#_WCWSAX$NOS7\:ZT^E>K"U'P-H.M;J74CR3E"
M6J4ZO?U8;V#25$T%*'(HW4VDO7']QF_F-.W70!N.,+##Q;+A/>H?,<,P-["T
MM90].#%:(F!EWN>.4APB*";^N\;A4J'LT^_#K*W3:EZZY'#=M:*^AG5UGBDK
MW:H:C!Z[#;:.I%K4<Z^Y;$![[\L]YQ!1[<.N2?_M?#L])58_K%57YM[K7I."
M6_A'>@46SE$#?]G21CQ'5FN WSOPG)XZ8H36Y<YJ_M-]]Y?XUF9! P9!VZOD
M']CTEY_+^6']HFR ];%QEVE]B #?H/9B>WN,,VS-AOWS]_0D"P2V%Y6$90$E
M%-N:YCX-2,S]7*1"4A6N5- ]$I5_L)_>\S.-;/202O]3[Z6UQ4&@8=%^#Z%D
M"5I_B#DU:%\ST'\=RK3)Y5W5A7>\Y[9YR9 A:)1HY(&HDEN%SF5#5G77;Z1?
MYK'<M68^*.>QA1*LULC)/55NY3E6LQ98WDRP/:/4@ &F],PD/2LXI&V69K="
MUKDB^ZK"9LX:]9SF/4H8>7O Y\H:5W1DP]CF199$1AC!^GJ'QS9;=) MFFZS
M1;?9HMNTPFVVZ'9;M]FB/\@\[B-;]!;9G]_6!G)1]^<ZD:@/__8+VC0'+TZ#
MDSQ*12B2A(1%X!.:Y#'ADE(BBH@78._$?KZ:COF(W4MWM(O:-(P^13R>:,@@
MKMQFS(G>6"U$\'(&B,4N0L]25Z*MJ_^T:T>UY>[&>KH.UZW+!G0#Z)<$M@ZY
M^; +SJ "$*=R30;7AI<,:S+G%K7..<=DS^)R32;;*O^5[#C3/;++CMHT-5/[
MWS:*&S;V,5U\< ?L[>O'XJ(Z;;9L+Y^RUSH3:U&K2F(\8*>?!=3:>AW,G0[N
MC&V+V[XA?Y,Y^'-XA8^T@V#LF5!#1]XFJ,,M-L_ \[N**+&\%2OPWDVST'UD
M7VE8]#F;GI;=V1C&T>:7,U04$31-[X^.4[)^W,;E?&*'*B;.1NW9,Q!A@C7]
M\%$/:V(=EHY!8R^;%JC5)GC:K&TS1<,'F :5(:866,GV#@TXL^,=V391&K@(
M8;L1^P'[?V'4I]>A;"K->LQ<ZL69:1I53M?-SJ5;]@.)VI]>3G2D4V>2GP]@
MWKL9CVR"9F^<7J/&;<:*!>4V>2@PM]71K'EDKS<T'%?G9&_7LLL'<:DQL(_H
M>1^7A?I)0BG/-S#F%4S[#O7<L=B^*VLH!:QTT3S6$-QB6G&,2&EZ+:>SA06]
M:=Q? ^+H&.8-9%*YO!\,R^O^X1V02NMT&KD@&W?!;"WOSDK@%V[/>^VK/5AE
M&$ U-5W63'A"YQU+8J#9=12WHYYKCE++<H -8#C;QB&'1[*+ KH!VBTSD7MW
M(M9-;:<?\%C>,:S<MGL&(Q@Z'C4L2X<X:W8*GC2V0; V[-^TH>$==/8Y*!XM
M+!T/T_MG>L?!Q1B5-Z"./:;1H0XX;M7+:/M10R;8ZO2XUFM\>81IS=L R/[5
M:7P29QCT$#&)N4P(345$,I$IDH:<REA&,@S"QQ< T<Y(MYV>WL^'TO#U4+Q_
MG%[;=7349\X-46?2XV%&]<XU7-$'MK!R<;7-\+7HKW=/OM^;"H,/ 6S)1)"[
M3NRM=CP<<-\JT/AAGP4V1#6M5[I(B1FY9B:6S^R]19"GT0I&G F:-.UU.L^T
MT^! S"PM6*]NIG%78USG3(TUI\3TS:8P]@\.JP?%C^^ 49:STF6>;LIJ?=#4
M3J# W=:>^ZNNIA6V:]'QL"U&E&-4'_V35*1)HG*?A D"VL? H[CP,Q)'TD\2
M/TOR0M[>JY$\M*)WYV O>@K!.MF5U0Q/=T<SWI!H?@Y5]UBC&ED$;M!(S*1[
MC@_=#E>GQ]NDMWY1H6TK)?O9826P2C'?E$5NV)?F$JV>"FICI\BYD.1H8)0@
MQ*;&+G6*TKKN4 Z/NJS-1 8<Y_I=0C*U,0Z" 0V])6NV[?'1Z1ZV(;F&3#&&
M[;T'&]@2],]!MGM3[[\74V5!X)$BNJ!];RF.6N+]O8+_F)XM<OT5[V9:X7?U
MB;M'[]KR1'P+\:.1]PKU\[^UO;!OS BMO?]V7,U 8F6A_^^GFZX!@G]I=(HC
MK$HU%LE1EZ[]W*8X8"?O(\13U\D&I; 'Q"@R8LQJ+/\PB&.GB"2O82PQN</8
M-<ZAN>3 :8'9&_/RRWZFN.B]NNZ]U1QOL+;.2E[.;06)"2+JE+:E1XZLL\TV
MM^LE._2R.^W/FC1W/%ADM[BHI'5@ITL-@4R=#8Q$IT/C!:;*!B^S_,BT"N *
M:-@D.NL^\"_@F$RPK#2(7=\ G;&'^267+9= 2W=2SN?+^:6R4B93V/@ZG&L4
M&Y>U2X\IR;JQWBH+K Q \J!:?E.G/>>C[):JN<$$7)\78G"[;PH<!B%]\J4L
MX(%B:*%-[%G]]QOKC?NJ/@7#H%]KNCN5)O'/_/FBV[/'HSV^L=KC[/S#\6YX
M<+4+VMX[K3V^G^S#?2^OX!K_X)^W9Z !@@;YX>/!Y9+V.#D8[[^ 4;\X^/C!
M:(^@9<(8C_<O#UZ\"3[\\3)X/P$-<O(F^I\K<;E_M7?BQRR-"P9F;1&DA%(6
MDRPL,A()+F7"DS3ET3*NC6"IXD41A 45E$<)4*D401((7N11&.;+RN;MRG^]
M3?#Z'=7?[JR$49H]N38T>_,$AA-.4R%2FD=Q7C":4I_G8>'GH91%*!27Q8^I
M3Z\_MH,]NH,R]CCGN$$7^PP2^Y-&S3YRC3<UN,?/H6L=3D&'_&3%Z*BG<CDQ
MZ9K;F$9<?6<W: J6.[^J3868MYB6AC=/%_C$)T-^G2<TR/Q81CF/:1K'G&=)
M7(2TB(,BX+$\V</7!X$/;!I3[B=LW/R_3_8.7FW*5NC1WU^J1IV9G:K#XN\*
MM;\6S6#7^D6>>*A+P&-(^+ ,')BIH*_##Y?O_Q$)7!<<G'\,/[P8G^U?O8D/
M7KP:?SC_>'7XS_N+PW_>7'V8O(P_3-Z6!R]./\D__J;RS_\>?PC'G_@YO//J
M77AX_.'CX3\OKPY>P#O_^7MR>+P??SC?C=$M\/YX//GPQYY_^ J$Q@MQXDN5
M)O\_>V_:U$BNK0O_%0?WWC=Z1R"VQI34?8((NJBN0^_&U$!U'^H+H1%,&9OC
MH1A^_;N4F9YMP. " ]EG'PH\9"JEI4=K?I33B;\N(DX%0QIC@S@.+"K-/=>
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M!F4<5L\0(H,'>,K(HH#H )[2*0K'7<AYR9<1$P/8"+>-Q'C+G0]69!1$A[E
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MKJS)_-U>_',?OIN'BOF;<EGM=DPL*W!-F?\\:'/W& /\E>H_E9:S"MK)7.1
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M0[":S-^MC,W'@]4<(FWI$Q^+8$ASEI(D*$%6Q0@6)_P$8].:H#:VV:.3>-=
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MW4^/PK<!H TD8O'QMU7;Z>4?&3^YDXNN...=Z72NDV 6S1[+@%C(5Q$N/EC
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M;)33\3@PV(3WTGD1,)<:S@DNG"=*82E =N,&;!AG+E*LO-,/B0-D;#DV:WN
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M K@7#7#+=%;+J.,LX]I'PBE/E(,L",*DE<(2>1]\JV!MI; VK;PI$@55)I'
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M:^"N!7"?UO-< W=^P)T0N8)9JYE&S/LL<I5&1BB#1 C)*"52TF9J?$2-W+5
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MG'\53CDG543P/T/<V(0<H1(%G:+B'FN<,R0)-_.MH+5LQ09GTP-J JP)<(P
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M-CQ3]S;<\+3=RU="(88^7 8NO%E,&5K>^E==MMFKD3]HU1-RI ?WH#LE/$6
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MF8RP<2*726ZLKF7T5QE-#/H2//$P=+,R9TK[M=>SS=.L[6:V@P?[!MI_MG[
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M)<N1\92@)+$FG&KI601">W09TA=!:'-J0CU+%[<QIUF587;9MV!8[<T\QVG
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MM^V>T^'0]-X#(T73+I>^,3CD6O&>7I6]=G9R</+WR>[Q#MA<?[? OL)[_WP
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M5ZG@WOM&3P3)Y+[8$T30!OO'G4:T;=P]^!\B5Q 6$E>+63[]>[(D@9"$D4"
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MM5]B.<-[K9&&!!7A[I!P=_/; 5C+)AA+$9C2"7%,,;)8.<2CC8;Q)!1)KYE
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M[WESC$$2[12-1C++-=?&@BPQ@'.!E2":_CK-O #A^^J/8N@UXFXJ'[_6:K;
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M%EY!7@5Y8Y!GE>96&E @;#FXNII*SKC#@FD;=31S]^"L(&]1D#=^,LLK; V
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M)*?:W>?9W8]_G('3!6O@9<*YKI23?) W(9?R05X9%4X\"2OR0=[)8J21S7W
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M;B1?(5J%:$OGEDZ'M(=YINQ6Q[3"ML?$MF^CV,;!64W$)..80M10L-9((,C
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M@ H:PQ+G(6FKDM#!"4;!N0KXKO"?'@?7/UJ=3A]*#V/37VQXW^[9Q@?;;E_
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MX2;:=A-6LU.XV#V+L0D0!XO9ZV00SLAT#%C:"?7R-@!9&2Y;\/5VQDM8YR[
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M[,4(VT^ &6K';KQ)^W/:!A%LPU"SJG3JG=SO_AFVX'MV!OC#GG;B;MHX/6V
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MJ7?4&; 0E-8L!$.\C]X OC Z=^%*E0A9<'0:KKMU  X63U989"0/B#--D?8
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MF6'6QJC Y&!WJ8I6Z?4FZ_4#V1N57M^G7L_8&UP)K52P*',OQ*4SR'")40Q
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MWF-MTFL2#2/^$RR.DS/;^@@F>_,R&[1A5*=Y8,J.K-Q1.[$BB:5[G-Z41SI
M#%]V5=,/IT!H8)O'"5DC!< )=\C"_"-.24H4ILM9,UVE=(/]>C\UVMY<'^19
M)K4RH^3"-V\L!37#VTH[S^:OYC+5W5=W=1P_;"208+R#R\C;JJ% 27:(7CH4
M."?8,WP&6(UXFZ AD3O4J%O%(G_V'MU1E*T]P@F#98\2X2R7>]VZ:59WN1=/
M_\MA:[@Y=:^#$BO+R&K34NK64A-S7W$XN(WK_/I E9OG#V"2@A7#F2W\>_/\
MXCR[#[$4#S4OU]DWQ9PL/4TWJ*FS_EOVP;8"&CR)]S&F]'J Z;WVQ2N8G%K!
M?6KY,5]OA&8O.6L#;^?VY/:(;Z_2MYZVZ9G#M<V:O_E ^'^F9VI]S_]Z.@MB
MHQY\%4>I-MRDY+1SE%,P+WC$-&AB(W8B4%4X2O%M'*5/W++\]/%?W<\G;3 )
M/OWX_,>_X3N?FT?Y<W_4&Y\^?OC^^8^W_//7W[[6]\/7H_R9-X/O_.=?9^X\
M-(^_>O;YZ^_?/G_\?%X__W )9@3^1&$<)[]]^[Q_=G[TQQ&NTZ.K_)G_7!WT
MCAKXQY\G\-^O!QP^RT\QX3H[%A'!)B)N)$4F>8R $+.@J0I$V*U=2F:]YH-V
M%_<E_/G=%97@)U!UM_%,[Y05PE4(-YT*[G-AMB LR<Z_W#1.NV@< Y@S.>JW
M+,+== :U3 5_4T2EWPR2U\L22,_;!??00%E_,P64Q%FL>51(>*\1]Y@BYXQ&
M1%&ADF->T[2U2[8YGO7T;RA4KLQ[4_'/AK+;^2I\BYK=:S!FZ6J3.'<;>-)P
M"-R.B1!HI,SS0+7S@1C&>5 R.6G<0T0D*L1; ?$.9ZFA(;!01EKDJ0V()RJ1
MB4DCA:T1WKED@IL?M5@1[^;#RKVROZE;+G2%O'A%7MN9\[5TSZA4>B65GB$Q
ML$""$^^1$"K'D+1$-OF()*&PM (P6^&Y+38>3Z-OZYQ[2B3E>$[9NUSL[IZ9
MR)R9>GX MG8F4BS6F_&UNL8S +?C=&)__%66-%P]<R(U?L2 KF*G78'=2F!W
M-,9?WEX=[7_@IX[F8@04"(L(N0JH2$@K'E$0SJDH$Z6*;>T6*<#T]9ILMD?P
M8-V)PSQ="/CE84E,%QX8?KMW,*B4?B6EOV8X Z6GR6NJM$&<I=Q$S"1DJ&0H
MRNBYX5H+([=VU6P5GID8]D.H^DOPP PK=E8NEWM&N;4SG9E>X\/B8)WV^7YN
M6#-H_ME=!&?_759;J5#M3E3FB)Y2YZPU*B*PV"+BFG*D17#(X!A4",P9;G(Q
MI]DHW?*P5GEA-M>(6;L79GVJ75DO]T!D0.6%HL(G!7+N.,GG"!BR0#P0IU+0
MG*3-A%Z;]5+Y:U;2W.E27677A+D-18#TM!?U7ZW<.QODWIE7@JT]78*MU_YS
MV'6W0KZU(-_;*;+S%I"/8>>=5\CDDM'<*(F,RG:<85C80 DSM/+;/%7=?F"_
MS6V5NU+BE91XDKZ $CLOC<+<HF!H+O[.-3($<R2]48J;8)TS<R--E1_FGA1O
MHA'4J-3J<_*\['4:MODTF<>=J[%7!.26V/5IC( <7AV?'%Z=.ND\UUX@DYQ!
M/,(/IYA&2BDKHZ=6YYSHS3.]*K?+1A.06^EXI<LKZ?(U#\FZ?/3C-$4A+&<,
M:?@'<68#,L!!P)B@L*S*6BW9W*X,C^(X?0G.DR)D6KD^G@0!&?: 'X+4?C_V
MVL4"5NQC[>QCD*.G'69!>(=<R">RL,3(^B1SS7J>9'1!5NZ/IZO?CYNV<CM-
MKS3ZEAQDH-'"$J\%=8BI !JM'$?:6XPPD4HH:H()<5[;E1?A"OE9Q?Y'./=.
MEJYPOP:WR'(%!)X(LJT ;%@XY;WC21/.701<8T%Z9I/FW'-3ULV\112[@JJ5
MH,K/D@^BDT@YX)P LQ#7N;:F@-^2M(%2P7B,>&N7F'6=^5FZA,93<8B\5)66
M6!F96!)8)\ZHLCPJIBW($@T^:;>L2E?GGS<#&6:/#AG* DD8:193+K4>D"&1
M(2)"=+DD+2,Y!6V;*O(DL.$EN%HV[_#STS7<5BH+SJ1F#BNB*"<V&8:-%)@&
M'*+T:?G>J-7AYX>!NR^S1"@ZDEPT' 4O+>*$)V0D-4@+2[5*N;62G5_&M_+
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MW2NB)Q_S:[_;:Z3+\J4&R$2K]PKE#SW2D^N=DL[-_OSG!#F:JD-*+(V<ZV1
M\#W\2, GC98Z2"$(B7,]]9.6P8'MM&"6NG_%SOLSVXDG</'?FFW_[=%I_8<A
MK;\$NLP^T</+^LD'(-2?\.>/];-/YP??ZT#!ZR?AZ^>3O>_')U]$O6'PY_^<
M87_^[Y;]:/K'7P\YF -?/WT])/633U?UK^^:G^COC4\G>[1^Y4F=UIM'^WOB
M>/\;S9W@P$0X-3I*'Q-'/N8R>)YAY"@WB"I"M!9> D$OC;1"+O>R891+G<<
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MCYB?REP>Q8Z#1.9;M?*^H2'@!E_CI;K )VX*%_&H\0.=-4*(K5?5[O33W>D
M=J:]F4X6WG$65$ \N(@XAA_:$(>$(X)[G%14L9KUM<]ZU,XF;Y"5QB!N T&6
M:8H(QX$GZX+A:FOWKTYVI?0NMVN@ZJW>=G%<*OYOOW&13YUNUUJQ-T*]R?_<
MP@_VQ.V"I1[Q^=@$:W)-#+;0^1F@%?5?4<UGVDD('A+G6B#CB$=<.X]T"!@9
MR412@C/)LF=;XXWW:Z_,A"OH>:[0LR9W1 4]ZX2>F;X+G)C G7?(NIB[(TN.
MK-8625@^92.1FN=</_RD0VIW\S@\7>.O,B K _(Q@.9JCBG#-0E:&(YDP&!
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M$% 4T>O(J#:: ;3P1>>21] "%.8B^LQ%FI<%T !<'-D.D!M&M@M&6>L,V.>
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MEM8SZ)&.Q$9','"0OFK?P?(<,5?*YRR/9520>G>D7K:,HHF<,.Z18)$A+J0
MI":#0A0VF"B,E#9;1J0@]1DC==&ZOB#USDB=TO564",YAS554XJX,19IK#SB
MR6,3@B%)9!^&7*9C6Q=2M_?I5BM]FM=X((-K>4IV51;7ZUO5WGFZ]: ?_AHO
MZK",R]OI9NRTOTNAN.>M1Q9NXY\ON72IF,#Y@2HB92Z1LC5M^ L<9)+8@<UO
M)>)YA(S/1P08;RUUC @F5M;HG>W^:ZCAD<XC+NB]-[N_H/>>T'O9&2"X=\K9
MA")3#'%I K(X.P.2EU)P+94+*VML46'2@MYE1.^B?0$%O?>#WBD'0;0T;\4"
MS%H!Z/4:?@L4PP(<HR#48145K+W+A-X7=73'1DYWCOU!K7LP722I!/P>Q1B8
MC,G[H\-XT(^%A.8B(3]M %AC,%4\(6R-SWL,'=(J>21!$283#:,VG\"Y1#[*
M$DUX2OJ_ /:.@)T* "JE3201P<0$U6 =02YRA9P'L,KH%$MX96V9@@H%L$])
M\A? W@VP4S*?T)!+6 7DF,2(JYS?)X5"C'(7-/:4";=<*^PB'?],K2JQY$*_
MV1V<UD\^'V*JW<7C?[=TZR?-3PNS #I^_P(WE<2$N0EI9T:R7[ "&Y=W4[B
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MQZ2^#-W([&@=^&XGOK!TLW\\:O'"<==O5#U?2&8^DCF:(=T=H<%R09"Q"?2
M$1Q99BRB(0;"B=8VZ9EYZE,UDTN^RE.$Z.)K[A6(W@VBTY)=$<J2D,AJGK-4
ME$;.LX@2\]SZG(PNU<H:GRXK42#Z/""Z\%)Q!:)W@^B45&<*>X!D0#K2"%(]
M8.2,\<@PD7!R3! .$&73F62/ M$[5F(?G[E"[UJ,_?'#"*/LLJ<=0Z!7Q!#N
M.IBE)NFB^F>Y5Z+'-.>*N^B6:]#Q#$O."DDYH1Y1E<N/*8R1=2&AI(2.B0:&
M$UM9$XM.0;@[0!ZV<O/,]MZU<G-AT<*BCV9Q%Q:]/8M.&=M$,R*]5HBDS*+4
M6^18X(AS1P7Q0AL3@$7-@K,T"XL6%BTL^IA.D<*BMV?1*7^($I(Y(PQ2V O$
M@521P1ZCX%60V(,=P?7*FB2+"ET^.HO^QJ4R.<(6GC1>3[Q/^9.E$R:=\+O3
MYO-$S(<^CZ<>RDM4=<3SZ2O5G'M]J0[+K(.AT7V<#&U^1]?5P=#_(/]3&^%U
M^F=S-^;JC!T ZZ"?(^7M88BU0WO<J0Z13MU>K6-;0.C51H17M8$]BOU79Q^P
M*44_B*'FCFN#Z@#J@WX^V;QVV&OY''H/\>A5S1Z$6A?>[M7Z+7@^"Q>- _A
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M.41;J5IR;V[2<0R' )7K?'R0<CF_(@2)7" $"6$IX8$9*O*&XU=8W+E0P.(
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M69/3^7$UF'[ML<EQ7C#8$98GFCW,,(LK(=*KO1^"@1IKGT>&T-\30^B2.LR
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M5C@8;4Y]90U+,^TJ+-9P(<9G1XS+Q8O%&EX\!YY<YD!E4Y1))R12/D*-".!
M*CPBUG.CC<VG-V4.Q/I9FL/S$^'<Z2WCPXZ>3 ;+E]C[V?*Q9G=Z<53TY%:1
M^=\_]M+RW^Q=E#QR%8/.U?:X$6!+ 42<IMQ@%:@,)4=E26GO9$:.BB'*8DT\
M4CI:Q+%AR"4F4+"4ZZ!I4"KF>AP+R5&YA(2KM\C,AZ:90FII,74C3<%Y,E;G
M\U8=%Y1:A9U4$6.EJ9;XQF<&%K?3P\)K*@<#+"E" TM(<9%0WIX/\*(1A5P;
M$SM#F:M\[(0MZBC!1SA@]87B>2[GR?T#^DKG24'QG"B>2A:0B8,Y%\$6X"X@
MSAQ%CB:.F$O!QV2UYWAE3=+IL^IO[API\'W1RW%EXA>DSHG4J9@V#IAK[#W*
MQ[0@SBG(6>(-2M' 0HP33I&LK G"RVK[?.$:E=>"T*BEB5QK:I3!F%A*/%7>
M$UN"MLN)YJF@K6?8.A,=DDEXQ*5E2%LB$1<N&0&,&T9)>EA/)^D5/"\WGN=1
MSP\ Z**>%^9BFHHN)B<"35(B2[A&/&""C/,.>>N]EM90&04LRNJ9RN=GZAM>
M$N 6X7PKD$Z%O[B4)C'"D62>(>X<1\Y8A8P5!,<8K8@F*V<Z!=*%NX)_$UB:
M5+B#-L3K\58^63XY_R=ONVW_R<0UFST;8C[4<'0FX2#_61'NG7;G/\4U;&9\
MTT>"*2$\"H:Y]-@8;%4R#A8OQK"2);ZYI.L:F17?#,9XKRPL9BPB3@BL:)3
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M'\,^S.M^O_;6_V?8&K'0Z$S.];.[]%>K3Y,WM>9N"][M %L/:K]L'RY=3?<
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M;\ZMI ?#CHN]RT%E3,'R\DG2A#DC40=,&-A>DH$E9E68'53>:'R89;1O'.2
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MBVVX[@>:8R-%9;!"1A0#]N!Q0D+6^(2PRL6MA#LL329)6- 5\'];KT?]WE2
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M0C3H,[4YL3X3SP2<E5/P-5+.)L6Y$' *F15)2T<81.^.F&B(Y5S11$-@F#2
M\\>K(+N]_.-?IWL'H7UXNGN^?_#F\^[!>U@? )P'[^!]_O5Y=R? ?4X^'=+7
M. /.D !61I,0E8;D$5@"6688,MXE'!(!O"DR<0)9!#C_&I9#GN.%# JJZ6Z[
M$QW0O;2N<6PKUJHYU&D5#M$*A9A-'!R;8\A%*5#*Q K8L^@]SXYMG4Z;FS3G
MBI63"6]]HDSFL5B)1HN3L9GB!#MJ FN*CA]'.>=0I]$0D@NKD$PZISDM129A
MAH+4V MM.0D$E%.O89IS?*^Q2(JB>NMR^K\NUW@Q$/V/: >Q9;NAU1N>Q'ZK
MY^#!2@W-H/5(-3*+'NR>-3(_\=O*8UZ\2XG1,BREX\1H3D1PW)#$H@84"%ZE
M/CEK\-YW=2EB$=X+VFGG+)+"0B"$K4$6,XNTB1S#]TE2<F.+*K)&+J7!>ZON
M $W$"4$P%S)PCZFCT3LM [728!^;(0"/HYSS>(]XB,($1HPG@7CFWW$V1:0
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MQG> 'O<3G09ZK%J*/A^9J+7U%+RAS'Q*@3FDN3#(<:F)\ I'SNZ%0RY%YT8
M\J]1-[98OTIY7\IB/]P(/JK?JJ*J]< =A( D4TH5<9@;Y;5S- \9$MQQ[$(H
MN*-(-+J;:#>X8T5"?K%[Q)U,P7&.N/ 8<4PP,A$;9+B,-JAHN"D8Y#JVB0:#
MW!V#O,XZF]_[55W%"FI2NCK*P>O8L?P%%P<]FQ2E946\:[/P3*]P^7#?=C\/
MJA-7L"M?VSF8Z71F/CDI=AL?+K^Z>K*+ACU4G^R.2J_+C0^4E]K!%Z699:J
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M2M'D-*-),L$YH380!1 A!96B=*3R:A2#147WFI[8U"(L\%\?\/Z!)W /#,_
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M1<?HO#1]3S3+P/.YX%D &\.)P9G+Q%N+B8>8Q]<,%G<1BL;(+&MDX,TR:8G
M3!.&L"F@U@NDG<S,_)@Q;(PRRD&,LZEN#97)O(TI9F6O]Z4^X\>+[<K]PF7
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M-WL&/QF>-Y''769ZY^PG)]PS%@+RY?1+*HNLRU6-/,KHA&',TUQCO8!B:AR
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M-FF$^XG+I^TC*8-Q$0ND%8[@N[E!AA&/A$B")!JIYYE/@LPSX<W1FH%D+&;
M*PZW\);5O.;%P?<GY(Q@RP'EMTOJNO[6Z\T/FZW<?=H;@#D\[O<@%@5CM^^'
MO3JI33=;4X>D5XYJ!N.$[S C!+#3<(D'%!DLRN]./'L^;JJ,=;;UB^X\FPJF
MS]5A@UL#5%_.#?^T9\]E=MO50Z=V?;A:N=KZ;<_RV^9CI>.^/<TID\'H+ ]L
M*S -HL7/U>2^L[R2XT/ 2DZS>&406LZ:;H2B'R90LK[/S RY'"X/!J-XCT2O
MDIQH< PZ20I 7EMA0E!4",69),+=F8BA*29_L('VWS+7I(C2,X45PLF9G&\)
M2.N44!04(FOIB,!V<0'Y5?*%]M51I',B6R9.7DGC+6,;'YS4D\32R+E.QAKN
MX8\4#35:ZB"%(.2V>L]Y"9RN!ARS3H)$3EZ[F*5&]*X1O?/]G=TCKQU1QB6$
M'<ZY9&&1,3$BRH,WGOD0--O8TIOS,XP>P"^5"52M-%PY;+FB3%.9DTE8,&VC
MCN8V$M)&$%8M"/X(+(^1)@EDE:,YJ1.0Y5$A'8QBQ,%W?0&&JV>6LG ?:V*R
M&."H<MPY3AG!@0;N);?QECK_1AI6+0T''XZTHH1)BY'%066J=XX,300)ET!+
M#<9)Q3SFZA8ZH$6<474:[8<ZCFFVJ$8N[B87%[N?WAW!$A/E#4/>.98G#1%D
M-<20G$;-([<07*;U=Q?-]M]K^X^/G [<^-P6%W-_ON8.N6@=L@0K9QVS5N,G
MXB0:&;B/#%P<'@FGDW#8(6HR4( ]01:V OYPUJL\6]B+>[B&T6S NZ!J=AR,
M5-58]V@IA >5UEMNDJ80[&*0)N(H)P)<G6'87).=O)&#</[,&"1F<F;\8OM"
M_,7^P?&1)X3[8 /RQ%L0%JZ04T3E&8I@,U)@H+1+M92M+'G1[.#==A "0"$5
MB\@XIQ''&C1=<H^H#3KY**(@ZFX]8]?D(Z93%@UGY(V<D>)ZSLC\O$4^;R5;
M(T)M-$R3#=-D0TG8,$V^N&UMF":?QGLLR32Y[&'C#WHK0C>K&&C^SQL)@.Z3
M_KH*=\?5C.-AEZ]A-8?G.^U!K@$?]>,!W.S73L]__N$HU]<H]^SS'MT[/;SX
M</[Q]+78SRCWH'.Z__LA/CQ]_6WW]%#LTO?M7?KAXG 6Y9Z^8X?TXZ>]@W\!
M&OXL .62_;\/^<=/[]N'!Z_//W[Z?/'Q][<7'P_V/OWG8A>>;_M(T.1@X0PR
MP3/$8XK(>N>1BDD2XQ-V45:12!'"[6%IF-&6RYP<5SE3'JP745,M!35!2 ZN
M($+L<)9M>7\$!G.\!ZWQ)K3*+N1JK]DZV:LROI!']=:[/X\C^/C%=D:E!3D?
MKO>^=F-_<-(^>U7V(D<6(]NILDG5F?JXAKPTU,;Q^@Y[$ Q6)96QU2XE)U63
MX[_?OA[D;[2'K9,R8/3+>),FQ>BE23EW/(ZO5MTN9RJZ5?ME_F=I$:\K7/*'
M)\]12E+S;U<O4EHO\YU/X(4[YU7/;_Q6KM'N9KK8V((%!#1>&LD^C<)Q^6)\
MR]PR"3?)]3.G95E*Q<I@,*JFG4XUIEZV]YRT!\->/X,-N,5D@-JK7.C2/:[7
M+<%2EM[37\>_7VI.+Q_Z5;UNEPW9XP7-6Y,[4^MQT*7UW,5N3&T(]>!K>-S!
MR)^4M<X=VJ4=N&X.'U0_FFQ4::C+=[[L28?8<%B53SS?0IJI9OGKK<3SJZ^Y
M(@@V"TCKZTGLCK6Q"%3O:RQ=QZ'=+^WG\+V<3_A2*W9F!3[MP2KEP;FYM-1V
MA[DE&6Y0?QJN.FG,!O"8BVG]U0[M6K5JMH,RQ:+7RFF!OBO3@7..HDI-%B2>
M?PK/$C.A0R7GETWO^17@>A6Q0SV3^%56CORJ[5":1F_0D_H2FZVW,UHRZ9>'
MD*(342?"4\56)]K2P#51GZ\E*]H>OAJ/&ZT^^&JRG*?V4Z]4T/?;@\_C.^;+
ME"J]06[?#Z/8JI40M+MP.Y0/M";$")-U&O?.#^8?96XJ<[6>5=T)K$>^_ZO+
MNP\F7?I7>!'&/'.+I* '>VBOM++7[P%7.LO!56T<5[6UY<W.-Z]26Q3_$7JE
M O#$PF_9RT+ 6@:OX0BX<IF_)C8NWVU_ZLWZ-WWP-SLX:;WI]+YF+U/X-^H]
MS._=:5>L"I59K6<2U[T$5Z[Y:\5JT?KK).;?K0<=#VKG6%+LRYS49#(WPK@-
M3%@>M';<"6-3TD%$1Y._ZZ"H[?(J3Z6R][%AZVN2IX%%&9C&RJ)8J):X2\BD
MQ)&DT@8B=)0T']/3&^9:+WL0MZKM_>-2/)L]OGZ//Q\Q*7C$G",*$4D>1$V1
M\4X@+J@5G$=KA=S8$O/';>,MGBO"F">C658(E$LT&2J-PY2+A#5UB3A)/)=4
MJUH([E#EW^CX+?N?J6@]%3X)CFR0%/' -=))*61=9-S0/+2 @X[+!=UV]]7Q
M56UOH^-WV..]G0]'3@4G/.@X<SZ3.VB.-!C5PB6M##>*BFS'KZNJN:.B/]M.
MA+<3HK,2]G_H^I<:4;4'XRQ"J-!SA>%*6PY$55,D:I,% J#K;4XK3/^\8-F5
MQ%_M_DU1UVB0'WG\1'<+D"Y#C+>PW]6)+_SR2?ML G1;N>DB$['%X4DO3!'A
MU= XEM/F5^.H92:;-&G0N'KM2322U_0*F=4$U,^N1(D'KUXEYW[*E7K=+"#'
MYU/)JZR\$#G @Y\5!?=7.D$*Z5;U;;A*WW:K'-'@:F5^W50">]#[6@40=8"5
M^Y;K%>Q'"!5B2:Q4R2M8K;,2VY4V:7=>;T']##7Q64Y*#:[^I'[QE@TY5!P,
M^Q7-81IUBWF"I_^SGWG0:XJUJO'K=)(HBZUM4*5^YD]THT%.)0W&G("I-^K#
M(BTD&)DA8\I=X@MV:APRGYU8$#E?A4&E??:LWH&O)[W3+/5UZ!G&2:<L$/FB
MM1!-)1UA(?X)KU/ZTDO73VY4G[ ^E>@;%@\N67[6KF7YBQT,+R/O^LTO'VN\
MB&?CYM=K9*LF6HS?SDK*/B]J#F%;/^51%_V00_U\<7@;5_/I_6,Z#5&"<)"!
MT8QU+ 8"/K?4+%> G50PZ3UX)TR]5E833J2-C"@2PEWKJ!8?2U1_UJU$?\ K
MOJY?>;MTYCV5\KS'AA)OZ=[%ZR,EL67!2!1]+.0,$=D\2AZVPRN-!:?>+%5Q
MM:JYO<U>KWRO+00#+/-LF6AP+L4TR.E(4"9*P4%;JKC*0WOY7?B[Q['"#467
M-67%A)J@'\]@)RL2S6+G.J.*I+D[!._4SIBK3D@5^UQQ5@+*^5)<V-AN@@.K
M+>V4GWY5.^J<>"Q?91J-*C67A:C8R/9@W*0>OQ6W7SU&18 +3J/\SC%X$/#$
M$7X8P(.,!H,J#?9F<L"PUP,W2.2K,6'?Y4]^O_S=_ Q_%Z];H$=-VW>%T=)%
ML/A?JH?(6=B,:RZS@<543VQWE10<3-8GC]_N@S>JOGG%F]VI)NZ.I5\2;]P-
M[=;5*RB7JA1L>QO^18\"@*\Y5F<_ZEC]SXH6>KL;"I7%GP#_^G%8M_O^6B>0
MU_"4_=/VN);T&UB<S[L7[\YW+_Y]NOOI0[93[/#39[+W][\_[9V^._]X\.OI
M'OV ]W^;K25]<[I+WUWL[;R%^QZ>[QUD.Q7:^P<?R,>_=^G'G7]U=G\_9&#'
M>"$1 HMWQ&7T*7F+O&(,<6PT<MR&S#X0='2<4\%GC]D#3E[[[+B8XIQ08W"4
M1'*J;7( -F:/V>L]:8V7_QYGZ[??\NHCQA@I=<[JQ"0G3CLE@@O.1JL4-I(\
MD[/XZ7;XBJ K&WN Z!T(=VK^;%CHRV^,>;[KHQ2(_ZJM.>O8;F52QY\H\5?;
M5;.$JA_G<PBPJ)4;B:=GG=XY&.)E4AAW,6)KD\/8ZW51H=??J9>DEM_66)[_
MS*OR/#(6V_/D(5>YMB9!3W>\*C>+4F9)7R0MX'6K87N 4T)A4:JR$YG?M__5
M5K%WX?"WFQ.#,74"5@LJ.&Q7'RV.H0_<.MI<N5#?:O+$J3"5#6S']L]?U3Q-
M7; NG2N<X_D6[6[JU$,L#JZ<40ZF'Q#NW<G$Z@5N34!47JL2OR,(_D;5MZ>7
M9)SR&=1Q^R2HSY>-QSGB_C-/1O2MOVHX-A:S-WGDPF1"Q)__,R8HWFQM>U_8
MV8_'#U#1BM?Q+'RTVL)R^S&L2=53MJ:>LBSIY0N>PIID!HR<NNS!K6$CSPLS
M:7[C^D;C-YLZQ@7@[^LKC@9C-@/8'@!N9YU\8-X+E0VJ[U2]<\=^O:L!67\5
MFJ;4J=(:>0[%%+?.5)[N"O0][<$/0P13WEF A.D$"/\ZSLEL>\#G@YHW/JO,
MSN5=!J_&6'B\2],'STNR1_FDN#/214(3A)?$I*0(M1YP&)-*J[L>/.S43$*_
M9R*AM^-1%QF(C?WVY(R]EOML76L#L#^1LB=R:/'H:&Z&DOC3\9%G$(K20!&W
MWL ?.B#-C4>)6IY(T(XQ@&;ZU@.,&::H!;1056 XEK5+.[/<$'#,-7;>R\ X
M(]9I@*,R1:%ETB'PY8XO]],2XM:(U%U$:N^3/\*1<)&$0]I:#"*E<ILQX\A(
MK*SBPF*=9X&;)47JP^;_S(M4*7*9%,E<MJ)"7%$9O=HB3AUHMDYBIR)S@NO$
ML0W,LEE_MA*.JQ^;V,JK!W7M<8G0=54Y"^G6[LG'77F(*;PP;:^'N8HH7W.I
MXV(J*#=4DR0AG.;*P-=:<HNI3]%I?@LO[Z5>%7KX>YGN2YN] UOI>\==\*6A
M4;8[*=O.ZR/-N"3::N2Q$HB; ($Y6&Z$F6111"PBU1M;ZA;[7?-[U'5XZR%"
M@&D6"@^@V=%IA2!_AY@VIYX;T5E:= [>'7DAHQ%"(N&E0CRXB!Q3&"E,J (#
MKE0>"TNNHP,8BPZ8K#(IJ<J#VLO=J<]&<Z%\/YYDE?\2JVSJ3#QT-UK)*U8S
MM?L0?=S+:MX/>>01[DJ8E/ESN$[>2"UI,$PG(A/U8^0A&5ZUA:S<42/BRXHX
M_'UDC"IBC)+2$7$<*7+).F0PMM%2QGEDMT.1^UM'%RCESD<91. )1Y<$!<F)
M E,1E&%7,]7+B$]C';^GZ.QL'\&^*<<%1<27Z$A39&G"2%/LJ,!><4TVMMAM
MDS3RV?UJ3.("_-NP+MS(NB"O9UUH^!,:_H2FT;[A3W@QV]KP)SR-]UB2/V'A
M*?BMI]HSI^  @IE/SF/-"%>>&,&2$R%%R6CTG#_A4_#ID/'NA:F3F'&ITDKC
MHPF>",,P-XKH%)5S+&*N1"0XWI:;OG^$.'?\T2#^VQ'_6YISU8P%FHSVR&B5
MA["P7(B7FSA",BS(S"*A(4"\0PYD45+VWG$CR?/1DF?2Q,@#UO X@J28#$T1
MHEA2QXWD.N)4V,Y<S Y?-0'D(XD3V[WX<*2(-TP0CPA/&G&- ])>)*1XM+!;
MS$5;!JQ]GZ Q'U24*L[A8+X^_ZZ'#F05IM!Z!7)+@A>.)RR<HH%%+53"H%*:
M%E.(O\=Q0F,*[R.[/ \4"#)X[:1"L$TBMRM"6,PE03IFBATBO-0Y':QOFTBU
M:EOH#'%!$6.C)]P2Z1B/7+&8,'<Z,EP1"(]/&!9*56,+'U>>Q-[!ZR/+#0Y"
M.Y2(!'GR7B(MC$<\AR5!4..<V]AB=W"MR]K";/]^C[E=;=RL$T<EY,R-0YU8
MS.2D;6E2P%C]KFU]*H,=OP!P'?5C.87^CC4XDWKTI]+@>3/:GJWUFZHH*\UR
M4Y5RN3[N%*S!J)XSUDL+ZPAKQY3'W:#8#9LWCA9>06'X7_XDAE$G[J>]."X$
M_ZTW& Y*4N1EUX&_Y4>2"$843B@%&A L-?@'HBDR)))(HPB"N+DZ<$Z,P]@I
M'SP7 MN$ _;<.968UF*N#CS75'9CKA3MMWL!]CA^RPXECLL[YV3D:DEI*0FQ
MN5*SDPE6?KZYC/S&P';CNC+SV][HL9/!X/TV<95\738;+/BF-GSEV6!"-B4Q
M][KL33^CFXJRYF$I746>?2Q]H!QQX\:<[J)/WC&)CW,2>-'5B;A+RKA*QLUJ
M0"7\CY^B*RIV6$:OO9X9O38Q*ZL_X/@^;VN6[W<HK__3V^Z8GV3PCRMOO?AE
M:^,W[)W]#._:*H5RK?%S/ZV=SZ!A56]\K5X\UY6CS<K=<^7(,K;%6?\Y%P=T
M ZH?T?L84_KEOFOR>!;I]BBCK,BX\<5GS@YT2?<'9CD''S,#A&>E;F7+A%M/
M8;'^Z_N]_R^S)[5K]>)+9)@TD0X+0R2S@D?A'*:8.6^M=Y$$%FZ;4C??Q5+%
MP77XF/.2M<SF2/+))X8.__[7X./!V:?=TW=?/_[^#J[_+D\HQWL7K^%G_S[9
M_?1:'%Y\%A]WWG0./[WYM-NN?^<__SIQIZ&S?[I[_G'GU\\?X;GWX/EV=]ZQ
MW8/W)Q__?GV^>]#YM'_0^;S[][_;NW_OGO_G8G>X=XZ__7'P>@C7Y7L7[_B1
M"(I:V#(DO.>(!RN0MB0A+%)N/$@N1;JQ=5W)\W=3B/S3)17C)A?VH.>9]9&-
MU6NLWNP98YZA!O;.2F6Y$R)/:-1!8,<HP8[XVX8S-E;ONUJ]_;]FK)[E1$MF
M",*)$\2=D\ABQU&PQ-D0";<NW'"VV)B]QNPU9F^C#;@!)X.5P]+SA(U+@B4<
M/&B6BUS<.H^T,7O?U>SM9I-73-_;;_L['N]O'V%K15+$(&.)!;A''7(L1N1D
M(DD+&8A@8/B>#-Y;.H!/Y7]/*D:?,+:6(#V?S?1[GZ(?3AT.7AX&7IL8HLLM
MRD(C_:2-U2-$IN.=:JS5TM;JW7QHJIB"K2(.MB."K9(N(1M%1!@'X56PV"B_
ML75="<V=3=5BB_!=8=C,+:]-PKYXG7V$N*K1V0?H[%Q@!695&:4$H J&$1=6
M(=!2B; %8!@5E=I8P!?S7)R-TCX;I7V$J*!1V@<H[8*P0''&8M 8449 ;4,4
MR%+K$6?1*2R(IY&#VE[7V_TCU/:^1W=/"?F__G96X?Q^'([ZW=:$<>%>*'_!
M CP1X_/3>L'\\;:\+[NR/\4LT=BBI6S1AWG0;W.%/*$8&4H9 LQGD<8*#).@
MGA-K@PIXT7G47/7,DG;@,=*N#X(.+T-['P'P-]J[,NV=A_]2JR"D15&JB+BU
M!NE *6AO(D)[XD,2"W%$H[[/0GT? ?HWZKLR]5T0"-#,=$=\1(H+EF=I<G"_
M%+08'&^421(10ZZC6P\%?NSL_U2#PQ5:=3.^QG@.A/D1;4-%6[=/>_#L%U6#
M12^!LE[VV+7*;*_+01R%0[:,IAI,E0$.;F$G>?'YC95%&*5W<L[ 3>]@+^5>
MR<$?94ASF2(V=1[Z6S^&]A V\: /+UZ:XBY[=0>-3;R'33R<#TB("P;GWEWO
MA(> Q"CD5%3(JEPKXEA200.D6:/,2)/07-=3B$;AUT_AYV(8Y34+7F#DN",(
M-)\@&ZQ$(3I!K8*=MA##7-=JW2C\,U#XE84QC<*OG\(OB'J\AFVE4:+DF04?
M3R2R)CED.36,R$@9XRLH@F]./Y92V-]&>79M)\\*^B=(^K!3#9C-!-G-^<>/
M//]X/XDH]^)P0N8RB@>]OR;;--CNAJD-')#&3BUEI_R">BA")3<>(V^=S$7K
M&:)HBW0,.H(ATD&+19%(DUM]%HK]"$<CC6(_AF+/11S>4*V<C"@%#_!#>(U<
M-!S9R*V7(A$PX\V9YY-2[/4Z,[FG7D\SLJ7VMQC01>SW&GU?4M\7!!R&2V^)
M5:#L@>=Q<129Q","#V\(MB(Y AI?2)GH+ROJQ7B$L.-A)#A/Y9/W/76JFV%J
M+BIZIWX88M8\2-N;)A<;DX?5)&/+!L:W+="UW43/NKUPM8OS;-SF(\2Y(-M_
MUJ(]Q5[8^+^E_-_G^4#6"\NBQCHW]A#$F4U(J^10<B*Z1+",B:^NL6<UBO-(
MN?F[^H@[-V<WIK4QK6O8==68UI68UKE4 MA.(JT0*&@3$>R;!=.J#>(<W*.E
M*6 B-K96U7[5F-;&M#:F=<V2/8UI78EI7=0EEY(,WE"D P^ 6S5\):E',GKF
M52!,L,75[4_1NEZ=7C8W#7/).6!K1JZ?:=$O632ROK9\J;5HG<;A22^TVH/6
M:-CNE*K9/*B@D.MG*LSN#?F.5@]6M)!EQM.S3N\\QD'-JSXIL.VTTR7W^A6N
M]<W6A^M+=>'-XS<?8][5UK7FICLZ=;$_8W%L=(X9X3!3G'-JC,&:@UW!VD7L
ME"GS8^;"8WI+!<OXZ>JZE=C/;*_V.+X>/^7O_6B'L;^?_APO\]PXF?W^KNU_
MCL-_V\XH[J>9<A9$GZBANO]<@%V\O_/AB%":<!0:^90H #?#D(LD(4<()88&
M:DGNQ9TOP?^_X[D/Q]7:C_]Y$UU,JQ;%T[(3K2]Y*\J8D'K01*;_KZJ58C98
M?9N5"&6%NA1V"U_ UK?Z\=2VNUE"TZ@,VQT+?:4OU?21/"'W4CV:H;LW&"F"
M53-TMQFZFZ6LF<[:#-U]X=O:#-U]&N^QBJ&[MP[1G9F*I BWQL./K:/<4*Y9
M% +$B%#/(L9N$J)__TE7\UAYD,?A 8C/(\I>]LRK#^((0@\3)(F(4J_RS"N!
MM,,:86N-2#1!9"UF9U@]U0EN;[M5 4T6ZWX\MOTPGJ7@3VSW&&X$D>4\)*_[
M,J?&O=UQ5I<=3(_JNGX*WB)+\>C03PMV'^BG\"8WXJ[0[\>6D]SYI?(4*J:^
MR\@L_5U&9O&5H.0UJ==98A3.;<]AFBE<+V$*UX\M27M>\YB:&6"KF0'V@B99
M+5Z1WPJFN@92K;]2KW14PQ._P0^@=?DQ!\>_SN?C[1#D%_!TR:.7\>\E=SX6
MX)4^994'ONTQ%R3;\UXBMKD ZSL[B%62Z2<R&^^OA>X]N+']Z==D/,_*"D%8
MM"ER@3'E@5EC4F!*VTS;HJ2.Y9SS7K5J<P>7SZ26HD?V3E^+W9U=NO?[+CG\
M^QW^N+/+]G<^4_C^M]T#C_=VWN'=W^%YSV=J*3Y]H/!L7W<O#O'AQ;]//NZ\
MAWM[OG\ 3WGP^MO>Q;O\NU\_GKZ]*-3^LV5JQ."@;;3(.,(0]S$@C8U',4HJ
M?50BY#$D"C]#6IW& #U3 R0]==(*9IP,W$BGE1%1$Q88%]$J7PS0O2JZ&@/T
M8 ,TVX(0L H&NX1DQ!AQJ3'28'20MTH*;01F26]L:=5P?CRNODW/(U[3H.W%
M-RPW(W[7V-9]F =;"IQ2R"=M)I,7<J,),BHXY$V2S"0? "ZO;L1OPS&PABK;
MS*==;Y6=ZY!DWKLD%$J$<<0I-LA2T. HHV$TQ(2#6.%\VJ?(Q?PC-.[*),8G
M"$]>!'EC,^=QG8W=X3P^T43;)$U 5G&?9\;!5X9H1 77$>NHA23-G,=GK;/-
MG,<UU]E9@,*Q-M0'C614%G&K'#*>"\24U%@9&QS6:S;G\26D3R9]63>SI*XO
M0GFZT=B:<;1.)&%,]];8O*5LGI_'*=@'IA/LB:8$@C(C-=*,8D23$\F$9(T&
M>9<-3^,SU=I' "F-UCY8:V>12LYQ"BL%DF4D7308F0A;E!377@3OF,[DJFNB
MM2\ABU++^Z!U9MOA"6*4IQN1K1E&F3O7'DO&GR 8C>5;RO(=+RBR<80)&P"O
MX)Q$5H8BHU) VDG))!::";(PB7QWR]?D5-98@Q\!KS0:O%(-GL4NSH:H;/#(
MF-(MZ1S2@C($WQ5>$"Y+;RM["'9I$BPKF$GS!$',RPC9OO.HSCGS][;K^]$.
MXDZL_G[3ZT])S'8W7/+M-]9Q*>OX>1[?N*2BT@!H?"[?XU$:I+WE2(B(0U(:
M&TH6#>IKTC'/0K>_\U3.1K<?4[?G9ETQJ50(!@GB*>+!:60DD<B(()PE! L7
M0+?I>BCW2\C:O*XX#INLS5H;Q<<&/(.Q6#0!W])F[_77/PX^S'+,1L8L$<8B
MI:/('+,6V1@8 FNH8C21$*,>-N2OR=FLL?X^-JAI]/=A^NMG]5<P+T!'.7+8
M G"A@2"37$ I14*%H3P:O3;Z^]@9FQ_6:+_3_A('PW9FI1T\Q5YZNI:]]$TP
M^IBG9=,RW'2$/M!T?UL O20AA)%H$,%4(0Y[ARQQ!(7$$B,A]UZ8C2V.]7H$
MG4U&:6W!5Z/$CZ7$<_@K2.&%S_C+2ID31QXY[B3R-%%K#?S!,"CQFF2%UX0A
M\:E\\B7DV=[T^O#//%/$UXQFIV<@HH44MC<\B?TF][:F[F,%&'  +PQ?W>Y'
M:BGY;=3OQZX_?UT+RWL[C!417N-='NI=+A9 1.\HL80G%+D2B!./D9/$(1T]
MBYIK$H7?V!(/\2Y->FZ-57P%"+%1\;52\3D F?<QX1B1T=PB'AE%UON$L"(\
M&D:HXVECBZV)BO^ #-[XVO4E4/[\#Z+9OX%$,W9#0Y_YB/29MY&]/FM>N^5>
M?KW=X3* 5U#IM#/$*<>)U0XKD3+='?'<)H$7CQ9L&.\>P;/A1>#5!@ J(2%-
M+7@V)@&\LL 0-RD8HPDQDFYL$35?5',_5IGUF/Y\2_JS,6B-06LXA)^$09O/
M]7K'",$2 9J&:-P:@JQ)$(WG$;?@A' 0:B4LPH]BT&HH/WZ*L0R+8JY6'<JO
M2Y;WMN'7>:T9+&CHC?* JBN+?:^A!,LOT,H>\7GUQ]PVA6-J@-F:9JQ7<6CZ
M(Z_Q(DY#;+M_.95Z>BC>XD$9ZR5J#\Z6KMU^-%SOWQDH9H'_=Y;W_50(08JP
M-V!Q.;#(%D2_RDO)DDU(6IE9D"-#VIL _R1.$B5PX&YC2^IFY$1CAIZ*&?I^
M(R<:,[0:,S1_O$09I1Q'Y(CVB&-CD1:)(28(M2"^( ,88M8%/?T-<^)W9T[L
MM/IQ..IW6[VG$+\T!9N/67%3"<C[(A_[W<8HWM<H\@78S&*I:!0,*1$ FPD>
MD*;&H!@9]D8PIY+9V!(/Z9II"J_76(\?LZRFT>.5Z?$<N(E.Q!")1LGCA+C&
M#FFB%?+*"Z6"3S(S<LR30J]C[?6S2)^]/CWK],YCOU0/G]G\8&UXC&%1OW[;
MC=9Y.O+S+#=<GV;^WZ9EP)V/905$)?_TSTMI:6SCDK91+, XAF.7:/+(Z* 1
M5YXA)[!$3$N2%/=,1]Q,N7C6^OR=F_L;??Z.^CR'=;"2CCD=D%'>0,S"&#)<
M161P%,9P884C"QO-FCQ.0R[]T@.^1VB7OXSL&D[:>UN^MXLHBJ133.I03)U#
M/%B"8/\\TIPP+(21+"T>3MAD:YZ%\CY"FWRCO"M2WCG8PJ0*1%N)A/.@O!@[
M9 53R$<']I8%3_*PO0=12C?]\4U_?,-#^?PBW37BH;ST#PU_W?W]P_D"<"=P
MH#B8W->>:^I33E@1KU!0F$5-/,>1K0U_79.A6EMLU^CM=]7;^;JB$)WD7J*$
M&449R"&3(D?.8T4-Q=X3OS9Z^Q(249=L\$_Q?.UE1+*/D(::$H.FUN"^!N_B
MCX-W8X-'=P\^X+UW1]@D1:0FB!O+$!<:#)[3"1EKF,4F@N]2S?2/9ZNZCY"$
M:E1W-:I[.*6Z[_CN\9%F(NA$!:*.@>IZII"1 :,H0B0R:>$)."SZ0NN$&I+L
MET>2_3*"RT<FR6Z,]@.,]GR--C$>_*Q#$O/</X<%<E08)"S!UK,0I(8 DYDU
M(49K4D/K6KRTO/*F7O_4#N$9O@U_3NUO,:"+V.\U2KVT4L]EC8R0V% '49/+
M18D,0)AFTB/!HF3"J< RY?W_^S^:$OI+4\GTN-0'SY (^F7$IH_9EG9I)V?X
M8@_Z\+:=PC7UNVUW_^@-&ABTI,5<1*)GL*;)68*2,C''K@Q9E@3"7DMAJ? ^
MR8TML2;U$TW>:0WS3HUNKX=NSZ$A*V+R5#N /\P@'E(^/B,:8<.<93I:FDNZ
M'T3]O'YYJ4I%S;J#H9MXH*YP/:\7*EJ"0^X%T8LN]_+K[3S6@B^YH6M9@4L@
M"^">DR)XRA2R*7K$;<P4H_!/;:-U.!J:<D<S4?-G%?<+CM>#,_F!?%*-47M!
M1JVAPEMWHS8_H]BZ@(VS".(6##&LP,@20U$DQ&D28K0"KY(*[PGP)B_/U;JF
MC+7?BS=YA62VWYTW^0EV-;R!QX]9D^QP]-1CFA?@Y)^G*_^.\4D1[[^*=%?>
MO/'CR_GQ192VX+VEIE@AH@4$)RXQ9)Q)B%J;M!(B"NHWMAX\SF7]3N4;"_24
M+- RZ?7[1Q-WGZO8V**'VZ+Y_I.8J(2M09AIBSAV.7<N*-*<&R4929P8L$5X
M/:J#FICA;H#\:80-+R1R6#QQ9?L47F X:/6C[QUWX1=#9B\>GL26LV#;?&P-
M3F(<KE<(L=+2O!]YC1\P?_7'./'JZ'DX/G5[@N7A;"W+PQ]<3O&$H>RB5UQO
M*/N(P71NH)X4?TR-$!PL(/ZK=+,IE%T)O-U=Q'F5&"::I%P5HD-F^U/(6D^0
M]#XXHJF3C*ZL4';]"L :*_5,K=1#3^_N8Z4::[2D-9H/MJ4 J:06:18BXE*(
M/$Z&(84=#@$;V$6\L<7-&AFBYQ6*+=:[/WK=8S2,_=.G.S?F1;0R/2(TV^MU
M?6/W[F/WOBTZ\+ R2BXQBISEX5DR(N<E0Y2J /[+\X#3PL;Q)W_BT2CO#T L
MC?(^0'GG0$MN?G)", 2;Q!&W/"*=A$$^<@_;Q4"Y X"6^1."E]-F^,.S>YVV
M=>U.>]A^F@P0ZYGB:[JG5EYA\F?L#N!6V]VPGSMA_^P-AOTX;/<+6\^\(1_4
M\OW'I7@W%GTYB[Z0*Y1;YI()*!A*$1>4(!NC0I%$%IPV0N>1R@T/_#-5YE55
M?C?*_ .4>0Z>*2FUQS8@IEG*&6Z.7(PN\^D)93$)*D!L91Y2P-&DD^Z93IJ"
M94U.:4VMX8^"-E-FL(E7[VL0%Q%>,19LM HC1K5&G&=TXZU!3&BL3-0X*;ZQ
M1=>$4KG),ST7>-,H]&H4>I[>(08L=,XX&2,1!UB#'/42*:XH-E9)RS6$*_.G
M9D^*([TNDZPN!D\PW6]W7<O=VM,_'/2&MK->T.<A^_!".Z17N#+K[6;6HN>J
M+@Q^/ZD+?MO]M:H(_BL7!#<>93F/LH@,S EN+4T$>>DXQ,S2(JUX1/ M@ PV
MZ)#L"AJP5J<WCY0\N_%)[UMCUAC4EVM0UZR%K#&MJS:M<V ]N$Q%D2(BA(!I
MI80B(R5%*B@;5<1!&/S ?K(?;U8+QO_GT+I.?'2]HEFO6E?/2^&/\1.<VOYQ
MNUM>7,*EZK=%V5C^3/15"_II-!BVTWGUK78W0+SZ,\H?6K6U,'=ZJ9_(/[[+
MV?5=[GYUH=2FH'D5#G(W5F4^6CT':U:H&UOM0>G3.NOW/D4_C&'!9S;OLD'L
MJ6T07;<->I_+#. .PU[9$=\[/>O$O"-A>B9&+Y6?OM[\L-G*46%O8#NM;%/.
M"BGSA\W_F?M^N]M*[>P-6AG&EX]=>X/Q]7^#']KN>6DF4+\,6MNP>_TVK),;
M#>!M!H.K5Z4M.\BW]:/! "X(/SOMP<5"'-IV)__S3;L+KJD-G][K#6.+OFKE
M2U/\RZ_CZVW[_QVUJXJ+07G&:2;VS?)I\LMMDE@;4 (+^LM3%DZV;L(YTWIG
MAZU=V_<G+49>5?O?[OK.*,36?RV!DIS%1&/'N6*.>R]LL(($:X(TV$3_70K_
MI]N3NJ-3%'I#5%_[R4.FC_\YP?[TWUW[MQGM?WISNDO?7>SMO(7['I[O';QO
M'QZ$]O[!!_+Q[UWZ<>=?G=W?#]G'@W?\/Q?OONU^VCZ2*DJIO$<BI#P3B3OD
MG%$H<"Z"D3RX*&\HZ0=)[.0=[T?? 3EIIS:8@M3OG;8Z,T7IV<;57YW$3LB;
MT@)[%;,5.;/]X756:(%U>]7Z>M(&0?Q:#%"V&)7]F;)XFZU%I65S(OQ=-.ZN
M&&BL/C],[7/(]WB:N\JRB__/WI<VM9%D:_^5"NZ=B)X()YW[XIX@@O;2+S,#
MN&T\??$7(E<0%A*CQ3;^]>_)*HE%BT$@C(",F<8@565E99[SG"7/4CAZ)D>?
M[1QO':@$ADJ@ 4E)).+<,V0#<+13C"3L,-5,K&WHZ4KQ-^?HRSP%;'WYSX5X
M>X9&<R/>!H*,O?SD.ZH8(PVCGF^6@/DJFW67AKZF]>#1DNT,3X#=_ ^T$7.]
MKD'JJ-*?[]BH&3];!K#M0]O+BW=H885ACQ:!@Y_05&MS/,&+8O.%\6<R/M[9
M.SS /C"=8+V!NSCB1FJD&<6()B>2"<D:'=<VY#3C5V.>G[ :,@^>]F!M>T"
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M%*4BAP(^"F1\#I& [WJMW$TK]KZT?&[@V1]4O_A>#*W!JEK*SSZ2Z*>$ ?X
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MY:@%4B\.6KU8O^M(7^QG7;/NHU$W=+Z8\O2\X*E D*V)F66-&$UKQ'DVAUV
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MV.L6.%P4#B=K=!!"350*(\X!"3E/!%FK?%T.W:8HHU9L;:,^<*6_%5 LH%A
M<2XH<N$L5\1('!7G-EDM#4DF<!TE3:2 XHJ"XLY4W1&;O(9-1#%ICKC7 3G"
M,8K<8AE8M%[R HH%% LH7@^*P2JPC)W R4IN=7 >;.4H9928!DMU,9 ?&/PF
M-4(<.(T$9(D+2H%&F$/]-".(,!6(=B0*[HJ!7&"OP-Z/8,\8'CQ601D70&L
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MHBZ1=88A;Q,-*DGNTO*.-TL\\^KR-)CKQ!D>/56.XZB=(%8R9K'S+G K2C.
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MP@P[,.]\C>_!9^BTU_W2"OF*>F!8OU88+^T\*LG/A7W,&PIO\-S99Q[^79'
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M1X&],8Q#\R_B>C^N?Z@3'R@FZD5.30!8[%Z:;ACG!N2<E^-NIP]<DI\8.W6
M[^9I=Q _QYS%UJE^R58GQ;^]V]VL?R.__?T%O"HL9+"#;N]LSJOV_5$\:2K"
MM&#^IT>V=V+]V=6YYM0$>_9BE UXGF,!UE/7M\Z3 "\2&-XUH^1TB:=#3;U6
M_W--!%?S+9JM[,?)]:U)*&<5AA; ::^NE)<+G?3K,BEH#LV-"QJ>!X?;.IFF
M_[+ZI34JYCB*_YY!)=,SR#L%T':1%')BSRH7SQ-41H5TX*-:X-;L<;'S\*Y-
M";+9&2;]WV!2XUFU4IV;,S,3I0^P?FG"ES)_FK23)GLT)\OD<'8'!- 4\[F<
MG#*>.0@*>)\1 5X4*ID[PQSE#K.\-,W!960XZG;[#2KD24YO;3_7P8%IY+69
ML<$OKHPVFF(O%Q'KC1;8YIG",\8$T:GL29W\<B6UI8::T0+,2LSI12"AT9!U
M%E0N?A=Z]JMMGR<GG:U7F[Y9MX']')N]_]'VU?-M1]N,&@"S^E.9!Q?Y0K!]
MH35F=3NQ&"/Z&24HC!*$1LM2>\/4;_V9<V[JXEW)+\JS:HV<FD\$/EY-)5 U
M1%"G0O5RA;",O[4T^)% ^AI')5!/;*YS".MX?9K'BU$:[RC;@ZQ75R<S%C"[
MF_5@H.6@>A[-$^,W4-_JA+"YQD C2R=;.A#IL#!$,BMX%,YABIGSUGH726#A
M&K?1UL[;RQF?TU;!F]$"77F7=[&7LP'>U',^-Q;.;05$'ZFQ<(?4*C F-MD!
MX]$S"RH^]E@A3H)&ADJ+E&*"$&EM(GQM8]K[\[<:A"XZ#5WETTR-#:@ND@%\
M1\JXB<EXA2A^/QO32LG\G4\D?WX_("IZ:51 0FB9+4)0<7,Z'HO:.J$"ARW*
M88L_R/Q=A Z(Q9P !5BI+'="Y.@Q'01VC!+L1E5[[Q;[6NA@<3I@!Y+[P+&/
M2/D0$(^$(.NX1<R$* EAPN,<"S:_*$ M:Q8'!H %G Q6#DO/$S8N"99P\,P0
M%[EH3AKPF"!NE<-1"&)A@OA(#H*/RG'GD(N4(ZXP1L8:C)13W!F9#/$."(+.
MKQ*QN)9RM8K >O7[>=V9?$94JSZP*W[8;@R%JVIX!-TO:TC]\S(V%UKUV,X]
MUW-JET>=]!_K.C+=;_6][;-%-9Y;-;&Z4GS\BB^F]GW64_]0SWRDW(#Y_:P5
M&K*=%1J2" &RX\B+B!%GEB%MK$:@1U"OH]->Z;4-/4NCL;5E=97ZUN?O];*Z
ME5W2:,?X-+7=_;_.#:3=<R/XVEB.9XA+0 1;7P\()C0ED9!F-E>OL189#((J
M<8U9HE)X)]8V=KK3N#0VOFI[ZK(%=LDL';FV1GTFSFTDV[\"-4>V+B32JJL&
M9L(!(!F;N1=U;;/R?%-+]C%YD$E.I1^)V2MFY0A5GX;QOC>QW_;"#LINU8O:
M0U7??H%MZS?&TM@?^_[#N[$_]L+*C_"BN;+UA;-MO7HS]5GM"KGP\XUM=1BQ
M&I[FOQ834;<J=O)#"!OM_>6MSSN_;4&(#D\VZX(NDR;Z2.N*(X'VS*79]S=G
M!S0&K)0F2-ID0>-6!#D>#4H^""*2%F 9KVW,B*']V\A)V.I=$%0N=Q<[_9%3
MOE/WTLG%-K[E&G:GW?Z@_KTI$I)=2=GA6SM,JJWW'P  3UJ#B1I')_9S38H#
M?W1>$OK<"9!KSY^[-&/NH+$X728!5@5G\(\#4Q '0QCC5.(@F9=,R:71Y5CA
MWQZ]RY7O"SF^(3NO]^E!(#@P)RAB06C$M0W(*FVSFA4Q"1*(A:]MD!G]7<;T
M>(Y@YZ[?U.KU!P]&%EFY'L/.%3AZ[KO]^?M!- 9T:851(@*L.^L4<E0R)*0*
MV('E#Q"TML%F[_7I%?D4:O-ML4TV0EGC-1,YD4""-IT2["B 'G:&.Y4*[_\T
M:LCE_Q2H 3+9A&C*#0)IH,A03Y &$I$4IQ2#6=L0LUA_;.1W8&\?C @*I\_9
MVVURH(D@8+IBA),"3@<3&IF0//*.$DG E&7!KFU,NW%F<?I5#:&.6LBZ:E85
M:GT@-$>%N7=.K03.5A\NE3#,&G-V#]7Z2*<IB#8^M>PTY]*]Z&-N<F.;UC/U
MB%=.45N]\=,N/V3&5">.SB?.O,X;YM@OMM6NIY([/\5>W=FNKES8JPM!7K%X
M<I_"3O]23Z>LI6<\G!B]MCD7\HO>36N?ZQ>=!,A7H!OFS)+#NM9F\8G.XZ7=
MUYX<"&R3"8$!\UB!N+* DS9+3<U,#(2"SIX/2V9D3-_NM.2^*H44(K@E$>QM
MX@/@0)D<5B@I)4%8BH@L9P[E0O+,<Z*#QCF&<KK0QY6CDL4(P?)H34P6<\YK
MMSRG#!1V&KB7W-[ZE*00PFT( >[?\R!=#_'.]\/ONYL'"KM45TY(A@,N.">0
MT\XB;RC6  XV*)9MI_L\+"DMDG[4(FFR&$%ID51:))5>.J5%TG/<UM(BZ7&\
MQS):)-VEY=&#%U-?,*GE:DN0:A0!] 036W+T>_9*]*_DM)Q>??W+L=G]%[G)
M!KQO;L@Z:EZ<O3)PUU&T[<&1KQT?H%BV6RG[/?K#7MUO87R:^36VD^W%\Q/-
M<>) TR5X["0Y/XUJ#CM_>,9YJ85R$RB?6UXTTP\P/ P;+^F_Q!@S"C"?O+;6
MU"8N?5&!23,ZYS_ODCQ^]B@6I/;W!#N(+T9#G,38+$H=/)]5P5HESKVD>JTZ
M\'J]VAKEZHP2*/IS%KU_95F:U?@6_3#/ Y9C?'9^)7S^<@)$WHWS0O_V/"E@
M,K(^M;()5IL,""R&QN65^^V>PFR[H>6K7YHF''\?^ZG.S8S)H2;>8[3?%^_S
M%6:Q@+WJK9%,2B>=3SQ$9ID5 $-*RY!S1?$2PGUWXN#=Z#5'GV;CM<3-S&JT
ML7<HLA^8R^09TDHFQ+'#2.MH$%=<.4VE-R8NE/P;G. !6Q5"P%Q+;+7UV"06
M,>=$)[Z$R,VRQXOM<1!84"4M<D8[Q+E-R$:ND+0!-L;X:#%=K,P1IU%2PI3)
MD=I<&2T(Y@+&PD%J&9<0KEWV>+$]CH0D8ZA$. J*N,]G=41Y%'"*3GH6H[-K
M&YWI^+?K/[ACAE&6/F.1=B'-*CNWRV M519Q@PJ%@<2Q C56<DF29LY:AX7(
MIY4N\-O7&QC].B\ L_@^+U'AL><'(,@I4*%&,1*,N&$.64$) NW+>F6"Q!YL
M"S[_(&1A%[@4FOA(&>,2+)G@M4U.!^4!DJ0PFM^^2&39^P7V_I <2!Z-P)$C
M02-(&4,<,IQ%9#6).K* ,2%K&^)'YQ\+>Z[KE;[6LT$D6[M#0ZN',/()7V^2
M9J9_WG,'N]<PZI?:Y;_5 >5_6%<RV.R$_Q=#;@&8DXJ_U+T/7X.9T>YF8V1U
MNM5MCTD_WT=V_MCZNK/WI]@YV<9P;:ZGPO>_;YX!Z7[?_O[V:'MODVV?39)^
MGB.PRO%F#HFB^]___/:IKJ=R=)P#S3\=PQO\]>8;S.,[D/ZWG;W/]$ KZXP
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M.\\!"[9;'_I%!*3?BQ@!\J0S#N]-=JS">L,8LH.3%Y0PDX%6\.<<F&D(D<[
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M^N'.AH?P@5\[??/UT>W4H\I.Y>W=7_.C[M]G1V<GI'UXA(^Z;7CN/?UR^)7
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M50],YJS=9@-ED.XPACW+E^;(JG(ZWIJ2BBT&=W= 2AU9"9P07HDD$(G*C,:
M<N451:>:Z8\[MG6JX 'M7 ]> M2Z@OU$6H '+H!C%:N5O\A[Q>[&!1&MC!+S
M293X_SI[$D"_$]A+))Z9 '&=!*=07HP8+R"3G:3*;N9X?;H45 ]"G?8[=CC/
MH0,?'%W6V1!<ZZ?MC]NMDT'_8G0*&U8G :_"&GEUR6"$ "8,6P"$T]:D0R^
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M5<R,6F?ZWXJ)HMNM/;^LLBGJ>K,+P"?#^[67MZ)LFV>D,ZGVL2>3'1NW]".
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M:)HBZ2SU(/K25)HW;T<7_6**Q[Q(W6Z]6\J43J8RN:&>:ZZ '>P<IYBE4DB
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MH5M7Q9Q/)VOF6<\4]E+<%/8VA;U-!6A3V-M<:U/8^TS.<1>%O3<6ZLX5]G)
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M:M=38XJ*4D4\5XP(RCT!FK6DB+X RK>\,@*5/ZWXW490;L-*WS;:?+&FN&'
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MH(5SOR7;.;6WW7G^=Z<0A&O%.S^\_0V3:L/P$<\<)].LFDQ8]MOM9]<,,=C
M$NN'>6\SP4L,TJ$ELIZO$)YYB.&S"V?9XDH;DGS4:=UW;3C6V"_3KK8&Y (!
M#]'T6^[]^ZF>@3'KDX.US'KH%KOF4'5/41OR0 TZ-V*C;M'C\Y[RFEK,M[D-
ML9GC,.V;F_;,/1V;/G4NUO4$8LED[[Q%UL3&A>W.[V_F3?>WC>F^QG*/W3AW
MC ^+E1\41,)7\&',%#IF1?F\W4;YBEXP*BH<E/6M=='F+O]6)]V-3OK5]#^,
MINIH>Z$<Y)Y;U/\FA2*(WU'>NT)Z"R_5"J*:UTB+N<Q&RJ6HQAI(LI?3B;ES
MVFSZ!5,W7J\^V565SD?CIE%5W[![6N+T)KEY)G,OG)%OFNCQZW7/P>(WM^'O
M(=8Z82@Y?09N.>HVG4$)]:GFY4\GN9%R>L'1R0J055HZ9C_P"^\GP^X(ITJE
M?.[ARKVG&SL/<(6ICP0$F-3%4C]\'B<U2OAE)YTQ$.0B$%P6GQDV(']F%3=@
MON^,%W6[X)-1WKA!J1.WS@/(AIS-,I+"PY)>33CO/F72)C6,!M!-M.^<(808
M$6L+[Z:O3@TK'$[7A!EL1E^[[!L+'_[]]^=7O.QO WS6OX%H)\/0@$9.+3W@
MJZ$Y"_!1ASL\_H2/M+"2BS^Z]NI_O5V*_F8%/O?R@H4)WT$;YO5IOUO7[#B#
M%VLJ96J^OTZH[N+H#%@_RYU\+'+IO::VX$(X6UI#71D=<Z%@PL34R4=5(=@U
M.OF:>,SS-"*T#=:M3YH>?#D^BEH(K:DDRN$(YF J8J@M00 83K6D5E;EUC/.
MUX @Y/&KT\;9913;9+6RHJ#P9^I91D%9U"F>J;DP#&>@S1)X;+K2 !0>SL;L
M!>)QXNOH'*?$APP]W9#P:8:.2N8'PF,W>?YTWYLBYN(KO0&.7'YHEO!#:[9?
MY'>TJ_*0ZZE1O%Z>K!DS]R#LY"F"+KR4^NY+(8K.#R]V]G8.=M[M_"N;0*M"
M+E7*)8MM8>[R7';S0I,:3SVUE,^0@)9J_&96']+&RL#1QM1>"V: "[Q<U2Q"
M2+'5MO$IH&\S]C E=9,1G-O;<Q\N" 8RVP1@()=6G[J[FRZ);/SVTACG)@@B
MEP&=J&C6T)B<&:<@&::SFL_9M?$Y@6I FX3^:,XIGGVBF=>X4("42RH7ZS<:
M:[FY\UD8XO8W0V;,AS#M;%^WE,;2G[M"FJGP,9=2+-G=R_6O#>3VI^XHI\!G
ME_F_4V<(PSVI+K.)O2U%^U8VK[:.\&9SY: 7+R6?Z!+X;-L=?6%W-&^[H]ON
MZ+:-MNV.;H^U[8Y^),]Q%]W1EW8[+W5'&UH(*UA5E944U#(;*7PP&A%X24W4
M%W5'/Z+88)WYG(%N93?A87EQ3S\BN!(,6X!&GYKY7R^T5<C**U$ZK0,3DC($
M[K:LDJ$PGON0A_ 5!2]8&]JZXWZ P]VCH'W%7>6)]U4DPOB"6 $N?ND+)JLR
MB%B$&X2V:O(Y1;^O[R=U+*D)#,V35^J'?%A,OSZ)N3%>L\)!]QRJ2<&UW,_5
MA&P2C'D!S"6_:IPF!2A 0C"Z.7 P#<UL3F*N<^'_;)SUB1WA&)C^&.Y3E^CT
M5Q-L"W&,V7*F-Z\C)G/WS T;RWDZTS2KK!\W\W12=M/BI)R-Q!A;,WP56\9@
MB?C(&+<Z2^.]7,/[IG,R&)TA;TTKIJ;*HFY.J)7 W*YNG.0V-U6M21)A+=9"
MN/HMO V/G"+4%G$=>S5V?"KT@7<F&%JK\1AQ(!M<".-1\-//"-9DGPK419J!
MY8>3XP<70P:BSVU&>:2:.Y_'T(#'-Q^[H\ZO@YYW Y!"]9OW*7UV,C@KJR5.
M60CQ4V=_[_<LATJROT=8Q<32+("D%T:7SP( DC@>#(_32(N;#0) D!JV /RY
MH1A@COKF@LE-=F)58BU4"&QWX(L+=07S79D7E!8L8(QL%FXY- SRKY9K3U *
MT85Y?(UTF!:#74'&W"&FT$;(H M-W0&BI*XT_7OOI-+.E[(RHA*E 5_/^\*
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MZ6SE0+$K!@0H:?39501Y?%O!W)+=-0 V#O9VCSSUW&!ZL@13"TQ:HX@)PI!
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MC-M-SP"(9#,=*HEE'-A%L/R-C(+0'8V;B;43<.=Z]8!0["X X=DD.C;)\R6
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MXX>3X[IM)SGI#9(#',B',&ZP^J</NAC>M@GC/\&;N)Y!;\1MZ!E"ADK[DV?
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MM'$Q0R>A(LJ?G[M.KJQ->=WZDC@Z<1CF"YFR Y%:T7"-/F#)>NX@6QNWR_>
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M@7RU0LNKR+H6.>FKB46V)LQIO!5,44:\DYX(;AU1552D!$+WI3/2,O!YRCL
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MK;Z!') XDK"-?_V[>NL"2,(@)$! IRJV!=)6[]WK>=:EUR4+&9,-E)>#1J5
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M5!>IU5?.'\?7&&W:9^B5#+%R+SUT+ HWM<IYZ&&WUQYIJ4$Z:3!;%&ES=MD
M]-).H/2C2NJ5B_2Z9X='"+JA9AG25[,#X3P<IULY\B^W>M#5ZL%:/5C+S&KU
M8-W66CWX1.YC%=6#-T83IZ*/DLF0G8HER4Y*EYS2$!A0Z:0/GL$3CSY>'S.:
M&/037^=D]-[^^+W%O#L^G\HCG[(,KSH]Q9B[9+I?LLPOHA:G1^=]M'FAE-'D
MH>59OC'USEM#Z<,?=,YZC9%ZA+9@_\)9:_5*^D'C2ARC+39<07G/V+IOOA6-
MFDX8Q6 N>;HCHWD<(!LZX+,W/?:3R^G1EY)FCW^/\_$N^B=_Z;3* R^*X@@?
M.?G7&12'Y^+3(_-UF.A>G)ORUBO&\^AFQ]G[XQ/WY^,V7HE'3K9A$G2\0U]J
M]&B*C]6$ ;OH0A71&[?!'@492B1DRDF9.#B7H@TC/[&<9P[C <-P6#YKNFLW
M8C1QY*^$\BYR:>95VY18WDR*3KF5OP.R%$KXQ1'I;<I?1N'26]3OW%-FSLDP
M=#C)R;GR+"XU!2\)JF57YN[?B 6F4E<O9Y[BJB<>9J&*9BV7XSK#7;KD'>+5
M=[L]=%;P@TV]SJ!@LD0 )CXY+C\CQ -R0!IEQXXN<Q$\F'\_C; U!'5Q.R,/
MO_6YX:&QV]YP%Y)D$X<8B= D?^DB;G8E$C!Q:T>]UD>!V"$H_DA?2^K9?P_I
M;,YZJ]?[':]7T.KU5J^WND?5ZZW;6KW>)W(?J_!Z;_1BI[S>F(WUG"9OJ95&
M6V>9LME U#FF3$<]=NXSU2L<I7AVG/;R=-+7]H4%]?/YZ)<O.?UKY^WA@4\B
MQ#)\PTH6B4R!H[<C#=%!"BV$5DG-!#8BH#F$.RJ49E)8!P* <YV%$59K8:?3
MOZY'BUYK3_/"W;EL>P_-W,9/_,X<HZ'6F\V]&!6C=/&ZQVV8G"./VA-=5)HT
M6?#])H,5RI'F\7'W2__':TEH'N,\K F)RN45'9ILB]J0RKQR6J[<AF3TE7+J
M3I?]WN_X*\/%BU^L?A3K_%&'-8X2E:?F[4UNBJG;W-40G8]T7_,,PHVM#TT=
MT+NK=4!7;O,I;.*D(TYSP1]++*4=;K&K?]ONC$L0^C/#%.=-B;UN/B*='9&X
MYAM?+*A5W?'T[-MG_^1X?7)W?')L$6Z9G6,:0DH7<TP7?B;?9:3OQ7WN];&,
MO)&+O-M[Z1HV##;>&"*8C>B6ITS$JSF&8#D:&48R+LT[O3&LL]RNW@8Q]0L>
M\ L6QO!H%O%:& ZWM/[F)%\O.GKY!4QM?T*SUQ<H,K;6)L=M\A"9%,%[ Z4;
M7$8K0+*HV<*S]RX5&9>07%G"/]N#HS>C0\AW7T<9#:^;2H?T9-K"W3F,]>&?
M?^]_W#\]^;C_\63W[?'QWMN_GWPXV:%[^X?TP_X.?N;GHX^__LGWWI8!Z[_+
MO3>CS_S?WX_\23S>._EXO'OR@>Z5]> 5/WS[7>V]_:.4/G.\M[\^[G^0._P#
MWWU[*/_OVTX9OOZU&<+^Z9W<_?:[/%#4>9>U)%%R0V3DE'A) Y&&*R=8ECPR
MM%XDW=3LNH9RRX#EK@/5[\BXT_JA4M<SI2YNG(/L07'J)+46**0@*;(7#U%F
MNTQGC$I=CT)=Y]/4)5DRV@$!YY&Z3 !BC6($:(G-4^L$]4A=C&\R.3L^L%)7
MI:[UI*YF\!\O W0UR*@U:!$C4UXKJ810>IG6+I6Z'H.Z=J>M+FJBE3XRDIVP
MI#1W)%X81Z*R&2AS*D+<V&+6;7(S.Q/W\:CKKD&KI^3P_G:Y!'#_(N%PDN9]
M;0"4+_8@YI+RDV:NZ(R-*+]*:BV9\-9YD;D'4(:GK&/U%Y\6<_T^ZR]:X-SD
M%(@2"<J ]T2\EIH(3:F1 C=<H=$E-X6=;82Z(&_-YXY[-;FFOO+::.*+1[JW
MGJ*=K:@23'JJO6/,6A2  )$BV*I[]>20/NU>!30^+;,&94VCC:("(U9JB=Y6
M:3IEA8C6;FR)3:N7ME JTM<7Z24+43 K<]-S.F<''"SXC/#/UG);O9&GAO09
M;Z2$>5&=>\*,RD0F@4@'5;(B*0O>(L5GO;'%-ZV;;6#Z>$A_"8=OU]>:WLD)
MN6UDZ$D3%G->:^L9,UY(B,%3=$,HRX(I$6RFU0EY6H3UYZP3XL!&I60FVF9.
M9):>>,-Q/P4/U";%I52EZ^XF8TLSUOH%?BO4)^?3-&5F$@5FF*3&>*H,E49:
MRB,ZHDNU/Z]0?Q2H3WLA@.:FDX&3R+,FT@9+O!) N#5<@ ,%D!NH:SH[?Z-"
M_=E /="8-9>\C"^727-G1)+&6Y^C$T"K&_+DH#[CAB0:*2B:"9)W(A)T))XI
M2D ')U(J#;E++WVZ2=TZ'>>^A#.1*WU'ZOG'=23EM(L0O48I9C+)Y$R@AC*P
M&0RSS%37XVF1U(=9UX.CW^&XRD1I08D4Z'^@3PG$2XYZB;$07(F5T$WEEK9'
M:EAT?:&>M>2,ZX1F*5HEEGM&/7>)AA))$VJIJ8P5ZH\"]6G7P[N@E#6"X.9Z
M(CT8XJ-.A&EFHQ#(\B5)0^A-(56%^O.%>N*!:1X\1X&0S%@K8G1(]"DX:H+@
MU?5X:E"?/0%1DKF0&8DJ Y%9"8)<SHGB2.K!*&$LNAY";3J]3E!?T1'($+'N
MMFV&'@.N^]UAK\IAE>"B;MZUE5TO(4GVEC?_;.AZR2E.E:[7C*[#K!.6DHS:
ME[X]45JD:^,)[G4B5EK&#3,1-QB=,*,WS9S)BW<+%=T.1FM>$U")\ 41(1@K
M03MI/ 5IN+!<2R$]5<)"LLE5%_7)$>&TBYJM1+(+G+! T47E6:+=*AAQ5%&K
M#,TT 1*A%FBXKJIZLQ)A)<(UN.M%B!!D I<R4"F1#:7WD@M&(X\R: FI.O!/
MC0AG'/BHI!1:<\*U=40ZZ8@57I 2K4E<1J"JE+$+N\GYJO($[I<(1[[]>!5C
MV5<-S:TZQK=8=Q2!MQ2[9Z7+XI7;7>;R=8F/V6'FYN[?#](%ZKJ!JT^P*13_
M87JNP'VD!=5K/'S^Q0.@Y-:=F!X*&?,6=%=DB.N0L?0ITQ.VS.?=XK.QOZ.A
MQB5C&5=!AL1]4-(&FI.+UAJA;QV1/0E__?AKF8OZ6Z,>=M.@F]^-!JAOCZ=A
M[9491MO-&.YJ=*_.Z'[WI3&X&\-[&]<<Z-[K QZ]XPZ <*/0[+8I$U"@",_2
M1^=C5#Z5&D%.EXX^K-\)>>6K9\I77/,H?.+,NB3+Q$-JK-2<.Z^\\3S?.G!:
M^>IQ^6IGFJ^,2)'A_P0BDI8$:@A(P8ESSC*;&&Z[;"H=S=(9QI6O*E\]5&T$
MMQDM*16ID])E"9XF*;QVW@4TML2MXYN5KQZ7K_Z<YJNL0E:,:F)+LRCI R4E
MDDE"B 9< J]+MQ6^:;18([YZZ,KL1_/(;VP5]13]<WE3._,77XMF9#8F0&;@
M@W0A^YBCUE%%J97)EM^C/ULI=1%*_3K'986@7?!*$NY*PV.MD5)M-B3:8"((
M':AQ&UMJ9<?E:W0H7A$\L9B,XV"L<J"53-X!^&)!6<E"LB;+>_3P*H(71/",
M$P>*<^:X)=8I0:2AGD!@GFC07G*OP3*!"*:U]<,S1K",U.:0E%(V2AX3@ LF
M!:J-IY&EV]>#5P3?.X)GW!KAL\E9.^*$1;<F2$Y\2$",E:ETFX,0^<:6<$O7
M6CSA,N]'<VJN[SGU%+T9M8PW\R+*V[(/W&?!))5:.LUM$%DQ)90RUD@?ZNG<
M4Z#9\SFNCG=H#'$01#.3B12)$^!:$"I4#EJQ['GI,K[)6.W5^XP!KGBR6AJO
MK&9240TY)9F3YI&C$A90G9WUP?",L\-E5CS[2!(WE$@I!4$#EY-@G4F:.:/*
M:'FGGN%Y547P). 8N,M),)YUEEDZIXVAJKR"6%KQ5F=G?1 \X^R DSY;:H@(
MSI#2)H9 =)G0!)0999GC>F/+T'72P2_F!.=*8ZNGZ-_H&_.,7WRH*!D5G/8
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M9WOW()]2P30)Z) 1:7,FELI,DK:).9I8C&YCB_&E!VM7T*XO:%<V6+N"]CY
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M"INX <*R0-M-6TM\H$"":=HM1"Z=6!3X2_9MJ+NX\"X"#R%)W+OHC2BE6)I
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M-%9UI\->C\^TLD@_!=WQ_5+$&ZO2KI86W6D;:QCM <-H8+21(8&@2,N>11M
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MG4(O +)^-^WHOX)ZFXDD5Q:I_AVD7]X#<:9O@K2?+M_5']SR+%/I,85_2*=
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M?7C/#0\7;YH?"; EY(/).LMYPMMGD\^Y[,*NZY,K;A\*E_X#9SY&',-HCV&
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MT6A23V*>""-!L.T)U[<99L@.L'1L'*M@3->)A>K30J?AZ*U!H@WBUCHCT1)
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MA(%%$WC*OX)MSOQ8PJD2WZ&J':(/G[\SC&X8W?A+-XF?I_REL0AC'I' QER
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M-AP.[XWH)SU86<-:<&,78*XU[NM1I>(E:B8%N6FCQ=)<A]X==V#CN\J>@4]
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M]/$I^G0TC^/EQU>OOG__?O+]XH30V:OST].S5_]]>S/A38_2MH$?_EEJ_?1
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MWFDG5)M0* E7\;3410$=(G7*D3VMJ+(15$F-BB>E$AITB&0H1/RTHD$53DF
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M).0*+REV?)2&W3 [X)_8B1G1TN"L:ZP*]-@5=@/XPCZ[R&[ [6261+&6BJ>
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MQYL?"S==3__@41@J**_A^.(!'YY<D/J:0IO:FJH1;];@929(-A59#&CHR?)
M+<L**7 9ZBJOEHD6QM.&\O!W:1XKD153)F6SJ1]!'$?AK<@E9EH0W%C6^XGV
MVZNI3 @5%"%<HYM+10_8 (%>S";4?V)6T,A'/-],@+_:BQD.&;'[L=TB\;4.
M%@,FSG-G,H;,<ZZ@H,]&'*>/Y%JD<>^$RH0E 'H-O6],('[UZ<P/?<2&6\PB
MJC*H=>$-F.RM\R=7K\36A"H0ONLS2:!2RIJA#)A8BU@]>5^<A:D4U)R[ID06
M.^S"4&7JAI<[B67I%T4&NLV-#6"&00A[STU0P$.,V#*J(O/JVALP&?&D(WL
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MI6I%[YY[?69NT;?DAN$N[$&.Q50Y<,?]WFE:Q'!*_0<LM/LIT^[;%)'N@,B
M,T4JMGD=++@R9TH'2L.\Q2G05%RX#0I#/9V3?F_BS+&;!/CL_/0#;&\AX+-J
MM&PNTB*2#_V;4RMO@]+0ZZM"KC].W_2,!T6*XI@KU?5'C1ZPH?Q1]=;D-X_I
M?")(8=O"W5.'P%0YJ:,62D6;JX*(W_* AK&#).0*S(:R39XI:?&0YL8<9[?4
M Y<U]3T?QIV^_W/^2GQ&P_([0'[#R'[<G"NY=E5_2-^&"JI2K;/<4Z'P C4#
M&7!6IQH7H06-2^'Q; )Y]H1O*1L!0TZ(%S/=&$.240]L+)Z(*[B/P#GD)8P>
M7KTFVAK/L\]\D^X,-TQ J55N>.2WILVLVQG=#V7J7U^QE8B83K1 O_WM?P!0
M2P,$%     @ SXVH5O_?ZOT#2   D/X" !0   !M8VLM,C R,S S,S%?8V%L
M+GAM;.V]6Y=;-Y(N^-Z_PN-YG6CC?NG5U6?)NKBTCLK2DN2J,T]< 2 @L8LB
M=4BF;-6OGP S4\J[>,$FMWS&#[*22>W] ?$A+D @XC__QQ\?9C]\HN5JNIC_
MY4?Y[^+''VB>%V4Z?_>7'W][^PS"C__CO_[MW_[S_P+X7S^_?O'#DT4^^T#S
M]0^/EX1K*C_\/EV__^$?A5;__*$N%Q]^^,=B^<_I)P3XK\T_>KSX^'DY??=^
M_8,22M_\[?(_)!'&I!5XI3R8;#(DH378K*TF-))L^G_>_8<N%(IP%DAX!X9(
M0*@B@RI5R)QU1DF;A\ZF\W_^1_LCX8I^X,'-5YL?__+C^_7ZXW_\]-/OO__^
M[W^DY>S?%\MW/RDA]$^7W_[QXNM_W/K^[WKS;1EC_&GSVR]?74WO^B(_5O[T
MO_[VXDU^3Q\0IO/5&N>YO6 U_8_5YL,7BXSKS9Q_$]</]WZC_0277X/V$4@%
M6O[['ZORXW_]VP\_G$_'<C&CUU1_:/__[?7S+Z_\D/])J]5B+I7^][SX\%/[
M_4^/7_[ZYN6+YT\>O7WZY,U;_O-O3W]]^^;ELY>OGKY^]/8Y_Y:'L7GL^O-'
M^LN/J^F'CS.Z_.S]DNI??N0'0Q,W"W*#Y?_>XJ$_?<6;<9;/9IOI><$_7SRZ
MH>L+G?Y8T[S0^51=OGRVR->^-&N"6BPO_^4,$\TVGT[.5O .\>/DE^5BM7JU
M7-3I>N*R#J)4 UE* 288!VB10$9;38T:K?#7YZH-:,4CVDBVXBIMQ'OQ;!:S
M4C_1;+VZ_*3-J]K,Z1VO/Y_$_4?R>+%:OZR_+!9E]6A>WM#RTS33ZLUB5B91
M>8VN.+!293 Z$R2I'%3O@M.Q"D33>6#WH[D^SBMT>;3,/RR6A9:LRG[\X7=J
MBN<O/\)&K9UCPV6^1J3;B^KB&S^MSCY\V#P4IFOZ</GOFX[K(_[U8I#)/Y<U
M#^)0,KRF3S0_HV<\X,>+^7J)>?T/UO6/SU;KQ0=:/OTCS\Z:F7BT6O%2I/(6
M_YAH$TFBBA T\OBK4)"TSY!#<E%5)67&SBS9 ^8V]%%?Z?-=L&=H:76CU5-<
MSAG'ZA4MW[S')?V,JVF>&&5)6)W QX)MZ I"C@4JAEAX#J12MC-Q[@1RZ.B>
ML^_T@5ZP3"\E,9V?\5M>?J3EA@[M=9LW;=XYD3)A4M*"#[7PRN8_@A %A*0<
ME(HID>H\[ATA[JAK!UTLAW/GYK(94E[=ELQUD$^FJWR.D\I7F+\2&P]>U-?A
MUH*V.E\A>&+O6N4$*%, K:.-T@4?51R47CN '9-6'IIH0\EP,"W]9#H[XVAO
M0CX&BA1!J<QQ& -C,%J 9@ME!%)5O@RLIR^@'$537[SK7! ^D9>^-G.IV%QF
MGH44 YO+Z)RIJN;JPRET]5608];6^W!H+WV]M]1.I;&O 3;:&26SY*6NF[.?
M'&N97" G:CLCAB3UCK0.@#MFK=V?<,-)LAOUSF.)!G@2L^>1E02EY I&5@X;
M$[O[B*6B)NU4Z*VLO[[]F$MHXE%CJKR^M18L82P&,%0+KJJD2;B<9>_P81=\
M8]+*>_+CD'6QDW@&TL%WF0K^QGE0_&JQW$ACO5Y.T]D:TXS>+GY=S-N8>'+Y
M#>^>S]>TI-5Z0D891(P@DN%%K20K$X$9"AHE@E!>U^-';/N,9$R:>Q!2GD3D
MW>C+B^?K<#CT,$*)9*$&J=B4< 2*7FJ>&J.BKD'9DCJS[AJ CE9)VHPY\ "L
M5@9,X7@JLCV$9'PQQ$$-NF-9I=-JXOTE?)/W>\[N,%S=:DE9HT(.U8,LDE>Y
M]PJB2 H2%7:-BM(6>\=2.X/<44$.>\K0CRS#"FOLYIN]_5!+J1>N2!(& CI>
M)!P+$JE"EH;U%(<QWT/,[\]4%TLZ_QY[<;1Z^L=ZB4S\Z1R7GY\S75?W3'+Q
M6>3&D!@)F9XB YJ0H"J9G.>9=EX>?9+W'LZ8;,8(5L7N3M=QB-19\S#0IW]\
MI/F*?J8YM>.Y*%44N@IP)C&84B1@S@FLL5H[TD)E,0BK;T$9E64:+24/DV W
M.EW,P_S=!9C51*N8=&;#[6PA,"8+",DX4"[*X+RS JDSD6Z!.'14;V@CKE]X
M9I<X>S0OC\J'Z7RZ6K?7?**+UTR\3-Y)R=&<59I=!\%#%9E%68RRPH7(B[CS
M4+=#-B:E?AA#;I)_ ,ET6PN_X'3>-,5KFK7DP;>+%]/U]-UFCM[0>CVCEEHX
M,>Q0*F\$1!\XAO'60W0B0I$ND7791JU[)U%M VQ4:K<O:?H+IA]G%HOR^W0V
M>_[A(TZ7#<<F!,H<?7 T6T&JU.P#L2Y/V8**TAE/QE'H;8WO1K(-*_1WJ4DZ
MS/S!+/B0_SEYS?[ \BROSY;-0?@"!N?EY?H]+2\X^_@]+M_QB".YXHC'208E
MDY1=B) Y-C887/11V7333;N5KKKS2[?A@/FN.##LO/=WKJYLC@A;*QK/NLFV
M- W!U$3E-!2T6)BS%+&WSW$'C(/5WI7$0$G5H"8%HAT?&B,-Q-*20),(2D<,
M$KL;Q/NRBD?B*NTI[ULJ;L]9'C Z<*8@RJPAHF$CJY!C7E\K%.=D)*]*B;WW
MQ[\1'8S%T^DD\\.F_(@;G/OOFSAG9";I@)P,8&I(D%S5K/%S)<RB4/=L_:-M
MP.T7=:P:,EJ]G/-+^=%GT]7[9LM>UB>4UA.>H(0J!4B2Q6YL9I>FLI^K"QE-
MMB87>A_J?A/4F-3N6+AZ5]C23[+]SL,6\\5UI749=5<O449$J [9%8NUL :C
M!,JB$\K8&G/N?>YU'Y@Q)0",E6!])#FHN\O.?:[&!I!)L"G,+@*ZX,%%0A6*
MPJAZIP9\T]T];10\5C(=*KV.KL?Y:"ZY'(@\HT_@J[+L3:G, :)'L*H8@=**
M;/KG-%V#L&, ?>H3C=/PYQ"QW>#.?_YT<Z)?\,^=KPP_?OFW5Z^?_O7IKV^>
M__WI\U_YQZ<O7K[I>7_XOC<,>)EXJT%UNEF\V69YO/CP<4GO6>+33_25FE^2
M*UW150J2X*ISS()@VW8<AS%LC="[6+-VO?7_%K@.-G4/O.,9+[[IN_GCL^62
MYOGSVR7.5Y@WZF)>-C]=*(_RWV>K=?,&O\Q6*MY'=OV@4&[ZEC;W:GCU)&>E
M)E>E[1T9#3.2,84'W7EZRW*>G@S]?+@'QO(85^^?S1:__Y7*.[H\DWE4UVVS
M-<]PM9K6Z7G=B#8V'H$E;.4S/&3+EL1X70!%M4 V:!VER[[T3F?JB7],(<A)
M23RHX(]"W5?M@PV\S;=>+5;K):VGR\W)X44"QJL9K\:[UJ%(3BLJH&1;AT%F
MB$4E*$ZE6-NMG7Q,I7S 4'8,@P;>.#TEHX_%AV[DOF,<7P")4%#$8$"ZU+*J
ME6AY:+)=^S;>$PM']#Y2>@#.@"/=*U7+ZIA--!:29R$9:SD.L98@68VF5A4<
M]CZ*[SR$,3E3O7AXN[[,Z:1^C$6Z%>CH$(TS'FQM1]-2$D0,[1C)&C:9T0LZ
M(E6_NUL()^!F=[$>@XM[+:CD2 F4""XA3Z!F<YRRYUF,0K)MSEJ4W@>_@ZK1
M@?8[V%WQ-@N>IJS;T:\P$#7[P!%U25D:G[#WY8+=]SM&:T(&9^8N/N)>,AWB
MIKP.E0+[E4!"ML1PYR$%+,"84LQ8;'*]R_;M=B?Q6$'PF)BSIWR.M=/]\Z,7
MCWY]_/3-7Y\^?7OHGO;U9W7>O7X :*=]ZC?K1?[G^\6,J;IZ^K_/INO/$QVC
M1NDL9!T5&$6Y)0T+T-*XH$(U4O0.Z6^CZ&#A/RSFF^?^'6=G- FHV.UE=[<:
MRSXO"O8S3,P@'(ELG8XN][ZV>A/#F.S,@7*_PPO<?[J[F85'.9]].-NDMFZW
M@>*E3*(H<.QMMNS:"JA\805E2LC"%:+>*1T[0AR3@>E,F2&%U;&2ZAJG<RJ7
M]8FN@'Y"=9JGZXG!8"Q6#1Q3RY:FU"J\2@]9>"]%CAQ3]4[B^#:J,>5T=.9-
M9Y'T4SZE3-MLX.P53LOS^6/\.%WC;,)OH]H"7)$=C]5EIFSQ'&MG%#45%6/I
M;4[O@3*FJPZ]E4F'R>_&A+=+PM79\O-FC.>6\=PHRF@5M4PSHT0$XS% <I9
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MR/X&\I+(-3L1390B#Z7U]P8]IA.'(_-O*-$.S,C-N>^DRAHHR,33(5I)"HW
MBX*A255\D4EFU_LJQP-PQG0 <&06[2Z./NT?[@3SM6OQHIY==BV>E.HSNM;<
ME7(%$P6#2U%":59;JEJ*W:I7T_:O'--&?7<^##G]0^B.<QB_+!>KU20J4Z6T
M#DB9 $;)P"&QYA\=#U588P+UKNYQ-Y+NX^._W/!=7].*EI\V;8\W?0%QMFIU
M,7]OH>&SQ?+)XBRMZ]GLLKOJQ+LBHA81M%(.3,H*4JS$<Z/1DT*I_.!S<_ H
MQABZ',#!!W3P*<3>6W5OQG!7+@Y'3\F1;+=F6N.KFHCG*"H0)-F<Z"A3MKNI
M[/M>-<8 I -AAICHX93S;19?32)@M!<;F:N)\(4C("LAJ%8GER*UU#[-H1'I
ME#4['GG O90=T8XQN#BN,NHAQD%I]YA_GJX?XW+YN2Z6O^.RK"8626KDZ7"U
MW5@WN3 NGJ+D,;9 R$<<,(Y]"-H8XXR!"76H@(8Q6<W1?9EF%^JTI1U;M-%:
M4 4]&"TR!)LC9%^BJ8*RU=ND=WSK/6.,*X8R5H=,\7 JXSS<]=&%PO]!#4:T
MQL4>D#CF=3H;79)7+@UU*?HZDC&E\QQ#(>P^_<-1H76P)JF(=5"%;#UQ_%P%
MH!,<VP:G#95L5!KJ]N]5' -%RQ53BH$$"&]Y=,D[0!%]VQW(9$K)09\B6AY9
M5+<K#[Y)\MTG?SB2_QUG9^<S?1E#3K*W4OL:050M.61 "XB!]7(M$4T6.?O!
MW:/;L$;5?V1XCAPHEX'WZ"=!&>.J*R#)JW;;/D",%* H1B.R%Z3$<!P9X.C_
MR^[I5WE:K*2U*,"3V^IP. '!('LE2BLCVKZF&.H(XC::'37DT>B_+RF^611E
M/SD,5P_ERD WBQUSL5)%H.HT+W;#B[%@8N=51>\4I2"'VJ>X!])(-[H&(\@!
M ADR+>TI+N?3^;M5RSI_1<O'BP\?+B[/?"VU_C.NIAGGY<ET=K:F<OE//E[[
M^OY9:]TA=$AJ&W9:CE9W?J)BJW(=76LV+EKV8X88*KMN1>>2'"+5XY>/'[Z,
M]O/+/J6O%LN-3EFOE]-TML8TH[>+>ZHYDP\J4$:H(F_N+T; 5%N%\%J]IF"4
M':;07N^1C"D\Z<S1W:MH#TZ%;C:<S<+7X6P%4WJ>(6D,I)I3<[$+Q*0M!)V#
ME-GY8GN[?#N#'%4@-# ;AY5@-Z+]8S/75!ZU;N_OZ->S#XF6+^N%'=N8K=7+
ML_5JS<:-P4XT>AD=A_ZA! ,MUF\=MQSHG)W2SLI(O9W''2%VL"A+:KF..+MB
MNV^(\.N5XE?XN7WYT7*)\W=TWI9,&:^=9V??8V1)VJ0AH%) 6&1,Z"IA[Q#S
M<-1CLA1#LO(.LW%,>0^]<F]-SL8UG83J8P@N@&I!C/$M")550 U$MHKDI.Q-
MR9T CBD$/";[AI/B,+[(A,G<JN]+*-56,$)XP) S6&6U(VM<ZMX6X1J X0.&
MB?&A&DD1BFGR#(H@I:1 6F],MBE[/4RIFNT#I1,WB-V;$;O[[#M)8Z#N3$^F
MJWP.C<I79%]Z=%.T1J: 8%M=;*.#!"22D(6OVI(T/ F#\N5A?&-2K4,QIZ.$
MAMQAVV0.K-Z<??PXNW Y+NY#OGE/;6;J8GD^C?OOH.W\B@X[9(<-J],.V+/I
MO+UR@^5R@_7SQ CI'?D,3ED)AA4)I" *>)(64RP6<^]*%'<".50AW?G0BZ+]
M$U:$ECG=ZK\2TUN0YQ@2 UBA$],^&:5[E]-]",^83-7AK+BI>+I)HINQNA-1
MVV2X %6MTR() TU)M';'#*HD ALL:2%*PMK;9?L&I#&9I",Q9$]Y]&L_?=GD
M^,9 XR;?U7F0&_?*HX=HI0++A"7)@:OPO0/#>Z ,-,++I1F\E%F(EGX@'!A5
MVCVP0*"4]1*5L"KV5I(/(QJ3FNS!CEOMM?O)8^A5<&5Q6N^#:2H[J"0XW+ 1
MDG(5BFHG]T:ZI'OOHW\3U)C4Y1&9LJ=4AG?@O]8V6=3-)YNZ"X?Z[ \_M9N;
MO@/X SWSECM]U1:V%TTB.4Q9!:C*M-Q!7OL!4V4[&XST6<<4MJG,=?.Y/7VH
MS371E_6WBVNBCSZTT\)_;>9[DG3R:(J%%+UH]1V1*1D]$*IJ;<DAFMYE*[:$
M-@9S<K#$'W*E>HEE$+_[\A3OXG+1Q,>$LH@*PK2KBU(1!&?;968;O::"JO0^
M)WL SA@,R*#<.&3ZN_'AZ[ VG>.US2!E2Y".[.%C]AZJ2U1K(C2J=_I(-TWX
MYCVOJ[>T_/!U.*7RI&&RH%RK/6KEI@ZD!JH^.N8 >=E[@_,VBC'HM\,D?9/
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M6UM]_872;V=]*VR/SY9+CF<F%&2ICMI]KE:E0"8)J*0 4AP\%O39^N[)]KL
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M:7Z87X?QL#_\/+E )4DY@T($^I=,UI0UX0L<7(A&ZZR%O+=CZC9ZL!S),2A
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M2\F+@.@=;=$YRN*"UM:N4]]S1QC?BVKMF[$N"@1N*[EYJKQ(M#XRDY"CJSU
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MQN1>>6_XZE]QK\)UL6+70;:)T?F 9MZ/9K^6YWY9'75*2>--[@&$-G)I2K:
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MT1Q8;3ZM$P/'M $7G3>9D?ASZV8D+S'-X" BGT39YY)FL Z*6<9^9HM9:LE
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MR!#A=^#&C^'S>!&N-J^J;R*\#=,6T2EP-$V:+F<0<J@WET$S=)D%V?J-X%%
MQS=8FZIOVDOV'1+I[L='CFMAR=>AIO6_*7?#)I<%(Z35Z)P @^3>JQ(3A&0B
M>(&&,5LPJ9WRZ?>.=WX,W649))VTTB$$<".^=H5R7>EE!VB=K)-'8)W&,NFE
MT<=CXP]61X>CZ#&(3CMCA4+0F="I$-S--DM[(>=...Y;I^8=G2E/F"=G0)0A
M6F@<_OXZK"H=OYWA/,W&G^O?WGP>AP7^1J+_L/SIS<&I,IV\3'!0L58S5H@0
MHI(@Z"PVF1=N^,8ERM9WI-U'/+Y5TDQ)T^X2/GJ.?TH^>*<CV%![9PO&:/[>
M@M8^H(W.HWD1.?Y]#)!VLN\0QGT_Z747,"\UDW^0HA[-Z]Y'RMTS^;/((3KD
MD(.(H$Q]R(Z1X$47LW/:&-?Z1N/<,_G;:7R(<!M; <M7P<G-074_&=U8:5 7
M US3_JB""A"3-R"X8;+&^*,6.YSZ#X]PZAS^06*?-I=9AW/\]H1Z=;WXN&RI
MMK)>=0V:=0J8KM:KDQJ"IM,J1AFS-3[*U-K6WX[DLD[N!M+NT//]6U1KNN^
MJ]/I_1"F4S8O.DQO3U+A *%W.,P?Q*=B,9D%.KIL36OE4D%$\CZR*REE)X7,
MK<-SCDN&G?H!'8<+0V3=HZ,4H9HOQNG'FD8Q^[*N\1YB)#P%I VA%JVUM7%,
M!-H8>?',"95:&W9;@9PP<N8@/6UF1!TLY%[N_:M)_HU^\^K_7,_&\SQ.=VX?
MN'>HK;2DJJQ ^9+H.$P)3(R"6Q>=W2S6W,;!?QC2A;"AI> [[ @WH5SWN>JB
MS999!3D7!DJ;#+%H 6@4LY(7%*DU&;;AN! &'"SB#@])]W*]?[P*\_FXC-,J
M":\>?D)KM.@8I* ]**6P/LXG8%D&%[15MK2.?GH"TF7Y#2WEWR.U^F%XZ^)W
M.P \1I?4;>!.XU(T5>GN=#E '[U;EFX%&I#3CBD=:%FO1W(-,P]:0^:26><"
MUZQU';<3$>8)M^.T?!FBAMX\^2^\RF4ZJZTN'BH[LBZ$K8T-.FD$+DL!%0T'
MSUT!(92T)2BK1>O8J3VAGK@;Z>%*?XQ2G336[3JT>[/?$I(ST430M>.O"DI!
M2!A!()?!1DQ1]\DQZ#VSRS*[SI -'>J=[-N6>!?8Q[#I3MT_?+?+X_-B4:,&
MXOM0H+=Y, 2^%)HE26ZZ9!$4DQ*"8@9<4L4&PWTQK8-FSXJY.]UT7R9Q!VB^
M=1'9/]>Q 3B_!__VAH^3(4]VCQ1.D04D#00=%20M4W%"Y2PW^AUN+P+[^# G
MMC=[J6K:1\Z-ZTW_^?\] *TNJ^N:01LFZ]]8A_N9XI4L&F16M9R(17"Y>GO1
M8;*!(Q>[E 8>/O+E$Z6S-GI$:=\&@R[+$:^VT8#HF6$(VFDR=*TG3)&V4:."
M*$[YDDOK6_AM."[+ SA8TAWJR6UBNO76GT;5*Z%C*Z(3Y7(<K+$G*'" N(^P
M%:Q3XG(.T= V*'0@=*((B"PH8+1KB5K).>KFN1I'),%3:1I'XL 0*7?0_5N<
MU(/QF]0 G@K9U-D!9FEIP^,2G"JE1A@:C28'AZW=F@>@G" KHX&FINW%W+BI
M\KM:WW3):O1TEG'NB<N)@])DCH3B:E" 12]DRB'LM-"?:)]Z.^!E'._[R[!A
M1=!;$#=\V@5&PS;(=X8^?N?C/86_J;X#)->XO_%=.-Q$)QDZB+)N-DQ$<%X6
M,)AX8C86Y7:RQ$^MP$>Z&+?5WQ"!-=;;[R2I3]>?UJ]/,L2(U9N3-=^_. Y!
MU,KC$E&2<\>Y< TT=V_0X_8AWEOLTQ8R:WP,_A[^O@.D)%MT,63@Q51?P-%#
MC-I X,(7 BF=WBDP^2GEW1WT&2IO;YD]N/(ZM8^L+6NFDYH\]:;<J?!^<PT]
M;])4<L<QFK::W&=>&PTHB^+:)X7&)::29M':8E$)SY$5J=AH^' ]VU(RHSFK
MW=J<7S5TL. ]F>!"J90<<O*^6G>.ZMJ6<M6YXE6<+V8A+49&.YMT4F1WTN:G
MT"9P/"!PYG5DFIG 6T>9W$=P;C4DA^A[T]LZ0+8=XD&^:5="_['^WDV-W7<X
MQ]E?R^J[-PT,Y[>-*7Z9SGZ:7L=%N;ZBG]6(WOE(^L*LB[132Z- 66; 1Y7(
M'XW2%G(IE6A]3]M^%L=GW"&\>*H'S7&5VO@]<7,V7^\I"/R/5V%,"]($Z4,)
M&:2S$91P!9Q2'&2I7I%0,3.UP^O1#D,]2V+T$&./*/RG>7NWS1_AONUW$8T.
M*NH(P7&R%C,2-37-(8:H.%D,P6P2X!B;S@-HGR6'CJRD'@T8MR#_MNY>O4A7
MG!P^"S:I6A2/CGA?N 4TY ARH2R9ID?@TA9H%T><0\7?N'WB-WMD;<S\)E[=
M;)3S$9?6\F(9&"$,**\U&7Y)0DU=$E$'PS>K$.YVSFR,\RSUW%R Q^B1^&;Q
M$6>C4+@H@1>(B9-U(X( 5^MMLJ),+(C!E-:OB=N1/$O%-Q1NC^C?353_F$WG
MM=RNBC8F!BYK"8JY9='3 %9'E#SP*'3IK?(EDLM2^7#A=@@@V:4'I\_6AI0"
MA&5[#[)L(=174^V%]ZX(+TSW)7\.G5![DN% L7=H3O@-Q->X&'''+%D8!@+#
M3&9II#,IU]N<)+*-EK$8=WH4.80*A..R=#]4L!V:$*Z[C]7.4>LY)L-U_7\R
M/:0#I33QC\D 4FHI7<IH??L@PF]@7-)]YJ%2[I$N\96,=]!M.JFKPNBU)=2O
MD[]P0A_YY<?IG-Q4XJAVOM >91TY((860XPJ@DJ&>2Z,\[EY2NY!B$\1A72@
MTA_>/GIK[&A\>SN;?L;9XLO;JS"I^20__\_U^/.R!:+S/CH9/2!355R>MMSJ
MX=J,@NF896P>R3P0XJ4RJHU.^EY]WH'[C^DT_V=\=;5J?!@F'VI3S=7YNOGW
MD9%D0KGL(7J:A1)*@+>I %,L>B%U=+RC%;,?Z$NE62^]-;P4W;BMN0-^>6?S
M;OSAXV):KN=KF-:K((+)D&I9'A64@TCR J=K#Q&G>#;R/KV>NOEZ:LCG2XZ>
MLNU0'G,[U-7E#>V(BNF<P3B4-0:8>"J(IRQI+113JFPFZW7:54YT/7:<_6*X
MK#O>C=ZZ"G< UBC(:$W2H.TR"C)K")D%X%P+E,5&S9IG$C^"YW*(<+"T^UZ9
MWD65F718VRS'8 A5L!R"Y@X$;5\Q:98"=GQC/:GV^[G/#63=T1S]6@#P]E)'
M$ZPBEG&4JG;<S@JJB0(B*R.%J=U@>EV<?HOF$IEPH,P[/IQOVZLJO$)D-,@5
M\(BT&:*.$'.I7XSA,3':M7JY'@] NFA>'"#]GL75OTE<XKZ0^Q(X)&]8O4^V
MQ%\>H:2@-:_=U9LWR#CS1M.'T*"-G,^ET?13U?Z*1*FD]I"5#[4,, <G,)-?
MI),/PCH=FOL=SZW@ZB"]#RRX.D3^)ZF;N0O [P57]U;IX *:^^CC),21R7'%
M"5F(IO:5HP4362W)5$HLP4C'E+P,PAQ8<+4O7X:HX9P*KBH5LG$6L#8R4B(5
M<(%LKT!'NU"Q%%Z:^\"74W!UD-);%5P=H+$'$VQ:9@"^PXSXJ9[@KZ>3BIN^
M2Y_R8=E#"^>+>9CD!W[R.LSJY/["_7,#6XY^>-9@-UELY!/&)*S@J@3ER=:V
MPF==?#'):]1"<CMJ">2PG>GW\639:6']^5^]!ZY-3#RDF^9LUCD(PFLH,C-:
M5E8SU?K9^$$PASP[O9I,KL/5.TS7LQD)\FZVP%N<_?$QS' Q?4#8H^H^>2<<
MR%@L*(:Q)N9;"#Q9'9T,Z/,32^!0#,??6=MPXN[SU-%TT"%G\34N5DY1[5#\
M:K&8C>/UHB[=]].GEO%(F1RSK]T(,Y?D@0LZ"(P.8'3F,1O.@FQ]>WD W.?.
MM&-KK'4_\.W\?WN]6#[A_OPW>?'C.;Z=C1..6,G">B; )$PU!DG4N_L"*0F!
MP64KC=YA8QHRYG.G1U<9-WP5J3C7@&I,,ZYAO@L+_./S#$,>H5/:^<A QRA
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M?!;IA%N\(2E4C+_GY=ORZV)Q43/G7\\6R\69\84;%Q'(3T_D+9!Z8D8/Q8C
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M<BR2Z59\'2KH49O@I1-"1E5,?J+YQ<;G[OEN3Z;Y;;GSV=]^^Q[HMS98[VT
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M7Z]\+EK9ZG/>S1;+>5Y.YJO\M5MR6KR9S7_/RVNA_)3+;)X_X-]GB6LR-&R
M8B/9K"5Y.B[0@PU,28\Z:MDZ%'+8%9_2.W$<$AVD0VM>H08#FC=N"V?DDG$7
M"*,(JF:,2 .!DXRYX<%RIWG&UA6C6\ Z165LS<8:C=D[Y?LAQE_^_K)R]=]<
M+$D2US^XZH/R>_Y[^>&O?/XU_W,V77Y:G#&GE$6"+JRG0P,# R^8!1F20BNR
MYLETUZ9!D%^&IO5C<8T6[MW8:"#^_\HX__#7["S+S(-/#B*R7&<H)0B!#)B8
MR<5+VKC2O#)O-Z0_=&XGSM:HVMZ-DW:!3;J3S[B1BA>=@:VJCGF6@+[6YFCA
MR3@6Q>G^.6W;8?VA;CORMD;A&O1R&@S\S>QB?F8\(4M>0="N)O76:12N7A"P
M0)NU<3G%?'A]JU!_J-MNK*W1M@ZAC\VXR4LZLTD6CUY"0:% Q<@@6)E <K3H
MG*>-N7E&ZFY0?VC;;JRMT;:=XR8[XJZ8WY#H\+RN8/&!?.R,95G+"IP/AHL,
M212L0QXR.%4[L 9ML)!DL^H?C=L-^P]];,3K&@7M$(2YNY!?/G\YGWVK5T;3
MY7P2+E97^-4]NEG.64PH1$[DG6?O09FDP$G-(-KH@C$E9]_Z8K ![)>HEJW9
M7*.1C6,NCP>.?L_+=WD^F:5)O/K[KV>+5=1HU8OV2YXN\.;V_M=I_<E/N)@L
MWLV(O\59S$7R$#RP@F2(2$7KK$7$(A:?@K.,B7O-7;9-N>D%^90T]IC97I.A
MO7/LIJ[S3Z+I*OWG-2X^O9JF^LLO__=B\A7/Z_%P%F)ABN4 6%MP*AX=!,XB
MZ.Q<"B1#^OD6NKCQ0:>F06TENX;WO4I"GHR6/!3,XGM"[FI)9XA!^MKAA/L2
M:ZS$@,M8^V08C@63*_?'(*Q5BOU0G)K&C,C)&G7:K]+CX>&^[CB_2E.\S%'\
M#O_,BQR3%0:,([QD8CIZ)4R$P$I47EC.5-GIN!L XM24:3Q&UNA2AYC"'=0_
M?;M>S)FUP3-2!?!1UBZ2FH/72@-Z%1P9BZJ,8. _ NZ4=*HO,VMT:*]JC7]>
MG"\G^0I)!?GFHI;AOU_B\N)6LO29XS;4$57D1A0&*@8RO411%6AQM)T6A7Z+
MG6?+QYV2/O22\AI-V/L6_P'.Q7].EI_2'/_"\UOA?)YXTD8[D$X*4,Q(\#Q;
M*&2.J2"*C/<SX/;>2K9#=DIZTY&3-:K3ZDK^]AY7P5YU 7PUG5[@^?T#]6H'
MS%=OP%DPGIE8[RJTLJ!20@A2)B CGY%IQC#U.J+V@7V*2C<VFVLTLM6U_?TU
M7!^[_\1E_%3GH]W^^15T&T.VZ,C#+'0LJ^ ]B0XS*)V89$I(I>0XBK@%VA>D
M?ZVY6Z-V.U_&UW/^^A6X\VJ<N1PDUMG>.>H:+346 IWT('-TM:F%)Q=T"]MI
M[8>?$OEM)+B&TYVOLS>HX^KV\J;.E2!Z:ZT ZV3U!2T=P3F+51A("N],-IT2
MM9X&=DHZTH^1-2T7]D[V?RB']5?@9S(GU XMU&E[M%61'^AY8F ETUSG:(1M
M;5%OB^V$M:<M+VL4:.]4]YONN6NN-6^D<M5#5R09%1,6K.4D$E020AT2G%(V
MDAE!&M\Z>6\0P/'&ZO56H'Z\'+J']?4*__A^H5[7]/Y+[<LY_VUV55126[<Z
M67R(14-R>=64TP*JXH!LK"RS$-')UD;R1E"'[W+=7!\>3&MMR4N'_K=/ KQJ
MY;H-Q$Y#_;: =Y@9?XV)':(V>[!R( 620EG-.$+B4=$;9 .=RP0UE1RL9R[G
MYI- #Z8X&^8#'EYOAI#105\(15XL)W%U0779OYDQ6A/*"$+3J:X"[:U.6EJV
M3)DI9A+>;U.VOSG] ,7XAG-SLNZ;S?M)NF$WV%5S@?FWLS_?GVDZ/C.Q 2X:
M"\H6A! 8^7BE3C=$%H)^*J=[D>._?)Q]_=>K3[RD^NJ;&Y9OGG< =VA/J<_V
M$EF'%_;-;)XG'Z>WUF,Y5T);!HQ+34K)&+A$.LH5CSXQ[:/<:B#"@/?U 8C3
M>UWWDW/WD_T#_5>K\TG[(+D.#'0)=?2+*!"43! #RE#H>W<_<:[Q87Z-Y*5Y
M#SLQT&$BUT-4US-0M\ UBI]P@^D8G(/=>-NH"GL(?93-XGI+])X.*L?I]**M
M2X6(X"4+(&)DR>EH7&X]]W%<91AD\/?5A2&R[J #MUJ,+NYNC5<'FM*T!UIM
M@#/ZHA(=;<'+7/M+1=H,&0%N?71LPG1H.V)7]F8=1=]A#L2&WC5K(;-8G&66
M0[(\@9(^@E?TQCC-,'!5,LFIL;;L /-$%*@W0=V/G)JC-YE^O$S26VVQHM0I
MA:R.NM09%%=U)+MC4- +HYE6K'E:R 9(+\UBW8^3AEWUMX!W]0YM W 4&W8-
MN&,P9O>D='MUV8./<?>:Z^MXFU@./H!-C@PZK1/0QQC(T?*8O0C:M6XZ=2"%
M&63PCJTO0VCHH"=_3LLJ5_S6+4[TV@2;/<C+<G,Z+]&X ";2.<FDX0E58\5X
MB.+05LK>5,V:RKF#A7MG%,/KNTT=J]J':AJ1<I.QE",HQ3492R*3/<XT#UAR
M,,U;YSP-Z?2MD9:<-)R[L@6\JU=D&X"=K)&-X YCC32E='MUV8./'C'4S4#1
MA]JK$ZS,NFZ&"0*]1^!,D3DY%C*.N-L<T!HYL+X,H*&WGOQ;/D]E-J=O\V,S
MT1971ZE(0<GB#&@ZGTDH,H!3T1'L:+A$C=$VK^S9#>H!XKMM27]*I3HQUMOX
MN?R&0):?OKW? KM!45)4'$Q@#)0Q!+MX!D:Y9$+(7(C6$8)]\)ZTRO7DKKM;
M_CM^O@RN%!63,I9\2E=;!XN4 36)0WN7N$TQI-0WW^P:R>F;V T8:#A$[G%4
M5R_*-KA&N=Z[P70,MWJ[\;91%?80^BB;Q77<A$<Z*YD"C[GBBQ%<LA$":LT8
M*UJ%OB'JWLHPZ,:NKRX,D77C<>&_S^9_Y8\3G+Z[".>3^#[/OTYBOHJ<U@NJ
M]^_^_7O&GE?6%0&1#E0@2![JO%^P(A5R&'S-W+NK$6MK0+=_XJ'OYW9E:-9=
MO VMU5O]@QZ6RE^6**\4GSOI5"9[IC Z"E5.#)R3FGQ"E9SA6D8,6["_Q:-.
MUS[H(>N&4SFW@'?U.FP#<+W%L(M2',(DZ$+5]FJPAYP;'Q#; <T^QR*"@BA5
M#6*Y2)M70BC2.PP8I+3FN!7A$7/@./1@B'@;\_]F,E\LW^%\^;:\PV^W<5Z=
M6SP1BUP4$-'5^F*=P<6(8)%)XV31PFXS,GK3<\8S!CK1,NLDT\:VP/L<9]/T
M%+B<=) J:V"IYO/[9  C+=V7*'GPPG"UC1VX\4&GQ'A;J7;P R^G[]50]&6:
M&]+:8W[_*>=EG4&9TDKT>'[+#OKIVYU;L@5]Q/E%#6BOOQQ;;9.293)O8X"B
M:W:<(IUV.BM()F;2>"Z]M8V]RG%6=KI&ZQ%K2,,!XVLO?C<!ONT@;@%[C*#T
M]I /<\5VC%KTU-U_9Q7H'=\< %]X#!H9 O>YSGM3")[59C&,BVBD"+9Y/?I1
M:>Z&^\ 35MPAS#?V+G[Y\Z>+!1U;BT5>W(%_7:%A%8M%UBG7GM.!13+Q9"=!
M\(9,(J,9S]L,Q]CPF -'+WM1->LCY\8.QY___C0T'>A]R+JZ0:8V0-.)4 D.
MS!LLB1PBGNT6*K#A,:>O BWEW'@7>'6Q('<(I]< 'T346:!-,#@!@0=7QZ<9
M\-DPX$(;QE11QO(M=&#3<TY?"9I*NF$9=<7VCSS_C-/__$3BJ]D]UQ"O@'DD
M;\49<EUB2O5*I,9B D).0G'N8@Q\F[D13S[D]/EO)^-'"Y'^OW^])[W?Z-O5
M#U9_7J7S1R[_J_[ZYQ^_?I<DH2,@LRD7\E_(TOK7E12O F57/NWBVMF=E5N]
M#NMDL>DBE]G\;KWG$B?GB[MH%Y//7\XWW4WM_\Q_O5GM72E</?B.!HVQ[OSW
M,M?"@/_]OR;I___?$Z94\D8DKVQ6(FL7BY889/;9>I;BV?Z/;]US=%WSP^(<
M9IDD[4W)U .+3&7+.:18@G7T+U/])Z&N =:^X^I5V'C5SM/*4DTU \6N.D*'
M NA#!%XB5U(Y%GS_5=\"=*R]58=HQ^;>JKLRT".M] &X7Z?+3.[F9;O7FIU"
M[W$$@X[0*3+BG<@17*[&G9*2!--=/VXC>AD*LC,'/6Z 'J"[GK[Y1UY>S*=O
M5WOU:OC3XDR@+0$#K9ME\OR2"^"E3R!0>A=*+BJU;B@P!-_+T)Y&_#0VR!_B
M?/5Y-E]._F=ECL[*/TB<B]]FU:%\1T;!_-8F^7J>TV2)T_1A3E;!BK&;02^+
MJZ65:))3FH')BM>[K@!HA8(@(B>!>L7C-IY]9YBGI(''QFJ';@8/EW?33)_,
MU[JZNKB?+_*'V?N\7%[VG%[4D9T7\VJ\KK[E9Y:+(LD7ANQH!8HS#4'S"$&F
M(!5:CJ7_.;H3]%-2V$.RVJ.X]<$R'FG:GQ/GB9-_SY2EE\B1$QY43D "1"-#
M-GD$*^YY#5-HJUX->.E0PC$LVF^"X2SK!.3E)U!%>? B(B"/H43)C(NM7<5G
M/$MA'_WIQ\MQSE+XWK'/9RE2H,/>&U/H?<B2SGD70<J0:#,5''G?!B_/J^_I
M(.:WZWLZA($Q6UQN@^LE]ST=Q-NVO2YW$?J82H':%5?#%K(&*Y1,!9SC!7C(
M.5HRS71IW8'A.?0][:(+0V1]B+ZG*",367HZ8&LN8B0KW/ND0 @?!>V$Z%WK
M%E#/J._I(/:&]CT=(OH.-]B;QWV8$EFL[?Q3"!&4R Y01?+5N#?26[1>MG9_
M3F0N4SL+8U]>NC=97S]M8!N(/^8R[47L#O-U=F'E0'.95/%,YY3!TP8,*J]2
M*W+U^(76M#7J5,2I*,[><YEZZ\T0,D89\Q)UMD6[>D'@+1V=B!"L$K33YAK]
M95;RUB?3,QGS,HBJC6->ALCY41-EE%2DUY]P^C$O)M<_NA41P6FZB>1UR$@:
M^NB.B4E[2>%>?A(&GVSRUH:BE8[.)2-"$I&V$]36L<?SDX:B&"--*3NF SH-
MF4M;.X8((+O>030E2XTYI>8^[X'2E"ZE_^M#X?\Q.S^G5_POG*>S'&@?\+Y
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M*LE DH15U2$W/@4#P4HNA/72A_Y)D5O<7C61P$6M/JB]_2\6ET\ZX](*H9*
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MQF6TJ"'.<U#@/9?L[?6WB\ :Z^TWDM3%Y<4*B(BVF*0E4Z)>C$2(+$0>6$P
MR6=MK&RQKWZWZ' >V4%BG[206</+I 60Y77%>A=PF2<K@1G(-23 2IM)S\25
MC0C*H>A6!_R0\FXN^@R5M[?,>BA2V72JO_CV!N84^2V+=!1&Y56JQ/+U*2$P
M2+5(![$2* D90VMJXH<P'9LOU(LN>JBBW(1OB6Y=JM<!7T\EE ]A>YSZR;8:
M[6 N!ZMCH"WF.YRF:.V$H]<E*LTT!\]"0LN4S,$:(WW@0]3-]&\N#]1,/JZU
M[**% 2H-?AU_Q5H[\^T]?KF<IL\PP^O2KC6QI@;#D2<6;:[$FBK4>2>196]2
M4E$6,%TX*_=<_FDD\O;7X0/YW]8*:,QLN@GRZ>5L/KG Z:SVQ*\@1L  UB0F
MHR?GF%QB%@OGY"$'D;-!^KO8TT8V+'?D-G&H@'LX73[4A'/\=BL3O<)62I Z
MRSHR%^B/6B$!O&C&)8*DJ+F4W'H8XC8\1V(=S45_KZ_:LI3Z=')Q,9HORKX)
M=N7B&E$L-Y[?:)G:OYIZAP\_O*!ZWR>YS?EDT3F7HTN):^-5(.4G$TR1B3M:
M\&R'=0XE'9K-KCX^T<=>WT XX#IRGUB2M53!2<YB<)HI]*K.240)K5N+[T=S
MR'GU_:=^>W-9WY*W9<$A_!(+*8;>T]E9XEG'&C!J:V2E^K$,)"0&:#-RIU%%
MWN&XZK;:\/M1(TW?/*=Z$&QC5V4CPDFA[7..LS- P%@<9UKE4BD #?-:6>:E
ME5BT L NA4];%SE>1>\EQA[<D'?P;=FT/9F^QD]P_H$.Q>7%X^Q,9".TJ9?@
MA+#FA 3S,=*CHY6*ON^X:LWVL@7.L[>%UB+O(5/VFB2Z]+:N02TK(D[^ %HC
M?YPL]J=W,)U_.^/&"$B$TZ(G^XVEMH5$P6R")$LJ7KG64YUV G@T%M.?6AH7
M56\$6B$NT7Z<O,#?9YA??%ML?K7OGS[N_)?)5YR.Z^^><>^YUE*Q$BJ7B!">
M>>X""R[E7*!HA"YU<8?B>/:6,[@R&A=AW^,<G<*,?/?1[&(T(^1G/EF50E#,
MI=KVZNG8C#4<=-Q873EHO._2J-%IL>,PB>9B;5QF?0O@Z3F,+F9+\\UKM!\N
M8QY]'=74].PL&ZN<#;5\DY./K+QBP=O(DB^\0+)&E2YILEW7/49K:"OLQI76
MM[!>[VB50A3.S^M?UXY5Y9\]RS:)E LR5+(.+O+D5QOER+DN$G4T]/%=^G5V
M7?<8#:.ML!N64W<UXO]].1W-\B@MTXB3>?631FGT!>:+(:K7SW=62WL#9,="
MB9'IH@V+)1D&.I2<>2I@;:/MI#.H8S2I =74L#S[7J_J/E_\'4X3_1P^X=OR
M<3*_&>NMW:^/D_?T=1Z1"_82+N@W9V<I 9!DR8&'G)D.,;-8_7E0]*1!RP(J
M[NL$-T5Z');YM!1ZUUS#X=SX&[V^=_0.TC=+F9UQZPP6XYDUM=U2F4(>'P2F
M<T;AA>7H6H\Y>1#4LS>N?L2_(0=X,*W&+83O<-$*L]RCEW#)]2N>\T@1H#-D
MPO1EG13'64ZE.%V*5Z%U+O!A5,=J(H<J8(.-'%3G<AM>W0DI,)C-1_/+*N\E
M.<Q\\FZ*M?:BAI.K:!+.SQ)7#H3R+-@Z15;*P$)4DLYJQ&2=YJ+L<3.T$X9G
M;R>#*F&#]1Q$OG$+.,40EZ607U=!UF03'9'K/;'^;%KG6KZ;G-??H*,S0PX"
M%,N$D:15@/E*(:M\*K%(;;GL4BIU"(9CM)[^E+#!>@Y+*6^^/7N/Y_4?S<Y4
M+,J:.L(4-0E$J5JX;(!%B,'6"=5!N]T-Y/8RQV@#!XER@YI;)GQ7GO.'R>6G
MSW/:V?XQFIPO?/3EC!A1C*9CT#&CZ$34M7L!9'',@Y8>9'02]CA3MB]ZC";0
M4,P;#*)Q)G@V.UFD!M9V^S/\B3.*M4B4BS9_"M(6OW6FL'#A'5;*F,*T%I)Y
M(Y%9[Z4V.A0>]DC][8#@&$VE+P5LL)N6B>+[82<<?<5\EK,VICC#;#*6_&IM
MR;S!LY*5=#PI$<U^&;^MR_Y8%K*'J#>8Q>&L&QLWOU669[GC9?*'=>"*'&/E
MF.92T]_ ,:51:2.T!=F:UOAA5,_>6'I2P 8;.2RUNSE1<^4?Q1BMY(D.P5C=
M8*L"N4;&L8B&GMI*%:+>U]5\^P.XFGN*<H.:]TZ);KL$7Q0&_SPZKZ,G7N!G
M."]ORYE%7JF[-7,B^4K=75C,*)C*O%CEBI$Z[:_SC6L>LP$<+N0-56_MBUS?
MKJHS;P.-)@;I4V0\6Y*&@<*""E"SM9!=**+XO+\U;%SSF*WA<"%OL(:6F<XU
MT).<%T*'\QN5V=FFD+*G<"A9))R2MJ^4,[FZ:*-6' KN47JR;<ECMH6#1;S!
M%%JF+:]<VLGTHN(MHX0U9Y)4=G7RO5H,/PO6,*]"9MDK9;,T(9N]?8+;BQVO
M^@\2ZP;%[YUQ7#_XU1CXJV0H13$U3UK3H49"]I(C<U[7SD'T+ B>:BV415,T
M_;#U7=@V/,_>+)H+?8-%')2<O&K9F)0Y!2OX;CK)EXGV)Q!!6IZK&UL'#IM@
M:V*\SJJ6I= >A3%U\0[O^_QGK]EFPMN@T8.RBV^_C":C_&&.-?:<?1Y].4GS
M-_C'OR;3?Y^,QY=P_F'1.C[]A&?1FRQ4U,Q DI5+D,Z@$@5+(8@D@XXQ=3GF
MNZ]X%%KO2< ;[&#O;.$]68F3E*:$C\QT6?9ZIH)RMK(*!R$#B0 4BW5V992F
M2&-\(<>TWYS0;4C/WD+Z$/T&TVB=,5SC6Y6^GFG(P%5)S,EJN<%QYB%RYGCR
M :63SC=O@-J*Z-@-8Q_!;["+@[*$K\9?1]/)HD,&SF_C_#1%S.OZOZM$.$6Z
MH]KK&6) \+2_*6=\K>&ALR\GRSA'3"X*X4J7EMG]$3Q[^QA0 1OLIG4EYMKA
M?5O>T0]&\1SK+YS9DFV4$%C1GAPCQ,"\@,30B:Q"*B27GK>5S<">O?7TIX8-
M?90'5V6N-CV*C+=8? V-='+"YV282HA+(M60,QFY+$F40%LB;SV%O"NVHS&9
M7I2QP6H.RE[^'?Z;O.W)Y6Q1%U@#Z.6V5S#7V+G272E+'K:-9,EU:'8P//'H
M"X@N?9+W?/RSUW$KT6U0YT$9R'LPO<<T^E(+]]Z6EZ,IIOGH:ZW1LPYEYIY%
M+A=\K, ""$/[5LXR@G7N=H'V+CK>N.8Q*_YP(6^PAH,*(:^R8]]M0">S&<YF
MBYZ5<3X]1QA??CF=S,A'5EXD94VEDJA-!3):YEV(]?A"8T4&=SMLW>QL[K;L
M4=A$GZ+>8!9[YR:O&$6F$SIL\NQG$LX=2I&4#<^!G%P12ZVHX)%%QQT38*3P
M2E@?0F/O8!N>9V\@S86^P2(.RFUNBX\6-ZX7BVWM:O(T.;T+#;RJ-&L+]_?5
M^/("I\OX:3)_.9HMYY3\? Z?SI1P.5$059\L5R[7PCP69#PFGJW0/MDNI;>]
M@GSV-O:TU+C!0!LG74E@2QIR[V4.F=Z6D#$Q';UC%+$7IG2218I:0-AO(^(:
MR5!SC :)</<2[U.86W3=FUO;F19<T@X49"4RRU*2XU6,8#Y$R43F"%JCM*E3
M-OZ!60UW5WXL]OX6JIPT$VGC(2K?H_E(_V+%[]H%4\.11O?A&'Z^T:'ZN5?5
M!PIW*,4#%,^U+\PH74EXK2//B4+OP).3RA9M1"=2_2>E\"WSD(;0]RXR;4R1
M_P:615WOICA+T]&7^M7;+Y4<X1KMBGG9<)%<H@,N@JB\==HS7TQF8+PJ!3*4
MU*63K_N*PX[@::.=2>^B;4PB^SO)%/.RTA/_G.+Y3[^1O_H99W.<?OWIW>4T
M7^*[SS"]@-<_O?L)R===80Z<VU (LS/T!SD\D@6E P'W)JEL4&*7_,6^ZS]S
MXQA$[(WWBIN8)^6$8I=1@B7X4YB>_Q\\/\=O,,Z_C=)GP//?TJOS\]&GR7PN
M0OHJI5+TL\6_GI13.!^5R70\ZO3O3W\Y%<$X&Y1824''8G4NDJ$U) 5' H@\
M N.&'*V$)EKLPD/Y=)[HB,SY&9E&0XK>*H6KNLAUR_Z=C5[$A#891WN\0/HC
M1!8+6)8MRDR1/;>=6.\>7.B9FU-;038FT?U(0?7?$<[GGT\_CZ:3+U-(\U'Z
M=9P6V_1/7W_Z+?V?Q7"%T\GTRV29W[FQ@:-(0+LV,,<]D$Q*9M';P()-&:5"
M;V[?!F\T@<-0/'/[&% %C8ES;VZ4K_Y\C^?O1E 9RT;G^(^3BT\XIH=X-3]9
M(Y59<<N38J&(6E6M:KMEB:R@55J A:1V=;(>7O69&T>/(F[,IGO7"7Q[,1XM
M#3O!%*M!WVO+/ZUW0N\J!7VL=%."=L),480+F14?@LR5]U7+O?SPW;$<D>$,
MHH[&'+ROOL)X-I^,%[Q ^&Z9W/CY<IPW@E[AY49K"<8RE3/MA;G&$\9QEAP8
M!X%#$%T\DGW6?N;FTKNX&S/QWMD7_P[3^3\V0*V;HS"G7SD/7+T_6<]C0R<4
M6+)IA?5&JI3E)7KV$6WD(MO<A?7T,!3/W&0&5$%C6MW3T=?1>1W=.%N*Y"N^
MQ L*R&;QV_PS_O[3AY].YO2OQ_AMMFP2I!".?O *:D)C_'(TFU-$.)^458_)
M^FTH*K@B# O1U!8CA2RF%)@*](2*"PC0Y>SJ!=PS-[7'5UA#IMS% RW8-D_&
M>?4<M:[C>AC&R>KR[;M;^=/)>-FTO)XK&B,H4>C=*5!]/2L<\X1_D2"0OM![
M%+NDC1I >>[6-; R>F'5O2:6I@WY<K:XVX&4M<Q9D$77SA5G$FVQ I@5*'C.
MR05_JP6DY<RD*QQ'<)G=3,S]SM%:8%J_#1U0]31G?C.BQYDN?[C&'C"! \3=
MPXB]>]#I)(*WTC)1!QEHZ3(#P8&!%M$7$PVW\1D;P0,SXX>R@5VDW(/N5Q,N
M[J27'9T^I>:35?2:PK3(Z4D]LD*0/ CDZC:M\>$#GC=#>81:R0::NCW1N8&8
M&]Y[5Y?HJD3S%YQ\FL*7SZ,$YPLK1Z>S,*"9,!KJ@TH634GDIH3J%'%,MQDG
M]ZIPN1? $9S][03<\.YF 6I9\W@3TLJ\NX!J6-!V+Y#A*]H:*6K2EY0;5[;=
M#\Y@-%*XR& QTM7PS"J)%6U.H$#7OG7>Y,4?5O5;:MN&U/PNPFVH\50'!4V_
MG9V>G$47Z90JM;ZJ]@M[H9D/PC+G4X@2"K=^6Z/-#--/GR9?_[;ZQ*6&5U]<
M*_AZO6$C_$:"GQPDM89']+V'THMO;\@IF>+;<I-6H-HL#PI"M)I!):O1BDX]
M7Q\TVQBSR6"4[9<;>!NZ(SC4>U9)PXOV^R8[+5"N7HLNT/J*]>^']4@!?T\:
M?6#0UJ'JZ",7L 6BSPB!@ER&LO*><IMH(\V5$:MV'0>EK'//W5(>R@H\OJ'L
MHH7'JY57*08E(Z'TPM/^FNI$P=H@Y@M!I)\8T^5BZRG6RC=7TGXE\[M(N'')
M_.I*;$FA]Q'^O*+*6T-#&TO0AA&>2HY:#/,H:O>YM.1)Q6"Q4Z/$]F6.1.,-
M9=GX=?^^P?=. 6I)1H6HF"Q($5)E-R,!*%9"S%X8YY7I4@ZQ=9'C4'$[.3:\
M"<HX.ENP KRBAYTOCRRA0669#*.SB1Y+"'*/O:<8V*%37'C(85OKZCI I(]>
MGNWTE^LC?<."1Q 3'"K&A@65%<H2Q<I>N^#HX.$_K-:;JP[KP!\L_DE#V37<
M?N_@ 9Y<QE!15*)1F34+DJS=D%%:X3%%ONT^YBGH\![7NC<5[B*RQB?G1U(!
MOJZG^&S^^X=E&UO"R_DB*[6H+(J7=<S,NOO1T1$ UK*4@F*Z4- 0LL'*RV:Y
MI*^[C8C<;=7ASM;#-#,91*R-/>0%TBMG_B&@'GTTH!R+G!P][7A@7I(KKR%[
M%[%8$;M0UNRTZ'-5?R]";7S#\A[(L5AVRBNG"W#/G)?USI@+%LAG9 D0)9!#
MF3!MV;:[WJA<+7@$'M7^ FS837 %8GU/WP%&P\O1&TL/?QVZI_!OJ^\ R?7Q
M.J[A6!")3))E[PO%<#FR:.E+Z;0"S:61H=D+V:<"MUQJ-M;?#@)KK+??2%(7
MEQ<K(+2-I.*Y9%FK7/-=HN:[ D..6B<C $ WT-QWBPY[A;FWV"<M9-:XO.@W
M^/,&$ ?DM(,&5KRBPUBXQ+S)B96054G90NK&\?B0\FXN^@R5M[?,&K]YI_7Z
M&Z=?8#K_]@8NEKN)JKN(\X%%[<F-0E]SS=HQX;,K2F5EH07QT::UC\2M.5BL
M#1OB%C:+7Q;9YADNQA+4!.5MB"N7O0O(EOY/5V##>T>'ZW RE ):NU&=P?JB
M 3EX9CFG_2\GQ8#3FV+0:Q#.*6DZ]9 \;2O9XH(]DI'L(O?&&:]%)=W;<D+?
MA@LX&></ES&/EE.2UA%Y<4#^",&CL!PJ98FD RTHYD'Y8$QU5;L0?W18:N"C
MOQ\%3?J3;N-LU^EGG$[^O<[-K#E&M#=H#+(D(%9V6$G'I2C,$!:;$43A768Z
M;/KL8U/OP?)K_#+_.J[&E2_A?-'F"./Y"I/U9$0J6E;OG9DNP3% 5UCF0&J+
M)3E7.NCTOL\_-KTVD6-CBJ[55O)/G,W_,9I^(@G?LY^H)+)PFC-C,\6.G(ZK
MP,$1Q@22HIMD?9=+B:[K'9ON>Y%S8R*O-XNV^!59W?CC=!1Q]G9.F]''SS#>
MN"E%)4H1W#($J/,.@V?@@6(@:4&A3#)V,HJ=%SXVZ^A7\HTINQ;-:Q0"7_>W
MKRYK*2"NDT8VP:U<4KQ(\D:,5DS7BQX/EG:XI'1,CF>MNU0'[;'TL9E*W])O
M6(%RU>VX;JMY<3D;C7$V6S5G+)MHN8\%>2%(MA@"9^ML3#H!>1$Z\:0PQ%N$
M2X>WEFX#= 3)I?:";\B><]T#N\"RKG?O *:G]H/O@#Q.PT%#1=WI-#Y4RKUT
MF=\$%5%QIY6DLPO(^\VRL! %;8PJJ&R#LE&W'@<Y@,H?Z!P82N.["+<U/?:M
MDIP5L'7,8R&9E L33JK*VTU^;D1@/@<=)3?>%-7!(]BZR/#UP@<(?]*'Y!K?
MXM'Y-)N<C_+"N5A,_5F:*YJ0LHS,"$,QBTN1^5@G-*D8,1M.86VG < /7@5M
M6OT(SNM&HFU(,+89T?H4Z8"IX>W/?3@>X[+G<!UM5?D! FY^Y7L/-BNTK"0E
M+.54*4HH^@R FN42?2G*&<WELU/ZUKN;872^BUQ[<,G>?EE,WAM_6OLAZ[))
M;12@2DS0OD:>"'(&7B3&O0CUO-&$K+%S=@^480/Y-GJ:M!=R7[0_'Q*.83J:
M+.\FJT%[OBBSIT/,&ZQL"<B<4SZD5$3JQO75E?+GYN)'<IX?+MB6'(\+1"L@
MOX]G7S"-R@CSNIJ@ ZJ67#_W 7E$KI_]M33I2\*M>7[N!0=2EUH;SY+PH084
MGGD?+0O%Y5ALR3*T**4<6.U=>'YZUOHN@NU)VS]/IIA@-K^Z158A&%7#QMI=
MJB42&!F84M'8"$[;U(D3IJ.JOU]]8 :@-FK9H.@#9'KOZ?T__W9+**_IR\4/
M%M^O#_T>RW_4__[^_M<K 5VD?R^HTH54/Z7)Q=\6PCF=7%R,Y@L' \;YZDR;
MOQY!')TO;@JN)L:?I#2]K&W(RQ]]>XES&)W/OL<[&UU\.7]HZD&+5?]V_<3?
M2V*U]'?&,<RS8QU/G3'_YW^,\O_ZSY''Q&TJ+OGBM"_22])Q<CK9(!1% &<M
M #2FB'I]-:*Y5I!(3;L;UNL?;:!R7SE!WF8Q 42V(3;G<+T736-NFI4P3V$Z
M_4;?^@><7^+IY71*LC\3+O/":\I,660:,# 0RZLPHU#RX%*G!-7^5#5;T#TV
MJ\'>%O( 34TKA?3.HK81Z9O).*W EL(U^,B9H7V=Z=HQ00&@8$X)%"X));M5
MNK>UGFN /Y(![:F6_JFQ5F!/YM_!)9\^Z^!+9!X+B2-PS<BV%5,@"V"4@CL_
MB.W< G;D-G.(&OK@U]^<6Y B2TRRSFNTM1_+6T8!!V>9W$<TF4#I3FU0AQS'
M"R0-K0'.SQ_9!O82[Z8-XC_J0^;Y_TCGDQF2\S>?7N+U-VD]\@U?G2\"2?*1
MERF] ?D]8P#G..U_Z!:%7YDSR$DRK+-"5)+*N]Z=N>?"[[F3*>S/[[F+2@9F
M:^P"[2]^S\,TN@-MXS[J&-ABN-2*?/3$1,JJEI@F.CUM8DEI)P.$;%2GWOBG
M;"GM^#W[,I1=M/!X_)X$T$?OD1E%6ZNN;<HA0TV@%IMM"9[GKH7@SY'?<R<E
M[<?ON8N$!\DR?IA/TK\_3\[I\V>O_NMRD;XJHS2:?TB?,5^>XZ1\^ Q3O"Z)
MGNV?7#Q@L<-SBJV>]%8JD6Q&%H6Z0 !R?'DE!O:D6'12V&#$V0'K'G8J4!"%
MY_6J&O/M!:X=]F! .BN06?+.F?8Q,.^U9B+4W2XHGZ#3=(@=CH<NN X]$3].
M$6:7TV\+X2]6F9TD$OX4\UEPQG(E@:E0)_0YHVB/YXYI>F)2F+#)MF:\W@)G
M^"VPN5W</@A;";^'E.%WT-:@3KZ2-#[AZ60V?X?3!> S;5!G)>@$X+0]ZU (
MI\B9Y1"\<Q[0\M9!?5=LQVXQK=32NAG^UI.??/DRG?RYN )Z.3D_A^DB1[7:
MS&?SSS#_#;[]"^<O\-WJG^3?Z=RHXVC?3>L\DXO9>_IW/T^F?\ T5\\3Z!BI
M4Y#)Y=#D%3"O,[*D4RK<!^NO*U2V]5;UBO*(3.^)J;2'=.7B9;I^NA7"]UCE
M3N[OR>7\\V0Z^F_,-]K=+FJ;FSB3!KQ-Y*$ZFPK3UE6NHUI$8:7@28(JMOF@
MP+W1#F>43\UF[C2*#:+P'A(8W^W_"P&N#X&Z^_^&!#S3WB]"30 RG1:Y9<(8
MM%7,B.2,-TBB:=UBV 777^;7EQ('VQ.OWXSU^Z"+QV"C8P$JK4^=TA","PR1
M3A3D(44O!MD [T#[R]QZ5&5#*H8&FW(&'WPJFO%<A\&H)!C8 BP!I)+)#5:E
M4Y/&(YS"N[G6B^O>NP[>F;69U,,3HX?-U48\ Y=IQ^!!1VO VJ([^,3W?/R1
M.;,MA-B__>>7EU,R) KH1I,EUME9M#)XY)&9Y!73T7'F53T=)"J3K2PNM^<.
M> C5$5E'3ZKH8;3A%A$L;X"5U5Y%6XV9!Z:%]BR49)C502<MK$:U;9A-XW3E
MH%47O9M'4^$_E4J,6T^R]A+J75_V"F,!) <4)--9*U8;!)@SQ2J3BFB?XKL?
MS6-56K15^NT-IXWP^^"NV(AL=0_8!5M?+"9;<#T2J4DC'78RC0,4,+216.60
MB^*95*K4;D_#HJINE><V*@1K<NMB].&-XR'ZDT>PC5WDWO@&X.T7'/\&TW_C
M_.,4QC-(\QN,?\FHJ&Q.#,6"*J1D1O^:GEIS)R/W!6.7VHEM:SP"$4HS34QZ
M$&-CPMO[C\+?X!LI2JP@:AMTMA212Q\-TUI;YIVG$S$5A70V9K1=!CMU7.Y(
ME-Z'<!N_WO=#_!GC]!*F%:=<%_(4<GP<=RP&<J]UT84%*2,3PH(VWB$@'&0$
M=]<\>DLX4,R-.74?LM@U1&7H?W3*,1&C)P<Y5HKN;!D6G2%J+VWJ0H#><;FC
M-X+]A=N81_=^B"\Q+=#=P!F4DU8 9R'7%F+/D447:J%Z+ERCU2F:@XS@[II'
M;PD'BKDQ7^X6BUUY+M;[%- R%6S%5DM3$KDO'H5W J%..3UL'_@QU+Z'.'M@
MNWT!YS!.^.$SXOQU_>TJXN7 CT@JLXEQ&0(9GDHLE!)9%C9QYY"<U-9QWWU8
MCC)GU$3P/=P<;\)U-<;G860]Y8ON1_4XV:(VVNM@$@>(OH=,T3:$2NE@(J\,
MX>3!2$='%A>*V0R"D_\2">,S-XH'LD2#V\0.$N^#@Z\R_J\8$F[0A:R.-="$
M2G)@/-;;6,<C@QSH^$0O1$X&7//*NJV AG<G6FGN-BM?,[$_E;Z;T\]U^N1L
M-*;S]O+B\KR>M\NGG%Q\F>+G^OI]Q5_'])D8O]5O3L:5M;C/]IP#,0W2Q=-2
M;K>:?3@HX;77+G/4LO8(AL2+)7,2M%>AZ=+L<R"\!E<:+^KE?_U@6FJY&T^G
M%=."R/S;]:^\@V_U6R>U5.OUU16S#<59;Y$YS(GII 0+M7(T\J!$"2I!:'V@
M'8[ZX,*$MZ>_GLR7T^BKB_MQ\@[J3O,&YV_+1_CS9E%;,D*D ([)6F:C(24*
M4BE\29 K,UT(6%IWW.X [Y'BQ^%L[DY90T^JZZ$[Z>[N0=O ^66N53J3Z4)J
MWSU(I=&9C.>D#/K$3[_6 34XFY])G@(]!M8Z[EI5Z34#])YQDW,!6QR_/9*Q
M33W5P<@?H>:J+^/85'HUK&9[<VWO'E.UJ?H%EDE-!:1SF,U&=.8MWO+96I!G
M45I9%&2&<M'Y[.D5EMPP 2CI@(TBE]9&>0#<X[7$H7380PKF-K"?28@=G*A5
M4+"L<[QZ%LRA:"B!H8@DPV(H(G#T98*D%8*)+K:N_FJ)_W@-]-&TW$/Q\[:7
M[0JC#,9K%2@V78R0IHB"@2 /QT#(6O%49P /N#,>OX4UUTH/E=!=,.[D.8#/
M(BG.$()B6H? @C/(BDDRFF*]A]8-38T?X<>VQ[YTW</5V=Z/LY3NF31U6'(N
MS,DLZY6B8!$+L& -+RIGKZ 3D?T0IKJ$_)=IMM#E75.T!UW8Y__O<K:D\/XX
M.<EYM")I@E'^=7P*7T9UY.J?.$VC&;XM[R[G[T>?/L_/HA5:*.!,H<9Z[VP8
MR#J^CPME('/KL=,U_EZK'Y\A#:2)N[;CGD@R!G2 &!,R&2JI6/*.18$D-*-R
M"*8@=ZT)EOI(QC0_!GX=?\6E4?P=\R?\A8RU_N2V][\,2:M#5A9]XUPP[HMG
MFDXQYBTO#("B3NW()\/6>>?&C_##I5X?TP1Z8:F \>Q\*<*K+8TVQ[N/0H]9
MR1!J"=OBO[],Z;F6<86*6O*B%>/DB=66=U_;T9'5"6&18XE6M6[J;H'[A[/=
MP97=0\)LCUQ?12WH=4+PFG&9 AVW#A@DG9DN"D'YXMSMVO;'2-7^B$8Y@$)[
MR()MS.A-TNB[E-WB=0D11(Z).2V :9$DBUX&9DN)A#^!%ZTS85VQ_7"FUHO2
M>DB4K0LKWI8'!3:[3V++JE6>R5/WF7;G4NC=H'>&^3H&3 5;AT,%BN]:#_EH
M!GXH$H)'-LK'4?:3X3)8#SQ<!G57I4'+6<:.DWL,T3$?R</0LC*K.NU82C()
M&5V$YH7I6P$]5G7Z(]G(G0O_5KKJ(9"YA6E5?=D%5$]E[!L!/1+?03O%3?J2
M^F F@49RD0 J1Q\YCF@U"\@5<TFJF@04A/[YFL)#[ 8#6\(NPN[! JISMT^>
M<%5A74(,7$O+K$F&W$"9F;=1,TE?.M0J.]><F>D@Q,-[] W4?KNV<3B=]5#N
M>*.JHP[C'7T:+X.+].TZXW+ TT5?..<F,@?&DV!%9J#(VXP^J>1CS<&TSK3U
M^T2/<#LTH'W=92-[*L;1FF>B7KE=/]TZ[7TWL3B[>KZMCQ*$#\)Y16YJI@ \
M&\VBYH)!<<*8Z*3AG5@RV\+Z(8SUL=790\YXPZ.<PNSSS^>3/];9[@X/07&2
M<5)PAFE!XQ,5\Y*>24AZE.B*A=*:TK,)\!_":A]/U3TDEV\\1&VU&F-^@6/Z
MR_S=.8QGUV<%O8_KASQ W$HH'E E)DPBKU_D2D7A) ,?HHST<MK0 __H< _X
MH]K_$S.='O+D+W$Z^@KSQ971;#Z]7.2_UH_UXEM]X0GS>UQ>><X^C[XLPUS/
M491H&4>DMUMI9-'PR)#\) C)B>!-8X/?#^F/G6X<0+L]^!H;8*VS8AV ]92+
MO!?4X^0CA]#LI$^U])"JNA^@4 JYX8XE%VLRQ0468\@LD9:+S=**YM4U ]O+
M TG+)V4NNVBC!S.Y$X(1RC6[5#2V<&?)3T!'>RW285R<I\,X6R=4H+VX=8WY
M_6B&=[H:J6S2B[Q[R#2N4T<?_H O:Z)1472R9/&*U[*%8) %%)$ISU-)+I-7
MUKH?]2Z*8]'\@?+M[XAXB;/1I_$UY9"/R6*TG@557.63#"QPDYB-A7L?"F3;
M^KW?C.3'=E<;:*>'5,)=5*M7HPNN?KW1.Y@>QQEMH;<'3>$ H0^RD:SP1:V,
ME3$Q"9CK!7!DH&J3<8Q1")UYNCVP]9D9PP.>YI"VL(NL>["!-2#,)[,5QFOO
M>NWA.)^X)I=9V:#IN2$Q,'3H@<O*I22C%JU/E@ZP'LW!.%"'=](;;170@XOY
M$N/\&M/B53 Y9O3!,2$%!54(]%)P'5A21F*DG\C0NB+O+HH?V]$X4"N]Y&%O
M(GH#%[AZ/[K@ZLG)N _38V6\#M/95A,X4."]'"[WX -3 L&+3&K:-76L)0HR
M>\+'(7@>.>>M&QZ'-80'4UG#V,$N<FY<"O+J<CIYB>/)Q6AQN+V9S*\82PLW
MAIXF,)\37T[R T.;H#8>I2F8G+NE_8U5'?>O,+QKT$8#D^;B&X3P=9%QJ<?;
M=/YM18$[@W&^.0)I?^;6'3[\< K6?9_D%I>JE[FXK+67J6@G0P 5,* JA6L7
MDS_;89U#^].N%[KQZ:^OIVKZ3 Z($@RU%$SGHIAWMC*@.:VR,&2_[?O2MF,Z
MO"?O*XXOL79UW5AJ5$? TC-"I1>4BWI4'54E>0O,6(1D>2S0O&SR7C##[U%-
M;>%N3UT+H?=!/'KEK-_S_.2B?_>3A6-.,14'R1.CUYA$ ?0W+]$P$Y7.PB?D
M[9F ]P$Z5'-<K[;3OXJ>2IM;M^=;^(.!W,#@>&'D*) _R+FAQ].9.2>XS*#)
M 6A=CM4=W>-'WKU9RIU]K1>-]1!LW<2S<CZ[(.HI[KZ+YG$B[K[TM\5,#A#^
M,&;A"5@(AH[@F.MUJ 'FDTZ,YY@JT4RB4.69FL,#<??C6<,N,N_!"I;%"[B>
M0.8P2*VB8$&!8EH1+J^-HX?S5J&S*L;67O_W"![7^]U')Y-F NV%77_5S_GB
M<D8NV6SV8>FO+/LYA4TYZ$(>N$AUD)V0+-"W6-:J!*Z35Z9UH>M60#^.]]!.
M+SV4J*ZPK&MD.H#IR5?X#L@CM\8?KJC;)G"PE'LX#KX'Y5RQB7Z)B5(WKQ*0
MQ60TG7S2:,@V"-V<Q[%_E7=M@>]9X[L(MW$*?M&EL;RHAO,5JO5YE8V-H026
M<P*F;8XL2G L0YU-!U93&-\A!7__"H] *K6_V"?-9=;PC*^H?O_IPT_O/L/T
M A)>SD>IIHSSAR^81G ^__9A<GZY.+[6[3B2GD\)8"62'Z)EJH-K$WDDT9,W
MHIT/N<O]RDZ+/E=]]R?9>U_FIK/V5IO6I%QM8U?3V%8_^W5<)O1XBW*5_>?G
M[;5.@YEXAS_?K;L9*3*&K"TFCMHF[8/&**4&C'1(H3S;;\DFY_%[_%)[[VH%
MT-4"URG6+-!KB!2'NN28UD61B<O,C.3&4Z!A9&I=AM4%5Z/KFME)G,VGY(>?
M!0^6<Q$9O6N>Z2SI[(T.R(E33EOMH^6M&ZQO8WBTW:R=!=QS0;.?F'L(66]<
M&)W6QE*"],_1_//IY6P^N<#IJS]7W:@GLQF]@KC@8S2A:%\)9#SXVH^=D7GN
M"^,B*PJ_*5QO/F%V#YB/D=LX1+?WW^3UHI@^AK=]J2/;%V_-FC+V2A2>QQ!\
M)2:.BXNIY!F4*%AQ*4/UY(UI?>>[!<X1;BRMA-\X^%E05;^;3LJH-KE/RJL_
M:WWF#::2!>'P$O-9-%B4D889TB73*FH67$@L19&3,,9GG3MXS+NL.;PE-%/4
M9  I-[:&T\F4[)\B_BLAK)"2MW\#(CW#6?9<!2,T@P3DX]M4]\X@F=?.(/="
M0>(=;*'[BL=A"3U)N(>\9VT9GM5GQMG;\:L_*]3+T>QSW27?EEK(=U9K];@R
MP-"JFOUQA?FL D5]2A2%08%SC<^,!T$]?ROI1_X]-,NMV4U6!GSF9/&E-G6$
M8NEADT@L0"PL6 >&YVJNK=W.6Q".1_F'R+:'EH7KIUO[NZ/Q93VVEH]?KX06
MLP>6OT>N+L[(8J= ZX_&,/VV<)_N&8^D8PP.T3'.8VT,M^1>F=HN!C* BUJJ
MTKJ+KL?'.283?!HZ[V$^X4O\,JVIRX5BQOGDHOK\_[W\<BTZ$2!8B73<>DN;
MJ_:) 8;,,E@PQHAH?>O;G@ZPCC P:JV,'ERA+1#/C/>9UZ0!^OJ*18(6G*&=
M660+F9=4FA<@;H'S&"T=C=77W3QVDGT/^915HV(=:9C^ZW(T18KP\F6JU#LU
MZS._WH>+H/< 4V8:L8XMX\B 6\)M'(J8Z?6!UMF5SN".<$OI1S$]N- / JU#
MJ#F(DIFUBI,8 $D@,K&2ZD5J)F]0MZZP?Q#4\!;3DT)W-9N=M-$X-;/*-R_8
MO3!7E^P#3K^.$L[>X301;/B$9X#D1F6@'1!JIYOF=:B.(3=+.@Q.>E7<K0%&
M&Y,R7=8ZHFVC%_'V$(61.2;$O/#'7^.G6G@QGR];+V9G*;D@$P_,837-4 3S
M.D7Z@PL#01=,K:L7M^$Y(O-H+OX>(II:9SNF7_GV^M>?W[['&=DN+@>TG7Z&
M*9EN,,+:+ )3 )H>/!L&5@&34A3RE:Q/IK6;^A"F(S21IFIH. U]C6\Y?^0W
MG'^>Y&NBOO<(YZ/_OJ8 ?SM^.9I]F<S@_ Q2R5&@92(X7HNY,@7J)!N,%F-&
M45(,C<UF5XQ':$:]JJF'0>DW=\8/4"O'-S_![,S)J%6TF958F_*+\BP*91E/
M18B@:=^,S=W9KN".T)#Z4<Q="_*'6M!B\L BQ?AI,> EI>DEG!/\KZ-:IGQF
MM4W<TVY9<AV)H2&1YZ4<0P0C#"97L'6QTP.0CM!:6BKAKHV$9C[./Z>C.;Z<
M_#$^"[F2OQC/9($Z>9;7JW)3+TATE H4!62MG=Z[*([0$@X4]8;0]W!VM=59
M]\MT<OGES61.7Z?EG03FJRN):L'U>'P[O@:>LI>%>\VB-)+.QE 8"$4QNPCH
MBO?6M.=@VQ/K$5K2(&K;8&\')W>OO:SEP;FN<C[S-F,(P;)4DTOD:PD6T<&"
MS]#1_Y56K8^B^[ <H;TT$?L&>SCX#NBWT7A"QOEM?8?Y]H\Q3BMY]G5^Z,6W
M[Z\[E[]R)JVT1DM@V4?:+Q4F<LZS8]P4'S!++IH7:N\-]@@M:AC%;3"Y@V\'
M?IE,\A^C\_-?+[[ :%JE5-^,,Z6$=!8UX[*>OX63&R9%9$@222BEDEFUWH V
M(CE"8VD@\@V6<'#F=W']<(UIF4R:G45>O*NU7Q3]TY.B%LRCP=J(*53.R2AH
M7:.P&<D16D(#D6^PA(,3O=?GX[KKX"-.%^R'-4+CB,@U!6=%54RFUM6HZK-G
MR-ES$2SV49%Y+Z CM(MV"MA@'GLG>!=%YM=YP:L10#>Q14PVU*(KF6H5AB/[
M#38ARP$$4$#G3;AE')NK][<O<T0J;RW4#0H_./6Z.6=S"M/I-_K6/^#\<G4!
M\>LX31%F^!*7_ST#U,$[J$5WAMSH5 +SJ3H[R>:@G.&J^;CVO<$>D5$-J[@-
M)G=XKI9$_VDAB>L+T'6=LO&)@S&NO@F&7.;:]!VX95FJ$E3**4+S/.W]<([1
M;!H)?X-A')R@?8^5V3G-+Z?TY&N'*;C$=32<J44>1VC:($/QC%L#UJ+$J%JW
M8V_"<82F<+"X-U3*'IRF7=XO?<!$J"JO[<]?WXS69^B9U<I&<I-94KGVVYK"
MP(G$*O=W]@0/?>LRR&UXCM FFHE_@VT<3J=T/1#D?CF\^+;ZX9)63&!PW''-
M($IRJ*6PS!NGF8C<&>NT2+EU4]$>,(?B%^[=?OI6T5-A&-Y.:Y4-"H3 6<HZ
M,LU#9IYSQQ1]VVIO,/'6^]039P+LR1IVX@'<12N]D\%U ?.C\@#NI*BMK'#[
M2+EWU5.XKY/5B640=(RBA<H:$NL?145E(23__%1^$ ]@.XWO(MS&%?:_?_B>
MX>Q[6CL@5SIRG5GTNDZH28F"JZ1KF!53MK5"JDMI_=9%'IL=;B?A3_J07&-"
MP'=3G*7IZ$L5XD=,G\>3\\FG:[JZ[W$B'5'!!,&0:T)G@F$0(#(K9)W 02AS
M%PWOLN9S57AO<FW\2O^&>6&/E]-/B_]N!BAEM-*9R 0: N@L&6A)BJ403>"2
M1 1=B" [+?9<-=Y>D@W[=!]@)+6>=)6]J+5#F;8=41E);6:"!RE,*<6;U$&_
M3Y?%=5^E-I)9P\;(V71^=DIF-3D?Y06N14B[XAJF4X0V#A9CI</) ,P#/2ED
M[8/7'I7M=-E-2]QPN>BK:W?K_M6//0)K)/>&[_1F1%?\X ]CVB7ZVMDF'B/X
M:J6CK2H_0, -S^ZMV$ 4F9,+S,7:A9D5H92*C-Q*%2@*R4YV*OI^4DJ_)_P:
M4N>[R+5/=LIU9+GV*2*JK)$S6PKY%-Q(%F2A@TG7,ZY(;6Y[9^V8*;^',MPQ
MWTY/][%0'B#D'EANKUCQWM1[S9M^B!!2>)L+"UDJ J8X\RH)9C6/06&6,;<N
M<;L7S!'HOXV@>WC[OR^'&.'LQ;<W,+^<DN=SLTJB;GP 3O&B%<-DZ?FY*,R+
M"$RJ!"IP3R%(:\*P[NB.W5'L65\]<*S<*K19HER_2AV@]93%WP+K<7+Z?6ET
M>]W3P>KH?2_Z'B)"]JY23O&@:_$5*!9IQV3264A!"Z%TZX;XP2WE@:N )V H
MNVBA<4KQ#?[QK\GTWV^_C":C2NK^X7*:%K4WJW,T10%@@J9GA%@YR3P+5@?R
MTJ63Z)T*JDL6^8%EAL\X-5/'I!]9-KXY>+/*BMW,=!-.\IRN*_!6*+G#D%'7
MUD3MF18^,4)JR)4FD61C,$?=1>.=5SP2Y?<CX1[.@^]Z6$_/838;E5%:,A+6
M72ZF%)1(FIDD:B>(J?2&.C-I01CAE>+->; ?@/2C>*$M-=,#8=<6>*N7IPO
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MG8KF'SC_=P9VZ![ZV^0K+LOXKI<^/Y_\4<EO9@3B/<YP^A5G[R?GYS]/IG_
M-)_)6*PL/#),HN;::JZETJ,6BMO(&]"9Q]8T)'O ''9/[M>B;N_5?6NMA\-Z
M.] 5=_29T"7$&#T+3@6F%1<L&AV95!BYB5+33QN;5B=@PR=?>E?QI&_]]'!'
MMAWDZ6**8_XX.9W,%C7*?WZA0 ?/#""/V95*DDF@T9'#:G,FT#HJE!R@^4W[
M7D!_="-KH;\>[N0[@GX[_XS3]89_1CXS<F,D\S$29HJ)"7TA3[R *]GGD&]S
MX0YE<]_A_,OD#M9>#\/#MV-^B?ER25)TE@,();FBP,R&52HF)Z@XE9:0O'+#
M6MDUMA_=LO;44@_S0+N=[,JA#")&5I+*3 =OF*>XCH')3EHG"6KK!,H>GM=N
MUW4?7IVN;S6$Y&'#>G!C*[B<3FNGU$7= LZ"#-S&.F5$IE(S()Q!\(DEI8PH
M4FOZ?H?KO/T1'&/X,J!.&E\,=)7/\EHL%T0KO6<E9U^'4U?>+V&9JEZSU)Y>
MITZCF1LE"P9I%QO.BOK5QV-WBW7;'"L-RK(H3H 6-EIF,"U2\)(%;BSSVFD>
ME."*MR9SZ(9LZ&OLGJUBI[-_+^T,'BZOZSHZ8.RIR+@+OL>I/>Y#O[NYC_LK
MY[$,B5O!N8': ^QM+<'CS!=?SVCKT&&1Q;=N:WD\ WJ@DOFIV,\N.NG!;JZ@
M4;QU.L4\FK^>7/&N8^%('EMD2M6Q:H&\@."<99"CH^?FT8?6;?;;\ P?L+;7
MX&V2EU;B;UPQO4RV7#WT^M(9<BF&2U9"J.S^Y OZ0%$Y1U.+>S5/\-#=[+T?
M?D3*;2/ QC7077,A_YR.YG,<ORUE/4TC8^:B(,/*LZA1&1:5)7OT24<N;$A.
M=5#ZONL?F5T,HH;&-=5=,2\WL#NYVO4#1,>-"8(IJ.S=+I#$5"HLZ^*\]$(X
MT:6\O@F8']2HVBGHWI3ZGB5%=UR%A6P1\\7?7M5BEMF(XL%7X\N+U1B_UZ/9
MO$-IT [N2%UP=NV/U*5WJ_=I\ A7=3LM>19;.VA;*!1WAWHO:=4;; U\ZU*/
M3!1XGWO813P]! 6O1Q!'YR2!Z_QN/\:T9:%#'V$R_O01IQ<O,5;!K7C/7B/,
M\&T\7W$(KQ=M_50[K3VXZ3VLW=MFN)<P=ZTZ77V[_A'I@__?_^?_!U!+ P04
M    " #/C:A6,-T];/$J  !T+   $P   &UC:RTR,#(S,#,S,5]G,2YJ<&>=
MNG=8$\W[Z+WTWJ37*%4IHB""M"@^@H" ($40"(I($Q"1(H1$NM0(""@J$1%1
M*0'I-704Z2U2I",=$NI"VHG/^9W?>][O]?[QGC/9:Z_,[.[,W/?<Y3.;4']1
M9P%>$T-C0X".C@Z8HGT ZB1P%6"@I_][T HC[6!B96)B9&1B9V%A9N5DY^3D
M8.?@X.(^P<O%S<?-P<$KQ,O'+R H*,C)(RPB)"!R0D!0X&\G= RT9QB9V)B8
MV 2X.+@$_H\+M1G@8P7TZ5XQT$D#]'QT#'QTU'8  @!T3'3_%N"_"AT];8[,
M+*QL[!RT&RIY 7HZ!@9Z1H:_LZ9=#:==!QCYF$Z<.G^%F=_R+HNTOX!:1&HN
MJXQ!68N@U2!>5OW>XT@V=B%A$5$Q.7F%TV<4+VA<U-2ZI'WUGVN&1M>-36Y9
MV]C:W;9W<+WO]L#=P],KX$E@4'#(T]"HZ)C8N.?Q"6GI+S,RLUZ]SOZ0]S'_
M4\'G+U^_E5=45E77U-:UMK5W='9]_]$]-#PR.H;[-3XQ-[^PN/1G>65UC;"S
MN[=_< @>'?^5BPY@H/M?Y?]3+CZ:7/2,C R,+'_EHJ,/_GL#'R/3J?/,)ZY8
MLMSUYY=6BV 5,$C-+6MADU&WP@O>>SS(+B1[84Z.\%>T?R7[_R=8Y/^59/\M
MV/\CUP3 R4!'6SP&/@ *D,7!%@+,!%2=?8/F7S\WU>_*&"\N]S467M8\FSHS
MW02G G%9\(M4X+UA(Q5 R%"!^?6O5"#R&17X4;4.V=_WH0)Y3(B;H79C2Y?<
M.-V$M>NG0/BZ9ONL/_L[)8>N-60D%9A]C^8F^<SWRERN+AO=/*NA]+(RP?NS
MI:MM0(SR5;S:Y5681<K335B4D.;0:O78X:/SQK.I;H8LC&IO(WE&[#8+6OHE
MKQ&4YM!QND8<<9IC_C\4*EZUH8@K8G]Z=WZYU+J9/@A<?%I\ WE!"7Y] \3D
MZ)]%3.8P@3H+B1B.M<RZ=UNY7L^'&E]>'_SBQBDL%Z<ELXL)&].X?L%,<?=F
MK=_9B3&A;$.]C"L*>X)@/$&G\Q;\,A@S#^&[,?G&LC'-'Q>C'!2QF61[R9!>
M:R+M ,U^L5_]S-+>_!?X#3+W?ZO'_+_5,XY@0 Q*29'?[VW:'K8=5(^5K0Y]
MM$H<L9$ME77E#)G%+:@@XJA RUDJL&A):*$"!9-(,EWA:,_.6WUASK7AQG[Q
M,WUEMWNL/48K7Q^0G[IWS$S<:88PV?TD2%6@)Y3KL\PJI'Q^<G>Y$-\?EP$X
M':(S/,PO LIYOVZX&\WK=</G";[ME$A4G0%T'%*BM&-J.Z9:2;9:MAPI^=2$
MK0V0Q?'7N@?I&2N0",Y!]B_)_F$.*8-Z-Q:TCY,:,P2?(HQ6A,JH -/E@=P:
MMV&X*#* 5==8;\C0@L3(0%HS$Z:PA\]-QH]J6+"L7?1W_Y,Y/2?7O#\9@>YK
MN@+>(9XC&8$=7M5-$GABU:L[?@<QBXF,+.2A+A4J0,=<[R= :<:*Z*H75$YX
M'(0.G9P:7 V^9PP<&++?)IZ6;ZR=??S5;[S;X1BM9W&^STO54Z2JD6<(&0T5
M(ZD2VBYGV>$;>X8GKRIDJ/4S& [JTTT\/F?.@T]WQ':A)A+;(.6_#S)\YCGT
M#/Z8&6JFJ99V%@%6='VW0\=0&[WXSW!)4"?70^W:TAKSJ8"P+OG@HU>03P84
MP1T+DB 'Q=""$8DK[J)$5^[>=M20,-3\A8F[M7[^58.AL.K!]L+ ?C*4PGX-
MOWRSJ:H298+[)_U[V1D/&0;960AVS7L-=.,W2%,UO-FVXHU'MRY0%'UD*$WS
M5&"@ ['@Y"V$@. 7O!QBVH.J;*LH#X>O/_K\M586Y^SW+#_JD;7MLKS1:]LN
MP\<E!VH(>;C) (4_Q/"P'7&REG@1[57;N@!/"I7FWK"X M.B FT_F\21 PK.
M7>2P+BK0@?L.K2S8E LF[';V9/K)86,NC)TIF"B3Z;G4\J[K\-4CEKM=)?#$
MEB:>,=WP>5,5%H-O:53@5D/ZSP39XQWC#6!98:CQAKSIM9L'KXHABR%@WTF,
MLE%Y2S%4?5]X#K6)G;-(S%$MQV_'P?4P4S..$ID>,GSM487U?G-&H7NH%(CD
M!>BS)O&JL?WUL/HW=^([ZHJSF7W:^:=2M(H@X^B#@"&D^PRSD:>(*9;7Z7.X
MD>5D#XK<L7>M#]@>P:4C6TRQB\DK5.! P()F_\TQRGKPAYY6S@ON0^9-JCS/
M,D)[ ]+^BHP0AQQ%K\^ /! J(&Q$TJV?PY+I [>)A+]UV&M'W+5/I$L$VW)7
MP<VX. W32>-8UYSI/B/#%IE3S_89$8+[0S_.W;3+1*O/Y[5?BMY+1G\G\__K
MMYK_N]^N0/%6V[%48(\-A\5+02EGL7K8.2MPDA*CXDT% #G:+1Y4(,9TP>]8
MH!)# K*H0'P1%?BF1@7^D,R@U>K0)1+/6/\S;(5='-;##&I3CR<7[Q>%/BP4
M^+ O:*S,QG@7E1_:"(=1 48<OJ1\#LD5,J@1?G;7]"GFI,?8%O/S4M;F6;ZA
MQK:#?' *3:\OZ+SNSY1N6^/O7M#^6^P!8Z31AV>]X+VFJWRQ"1UU A=7POOX
M156_*)O+&/F8S22@(;I<^ >C]PGFC7YN_M);"1T\KP-4ZSJQ%Z$36E(?[7J=
MI6EQ.R?$>6PNW1"?F?_Y'QY^QQLOW"D,NW;+,_&Z9E]#NASKQS0*QRLE359[
MTOIUA.Y9^+V7!/8*]87PT.<-/D]\2-#<-;&1A:^W)W4_A@>AEF%V1C)MEG$7
MI>V0$00-,%'8.2]%U#Y\@Y@- 155XEXU!4?X-GQ[>B:T%@)NABI$(6<_4 $.
MTA791VLS$\X2&36J@;[WXY&SQNE4( 77C(.6*W2$W;[Q#0[%):28_Y1W/:(C
M*\7@=-4+P0=SQ?M_E?4NY/SOYL&+B&A;E.+/0D^S]<6>L<#LFV,?AGLAU<X\
M8,0<YKG#TT;\6.W=XDG_VHT2(;/H/4ZZ;K1KE!,7/("F_$&\YQ!":!UQ*DT/
M\Q7V*N_>I9V%FUH'/R'=]>A)V$%T#2B#/] Q$W)#M4\,>JC<7_-98%C.DLI[
MIM=?"0^\ 2'>:;,*'NOZ;47SP#)EIT"?LT$S0DC/[3@TL^A[ G.]N)?+?<_,
MJWVU).OP&9!/%).C@0'/T QN<TOT0C^+E_#-Y7C?LU9J1L3WD&58#@YWJ/UN
MXS K_6=PL+JH7/8#Y:WVQ33C1;)W<"N2"VZ_T"G3UB0QJE%<P#EFBU$L";\N
M HG'8 I2YSQ:3!HP((3'[KE_3?S.W(+;8?F6N 6H*)\]3!<PZUV9F.NQ?3,5
M],%8X.U( C)S%@E26H$</V>X^J8@FQR/[_435VL0"H)'Z^%$#9+U<*Y:_RQ7
MB*%Z6J8Y>*@EJ5_9XI6M0HE[Y+,O+I[(-O+"M28^M68S\DQ#@6H)-E )*B_W
M[L\3L4#7@FSH8Y+F?+%XI[:7E[90H7OA+RB'OZMV+Z1$\XR,+JJO$OL.ODQD
M &5!Z$'@X)]4W=K]^*61F:E+['$4\@>[,K@%&)\/5\*;?YGWN6>6&71>>();
MS%!74;56"Y(,UW/0K?PM%KKNNJ<MD@*_X#TZ;)JEZ[K0R#!'2;Q8.*_G@+L^
MO "Y@+-B8OG%710>:XS):G"GY2]%O%2BOZP8-^H+&'VF"QWA)QXJ^'N7;Y^^
MZ00X3JAO1TKJ.NF7ESA=JN9L[6NY_=PG[T?KU^,%4=<?)<S3TW>^9(J'Y'C>
MV>H2VW+= #!EK8L7\IAT34= 1_<3MF^/SGW]3MR!@HH:F01L<Y:.SF;33>2>
MV+Y%' 1_$Q(KI547^].JM@9?O!A]6OL#';/QZI^H9WJ3'IA>LZMSL*2*=[JP
M:=#N=N4W&:A'9J>-14D03F581@)G_<U1\#XYAW)C+B7\E65:H(:S!WFYLB&2
M,GY69<EX]@6SL8Q+=_/>R911/80=H@M=&9N'3VP?TY<@<&U4ZW,TOC#XYV/U
M+\D4QD1*)V(GI3T5]J6T)XOW8UEIR!2S[:T75U:\YPF_SLQ^?6SJ&[<BZNMJ
M<2Z_7W)LA8!*H0*5[C%(]TUOL^% HHKAG[ 53D+E2Z_FTSX%E^[V>?<@YY:P
M7-@5/@QRYCD5 .L(,^"90])+"U;DK_.TJ.F)23S?$:X/>WFW3,MC]$M8^:*Z
M\JYP3$=?\L6B!M2X!0T8*ZJCL1ZG-2Q H^3>RK&WZ\OVTY^-@\X=.5U64'IA
MY'Q^2VGLV&Z^:^.0$+D]BVHGJ[;?5']S;OK:GJ*Y7/4]!L[0)&:I-:4#V)6Q
M(I)1WOA:)K]*;\:BT@6UW.]N=U]<"['_!-M7;-IN[<_[40[=9'>F IW5E[83
M(?Q/^J/U69L(AABN]@.AL.#\K[$OMDYRTAL5PS>P_Q'TZS&3A12SZO:9V\@]
M%\P/]KUO;ZMBU1+?.2?ME!=-\D=@Q)X$>9!;0#L"Q!RLGM53[0B]<:NM8.W4
MQ.DM >6HATEQ)_E_\R#V[-X@VK [WA16*E!B!SFV41'<M9G],OI2Z$?Y>FFE
MG&VT@LJ$H29)@(,VF#T5P!3ZD464=B*Q=G]I&;;C4]=/#K^#7.DFH7TS#M]"
M*6MDB]Z0-V1"Z DSALE2>]X\EW.<YQZ%0KJQ1K0GLI%\5*!:7\H;P5N3KBFF
M\CU'4 $M[9BCGU)\E'#$O[#<1@4V("SP<P3E\QE58WL7C$4X>;3E3U)T3,:Z
M-C0)_!3!PTVV/.6AIT':0Q<S]$/=OI]'$\'/^M$XP[LB"X^L7@;#<G]DC&3"
M4)&9_?OZ2^3Z)AD(0*(;/1EKEE6W^"6_+>6]ELHI$M\=@C16H7@N;?Y^K*RG
M;$",C:C"+_9C*D!A-R- *"=4X[.A,2J+O25QWLLF[PG+/Z/Z7:.M21,-;PY,
MP3 JP+;<P>:6*2.7F?AI:NV6Q'TWUU-T5"#B&V$UNTTIH64VO*)N[8F[AEQ*
MCUZ2MD=(_1E;Q39&"3Y8[@S>%'LDT.!/!6!55."8P6ZYN)\4;D8%G,2/LLGL
MM,SG1 6^YR^@CLG5-"X3J^I[AU<Y%L$?5]T57'LZ0Q)8<,A>F ^.O?"M=]%A
MM5C+>?+CBTC_O2M'N!X(&UQ&&-6D -YIJ^:TG;0<.15YCYLGT]$/.,Y@@5C"
M[M!8WD)77%=?!I^5<$+-YU-U6JN]#K/M=!2!<R8#[CT[(^ 4(M,QH?E<.<-Y
M^T9]RI;&O<OW4L0]9<HZH?PVF<3Q4.O#<N*/WO"I/O,2',R?B,I;.7#@SO(N
M6#T8'!^?-)1.8+56_!#Q#)#\>N@UV\0/]\)C.E6Y)KV:("-S[Q8O#XW71^AR
MI=@,7V*$M-9+FMXN&RQ:K,<V1G9/G,_,?DI_^C@=]M:</VGJ0274-M_JY?M\
MYB*G?4P_+7X)DY)R:#:*\4:1V;SWI$73Y@72-.WYFMW<+C%*1=LM=_V_X7C]
M_H3KW5W=&U3 D3%[1_\L_@?'O)E<?&MBC;%"$GP=9HN8A%;>)2SF->L+UE&!
M!$0/TXBJM*^J',,6 Q70'4D)MQAJNBQY14!3XUC2445[]*ZM%ZE@:<0_X[3E
M.Q%HXN,_R7G38)QUY?"327M5OZV/M]]7QP2KEVD![&1[<BH5<"M4?481<;IJ
M?7U;UQ7Q[/<474;UK>^QZBLZ.<N3] WN%+9J_'I+<*ASWGQG'<J*\/)$!?/8
M9?6[?,2B]_NJ_7UZYW\M;[.#4^OG7_[!#PRJD/H;YT@EO)$=UJ.-#9%-5VB&
M0@.['Q*#-(<YC3[FL,/M[["0!-HHU_^@J,#=?VBVX]#PL)R\@_ZR[0[9T@CG
MZ5DC(\B)5<@V-5!<)^# 7IL*X)XJ[3!7/B39EW@>K/IY%ZT)E1JU=G"-)!3V
M/0)T'ULLPY"O9]U2"D0Z;<N.4FQ>&9W]HIB&TNC_C?Q]7"R*&O7&UX +[>B]
M<UY84%R5"@@:TSRC*QZZXC(*Q5^$412;@LE.7Z@ %,JPAAW+1NZN$Z"!PI+/
MNBKA-"1FNI&S](2&&^>^W/48FM'->=/:4DYHTPM7)RHZ]883=4#NL-<?:W+,
M-$07,Q+5)7*,==/M9RJ#F]U (K[;27%\2-*WTZ)R=1CZ>Q<XF2?5$B$S&371
MH"NQ$-W9T7^?%FT@UU(*E'UA<F;>LN@UA"[:BZQ'CJ6<@^OX13M 8S=5'U;X
M\4Z<,5TWS;S],<>L_?45*/PBDOM=X:Y?QS376 -#R93',>6=_NO/S9,.XM&*
M%GI7MKBU$[IL[[NLF91>HKGSEM*>A*^0:(R@H&H-J8TA*<?.J;=SV\=B^M5B
MBINMH:VM*&?!R3&C!%WAW)!)LS"N8..*41\)EXY 7O_^3Z$(01 WBT6A>2F0
M'Z(#)*<O$])2)SU[4B5"\^[S[0ON';9:@&=L*^_Z^[D16(SC;E7<$ZPTTX#7
MIH]F0^MF\)*-/,Q-!DW&";G;MX))_75M!&X>OBU;E.IB^-RL!?W*#!=)W7N.
M3#^\X>#T)4! )]%GJ@.E\#L9 4>VF"G4^B5,2Z1<OE;G&=VQBCZW!>W&&C0(
M+_@(ST/BE/=_TU-4C&[4.1%Z^4@MDL^WN$*,-LN(6D[P1WBWJOQ<16Q\Q<U^
M1MF%S?-\F8EZ;YX98277$U5*2L$.[2Z$SY7Y1]Q: 3MODA:3<.N8C7I"XEQ_
MO+[HBC8L3H-#4GMM:$BK8&C1+<%CD9WA1,'V_<4MR0!86EUG,G*.;!C&9=[G
MHW_ /"G7V"H0>'+O9 *&<^A.][=_-B42'I=$1^JU8.JZ7/)>79%3NDU:/MNC
MD&GCT[J\?=WM(5^48U=*DT@(;-XV\T!*=E!Y_[:(C]03ESIB82 D!O%/B,)!
M%O@&?_ /I8N >)^J8!KV6A?$"CRZ%FZ#=Z>PW\0)9Q[[M8<KGN;[;EGDZ1+C
M/)XF;2&UAIR5;C*H,DUL(^[]WIP,V'IT=, AZ!5H@YEQW8)R@4%=K:%<L<F?
MKAZ$ZW<*1K)^,Q^Q? 95!&D]!A!.W%[$5T>J+"E)/#]^-^5"GA6_;R_U^@2D
MV>YWJ%2MZ[S>V4FK8=^\QK+:*[+JK9,9(RFL&D=^--?@'G$@'J0VQB3R>7Z:
M:*VO<XE-1SVL)7LK9Z,K.DL0L>/[,/=G7CE]WX_0J["O-+[OW^CZ2#J-/_L:
MXS5VWA%LLXKP=<^VX?01C+65[3>@$W^^%C"!5:<(KYY?GSG1<*;@1FYNW:C/
MO=0[SZR[<^/FU6$U+]I+6Y_GL7\%!#?]F:4?)9WN&%=?!MW9V-/>/2V<O"L;
M>XDO[XFMH8BB$:/=<O4FF:BVBA H3YR'Q"H/=4X;9TJ:]S%-BCR8D[.1O#2[
MD'(-$8O+H(QD7] ^W-@ET$\'3I6M' I?1E:>$+6F>"C]42/=P(//NU7-"WX]
M>&42\E9Y)/.+!X*V2=4F/R8_I\B8$?AGI1(.'XOZ5;1.P'NZE/\)8;48]3^R
M6_1!)-(RF>K61R0 MM*/)VM<<).*;J^E&#3UZW\JB%E>>XW7U;2U)C2\$]/=
MIK"'4P$YX5;( 2>2+#9*\"K48;II_VKV].);/"!X@"()$"DF"M'0#1%:-KZ
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MX!S!R3?9FMHAUB4&?$VH 9X /":=U;S5XI8QC69XDJJG@G,^F4>#C*8PKLP
M)!ZAN$_\ 4_/G)B!G6MS-$WBWV"YK&/WDZ;FF^@8)!_E))AN/'(!RN/DK2\V
MK,)*6Q/RQ@=;OU>OXOI"&#)8(F#!EETW[/IN=EKGP=9Y[)^B;9[_7+5K"[<)
M*]N!,FTK^SZ9C(O<FO"V7]!QOI1WNMOHYA5)+S%R/T&8QG(+C QW!I[\MF,
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M*4XK.N"@=<#9GJ<:1TEYW\U40[^.-'#J>/,B-O#E=0BGD-< [EC^*4Z2Y]C
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MKH8-:$>S >1/-A!CBYZCHW]+H]<_-W4Q_8BX#?8?I^IC T\,A9FG25.;V]E
M]R\VL'*3#6PO80.]G)J^#L;QR*'-7S .:RUJG+Z:HBQ,@9<Y?-+1K3X<7=30
M8(R/G#$!?XL.&>=XPAQ:!SV.'YN87O_>-6*]H27F<F\L*LA6)#I-=W^/^^WJ
M!*O^G'73Q6^*::25)KG7D1VFJ;XS]?4!C3^&"ZHJG,[&'<3Q;%[Y7[==_B/
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M@^X=4(E&YW%:=N%<\+-/ 303A[#\<H?.WZUG3?*;+IYCSK@;GJ);(_7!%KH
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MI@B[6];&[M?W>"HZ=9Z3=8"7H,:Q-0%8NG)3/ '/R^IC&8 U5.[V4D?'GR@
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MXQDA..\FE<8LB'1\;#&^JK)GXO;C9O6$0)T@;65O&GP?1*5'U0Q@GGU3AXN
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M=\,=XEOX+?P6?@N_A?]/P2/[Z<ZL*2G\3J0?G*[&^N@L:!&#E=5[KF^/"!"
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M2!&*<M;Q#.)Z+..RS<Q)1"6:WQ/F\_[9M\<-+M_PFL$OJ>E4# B#4BPA<6Q
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M[4YL9LIF[S*M\8:-(-3OBAUI-9*(3,\\GD-67DIW_WU72R"VF>0>W7ZFTS?
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M*X+GJZ[(*2DO^="TWEKG%-0YO$1[9EL0?R=-F^\ZOKW+Z(!5(MKM:T\#8]0
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MY_%J <<^BS]Y+"#VL#AT2PMX"DQZ@3I_'D'EH,074MZZ(S(6)G=MUS*:'D#
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M@N^]!2!:,W4:R%6E_<DY2!ZC=(L4V(ZDZF\,G88U!\Z2(69 R[R(MG\^R^C
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M0>TA,L\>;/?4&QU^"5>3_^#U\<LN;[7HWI[U2R:HS0;%DO/98/(<@]T>3;8
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MCEDYZ+L9?9$[>S2/W68LE,3!X$10%5&"9".@D-"K9 XDD_<;\#LBJ03'W9%
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M9MV_;/V\$B/D@2LM7J\E?Z5\[7&J!N#238HUFV8*^$:Q8/5KY[6N<JK/;W6
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MC-5Z?/TC85_G(8XJ,UBFU9PH:\(U@2N =/)<"UJR20)UN8Z$?8)2)\1@H@:
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MD\N^1&%?48W%_9_O,]AH1X<JJ0C!)2;H8,/9@_GN2NGP?#W\E&O-$R:H(?'
M=-[T\1%T'+B\OP4Q"3:J^-ZD0M,M([/GQO8JO+6.)78_%)'/%362]AU]K$FU
M[S'YQ=X;-^QO,/?0Z.W%K':+Y,VX.1H_@L(7W/LSCA2^85R#V$7D(@MO/XOZ
M'OKNT\948Q"NG E:32 1*=XC@1+09LG39,?!9:LE[HF56>DTRB%+FY<NMLJ?
M-V,7W[WC,?O0X$ZT7JTEJQ,0\3_)_>$0EC.4!.1-$,>]LN$\AU,N)#D@^(QP
MP769P:K=3%";8MALFKHN*[X,?^5X/69PSAYPSG-XL'70%!\US 7:NQZ]H,N-
M1!/F(E$<!U^1JPGLF!?;6YEZNMB\)1/78PDINQQ).8^O$F5JL9+#E2P'=ZXJ
MYM.TBBX(.%T\P?EVLCB^.'_JQMWNR>-?U38ZE>.5,X?W;;D*;B+^+'T!9P]&
M=6*I((^ZK]BY5]> /'<.B2^V0S)+HXW5!)[X;=P^U,5Z\AJNK='>H:F\(MZ-
M-/NT4'6Z[]O[[!AI#KF:S DN#[;<#TW>K.@]$6X'GR*"Q^>(HS$8G.I86Q72
M,/]HXMLG6R41>'?:,65*,%!)I*OCPV+ T15K_E8)V:5EH[330=Z-R6)7N<N.
MP9)M?C?[7I9<T/?-8@V'!SH<!GIU\Q51J3U.O2V_L/L4O#_?R-+=@Y(*>GRY
M<[O/=[2T C8%H5PC'QW("1MJVI\PM=X^*U]A""$)O51?NBR257T/5ZY?W5S8
MTS^):*_:TTT7!Z\67SM#K2GYHJ5?)JL@E?EK'_N5F<<7(7(!D&-(_PZ?'C0^
M[LJZ0J*;OO(UJ9<@I.+CC)S8X_?B0]+(<]&PBL6UDU2H83:02DD&,OP)CG:=
M;5^?_"BMKHR?<=APM?'.CC_O]S_8>^^PIMHM?3B*BHB(]"I1BH"(L5 4(;&\
M@(@8B@*"$)4.(B(@ 4*"($6J@("B$*6(B!"1IK0 H0B(2&]*FHCT!"%N2?LV
MY\SU_6;..W.FG&_F=^9\[Q_/=85LGNRUU[/6O>ZU][/7.J%=$^![.?U.<L"Y
MX2I?A8^\KD&UJ-ZX#OW,T<]%Y81NC 6C!$9'35H]\:(]G7^I^ME#DI794U8>
M5EH=&OX3@KZ71'VH,72W*#:;J/+F@:/=@&WZC%I8T&?V $^(3.L=DT$!K%I8
M.TJ^3:G&UU\>[6$QZ,L:=7:2X-B(7WA?M,'%]]G#1.FC#MR3P[HY*J1QI_9W
MA-GJ83W;5+D;!)BZ?5XTI-/C]FX-@6)U*0YEX\GWNFO&8&RO!GIHA'$VM::-
M$(NH\6O50DARX(RDV!BU?IO6>[Y>TKEWEK)/ZP[Z**8E#5=_K>\_M'OG>;F:
M\. M#'>;EF.(P=="GND/\&W6=F<7N\,#'50SLO ]3*24NZ'QHU>VAUGIWIH8
M';K' 8+O_LG2:L)SLC$ZED5C\B$=OC>FJ2/S HPOF$N&X@]UH7&URPTUL8'M
MW\\V"GQYRYMW>7NU(< YBZW+$03N,"+)=DR9-D**PU(RQYRF'N-D.\MYI2?]
M_"#;I:+:JOK+EA]/H(\A]PU$A0<1E"*R2)!P.@/&$RIG&\Z295>=-(0OP,4J
MG8Z3Y$_.5WB+:T1?<-VILMG>57"]<V:,&+<<X4, 'O$AS:<1WI<JET0O8WH9
M*=1-:5[C/GOXD$R[K%)>ZNVMU/3%R,,$5(!B66"6W@'OM/G5QRN1(],'+G[#
M7*[(#OI*O1/UBEVZN\%]9=7JFT_Y!.<VZ-XOL!]00AQ[LA!6\;,W60J[^YUK
M#4.?I"7QTDE0<).%*JXV0E,%^VTR7_UJF[\@]4]Y;3_W9SOLGAZB G^G+!1P
M; HV?X'.^R;!D?!6#;$MC;K_281TOQ-EQA'B9O,V8C_D2J V<00 9![@>+[E
M5_G,[:NN;U4B!LX&J"[P!A-[EIS:$(2K!VNO:LYQ!BKQ78CMV!G=_E.\C^UT
MW?:AG[BT'#KT2>,QS!.;.0DPL7!' .K3\_ELU;I9/D0(+N-8$W=#7Y</2=3M
M%.&5HQ=^?EE\WEVV^*JX7(@GSXK7(, ;E1OWYA<[G+<.=ZPS.@=7$+U;4&P9
MF6CWVRLB)"]>2^+F?W<[^_\O1ID=/;89$<V'5,:V0,4P@L 052L\N"57J[]P
MH.K+WN^O'>-497<?OO^>%&-G+7?IXH/(#64OZXFL+D"+B6#=X>)UD3%@$,;N
M=P2@;?EV?:NX'>C<'V?T&0[.7K6ES_/ENV^HQ75+)GDJ!TW"S>RIY9416!,T
MX@(7S%,H$_AQA0XR(^7 .V8'ZVQ?1^Q3IN_'PH,X<?26KN^?M5/O+@H;5:H5
MG-KXZKJ3B7;G=G+YI!'S_!UZRMB  Y,0K7MT*;#!I=E.?]SWZZ4)H_KJ)-5;
MVW_$V&X*]Z'U)J#*]1=^L:_[(*3!%(H/&9=&Q4YN9"!;?6$D/:6CS. H/[\J
MA5+GEH'>L 2GPPHE:.M^LULJ(6XAG(STJ4OV,:@W<%6./M,DBWW\"T:>FUOI
MNZ7?DZ,3:+1MUVT6^M6\=MN[2#WXA5N&D;H3=W\%NRB,E$(P1?_J'F04^"WA
MTJR\W_PSYL]SS(-7:0JX\8ZV5.">N^P#IP1?'3CGQY,H8'JR,1=TG=.\=K(\
M@I)++I>)1K@@$G+5&!UQ*HQ33AT%0 KIS645E&E >,#M%I^0?"6KTT<MNU5B
M!53W'OOPB0^YADCF0]YT+.P"DYS@^6.O !6V.MWWJT%O?+T:O:@^AFS,5-Z3
M['2MKU2LI^6SIFUN'R=O^3>Y&RK;+T"P,-Y0M9+^,.(*#-CWG$BUG\:)U"S<
M<Z\1@>S5/X2^RRU@-G/I8^6(Q734*P3#H7MI^R@('1"XUF6'>M18*>/Q^>2F
M1-\]7RO/' +>N# (UH 0"+7%7'RC!+89KLZ-J@_P#Z#OTJ=I#)7Q--!I+*F:
M.J92:7':2/:]"^\C+28,GQ8\S-QJ\LWU,V;@;WYO]8+ )/$_7(/GQ8*O[W5?
MES=OJI-EKR:J'FR]<U%R^V;(38@B9-]9R'^M/,_%Q0>6@A^A#"14<NXP1V2P
M$+>9K()(TK5SW?_NU,"-?>&#:45?+,*(_ZQJ0.KO.ZZNUXO\/W4^_D6-CW^J
M-/G/"GVD_)\B'W^N-/D?GMD(+E5DOS=6=A#CSPCC23@I^9A9PW;B/+@OBI,^
M5S_*(9^2V?7&Q&?%@+@/09D"J30B$F/.D+!UA0D0XI5KC6==$&.**3=/(&*.
M#Q\M@Y:VV1N,6>Q[4[3O4[9U5&56[63*Q^$?YT=.\<C/6E8UOV4\DVMY0!E/
MJ[\^+14\$_;+83K#RODB TF_@2^UGYB1+WN1WKSOSM47?N_A<=/E\T)K\BLP
M:72%&>-VVGA9":SR8/&O0K_%%.8":KI&C"$J?I,LOC^S2F;?F]M%7?@EJ?DG
M.-;7U03R.VYQ*C/9&.^*&J_T+K30^K@0EHU"]96J?>H!2H,H8;!MW<'T$HTR
M7[JMY]-;I\^,&F[?&1JTD%RUTMN"F\@"<_$[ ? L]BE<LPG'=2TU T<S#Y9:
MBGE:(SNU5Z)$Y<E/6TM!EV'B8807+%G&H.7S3%(H(3PP!J:\MVO\5&A*L6+H
M#_Q97@;&@T&FDEM]8/.]<<X;^X+F? NQO:]F;G[9*VI5??$J:@PC0-TB&(T^
M'[O6^M(VQT-38]^;I*..F9S7PX?K0CL+;Y=5EG-*V^$:+NC'\5JDV*GS#SPU
MBLT&K)],W*KZEOT@Y$+@659#;@U<F3$]'\:6XWV:5'L[4K^!;3V7JU)3EQ54
MC:<B%;QDL" >W7RODFVW-%3A'%V :]9&N(7)<G+\FB8-ABU3<HW,VX.W$59W
M&KHLEY70U#GBICRA.J91+E*,]QXK415\#$;]KMI_!IX_#Y,6\2<SIHFQ2J)*
M'O-<]F4,&O"OX!IGQ3:J]&C?7Q'9W-*XJA1=LO0:H]4TJH_9)=N'6_TFS(?L
M3:CC0YJ0J:U,=06:5+EUD%V&%Q\R<R0IB[<I7(B*$@(\FG$BI=B=0!C5MQ6K
M\*:?#ZEXVE_TY"/>;=2FRT7KB$&&ZJ[6-%'=7@#'"N+F&&I6 GZLTXR,='4S
M7X[V-<*J]M17WMYZ/YX<@K>MD#$]#3B" 4IGP-#J.GXV$!]'W.Z+Y*X&7Y_T
M\9CA?.=#HD$NM+D$\.E(0+CU1D'%Z2G/&/I)98%>;KLJN 6%%QO"/,8;"//O
MD<#%F>YO=#ZD\ 6A=9E8-8T$ .]R/J3FPOJ]ON=\B,!,DK*](4)PK!(:$]..
M^#7ML<D*]O5M"?Z?UU1 :8- T8L]@I:8XC[%4;+(BH$[B7.+]6K/'8'D8:BM
ME^^7@_F# BNEZ]L?FKV)E)S:ZCP=42F.*Y&!+>&$HA(Y6B^\EDUY/PSW@CX<
MWA^BY^73GI[&6WC>"%0?G?YEM&#0)5JY)/C3PAA_]E\4:8#^<SDNUY (X[TL
M1Z!NBM"R-*[?Q-N==LXWZ@SS8L%R9)AL_ZFN\+@M#5O>[K,N,;E<D8#LL5_5
MM,UW-AS\6E!7A'O_5ZH-56N\ZMG^K]<I\KD6#_FK,Y_^ER?N,&VO/7^'J4(:
M0)O31%LT@GH.3"MA\24.I_V%4S\]N&EBZC)X>WWK2.QU+ DWSH=,X!COK4(F
M?E[G#=4M!SSA0U[^X-2'^;:%'S&&W()OZP\4C>$IQ;:@1!O%3C^;N3VVK,/=
MVZ^ MLPM4(8<#LLM:O#Y%\K]I]K7_WKUC.$_U[[^MZIG_%^;N_YN+3H[[)[M
MT3[SXW57-':9J1="7/F0?]MJ4"E$7^B8,/7&"G"/;0D(F&0:+E83F4'9Y\+O
MNEO,AT?HTB>5P5 R AKO,9W'K#[#8\S&I3:#^^SLX+OU6B_(G>KL5_=#/'CL
MLO%C[BYQ=H4FULY6?BN&:[^J+T;?+G46"W^2A@OJ+<3]&W&-D D&KEGL$29^
MD;<9/(D>SA,J?H,/L0E[A3YK)-^%.E71JTG__"*?)Z_"$Q9@;J(WD1G(E(UH
M>7T^Y&( ?2E>C,P<RS8R$H"Q&XS]N"F)*<QC5WF:S8AW77S(G1YN0T06X\$T
M3SX@C3T8@I.8@8F-S2@=JC%'RF#V)ER,/XQY6Z5UU.-B[V7!3=MI;TM]6->X
MCPR-WU411LG- W5!&?6:UZ"\-;$8KL][(A4)2N@%WQ- 6YH0I0J2FM4GE00
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MV\P9\S> 8V#0MR(.:>?S(78%'&,@R.5%2.[CLKY,*V!'@"E'C<APQ,40EQ4
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M^:)3)PC?_7A;=2E$00=<\V&X'% [TA+JZE!%9HV,KYZ95W&\5SUG][WNJT#
MU8L77!F2.R*)N6=Y"43*711XIFC<3\7U,SU#"=$D?-2BB=,TD#VZ8U.I@2X'
M=A>#_GZ@D \I;%J;C=<@M*>0_VMOG_XO&O7YK$Q G:W.&\^5'<&Y^(W;-!L@
M$N;+ L/"[:P8PT7"]_9$7E*/$7[OYE0J&7G&_6*FNKB)Z<4=^J$-Z)$.O]$$
MZDC[4F(V=$&NB/,;L_<.;S<ZS#C+=(!SB>(G%IYK.E#PX!PK??RSJ6[.H+.G
M^#5/Z/8-@G<B1#_P(8 *MH[ML'[K%N>)'"MBJ3+UV\-Z[Z$V$;WPD3TTLH##
MG,OM?(KVV1'36*OZ2K,-Q\I==O_F+!/86665=EJ?C&?8H>*Q,""<+8+.:B(*
MP^I3%#D7&\N!((J>=7!9<>G':N'#]&>1<AZUZF\F#BU8\TA0A@4AA@]YHY=$
MA<FAB:WCA&3>WN]0$1WBEIHDS.FP:6$1@^&M&:\"1Z7$M;1L5,,8J?=<6^0*
M,A[(KT(3B!4($A^21)2"RW/LF3VL8K6.E@;LDB/H;B*MU]I]3X7)O;*ET?1.
M]1L>_(R<DG(;[<\\'B<+F01T&44MT(U8,;0C)8O$AE9X.HLR%C(3\AV9[#I'
M>_&M=SK"X]X1HG 42LKH8RH?DM@H\)U87=.,%![WQ%6:DLAQ2G+IU*SX%<>@
M**LA0IEN@OF9E<Y'$)\"G.&;_!L:-BI;^V/8CJQB[B.L#&^4#ZD "3W"G9A8
M/NM!PFI6)>\Z6>EDZZCUXD. J:&UL<YOAP]W2UXW*)Z(V5Y03"%ZH !U9 ML
MC/?CU' 0(1XE@57WSI6V59(:Y&D#R]..X;(//YB8>^*OB_5,59BR4O9_%/NR
MZ8[3@XBP51 _Y. &%<PDD'3XS?.@<]+9V"K535XC-</?[*^FJVS_#F>TH]=[
MS=\5Y&T#\PTPUV_" V=!JM%F5VMU KI>-^LZ!DT4"%+#.Y5["2;I6FD)V\3<
MMXA5R=W@V[JC*?XGKAQ-YD7=1@';<>WU*?_*F^/K#R6N,8G<+?-$!O@Q"?K/
M__CS,XL_#O]Q^(_#?QS^X_ ?A_\X_(]U6$C67_Z>O?2X_LZC>_^'GHC\,?[M
MH=6!\().'&\F0N J (RR-X%2ZM).%,<J*XPPLB(Q"+7Z '-?+]FTV;5O88]<
M8H:'=[^7^Y)PY.B9?I-?/J-S%# ST,+/'V*[H)?HHB08H+%^^PW7)F\)]#'<
M^WD?$9N!I,@9'JQO,>+(Z)&*?1WJ9.%W]Z%'X*Y^\KJ0T.!YD&)NEF$*+JBH
MD\@;,)[<QX86%)@4YP2 ]*.7"EK"?$*>SNDY7TQ]QU;[<*0^M5.!W/SP@$KR
MB3>:OV)U?5@+ZPUZ 3_6'J;S'<;/,]P'C4<X[LP#[XIZ7GQ&!U/PD0J7Z_KF
MK4^*.SDKO\_]S;KSFZF"XI*GFL"B/,,/V-W+D4QGV7"K^! /<BQNHW(?S!#&
MQ%-&2"+Z)H.</;3' 9N9 VT93TRM*M2AGI5OQ1S-[NOO_?Y30T2A,X?MA6U&
M,>SQ,?C*D5910.-/U0KF/ZWZHEIWCCXFW&F$,0PUB[P-L'B)TL8<J;FS2W4_
MTU]WC/W0_E#ZK:.>(C"W-$9B=?3S]+$?9%!5J#9$I)(AH)4W:HH+*/:"RJZ@
M5Y+.MG1].I2Y3!,]]&$G5?7*Y4@K?;J/)MSI&9B*.1CNF-S$0"U(,44IZ@GU
M*@Q'VH$*K^> *2VSSBBO%3O*W@_S>S5L8Q2=,7%]9^_NHS_RCJAN6(9K@CI[
M!<X_%P2=\.")W&.F+.A3R-N< <1EYH'"(L"NPWE7QL3'/MBUX2M1EI7[3ZA!
MN_?I0]JU(F2WO(>"27^S)WP7VNX,'Q(5TJB&,62KHL9JH2W:RL>W5B>]N/[U
MC0_FMBPZ7^6[AL!2EU8[Z+ Y<#@3T>8'J(\T$>*5]&HSPSU:<8*&1UYZ__AH
M%G*C3*?$R^VV>IIYG5+(MX:TB&U:B#:L%F/Z3OVQ8!I9>I8QZE6]\Y$?3/WH
MF?3G].3/(T]PI #>>SYDQ;D2RN: )F<!N?K[CI=?R:-D5@$WER?-V4?\5!_.
M]#@S4+98;_?2>:)-M8W3'7)#MB#BJ<HF ;)A@',Y'R+RA0VF/GWH/L12,0*(
MAZR^U.K$4>N(KH@UF+PZ=U6=#Q$SY>@'S\>"F1']-SZDL8 /H6D(#+\@J/$A
M,8O<^WS(]WI/_,]!/,<8ROA"?@/ERB1)\-;2^9"XIZ(.>?59/(4ZUFD^)(^9
MAR-;XYB2.%(P]CUNQ5D'R9Y%\I0CC+SCEU' C:4Q45Y"^ST^)!Q,O5JM_F.B
M61$6YMB[=1:NPX][*62<5"UHQFT9BUK9$F$4^E__T;_CZ_U'$,T4MKYFIV84
M.+?[A5)?UUF["\R>\E_5V3 W:)?&A_Q+D5+^4AI+P5(K9_/?B83X"VE.*%49
MA\!^+]+OI(&$#DE])?Z%MO+_4E$;YB[\_UHVS73L).Z-2+V%#G[7RBU)U[N7
M['F0/7LCC&['+QMSZQ&N^I9T>GM"Y.$CWP1^21;^'5_)W[.6_P=D.RVX[GR7
MGZ4ADL=/;(CCTL[%IKB?_#6(__O%B[]C*/MO%^V]'6N5>U_^=C5T5V52U],T
MZRO$J.O-:P+6_YB7^P\@VIZL]17;$YC$.^ZUZ?VH4_&1#:M[CJYEI_]C HKE
MS'AT9FE1\\N9&F'=A@]:VO7%?7T1^TBCD2(6?WIX]V\.-!1DR>/'Z?@FV#C.
MHFH(Y]$KCR90=]10IAQ3Q 'H:2?;<('+\;/6+6%:MT;>D'3K4SE,8PV3.R>L
M&M[_[-(06"[A"?U@'P3J6+G<YP@7PD1""WY+E=\6M",E=K[3)\]G\O#("OGU
M96!V[<=OD</"&MIDB6X/3X(A;?:B_9<I*YF'Q*-K*2T(AA5Q7,M^O1=E%%9M
M?<\=QW=@=4'8N?8-H[WH>BUF$LK<G'?,'F92LI_1=KWLZ9GOIRN]1U&ZS6?7
M"!8#@0LRYVOZ5L+APN;F9\05'!T][_J3Y"->QKV$7(1 ()0-\;D1<!6F'T=<
MPAS(X4,V/0,>L3<!/UI#KSMK N4O?)RUF-+OBEJ_M0^TZ:\]]G[/*-[04]KP
M*5*-ZD2-$)=Z<N<;M#(V"G<=,3'"$\J@]@)JK&(V JAKYD/$,<9N3X$ &A^2
M4)6D\3SZJ;W]94<C7I$O!IE:+)Q1I3PI?#L-N9(ZO?7V,6AAH.46?1(> GA0
M[4A?!*FXR%?8[GRTGTE5?V6"[]BRKR_-_MJYGRW**2W5GGD1RHVORX>T50=6
MCVN4:4\YO6DVO-K7\<RF>;WOZ;8Z*IXKT2"\7FZ"#V'JUAE#KB!:"-'+.UT!
MOZ>'! 0,# 7Y$#?0 J,M& 3>O2+0*!D6X%=B3ILE-_3R(2W/ 3L^Y+<!$IA*
M[XWZDP5*Z;<0U_;F0M?W64 YQH&2EH((\$R/J2BN!%(4S*>R1==-\ )Y&VC-
MV6@<J,E/.*;4)ZL3BF NM,\O&K=B80C.B/3\DWO88+1 >_:BKJ?F)T%;M3MI
M# D I2ANE +=2(>QWICFZ9\]Y#\J(T&" 2/U0BS8(>@ED\=-X\?'2)2D V=\
M%<[%M2>[7G_M]';33^7&Q#*_<X -=9<*+;F8&?E1KKVJ9.:U_63=^7/NLO<T
M-MX^9A3V:1/^;Y'C?X.N_H%DK$>R"H 0BLAQNGISF!.B:=Q0S F8M%_,CSUW
MS]:5?617V49J3)C\VN%W1 6.)B.E%2J&#FA34HFY7<>H+A@9-XNY%5\AJ6$N
M2I,UTMB(_,LKEL3]3K"RR'C(-!_RNVNV^IULM=LT!/"_OV+3O]3?=XVG.W!_
M>;G0WRE/ZVE>Q#%0BC]$7!?1V8GMP]$'@@MX7=AC@Y6$#9[5(SN_W^A#^A6V
M),?>6I8]<'+-[NVP>FM*[*0B4$)Q0E+)"7D9*U\<1IO1K\]:=8F+;C=0 G\:
M\&)44),Z2"FBO0A2TN8O*^8FP>%*&^T?7D@S<[;P_5=,LS1<X6SEI\ P"U&D
M[<Y+CJ:;-DRH*FM<[%R\N?G2WYN:_A>LY/^,B+]Z6=O6@<*#,ED2] JM8%J7
M@?$K:7]S>2;U3+/TUVC+2V9-NP2]6;V_ SUH"SD:+@884<<X,,I;#W/SI+.T
MM9/^QU+K9_!A3W+'OA^W,_M[@\7_#=#]/R;C#_P=K!)ZH]]$=T>HSN26OLF/
MT$U>MTY[CKN:Z 2HN$4N-*F_DUKX?=3?9W2$BKP;F!)O4-0N?-1#?ICPO-DE
M=.'8H8?75)\*C7Y=77)2^T?3U3^4C!]Q5>H@)_0BR\&%QV=X6_HH\4OMRQU!
MB@:N9RO4QQXNW)39?F1TI/KWB/&"X\<H:D'LQ!A3>R71R7+C2RWCZ2BOO7)=
M^SY8/MN/B+NR4I;VCP60UP^2_+8Y3K26M\=+B<EL.$&!")X\_S<^R]-433OJ
MXN66>E'*S-TE C)K5OBR=O%>(?KQ;_6,;W6N-7H&T:\R1S(7SX]=2SU;JQ@0
M69#2'H% P/5QS2WP;8": .;J>C%6'"9T"+ZI+5Q1'!/TAE'O4] CW#GU_-FF
MPV<JS*[-V[F1MK;>N7-BXK[^"$J,Z(L<>TSUF$_W9P>@:V@Y\1A8; L#'0F5
M:)(_L_BJZ#>?@&T;:DT?=LJ;RBH\^GJQ_;Q6+XY2XL!*H>(!]9I6T:A<)<9E
MAX\-3)66G\X;P) Q87]AEYW=X()K955-TE%AQ:O9(0K1\<)>KFJVATV;B P[
M8D1HUOPC4+F_N%%$RI,%F@"N )H"%V20$Y;R58V+PW-DSQ9 ?[G^J#O[(C3$
MC#L.88,6C&=8 BM\R#V\*$\1VX^KJ(G'2D(3?%41(E6B$JBQRZ9AH>4A=/-Z
MM@Z!)7*2VEVPPTDQ/Z_+%;5_E5ACNE#!&&!MY.:N]HX?IQ&C#%W*/-=$TK\X
M.:#U2=;D#V+;(C_2K^O-"J?D>JE<]MBTH,O$<78%TW:=;H(RSI%%,5<8@Z6B
M<89BS#J2P5+,@3Q5L\T<V-&D3\FG(3T#V6LPGG"H &A8>XB>I=U\B [>]J@1
M\::GP"3.8REAW&-A,T.F&:I4Z:0<#N]MY^T<"&*;"Q?99HYK==LO2JMK-;N)
M;U;UO^_OK$XE QK5Y4R?9F=U8(RMP^MN5 7N,*9;LG/S7=3C [DWVH?]=IH5
M=:OJEQ8X].S63^W8;]VJ9%<C7G].9;+N4ITHL)? R7],$>6F(D KGLD;)N[A
MF+'/\OIP#&,C%]K2?#2CIIW(>,#K',>GJ/?[-NIY.2N^&_P&J!3/5LC! G_E
MIUP/[I]XU59?A5$=:/V(:0_3AW#?</%8(XPV]T6C$.#"B@;4:1>'#35I7"5M
M\].#TGJG50]OIZ9&N 8=LS6!E&AIRFVIDU\FC/I1]>=!IX2Q$( _(Y]E.TP=
M@N_ZSA.O3&EQJ-?OOJ6K97)2^<LCR\VISP^XN5M*5L9"MF^8K?QK>]DW+)LN
M1(.9NO40P@,?5]O1DA(!?=W1MI2\UGN7$H]2M&#0?S,I_^1PQC:P*HUFJQ1$
MO4-[//^IY'6R?;?4@:=K4(X$F;=-@7T<7"QSA$<<SI,X1K<<5'F=8O788B30
MXO:@XZS\WF<[;=/Z9W7=+]XL2]Y6H6EG+6IIA+3"4XN:85M\)O6&/ 8PQY^-
M"7\): TM)+VR;#TX\/G+A^E/6]ROH2]V0" (6+T,(Y^F/I\/&KD?MP;AVPW=
MX0S8H(!?.+I?G+/B)[>(B2^>\A8KAXV+Y%PH;4%?R^N"*/GG7C1?DK44'!R!
M,NP(L?HH85T^9'S]ULA&CB,!LXE170//*<6@!MRK/%63)^GS(Z$YA5F/6(][
M#":OS*FU:%Q3SJ#'7["8GEDPI2&CM>%*L#:CP[0YA[[" 5KC&SPI%#/^(.OU
M&:E\M$J574C4%NMM&P\&!W82XG!7\;'.4C5\2)0/1Y-B7G+FL?D0T:VD4W=K
M?%(9+/#1-SS"]E'G6O8X^!^^]>&TE'L(QF\I$8U[F.&#%4X3G@Z9&9+IA]3G
MJPT:5C/>)++LM6E6\_F*EH+EH)J/(RC/B-L1E +R-LY%9BP5=L?0@LJ%M? A
M.X-$A;J]:',ZU0V9M(]:P9DFT;LXJ;7ASV27%'90"A:D><K8"6%?)OL2-Q/A
MD7)7/JL5OPMP/%4UQ/'P<BD9GV$I[:JI);..EBT6^65^H[JDTNZ(C1:X?6Z/
MEFN\ LKJ)PEK@HUK7K@B.B':<4(4D,H)&9D?8)\&7'A"ZY5AGG)+#$79:"##
M4.8I)FQH!27)V0M$T79]FC%HO3W<?WKODYIS>ON90FFZ]^(0;Z_ .6%-<!8W
MD>B+CT94]T96?0ENRG8N?3K'V\'4[HTU#*>DB#<K.A3%K(;=;JVN$5:HO[Z5
MI%I>UZ'\I$1<%E9N-Y7"$8?1X%G,=)YP!1O-.0\<\$.2)D8Q"B*DSUX58Z]J
M*QUP:;U3Y^.HB:DHO;-)S5&WY,RXY__JIG)146XET7=!AG5J0,="X12@3L?%
M*QDP;2[C6K09/ZC?T@Y4"8^6MN(\ZS)R,K4<[<]]VI_^OFE+KNZ&1Q$$T,(B
MP\%%0O$D>)_QLAPG]GXT@8)/AN_$7&,8Y9%]B")8Y9F9S1.C%<H)=<$F6CJG
M>V+5M_GO.QQC(H*Z6!1=?QP:[\I\\_T3SL>\J#!A=O,1V%CJN'&<4G?#6-RN
M\T>>;,<@&01*:<J"-JCP=F;PP@(U02VE!;<5*T%HF?-UUVF9XZF$_;JQU'H#
M,=SF(IG@/?WT;=J9Y@\[7FY80.S$W9CSQ'DV!+.0W">\[=Y\B 0G@+*P8\2.
M.56647)I]!+ZMO#3]OY)VK=98U3UY7W'VVX\G9*L3Q'/<!\ 0,JP>2,W&Z[-
MZZS%+V0]1[^<,V=DQ3XC*NVO&=Z?;61ZHK[</?D'LK;:8K'&_\QSA)I^UK5<
M9Z:R--#+$^D<7D7=PQIRJ[#'T-6VZ9='^!#OA1M=S*ECZ(4%,>-ZQ1]O=)[D
M)3?[7P#Y2.+PFE\<:.0(AA4THO9CAM12M XN)50&Q&QXT)=-H56#-35'SLL4
M/51_796.F+P7\,E2, C4O. FM#HUN*UW&V##:N)&8H]AQ!FFR:MW^SEJS",T
M]=AG4<BP1\?N^5FIN9?O/WR[W-U2V.!ER1NN&_LR;Q2Q'>%"V/1]4IDYE%ST
MR@>^GZE=%&LH0N%#1-L4L[/B5A,RE16.NV7TZQ[=OJ2:G-H>]V$>,CT-!0YD
M-7?[3> H=G<1E&PEV4I'@B3F,K/]48 .LUV.<YS*U5M4*+5QN(5.<DE4>SFM
MY#K29W*DGMY%O+%@9\7TXR@^9HMQY(=R4F(Q^A0_&71\>\_#!V'3 W[YHE%#
MZ?/W#ZJG1LUZ"LRG1.&JAS/HJ'%I-NLWH)O1;06$, ^+;B^*6VD0L!XL7?*M
MZMG==36L1.N%[*OG<B>2/7.LSW1K;?8<<X5/H1[A&/:].V<1.Q"4<A3C/%$)
M.&L2=7'0,(26LV65>E1?/ORS_'4)%?K2OE?+BDH;KOFL]/^_/<_^M2%NIA*C
MEWE)RNI"IOM1R(Z";,X/X NX!%L!+<H#$6;,.A'D,N<N !)2*S?-F,/=+<RR
M=!V8>F;VW9V=RCUJ">5.6=M5Q+=L%KAQ@OPT]-]C9HV!H'.5^HPC8G"47/).
M^ YT6+._C\'/UA3A+VA!ZG24[U7+(">4355:__"D#F6_?XS7UQO2&MJ%]S/L
M.R%*T4P%UB#W4:,TME,?6J.?@-4<+6H!,##!N#U,PPT%R;-=@28U!Y\J%(0D
MIA;XWWF7:WS9E?86M@W7?)H^P-N+ 8,NVXSW<5(3L,1J5][GZ T:6N#<_'<M
MS+9-)QWX,=]/'-45C#UP_UC@K>0$S51,!4.0([5$42ID[\4UPW%7E@#UX^@(
M\HP@O?<.1Y_&_MXIYHWR,!$O%N1=,ESL?ZF4:XV[W1# VU''W/&, A(/O]C&
M@VAOV]A6I:W %VI.,$G&2EPUDB?SQ.2[Z9X(]YD>2+@VVP/7;': #W''[4J)
M0FU"N(K>XT,4.7Y^A<8O?6IE2.&:2B+;NFR#HI=N3+DE:[H?>G_M3G#7G(+>
MD-.K<2C#HA?0[&V" 9H$DE-P&Q\BI..W$_!K5=HQG)Q")V] =R"ELXFQ?NW4
MJ<N_R<4,:^ZV%4Q7*-[V_7OC#Y>G ++%9@ZN43E0JO-+UR?UA4]-D=!T]ZYZ
M2Z%"EW9;6>5SN1O;C;3HHH JONGM*G)<@062U,@',VOF7K6B"Q+TTF,<0?>K
MR[R)IS/2!*\MY941%U#=VFU=-^0\LS414Z60T*QV4+2:%F@4L0;1TCLJ<1'P
MH3].D>38U@ZZ]*W.&!Y7>YZT;>Q29\ Q&7T%^&#3?I^$H%33)W4YH= "GQ\5
MO&UW!3EP.D_HP^@TVX.&0OP4*"?T&?SU[7]?4R:$>=L*7V)[$6)!*=%0".)J
M2@)YURI>J%FR\>AC:GM<DLO3RONO9GS46E\9SI$$VO3'GME=52S/W.=T<FWR
MW8()+@:_J5Z.@)ZXB+=@+,:ZPH)ZQ6:S=I2?WDE"!@0?P9^0>W2/:J<(@4"6
M>P%U(D=2G[7^:GHFMG<G2"LKVI^],+VJE*_WN.Q[]L*+FD$=BU.[2]4*![T_
MO*0Z*4JY6Y<5*#T-:>C@2,U1>T9:>G"L,@:NB2@]1]Y@J%W:6^2#DED9*W40
M4JEYR]:=+/)R^Q;^_,?YFH<&G3?C9>,*T;0,B9!?'LVX;7!E;!=BO=W+1 #K
M<SEC82D:C%XI63P]()K:L\5>I&'X3@'YM*J#?R9\NYVSN4*-\S:=KD2IU.@P
M_?DCC+F6:I"+^N*B#86"O"2\0FOFJT+V/A.SJFI;3#<<F)X=.(:P.0$UQPZB
MJI=(?F,$ZH%H)LR,D74/KNJM="17"Q?+VPGX%HD@K9DZ;TZ,;!ONDMU]YXIM
MMGFL6_S1=MK8OE(:N1S%D<911Q:.LRW)6!)9@>A.C,,)P&&D KW2 D"?9I3H
MJ5LGM3G;\1CM6H74Q=M:$=O:I\Q_W;H^C:!\%K%%Q9,9IJ)C=!HA^97M7*L\
M+#J(*#H3FM.UF"UBL,L[[$*T[/+.MJ*QQ-!3.=&.0!+#MH-5#ZX$G:,+.IR6
M&J^5FU$O47J2EB)V"J\V'1?4[19#-A'E^/JZ+H7LWA3'&]N8Z[8;<AM:+<.1
M,K_ S<4JST&WP2%8$E2F\?@<7")2$^.O3TH2D^\XZ;7G4O^P^3W[D)$8P7B_
MBE-E+<=<]E^HC?J.9R!1@ 9J_@<86V'<W*?</)R'(]=XOXU5UKD1':-;GQQG
M#?;FKQ/H;W\BT(G;*K2TB@5?*!6^Z&4,4+*B=)<4O"MF&G=]FH]>?$<SLJ8.
M:UR3]5J\\2W@N\"10X;[Z!$0J!I(2201[DX!5 0I)0%?R8?$&ZH%4+OQXUIT
MDQJF\%E&PU1Y9+BZ25T63XV)%(/6O46;CJN>WZ80L;[@D/"2O_9^I#.4[86=
M&(?-1S_WS-:+9B#;^1!)PR#:\[=\R%U'ZC2I1]7)6Z;<,8[7%ZQU?+]M]>M'
M3R^IIT:(&'H+'-G@3+T@T3*Y*Z7M,'HLT!-153C0W[:Z\5'6_/L%Y591M\GY
MUAU%<A^W0. 7_A9NY33="IVH'8>.PYRXZ7R(!R)*GM@*0B5P_#1(?T-\"KV'
M;TL[[XK\?JBRYNV[VE2[A:QMR4S'%\>,82JMA9?J':D>S8ZP<4>><!)M:6*"
M)&T.O<O;R5%'10^/?_"*'JDW^;G\A1SW&5<:WZXI/=1[TE\U->KA+CLP>Z5\
MSO&["&31>R?LZ%D);EZZZRX[/$]0LLE*GNR3=&SN/:YBUJ4Q+R.Y@>71D@)H
MR,SW,?U8%H-\R/6&(VUV#JB[]48B -.ML=RU;]9@\U2"3G!V^- ;OZ"Z>.-#
MOS3KZR27?][;6?-!G\RX:1J)E<%<9A"B$==%1]7I6<VP3>@E>PM8"TH"KHP.
ME=7Y^2[]8>:JN*V/.$G=1]H-4O'R91U,&$RLW&L&,.L] M9[Y,5Q-@\'OB!@
M-/,Y89_J;8IF?CS_KC)4YMKP+OMF@V&S4?2K1[R5L\B3S@W@A'[@F"_;C[.-
M$<N1.$V23@BBI23D'ATXX)Y[E(2(Q2">?R$%O?0YCQ1[Y7^WZC+]0_::1GOP
M$TBX%-L>.T1D]!@<>'R5"HMTA@&/Z<B=<D2J D/FSL*UL.[*N^HY ?LK.A6E
M,\OEKMGEVET4T?%\EC.$S,8U&Z[WK$&((OP0"@#XT9G L&M';>-I<F"UD0AY
MS#'FEU=>P;[;*0]O7$W;ZYHK#<&0H"$[MAG>()L">2QZ"U:^=H2#H(1]"66U
MOT^P4#F;-G:@K*E]3])B8?QN)%<G52;9 GL3U[P/YTW<BK$&=5*)[5=2XC['
MN2U)879S\S%FSV=J;'-W,=4^R.@- (CSR<<=_=Y</OGPV_WWW[QRY/H^Q*O<
MME?P%)RI^FL;'?XKPQWH:,4Q8@'S"\PKGX*T+\QD8T9.G^LKQ;#K*N1EEJ^D
MJ&!*DUZ^D[NVQ=2A/R\"L=]09IVXKW=\L6!VVW#SX(=!-Q+A'?<97Q$)* )V
MM$_R(1;F".&9'4U2T0ZG'):_*NNV=3;O5M60/MJ9/H3S[1V+93W_ITW2AP,1
MTN@$RD(1"9K4*,<L);2*QDP*#56):?8OK<P5&Q=F+/1V/7=,L+WYX9GXL0,[
M%>,2],D7+ 6G1Q8J&!4T$-+%49&XBD%RQ7021X2"$N&8#-3[,\O8':$J7C2I
MUS$H&(DUZ2%_MZ)'3XDV$?[&5.BJUI%]^F]PS6XK,$7,25 .'XX3H,6HH!+B
M.)=H1$6T,MN$L9A [5%RS,K^YCJZ/3F_^\Z6A;8"MTT;MR"E5D4D-U#)#(L[
MM%WZK.V &04A!RBT*LF-<-09Y%.?,"?ST0EG,OO#'.<L]";E,C#-U:X[BL3;
M+RDHZIT4F )Y6PW)*(RESXT,6@+V3B^4L \ $QVAN8]+@$SAA 6%YF#YX<?,
MPQW6@S?*^K]_:2WU\]U?'+@G%395XSENF"D4 \T#+[\'Q3#E0\9$:3+S(!IO
M^@IXL+4Y%X?$IU&,J>CYVD0K9V[A?H=%WK?5ZYFH7]Z[':.CT+_L6\]R"K:M
MV?X[KX#\"&-]YI8CKJ,D>8,5&%@*3TB=642#-A,VDTUU:SU;NL;)[:'UAQ?-
M$U)U'H4;"!JG:1RZ-R6\_^&983U6[QV<!!R^OON]40IS"3C.=N"U8%4!=8IV
M0$L:^H8"5,;[YF?O<?+$PJ)R?88T]$NSY*'*JV:3'Y<E'BPSR Y])Z"/\-L-
M%=@^&!%P:<[.01EF@5R\(7+]U@H']I)CQ(A-F%]I1VY'S>CO]0FS"%]5/J=7
M?M+#0"?SC?YX_<2M>\*+UMB/W&00EF'K=2J-$-<0&WD]M9MJQG-S&$LM]^T_
M.WF-7QB1D8]N^K5X0'Q2*D38_'CWWC9!!>X6GS'/IZ*]1&"W: 3O,$8:\&.6
M4']VI$0TZC#@)33\N&B;DLXG%^;>*%7++S/Z[0.=_@:+]]RZ7A^L$*3<+]AH
M.@"M)"S(,%-(M;>+&-TL2V # >B@&3(?A^^C._8M!O:*>*75)M74U&:TJ-HX
M=M0%&+M[Y'3]\HXW<V-U:0A,^P%[LS@2? AIO4$:_H[=I$@]\\DDC#F=R#$-
MHN'CL?#Z"%-$7-5<-=G?OP9_8#?6GM[;E:^^?Q'9I_/7'1VZ7B7E(LZ[=T*"
MJE8=S?!@G>$FP371/WGBQC\,W>@(B*FO8O;>QYEVD5V.L=M@4Q.59RXD!.)T
M!,,3[*'E^@M);%N@HJ-1D)M5OVYS(4QBLVALK6]]\4MT?OM:5<6EF<R#)Q;+
M3TK5R>1^\ZJO_+QXZ)MAZ;>=%QNG\B+@V[BYC=O1('WV9WOQ/C7N3J *)AI>
M8CRF$^-HS.GH)8P0=2;(,4F]]=;^A&(0"QD"JJ="M@><O'G1=RA8-6V/I05R
MM(Z"ZD@!U/WFZ<PEUF?FS_DI GJ$CNR WC-(2;K!DP+@Z!L'YOM#<@)[I,H$
M9'%]]-1LKV8WY.$3N3?:R&L;C"%8.\QZ,8=(7/-)K%1;&<:22>3L[* 7)< U
MT&5'R:V-*EDV [Z^8]<F?5<FC,DJ#EZ,D&251+]KSF8%ARWV)T\.L .QG7Q(
MI7XB?!\6#,<,&U%!CE&4+5#,./"+#Z%> ;1(UF4+=L9#UZ/+")OO/&K*]O%=
M[MQT8^Y;<6JPGX;H%TE+09(\>?XG'34!IK3;'C$>L[J9,)*?&-J'BIIG4DN=
MZI4-W?+-GZ/0*:VU>06'WV?J;[BQIZHZ4O9QSR.5P^<E3<KBG1NG_YVG%3W,
ME#A0'E%&9C&M^>FL0_& SJ^RF$?Y#K]^!KOKP+XV*YG\<E2X>.MPZ_;DJE_1
M%"+(%#B2&_V2'? +8LPLWE8_YH3SR%.?'$33;;V?:]Z7 -29VY!7^_K%1[+V
MB)4=."^T8<^)\O9S^.(52\$F8O7T/(EM@VNVQ5$>&4 3#(T9MP>H*>WD[<#P
M"$V0Y+=I=CSNP4SP6M!@7G\7:WK*1KNMY*B[Y3W%K*T[?C/.+OK;T/R[MN2&
M7TM@6-K'+<'YY"#I3W 5?I$XRD.<+%8-H_0ZPISN:]["A[A6);1+W'^5?26D
M0(2;O0'A*2MRRS3-7S#[@-%CE@*W'.>#&X^EG2]^AK%9KY4$Y%,\(CE&U!5/
M/T/_XI-JDR7AJB]?-_M($3L5#QDKMIM<:WVT!Z(A&#RX'I%B.9+I))R,H1LH
MQPUN,O8(!@$"%XX&W<J1'3*\JMZ*$//D2;[-'&\.<M(;'A_M6(ZI)9FT<:+3
M/66GWN2O'!ZG'2]!+^;9"2L+6JE>3]P@-V6_L6@TPC0T_*]7D+'[]G/A'?L:
M=K11DUOL#J"@''$D'=F*B'(6;DSV">R+SJ@B)JZBW3YGR2A['5X+W)&@:NDB
MT25]Z6#J*]^UT\803 8#1O/H( .:62V$!(0@S@<UBFS%;^)L+D-;(T5(+K2%
M\PI)CH[L\(96N[0\$ONM<HQ>HN;QL<E3MW*=%9JPLFA]UC"@ *)"QC""DC;#
MAJ/Q#@"Q"$!=!,*HHC)C,XFYLL3^&^>&6=GLV=\>^EZ+_!CHI>WJ5Q52/24N
M\[F ]P@$_HV8RPFLQ/6Z:NNP#9?DM9)?Z\]7T8GQV:Q'3YOSR4!^2ZA3Q=XD
M\?LCX[D366)5G_L[CS0+;TER^MG]3F5YJH@-Y8WAJQ9RZRBXL6!J%D<LEA9,
M0HE.SH$N*R2: E<!8L9]?(X'9Y0%B9R:H;EG+[,PYX+K!-1:9Q=[NFJ^&X%F
MU,"^@1W%5\/B<=Z7&F4ZP&M*!P:8HI21R*7\["\Z5]U\_>A&SG+!:FWOL\\U
MY@CD=4K*MBY'9YY3]5$(A[&%L4/D*H\%NQ*@R &88V\'8BFXV!7[TMV?? T]
MBHW]B^>"#X<D&3Z[POU\\+<2\<0L+WG;J4UHO[P7?[TX2>,Q4#$O>4/X:O46
M<U]A2N]\*EL>8\U<XJ@F?$-WMV,AR>/'="ST]Q,V/ZC9(8GJKO&\7RS]G>>Y
M@RW=V X"L#SW'O&ZWWA-6ZX1 S'?0(4!*KU)O*T8HP'?*0N;-B7]H=+LWG/E
MD8)!\5M+1^M_'K&8>C[MGW)HRN]@9"F>;821979PQ.FL >XSS$F9%E%9= 55
MOP,GUD;O%9X$)$C]LS7RR+BOEV1L!FZ44K:<N;LL^RV2\G+BY:*9ZJFG^(;U
MP,J'_(T8/D4&B2?E*9YAB8KV]\%+&OJ!ZW,(F*'UQBMI)>LS87%3@RL3CK?M
M:QZ'Z_4%OQ_.QBBYQ-$51K/2O+:GFZO4S"9);O@1W Z;\*"GS(_!2$8*-,3\
M$2:L T8KW>S*),1A1;\7EUP"?&SLZ3]VA^'T%T2D69@S&WY=< ESW>%!#9[_
M =( "=XV*Q_0S?<RB2TYR&8#Y%V>I#D%O\D+JYJL417NM$C #@6\N'Q:@3AV
M)>E$C*S;U2,Z(SMF9,66UB;_[[^4^L?X8_QM@Y@#!0XL<0I=:$7<)CYDI:UH
MI('T3IW%TK/'>75ZOG,>&2OT<0J&^\2C8[D.W?1XEO- ]EF];U-?S"99X=4U
M-FL'\HBIH5KS1)H";M".9\:'3.!!LB[FP7O*ARP7\2$!B+)XK6483\2)#\E>
MX$-N$7E3):O]C:(&W;@W1PP>GL?></3Q<68B?1JYO?VWMD^P S2*DK]^G6[,
M:BA5WS5?A[J2%Z_5;70_KQB=0%KSB*\TQ^^8TSKV_W#VYM%0OW\<Z$A"E.Q;
MC)T:6]DJS+0)7TD;LDZE[$R%C(R9(ME)A4I2UJR3?3=VE>S[D%E$TDP^0XU/
M9G''[YY[SSWWW+_N'\[AG/F8YWD_[_?[]7H]G^=YO^M:XON/U;<\$S;=AM1H
MG*^,^V9C NZ4P,WCE!!\43,[E*R3ZC"+8CX#9ZEK4NQ#X#:$BE>88<NT,XH3
M46$.-'N';JSV9&AG8<'FLT]?/(DS,MT8NMZ[I9<C@G03:2J"EYM2WYJ ZJP3
M'BYLY6?J#&C_@PI\3+M<]^'?2/HWJ^2+\T<W$Z<0)YB7MB$6@4OX9 1YTAY)
M%>R%@MK<.D;N(K(/JHC^U5O-/C\56F(R+(\>N#CQ+4C%[M+!2X5??Z?KF&<O
M09:&;-^)C1-A7>R=]VCZG"<6LM0!E#"ZF!DW5HZ=ID)I0B:?:;^?)(9=__JD
M8S7/X&/%I]!0PU?=9267WS^29OBP99E0:?059ADGV0L0["7%*\O$49WIL@5H
MMW[3=DDPMO3G'?^MJYM.ES[O3G>=S^/_6!WGN-^LP6)$<-52&MBD:U)^#8,Z
M:TD5""_H[!5J>#)&DP=URFKQF*O@,'E8EN3B[N; )[J@./8[[X5BR[2JU<30
MK<31HX\MUJH1E5Q%]G' N8,0-P(BNE^G%C5?R.*[W\K03D"9P!Z6YH<^^T:R
MU\5W?:]I^AWERU^4UVK>10(NXV9B^I#2H6+16]ITOJ)* G7R/A 8SI2]G]FN
M(1Q](3O"XE#0A^0#I^J?V7=\]VX62T+6A]-(P)F>S?;]8-SBK_@Z)=AY>SN/
M&%O@+[?(V$W;H'J50R-G!*JB]$]7N\N-/@X^I6H+4<ZWBJ@O9GEBAQXX=VY#
M1-AH7$+]IJ<<H^=^!;FE[>@7ZOHBTLSP%=D.=DT],JE)6=IO]]USPU7R5;$W
M==G[."78W=@QV0?<5T!(/Y*8U2[5FCC>LW6[[U78[? "]T^Q8R(O]?-2KVGJ
MF$4$OW^H\I1?].$# 6G*B0:VU#A3<J3NEZ6L"R?O3Y);D+7;"9.X!)_:9H\]
MBY?W?PH<=SX2]:AX?_D353BPZJSX2'H"X\>IV8;<-IB=ZV^7!J\P:A:W(4\L
MS*FY!_V9KWT>MQI%E10S4TM"PHXU/+0*;'J1_U^G:,M9?X>O70\M3R0":X^0
MP&7\C#GS-3A;CAW*A1#\$7O197T/E&KF2;ZO[1?-+70HRM<T#JLW6]WD-]:E
MA'R6_BUA>_!2;76CXT4[HX,0P9"3(E;8V[A.!/<PV,(5J6/X4-/H"!ZFMJN/
M\U0XE!^<0@FQ=4 4I>W!K_]B>JKG^@\V*/15Z!6D#Z*5O!N.N!EQ<LP,;]T_
M3?_-DU8HMF3956"IOYLDS^V%'F![D>L 4B].Q!]K "AG4W]]-G807WGJSTR+
ME"2Z_\?HU+@#&U+FD\_ZO%ZPP:_?(8;_@+<$!UA7V7M P?)K()**3$UV72CV
MTUO(H0Q"_VN9#'/+OA8O,5^8DGS%W5C(Y<Q_ZC.%#W6%I:]TY-;C:-D,&-EC
MFFY")O&"2Q8A]H>9;H*4&:P\@[I=]%E1X!FL1.NV3+7ZT2>I'JF%#U5N710L
M&D6:^/&DX#4\J,DMCB"WP%!SJ(Y'7-6Z'VQ5.KSHIOTIO6#ONM<>O]_?3!IN
M>&N<>3H!=K;+%..(5,1U^B'(&00QK)(5(Z 7V@!]=*4[2UF]::2\S@VVV9*Z
MOO5-+6*,;Y>YNT: A691LK'=LH[!\T3(%C9QJ=6$T4^>3H8?<...>,J#)106
M:=<WWQ].<;W ZDB.\<QC_6FMQ?#,JM)HEP2^^V\6][1N0SJ0P,6U&1+5H:="
MD2+VI-UDSHH*E71M&WY,"ZO0VCR/%#_]T,BV:"!"]-+J8:DGWP+'4@AF%WSY
MB;YX&7#G5(8<)Q8NPK[0"AHPSC K@7-IU HSJY;)NJ"]/]R3Y_WJG48CQNU#
M2QUF7UAOB)G=P";*O7%TV(_KM,/=P,NS58"L?L1N[LAK[Q;*-D1YU4Q&>2^W
MJZJEC3 =3!]((->.DV,K?SRS3/:0D+AT;IG/1H/_FPY>#="F4UB:[/.@/960
M\E8 _.SS804NT/)VO _ND?+%<V7Z(H?EEBT;[V%U]QDD-D_BB,KA9R?Q8CS&
MS..'G;<1WCQ\R2?'Q<--T#']"K@8>KE)Q?U5<YPX;,:Z&(T=VX;0ZC>=PXUN
M+AQ7$KWP:QE3<0A)&81$95MA2#M-*X$T&@P89R+J1W'D7*3X7 ].A,ZV*AL,
MJAS&S_N+MXVVI%<RY]WO,<I;'M[(4 F>[TVJ7\[@64N7\Z0N379%6;2.\SZT
M\3O#^UV@A7K9@HN'VT\%SH+-@6O^]WKJG:LEA*Y&^WA;Z&@]M!Q+7!].1-2O
MT1( 9^IR#"!"S:7+4BQE^Q:TGE:F4.PJ/!$-7_*T7WP9*3$0=1.?&WRJBSOT
MKTR1R9.=T:G8;ER]<YK%&:"?B>04LDT6+2.[1A+J*HQL&D,T[L@*Z:LOE.JK
MSG^Q6$GJSW+(7G9_&'G[_[U7)/TCM\Z #B439AW(17A&=M^7<:N;24I/<A5C
MGVW1P40![2('#3+=T;MS+I'MRBG !1.(SLQW#.FA8@8_U833_DKC,1%$_=<4
M&2ER:WBOVA56%X*@]0/>]H%_,R^1&P&783\ 1P$']Z0>Y%ZX=H"K],0%1<XN
MSM1QPY $=8V"I-7* F4JP9- ?D4 +NIL0P+7=BV@P_MEIJ:PQX#OEW*<8#?J
M8:S[_YQ^FPP/;& J\V-O%EP_=I'O[[[_>PK_O,)8UNP]G#P"N1$IC[N)Y %5
M3XK=V1I@Z!6%A9O=Z#B1EO#[3XJDJUT2 KZU:6@G%3Z]9IQ>?OIRK[B'VN6?
MJE G[A=<%;Y';-:'.0@^JEC9ALBRPZD&L6]5 .7DMV(CK3[4N;8;%D91^[YM
M$NEZWBW/;#&9UO5A^[\.?-DS$U_*&X[TOUF>#U YA29K,5!)W&V'6&53!K>,
MXA"#E&@_F@*C<IL*?DG\+'*[FJH>X&7Y_7R:0,&P1LIQ9_M1MX^ZLO?O$VXZ
MI!#X=ZJG)$/EX=JVC'$[P(#6C2>M..'VX.%JZ!%7O]=%5=)UGZ?T0ZTGBD1#
M_QGY'N@[+_%9=+W+5.(WW^:@- /!EAGH>R"83" _A4KC? F/H/)U0K]#$7L&
MRM!F?:3]K:B[0?57&^,CTMUG+I0=E8@5TGR1TJT4\!VW<_^N70,CR/.LW1CX
M_TIZ#R/KK?N0PAA/@!=8VQ A=+?3Y%]4LL)"31$Z=75=1*8Y>N/"I/YO/:5;
MD:_DI=4N'LQ[5//]G=CL7E@_@OR64&N=1 A S010$'2CQ;5]O04!V.. 3':Y
M?[W,RH"$N_VNFMI3"6K:-SWX-!Z'??^+4,=UHGF*[SVTIKBC(H!"H#DS-I@%
M8 P0<A),,"8VI,)5V89N\7]S8';UG^H:&AJCY5_/5J).RZ1[A7QW<>]SWBP]
M*;BR),T@L26-F!&<5]L0[]SH=E5."5P4UWFFW1#S /!)#+W5GM:+D,(>VH9T
MV085$UV%WR*K=>_T/#VB^;CSQ2<%Z2NU98=X,P:U!6-V6M0+8#CQ;!XS%> #
MNQF2O42S%+@..@:Y#8FU#,M'5S)[X<H_IYR-7/P^WY9N+3N0H=T0X9.1D?)9
M\S9)3@B"L-?!?T(>X!DP!'L<9'&%C( -9AS@L529P?A!Q:56P"5Z/UC[IBCG
M4+4;,^7_:L8IW@MZ'Q![/M#6)_EZ*7D+SY:Z[^8 J@M&P_=S>2ZV&Q- +:D-
M,J)>R*+@4NK?:C!N_RZP<'E/*D@?_O"-4^J\[T/W"6OC<)&J&HWTYTOU7R <
MS;Q$=@5C.*[N X&\(B:"';Z(<0<3H ]-Q&:I#K*>H!8BP?7+S\NK7>OK,^>#
M8J<S96_Y8C[N"KXX%S((P99<\H124> A'YH@>0T*EE'"X[<A ?A=;K\6]HP4
M3K)O7S=9>;-27S5_)I#D%ZJIFC7<^.0(OSC,N%1Z?T >)P,1N#8;SB2#N! >
MB%P&APO0XV>K)G(=",WCHO',+!M^8R.KPP7IIE-.?!.WKXD_#3FIG&.%V:EE
MA.14([S:0IA:X$^@Y3*X44+T?Z =\[<"P0KHFG9MJ\A\194>_V':'#54<5-F
M"O;\> JVWX+<4JU^KC<ZAP!J&/0,[\+P<DHT#+,;?,YP[LM44$XJ9FN/W9HP
MB?*DWTP\^JGT78VR2TZ&XSF75QDG-1Z>A'?EM>(H@G0Z2XL=QF"V 5F4AMY'
MB"2V45&*M0MPO_@]R:^YQ]1'KM%-\9-:8Z9Z!M]BRHO,2V\^"B(HUFRI.*8V
M^*,$'#X+6C$6AGMD"?MIFBV,P<R<PH56XL&[-;"D%^OAUEJ73ZJI?X5??7FE
MZB/?;REG)4"=1^2ZH$04I2ZW3^R1IU%:#UQNP@[G$^ T56,M0$R^33V:]Z]D
MB+_RZM.3QP654B!2EZS^'S_GFYKJJ^N?K:]3U)YH&.CRV)H5OV:"!43P> 'Q
M/YJ?*2UN%)F+;!"C_RS!V$\4@C< I.O;\>[ZYVGU_LPQN>\3!5?2JY[L[1+Z
M]/O[+<8CSV[67NXW)Y(,O:)= N,V\0PJ=?J1,?W<9>FPV_R_WW;=.9&VN'K\
M$_[KT349T,&(VG3K16G$Z:(WSW.O]7+F\7XMA<R(=I8BI5_\^K$'QRML(KY
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MK3+0^1U&_F9$>"HQJF#\<X%G2ZO3H/&@Q/H>!1<Y^N>;MB8\+]_3:'V0!-A
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M&AX3L1\?I)13GZ,:HO>^S@UU^.S33TNO)@L^[SZF$WL2'O-_7:S!Y]3E)B"
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MM6!["'(9Z(/;6,TT'B$8!5*HR98FW#>ZISO?U=+FW\=\<PM51_> MS*#BOP
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M1.0%+2(7'O_V@+@"'08GOCS'!\,+&TN7I\=+46W^(^:E:#YT#KTT&4<:"$U
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M%VHA?MGYY[>A(?D&E'M5[/C6[:B:L?#\@S17689>>6E]D]=II@O\-;J!G6Y
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M.)6&/H-^E/K4DT%(/<O*$L<[6AJ9[N6L#_@N">$_B:W9B:L+Q":FT7%@C<B
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M8J1&_RC%[(6QZ3]H?2:SSLMML<^!AACS_3@)81Q%RAX.:  Q]Q@,4(@%"<,
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M811B$@A(0^E!)"-=Z<H7,*&^3!(_D+$7VR11<".6%6O,D'^AKF4&N) 9LTW
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M7HF/N0FJJWL=CO _52G7C?Q/=ZW0QWP9S"3@O\$2CRQF3[5@?U.!\#>@85B
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M>%NT^C&7Y4G.Q3F,4,'@%9?0:;'^:3EXA3X K[)$IUL,O XI=J<M%]GR?9V
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MG1EO\O5AJHZ6M&7TTS79BEMUHQ)%'3^-4>13!1[T&98029I"RCB&41RSF+)
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M9-7TK5UBS 1C(8%!) 5$D;J8IEZ$H(P(BZ(P30CER[6XU=$V/RT,\5V3&FW
MM-J 1U./:(LN:=:[C>DM*5>;OXHJ3D!6W-1=LRRM]IWP&UKP+T9S(FM^C5/=
M'&M/ZKYMM4/+O@DDKJS\G7--:_$W8?O(^F_TT##I\F7S6,8>?UJ_C!SXOEFM
M/FYR'8"\%"(F<< $C+Q(75,3RB".?0299$DLB<0>M?+S&<TZMSMK617^;K-2
MX!;_NPDO,BZ:HAD#-6>6=C&S-3(31<Z1'UDD30&ZM?"R M&1$#.;<U)A9@7#
M2Z%F]_" BN(ZE:)Z<=Z+/'M4RMFCN&*M.LW4"UB@7D"(<*J%6NQ!HCZ ?LH)
MX314]UCC1C:]L\U.F!T(!@>*046R137L7I3[K7!.L1M;''7!-J2:>"]^%M7$
M7>(X537Q0:^A70EQ4UBZ2HCWCC%="7%3=IZ5$#=^R$&'FWWIL).](JXWZT)=
MG*M?ENIV&O@>PY#ZD0=1'$:ZPA>#<91B$?O,PYP,;G%C0<C<Q/,SX@"YS87@
M8/?0U/LFJ[(D.-T5V5K8%DL<O%AF&N842S"VD_9%&YQ#K<33W6\6X!DG([7
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MF_U/97,Z5ZQM*8.0\321D.+(@TC&".* ^C F(<<DX%Y*AH1)NJ)OIN$U+?8
M;_%7*EJDQ9B=:NIL5<T4V4D7:9HSJ;TP;9X68,]5N49MOI3P?%[#<_&\B*<[
M7=DUX(XT:V=D3:J'NP;SI=;N?/Q+HY$^DBS70:SB1AX^;"*?GI8B3#D-6 Q%
MFC*(D& Z<S.$89!Z(0VQ$!P-BS_JGGAN.O['9W42^)[@Q?#H1\,5,).Z8^ Z
MME-[3]T^#%+)RA\[^G\%V^HB%5](H996AT7JEB?@*L_5XZ*J@$R%W.0"W$A9
MN(V:M(/1>?A1S[2O%'!D!L;Y$"/#YP?VJGG6%B<3Q>=L+3YMQ7VQ#/P42YP*
MZ/O<ARC!,212<LB8%Z>(IF'D>59-9\Y.-3=Y]:)Q4UE47Q,+2FIM.[V?1]A,
M.KG!;61Y-!0R^^XLO6BX:K-R?J)I^Z7T,GS4^*3_B5$C$*])GC^I/]9"Z_0=
M?)D&V%?_AR%%$8(HC1E,:4BAQ[#G^9&4H6_D6AV#N+D)I/>9+NNJ+E"LIOZ@
M3:V?VY^RF@-P)U8<T"=PGZTW>5D$5EM4[S8KM=P69:J<+WN_[?4U%W-LK<TZ
M:*WAL,QKU"H;.&-P?,4E'24FT?G2SC8N\?(E'BLXT6H-W 0HFDTYQR!%*[ &
M!BK:S3&T#)4:9DU6OQ?BQT9N_U*GQK?-*F-/2UUU2OH1@6&2I! %,H+$"STH
M?<2#D$0ICJRZ4)Z=:6['[S5YR+9DI2-!04,I^+L^8'5W@X8-H/BPK9UT#FJS
MFX$3 $<^\MKH[,%;@(I.\&?]K].B>\;P."NK=&Z>B0LK];![7%JI[P%778)T
M[2:F]->/N^TN;THXU<7VBJ]J[7_^)5:/XHL29G?%,DU)0GT10$ZDA(CB %*<
M(DBC2!)/\!#%R:6]:ZPHLME.TS2T:<C?E\5[J$G771_4"XHN[7!CMV*F9M;)
M5F%TZ^NI7CC[1:G8.?RU8F@!_BE(#F[6;@N2N(!TM(8X=M2\<I><0=#UM\X9
M-NRH%IJ^ZA$2>TJE0P3*&"6Z7K@'"?$#*/P@BGR)(A(;.:[<DC4WM=!5.17'
MB^?4PO)O5"'$^N)]44V1,5=P%(.*PY6<K2EEFBHQXP#OQGXRBUHRXP TT&8R
M;F6:*\8V.W6.?Q=,9(^Z''C328@+CT4T4D=H@'1A:0DI#3G$!%,%98(2;%5J
M[-Q$<SL4&SK!@5#KB+O3B)I=,ES@-/))=0*B$9JV]P'A+E+M]#131YYU,GLB
MDJS[^T.3P^[O-^L?VPW[5VFB749^'# />="GD8#($PFD:9K"V)-)Q*(PH;&P
MD0(O)YC;[J_H X4F< '^'^^MYX,'4@=_+0#VO,H/60"RV]YM<FU278 @2<KX
MSB")FC]G1:'/=K(%7]0JW('07VB[1EA]3[V$"Z"^IB]6V:-868:/'2V3F6BY
M!/R114J-^X\*]S\JM#^5&+K,*SO-O[-LLA?#3YQ#=IJYX\RQ,]\;K#^(E=94
M!"_;D'P7#^J=N".%J)J++$D4,D2$MGY* E'D$XB%B&#BR0#[J=H2V"H*JV_"
MN4F4%KU5FQ_0HKCNV6,9D=6+N;&FX0S)\36."T <HGH8(>-.!>F>;FI5Q(CY
M$RJ)V7.7=!?2H6$?%<DG;TKZ.G0CU0WIF\C?9ZM=0\F2,$_*U).0EW4T)<'J
M+J/T&0][02HYC1FRTF(NH&5NXNF9)>)0":Y,9N6;U8KDA74^JXLE,W4@3[(0
MH[N82V-/U>89Z!UYQD!49=WOS4H;>>Y[I:%(_UWQK0N'Y:!FO9*>KOO^7+0
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ML)A.YZT8 '*3@S;PB@GP?7S@S6]P(R_ 1'>Z,1;"ZK)W 8P=U[\AHTYV(;R
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M4A-K)P8[<343=*[0&EF4-60N0$,HJ"AU[B,S <21).J<:E)98\+T2VEB],R
MCFSEK8ZLOJG7A^596:OJYB$CVGO6E#FI(]-8C 3F,H(^)]IWA05,0QE (2(O
M0C%!46P4Y6<W[=QD2$,Y:),.*MI;]7@L&E&9KT"_\64<7$>6-H:0#FC*;(&M
M16^O43">R,KR:0UR\9_ &>1V[;RLD>OJXF4^V'3-NZP9?-:SR_[I80KB%Y'?
M*E%9'B5%5F9\7ZUY51^D^E57!5EM"MU>^M#%(R0H#,,X@4G =94.YD.<Q"E,
M4HJDC#$*/-]&=1Q&QMP.A'>[(EN+TE!YX*-TL;_7G2>V6=FDVT[3'+A 9CKH
M^+"/?%[4#"Q.(7Y@ K2X '\Z[;SB!DE':NU (B95>"\#ZJ4J?.%H RNLU^$T
M-[*ZHVOC]N9VG?V/#C'K\I#^U!: PQY-?.$GB20P%22&B*82$B^0$'L)8R'V
MTRBPZG7HB*ZY2=6&+>WOV511&'>ZTFX!LC5XT"GE57I?N>VI6 N9;<&&KNIC
MLG2%UC#H)S9G SDL*Z4[>@O,)/4KK.W(HKN]K#5/X/NSE>H-$E&RO+2QCB+1
M'2/NJBJX(ZJF+>GM%LJC>MR.A[_0U+H^"C0^G$'[2%/"L (R2& 01+I@ I>0
MZDK;R&.!H"GR8SS,]FHR^]PD_,$8NSX1I-_2WJQC?X<MCJ4!US7D$UETG: ]
MW,IK@YIKLZ_1W*]C![:!Y:QAV&J0P3V^R_[A31_Q3^LKQO)=61M;%-_(DY:M
M2^0K\1:&,22I%G.ZG3?%80@12H- 1+X,A55JF-&L<Q-O)6W6?;L-T#634\XQ
M&UD^-?2"-PW%?]/:8$UTU74;U&0[;;IMCI*[_MH&<T[=2ML<AA-=LRT>OB!A
MH9)IVI=>=6A<)I)QXC$*DX0H)2H@ 4Q]C"%-(A\GG$4$2[LNJR?GL=DETS18
MK>Y(Z\T:UB36E^$!B0A'H)J)EXN!&EF<5 @U^9X'$AUG%9Q#P&4:P=$<T^<-
MG&/S9*+ V2\/]%7L5MNLKE*;ZT)VQ3^R[1W/R5]D=;.W]RR],/88\V(8<4$A
MBI@/B4\%C&(22\P9\0-IY9LPFG9N2D=C4B'UL2DW^;Z<^/FZL)?@;NAR<([F
MV"Z&-L%E"4LE1@XT@P/1#KT)5B"Y\AZ833JMM\ *B"/O@-W3%_1;?=??#>[=
MF6YP5YQGE;.WY:K8FR)2AFB0DACZOHZT06D,*<4<LB#DF'"&6&SG(QB3VKG)
MP*X*'"\[4@XKOS'NXANZ!N:RI&,[#!PV-3WP_-PW/(+!:Y+E<=ES=#1:IV\C
M.C;L)SN#CC[IZYQ3=7_R,HB]S.Q:DD3@A& *8RYT^7?J0TPEAC*F@H0"AP0Q
MNTNW<QKG=V$O6[Z#345OV:![W[=[3SMXDZU!H1F=^CPZ7N1ISJ"+%N[?Z-QI
M\=FDL<[GI#F["#,Y78[I^[<Z4<["Z_H4.3_1T-Y+#[E@64F%^GDE2G+6O%TV
M:QEZ(DHQXC"25!T&//5@&L84^CAEB4 DDL3*ZF(RZ=SN&VV:E3PO^UZ5AI>'
M?/,@<IWMI^.5MHM*X/_W+GO0:U?]2MKUYW09A_^/O'=];AM7]D7_%7RXN\Y,
ME3&+($$2V-^<UYS<G4E22696G9H/*CP=[I$E+Y'RQ/NO/P ?$F7+$D"!-->]
MY['&L4FB^]=DH[O1CW:T6=U>U#.>ZR0Q-\T>6@XC*^L^N5=@1W"-<)_DD).1
MW $*-@/)8<F)IQVY@_!TKI''O1?8OOR\1N6/->KG=E[P9SLN^)-N*C1K$ZZ;
M4Q:KF"5<*)A&=KI<+'/(%1+FGS).5$8BEGAEPH]'ZMRT94N6#<L8=7?+-G^I
MJIG+7.O,VO[=#6P>8 :/(V\/>_C%I3A_P[AC%]3\VO>@X1C4+._FVP6VD4<5
M3$AC>1Q"I[>:1P7\J/D\[HH#.INILEQOZD[=[9)EM>9JW]Z)X3S-6 HYHK'9
M1A($28H%C%/%HBB-,\*=AI0ZK#6W?>"W8E7<;F]!N>5-*WV?;'P7;$^K[,"(
MC:QS&TJONN;Z';6@6@.NAK0A._=>NK<="X?A5&W&+L/2KZF8&SJGFHB=><)T
M3</<6#EH$N9XR]!4U#J,JMKR;8TC+91M:R*$A#C)C"IE.H<1DC+E-BP=.<TB
M//[XN6G/CCK?_-(#R-R,VN% C*P4.\)&F"MTG.=@^9\'#Y\XT?,88T\S.H]>
M%7R^2-_7;P?&7VOS^=@S^7?F!NMFQY'$"'([90@+F4*:)1G4.HZS**>13+P&
M#%U R]PTP-NR*FY9<XRTLND,!Y'$-@QY!9CE 9AWD 2;,')6:FYZ92)9C*R$
MS@Q*M-0+*Z0^2YU4+#O \C/)Q!%74,>?.G*6DKE,'G&%S&/ZB/,C_9W-WW_Y
M^LMGX^+>FC=U6Q7"-GJ47^]LD'59/7Q=+^OA\&6[^2-"-)61T:HIC2#6QNND
M",<P5XBG28QUQ!)7U]-KY;DI4DL\.*2^/C?8T0]V#+@[6'ZR..^JCH;PR.K1
M ]P!W9W\4'9W:D=#>R(7-RCJ7@[O(.1.N+]^SYO,&1[$9M\U'O: (0%(XWR;
M1]>%&?ODY^Z3X#)#6*$(IE0RB%6,(4DI@1Q'/)&IT EU.KX_O]3<M'Y-;?U1
M-)U!>IU#?,)H)]%UB4"&PFST &0'5U-8U:-U@-X^@YM/]#$4?I,%'R_ T3/T
MZ +-R<CCR0=,&'AT8>0P[NATQ[!PA@UJ*G4XA=56$MB3HU4[XT^Q'/,\@RA.
M*,09SB&-)8&4JB1C*,69\$J*.K_D/+5K51=8%"OP,*#&P@%GMSA#6/0F..A1
MRJ:./IJG7!>KU ?E#<WA0@;N^ 2*##@L.&D P!V QWZ^QYW^ T5?VTI.M;EC
MF^KAHWEEKG\4Y8)*SEDN;+$[,:X[T@IRCF(H2,(QQ4IB[-1 Z+D%YJ9(^C0"
M2R3XTY+I,0/T*(RG-4<(<$;6$]ZX>(WM/,7\!4,ZCSYVLI&<IYCJ#^ \>9V_
M!]9TI63+7S?K[=W'=65+?.K!25LE6\VQ7MFV9+^R8K5>_7-35$JN_UZA193R
M**=)!%F4"X@E%Y!$F$"!E8HBI+2,T\5*W=A#@&]N/MI@8IQ>?=J\^D](&N\S
M^*)NC<[=;IJD,[,]MCTAS4^\[<JK2O!=+9M*>,.YLN?\FA4;<,^66YMG799
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M]=6MD[Y :9)&6 FH8IK8B4T:<AG%$,DHXSB/>!(S/U/BU'+SLR ^J@K<&.K
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M_%% ,+Q&5@C/0C7@>/<T9NZ!^6#8311UOP!#KTBZ$RXGPN2G[Y\L!N[$1C_
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M7F.MAY,R-QW7T&WUVIUM#.$3S@D@%S?E-@W:8P=ICG;CV,._'UAMBV9Z73K
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M*B&/"(,1XCQ!.L69II?-"_<A9VY>0DNQV<!$.[[ZUEQ9#1U%<J&L'(_+)Y/
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MI+2L@*T]Z&66%\!:9H8>:X61K>]1U^02&_OXZUQ*\YXU4/-6G]5?@8ZQB<[
M@L(>_%PL#'4O=%86%-KGS\_"+C,@^MV>W^U/ZCH3N?O+KYMU:8S5-)$REL+V
M%<@@UK&$I$Y38%BE0LHT9DY)2AYKSDV![XZ(6$NE1^36$66'$'AX[$96I1U=
MO0R!JYW'W<LMJ.D.#ZE'3#P\M%.5) :!V"],[@?6J6BYXY.F"YK[L780._>\
M=9@A__MJTQ2I_$\=MWBE5DJ;#>+;=U;]<[U=RO>WYCVIWFIM>R3?*SM/T#99
M$YKI*&81S'-!(4X2"1G%=M SE5A)R2B*_5K##"/$YP.:ICM,GX^ZI2AO.0&5
M807\;7D!#3.@:,:>VJML%])5J6KWVD[S41VC]5\WSJWQ+I2KFZT^OJQ&WD<.
MA&3[A[XZ$-(_^T+:L5%?^"5( [XP0 8RL@<2,:DM?1E0CTWF"Y\V,&1RM'"P
MYPB^>MA?TOJ)M9W^]L==T>2H-%6%"Y590SDQRC?+C/+E/(.<<@PY02SC&K,T
MTE[!DE"4S<W*;KSI)A8BVLC]EBV!6?O6,R823'B.T9"7$,F$<9 ^5_U@". /
MQTO +6]US^>6.]"P%S 0$AKQ4"&08'1-&_P(#>>3L$?P!2Y0ZT^"+O5OR^MM
M]7V]L;O,[ROSQ%H=?;JKES9?1OGVA]J(HFU%_<72_6']M]HT/]F6)8M$HDP0
MBF&2L\28V5)#QKF&/$YD0BG*,7'JPS0%L7-3_C5E-D*N6LK!G26]!$M+-UA:
MFL%/Q0K(]7+)-B6X,[\M+10_#]@;QGH#/+:+&<CUI2/I#5]VGVA%7G,%:F9L
MJ8D5?/->U*P%WCU&%D#(#64L4J??8T8&_>BV,_::PW8BC\:!!Y4VURM9%]OL
M TT?5;6(8D0(BU.82\PASC2#7-,<YBJ+5(89U;%7&ZJ@U,UNK]F7$%[9ML!^
M&TA8P;GM&"\FCI&WB %=4P\K$NL(7%.4V(^ ?SPA5._=8A3P VT/86F;=#\8
M!=;'&\ XB_@?MKY?&<6V8DV'JJ_JQAI ;>D&$2C!$<<PC7@,<:Q3R'&,8(Y3
MG:9"\DA1M^#\Z87F%WP_H-7]_.\$EGF&$\Y8#J6(,HBY1)#G$8)2IC12A"/I
M5@,:#LDI]K/P.)X_C0Z#SLC;RP&1H*5R0/G5":3<#YG#(#;1N?) Y+P.DL\#
M<N+L^,3-DQT7GV>@?T+L</4P3^)]?2[YC?UH/9KJH6V)8\]U4X4$%#PQ3@&E
M##)*$4Q4CO.$$!SCQ,<I>&ZA^>G#^J#6'@#N*!W8:>A9;-WL]A"(C:XCAX#E
M;42?0R*0/?SL,I.:MN>8?6REGKU^F&+H#\YN W#EN_7F4_5=;7:-.MJ\PD*5
MBS@B44*QAA&+B>TUJ"%GUGK2F.0DCU7&E(^^\%Q_;FJDIM-/7?@B[J9%1L1Q
M9.724=Z4WOW4$6^[0?\,:OI[?83V'(13.P.A"Z2-?%>?5$D-A.:Q[AKZ&'\?
M^J/Z^_^L-W]]NBO615VU5\^&W=RHKEM')E*I\QQB%9O_R3(%&<8,YD3%A&EM
M/$&G1 N'M>:FJ@RYP-(+&H+KW7Q'LKN?<P[A\VYA0-Q&5DTG(1O@(Y[#SMU1
M#(CA1-[BL-?/RUET!.6$QWCN"9.YC8ZL]'U'UUN&V8FUKK8'9!OUW8Z&NU>-
M0?IA798?5?5^92<HVM?H?RMYHWXUAJG]RQ<EEJPL"UTT,[E?*;.K6R-VH32F
M<2(9))0:14Q3#'F*4R@CGJ=Q+E-!8Q\[,C!]<U/>;]2FN&<V=;$$4I7%S8K9
MXC)6UB,KBQUWX+MEK_Q//Y,TM'#=3-87%-G(^T9CM1ZP!EH?^B?+P\_UZ1/8
M<PAJ%J^ 97)WR6-.KP"O>;6J,YSU.Y(4 EG'H:F;U'H>"=K'UO58RPR>E6[L
M>?7!3O3YIRINOAL]=7VO-NQ&?5$V8&%,_?J/W]3F%BU8;CZA/.,0I2B&F",,
MB<H%E%SG6.51SH57FPN_Y>>FYEOJP=)2Z-F[V!-X-QT]'IPCJ^ .R9JX*]#1
M#EKBP8[ZY@KP[50"^9#YZ0-@"S=)W6?QJ6>J#P#FR'3U(4\9IM#LG*?F\'^Y
M7/]MUWVCM-ILZD*3>L3KZ^\VX>O]ZOK6)@<L8DJ$1)+"C!,*,<8<<BX2R%",
M<!(1EJ7(KY+.EX0Y'N.W,]Y^DJKYZ6=CM8+[CC' .L[\E)ZW<-S4WIB CZSX
M=J2#'>U7H*.^.<*Q]/?&[OWTIA/)%6C8":<(AP(92!5Z+S^I,AP*SF-U./@Y
M RT\5FSJX7<V16JY+K<V49:7=2W6(HKR-$*9@"0FQIY3A$.2LP@RQ6B,.4&8
M>_GUIQ:;G?5F: 4UL:!'+?BSH]?S7/DDSH[F6R#TQC;6!@/G;YDY(!+*#CNU
MU+16EP/33VPLEWO\#VALLQK;MX95JGS[XXM:?BZ8;=E>+-4?U[<W:F6VI;?5
M];)+UHN4%C2.8)I%"N*8),8]E,:6B@3&49XK0IV3]?R6GIMR::@'#?E _0 ;
MM?P%[%D ][^ F@N[L?]R!51E;*I?W,\F/ 5S_IAG/+A'UD;#D!YP'.0)N?OI
MT'C03W18%/AE]SI%&@;>B4,ESP=.=L8TC-'^D=/ )PP=?+I2G_1K8]46U3LF
M[.#%AYVW_VJ]V:S_MLTQF7FES%\6*..":)K!Q-J@.*'(SDTD,)&,9%((FA(O
M0]1O^?GM'F)]>UM4]JOB;.GO:'NB[V:>CH?IR%N$)=P6(C>D@X[VJUY8<4<^
MZ.@/.8-U"&[!YK-Z+3[Q[-8AP#R=ZSKH*0.,X:^?O[/-K7G'ME4A'I<-""9H
MIJF"*K9'Y$G,(!%9!/-$\(QIA5CLI,'.KC0[9?7+5[/9']#K852=Q-3!; V%
MU-A6ZE.0+JA>.8V:A^49"KVI#,U+4/0S*UV0.65%GKQ_.J/1A8T#&]'IAI"=
M6IYVC'GUN&-,4\-?_J%*>W*TLAUDE.VG^VUM?]66]=N*SNN;FXVZ,?;M^U6U
M*59E(>J8R (G0FM%-12Y+2(4VEB72'$8R51$G*!8I5[6Y8MQ,C?=WS!2EVRK
M/?$AVK=,\5JXF;W_%L(>>?L*T#JL1>,*]-Z9#A%0K>M?[QK'-#7_.US #I@F
M[CQVWY@)A3MJ4YDI^)A!QYD)Q>76CF9*@@;VJMEEJ+Y?V6$E=9&'(<,FG1U4
M=^S/$W:'61F10F&,8<*R%.(8*<@)CR$7N58JBI66TJLSS7!:YK8?[ED!/5YJ
M7==RTZN)ZIV>#3YUO$2.;MO?1-(9>0,;4S#^[6<NAS14LYD+*)FVM<SED#UI
M)!/@D0/GWA_$JJY_%.4"TTAE+!60HSB!&&L.>9XJ*(BB/)<,(^S5[>OI$G-3
ME8^"L>9#,T1Z:K\C0+HIM<O@&5E7>2+C/[#^6>9#S:A_NL"T8^F?9?#))/KG
MKQQX[+5>W=@TUC>*VZEOK]E=4;%EG=WZB2^+F]H\+!>1C)10G$*E&($XPS:/
MGMK,4X20Q$SFL5<'<;=EYZ8"+-70]@('TM#M><+E!K0F(DIDGL,\00)BIB@D
M<:8A%HB*A.N8$>R7W1L>ZFER>K^M#9E@.3[DCH>)P6$<^Q#1(F<I!I;DIDMA
MG9"[)S?@D:$7.J&."MT6G?:(T N()T>#?G?[J7RQW6S42CPL?O_Z9I%2E:$<
M1_;TCT*L4@Z9R!.(,IT8GQ@9!]FI47C_H7-3UX8D-X5Q@,QI=3"4W[&/ZPXR
MFM8:7-\:;T&P*_"F:59^^:=^C/,C'W*IQ"\WZ_M_=)<W'W+WK_U'?/"X23[1
M8PQT'^#1OTU\:O3V7UMCT_5\N[KR\MMWMCJ(O;WO!H.D:4(DTCG,(IE#+&,,
MF5011$(+GJB<JEPO5G4H3GZ;X*S(DWZGKX<V7\\3+D8_(;)]_NO>_F60YOXC
MB'_DPZ QI/EO<_;3,'\0>6N*[BO#_Y.3H6*DX3(3BNVE3W5\R?[W.,09*(Q@
M9S9#U_?;^*0J%F]753T8^,=[:1-TNZK_C]NFS (G"=4R@SB/C"L;F9\(3V,8
MI9GB(B4H<0L6GEUI;A9H0VQ=%GE(+FCH==M:S@-\>B\("MO(RGLP8LXJUAF-
M$\:M>4:C#LT/>RUX_LF3J"UG!CL]XW[#I6>WY:[LZT.Q4N\K=5LN!)5Y&F<)
MU"*)("8YAC33&11I@K0FW*@+-.QT]LAJ<U,0/6*O0*].\4]+,:A)'GS >@QL
MWR/4"R&<[)!T 'H7G(*>0"7X.>>QM5[H)/,$V\^?59ZZ:6('NU%FG_3CX4N+
M1&:<R53#7! )<::L"LJ-)XTS%D52YYER*@,=C<*YJ:V&3AMG:GQDP':D@I^F
M=9N?%>K(_G$(4<W?$=X+NN$3[!F=@;-[3@8O[=4^2]^_A_MZ#MY@?NK9A0:F
MK:S+JKPNR[4H;/3PGT7U_>V/HOJTZ48R[5-F/FV^*.LEBVJ[*58WY>?ULA /
MW]2/ZI6!\J]%Q%.5Q4K")-448DTCR C-(4]8%J=28(R]^LB%(VUN6\,!L>!U
MW2+6L]5<0+FY;0(O(XV1M7_-%-AS!?XV; '+E_F(P&[L72^+T/SZD+DKT+ '
M_FS_:_D$-:,ATWN"HQ\J+2@<8=.F$P4']$D:4O@5AH86#CM1E>:'[G<V0WU5
MJH.]:"5?J972154N1(HB)HF&"J4YQ%&D(;4GX'FFC2^09$S[C1H93LK<5/B!
MK6CS1GA#J&V3T?2%%F*S_;_DO6MSXSB3)?Q7$+&QN]410@\OX&WFD]OEZJF8
MZK*C7/U,S-L?%+C:G)9%#RFYRO/K7P D)=J6*( ":>[NQCX]+ILD,@_(@UOF
M2;RRI/4S^LITVV**'AA]3^.UEIZD8?7S[@^-*POPII]:=USN>9P+J;,-D<&&
M3+Q;<BY@;[=2SGZBO72 "D)2U4=W12TC@H7'8)#&<OH;I0BF'DYA0&D4)CYC
M?DI-M0)>/GINW*<#YI1YYLGMK[#JYZKS$!B9>W;.#TCQ?X6">4[_<#0F2N(_
M_4I89>H?]K<G-?_5#9/EXA\VM)M\?^0*.[JIRHV<3ZXK.2]D:G:A3Z)4%DM=
MY9!&D4B3A$'!Y'^0"'RYZ&8$1EY(<2R"@'M&@8K]S<R-AKJ6@M94RP*2)X#M
MYREW<(V^S!V$E/$G:P9$WRQ'/J$SPY'_VL]N3CQ\DD_=S,'VLS>\>MAJ[O<M
M+O%ZP[O!SG_@G_G#]D'.='1&VS*4-$!#+X."!Y(/)#DH/I#TD%*$0XZ#-/-L
MEFT&;<Z-'!J3BQ(4>YL7X*&V&O#&;+O5F0GV9LLPQXB.S!][,*^[8#8&@];B
M!?ASS?***H%KEV<?%F Y6DF9M#CIDLD"@M=K(YM;!V\PY6O>+JENY*MS0>6L
M<ZLW0HZ5QOG*-ZH.3J4*X?!J7[@J#21UA3R"J:].$52H"TE# >, XRA(28J2
M=$#$MDL;C;[,Z:.R53TK3#>RNW.=%%;9[SVYZT;CW:AI>V6R_2GE5KO7!)1C
M"]!Q#1B4)WM1B&R,LF-C@.]N)\N=:5/O;3D']<!NE_LVABH";YHQY99O-BM]
M@MULN"U)'*9>&A&8$A]#A&D(21PD,*.99''/CQ)A%3'4T];<9I][4T&ULQ4\
M-G67;65_CT-LQK*.@!N9-#N8[<U<M#OY+I5[3Z+A3*;W>$L3:_*>=/FM ._I
M6US-%K]Q6MRM53!+0U**HSYN^?=BW[82<;G<EAN<K_0__:7OX92F(H0XPVJ1
MRSC,<(0@]CBB&8Y3P;"3B>(@\V8Z1^S8^$\=9KJ37IT[61S6BT/GB>-URGM.
M$=44OLXSRNGN3RJ0 'RH54U>S@N!=%C)+.Y=UD><'9_'G"V>U06C312'6?7.
M<\2SH#P]/3SO\0,CT.D]9]L5OQ970G"ZV4U$Y:3SFZ0[9=-:2?3H0>:[4D7<
MAZ3A,/ $BCV(_,R'*/0PS'@8PY!D0<1QF@9V4\=SC)G;W++U104<ER_LEJO$
MS0_.UX"W3H(-_@E*);8J_YK7ZTOU/@)YVR9?;U7X8?'(RWI72)-'M<&;K:2"
MY]V]ED'JY_2[V6@P56^./ 1T.W+G2+L+H*)9E"_@I3/@+^W..$&&+G!U%4Y^
MCBG31HX[ .U-D+B+9PZ,!\?5O?J?2HM^PBLU$NC8Q%SIV*H_R&'BY2\Z5]93
ME[:J:5O35/Y[M662:JY^4ET$4[E0.[:,./<%#@3$480A0MR'68ABB&.112S&
M*$OBY4:I7)D1_;3F6PT-.R?&W0'.#Y?YI=+5A?XOX'N/%YKRRQT@^@++0/1I
M7QBS$6*^K\'8)_VZF]5_P56WF_?.@OH2U>^O?OGRCAJ%PR6*=UB %HQZK*KA
M<!CU_B[=Z"HR?EKCIXV>?Y>.>1-A_SY6#!M8]P/XB\%;JY%).[_(CV&UNX97
M2S\-TC@@ ?1$F*BRJQ02ZJ70"Z(@#B(:1FID-%\"6;8_NU6/LK-=PFR4A0NP
MEL.=G#L++GL!K_1ZI8G"MQO";+O&; P:$?"1!Q'3Q<BBUM*K93.5.YWK5?^X
MKF0_$%%'?&[;^J2$/!":UXPZ]#'#*/%"I<AP]B7'1$DUY[QJ J-3$7.&5,!:
M%&408:'6!XD/ ^K[H8_",*+83N#W6%,V7]TTDKYU9$!C+^@8;,=I1[$U(R\7
M>(W,4@<@<E@OSA0(1^1RM)E)6>24LZ_IXN3UYVX=OTB+U+,Y'>.@4ROWNX:(
MAD&J]@]PZ!&(TBB%J4@9]&(2,=_+LB2V$EZW;']V4Z7MPP,NG]74B'&UGU\!
M492 UFGF>L]8=L;Q^$PG?6*[D^L<Z9'9YV4*?[V:KD.[ZISR:?9IK5!SOC5K
MUOH[[<9:07-\ ];N,4-%(2_EBK144RO&?_X;?U[Z(>(QHSX4811"Y!$A&0T+
M2)*8I'$8Q8F?V(E!OFIA;IS52!HV5@)M)I!VVHH_O@:RGX:<P#/V8LP6F0$B
MCT>\/T/<\?43)Q9U/.+06S''8Q<.W>-YDG2ACL_K1=+GM?QVY&^6OD^\*(AB
MZ$=<SE $E7,5CD/H\3BBW!<>"D*[S9S##<WMLV[M:C9N;+=ECJ!INO]R/D8C
M?]M[$YN=$[6U7EOI<M>D'P=GVR-'FIEX'Z3?V;<;'B>N=Q7C>*EWDS^O=TJ/
MUT(';FNU@B_\B:_"EWLNWXK5ZE-1*NFOI1>%69J*&(H$QQ 1'D!,: *S."29
M\",_"2WE7UV:-S?2.1Q:IYT (?A+60X:TZUU8YUVJQF/O5]GC<Q^A_NI=DX=
M67?$:N525OUUI_72=N;KX!BSOG40^^BB"T8+@3S+N'>.A'0![.F 2">M#!L:
M/N6J#-&7_$G5%-A(,W)5#UHW_-OS'_@_B_)RA:M*U[T,4,JXX A2@2A$+"8P
M92R#//$\DI(PY=1JVFC1]MQ(O38=:MO!WOB&$91"J[8?: <&U1VUZ1@SYAX)
M[I%IV2G2UE0[ #-'/&K3\J0D.0"2UPPXY!'G[MV?5+JMCDG=ZJW394HYP;Y<
M)&>"^1 %",.,13[TPBQ(<)C1@%II#SJS;&[4V(TC-I&S;C>G+?G17<_:G@U,
MV%\C<ZM]5_5)CY_LQS-.%AQA[OS,X5R[WNDTPA&<Q\\I7#4PC/5_VU9RAEU5
MLFV2KW732@ I9TUJR7=I1E7+,?I+/\ZP2(( 9CQ.(2(D@BD7!":$QZ&JN4JI
M4:6K(8W/C;OK LZ/\G'W*LB6=NVVHV>K+C!CX+& '9ED6[-!QVXE!-NQ''1,
M=\>>0_!R1)!634_*@4- >4US@YXQM!Z"]$J=">E5?U[]7>?=JI^6A'/BX1!#
MELG)* H2#M.$Q5#^,B%IPI,T-E)X-6AK;CSUPE1=/+FV%2ACF_ 'RO,G-998
M5S(XCK@93SG"<61:>F&EQFW1!7&J.@(GH7)6&.!X2Q,K_9]T^:UT_^E;AH9Z
M-,JB&>5^A+,$AB207!+R$!*64LA8D,BU;423V#+"8YXBK4WX@ITJZQNT3,,X
M9J>\:NK^@*"-D^*JIK$:4PJI'C/_;62&$['42_R8RPFV4CY0RZ*M?.-O"[&1
MRQZEA[6D:19%22B@%R@)&28'=.)%'HQX1$4J,/&9E4YJ?W-S^S0[UH*J,1/<
M\Q73X:*Y.@E?R\7)5I516'/+G)H3R!L.[,[P''ML[T#96@I:4[6LB\ND2!-0
MG"4Q]C8V<=*AB>-ODP2-[K(O__!%Y0NVH>_/S8Z*4E6Y$+*-_^"X_)0_\26+
M<.3Y,849Q8GD&"P'>B(RZ'F4$3_ 'F+$),/=O$DKGID@*_W[/2\Y5A::5THP
M!+>?1L:!;&0JT08O=EDMSXMVS[=::+DG;3=0A@-EN7-(S8M2N(=VHF(5KB"V
M*FEAAU9/J0O#!TU6 L/.L6YI#,L[[5=<E_*Q%Y)[+@O&EPEA69P&Z@"1$HBH
M6G%E40 1"3P2)C%.*#9=<74?/+MIG5IP*.. LLY\P?4"K-,+KJ$0C#T3,_/>
M:KUUR-5!ZZT7#YILO77(_.YZZ^#?!V;TZI"""U)M2DPWRX2'JB(-AUBH.A0J
M>#4+@QC&-"7<CSW&?62SOGKY^+E]>!>WMU??;RW3=%\"AA'!@DAZ$IF70A02
M#%,_P3#S$Y+A)$T(14NY%AL-KITBZ69LL+1M9X%%A8>],$8P"+"D<29?K#2@
MJ<0N"D3"$0DCVRSQP>_7-+GAM_RN%OD\'SRS!?AP0$:F^288[:_6-)<9WP=]
M=I7G_?+ATV9W'W3L34[WX:L&B]Z\DM?1\@;7M>3D^JY9G*L=H90%U(^0!Q."
MN9R4Z?*)J0<]EG)5/Q$%9%?WP^QK-F_<CAKW)HSW?FM+K55L3+$V^_@=XS=5
M2M4;O3*52U"K:NQ,;X-9M7+-7KW \4Z=/8#NI&I,&YY:I<82D ,"-;9/L-_9
M^X@WN,GSWA3?;O]L"G4_OQ*K#7T1X2#SY?PCI1#Q((5$> +B-(Q%%'+L<Z/H
M?/,FYS;C[88S,NG!KOCUINB*2E8;:3O8KG,Y<]%QB[CQSGSSRK!+3N\'N@=Z
M9$)3!N^T)22NTF;0&FVC,C$44O/]0/?03K0?Z IBJ_U .[1Z]@,-'S39?J"=
M8]W]0,L[!R8H\)7\Z]WO?*U$ R_6[((]Y.N\TM$>3[RI<5+503C[ST#0+.:"
M*5$AX:EC' (SAB/)^#A)J(^%'UK),0XS8W8#P'W^^-@*X/RK_(_RJ5; L4PN
M&-8K9A/9\;$>>0QH'%B Q@4-]TLGVCI)U31Q9.=!ZBHK8)@1TZ8 G 74FWC_
M\Y[FK+RG%O:L]F5%/J]_P_+WE-_><[F^1 FG'@HS&(21TBL($I@&(H T\@@.
M.6*AY]NHNEM;,+LC<-7&V=4X3Z!N1H:C8CGV7/AP7<W:?AVUI-?UX,/N4/$7
ML'=+[0-H)5.]ARJ7+)_RM?12%4N]*:J\-^7"17%-,YC'JZ!YHOWW+I-I!H]!
M+4S#!]GO"QPKK?G6ANHKW^BDA)5>NK0EER[*O)+T_5&+R=4"Y/N*N6%"HC@3
M:E[)4XAPF$*<"0%#$K.4)D2@C%G4LQO=X &;IE-4N/LDK<OOUH"WE0GR!WEE
M71BM,-]5';^_3^]5O'_W34/K/<60#S%^I<OD==RM2^(IAT'C,:A=;HM8_':Z
M>O+$G6^^JS*;EV"BS9@YO Q6&SF3=%#/_L^X[4^V;30)C-W=IFD:M)]E7 1I
M]+78<!4(]X>\\]Z/5)\W\NU)YI' CS(HPHPJ95@&,?5\&' >Q\P/61@&IH<.
MO2W-;:LI^#6-_B?0Y@*VY4 ;#/QH 93-YKS>#^_I0=D9:",/JEV\/K[!Z[12
MOB5PY@.:,P G&I#Z@70SAAAATC,&]-\_&8<;N='E8+,;AFU;'>-W1=V2T*^%
MI.F;HM0R&9M-F9/M1I\S%%^EH\5Z(YU6>VT[U=DPB7T1B!CZ/$00J45:EH81
MY#2)8YS&49I851EP;-_<^+J>Q]$7\[@A*L"NNY'Q1* P49IZ*LY(C:)9+/])
M4!PR% 0QIJE=U. [=N0T88=?>%7],\#--AON^*!.2]<OO&@*2C+.'_0%K_Z:
M-TY:'@^Y?@G,MDK?L6/?;\5=5Y:O2]$70BV3U(E262M3O>KZEWZ.H%T]4@\X
MVF-U;=VD.[ C0?MZ?W:L9NS756]#Q[[DF_RNUGC@%2^?^%*)49$T#"$F.).K
MJX1#[(4^9#C(*,*!EV"CNO.&[<UMS-X;"%:VA<=,(3Z]PG(,W,A4>B3@M -E
M8[-;&,W76X[AG&C5=3ZL5@LP"Y!ZEF$F3YEL,6;A4G=)9G/;L(79EV)]]YV7
M#Q\YV?R!564EQ3+?^&.3 'HM;DJY4L@?55V6K_SGYOL/OGKB?\C1X+Y:"N[Y
MV(\]R#TA(.*<0L(" @4)?.S%B!-N1-%.K)D;@;<!N0P\MD:#UA$UFUM)9Z$T
MY $PZ:[ZH.0[C.SFXN=UG]G,>[).&7EP4'Y Y0A0GBQ X\OSHLXNOUX[H"^G
MF#F:&9]GRZ3S8">PO9[UNGGH,'KMMG)[+Z?6K2%+&@>)B!""*(B92EB0\UP_
M1E @.:T-1"Q$$EI$&)QL<*81 GM[%256RN*:$TE1EL4/N=JPW)TXCK@9VYT'
MX%3U+KN@:2OWQ.:.Q$Y"X8B@CK<S*?F<=/<UL9R^86!4_"GYZ&/JT=>/6A'T
M=WGAIOJ\KH]!_YWG=_?R:[YXXB6^X_J/'^7GO2NWLL0L")$?84@#=8R9^3[,
M"&4P9B'BV/.S.#82XW@G^^<V[VL-AKBV&-PIDU5.%@="E5%ZTF64'GG9)&,5
MVFWP0<X 6;%:X;*J_Z@P^L4R='_B5\>,4V?\0HS,U"9U!7K+"BQ @\$"U"BH
M=4*-PP*T2( &BOH2H,#H%.QRF&CP/OWH*D-A8NNG36UXGZYYDQ/Q3F8,&VC_
M@<M<;7!_D\_4I:0XYMP/&8%)@$*(XH! $F,.O8212,2,H\2JQM?K!N8V5+7V
M 67@H$)=;R T&Q'. 69DRK;"Q)I"CSGNB./>/'Y2$CKFW&N6.'K=&<$E'>4(
M=5JU+4M)+4ONI[X7IP+Z01;)#YJG, UY N,D#?R 8YRD0P(,#C8VOUB!^F1Y
M7:QA8Z+]29(!QA;G]V?C-LE1_$L1DIV=CD_2>[%P>2A^N*'IS[=['3YX5-U_
MQV 5I.;$^Y,T\^J_MOGF^0^^N2_8OOQTM:08>XR@&&*6*'U*Q"$A(8)9@)'P
M.><D"NUXPZC=^5%(;:A:='!<KM5VW #]<3/,S7C$.8[C'TGO(WF ^C1 @VEM
M->B8[53MR!PE=T)'!FU.K7%D#L,!>2.+F^UC8&ZVFV]J?:-7,FU,C9H2W3Z6
M'+,E1U$0!BR%84(3B */P303$21^B#(_BP0+C;;E#-J:V[KD8KW>XI4*4:WC
M#B3]M,&*X,,C+U5!&,.=,1.D^YG',7XC\XVT%&A3Z\V?Q2X0L%[/U/:Z@\X\
M],4AA!.%O9P'I57(BR$X/>$NIYXP6:B+H2O=,!?36X;-^%HM\^_%!94D7O*;
MLI <LGE6Z62;BS53U/ZH+EG&'DD3DB"8Q-B#<J:'81;['O09Q9[':1B'GIWN
MI7GC PYH1V;AUG8MYO#8V+T C\KRA8XMYZWQ=O-!BQXQFQ0Z1GDBIF[AW12@
M,1O<[%"^V:-\=1)EZ_FA/6".)HD6#4\Z4[0'Y/5T<< 3[.>,?]!_XU55K/^\
MO9:STU5Q]ZS" %6R5IOZQ].0!YDDKTPPB+!0A16" 'K89V&6"I5N8SII/-78
MW&:-TLYOYC.;DU">GA6Z!&ADLFE-!7_^>OLK:,T%K;T#4E!/OXK&4T.7.$XT
M-SR!IYM9H2DN/=/"DX^8;%YHZDQW8FA\SU Q-3F_I'E]1KEF%P\J]^6_ZW_N
MRF9$B>!!ZD&Y%N=*:S* *?<32+"7481"'/E&A&K1YMQXM:UTP#JFZXD)[AAO
M*ZAV&GFSJ9]C/$>FX:ZU"R#_M>([-+NFCU),P0(J9\)GIUN<6.K,&(*WXF;F
MMPZCHT_Y.M_P+_F3DDG;R-<F)RO>E(#HM-8(2[Z)YD_#,/%Y2B#R8@&1SSV(
M>4+EXM4/N& 9CY30HSE3G6?.W$CLJMKD#UI4&M>;BUWR KQV8C$@!>/,7C-C
MN>GZ8F0"K!V!VA.P=Z76BEQHX5PM4]_U:HP$#3> .J+),XV9E$'= />:7!T]
MU96F;O/C-5DUR7;+@"04^2*%@J 4(D0YS.(PAHCZ-/,\)&>(J=TT\&2;<V/0
MF[+XS_KC)(WF6[&S]5PYW;> "XJI)WP&PP1)F(4<US"-U&$8%Q[EE',1+!]U
MF.#M!I>&5=@<P_ZZ_?' _^T-Y !O9$?<Y6MU*J_R0&ICW/=$'*5>%/@>C&)5
M!X\%#.(8,QB@C :>" 1.6-,35VO#;?%1^J%M?>I>X$K-=#S\3==!3A$=?1UT
M2#RZ_=?U:5YQH %]%)_15)_?MOC..L]'(3BM['S\UL&+'R4+;5@8VPODX!#(
MT2&).9=K'3D<DU1X,/3CE,1"!''D6:YUS%N?V\!L6]-]&.3&"Y5Q@!Q_7:+L
M!F_+D6\*.<R"&YRS!<"NBY&?!9N[U8=%VU,O-NQA.;"V&/"0@:F;C>;#M;AJ
MPB5O>-EFO.3T8LT^YJNMRJU^6=C+ST20LM17<RP"4>8Q2(B702YBRC@.?2&L
MA#0&VC$W9NO6M"/*<+U1RFK3=Q&I.EN2%@\/<CJFDR8M<R8']ID9(4[0$R-3
M8[<36A]4"F*=M"AG;;N.:3P9I4R;(SQ=Y1(.M&+:G,#SH'J3VW?FXP8J:*C
ML&OQ9U5O!UV3#58ST<_KJZ:FQ*=B7W'T)<<O$RQ(DH89)+'O0Y2@#*8AC6!
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MA.+Q/J<J4T8_KP*XDC>N5NK_;NX+N<XM\^KO"I1<9[^S)G!*MZ=BQI_!"O\
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M*&M!S,W%RH\NG^24S N_731?68@BWPNR$ :9G%2CU \@\3B!.*%9B-/02[/
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MO2W-C8L;8P%OK-4ACX6RUYPU^J$]3;O. !N9<%NLKKI8:5,'G+'U@V9.LL[
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M:V9X@M!_\XSHI#$2=*RT/I,Y@92%/H(3Q*:2.AB&G)UBP4E ^L0'CM\\G8[
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MZTR)-;O-[]:YR"E>;YK26TH:OUCE-.^JK@<BBJ,8!1#'*(2()@QF*8L@2OW
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MS@+J3?V9\YXVC%B_<WJ_+E;%W;,^EY2/ER^DBK"]J"J^J1HEBX![,4T$@7Y
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MNV#G+[@68.<Q:%T&>Y]!QVD@O08[MX'RVUSJ8-P7I9]K9]7](U/T_VL];ZZ
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M=/UL=2I:3^N2H7M?0>/L+DKKU([R8#V>T;K$L62/>SO?1=5G-+B/"?^,U^#
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M)E3J&5J0Q9 %*8$Q%RS"(DPI"UV\K^--S4T_C<.UAPI:K&XNU@EB*0H(#44
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M]B1G!GW%3EJW.VT,I2L=![&4SC<8)ED?\TU^6ROB%UG)\KLT^3FV96E.P_!
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MT.)< (-4\P@,5CN%.$7H:67P1-/8B^9#&+*6 PL.7I"!2O*_WA;?_T-?W2B
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MR96H5Q1J3WNM7[9M)1> [DT"M&>38T2<>[?9R=JXG3&RR/7[H4,/.O@+T#,
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MLJ+4$+Y'#/:0%^"3K&<1>JZ_ %?/V/],RU,9K 9&V-A0Z#6TYF2#KQ!38T/
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MY&[J7AK;_7NA@[0IO?TI4!M3!S+49H!?.H/^L@"U36;74%OE3S9]<NQ)6;U
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M)D-(,AGIT</$[L41@E$2X31(5!RBU#J)AEO;<Y.G'GQ0M?C!G38 : M WIH
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M8-:%VDUOS!".1:),YML0(CTZ0(QD!'DF2$PB[92G5J>7CS4P-W_;0 3-A-:
MM(\P>)&]\_$=EW(RLDH^HV- Y,6+O-B'4ES*ST2Q$;:/C5.0PRG;3T0MO'C9
M9&$(IT#WXPI.?F^8M]RKH_U!]_CZ-M^5VC;Q"JNBVI:]+&MQ(&@6$PD1#K2T
M)5$*<10QF$@:)#B6"F=.2Z!NS<]-^#KT=2#L'G]3L+E:&+?(S75U[ T[IW0\
MCD<6TM/T@CWXD8[Q#2/.DUOHV/BD#M\P8IZ[<@/OXNZD-2>55ZOBAPEC[H+]
MHT @'"D,21!0B%280!(2!1-!F/;1XHPEUE[:BRW,3:V:6 &Z0VGOC[Q,X'E'
M[6):)HF>V ,<X*J]3(V]KW8Q11,Y:^Y4.;EM)VDXX;>]?-UDCMM)V'W/[?07
M+R_7^26_O=O<*#W5K074H6ZCS%! $B1@PH0RH9H!)$3JN2O!.!),D31URLWG
M!=7<I/-9E<?:+E@HJ"UKO)'7*-8YO,_M_,;)>W)DM7^-3KRH5.?%I(]0J7,X
MIE<KU'DQC:?J=%Y^<W=_]BLMZ=TU7:]-J:]*ZFOO/JRK3;[9;MKZZTN.11)R
M%4(E8@Q1)B5D$0YAFB2)BI(08Z1LG=OSS<U-KK]>?_E@[\)9T'G>U?5+TLA*
M6(,%#5K0P04[O /<8 L.[7UBOUQ.Y""?X=2/FVS/S F?V>(FDSG0]@;UO6F'
MJX:YUI]+LP^]>33+K)NKM7CWKVW^8!ZBYQE-$R5"S@F%&6<2HBA.(%,\@R%-
M(AX@D45!XN(]VS8\-\7M<"_JI?Q-O6*WPSY@(=2Z ^Q<V3%H'5FCSS Z12I9
M5]8\N9O6S4[J4;J2\=QI=+Y^J')))<M2BF:;B)8W9>V3BC_H:BL_R[(.6%TF
ME$5ZXL^A#-(8(L%#2 7-H, H$301(HVM:I6Y-3L_U6I1-S'L"_! 2_#=(*[#
MV46Q6M&R KK?FM!VQ\AVR[ZPE3#?#(\N8!VY7QMR-6;]*#=S; %JV";:O8ET
M]ZE:+D1YTRRK1B=6+!<B#O7*Z>KA65^EW(7FU#/J[D3\8U><]>U6FOJL[_63
MN8Q)$B)!S7Y-S"&BDD*L5 "YP"%%C$F1,-<,L"X YJ9@[_/*I![4SV/FGA+6
MB7D[E1J3SY'UJH&^Z,4FM@N%._P+$]7(M&C17+2UHHT-?O/&#F'/8PY9I^8G
MSR<[A)R7<LL.NL_@J2274E3FC.G7NZ+<?)/E_5O)-LL$(ZF8BB"GQ&1_C#)(
M.4V@X#)@7(4JC3*WF/*C;;F\9M,$AG=0F_/EE0$+M6#> U:49?%#=XSC,9WC
M/%M/$2_G;OPY88^T&B4T,('!Z77>=YH*?Q.](^U,/;,[;>X+4[DS%UQR#'"W
MA; [>Z "R<)$29BDF9ZLA5Q!BCB'7(DLQ"%AD7*:K!UI9VZ^37N@8+\G9W%
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MI_S_"M)N&V,H_$;>X0[05836&64'Y#[T(.?? - !DE!- /NFFK81H /3)\T
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MZ]=MT^;=&$2J8<//@ TG23<+]D7D,[)"KYB %1=MZ0!PM]V:1ZH05EN M>;
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M\MS\+48Q9R3*4DIBO^8"1S/,;2$VM?3W5-95]1U/>Y=QO+XN;T9GY/7I"\R
M-@,7F+^AT<#QB!.W&KC T&FS@4L/#CWO'*J^WJWEW8/-1OI74_/8'&TB;18T
MTZDP"YIGD"<B@43%B8JQ0KGV-+DOSC6WI5W[;[H5ONORWQV2?>WPRSB[6N%!
MT!O=!C]0N; EH5=JCUZ7Y.KVXW&[D4\B3+UH#YB"F>679YK8*+_*\JE)?OV5
M80KE[YN-_*M8K0XUIVV'YJ6D#'$44XA5K"'*,(8D,@I%T!A1C$2<"C3@?OG\
M;#.]#VZ)[705 *(NR.VG3"Y@S*4@<:9B*(66Y@1$""0$F7_F*))44X3CS$=?
MWP#NA*KZ,JI!0'53SK=#-;)>;@E<= OZ6QK#:=Y^# (IW0N33*IO^QD]5K57
MGA[8XJ5\M]E:3TKC5"E/?2QM3+#2C"<99S"/>&2T K<W=#*!4F8LUZE$4>)4
MB\Q_ZKEIBC;CWB<M9@#@_1IC7!A'UB)-:(N-:[<$MI[6TEIZYWROWNGOGE![
M=F49!?(IN[$$A-Z_$8LW>M<:L+@/.&WC%6]&3QJN^(\PH%Q+/69U+UKP)_OU
MV8%_9SOQS<:\;QY8L5Y2P3*>I1RFB-O&7DA!DC,&LU1AK9!6-'<ZPSO/.#>E
MWZZ.+M7U"FKI!G_6E#LZTMVQO[X1!$=THANV%P#3HYQ):% GTO M<I6.=T$Z
M4(=T;\SZ"HTXC3-=$1$?MIX5"/%Z<9BGY/U:;!Y4U1NIJO]5%R[\\DVIG77)
M2%G8:=G*9B^M-N63^=9>_7R6X%3V9SB5OQD>WIO1RR62 E..,,P4R2%2*H($
MYQ0*G"NJ"$X)<NKO^ *TSVY#.9M>6((.JWZ.ARF_ S=OQDRE._+F5G,-]FPO
M0,,XJ#BO7=A[WKORMC4HG^>CEM<34DOPIT4!5# $4.,O*+Q OITI*9_48?0"
M(CGV0KT$"<.VQ7?%VI)6E=LZJ@=33?RTWGTV7#1]B98YPIJG6089C21$<9)
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M84H#!K%*@R",DC1&5DDRIQ'WU#AVJX0AV6KW"\J-'J8"&9-@;7*;Z!^7K3)
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MV^&I[1M:><W)0UT,SA19J&0^,Q6&]%;RL5B BSDMRZX1=/>CJ'\)_I"KAT*
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MH$H0@B3+)*1("D@DIX0E@6(FI*U8T;F=$673J1,E;[H>[^NO)32ES+2(@*Z
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METCQ.\T71K -A_Y+BEG"$B6(9BR, KWI17K3FX:I@*%(TI2J-,U8:%WARX-
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M^O;NNO?IP0&QFX,';<U]D:N\]N[>)MG9)#IA' <4IPF,:1AIPRJ*((TX@T&
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M#A(>X9 I%G%;0G;H]]28N9;5Q";0C;1 ;,1U*$_M@/UA=AX)T=%WHB]=L,_
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M-OQ!0EA-T.D3XU^;T^;\\6F]JJ;G@3SB'L;"C@#]0SM9-3,C-Z@$/P,;T<]
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M5S *(C/*G"314HR\-8_$*H%Q"34V9ZEUVCF?>"]?IPUA0T#301!X[-M4U\8
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M;MMHZ3<'U1&NJ@A^./U2GTII!.5)@#) A)/H,-KL,+( 1YA(DFNG57*Y\\1
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M7Q?W6I/Y$3,0\&A!7[H,]9 9Q>RI F*I*S5R$E*LW>[FQU3U&V6_!$KK*F9
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MD]FB:.1^_P3N>."EBB^6>W>4$K'6>I(B8]0KQJFMG</8C])^35^':'ML#E]
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M#C5R:R)&SZ#YZF:%34Y!<#HESACA(N$>\U$31[E$J2@C($K.96TO]UD$]FO
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M#%,JZ]H-0)Y+8\]34KL!6:>*&@ 0?U^@0WB\6(XO_1(6(Z]T1-$@S3'*<LL
MQ)=;T& HH[B] KC:A<@/*6@%(OG*0'2 D < D<T#J1^?SM8PR;)EQ%H?4#X&
M=X!1GJ#4J'(^YDQ-;?>H#6&M *5>&:#JJV2P.&LFZ(QC&06Q@^E12HXY2R-)
M5,723B<0*Y@C(+W)WHB@W<O KQV]K5"I_RE0V8$"!P#6U67];[#\,DLGTS(L
M\G*-&<ZU $,]0=^S-'<J]=A&HYGWCKI(M8S57Z?O)*@5W,PK@UL]%0P 3^A<
M NZ(,($G9IQR13. )- T-G5)$V=U),!H"IXJD:H/,]I.32LDV5>&I$K"'P",
MWLZF$>4X7XU0&B_^\19I&"_+WT:464:%4D1KP7%'4$EL:4 G(00:,T>[6[\\
M=RLYK8#D7AF0:HE_ $@J%G6*OW+]) VG,W6,6:*E*%XE,N.]+R_+O=!.*XM[
MHC*,MM'2+@=*7QF(JDA^  @ZAV:PP*\PA;DO?>..TN5X.EXTV^/;[6RF)Q8W
MRP"!!T."X@ZC8X>!L0Z6*'"<!Y$,5;7QM1^E[=#WVE+P+Z"U'K%9WCW]#28I
MKUK^/N8"*#6>2DT2<Y1()6.Y8BBM>#CWX(3BCPM[-KXNV[Y".\R\EDQ\16D.
MP%Z=S<OTN.7UV:3<L$Y3B2^^EI#B,5\R!LX2BLI#+!5-G):";TI$CGC$)YL-
MKVVAVM+6#E^O+PG?@68&@+A5"_M59^C'K"2AJ7<.+:@IMYU<!707 R<\I6!P
M%X$+M;WU'>2TP]5KR\O7DO\ H+2C/>_MCVX2(Z!X9EPJDI-#@940)*@8")[2
M#AF..<;:[0%;$]<.9J\M6]^-;@8 NL?<O$='<0D?T$U,-PS)Y)60PA$&!MW"
M +QTA$6#'*2U21A(L?XXR1\0U0YDKRWY7E<7PP 7S*=^\OL"SF=Y^2<*]Y81
MI[/RVA+0'*-?3C.Q'NUS&9A)O4U@>:P/JLW$M /3:TNMUY%]SW'>R71Q-2_/
M]-!]_#SWET^.^, C3TQKDJGD1*)Y15Y$*G."DI2N%' \NC/<&.W]:)UV$'DM
M.?/JDAV J?D$WV!Z!>]1=J4[0)'-'^/EE[=7B^7LLG2\?,A=1/\/0L@DV*:/
M$]/$&>^(BIX9@\:5N]HOI9]'83O$O;;D>H=:ZME2G5]]_3H9-]/E4;QX9-]L
MJ,<L:5WNP94D8%B9.<TPT!56$26#<?@CEV1L8;!:+M>N:/2U9->[DO- H/,)
MM3/_]C2,#13#AN0M";I,\=6\M&XRE@@%D)GPD1G^#,AL6:8=5%Y+*KRV7 =P
MPMU-G']B)67T)E-'3"XU8M)CQ)D4(UHK-)XL&0^U7^YNHZ4=B%Y+;KRJY >!
MH)O!!:L+H">UAMFGF&SI(0 4@TN/SIXH+>)$%C$+QI3H(-#?05$[-+VV3'A%
M+0P 4^]G<QA_GKZ]PK6G\6&'BIO.*I-&94_,KV)9^I!UZ2)A2W]Y1[Q3E%@0
MBG'K&<3:9FMO8MLA\;7ESE]&=P, Z7W;[R>< %<9D';B8YDL[&0J-?RV%/=P
M$RUE+->?=[:-FG8P>VVY\TK2'P".RKB..7PIPS1*!_GB%6R./A1D"<%Y]"6I
M+X^M%3H&@1(J C/@><[0Q5R8-K2UP]AK2YUWHIE!(&[M->WY55B,T]C/46JG
M\V:2RUK1]/VO0CJ^&?MVF_%%UD1,B:ABJ646N.%\X,0P=%/1447OM8.RT<,)
M;X?5UY:9?WF=#@#(YU]0Y&_\ M+ZS*/3KS<]+.[2.:4^Y)9%[;RTKE2!."A=
M7&TF&&X98CP-&0* J'Y)M >9[4#Z6NX&7DI? X#DCI["3U)%Z(B@=T*)B]H7
M]@+Q/%$B@$M+G=&2UVZ1T9ZZ=@!\;5<%'6EG$+A;($^+Q2R.BUTO%R#'W\?+
MT_F[\>+K;.$G]V.(3N?-T[NKN+R:(_M/XS 7A:."DIQ1RC(&])]C8H2AY'V&
ME*VOW5*@'O7MF@V\ELN)GK4[ %S?]JW$G1O&T_7$P<@9H%8H3PQEL8Q=1:\[
ME%'RG+(D0DX M=^_;:>F'>Y>RTU'9>GW?!=V,6_&?ETW3;6?/.0S*KA2$"QE
MXD2*[,N4%/2 $Q5"99X"?X2BC1=AN]9HAXW7<H%15:(#L# ?X<\U"<UG4_QK
MA+4GPT_XD]JY"()$K]"">F@&V4>BJ=+4>R>,K=U7^[DTMD/<:[ODZ%13K[$]
MX47S-/DA!X<W)[SYU,Y;$VZBOOO&A!&BQ__#*#(8].M]ML1)R0F 9 SEXV/U
M9ZK=-2:\[]UYVZ6SC(E8?)CYYK;E9I+7]//]0_;UEWDJ(\.>,%_&4P@6<">6
M3LF@#5/:A0"^=B)D?W('V];P.7AZD@]Y(?4-X)3=^E1KC2-AP=C2],J54;A:
M.Y0I1&2+ E54)$7KM[+[$56#[9!X".XJ*V.@1^=M\'(4D;W%N E>_#2]*W>&
MR_&RF92Z[P':_K-K'*-[<E+I,-T0!);GW^4UR1I!=\"4P*W65A/#(R_U2YYX
MZC1A$7@(,D*"VD,0GD=AO4,7[?(,'9S_@7222N8ZCV&UZDI3N V0C+59C/BS
MJTM(%P\MN8[&)'2+RWQ>W&JR;#5+)0&>& N.>1IKQQ.56>CW<.X0G]L/[)=7
M_0 .\7OV;_..O\YG5U\7)],XN4HW<SB:I/H5I%,\8E89H]75^3DBH@G6;H9D
MG7\!6#9])%*C(#_9.,*:!@C>,4FR9^CG.!Y*.61LWHV A*A,]>&A/;#9KYO1
MRPX:)H0&ZLL\R.F?7'[UXWF1 SH!-].VWG[Q\\^P^ C+O7V:YZ]19WS>09Q5
M&Z:W1L71W=KWURIWX&>!9T^3(\K'TL=9!N(\[@5EO8LNTR!3[?Q!:^)J>C8;
MEVSNH=9Z(7"01N+.QQB!XAE&*;$R)B(\95J+*.WC1R15/9<6)/8]9J\+5.UR
M2FIK;5!.QP/V;A[@O+F^P,\YS87'M5'-W"NIF",VTX06O_2?2IP1"$DX#).U
M8=7']3Z?S'X/_5[!64U[ SVO-U<Z[9^OW_5Q51+UK>FM=.#>.VI%^_=+KINL
MAJA0B#KSUZNBG5M("A%S@BB(@(@VS%I6JG,8B5082QWBQ-8^A0^CN)X57%^[
M+/I^-K_7WLVR1_.YGWY>78T=39I/+X5V>;.:&]+?--G 1_%I4$Y'3Q4!#$3+
MC$96YGL)$BC$E T%ZVMW3^^%T7[=A!?<"]O-\U!A57$TYYXOJ6]$-,M/='#T
MIY^GIKSZXHN_J6-=W$_1*RF?U?<>\9]33#%@+$I1 $0&)0BZ8I3X:"1/4= G
M%7:;'U]7IZQ?CZ2'?3  !0_*Q=Z\D^]'-30%/[]/QRCV(IH;9_'Z$?N4&R=3
ME,0&J3#"< HC#)8)>%T:+B:NJ@_=J,Q"OS.K!G$@O#P4>BX3?.>7_D;"R]FG
M\]^W<)0E".]*IS1?IC1IR4BP>((EQX(!89U.JH7Q;K=:OV.O>C+('2CB%1C9
MYKN+HZOEE]F\W"O]CE'6O-EDJW.G>13SYOKX.\SC> %GN OA4W''UC9;CEE+
M=*2TRF(UV,FY)%$LT4M&*9C073ZN*Z[Z'=0U8%/\PH!Y#5OHGOG%%J.A4I"&
M!E$:-WGTS/ /)X0DWFNP,@:C[XOT7VJ+_)#J?J>"#7D+U%5XWSV[?L#M>OC]
MYOII=%[<L+6S\V*V)IXMTG&:TPA9D>P-!BH2P_%02LELRA"91N=-IV=$HB]'
M>;^3RWJ.5 <*D('FXF_>OY<"@D.NQS=^3(W<^X_IJY1S;Q;Z.)O.5F45T\^K
M16]Z1MVA4U'F?4J:L)#08H(7)63C)/F 7X"FQM2.WMM15L]]V++>F^NRFV;3
M!Y6PWD;@9<A;3A9C#5">>)84<=$G':6FSG;G,3R#T'YSV!U@:[LST)7Z!FK
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M\( ?K-ABA /@:'KN"]XWC5'_6'R7":B%Q1)E FZL)+8<<:0+,9BL#4H%J?*
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M91E!AQ148#&RYBA[B([3O/MO;+[VU4NGV**-,YEE$M_\$YX9JS46%FKR*Y*
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MH TDXJ!&<PPBTH&>,*&3)0DFMYE[UF)09W?37G=2\PZ#.G>1>>>#.LVJ@9!
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M=?.">>LY\NJZI0XRJ\T0!GO=?6[%8[S;[L1U'R^RWOE20KUR2KFF=L:5[X-
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M7OY*RGIX>C,R5Y1&#<&;^F@O!(2H"V!6UM"_152M_; GB7JF$T+:P+BMRCK
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M9&L?^U&".@34L:J__[K93 \=@&K-Q;4-G]9]R&]#W77TKMPR[9L-7-)J=$Z
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MB6R;*?YH^77@&SYTV[VYWA\;/$'5*&*!.4DH)B^:7)8$3)IDK W,WE_L/,B
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M&9S1]1<K"O*8?&R=6CN:V+Y<N*' .93V.H#I@R*<9!L<9B<H9!+KJ2<DNMI
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MBKR.@4650$ER)SVB!Z&9S1@")B.?\(OV^J".0'&,&N=#R;0#2_)X99'B3I.
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M2:9"ZW?W '*[]9;;P/)8BCS)5K![_VCJL7//?G#Z!J]Q/,_2R\5]B>1UUQ%
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MV89 UG(*Y--+^O.Y<5D)'0;+DTHI3*^PDT3EXDL^8]R7:-!#XO7\(<G6%1:
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M#,[SW]M<HR/_[V$7Q.WDZXMENEDU>0/R%V&S76/<GG%K%(]:@F/D]BJ'&KQ
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M.IU(%C1@#-)PH[E4K>,Z)]@*,$K-S[8"C)%Y!Z 9EC3/CNE %@-D+NE"%TD
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M6GI>6E>?_5 )Z5& &-_H.T([O</M.B?FA=8L*8C,D:UD/9*M) MP'XIW,J;
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MM2FJ.:H.*R ?H[,.@@'/5Z:6C)A\,>3O: 4JH@;TY+G5.IXLDY>V^?3F'ZJ
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M[H>:[[\T""_VE/%RD&Q[>)^NJ]E^^GJ_L.W7_"6?7R;6.7*'.D$.J?:46(3
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MD2&S&52V$_E,&VI=5BA\2XETX$M8P0BW%D\$&)9\GSR-)Y9HQ0.N")!:#&W
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M/0'+ \E6J^PQ,I-0._.YQ[;&,8R#8>&^+JHMF!'=JL5\>?X)9E_3*M#70;!
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MD![DHI.K1L;:!1X4>%V[KOBY/?7"FWLY>!M$%HWV^GW=75Y.EJM2022MC+)
M\DJKO-M*A\/S[_?X\!HI^(?24JFUUIWES^XL'\JR-\V/;E*PJ7.*)28)#:4&
MKJ (S:(G*2E+G0(55.TBF[TV>'RIVF+QPQ+KIP9K>721>N+0?R326T,<:FI2
M&F]GSJ)4JO;,HMT[&??*?3BL/"Q/.UH.(Z=KOL.3N];KKV&QS@<R( #U=R21
M<U5Z^#/4ZIX3%FD"*1/7H5>.WC,YFP]7'A<U-63956-L4["X,_(+(%LJ;9F?
M*LN+MC;$&Z&)H\%PH;-4K-?[[U[@&'L 8PUY/@J- YD[<OCV'M:#&3ZB",)\
M\JU\]^';!);IEKKMX&3*@@D&W4)@M(R$L,1F%4N!IBA/DI#O=ZK?&;#U7[$5
MD!PJV6YP-H\,GM]GDV6*GU$F*)H_YVGZTV\P"Q=I@1___:>/5_-XE3Y>P/P2
MWOWT\2?T*J<;&AVEVF6DT2C\0VH,.)R0#@FU*HBH$D_0 TJ'KC]>94%U8)U$
M! W!K,MGEVD^"; F]C7,I_^=IM-TC<',;Y-P 6GZ6W@[Q2"W6RZ9"]\Y%P)_
MM_K7I=7P=)*[^6S2Z]^__N4U<\IH)]B&:])G+6/F)*TG998N;]0#H0H=BI"4
MUZG/I54[%(WS9CWX47A!,!GY</TZPRBJC.Y\W7U/<_CZT" Q'Y(.I96A9PG_
M<)[XC-%5U(G'0"/5J<]3Y;,+C?/>/0@4ZS)U9(1\F5^EOR68+B]>7TSFW;<2
M;4_"K[.P,B<_??_IM_#?JWNFU]W\6S=?47G'T"2&H;CC0 RUI5M7+I,CM"-.
MAYBX2%;1V ,^Q^UBG(?O0;!U0G$T9/??_ODI33].(""[)]/T][-+C.Z1Z+?+
MLRUE/ JJ:1#$9592_H4D(+,G.6DA&6@(8E^G\OE5QWG^'MQ^5F9W0T!:&_0/
ME[/)^A %9'0Y/(^>FY^V&ML:6WH%E8G4C)1T-F2KBR1;YWBD&8+LDU%88R_C
MO)"?*'X96#0C0_'M=Y@MEMWL8S>=A/0QS19(2YE'MY/(;>=G)24'I8F($75V
M++&:,I0$ \J H^!8'P_LD+7'>28?!&J#L[XA+;?2WW^#^?+O.T@K2IRIU]\I
M=51\.MM6S"7#!&@\/R(A6V7.>)Q<J;CT27O*HKX_=[.?^=QK%^.\DI_&G XG
MCI&!]WKR?3(M1;V+-0O+\-A+#)07_GIYD7[_Z?-/9TO\U[-TO?B0,YX]#*WQ
M%V^A7%+-WDP62XS4EUU^G_[X9S?_U_;D9>%,9HHXKUB9$Y:(#\$1X9 C@C)P
MT,?>#K*Y?C?3]$7@='SIC0W?*4PNRPOSANZ?D=^_E+A]5IZ>SS:OB&]GWS':
M6OT(IJ^[69RL"VHVI]6#8!D/:H;B#&MFB$5Z5[<^W&8\M/?;S.X&Z_%;Z0?-
ME_%J<FK)M)#:=L/#8CFN%JL'2@A1\A@9GI[ B30JH"U@0#1+C,88C+.U6W+O
MVL>XA7(5W_6K,;M!P&R.G S,6<TU85#R.+F)!!@%#-&9MUEY177M*>J[=S)R
M,LC1$GX&,@>PNP'0?$[+Y117O7\K;5 =YG(-+;R5&.UXBIRQB60DP0)+5/#J
MO6)W;Z4MV!PBY?NM)2JP?.1DHE4L4\SL+ZG[.H=O%Y, ZPEKR<C(%$C"E(3"
M&$Z\R@%MKBL6GJ:@:K0"?70#XU;>5LXXJ\/FL;&2OMXG8=N?)7G%F?$$O$?M
MJV@D7@J*^ <!TB5NJK2-?70#XV4551)L5YO+(T(EE!*!^?7YZ[-S;SQJT#)T
MQUN,&"V3Q#JFB;'!>0Z9:OO4I(Y%"C]][;[_U^83U]#8?'.+C-OU1H1!':%U
M1W&P 2?D@=K<=C/\D&]_O!XO1IT Y[4D($INM_")V,*8J+V/*H(2]WO+U$^(
M?W1WX];I#Q$6#2.8YB!W_4/?,!L3.'3^2>*ZS-G6 0]?:?P/VB3NA-"F]JC=
M)[;36 Y])00\";3#Q?%R<JA%\$YPCU195CK4!=3P@=/2U E)PM^H^P-/7V0.
M=74!'Y9*O0^WQ\;0^O8<">DF\0O\^7G5&'5^VX8\:9^=5 3WKXET61&;T+9S
MY!Z:?.]TZI5\__0R+=WP54)+1;Z.G3IP]Y[[84)A#DHX+PC/"4,(\+24< N2
MG8^6*6.%ZO-\^^0B+879=>!1CZ<C@B.FR?F[]!6F;Y$YR[599A)$Y$$1M+_(
M!L;0$[06 TR3C*#,0GRR0?\VFL*/7CLR^,6M_[)CP7$["U5T@H]EYL@X6.]Z
M^^Y&@XG)E=UR1R2/DCB.#II"PC6S*?@G>^@_#X*[JXWC:1PMKJX"[\9.T"Y]
MK=X5H[98_OYY7>T3TM5R=;.P>I_W5_BOMR^BRJ!6@]( *SA1VC @95$E_"-J
MRDM;!MG'E=AOU?'0<;A4NY.PN 7PW/C4SQ%FD_4*A"&>HL\D#77$<O2H)41K
M?,J:>=H7.WT7'<<IK0N=01C<PBRX=0&U,#(#M<187M[%*",.W2\2("4.Z)N%
MU*M!?=6A@(/UG*O\W',8&UN0_?8%4P,+2#F)UF;TO:,O0SLHX48*D)0K[JI)
M?^S"\ .%]<@<P'TX-_8XN!_FV"',0[:4DRA%+!<KK%RL.))HDC(H!@"R@L@;
MG .XE\@>G0.X#__&%OP/<^P,H/L,$DC&V!==:Q.(53%@1!Q%#E%#<$\]TKW@
M.8 '"_Y@_HTL^-?E83'-D4O+Z_=PN=9ZHF@[8QWQTM+2D;E<IDI#F(TF"Q&%
M[C=,^AGY[UI[W+:@E8W^T<P=V_[?3.XZ^XKN;;D_NT_2]F8N2TAE"(^F%,]-
M#(( 15ZI9"4P8P17O7)7G_,.^FYH/#-RO,R[H04P<BRZ2I#YD,_PQW )9[/X
M^<K'R??)XDX^=S: QA/)P2@)2N$\1PV*0;8%89U2Q2?K4T[>8ZD1'8YAA-L-
MQ^FQ2S@NTKS[US;,WE:Z2ZN24HD$!AY#:<Y12[-,%.Y=QP0LTSXS&W9]]H@N
MR>#0.)J7HS<T*4".5S!=E8_ ;#N_35L$K/":E%<](K,S!)+))%) D?L<S/V1
M9X_T,=G]^>-UTAD>$U5XVH9Q^4=:+/\^F7_%>.P1O2<"B\Q(2I2.&)R5@2..
M@D&: G , 8*V?>['^ZXW7MN;DYF9NCP?.U-C52.Y:2\U^S*?^+3XL$2E^>4"
M9CN5IQ<L9T8U20 .E:>S!"Q@N, UB,0#][T M??"XS6]&1Y9PTIA;%55:D4P
MTKRM==R\;V+<63HA[R*O=&&AF:.WIJ0@LKQ16-"HB8.0/A@:I>R3_W' TN.U
MP#F! AM8$@WDQ-Y4);RZ6DQF:;'8Y*>O:^6H]3G1C"3HK) 839$8M/(T,QEH
M$,GYVAW8G]S0N&,[!DBVKL?^%K"TWOOFT/DDJ)&"HXH%= XCS\1YAF=0.!&U
M$]K+6!L[=S<P;NYK1<$^*"4\E,MC=ZBYESFQ(60;2V@(*L1,F.&B=*0MT]H3
M$!N=])PJJW*?85-/+C(R) X77#<$%T=_89@MNNDDKOB_FD2S/AI)N1"Y)XHI
MC 5,\,1ZU*96>)^BHAAJTCYJX]DWAEVKCSNFI_HKP]$,;@XBF\.CF>2E<)J$
M&$K9-+KT#I(D,9?YV,(H27M->-H;).._(APOTR<A<@"#&_ \/GQ+I9O6[.O6
MRF[SJ:02D$0@#,\0VME$,>IC@5#+7-&($BFI[(,\LI66('.(C+OZ#!^[1GWK
MH7T.:0;S2;=^D2N'Q])5SC J6ZM2*<=-!(-$ZT+(+/3KG-*WE\'=Q4?J*S9T
M(X.#^3LV0#;[_GVV^);")$]2W":#<IE+GB8)JZ%VVEEBK=?$91-]UCER5R,!
MZM$---#$X'"A=K4YW A,?N[F*<!B>?-F)IQ3HCCAI7I(\H2;YXX(X97V8*0.
MO8K6>V+DQ]5'!$@=D>X R1'\;<!#>:!<W]W,WS1 I:=X< (O Z1-*5%U1A*1
MK$ VL<1AV-+SN[L9J8'@*?L9',;YD2]/[I<_7I5#\"&O'CW>X'9F$= +.P\T
M(G<X\D@KI"@$38!#()!T3-3()'I5:/1;K:7J\L/EV@W*Y!9AT^5U7^)S2)!\
M-I1($3/RB:G2O4$3RS5/60J I Y%RW:1EHK*AP/)02QMP"Q]A.M5^(;&=55'
MN>Y3M_K1.8N*255&-R-%)99CQ*XZ$R7-!?[<4-&K5=<>=NF)[;14?7XTCFJS
MOP$DW6F:>$/$>@;XV1^ THE?NI4>_5C>9L\I&FP(2)<N.:_29X':TS.B Z!%
M#]D*T^N6][ &I<]OL+&N3G70-IR(QK9RNP@K)*VI^]*]2K\O4GQUO5+29[/X
M#C]N>ONJ?TZMI1A"E-X.1I>:<8Q-J''$F1!CABP3]&G@?>P^&FNC4,%6GE(P
M8X-PM_-8FJ&7@>67DP52>FZ#%L$Y04S01:NC:^"]D,10I67&'UK;)RVYUV*-
M%<H.YI\?P>*V,+/N>+_I%;RE[FZ^Y'E46ACM,.!P%.,/805Q5GL2;"Z#CK02
MF>T/GV?7;:SZJCJ2ZC*^+5#=:MY?9XLE3*?ERZWC^27-+\^C#BS$G$@2I=<
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MI3P\#"2-L0WU/6J*QL:H:[&<+*^*I%![3[JX[#[.T_=2W8-Q_B;,A^EYH,(
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M^S)JYF\^?2.,#VO?YE4YR871R/J-JIH7&:VZ<+ZZOOT[FV%:9\6_63_<T>C
M6_1J8JFOE1 S.CD8&@JGM0_&(7RKUT'6VGS3Y8/[8.Z!DAY%O$TX#9L>V&N&
MWNB.Q2HKQM#L&& (:+TIHP#*>YV1AH3  ^/>>*B>@O;DAD;&WS@@>>!/U))8
M _"[1\,F?R8I3AE&7^62S)&2V4M<H@(/-A<</7"&5%:&W<Z-C*WNJ@GZ_LCK
MH[G> '3.NC!!EV=Z%8L[W<U78EDNYQ-_M2R'[$M7NHIULR6NBY_Q]=<9KIW*
ME>PJDRH[[ZCDFF@5%)&,1V*UEX3CMR9)$8VI7IQ_U(['!6,%R-Q/0CJ=_%I
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MAT)4*!QDHI(J]7\>"(((Y$0Y^9VJ?XJ09(G;V#)+) PH+N4#QA'FN@H2A8G
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MA$2A\D,#EPFB.F598G4FX &X@*,%B"=G(]QIB8A'/$"39FJ$\F.5E]L02$0
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M;:O5J.D27*'>*EPL7%3GEJG.;17>G*NW+==M?W7:L=Q[S>'30;5U+\YO*MO
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MA<\!*J@L%6BB GH8WI$ #JY&K*P0?P=V?X7BI(HJG!;:5R;X[S)R0R _ (E
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MPFC[S?=@$UFPB9IZ1%=,0<0'6-R#SU9%F@ :Y0E0$7P7BV$>E@U\$[,S;)F
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M(3HN,E=>DR,6Z(D8'&HK6#(-H)@H8=[*%TV6,IGBQ>O@R/QFJD[LL2*3+:9
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M:%NBNA'S41@])( ,H#: V@!J6^6895AEHQ%\UHH]:_>*:@?H8:@?7%O,!;,
MJ'[=.]^+$H2!<D"@ 8$&!!H0J'\#N-"7#V6]63TQYXS-.Y1&6Z:,LTF*<H"A
M 88&&!I@Z+HX,EVB6T%-*=QC0R6Q9JW&)>E>-EX^-;XLGVT#/M]8NNUKYZ \
M^,/R3;K= J?PJA5(AZ>VI,%7K-YW='S[\FO.,$'B/1=(Q.-U\/2%B4Y]]45J
M&H5]ZR1!,LN*);?#E/WYFN4-_Z -HD=M7]OPM3.8F+W;6\@04U@C LS]%Z^J
MJDS'-<L!F)-$WQ^\B,P,TY;F6N6H$<&KSK6O^8WN695Q*@XV^]&[N+"H*F%F
M4AH<:0(SJ#C99D<]_.MW!\?[+XA44%ZZ4EFM7=E=N*XR:(_Z3?R_5%4U&(^2
MH!*-4T^EXB?6(OJA4"4UIWY-U8&+TI![>&<</&Y1:D*TQA-+/0?217(-RAG9
M'VG>G(V7:ZQ'3(4;153#7K2EK8M+6RDP2AOA3/G81K@*0O%\L!W@+8F$L(UH
M3INC!2VM;'4"EU],.\!C%B4YOU%3792X'\[BYG9$RM!2450<AHD )P$<2E%&
MESR=IK- *UR>U_,(A#ZX6THJ=S (2I.RV6M!MM2B+DV-14U%K0XR\:@HKGN3
M[0:<U]"-0X\1_#E?X%&A<LSS=-=5A86MTBGW>,;MZ:2,()@ZIA="[[JDA WX
M@?PT!&UWHPCKC0[]:8&M<M.$;;3UV*1)JLI5Q]$7BZY< ,?8L%&8[22-]_X0
M:RV/D3ZJE-X2#B*9@4!NG!SC"D!G!;*0Q)90[KH/[_+GDN_$KM)86[>.Z6:9
MPZ^ N;@2(#,FVE=SV*A8B4CC7SE6 M9\B&4DOP^$:T@YG9>GY(8#!8F2<AD#
M/5T)L0%N1%.=P[1I'93$ZW>J;Y;WD #//F&L(6Q&#\=AY\3<XK&7+93/#!54
MM2=?2>CBLQ?1SH&@_YO05<'5Z[AS#K[F[D/ K@K;!YXZ?8=/0W>M;Y*I$9*E
M&0_7X23XR5*=LUUQ@5.K*OZ:.(L#0\1"OM ;+_DT[!S*]-=X\XW6X**I$,2!
M":RNA5X*1>)NU47'VO'OSO6/HB#*B\8VUZV\:RI^'^[AB0A)M0N'X0] #Y ,
M*(4;)' D3]-TQN'6UIAI;;B'0EXA"EVI-",*:J#=6&7T'LU,ZVKTQ\#;$('W
M\MD0@?=5(_#N$"+\-\BZ?,X_4#<,/,,FNO!XW2.NA8@.\JXO/!'\8)I8SXT.
MQ,@C55X;W"04]ED06^I-UQN=923 YU=Z12/[2%^:Q@0M4C"88]6JL<I0Y!1X
M(4F?6KW8 :Z=]D-2!2TWI8N(3P%O,K YFT?NF]!#4C"G)=6T5$& EXM(1ETU
M7UG\--+,A"!XQ[:@R(MEI#^EQFHE,%^#?\J4)C5)U!SI#/H0=0&$*6Y<+DL/
M]&A6IPE*;04+\DK$69U0$Q=;(<-SY1'Q&#+Y5XCPLC*8$VF6':NQ=^05ZJ0L
ME. WTUKA[FCM7WQ#R6Z*)GVC-]:.0>!%K'5B-MY"8A$]3W8@4!H ".",EG!N
MW6M&^J>GA//A6]9>JUD;A4B V=^:=02?[O3H?[/4TSA^L+(BNR*)]IJEWT-9
MJ/O@=<%="!16-N87J/,I<$8BMKR@=G578M+PHFK'F[,E'4#<P8,YN?;U>,L6
M/&91E&W3N!?.Y-RN'8<=/$'P-,T)WPXH'WIJ="@)BK,[74D3_SIV8D=_D@/?
M.).3YN.##>GNL>20#4$B7-/#!E\HM1C:>&# &%7B,PF9?!E@'I$[GN+[:# B
M@3\.("NQC4Y=,CB/:\!'W,=.8^2UO!)0&Q@!.S7LH.XUP*4;]S&H=!1LUI]F
M[<0%CX2"Q#!G;/DGL<P(8KHE;R"J,*/GNL.!"[9<2"!9&9_^(TMNAAG>4/R!
M-\N=X3+;3%<^D?@A!XM_<T=K9(V6KLNN6*Q+C43_9WS)(V_SIEL8.'(QDRY1
M4^]]I=BDC8MRP4S1[F5Y.IS_::FU]#K#Q4XE>*&,T"Y;.FMPL&6XDV3#MLQR
M18;T%C>$9Y?!2M:H9B?^TM6$( <[C^9^<M]Q40WLWR5&\R:+(2^7-P$V&WFI
MVJS=1(&O\2S5,%XL+L(,/F0,M6S$A"V"9];9UW6*_6EZ?KUM&'_>HMGK5GK'
MJ+Z<:]>&R1BCR!115K#I,0B=?D>&/_8BA7Z1$5(G];6CDG1(RO:3V,1HE!X+
M/ %3#-H\%V^@MAR<L-V0)2943R_7*_3>E,42K=?6L![8(15<5%8H!X'\G.D$
M_[NNK\!8:(>,=@1XR2AIP95(N)0T%*=9C*)0CRF6.0O2B)]L-E0Q1PZ,V@R%
MSD[/XIU2HO_%;A[B'JKB?NA6&_%65UHA31V Z1)_LS=2*+J_ER!D!YUHJN(.
M)@N&3(EHKXJ'/#&[=^%FCT!/0T,7I^8T>F'BD:[*E(&:Q5)\S1@3O[IW7=H.
M]YZ='/T>H50'SV[1J)MVX.1P[_CI=A/ZT@"MX_L0H'6C)?6>K"?;Q!9]JTU@
MAP]B*0O#KENH;[+DK$*"-E2UA] IO&H,6@S.2_6!:3-LG4VG]R]J= "E 90&
M4+HA*'4B$)G"0*ACEUN@*Y<4K<5-*,E^U&K979?Q# WL"Q"4M+?>BAS9N+WA
MS'1.>+2V=]F\>L5(UVBJ!KQDY=J;]*Z=D\1DE: $<.0'M93)0="K0S-![IJ9
M-R;=.V]X%*UUU-Y5^!;E4] BCH[WHT2MC+C>Q<KM]ESJGC1<%B!O9\Z*PP%3
MF7;YFCA L)2UE=#G^1RKT-M7-JE!B'6!-VX4_PA:-(834! /&@P&3C-PFH'3
M#)QF:T[C5/EF\,I2C!;]UA%D%=90SP;'Y:Q ?9\M$%\J_ [A*"]/AG"4H2#4
MP-<&OC;PM<_3H'SP#044W=RP U+U7)=3ZR\4D;T9I&X5H-#Y5:YI:T[-&;DL
M$AL<$RARS00<^=1H^HT!\>6<W1_HS$Q+S1[C5M1^\_= 3[LA7QZ@<8#& 1KO
M.#0ZGV"OK)_FT41=%:7%I-X<'^M9Q!\:=JEP!!]Z11$K)5>17<"#:6,1RV _
M*?O C^$M4]:O[U( P[@0MN!SQ 3A(LRD9@>N'X&[$5]OW]IHO$(/HRQWH<H>
M&]N(TP4W&HH8Y V-$)J$1M<D9-+;'(6!I..ZXF9YZ.''6--B)&DM;H$= 2VP
M\: A<;H?;%R1X9A)C=Y4F&>IKW1>TP8:&#93I=^#P=HTL)Z!]0RL9YO28 "3
MU/[$$+*5.M=+10!::CC L<2UD21+_533*^UO,.X.T[J% )!,3Q+M2& \<FG@
M%)&B);[<Q_RYL)$!P@8(&R!L@+!M.BV(W,DB)<;&BCQM57DK'_'7K2RBCBAC
MBG[;(':["%@;CLQ-@6U8:^,I&*H'0TX+V."<'(@N%VB N 'B!H@;(.X&$,<!
MRH WB29/FK&!R=@U)M%ADB2E'G"5FZ*\#(I38?P#W. ,EPX=]30UF?L:%5)Y
MJM@$TC*NYVC,C-LEIP?LNATH,V#7@%VW%KNLP6O-S@7 PW8WS%V&30AM9YNE
MJM_J9.KBS]12E<D 3 ,P#< T -/V7I=)H+I5ZA.G6:)EWQBQ8V4J3V!&B9.@
M!(NP,)/[*Y[!0KDL5IIP*41)GY5*;-9IX%)8Q8>!85FEF:4+JWGZ"%ON\T%N
MZMY4.%MHI*2$KXW^!'HZI<))VCYGQU'V'8V2%)R/E^:2 );F9!2T*:]85-#7
M\:[-6E2P5:G#T%@<J;EFY4M:]/FU9&]<,<KP(2WGC[&NJ 'Y!^0?D'] _JV1
M/^QYTEFDH9F5VU7"B7%SIJX 6;7.(P SK-9I#*R1O=;K)9W$X6&C<W_A.DO4
M^:E1XK51PDY*"??46OD="].Y*A#D\ZFD($2F?>P2><)]AZLP.@'KH.HYKW>*
MCJ,RY896DI+<#E^P/OK28CI>L:GVD51.Y:)'(1\(^T ,K.!V@/; "@96<$M9
M07_H50_P[W@+16<A+BJLMTD8WZ):S=X7(MCM+HZRL<3(NZ+"77*5<XC'C(LK
M/5JOJ=A?WG>N5KZ(WWIMC-$6142Z*X80\Q+-JZBSL$7[6(?Q8+V5,-A.Y8L\
MD5;$*8W **E,QV1"@TA90ARI41 :OVD45<'89FX(@,'-22%=V[ P!]QRL/\7
MNV%5@=JII?6<(K ;16]-NJ$ SY  ]/)@?\@ ND<%:>E1GUO&Z=S6\'Y+-;Q_
MP!K> <:;O>AVMD YWUP&W5?\:?<@"<MV2IESM-A@MQ!;/['4.EIIA6U(&M49
M>ZU!DY [8XE1P$TB-;BNSFEH5V&2^</F$DJ$V6--B1A59@/0 .";X+^.^=*R
M16:"18$U+S+A^H>VW3E ,7XM59HL)U@O5=]1Y374 6]6ZZFKJ8NO!^L4MV;P
M<F,-N+6=4T]+[D<#Q_92VR8Q.ULVFWE(\V[,AQZ$.B/O?2,^NRC;"?W;!6JW
M K0#,VHAS6PPZ\;F\(<O>B^Z:/#IH J_*TM&]:JHP4R80N2%D3Y:(SYE.$^)
MRV=M/EA2G[A?$ABUQ(#?C='_*=N/'>X?/N&R<W_^MEK7E@/VBX4SK$I?K:[5
M4^E@[PF(# P+V-,(L1?XSAM?LI8N#X8#@7>A5FQER>&[*ST?8P@)CG#PU'4\
MDH&BUF3HT,P5]3GJN'U$U]Z!OF<;7]!'C?H'H Z:P-K[:PN=2 N3>@J+:F[/
MR'<5(=T@-<(XY_#D&;YPQ"O!9MIKK%>84&LK&WA-952HVCTL;-0(PYZ4Q9PA
M#-&1?FZ5_2._F#(S'H36,:>?I" ,SXJT8"RQ%<=EC1PD1XZ\4&E0$9D #>9X
MJ7<Y'GP!,)S6<^I6ALR/M>!VJR3'-0+CXH9&>W>=GMY35!8QADU4L]Q$=M^$
M,)S<@'J*L^SZ1F,L(5EQ1R27159O)B)D?#:-*LBL8L;N9I#< T)X XP\240X
MVOBZ[9L*WKO?0GG? 2$X5/)X0F^X^[5>_\Y(6@I<Z]A@B6)U8I!<NP__ED<]
MNONOF%PN5T&-,-JU4DM;*5C@+.P+ J)SSIUL)5?0WG9:S!>D/(4]LQ1(C<M\
M6E+(*/7T:$L36;&,J/C_%;Q(DIGY:BG3#+(^"0#RD _TK8E>36%^9!Y=;X&W
MW:M]:.M\J8 X0&9)BV1D5;UP63.JE*ZOTJ(V&68RZ3).21U#0B-0H%Q)AQ#<
M?9Q,L%;S$OV@$R?#9Y%8,]:^XR^6'IA@)Q2N>VX5F/8I)$2%[VR/X>!0H6$8
M#VAPN X<9JX9^+I U#_HRT#4]B_SZ[A[FL'Q?=(,CK?3#(X/GZQI!AV*P7&G
M8O >]'LGV!_MM_6"S6J!W!P=[9/L<GS7^7:G0G#<SZIO(J*M<>[?3VJ_ZZ_I
M>O%JPSN[Z^+5X/QY>7 P.'^^N?/GE@+%MQ32JS9;OY\B^O'7%-&/OY6(?CR(
MZ-N)Z"?W240_V49$/]H[Z!#1NV3TDTX9_4<]+FM*6N\VWK?FTA+2VW>3J'YR
M-]HSW5Q:/^DTWW?Z-YY]O@%_L-_?49I:,^'W44ZGVG$R&/'O#@>X7LL\N;]:
MYIUYQ7^($?_DGFL(ZSCY!1K"R;?2$$X&#6$+#>&T@*-3YC;L[:*$:6I]]R6'
MCSK+3/0C+*>(?E#YY2AZI^18O#*FB%-7%SO8EJ $C!?*N@X-41YU]40VY'K
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M"U!+ 0(4 Q0    ( ,^-J%:^:'U(C&H& 'V11@ 0              "  0
M  !M8VLM,C R,S S,S$N:'1M4$L! A0#%     @ SXVH5CTE#=+!+P  [A,"
M !               ( !NFH& &UC:RTR,#(S,#,S,2YX<V102P$"% ,4
M" #/C:A6_]_J_0-(  "0_@( %               @ &IF@8 ;6-K+3(P,C,P
M,S,Q7V-A;"YX;6Q02P$"% ,4    " #/C:A6A$!L*?,Y 0"N$0X %
M        @ '>X@8 ;6-K+3(P,C,P,S,Q7V1E9BYX;6Q02P$"% ,4    " #/
MC:A6,-T];/$J  !T+   $P              @ $#'0@ ;6-K+3(P,C,P,S,Q
M7V<Q+FIP9U!+ 0(4 Q0    ( ,^-J%:_3UTCA0H! ).5 0 3
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M,RYH=&U02P$"% ,4    " #/C:A6#APZ]P0$   :#   &0
M@ & 4PT ;6-K7V5X:&EB:70R,W@S,S$R,#(S+FAT;5!+ 0(4 Q0    ( ,^-
MJ%9X6.WX9P@  (0H   :              "  ;M7#0!M8VM?97AH:6)I=#,Q
M,7@S,S$R,#(S+FAT;5!+ 0(4 Q0    ( ,^-J%:_Q8%9=@@  )(H   :
M          "  5I@#0!M8VM?97AH:6)I=#,Q,G@S,S$R,#(S+FAT;5!+ 0(4
M Q0    ( ,^-J%8:([DH,08  $LD   9              "  0AI#0!M8VM?
M97AH:6)I=#,R>#,S,3(P,C,N:'1M4$L! A0#%     @ SXVH5MF"@#";,0
M'Z@! !H              ( !<&\- &UC:U]E>&AI8FET-#$U>#,S,3(P,C,N
9:'1M4$L%!@     .  X LP,  $.A#0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
